PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Riemann, L; Beqiri, E; Smielewski, P; Czosnyka, M; Stocchetti, N; Sakowitz, O; Zweckberger, K; Unterberg, A; Younsi, A				Riemann, Lennart; Beqiri, Erta; Smielewski, Peter; Czosnyka, Marek; Stocchetti, Nino; Sakowitz, Oliver; Zweckberger, Klaus; Unterberg, Andreas; Younsi, Alexander		CENTER-TBI High Resolution ICU	Low-resolution pressure reactivity index and its derived optimal cerebral perfusion pressure in adult traumatic brain injury: a CENTER-TBI study	CRITICAL CARE			English	Article						Cerebral autoregulation; Cerebrovascular reactivity; Cerebral perfusion pressure; CPPopt; Traumatic brain injury	INTRACRANIAL-PRESSURE; CEREBROVASCULAR REACTIVITY; MANAGEMENT	BackgroundAfter traumatic brain injury (TBI), brain tissue can be further damaged when cerebral autoregulation is impaired. Managing cerebral perfusion pressure (CPP) according to computed "optimal CPP" values based on cerebrovascular reactivity indices might contribute to preventing such secondary injuries. In this study, we examined the discriminative value of a low-resolution long pressure reactivity index (LPRx) and its derived "optimal CPP" in comparison to the well-established high-resolution pressure reactivity index (PRx).MethodsUsing the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study dataset, the association of LPRx (correlation between 1-min averages of intracranial pressure and arterial blood pressure over a moving time frame of 20min) and PRx (correlation between 10-s averages of intracranial pressure and arterial blood pressure over a moving time frame of 5min) to outcome was assessed and compared using univariate and multivariate regression analysis. "Optimal CPP" values were calculated using a multi-window algorithm that was based on either LPRx or PRx, and their discriminative ability was compared.ResultsLPRx and PRx were both significant predictors of mortality in univariate and multivariate regression analysis, but PRx displayed a higher discriminative ability. Similarly, deviations of actual CPP from "optimal CPP" values calculated from each index were significantly associated with outcome in univariate and multivariate analysis. "Optimal CPP" based on PRx, however, trended towards more precise predictions.ConclusionsLPRx and its derived "optimal CPP" which are based on low-resolution data were significantly associated with outcome after TBI. However, they did not reach the discriminative ability of the high-resolution PRx and its derived "optimal CPP." Nevertheless, LPRx might still be an interesting tool to assess cerebrovascular reactivity in centers without high-resolution signal monitoring.Trial registrationClinicalTrials.gov Identifier: NCT02210221. First submitted July 29, 2014. First posted August 6, 2014.	[Riemann, Lennart; Zweckberger, Klaus; Unterberg, Andreas; Younsi, Alexander] Heidelberg Univ Hosp, Dept Neurosurg, INF 400, D-69120 Heidelberg, Germany; [Riemann, Lennart; Beqiri, Erta; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge, England; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Sakowitz, Oliver] Klinikum Ludwigsburg, Dept Neurosurg, Ludwigsburg, Germany		Younsi, A (corresponding author), Heidelberg Univ Hosp, Dept Neurosurg, INF 400, D-69120 Heidelberg, Germany.	alexander.younsi@med.uni-heidelberg.de	Sahuquillo, Juan/B-3577-2008; Younsi, Alexander/AAW-7869-2020; Moller, Kirsten/A-4751-2009; Raj, Rahul/K-7693-2012	Sahuquillo, Juan/0000-0003-0713-5875; Younsi, Alexander/0000-0002-8218-9243; Kondziella, Daniel/0000-0001-5562-9808; Moller, Kirsten/0000-0003-3058-1072; Radoi, Andreea/0000-0002-0677-3544; Raj, Rahul/0000-0003-4243-9591; Sakowitz, Oliver/0000-0003-3248-6335	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), OneMind (USA), and Integra LifeSciences Corporation (USA).	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Lang EW, 2015, J NEUROSURG, V122, P588, DOI 10.3171/2014.10.JNS14602; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; R Core Team, 2018, STATS PACK LANG ENV; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	25	3	4	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	MAY 26	2020	24	1								10.1186/s13054-020-02974-8			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY0ZF	WOS:000540251500012	32456684	Green Published, gold			2022-02-06	
J	Edwards, KA; Gill, JM; Pattinson, C; Lai, C; Briere, M; Rogers, NJ; Milhorn, D; Elliot, J; Carr, W				Edwards, Katie A.; Gill, Jessica M.; Pattinson, Cassandra; Lai, Chen; Briere, Misha; Rogers, Nicholas J.; Milhorn, Denise; Elliot, Jonathan; Carr, Walter			Interleukin-6 is associated with acute concussion in military combat personnel	BMC NEUROLOGY			English	Article						Inflammatory cytokines; Concussion; Biomarkers	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; TEMPORAL PROFILES; BLAST EXPOSURE; MODERATE; IL-6; BIOMARKER; STRESS	Background: Concussion is the most common type of TBI, yet reliable objective measures related to these injuries and associated recovery processes remain elusive, especially in military personnel. The purpose of this study was to characterize the relationship between cytokines and recovery from acute brain injury in active duty service members. Inflammatory cytokines (IL-6, IL-10, and TNF alpha) were measured acutely in blood samples within 8h following a medically diagnosed concussion and then 24h later. Methods: Participants (n = 94) were categorized into two groups: 1) military personnel who sustained provider-diagnosed concussion, without other major medical diagnosis (n=45) and 2) healthy control participants in the same deployment environment who did not sustain concussion or other illness or injuries (n = 49). IL-6, IL-10, and TNF alpha concentrations were measured using an ultrasensitive single-molecule enzyme-linked immunosorbent assay. Differences in cytokine levels between concussed and healthy groups were evaluated at two time points (time point 1 <= 8h after injury; time point 2=24h following time point 1). Results: At time point 1, IL-6 median (IQR) concentrations were 2.62 (3.62) in the concussed group, which was greater compared to IL-6 in the healthy control group (1.03 (0.90); U=420.00, z=-5.12, p < 0.001). Compared to healthy controls, the concussed group did not differ at time point 1 in IL-10 or TNF alpha concentrations (p's > 0.05). At time point 2, no differences were detected between concussed and healthy controls for IL-6, IL-10, or TNF alpha (p's > 0.05). The median difference between time points 1 and 2 were compared between the concussed and healthy control groups for IL-6, IL-10, and TNF alpha. Change in IL-6 across time was greater for the concussed group than healthy control (-1.54 (3.12); U=315.00, z=-5.96, p < 0.001), with no differences between groups in the change of IL-10 or TNF alpha (p's > 0.05). Conclusion: Reported here is a significant elevation of IL-6 levels in concussed military personnel less than 8h following injury. Future studies may examine acute and chronic neurological symptomology associated with inflammatory cytokine levels, distinguish individuals at high risk for developing neurological complications, and identify underlying biological pathways to mitigate inflammation and improve outcomes.	[Edwards, Katie A.; Gill, Jessica M.; Pattinson, Cassandra; Lai, Chen] NINR, NIH, 3 Ctr Dr,Bldg 3,Room 26E, Bethesda, MD 20892 USA; [Edwards, Katie A.] Henry M Jackson Fdn Adv Mil Med, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [Gill, Jessica M.] Uniformed Serv Univ Hlth Sci, CNRM Codirector Biomarkers Core, Bethesda, MD 20814 USA; [Briere, Misha] Joint Base McGuire Dix Lakehurst, Med Grp87, 3458 Neely Rd, Trenton, NJ 08641 USA; [Rogers, Nicholas J.; Milhorn, Denise] US Army, Res Inst Environm Med, 10 Gen Greene Ave, Natick, MA 01760 USA; [Elliot, Jonathan] USS Gerald R Ford CVN78, FPO, AE, Norfolk, VA USA; [Carr, Walter] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Carr, Walter] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Edwards, KA (corresponding author), NINR, NIH, 3 Ctr Dr,Bldg 3,Room 26E, Bethesda, MD 20892 USA.	katie.edwards@nih.gov	Pattinson, Cassandra/AAY-5974-2020; Pattinson, Cassandra/A-5543-2019	Edwards, Katie/0000-0002-7682-8598; Pattinson, Cassandra/0000-0002-5975-7935	National Institute of Nursing Research (NINR) Intramural Program; US Army Medical Research and Development Command (USAMRDC)	This work was supported by the National Institute of Nursing Research (NINR) Intramural Program and the US Army Medical Research and Development Command (USAMRDC). NINR support was responsible for analysis, interpretation of data, and writing the manuscript. USAMRDC support was responsible for all aspects of this work, design of the study, collection, analysis, interpretation of data, and writing the manuscript. While producing this article, KAE was supported as a Jonas Nurse Leader Scholar. WC was supported in part by an appointment to the Research Participation Program at the Walter Reed Army Institute of Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAMRDC.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Conaton E, 2012, DOD POLICY GUIDANCE; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Prieto DA, 2008, EXPERT REV PROTEOMIC, V5, P283, DOI 10.1586/14789450.5.2.283; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Zou RY, 2017, INFLAMMATION, V40, P100, DOI 10.1007/s10753-016-0457-5	48	3	3	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	MAY 25	2020	20	1								10.1186/s12883-020-01760-x			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LU4DE	WOS:000537706900004	32450801	Green Published, gold			2022-02-06	
J	Lancioni, GE; Singh, NN; O'Reilly, MF; Sigafoos, J; D'Amico, F; Buonocunto, F; Lanzilotti, C; Alberti, G; Navarro, J				Lancioni, Giulio E.; Singh, Nirbhay N.; O'Reilly, Mark F.; Sigafoos, Jeff; D'Amico, Fiora; Buonocunto, Francesca; Lanzilotti, Crocefissa; Alberti, Gloria; Navarro, Jorge			Mainstream technology to support basic communication and leisure in people with neurological disorders, motor impairment and lack of speech	BRAIN INJURY			English	Article						Neurological disorders; motor impairment; communication; leisure; smartphone; tablet	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ASSISTIVE TECHNOLOGY; SOCIAL VALIDATION; DISABILITY; CHILDREN; REHABILITATION; INDIVIDUALS; UNHAPPINESS	Objective To assess a simple technology solution to support basic communication and leisure in people with neurological disorders, extensive motor impairment, and absence of speech. Design The design was a non-concurrent multiple baseline across participants. Methods The study included eight participants and assessed a technology setup including a Samsung Galaxy Tab S2 LTE tablet and a Samsung Galaxy A3 smartphone. The smartphone, automated via MacroDroid, presented the participant with leisure, messages, and caregiver options. Choosing leisure or messages (by activating the smartphone's proximity sensor) led the smartphone to present the alternatives available for that option and eventually verbalize the alternative selected. This verbalization triggered the tablet's Google Assistant and led the tablet to present a leisure event or start a message exchange. Choosing the caregiver led the smartphone to invite the caregiver to interact with the participant. Results During baseline (i.e., when a standard smartphone was available), the participants did not activate any of the options. During intervention and post-intervention (i.e., with the technology described above), participants activated all options and spent most of the session time positively engaged with them. Conclusions The aforementioned technology seems to be a useful tool for individuals like those involved in this study.	[Lancioni, Giulio E.] Univ Bari, Dept Neurosci & Sense Organs, Corso Italia 23, I-70121 Bari, Italy; [Singh, Nirbhay N.] Augusta Univ, Med Coll Georgia, Augusta, GA USA; [O'Reilly, Mark F.] Univ Texas Austin, Dept Special Educ, Austin, TX 78712 USA; [Sigafoos, Jeff] Victoria Univ Wellington, Sch Educ, Wellington, New Zealand; [D'Amico, Fiora] Silver House Hlth & Care Serv, Bari, Italy; [Buonocunto, Francesca; Lanzilotti, Crocefissa] S Raffaele Rehabil Ctr, Ceglie, Italy; [Buonocunto, Francesca] INDICA Assoc, Ceglie, Italy; [Alberti, Gloria] Lega F DOro Res Ctr, Osimo, Italy; [Navarro, Jorge] Don Carlo Gnocchi IRCCS, Milan, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Corso Italia 23, I-70121 Bari, Italy.	giulio.lancioni@uniba.it					Anderlini D, 2019, NEUROREHAB NEURAL RE, V33, P167, DOI 10.1177/1545968319829454; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Basilakos A, 2018, SEMIN SPEECH LANG, V39, P25, DOI 10.1055/s-0037-1608853; Borgestig M, 2017, DEV NEUROREHABIL, V20, P129, DOI 10.3109/17518423.2015.1132281; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Buchholz M, 2013, TECHNOL DISABIL, V25, P87, DOI [10.3233/TAD-130370, DOI 10.3233/TAD-130370]; Caligari M, 2013, AMYOTROPH LAT SCL FR, V14, P546, DOI 10.3109/21678421.2013.803576; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Campbell SM, 2017, KENNEDY INST ETHIC J, V27, P151, DOI 10.1353/ken.2017.0014; D'amico F, 2019, EUR J PHYS REHAB MED, V55, P682, DOI 10.23736/S1973-9087.18.05521-1; Dahan-Oliel N, 2012, QUAL LIFE RES, V21, P427, DOI 10.1007/s11136-011-0063-9; Darcy S, 2017, DISABIL REHABIL-ASSI, V12, P341, DOI 10.3109/17483107.2016.1167260; Desmond D, 2018, DISABIL REHABIL-ASSI, V13, P437, DOI 10.1080/17483107.2018.1471169; Dillon CM, 2007, BEHAV INTERVENT, V22, P229, DOI 10.1002/bin.240; Feenaughty L, 2018, AM J SPEECH-LANG PAT, V27, P1051, DOI 10.1044/2018_AJSLP-17-0174; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Hagen C, 1998, LEVELS COGNITIVE FUN; Holmqvist E, 2018, ASSIST TECHNOL, V30, P201, DOI 10.1080/10400435.2017.1307882; Hwang CS, 2014, J MOTOR BEHAV, V46, P233, DOI 10.1080/00222895.2014.891970; Kazdin AE., 2011, SINGLE CASE RES DESI; Lancioni GE, 2014, AUT CHILD PSYCHO, P1, DOI 10.1007/978-1-4899-8029-8; Lancioni GE, 2016, INT J DISABI HUM DEV, DOI [10.1515/ijdhd-2016-0022, DOI 10.1515/IJDHD-2016-0022]; Lancioni GE, 2020, DISABIL REHABIL-ASSI, V15, P14, DOI 10.1080/17483107.2018.1508515; Lancioni GE, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00234; Lancioni GE, 2015, PERCEPT MOTOR SKILL, V121, P621, DOI 10.2466/15.PMS.121c19x1; Lancioni GE, 2015, NEUROREHABILITATION, V36, P355, DOI 10.3233/NRE-151224; Lenker JA, 2013, DISABIL REHABIL-ASSI, V8, P373, DOI 10.3109/17483107.2012.749429; Luiselli JK, 2010, BEHAV MODIF, V34, P403, DOI 10.1177/0145445510383526; Lyons EJ, 2015, GAMES HEALTH J, V4, P12, DOI 10.1089/g4h.2014.0072; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Makel MC, 2014, EDUC RESEARCHER, V43, P304, DOI 10.3102/0013189X14545513; Parsons MB, 2012, BEHAV ANAL PRACT, V5, P15; Pereira S, 2012, TOP STROKE REHABIL, V19, P122, DOI 10.1310/tsr1902-122; Pierce WD., 2008, BEHAV ANAL LEARNING, V(4th ed.).; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Sharpe B, 2016, APPL NURS RES, V30, P228, DOI 10.1016/j.apnr.2015.11.012; Shklovsky VM, 2016, PSYCH J, V5, P48, DOI 10.1002/pchj.127; Siegel S., 1988, NONPARAMETRIC STAT; Smith RO, 2018, DISABIL REHABIL-ASSI, V13, P473, DOI 10.1080/17483107.2018.1473895; Spataro R, 2014, ACTA NEUROL SCAND, V130, P40, DOI 10.1111/ane.12214; Stasolla F, 2015, COGN PROCESS, V16, P69, DOI 10.1007/s10339-014-0625-1; Tough H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4308-6	42	3	3	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 6	2020	34	7					921	927		10.1080/02699052.2020.1763462		MAY 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MI1BE	WOS:000539149300001	32442386				2022-02-06	
J	Sweeney, EA; Wilson, JC; Potter, MN; Dahab, KS; Denay, KL; Howell, DR				Sweeney, Emily A.; Wilson, Julie C.; Potter, Morgan N.; Dahab, Katherine S.; Denay, Keri L.; Howell, David R.			Symptom profiles and postural control after concussion in female artistic athletes	BRAIN INJURY			English	Article						Concussion; balance; head injury; gymnast; cheerleader	SPORT-RELATED CONCUSSION; HIGH-SCHOOL SPORTS; EMERGENCY-DEPARTMENTS; INJURIES; BALANCE; RECOVERY; CHILDREN; DURATION; EPIDEMIOLOGY; SYSTEM	Objectives The purpose of our investigation was to compare post-concussion symptom profiles and postural control measures among female youth artistic athletes (gymnasts and cheerleaders) relative to female ball sport athletes (volleyball or basketball). Methods/Findings We compared 27 artistic athletes (median age = 15.0 years; evaluated median = 13 days post-injury) and 49 ball sport athletes (median age = 15.3 years; evaluated median = 10 days post-injury) within 21 days of sustaining a concussion on measures of symptom profiles and postural control (Balance Error Scoring System [BESS]), tandem gait, and Romberg tests. After adjusting for the independent effect of time from injury-evaluation, concussion history, and pre-morbid migraine history, we observed that artistic athletes performed the BESS tandem stance foam condition with fewer errors than ball sport athletes (beta = -2.4; 95% CI = -4.7, -0.2;p= .03). Artistic athletes demonstrated a higher, yet not statistically significant, headache severity than ball sport athletes (median = 4.5 vs 4.0,p= .07). Conclusions Overall, artistic athletes had similar symptom profiles to ball sport athletes. Postural control measures, other than the BESS tandem stance foam condition, were not significantly different from ball sport athletes. This suggests that although their sports may require higher levels of balance, artistic athletes' performance on post-concussion balance tests may be similar to athletes of other disciplines.	[Sweeney, Emily A.; Wilson, Julie C.; Dahab, Katherine S.; Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Sweeney, Emily A.; Wilson, Julie C.; Dahab, Katherine S.; Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Potter, Morgan N.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Denay, Keri L.] Univ Michigan, Sch Med, Dept Family Med, Ann Arbor, MI USA		Sweeney, EA (corresponding author), Childrens Hosp Colorado, 13123 E 16th Ave,Box 060, Aurora, CO 80045 USA.	Emily.Sweeney@childrenscolorado.org					Ambegaonkar JP, 2013, RES Q EXERCISE SPORT, V84, P24, DOI 10.1080/02701367.2013.762287; Associations NFoSHS, 2019, PART STAT 2019; Associations TNFoSHS, 2019, 2018 19 HIGH SCH ATH; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Currie DW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2447; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Howell DR, 2019, J NEUROSURG-PEDIATR, V24, P54, DOI 10.3171/2018.11.PEDS18626; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Naiyer N, 2017, CLIN PEDIATR, V56, P985, DOI 10.1177/0009922817702938; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Kane JW, 2011, CLIN J SPORT MED, V21, P486, DOI 10.1097/JSM.0b013e31822e89a8; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pluhar E, 2019, J SPORT SCI MED, V18, P490; Ranganathan Priya, 2017, Perspect Clin Res, V8, P148, DOI 10.4103/picr.PICR_87_17; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; SANDS WA, 1993, AM J SPORT MED, V21, P271, DOI 10.1177/036354659302100218; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Singh S, 2008, PEDIATRICS, V121, pE954, DOI 10.1542/peds.2007-0767; Thomas R, 2018, PALGR CRIT UNIV STUD, P1, DOI [10.1007/978-3-319-95723-4_1, 10.1080/00913847.2018.1527646]; Tirabassi J, 2016, AM J SPORT MED, V44, P2925, DOI 10.1177/0363546516644604; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	42	3	3	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 6	2020	34	7					928	933		10.1080/02699052.2020.1763464		MAY 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MI1BE	WOS:000539149100001	32442387				2022-02-06	
J	Solla, DJF; de Amorim, RLO; Kolias, AG; Hutchinson, PJ; de Andrade, AF; Teixeira, MJ; Paiva, WS				Fontoura Solla, Davi J.; Oliveira de Amorim, Robson Luis; Kolias, Angelos G.; Hutchinson, Peter J.; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Incremental Prognostic Value of Coagulopathy in Addition to the Crash Score in Traumatic Brain Injury Patients	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Coagulopathy; Prognosis; Prognostic score; Mortality		Background/objective Multivariable prognostic scores play an important role for clinical decision-making, information giving to patients/relatives, benchmarking and guiding clinical trial design. Coagulopathy has been implicated on trauma and critical care outcomes, but few studies have evaluated its role on traumatic brain injury (TBI) outcomes. Our objective was to verify the incremental prognostic value of routine coagulopathy parameters in addition to the CRASH-CT score to predict 14-day mortality in TBI patients. Methods This is a prospective cohort of consecutive TBI patients admitted to a tertiary university hospital Trauma intensive care unit (ICU) from March/2012 to January/2015. The prognostic performance of the coagulation parameters platelet count, prothrombin time (international normalized ratio, INR) and activated partial thromboplastin time (aPTT) ratio was assessed through logistic regression adjusted for the original CRASH-CT score. A new model, CRASH-CT-Coag, was created and its calibration (Brier scores and Hosmer-Lemeshow (H-L) test), discrimination [area under the receiver operating characteristic curve (AUC-ROC) and the integrated discrimination improvement (IDI)] and clinical utility (net reclassification index) were compared to the original CRASH-CT score. Results A total 517 patients were included (median age 39 years, 85.1% male, median admission glasgow coma scale 8, neurosurgery on 44.9%). The 14-day mortality observed and predicted by the original CRASH-CT was 22.8% and 26.2%, respectively. Platelet count < 100,000/mm(3), INR > 1.2 and aPTT ratio > 1.2 were present on 11.3%, 65.0% and 27.2%, respectively, (at least one of these was altered on 70.6%). All three variables maintained statistical significance after adjustment for the CRASH-CT score. The CRASH-CT-Coag score outperformed the original score on calibration (brier scores 0.122 +/- 0.216 vs 0.132 +/- 0.202, mean difference 0.010, 95% CI 0.005-0.019, p = 0.036, respectively) and discrimination (AUC-ROC 0.854 +/- 0.020 vs 0.813 +/- 0.024, p = 0.014; IDI 5.0%, 95% CI 1.3-11.0%). Both scores showed the satisfactory H-L test results. The net reclassification index favored the new model. Considering the strata of low (< 10%), moderate (10-30%) and high (> 30%) risk of death, the CRASH-CT-Coag model yielded a global net correct reclassification of 22.9% (95% CI 3.8-43.4%). Conclusions The addition of early markers of coagulopathy-platelet count, INR and aPTT ratio-to the CRASH-CT score increased its accuracy. Additional studies are required to externally validate this finding and further investigate the coagulopathy role on TBI outcomes.	[Fontoura Solla, Davi J.; Oliveira de Amorim, Robson Luis; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Div Neurosurg, Dept Neurol, Hosp Clin,Fac Med, Dr Eneas Carvalho Aguiar Ave 255, BR-05403000 Sao Paulo, Brazil; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Fontoura Solla, Davi J.; Kolias, Angelos G.; Hutchinson, Peter J.; Paiva, Wellingson Silva] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England		Solla, DJF (corresponding author), Univ Sao Paulo, Div Neurosurg, Dept Neurol, Hosp Clin,Fac Med, Dr Eneas Carvalho Aguiar Ave 255, BR-05403000 Sao Paulo, Brazil.; Solla, DJF (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	davisolla@hotmail.com	Amorim, Robson/AAK-1368-2021; Solla, Davi/E-6988-2013	Amorim, Robson/0000-0003-2391-7519; Solla, Davi/0000-0002-5092-6595; Kolias, Angelos/0000-0003-3992-0587	National Council for Scientific and Technological Development (CNPq), BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); NIHR Global Health Research Group on Neurotrauma; UK aid from the UK GovernmentCGIAR [16/137/105]; School of Clinical Medicine, University of CambridgeUniversity of Cambridge; Royal College of Surgeons of England; NIHRNational Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); European Union Seventh Framework Program grant (CENTER-TBI) [602150]	This research was partially funded by the National Council for Scientific and Technological Development (CNPq), Brazil. Drs Solla, Kolias, Hutchinson and Paiva are supported by the NIHR Global Health Research Group on Neurotrauma, which was commissioned by the National Institute for Health Research (NIHR) using UK aid from the UK Government (project 16/137/105). The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Angelos Kolias is supported by a Clinical Lectureship, School of Clinical Medicine, University of Cambridge and the Royal College of Surgeons of England. Peter Hutchinson is supported by a Research Professorship from the NIHR, the NIHR Cambridge Biomedical Research Centre, a European Union Seventh Framework Program grant (CENTER-TBI; grant no. 602150), and the Royal College of Surgeons of England.	Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0	16	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2021	34	1					130	138		10.1007/s12028-020-00991-7		MAY 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QT6MJ	WOS:000534853100001	32445108	Green Published, Green Submitted, hybrid			2022-02-06	
J	Snyder, J; Zenone, M; Crooks, V; Schuurman, N				Snyder, Jeremy; Zenone, Marco; Crooks, Valorie; Schuurman, Nadine			What Medical Crowdfunding Campaigns Can Tell Us About Local Health System Gaps and Deficiencies: Exploratory Analysis of British Columbia, Canada	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						crowdfunding; exploratory analysis; Canada; health system	OF-POCKET COSTS; CARE; PRIVATE; ONTARIO; CANCER	Background: There are a range of perceived gaps and shortcomings in the publicly funded Canadian health system. These include wait times for care, lack of public insurance coverage for dental care and pharmaceuticals, and difficulties accessing specialist care. Medical crowdfunding is a response to these gaps where individuals raise funds from their social networks to address health-related needs. Objective: This study aimed to investigate the potential of crowdfunding data to better understand what health-related needs individuals are using crowdfunding for, how these needs compare with the existing commentary on health system deficiencies, and the advantages and limitations of using crowdfunding campaigns to enhance or augment our understanding of perceived health system deficiencies. Methods: Crowdfunding campaigns were scraped from the GoFundMe website. These campaigns were then limited to those originating in the metropolitan Vancouver region of two health authorities during 2018. These campaigns were then further limited to those raising funds to allow the treatment of a medical problem or related to needs arising from ill health. These campaigns were then reviewed to identify the underlying health issue and motivation for pursuing crowdfunding. Results: We identified 423 campaigns for health-related needs. These campaigns requested CAD $8,715,806 (US $6,088,078) in funding and were pledged CAD $3,477,384 (US $2,428,987) from 27,773 donors. The most common underlying medical condition for campaign recipients was cancer, followed by traumatic injuries from collisions and brain injury and stroke. By far, the most common factor of motivation for crowdfunding was seeking financial support for wages lost because of illness (232/684, 33.9%). Some campaigns (65/684, 9.5%) sought help with purchasing medical equipment and supplies; 8.2% (56/684) sought to fund complementary, alternative, or unproven treatments including experimental interventions; 7.2% (49/684) sought financial support to cover travel-related costs, including in-province and out-of-province (49/684, 7.2%) travel; and 6.3% (43/684) campaigns sought help to pay for medication. Conclusions: This analysis demonstrates the potential of crowdfunding data to present timely and context-specific user-created insights into the perceived health-related financial needs of some Canadians. Although the literature on perceived limitations of the Canadian health system focuses on wait times for care and limited access to specialist services, among other issues, these campaigners were much more motivated by gaps in the wider social system such as costs related to unpaid time off work and travel to access care. Our findings demonstrate spatial differences in the underlying medical problems, motivations for crowdfunding, and success using crowdfunding that warrants additional attention. These differences may support established concerns that medical crowdfunding is most commonly used by individuals from relatively privileged socioeconomic backgrounds. We encourage the development of new resources to harness the power of crowdfunding data as a supplementary source of information for Canadian health system stakeholders.	[Snyder, Jeremy; Zenone, Marco] Simon Fraser Univ, Fac Hlth Sci, Blusson Hall,Room 11300,8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Crooks, Valorie; Schuurman, Nadine] Simon Fraser Univ, Dept Geog, Burnaby, BC, Canada		Snyder, J (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Blusson Hall,Room 11300,8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jcs12@sfu.ca		Crooks, Valorie/0000-0002-2834-0213; Snyder, Jeremy/0000-0002-8236-2923			Canadian Institute for Health Information, 2019, WAIT TIM PRIOR PROC; Canadian Institute for Health Information, CIHI WAIT TIMES; Coyte PC, 2000, CAN J NURS RES, V33, P11, DOI [10.1016/j.healthpol.2011.08.015, DOI 10.1016/J.HEALTHPOL.2011.08.015]; Crooks VA, 2011, CAN FAM PHYSICIAN, V57, P527; Daw JR, 2012, HEALTH POLICY, V104, P19, DOI 10.1016/j.healthpol.2011.08.015; Flood CM, 2018, UNIVERSAL PHARMACARE; Harris A., 2017, FAST CO; Heller N, 2019, NEW YORKER; Johnston G, 2020, SOCIOL INQ, V90, P123, DOI 10.1111/soin.12269; Johnston R, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-23; Kenworthy N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229760; Kirkey Sharon, 2019, NATL POST; Law MR, 2013, HEALTH POLICY, V110, P141, DOI 10.1016/j.healthpol.2013.01.014; Longo CJ, 2007, EUR J CANCER CARE, V16, P500, DOI 10.1111/j.1365-2354.2007.00783.x; Longo CJ, 2011, CURR ONCOL, V18, pE1; Marchildon GP, 2013, HEALT SYST TRANSIT, V15, P1; Martin D, 2018, LANCET, V391, P1718, DOI 10.1016/S0140-6736(18)30181-8; Ministry of Citizens Services, PROV BRIT COL GOV BC; Obembe AO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192911; Office of the Provincial Health Officer, 2019, TAK PULS POP UPD HLT; Palley HA, 2011, INT POLIT SCI REV, V32, P79, DOI 10.1177/0192512110385291; Robinson M., 2019, VANCOUVER SUN; Simpson C, 2017, CONVERSATION; Snyder J, 2017, J MED ETHICS, V43, P364, DOI 10.1136/medethics-2016-103933; Steinbrook R, 2006, NEW ENGL J MED, V354, P1661, DOI 10.1056/NEJMp068064; Valle V.M., 2016, NORTEAMERICA, V11, P193, DOI [10.20999/nam.2016.b008, DOI 10.20999/NAM.2016.B008]; VANDENHOUTEN MML, 2019, BMJ OPEN, V9, DOI DOI 10.1136/BMJOPEN-2018-026365; Vox F, 2018, JAMA-J AM MED ASSOC, V320, P1705, DOI 10.1001/jama.2018.10264; [No title captured]	29	3	3	3	9	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	MAY 22	2020	22	5							e16982	10.2196/16982			9	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	LQ6VC	WOS:000535138400001	32348269	gold, Green Submitted, Green Published			2022-02-06	
J	Roll, L; Eysel, UT; Faissner, A				Roll, Lars; Eysel, Ulf T.; Faissner, Andreas			Laser Lesion in the Mouse Visual Cortex Induces a Stem Cell Niche-Like Extracellular Matrix, Produced by Immature Astrocytes	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						astrocyte; chondroitin sulfate; cortical plasticity; extracellular matrix; neural stem cell; niche; regeneration; tenascin	TENASCIN-C; NEURITE OUTGROWTH; NEURAL STEM; UP-REGULATION; BRAIN-INJURY; EXPRESSION; GLIA; PROTEOGLYCAN; MOLECULES; PROTEIN	The mammalian central nervous system (CNS) is characterized by a severely limited regeneration capacity. Comparison with lower species like amphibians, which are able to restore even complex tissues after damage, indicates the presence of an inhibitory environment that restricts the cellular response in mammals. In this context, signals provided by the extracellular matrix (ECM) are important regulators of events like cell survival, proliferation, migration, differentiation or neurite outgrowth. Therefore, knowledge of the post-lesional ECM and of cells that produce these factors might support development of new treatment strategies for patients suffering from traumatic brain injury and other types of CNS damage. In the present study, we analyzed the surround of focal infrared laser lesions of the adult mouse visual cortex. This lesion paradigm avoids direct contact with the brain, as the laser beam passes the intact bone. Cell type-specific markers revealed a distinct spatial distribution of different astroglial subtypes in the penumbra after injury. Glial fibrillary acidic protein (GFAP) as marker for reactive astrocytes was found broadly up-regulated, whereas the more immature markers vimentin and nestin were only expressed by a subset of cells. Dividing astrocytes could be identified via the proliferation marker Ki-67. Different ECM molecules, among others the neural stem cell-associated glycoprotein tenascin-C and the DSD-1 chondroitin sulfate epitope, were found on astrocytes in the penumbra. Wisteria floribunda agglutinin (WFA) and aggrecan as markers for perineuronal nets, a specialized ECM limiting synaptic plasticity, appeared normal in the vicinity of the necrotic lesion core. In sum, expression of progenitor markers by astrocyte subpopulations and the identification of proliferating astrocytes in combination with an ECM that contains components typically associated with neural stem/progenitor cells suggest that an immature cell fate is facilitated as response to the injury.	[Roll, Lars; Faissner, Andreas] Ruhr Univ Bochum, Fac Biol & Biotechnol, Dept Cell Morphol & Mol Neurobiol, Bochum, Germany; [Roll, Lars; Eysel, Ulf T.; Faissner, Andreas] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Eysel, Ulf T.] Ruhr Univ Bochum, Fac Med, Dept Neurophysiol, Bochum, Germany		Faissner, A (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Dept Cell Morphol & Mol Neurobiol, Bochum, Germany.; Faissner, A (corresponding author), Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany.	andreas.faissner@rub.de	, 黑麦面包抹着电子元气/AAX-4860-2020; Faissner, Andreas/A-5314-2008	Faissner, Andreas/0000-0002-2211-8259; Eysel, Ulf/0000-0001-6087-957X	German Research Foundation (DFG)German Research Foundation (DFG) [SFB 509, FA 159/16-1, FA 159/23-1]; International Graduate School of Neuroscience of the Ruhr University Bochum (IGSN); German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch Dienst (DAAD)	The study was funded by the German Research Foundation (DFG), SFB 509, FA 159/16-1 and FA 159/23-1 to AF, the International Graduate School of Neuroscience of the Ruhr University Bochum (IGSN) and by the German Academic Exchange Service (DAAD).	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barmashenko G, 2003, BRAIN RES, V990, P120, DOI 10.1016/S0006-8993(03)03447-4; Barmashenko G, 2001, NEUROREPORT, V12, P3023, DOI 10.1097/00001756-200110080-00009; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; Bozzelli PL, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5735789; BRODKEY JA, 1995, J NEUROSURG, V82, P106, DOI 10.3171/jns.1995.82.1.0106; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Czopka T, 2009, CELL TISSUE RES, V338, P161, DOI 10.1007/s00441-009-0868-9; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Deller T, 1997, NEUROSCIENCE, V81, P829, DOI 10.1016/S0306-4522(97)00194-2; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Dobbertin A, 2003, MOL CELL NEUROSCI, V24, P951, DOI 10.1016/S1044-7431(03)00257-4; Dobbertin A, 2010, EXP NEUROL, V225, P60, DOI 10.1016/j.expneurol.2010.04.019; Dohle CI, 2009, EXP BRAIN RES, V199, P423, DOI 10.1007/s00221-009-1964-5; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Eysel UT, 1999, CEREB CORTEX, V9, P101, DOI 10.1093/cercor/9.2.101; Eysel UT, 1999, RESTOR NEUROL NEUROS, V15, P153; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; Faissner A, 2017, MOL CELL NEUROSCI, V81, P22, DOI 10.1016/j.mcn.2016.11.003; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Hayes AJ, 2018, BIOCHEM J, V475, P2511, DOI 10.1042/BCJ20180283; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; Huemmeke M, 2004, J PHYSIOL-LONDON, V559, P875, DOI 10.1113/jphysiol.2004.069534; Kandasamy M, 2017, CELL TISSUE RES, V368, P531, DOI 10.1007/s00441-017-2594-z; Karetko-Sysa M, 2011, EXP NEUROL, V231, P113, DOI 10.1016/j.expneurol.2011.05.022; KIESSLING M, 1990, J NEUROSURG, V73, P909, DOI 10.3171/jns.1990.73.6.0909; Kim SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07394-3; Kim WR, 2012, NEUROSCI LETT, V513, P155, DOI 10.1016/j.neulet.2012.02.023; Lensjo KK, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0379-16.2017; LINDSBERG PJ, 1991, J CEREBR BLOOD F MET, V11, P88, DOI 10.1038/jcbfm.1991.10; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mittmann T, 2001, NEUROREPORT, V12, P3341, DOI 10.1097/00001756-200110290-00039; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Piccinini AM, 2012, CELL REP, V2, P914, DOI 10.1016/j.celrep.2012.09.005; Reinhard J, 2016, INT J BIOCHEM CELL B, V81, P174, DOI 10.1016/j.biocel.2016.05.002; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Roll L, 2019, SEMIN CELL DEV BIOL, V89, P118, DOI 10.1016/j.semcdb.2018.09.012; Roll L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00219; Roll L, 2012, CELL TISSUE RES, V349, P133, DOI 10.1007/s00441-011-1313-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STREIT A, 1990, J NEUROCHEM, V55, P1494, DOI 10.1111/j.1471-4159.1990.tb04931.x; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282	53	3	3	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAY 21	2020	14								102	10.3389/fncel.2020.00102			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW9LB	WOS:000539462000001	32508592	Green Submitted, gold, Green Published			2022-02-06	
J	Tobler-Ammann, BC; Weise, A; Knols, RH; Watson, MJ; Sieben, JM; de Bie, RA; de Bruin, ED				Tobler-Ammann, Bernadette C.; Weise, Andrea; Knols, Ruud H.; Watson, Martin J.; Sieben, Judith M.; de Bie, Rob A.; de Bruin, Eling D.			Patients' experiences of unilateral spatial neglect between stroke onset and discharge from inpatient rehabilitation: a thematic analysis of qualitative interviews	DISABILITY AND REHABILITATION			English	Article						Stroke; unilateral spatial neglect; awareness; rehabilitation; activities of daily living; thematic analysis	RIGHT-HEMISPHERE STROKE; TRAUMATIC BRAIN-INJURY; OCCUPATIONAL-THERAPY; COGNITIVE IMPAIRMENT; HEMISPATIAL NEGLECT; SURVIVORS EXPERIENCES; VISUAL NEGLECT; LESION SITE; UPPER-LIMB; OF-LIFE	Purpose: The purpose of this qualitative study was to explore how stroke patients with unilateral spatial neglect experience; (a) performance in activities of daily living; (b) alterations in bodily perceptions; and (c) personal hopes and expectations, looking at the period between stroke onset and discharge from inpatient rehabilitation. Materials and methods: We conducted individual semi-structured interviews with 7 (5 men, 2 women, mean age 69 years) consecutively sampled participants. All interviews were transcribed verbatim and analyzed using thematic analysis. Findings: Participants' experiences were captured in three over-arching themes: "unawareness of neglect," "emergent awareness for neglect-related difficulties," and "comparing the new life with the old one." Findings showed that participants progressed from initial unawareness to emergent awareness for their neglect-related difficulties over the course of rehabilitation. Comparing their current life situation with the one before their stroke triggered feelings of uncertainty and regret, with associated decreased pleasure in meaningful activities. Conclusions: This study informs health professionals regarding personal experiences of orientation in and reorganization of life of stroke patients with unilateral spatial neglect. The findings highlight that being aware of neglect-related deficits is a prerequisite for using coping strategies and incorporating them in daily life. Possible therapeutic strategies that fit the current stage of recovery and level of awareness are discussed.	[Tobler-Ammann, Bernadette C.; Knols, Ruud H.] Univ Hosp, Physiotherapy & Occupat Therapy Res Ctr, Directorate Res & Educ, Zurich, Switzerland; [Tobler-Ammann, Bernadette C.; Sieben, Judith M.; de Bie, Rob A.] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands; [Weise, Andrea] Univ Appl Sci Zurich ZHAW, Inst Occupat Therapy, Winterthur, Switzerland; [Weise, Andrea] Rehabil Ctr Valens, Valens, Switzerland; [Watson, Martin J.] Univ East Anglia, Fac Med & Hlth Sci, East Anglia, England; [Sieben, Judith M.] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [de Bruin, Eling D.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland		Tobler-Ammann, BC (corresponding author), Univ Hosp Zurich, Physiotherapy & Occupat Therapy Res Ctr, Directorate Res & Educ, Ramistr 100, CH-8091 Zurich, Switzerland.	bernadette.tobier@usz.ch	Tobler-Ammann, Bernadette/AAF-8243-2021; de Bruin, Eling D./A-4751-2011	Tobler-Ammann, Bernadette/0000-0002-5426-1762; de Bruin, Eling D./0000-0002-6542-7385; Sieben, Judith/0000-0002-5759-3383; de Bie, Rob/0000-0001-5882-9303			Adair JC, 2008, ANN NY ACAD SCI, V1142, P21, DOI 10.1196/annals.1444.008; [Anonymous], 2017, EFFECTS STROKE AM ST; Appelros P, 2007, EUR J NEUROL, V14, P54, DOI 10.1111/j.1468-1331.2006.01544.x; Appelros P, 2003, J REHABIL MED, V35, P254, DOI 10.1080/16501970310012455; Azouvi P, 2003, ARCH PHYS MED REHAB, V84, P51, DOI 10.1053/apmr.2003.50062; Azouvi P, 2017, ANN PHYS REHABIL MED, V60, P191, DOI 10.1016/j.rehab.2016.10.006; Barreca S, 2003, NEUROREHAB NEURAL RE, V17, P220, DOI 10.1177/0888439003259415; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bright FAS, 2018, INT J LANG COMM DIS, V53, P981, DOI 10.1111/1460-6984.12409; Brinkmann S., 2009, INTERVIEWS LEARNING; Buscherhof J.R., 1998, TOP STROKE REHABIL, V5, P19, DOI [10.1310/68M0-HTRY-V9JK-1NNK, DOI 10.1310/68M0-HTRY-V9JK-1NNK]; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Ceyte H, 2019, DISABIL REHABIL, V41, P1475, DOI 10.1080/09638288.2018.1430178; Champod AS, 2018, NEUROPSYCHOL REHABIL, V28, P491, DOI 10.1080/09602011.2016.1182032; Chen P, 2018, DISABIL REHABIL, V40, P2677, DOI 10.1080/09638288.2017.1347720; Cieza A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136271; Clarke P, 2005, J APPL GERONTOL, V24, P319, DOI 10.1177/0733464805277976; Clinin D.J., 2000, NARRATIVE INQUIRY EX; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dai CY, 2014, EUR J NEUROL, V21, P797, DOI 10.1111/ene.12413; De Luca R, 2019, APPL NEUROPSYCH-ADUL, V26, P96, DOI 10.1080/23279095.2017.1363040; Doyle S, 2011, STROKE, V42, pE18, DOI 10.1161/STROKEAHA.110.604348; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Ferreira HP, 2011, TOP STROKE REHABIL, V18, P155, DOI 10.1310/tsr1802-155; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fong KNK, 2013, CLIN REHABIL, V27, P628, DOI 10.1177/0269215512471959; Fotopoulou A, 2009, NEUROPSYCHOLOGIA, V47, P1256, DOI 10.1016/j.neuropsychologia.2009.01.018; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hartman-Maeir A, 2003, DISABIL REHABIL, V25, P35, DOI 10.1080/0963828021000007897; HARTMANMAEIR A, 1995, AM J OCCUP THER, V49, P507, DOI 10.5014/ajot.49.6.507; Harvey M, 2012, NEUROPSYCHOLOGIA, V50, P1018, DOI 10.1016/j.neuropsychologia.2011.09.030; Hayward K, 2010, DISABIL REHABIL, V32, P1973, DOI 10.3109/09638288.2010.481027; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Hoffmann T, 2011, EUR J PHYS REHAB MED, V47, P513; Hole E., 2014, SCI WORLD J, V2014, P1; Hoogerdijk B, 2011, SCAND J OCCUP THER, V18, P122, DOI 10.3109/11038121003645985; Horne M, 2015, DISABIL REHABIL, V37, P2344, DOI 10.3109/09638288.2015.1024341; Jehkonen M, 2000, ACTA NEUROL SCAND, V102, P378, DOI 10.1034/j.1600-0404.2000.102006378.x; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Klinke ME, 2016, DISABIL REHABIL, V38, P2429, DOI 10.3109/09638288.2015.1130176; Klinke ME, 2015, QUAL HEALTH RES, V25, P1623, DOI 10.1177/1049732314566328; Klinke ME, 2014, QUAL HEALTH RES, V24, P824, DOI 10.1177/1049732314533425; Koh CL, 2009, AUST OCCUP THER J, V56, P324, DOI 10.1111/j.1440-1630.2008.00764.x; Kortte KB, 2011, FUTUR NEUROL, V6, P33, DOI 10.2217/FNL.10.79; Kristensen HK, 2011, SCAND J OCCUP THER, V18, P11, DOI 10.3109/11038120903563785; Lampinen J., 2003, SCANDINAVIAN J OCCUP, V10, P147, DOI DOI 10.1080/11038120310016580; Legg L, 2007, BMJ-BRIT MED J, V335, P922, DOI 10.1136/bmj.39343.466863.55; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Loft MI, 2019, DISABIL REHABIL, V41, P396, DOI 10.1080/09638288.2017.1393698; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; Luukkainen-Markkula R, 2009, RESTOR NEUROL NEUROS, V27, P663, DOI 10.3233/RNN-2009-0520; Maxton C, 2013, INT J CLIN PRACT, V67, P369, DOI 10.1111/ijcp.12058; Moloney J, 2018, DISABIL REHABIL, V40, P1524, DOI 10.1080/09638288.2017.1300948; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Peoples H, 2011, SCAND J OCCUP THER, V18, P163, DOI 10.3109/11038128.2010.509887; Petzold A, 2014, TOP STROKE REHABIL, V21, P228, DOI 10.1310/tsr2103-228; Pollock A, 2015, STROKE, V46, pE57, DOI 10.1161/STROKEAHA.114.008295; Ranner M, 2016, SCAND J OCCUP THER, V23, P81, DOI 10.3109/11038128.2015.1115549; Salter K, 2008, J REHABIL MED, V40, P595, DOI 10.2340/16501977-0238; Sarre S, 2014, DISABIL REHABIL, V36, P716, DOI 10.3109/09638288.2013.814724; SODERBACK I, 1992, ARCH PHYS MED REHAB, V73, P1140; Starkstein SE, 2010, CAN J PSYCHIAT, V55, P355, DOI 10.1177/070674371005500604; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Tham K, 2003, AM J OCCUP THER, V57, P403, DOI 10.5014/ajot.57.4.403; Tham K, 2000, AM J OCCUP THER, V54, P398, DOI 10.5014/ajot.54.4.398; Ting DSJ, 2011, SURV OPHTHALMOL, V56, P114, DOI 10.1016/j.survophthal.2010.08.001; Tobler-Ammann BC, 2017, JMIR SERIOUS GAMES, V5, DOI 10.2196/games.8013; Tobler-Ammann BC, 2017, JMIR SERIOUS GAMES, V5, DOI 10.2196/games.7923; Towfighi A, 2017, STROKE, V48, pE30, DOI 10.1161/STR.0000000000000113; TROMP E, 1995, NEUROPSYCHOL REHABIL, V5, P319, DOI 10.1080/09602019508401475; Tsang MHM, 2009, DISABIL REHABIL, V31, P630, DOI 10.1080/09638280802240621; Turton AJ, 2010, NEUROPSYCHOL REHABIL, V20, P180, DOI 10.1080/09602010903040683; van Kessel ME, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00358; Visser-Meily A, 2006, DISABIL REHABIL, V28, P1557, DOI 10.1080/09638280600648215; Vossel S, 2011, J NEUROL NEUROSUR PS, V82, P862, DOI 10.1136/jnnp.2010.224261; Vossel S, 2013, CORTEX, V49, P1782, DOI 10.1016/j.cortex.2012.12.011; Vossel S, 2012, STROKE, V43, P1954, DOI 10.1161/STROKEAHA.112.657288; Welfringer A, 2011, DISABIL REHABIL, V33, P2033, DOI 10.3109/09638288.2011.556208; WHO World Heart Federation World Stroke Organization, 2011, GLOB ATL CARD DIS PR; Wolf T. J., 2014, AM J OCCUPATIONAL TH, V69, DOI 10.501/ajot.2015.012195; Yang NYH, 2017, CLIN REHABIL, V31, P1154, DOI 10.1177/0269215516679712; Yang Shang-Yu, 2017, J Phys Ther Sci, V29, P548, DOI 10.1589/jpts.29.548	83	3	3	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 21	2020	42	11					1578	1587		10.1080/09638288.2018.1531150			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	LV8OX	WOS:000538699400013	30466328	Green Published			2022-02-06	
J	Wu, YT; Gilpin, K; Adnan, A				Wu, Yuan-Ting; Gilpin, Kathleen; Adnan, Ashfaq			Effects of Focal Axonal Swelling Level on the Action Potential Signal Transmission	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Action potential; Axon; Focal axonal swelling; Membrane potentia	MICROTUBULE; INJURY; DAMAGE; BREAKAGE; NEURONS; MODEL	Focal axon swelling refers to localized swelling in axons that may occur because of trauma (e.g., traumatic brain injury) or neurodegenerative diseases (e.g., Alzheimer's disease). Since the swelling region can be many times larger than its original axon size, many researchers hypothesize that the swelling can alter the action potential (AP) signal. This article discusses the results of a series of newly developed computational studies to elucidate the possible intervention or blockage of AP signals due to swelling in the brain. We argue that the spherical geometry of the swelling site with its enlarged conducting interior causes the entering electric currents to spread evenly over the entire swelled membrane. As such, when the swelled surface becomes larger than the threshold size, the electric current will spread too thin to trigger the AP to spike. In this study, we have used a hybrid membrane model to simulate AP propagation across axons of different radii and swelling radii. We used an integrated model where a cylindrical symmetric 2D model is used to examine the electric current inside a spherical swelling site. In addition, two 1D models are used to capture the current flows along the upstream and downstream stretch before and after the swelling site. The parameters for this model are obtained from literature dedicated to modeling the experimental outcomes of mammal neurons. We observed two factors, which simultaneously affect AP transmission across a swelled axon: a) the axon radius and b) the ratio of the swelled and unswelled axon radii. In general, a thicker axon needs a smaller swelling size and axon ratio to block AP transmission. On the other hand, a thinner axon will reach the threshold at a larger swelling size and axon ratio. When only swelling size is considered, then thinner axons will block AP transmission at a smaller swelling radius. The AP transmission delay inside the swelled region determines whether the AP transmits forward or not. Notably, the blockage is worse if the AP fires at a high frequency. An increase in the charging and reset time due to swelling appears to be the main reason for the variation in axonal response.	[Wu, Yuan-Ting; Adnan, Ashfaq] Univ Texas Arlington UTA, Mech & Aerosp Engn, Arlington, TX 76019 USA; [Wu, Yuan-Ting] Penn State Univ PSU, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Gilpin, Kathleen] Air Force Res Lab, Dayton, OH USA		Adnan, A (corresponding author), Univ Texas Arlington UTA, Mech & Aerosp Engn, Arlington, TX 76019 USA.	aadnan@uta.edu	Wu, Yuan-Ting/S-4136-2017	Wu, Yuan-Ting/0000-0002-8142-087X; Adnan, Ashfaq/0000-0003-0683-2185	Computational Cellular Biology of Blast (C2B2) program through the Office of Naval Research (ONR) [N00014-18-1-2082]	This work has been funded by the Computational Cellular Biology of Blast (C2B2) program through the Office of Naval Research (ONR) (Award #N00014-18-1-2082-Dr. Timothy Bentley, Program Manager). The authors gratefully acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing HPC resources that contributed to the research results reported in this paper. URL: http://www.tacc.utexas.edu.	Dijkstra K, 2016, J NEUROSCI, V36, P11881, DOI 10.1523/JNEUROSCI.1934-16.2016; Elia S., COMSOL EUR C, P1; Ermentrout GB, 1996, SIAM J APPL MATH, V56, P1107, DOI 10.1137/S0036139994276793; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Khodorov B, 1976, PROGR BIOPHYSICS MOL, V30, P145, DOI [10.1016/0079-6107(76)90008-0, DOI 10.1016/0079-6107(76)90008-0]; Kolaric KV, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.59; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Ofer N, 2016, APPL MATH MODEL, V40, P3175, DOI 10.1016/j.apm.2015.10.017; Pods J, 2013, BIOPHYS J, V105, P242, DOI 10.1016/j.bpj.2013.05.041; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Rall W., 1995, THEORETICAL FDN DEND; Smith DH, 1999, J NEUROSCI, V19, P4263; Tahayori B, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065005; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tekieh T, 2016, CURR APPL PHYS, V16, P1413, DOI 10.1016/j.cap.2016.07.012; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Wu YT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29804-w; Wu YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05790-3; Xylouris K, 2010, COMPUT VIS SCI, V13, P409, DOI 10.1007/s00791-011-0155-7	28	3	3	2	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	AUG	2020	48	3					253	263		10.1007/s10827-020-00750-9		MAY 2020	11	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	NB8TH	WOS:000534442300001	32436129				2022-02-06	
J	Wrede, AH; McNamara, MC; Baldwin, R; Luo, J; Montazami, R; Kanthasamy, A; Hashemi, NN				Wrede, Alex H.; McNamara, Marilyn C.; Baldwin, Rodger; Luo, Jie; Montazami, Reza; Kanthasamy, Anumantha; Hashemi, Nicole N.			Characterization of Astrocytic Response after Experiencing Cavitation In Vitro	GLOBAL CHALLENGES			English	Article						astrocytes; cavitation; microbubbles; traumatic brain injuries; ultrasonics	NITRIC-OXIDE SYNTHASE; POSSIBLE DAMAGE MECHANISM; REACTIVE ASTROCYTES; BRAIN-INJURY; EXPRESSION; MICROGLIA; SCLEROSIS	When a traumatic brain injury (TBI) occurs, low-pressure regions inside the skull can cause vapor contents in the cerebral spinal fluid (CSF) to expand and collapse, a phenomenon known as cavitation. When these microbubbles (MBs) collapse, shock waves are radiated outward and are known to damage surrounding materials in other applications, like the steel foundation of boat propellers, so it is alarming to realize the damage that cavitation inflicts on vulnerable brain tissue. Using cell-laden microfibers, the longitudinal morphological response that mouse astrocytes have to surrounding cavitation in vitro is visually analyzed. Astrocytic damage is evident immediately after cavitation when compared to a control sample, as their processes retract. Forty-eight hours later, the astrocytes appeared to spread across the fibers, as normal. This study also analyzes the gene expression changes that occur post-cavitation via quantitative polymerase chain reaction (qPCR) methods. After cavitation a number of pro-inflammatory genes are upregulated, including TNF alpha, IL-1 beta, C1q, Serping1, NOS1, IL-6, and JMJD3. Taken together, these results confirm that surrounding cavitation is detrimental to astrocytic function, and yield opportunities to further the understanding of how protective headgear can minimize or eliminate the occurrence of cavitation.	[Wrede, Alex H.; McNamara, Marilyn C.; Baldwin, Rodger; Montazami, Reza; Hashemi, Nicole N.] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Luo, Jie; Kanthasamy, Anumantha; Hashemi, Nicole N.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA		Hashemi, NN (corresponding author), Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA.; Hashemi, NN (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	nastaran@iastate.edu	Hashemi, Nicole/AAW-1384-2021	Hashemi, Nicole/0000-0001-8921-7588; Wrede, Alex/0000-0001-9509-924X	Office of Naval Research (ONR)Office of Naval Research [N000141612246]; ONROffice of Naval Research [N000141712620]	This work was supported by the Office of Naval Research (ONR) Grant N000141612246 and ONR Grant N000141712620. The authors thank Timothy Bigelow for his help with ultrasound logistics, Dan Barnard for his willingness to lend an ultrasonic transducer, Travis Sippel for his help with imaging and willingness to lend equipment, and Jasmin Okuzono for her help with microfiber fabrication. The authors also thank RITEC, Inc. for lending a RAM-5000 power amplification system.	Achenbach J.D., 1973, WAVE PROPAGATION ELA; Bai ZH, 2014, J MATER CHEM A, V2, P4878, DOI 10.1039/c3ta14573e; Bhattacharya A, 2016, PSYCHOPHARMACOLOGY, V233, P1623, DOI 10.1007/s00213-016-4214-0; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bros M, 2007, GENE, V405, P36, DOI 10.1016/j.gene.2007.08.018; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Canchi S, 2017, J MECH BEHAV BIOMED, V74, P261, DOI 10.1016/j.jmbbm.2017.06.018; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Chernin L, 2017, RENEW ENERG, V113, P688, DOI 10.1016/j.renene.2017.06.037; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Elain G, 2014, GLIA, V62, P725, DOI 10.1002/glia.22637; FRANCK C, 2017, CONCUSSION, V2; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Haniff S, 2017, SHOCK WAVES, V27, P929, DOI 10.1007/s00193-017-0765-1; Hawkins BT, 2015, BRAIN RES, V1608, P167, DOI 10.1016/j.brainres.2015.02.025; He YB, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0904-8; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Ji B, 2014, J MECH SCI TECHNOL, V28, P1339, DOI 10.1007/s12206-013-1166-8; Lee HT, 2014, INFLAMM RES, V63, P389, DOI 10.1007/s00011-014-0711-y; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love S, 1999, BRAIN PATHOL, V9, P119; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; National Institute of Neurological Disorders and Stroke, 2018, TRAUM BRAIN INJ HOP; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Patel BB, 2019, MACROMOL BIOSCI, V19, DOI 10.1002/mabi.201800236; Philipp A, 1998, J FLUID MECH, V361, P75, DOI 10.1017/S0022112098008738; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Ransohoff R. M., 2015, COLD SPRING HARBOR P, V8, P1; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sharifi F, 2016, BIOMACROMOLECULES, V17, P3287, DOI 10.1021/acs.biomac.6b01028; Sharifi F, 2016, J MECH BEHAV BIOMED, V61, P530, DOI 10.1016/j.jmbbm.2016.04.005; Shima A, 1997, SHOCK WAVES, V7, P33, DOI 10.1007/s001930050060; Simic G, 2000, EXP NEUROL, V165, P12, DOI 10.1006/exnr.2000.7448; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun SQ, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14757; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Weinberg RP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34763-3; Wrede AH, 2019, ANAL METHODS-UK, V11, P5038, DOI 10.1039/c9ay01576k; Wrede AH, 2018, ULTRASON SONOCHEM, V43, P114, DOI 10.1016/j.ultsonch.2018.01.006; Xing CH, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1189-2; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	49	3	3	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY		2056-6646		GLOB CHALL	Glob. Chall.	JUL	2020	4	7							1900014	10.1002/gch2.201900014		MAY 2020	8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MP2SL	WOS:000533229500001	32642072	Green Published, gold			2022-02-06	
J	Hill, CS; Sreedharan, J; Loreto, A; Menon, DK; Coleman, MP				Hill, Ciaran S.; Sreedharan, Jemeen; Loreto, Andrea; Menon, David K.; Coleman, Michael P.			Loss of highwire Protects Against the Deleterious Effects of Traumatic Brain Injury in Drosophila Melanogaster	FRONTIERS IN NEUROLOGY			English	Article						wallerian degeneration; traumatic brain injury; neuroprotection; axons; highwire	NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; AXONAL INJURY; WALLERIAN DEGENERATION; SYNAPTIC GROWTH; NMNAT; MODEL; DISCONNECTION; CHAPERONE; INSIGHTS; SYNTHASE	Traumatic brain injury is a major global cause of death and disability. Axonal injury is a major underlying mechanism of TBI and could represent a major therapeutic target. We provide evidence that targeting the axonal death pathway known as Wallerian degeneration improves outcome in a Drosophila Melanogaster model of high impact trauma. This cell-autonomous neurodegenerative pathway is initiated following axon injury, and in Drosophila, involves activity of the E3 ubiquitin ligase highwire. We demonstrate that a loss-of-function mutation in the highwire gene rescues deleterious effects of a traumatic injury, including-improved functional outcomes, lifespan, survival of dopaminergic neurons, and retention of synaptic proteins. This data suggests that highwire represents a potential therapeutic target in traumatic injury.	[Hill, Ciaran S.; Loreto, Andrea; Coleman, Michael P.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England; [Hill, Ciaran S.; Sreedharan, Jemeen; Coleman, Michael P.] Babraham Inst, Cambridge, England; [Sreedharan, Jemeen] Kings Coll London, Inst Psychiat, London, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England; [Menon, David K.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England		Hill, CS (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England.; Hill, CS (corresponding author), Babraham Inst, Cambridge, England.	ciaran.hill@ucl.ac.uk	sreedharan, jemeen/E-7327-2016	sreedharan, jemeen/0000-0002-8682-6844; Loreto, Andrea/0000-0001-6535-6436; Hill, Ciaran/0000-0002-4488-4034	Wellcome TrustWellcome TrustEuropean Commission; National Institute for Health Research, UK (NIHR)National Institute for Health Research (NIHR); Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre; European Union (CENTER-TBI) [602150]; John and Lucille van Geest Foundation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K010611/1] Funding Source: UKRI	I would like to thank Vishnu Janardan for fly-keeping support, Elena Fineberg and Myriam Hemberger for histology support, Barbara Sobotic for flow-cytometry support, Alex Whitworth, Alvaro Sanchez-Martinez, and Victoria Hewitt for dopaminergic neuron staining support, Claire Durrant and other members of the Coleman lab for scientific discussions. I would also like to thank Marc Freeman and Frank Hirth for fly lines. CH is supported by a Wellcome Trust Ph.D. for Clinicians. DM is supported by a Senior Investigator Award from the National Institute for Health Research, UK (NIHR), by the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, and a Framework Program 7 grant from the European Union (CENTER-TBI; Grant no: 602150). MC is funded by the John and Lucille van Geest Foundation.	Agrawal T, 2015, ELIFE, V4, DOI 10.7554/eLife.07046; Ali YO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002472; Ali YO, 2013, TRENDS NEUROSCI, V36, P632, DOI 10.1016/j.tins.2013.07.002; Ali YO, 2011, J BIOL CHEM, V286, P19089, DOI 10.1074/jbc.M111.219295; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Bae JR, 2017, BMB REP, V50, P237, DOI 10.5483/BMBRep.2017.50.5.038; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Brazill JM, 2017, CURR OPIN GENET DEV, V44, P156, DOI 10.1016/j.gde.2017.03.014; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Fang YS, 2012, ANNU REV CELL DEV BI, V28, P575, DOI 10.1146/annurev-cellbio-101011-155836; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Grill B, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0063-0; Harwell CS, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0110-7; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lavado-Roldan A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002522; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Loreto A, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104678; Loreto A, 2015, CELL REP, V13, P2539, DOI 10.1016/j.celrep.2015.11.032; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milde Stefan, 1800, Bioarchitecture, V3, P133, DOI 10.4161/bioa.27049; Mutsuddi M, 1998, CURR BIOL, V8, pR809, DOI 10.1016/S0960-9822(07)00506-4; Neukomm LJ, 2017, NEURON, V95, P78, DOI 10.1016/j.neuron.2017.06.031; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; Neukomm LJ, 2014, P NATL ACAD SCI USA, V111, P9965, DOI 10.1073/pnas.1406230111; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Rosell AL, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190118; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Zang SY, 2013, EMBO REP, V14, P87, DOI 10.1038/embor.2012.181; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416	57	3	3	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 12	2020	11								401	10.3389/fneur.2020.00401			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT6WU	WOS:000537209800001	32477254	Green Published, gold, Green Submitted			2022-02-06	
J	Carlstrom, KE; Chinthakindi, PK; Espinosa, B; Al Nimer, F; Arner, ESJ; Arvidsson, PI; Piehl, F; Johansson, K				Carlstrom, Karl E.; Chinthakindi, Praveen K.; Espinosa, Belen; Al Nimer, Faiez; Arner, Elias S. J.; Arvidsson, Per, I; Piehl, Fredrik; Johansson, Katarina			Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate	NEUROTHERAPEUTICS			English	Article						Nrf2; NF kappa B; HIF; dimethyl fumarate; multiple sclerosis; redox regulation; pTRAF; sulfoximine; traumatic brain injury; microglia	PLACEBO-CONTROLLED PHASE-3; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; ORAL BG-12; PATHWAY; CELLS; ACID; NRF2; DEFENSE; ROS	The Nrf2 transcription factor is a key regulator of redox reactions and considered the main target for the multiple sclerosis (MS) drug dimethyl fumarate (DMF). However, exploration of additional Nrf2-activating compounds is motivated, since DMF displays significant off-target effects and has a relatively poor penetrance to the central nervous system (CNS). We de novo synthesized eight vinyl sulfone and sulfoximine compounds (CH-1-CH-8) and evaluated their capacity to activate the transcription factors Nrf2, NF kappa B, and HIF1 in comparison with DMF using the pTRAF platform. The novel sulfoximine CH-3 was the most promising candidate and selected for further comparison in vivo and later an experimental model for traumatic brain injury (TBI). CH-3 and DMF displayed comparable capacity to activate Nrf2 and downstream transcripts in vitro, but with less off-target effects on HIF1 from CH-3. This was verified in cultured microglia and oligodendrocytes (OLs) and subsequently in vivo in rats. Following TBI, DMF lowered the number of leukocytes in blood and also decreased axonal degeneration. CH-3 preserved or increased the number of pre-myelinating OL. While both CH-3 and DMF activated Nrf2, CH-3 showed less off-target effects and displayed more selective OL associated effects. Further studies with Nrf2-acting compounds are promising candidates to explore potential myelin protective or regenerative effects in demyelinating disorders.	[Carlstrom, Karl E.; Al Nimer, Faiez; Piehl, Fredrik] Karolinska Inst, Sect Neurol, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Chinthakindi, Praveen K.; Arvidsson, Per, I] Univ KwaZulu Natal, Catalysis & Peptide Res Unit, ZA-4000 Durban, South Africa; [Chinthakindi, Praveen K.] Uppsala Univ, Drug Design & Discovery, Dept Med Chem, Box 574, S-75123 Uppsala, Sweden; [Espinosa, Belen; Arner, Elias S. J.; Johansson, Katarina] Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Arvidsson, Per, I] Karolinska Inst, Sci Life Lab, Drug Discovery & Dev Platform, S-17121 Solna, Sweden; [Arvidsson, Per, I] Karolinska Inst, Div Translat Med & Chem Biol, S-17121 Solna, Sweden; [Johansson, Katarina] Pfizer Innovat AB, S-19190 Sollentuna, Sweden		Carlstrom, KE (corresponding author), Karolinska Inst, Sect Neurol, Dept Clin Neurosci, S-17177 Stockholm, Sweden.	karl.carlstrom@ki.se	Arner, Elias/K-6737-2019; Nimer, Faiez Al/ABB-9465-2020; Arvidsson, Per/N-4864-2013	Arner, Elias/0000-0002-4807-6114; Arvidsson, Per/0000-0002-9453-6812; Al Nimer, Faiez/0000-0003-0937-5995	NHR Sweden [NN-678-32]; Karolinska InstitutetKarolinska Institutet; Swedish Cancer SocietySwedish Cancer Society [2018/333]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2017-01872]	KEC/FP has received funding from NHR Sweden (NN-678-32). ESJA have received funding from Karolinska Institutet, The Swedish Research Council (2017-01872) and The Swedish Cancer Society (2018/333).	Abbas K, 2011, FREE RADICAL BIO MED, V51, P107, DOI 10.1016/j.freeradbiomed.2011.03.039; Al Nimer F, 2013, ANTIOXID REDOX SIGN, V18, P784, DOI 10.1089/ars.2011.4440; Al Nimer F, 2011, BRAIN BEHAV IMMUN, V25, P981, DOI 10.1016/j.bbi.2010.10.017; Blank T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00047; Boger DL, 2017, J ORG CHEM, V82, P11961, DOI 10.1021/acs.joc.7b02088; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Carlstrom KE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11139-3; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Chinthakindi PK, 2016, SYNLETT, V27, P1423, DOI 10.1055/s-0035-1561573; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Goldberg FW, 2015, DRUG DISCOV TODAY, V20, P11, DOI 10.1016/j.drudis.2014.09.023; Gross CC, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000183; Gupta S, 2017, ORG BIOMOL CHEM, V15, P8493, DOI [10.1039/c7ob02234d, 10.1039/c7ob02234drsc.li/obc]; Johansson K, 2017, ANTIOXID REDOX SIGN, V26, P229, DOI 10.1089/ars.2015.6419; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Lee JA, 2015, BRIT J PHARMACOL, V172, P1087, DOI 10.1111/bph.12973; Lemasson FA, 2011, J AM CHEM SOC, V133, P652, DOI 10.1021/ja105722u; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Moharregh-Khiabani D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011769; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Noubade R, 2014, NATURE, V509, P235, DOI 10.1038/nature13152; Penner N, 2018, C EUR COMM TREATM RE; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schulze-Topphoff U, 2016, P NATL ACAD SCI USA, V113, P4777, DOI 10.1073/pnas.1603907113; Sthijns Mireille M.J.P.E., 2017, BIOCHIM BIOPHYS ACTA, V1861; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Teng F, 2014, CHEM COMMUN, V50, P8412, DOI 10.1039/c4cc03439b; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Woo SY, 2014, J MED CHEM, V57, P1473, DOI 10.1021/jm401788m; Wu Q, 2017, J IMMUNOL, V198, P3069, DOI 10.4049/jimmunol.1601532; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003	41	3	3	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	JUL	2020	17	3			SI		1142	1152		10.1007/s13311-020-00855-0		MAY 2020	11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	OL3SN	WOS:000531767700002	32394330	Green Published, hybrid			2022-02-06	
J	Zhang, L; Zhao, L; Zhu, W; Ding, YX; Chen, HG; Chi, N				Zhang, Lei; Zhao, Li; Zhu, Wei; Ding, Yuexia; Chen, Hongguang; Chi, Nan			miR-146a Mimics Ameliorates Traumatic Brain Injury Involving JNK and NF-kappa B Signaling Pathway	NEUROMOLECULAR MEDICINE			English	Article						Traumatic brain injury (TBI); miR-146a; NF-kappa b pathways; JNK	EPIDEMIOLOGY; MICRORNA; EXPRESSION; POPULATION	Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality among the world, while the advance of TBI management is rather limited in recent years. The deregulation of microRNAs (miRNAs) has been widely reported in TBI patients and animal models, and certain miRNAs have been identified as the emerging biomarkers of TBI. However, the role of miRNAs in the regulatory mechanism of TBI remains unclear. To demonstrate the effect of miR-146a mimic on TBI-induced neural damages, TBI mouse model was constructed by cortical impact injury (CCI). The chemokine levels were examined by ELISA assays. Behavioral experiments were used to estimate the impact of miR-146a mimics on neurological functions in mice. Western blot assays were performed to demonstrate the protein levels. qRT-PCR assays were utilized to investigate the expression alteration of RNA levels. It was found that miR-146a was upregulated both in brain and serum in TBI mice. miR-146a mimic downregulated inflammatory cytokines secretion in mouse brain. The NF-kappa B signaling pathway was inhibited by miR-146a mimic. miR-146a treatment attenuated the impact caused by TBI to mouse brain and improve the long-term neurological function. In conclusion, miR-146a mimics ameliorate TBI-related injuries via JNK and NF-kappa B signaling pathway.	[Zhang, Lei; Zhao, Li; Ding, Yuexia] Qingdao Univ, Yuhuangding Hosp Yantai, Dept Pharm, Affiliated Yantai Yuhuangding Hosp, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China; [Zhu, Wei; Chen, Hongguang; Chi, Nan] Qingdao Univ, Yuhuangding Hosp Yantai, Dept Neurosurg, Affiliated Yantai Yuhuangding Hosp, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China		Zhu, W; Chi, N (corresponding author), Qingdao Univ, Yuhuangding Hosp Yantai, Dept Neurosurg, Affiliated Yantai Yuhuangding Hosp, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China.	zhuwei0535@163.com; chinan001@126.com					Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Barry G, 2014, MOL PSYCHIATR, V19, P410, DOI 10.1038/mp.2013.196; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bhowmick S, 2019, J MOL MED, V97, P1627, DOI 10.1007/s00109-019-01851-4; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Danborg PB, 2014, BIOMARKERS, V19, P259, DOI 10.3109/1354750X.2014.904001; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Paterson MR, 2017, PHYSIOL GENOMICS, V49, P243, DOI 10.1152/physiolgenomics.00133.2016; Pellegrini KL, 2016, TOXICOL APPL PHARM, V312, P42, DOI 10.1016/j.taap.2015.12.002; Pereira P, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1409; Quinlan S, 2017, INT REV CEL MOL BIO, V334, P309, DOI 10.1016/bs.ircmb.2017.04.002; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Shah SZA, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00139; Sheinerman KS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0316-0; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Theus MH, 2017, J IMMUNOL, V199, P3547, DOI 10.4049/jimmunol.1700251; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Zhu W, 2020, NEUROSCI RES, V157, P44, DOI 10.1016/j.neures.2019.07.008	41	3	3	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	DEC	2020	22	4					484	492		10.1007/s12017-020-08599-y		MAY 2020	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OS6FT	WOS:000531206200001	32388802				2022-02-06	
J	Daugherty, J; Waltzman, D; Snedaker, KP; Bouton, J; Zhang, XJ; Wang, D				Daugherty, Jill; Waltzman, Dana; Snedaker, Katherine P.; Bouton, Jason; Zhang, Xinjian; Wang, David			Concussion Experiences in New England Private Preparatory High School Students Who Played Sports or Recreational Activities	JOURNAL OF SCHOOL HEALTH			English	Article						concussions; school sports; injury prevention; private schools	TRAUMATIC BRAIN-INJURY; UNITED-STATES; ATHLETIC TRAINERS; FOOTBALL PLAYERS; KNOWLEDGE; MANAGEMENT; GUIDELINE; RECOVERY; ADDRESS; YOUTH	BACKGROUND Sports- and recreation-related (SRR) activities are a major cause of adolescent concussions. Most adolescent SRR concussion research has been conducted among public school students. As private schools are qualitatively different from public schools (eg, location, socioeconomic status, sports played), this study explores the concussion experiences of a large group of private high school students. METHODS We surveyed 2047 New England private preparatory high school students who played sports or engaged in a recreational activity in 2018 about the sports they played, and their self-reported concussion experiences (eg, age at first concussion, if concussions were sports- or recreation-related). Descriptive, bivariate, and multivariate statistics are presented. RESULTS One-third (33.0%) of students who reported engaging in sport- or recreation-related activities self-reported experiencing a concussion in their lifetime. A higher percentage of boys, students who played contact sports, and those who played multiple seasons of school sports reported a concussion. Sex, contact level of primary sport played, and age of first concussion were also significantly associated with reporting a sports- or recreation-related concussion. CONCLUSIONS A sizeable proportion of private preparatory high school students reported experiencing a concussion, with some students at higher risk. Private preparatory high school-specific concussion prevention strategies may be needed.	[Daugherty, Jill; Waltzman, Dana; Zhang, Xinjian] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway, Atlanta, GA 30341 USA; [Snedaker, Katherine P.] PINK Concuss, 15 Shorefront Pk, Norwalk, CT 06854 USA; [Bouton, Jason] Sacred Heart Univ, 1450 Newfield Ave, Stamford, CT 06905 USA; [Wang, David] Connecticut Childrens Med Ctr, Elite Sports Med, 399 Farmington Ave, Farmington, CT 06032 USA		Daugherty, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway, Atlanta, GA 30341 USA.	jdaugherty@cdc.gov; dwaltzman@cdc.gov; katherine@pinkconcussions.com; jbouton@kingschoolct.org; xaz8@cdc.gov; dwang01@connecticutchildrens.org			Intramural CDC HHS [CC999999] Funding Source: Medline		Allen J, 2016, TIMES UNION; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bureau of Labor Statistics, 2019, UMP REF OTH SPORTS O; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 2009, BRIT J SPORT MED, V43, P981, DOI 10.1136/bjsm.2009.067728; Centers for Disease Control and Prevention, 2018, SPORTS FACTS BEN YOU; Choy SP., 1997, PUBLIC PRIVATE SCH T; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen J., 2013, STAT POWER ANAL BEHA; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Comstock R. D. C. D., 2017, NATL HIGH SCH SPORTS; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HUGGINS RA, 2018, ATHLETIC TRAINING LO; Kennedy R., 2019, ATHLETICS ARE NOT OP; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mirabelli MH, 2015, AM FAM PHYSICIAN, V92, P371; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; MOSES S, 2018, SPORTS CONTACT LEVEL; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; National Federation of State High School, 2017, HIGH SCH ATHL PART S; National Federation of State High School Associations, 2019, HIGH SCH PART INCR 2; National Research Council Committee on Sports-Related Concussions in Youth, 2014, SPORTS RELATED CONCU; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Potteiger KL, 2018, INTERNET J ALLIED HE, V16; Prasad D S, 2009, Indian J Med Sci, V63, P33; Rafferty J, 2019, BRIT J SPORT MED, V53, P969, DOI 10.1136/bjsports-2017-098417; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rodriguez G, 2003, STATA J, V3, P32, DOI 10.1177/1536867X0300300102; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Shendell DG, 2019, J SCHOOL HEALTH, V89, P527, DOI 10.1111/josh.12775; Snedakar K., 2019, PINK CONCUSSIONS FEM; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; US Centers for Disease Control and Prevention, 2017, WHAT IS CONC; US Centers for Disease Control and Prevention, 2016, HEADS; US Centers for Disease Control and Prevention, 2010, ASS SCH BAS PHYS ACT; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	55	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	JUL	2020	90	7					527	537		10.1111/josh.12899		MAY 2020	11	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	LW3IW	WOS:000530394000001	32369871	Green Accepted			2022-02-06	
J	Ibrahim, O; Sutherland, HG; Maksemous, N; Smith, R; Haupt, LM; Griffiths, LR				Ibrahim, Omar; Sutherland, Heidi G.; Maksemous, Neven; Smith, Robert; Haupt, Larisa M.; Griffiths, Lyn R.			Exploring Neuronal Vulnerability to Head Trauma Using a Whole Exome Approach	JOURNAL OF NEUROTRAUMA			English	Article						concussion; genetics; head trauma; ion channel; neurotransmitters	UBIQUITIN LIGASE TRIM2; BRAIN-INJURY; SQSTM1 MUTATIONS; HEMIPLEGIC MIGRAINE; CELL-DEATH; DISEASE; GABA; EXPRESSION; GLUTAMATE; ATAXIA	Brain injuries are associated with oxidative stress and a need to restore neuronal homeostasis. Mutations in ion channel genes, in particular CACNA1A, have been implicated in familial hemiplegic migraine (FHM) and in the development of concussion-related symptoms in response to trivial head trauma. The aim of this study was to explore the potential role of variants in other ion channel genes in the development of such responses. We conducted whole exome sequencing (WES) on16 individuals who developed a range of neurological and concussion-related symptoms following minor or trivial head injuries. All individuals were initially tested and shown to be negative for mutations in known FHM genes. Variants identified from the WES results were filtered to identify rare variants (minor allele frequency [MAF] <0.01) in genes related to neural processes as well as genes highly expressed in the brain using a combination of in silico prediction tools (SIFT, PolyPhen, PredictSNP, Mutation Taster, and Mutation Assessor). Rare (MAF <0.001) or novel heterozygous variants in 7 ion channel genes were identified in 37.5% (6/16) of the cases (CACNA1I, CACNA1C, ATP10A, ATP7B, KCNAB1, KCNJ10, and SLC26A4), rare variants in neurotransmitter genes were found in 2 cases (GABRG1 and GRIK1), and rare variants in 3 ubiquitin-related genes identified in 4 cases (SQSTM1, TRIM2, and HECTD1). In this study, the largest proportion of potentially pathogenic variants in individuals with severe responses to minor head trauma were identified in genes previously implicated in migraine and seizure-related autosomal recessive neurological disorders. Together with results implicating variants in the hemiplegic migraine genes, CACNA1A and ATP1A2, in severe head trauma response, our results support a role for heterozygous deleterious mutations in genes implicated in neurological dysfunction and potentially increasing the risk of poor response to trivial head trauma.	[Ibrahim, Omar; Sutherland, Heidi G.; Maksemous, Neven; Smith, Robert; Haupt, Larisa M.; Griffiths, Lyn R.] Queensland Univ Technol QUT, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Genom Res Ctr, Kelvin Grove, Qld, Australia		Griffiths, LR (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.	lyn.griffiths@qut.edu.au	Haupt, Larisa M/C-6066-2017; Ibrahim, Omar/ABB-6012-2021	Haupt, Larisa M/0000-0002-7735-8110; Ibrahim, Omar/0000-0003-2495-9286; Maksemous, Neven/0000-0002-4891-4333	US Department of Defence for Post Traumatic Headache Research; QUT Health Faculty	We acknowledge funding support from the US Department of Defence for Post Traumatic Headache Research and funding provided by QUT Health Faculty in the form of a PhD scholarship to the first author. This work was also supported by infrastructure purchased with Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project.	Aggarwal A, 2013, ANN HUM GENET, V77, P299, DOI 10.1111/ahg.12024; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Bandmann O, 2015, LANCET NEUROL, V14, P103, DOI 10.1016/S1474-4422(14)70190-5; Bartolome F., 2017, SCI REP, V7, P1; Benton MC, 2019, J MOL DIAGN, V21, P951, DOI 10.1016/j.jmoldx.2019.07.001; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Blumkin L, 2010, J CHILD NEUROL, V25, P892, DOI 10.1177/0883073809351316; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Borkum JM, 2016, HEADACHE, V56, P12, DOI 10.1111/head.12725; Bottger P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22047; Busolin G, 2011, EPILEPSY RES, V94, P110, DOI 10.1016/j.eplepsyres.2011.01.010; Carson AR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-125; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Machado AAC, 2008, PARKINSONISM RELAT D, V14, P246, DOI 10.1016/j.parkreldis.2007.08.002; Curtain RP, 2006, PEDIATR NEUROL, V34, P329, DOI 10.1016/j.pediatrneurol.2005.08.033; Dhillon KS, 2011, MED HYPOTHESES, V77, P147, DOI 10.1016/j.mehy.2011.03.050; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; East DA, 2014, CHEM BIOL, V21, P1585, DOI 10.1016/j.chembiol.2014.09.019; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Frejo L, 2016, J NEUROL, V263, pS45, DOI 10.1007/s00415-015-7988-9; Gargus JJ, 2009, ANN NY ACAD SCI, V1151, P133, DOI 10.1111/j.1749-6632.2008.03572.x; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glass K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04191; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Hall E.E., 2014, J ALZHEIMERS DIS PAR, V4, P1, DOI [10.4172/2161-0460.1000137, DOI 10.4172/2161-0460.1000137]; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Korvigo I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192829; Larson-Dupuis C, 2015, BRAIN INJURY, V29, P963, DOI 10.3109/02699052.2015.1016452; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Lee AS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0006-16.2016; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Leonelli M, 2009, BRAZ J MED BIOL RES, V42, P68, DOI 10.1590/S0100-879X2009000100011; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Maksemous N., 2019, CEPHALALGIA REP, V2, p2515816319881630, DOI 10.1177/2515816319881630; Maksemous N, 2016, MOL GENET GENOM MED, V4, P211, DOI 10.1002/mgg3.196; Mazzo F, 2016, J NEUROCHEM, V138, P384, DOI 10.1111/jnc.13675; McKinnon C, 2014, ANTIOXID REDOX SIGN, V21, P2302, DOI 10.1089/ars.2013.5802; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mendez-Gonzalez MP, 2016, J BIOL CHEM, V291, P7716, DOI 10.1074/jbc.M115.679910; Muto V, 2018, NEUROLOGY, V91, pE319, DOI 10.1212/WNL.0000000000005869; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Narayanan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158838; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Niechwiej-Szwedo E, 2015, J VIS, V15, P676; Pehlivan D, 2015, HUM GENET, V134, P671, DOI 10.1007/s00439-015-1548-3; Pelzer N, 2017, CEPHALALGIA, V37, P737, DOI 10.1177/0333102416651284; Pena-Quintana L, 2012, J PEDIATR GASTR NUTR, V54, P48, DOI 10.1097/MPG.0b013e318230130c; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; Raymond GV, 2010, J NEUROL SCI, V290, P70, DOI 10.1016/j.jns.2009.11.005; Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Reyes S, 2009, OTOLARYNG HEAD NECK, V141, P502, DOI 10.1016/j.otohns.2009.07.004; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Russo L, 2005, AM J HUM GENET, V76, P327, DOI 10.1086/427521; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Schmunk Galina, 2013, Frontiers in Genetics, V4, P222, DOI 10.3389/fgene.2013.00222; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Thompson S, 2011, J BIOL CHEM, V286, P19331, DOI 10.1074/jbc.M110.197707; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; van der Zee J, 2014, ACTA NEUROPATHOL, V128, P397, DOI 10.1007/s00401-014-1298-7; Vikelis Michail, 2007, CNS & Neurological Disorders-Drug Targets, V6, P251; Wada T, 2002, PEDIATR NEUROL, V26, P47, DOI 10.1016/S0887-8994(01)00371-X; Walter A, 2019, J NEUROTRAUM, V36, P1115, DOI 10.1089/neu.2017.5622; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030; Xie YJ, 2018, HEREDITAS, V155, DOI 10.1186/s41065-017-0054-0; Xu J, 2008, J BIOL CHEM, V283, P29355, DOI 10.1074/jbc.M800393200; Yamaguchi Y, 2013, CELL MOL LIFE SCI, V70, P3171, DOI 10.1007/s00018-012-1227-7; Ylikallio E, 2013, HUM MOL GENET, V22, P2975, DOI 10.1093/hmg/ddt149; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zamponi GW, 2016, NAT REV DRUG DISCOV, V15, P19, DOI 10.1038/nrd.2015.5; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133870; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	88	3	3	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2020	37	17					1870	1879		10.1089/neu.2019.6962		MAY 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NK7JF	WOS:000530255900001	32233732	hybrid, Green Published, Green Submitted			2022-02-06	
J	Aida, V; Niedzielko, TL; Szaflarski, JP; Floyd, CL				Aida, Virginia; Niedzielko, Tracy L.; Szaflarski, Jerzy P.; Floyd, Candace L.			Acute administration of perampanel, an AMPA receptor antagonist, reduces cognitive impairments after traumatic brain injury in rats	EXPERIMENTAL NEUROLOGY			English	Article						Protection; Fluid percussion injury; Elevated plus maze; Cognition; Apoptosis	LATERAL FLUID-PERCUSSION; ELEVATED PLUS-MAZE; FOCAL ISCHEMIA; ANIMAL-MODEL; HEAD-INJURY; IN-VITRO; GENDER; MEMORY; NBQX; RETRIEVAL	Traumatic brain injury (TBI) is a major cause of death and physical as well as cognitive disability for which an effective treatment option remains to be identified. Evidence in preclinical models has indicated that antagonists of the a-amino-3-hydroxy-5-methyl-4-isozazole propionate (AMPA) receptor exert neuroprotective effects after mechanical injury in vitro and in vivo. In particular, 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile hydrate (perampanel), a selective AMPA receptor antagonist with good bioavailability, was recently shown to therapeutically protect against the sequelae of TBI in the rodent controlled cortical impact model. However, this model induces a largely focal injury and is less representative of diffuse injury components that occur in TBI resulting from acceleration/deceleration forces. Here, we investigated the neuroprotective effects of perampanel in the rodent lateral fluid percussion injury model (LFPI), which produces both focal and diffuse injury. Pre- or post-injury administration of perampanel in male adult rats attenuated the injury-induced increase in the pro-apoptotic bax/bcl-xL ratio in the hippocampus; reduced impairments in learning and memory, assessed by the Morris water maze test; and reduced impairments in reward-seeking behavior, assessed by a female encounter test. Although additional studies are needed to determine the sex-related differences in the neuroprotective effects, these results provide support for the therapeutic potential of perampanel in TBI.	[Aida, Virginia; Niedzielko, Tracy L.; Floyd, Candace L.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, 1717 6th Ave South,Room 190, Birmingham, AL 35249 USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, 1720 7th Ave South,Suite 350, Birmingham, AL 35249 USA; [Niedzielko, Tracy L.] Univ Utah, Phys Med & Rehabil, 383 Colorow Dr,Room 298, Salt Lake City, UT 84108 USA; [Aida, Virginia] Auburn Univ, 153 Lee Rd 953, Auburn, AL 36832 USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, 1719 6th Ave South,CIRC 132, Birmingham, AL 35249 USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, UAB Epilepsy Ctr, 1719 6th Ave South,CIRC 132, Birmingham, AL 35249 USA		Floyd, CL (corresponding author), Univ Utah, Phys Med & Rehabil, 383 Colorow Dr,Room 298, Salt Lake City, UT 84108 USA.	vza0016@tigermail.auburn.edu; Tracy.niedzielko@hsc.utah.edu; jszaflarski@uabmc.edu; Candace.floyd@hsc.utah.edu			Eisai, Inc.Eisai Co Ltd	This work was supported by an investigator initatied study (IIS) to JS from Eisai, Inc.	Ago Y, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv062; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Azouvi P, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000169; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; BENNETT M, 1995, IRISH MED J, V88, P59; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Centers for Disease Control and Prevention, 2017, SEV TBI; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Council NR, 2011, GUIDE CARE USE LAB A; Damasio A. R, 2008, DESCARTES ERROR EMOT; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Follett PL, 2000, J NEUROSCI, V20, P9235; Furukawa T, 2003, J NEUROTRAUM, V20, P269, DOI 10.1089/089771503321532851; GASPARY HL, 1994, EUR J PHARMACOL, V262, P197, DOI 10.1016/0014-2999(94)90733-1; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gorwood Philip, 2008, Dialogues Clin Neurosci, V10, P291; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hanada T, 2011, EPILEPSIA, V52, P1331, DOI 10.1111/j.1528-1167.2011.03109.x; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ji JZ, 2008, LEARN MEMORY, V15, P244, DOI 10.1101/lm.794808; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kawasaki-Yatsugi S, 2000, NEUROPHARMACOLOGY, V39, P211, DOI 10.1016/S0028-3908(99)00117-3; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Landucci E, 2018, NEUROSCI LETT, V668, P103, DOI 10.1016/j.neulet.2018.01.023; Laskowitz DT., 2016, TRANSLATIONAL RES TR, P97; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Lin YP, 2015, NEURAL REGEN RES, V10, P1088, DOI 10.4103/1673-5374.160100; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; Maria NSS, 2017, J NEUROTRAUM, V34, P1692, DOI 10.1089/neu.2016.4747; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Milner B, 1972, Clin Neurosurg, V19, P421; Nakajima M, 2018, NEUROSCIENCE, V386, P256, DOI 10.1016/j.neuroscience.2018.06.043; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Niu HX, 2018, CELL MOL NEUROBIOL, V38, P459, DOI 10.1007/s10571-017-0489-x; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Patsalos PN, 2016, THER DRUG MONIT, V38, P358, DOI 10.1097/FTD.0000000000000274; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; REDMOND JM, 1995, ANN THORAC SURG, V59, P579; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rosenberg LJ, 1999, J NEUROSCI, V19, P464, DOI 10.1523/JNEUROSCI.19-01-00464.1999; ROSS DT, 1995, BRAIN RES, V683, P117, DOI 10.1016/0006-8993(95)00344-P; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimizu-Sasamata M, 1998, STROKE, V29, P2141, DOI 10.1161/01.STR.29.10.2141; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith S E, 1993, Funct Neurol, V8, P43; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Umemura K, 1997, BRAIN RES, V773, P61, DOI 10.1016/S0006-8993(97)00894-9; Vazquez B, 2015, EPILEPSIA, V56, pe90, DOI 10.1111/epi.13019; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001	70	3	3	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2020	327								113222	10.1016/j.expneurol.2020.113222			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KX8RA	WOS:000522140800028	32027929				2022-02-06	
J	Barr, WB				Barr, William B.			Believers Versus Deniers: The Radicalization of Sports Concussion and Chronic Traumatic Encephalopathy (CTE) Science	CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE			English	Article						concussion; chronic traumatic encephalopathy; neuropsychology; availability cascade; fake science	COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; BRAIN-INJURY; PROFESSIONAL FOOTBALL; KNOWLEDGE; SUICIDE; MISCONCEPTIONS; CONSEQUENCES; EXPECTATION; LEGISLATION	Unprecedented media coverage of concussion in sport has led to increased fears regarding the potential negative effects of participation in contact sports including North American football and ice hockey. Initial responses of professional sports leagues to implementation of acute concussion management practices and reports of a neurodegenerative condition known as chronic traumatic encephalopathy (CTE) developing in retired players caused an atmosphere of distrust whereby the leagues were accused of maintaining cover-ups analogous to what had been seen in association with studies of tobacco and smoking. This article reviews the important role that psychology has played in the study of sports concussion and in the establishment of methods currently used to diagnose and track concussion symptoms. Results of existing studies have shown that the neurobiological effects of concussion are rather short-lived with development of persisting symptoms in some individuals associated more with psychosocial factors than underlying physiological effects. With regard to CTE, the status of the science remains preliminary with little definitive information known about its epidemiology or cause. In the midst of the ongoing controversy. a polarized climate has developed in association with concussion and CTE, divided by believers in the dangers of long-term consequences and deniers who question the status of the existing science. The conclusion is that it is important for psychology to extend its scope of study to provide increased understanding of the social factors underlying the current polarized climate while continuing to provide the public with an accurate and reliable account of the existing science.	[Barr, William B.] NYU Grossman Sch Med, New York, NY 10016 USA		Barr, WB (corresponding author), NYU Grossman Sch Med, Neuropsychol Div, Dept Neurol, 724 Second Ave, New York, NY 10016 USA.	william.barr@nyulangone.org		Barr, William/0000-0001-7711-7758			Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychological Association, 2017, ETH PRINC PSYCH COD; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Barr W.B., 2014, HDB NEUROPSYCHOLOGY, DOI [10.1007/978-1-4939-0784-7_18, DOI 10.1007/978-1-4939-0784-7_18]; Barr W. B., 2019, HDB NEUROPSYCHOLOGY, P727, DOI 10.1007/978-3-319-93497-6_43; Barr WB, 2013, NEUROPSYCHOL REV, V23, P271, DOI 10.1007/s11065-013-9244-3; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; Barton CJ, 2019, BRIT J SPORT MED, V53, DOI 10.1136/bjsports-2017-098367; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Broglio SP, 2008, MED SCI SPORT EXER, V40, P33, DOI 10.1249/01.mss.0000320764.14496.bf; Bullock J., 2019, AM NEWS HOUR    0814; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Casson Ira R, 2006, Neurosurgery, V59, pE1152; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Chung JS, 2019, J PUBLIC HEALTH POL, V40, P393, DOI 10.1057/s41271-019-00179-0; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Concussion Legacy Foundation, 2019, CTE RES; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Festinger L., 1957, THEORY COGNITIVE DIS; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; GRONWALL D, 1975, LANCET, V2, P995; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heider F, 1958, PSYCHOL INTERPERSONA, DOI [10.1037/10628-000, DOI 10.1037/10628-000]; Hempstead KA, 2015, AM J PREV MED, V48, P491, DOI 10.1016/j.amepre.2014.11.006; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Iyengar S, 2019, ANNU REV POLIT SCI, V22, P129, DOI 10.1146/annurev-polisci-051117-073034; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kahneman D., 2012, THINKING FAST SLOW; Kain Daniel J., 2009, RUTGERS LJ, V40, P697; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Kuran T, 1999, STANFORD LAW REV, V51, P683, DOI 10.2307/1229439; Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998; Lelkes Y, 2017, AM J POLIT SCI, V61, P5, DOI 10.1111/ajps.12237; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; LEWIS GM, 1969, RES QUART, V40, P717, DOI 10.1080/10671188.1969.10614909; Lovell MR, 2004, STUD NEUROPSYCHOL DE, P209; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nisbett R., 1980, HUMAN INFERENCE STRA; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Paolini M., 2019, EMORY LAW J, V68, P607; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Peters A, 2018, J HOSP INFECT, V100, P365, DOI 10.1016/j.jhin.2018.08.001; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Russell K, 2017, CAN J NEUROL SCI, V44, P225, DOI 10.1017/cjn.2016.423; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Solomon GS, 2014, PHYSICIAN SPORTSMED, V42, P26, DOI 10.3810/psm.2014.09.2072; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Taranto E, 2018, J NATL MED ASSOC, V110, P635, DOI 10.1016/j.jnma.2018.10.001; Tator C, 2019, CAN J NEUROL SCI, V46, P280, DOI 10.1017/cjn.2019.15; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Van Bavel JJ, 2018, TRENDS COGN SCI, V22, P213, DOI 10.1016/j.tics.2018.01.004; van Prooijen JW, 2019, CURR DIR PSYCHOL SCI, V28, P159, DOI 10.1177/0963721418817755; Wang YX, 2019, SOC SCI MED, V240, DOI 10.1016/j.socscimed.2019.112552; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	91	3	3	3	13	CANADIAN PSYCHOLOGICAL  ASSOC	OTTAWA	141 LAURIER AVE WEST, STE 702, OTTAWA, ONTARIO K1P 5J3, CANADA	0708-5591	1878-7304		CAN PSYCHOL	Can. Psychol.-Psychol. Can.	MAY	2020	61	2			SI		151	162		10.1037/cap0000210			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	LI2UQ	WOS:000529339500007					2022-02-06	
J	Brown, LA; Hall, EE; Ketcham, CJ; Patel, K; Buckley, TA; Howell, DR; Vallabhajosula, S				Brown, Lauren A.; Hall, Eric E.; Ketcham, Caroline J.; Patel, Kirtida; Buckley, Thomas A.; Howell, David R.; Vallabhajosula, Srikant			Turn Characteristics During Gait Differ With and Without a Cognitive Demand Among College Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; Mini-Mental State Examination; gait variability; dual task	DUAL-TASK GAIT; EXECUTIVE FUNCTION; DIVIDED ATTENTION; DYNAMIC STABILITY; BALANCE CONTROL; SINGLE-TASK; CONCUSSION; WALKING; ADOLESCENTS; VARIABILITY	Context: Sports often involve complex movement patterns, such as turning. Although cognitive load effects on gait patterns are well known, little is known on how it affects biomechanics of turning gait among athletes. Such information could help evaluate how concussion affects turning gait required for daily living and sports. Objective: To determine the effect of a dual task on biomechanics of turning while walking among college athletes. Design: Cross-sectional study. Setting: University laboratory. Participants: Fifty-three participants performed 5 trials of a 20-m walk under single- and dual-task conditions at self-selected speed with a 180 degrees turn at 10-m mark. The cognitive load included subtraction, spelling words backward, or reciting the months backward. Interventions: Not applicable. Main Outcome Measures: Turn duration, turning velocity, number of steps, SD of turn duration and velocity, and coefficient of variation of turn duration and velocity. Results: Participants turned significantly slower (155.99 [3.71] cm/s vs 183.52 [4.17] cm/s; P < .001) and took longer time to complete the turn (2.63 [0.05] s vs 2.33 [0.04] s; P < .001) while dual tasking, albeit taking similar number of steps to complete the turn. Participants also showed more variability in turning time under the dual-task condition (SD of turn duration = 0.39 vs 0.31 s; P= .004). Conclusions: Overall, college athletes turned slower and showed more variability during turning gait while performing a concurrent cognitive dual-task turning compared with single-task turning. The slower velocity increased variability may be representative of specific strategy of turning gait while dual tasking, which may be a result of the split attention to perform the cognitive task. The current study provides descriptive values of absolute and variability turning gait parameters for sports medicine personnel to use while they perform their concussion assessments on their college athletes.	[Brown, Lauren A.; Hall, Eric E.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, Elon, NC USA; [Patel, Kirtida] Elon Univ, Dept Athlet, Elon, NC USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA; [Howell, David R.] Childrens Hosp Colorado, Inst Orthoped, Sports Med Ctr, Aurora, CO USA; [Vallabhajosula, Srikant] Elon Univ, Dept Phys Therapy Educ, Elon, NC 27244 USA		Vallabhajosula, S (corresponding author), Elon Univ, Dept Phys Therapy Educ, Elon, NC 27244 USA.	svallabhajosula@elon.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Ketcham, Caroline/0000-0002-6713-130X			Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cohen J., 2013, STAT POWER ANAL BEHA; Crenna P, 2007, GAIT POSTURE, V26, P172, DOI 10.1016/j.gaitpost.2007.04.010; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fuller JR, 2007, GAIT POSTURE, V25, P393, DOI 10.1016/j.gaitpost.2006.05.013; Grants L, 2017, INT J SPORTS PHYS TH, V12, P1011, DOI 10.26603/ijspt20171011; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Hollands KL, 2014, GAIT POSTURE, V40, P564, DOI 10.1016/j.gaitpost.2014.06.019; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Huxham F, 2008, MOVEMENT DISORD, V23, P1391, DOI 10.1002/mds.21943; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Mancini M, 2016, J GERONTOL A-BIOL, V71, P1102, DOI 10.1093/gerona/glw019; Nadkarni Neelesh K, 2010, Motor Control, V14, P195; Paquette MR, 2008, EXP BRAIN RES, V190, P1, DOI 10.1007/s00221-008-1448-z; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Vallabhajosula S, 2013, GAIT POSTURE, V37, P280, DOI 10.1016/j.gaitpost.2012.07.018; van Iersel MB, 2007, ARCH PHYS MED REHAB, V88, P187, DOI 10.1016/j.apmr.2006.10.031; Vaugoyeau M, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2004.050666; Verghese J, 2007, ARCH PHYS MED REHAB, V88, P50, DOI 10.1016/j.apmr.2006.10.007; Yang WC, 2016, J NEUROL PHYS THER, V40, P249, DOI 10.1097/NPT.0000000000000148; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2012, GAIT POSTURE, V35, P641, DOI 10.1016/j.gaitpost.2011.12.016	55	3	3	3	8	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAY	2020	29	4					448	453		10.1123/jsr.2018-0129			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LX7PX	WOS:000540020400010	30860425				2022-02-06	
J	Dabrowski, W; Siwicka-Gieroba, D; Robba, C; Badenes, R; Bialy, M; Iwaniuk, P; Schlegel, TT; Jaroszynski, A				Dabrowski, Wojciech; Siwicka-Gieroba, Dorota; Robba, Chiara; Badenes, Rafael; Bialy, Mateusz; Iwaniuk, Paulina; Schlegel, Todd T.; Jaroszynski, Andrzej			Plasma Hyperosmolality Prolongs QTc Interval and Increases Risk for Atrial Fibrillation in Traumatic Brain Injury Patients	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; cardiac arrhythmias; plasma osmolality; osmolar gap; electrocardiography	ST-SEGMENT ELEVATION; OSMOLALITY; MORTALITY; LIMITATIONS; VALIDATION; DIAGNOSIS; CALCULATE; ETHANOL; FORMULA; ECG	Introduction: Hyperosmotic therapy with mannitol is frequently used for treatment cerebral edema, and 320 mOsm/kg H2O has been recommended as a high limit for therapeutic plasma osmolality. However, plasma hyperosmolality may impair cardiac function, increasing the risk of cardiac events. The aim of this study was to analyze the relation between changes in plasma osmolality and electrocardiographic variables and cardiac arrhythmia in patients treated for isolated traumatic brain injury (iTBI). Methods: Adult iTBI patients requiring mannitol infusion following cerebral edema, and with a Glasgow Coma Score below 8, were included. Plasma osmolality was measured with Osmometr 800 CLG. Spatial QRS-T angle (spQRS-T), corrected QT interval (QTc) and STJ segment were calculated from digital resting 12-lead ECGs and analyzed in relation to four levels of plasma osmolality: (A) <280 mOsm/kg H2O; (B) 280-295 mOsm/kg H2O; (C) 295-310 mOsm/kg H2O; and (D) >310 mOsm/kg H2O. All parameters were measured during five consecutive days of treatment. Results: 94 patients aged 18-64 were studied. Increased plasma osmolality correlated with prolonged QTc (p < 0.001), intensified disorders in STJ and increased the risk for cardiac arrhythmia. Moreover, plasma osmolality >313 mOms/kg H2O significantly increased the risk of QTc prolongation >500 ms. Conclusion: In patients treated for iTBI, excessively increased plasma osmolality contributes to electrocardiographic disorders including prolonged QTc, while also correlating with increased risk for cardiac arrhythmias.	[Dabrowski, Wojciech; Siwicka-Gieroba, Dorota; Bialy, Mateusz; Iwaniuk, Paulina] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, PL-20954 Lublin, Poland; [Robba, Chiara] Policlin San Martino, Dept Anaesthesia & Intens Care, I-16100 Genoa, Italy; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ Valencia, Dept Anesthesiol & Intens Care, Valencia 46010, Spain; [Schlegel, Todd T.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Schlegel, Todd T.] Nicollier Schlegel SARL, CH-1270 Trelex, Switzerland; [Jaroszynski, Andrzej] Jan Kochanowski Univ Humanities & Sci, Inst Med Sci, Dept Nephrol, PL-25317 Kielce, Poland		Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, PL-20954 Lublin, Poland.	w.dabrowski5@yahoo.com; siw@wp.pl; kiarobba@gmail.com; rafaelbadenes@gmail.com; mateuszbialy@interia.pl; paulina.pawlik89@gmail.com; ttschlegel@gmail.com; jaroszynskiaj@interia.pl	Robba, Chiara/AAS-7421-2020	Siwicka-Gieroba, Dorota/0000-0002-1001-0080; Dabrowski, Wojciech/0000-0003-0449-2375; Jaroszynski, Andrzej/0000-0001-8194-1723; Schlegel, Todd/0000-0003-1997-3227; Badenes, Rafael/0000-0001-7017-0150	Medical University Grant [DS 352]	This research was founded with Medical University Grant (DS 352).	Figuero SB, 2014, INT J CARDIOL, V172, pE472, DOI 10.1016/j.ijcard.2014.01.033; Chai CM, 2007, ACAD RADIOL, V14, P162, DOI 10.1016/j.acra.2006.11.009; Cortez DL, 2010, J ELECTROCARDIOL, V43, P302, DOI 10.1016/j.jelectrocard.2010.03.010; Dabrowski W, 2018, J ELECTROCARDIOL, V51, P499, DOI 10.1016/j.jelectrocard.2017.12.038; EDENBRANDT L, 1988, J ELECTROCARDIOL, V21, P361, DOI 10.1016/0022-0736(88)90113-6; Etchegoyen CV, 2017, CURR CLIN PHARMACOL, V12, P210, DOI 10.2174/1574884713666180223123947; Finsterer J, 2014, INT J CARDIOL, V177, P322, DOI 10.1016/j.ijcard.2014.08.101; Garcia-Morales EJ, 2004, CRIT CARE MED, V32, P986, DOI 10.1097/01.CCM.0000120057.04528.60; Garrard A, 2012, CLIN TOXICOL, V50, P562, DOI 10.3109/15563650.2012.704039; Han J, 2015, SHOCK, V43, P244, DOI 10.1097/SHK.0000000000000303; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Howarth FC, 2002, PFLUG ARCH EUR J PHY, V444, P446, DOI 10.1007/s00424-002-0830-0; Hrishi AP, 2019, INDIAN J CRIT CARE M, V23, P329, DOI 10.5005/jp-journals-10071-23208; Burgos JI, 2019, APOPTOSIS, V24, P785, DOI 10.1007/s10495-019-01558-4; Kaya H, 2017, KARDIOL POL, V75, P316, DOI 10.5603/KP.a2016.0168; Kraut JA, 2015, CLIN TOXICOL, V53, P589, DOI 10.3109/15563650.2015.1056880; KRUSE JA, 1994, J CRIT CARE, V9, P185, DOI 10.1016/0883-9441(94)90015-9; LANG F, 1987, RENAL PHYSIOL BIOCH, V10, P160; MARMOR A, 1993, INVEST RADIOL, V28, P439, DOI 10.1097/00004424-199305000-00012; Michels G, 2016, MED KLIN-INTENSIVMED, V111, P302, DOI 10.1007/s00063-015-0071-6; Niemeijer MN, 2015, HEART RHYTHM, V12, P2078, DOI 10.1016/j.hrthm.2015.07.011; Nomani AZ, 2014, RENAL FAILURE, V36, P1169, DOI 10.3109/0886022X.2014.926758; Oe K, 2008, INT HEART J, V49, P629, DOI 10.1536/ihj.49.629; Persson PB, 2005, EUR RADIOL, V15, pD65, DOI 10.1007/s10406-005-0113-x; Pfeiffer D, 2016, HERZ, V41, P498, DOI 10.1007/s00059-016-4463-z; Purssell RA, 2001, ANN EMERG MED, V38, P653, DOI 10.1067/mem.2001.119455; Raheja H, 2018, OPEN CARDIOVASC MED, V12, P1, DOI 10.2174/1874192401812010001; Raslan A., 2007, NEUROSURG FOCUS, V22, P4; Shawkat H, 2012, BJA EDUC, V12, P82, DOI 10.1093/bjaceaccp/mkr063; Shen YF, 2017, INT J CARDIOL, V229, P53, DOI 10.1016/j.ijcard.2016.11.228; Silvani A., 2016, PHILOS T A, V13, P374; Staikou C, 2014, BRIT J ANAESTH, V112, P217, DOI 10.1093/bja/aet412; Steinberg C, 2018, CURR OPIN CARDIOL, V33, P31, DOI 10.1097/HCO.0000000000000465; SWEENEY TE, 1993, AM J PHYSIOL, V264, pR469, DOI 10.1152/ajpregu.1993.264.3.R469; Tatlisu MA, 2017, CORONARY ARTERY DIS, V28, P70, DOI 10.1097/MCA.0000000000000426; Voulgari C, 2013, CURR CARDIOL REV, V9, P197, DOI 10.2174/1573403X113099990031; Whittington JE, 2010, CLIN CHEM, V56, P1353, DOI 10.1373/clinchem.2010.147199; Zhang NX, 2018, PACE, V41, P321, DOI 10.1111/pace.13292; Zhao F, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0224-6	39	3	3	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAY	2020	9	5							1293	10.3390/jcm9051293			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY0OO	WOS:000540223800050	32365845	gold, Green Published			2022-02-06	
J	Eskandari, F; Shafieian, M; Aghdam, MM; Laksari, K				Eskandari, Faezeh; Shafieian, Mehdi; Aghdam, Mohammad M.; Laksari, Kaveh			A knowledge map analysis of brain biomechanics: Current evidence and future directions	CLINICAL BIOMECHANICS			English	Article						Brain biomechanics; Mechanical properties; Neurological diseases; Traumatic injuries; Research trends	MAGNETIC-RESONANCE ELASTOGRAPHY; TISSUE IN-VIVO; MECHANICAL-PROPERTIES; FINITE-ELEMENT; CONSTITUTIVE MODEL; PORCINE BRAIN; WHITE-MATTER; VISCOELASTIC PROPERTIES; MR ELASTOGRAPHY; LARGE-STRAIN	Although brain, one of the most complex organs in the mammalian body, has been subjected to many studies from physiological and pathological points of view, there remain significant gaps in the available knowledge regarding its biomechanics. This article reviews the research trends in brain biomechanics with a focus on injury. We used published scientific articles indexed by Web of Science database over the past 40 years and tried to address the gaps that still exist in this field. We analyzed the data using VOSviewer, which is a software tool designed for scientometric studies. The results of this study showed that the response of brain tissue to external forces has been one of the significant research topics among biomechanicians. These studies have addressed the effects of mechanical forces on the brain and mechanisms of traumatic brain injury, as well as characterized changes in tissue behavior under trauma and other neurological diseases to provide new diagnostic and monitoring methods. In this study, some challenges in the field of brain injury biomechanics have been identified and new directions toward understanding the gaps in this field are suggested.	[Eskandari, Faezeh; Shafieian, Mehdi] Amirkabir Univ Technol, Dept Biomed Engn, Tehran Polytech, Tehran, Iran; [Aghdam, Mohammad M.] Amirkabir Univ Technol, Dept Mech Engn, Tehran Polytech, Tehran, Iran; [Laksari, Kaveh] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA		Shafieian, M (corresponding author), Amirkabir Univ Technol, Tehran Polytech, 424 Hafez Ave, Tehran 1591634311, Iran.	shafieian@aut.ac.ir		Eskandari, Faezeh/0000-0003-1221-6733			Alastrue V, 2007, INT J SOLIDS STRUCT, V44, P5894, DOI 10.1016/j.ijsolstr.2007.02.004; Alfasi AM, 2013, J NEUROSURG, V119, P1255, DOI 10.3171/2013.7.JNS121973; Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Badachhape AA, 2018, J BIOMECH, V73, P40, DOI 10.1016/j.jbiomech.2018.03.028; Badachhape AA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036146; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Begonia MT, 2010, ANN BIOMED ENG, V38, P3043, DOI 10.1007/s10439-010-0072-9; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Bosche KV, 2017, P I MECH ENG H, V231, P851, DOI 10.1177/0954411917711201; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chaze CA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101750; Chen FQ, 2015, ANN BIOMED ENG, V43, P2903, DOI 10.1007/s10439-015-1350-3; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; CHU BM, 1972, ANN BIOMED ENG, V1, P204, DOI 10.1007/BF02584207; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; de Campo D, 2018, PEDIATR NEUROL, V86, P19, DOI 10.1016/j.pediatrneurol.2018.06.005; Destrade M, 2015, INT J NONLIN MECH, V75, P54, DOI 10.1016/j.ijnonlinmec.2015.02.014; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Falland-Cheung L, 2018, J MECH BEHAV BIOMED, V77, P609, DOI 10.1016/j.jmbbm.2017.10.026; Fattahi N, 2016, AM J NEURORADIOL, V37, P462, DOI 10.3174/ajnr.A4560; Feng Y, 2016, PHYS MED BIOL, V61, P6121, DOI 10.1088/0031-9155/61/16/6121; Feng Y, 2017, J MECH BEHAV BIOMED, V71, P407, DOI 10.1016/j.jmbbm.2017.04.008; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Ferrant M, 2001, IEEE T MED IMAGING, V20, P1384, DOI 10.1109/42.974933; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Freimann FB, 2012, NEURORADIOLOGY, V54, P189, DOI 10.1007/s00234-011-0871-1; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guertler CA, 2018, J BIOMECH, V69, P10, DOI 10.1016/j.jbiomech.2018.01.016; Guo ZY, 2009, MED ENG PHYS, V31, P1104, DOI 10.1016/j.medengphy.2009.06.011; Haslach HW, 2017, J MECH BEHAV BIOMED, V68, P88, DOI 10.1016/j.jmbbm.2017.01.036; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Kurt M, 2019, J NEUROIMAGING, V29, P440, DOI 10.1111/jon.12619; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0; Labus KM, 2016, J MECH PHYS SOLIDS, V96, P591, DOI 10.1016/j.jmps.2016.08.010; Labus KM, 2016, J MECH BEHAV BIOMED, V62, P195, DOI 10.1016/j.jmbbm.2016.05.003; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Laksari K, 2015, BIOMECH MODEL MECHAN, V14, P459, DOI 10.1007/s10237-014-0616-2; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Levadnyi I, 2018, J MED BIOL ENG, V38, P587, DOI 10.1007/s40846-017-0324-3; Li DL, 2012, INT J NUMER METH ENG, V92, P457, DOI 10.1002/nme.4342; Li G, 2016, J MECH BEHAV BIOMED, V57, P224, DOI 10.1016/j.jmbbm.2015.12.002; Li K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123506; Li WQ, 2020, J MECH BEHAV BIOMED, V102, DOI 10.1016/j.jmbbm.2019.103460; Li WG, 2016, ANN BIOMED ENG, V44, P3109, DOI 10.1007/s10439-016-1603-9; Liao HY, 1999, J BIOMECH, V32, P183, DOI 10.1016/S0021-9290(98)00169-9; Lipp A, 2013, NEUROIMAGE-CLIN, V3, P381, DOI 10.1016/j.nicl.2013.09.006; Lippert SA, 2004, BIORHEOLOGY, V41, P681; Liu YL, 2018, J MECH BEHAV BIOMED, V83, P120, DOI 10.1016/j.jmbbm.2018.04.017; Liu YL, 2017, J MECH BEHAV BIOMED, V65, P652, DOI 10.1016/j.jmbbm.2016.09.026; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Miller K, 2010, INT J NUMER METH BIO, V26, P117, DOI 10.1002/cnm.1260; Murphy MC, 2013, J NEUROSURG, V118, P643, DOI 10.3171/2012.9.JNS12519; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Natali AN, 2005, MED ENG PHYS, V27, P209, DOI 10.1016/j.medengphy.2004.10.011; Pena E, 2010, J BIOMECH, V43, P984, DOI 10.1016/j.jbiomech.2009.10.046; Pepin KM, 2014, MAGN RESON MED, V71, P1834, DOI 10.1002/mrm.24825; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pong AC, 2016, J BIOMECH, V49, P1751, DOI 10.1016/j.jbiomech.2016.04.005; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Qian L, 2018, J MECH BEHAV BIOMED, V82, P210, DOI 10.1016/j.jmbbm.2018.03.031; Qiu SH, 2020, J NEUROSCI METH, V330, DOI 10.1016/j.jneumeth.2019.108463; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Romano A, 2014, MAGN RESON MED, V72, P1755, DOI 10.1002/mrm.25067; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Samadi-Dooki A, 2018, J MECH BEHAV BIOMED, V77, P24, DOI 10.1016/j.jmbbm.2017.08.037; Samadi-Dooki A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036486; Sarvghad-Moghaddam H, 2017, SHOCK WAVES, V27, P919, DOI 10.1007/s00193-017-0749-1; Sawyer TW, 2018, SHOCK WAVES, V28, P85, DOI 10.1007/s00193-017-0756-2; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Shulyakov AV, 2011, J MECH BEHAV BIOMED, V4, P484, DOI 10.1016/j.jmbbm.2010.12.012; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Testu J, 2017, J MECH BEHAV BIOMED, V74, P333, DOI 10.1016/j.jmbbm.2017.06.027; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; van Eck N. J., 2013, VOSVIEWER MANUAL; van Eck NJ, 2011, TEXT MINING VISUALIZ, V7, P1; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V84, P88, DOI 10.1016/j.jmbbm.2018.04.009; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V77, P702, DOI 10.1016/j.jmbbm.2017.08.029; Weickenmeier J, 2017, J MECH BEHAV BIOMED, V76, P119, DOI 10.1016/j.jmbbm.2017.04.017; Yang J., 2011, INVESTIGATION BRAIN, DOI [10.1007/978-1-4419-5874-7., DOI 10.1007/978-1-4419-5874-7]; Yeung J, 2019, BIOMECH MODEL MECHAN, V18, P1497, DOI 10.1007/s10237-019-01157-x; Yue HZ, 2017, J MECH MED BIOL, V17, DOI 10.1142/S0219519417500014; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang W, 2016, J BIOMECH, V49, P3990, DOI 10.1016/j.jbiomech.2016.10.032; Zhang W, 2016, J APPL MECH-T ASME, V83, DOI 10.1115/1.4033890; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhou YJ, 2015, MATER DESIGN, V88, P162, DOI 10.1016/j.matdes.2015.08.120	134	3	3	1	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	MAY	2020	75								105000	10.1016/j.clinbiomech.2020.105000			11	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	LN1BE	WOS:000532679000001	32361083				2022-02-06	
J	Godeanu, CS; Costea, T; Ghica, M; Lupuliasa, D; Gird, CE				Godeanu, Constantin Sorin; Costea, Teodora; Ghica, Manuela; Lupuliasa, Dumitru; Gird, Cerasela Elena			EVIDENCE-BASED USE OF SEA BUCKTHORN FRESH JUICE FOR PATIENTS WITH TRAUMATIC BRAIN INJURY. A PILOT STUDY	FARMACIA			English	Article						sea buckthorn berry juice; polyphenols; antioxidant capacity; traumatic brain injury	ANTIOXIDANT ACTIVITY; SIGNALING PATHWAY; L.; POLYPHENOLS; HYPONATREMIA; EXTRACTS; BERRIES; LEAVES	Sea buckthorn (Hippophae rhamnoides L.) berries are widely used for their nutrional value and therapeutic effects. The aim of our paper was the evolution of phenolic content (by means of spectrophotometric methods), antioxidant capacity (scavenger activity towards DPPH, ABTS center dot+ free radicals and ferric reducing power) and evidence regarding sea buckthorn fresh juice association in the management of hospitalized patients with traumatic brain injury. According to our results, sea buckthorn fresh juice is a source of phenolic compounds (0.28 g total phenolic content expressed as tannic acid equivalents/100 mL fresh juice and 0.09 g flavones expressed as hyperoside equivalents/100 mL fresh juice), with antioxidant activity. Our clinical results have shown beneficial effects (a decrease in lactate and sodium blood levels and an increase in Glasgow coma score) of sea buckthorn fresh juice (given together with specific medication) in the management of patients with traumatic brain injury.	[Godeanu, Constantin Sorin] Floreasca Emergency Clin Hosp, Dept Anaesthesia & Intens Care Unit, Bucharest 014461, Romania; [Costea, Teodora; Ghica, Manuela; Lupuliasa, Dumitru; Gird, Cerasela Elena] Carol Davila Univ Med & Pharm, Fac Pharm, Bucharest 020956, Romania		Costea, T (corresponding author), Carol Davila Univ Med & Pharm, Fac Pharm, Bucharest 020956, Romania.	teodora.costea@umfcd.ro					Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Chang CH, 2008, AM J MED SCI, V335, P390, DOI 10.1097/MAJ.0b013e318149e6f1; Chen DY, 2018, MOL MED REP, V17, P1340, DOI 10.3892/mmr.2017.7987; Christaki E., 2012, Food and Public Health, V2, P69; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Costea T, 2014, FARMACIA, V62, P961; Dong RF, 2017, J FUNCT FOODS, V37, P513, DOI 10.1016/j.jff.2017.08.019; Ghica M, 2020, P 6 INT C INT MAN DI, P98; Ghica M, 2018, PROCEEDINGS OF THE ROMANIAN NATIONAL CONGRESS OF PHARMACY, 17TH EDITION, P84; Gird CE, 2017, FARMACIA, V65, P703; Gritti P, 2014, J ANESTH, V28, P687, DOI 10.1007/s00540-014-1814-x; Guo RX, 2017, FOOD CHEM, V221, P997, DOI 10.1016/j.foodchem.2016.11.063; Khalatbary Ali Reza, 2014, Iranian Biomedical Journal, V18, P120, DOI 10.6091/ibj.12782.2014; Korekar G, 2014, LWT-FOOD SCI TECHNOL, V55, P157, DOI 10.1016/j.lwt.2013.09.006; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Maggiore U, 2009, CRIT CARE MED, V13, P1; Mair P, 2020, BEHAV RES METHODS, V52, P464, DOI 10.3758/s13428-019-01246-w; Mendelova A., 2016, Potravinarstvo: Scientific Journal for Food Industry, V10, P59, DOI 10.5219/551; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rop O, 2014, TURK J AGRIC FOR, V38, P224, DOI 10.3906/tar-1304-86; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Teleszko M, 2015, J AGR FOOD CHEM, V63, P4120, DOI 10.1021/acs.jafc.5b00564; Tian Y, 2018, FOOD RES INT, V106, P291, DOI 10.1016/j.foodres.2017.12.071; Uivarosan D, 2018, FARMACIA, V66, P826, DOI 10.31925/farmacia.2018.5.12; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Yang W, 2016, J AGR FOOD CHEM, V64, P1274, DOI 10.1021/acs.jafc.5b05718	31	3	3	1	4	SOC STIINTE FARMACEUTICE ROMANIA	BUCURESTI	BUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI, 020956, ROMANIA	0014-8237	2065-0019		FARMACIA	Farmacia	MAY-JUN	2020	68	3					541	546		10.31925/farmacia.2020.3.21			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	MC5KV	WOS:000543326400021		gold			2022-02-06	
J	Gromisch, ES; Turner, AP; Leipertz, SL; Beauvais, J; Haselkorn, JK				Gromisch, Elizabeth S.; Turner, Aaron P.; Leipertz, Steven L.; Beauvais, John; Haselkorn, Jodie K.			Risk Factors for Suboptimal Medication Adherence in Persons With Multiple Sclerosis: Development of an Electronic Health Record-Based Explanatory Model for Disease-Modifying Therapy Use	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting of the Consortium-of-Multiple-Sclerosis-Centers	JUN 01, 2019	Seattle, WA	Consortium Multiple Sclerosis Ctr		Appointments and schedules; Electronic health records; Medication adherence; Multiple sclerosis; Rehabilitation; Risk factors	INJECTION ANXIETY; PERSISTENCE; VETERANS; DRUGS; BETA	Objective: To determine which factors are associated with suboptimal disease-modifying therapy (DMT) adherence and to develop an explanatory model that could be used to identify individuals at risk and potentially inform interventions. Design: Cross-sectional cohort study using electronic health records. Setting: Veterans Health Administration (VA). Participants: Veterans with multiple sclerosis (MS) (N=2939; 79.69% men) who received care through the VA and were included in the VA MS Center of Excellence Data Repository. Interventions: Not applicable. Main Outcome Measures: Suboptimal DMT adherence (<80%), demographics, co-occurring conditions, and health care use. Results: Nearly 31% of participants had suboptimal adherence. Flags for suboptimal adherence included >20% missed appointments (odds ratio [OR], 3.78; 95% CI, 2.45-2.82), traumatic brain injuries (OR, 1.55; 95% CI, 1.12-2.14), age younger than 59 years (OR, 1.47; 95% CI, 1.23-1.74), >= 1 emergency department visits (OR, 1.40; 95% CI, 1.18-1.67), mood disorders (ie, depressive and bipolar disorders) (OR, 1.40; 95% CI, 1.181.66), and service connection (OR, 1.22; 95% CI, 1.01-1.47). Hyperlipidemia (OR, 0.77; 95% CI, 0.65-0.92) and being issued a wheelchair (OR, 0.83; 95% CI, 0.70-1.00) were associated with lower risk. Conclusions: Suboptimal adherence to DMTs continues to be an issue. Interventions that focus on person-level barriers should be urgently explored to increase adherence and improve self-management abilities. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine.	[Gromisch, Elizabeth S.] Trinity Hlth New England, Mt Sinai Rehabil Hosp, Mandell Ctr Multiple Sclerosis, Hartford, CT USA; [Gromisch, Elizabeth S.; Beauvais, John] VA Connecticut Healthcare Syst, Psychol Serv, West Haven, CT USA; [Gromisch, Elizabeth S.] Univ Connecticut, Sch Med, Dept Neurol, Farmington, CT USA; [Gromisch, Elizabeth S.] Quinnipiac Univ, Dept Rehabilitat Med, Frank H Netter MD Sch Med, North Haven, CT USA; [Gromisch, Elizabeth S.] Quinnipiac Univ, Dept Med Sci, Frank H Netter MD Sch Med, North Haven, CT USA; [Turner, Aaron P.; Leipertz, Steven L.; Haselkorn, Jodie K.] US Dept Vet Affairs, Multiple Sclerosis Ctr Excellence West, Seattle, WA USA; [Turner, Aaron P.; Haselkorn, Jodie K.] VA Puget Sound Hlth Care Syst, Rehabil Care Serv, Seattle, WA USA; [Turner, Aaron P.; Haselkorn, Jodie K.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Beauvais, John] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Haselkorn, Jodie K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Gromisch, ES (corresponding author), 490 Blue Hills Ave, Hartford, CT 06112 USA.	elizabeth.gromisch@trinityhealthofne.org	Turner, Aaron/A-7902-2009	Turner, Aaron/0000-0001-6897-8003	Bell-Kerns Award from VA Connecticut Healthcare System; VA MS Centers of Excellence	Supported in part by the Bell-Kerns Award from VA Connecticut Healthcare System and the VA MS Centers of Excellence.	Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Burks J, 2017, CLINICOECONOMIC OUTC, V9, P251, DOI 10.2147/CEOR.S130334; Culpepper WJ, 2006, J REHABIL RES DEV, V43, P17, DOI 10.1682/JRRD.2004.09.0122; de Seze J, 2012, PATIENT PREFER ADHER, V6, P263, DOI 10.2147/PPA.S27038; Evans C, 2016, MULT SCLER RELAT DIS, V8, P78, DOI 10.1016/j.msard.2016.05.006; Freedman MS, 2006, EXPERT OPIN PHARMACO, V7, pS1, DOI 10.1517/14656566.7.1.S1; Halpern R, 2011, ADV THER, V28, P761, DOI 10.1007/s12325-011-0054-9; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; Lafata JE, 2008, J AM PHARM ASSOC, V48, P752, DOI 10.1331/JAPhA.2008.07116; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Mohr DC, 2001, ANN BEHAV MED, V23, P125, DOI 10.1207/S15324796ABM2302_7; Ogedegbe G, 2007, J GEN INTERN MED, V22, P1176, DOI 10.1007/s11606-007-0244-y; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Sainani KL, 2014, PM&R, V6, P841, DOI 10.1016/j.pmrj.2014.08.941; Siegel SD, 2008, REHABIL PSYCHOL, V53, P73, DOI 10.1037/0090-5550.53.1.73; Stecker T, 2010, PSYCHOSOMATICS, V51, P503, DOI 10.1176/appi.psy.51.6.503; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thach Andrew V, 2018, Int J MS Care, V20, P251, DOI 10.7224/1537-2073.2017-031; Touchette DR, 2008, J MANAGE CARE PHARM, V14, pS2; Tremlett H, 2008, PHARMACOEPIDEM DR S, V17, P565, DOI 10.1002/pds.1593; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Tsivgoulis G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144538; Turner AP, 2007, MULT SCLER, V13, P1146, DOI 10.1177/1352458507078911; Turner AP, 2014, REHABIL PSYCHOL, V59, P136, DOI 10.1037/a0036322; Turner AP, 2013, PM&R, V5, P1044, DOI 10.1016/j.pmrj.2013.07.009; Turner AP, 2009, REHABIL PSYCHOL, V54, P116, DOI 10.1037/a0014460; Vollmer TL, 2002, J REHABIL RES DEV, V39, P163; Wallin MT, 2019, NEUROLOGY, V92, pE1029, DOI 10.1212/WNL.0000000000007035; Wiegand P, 2012, AM J MANAG CARE, V18, P193; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	32	3	3	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2020	101	5					807	814		10.1016/j.apmr.2019.11.005			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	MC0ZD	WOS:000543025400008	31809751				2022-02-06	
J	Howell, DR; Oldham, J; Lanois, C; Koerte, I; Lin, AP; Berkstresser, B; Wang, F; Meehan, WP				Howell, David R.; Oldham, Jessie; Lanois, Corey; Koerte, Inga; Lin, Alexander P.; Berkstresser, Brant; Wang, Francis; Meehan, William P., III			Dual-Task Gait Recovery after Concussion among Female and Male Collegiate Athletes	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						LOCOMOTION; ATTENTION; MILD TRAUMATIC BRAIN INJURY; SEX DIFFERENCE	SPORTS-RELATED CONCUSSION; GENDER-DIFFERENCES; CONTROL DEFICITS; NORMATIVE DATA; RISK-FACTORS; SINGLE-TASK; INJURY; ASSOCIATION; ADOLESCENTS; PERFORMANCE	Purpose Few studies have investigated recovery between sexes using objective outcome measures. Our purpose was to examine the independent association between biological sex and recovery of postconcussion gait among collegiate athletes. Methods We evaluated participants with a diagnosed concussion <7 d postinjury, and approximately 1.5 months and 3.5 months postinjury. Participants completed a single/dual-task gait evaluation and symptom inventory. During dual-task trials, they completed a mental task (backward subtraction, spelling, or month recitation). The primary outcome measure was height-adjusted gait velocity recovery, defined as achieving normal gait velocity using established values: >0.56 and >0.50 gait velocity (m center dot s(-1))/height (m) under single and dual-task conditions, respectively. We used a multivariable Cox proportional hazard model to identify associations between sex and dual-task recovery, controlling for age, concussion history, symptom severity, and loss of consciousness at the time of injury. Results Ninety-four individuals participated in the study: 47 (50%) were female athletes (mean age = 20.1, SD = 1.3 yr) and 47 (50%) were male athletes (mean age = 20.3, SD = 1.3 yr). Sex was not independently associated with height-adjusted single-task gait velocity recovery after controlling for potential confounders (hazard ratio = 1.62, 95% confidence interval = 0.87-3.01). However, male sex was independently associated with longer dual-task gait recovery time after controlling for potential confounders (hazard ratio = 2.43, 95% confidence interval = 1.11-5.35). Conclusion Male athletes required a longer duration of time after concussion to achieve dual-task gait recovery than female athletes. Thus, functional dual-task abilities after concussion may be affected differentially by sex and should be accounted for within individualized concussion management strategies.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Howell, David R.; Oldham, Jessie; Lanois, Corey; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Oldham, Jessie; Lanois, Corey] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Koerte, Inga; Meehan, William P., III] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Koerte, Inga] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Lin, Alexander P.] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Berkstresser, Brant; Wang, Francis] Harvard Univ, Hlth Serv, Cambridge, MA 02138 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA		Howell, DR (corresponding author), Univ Colorado, Childrens Hosp Colorado, Sports Med Ctr, Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu	Koerte, Inga Katharina/AAW-3031-2021		National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952]; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League	Research reported in this work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS100952.; Unrelated to this work, Dr. Howell has received research support from the National Institutes of Health (R03HD094560 and R41NS103698). Dr. Meehan receives royalties from 1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents and Concussions; 2) Springer International for the book Head and Neck Injuries in the Young Athlete; and 3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and a grant from the National Football League. The remaining authors have conflicts to disclose. The results of the present study do not constitute endorsement by the American College of Sports Medicine. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bruening DA, 2015, GAIT POSTURE, V41, P540, DOI 10.1016/j.gaitpost.2014.12.011; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Chermann JF, 2014, ASIAN J SPORTS MED, V5; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dudley William N, 2016, J Adv Pract Oncol, V7, P91; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hassler C, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0106-7; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, J APPL BIOMECH, V35, P290, DOI 10.1123/jab.2018-0454; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson A. L., 2018, AM J SPORTS MED; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Plummer P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00225; Read PJ, 2016, SPORTS MED, V46, P1059, DOI 10.1007/s40279-016-0479-z; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Smith LK, 2002, J WOMEN HEALTH GEN-B, V11, P453, DOI 10.1089/15246090260137626; Stoet G., 2013, BMC PSYCHOL, V1, P18, DOI [10.1186/2050-7283-1-18, DOI 10.1186/2050-7283-1-18]; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	40	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	MAY	2020	52	5					1015	1021		10.1249/MSS.0000000000002225			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LP5GM	WOS:000534345900002	31985574	Green Accepted, Bronze			2022-02-06	
J	Hwang, HF; Chen, CY; Wei, L; Chen, SJ; Yu, WY; Lin, MR				Hwang, Hei-Fen; Chen, Chih-Yi; Wei, Li; Chen, Sy-Jou; Yu, Wen-Yu; Lin, Mau-Roung			Effects of Computerized Cognitive Training and Tai Chi on Cognitive Performance in Older Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive training; older adults; physical activity; traumatic brain injury	RELIABLE CHANGE INDEXES; MINI-MENTAL-STATE; REHABILITATION; EPIDEMIOLOGY; DEMENTIA; VALIDITY; OUTCOMES; SCALE	Objective: To compare the effects of computerized cognitive training (CCT) and tai chi (TC) with usual care (UC) on cognitive functions and secondary outcomes in older adults with traumatic brain injury. Participants and Settings: Ninety-six patients aged 55 years and older who had a diagnosis of traumatic brain injury requiring hospital admission. Design: Randomized controlled trial. Main Measures: The Mattis Dementia Rating Scale (MDRS), Mini-Mental State Examination, modified Telephone Interview of Cognitive Status, and Trail Making Tests A and B. Results: Compared with UC, CCT increased scores on the MDRS's total, attention, and memory and those on the Mini-Mental State Examination and Telephone Interview of Cognitive Status over the 6-month intervention; TC increased scores on the MDRS's total and conceptualization and those on the Mini-Mental State Examination over the 6-month intervention, while it also increased scores on the MDRS's total and initiation/preservation and those on the Telephone Interview of Cognitive Status and reduced the time to complete the Trail Making Test B over the 12-month study. Furthermore, compared with UC, CCT increased handgrip strength and TC reduced the time to complete 5 sit-to-stands over the 6-month intervention. Conclusion: Both CCT and TC may improve global cognition and different specific cognitive domains in older traumatic brain injury patients; the TC's effect may last for at least an additional 6 months.	[Hwang, Hei-Fen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Hwang, Hei-Fen; Chen, Sy-Jou; Lin, Mau-Roung] Taipei Med Univ, Inst Injury Prevent & Control, Coll Publ Hlth, Taipei, Taiwan; [Wei, Li] Taipei Tzu Chi Hosp, Div Neurosurg, Dept Surg, Buddhist Tzu Chi Med Fdn, New Taipei, Taiwan; [Chen, Chih-Yi] Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan; [Yu, Wen-Yu] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Lin, Mau-Roung] Taipei Med Univ, Master Program Long Term Care, Coll Nursing, Taipei, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 11031, Taiwan.	mrlin@tmu.edu.tw			National Health Research InstitutesNational Health Research Institutes, Japan [NHRI-EX106-10317PI, NHRI-EX108-10804PI]; Ministry of Science and Technology [MOST103-2314-B-038-012-MY3, MOST106-2314-B-038-046-MY3]	This work was funded by the National Health Research Institutes (NHRI-EX106-10317PI and NHRI-EX108-10804PI) and the Ministry of Science and Technology (MOST103-2314-B-038-012-MY3 and MOST106-2314-B-038-046-MY3), Taiwan.	Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Chan AS, 2003, J INT NEUROPSYCH SOC, V9, P45, DOI 10.1017/S1355617703910058; Cheng ST, 2014, AM J GERIAT PSYCHIAT, V22, P63, DOI 10.1016/j.jagp.2013.01.060; Cheng Y, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-30; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Guo N.W., 1988, J REHABIL MED ASS, V16, P52, DOI DOI 10.1007/978-94-011-7973-7_3; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Hensel A, 2007, J NEUROL NEUROSUR PS, V78, P1298, DOI 10.1136/jnnp.2006.109074; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lines CR, 2003, NEUROLOGY, V60, P261, DOI 10.1212/01.WNL.0000042481.34899.13; Lu L, 2000, Appl Neuropsychol, V7, P243, DOI 10.1207/S15324826AN0704_6; Maths S, 1976, GERIATRIC PSYCHIAT; Max Planck Institute for Human Development and Stanford Center on Longevity, 2014, CONS BRAIN TRAIN IND CONS BRAIN TRAIN IND; Meng C, 2015, CHINESE MENTAL HLTH, V1, P34; Pedraza O, 2007, J INT NEUROPSYCH SOC, V13, P716, DOI 10.1017/S1355617707070920; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Stein J, 2010, DEMENT GERIATR COGN, V29, P275, DOI 10.1159/000289779; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sungkarat S, 2017, J AM GERIATR SOC, V65, P721, DOI 10.1111/jgs.14594; Tao J, 2017, J ALZHEIMERS DIS, V60, P389, DOI 10.3233/JAD-170477; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P95, DOI 10.1089/acm.2007.7170A; Wayne PM, 2014, J AM GERIATR SOC, V62, P25, DOI 10.1111/jgs.12611; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu Ge, 2008, V52, P30, DOI 10.1159/000134282; Zanesco AP, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00566	41	3	3	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		187	197		10.1097/HTR.0000000000000533			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200003	31479083				2022-02-06	
J	Kuperman, P; Granovsky, Y; Bahouth, H; Fadel, S; Ben Lulu, H; Bosak, N; Buxbaum, C; Sprecher, E; Crystal, S; Granot, M				Kuperman, Pora; Granovsky, Yelena; Bahouth, Hany; Fadel, Shiri; Ben Lulu, Hen; Bosak, Noam; Buxbaum, Chen; Sprecher, Elliot; Crystal, Shoshana; Granot, Michal			Explaining very early acute mild traumatic brain injury after motor vehicle collision pain variability: additive value of pain sensitivity questionnaire	PAIN REPORTS			English	Article						Mild traumatic brain injury; Pain; Quantitative sensory testing; Pain Sensitivity Questionnaire; Motor vehicle collision	POSTOPERATIVE PAIN; MODULATION; PREDICTION; VALIDATION; EXPERIENCE; INTENSITY; ANXIETY	Introduction and Objectives:Chronic pain is a common postcollision consequence. Wherein, a clearer understanding of acute pain can help stem the acute-to-chronic pain transition. However, the variability of acute pain is only partially explained by psychophysical pain characteristics as measured by quantitative sensory testing. The Pain Sensitivity Questionnaire (PSQ) may reflect inherent psychocognitive representations of patient's sensitivity and thus may reveal less-explored pain dimensions. In the vein of the biopsychosocial approach, this study aimed to explore whether PSQ holds additive value in explaining head and neck pain reports in very early acute-stage mild traumatic brain injury (mTBI) after collision, above the use of psychophysical assessment.Methods:Study cohort (n = 130) consisted of mTBI patients (age range 19-66, 57 F) after accident with area-of-injury pain of at least 20 on the day of testing (mean pain 58.4 21.6, range 20-100 Numerical Pain Scale) who underwent clinical, psychophysical, and pain-related psychological assessment within 72-hour after injury.Results:Pain Sensitivity Questionnaire scores were significantly correlated with acute clinical, psychophysical, and pain-related psychological measures. Regression model (R-2 = 0.241, P < 0.001) showed that, together, age, sex, high PSQ, enhanced temporal summation, and less-efficient conditioned pain modulation explained head and neck pain variance. This model demonstrated that the strongest contribution to degree of postinjury pain was independently explained by PSQ (<ss> = 0.32) and then pressure pain threshold-conditioned pain modulation (ss = -0.25).Conclusion:Appraisal of cognitive daily-pain representations, by way of memory and imagination, provides an additional important dispositional facet to explain the variability in the acute mTBI postcollision clinical pain experience, above assessing nociceptive responsiveness to experimentally induced pain.	[Kuperman, Pora; Granovsky, Yelena; Fadel, Shiri; Crystal, Shoshana] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Bahouth, Hany; Ben Lulu, Hen] Rambam Hlth Care Campus, Trauma & Emergency Surg, Haifa, Israel; [Bosak, Noam; Buxbaum, Chen; Sprecher, Elliot] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel; [Granot, Michal] Univ Haifa, Fac Welf & Hlth Sci, IL-31905 Haifa, Israel		Granot, M (corresponding author), Univ Haifa, Fac Welf & Hlth Sci, IL-31905 Haifa, Israel.	granot@research.haifa.ac.il			Office of the Assistant Secretary of Defense for Health Affairs [W81XWH15-1-0603]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under award W81XWH15-1-0603. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Albu S, 2015, PAIN, V156, P260, DOI 10.1097/01.j.pain.0000460306.48701.f9; Bar-Shalita T, 2015, RES DEV DISABIL, V45-46, P157, DOI 10.1016/j.ridd.2015.07.028; Carroll LJ, 2006, PAIN, V124, P18, DOI 10.1016/j.pain.2006.03.012; CHAPLIN WF, 1988, J PERS SOC PSYCHOL, V54, P541, DOI 10.1037/0022-3514.54.4.541; Chung F., 2011, ANESTHESIOLOGY, V114, P445; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Coronado RA, 2018, MUSCULOSKEL SCI PRAC, V36, P61, DOI 10.1016/j.msksp.2018.04.009; Drory Y., 1989, STRESS QUESTIONNAIRE; Edwards RR, 2005, NEUROLOGY, V65, P437, DOI 10.1212/01.wnl.0000171862.17301.84; Granot M, 2005, CLIN J PAIN, V21, P439, DOI 10.1097/01.ajp.0000135236.12705.2d; Granot M, 2003, ANESTHESIOLOGY, V98, P1422, DOI 10.1097/00000542-200306000-00018; Granot M, 2008, PAIN, V136, P142, DOI 10.1016/j.pain.2007.06.029; Granot M, 2009, CURR OPIN ANESTHESIO, V22, P425, DOI 10.1097/ACO.0b013e32832a40e1; Granovsky Y, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000725; Granovsky Y, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10131; Granovsky Y, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0361-8; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Kim HJ, 2014, PAIN PRACT, V14, P745, DOI 10.1111/papr.12123; Kuperman P, 2018, NEUROLOGY, V91, pE931, DOI 10.1212/WNL.0000000000006120; Larsson B, 2017, CLIN J PAIN, V33, P579, DOI 10.1097/AJP.0000000000000441; Lewis GN, 2012, J PAIN, V13, P936, DOI 10.1016/j.jpain.2012.07.005; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Martorella G, 2008, J ADV NURS, V63, P417, DOI 10.1111/j.1365-2648.2008.04699.x; Melotti R, 2018, J PAIN, V19, P1424, DOI 10.1016/j.jpain.2018.06.007; MELZACK R, 1989, REGION ANESTH, V14, P208; Melzack Ronald, 2005, Pain Pract, V5, P85, DOI 10.1111/j.1533-2500.2005.05203.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Niesters M, 2014, BRIT J ANAESTH, V113, P148, DOI 10.1093/bja/aeu056; O'Brien AT, 2018, J PAIN, V19, P819, DOI 10.1016/j.jpain.2018.01.010; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Osgood E, 2015, RHEUMATOL INT, V35, P1005, DOI 10.1007/s00296-014-3191-z; Rehberg B, 2017, CLIN J PAIN, V33, P57, DOI 10.1097/AJP.0000000000000380; Ruscheweyh R, 2012, PAIN, V153, P1210, DOI 10.1016/j.pain.2012.02.025; Ruscheweyh R, 2009, PAIN, V146, P65, DOI 10.1016/j.pain.2009.06.020; Sellers AB, 2013, REGION ANESTH PAIN M, V38, P508, DOI 10.1097/AAP.0000000000000007; Stern AF, 2014, OCCUP MED-OXFORD, V64, P393, DOI 10.1093/occmed/kqu024; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Turner JA, 2001, CLIN J PAIN, V17, P65, DOI 10.1097/00002508-200103000-00009; Yarnitsky D, 2015, EUR J PAIN, V19, P805, DOI 10.1002/ejp.605; Yarnitsky D, 2014, PAIN, V155, P663, DOI 10.1016/j.pain.2013.11.005	41	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA		2471-2531		PAIN REP	Pain Rep.	MAY-JUN	2020	5	3								10.1097/PR9.0000000000000821			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	UN1MN	WOS:000693786400002	32903910	Green Published, gold			2022-02-06	
J	Kurowski, BG; Taylor, HG; McNally, KA; Kirkwood, MW; Cassedy, A; Horn, PS; Stancin, T; Wade, SL				Kurowski, Brad G.; Taylor, H. Gerry; McNally, Kelly A.; Kirkwood, Michael W.; Cassedy, Amy; Horn, Paul S.; Stancin, Terry; Wade, Shari L.			Online Family Problem-Solving Therapy (F-PST) for Executive and Behavioral Dysfunction After Traumatic Brain Injury in Adolescents: A Randomized, Multicenter, Comparative Effectiveness Clinical Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; executive function; online; therapy; traumatic brain injury	DIFFICULTIES QUESTIONNAIRE; RATING INVENTORY; COMPLICATED MILD; STRENGTHS; SELF; CHILDHOOD; OUTCOMES; TEEN; CHILDREN; EFFICACY	Objective: To examine the comparative effectiveness of 3 modes of family problem-solving therapy (F-PST): therapist-guided online, self-guided online, and face-to-face. Setting: Four children's hospitals and a general hospital with pediatric commitment. Participants: A total of 150 adolescents aged 14 to 18 years, previously hospitalized with traumatic brain injury (TBI), and evidence of behavior problems at enrollment. Design: Multicenter, randomized clinical trial. Main Measures: Behavior Rating Inventory of Executive Function (BRIEF) Global Executive Composite (GEC), Behavior Regulation Index, and Metacognition Index, and Strengths and Difficulties Questionnaire (SDQ) Total at baseline and 6 and 9 months later. Results: Mixed-model intention-to-treat analyses of comparative effectiveness failed to reveal statistically significant differences among treatment groups. At 6 months, parent BRIEF-GEC improved for the therapist-guided and self-guided, online groups. Effects remained significant and increased in magnitude at 9 months for the self-guided online group. Scores for the Self-guided online group significantly improved from baseline to 9 months on the SDQ Total. Conclusions: This comparative effectiveness study supports the utility of both self- and therapist-guided online F-PST in improving executive function behaviors in adolescents following TBI. Further work regarding clinical implementation and how best to integrate telehealth with ongoing rehabilitation care is warranted.	[Kurowski, Brad G.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med,Dept Pediat, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med,Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Cassedy, Amy] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Epidemiol & Biostat,Dept Pediat, Cincinnati, OH USA; [Horn, Paul S.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Neurol,Dept Pediat, Cincinnati, OH USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med,Dept Pediat, Cincinnati, OH USA; [Taylor, H. Gerry] Nationwide Childrens Hosp, Biobehav Hlth Ctr, Abigail Wexner Res Inst, Columbus, OH USA; [Taylor, H. Gerry; McNally, Kelly A.] Ohio State Univ, Columbus, OH 43210 USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Med Ctr, Cleveland, OH 44106 USA; [McNally, Kelly A.] Nationwide Childrens Hosp, Columbus, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org			Patient-Centered Outcomes Research Institute AwardPatient-Centered Outcomes Research Institute - PCORI [PCORI-CER-1306-02435]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA199160] Funding Source: NIH RePORTER	Funding for this study was provided by thePatient-Centered Outcomes Research Institute. Information reported in this work/publication was funded through a Patient-Centered Outcomes Research Institute Award (PCORI-CER-1306-02435). The views, statements, and opinions in this work/publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors, or Methodology Committee.	Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Brown H., 1999, APPL MIXED MODELS ME; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Faul M, 2010, TRAUMATIC BRAIN INJU; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1111/1469-7610.00494; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kurowski BG, 2018, CONT CLIN TRIAL COMM, V10, P111, DOI 10.1016/j.conctc.2018.04.001; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Musiat P, 2014, PSYCHOL MED, V44, P3137, DOI 10.1017/S0033291714000245; Office of Health Policy Office of the Assistant Secretary for Planning and Evaluation, 2016, REP C E HLTH TEL; Ownsworth T, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000350; Pew Research Center, TEENS SOCIAL MEDIA T; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, P158, DOI 10.1097/HTR.0000000000000331; Rhine T, 2018, J HEAD TRAUMA REHAB, V33, P210, DOI 10.1097/HTR.0000000000000319; Roth RM, 2005, BRIEF A BEHAV RATING; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Tran V, 2017, BRAIN INJURY, V31, P1701, DOI 10.1080/02699052.2017.1387932; Wade SL, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000487; Wade SL, 2019, J PEDIATR PSYCHOL, V44, P388, DOI 10.1093/jpepsy/jsy087; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2018, COGNITIVE REHABILITA, P100; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060	51	3	3	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		165	174		10.1097/HTR.0000000000000545			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200001	31834062	Green Accepted			2022-02-06	
J	Lampart, A; Kuster, T; Nickel, CH; Bingisser, R; Pedersen, V				Lampart, Alina; Kuster, Tobias; Nickel, Christian H.; Bingisser, Roland; Pedersen, Vera			Prevalence and Severity of Traumatic Intracranial Hemorrhage in Older Adults with Low-Energy Falls	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						traumatic intracranial hemorrhage; low-energy fall; anticoagulation therapy; antiplatelet therapy; injury severity	GROUND-LEVEL FALLS; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; HEAD-INJURY; ANTIPLATELET; RISK; ANTICOAGULANT; GUIDELINES; MORTALITY	BACKGROUND/OBJECTIVES To determine the prevalence and severity of traumatic intracranial hemorrhage (tICH) in a large cohort of older adults presenting with low-energy falls and the association with anticoagulation or antiplatelet medication. DESIGN Bicentric retrospective cohort analysis. SETTING Two level 1 trauma centers in Switzerland and Germany. PARTICIPANTS Consecutive sample of older adults (aged >= 65 y) presenting to the emergency department (ED) over a 1-year period with low-energy falls who received cranial computed tomography (cCT) within 48 hours of ED presentation. MEASUREMENTS The prevalence and severity of tICHs was assessed and the outcomes (in-hospital mortality, admission to intensive care unit [ICU], or neurosurgical intervention) were specified. We used multivariate regression models to measure the association between anticoagulation/antiplatelet therapy and the risk for tICH after adjustment for known predictors. RESULTS The overall prevalence for tICH detected by cCT was 176 of 2567 (6.9%). Neurosurgical intervention was performed in 15 of 176 (8.5%) patients with tICH, 28 of 176 (15.9%) patients were admitted to the ICU, and 14 of 176 (8.0%) died in the hospital. CT-detected skull fracture and signs of injury above the clavicles were the strongest predictors for the presence of tICH (odds ratio [OR] = 4.28; 95% confidence interval [CI] = 2.79-6.51; OR = 1.88; 95% CI = 1.3-2.73, respectively). Among 2567 included patients, 1424 (55%) were on anticoagulation/antiplatelet therapy. Multivariate regression models showed no differences for the risk of tICH (OR = 1.05; 95% CI = .76-1.47; P = .76) or association with the head-specific Injury Severity Scale (incident rate ratio = 1.08; 95% CI = .97-1.19; P = .15) with or without anticoagulation/antiplatelet therapy. CONCLUSION Medication with anticoagulants or antiplatelet agents was not associated with higher prevalence and severity of tICH in older patients with low-energy falls undergoing cCT examination. In addition to cCT-detected skull fractures, visible injuries above the clavicles were the strongest clinical predictors for tICH. Our findings merit prospective validation. J Am Geriatr Soc 68:977-982, 2020	[Lampart, Alina; Kuster, Tobias; Nickel, Christian H.; Bingisser, Roland; Pedersen, Vera] Univ Hosp Basel, Dept Emergency Med, Basel, Switzerland; [Pedersen, Vera] Ludwig Maximilian Univ Munich, Dept Gen Trauma & Reconstruct Surg, Marchioninistr 15, D-81377 Munich, Germany		Pedersen, V (corresponding author), Ludwig Maximilian Univ Munich, Dept Gen Trauma & Reconstruct Surg, Marchioninistr 15, D-81377 Munich, Germany.	vera.pedersen@med.uni-muenchen.de	Pedersen, Vera/AAA-9026-2022	Pedersen, Vera/0000-0003-0542-5684			Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Firsching R, 2017, J NEUROL SURG PART A, V78, P478, DOI 10.1055/s-0037-1599239; Galliazzo S, 2019, THROMB RES, V174, P113, DOI 10.1016/j.thromres.2018.12.015; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Gelbard R, 2014, AM J SURG, V208, P249, DOI 10.1016/j.amjsurg.2013.12.034; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Minhas H, 2018, BRIT J HAEMATOL, V183, P119, DOI 10.1111/bjh.15509; NICE, 2014, HEAD INJ ASS EARL MA; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Pedersen V, 2019, J AM GERIATR SOC, V67, P1527, DOI 10.1111/jgs.15915; Reddy S, 2014, AM SURGEON, V80, P975; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Trauma Audit and Research Network (TARN), 2017, MAJOR TRAUMA OLDER P; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; World Health Organization, 2016, INT STAT CLASS DIS R, V5TH; Worster A, 2005, ANN EMERG MED, V45, P448, DOI 10.1016/j.annemergmed.2004.11.021	25	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAY	2020	68	5					977	982		10.1111/jgs.16400			6	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	LO3QF	WOS:000533543300026	32142155				2022-02-06	
J	Mannes, ZL; Ferguson, EG; Perlstein, WM; Waxenberg, LB; Cottler, LB; Ennis, N				Mannes, Zachary L.; Ferguson, Erin G.; Perlstein, William M.; Waxenberg, Lori B.; Cottler, Linda B.; Ennis, Nicole			Negative Health Consequences of Pain Catastrophizing Among Retired National Football League Athletes	HEALTH PSYCHOLOGY			English	Article						National Football League; pain; pain catastrophizing; depression; quality of life	QUALITY-OF-LIFE; PRESCRIPTION OPIOID USE; LOW-BACK-PAIN; DEPRESSIVE SYMPTOMS; PHYSICAL-ACTIVITY; BINGE DRINKING; INTENSITY; VALIDITY; PLAYERS; RISK	Objective: This study examined the association between pain catastrophizing with pain interference, depressive symptoms, and health-related quality of life (HRQoL) among National Football League (NFL) retirees. Method: Former NFL athletes from the Retired NFL Players Association (N = 90) were recruited from 2018 to 2019 via telephone and were administered measures of pain, substance use, depressive symptoms, and HRQoL. Multiple linear and binomial regression analyses examined the association of pain catastrophizing with pain interference, depressive symptoms, and HRQoL while controlling for covariates (i.e., pain intensity, concussions, opioid use, binge alcohol use, years since NFL retirement, and marital status). Results: Many retired NFL athletes reported moderatesevere depressive symptoms as well as poorer perceived physical health compared with general medical patients. Greater pain catastrophizing was associated with more severe pain interference, greater odds of reporting moderate-severe depressive symptoms, and lower odds of reporting average and above physical and mental HRQoL after adjusting for relevant covariates. Concussions were not associated with any of the study outcomes. Conclusions: Given the findings from this study, health care professionals should monitor symptoms of catastrophizing among current and retired NFL athletes. Assessment and requisite treatment of pain catastrophizing may assist these elite athletes in reducing depressive symptoms, while improving pain interference and HRQoL in this population.	[Mannes, Zachary L.; Ferguson, Erin G.; Perlstein, William M.; Waxenberg, Lori B.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, POB 100165,1225 Ctr Dr,Room 3146, Gainesville, FL 32610 USA; [Cottler, Linda B.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32610 USA; [Cottler, Linda B.] Univ Florida, Coll Med, Gainesville, FL 32610 USA; [Ennis, Nicole] Florida State Univ, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA		Mannes, ZL (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, POB 100165,1225 Ctr Dr,Room 3146, Gainesville, FL 32610 USA.	zmannes@ufl.edu			National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [1K23DA039769-01]; NIDA University of Florida Substance Abuse Training Center Grant [T32DA035167]	This study was funded by the National Institute on Drug Abuse (NIDA) Grant 1K23DA039769-01 and NIDA University of Florida Substance Abuse Training Center Grant T32DA035167.	Backmand H, 2003, INT J SPORTS MED, V24, P609; Backmand HM, 2009, ARCH GERONTOL GERIAT, V48, P1, DOI 10.1016/j.archger.2007.09.002; Borsbo B, 2009, DISABIL REHABIL, V31, P1605, DOI 10.1080/09638280903110079; Bousema EJ, 2007, PAIN, V130, P279, DOI 10.1016/j.pain.2007.03.024; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Churchill TW, 2018, AM J MED, V131, P1491, DOI 10.1016/j.amjmed.2018.07.042; Cleeland CS., 2009, BRIEF PAIN INVENTORY, P1; Cosco TD, 2017, J NURS MEAS, V25, P476, DOI 10.1891/1061-3749.25.3.476; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Craner JR, 2016, PAIN MED, V17, P2026, DOI 10.1093/pm/pnw070; Ctr Dis Control Prevent, 2016, J PAIN PALLIAT CARE, V30, P138, DOI 10.3109/15360288.2016.1173761; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Edwards RR, 2006, PAIN, V126, P272, DOI 10.1016/j.pain.2006.07.004; Edwards RR, 2016, J PAIN, V17, pT70, DOI 10.1016/j.jpain.2016.01.001; Ehde DM, 2014, AM PSYCHOL, V69, P153, DOI 10.1037/a0035747; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Farin E, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0359-5; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Geneen LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011279.pub2; Golightly YM, 2009, J PHYS ACT HEALTH, V6, P638, DOI 10.1123/jpah.6.5.638; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hair J.F., 2006, MULTIVARIATE DATA AN, V6; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HAYES CJ, 2017, HLTH CARE, V5, DOI DOI 10.3390/HEALTH-CARE5020022; Hirsh AT, 2011, AM J PHYS MED REHAB, V90, P713, DOI 10.1097/PHM.0b013e31822409b2; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Huo T, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0858-2; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Karafin MS, 2018, HEMATOLOGY, V23, P856, DOI 10.1080/10245332.2018.1479997; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kerr Z. Y., 2014, ORTHOPAEDIC J SPORTS, DOI 10.1177/; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lackner JM, 2004, PAIN, V110, P597, DOI 10.1016/j.pain.2004.04.011; Latkin CA, 2017, ADDICT BEHAV, V73, P133, DOI 10.1016/j.addbeh.2017.05.005; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Leung L, 2012, INDIAN J PSYCHOL MED, V34, P204, DOI 10.4103/0253-7176.106012; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Luo XM, 2003, SPINE, V28, P1739, DOI 10.1097/00007632-200308010-00020; Mannes ZL, 2019, INT REV SPORT EXER P, V12, P265, DOI 10.1080/1750984X.2018.1469162; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGowan SK, 2016, BEHAV THER, V47, P460, DOI 10.1016/j.beth.2015.12.003; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; Mok LC, 2008, J CLIN NURS, V17, P1471, DOI 10.1111/j.1365-2702.2007.02037.x; National Institute on Alcohol Abuse and Alcoholism Council, 2004, NAT I ALC AB ALC COU; Nicholas MK, 2012, EUR J PAIN, V16, P93, DOI 10.1016/j.ejpain.2011.06.005; Nicholas SJ, 2007, AM J SPORT MED, V35, P1674, DOI 10.1177/0363546507302219; Okoro CA, 2004, AM J PREV MED, V26, P230, DOI 10.1016/j.amepre.2003.10.022; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Paljarvi T, 2009, ADDICTION, V104, P1168, DOI 10.1111/j.1360-0443.2009.02577.x; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roditi D, 2011, PSYCHOL RES BEHAV MA, V4, P41, DOI 10.2147/PRBM.S15375; Salas J, 2018, J PAIN, V19, P88, DOI 10.1016/j.jpain.2017.09.004; Scherrer JF, 2016, ANN FAM MED, V14, P54, DOI 10.1370/afm.1885; Schutze R, 2018, J PAIN, V19, P233, DOI 10.1016/j.jpain.2017.09.010; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Semeru GM, 2019, KOREAN J PAIN, V32, P22, DOI 10.3344/kjp.2019.32.1.22; Severeijns R, 2004, PAIN, V111, P226, DOI 10.1016/j.pain.2004.07.024; Smith MT, 2001, J BEHAV MED, V24, P93, DOI 10.1023/A:1005690505632; Somers TJ, 2009, CURR OPIN RHEUMATOL, V21, P501, DOI 10.1097/BOR.0b013e32832ed704; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tan G, 2011, CLIN J PAIN, V27, P769, DOI 10.1097/AJP.0b013e31821d8f5a; Toth C, 2014, J PAIN RES, V7, P327, DOI 10.2147/JPR.S56883; Verbunt JA, 2008, EUR J PAIN, V12, P508, DOI 10.1016/j.ejpain.2007.08.001; Vilagut G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155431; Weir DR., 2009, NATL FOOTBALL LEAGUE; Yakobov E, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0955-2; Yazdi-Ravandi S, 2013, BASIC CLIN NEUROSCI, V4, P117	71	3	3	2	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-6133	1930-7810		HEALTH PSYCHOL	Health Psychol.	MAY	2020	39	5					452	462		10.1037/hea0000847			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	LD5JH	WOS:000526065400010	31999177	Green Accepted, Bronze			2022-02-06	
J	McFarlane, TD; Love, J; Hanley, S; Dixon, BE; Hammond, FM				McFarlane, Timothy D.; Love, Josh; Hanley, Shane; Dixon, Brian E.; Hammond, Flora M.			Increased Risk of Stroke Among Young Adults With Serious Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; epidemiology [Mesh]; hospitalization [Mesh]; stroke [Mesh]; traumatic [Mesh]	ACUTE ISCHEMIC-STROKE; CEREBRAL-BLOOD-FLOW; UNITED-STATES; PATHOPHYSIOLOGY; SURVEILLANCE; DISSECTION; ACCURACY; DEATHS	Objective: To quantify the risk of acute ischemic stroke (AIS) following traumatic brain injury (TBI) according to severity. Setting: Indiana Network for Patient Care, including medical records from more than 100 Indiana hospitals and affiliated practices. Participants: Individuals 18 years and older with TBI from 2005 to 2014. Design: Retrospective cohort. Main Measures: AIS incidence in the first 30, 31 to 180, and 181 days after TBI. Time to AIS using a stratified Cox proportional hazards model. Results: Among 58 294 patients with TBI, AIS risk was greatest in the first 30 days (incidence rate = 23.3 per 1000 person-months), declining to 3.1 and 1.3 per 1000 person-months after 31 to 180 and 181 days or more, respectively. Cervical artery dissection increased the risk of AIS in the first 30 days (incidence rate = 170.9 per 1000 person-months). In the first 30 days, serious TBI increased risk for all age groups, with the largest effect observed among those aged 18 to 24 years. Over time, serious TBI modified the effect of age on AIS only for those aged 18 to 24 years. Conclusions: These findings add to a growing body of work demonstrating that the acute and postacute stages of TBI play an accelerative role in AIS risk, particularly among younger patients, cervical artery dissection, and serious TBI.	[McFarlane, Timothy D.; Love, Josh; Hanley, Shane; Dixon, Brian E.] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, 1050 Wishard Blvd,RG 5133, Indianapolis, IN 46202 USA; [Dixon, Brian E.] Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN USA; [Dixon, Brian E.] Roudebush VA Med Ctr, Dept Vet Affairs, Hlth Serv Res & Dev Serv, Ctr Hlth Informat & Commun, Indianapolis, IN USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA		McFarlane, TD (corresponding author), Indiana Univ, Richard M Fairbanks Sch Publ Hlth, 1050 Wishard Blvd,RG 5133, Indianapolis, IN 46202 USA.	timmcfar@iu.edu	Dixon, Brian E./A-9494-2013	Dixon, Brian E./0000-0002-1121-0607	Lilly Endowment, Inc; Indiana METACyt Initiative; Lilly Endowment, Inc.; Indiana SpinalCord & Brain Injury Research Fund from the Indiana StateDepartment ofHealth	The research was supported, in part, by Lilly Endowment, Inc, through its support for the Indiana University Pervasive Technology Institute, and in part by the Indiana METACyt Initiative. The Indiana METACyt Initiative at Indiana University was also supported in part by Lilly Endowment, Inc.; This project was supported, in part, with funding from the Indiana SpinalCord & Brain Injury Research Fund from the Indiana StateDepartment ofHealth. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the Indiana State Department of Health.	Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention, 2016, BEH RISK FACT SURV S; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Clark DE, 2010, ICDPIC STATA MODULE; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dixon B, 2016, GIS AND GEOCOMPUTATION FOR WATER RESOURCE SCIENCE AND ENGINEERING, P3; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Faul M, 2010, TRAUMATIC BRAIN INJU; Fridley J, 2015, J NEUROTRAUM, V32, P75, DOI 10.1089/neu.2014.3350; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; GRAHAM DI, 1985, BRIT J ANAESTH, V57, P3, DOI 10.1093/bja/57.1.3; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Kochanek Kenneth D, 2014, NCHS Data Brief, P1; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Qureshi AI, 2011, ARCH NEUROL-CHICAGO, V68, P1536, DOI 10.1001/archneurol.2011.213; Rahurkar Saurabh, 2017, AMIA Annu Symp Proc, V2017, P1440; Shahan CP, 2016, J TRAUMA ACUTE CARE, V81, P173, DOI 10.1097/TA.0000000000001058; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thanvi B, 2005, POSTGRAD MED J, V81, P383, DOI 10.1136/pgmj.2003.016774; Villarroel, 2015, TABLES SUMMARY HLTH; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	31	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		E310	E319		10.1097/HTR.0000000000000539			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200014	31834059				2022-02-06	
J	Morinaga, Y; Nii, K; Hanada, H; Sakamoto, K; Inoue, R; Mitsutake, T				Morinaga, Yusuke; Nii, Kouhei; Hanada, Hayatsura; Sakamoto, Kimiya; Inoue, Ritsurou; Mitsutake, Takafumi			Efficacy of trazodone for treating paroxysmal sympathetic hyperactivity presenting after left temporal subcortical hemorrhage	INTRACTABLE & RARE DISEASES RESEARCH			English	Article						paroxysmal sympathetic hyperactivity; temporal subcortical hemorrhage; trazodone	TRAUMATIC BRAIN-INJURY; DIAGNOSIS; DYSAUTONOMIA; MANAGEMENT	Paroxysmal sympathetic hyperactivity (PSH) is a clinical condition characterized by abnormal paroxysmal surges in sympathetic nervous system activity. PSH is known to occur after severe head injury and hypoxic encephalopathy. Cases of PSH that develop after stroke have been reported worldwide; however, PSH is not commonly reported in the field of stroke research in Japan. Some studies have suggested that gabapentin may improve the symptoms of PSH. To our knowledge, this is the first case report demonstrating the efficacy of trazodone for the treatment of PSH that developed after temporal subcortical hemorrhage. A 49-year-old woman presented to our clinic with mild confusion and sensory aphasia after experiencing left temporal subcortical hemorrhage; a conservative treatment was initiated at our hospital. Immediately upon hospitalization, she developed prolonged consciousness disorder, high fever, tachycardia, malignant hypertension, tachypnea, constipation, and overactive bladder. The patient's symptoms improved after the administration of trazodone. She was diagnosed with PSH after intracranial hemorrhage and was subsequently transferred to a recovery and rehabilitation hospital unit where the oral administration of trazodone continued. Prolonged PSH contributes significantly to the impairment of daily activities in patients with stroke; therefore, early diagnosis and treatment are critical. Here, we report on the efficacy of trazodone as an effective treatment option for improving clinical outcomes and reducing the stay in the stroke care unit.	[Morinaga, Yusuke; Nii, Kouhei; Hanada, Hayatsura; Sakamoto, Kimiya; Inoue, Ritsurou; Mitsutake, Takafumi] Fukuoka Univ, Dept Neurosurg, Chikushi Hosp, 1-1-1 Zokumyoin, Chikushino, Fukuoka 8188502, Japan		Morinaga, Y (corresponding author), Fukuoka Univ, Dept Neurosurg, Chikushi Hosp, 1-1-1 Zokumyoin, Chikushino, Fukuoka 8188502, Japan.	yu_the_morio@yahoo.co.jp					Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; DETEJADA IS, 1991, J UROLOGY, V145, P60, DOI 10.1016/S0022-5347(17)38247-2; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Inoue Daisuke, 2019, No Shinkei Geka, V47, P79, DOI 10.11477/mf.1436203899; Li YC, 2015, PAIN PHYSICIAN, V18, pE583; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Morinaga Y, 2019, DRUG DISCOV THER, V13, P239, DOI 10.5582/ddt.2019.01046; Morinaga Y, 2019, DRUG DISCOV THER, V13, P168, DOI 10.5582/ddt.2019.01038; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Samuel S, 2016, J NEUROSCI NURS, V48, P82, DOI 10.1097/JNN.0000000000000207; Yamada H, 2018, J STROKE CEREBROVASC, V27, P2768, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.002	20	3	3	0	0	INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT	TOKYO	INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT, TOKYO, 00000, JAPAN	2186-3644	2186-361X		INTRACTABLE RARE DIS	INTRACTABLE RARE DIS. RES.	MAY	2020	9	2					119	122		10.5582/irdr.2020.01021			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NN9FH	WOS:000569092700010	32494561	gold, Green Published			2022-02-06	
J	Page, PS; Josiah, DT				Page, Paul S.; Josiah, Darnell T.			Traumatic vertebral artery injuries in the geriatric population: a retrospective cohort study	JOURNAL OF NEUROSURGERY-SPINE			English	Article						vertebral artery injuries; cervical spine trauma; neurotrauma	OUTCOMES; DIAGNOSIS; CENTER.	OBJECTIVE Traumatic vertebral artery injuries (TVAIs) are a common finding in cervical spine trauma and can predispose patients to posterior circulation infarction. While extensive research has been conducted regarding the management and criteria for imaging in patients with suspected blunt vascular injury, little research has been conducted highlighting these injuries in the geriatric population. METHODS The authors performed a retrospective review of all patients evaluated at a level 1 trauma center and found to have TVAIs between January 1, 2010, and January 1, 2018. Biometric, clinical, and imaging data were obtained from a trauma registry database. Patients were divided into 2 groups on the basis of age, a geriatric group (age 65 years) and an adult group (age 18 to < 65 years). Variables evaluated included type of trauma, mortality, Injury Severity Score (158), and ICU length of stay. The Student t-test was used for continuous variables, and Pearson's chi-square test was used for categorical variables. RESULTS Of the 2698 of patients identified with traumatic cervical spine injuries, 103 patients demonstrated evidence of TVAI. Of these patients, 69 were < 65 and 34 were >= 65 years old at the time of their trauma. There was no difference in the incidence of TVAIs between the 2 groups. The ICU length of stay (4.71 vs 4.32 days, p > 0.05), hospital length of stay (10.71 vs 10.72 days, p > 0.05), and the ISS (21.50 vs 21.32, p > 0.05) did not differ significantly between the 2 groups. Mortality was significantly higher in the geriatric group, occurring in 9 of 34 patients (26.5%) compared with only 3 of 69 patients (4.4%) in the adult group (p < 0.001). Ground-level falls were the most common inciting event in the geriatric group (44% vs 14.5%, p < 0.001), whereas motor vehicle accidents were the most common etiology in the younger population (72.5% vs 38.2%, p < 0.001). Incidence of ischemic stroke did not vary significantly between the 2 groups (p > 0.05). CONCLUSIONS TVAI in the older adult population is associated with a significantly greater risk of mortality than in the younger adult population, despite the 2 groups having similar ISSs. Additionally, low-velocity mechanisms of injury, such as ground-level falls, are a greater risk factor for acquired TVAI in older adults than in younger adults, in whom it is a significantly less common etiology.	[Page, Paul S.; Josiah, Darnell T.] Univ Wisconsin Hosp & Clin, Dept Neurol Surg, Madison, WI 53792 USA		Page, PS (corresponding author), Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA.	page@neurosurgery.wisc.edu					Beliaev AM, 2014, ANZ J SURG, V84, P429, DOI 10.1111/ans.12439; Berne JD, 2009, J TRAUMA, V67, P1333, DOI 10.1097/TA.0b013e31818888c7; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Gioffre-Florio M, 1939, G CHIR, V39, P35; Gubler KD, 1996, J TRAUMA, V41, P952, DOI 10.1097/00005373-199612000-00002; Hasan I, 2002, PEDIATR NEUROSURG, V37, P168, DOI 10.1159/000065391; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; Newhall K, 2016, ANN VASC SURG, V36, P145, DOI 10.1016/j.avsg.2016.06.001; Scott WW, 2015, J NEUROSURG, V122, P1196, DOI 10.3171/2015.1.JNS14642; Scott WW, 2015, J NEUROSURG, V122, P610, DOI 10.3171/2014.10.JNS14875; Wang H, 2008, J NEUROS-PEDIATR, V1, P415, DOI 10.3171/PED/2008/1/5/415	13	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAY	2020	32	5					657	660		10.3171/2019.11.SPINE191055			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LK4SB	WOS:000530854600004	31952030	Bronze			2022-02-06	
J	Stephen, SJ; Shan, GG; Banks, SJ; Bernick, C; Bennett, LL				Stephen, Steve J.; Shan, Guogen; Banks, Sarah J.; Bernick, Charles; Bennett, Lauren L.			The Relationship Between Fighting Style, Cognition, and Regional Brain Volume in Professional Combatants: A Preliminary Examination Using Brief Neurocognitive Measures	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						boxing; martial arts; mixed martial arts; sports-related concussion	SMALLER THALAMIC VOLUMES; RELIABILITY; VALIDITY; CONCUSSION; INJURY; SPORT; AGE	Objective: Repetitive head impacts (RHIs) in combat sports are associated with cognitive decline and brain volume reduction. While fighting style differences between boxers, mixed martial artists (MMAs), and martial artists (MAs) have resulted in a broader spectrum of injury, the effects of RHIs on MAs relative to other fighters have not yet been explored. This study aimed to determine a differential effect of fighting style on cognition and brain. Setting: A large outpatient medical center specializing in neurological care. Participants, Design, and Main Measures: In total, 40 MAs, 188 boxers, and 279 MMAs were compared on baseline measures of subcortical regional brain volumes, after controlling for total brain volumes, and cognitive performance. Results: Significant differences between MAs, MMAs, and boxers were observed in subcortical brain structure volumes and cognitive measures. MMAs and MAs consistently had larger volumes and higher scores than boxers. Fighting style significantly moderated the relationship between the number of professional fights and the volumes of various subcortical brain structures and performance on a measure of processing speed at baseline. Conclusions: Differences in RHIs across fighting styles may be of clinical significance. Exploring changes over time within the MA, boxer, and MMA cohorts may provide insight into longer-term discrepancies in subcortical regional brain volumes and cognitive functioning across fighting styles.	[Stephen, Steve J.; Bernick, Charles; Bennett, Lauren L.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Shan, Guogen] Univ Nevada, Sch Publ Hlth, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA; [Banks, Sarah J.] Univ Calif San Diego, La Jolla, CA 92093 USA		Bennett, LL (corresponding author), 3900 West Coast Hwy,Suite 310, Newport Beach, CA 92663 USA.	LBennett@shankleclinic.org			Belator; UFC; August Rapone Family Foundation; Top Rank; Haymon Boxing; Institutional Development Award (IDeA NIGMS) [P20GM109025]	Funding for this study was provided by Belator, UFC, the August Rapone Family Foundation, Top Rank, Haymon Boxing, and an Institutional Development Award (IDeA NIGMS; P20GM109025).	Bernick C, 2012, THRESHOLD EFFECT REP; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Demorest R, 2018, PEDIATRICS, V138, P1; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hammami N, 2018, SCI SPORT, V33, P73, DOI 10.1016/j.scispo.2017.04.014; Harrison JE, 2000, BRIT J CLIN PSYCHOL, V39, P181, DOI 10.1348/014466500163202; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McPherson M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-795; Nevada State Athletic Commission Nevada Department of Business and Industry, 2018, RES; Pappas E, 2007, J SPORT SCI MED, V6, P58; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Sieko-Awierianow E, 2016, CENTRAL EUR J SPORT, V15, P27; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Uttl B, 2002, J CLIN EXP NEUROPSYC, V24, P1123, DOI 10.1076/jcen.24.8.1123.8375; Venkatagiri HS, 1999, J FLUENCY DISORD, V24, P209, DOI 10.1016/S0094-730X(99)00010-8; Woodward Thomas W, 2009, WMJ, V108, P40; Xu H, 2019, JAMA NEUROL, V76, P1184, DOI 10.1001/jamaneurol.2019.2455	25	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		E280	E287		10.1097/HTR.0000000000000540			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200011	31834060				2022-02-06	
J	Stumpf, TR; Sandarage, RV; Galuta, A; Fournier, P; Li, TD; Kirkwood, K; Yi, XA; Tsai, EC; Cao, XD				Stumpf, Taisa Regina; Sandarage, Ryan Vimukthie; Galuta, Ahmad; Fournier, Patrick; Li, Tongda; Kirkwood, Kathlyn; Yi, Xinan; Tsai, Eve Chung; Cao, Xudong			Design and evaluation of a biosynthesized cellulose drug releasing duraplasty	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Biosynthesized cellulose; Drug delivery; NSPC; Stroke; Nerve regeneration	EPIDERMAL-GROWTH-FACTOR; BACTERIAL CELLULOSE; NEURAL STEM; MECHANICAL-PROPERTIES; HUMAN DURA; IN-SITU; BRAIN; DELIVERY; CELLS; DIFFERENTIATION	Decompressive craniectomy (DC) is a standard surgical procedure performed on stroke patients in which a portion of a skull is removed and a duraplasty membrane is applied onto the brain. While DC can significantly reduce the risk of death, it does not reverse the stroke damage. In this study, a novel biosynthesized cellulose (BC)-based drug releasing duraplasty was developed and studied. The BC duraplasty fabrication process allowed readily incorporation of growth factors (GFs) in a sterile manner and control of physical and mechanical properties of the resulting duraplasty. Our results showed that BC duraplasty containing the highest amount of dry cellulose presented swelling ratio of 496 +/- 27%, Young's modulus of 0.37 +/- 0.02 MPa, ultimate tensile strength of 0.96 +/- 0.02 MPa, while releasing GFs for over 10 days. In addition, neural stem/progenitor cell (NSPC) cultures demonstrated that the GFs released from the BC duraplasty promoted NSPC proliferation and differentiation in vitro. Finally, animal studies revealed that the BC duraplasty did not cause any inflammatory reactions after the DC procedure in vivo. In summary, this newly developed GF loaded BC membrane demonstrates a promising potential as drug releasing duraplasty, not only for stroke treatments but also for traumatic brain injuries and spinal cord injuries.	[Stumpf, Taisa Regina; Fournier, Patrick; Li, Tongda; Kirkwood, Kathlyn; Cao, Xudong] Univ Ottawa, Fac Engn, Dept Chem & Biol Engn, Ottawa, ON, Canada; [Sandarage, Ryan Vimukthie; Galuta, Ahmad; Tsai, Eve Chung] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Sandarage, Ryan Vimukthie; Galuta, Ahmad; Li, Tongda; Tsai, Eve Chung] Ottawa Hosp Res Inst, Neurosci Program, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada; [Yi, Xinan] Hainan Med Univ, Haikou 571199, Hainan, Peoples R China; [Tsai, Eve Chung] Univ Ottawa, Dept Surg, Div Neurosurg, Ottawa, ON, Canada; [Cao, Xudong] Univ Ottawa, Fac Engn, Biomed Engn, Ottawa, ON, Canada		Tsai, EC (corresponding author), Ottawa Hosp Res Inst, Neurosci Program, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.; Cao, XD (corresponding author), Colonel Hall,161 Louis Pasteur Private, Ottawa, ON K1N 6N5, Canada.	etsai@toh.ca; xcao@eng.uOttawa.ca	Tsai, Eve/ABE-6056-2021; Tsai, Eve/D-7007-2014	Sandarage, Ryan/0000-0002-7998-5505; Tsai, Eve/0000-0002-8152-349X	Canadian Stem Cell Network; National Council for Scientific and Technological Development (CNPq, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Ontario Graduate Scholarship (OGS) programOntario Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Neurosurgical Research and Education Foundation (NREF)	The authors would like to dedicate this research in memory to their dearest friend and collaborator Dr. Kirkwood. The study was support by a grant from Canadian Stem Cell Network to ET and XC. TS wishes to thank the National Council for Scientific and Technological Development (CNPq, Brazil) and Ontario Graduate Scholarship (OGS) program for financial support. RS acknowledges support from Natural Sciences and Engineering Research Council of Canada (NSERC) and Neurosurgical Research and Education Foundation (NREF). The authors would also like to thank Dr. John Woulfe and Dr. Peter Gordan Jessamine for technical support in this study.	Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026; Carvalho T, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201900059; Chen SQ, 2018, FOOD HYDROCOLLOID, V81, P87, DOI 10.1016/j.foodhyd.2018.02.031; Codman & Shurtleff Inc., IN VIV TISS REACT RE; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Dai Z, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416648810; Danish SF, 2006, J NEUROSURG, V104, P16, DOI 10.3171/ped.2006.104.1.16; Dash S, 2010, ACTA POL PHARM, V67, P217; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Dibajnia P, 2013, ACTA PHARMACOL SIN, V34, P78, DOI 10.1038/aps.2012.107; Ding SY, 2016, NAT REV MATER, V1, DOI [10.1038/natrevmats.2016.71, 10.1038/natrevmats.2016.21]; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; Ghosh AK, 2017, INDIAN J NEUROSURG, V6, P36, DOI 10.1055/s-0036-1584585; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570; HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018; HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210; Hu FH, 2013, CELL REPROGRAM, V15, P224, DOI 10.1089/cell.2012.0077; Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149; Ikeda T, 2005, AM J OBSTET GYNECOL, V193, P849, DOI 10.1016/j.ajog.2005.01.029; Jendelova P, 2016, EXPERT OPIN BIOL TH, V16, P43, DOI 10.1517/14712598.2016.1094457; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P409, DOI 10.1002/polb.1986.090240215; Lamboni L, 2019, MAT SCI ENG C-MATER, V102, P502, DOI 10.1016/j.msec.2019.04.043; LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519; Lu JF, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5868632; Meftahi A, 2010, CELLULOSE, V17, P199, DOI 10.1007/s10570-009-9377-y; Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143; Narotam PK, 2009, J NEUROSURG, V111, P380, DOI 10.3171/2008.10.JNS08993; PEPPAS NA, 1983, J POLYM SCI POL PHYS, V21, P983, DOI 10.1002/pol.1983.180210614; Rogalewski A, 2006, STROKE, V37, P1129, DOI 10.1161/01.STR.0000209330.73175.34; Rosen CL, 2011, NEUROSURGERY, V69, P1093, DOI 10.1227/NEU.0b013e3182284aca; SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123; Shezad O, 2010, CARBOHYD POLYM, V82, P173, DOI 10.1016/j.carbpol.2010.04.052; Staykov D, 2011, STROKE, V42, P513, DOI 10.1161/STROKEAHA.110.605642; Stumpf TR, 2013, MAT SCI ENG C-MATER, V33, P4739, DOI 10.1016/j.msec.2013.07.035; Stumpf TR, 2018, MAT SCI ENG C-MATER, V82, P372, DOI 10.1016/j.msec.2016.11.121; Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006; Ullah H, 2016, CELLULOSE, V23, P2291, DOI 10.1007/s10570-016-0986-y; Ullah H, 2016, CARBOHYD POLYM, V150, P330, DOI 10.1016/j.carbpol.2016.05.029; Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032; WHO, GLOB HLTH EST 2015 D; World Health Organization, GLOB HLTH EST 2016 D; Xu C, 2014, INT J MOL SCI, V15, P10855, DOI 10.3390/ijms150610855; Yao SL, 2013, PROG NAT SCI-MATER, V23, P103, DOI 10.1016/j.pnsc.2013.02.009; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412; Zang SS, 2015, MAT SCI ENG C-MATER, V46, P111, DOI 10.1016/j.msec.2014.10.023	50	3	3	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	MAY	2020	110								110677	10.1016/j.msec.2020.110677			11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	LF4NH	WOS:000527395900052	32204106				2022-02-06	
J	Venkatesh, V; Fracol, M; Turin, S; Ellis, M; Alghoul, M				Venkatesh, Vishnu; Fracol, Megan; Turin, Sergey; Ellis, Marco; Alghoul, Mohammed			Utilization of Intraparotid Segments of Superficial Temporal Vessels for Head and Scalp Free Flap Microanastomosis: A Clinical, Histological, and Cadaveric Study	JOURNAL OF RECONSTRUCTIVE MICROSURGERY			English	Article						head and neck reconstruction; superficial temporal artery; superficial temporal vessels	MIDDLE CEREBRAL-ARTERY; RECIPIENT VESSELS; RADIAL ARTERY; FACIAL-NERVE; ANATOMY; RECONSTRUCTION; GRAFT; REGION; BYPASS; BRANCH	Background The superficial temporal vessels (STV) are an underutilized target for head and neck microvascular reconstruction. Most surgeons regard the dissection as difficult, unreliable, and the anastomosis prone to vasospasm. The intraparotid course of the STV may provide more reliable flow without accompanying morbidity. Methods A retrospective review of patients who underwent head and scalp free flap reconstruction utilizing STV intraparotid segment was performed. Demographic factors such as intraoperative and postoperative complications are reported. Five bilateral cadaver heads were dissected to describe the relationship to the facial nerve. STV histology was performed on four of the cadavers, noting intraluminal diameter and vessel wall thickness. Results Thirty-nine patients underwent free flap reconstruction with anastomosis to intraparotid STVs. Defect etiology included tumor resection (71.8%), traumatic brain injury (10.3%), intracranial bleed (12.8%), and acute trauma (5.1%). Flaps transferred included anterolateral thigh (51.3%), latissimus (33.3%), thoracodorsal artery perforator (7.7%), radial forearm (2.8%), and vastus lateralis (5.1%). Two flaps (5.1%) required takeback for arterial thrombosis, with one incidence of total flap loss (2.8%). There were no instances of transient or permanent facial nerve damage nor sialocele. On cadaver dissection, three distinct vessel segments were identified. Segments 1 and 2 represented the STVs superior to the upper tragal border. Segment 3 (intraparotid segment) began at the upper tragal border and STVs enlarged with a targeted anastomosis point at an average of 16.3 mm medial and 4.5 mm inferior to the upper border of the tragus. The frontal branch coursed 11.7 mm inferior and 11.5 mm anterior to this point. On histology, the intraluminal diameter of segment 3 was significantly larger than segment 2 (1.2 vs. 0.9 mm, p = 0.007). Conclusion Head and neck free flap reconstruction with microanastomosis to the intraparotid segment of STVs can be safely and reliably performed.	[Venkatesh, Vishnu; Fracol, Megan; Turin, Sergey; Ellis, Marco; Alghoul, Mohammed] Northwestern Univ, Feinberg Sch Med, Div Plast & Reconstruct Surg, Chicago, IL 60611 USA; [Ellis, Marco] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA		Alghoul, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Plast & Reconstruct Surg, Chicago, IL 60611 USA.; Alghoul, M (corresponding author), Northwestern Mem Hosp, Div Plast & Reconstruct Surg, 675 N St Clair St 19-250, Chicago, IL 60611 USA.	malghoul@nm.org	Turin, Sergey/AAP-6791-2020	Turin, Sergey/0000-0001-8515-7637			Buyukmumcu M, 2004, NEUROSURG REV, V27, P185, DOI 10.1007/s10143-003-0317-2; Carniol ET, 2017, LARYNGOSCOPE, V127, P325, DOI 10.1002/lary.26039; CHARDIGNY C, 1993, CIRCULATION, V88, P115; CUTTING CB, 1984, PLAST RECONSTR SURG, V74, P603, DOI 10.1097/00006534-198411000-00003; Doscher M, 2015, J RECONSTR MICROSURG, V31, P249, DOI 10.1055/s-0034-1394160; Gray H., 1918, ANATOMY HUMAN BODY; HALLOCK GG, 1989, ANN PLAS SURG, V22, P65, DOI 10.1097/00000637-198901000-00012; Halvorson EG, 2009, J RECONSTR MICROSURG, V25, P383, DOI 10.1055/s-0029-1220859; Hamada J, 2002, J NEUROSURG, V96, P867, DOI 10.3171/jns.2002.96.5.0867; Hansen SL, 2007, PLAST RECONSTR SURG, V120, P1879, DOI 10.1097/01.prs.0000287273.48145.bd; HARII K, 1974, PLAST RECONSTR SURG, V53, P410, DOI 10.1097/00006534-197404000-00005; Janis JE, 2010, PLAST RECONSTR SURG, V125, P1422, DOI 10.1097/PRS.0b013e3181d4fb05; Kim Byung Soo, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P145, DOI 10.7461/jcen.2013.15.3.145; KIM YO, 1995, PLAST RECONSTR SURG, V96, P576, DOI 10.1097/00006534-199509000-00009; Lahtinen S, 2018, BRIT J ORAL MAX SURG, V56, P684, DOI 10.1016/j.bjoms.2018.07.009; Lei T, 2005, PLAST RECONSTR SURG, V116, P623, DOI 10.1097/01.prs.0000174001.95115.9e; Maral T, 2000, PLAST RECONSTR SURG, V105, P1754, DOI 10.1097/00006534-200004050-00024; Maricevich M, 2018, PLAST RECONSTR SURG, V142, P1025, DOI 10.1097/PRS.0000000000004770; Menovsky T, 2016, WORLD NEUROSURG, V89, P72, DOI 10.1016/j.wneu.2016.01.012; Meybodi AT, 2017, OPER NEUROSURG, V13, P517, DOI 10.1093/ons/opx013; Mu DL, 2011, J RECONSTR MICROSURG, V27, P337, DOI 10.1055/s-0031-1278711; Mucke T, 2016, J CRANIO MAXILL SURG, V44, P1292, DOI 10.1016/j.jcms.2016.04.029; NAKAJIMA H, 1995, BRIT J PLAST SURG, V48, P439, DOI 10.1016/0007-1226(95)90118-3; PANJE W R, 1991, Ear Nose and Throat Journal, V70, P311; Pinar YA, 2006, SURG RADIOL ANAT, V28, P248, DOI 10.1007/s00276-006-0094-z; Shin KJ, 2018, CLIN ANAT, V31, P608, DOI 10.1002/ca.23033; SLAVIN ML, 1986, ARCH OPHTHALMOL-CHIC, V104, P1127; Takeuchi S, 1997, SURG NEUROL, V48, P615, DOI 10.1016/S0090-3019(97)00015-3; Tall J, 2015, ANN PLAS SURG, V75, P309, DOI 10.1097/SAP.0000000000000081; Tayfur V, 2010, J CRANIOFAC SURG, V21, P1945, DOI 10.1097/SCS.0b013e3181f4ee6a; TOMSAK RL, 1991, J CLIN NEURO-OPHTHAL, V11, P202; TSURUTA T, 1992, TOHOKU J EXP MED, V168, P549, DOI 10.1620/tjem.168.549; Turin SY, 2018, J RECONSTR MICROSURG, V34, P242, DOI 10.1055/s-0037-1612601; Wada K, 2018, J STROKE CEREBROVASC, V27, P3505, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.020	34	3	3	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0743-684X	1098-8947		J RECONSTR MICROSURG	J. Reconstr. Microsurg.	MAY	2020	36	4					253	260		10.1055/s-0039-3401830			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	LH4YY	WOS:000528793800004	31877564				2022-02-06	
J	Vincenzi, F; Pasquini, S; Gessi, S; Merighi, S; Romagnoli, R; Borea, PA; Varani, K				Vincenzi, Fabrizio; Pasquini, Silvia; Gessi, Stefania; Merighi, Stefania; Romagnoli, Romeo; Borea, Pier Andrea; Varani, Katia			The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A(1)AR Positive Allosteric Modulation	CELLS			English	Article						adenosine; glutamate cytotoxicity; positive allosteric modulation; neuroprotection; apoptosis	ANTIPORTER SYSTEM X(C)(-); BIOLOGICAL EVALUATION; TNF-ALPHA; THIOPHENE DERIVATIVES; MOLECULAR-MECHANISMS; ENHANCER ACTIVITY; CLINICAL-TRIALS; RECEPTORS; EXCITOTOXICITY; PATHOGENESIS	Glutamate cytotoxicity is implicated in neuronal death in different neurological disorders including stroke, traumatic brain injury, and neurodegenerative diseases. Adenosine is a nucleoside that plays an important role in modulating neuronal activity and its receptors have been identified as promising therapeutic targets for glutamate cytotoxicity. The purpose of this study is to elucidate the role of adenosine and its receptors on glutamate-induced injury in PC12 cells and to verify the protective effect of the novel A(1) adenosine receptor positive allosteric modulator, TRR469. Flow cytometry experiments to detect apoptosis revealed that adenosine has a dual role in glutamate cytotoxicity, with A(2A) and A(2B) adenosine receptor (AR) activation exacerbating and A(1) AR activation improving glutamate-induced cell injury. The overall effect of endogenous adenosine in PC12 cells resulted in a facilitating action on glutamate cytotoxicity, as demonstrated by the use of adenosine deaminase and selective antagonists. However, enhancing the action of endogenous adenosine on A(1)ARs by TRR469 completely abrogated glutamate-mediated cell death, caspase 3/7 activation, ROS production, and mitochondrial membrane potential loss. Our results indicate a novel potential therapeutic strategy against glutamate cytotoxicity based on the positive allosteric modulation of A(1)ARs.				fabrizio.vincenzi@unife.it; psqslv@unife.it; gss@unife.it; mhs@unife.it; rmr@unife.it; bpa@unife.it; vrk@unife.it	Gessi, Stefania/AAS-3844-2020	MERIGHI, STEFANIA/0000-0003-0839-6671; Pasquini, Silvia/0000-0001-9442-1428; Gessi, Stefania/0000-0002-2197-5611; Vincenzi, Fabrizio/0000-0002-5027-1699			Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Bak DH, 2016, INT J MOL MED, V37, P378, DOI 10.3892/ijmm.2015.2440; Bartuzi D, 2018, METHODS MOL BIOL, V1705, P297, DOI 10.1007/978-1-4939-7465-8_13; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Borea PA, 2017, BRIT J PHARMACOL, V174, P1945, DOI 10.1111/bph.13763; Borea PA, 2016, TRENDS PHARMACOL SCI, V37, P419, DOI 10.1016/j.tips.2016.02.006; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724; Dias RB, 2012, HIPPOCAMPUS, V22, P276, DOI 10.1002/hipo.20894; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Dong ZSW, 2019, EUR J PHARMACOL, V853, P325, DOI 10.1016/j.ejphar.2019.04.015; Fusco I, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00399; Galvao J, 2015, EXP EYE RES, V140, P65, DOI 10.1016/j.exer.2015.08.009; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Hartwick ATE, 2004, INVEST OPHTH VIS SCI, V45, P3740, DOI 10.1167/iovs.04-0214; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kiesman William F, 2009, Handb Exp Pharmacol, P25, DOI 10.1007/978-3-540-89615-9_2; Kim JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163433; Kritis AA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00091; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lv C, 2017, EUR J PHARMACOL, V815, P487, DOI 10.1016/j.ejphar.2017.09.009; Martire A, 2019, J NEUROCHEM, V149, P211, DOI 10.1111/jnc.14660; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mouro FM, 2018, BRIT J PHARMACOL, V175, P4386, DOI 10.1111/bph.14497; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Olloquequi J, 2018, J PSYCHOPHARMACOL, V32, P265, DOI 10.1177/0269881118754680; Pedata F, 2016, NEUROPHARMACOLOGY, V104, P105, DOI 10.1016/j.neuropharm.2015.11.007; Pedata F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/805198; Romagnoli R, 2015, EUR J MED CHEM, V101, P185, DOI 10.1016/j.ejmech.2015.06.041; Romagnoli R, 2014, J MED CHEM, V57, P7673, DOI 10.1021/jm5008853; Romagnoli R, 2014, BIOORGAN MED CHEM, V22, P148, DOI 10.1016/j.bmc.2013.11.043; Romagnoli R, 2013, EUR J MED CHEM, V67, P409, DOI 10.1016/j.ejmech.2013.07.002; Romagnoli R, 2012, J MED CHEM, V55, P7719, DOI 10.1021/jm3007504; Romagnoli R, 2012, BIOORGAN MED CHEM, V20, P996, DOI 10.1016/j.bmc.2011.11.044; Serpa A, 2015, NEUROCHEM INT, V87, P106, DOI 10.1016/j.neuint.2015.06.005; Tschammer Nuska, 2016, Adv Exp Med Biol, V917, P185, DOI 10.1007/978-3-319-32805-8_9; Varani K, 2010, FASEB J, V24, P587, DOI 10.1096/fj.09-141044; Vincenzi F, 2017, ONCOTARGET, V8, P7216, DOI 10.18632/oncotarget.13802; Vincenzi F, 2017, J CELL PHYSIOL, V232, P1200, DOI 10.1002/jcp.25606; Vincenzi F, 2016, NEUROPHARMACOLOGY, V111, P283, DOI 10.1016/j.neuropharm.2016.09.015; Vincenzi F, 2014, NEUROPHARMACOLOGY, V81, P6, DOI 10.1016/j.neuropharm.2014.01.028; Zhang M, 2010, NEUROCHEM INT, V56, P35, DOI 10.1016/j.neuint.2009.08.011	45	3	3	3	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	MAY	2020	9	5								10.3390/cells9051242			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	LW7RF	WOS:000539340200176	32443448	Green Published, gold			2022-02-06	
J	Waid-Ebbs, JK; Wen, PS; Graham, DP; Leroux, AJ; O'Connor, MK; Helmer, DA				Waid-Ebbs, J. Kay; Wen, Pey-Shan; Graham, David P.; Leroux, Audrey Josee; O'Connor, Maureen K.; Helmer, Drew A.			Measurement Properties of the MPAI-4 in Veterans With mTBI	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Psychometrics; Rehabilitation; Veterans	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; PORTLAND ADAPTABILITY INVENTORY; OUTCOMES; REHABILITATION; AFGHANISTAN; PREVALENCE; CHECKLIST; UTILITY; SAMPLE	Objectives: To determine whether the measurement properties of the Mayo-Portland Adaptability Inventory Version 4 (MPAI-4) and its participation index (M2PI), which have been adopted as 2 outcome measures in the Veterans Health Administration (VHA) National Polytrauma Rehabilitation Systems of Care, are adequate in veterans with mild traumatic brain injury (mTBI). Design: Cross-sectional. Setting: Outpatient rehabilitation. Participants: Postdeployment veterans with blast-related mTBI (N=177). Intervention: Not applicable. Main Outcome Measures: Mayo-Portland Adaptability Inventory Version 4 (MPAI-4) and Community Integration Questionnaire (CIQ). Results: The unidimensional factor structure of the MPAI-4 total and 3 index scores (abilities, adjustment, participation) were confirmed. Eight of the 30 items were removed for violating monotonicity (6 items) and exceeding Rasch infit (2 items). The rating scale was collapsed from 5 to 3 ratings because of structure issues. The remaining 22 MPAI-4 items demonstrated excellent item/person reliability (0.98/0.91) and separated person ability into 4 strata. Two of the MPAI-4 index scores (abilities and adjustment) had good measurement properties. The third index, M2PI, retained only 3 items that had adequate person reliability (0.75) but separated person ability into only 2 strata. A significant but fair association with the CIQ was demonstrated with the modified MPAI-4. Conclusions: The MPAI-4 has been validated in moderate to severe traumatic brain injury but required modification when used in active military personnel with mTBI. We also identified the need for modification of the MPAI-4 to support adequate psychometrics when measuring outcomes in veterans with mTBI. Additional validation of the M2PI is needed in veterans and active military personnel with mTBI, to determine whether the M2PI should continue to be used as an outcome measure in the VHA polytrauma rehabilitation systems. (C) 2019 by the American Congress of Rehabilitation Medicine	[Waid-Ebbs, J. Kay] Brain Rehabil Res Ctr, North Florida South Georgia Vet Hlth Syst, Gainesville, FL 32608 USA; [Wen, Pey-Shan] Georgia State Univ, Byrdine F Lewis Coll Nursing & Hlth Profess, Occupat Therapy Dept, Atlanta, GA 30303 USA; [Graham, David P.] Michael E DeBakey VA Med Ctr, Traumat Brain Injury Ctr Excellence, Neurorehabil Neurons Network, Houston, TX USA; [Graham, David P.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA; [Graham, David P.] Baylor Coll Med, Menninger Dept Behav Sci, Houston, TX 77030 USA; [Leroux, Audrey Josee] Georgia State Univ, Dept Educ Policy Studies, Atlanta, GA 30303 USA; [O'Connor, Maureen K.] Bedford Vet Adm Hosp, Psychol Dept, Bedford, MA USA; [Helmer, Drew A.] War Related Illness & Injury Study Ctr VA New Jer, E Orange, NJ USA; [Helmer, Drew A.] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA		Waid-Ebbs, JK (corresponding author), Brain Rehabil Res Ctr, 1601 SW Archer Rd 151A, Gainesville, FL 32608 USA.	julia.waid-ebbs@va.gov		Leroux, Audrey/0000-0001-8796-9911; Wen, Pey-Shan/0000-0002-8921-8801; O'Connor, Maureen/0000-0002-2466-0367	Neurons to Networks TBI Center of Excellence [B6812C]; United States Department of Veterans Affairs Rehabilitation Research and Development Service	Supported by the Neurons to Networks TBI Center of Excellence (award no. #B6812C) from the United States Department of Veterans Affairs Rehabilitation Research and Development Service.	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brown TA., 2015, CONFIRMATORY FACTOR, V2; >Centers for Disease Control and Prevention (CDC) the National Institutes of Health (NIH) the Department of Defense (DoD) & the Department of Veterans Affairs (VA) Leadership Panel, 2013, C TRAUM BRAIN INJ US; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kean J, 2013, ARCH PHYS MED REHAB, V94, P2417, DOI 10.1016/j.apmr.2013.08.006; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, MAYO PORTLAND ADAPTA; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; O'Rourke J, 2019, J HEAD TRAUMA REHAB, V34, P30, DOI 10.1097/HTR.0000000000000405; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Quinones AR, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116643906; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tomaszewski R, 2016, DISABIL REHABIL, V38, P1016, DOI 10.3109/09638288.2015.1070296; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Velozo CA, 2012, ARCH PHYS MED REHAB, V93, pS154, DOI 10.1016/j.apmr.2012.06.001; Weathers F, 1991, PTSD CHECKLIST MILIT, P42; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Wright BD., 1982, RATING SCALE ANAL; Wu E, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000152; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03	41	3	3	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2020	101	5					789	796		10.1016/j.apmr.2019.10.191			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MC0ZD	WOS:000543025400006	31821800				2022-02-06	
J	Feng, JF; van Veen, E; Yang, C; Huijben, JA; Lingsma, HF; Gao, GY; Jiang, JY; Maas, AIR				Feng, Junfeng; van Veen, Ernest; Yang, Chun; Huijben, Jilske A.; Lingsma, Hester F.; Gao, Guoyi; Jiang, Jiyao; Maas, Andrew I. R.		Collaborat European Neuro Trauma	Comparison of Care System and Treatment Approaches for Patients with Traumatic Brain Injury in China versus Europe: A CENTER-TBI Survey Study	JOURNAL OF NEUROTRAUMA			English	Article						comparison; provider profiling; TBI care; traumatic brain injury; variation	NEUROTRAUMA EFFECTIVENESS RESEARCH; CLINICAL DECISION INSTRUMENTS; CT HEAD RULE; COMPUTED-TOMOGRAPHY; MANAGEMENT; CRITERIA; ADULTS	Traumatic brain injury (TBI) poses a huge public health and societal problem worldwide. Uncertainty exists on how care system and treatment approaches for TBI worked in China may differ from those in Europe. Better knowledge on this is important to facilitate interpretation of findings reported by Chinese researchers and to inform opportunities for collaborative studies. We aimed to investigate concordance and variations in TBI care between Chinese and European neurotrauma centers. Investigators from 52 centers in China and 68 in Europe involved in the Collaborative European Neuro Trauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study were invited to complete provider profiling (PP) questionnaires, which covered the main aspects of care system and treatment approaches of TBI care. Participating Chinese and European centers were mainly publicly funded and academic. More centers in China indicated available dedicated neuro-intensive care than those in Europe (98% vs. 60%), and treatment decisions in the ICU were mainly determined by neurosurgeons (58%) in China while in Europe, (neuro)intensivists often took the lead (61%). The ambulance dispatching system was automatic in half of Chinese centers (49%), whereas selective dispatching was more common in European centers (74%). For treatment of refractory intracranial hypertension, a decompressive craniectomy was more frequently regarded as general policy in China compared with in Europe (89% vs. 45%). We observed both concordance and substantial variations with regard to the various aspects of TBI care between Chinese and European centers. These findings are fundamental to guide future research and offer opportunities for collaborative comparative effectiveness research to identify best practices.	[Feng, Junfeng; Yang, Chun; Gao, Guoyi; Jiang, Jiyao] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, 160 Pujian Rd, Shanghai, Peoples R China; [Feng, Junfeng; Yang, Chun; Gao, Guoyi; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [van Veen, Ernest; Huijben, Jilske A.; Lingsma, Hester F.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van Veen, Ernest] Erasmus Univ, Med Ctr, Dept Intens Care, Rotterdam, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, 160 Pujian Rd, Shanghai, Peoples R China.	gao3@sina.com	Vande Vyvere, Thijs/AAB-5180-2022; Laureys, Steven/AAN-2097-2021; Castano-Leon, Ana M/ABF-6322-2020; Sahuquillo, Juan/B-3577-2008; Cooper, D. James/G-7961-2013; Posti, Jussi P./Y-2908-2019; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014	Vande Vyvere, Thijs/0000-0003-4032-5443; Laureys, Steven/0000-0002-3096-3807; Castano-Leon, Ana M/0000-0002-7918-5049; Sahuquillo, Juan/0000-0003-0713-5875; Cooper, D. James/0000-0002-5872-9051; Posti, Jussi P./0000-0002-5925-5193; Stewart, William/0000-0003-2199-2582; Raj, Rahul/0000-0003-4243-9591; Radoi, Andreea/0000-0002-0677-3544; Newcombe, Virginia/0000-0001-6044-9035; Kondziella, Daniel/0000-0001-5562-9808; Zeiler, Frederick/0000-0003-1737-0510; Coles, Jonathan/0000-0003-4013-679X; Kolias, Angelos/0000-0003-3992-0587; Sakowitz, Oliver/0000-0003-3248-6335; Van Essen, Thomas/0000-0003-4657-5283; Dark, Paul/0000-0003-3309-0164; Sanchez-Porras, Renan/0000-0002-9084-8114; Gomez, Pedro/0000-0002-4185-5238; Rossi, Sandra/0000-0002-9963-8121	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971699, 81671198]; European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	This research was supported by grants from the National Natural Science Foundation of China (grant numbers 81971699 and 81671198), and CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). The funders had no role in the collection, analysis and interpretation of data, nor in the writing of the report or in publication decisions. The authors had full access to study data and the senior authors had final responsibility for the decision to publish.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheng YJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001515; Cnossen MC, 2019, J NEUROTRAUM, V36, P176, DOI 10.1089/neu.2018.5712; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2005, JAMA-J AM MED ASSOC, V294, P1551, DOI 10.1001/jama.294.12.1551; Huang X, 2013, PAK J MED SCI, V29, P951, DOI 10.12669/pjms.294.3469; Huijben JA, 2018, J NEUROTRAUM, V35, P323, DOI 10.1089/neu.2017.5194; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Liu T, 2018, CHIN J TRAUMATOL, V21, P80, DOI 10.1016/j.cjtee.2017.06.004; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; van Essen TA, 2019, ACTA NEUROCHIR, V161, P451, DOI 10.1007/s00701-019-03815-6; van Veen E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2241-4; Volovici V, 2019, WORLD NEUROSURG, V125, pE515, DOI 10.1016/j.wneu.2019.01.116; Volovici V, 2019, J CRIT CARE, V49, P158, DOI 10.1016/j.jcrc.2018.11.002; Xu D, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000014439, 10.1097/md.0000000000014439]; Yang XF, 2017, J CRANIOFAC SURG, V28, P1594, DOI 10.1097/SCS.0000000000003759	29	3	3	4	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2020	37	16					1806	1817		10.1089/neu.2019.6900		APR 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MW0CL	WOS:000529989700001	32174214				2022-02-06	
J	Forti, RM; Katsurayama, M; Menko, J; Valler, L; Quiroga, A; Falcao, ALE; Li, L; Mesquita, RC				Forti, Rodrigo M.; Katsurayama, Marilise; Menko, Julien; Valler, Lenise; Quiroga, Andres; Falcao, Antonio L. E.; Li, Li M.; Mesquita, Rickson C.			Real-Time Non-invasive Assessment of Cerebral Hemodynamics With Diffuse Optical Spectroscopies in a Neuro Intensive Care Unit: An Observational Case Study	FRONTIERS IN MEDICINE			English	Article						cerebral blood flow (CBF); neuro intensive care unit; diffuse correlation spectroscopy (DCS); diffuse optical spectroscopy (DOS); aneurysmal subarachnoid hemorrhage	NEAR-INFRARED SPECTROSCOPY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; TISSUE BLOOD-FLOW; OXYGEN-METABOLISM; TOOL; ACCURACY; PHASES; MEDIA	Prevention of secondary damage is an important goal in the treatment of severe neurological conditions, such as major head trauma or stroke. However, there is currently a lack of non-invasive methods for monitoring cerebral physiology. Diffuse optical methods have been proposed as an inexpensive, non-invasive bedside monitor capable of providing neurophysiology information in neurocritical patients. However, the reliability of the technique to provide accurate longitudinal measurement during the clinical evolution of a patient remains largely unaddressed. Here, we report on the translation of a hybrid diffuse optical system combining frequency domain diffuse optical spectroscopy (FD-DOS) and diffuse correlation spectroscopy (DCS) for real-time monitoring of cerebral physiology in a neuro intensive care unit (neuro-ICU). More specifically, we present a case study of a patient admitted with a high-grade aneurysmal subarachnoid hemorrhage, who was monitored throughout hospitalization. We show that the neurophysiological parameters measured by diffuse optics at the bedside are consistent with the clinical evolution of the patient at all the different stages following its brain lesion. These data provide support for clinical translation of DOS/DCS as a useful biomarker of neurophysiology in the neuro-ICU, particularly in locations where other clinical resources are limited.	[Forti, Rodrigo M.; Quiroga, Andres; Mesquita, Rickson C.] Univ Estadual Campinas, Inst Phys, Campinas, Brazil; [Forti, Rodrigo M.; Katsurayama, Marilise; Valler, Lenise; Quiroga, Andres; Li, Li M.; Mesquita, Rickson C.] Brazilian Inst Neurosci & Neurotechnol, Campinas, Brazil; [Katsurayama, Marilise; Valler, Lenise; Falcao, Antonio L. E.] Univ Estadual Campinas, Clin Hosp, Campinas, Brazil; [Menko, Julien] Albert Einstein Coll Med, Dept Emergency Med, Bronx, NY 10467 USA; [Li, Li M.] Univ Estadual Campinas, Sch Med Sci, Campinas, Brazil		Forti, RM (corresponding author), Univ Estadual Campinas, Inst Phys, Campinas, Brazil.; Forti, RM (corresponding author), Brazilian Inst Neurosci & Neurotechnol, Campinas, Brazil.	rforti@ifi.unicamp.br	Forti, Rodrigo Menezes/K-2285-2017	Forti, Rodrigo Menezes/0000-0002-8978-2525	Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/02500-8, 2014/25486-6, 2013/07559-3]	We acknowledge the support by the Sao Paulo Research Foundation (FAPESP) through Proc. 2012/02500-8 (RM), 2014/25486-6 (RF) and 2013/07559-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi YZ, 2010, WORLD NEUROSURG, V73, P654, DOI 10.1016/j.wneu.2010.02.005; Alexandrakis G, 2001, APPL OPTICS, V40, P3810, DOI 10.1364/AO.40.003810; Baker WB, 2019, J CEREBR BLOOD F MET, V39, P1469, DOI 10.1177/0271678X19846657; Baker WB, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035004; Banu SH., 2014, BANGLADESH CRIT CARE, V2, P28, DOI DOI 10.3329/bccj.v2i1.19954; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; Buckley EM, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011009; Buckley EM, 2013, J THORAC CARDIOV SUR, V145, P196, DOI 10.1016/j.jtcvs.2012.09.057; Busch DR, 2019, NEUROCRIT CARE, V30, P72, DOI 10.1007/s12028-018-0573-1; Busch DR, 2016, BIOMED OPT EXPRESS, V7, P3461, DOI 10.1364/BOE.7.003461; CARPENTER DA, 1991, J CEREBR BLOOD F MET, V11, P837, DOI 10.1038/jcbfm.1991.143; Culver JP, 2003, J CEREBR BLOOD F MET, V23, P911, DOI 10.1097/01.WCB.0000076703.71231.BB; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Davies DJ, 2019, J NEUROTRAUM, V36, P1175, DOI 10.1089/neu.2018.5667; Delgado-Mederos R, 2018, BIOMED OPT EXPRESS, V9, P1262, DOI 10.1364/BOE.9.001262; Demchuk AM, 2000, J NEUROIMAGING, V10, P1; Diop M, 2011, BIOMED OPT EXPRESS, V2, P2068, DOI 10.1364/BOE.2.002068; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Fantini S, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031411; Farzam P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15995-1; Favilla CG, 2019, NEUROTHERAPEUTICS, V16, P1296, DOI 10.1007/s13311-019-00744-1; Favilla CG, 2014, STROKE, V45, P1269, DOI 10.1161/STROKEAHA.113.004116; Ferradal SL, 2017, SCI REP-UK, V7, DOI 10.1038/srep44117; Forti RM, 2019, J STROKE CEREBROVASC, V28, P1483, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.019; Gagnon L, 2008, OPT EXPRESS, V16, P15514, DOI 10.1364/OE.16.015514; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Gagnon L, 2011, NEUROIMAGE, V56, P1362, DOI 10.1016/j.neuroimage.2011.03.001; Goodwin JR, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015002; Green MS, 2016, SEMIN CARDIOTHORAC V, V20, P213, DOI 10.1177/1089253216644346; Gregori-Pla C, 2019, J NEUROL, V266, P990, DOI 10.1007/s00415-019-09226-y; Greisen G, 2011, PHILOS T R SOC A, V369, P4440, DOI 10.1098/rsta.2011.0261; Hallacoglu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064095; Hametner C, 2015, J CEREBR BLOOD F MET, V35, P1722, DOI 10.1038/jcbfm.2015.181; He L, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.4.045006; Huppert TJ, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.010401; Jain V, 2014, J CEREBR BLOOD F MET, V34, P380, DOI 10.1038/jcbfm.2013.214; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Liemert A, 2010, OPT EXPRESS, V18, P9266, DOI 10.1364/OE.18.009266; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mesquita RC, 2011, PHILOS T R SOC A, V369, P4390, DOI 10.1098/rsta.2011.0232; Messerer M, 2012, MINERVA ANESTESIOL, V78, P810; Milej D, 2020, J CEREBR BLOOD F MET, V40, P1672, DOI 10.1177/0271678X19872564; Muehlschlegel S, 2009, NEUROCRIT CARE, V11, P288, DOI 10.1007/s12028-009-9254-4; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Oliveira MD, 2015, NEURAL REGEN RES, V10, P748, DOI 10.4103/1673-5374.156969; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Papanikolaou J, 2012, CRIT CARE MED, V40, P223, DOI 10.1097/CCM.0b013e31822e9fab; Pennekamp CWA, 2012, CEREBROVASC DIS, V34, P314, DOI 10.1159/000343229; Proenca Martin, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1502, DOI 10.1109/EMBC.2018.8512504; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Ritzenthaler T, 2017, STROKE, V48, P3390, DOI 10.1161/STROKEAHA.117.019176; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Saito H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19668-5; Sandsmark DK, 2012, STROKE, V43, P1440, DOI 10.1161/STROKEAHA.111.639906; Sarrafzadeh AS, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00134; Selb J, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.4.045005; Selb J, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015005; Shang Y, 2017, PHYSIOL MEAS, V38, pR1, DOI 10.1088/1361-6579/aa60b7; Shang Y, 2011, PHYS MED BIOL, V56, P3015, DOI 10.1088/0031-9155/56/10/008; Valabregue R, 2003, J CEREBR BLOOD F MET, V23, P536, DOI 10.1097/01.WCB.0000055178.31872.38; Verdecchia K, 2016, BIOMED OPT EXPRESS, V7, P3659, DOI 10.1364/BOE.7.003659; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Wong F, 2016, NEUROMETHODS, V109, P69, DOI 10.1007/978-1-4939-3014-2_5; Yokose N, 2010, WORLD NEUROSURG, V73, P508, DOI 10.1016/j.wneu.2010.02.061; Yu GQ, 2012, CURR MED IMAGING, V8, P194, DOI 10.2174/157340512803759875; Yucel MA, 2016, BIOMED OPT EXPRESS, V7, P3078, DOI 10.1364/BOE.7.003078; Yundt KD, 1998, J CEREBR BLOOD F MET, V18, P419, DOI 10.1097/00004647-199804000-00010	74	3	3	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	APR 28	2020	7								147	10.3389/fmed.2020.00147			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LO2BJ	WOS:000533430900001	32411712	gold, Green Published			2022-02-06	
J	Gaertner, LHC; Tsur, N; Haller, CS				Gaertner, Lynn H. C.; Tsur, Noga; Haller, Chiara S.			Patients' recovery after severe TBI is associated with their close relatives' interpersonal functioning: a 12-months prospective cohort study	BRAIN INJURY			English	Article						Traumatic brain injury; relatives; interpersonal functioning; health-related quality of life; neuropsychological functioning	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SOCIAL SUPPORT; HEAD-INJURY; MINDFUL CREATIVITY; CAREGIVER BURDEN; FAMILY-THERAPY; CHRONIC STRESS; UNITED-STATES; HEALTH SURVEY	Objective: The aim of this study was to investigate the association between relatives' interpersonal functioning and patients' recovery after severe traumatic brain injury (TBI) across one year in Switzerland. Design: This prospective, multi-center cohort study is comprised of 188 adult patients with severe TBI (Abbreviated Head Injury Score > 3) and their relatives. Patients and relatives were assessed 3, 6, and 12 months post-injury. Main outcome measures: Interpersonal functioning (Patient Competency Rating Scale for Neurorehabilitation, PCRS-NR), Physical and Mental Health related Quality of Life (HRQoL, SF-12), and overall functioning (Glasgow Outcome Comma Scale Extended, GOSE). Results: Multilevel analyses showed that relatives' interpersonal functioning was positively associated with a) patients' mental HRQoL (p =.002; slope = 2.95; beta =.24) independently of age, b) a moderation time*patients' physical HRQoL among patients > 50 years of age (p <.045; slope = 2.63; beta =.2) and c) patients' GOSE among younger individuals (p <.001; slope =.60; beta =.23). Conclusion: These findings show that health and overall functioning are linked with interpersonal dimensions. Thus, the interplay between relatives and patients with TBI needs to be further investigated.	[Gaertner, Lynn H. C.; Haller, Chiara S.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Gaertner, Lynn H. C.] Univ Lubeck, Dept Psychol, Maria Goeppert Str 9a, D-23562 Lubeck, Germany; [Tsur, Noga] Tel Aviv Univ, Sch Social Work, Tel Aviv, Israel; [Haller, Chiara S.] Harvard Med Sch, Massachusetts Mental Hlth Ctr, Div Publ Psychiat, Boston, MA 02115 USA		Gaertner, LHC (corresponding author), Univ Lubeck, Dept Psychol, Maria Goeppert Str 9a, D-23562 Lubeck, Germany.	lynngaertner@gmx.de			PEBITA in 2017	The senior author is the PI of TRAST-MI (Chiara S. Haller) and as such received a grant by PEBITA in 2017 for her continuous commitment to investigations in patients with brain disorders. Neither her nor any of the other authors received any financial support for the research, authorship, and/or publication of this article.	[Anonymous], 2015, IN STAT VERS; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Berry JW, 2012, REHABIL PSYCHOL, V57, P98, DOI 10.1037/a0028229; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bosma CM, 2018, ARCH PHYS MED REHAB, V99, P1576, DOI 10.1016/j.apmr.2018.02.008; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Collins NL, 2000, J PERS SOC PSYCHOL, V78, P1053, DOI 10.1037//0022-3514.78.6.1053; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Eisenberger NI, 2007, NEUROIMAGE, V35, P1601, DOI 10.1016/j.neuroimage.2007.01.038; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feeney BC, 2015, PERS SOC PSYCHOL REV, V19, P113, DOI 10.1177/1088868314544222; Gad AM., 2017, INT J STAT DISTRIBUT, V3, P72, DOI DOI 10.11648/J.IJSD.20170304.13; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Groswasser Z, 1996, TRAUMATIC BRAIN INJU, P25; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Gujral IB., 2007, UNDERSTANDING ASS AB; Haller CS, 2017, BRAIN INJURY, V31, P1903, DOI 10.1080/02699052.2017.1346295; Haller CS, 2017, J PERS, V85, P481, DOI 10.1111/jopy.12254; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Haller CS, 2017, QUAL LIFE RES, V26, P893, DOI 10.1007/s11136-016-1416-1; Haller CS, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14177; Haller CS, 2015, BRAIN INJURY, V29, P517, DOI 10.3109/02699052.2014.989906; Haller CS, 2016, SWISS ARCH NEUROL PS, V4, P114; Hill A, 2007, DATA ANAL USING REGR; Honaker J, 2011, J STAT SOFTW, V45, P1; Hoofien D, 2001, BRAIN INJURY, V15, P189; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; Iob E, 2018, PSYCHONEUROENDOCRINO, V96, P100, DOI 10.1016/j.psyneuen.2018.06.008; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Medicine A, 2001, ABBREVIATED INJURY S; MILLER L, 1993, AM J FAM THER, V21, P111, DOI 10.1080/01926189308250910; MINUCHIN P, 1985, CHILD DEV, V56, P289, DOI 10.1111/j.1467-8624.1985.tb00106.x; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Institute of Health, 2016, DO HLTH CAR PROV DIA; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Pinheiro J., 2018, NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Seckl JR, 2007, PROG BRAIN RES, V167, P17, DOI 10.1016/S0079-6123(07)67002-2; Spiegel D., 2001, EMOTION SOCIAL RELAT, P97, DOI [10.1093/acprof:oso/9780195145410.003.0004, DOI 10.1093/ACPROF:OSO/9780195145410.003.0004]; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Su YS, 2016, NEUROPLASTICITY TRAU; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Tramonti F, 2017, CONTEMP FAM THER, V39, P73, DOI 10.1007/s10591-017-9405-2; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE., 2002, SF 12V2 SCORE VERSIO; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; ZARSKI JJ, 1987, AM J FAM THER, V15, P62; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	95	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					766	774		10.1080/02699052.2020.1753241		APR 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000531989600001	32338545				2022-02-06	
J	Kersey, J; McCue, M; Skidmore, E				Kersey, Jessica; McCue, Michael; Skidmore, Elizabeth			Domains and dimensions of community participation following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; community participation; enfranchisement; environment; depression	INTERNATIONAL-CLASSIFICATION; SOCIAL INTEGRATION; HEALTH; STROKE; DISABILITY; PEOPLE; INTERVENTION; COGNITION; OUTCOMES	Primary Objective: To examine patterns of community participation, as well as the relationship among community participation outcomes and time since injury, impairments, environmental factors, and enfranchisement in adults with traumatic brain injury (TBI). Research Design: Cross-sectional study of a sample of 61 adults with TBI. Methods and Procedures: We administered the Participation Measure- 3 Domains 4 Dimensions to examine community participation in the three domains (productivity, community activities, and social participation) using four dimensions (diversity of activities, frequency, difficulty, and desire for change). Main Results and Outcomes: All dimensions of community participation seem to be impaired following TBI, as evidenced by scores in the lower half of the available range. Most impaired was social participation (frequency: M = 10.0, SD = 3.4, possible range 0-24; difficulty: M= 11.3, SD = 3.2, possible range 4-16). Correlational analyses revealed that depression (r = 0.51), environmental factors (r = 0.51), and enfranchisement (r = 0.42), seem to play an important role in community participation outcomes, and may be potential targets for intervention. Results did not vary based on time since injury. Conclusion: Our results suggest that depression, environmental factors, and enfranchisement may be important considerations for future interventions aiming to promote management of identified barriers.	[Kersey, Jessica; Skidmore, Elizabeth] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA 15219 USA; [McCue, Michael] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Rehabil Sci & Technol, Pittsburgh, PA 15219 USA		Kersey, J (corresponding author), Univ Pittsburgh, Dept Occupat Therapy, 100 Technol Dr,Suite 350, Pittsburgh, PA 15219 USA.	jmk286@pitt.edu		McCue, Michael/0000-0002-0850-6714			Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Chang FH, 2017, ARCH PHYS MED REHAB, V98, P2498, DOI 10.1016/j.apmr.2017.05.027; Chang FH, 2013, ARCH PHYS MED REHAB, V94, P771, DOI 10.1016/j.apmr.2012.10.031; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Gerber GJ, 2016, BRAIN INJURY, V30, P1552, DOI 10.1080/02699052.2016.1199896; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS1, DOI 10.1016/j.apmr.2009.08.155; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Jette DU, 2005, PHYS THER, V85, P238, DOI 10.1093/ptj/85.3.238; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Juengst SB, 2014, AM J PHYS MED REHAB, V93, P1086, DOI 10.1097/PHM.0000000000000163; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Latham NK, 2006, AM J OCCUP THER, V60, P369, DOI 10.5014/ajot.60.4.369; Law M, 1990, Can J Occup Ther, V57, P82; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Orff HJ, 2016, J REHABIL RES DEV, V53, P541, DOI 10.1682/JRRD.2014.11.0295; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Richards LG, 2005, ARCH PHYS MED REHAB, V86, pS51, DOI 10.1016/j.apmr.2005.08.127; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schalet BD, 2016, J CLIN EPIDEMIOL, V73, P119, DOI 10.1016/j.jclinepi.2015.08.036; Smallfield S, 2009, AM J OCCUP THER, V63, P408, DOI 10.5014/ajot.63.4.408; Taylor HO, 2018, J AGING HEALTH, V30, P229, DOI 10.1177/0898264316673511; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17; Zunzunegui MV, 2003, J GERONTOL B-PSYCHOL, V58, pS93, DOI 10.1093/geronb/58.2.S93	34	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					708	712		10.1080/02699052.2020.1757153		APR 2020	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000528367500001	32320307				2022-02-06	
J	Kita, H; Mallory, KD; Hickling, A; Wilson, KE; Kroshus, E; Reed, N				Kita, Helena; Mallory, Kylie D.; Hickling, Andrea; Wilson, Katherine E.; Kroshus, Emily; Reed, Nick			Social support during youth concussion recovery	BRAIN INJURY			English	Article						Concussion; social support; youth; pediatric; peer support	SYMPTOMS; CHILDREN	Purpose: We explored the lived experience of high-school aged girls receiving social support during concussion recovery to better understand (1) how they define meaningful social support and barriers/facilitators to receiving it; (2) who provides that support; and (3) the role of peers. Methods: In person, semi-structured interviews were conducted with 10 girls (aged 14-19 years) with a personal history of concussion. Results: Close friends, youth with personal history of concussion, and parents were identified as key providers of meaningful social support during concussion recovery. Participants identified specific examples of support provided by each group. Close friends built asense of social inclusion that mitigated feelings of social isolation. Youth with apersonal history of concussion used their lived experiences to communicate empathy and validate the participant's challenges. Parents assisted with practical challenges (e.g. accessing accommodations) by leveraging their "adult power". Participants identified that lack of understanding of their lived experiences was a key barrier to receiving support. They proposed solutions focused on education initiatives highlighting personal accounts from youth with concussion, and specific examples of how peers can help. Conclusions: Fostering social support may require strategies tailored to each group of key providers as they mitigate different challenges in recovery.	[Kita, Helena; Mallory, Kylie D.; Hickling, Andrea; Wilson, Katherine E.; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Bloorview Res Inst, Toronto, ON, Canada; [Mallory, Kylie D.; Reed, Nick] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Hickling, Andrea; Reed, Nick] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Reed, N (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.	nick.reed@utoronto.ca		Hickling, Andrea/0000-0001-6251-6369	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [153025]; Ward Family	This work was supported by the Canadian Institutes of Health Research under grant #153025 and the Ward Family.	Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Andre-Morin D, 2017, SPORT EXERC PERFORM, V6, P289, DOI 10.1037/spy0000106; Berger R, 2015, QUAL RES, V15, P219, DOI 10.1177/1468794112468475; Birks M, 2008, J RES NURS, V13, P68, DOI 10.1177/1744987107081254; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cassilo D, 2019, COMMUN SPORT, V7, P678, DOI 10.1177/2167479518790039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Creswell JW, 2009, RES DES QUAL QUANT M, V3rd, P260; Demaray MK, 2003, SCHOOL PSYCHOL REV, V32, P108; Don BP, 2017, PERS SOC PSYCHOL B, V43, P1112, DOI 10.1177/0146167217705119; Doyle Susanna, 2007, Health Care Women Int, V28, P888, DOI 10.1080/07399330701615325; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kasamatsu TM, 2017, TEACH TEACH EDUC, V68, P181, DOI 10.1016/j.tate.2017.09.005; Kersten P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020672; Koch T, 1998, J ADV NURS, V28, P882, DOI 10.1046/j.1365-2648.1998.00725.x; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuckin M. E., 2016, J SPORT BEHAV, V39, P426; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; Morris RPG, 2017, CLIN REHABIL, V31, P1030, DOI 10.1177/0269215516676303; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Paniccia MJ, 2017, CAN J OCCUP THER, V84, P111, DOI 10.1177/0008417416688302; Provvidenza C, 2018, SCHOOLFIRST ENABLING; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; SHUMAKER SA, 1984, J SOC ISSUES, V40, P11, DOI 10.1111/j.1540-4560.1984.tb01105.x; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Uchino B.N, 2004, AM J EPIDEMIOL, V161, P297, DOI [DOI 10.12987/YALE/9780300102185.001.0001, 10.1093/aje/kwi036, DOI 10.1093/AJE/KWI036]; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wijma AJ, 2018, DISABIL REHABIL, V40, P2181, DOI 10.1080/09638288.2017.1327990; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	40	3	3	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					784	792		10.1080/02699052.2020.1753243		APR 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000528168400001	32315217	hybrid			2022-02-06	
J	Venkatesan, UM; Lancaster, K; Lengenfelder, J; Genova, HM				Venkatesan, Umesh M.; Lancaster, Katie; Lengenfelder, Jean; Genova, Helen M.			Independent contributions of social cognition and depression to functional status after moderate or severe traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Social cognition; Depression; Functional outcome; Social functioning	QUALITY-OF-LIFE; EMOTION RECOGNITION; SELF-AWARENESS; COMMUNICATION-SKILLS; PREFRONTAL LESIONS; ASPERGER-SYNDROME; INVENTORY-II; MIND; IMPAIRMENTS; DEFICITS	Impairments in cognitive processing related to social understanding and communication (i.e., "social cognition") are well documented after moderate or severe traumatic brain injury (TBI) and can contribute to negative functional outcome. Depression is also a common feature of TBI with detrimental functional consequences. We evaluated relationships between social cognition, depression symptom severity, and functional status in individuals with chronic TBI (>1 year post injury; n = 25) and healthy controls (n = 30) using objective tests of social cognition as well as self-reported depression (Beck Depression Inventory-II) and functional status (Functional Behavior Profile). Results revealed significant relationships between depression and functional status across the sample, and relationships between social cognition and functional status specific to TBI. In the TBI group only, social cognition significantly predicted both overall and social functional status above and beyond depression. Group differences in functional status were independently mediated by social cognition and, especially, depression. Our findings suggest that social cognitive impairments and depression are distinct, functionally relevant TBI sequelae. Interventions to improve social functioning in this population may be most effective when contextualized within treatments for emotional disturbances.	[Venkatesan, Umesh M.] Moss Rehabil Res Inst, 50 Township Line Rd,Suite 100, Elkins Pk, PA 19027 USA; [Lancaster, Katie; Lengenfelder, Jean; Genova, Helen M.] Kessler Fdn Res Ctr, West Orange, NJ USA; [Lancaster, Katie; Lengenfelder, Jean; Genova, Helen M.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Venkatesan, UM (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd,Suite 100, Elkins Pk, PA 19027 USA.	venkateu@einstein.edu			New Jersey Commission on Brain Injury Research [CBIR13IRG026]; William Randolph Hearst Foundations Fellowship	This work was supported by Research Grant CBIR13IRG026 of the New Jersey Commission on Brain Injury Research to JL and HG, and a William Randolph Hearst Foundations Fellowship to KL.	Allain P, 2019, BRAIN INJURY, V33, P1, DOI 10.1080/02699052.2018.1533143; Allen DN, 2007, SCHIZOPHR RES, V93, P325, DOI 10.1016/j.schres.2007.02.008; Andrews-Hanna JR, 2014, NEUROIMAGE, V91, P324, DOI 10.1016/j.neuroimage.2014.01.032; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Azouvi P, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000169; BAANDERS MF, 1993, REC RES PSY, P471; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Baum M C, 2000, J Gerontol Nurs, V26, P34; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Binder AS, 2019, J INT NEUROPSYCH SOC, V25, P890, DOI 10.1017/S1355617719000559; Bivona U, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5205642; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bora E, 2016, J AFFECT DISORDERS, V191, P49, DOI 10.1016/j.jad.2015.11.023; Bower GH, 2000, COGNITION EMOTION, P87; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burgener S. C., 2005, DEMENTIA, V4, P463, DOI DOI 10.1177/1471301205058303; Bzdok D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00232; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Cotter J, 2018, NEUROSCI BIOBEHAV R, V84, P92, DOI 10.1016/j.neubiorev.2017.11.014; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Cusi AM, 2013, PSYCHIAT RES, V210, P672, DOI 10.1016/j.psychres.2013.06.018; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dodell-Feder D, 2018, NEUROSCI BIOBEHAV R, V92, P150, DOI 10.1016/j.neubiorev.2018.05.034; Forgas JP, 2013, HDB PSYCHOL EXPT PSY, V2nd, P61; Genova HM, 2017, SOC NEUROSCI-UK, V12, P303, DOI 10.1080/17470919.2016.1173584; Genova HM, 2016, J INT NEUROPSYCH SOC, V22, P83, DOI 10.1017/S1355617715001137; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Goverover Y, 2005, ARCH PHYS MED REHAB, V86, P2303, DOI 10.1016/j.apmr.2005.05.016; Goverover Y, 2016, ARCH PHYS MED REHAB, V97, P1901, DOI 10.1016/j.apmr.2016.05.003; Goverover Y, 2009, REHABIL PSYCHOL, V54, P60, DOI 10.1037/a0014556; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Han KW, 2018, HUM BRAIN MAPP, V39, P2955, DOI 10.1002/hbm.24052; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jolliffe T, 1999, J AUTISM DEV DISORD, V29, P395, DOI 10.1023/A:1023082928366; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Knight MJ, 2019, DEPRESS ANXIETY, V36, P54, DOI 10.1002/da.22844; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Lancaster K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00825; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Mitchell EJ, 2014, DISABIL REHABIL, V36, P1474, DOI 10.3109/09638288.2013.845259; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Peterson AB, 2019, SURVEILLANCE REPORT; Quemada José Ignacio, 2017, rev.colomb.psiquiatr., V46, P36, DOI 10.1016/j.rcp.2017.05.005; R Core Team, 2018, R LANGUAGE ENV STAT; Rigon A, 2018, NEUROPSYCHOLOGY, V32, P476, DOI 10.1037/neu0000368; Romera I, 2010, EUR PSYCHIAT, V25, P58, DOI 10.1016/j.eurpsy.2009.02.007; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sergi MJ, 2007, SCHIZOPHR RES, V90, P316, DOI 10.1016/j.schres.2006.09.028; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Sirois K, 2019, NEUROPSYCHOL REHABIL, V29, P1383, DOI 10.1080/09602011.2017.1413987; Smith A., 1982, SYMBOL DIGIT MODALIT; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stone V. E., 2015, OXFORD HDB SOCIAL NE, P455; The jamovi project, 2019, JAMOVI VERSION 0 9; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Varo C, 2019, ACTA PSYCHIAT SCAND, V139, P369, DOI 10.1111/acps.13014; Wang Yu-lin, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P416, DOI 10.3881/j.issn.1000-503X.2013.04.011; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Weightman MJ, 2019, PSYCHIAT RES, V274, P195, DOI 10.1016/j.psychres.2019.02.035; Weightman MJ, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00179; Westerhof-Evers HJ, 2019, BRAIN INJURY, V33, P78, DOI 10.1080/02699052.2018.1531303; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Yogarajah M, 2019, EPILEPSY BEHAV, V100, DOI 10.1016/j.yebeh.2019.05.017; Zwick JC, 2017, J AFFECT DISORDERS, V210, P90, DOI 10.1016/j.jad.2016.12.022	92	3	3	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 3	2021	31	6					954	970		10.1080/09602011.2020.1749675		APR 2020	17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	SB4HE	WOS:000527814600001	32314644				2022-02-06	
J	Salehi, PP; Heiser, A; Torabi, SJ; Azizzadeh, B; Lee, JN; Lee, YH				Salehi, Parsa P.; Heiser, Alyssa; Torabi, Sina J.; Azizzadeh, Babak; Lee, Jonathan; Lee, Yan H.			Facial Fractures and the National Basketball Association: Epidemiology and Outcomes	LARYNGOSCOPE			English	Article						Fracture; facial fracture; face fracture; head injury; National Basketball Association; basketball; orbital fracture; nasal fracture; maxilla fracture; zygoma fracture; sinus fracture	CRUCIATE LIGAMENT RECONSTRUCTION; PSYCHOLOGICAL SEQUELAE; PERFORMANCE OUTCOMES; RETURN; INJURIES; PLAY; MICROFRACTURE; CONCUSSION; REPAIR; SPORT	Objectives/Hypothesis To identify the epidemiology and impact of facial fractures on player performance and return to play (RTP) in the National Basketball Association (NBA). Study Design Retrospective case-control series Methods Fifty-three NBA players who sustained facial fractures between 1984 and 2018 were identified. Players with pre- and postinjury statistics were included in the performance analysis. A control group was matched by age, body mass index (BMI), position, NBA experience, and player efficiency rating. Fisher exact tests and Student t tests were performed to analyze player demographics and performance variables. Results At the time of injury, the average player's age was 26.17 years, BMI was 24.80 kg/m(2), and NBA experience was 4.97 years. Players missed an average of 3.77 games and 18.21 days prior to RTP. Forty-eight players (90.6%) did RTP the subsequent season, whereas 43 of those players (81.1%) met inclusion criteria for performance analysis. There was no significant change in performance between pre- and postinjury seasons. Players managed operatively missed significantly more games (8.15 vs. 1.85; P = .034) and days (51.08 vs. 5.53; P = .003) than players managed nonoperatively, whereas performance was not impacted. Average career length following facial fracture was significantly shorter compared to controls (5.14 vs. 6.42 years; P = .010) and a decrease in three-pointer percentage (P = .004) was observed. Conclusions The majority of players who suffer facial fractures RTP in the NBA and do not experience significant decline in performance following injury. These results should aid physicians caring for basketball players at any level, and may help inform future guidelines for treatment and injury prevention. Level of Evidence 3b Laryngoscope, 2020	[Salehi, Parsa P.; Torabi, Sina J.; Lee, Yan H.] Yale Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, New Haven, CT USA; [Heiser, Alyssa] Univ Vermont, Med Ctr, Dept Otolaryngol Head & Neck Surg, Burlington, VT USA; [Azizzadeh, Babak] Ctr Adv Facial Plast Surg, Beverly Hills, CA USA; [Azizzadeh, Babak] Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck Surg, Dept Otolaryngol Head & Neck Surg, Los Angeles, CA 90095 USA; [Torabi, Sina J.; Lee, Jonathan] Baystate Med Ctr, Dept Surg, Div Plast Surg, Springfield, MA USA		Salehi, PP (corresponding author), 47 Coll Pl, New Haven, CT 06510 USA.	parsa.salehi@yale.edu		Torabi, Sina/0000-0002-1964-7109; , Yan/0000-0003-4980-9663			Abosadegh MM, 2017, DENT TRAUMATOL, V33, P369, DOI 10.1111/edt.12349; Amin Nirav H, 2016, Clin Res Foot Ankle, V4, DOI 10.4172/2329-910X.1000205; Amin NH, 2013, AM J SPORT MED, V41, P1864, DOI 10.1177/0363546513490659; Anakwenze OA, 2010, SPINE, V35, P825, DOI 10.1097/BRS.0b013e3181d3cf45; Begly JP, 2016, SPORTS HEALTH, V8, P342, DOI 10.1177/1941738115621011; Bisson JI, 1997, J TRAUMA, V43, P496, DOI 10.1097/00005373-199709000-00018; Busfield BT, 2009, ARTHROSCOPY, V25, P825, DOI 10.1016/j.arthro.2009.02.021; Cannon C Ron, 2011, Ear Nose Throat J, V90, pE8; Cerynik DL, 2009, KNEE SURG SPORT TR A, V17, P1135, DOI 10.1007/s00167-009-0765-5; Chorney SR, 2017, LARYNGOSCOPE, V127, P1296, DOI 10.1002/lary.26441; Conforte JJ, 2016, INT J ORAL MAX SURG, V45, P575, DOI 10.1016/j.ijom.2015.11.022; DiFiori JP, 2018, SPORTS MED, V48, P2053, DOI 10.1007/s40279-018-0950-0; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Gandy JR, 2016, LARYNGOSCOPE, V126, P1054, DOI 10.1002/lary.25584; Glynn SM, 2010, ORAL MAXIL SURG CLIN, V22, P217, DOI 10.1016/j.coms.2010.01.008; Guss Michael S, 2016, Hand (N Y), V11, P427, DOI 10.1177/1558944716628500; GUYETTE RF, 1993, CLIN SPORT MED, V12, P247; Harris JD, 2013, SPORTS HEALTH, V5, P562, DOI 10.1177/1941738113495788; Hollinger J., 2005, PROBASKETBALL FORECA; Holmes B., KNIFE EXPOSING AM YO; Holmes B., THESE KIDS ARE TICKI; Hwang K, 2017, J CRANIOFAC SURG, V28, P803, DOI 10.1097/SCS.0000000000003482; Hwang K, 2009, J CRANIOFAC SURG, V20, P825, DOI 10.1097/SCS.0b013e3181a14cda; Kester BS, 2017, KNEE SURG SPORT TR A, V25, P3031, DOI 10.1007/s00167-016-4060-y; Lewis M, 2018, J ATHL TRAINING, V53, P503, DOI 10.4085/1062-6050-243-17; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Mack CD, 2019, J ATHL TRAINING, V54, P466, DOI 10.4085/1062-6050-18-19; Mai HT, 2017, AM J SPORT MED, V45, P2226, DOI 10.1177/0363546517704834; Marshall SW, 2003, JAMA-J AM MED ASSOC, V289, P568, DOI 10.1001/jama.289.5.568; Marsupalami Z., WHY M JORDAN WAS BET; Martin J., BREAKING WHY NBA TEA; Minhas SV, 2016, AM J SPORT MED, V44, P1056, DOI 10.1177/0363546515623028; Minhas SV, 2016, SPORTS HEALTH, V8, P43, DOI 10.1177/1941738115608361; Morse KW, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117690002; Namdari S, 2009, AM J SPORT MED, V37, P943, DOI 10.1177/0363546508330150; Nguyen MV, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118800479; Nwachukwu BU, 2017, PHYSICIAN SPORTSMED, V45, P303, DOI 10.1080/00913847.2017.1325313; Okoroha KR, 2017, ORTHOPEDICS, V40, pE658, DOI 10.3928/01477447-20170503-04; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Povolotskiy R, 2019, ANN OTO RHINOL LARYN, V128, P516, DOI 10.1177/0003489419830114; Schallmo MS, 2018, AM J SPORT MED, V46, P1959, DOI 10.1177/0363546518773080; Starkey C, 2000, J ATHL TRAINING, V35, P161; Trofa DP, 2017, AM J SPORT MED, V45, P2864, DOI 10.1177/0363546517713001; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956	44	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	DEC	2020	130	12					E824	E832		10.1002/lary.28690		APR 2020	9	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	OS0EX	WOS:000527277600001	32311769				2022-02-06	
J	Singh, J; Barrett, J; Sangaletti, R; Dietrich, WD; Rajguru, SM				Singh, Jayanti; Barrett, John; Sangaletti, Rachele; Dietrich, W. Dalton; Rajguru, Suhrud M.			Additive Protective Effects of Delayed Mild Therapeutic Hypothermia and Antioxidants on PC12 Cells Exposed to Oxidative Stress	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article						oxidative stress; hypothermia; therapeutic hypothermia; reactive oxygen; ROS; antioxidants; PC12; cell viability	TRAUMATIC BRAIN-INJURY; TRANSIENT GLOBAL-ISCHEMIA; COMBINATION-DRUG THERAPY; COMBINED POSTISCHEMIC HYPOTHERMIA; OXYGEN-GLUCOSE DEPRIVATION; (ROS)-INDUCED ROS RELEASE; SPINAL-CORD-INJURY; RAT MODEL; CEREBRAL-ISCHEMIA; POSTTRAUMATIC HYPOTHERMIA	Mild therapeutic hypothermia is protective against several cellular stresses, but the mechanisms underlying this protection are not completely resolved. In the present study, we used an in vitro model to investigate whether therapeutic hypothermia at 33 degrees C applied following a peroxide-induced oxidative stress would protect PC12 cells. A 1-hour exposure to tert-butyl peroxide increased cell death measured 24 hours later. This cell death was dose-dependent in the range of 100-1000 mu M tert-butyl peroxide with similar to 50% cell death observed at 24 hours from 500 mu M peroxide exposure. Cell survival/death was measured with an alamarBlue viability assay, and propidium iodide/Hoechst imaging for counts of living and dead cells. Therapeutic hypothermia at 33 degrees C applied for 2 hours postperoxide exposure significantly increased cell survival measured 24 hours postperoxide-induced stress. This protection was present even when delayed hypothermia, 15 minutes after the peroxide washout, was applied. Addition of any of the three FDA-approved antioxidants (Tempol, EUK134, Edaravone at 100 mu M) in combination with hypothermia improved cell survival. With the therapeutic hypothermia treatment, a significant downregulation of caspases-3 and -8 and tumor necrosis factor-alpha was observed at 3 and 24 hours poststress. Consistent with this, a cell-permeable pan-caspase inhibitor Z-VAD-FMK applied in combination with hypothermia significantly increased cell survival. Overall, these results suggest that the antioxidants quenching of reactive oxygen species likely works with hypothermia to reduce mitochondrial damage and/or apoptotic mechanisms. Further studies are required to confirm and extend these results to other cell types, including neuronal cells, and other forms of oxidative stress as well as to optimize the critical parameters of hypothermia treatment such as target temperature and duration.	[Singh, Jayanti; Sangaletti, Rachele; Rajguru, Suhrud M.] Univ Miami, Dept Otolaryngol, 1095 NW 14 Terrace,Lois Pope Ran 4-25, Miami, FL 33136 USA; [Barrett, John] Univ Miami, Dept Physiol & Biophys, Miami, FL 33136 USA; [Dietrich, W. Dalton; Rajguru, Suhrud M.] Univ Miami, Dept Biomed Engn, Miami, FL 33136 USA; [Dietrich, W. Dalton] Univ Miami, Dept Neurol Surg, Miami, FL 33136 USA		Rajguru, SM (corresponding author), Univ Miami, Dept Otolaryngol, 1095 NW 14 Terrace,Lois Pope Ran 4-25, Miami, FL 33136 USA.	s.rajguru@miami.edu			NIH NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1R01DC013798]; Cochlear	NIH NIDCD 1R01DC013798 and Cochlear (Research Grants to SMR).	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Alva N, 2009, CAN J PHYSIOL PHARM, V87, P471, DOI [10.1139/Y09-033, 10.1139/y09-033]; Amer AR, 2018, PEDIATR NEUROL, V84, P5, DOI 10.1016/j.pediatrneurol.2018.02.009; Anderson I, 2001, BIOCHEM SOC SYMP, V67, P141, DOI 10.1042/bss0670141; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Antonic A, 2014, INT J STROKE, V9, P544, DOI 10.1111/ijs.12224; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Baburamani AA, 2020, J PHYSIOL-LONDON, V598, P905, DOI 10.1113/JP279518; Bhandari R, 2018, DRUG TODAY, V54, P349, DOI 10.1358/dot.2018.54.6.2828189; Biary N, 2011, J PHYSIOL-LONDON, V589, P5167, DOI 10.1113/jphysiol.2011.214239; Cao X, 2015, J CELL BIOL, V211, P741, DOI 10.1083/jcb.201510105; Cappuccino A, 2010, SPINE, V35, pE57, DOI 10.1097/BRS.0b013e3181b9dc28; Chanvitayapongs S, 1997, NEUROREPORT, V8, P1499, DOI 10.1097/00001756-199704140-00035; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chwastek J, 2017, INT J BIOCHEM CELL B, V87, P38, DOI 10.1016/j.biocel.2017.03.015; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; David G, 2000, J NEUROSCI, V20, P7290; Dede S, 2002, J VET MED A, V49, P286, DOI 10.1046/j.1439-0442.2002.00449.x; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich W Dalton, 2017, Brain Circ, V3, P186, DOI 10.4103/bc.bc_28_17; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; Doti N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.518; Dunkley S, 2017, NURS CRIT CARE, V22, P150, DOI 10.1111/nicc.12242; Eroglua O, 2017, INJURY, V48, P2675, DOI 10.1016/j.injury.2017.09.032; Ferrigno A, 2009, CRYOBIOLOGY, V59, P327, DOI 10.1016/j.cryobiol.2009.09.005; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Gamez A, 2008, EUR J PHARMACOL, V590, P115, DOI 10.1016/j.ejphar.2008.05.039; Gao XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07091; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GREEN EJ, 1995, BRAIN RES, V702, P145, DOI 10.1016/0006-8993(95)01034-1; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; HALLECK MM, 1992, FREE RADICAL BIO MED, V12, P137, DOI 10.1016/0891-5849(92)90007-4; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hasegawa M, 2009, BRAIN RES, V1283, P1, DOI 10.1016/j.brainres.2009.06.016; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hroudova J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175062; Ikeda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140316; Ishii H, 2018, BRAIN RES, V1682, P24, DOI 10.1016/j.brainres.2017.12.035; Jang JH, 2001, MUTAT RES-GEN TOX EN, V496, P181, DOI 10.1016/S1383-5718(01)00233-9; Kawabori M, 2013, THER HYPOTHERMIA TEM, V3, P189, DOI 10.1089/ther.2013.0020; Kawai N, 2000, STROKE, V31, P1982, DOI 10.1161/01.STR.31.8.1982; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Levi AD, 2009, J NEUROTRAUM, V26, P407, DOI 10.1089/neu.2008.0745; Lin WL, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-491; Lu J, 2014, WORLD J EMERG MED, V5, P298, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.010; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Martin-Guerrero SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187130; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Nonner D, 1996, J NEUROSCI, V16, P6665; Novack TA, 1996, J CLIN EXP NEUROPSYC, V18, P685, DOI 10.1080/01688639608408292; Palee S, 2016, CELL PHYSIOL BIOCHEM, V39, P341, DOI 10.1159/000445628; Pazos AJ, 1999, BRAIN RES, V846, P186, DOI 10.1016/S0006-8993(99)02010-7; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Pronsato L, 2016, STEROIDS, V106, P41, DOI 10.1016/j.steroids.2015.12.007; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Schaible N, 2018, CRYOBIOLOGY, V81, P57, DOI 10.1016/j.cryobiol.2018.02.010; Schmid-Elsaesser R, 1999, STROKE, V30, P1891, DOI 10.1161/01.STR.30.9.1891; Scholler K, 2004, BRAIN RES, V1023, P272, DOI 10.1016/j.brainres.2004.01.094; Tang XQ, 2005, BRAIN RES, V1057, P57, DOI 10.1016/j.brainres.2005.07.072; Thiemermann C, 2003, CRIT CARE MED, V31, pS76, DOI 10.1097/00003246-200301001-00011; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Vairetti M, 2009, LIVER TRANSPLANT, V15, P20, DOI 10.1002/lt.21581; Van Hemelrijck A, 2005, J NEUROCHEM, V95, P1287, DOI 10.1111/j.1471-4159.2005.03450.x; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wassink G, 2020, J PHYSIOL-LONDON, V598, P999, DOI 10.1113/JP279131; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Wu CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18935-1; Wu YY, 2011, CELL PHYSIOL BIOCHEM, V27, P539, DOI 10.1159/000329955; Yager JY, 1996, STROKE, V27, P919, DOI 10.1161/01.STR.27.5.919; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zausinger S, 2003, STROKE, V34, P2246, DOI 10.1161/01.STR.0000083622.65684.21; Zhang JJ, 2014, ONCOTARGET, V5, P841, DOI 10.18632/oncotarget.1780; Zhou TE, 2018, CRYOBIOLOGY, V80, P55, DOI 10.1016/j.cryobiol.2017.12.004; Zhou TY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020417; Zhu YL, 2015, CELL BIOCHEM BIOPHYS, V73, P581, DOI 10.1007/s12013-015-0584-x; Ziganshin AU, 2017, MUSCLE NERVE, V55, P417, DOI 10.1002/mus.25263; Zitta K, 2010, EUR J PHARMACOL, V628, P11, DOI 10.1016/j.ejphar.2009.11.023; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	90	3	3	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	JUN 1	2021	11	2					77	87		10.1089/ther.2019.0034		APR 2020	11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SO3AG	WOS:000526656100001	32302519				2022-02-06	
J	Bissett, JE; Tamminen, KA				Bissett, James E.; Tamminen, Katherine A.			Student-athlete disclosures of psychological distress: Exploring the experiences of university coaches and athletes	JOURNAL OF APPLIED SPORT PSYCHOLOGY			English	Article; Early Access							MENTAL-HEALTH; PREVALENCE; BARRIERS; PREFERENCES; CONCUSSION; DEPRESSION; SYMPTOMS; SUPPORT; HELP; CARE	Student-athletes are suggested to be an at-risk population for experiencing psychological distress, and coaches have been identified as support providers for distressed athletes. However, little is known about the interactions between student-athletes and their coaches when athletes disclose psychological distress. Therefore, the purpose of this research was to explore the experiences of student-athletes disclosing psychological distress to university coaches. Semi-structured interviews were conducted with 15 student-athletes (2 male, 13 female;M-age= 24.5 years) and 15 university coaches (11 male, 4 female;M-age= 41.9 years). Data were analyzed using a thematic analysis. Results indicated that perceived barriers (emphasis on athlete toughness, power of coaches, athlete's position on a team, poor visibility of distress, and previous negative experiences with disclosure) discouraged student-athletes from disclosing distress and suggest that barriers may be overcome by coaches fostering supportive team cultures. Strategies for coaches to establish supportive team cultures were identified, such as building diverse coaching staff, using nondiscriminatory language, and role-modeling desired behaviors. Based on the findings, guidelines are provided for effective coach support following disclosure. This research suggests that coaches have the potential to positively influence student-athletes' disclosures of psychological distress and facilitate the process of athletes seeking help; however, clearer boundaries need to be established to govern the appropriate role of coaches in supporting psychologically distressed student-athletes. Lay SummaryWe examined experiences of student-athlete disclosures of psychological distress to university coaches. Barriers, such as previous negative experiences with disclosure, perceptions of athlete toughness, and the athlete's position on the team, prevented athletes from disclosing distress. Strategies for coaches to create cultures that support athlete help-seeking behaviors are presented.Implications for Practice: As a frontline preventative measure in supporting the psychological well-being of student-athletes, coaches should establish team cultures that address perceived barriers to disclosure and encourage athlete help seeking behaviors. Coaches may foster desired team cultures by applying recommendations made by the present research, such as adopting a holistic coaching philosophy, speaking openly with athletes about psychological distress, and providing transparent selection criteria. When working with psychologically distressed student-athletes, coaches should engage in immediate, short-, and long-term support practices inclusive of responding supportively to athletes' initial disclosures, assisting athletes in developing plans for managing their distress, and maintaining consistent communication and engagement with the athlete throughout the recovery process. Coaches should prioritize the development of coach-athlete relationships founded on trust and bidirectional communication with student-athletes to facilitate student-athletes' willingness and abilities to disclose distress and access early support.	[Bissett, James E.; Tamminen, Katherine A.] Univ Toronto, Fac Kinesiol & Phys Educ, 55 Harbord St, Toronto, ON M5S 2W6, Canada		Bissett, JE (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, 55 Harbord St, Toronto, ON M5S 2W6, Canada.	j.bissett@mail.utoronto.ca		Bissett, James/0000-0003-2152-5706; Tamminen, Katherine/0000-0003-0880-4428	Social Sciences and Humanities Research Council (SSHRC) of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC)	This project was supported by the Social Sciences and Humanities Research Council (SSHRC) of Canada.	Albuquerque A., 2014, POSITIVE HUMAN FUNCT, V3, P107; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bandura A, 1986, SOCIAL FDN THOUGHT A; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bauman NJ, 2016, BRIT J SPORT MED, V50, P135, DOI 10.1136/bjsports-2015-095570; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Breslin G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0568-6; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Chatterton JM, 2013, EAT DISORD, V21, P328, DOI 10.1080/10640266.2013.797822; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Davis L, 2014, J SPORT SCI, V32, P1454, DOI 10.1080/02640414.2014.898183; Davis L, 2010, J CLIN SPORT PSYCHOL, V4, P112, DOI 10.1123/jcsp.4.2.112; Druckman JN, 2015, SOC SCI QUART, V96, P369, DOI 10.1111/ssqu.12135; Durand-Bush N, 2018, J SPORT PSYCHOL ACTI, V9, P227, DOI 10.1080/21520704.2018.1496211; Early, 2015, ATHL INSIGHT, V7, P177; Etzel EF, 2006, J STUD AFF RES PRACT, V43, P518, DOI 10.2202/0027-6014.1682; Fenwick D, 2017, J SPORT BEHAV, V40, P131; Giacobbi P. R. Jr., 2002, Journal of Sport Behavior, V25, P164; Greenleaf C, 2009, J AM COLL HEALTH, V57, P489, DOI 10.3200/JACH.57.5.489-496; Guba EG, 1994, HDB QUALITATIVE RES, P105; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-157; Hagiwara G., 2017, Journal of Physical Education and Sport, V17, P753; Kim J, 2016, QUAL RES SPORT EXERC, V8, P394, DOI 10.1080/2159676X.2016.1176068; Knust SK, 2015, INT SPORT COACH J, V2, P94, DOI 10.1123/iscj.2013-0045; Kroshus E, 2018, J INTERPERS VIOLENCE, V33, P293, DOI 10.1177/0886260515605122; Kroshus E, 2016, J AM COLL HEALTH, V64, P371, DOI 10.1080/07448481.2016.1158179; Kroshus E, 2014, EAT DISORD, V22, P136, DOI 10.1080/10640266.2013.867744; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th, P97; Lopez RL, 2013, J COLL COUNS, V16, P19, DOI 10.1002/j.2161-1882.2013.00024.x; Maniar SD, 2001, SPORT PSYCHOL, V15, P205, DOI 10.1123/tsp.15.2.205; McCray KL, 2015, TRAUMA VIOLENCE ABUS, V16, P438, DOI 10.1177/1524838014537907; Moreland JJ, 2018, J SPORT HEALTH SCI, V7, P58, DOI 10.1016/j.jshs.2017.04.009; Navarro K., 2015, J COLL CHARACTER, V16, P263; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Proctor SL, 2010, J CLIN SPORT PSYCHOL, V4, P204, DOI 10.1123/jcsp.4.3.204; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Rao AL, 2015, SPORTS HEALTH, V7, P452, DOI 10.1177/1941738115587675; Ridner SH, 2004, J ADV NURS, V45, P536, DOI 10.1046/j.1365-2648.2003.02938.x; Robbins J, 2001, J SPORT BEHAV, V24, P277; Sudano LE, 2017, FAM SYST HEALTH, V35, P77, DOI 10.1037/fsh0000242; Sullivan P, 2019, CAN J HIGH EDUC, V49, P47, DOI 10.7202/1060823ar; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Yang JZ, 2010, J ATHL TRAINING, V45, P372, DOI 10.4085/1062-6050-45.4.372	44	3	3	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1041-3200	1533-1571		J APPL SPORT PSYCHOL	J. Appl. Sport Psychol.												10.1080/10413200.2020.1753263		APR 2020	21	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	NA5HK	WOS:000559847300001					2022-02-06	
J	Brett, BL; Breedlove, K; McAllister, TW; Broglio, SP; McCrea, MA				Brett, Benjamin L.; Breedlove, Katherine; McAllister, Thomas W.; Broglio, Steven P.; McCrea, Michael A.		CARE Consortium Investigators	Investigating the Range of Symptom Endorsement at Initiation of a Graduated Return-to-Play Protocol After Concussion and Duration of the Protocol: A Study From the National Collegiate Athletic Association-Department of Defense Concussion, Assessment, Research, and Education (CARE) Consortium	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						sports-related concussion; mTBI; asymptomatic; CARE; injury management; return to play	SPORT-RELATED CONCUSSION; BASE-LINE; HIGH-SCHOOL; SCORES; STATEMENT; RECOVERY; EXERCISE	Background: Organizations recommend that athletes should be asymptomatic or symptom-limited before initiating a graduated return-to-play (GRTP) protocol after sports-related concussion, although asymptomatic or symptom-limited is not well-defined. Hypotheses: (1) There will be a range (ie, beyond zero as indicator of "symptom-free") in symptom severity endorsement when athletes are deemed ready to initiate a GRTP protocol. (2) Baseline symptom severity scores and demographic/preinjury medical history factors influence symptom severity scores at the commencement of the GRTP protocol. (3) Greater symptom severity scores at GRTP protocol initiation will result in longer protocol duration. (4) Symptom severity scores will not differ between those who did and did not sustain a repeat injury within 90 days of their initial injury. Study Design: Cohort study; Level of evidence, 2. Methods: Across 30 universities, athletes (N = 1531) completed assessments at baseline and before beginning the GRTP protocol, as determined by local medical staff. Symptom severity scores were recorded with the symptom checklist of the Sport Concussion Assessment Tool-3rd Edition. Nonparametric comparisons were used to examine the effect of medical, demographic, and injury factors on symptom endorsement at GRTP protocol initiation, as well as differences in symptom severity scores between those who did and did not sustain a repeat injury within 90 days. A Cox regression was used to examine the association between symptom severity scores at GRTP protocol initiation and protocol duration. Results: Symptom severity scores at the time when the GRTP protocol was initiated were as follows: 0 to 5 (n = 1378; 90.0%), 6 to 10 (n = 76; 5.0%), 11 to 20 (n = 42; 3.0%), and >= 21 (n = 35; 2.0%). Demographic (sex and age), medical (psychiatric disorders, attention-deficit/hyperactivity disorder, learning disorder), and other factors (baseline symptom endorsement and sleep) were significantly associated with higher symptom severity scores at the GRTP initiation (P < .05). The 4 GRTP initiation time point symptom severity score groups did not significantly differ in total time to unrestricted RTP, chi(2)(3) = 1.4; P = .73. When days until the initiation of the GRTP protocol was included as a covariate, symptom severity scores between 11 and 20 (P = .02; hazard ratio = 1.44; 95% CI, 1.06-1.96) and >= 21 (P < .001; hazard ratio = 1.88; 95% CI, 1.34-2.63) were significantly associated with a longer GRTP protocol duration as compared with symptom severity scores between 0 and 5. Symptom severity scores at GRTP initiation did not significantly differ between those who sustained a repeat injury within 90 days and those who did not (U = 29,893.5; P = .75). Conclusion: A range of symptom severity endorsement was observed at GRTP protocol initiation, with higher endorsement among those with higher baseline symptom endorsement and select demographic and medical history factors. Findings suggest that initiation of a GRTP protocol before an absolute absence of all symptoms is not associated with longer progression of the GRTP protocol, although symptom severity scores >10 were associated with longer duration of a GRTP protocol. Results can be utilized to guide clinicians toward optimal GRTP initiation (ie, balancing active recovery with avoidance of premature return to activity).	[Brett, Benjamin L.; Breedlove, Katherine; McAllister, Thomas W.; Broglio, Steven P.; McCrea, Michael A.; CARE Consortium Investigators] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Breedlove, Katherine] Brigham & Womens Hosp, Ctr Clin Spect, 75 Francis St, Boston, MA 02115 USA; [McAllister, Thomas W.] Indiana Univ, Sch Med, Dept Psychiat, Bloomington, IN USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA		Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbrett@mcw.edu	; Rowson, Steven/B-1270-2012	Chrisman, Sara/0000-0001-5373-7223; Susmarski, Adam/0000-0003-3698-4163; Rowson, Steven/0000-0002-3227-0596	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; National Institute of Neurological Disorders and Stroke under the National Institutes of Health [L301L30NS113158-01]; US Army Medical Research Acquisition Activity; Department of DefenseUnited States Department of Defense	One or more of the authors has declared the following potential conflict of interest or source of funding: This publication was made possible in part with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded in part by the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award W81XWH-14-2-0151. B.L.B. acknowledges support from the National Institute of Neurological Disorders and Stroke under the National Institutes of Health under award L301L30NS113158-01. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Beebe DW, 2018, CLIN J SPORT MED, V28, P395, DOI 10.1097/JSM.0000000000000454; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kaye S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00396; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	41	3	3	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2020	48	6					1476	1484	0363546520913252	10.1177/0363546520913252		APR 2020	9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	LM7BR	WOS:000527786600001	32298132				2022-02-06	
J	Vijapur, SM; Yang, ZH; Barton, DJ; Vaughan, L; Awan, N; Kumar, RG; Oh, BM; Berga, SL; Wang, KK; Wagner, AK				Vijapur, Sushupta M.; Yang, Zhihui; Barton, David J.; Vaughan, Leah; Awan, Nabil; Kumar, Raj G.; Oh, Byung-Mo; Berga, Sarah L.; Wang, Kevin K.; Wagner, Amy K.			Anti-Pituitary and Anti-Hypothalamus Autoantibody Associations with Inflammation and Persistent Hypogonadotropic Hypogonadism in Men with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autoantibodies; autoimmunity; hypogonadism; hypopituitarism; IgG autoantibody; IgM autoantibody; inflammation; TBI	CD8(+) T-CELLS; CEREBROSPINAL-FLUID; APOPTOTIC CELLS; LONG-TERM; TRANSLATIONAL REHABILITATION; ANTIPITUITARY ANTIBODIES; REHABILOMICS RESEARCH; PROGNOSTIC BIOMARKER; MULTIPLE-SCLEROSIS; OUTCOME PREDICTION	Traumatic brain injury (TBI) and can lead to persistent hypogonadotropic hypogonadism (PHH) and poor outcomes. We hypothesized that autoimmune and inflammatory mechanisms contribute to PHH pathogenesis. Men with moderate-to-severe TBI (n = 143) were compared with healthy men (n = 39). The TBI group provided blood samples 1-12 months post-injury (n = 1225). TBI and healthy control (n = 39) samples were assayed for testosterone (T) and luteinizing hormone (LH) to adjudicate PHH status. TBI samples 1-6 months post-injury and control samples were assayed for immunoglobulin M (IgM)/immunoglobulin G (IgG) anti-pituitary autoantibodies (APA) and anti-hypothalamus autoantibodies (AHA). Tissue antigen specificity for APA and AHA was confirmed via immunohistochemistry (IHC). IgM and IgG autoantibodies for glial fibrillary acid protein (GFAP) (AGA) were evaluated to gauge APA and AHA production as a generalized autoimmune response to TBI and to evaluate the specificity of APA and AHA to PHH status. An inflammatory marker panel was used to assess relationships to autoantibody profiles and PHH status. Fifty-one men with TBI (36%) had PHH. An age-related decline in T levels by both TBI and PHH status were observed. Injured men had higher APA IgM, APA IgG, AHA IgM, AHA IgG, AGA IgM, and AGA IgG than controls (p < 0.0001 all comparisons). However, only APA IgM (p = 0.03) and AHA IgM (p = 0.03) levels were lower in the PHH than in the non-PHH group in multivariate analysis. There were no differences in IgG levels by PHH status. Multiple inflammatory markers were positively correlated with IgM autoantibody production. PHH was associated with higher soluble tumor-necrosis-factor receptors I/II, (sTNFRI, sTNFRII), regulated on activation, normal T-cell expressed and secreted (RANTES) and soluble interleukin-2-receptor-alpha (sIL-2R alpha) levels. Higher IgM APA, and AHA, but not AGA, in the absence of PHH may suggest a beneficial or reparative role for neuroendocrine tissue-specific IgM autoantibody production against PHH development post-TBI.	[Vijapur, Sushupta M.; Vaughan, Leah; Awan, Nabil; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Yang, Zhihui] North Florida South Georgia Vet Hlth Syst, Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Yang, Zhihui; Wang, Kevin K.] Univ Florida, Dept Emergency Med Psychiat & Neurosci, Gainesville, FL USA; [Barton, David J.; Wang, Kevin K.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15213 USA; [Kumar, Raj G.] Mt Sinai Icahn Sch Med, New York, NY USA; [Oh, Byung-Mo] Seoul Natl Univ, Dept Rehabil Med, Seoul, South Korea; [Berga, Sarah L.] Univ Utah, Hlth Sci Ctr, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	kwang@ufl.edu; wagnerak@upmc.edu	Barton, David J/C-9282-2011	Barton, David J/0000-0003-0976-0383	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155-03]; United States Department of Defense (DOD)United States Department of Defense [W81XWH-071-0701]; University of Pittsburgh Medical Center Rehabilitation Institute; University of Pittsburgh Physicians Foundation; National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-NINDS R21 NS085455-01]	This work was supported by the Centers for Disease Control and Prevention (CDC) grant number R49 CCR 323155-03 (A.K.W.), The United States Department of Defense (DOD) grant number W81XWH-071-0701 (A.K.W.), the University of Pittsburgh Medical Center Rehabilitation Institute (A.K.W.), and the University of Pittsburgh Physicians Foundation (A.K.W.), and National Institute of Health (NIH) grant number NIH-NINDS R21 NS085455-01 (K.K.W.). The sponsors had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the manuscript for publication.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; American College of Physicians (n.d.).Normal laboratory values, 2019, NORM LAB VAL; Aspinall R, 2014, BIOCHEM SOC T, V42, P651, DOI 10.1042/BST20140021; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barton DJ, 2016, J HEAD TRAUMA REHAB, V31, P277, DOI 10.1097/HTR.0000000000000188; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Campbell IK, 1998, J IMMUNOL, V161, P3639; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2016, TBI GET THE FACTS; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi P, 1998, CLIN EXP IMMUNOL, V113, P317; COPE AP, 1995, IMMUNOLOGY, V84, P21; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cuesta M, 2016, CLIN ENDOCRINOL, V84, P92, DOI 10.1111/cen.12874; DANIEL PM, 1959, LANCET, V2, P927; Decaroli MC, 2017, VIRULENCE, V8, P545, DOI 10.1080/21505594.2016.1259053; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Eriksson UK, 2010, J ALZHEIMERS DIS, V21, P577, DOI 10.3233/JAD-2010-091705; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Fiskesund R, 2010, STROKE, V41, P607, DOI 10.1161/STROKEAHA.109.558742; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Graber JJ, 2009, PHARMACOL THERAPEUT, V121, P147, DOI 10.1016/j.pharmthera.2008.10.001; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Guaraldi F, 2015, J CLIN MED, V4, P1025, DOI 10.3390/jcm4051025; GUNNET JW, 1988, ANNU REV PHARMACOL, V28, P347; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hedegaard CJ, 2009, IMMUNOLOGY, V128, pe451, DOI 10.1111/j.1365-2567.2008.02999.x; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kansagara D., 2013, COMPLICATIONS MILD T; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Katzman SD, 2011, CYTOKINE, V56, P116, DOI 10.1016/j.cyto.2011.07.005; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lobo PI, 2010, J CLIN IMMUNOL, V30, pS31, DOI 10.1007/s10875-010-9412-7; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; McAlister CC, 2004, LIVER TRANSPLANT, V10, P315, DOI 10.1002/lt.20062; MELTZER HY, 1982, ADV BIOCHEM PSYCHOPH, V32, P303; Mikolajczyk TP, 2016, FASEB J, V30, P1987, DOI 10.1096/fj.201500088R; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; [NAMI: National Alliance on Mental Illness (2020) NAMI: National Alliance on Mental Illness], 2020, MENTAL HLTH MEDICATI; Nielsen CH, 2001, EUR J IMMUNOL, V31, P2660, DOI 10.1002/1521-4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Notley CA, 2011, J IMMUNOL, V186, P4967, DOI 10.4049/jimmunol.1003021; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; PAGANELLI R, 1992, CLIN EXP IMMUNOL, V90, P351; Pandey M, 2003, AM J PATHOL, V162, P933, DOI 10.1016/S0002-9440(10)63888-6; Pereira BI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00445; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Rijnhart JJM, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-018-0654-z; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Saltzman J.W., 2013, CURR PHYS MED REHABI; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schubert M, 2005, J Endocrinol Invest, V28, P23; Schwartz M, 2014, J AUTOIMMUN, V54, P8, DOI 10.1016/j.jaut.2014.08.002; Schwartz M, 2014, NEUROSCIENTIST, V20, P343, DOI 10.1177/1073858413516799; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Shin MS, 2015, J IMMUNOL, V195, P2861, DOI 10.4049/jimmunol.1500877; SMITH C G, 1982, Clinical Obstetrics and Gynecology, V25, P525, DOI 10.1097/00003081-198209000-00008; SMITH CG, 1983, AM J IND MED, V4, P107, DOI 10.1002/ajim.4700040110; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tanriverdi F, 2017, BEST PRACT RES CL EN, V31, P3, DOI 10.1016/j.beem.2017.02.001; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Torre Daria La, 2007, Ther Clin Risk Manag, V3, P929; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vas J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00004; WAAGE A, 1994, LEUKEMIA LYMPHOMA, V13, P41, DOI 10.3109/10428199409051650; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2014, AM J PHYS MED REHAB, V93, P913, DOI 10.1097/PHM.0000000000000114; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Yang Z., 2017, CURR PHYS MED REHABI, V5, P22; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	119	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2020	37	14					1609	1626		10.1089/neu.2019.6780		APR 2020	18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	MG9ML	WOS:000525897000001	32111134	Green Published			2022-02-06	
J	Post, A; Hashim, E; Hoshizaki, TB; Gilchrist, MD; Cusimano, MD				Post, Andrew; Hashim, Eyesha; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Cusimano, Michael D.			A preliminary examination of the relationship between biomechanical measures and structural changes in the brain	TRAUMA-ENGLAND			English	Article						Mild traumatic brain injury; concussion; diffusion tensor imaging; biomechanics	MATTER TRACT ABNORMALITIES; INTRACRANIAL-PRESSURE; AXONAL INJURY; CONCUSSION; RECONSTRUCTION; ACCELERATION; MODEL	Introduction Currently, biomechanics has not been able to effectively predict when a mild traumatic brain injury may occur as a result of head impact. To improve prediction of brain trauma and the development of protective innovations, it is important to create an understanding of the relationship between the biomechanics of the head impact event and the structural damage incurred by the brain as a result of that event. The purpose of this research was to examine the relationship between diffusion tensor imaging measures and biomechanical characteristics of a head impact. Methods Diffusion tensor imaging was conducted on concussed subjects to identify regions of white matter structural differences. The injury event was reconstructed using physical and finite element methods to identify the biomechanical parameters of the impact as well as strain to the regions of the brain. Results A significant relationship was found between shear strain, rotational acceleration, and impact velocity on increases in radial diffusivity and mean diffusivity in the fornix. Linear acceleration was also found to have a weaker but significant relationship with a decrease in radial diffusivity in the cingulum hippocampus. Conclusion These results demonstrate that impacts resulting in high shear strains may affect radial diffusivity and mean diffusivity measures, and that impact mechanics likely have an important role in what regions may present differences in diffusion tensor imaging measures.	[Post, Andrew; Hashim, Eyesha; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Post, Andrew; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552	Canadian Institutes of Health Research Postdoctoal FellowshipCanadian Institutes of Health Research (CIHR)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Canadian Institutes of Health Research Postdoctoal Fellowship funded this study.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Gennarelli T.A, 2015, CENTRIPETAL THEORY C; Gennarelli TA, 1972, 720970 SAE; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hashim E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00097; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T.B., 2014, J NEUROL NEUROPHYS, V5, P1, DOI [10.4172/2155-9562.1000181, DOI 10.4172/2155-9562.1000181]; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lao Y, 2015, PROCSPIE INTSOCOPTEN, V9287, P1, DOI DOI 10.1117/12.20; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Nahum A, 1977, 21 STAPP CAR CRASH C; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Post A, 2015, J BIOMECH ENG, P137; Post A, 2017, IJ CRASH, V23, P278; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236	36	3	3	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JAN	2021	23	1					24	32	1460408620916578	10.1177/1460408620916578		APR 2020	9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	PS6IB	WOS:000527132700001					2022-02-06	
J	Geraerds, AJLM; Bonsel, GJ; Polinder, S; Panneman, MJM; Janssen, MF; Haagsma, JA				Geraerds, A. J. L. M.; Bonsel, Gouke J.; Polinder, Suzanne; Panneman, M. J. M.; Janssen, M. F.; Haagsma, Juanita A.			Does the EQ-5D-5L benefit from extension with a cognitive domain: Testing a multi-criteria psychometric strategy in trauma patients	QUALITY OF LIFE RESEARCH			English	Article						HRQL; EQ-5D-5L; Cognition; Bolt-on; Responsiveness	STANDARD EQ-5D; HEALTH-STATUS; EUROQOL; QUALITY; VERSION; RESPONSIVENESS; TRAJECTORIES; IMPACT; 3L; 5L	Purpose This study investigated the psychometric yield of extension of the EQ-5D-5L with a cognitive domain (EQ-5D+C) in a mixed cohort of trauma patients with repeated data. Methods A stratified sample of patients that presented at the emergency department filled out a follow-up survey 6 and 12 months after trauma. The surveys included the EQ-5D-5L+C, EQ-VAS, and the impact of events scale-revised (IES-R), a validated post-traumatic stress disorder (PTSD) self-assessment scale. Generally, results of the EQ-5D and EQ-5D+C were compared. Psychometrics included the following: distributional features (ceiling/floor effects), discriminatory performance, convergent validity with the EQ-VAS as reference, and responsiveness to change. Psychometric properties were compared between predefined subgroups based on conditions with cognitive impact (Traumatic Brain Injury (TBI)/PTSD). Results In total, 1799 trauma patients responded 6 and 12 months after trauma, including 107 respondents with PTSD, and 273 with TBI. Six months post-trauma, ceiling of the EQ-5D (26.3%) was reduced with 2.2% with the additional cognitive domain. Using EQ-VAS as reference, convergent validity increased slightly with the addition of the cognitive domain: correlation increasing from 0.651 to 0.664. Cognitive level was found to slightly improve over time in TBI (delta: 0.04) and PTSD patients (delta: 0.05), while (almost) no change was found in patients without TBI and PTSD. Conclusion Adding a cognitive domain to the EQ-5D-5L slightly improved measurement properties and better captured change in health status for trauma patients with TBI and PTSD. Inclusion of the cognitive domain in the EQ-5D-5L when measuring in populations with cognitive problems should be considered.	[Geraerds, A. J. L. M.; Bonsel, Gouke J.; Polinder, Suzanne; Haagsma, Juanita A.] Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Panneman, M. J. M.] Consumer & Safety Inst, Amsterdam, Netherlands; [Janssen, M. F.] Erasmus MC, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands		Geraerds, AJLM (corresponding author), Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.geraerds@erasmusmc.nl			Euroqol Research Foundation [2016670]	This study was funded by Euroqol Research Foundation (Grant No. 2016670).	Bonsel, 2019, 36 EUROQOL PLEN M 20; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Buchholz I, 2015, QUAL LIFE RES, V24, P829, DOI 10.1007/s11136-014-0838-x; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Devlin N. J., 2008, USING EQ 5D PERFORMA; Devlin NJ, 2017, APPL HEALTH ECON HEA, V15, P127, DOI 10.1007/s40258-017-0310-5; Geraerds AJLM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227131; Geraerds AJLM, 2019, QUAL LIFE RES, V28, P1931, DOI 10.1007/s11136-019-02144-6; Golicki D, 2015, QUAL LIFE RES, V24, P1555, DOI 10.1007/s11136-014-0873-7; Haagsma JA, 2013, J DEPRESSION ANXIETY; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hruska B, 2016, PSYCHOL TRAUMA-US, V8, P676, DOI 10.1037/tra0000145; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; JELSMA J, 2015, ANAL DESCRIPTIVE STU, V13, P13; Jia YX, 2014, QUAL LIFE RES, V23, P2355, DOI 10.1007/s11136-014-0670-3; Johnson JA, 1998, PHARMACOECONOMICS, V13, P421, DOI 10.2165/00019053-199813040-00005; Kim SH, 2012, QUAL LIFE RES, V21, P1065, DOI 10.1007/s11136-011-0018-1; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Linde L, 2008, J RHEUMATOL, V35, P1528; O'Donnell ML, 2007, BEHAV RES THER, V45, P601, DOI 10.1016/j.brat.2006.03.015; Ophuis RH, 2019, QUAL LIFE RES, V28, P1941, DOI 10.1007/s11136-019-02156-2; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Pickard AS, 2007, MED CARE, V45, P259, DOI 10.1097/01.mlr.0000254515.63841.81; PIELOU EC, 1966, AM NAT, V100, P463, DOI 10.1086/282439; Poor AK, 2017, QUAL LIFE RES, V26, P3409, DOI 10.1007/s11136-017-1699-x; Scalone L, 2013, QUAL LIFE RES, V22, P1707, DOI 10.1007/s11136-012-0318-0; Shannon CE, 1997, M D COMPUT, V14, P306; Swinburn P, 2013, VALUE HEALTH, V16, P1156, DOI 10.1016/j.jval.2013.10.003; Toet H, 2019, RAPPORT LETSEL INFOR; Veiligheid NL., 2019, LETSEL INFORM SYSTEE; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Wolfs CAG, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-33; Yang YL, 2015, VALUE HEALTH, V18, P52, DOI 10.1016/j.jval.2014.09.004	34	3	3	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	SEP	2020	29	9					2541	2551		10.1007/s11136-020-02496-4		APR 2020	11	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	ND3BB	WOS:000557488600001	32277337	Green Published, hybrid			2022-02-06	
J	Carroll, NW; Hall, AG; Feldman, S; Thirumalai, M; Wade, JT; Rimmer, JH				Carroll, Nathan W.; Hall, Allyson G.; Feldman, Sue; Thirumalai, Mohanraj; Wade, Jamie Tinker; Rimmer, James H.			Enhancing Transitions From Rehabilitation Patient to Wellness Participant for People With Disabilities: An Opportunity for Hospital Community Benefit	FRONTIERS IN PUBLIC HEALTH			English	Article						disability; community benefit; wellness; transitions in care; hospital; quality of life	TRAUMATIC BRAIN-INJURY; HEALTH-CARE-SYSTEMS; SPINAL-CORD-INJURY; UNITED-STATES; INPATIENT REHABILITATION; PHYSICAL-ACTIVITY; BARRIERS; FITNESS; FACILITIES; ADULTS	Pressure is increasing on not-for-profit hospitals to demonstrate that they provide sufficient benefit to the community to justify their tax-exempt status. Many industry observers have suggested that this community benefit should address unmet medical needs within the community, deficits in the social determinants of health, or health disparities within communities. We argue that one area of clear unmet need is assistance in helping bridge the transition that people with disabilities (PWD) must make from rehabilitation patient to wellness participant. Programs to bridge this transition are necessary because many PWD struggle to identify strategies to maintain and maximize their own well-being after discharge from the healthcare system. As a result, PWD have worse health outcomes than non-disabled individuals. To address these needs, we propose hospitals take a leading role in establishing new, community-based efforts to provide PWD with benefits that will support their effort to self-manage health. Hospitals are well-suited to lead the creation of these programs because of the important role they play in providing services to PWD and because of their ability to bring together multiple stakeholders required to make supportive programs sustainable.	[Carroll, Nathan W.; Hall, Allyson G.; Feldman, Sue; Thirumalai, Mohanraj] Univ Alabama Birmingham, Dept Hlth Serv Adm, Birmingham, AL 35294 USA; [Carroll, Nathan W.; Hall, Allyson G.; Feldman, Sue; Thirumalai, Mohanraj; Rimmer, James H.] Univ Alabama Birmingham, Sch Hlth Profess, Birmingham, AL 35294 USA; [Wade, Jamie Tinker] Univ Alabama Birmingham Hosp, Spain Rehabil Ctr, Birmingham, AL USA		Carroll, NW (corresponding author), Univ Alabama Birmingham, Dept Hlth Serv Adm, Birmingham, AL 35294 USA.; Carroll, NW (corresponding author), Univ Alabama Birmingham, Sch Hlth Profess, Birmingham, AL 35294 USA.	natcar@uab.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [NU27DD001157]; National Science Foundation's Center for Healthcare Organization and Transformation (CHOT) [NSF1624690]	We would like to acknowledge funding support from the Centers for Disease Control and Prevention (Grant #NU27DD001157) as well as the National Science Foundation's Center for Healthcare Organization and Transformation (CHOT) grant #NSF1624690.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Arbour-Nicitopoulos KP, 2011, ADAPT PHYS ACT Q, V28, P1, DOI 10.1123/apaq.28.1.1; Baum FE, 2009, AM J PUBLIC HEALTH, V99, P1967, DOI 10.2105/AJPH.2008.154856; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Dolbow DR, 2015, SPINAL CORD, V53, P515, DOI 10.1038/sc.2015.26; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Forchheimer M, 2004, NEUROREHABILITATION, V19, P103; Ginis KAM, 2016, HEALTH PSYCHOL REV, V10, P478, DOI 10.1080/17437199.2016.1198240; Ginis KAM, 2010, ARCH PHYS MED REHAB, V91, P722, DOI 10.1016/j.apmr.2009.12.027; Henning-Smith C, 2013, MED CARE, V51, P1015, DOI 10.1097/MLR.0b013e3182a95d65; Hiremath SV, 2017, ARCH PHYS MED REHAB, V98, P2385, DOI 10.1016/j.apmr.2017.05.020; Iezzoni LI, 2011, HEALTH AFFAIR, V30, P1947, DOI 10.1377/hlthaff.2011.0613; Kehn M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-168; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Middleton A, 2018, ARCH PHYS MED REHAB, V99, P1067, DOI 10.1016/j.apmr.2017.05.001; Mitra M, 2011, DISABIL HEALTH J, V4, P219, DOI 10.1016/j.dhjo.2011.08.003; Mulligan HF, 2012, ADAPT PHYS ACT Q, V29, P243, DOI 10.1123/apaq.29.3.243; Nary DE, 2000, TOP SPINAL CORD INJ, V6, P87; Nicholson S, 2000, HEALTH AFFAIR, V19, P168, DOI 10.1377/hlthaff.19.6.168; Norris T, 2019, CAN HOSP HEAL AM COM; Okoro CA, 2018, MMWR-MORBID MORTAL W, V67, P882, DOI 10.15585/mmwr.mm6732a3; Rasch EK, 2008, ARCH PHYS MED REHAB, V89, P219, DOI 10.1016/j.apmr.2007.08.159; Rimmer J, 2017, DISABIL REHABIL, V39, P173, DOI 10.3109/09638288.2015.1047967; Rimmer JH, 2017, DISABIL HEALTH J, V10, P214, DOI 10.1016/j.dhjo.2016.12.011; Rimmer JH, 2005, AM J HEALTH PROMOT, V19, P327, DOI 10.4278/0890-1171-19.5.327; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 2000, ARCH PHYS MED REHAB, V81, P182; Scelza WM, 2005, AM J PHYS MED REHAB, V84, P576, DOI 10.1097/01.phm.0000171172.96290.67; Shortell SM, 2009, ANNU REV PUBL HEALTH, V30, P373, DOI 10.1146/annurev.publhealth.032008.112750; Stillman MD, 2016, JAMA-J AM MED ASSOC, V316, P585, DOI 10.1001/jama.2016.4460; Strauss DJ, 2006, ARCH PHYS MED REHAB, V87, P1079, DOI 10.1016/j.apmr.2006.04.022; Stuifbergen A, 1990, FAM COMMUNITY HEALTH, V13, P11; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422	33	3	3	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	APR 8	2020	8								105	10.3389/fpubh.2020.00105			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	LH5ZA	WOS:000528862000001	32322569	Green Published, gold			2022-02-06	
J	Corrigan, JD; Hagemeyer, AN; Weil, ZM; Sullivan, L; Shi, JX; Bogner, J; Yang, JZ				Corrigan, John D.; Hagemeyer, Abby N.; Weil, Zachary M.; Sullivan, Lindsay; Shi, Junxin; Bogner, Jennifer; Yang, Jingzhen			Is Pediatric Traumatic Brain Injury Associated with Adult Alcohol Misuse?	JOURNAL OF NEUROTRAUMA			English	Article						alcohol drinking; health surveillance data; pediatrics; TBI	TBI IDENTIFICATION METHOD; ETHANOL-CONSUMPTION; NUCLEUS-ACCUMBENS; SEX-DIFFERENCES; RELIABILITY; HISTORY; GENDER; DEGENERATION; INFLAMMATION; INDIVIDUALS	Evidence suggests that pediatric traumatic brain injury (TBI) may be causally related to alcohol misuse later in life; however, the nature and extent of the association has not been well described. This study examined the relationship between pediatric TBI and adult alcohol misuse in a population sample >= 20 years of age. We sought to determine (1) whether first self-reported incidence of TBI with loss of consciousness (LOC) before the age of 20 increased the risk for alcohol misuse later in life; and (2) whether sex, injury severity, and age at time of injury modified the association. We found a greater likelihood of binge but not heavy drinking for those whose first self-reported TBI with LOC occurred before the age of 20 when compared with those whose first self-reported TBI with LOC occurred later in life (28.5% vs. 20.4%, p = 0.003). When limited to those with only mild TBI, the relationship to binge drinking remained significant (31.9% vs. 19.3%, p < 0.001) and was evident for both males (38.4% vs. 25.6%, p = 0.016) and females (20.9% vs. 12.4%, p = 0.044). When controlling for sex, age, and race/ethnicity, reporting a first TBI with LOC before age 20 was associated with binge drinking only for those with mild TBI (adjusted odds ratio [AOR] = 1.32; 95% confidence interval [CI] = 1.00-1.74). Results also showed that those with first TBI with LOC occurring between the ages of 10 and 19 years were more likely to binge drink as adults than those first injured earlier in life, regardless of TBI severity. Further research is needed at both the epidemiological and pre-clinical levels to better understand this relationship.	[Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Hagemeyer, Abby N.] Ohio Dept Hlth, Violence & Injury Prevent Sect, Columbus, OH 43210 USA; [Weil, Zachary M.] Rockefeller Neurosci Inst, WVU Dept Neurosci, Morgantown, WV USA; [Sullivan, Lindsay; Shi, Junxin; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res Inst, Columbus, OH USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	johncorrigan1@me.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0001]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17 CE924827]	Drs. Corrigan, Weil, and Bogner's effort on this project were funded in part by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR #90DPTB0001). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). Dr. Hagemeyer's effort on this project was funded in part by the Centers for Disease Control and Prevention (U17 CE924827). The contents of this report do not necessarily represent the official views or policy of NIDILRR, ACL, CDC, or HHS, and endorsement by the federal government should not be assumed.	Agrawal RG, 2011, BRAIN BEHAV IMMUN, V25, pS165, DOI 10.1016/j.bbi.2011.03.002; BLANCHARD BA, 1993, ALCOHOL CLIN EXP RES, V17, P968, DOI 10.1111/j.1530-0277.1993.tb05650.x; Block P., 2001, DISABIL STUD QUARTER, V21; Bogner J, 2020, J HEAD TRAUMA REHAB, V35, pE43, DOI 10.1097/HTR.0000000000000488; Bogner J, 2015, BRAIN INJURY, V29, P905, DOI 10.3109/02699052.2015.1005136; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Cailhol S, 2001, ALCOHOL CLIN EXP RES, V25, P594, DOI 10.1111/j.1530-0277.2001.tb02255.x; Cannella LA, 2019, EXP NEUROL, V317, P191, DOI 10.1016/j.expneurol.2019.03.003; Centers for Disease Control and Prevention, 2014, BEH RISK FACT SURV S; Coleman LG, 2018, HANDB EXP PHARMACOL, V248, P369, DOI 10.1007/164_2018_92; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Cuthbert J, 2012, BRAIN INJURY, V26, P363; Enoch MA, 2011, PSYCHOPHARMACOLOGY, V214, P17, DOI 10.1007/s00213-010-1916-6; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karelina K, 2018, BRAIN BEHAV IMMUN, V69, P532, DOI 10.1016/j.bbi.2018.01.012; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Lancaster FE, 1996, ALCOHOL CLIN EXP RES, V20, P1043, DOI 10.1111/j.1530-0277.1996.tb01945.x; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Mann K, 2005, ALCOHOL CLIN EXP RES, V29, P896, DOI 10.1097/01.ALC.0000164376.69978.6B; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McKinlay A, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000284; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rosenberg DE, 2013, ARCH PHYS MED REHAB, V94, P731, DOI [10.1016/j.apmr.2012.11.014, 10.1016/j.apmr.2012.09.020]; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Torres OV, 2014, ALCOHOL CLIN EXP RES, V38, P108, DOI 10.1111/acer.12213; Weil ZM, 2019, EXP NEUROL, V317, P284, DOI 10.1016/j.expneurol.2019.03.012; Weil ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00135; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Winqvist S., 2006, J ADOLESCENT HEALTH, V39, P275; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Zilberman M, 2003, J ADDICT DIS, V22, P61, DOI 10.1300/J069v22n04_06	50	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2020	37	14					1637	1644		10.1089/neu.2019.6897		APR 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	MG9ML	WOS:000525166700001	32111142				2022-02-06	
J	Nazarahari, M; Arthur, J; Rouhani, H				Nazarahari, Milad; Arthur, Jordan; Rouhani, Hossein			A Novel Testing Device to Assess the Effect of Neck Strength on Risk of Concussion	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Dynamic neck strength measurement; Head injury metrics; Head kinematics; Inertial measurement units	SEX-DIFFERENCES; PROFESSIONAL FOOTBALL; HEAD ACCELERATION; MUSCLE STRENGTH; BRAIN-INJURY; IMPACTS; BIOMECHANICS; EPIDEMIOLOGY; KINEMATICS; PROGRAM	Concussion awareness has become more prevalent in the past decade, leading to growing calls for prevention programs such as neck strengthening. However, previous research work has shown that not all training programs have been effective, and there is a need for a reliable testing device to measure cervical strength dynamically before and after training. Therefore, this work proposes a novel Concussion Active Prevention Testing Device composed of inertial measurement units mounted on the head and a custom-designed frame to measure head kinematics during controlled sub-concussive impacts. Through an experimental study with able-bodied participants, the proposed testing device demonstrated high intra-participant repeatability between waveforms of the head acceleration and angular velocity in the sagittal plane (multiple correlation coefficient of 80%). Similarly, good and excellent intra-class correlation coefficients were obtained for head injury metrics, including range, peak, Gadd severity index, head injury criterion, and range of motion. Finally, the results showed that significantly higher head injury metrics were measured for female participants, which was in line with the findings of previous research works. We conclude that the proposed testing device can be used to measure repeatable and informative metrics for evaluating the effectiveness of athletes' neck strengthening program.	[Nazarahari, Milad; Arthur, Jordan; Rouhani, Hossein] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 1H9, Canada		Rouhani, H (corresponding author), Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 1H9, Canada.	hrouhani@ualberta.ca	Rouhani, Hossein/AAB-1542-2021	Rouhani, Hossein/0000-0002-4790-9313	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [EGP 509196 - 17]	The authors would like to acknowledge the support of Gemini Performance Solution Inc. and Ms. Kim Adolphe and Mr. Sherwin Ganpatt, founders of CAP Corporation, for providing the testing device. The authors also thank the assistance of Mr. Sherwin Ganpatt in data collection. This research was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, Grant No: EGP 509196 - 17).	Allison P.D, 1998, MULTIPLE REGRESSION; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Bussone W., 2005, LINEAR ANGULAR HEAD; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Caswell SV., 2014, INT J ATHL THER TRAI, V19, P22; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Corp. C., 2017, APPARATUS METHOD DET; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Hall T, 2017, INT J ATHL THER TRAI, V22, P43, DOI 10.1123/ijatt.2016-0070; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mihalik JP, 2020, ANN BIOMED ENG, V48, P104, DOI 10.1007/s10439-019-02343-9; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Naish R, 2013, J SPORT SCI MED, V12, P542; Nazarahari M, 2019, IEEE SENS J, V19, P12465, DOI 10.1109/JSEN.2019.2939981; Nazarahari M, 2019, J BIOMECH, V85, P224, DOI 10.1016/j.jbiomech.2019.01.027; Noamani A, 2020, MED ENG PHYS, V77, P53, DOI 10.1016/j.medengphy.2019.10.018; Palermo E, 2014, MEASUREMENT, V52, P145, DOI 10.1016/j.measurement.2014.03.004; Patel BH, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119854199; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Salmon DM, 2011, AVIAT SPACE ENVIR MD, V82, P978, DOI 10.3357/ASEM.2841.2011; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	41	3	3	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2020	48	9					2310	2322		10.1007/s10439-020-02504-1		APR 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	NF2RZ	WOS:000525213500002	32253614				2022-02-06	
J	Monroe, DC; Cecchi, NJ; Gerges, P; Phreaner, J; Hicks, JW; Small, SL				Monroe, Derek C.; Cecchi, Nicholas J.; Gerges, Paul; Phreaner, Jenna; Hicks, James W.; Small, Steven L.			A Dose Relationship Between Brain Functional Connectivity and Cumulative Head Impact Exposure in Collegiate Water Polo Players	FRONTIERS IN NEUROLOGY			English	Article						head impacts; concussion; sports; inhibitory control; brain connectivity; electroencephalography	DEFAULT MODE NETWORK; CONCUSSED INDIVIDUALS; FOOTBALL PLAYERS; INJURY; PHASE; EEG; ORGANIZATION; SEVERITY; NOISE; SPORT	A growing body of evidence suggests that chronic, sport-related head impact exposure can impair brain functional integration and brain structure and function. Evidence of a robust inverse relationship between the frequency and magnitude of repeated head impacts and disturbed brain network function is needed to strengthen an argument for causality. In pursuing such a relationship, we used cap-worn inertial sensors to measure the frequency and magnitude of head impacts sustained by eighteen intercollegiate water polo athletes monitored over a single season of play. Participants were evaluated before and after the season using computerized cognitive tests of inhibitory control and resting electroencephalography. Greater head impact exposure was associated with increased phase synchrony [r((16)) > 0.626, p < 0.03 corrected], global efficiency [r((16)) > 0.601, p < 0.04 corrected], and mean clustering coefficient [r((16)) > 0.625, p < 0.03 corrected] in the functional networks formed by slow-wave (delta, theta) oscillations. Head impact exposure was not associated with changes in performance on the inhibitory control tasks. However, those with the greatest impact exposure showed an association between changes in resting-state connectivity and a dissociation between performance on the tasks after the season [r((16)) = 0.481, p = 0.043] that could also be attributed to increased slow-wave synchrony [F-(4,F- 135) = 113.546, p < 0.001]. Collectively, our results suggest that athletes sustaining the greatest head impact exposure exhibited changes in whole-brain functional connectivity that were associated with altered information processing and inhibitory control.	[Monroe, Derek C.; Small, Steven L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Cecchi, Nicholas J.; Gerges, Paul; Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Phreaner, Jenna] Univ Calif Irvine, Dept Psychol Sci, Irvine, CA USA; [Small, Steven L.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX USA		Monroe, DC (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.	dcmonroe@hs.uci.edu	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163; Monroe, Derek/0000-0003-3885-6878; Small, Steven/0000-0002-5293-6172	 [5T32AR047752-15];  [5TL1TR001415-04]	DM was supported by 5T32AR047752-15 (PI: Caiozzo) and 5TL1TR001415-04 (PI: Caiozzo).	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; Asken BM, 2019, JAMA NEUROL, V76, P515, DOI 10.1001/jamaneurol.2019.0125; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2007, VARIATION WORKING ME, V3, P106, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Cavanagh JF, 2020, BRAIN IMAGING BEHAV, V14, P2210, DOI 10.1007/s11682-019-00171-y; Cecchi NJ, 2020, P I MECH ENG P-J SPO, V234, P162, DOI 10.1177/1754337120901974; Cecchi NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216369; Choi JW, 2018, BIOL MED PHYS BIOMED, P125, DOI 10.1007/978-981-13-0908-3_6; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Cohen MX, 2015, J NEUROSCI METH, V250, P137, DOI 10.1016/j.jneumeth.2014.09.005; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Karton C, 2016, ISBS C P ARCH INT SO, V34; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kuntzelman K, 2017, PSYCHOPHYSIOLOGY, V54, P51, DOI 10.1111/psyp.12600; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Macleod CM, 2005, COGNITIVE METHODS AND THEIR APPLICATION TO CLINICAL RESEARCH, P17, DOI 10.1037/10870-002; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mountjoy M, 2019, BRIT J SPORT MED, V53, P25, DOI 10.1136/bjsports-2018-099349; Mountjoy M, 2010, BRIT J SPORT MED, V44, P522, DOI 10.1136/bjsm.2010.071720; Muller AM, 2018, ASN NEURO, V10, DOI 10.1177/1759091417753802; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Nunez P. L., 2006, ELECT FIELDS BRAIN N; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Oja E, 2006, IEEE T NEURAL NETWOR, V17, P1370, DOI 10.1109/TNN.2006.880980; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ploner M, 2017, TRENDS COGN SCI, V21, P100, DOI 10.1016/j.tics.2016.12.001; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith EE, 2019, J INT NEUROPSYCH SOC, V25, P314, DOI 10.1017/S135561771800108X; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Suzuki K, 2015, BRAIN COGNITION, V100, P7, DOI 10.1016/j.bandc.2015.09.001; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Themanson JR, 2006, NEUROBIOL AGING, V27, P1335, DOI 10.1016/j.neurobiolaging.2005.07.002; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Wang C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00571; Wang XP, 2015, NEUROPSYCHOLOGIA, V70, P177, DOI 10.1016/j.neuropsychologia.2015.02.031; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021	81	3	3	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 2	2020	11								218	10.3389/fneur.2020.00218			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC3UI	WOS:000596930200001	32300329	Green Published, gold			2022-02-06	
J	Amoros-Aguilar, L; Portell-Cortes, I; Costa-Miserachs, D; Torras-Garcia, M; Riubugent-Camps, E; Almolda, B; Coll-Andreu, M				Amoros-Aguilar, Laura; Portell-Cortes, Isabel; Costa-Miserachs, David; Torras-Garcia, Meritxell; Riubugent-Camps, Elia; Almolda, Beatriz; Coll-Andreu, Margalida			The benefits of voluntary physical exercise after traumatic brain injury on rat's object recognition memory: A comparison of different temporal schedules	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Physical exercise; Object recognition memory; Neuroprotection; Adult neurogenesis; Microglial reactivity	CONTROLLED CORTICAL IMPACT; HIPPOCAMPAL NEUROGENESIS; NEUROINFLAMMATION; EVOLUTION; PATHOLOGY; RECOVERY; WHITE	Physical exercise can reduce the cognitive decline associated with traumatic brain injury, yet little is known about the optimal administration schedules. Here, different protocols of voluntary wheel running were evaluated for their effects on object recognition memory (ORM), neuroprotection (NeuN(+) cells), microglial reactivity (Ibal staining) and neurogenesis (DCX+ cells) after controlled cortical impact injury (CCI). CCI-lesioned rats were divided into a sedentary group and three exercise groups: early discontinued exercise (3 weeks of exercise initiated 4 days post-injury, followed by 4 weeks in a sedentary state); delayed exercise (3 weeks of exercise initiated 4 weeks post-injury), and early continuous exercise (7 weeks of exercise starting 4 days post-injury). The deficits induced by CCI in a 24 h ORM test were reversed in the delayed exercise group and reduced in the early discontinued and early continuous groups. The early discontinued protocol also reduced the loss of NeuN(+) cells in the hilus, while attenuated microglial reactivity was found in the dorsal hippocampus of both the early exercising groups. Running at the end of the experiment increased the number of DCX+ cells in the early continuous and delayed groups, and an inverted U-shaped relationship was found between the mean daily exercise time and the amount of neurogenesis. Thus, exercise had benefits on memory both when it was commenced soon and later after injury, although the neural mechanisms implicated differed. Accordingly, the effects of exercise on memory and neurogenesis appear to not only depend on the specific temporal schedule but also, they may be influenced by the amount of daily exercise.	[Amoros-Aguilar, Laura; Portell-Cortes, Isabel; Costa-Miserachs, David; Torras-Garcia, Meritxell; Riubugent-Camps, Elia; Coll-Andreu, Margalida] Univ Autonoma Barcelona, Inst Neurociencies, Dept Psicobiol & Metodol Ciencies Salut, Barcelona, Spain; [Almolda, Beatriz] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Inst Neurociencies, Barcelona, Spain		Coll-Andreu, M (corresponding author), Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, Edifici B, E-08193 Barcelona, Spain.; Coll-Andreu, M (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici B, E-08193 Barcelona, Spain.	Isabel.Portell@uab.cat; David.Costa@uab.cat; Meritxell.Torras@uab.cat; Beatriz.Almolda@uab.cat; Margalida.Coll@uab.cat	Costa-Miserachs, David/E-1318-2011; Costa-Miserachs, David/N-2794-2019; Torras-Garcia, Meritxell/K-9068-2014; Coll-Andreu, Margalida/C-9119-2011	Costa-Miserachs, David/0000-0001-5781-0774; Costa-Miserachs, David/0000-0001-5781-0774; Torras-Garcia, Meritxell/0000-0003-2511-8788; Coll-Andreu, Margalida/0000-0003-4106-2606	Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission [PSI2009-08034]; Ministerio de Economia y competitividadSpanish Government [PSI2014-55087-R]	This work was supported by Ministerio de Ciencia e Innovacion (grant number PSI2009-08034) and by Ministerio de Economia y competitividad (grant number PSI2014-55087-R).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Akkerman S, 2012, BEHAV BRAIN RES, V232, P317, DOI 10.1016/j.bbr.2012.03.024; Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Alkadhi KA, 2018, MOL NEUROBIOL, V55, P3112, DOI 10.1007/s12035-017-0516-4; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; Diederich K, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00047; Esopenko C, 2017, CORTEX, V89, P1, DOI 10.1016/j.cortex.2017.01.007; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Garcia-Capdevila S, 2009, BEHAV BRAIN RES, V202, P162, DOI 10.1016/j.bbr.2009.03.020; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Kealy J, 2011, PROG NEUROBIOL, V93, P522, DOI 10.1016/j.pneurobio.2011.03.002; Ko IG, 2018, J EXERC REHABIL, V14, P327, DOI 10.12965/jer.1836248.124; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Mckee A.C., 2015, BRAIN INJURY, P45, DOI DOI 10.1016/B978-0-444-52892-6.00004-0; MONDON CE, 1985, J APPL PHYSIOL, V58, P1553, DOI 10.1152/jappl.1985.58.5.1553; Morris T, 2016, RESTOR NEUROL NEUROS, V34, P977, DOI 10.3233/RNN-160687; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nguemeni C, 2018, NEUROSCIENCE, V369, P202, DOI 10.1016/j.neuroscience.2017.11.026; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Nishijima T, 2017, AM J PHYSIOL-REG I, V312, pR347, DOI 10.1152/ajpregu.00397.2016; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryan SM, 2016, NEUROSCI BIOBEHAV R, V61, P121, DOI 10.1016/j.neubiorev.2015.12.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider M, 2013, CELL TISSUE RES, V354, P99, DOI 10.1007/s00441-013-1581-2; Shih PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078163; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Toni N., 2015, COLD SPRING HARB PER, V8, DOI [10.1101/cshperspect.a018903, DOI 10.1101/CSHPERSPECT.A018903]; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Voss MW, 2019, TRENDS COGN SCI, V23, P318, DOI 10.1016/j.tics.2019.01.006; Yurt KK, 2018, J CHEM NEUROANAT, V93, P16, DOI 10.1016/j.jchemneu.2018.02.009	53	3	3	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2020	326								113178	10.1016/j.expneurol.2020.113178			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KN9UO	WOS:000515193000003	31926165				2022-02-06	
J	Breeze, J; Bowley, DM; Harrisson, SE; Dye, J; Neal, C; Bell, RS; Armonda, RA; Beggs, AD; DuBose, J; Rickard, RF; Powers, DB				Breeze, John; Bowley, Douglas M.; Harrisson, Stuart E.; Dye, Justin; Neal, Christopher; Bell, Randy S.; Armonda, Rocco A.; Beggs, Andrew D.; DuBose, Jospeh; Rickard, Rory F.; Powers, David Bryan			Survival after traumatic brain injury improves with deployment of neurosurgeons: a comparison of US and UK military treatment facilities during the Iraq and Afghanistan conflicts	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SURGEON LESSONS; OPERATIONS; COMPETENCES; MANAGEMENT; CASUALTIES; FREEDOM; WAR	Introduction Traumatic brain injury (TBI) is the most common cause of death on the modern battlefield. In recent conflicts in Iraq and Afghanistan, the US typically deployed neurosurgeons to medical treatment facilities (MTFs), while the UK did not. Our aim was to compare the incidence, TBI and treatment in US and UK-led military MTF to ascertain if differences in deployed trauma systems affected outcomes. Methods The US and UK Combat Trauma Registries were scrutinised for patients with HI at deployed MTFs between March 2003 and October 2011. Registry datasets were adapted to stratify TBI using the Mayo Classification System for Traumatic Brain Injury Severity. An adjusted multiple logistic regression model was performed using fatality as the binomial dependent variable and treatment in a US-MTF or UK-MTF, surgical decompression, US military casualty and surgery performed by a neurosurgeon as independent variables. Results 15 031 patients arrived alive at military MTF after TBI. Presence of a neurosurgeon was associated with increased odds of survival in casualties with moderate or severe TBI (p<0.0001, OR 2.71, 95% CI 2.34 to 4.73). High injury severity (Injury Severity Scores 25-75) was significantly associated with a lower survival (OR 4x10(4), 95% CI 1.61x10(4) to 110.6x10(4), p<0.001); however, having a neurosurgeon present still remained significantly positively associated with survival (OR 3.25, 95% CI 2.71 to 3.91, p<0.001). Conclusions Presence of neurosurgeons increased the likelihood of survival after TBI. We therefore recommend that the UK should deploy neurosurgeons to forward military MTF whenever possible in line with their US counterparts.	[Breeze, John; Rickard, Rory F.] Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham, W Midlands, England; [Bowley, Douglas M.] Univ Hosp Birmingham NHS Fdn Trust, Dept Surg, Birmingham, W Midlands, England; [Harrisson, Stuart E.] Univ Hosp North Staffordshire NHS Trust, Dept Neurosurg, Stoke On Trent, Staffs, England; [Dye, Justin] Loma Linda Univ, Dept Neurosurg, Loma Linda, CA 92350 USA; [Neal, Christopher] Walter Reed Natl Mil Med Ctr, Dept Neurosurg, Bethesda, MD USA; [Bell, Randy S.] Walter Reed Natl Mil Med Ctr, Natl Capital Neurosurg Consortium, Bethesda, MD USA; [Armonda, Rocco A.] Georgetown Univ, Med Ctr, Dept Neurosurg, Washington, DC 20007 USA; [Beggs, Andrew D.] Univ Birmingham, Surg Res Lab, Birmingham, W Midlands, England; [DuBose, Jospeh] R Adams Cowley Shock Trauma Ctr, Ctr Sustainment Trauma & Readiness Skills, Baltimore, MD USA; [Powers, David Bryan] Duke Univ, Div Plast Reconstruct Maxillofacial & Oral Surg, Med Ctr, Durham, NC USA		Breeze, J (corresponding author), Royal Ctr Def Med, Birmingham B15 2WB, W Midlands, England.	johno.breeze@gmail.com	Beggs, Andrew/A-6912-2013	Beggs, Andrew/0000-0003-0784-2967; Harrisson, Stuart/0000-0003-4995-4270; Breeze, John/0000-0002-2352-1365	Cancer Research UK Advanced Clinician Scientist award [C31641/A23923]	ADB is currently supported by a Cancer Research UK Advanced Clinician Scientist award (ref C31641/A23923)	Apodaca A, 2013, J TRAUMA ACUTE CARE, V75, pS157, DOI 10.1097/TA.0b013e318299da3e; Bahadur S, 2017, J ROY ARMY MED CORPS, V163, P355, DOI 10.1136/jramc-2016-000703; Bahadur S, 2016, J ROY ARMY MED CORPS, V162, P120, DOI 10.1136/jramc-2014-000393; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Breeze J, 2011, BRIT J ORAL MAX SURG, V49, P464, DOI 10.1016/j.bjoms.2010.08.002; Breeze J, 2010, BRIT J ORAL MAX SURG, V48, P613, DOI 10.1016/j.bjoms.2009.10.013; Breeze J, 2010, J R Army Med Corps, V156, P125; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P133, DOI 10.1136/jramc-2017-000881; Breeze J, 2011, J TRAUMA, V71, P108, DOI 10.1097/TA.0b013e318203304a; Bricknell M, 2014, J ROY ARMY MED CORPS, V160, P64, DOI 10.1136/jramc-2013-000228; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; Chan RK, 2012, J TRAUMA ACUTE CARE, V73, pS453, DOI 10.1097/TA.0b013e3182754868; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Eisenburg MF, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS108; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; Hawley CA, 2015, J HEAD TRAUMA REHAB, V30, pE47, DOI 10.1097/HTR.0000000000000023; Howard JT, 2019, JAMA SURG, V154, P600, DOI 10.1001/jamasurg.2019.0151; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Kotwal RS, 2016, JAMA SURG, V151, P15, DOI 10.1001/jamasurg.2015.3104; Krueger CA, 2012, J TRAUMA ACUTE CARE, V73, pS438, DOI 10.1097/TA.0b013e318275469c; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marsden MER, 2016, J ROY ARMY MED CORPS, V162, P373, DOI 10.1136/jramc-2015-000521; Masini BD, 2009, J ORTHOP TRAUMA, V23, P261, DOI 10.1097/BOT.0b013e31819dfa04; McCafferty RR, 2018, MIL MED, V183, P67, DOI 10.1093/milmed/usy071; Ministry of Defence, 2015, MIN DEF ALL JOINT PU; Powers D B, 2010, J R Army Med Corps, V156, P117; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS09324; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Ramasamy A, 2010, INJURY, V41, P453, DOI 10.1016/j.injury.2009.11.012; Ramasamy A, 2009, INJURY, V40, P493, DOI 10.1016/j.injury.2008.03.028; Roberts SAG, 2016, BRIT J NEUROSURG, V30, P529, DOI 10.1080/02688697.2016.1208807; Rosenfeld JV, 2010, INJURY, V41, P435, DOI 10.1016/j.injury.2010.01.004; Rosenfeld JV, 2006, J CLIN NEUROSCI, V13, P986, DOI 10.1016/j.jocn.2005.11.013; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Shackelford SA, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18404; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Teff RJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1017; Turner CA, 2018, J TRAUMA ACUTE CARE, V85, P140, DOI 10.1097/TA.0000000000001915; van Egmond T, 2012, REPORT COMEDS NATO M; Vassallo J, 2017, J ROY ARMY MED CORPS, V163, P383, DOI 10.1136/jramc-2017-000771	41	3	3	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	2020	91	4					359	365		10.1136/jnnp-2019-321723			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	LA0XD	WOS:000523679000005	32034113	hybrid, Green Published			2022-02-06	
J	Deng, RM; Liu, YC; Li, JQ; Xu, JG; Chen, G				Deng, Ru-Ming; Liu, Yong-Chun; Li, Jin-Quan; Xu, Jian-Guo; Chen, Gang			The role of carbon dioxide in acute brain injury	MEDICAL GAS RESEARCH			English	Article						carbon dioxide; hypercapnia; hypocapnia; intracranial pressure; nervous system; neuroprotection; stroke; traumatic brain injury	CEREBRAL METABOLISM; INTRACRANIAL-PRESSURE; HYPERCAPNIA; ISCHEMIA; RECEPTORS; GLUTAMATE; ACIDOSIS; STROKE	Carbon dioxide is a common gas in the air which has been widely used in medical treatment. A carbon dioxide molecule consists of two oxygen atoms and one carbon atom through a covalent bond. In the body, carbon dioxide reacts with water to produce carbonic acid. In healthy people, carbon dioxide is maintained within a narrow range (35-45 mmHg) by physiological mechanisms. The role of hypocapnia (partial pressure of carbon dioxide < 35 mmHg) and hypercapnia (partial pressure of carbon dioxide > 45 mmHg) in the nervous system is intricate. Past researches mainly focus on the effect of hypocapnia to nerve protection. Nevertheless, Hypercapnia seems to play an important role in neuroprotection. The mechanisms of hypocapnia and hypercapnia in the nervous system deserve our attention. The purpose of this review is to summarize the effect of hypocapnia and hypercapnia in stroke and traumatic brain injury.	[Deng, Ru-Ming; Liu, Yong-Chun; Li, Jin-Quan; Xu, Jian-Guo; Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China		Li, JQ; Xu, JG (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.	jinqli2007@yahoo.com; xejianlov2013@hotmail.com					Akca O, 2006, CURR OPIN ANESTHESIO, V19, P19; Akhondi-Asl A, 2018, CRIT CARE MED, V46, pE1160, DOI 10.1097/CCM.0000000000003434; Aly S, 2019, J PERINAT MED, V47, P979, DOI 10.1515/jpm-2019-0031; Asai Takashi, 2017, Masui, V66, P449; Beqiri E, 2020, ACTA NEUROCHIR, V162, P345, DOI 10.1007/s00701-019-04118-6; Brandi G, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2304-6; Brogi S, 2019, ACS MED CHEM LETT, V10, P228, DOI 10.1021/acsmedchemlett.8b00450; Chang QY, 2018, NEURAL REGEN RES, V13, P573, DOI 10.4103/1673-5374.230272; Cinotti R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.08.16; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; EKHOLM A, 1995, EXP BRAIN RES, V104, P462; Esnault P, 2019, NEUROCRIT CARE, V30, P405, DOI 10.1007/s12028-018-0639-0; Herrington BA, 2019, AUTON NEUROSCI-BASIC, V222, DOI 10.1016/j.autneu.2019.102581; Howarth C, 2017, J NEUROSCI, V37, P2403, DOI 10.1523/JNEUROSCI.0005-16.2016; Ischiropoulos H, 1998, AM J PHYSIOL-CELL PH, V274, pC853; Jarvis JM, 2020, PEDIATR CRIT CARE ME, V21, P105, DOI 10.1097/PCC.0000000000002168; KATSURA K, 1994, J CEREBR BLOOD F MET, V14, P243, DOI 10.1038/jcbfm.1994.31; Lafave HC, 2019, EUR J APPL PHYSIOL, V119, P2529, DOI 10.1007/s00421-019-04206-6; Mas A, 2000, CRIT CARE MED, V28, P360, DOI 10.1097/00003246-200002000-00012; MILLER CL, 1980, STROKE, V11, P542, DOI 10.1161/01.STR.11.5.542; NAKAGAWA Y, 1984, STROKE, V15, P275, DOI 10.1161/01.STR.15.2.275; Nunez-Figueredo Y, 2014, NEUROPHARMACOLOGY, V85, P517, DOI 10.1016/j.neuropharm.2014.06.009; Nyholm L, 2017, UPSALA J MED SCI, V122, P177, DOI 10.1080/03009734.2017.1319440; O'Neill N, 2018, J NEUROSCI, V38, P9840, DOI 10.1523/JNEUROSCI.1000-18.2018; PALJARVI L, 1982, ACTA NEUROPATHOL, V58, P87, DOI 10.1007/BF00691646; Pucciarelli G, 2017, STROKE, V48, P733, DOI 10.1161/STROKEAHA.116.014989; Putzer G, 2018, RESUSCITATION, V128, P51, DOI 10.1016/j.resuscitation.2018.04.038; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rolfs A, 2013, STROKE, V44, P340, DOI 10.1161/STROKEAHA.112.663708; Sakurai A, 2020, THER HYPOTHERMIA TEM, V10, P71, DOI 10.1089/ther.2019.0032; Silva NT, 2015, RESP PHYSIOL NEUROBI, V212, P1, DOI 10.1016/j.resp.2015.04.004; Soliz J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00432; Somerson S J, 1992, AANA J, V60, P83; VANLEUVEN F, 1977, ARCH INT PHYSIOL BIO, V85, P295, DOI 10.3109/13813457709058762; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Vannucci RC, 2001, PEDIATR RES, V49, P799, DOI 10.1203/00006450-200106000-00015; Wettervik TS, 2020, WORLD NEUROSURG, V133, pE567, DOI 10.1016/j.wneu.2019.09.099; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Xie YL, 2018, NEUROL RES, V40, P828, DOI 10.1080/01616412.2018.1488654; Xu H, 2019, EXP NEUROL, V315, P21, DOI 10.1016/j.expneurol.2019.01.018; Xu YJ, 2017, MOL CELL BIOCHEM, V436, P23, DOI 10.1007/s11010-017-3073-2; Yokoyama S, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0353-1; Zhang L, 2019, J CELL MOL MED, V23, P2995, DOI 10.1111/jcmm.14206	43	3	3	2	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	APR-JUN	2020	10	2					81	84		10.4103/2045-9912.285561			4	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	MA8DP	WOS:000542141300006	32541133	Green Published			2022-02-06	
J	Ettenhofer, ML; Gimbel, SI; Cordero, E				Ettenhofer, Mark L.; Gimbel, Sarah I.; Cordero, Evelyn			Clinical validation of an optimized multimodal neurocognitive assessment of chronic mild TBI	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EYE-MOVEMENTS; STATE; RELIABILITY; EMPLOYMENT; SYMPTOMS; VALIDITY; DEFICITS; HISTORY; TRAIL	Objective Previous laboratory-based studies have shown that neurocognitive eye-tracking metrics are sensitive to chronic effects of mild traumatic brain injury (mTBI), even in individuals with normal performance on traditional neuropsychological measures. In this study, we sought to replicate and extend these findings in a military medical environment. We expected that metrics from the multimodal Fusion n-Back test would successfully distinguish chronic mTBI participants from controls, particularly eye movement metrics from the more cognitively challenging "1-Back" subtest. Methods We compared performance of participants with chronic mTBI (n = 46) and controls (n = 33) on the Fusion n-Back test and a battery of conventional neuropsychological tests. Additionally, we examined test reliability and the impact of potential confounds to neurocognitive assessment. Results Our results supported hypotheses; Fusion 1-Back metrics were successful in multimodal (saccadic and manual) classification of chronic mTBI versus control. In contrast, conventional neuropsychological measures could not distinguish these groups. Additional findings demonstrated the reliability of Fusion n-Back test metrics and provided evidence that saccadic metrics are resistant to confounding influences of age, intelligence, and psychiatric symptoms. Interpretation The Fusion n-Back test could provide advantages in differential diagnosis for complex brain injury populations. Additionally, the rapid administration of this test could be valuable for screening patients in clinical settings where longer test batteries are not feasible.	[Ettenhofer, Mark L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Ettenhofer, Mark L.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Ettenhofer, Mark L.; Gimbel, Sarah I.; Cordero, Evelyn] Naval Med Ctr San Diego, San Diego, CA USA; [Ettenhofer, Mark L.] Univ Calif San Diego, San Diego, CA 92103 USA; [Gimbel, Sarah I.] Gen Dynam Informat Technol, Falls Church, VA USA; [Cordero, Evelyn] Henry M Jackson Fdn, Bethesda, MD USA		Ettenhofer, ML (corresponding author), 34730 Bob Wilson Dr, San Diego, CA 92134 USA.	mark.l.ettenhofer.ctr@mail.mil			Congressionally Directed Medical Research Programs (CDMRP)United States Department of Defense [W81XWH-13-10095]; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs	Support for this research was provided by Congressionally Directed Medical Research Programs (CDMRP) Award #W81XWH-13-10095 and institutional support from the Defense and Veterans Brain Injury Center (DVBIC).	Barker F, 2013, REVIEW; Barry DM, 2016, ARCH CLIN NEUROPSYCH; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Danna-Dos-Santos A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22825-5; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Delis D.C., 2000, CALIFORNIA VERBAL LE; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Dvbic, 2020, DOD WORLDW NUMB TBI; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Ettenhofer ML, 2013, J INT NEUROPSYCH SOC, V19, P977, DOI 10.1017/S1355617713000763; Ettenhofer ML, 2018, BRAIN INJURY, P1; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hershaw JN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171752; Johnson B, 2014, BEHAVIOUR, P1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Klein C, 2010, EXP BRAIN RES, V203, P759, DOI 10.1007/s00221-010-2276-5; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pearson, 2009, ADV CLIN SOLUTIONS W; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WAIS 4 TECHNICAL INT; Wechsler D., 2008, WECHSLER ADULT INTEL; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	50	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	APR	2020	7	4					507	516		10.1002/acn3.51020			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LH8DE	WOS:000529012600010	32207241	Green Published, gold			2022-02-06	
J	Gala, K; Bryden, PD; Paolini, C; Wang, M; Mihovska, AD; Sarkar, M				Gala, Kinjal; Bryden, Paul David; Paolini, Christopher; Wang, Matthew; Mihovska, Albena Dimitrova; Sarkar, Mahasweta			Real-Time Indoor Geolocation Tracking for Assisted Healthcare Facilities	INTERNATIONAL JOURNAL OF INTERDISCIPLINARY TELECOMMUNICATIONS AND NETWORKING			English	Article						Assisted Healthcare Technology; Indoor Geolocation; Indoor Location System; Indoor Positioning System; Kalman Filtering; Location Tracking; Trilateration; Wireless Sensor Networks	FALLS; HOME	A leading cause of physical injury sustained by elderly persons is the event of unintentionally falling. A delay between the time of fall and the time of medical attention can exacerbate injury if the fall resulted in a concussion, traumatic brain injury, or bone fracture. The authors present a solution capable of finding and tracking, in real-time, the location of an elderly person within an indoor facility, using only existing Wi-Fi infrastructure. This paper discusses the development of an open source software framework capable of finding the location of an individual within 3m accuracy using 802.11 Wi-Fi in good coverage areas. This framework is comprised of an embedded software layer, a Web Services layer, and a mobile application for monitoring the location of individuals, calculated using trilateration, with Kalman filtering employed to reduce the effect of multipath interference. The solution provides a real-time, low cost, extendible solution to the problem of indoor geolocation to mitigate potential harm to elderly persons who have fallen and require immediate medical help.	[Gala, Kinjal] San Diego State Univ, Wireless Commun & Networks Lab, San Diego, CA 92182 USA; [Bryden, Paul David] Univ Strathclyde, Glasgow, Lanark, Scotland; [Paolini, Christopher; Sarkar, Mahasweta] San Diego State Univ, Dept Elect & Comp Engn, San Diego, CA 92182 USA; [Wang, Matthew] Univ Calif Los Angeles, Los Angeles, CA USA; [Mihovska, Albena Dimitrova] Aarhus Univ, Dept Business Dev & Technol, Aarhus, Denmark		Gala, K (corresponding author), San Diego State Univ, Wireless Commun & Networks Lab, San Diego, CA 92182 USA.			Paolini, Christopher/0000-0001-6563-917X	University Grants Program (UGP) of San Diego State University	We thank Professor Harsimran Baweja, Director of the Neuromechanics and Neuroplasticity Laboratory in the School of Exercise and Nutritional Science (ENS) at San Diego State University, for allowing us to use his laboratory facilities and for providing comments and ideas that initiated this research. This work was supported by the University Grants Program (UGP) of San Diego State University.	Alvarez Y, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/254345; BeagleBoard.org Foundation, 2019, BEAGLEBONE BLACK; Bin Xu, 2012, Information Technology Journal, V11, P1063, DOI 10.3923/itj.2012.1063.1069; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Bulten W, 2016, 2016 IEEE 1 INT C IN; Chitte S. D, 2008, 2008 9 INT C SIGN PR; Gala K, 2019, IJITN 2019 REAL TIME; Google, 2019, MAPS EM API GET API; He J, 2014, IEEE SENS J, V14, P3996, DOI 10.1109/JSEN.2014.2356857; Kjaergaard M. B, 2010, INDOOR POSITIONING U, DOI [10.1007/978-3-642-12654-3_3, DOI 10.1007/978-3-642-12654-3_3]; Lauszus K., 2018, LONGCONGDUOI KALMANF; Lauszus K, 2012, PRACTICAL APPROACH K; Liu H, 2007, IEEE T SYST MAN CY C, V37, P1067, DOI 10.1109/TSMCC.2007.905750; Pahlavan K, 2002, IEEE COMMUN MAG, V40, P112, DOI 10.1109/35.983917; Priyantha N., 2001, P 7 ANN INT C MOB CO, DOI DOI 10.1145/381677.381679; Priyantha N. B., 2000, P 6 INT C MOB COMP N; Proximity Networking, 2018, FALL PREV TRACK ANDR; Teller S, 2003, IEEE COMPUT GRAPH, V23, P14, DOI 10.1109/MCG.2003.1210859; The Apache Software Foundation, 2019, AP NETBEANS; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; Wei W, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/135054	21	3	3	0	8	IGI GLOBAL	HERSHEY	701 E CHOCOLATE AVE, STE 200, HERSHEY, PA 17033-1240 USA	1941-8663	1941-8671		INT J INTERDISCIP TE	Int. J. Interdiscip. Telecommun. Netw.	APR-JUN	2020	12	2					1	21		10.4018/IJITN.2020040101			21	Telecommunications	Emerging Sources Citation Index (ESCI)	Telecommunications	KI2DX	WOS:000511158500001					2022-02-06	
J	Guo, T; Zhang, L; Xiao, H; Yang, Y; Shi, YW				Guo, Tao; Zhang, Lei; Xiao, Hong; Yang, Yan; Shi, Yawei			Ezrin interacts with L-periaxin by the "head to head and tail to tail" mode and influences the location of L-periaxin in Schwann cell RSC96	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Schwann cells; L-periaxin; Ezrin; Interaction; Myelination	DOMAIN; LOCALIZATION; COMPLEX; CORTEX	In the peripheral nervous system (PNS), Schwann cells (SCs) are required for the myelination of axons. Periaxin (PRX), one of the myelination proteins expressed in SCs, is critical for the normal development and maintenance of PNS. As a member of the ERM (ezrin-radxin-moesin) protein family, ezrin holds our attention since their link to the formation of the nodes of Ranvier. Furthermore, PRX and ezrin are co-expressed in cytoskeletal complexes with periplakin and desmoyokin in lens fiber cells. In the present study, we observed that L-periaxin and ezrin interacted in a "head to head and tail to tail" mode in SC RSC96 through NLS3 region of L-periaxin with F3 subdomain of ezrin interaction, and the region of L-periaxin (residues 1368-1461) with ezrin (residues 475-557) interaction. A phosphorylation-mimicking mutation of ezrin resulted in L-periaxin accumulation on SC RSC96 membrane. Ezrin could inhibit the self-association of L-periaxin, and ezrin overexpression in sciatic nerve injury rats could facilitate the repair of impaired myelin sheath. Therefore, the interaction between L-periaxin and ezrin may adopt a close form to complete protein accumulation and to participate in myelin sheath maintenance.	[Guo, Tao; Zhang, Lei; Shi, Yawei] Shanxi Univ, Inst Biotechnol, Minist Educ, Key Lab Chem Biol & Mol Engn, Taiyuan 030006, Peoples R China; [Zhang, Lei] Hubei Univ Med, Renmin Hosp, Inst Clin Med, Shiyan 442000, Peoples R China; [Zhang, Lei] Hubei Univ Med, Renmin Hosp, Dept Cardiol, Shiyan 442000, Peoples R China; [Xiao, Hong] Shanxi Med Univ, Affiliated Hosp 1, Dept Pathol, Taiyuan 030001, Peoples R China; [Yang, Yan] Taiyuan Univ Sci & Technol, Chem & Biol Engn Coll, Taiyuan 030006, Peoples R China		Shi, YW (corresponding author), Shanxi Univ, Inst Biotechnol, Taiyuan 030006, Shanxi, Peoples R China.	yaweishi@sxu.edu.cn	石, 亚伟/AAQ-4263-2020	石, 亚伟/0000-0001-5887-4366	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170748]; Natural Science Foundation of Shanxi provinceNatural Science Foundation of Shanxi Province [201701D121085]; Youth Science Foundation of Shanxi province [201701D221163]	This work was supported by the National Natural Science Foundation of China (No.31170748), the Natural Science Foundation of Shanxi province (No.201701D121085) and the Youth Science Foundation of Shanxi province (No.201701D221163).	Biri-Kovacs B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177489; Bobinski F, 2011, NEUROSCIENCE, V194, P337, DOI 10.1016/j.neuroscience.2011.07.075; Brennan KM, 2015, NEUROMUSCULAR DISORD, V25, P786, DOI 10.1016/j.nmd.2015.07.001; Castelnovo LF, 2017, NEURAL REGEN RES, V12, P1013, DOI 10.4103/1673-5374.211172; Celik H, 2015, MOL CELL BIOL, V35, P3145, DOI 10.1128/MCB.00332-15; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Choi YJ, 2015, J CLIN NEUROL, V11, P92, DOI 10.3988/jcn.2015.11.1.92; Dukic AR, 2018, BIOCHEM J, V475, P455, DOI 10.1042/BCJ20170529; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Feltri ML, 2016, NEUROSCIENTIST, V22, P252, DOI 10.1177/1073858415572361; Ferreira ER, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02230; Gatto CL, 2003, J CELL BIOL, V162, P489, DOI 10.1083/jcb.200303039; Han HJ, 2014, J BIOL CHEM, V289, P14121, DOI 10.1074/jbc.M114.554816; Horwitz V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162502; Kalender AM, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-6; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Maddala R, 2011, DEV BIOL, V357, P179, DOI 10.1016/j.ydbio.2011.06.036; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Miyaji K, 2014, HUM IMMUNOL, V75, P1089, DOI 10.1016/j.humimm.2014.09.010; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Raasakka A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00084; Roberts SL, 2017, J NEUROCHEM, V141, P37, DOI 10.1111/jnc.13929; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Sherman Diane L, 2018, Wellcome Open Res, V3, P20, DOI 10.12688/wellcomeopenres.13673.1; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Tsai FC, 2018, ELIFE, V7, DOI 10.7554/eLife.37262; Wang J, 2016, ACTA VIROL, V60, P62, DOI 10.4149/av_2016_01_62; Yang Y, 2016, ACTA BIOCH BIOPH SIN, V48, P326, DOI 10.1093/abbs/gmw008; Yang Y, 2015, RSC ADV, V5, P84356, DOI 10.1039/c5ra12703c; Yang YN, 2017, RSC ADV, V7, P44112, DOI 10.1039/c7ra06853k; Yang YA, 2015, NEUROSCI LETT, V609, P23, DOI 10.1016/j.neulet.2015.10.020; Zhang B.W., 2011, PROGR PHARM SCI, V35, P296	36	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	APR	2020	1864	4							129520	10.1016/j.bbagen.2020.129520			14	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	KT0FI	WOS:000518686000007	31931020				2022-02-06	
J	Hutter, BO; Altmeppen, J; Kraff, O; Maderwald, S; Theysohn, JM; Ringelstein, A; Wrede, KH; Dammann, P; Quick, HH; Schlamann, M; Moenninghoff, C				Huetter, Bernd-Otto; Altmeppen, Jan; Kraff, Oliver; Maderwald, Stefan; Theysohn, Jens M.; Ringelstein, Adrian; Wrede, Karsten H.; Dammann, Philipp; Quick, Harald H.; Schlamann, Marc; Moenninghoff, Christoph			Higher sensitivity for traumatic cerebral microbleeds at 7 T ultra-high field MRI: is it clinically significant for the acute state of the patients and later quality of life?	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS			English	Article						traumatic brain inury; traumatic cerebral microbleeds; diffuse axonal injury; susceptibility weighted imaging; 7 Tesla MRI; clinical significance; acute clinical state; health-related quality of life	DIFFUSE AXONAL INJURY; SICKNESS IMPACT PROFILE; WHITE-MATTER LESIONS; BRAIN-INJURY; HEAD-INJURY; CHRONIC PHASE; MILD HEAD; 1.5 TESLA; DAMAGE; POST	Background: The present study evaluates the possible prognostic benefits of 7 T susceptibility weighted imaging (SWI) of traumatic cerebral microbleeds (TMBs) over 3 T SWI to predict the acute clinical state and subjective impairments, including health-related quality of life (HRQOL), after closed head injury (CHI). Methods: The study group comprised 10 participants with known TMBs All subjects underwent 3 T magnetic resonance imaging (MRI) and 7 T MRI, respectively. Location and count of TMBs were independently evaluated by two neuroradiologists. The initial Glasgow Coma Scale (GCS), the duration of coma and further clinical data were taken from the patients records. HRQOL was assessed by means of a questionnaire. Memory complaints and neurological symptoms were inquired at the time of the MRI examinations. Results: SWI revealed a total of 485 TMBs at 3 T, 584 TMBs at 7 T with similar spatial resolution, and 684 TMBs at 7 T with a factor of 10 higher spatial resolution. The TMBs depicted by 7 T high-resolution SWI were correlated with the duration of coma (Spearman's rho of 0.77). The corresponding association with TMBs in 3 T MRI SWI showed a Spearman's rho of 0.71. The initial GCS score and TMBs correlated with a Spearman's rho of -0.35 at 3 T SWI MRI and a rho of -0.33 at 7 T high-resolution SWI, respectively. The physical aspect of HRQOL correlated substantially with the count of TMBs (rho = 0.44 for 3 T SWI and rho = 0.35 for both 7 T SWI sequences, respectively). Conclusions: The number of TMBs showed a substantial association with indicators of the acute clinical state and chronic neurobehavioral parameters after CHI, but there was no additional advantage of 7 T MRI. These preliminary findings warrant a larger prospective study for the future.	[Huetter, Bernd-Otto; Wrede, Karsten H.; Dammann, Philipp] Univ Hosp Essen, Dept Neurosurg, Hufelandstr 55, D-45147 Essen, Germany; [Huetter, Bernd-Otto; Altmeppen, Jan; Theysohn, Jens M.; Ringelstein, Adrian; Moenninghoff, Christoph] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Kraff, Oliver; Maderwald, Stefan; Wrede, Karsten H.; Quick, Harald H.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Quick, Harald H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Schlamann, Marc] Univ Hosp Giessen, Dept Neuroradiol, Giessen, Germany		Hutter, BO (corresponding author), Univ Hosp Essen, Dept Neurosurg, Hufelandstr 55, D-45147 Essen, Germany.; Hutter, BO (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	otto.huetter@uk-essen.de	Wrede, Karsten/AAZ-2154-2020	Wrede, Karsten/0000-0001-7076-3503	Open Access Publication Fund of the University of Duisburg-Essen	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Allkemper T, 2004, EUR RADIOL, V14, P1000, DOI 10.1007/s00330-004-2241-4; Andreasen SH, 2020, J NEUROTRAUM, V37, P581, DOI 10.1089/neu.2019.6608; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Conijn MMA, 2011, AM J NEURORADIOL, V32, P1043, DOI 10.3174/ajnr.A2450; de Haan S, 2017, NEURORADIOLOGY, V59, P963, DOI 10.1007/s00234-017-1898-8; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hilal S, 2014, ALZ DIS ASSOC DIS, V28, P106, DOI 10.1097/WAD.0000000000000015; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hutter BO, 1997, PSYCHOL HEALTH, V12, P149, DOI 10.1080/08870449708407396; Hutter BO, 2002, ZENTRALBL NEUROCHIR, V63, P37; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; JENNETT B, 1975, LANCET, V1, P480; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Lupo JM, 2012, INT J RADIAT ONCOL, V82, pE493, DOI 10.1016/j.ijrobp.2011.05.046; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Monaco EA, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000430738.63491.f3; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Park SJ, 2009, J KOREAN NEUROSURG S, V46, P205, DOI 10.3340/jkns.2009.46.3.205; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schlamann M, 2010, ACAD RADIOL, V17, P3, DOI 10.1016/j.acra.2009.10.001; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Soria G, 2011, ANAT REC, V294, P1035, DOI 10.1002/ar.21383; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Studerus-Germann AM, 2018, NEUROL NEUROCHIR POL, V52, P710, DOI 10.1016/j.pjnns.2018.08.011; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tatsumi S, 2008, AJNR Am J Neuroradiol, V29, pe13, DOI 10.3174/ajnr.A0908; TEASDALE G, 1974, LANCET, V2, P81; Theysohn JM, 2011, J MAGN RESON IMAGING, V33, P782, DOI 10.1002/jmri.22513; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wargo CJ, 2013, MAGN RESON IMAGING, V31, P810, DOI 10.1016/j.mri.2013.01.013; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	73	3	3	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1756-2856	1756-2864		THER ADV NEUROL DISO	Ther. Adv. Neurol. Disord.	APR	2020	13								1756286420911295	10.1177/1756286420911295			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LH1LU	WOS:000528551600001	32313555	gold, Green Published			2022-02-06	
J	Khodaei, S; Avramescu, S; Wang, DS; Sheng, HP; Chan, NK; Lecker, I; Fernandez-Escobar, A; Lei, G; Dewar, MB; Whissell, PD; Baker, AJ; Orser, BA				Khodaei, Shahin; Avramescu, Sinziana; Wang, Dian-Shi; Sheng, Heping; Chan, Nathan K.; Lecker, Irene; Fernandez-Escobar, Alejandro; Lei, Gang; Dewar, Michael B.; Whissell, Paul D.; Baker, Andrew J.; Orser, Beverley A.			Inhibiting alpha 5 Subunit-Containing gamma-Aminobutyric Acid Type A Receptors Attenuates Cognitive Deficits After Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						gamma-aminobutyric acid type A receptors; cognition; synaptic plasticity; hippocampus; L-655,708; traumatic brain injury	LONG-TERM POTENTIATION; MEDIATED TONIC INHIBITION; DENTATE GRANULE CELLS; MOUSE MODEL; FUNCTIONAL RECOVERY; GABA(A) RECEPTORS; MEMORY DEFICITS; EPIDEMIOLOGY	Objectives: Cognitive deficits after traumatic brain injury are a leading cause of disability worldwide, yet no effective pharmacologic treatments exist to improve cognition. Traumatic brain injury increases proinflammatory cytokines, which trigger excess function of alpha 5 subunit-containing gamma-aminobutyric acid type A receptors. In several models of brain injury, drugs that inhibit alpha 5 subunit-containing gamma-aminobutyric acid type A receptor function improve cognitive performance. Thus, we postulated that inhibiting alpha 5 subunit-containing gamma-aminobutyric acid type A receptors would improve cognitive performance after traumatic brain injury. In addition, because traumatic brain injury reduces long-term potentiation in the hippocampus, a cellular correlate of memory, we studied whether inhibition of alpha 5 subunit-containing gamma-aminobutyric acid type A receptors attenuated deficits in long-term potentiation after traumatic brain injury. Design: Experimental animal study. Setting: Research laboratory. Subjects: Adult male mice and hippocampal brain slices. Interventions: Anesthetized mice were subjected to traumatic brain injury with a closed-head, free-weight drop method. One week later, the mice were treated with L-655,708 (0.5 mg/kg), an inhibitor that is selective for alpha 5 subunit-containing gamma-aminobutyric acid type A receptors, 30 minutes before undergoing behavioral testing. Problem-solving abilities were assessed using the puzzle box assay, and memory performance was studied with novel object recognition and object place recognition assays. In addition, hippocampal slices were prepared 1 week after traumatic brain injury, and long-term potentiation was studied using field recordings in the cornu Ammonis 1 region of slices that were perfused with L-655,708 (100 nM). Measurements and Main Results: Traumatic brain injury increased the time required to solve difficult but not simple tasks in the puzzle box assay and impaired memory in the novel object recognition and object place recognition assays. L-655,708 improved both problem solving and memory in the traumatic brain injury mice. Traumatic brain injury reduced long-term potentiation in the hippocampal slices, and L-655,708 attenuated this reduction. Conclusions: Pharmacologic inhibition of alpha 5 subunit-containing gamma-aminobutyric acid type A receptors attenuated cognitive deficits after traumatic brain injury and enhanced synaptic plasticity in hippocampal slices. Collectively, these results suggest that alpha 5 subunit-containing gamma-aminobutyric acid type A receptors are novel targets for pharmacologic treatment of traumatic brain injury-induced persistent cognitive deficits.	[Khodaei, Shahin; Wang, Dian-Shi; Sheng, Heping; Chan, Nathan K.; Lecker, Irene; Fernandez-Escobar, Alejandro; Lei, Gang; Dewar, Michael B.; Whissell, Paul D.; Orser, Beverley A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Avramescu, Sinziana; Baker, Andrew J.; Orser, Beverley A.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Avramescu, Sinziana; Orser, Beverley A.] Sunnybrook Hlth Sci Ctr, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] St Michaels Hosp, Dept Anesthesia, Toronto, ON, Canada		Orser, BA (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.; Orser, BA (corresponding author), Univ Toronto, Dept Anesthesia, Toronto, ON, Canada.; Orser, BA (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Anesthesia, Toronto, ON, Canada.	beverley.orser@utoronto.ca		Chan, Nathan/0000-0001-7516-1616; Khodaei, Shahin/0000-0002-0931-9427	Ontario Graduate ScholarshipOntario Graduate Scholarship; Canada Graduate Scholarship-Doctoral Program from the Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); New Investigator Research Award from the Canadian Anesthesiologists' Society; Department of Anesthesia, University of TorontoUniversity of Toronto; International Anesthesia Research Society; Hurvitz Brain Sciences Summer Research Program at the Sunnybrook Health Sciences Center; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; CIHRCanadian Institutes of Health Research (CIHR) [FDN-154312]; Idorsia; BiogenBiogen	Mr. Khodaei was supported by an Ontario Graduate Scholarship, and a Canada Graduate Scholarship-Doctoral Program from the Canadian Institutes of Health Research (CIHR). Dr. Avramescu was supported by a New Investigator Research Award from the Canadian Anesthesiologists' Society; a Clinician Scientist Transition Award from the Department of Anesthesia, University of Toronto; and a Mentored Research Award from the International Anesthesia Research Society. She also receives "in kind" cognitive assessment tools from Cogstate for clinical research studies (unrelated). Mr. Dewar received funding from the Hurvitz Brain Sciences Summer Research Program at the Sunnybrook Health Sciences Center. Dr. Whissell received funding from the Natural Sciences and Engineering Research Council of Canada and CIHR at the time of work. Dr. Baker received funding from Idorsia and Biogen. Dr. Orser was supported by a Foundation Grant (FDN-154312) from the CIHR. She is also the named inventor on two patents held by the University of Toronto for the treatment of cognitive deficits after anesthesia and surgery (US20130302352A1, CA2852978). The remaining authors have disclosed that they do not have any potential conflicts of interes.	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; Atack JR, 2006, DRUG METAB DISPOS, V34, P887, DOI 10.1124/dmd.105.006973; Atack JR, 2005, NEUROPHARMACOLOGY, V49, P220, DOI 10.1016/j.neuropharm.2005.03.004; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Boychuk JA, 2016, EXP NEUROL, V277, P178, DOI 10.1016/j.expneurol.2016.01.005; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Chun H, 2018, EXP NEUROBIOL, V27, P155, DOI 10.5607/en.2018.27.3.155; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; DOD/VA Traumatic Brain Injury Task Force, 2008, REP SURG GEN TRAUM B; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Engin E, 2018, TRENDS PHARMACOL SCI, V39, P710, DOI 10.1016/j.tips.2018.04.003; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Li ML, 2016, ELEMENTA-SCI ANTHROP, V4, P1, DOI 10.12952/journal.elementa.000103; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Scholten J, 2017, BRAIN INJURY, V31, P1246, DOI 10.1080/02699052.2016.1274780; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Soh MS, 2015, CURR DRUG TARGETS, V16, P735; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Uhl RL, 2013, J AM ACAD ORTHOP SUR, V21, P624, DOI 10.5435/JAAOS-21-10-624; Wang DS, 2018, ANESTHESIOLOGY, V129, P477, DOI 10.1097/ALN.0000000000002311; Wang DS, 2012, CELL REP, V2, P488, DOI 10.1016/j.celrep.2012.08.022; Whissell PD, 2013, ANN NEUROL, V74, P611, DOI 10.1002/ana.23941; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wu X, 2013, J PHARMACOL EXP THER, V346, P146, DOI 10.1124/jpet.113.203653; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Zurek AA, 2014, J CLIN INVEST, V124, P5437, DOI 10.1172/JCI76669	53	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2020	48	4					533	544		10.1097/CCM.0000000000004161			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LG3UU	WOS:000528030700021	32205600				2022-02-06	
J	Manchester, K; Corrigan, JD; Singichetti, B; Huang, LH; Bogner, J; Yi, HG; Yang, JZ				Manchester, Kara; Corrigan, John D.; Singichetti, Bhavna; Huang, Lihong; Bogner, Jennifer; Yi, Honggang; Yang, Jingzhen			Current health status and history of traumatic brain injury among Ohio adults	INJURY PREVENTION			English	Article						concussion; traumatic brain injury; public health; surveillance; burden of disease	HEAD-INJURY; RELIABILITY; MORTALITY; VALIDITY; OUTCOMES; RISK	Introduction Lifetime history of traumatic brain injury (TBI) with loss of consciousness (LOC) is prevalent in 21% of adult, non-institutionalised residents of Ohio. Prior history has been associated with lower incomes, inability to work and disability. The current study sought to evaluate the relationship between lifetime history and adverse health conditions. Methods Data came from the 2014 Ohio Behavioral Risk Factors Surveillance System, which included a state-specific module eliciting lifetime history of TBI. Results Non-institutionalised adults living in Ohio who have had at least one TBI with LOC were more likely to report fair or poor health, more days of poor health, more days when poor health limited activities, being diagnosed with a chronic condition and having less than 7 hours of sleep per night. The relationship with increasing number of TBIs was monotonic, with the likelihood of adverse health increasing as the number increased. A similar relationship was observed for increasing severity of the worst lifetime TBI. Experiencing a first TBI before age 15 was associated with poorer health but was not statistically different than incurring a first after age 15. Conclusions Adults who have experienced TBI with LOC in their lifetime are two to three times more likely to experience adverse health conditions when compared with same age-matched, sex-matched and race-matched adults without such history. These findings support re-examining the public health burden of TBI in light of lifetime exposure and not just the consequences of an index injury.	[Manchester, Kara] Ohio Dept Hlth, Columbus, OH 43266 USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Coll Med, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Singichetti, Bhavna; Huang, Lihong; Yi, Honggang; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA; [Huang, Lihong] Fudan Univ, Zhongshan Hosp, Dept Biostat, Shanghia, Peoples R China; [Yi, Honggang] Nanjing Med Univ, Dept Biostat, Nanjing, Peoples R China; [Yang, Jingzhen] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.	corrigan.1@osu.edu		Corrigan, John/0000-0002-7591-5622; Singichetti, Bhavna/0000-0002-2188-3979	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0040]; NIDILRRUnited States Department of Health & Human Services [90DPTB0001]; CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17 CE924827]	This project was funded in part by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR no. 90DP0040). JDC and JB's effort on this project were funded in part by a grant from the NIDILRR (no. 90DPTB0001). NIDILRR is a Centre within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). KM's effort on this project was funded in part by the CDC (U17 CE924827).	Bogner JA, 2018, J HEAD TRAUMA REHABI; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Centers for Disease Control and Prevention, 2014, BEH RISK FACT SURV S; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Holster JL, 2017, J HEAD TRAUMA REHAB, V32, P25, DOI 10.1097/HTR.0000000000000237; Hoot MR, 2018, BRAIN INJURY, V32, P1169, DOI 10.1080/02699052.2018.1482427; Ilie G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188908; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Institute of Medicine, 2009, GULF WAR HLTH; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Motamedi V, 2018, SLEEP MED, V43, P71, DOI 10.1016/j.sleep.2017.11.1121; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Yi HG, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000352	37	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2020	26	2					129	137		10.1136/injuryprev-2018-043056			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KZ7QD	WOS:000523453000007	30803993				2022-02-06	
J	Morelli, N; Heebner, NR; Bergin, RT; Quintana, C; Hoch, MC				Morelli, Nathan; Heebner, Nicholas R.; Bergin, Reiley T.; Quintana, Carolina; Hoch, Matthew C.			The effect of cognitive dual-tasks on dynamic postural sway during gait using inertial measurement units	PHYSIOLOGICAL MEASUREMENT			English	Article						dual-task; postural sway; motor variability; inertial measurement units; gait	CENTER-OF-MASS; CONCUSSION; BALANCE; RELIABILITY; STABILITY; SYNERGIES; DEFICITS; SINGLE; INJURY	Objective: To investigate the influence of cognitive dual-tasks on dynamic postural sway variability, measured with a single inertial measurement unit, in healthy collegiate athletes during dual-task gait. Approach: Thirty-four athletes ambulated down and back a 10-meter course. Root mean square values of postural sway acceleration were calculated for four sway-planes. Single and dual-task trial times were calculated from gait initiation to termination. Single and dual-task root mean square values were compared using Wilcoxon signed rank tests for each sway plane to determine significance. The relative difference between each sway measures and trial times for single and dual-task gait (i.e. dual-task cost was calculated). Spearman's correlation was used to analyze the association between dual-task cost of sway and trial time data. Main results: During dual-task conditions, participants ambulated slower and demonstrated a significant reduction in root mean square sway in all planes of motion. The greatest decreases were in the medial-lateral (Z = -4.83, p < 0.001, ES = -0.83) and superior-inferior planes (Z = -4.93, p < 0.001, ES = -0.85). Increased trial time cost was associated with a decrease in dual-task cost of postural sway (p < 0.05). Significance. Performing a cognitive task while ambulating decreased postural sway variability in task-relevant planes of motion compared to single-task conditions. Reduced dual-task cost of sway variability during gait was associated with maintained trial times between single and dual-tasks. These data support the use of instrumented dual-task gait assessment to evaluate postural sway variability.	[Morelli, Nathan; Heebner, Nicholas R.; Bergin, Reiley T.; Quintana, Carolina; Hoch, Matthew C.] Univ Kentucky, Coll Hlth Sci, Sports Med Res Inst, Lexington, KY 40506 USA		Hoch, MC (corresponding author), Univ Kentucky, Coll Hlth Sci, Sports Med Res Inst, Lexington, KY 40506 USA.	matt.hoch@uky.edu		Morelli, Nathan/0000-0002-9905-9736			Bayot M, 2018, NEUROPHYSIOL CLIN, V48, P361, DOI 10.1016/j.neucli.2018.10.003; Bolton DAE, 2015, NEUROSCI BIOBEHAV R, V57, P142, DOI 10.1016/j.neubiorev.2015.08.014; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Falaki A, 2017, EXP BRAIN RES, V235, P2243, DOI 10.1007/s00221-017-4971-y; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Floor-Westerdijk MJ, 2012, IEEE T BIO-MED ENG, V59, P2080, DOI 10.1109/TBME.2012.2197211; Ghai S, 2017, CLIN INTERV AGING, V12, P557, DOI 10.2147/CIA.S125201; Glenn JM, 2015, J AGING PHYS ACTIV, V23, P433, DOI 10.1123/japa.2014-0069; Hamacher D, 2015, NEUROSCI BIOBEHAV R, V57, P310, DOI 10.1016/j.neubiorev.2015.08.002; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D R, 2017, CLIN J SPORT MED; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mancini M, 2016, GAIT POSTURE, V43, P125, DOI 10.1016/j.gaitpost.2015.08.015; Mancini M, 2012, GAIT POSTURE, V36, P471, DOI 10.1016/j.gaitpost.2012.04.010; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pitt W, 2019, GAIT POSTURE, V71, P279, DOI 10.1016/j.gaitpost.2019.05.014; Remaud A, 2013, EXP BRAIN RES, V231, P219, DOI 10.1007/s00221-013-3684-0; Rosso AL, 2017, GAIT POSTURE, V57, P193, DOI 10.1016/j.gaitpost.2017.06.013; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Ting LH, 2007, CURR OPIN NEUROBIOL, V17, P622, DOI 10.1016/j.conb.2008.01.002; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	36	3	3	2	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	APR	2020	41	4							045002	10.1088/1361-6579/ab8050			7	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	LL6FY	WOS:000531654600001	32176875				2022-02-06	
J	Pareja, RR; Delgado, RC; Fuentes, FT; Thissard-Vasallo, IJ; Rosa, DS; Gonzalez, PA				Pareja, Rodolfo Romero; Delgado, Rafael Castro; Fuentes, Fernando Turegano; Thissard-Vasallo, Israel Jhon; Rosa, David Sanz; Gonzalez, Pedro Arcos			Prehospital triage for mass casualty incidents using the META method for early surgical assessment: retrospective validation of a hospital trauma registry	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Mass casualty incidents; Triage; Prehospital Trauma care; Surgical assesment; Trauma scores	SYSTOLIC BLOOD-PRESSURE; SHOCK INDEX; LIFE-SUPPORT; PREDICTION; MORTALITY; SURVIVAL; HYPOTENSION; VARIABILITY; INTUBATION; GUIDELINES	Background In mass casualty incidents (MCI), death usually occurs within the first few hours and thus early transfer to a trauma centre can be crucial in selected cases. However, most triage systems designed to prioritize the transfer to hospital of these patients do not assess the need for surgery, in part due to inconclusive evidence regarding the value of such an assessment. Therefore, the aim of the present study was to evaluate the capacity of a new triage system-the Prehospital Advanced Triage Method (META)-to identify victims who could benefit from urgent surgical assessment in case of MCI. Methods Retrospective, descriptive, observational study of a multipurpose cohort of patients included in the severe trauma registry of the Gregorio Maranon University General Hospital (Spain) between June 1993 and December 2011. All data were prospectively evaluated. All patients were evaluated with the META system to determine whether they met the criteria for urgent transfer. The META defines patients in need of urgent surgical assessment: (a) All penetrating injuries to head, neck, torso and extremities proximal to elbow or knee, (b) Open pelvic fracture, (c) Closed pelvic fracture with mechanical or haemodynamic instability and (d) Blunt torso trauma with haemodynamic instability. Patients who fulfilled these criteria were designated as "Urgent Evacuation for Surgical Assessment" (UESA) cases; all other cases were designated as non-UESA. The following variables were assessed: patient status at the scene; severity scales [RTS, Shock index, MGAP (Mechanism, Glasgow coma scale, Age, pressure), GCS]; need for surgery and/or interventional procedure to control bleeding (UESA); and mortality. The two groups (UESA vs. non-UESA) were then compared. Results A total of 1882 cases from the database were included in the study. Mean age was 39.2 years and most (77%) patients were male. UESA patients presented significantly worse on-scene hemodynamic parameters (systolic blood pressure and heart rate) and greater injury severity (RTS, shock index, and MGAP scales). No differences were observed for respiratory rate, need for orotracheal intubation, or GCS scores. The anatomical injuries of patients in the UESA group were less severe but these patients had a greater need for urgent surgery and higher mortality rates. Conclusion These findings suggest that the META triage classification system could be beneficial to help identify patients with severe trauma and/or in need of urgent surgical assessment at the scene of injury in case of MCI. These findings demonstrate that, in this cohort, the META fulfils the purpose for which it was designed.	[Pareja, Rodolfo Romero] Univ Europea Madrid, Sch Med, Hosp Univ Getafe, Serv Urgencias, Madrid, Spain; [Delgado, Rafael Castro; Gonzalez, Pedro Arcos] Univ Oviedo, Fac Med, Dept Med, Unit Res Emergency & Disaster,Publ Hlth Area, C Julian Claveria 6, E-33006 Oviedo, Spain; [Delgado, Rafael Castro] Serv Salud Principado Asturias, SAMU Asturias, Oviedo, Spain; [Fuentes, Fernando Turegano] Hosp Univ Gregorio Maranon, Madrid, Spain; [Thissard-Vasallo, Israel Jhon; Rosa, David Sanz] Univ Europea, Sch Doctoral Studies & Res, Madrid, Spain		Delgado, RC (corresponding author), Univ Oviedo, Fac Med, Dept Med, Unit Res Emergency & Disaster,Publ Hlth Area, C Julian Claveria 6, E-33006 Oviedo, Spain.	romeropareja@gmail.com; rafacastrosamu@yahoo.es; fernando.turegano@salud.madrid.org; israeljhon.thuissard@universidadeuropea.es; david.sanz@universidadeuropea.es; arcos@uniovi.es	Sanz-Rosa, David/AAL-2951-2021; delgado, rafael castro/H-8393-2013; Gonzalez, Pedro Arcos/T-7630-2019; Sanz-Rosa, David/D-1704-2011	Sanz-Rosa, David/0000-0003-2177-5895; delgado, rafael castro/0000-0001-9520-656X; Gonzalez, Pedro Arcos/0000-0003-4882-5442; 			Arabian SS, 2015, J TRAUMA ACUTE CARE, V79, P359, DOI 10.1097/TA.0000000000000788; Arcos Gonzalez P, 2011, MADRID FUNDACION MAP; Gonzalez PA, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0255-y; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Belzunegui T, 2013, AM J EMERG MED, V31, P1382, DOI 10.1016/j.ajem.2013.06.026; Bouzat P, 2016, INJURY, V47, P14, DOI 10.1016/j.injury.2015.10.035; Brown JB, 2011, J TRAUMA, V70, P38, DOI 10.1097/TA.0b013e3182077ea8; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Byrne JP, 2015, J TRAUMA ACUTE CARE, V79, P850, DOI 10.1097/TA.0000000000000843; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Challen K, 2013, INJURY, V44, P629, DOI 10.1016/j.injury.2012.06.026; CUARTAS AT, 2014, EMERGENCIAS, V26, P147; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; DeMuro JP, 2013, AM J EMERG MED, V31, P1260, DOI 10.1016/j.ajem.2013.05.027; Dinh MM, 2014, EUR J TRAUMA EMERG S, V40, P67, DOI 10.1007/s00068-013-0315-1; Einav S, 2004, ANN SURG, V239, P304, DOI 10.1097/01.sla.0000114013.19114.57; Price MF, 2018, EMERGENCIAS, V30, P224; Garner A, 2001, ANN EMERG MED, V38, P541, DOI 10.1067/mem.2001.119053; German Trauma Society, 2014, TRAUM DGU ANN REP 20; Goransson KE, 2005, J CLIN NURS, V14, P1067, DOI 10.1111/j.1365-2702.2005.01191.x; Haas B, 2008, CRIT CARE, V12, DOI 10.1186/cc6980; Hannan EL, 2005, J AM COLL SURGEONS, V200, P584, DOI 10.1016/j.jamcollsurg.2004.12.016; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Kahn CA, 2009, ANN EMERG MED, V54, P424, DOI 10.1016/j.annemergmed.2008.12.035; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Lerner EB, 2006, PREHOSP EMERG CARE, V10, P303, DOI 10.1080/10903120600723921; Lerner EB, 2008, DISASTER MED PUBLIC, V2, pS25, DOI 10.1097/DMP.0b013e318182194e; Lidal IB, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-28; Lin G, 2012, INJURY, V43, P1381, DOI 10.1016/j.injury.2010.11.014; Lipsky AM, 2006, J TRAUMA, V61, P1228, DOI 10.1097/01.ta.0000196694.52615.84; Lustenberger T, 2016, WORLD J SURG, V40, P3073, DOI 10.1007/s00268-016-3647-2; Newgard CD, 2010, J TRAUMA, V68, P452, DOI 10.1097/TA.0b013e3181ae20c9; Pakkanen T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0438-1; Parks JK, 2006, AM J SURG, V192, P727, DOI 10.1016/j.amjsurg.2006.08.034; Peleg K, 2004, ARCH SURG-CHICAGO, V139, P1231, DOI 10.1001/archsurg.139.11.1231; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; Raux M, 2006, INTENS CARE MED, V32, P405, DOI 10.1007/s00134-005-0063-8; Sanjaume JS, 2017, EMERGENCIAS, V29, P301; Sloan EP, 2014, WEST J EMERG MED, V15, P795, DOI 10.5811/westjem.2014.7.21304; Smith RM, 2009, INJURY, V40, pS23, DOI 10.1016/j.injury.2009.10.033; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Sturms LM, 2006, LANGENBECK ARCH SURG, V391, P343, DOI 10.1007/s00423-006-0057-1; Thompson L, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0419-4; Van Haren RM, 2012, J TRAUMA ACUTE CARE, V73, P1512, DOI 10.1097/TA.0b013e318270d40f; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; Zarzaur BL, 2011, J TRAUMA, V61, P882, DOI [10.1097/TA.0b013e3181fd0dae, DOI 10.1097/TA.0B013E3181FD0DAE]	48	3	3	1	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	APR	2020	46	2					425	433		10.1007/s00068-018-1040-6			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KY8PT	WOS:000522839100023	30406394				2022-02-06	
J	Parrington, L; Jehu, DA; Fino, PC; Stuart, S; Wilhelm, J; Pettigrew, N; Murchison, CF; El-Gohary, M; VanDerwalker, J; Pearson, S; Hullar, T; Chesnutt, JC; Peterka, RJ; Horak, FB; King, LA				Parrington, Lucy; Jehu, Deborah A.; Fino, Peter C.; Stuart, Samuel; Wilhelm, Jennifer; Pettigrew, Natalie; Murchison, Charles F.; El-Gohary, Mahmoud; VanDerwalker, Jess; Pearson, Sean; Hullar, Timothy; Chesnutt, James C.; Peterka, Robert J.; Horak, Fay B.; King, Laurie A.			The Sensor Technology and Rehabilitative Timing (START) Protocol: A Randomized Controlled Trial for the Rehabilitation of Mild Traumatic Brain Injury	PHYSICAL THERAPY			English	Article							SPORTS-RELATED CONCUSSION; VESTIBULAR REHABILITATION; PHYSICAL-THERAPY; HEAD-INJURY; DISORDERS; DIZZINESS; SYMPTOMS; RECOVERY; EXERCISE; ADOLESCENTS	Background. Clinical practice for rehabilitation after mild traumatic brain injury (mTBI) is variable, and guidance on when to initiate physical therapy is lacking. Wearable sensor technology may aid clinical assessment, performance monitoring, and exercise adherence, potentially improving rehabilitation outcomes during unsupervised home exercise programs. Objective. The objectives of this study were to: (1) determine whether initiating rehabilitation earlier than typical will improve outcomes after mTBI, and (2) examine whether using wearable sensors during a home-exercise program will improve outcomes in participants with mTBI. Design. This was a randomized controlled trial. Setting. This study will take place within an academic hospital setting at Oregon Health & Science University and Veterans Affairs Portland Health Care System, and in the home environment. Participants. This study will include 160 individuals with mTBI. Intervention. The early intervention group (n = 80) will receive one-on-one physical therapy 8 times over 6 weeks and complete daily home exercises. The standard care group (n = 80) will complete the same intervention after a 6- to 8-week wait period. One-half of each group will receive wearable sensors for therapist monitoring of patient adherence and quality of movements during their home exercise program. Measurements. The primary outcome measure will be the Dizziness Handicap Inventory score. Secondary outcome measures will include symptomatology, static and dynamic postural control, central sensorimotor integration posturography, and vestibular-ocular-motor function. Limitations. Potential limitations include variable onset of care, a wide range of ages, possible low adherence and/or withdrawal from the study in the standard of care group, and low Dizziness Handicap Inventory scores effecting ceiling for change after rehabilitation. Conclusions. If initiating rehabilitation earlier improves primary and secondary outcomes post-mTBI, this could help shape current clinical care guidelines for rehabilitation. Additionally, using wearable sensors to monitor performance and adherence may improve home exercise outcomes.	[Parrington, Lucy; Jehu, Deborah A.; Fino, Peter C.; Stuart, Samuel; Wilhelm, Jennifer; Pettigrew, Natalie; Murchison, Charles F.; Chesnutt, James C.; Horak, Fay B.; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Parrington, Lucy; Fino, Peter C.; Horak, Fay B.; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA; [Jehu, Deborah A.] Univ British Columbia, Ctr Hip Hlth & Mobil, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Jehu, Deborah A.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Fino, Peter C.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT USA; [Stuart, Samuel] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England; [Murchison, Charles F.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [El-Gohary, Mahmoud; VanDerwalker, Jess; Pearson, Sean; Horak, Fay B.] ADPM Inc, Portland, OR USA; [Hullar, Timothy] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, Portland, OR 97201 USA; [Peterka, Robert J.; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA		King, LA (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; King, LA (corresponding author), Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA.; King, LA (corresponding author), Vet Affairs Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA.	kingla@ohsu.edu	Stuart, Samuel/I-6449-2019	Stuart, Samuel/0000-0001-6846-9372; Parrington, Lucy/0000-0001-8507-9974	Assistant Secretary of Defense for Health Affairs [W81XWH-17-1-0424]	This work was supported by the Assistant Secretary of Defense for Health Affairs under award no. W81XWH-17-1-0424. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the US Department of Defense.	Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Argent R, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8518; Bamiou DE, 2000, SCAND AUDIOL, V29, P238, DOI 10.1080/010503900750022862; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; Chang YJ, 2019, J NEUROTRAUM, V36, P126, DOI 10.1089/neu.2017.5499; Collins MW, 2015, STAT AGR TARG EV ACT; Cowand JL, 1998, OTOLARYNG HEAD NECK, V118, P49, DOI 10.1016/S0194-5998(98)70374-2; Department of Veterans Affairs and Department of Defense, 2016, VA DOD CLIN PRACT GU, P1; Dix M, 1952, PATHOLOGY SYMPTOMATO; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; El-Gohary MVP, 2017, GAIT POSTURE, V57, P284; Fino P. C., 2018, J HEAD TRAUMA REHABI; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; Friedrich M, 1996, PHYS THER, V76, P1082, DOI 10.1093/ptj/76.10.1082; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Kao CL, 2010, ARCH GERONTOL GERIAT, V51, P264, DOI 10.1016/j.archger.2009.11.014; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kaufmann CN, 2019, BEHAV SLEEP MED, V17, P12, DOI 10.1080/15402002.2016.1266490; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Lennon A, 2018, J NEUROL PHYS THER, V42, P123, DOI 10.1097/NPT.0000000000000227; Libin AV, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0061-2; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Institute of Neurological Disorders and Stroke, NINDS TRAUM BRAIN IN; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterka RJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01045; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Reeves D, 1992, AUTOMATED NEUROPSYCH, VI; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Rose SC, 2016, SPORTS HEALTH, V8, P37, DOI 10.1177/1941738115591948; Scholten J, 2017, BRAIN INJURY, V31, P1246, DOI 10.1080/02699052.2016.1274780; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Stuart S, 2014, IEEE ENG MED BIO, P5739, DOI 10.1109/EMBC.2014.6944931; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	54	3	3	1	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	APR	2020	100	4					687	697		10.1093/ptj/pzaa007			11	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation	LU0CJ	WOS:000537431100011	31951263	Bronze, Green Published, Green Accepted			2022-02-06	
J	Singh, V; Dey, S; Parikh, SN				Singh, Vivek; Dey, Sukalyan; Parikh, Shital N.			Missed Diagnosis and Acute Management of Radial Head Dislocation With Plastic Deformation of Ulna in Children	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						Monteggia; Monteggia equivalent; ulnar bowing; plastic deformation; missed injury; children	MONTEGGIA FRACTURE-DISLOCATIONS; RADIOCAPITELLAR LINE; OPEN REDUCTION; OSTEOTOMY	Background: Radial head dislocation with ulnar bowing (Monteggia type I equivalent injury) is a frequently missed injury. If not recognized acutely, these missed injuries can lead to serious long-term complications. The purpose of this study was to evaluate the rate of missed diagnosis and to report on the characteristics and early management of this specific injury pattern. Methods: A total of 112 patients with Monteggia fracture-dislocation were identified, of which 18 patients had sustained a Monteggia type I equivalent injury. The total duration between injury, diagnosis, and treatment was noted. Medical records were reviewed to identify cases with the initially missed diagnosis. The radiographic assessment included the direction of radial head dislocation and location/displacement of the apex of the ulnar bow. Clinical outcomes were evaluated using Kim elbow performance score. Results: Thirteen of 18 cases with Monteggia equivalent injury were missed at the initial presentation. The diagnosis was established when the patients followed up in the orthopaedic clinic. Of these 18 patients, 11 were treated by closed reduction/cast and 7 patients required surgery. Significant differences were found between the closed reduction/cast and operative group for the mean time from injury to treatment (3.2 +/- 2.6 vs. 12.7 +/- 13.6 d). For each day of delay in treatment, the odds for surgical intervention increased by a factor of 1.126 (12.6%). There were no significant differences between the location and magnitude of the apex of the ulnar deformity between the 2 groups. Kim elbow score was excellent in all cases at the latest follow-up. Conclusions: Clinical suspicion and careful radiographic assessment are of utmost importance for every child with forearm and elbow injury without an apparent fracture, as there is a high rate of missed diagnosis for this specific Monteggia injury pattern. Prompt treatment would allow for successful closed reduction while even minor delays would increase the need for surgical intervention.	[Singh, Vivek; Dey, Sukalyan; Parikh, Shital N.] Cincinnati Childrens Hosp Med Ctr, Dept Orthopaed Surg, 3333 Burnet Ave, Cincinnati, OH 45229 USA		Singh, V (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Orthopaed Surg, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shital.parikh@cchmc.org					Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Fader LM, 2016, J PEDIATR ORTHOPED, V36, P161, DOI 10.1097/BPO.0000000000000426; GLEESON AP, 1994, J ACCID EMERG MED, V11, P192; Goyal T, 2015, J PEDIATR ORTHOP B, V24, P191, DOI 10.1097/BPB.0000000000000147; Gyr BM, 2004, J PEDIATR ORTHOP B, V13, P402, DOI 10.1097/01202412-200411000-00011; HAMILTON W, 1973, CLIN ORTHOP RELAT R, P94; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; HUDSON DA, 1986, J BONE JOINT SURG BR, V68, P378, DOI 10.1302/0301-620X.68B3.3733800; Kemnitz S, 2000, Acta Orthop Belg, V66, P359; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; Kunkel S, 2011, J PEDIATR ORTHOPED, V31, P628, DOI 10.1097/BPO.0b013e3182210988; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; LINCOLN TL, 1994, J PEDIATR ORTHOPED, V14, P454, DOI 10.1097/01241398-199407000-00006; Malik M, 2016, ORTHOPEDICS, V39, pE203, DOI 10.3928/01477447-20151222-01; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; ONER FC, 1993, J BONE JOINT SURG BR, V75, P577, DOI 10.1302/0301-620X.75B4.8331112; Ramirez RN, 2014, J PEDIATR ORTHOPED, V34, P763, DOI 10.1097/BPO.0000000000000199; Ramski DE, 2015, J PEDIATR ORTHOPED, V35, P115, DOI 10.1097/BPO.0000000000000213; Sano S, 2008, J SHOULDER ELB SURG, V17, P768, DOI 10.1016/j.jse.2008.03.007; Seel MJ, 1999, J PEDIATR ORTHOPED, V19, P306, DOI 10.1097/00004694-199905000-00006; Shah AS, 2015, ROCKWOOD WILKINS FRA, P527; Vesely DG, 1997, CLIN ORTHOP RELAT R, V50, P31	24	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	APR	2020	40	4					E293	E299		10.1097/BPO.0000000000001501			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	LE0FR	WOS:000526401000018	31990821				2022-02-06	
J	Svirsky, S; Henchir, J; Li, YM; Ma, XC; Carlson, S; Dixon, CE				Svirsky, Sarah; Henchir, Jeremy; Li, Youming; Ma, Xiecheng; Carlson, Shaun; Dixon, C. Edward			Neurogranin Protein Expression Is Reduced after Controlled Cortical Impact in Rats	JOURNAL OF NEUROTRAUMA			English	Article						CCI; cognitive dysfunction; neurogranin; PSD-95; synaptic plasticity	TRAUMATIC BRAIN-INJURY; KINASE-C SUBSTRATE; LONG-TERM POTENTIATION; FLUID PERCUSSION INJURY; CEREBROSPINAL-FLUID; POSTSYNAPTIC DENSITY; SYNAPTIC PROTEINS; OXIDATIVE STRESS; CORTEX; PHOSPHORYLATION	Traumatic brain injury (TBI) is known to cause short- and long-term synaptic changes in the brain, possibly underlying downstream cognitive impairments. Neuronal levels of neurogranin, a calcium-sensitive calmodulin-binding protein essential for synaptic plasticity and postsynaptic signaling, are correlated with cognitive function. This study aims to understand the effect of TBI on neurogranin by characterizing changes in protein expression at various time points after injury. Adult, male rats were subjected to either controlled cortical impact (CCI) or control surgery. Expression of neurogranin and post-synaptic density 95 (PSD-95) were evaluated by Western blot in the cortex and hippocampus at 24 h and 1, 2, and 4 weeks post-injury. We hypothesized that CCI reduces neurogranin levels in the cortex and hippocampus, and demonstrate different expression patterns from PSD-95. Neurogranin levels were reduced in the ipsilateral cortex and hippocampus up to 2 weeks after injury but recovered to sham levels by 4 weeks. The contralateral cortex and hippocampus were relatively resistant to changes in neurogranin expression post-injury. Qualitative immunohistochemical assessment corroborated the immunoblot findings. Particularly, the pericontusional cortex and ipsilateral Cornu Ammonis (CA)3 region showed marked reduction in immunoreactivity. PSD-95 demonstrated similar expression patterns to neurogranin in the cortex; however, in the hippocampus, protein expression was increased compared with sham at the 2 and 4 week time points. Our results indicate that CCI lowers neurogranin expression with temporal and regional specificity and that this occurs independently of dendritic loss. Further understanding of the role of neurogranin in synaptic biology after TBI will elucidate pathological mechanisms contributing to cognitive dysfunction.	[Svirsky, Sarah; Dixon, C. Edward] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15224 USA; [Svirsky, Sarah; Henchir, Jeremy; Li, Youming; Ma, Xiecheng; Carlson, Shaun; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15224 USA; [Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dixoec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075			AlvarezBolado G, 1996, NEUROSCIENCE, V73, P565, DOI 10.1016/0306-4522(96)00061-9; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Casaletto KB, 2017, NEUROLOGY, V89, P1782, DOI 10.1212/WNL.0000000000004569; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; Chen SJ, 1997, BRAIN RES, V749, P181, DOI 10.1016/S0006-8993(96)01159-6; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; De Vos A, 2016, J ALZHEIMERS DIS, V53, P1523, DOI 10.3233/JAD-160227; De Vos A, 2015, ALZHEIMERS DEMENT, V11, P1461, DOI 10.1016/j.jalz.2015.05.012; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fossati G, 2015, CELL DEATH DIFFER, V22, P1425, DOI 10.1038/cdd.2014.227; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Hellwig K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0161-y; Huang KP, 2011, NEUROSCIENCE, V178, P1, DOI 10.1016/j.neuroscience.2011.01.027; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Jones KJ, 2018, P NATL ACAD SCI USA, V115, pE5805, DOI 10.1073/pnas.1716750115; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kester MI, 2015, JAMA NEUROL, V72, P1275, DOI 10.1001/jamaneurol.2015.1867; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Kvartsberg H, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0124-3; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mahoney CW, 1996, J BIOL CHEM, V271, P28798, DOI 10.1074/jbc.271.46.28798; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Patel MV, 2019, J NEUROTRAUM, V36, P2129, DOI 10.1089/neu.2018.6291; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pijet B, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/3259295; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Ramakers GMJ, 2000, J BIOL CHEM, V275, P28682, DOI 10.1074/jbc.M003068200; RAMAKERS GMJ, 1995, J BIOL CHEM, V270, P13892, DOI 10.1074/jbc.270.23.13892; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Thorsell A, 2010, BRAIN RES, V1362, P13, DOI 10.1016/j.brainres.2010.09.073; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; van Dam EJM, 2002, NEUROSCI LETT, V320, P129, DOI 10.1016/S0304-3940(02)00037-X; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001; Wu JF, 2003, J NEUROCHEM, V86, P1524, DOI 10.1046/j.1471-4159.2003.01963.x; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015; Zhong L, 2015, J NEUROSCI, V35, P7503, DOI 10.1523/JNEUROSCI.0274-15.2015; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236	64	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					939	949		10.1089/neu.2019.6759			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000524528800003	31691647	Green Published			2022-02-06	
J	Tignanelli, CJ; Gipson, J; Nguyen, A; Martinez, R; Yang, S; Reicks, PL; Sybrant, C; Roach, R; Thorson, M; West, MA				Tignanelli, Christopher J.; Gipson, Jonathan; Nguyen, Arthur; Martinez, Regina; Yang, Simon; Reicks, Patty L.; Sybrant, Cori; Roach, Robert; Thorson, Melissa; West, Michaela A.			Implementation of a Prophylactic Anticoagulation Guideline for Patients with Traumatic Brain Injury	JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY			English	Article							VENOUS THROMBOEMBOLISM PROPHYLAXIS; MOLECULAR-WEIGHT HEPARIN; AMERICAN-COLLEGE; MODERATE; ENOXAPARIN; MORTALITY; COMMITTEE; SAFETY	Background: Patients with traumatic brain injury (TBI) are at an increased risk of developing complications from venous thromboembolisms (VTEs [blood clots]). Benchmarking by the American College of Surgeons Trauma Quality Improvement Program identified suboptimal use of prophylactic anticoagulation in patients with TBI. We hypothesized that institutional implementation of an anticoagulation protocol would improve clinical outcomes in such patients. Methods: A new prophylactic anticoagulation protocol that incorporated education, weekly audits, and real-time adherence feedback was implemented in July 2015. The trauma registry identified patients with TBI before (PRE) and after (POST) implementation. Multivariable regression analysis with risk adjustment was used to compare use of prophylactic anticoagulation, VTE events, and mortality. Results: A total of 681 patients with TBI (368 PRE, 313 POST) were identified. After implementation of the VTE protocol, more patients received anticoagulation (PRE: 39.4%, POST: 80.596,p < 0.001), time to initiation was shorter (PRE: 140 hours, POST: 59 hours, p < 0.001), and there were fewer VTE events (PRE: 19 [5.2%], POST: 7 [2.2%], p= 0.047). Multivariable analysis showed that POST patients were more likely to receive anticoagulation (odds ratio [OR] = 10.8, 95% confidence interval [CI] = 6.9-16.7 < 0.001) and less likely to develop VTE (OR = 0.33, 95% CI = 0.1-1.0, p = 0.05). Conclusion: Benchmarking can assist institutions to identity potential clinically relevant areas for quality improvement in real time. Combining education and multifaceted protocol implementation can help organizations to better focus limited quality resources and counteract barriers that have hindered adoption of best practices.	[Tignanelli, Christopher J.; West, Michaela A.] Univ Minnesota, Surg, Med Sch, Minneapolis, MN 55455 USA; [Tignanelli, Christopher J.] NMHH, Crit Care Trauma Surg, Robbinsdale, MN USA; [Gipson, Jonathan; Reicks, Patty L.] NMHH, Div Trauma & Acute Care Surg, Robbinsdale, MN USA; [Nguyen, Arthur; Martinez, Regina; Yang, Simon] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Sybrant, Cori] NMHH, Trauma & Emergency Gen Surg, Robbinsdale, MN USA; [Roach, Robert] Metropolitan Neurosurg, Minneapolis, MN USA; [Roach, Robert; West, Michaela A.] NMHH, Robbinsdale, MN 55422 USA; [Thorson, Melissa] NMHH, Patient Care Crit Care Trauma & Emergency Gen Sur, Robbinsdale, MN USA		West, MA (corresponding author), Univ Minnesota, Surg, Med Sch, Minneapolis, MN 55455 USA.; West, MA (corresponding author), NMHH, Robbinsdale, MN 55422 USA.	michaela.west@northmemorial.com		Tignanelli, Christopher/0000-0002-8079-5565; Yang, Simon/0000-0002-1250-1238			American College of Surgeons, NAT TRAUM DAT STAND; American College of Surgeons, 2015, ACS TQIP BEST PRACT; Baron DM, 2016, WIEN KLIN WOCHENSCHR, V128, P397, DOI 10.1007/s00508-016-1004-y; Brain Trauma Foundation, 2016, GUID MAN SEV TBI; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Corson AH, 2015, J HOSP MED, V10, P390, DOI 10.1002/jhm.2354; DeGuzman PB, 2015, CLIN NURS STUD, V3, P55; Jacobs BN, 2017, J TRAUMA ACUTE CARE, V83, P151, DOI 10.1097/TA.0000000000001494; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Lombardo S, 2017, J TRAUMA ACUTE CARE, V82, P489, DOI 10.1097/TA.0000000000001361; Lyon A, 2014, WORLD J SURG, V38, P1374, DOI 10.1007/s00268-013-2441-7; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Schouten JA, 2007, CLIN INFECT DIS, V44, P931, DOI 10.1086/512193; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P287, DOI 10.1097/TA.0000000000001745; van de Klundert J, 2010, J BIOMED INFORM, V43, P861, DOI 10.1016/j.jbi.2010.08.002	24	3	3	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1553-7250	1938-131X		JT COMM J QUAL PATIE	Jt. Comm. J. Qual. Patient Saf.	APR	2020	46	4					185	191		10.1016/j.jcjq.2019.11.007			7	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	KY0FS	WOS:000522250300002	31899154				2022-02-06	
J	Varela, MM; Fernandes, FAO; de Sousa, RJA				Varela, Miguel M.; Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.			Development of an Eco-Friendly Head Impact Protection Device	APPLIED SCIENCES-BASEL			English	Article						cellular material; finite element analysis; sports safety; brain injuries; head trauma; protective devices; passive safety; sustainable solutions	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; UNITED-STATES; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; HOCKEY INJURIES; COLLEGIATE; CONCUSSION; FOOTBALL; SPORTS	Nowadays, the number of people practising contact sports has increased. In many of them, using head protective equipment is not mandatory, even if the use of headbands could increase the level of safety regarding several types of traumatic brain injuries. Many commercial solutions are currently available, based on plastic-based foams providing a decent level of protection and comfort to the user. This work introduces the use of agglomerated cork as an eco-friendly alternative to synthetic foams but at least keeping safety levels. Cork is a natural cellular material that has been showing excellent crashworthiness properties. In this study, cork agglomerate density is carefully chosen to be incorporated into a protective headband. Results are compared against three other commercial headbands. For each one, the risk of brain injury was analysed for different injury thresholds and impact energies. The results clearly demonstrate that the cork-based apparel may provide comparable, and in some cases, better performances, outlasting the commercial ones.	[Varela, Miguel M.; Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.] Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Campus Santiago, P-3810193 Aveiro, Portugal		de Sousa, RJA (corresponding author), Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Campus Santiago, P-3810193 Aveiro, Portugal.	varela@ua.pt; fabiofernandes@ua.pt; rsousa@ua.pt	de Sousa, Ricardo Alves/E-4405-2010; Fernandes, Fabio A.O./H-2680-2012	de Sousa, Ricardo Alves/0000-0002-5848-6424; Fernandes, Fabio A.O./0000-0001-9751-8807	FCT-Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science and Technology [UIDB/00481/2020, UIDP/00481/2020]; Centro Portugal Regional Operational Programme (Centro2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund [CENTRO-01-0145-FEDER-022083]; Fundacao para a Ciencia e a Tecnologia (FCT)Portuguese Foundation for Science and TechnologyEuropean Commission [CEECIND/01192/2017]	work was supported by the projects UIDB/00481/2020 and UIDP/00481/2020-FCT-Fundacao para a Ciencia e a Tecnologia; and CENTRO-01-0145-FEDER-022083-Centro Portugal Regional Operational Programme (Centro2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund. The authors also acknowledge the support given by Fundacao para a Ciencia e a Tecnologia (FCT), Researcher under grant CEECIND/01192/2017.	Agel J, 2010, CAN J SURG, V53, P319; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Coelho RM, 2013, MATER DESIGN, V43, P384, DOI 10.1016/j.matdes.2012.07.020; Dassault Systemes Simulia Corp, 2010, ABAQUS 6 10 DOC ABAQ; Dick R, 2007, J ATHL TRAINING, V42, P211; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Fernandes FAO, 2015, MATER DESIGN, V82, P335, DOI 10.1016/j.matdes.2015.06.004; Fernandes FAO, 2014, MATER DESIGN, V58, P499, DOI 10.1016/j.matdes.2014.02.011; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Fernandes FAO, 2013, STRUCT ENG MECH, V48, P661, DOI 10.12989/sem.2013.48.5.661; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead PD, 2000, AM SOC TEST MATER, V1341, P93, DOI 10.1520/STP15230S; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jardin RT, 2015, MATER DESIGN, V68, P121, DOI 10.1016/j.matdes.2014.12.016; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall SW, 2007, J ATHL TRAINING, V42, P286; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Post A., 2016, P IRCOBI C MADR SPAI, P194; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rah K, 2013, COMPUT MECH, V51, P309, DOI 10.1007/s00466-012-0726-6; Santos PT, 2017, COMPOS STRUCT, V178, P277, DOI 10.1016/j.compstruct.2017.07.035; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; van den Bosch, 2006, THESIS, DOI [10.6100/IR613094, DOI 10.6100/IR613094]; Yard EE, 2009, RES SPORTS MED, V17, P35, DOI 10.1080/15438620802678495; Yoganandan N., 2000, FRONTIERS WHIPLASH T, P590	41	3	3	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	APR	2020	10	7							2492	10.3390/app10072492			16	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	LO0YT	WOS:000533356200291		gold			2022-02-06	
J	Velez, AM; Frangos, SG; DiMaggio, CJ; Berry, CD; Avraham, JB; Bukur, M				Velez, Ana M.; Frangos, Spiros G.; DiMaggio, Charles J.; Berry, Cherisse D.; Avraham, Jacob B.; Bukur, Marko			Trauma center transfer of elderly patients with mild Traumatic Brain Injury improves outcomes	AMERICAN JOURNAL OF SURGERY			English	Article						Elderly; Mortality; Outcomes; Triage; Traumatic brain injury	ACUTE-CARE; CENTER DESIGNATION; OLDER-ADULTS; GERIATRIC TRAUMA; GUIDELINES; MANAGEMENT; MORTALITY; VOLUME; PREDICTORS; SURGERY	Background: Elderly patients with Traumatic Brain Injury (TBI) are frequently transferred to designated Trauma Centers (TC). We hypothesized that TC transfer is associated with improved outcomes. Methods: Retrospective study utilizing the National Trauma Databank. Demographics, injury and outcomes data were abstracted. Patients were dichotomized by transfer to a designated level I/II TC vs. not. Multivariate regression was used to derive the adjusted primary outcome, mortality, and secondary outcomes, complications and discharge disposition. Results: 19,664 patients were included, with a mean age of 78.1 years. 70% were transferred to a level I/II TC. Transferred patients had a higher ISS (12 vs. 10, p < 0.001). Mortality was significantly lower in patients transferred to level I/II TCs (5.6% vs. 6.2%, Adjusted Odds Ratio (AOR) 0.84, p = 0.011), as was the likelihood of discharge to skilled nursing facilities (26.4% vs. 30.2%, AOR 0.80, p < 0.001). Conclusions: Elderly patients with mild TBI transferred to level I/II TCs have improved outcomes. Which patients with mild TBI require level I/II TC care should be examined prospectively. (C) 2019 Elsevier Inc. All rights reserved.	[Velez, Ana M.; Avraham, Jacob B.] NYU, Dept Surg, Sch Med, 462 First Ave,NBV 15 N1, New York, NY 10016 USA; [Frangos, Spiros G.; DiMaggio, Charles J.; Berry, Cherisse D.; Bukur, Marko] NYU, Dept Surg, Div Trauma & Acute Care Surg, Sch Med, 462 First Ave,NBV 15 N1, New York, NY 10016 USA; [DiMaggio, Charles J.] NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA		Velez, AM (corresponding author), NYU, Dept Surg, Sch Med, 462 First Ave,NBV 15 N1, New York, NY 10016 USA.	veleza04@nyumc.org; spiros.frangos@nyumc.org; charles.dimaggio@nyumc.org; cherisse.berry@nyumc.org; jacob.avraham@nyumc.org; marko.bukur@nyumc.org	Berry, Cherisse/AAO-5701-2020	Velez-Rosborough, Ana/0000-0001-7384-1677; DiMaggio, Charles/0000-0003-2356-6659; Bukur, Marko/0000-0002-1850-7147; Frangos, Spiros/0000-0003-2860-8969			Biffl WL, 2005, J AM COLL SURGEONS, V200, P922, DOI 10.1016/j.jamcollsurg.2005.01.014; Bradburn E, 2012, J TRAUMA ACUTE CARE, V73, P435, DOI 10.1097/TA.0b013e31825c7cf4; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Capron GK, 2017, AM J SURG, V214, P1182, DOI 10.1016/j.amjsurg.2017.09.002; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Center for Disease Control and Prevention, 2001, INJ PREV CONTR RAT T; Centers for Disease Control and Prevention, 2015, 10 LEAD CAUS DEATH A; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Martin GE, 2018, J TRAUMA ACUTE CARE, V84, P483, DOI 10.1097/TA.0000000000001767; Marx WH, 2011, J TRAUMA, V71, P339, DOI 10.1097/TA.0b013e3182214055; Matsushima K, 2014, JAMA SURG, V149, P319, DOI 10.1001/jamasurg.2013.4834; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nathens AB, 2004, J TRAUMA, V56, P173, DOI 10.1097/01.TA.0000056159.65396.7C; Rotondo MFCC, 2014, RESOURCES OPTIMAL CA, P30; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; US Department of Health and Human Services, 2016, PROF OLD AM; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wilberger J, 2014, GERIATRIC TRAUMA CRI	32	3	3	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2020	219	4					665	669		10.1016/j.amjsurg.2019.06.008			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	LD1PB	WOS:000525802700027	31208625				2022-02-06	
J	Velle, F; Lewen, A; Howells, T; Enblad, P; Nilsson, P				Velle, Fartein; Lewen, Anders; Howells, Timothy; Enblad, Per; Nilsson, Pelle			Intracranial pressure-based barbiturate coma treatment in children with refractory intracranial hypertension due to traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; barbiturate coma; refractory intracranial hypertension; outcome; trauma	CEREBRAL PERFUSION-PRESSURE; OUTCOME SCALE; HEAD-INJURY; MANAGEMENT; THIOPENTONE; MORTALITY; THERAPY; COMPLICATIONS; EFFICACY	OBJECTIVE Refractory intracranial pressure (ICP) hypertension following traumatic brain injury (TBI) is a severe condition that requires potentially harmful treatment strategies such as barbiturate coma. However, the use of barbiturates may be restricted due to concerns about inducing multiorgan system complications related to the therapy. The purpose of this study was to evaluate the outcome and occurrence of treatment-related complications to barbiturate coma treatment in children with refractory intracranial hypertension (RICH) due to TBI in a modern multimodality neurointensive care unit (NICU). METHODS The authors conducted a retrospective cohort study of 21 children <= 16 years old who were treated in their NICU between 2005 and 2015 with barbiturate coma for RICH following TBI. Demographic and clinical data were acquired from patient records and physiological data from digital monitoring system files. RESULTS The median age of these 21 children was 14 years (range 2-16 years) and at admission the median Glasgow Coma Scale score was 7 (range 4-8). Barbiturate coma treatment was added due to RICH at a median of 46 hours from trauma and had a median duration of 107 hours. The onset of barbiturate coma resulted in lower ICP values, lower pulse amplitudes on the ICP curve, and decreased amount of A-waves. No major disturbances in blood gases, liver and kidney function, or secondary insults were observed during this period. Outcome 1 year later revealed a median Glasgow Outcome Scale score of 5 (good recovery), however on the King's Outcome Scale for Childhood Head Injury, the median was 4a (moderate disability). CONCLUSIONS The results of this study indicate that barbiturate coma, when used in a modern NICU, is an effective means of lowering ICP without causing concomitant severe side effects in children with RICH and was compatible with good long-term outcome.	[Velle, Fartein; Lewen, Anders; Howells, Timothy; Enblad, Per; Nilsson, Pelle] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden		Velle, F (corresponding author), Uppsala Univ Hosp, Uppsala, Sweden.	fartein.velle@neuro.uu.se					Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Almaas R, 2000, ANESTHESIOLOGY, V92, P764, DOI 10.1097/00000542-200003000-00020; Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; Cole DJ, 2001, CAN J ANAESTH, V48, P807, DOI 10.1007/BF03016699; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Drummond JC, 1996, ANESTHESIOLOGY, V85, P1504, DOI 10.1097/00000542-199612000-00050; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; JENNETT B, 1975, LANCET, V1, P480; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; Nyholm L, 2012, ISRN NEUROL, V2012; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Paget SP, 2012, DEV NEUROREHABIL, V15, P171, DOI 10.3109/17518423.2012.671381; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SATO M, 1989, RESUSCITATION, V17, P233, DOI 10.1016/0300-9572(89)90039-7; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Swedish National Board of Health and Welfare, 2015, CAUS DEATH 2014; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363	38	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2020	25	4					375	383		10.3171/2019.10.PEDS19268			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	KZ3UK	WOS:000523190800005	31881539	Bronze			2022-02-06	
J	Yamanaka, S; Goldman, RD; Goto, T; Hayashi, H				Yamanaka, Syunsuke; Goldman, Ran D.; Goto, Tadahiro; Hayashi, Hiroyuki			Multiple intubation attempts in the emergency department and in-hospital mortality: A retrospective observational study	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; AIRWAY MANAGEMENT; ADVERSE EVENTS; ENDOTRACHEAL INTUBATION; SUCCESS RATES; REHABILITATION; COMPLICATIONS; INDUCTION	Objectives: Multiple intubation attempts in the Emergency Department (ED) have been associated with adverse events, but no study examined the influence of multiple intubation attempts on survival during hospitalization. Our aim was to compare one or more intubation attempts in the ED with risk of morbidity and mortality during hospitalization. Methods: We conducted a single center retrospective analysis of all patients undergoing emergency intubation in the ED and then admission to the hospital, during September 2010 to April 2016. The primary exposure was multiple intubation attempts. The primary outcome was mortality during hospitalization after intubation in the ED. Results: Of 181 patients, 63 (35%) required two or more attempts. We found no significant difference in mortality (p=0.11), discharge from the hospital (p=0.45), length of stay in hospital (p=0.34), intensive care unit (ICU) (p=0.32), ED (p=0.81) or intubation period (p=0.64), between one or more intubation attempts. After adjustment for the number of intubation trials, age, sex, intubation methods, first intubator training level and diagnostic category, use of medications during intubation was the only independent prognostic variable for hospital death (adjusted OR 0.21, 95%CI 0.1-0.45, p < 0.01). Number of trials to achieve successful intubation was not associated with discharge disposition (OR 0.77 95%CI 0.24-2.46, p=0.66). Age (OR 0.95, 95%CI 0.93-0.98, p < 0.01) and brain injury as a diagnostic category (OR 0.15 95%CI 0.04-0.56, p < 0.01) were independent prognostic variables. Conclusions: We found multiple intubation attempts were not associated with increased mortality and morbidity during hospitalization. (c) 2019 Elsevier Inc. All rights reserved.	[Yamanaka, Syunsuke; Goldman, Ran D.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Yamanaka, Syunsuke; Hayashi, Hiroyuki] Univ Fukui Hosp, Dept Emergency Med, Fukui, Japan; [Goto, Tadahiro] Univ Fukui, Grad Sch Med Sci, Fukui, Japan		Yamanaka, S (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.	yamanaka@u-fukui.ac.jp; hhaya@u-fukui.ac.jp	Yamanaka, Syunsuke/AAT-9326-2021	Yamanaka, Syunsuke/0000-0003-4510-1959; Goldman, Ran D./0000-0001-8318-5415			Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Cook TM, 2012, BRIT J ANAESTH, V109, pI68, DOI 10.1093/bja/aes393; Goto T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-014-0085-8; Hasegawa K, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-12; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Hasegawa K, 2012, RESUSCITATION, V83, P428, DOI 10.1016/j.resuscitation.2011.11.027; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Kim J, 2014, RESUSCITATION, V85, P623, DOI 10.1016/j.resuscitation.2014.01.017; Kim WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112779; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Martin LD, 2011, ANESTHESIOLOGY, V114, P42, DOI 10.1097/ALN.0b013e318201c415; Mort Thomas C, 2007, J Intensive Care Med, V22, P157, DOI 10.1177/0885066607299525; Okubo M, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0129-8; Pallin DJ, 2016, ANN EMERG MED, V67, P610, DOI 10.1016/j.annemergmed.2015.12.006; Park L, 2017, EMERG MED AUSTRALAS, V29, P40, DOI 10.1111/1742-6723.12704; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Smischney NJ, 2012, J TRAUMA ACUTE CARE, V73, P94, DOI 10.1097/TA.0b013e318250cdb8; Tayal VS, 1999, ACAD EMERG MED, V6, P31, DOI 10.1111/j.1553-2712.1999.tb00091.x; Walker RJ, 2018, PUBLIC HEALTH NUTR, V21, P3237, DOI 10.1017/S1368980018001908; Walls RM, 2011, J EMERG MED, V41, P347, DOI 10.1016/j.jemermed.2010.02.024	23	3	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	APR	2020	38	4					768	773		10.1016/j.ajem.2019.06.028			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MI4KE	WOS:000547378200014	31255428				2022-02-06	
J	Simonetti, JA; Piegari, R; Maynard, C; Brenner, LA; Mori, A; Post, EP; Nelson, K; Trivedi, R				Simonetti, Joseph A.; Piegari, Rebecca; Maynard, Charles; Brenner, Lisa A.; Mori, Alaina; Post, Edward P.; Nelson, Karin; Trivedi, Ranak			Characteristics and Injury Mechanisms of Veteran Primary Care Suicide Decedents with and without Diagnosed Mental Illness	JOURNAL OF GENERAL INTERNAL MEDICINE			English	Article; Early Access						suicide; firearm; primary care; veteran	TRAUMATIC BRAIN-INJURY; FIREARM-SUICIDE; UNITED-STATES; HEALTH; RISK; ASSOCIATION; PREVALENCE; SOLDIERS; IDEATION	Background In the United States, suicide rates are increasing among nearly all age groups. Primary care is a critical setting for suicide prevention, where interventions often rely on identifying mental health conditions as indicators of elevated suicide risk. Objective Quantify the proportion of suicide decedents within primary care who had no antecedent mental health or substance use diagnosis. Design Retrospective cohort study. Participants Veterans who received Veterans Health Administration (VHA) primary care any time from 2000 to 2014 and died by suicide before 2015 (n = 27,741). Main Measures We categorized decedents by whether they had any mental health or substance use diagnosis (yes/no) using ICD-9 codes available from VHA records. We compared sociodemographic, clinical, and suicide mechanism characteristics between groups using chi-square, Student's T, or Wilcoxon tests. Results Forty-five percent of decedents had no mental health or substance use diagnosis. Decedents without such a diagnosis were older (68 vs. 57 years, p < 0.001), and more likely to be male (98.3% vs. 95.8%, p < 0.001), non-Hispanic White (90.6% vs. 87.9%, p < 0.001), married/partnered (50.4% vs. 36.6%, p < 0.001), and without military service-connected disability benefits (72.6% vs. 56.9%, p < 0.001). They were also more likely to die from firearm injury (78.9% vs. 60.7%, p < 0.001). There were statistically significant differences in physical health between groups, but the magnitudes of those differences were small. Decedents without a mental health or substance use diagnosis had significantly shorter durations of enrollment in VHA healthcare, less healthcare utilization in their last year of life, and had little utilization aside from primary care visits. Conclusions and Relevance From 2000 to 2014, of nearly thirty thousand VHA primary care patients who died by suicide, almost half had no antecedent mental health or substance use diagnosis. Within VHA primary care settings, suicide risk screening for those with and without such a diagnosis is indicated.	[Simonetti, Joseph A.; Brenner, Lisa A.] Rocky Mt Reg VA Med Ctr, Rocky Mt Mental Illness Res Educ & Clin Ctr, G3-189,1700 N Wheeling St, Aurora, CO USA; [Simonetti, Joseph A.] Denver Seattle Ctr Innovat Vet Ctr & Value Driven, Vet Hlth Adm, Washington, DC USA; [Simonetti, Joseph A.] Univ Colorado, Anschutz Sch Med, Div Hosp Med, Aurora, CO 80045 USA; [Piegari, Rebecca] US Dept Vet Affairs, Vet Hlth Adm, Clin Syst Dev & Evaluat, Washington, DC USA; [Maynard, Charles; Mori, Alaina; Nelson, Karin] VA Puget Sound Healthcare Syst, VHA Primary Care Analyt Team, Seattle, WA USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Sch Med, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Sch Med, Dept Neurol, Aurora, CO USA; [Post, Edward P.] VA HSR&D Ctr Clin Management Res, Ann Arbor, MI USA; [Post, Edward P.] Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA; [Nelson, Karin] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Nelson, Karin] VA Puget Sound Healthcare Syst, Gen Med Serv, Seattle, WA USA; [Trivedi, Ranak] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Palo Alto, CA USA; [Trivedi, Ranak] Stanford Univ, Dept Psychiat & Behav Sci, Div Publ Mental Hlth & Populat Sci, Palo Alto, CA 94304 USA		Simonetti, JA (corresponding author), Univ Colorado, Anschutz Sch Med, Div Hosp Med, Aurora, CO 80045 USA.	joseph.simonetti@ucdenver.edu			VA Office of Primary Care	This work was undertaken as part of the VHA Primary Care Analytics Team (PCAT), funded by the VA Office of Primary Care. The funding office had no role in the design, conduct, or interpretation of this study or in the decision to submit this manuscript for publication.	Ahmedani BK, 2017, AM J PREV MED, V53, P308, DOI 10.1016/j.amepre.2017.04.001; [Anonymous], 2016, SUIC VET OTH AM 2001; [Anonymous], DESCR MHRN DEN POP 2; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Basham C, 2011, SUICIDE LIFE-THREAT, V41, P287, DOI 10.1111/j.1943-278X.2011.00028.x; Black SA, 2011, MIL PSYCHOL, V23, P433, DOI 10.1080/08995605.2011.590409; Boggs JM, 2018, PSYCHIAT SERV, V69, P677, DOI 10.1176/appi.ps.201700237; Boggs JM, 2017, ANN INTERN MED, V167, P287, DOI 10.7326/L17-0111; Bossarte R, 2015, VA HSR D CYB; Center of Excellence for Suicide Prevention, SUIC DAT REP SDR NAT; Centers for Disease Control and Prevention, 2019, WEB BAS INJ STAT QUE; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Greer N, 2019, J HEAD TRAUMA REHAB; Hahm HC, 2015, PSYCHIAT SERV, V66, P258, DOI 10.1176/appi.ps.201400116; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Heidari Shirin, 2016, Res Integr Peer Rev, V1, P2, DOI 10.1186/s41073-016-0007-6; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Johnson CC, 2020, CLIN GERONTOLOGIST, V43, P24, DOI 10.1080/07317115.2019.1686719; Kashner TM, 1998, MED CARE, V36, P1324, DOI 10.1097/00005650-199809000-00005; Kim HM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-18; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Massetti GM, 2018, PSYCHO-ONCOLOGY, V27, P1750, DOI 10.1002/pon.4720; Maynard C., 2019, VIREC DATABASE METHO; Miller M, 2016, EPIDEMIOL REV, V38, P62, DOI 10.1093/epirev/mxv011; Miller M, 2013, AM J EPIDEMIOL, V178, P946, DOI 10.1093/aje/kwt197; Naifeh JA, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-018-1978-2; National Death Index, 2016, NAT DEATH IND; Reger MA, 2018, JAMA PSYCHIAT, V75, P991, DOI 10.1001/jamapsychiatry.2018.2042; Rosland AM, 2013, AM J MANAG CARE, V19, pE263; Stone DM, 2018, MMWR-MORBID MORTAL W, V67, P617, DOI 10.15585/mmwr.mm6722a1; Sullivan DR, 2018, ANN AM THORAC SOC, V15, P1357, DOI 10.1513/AnnalsATS.201805-299RL; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P1022, DOI 10.1001/jamapsychiatry.2018.2069; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P596, DOI 10.1001/jamapsychiatry.2018.0296; US Department of Labor, STAT LOC UN RAT; US Department of Veterans Affairs, VA MISS ACT; US Department of Veterans Affairs, 2008, REP BLUE RIBB WORK G; US Department of Veterans Affairs, NAT STRAT PREV VET S; USDA, 2013, RUR URB CONT COD; Vannoy SD, 2017, SUICIDE LIFE-THREAT, V47, P723, DOI 10.1111/sltb.12318; Young Steve. Suicide risk screening and assessment requirements, 2018, COMMUNICATION   0523	42	3	3	1	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0884-8734	1525-1497		J GEN INTERN MED	J. Gen. Intern. Med.												10.1007/s11606-020-05787-1		MAR 2020	7	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	KX4XR	WOS:000521883400001	32219647	Bronze			2022-02-06	
J	Gempeler, A; Orrego-Gonzalez, E; Hernandez-Casanas, A; Castro, AM; Aristizabal-Mayor, JD; Mejia-Mantilla, JH				Gempeler, Andres; Orrego-Gonzalez, Eduardo; Hernandez-Casanas, Andres; Castro, Andres M.; Aristizabal-Mayor, Juan D.; Mejia-Mantilla, Jorge H.			Incidence and Effect of Diabetes Insipidus in the Acute Care of Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Craniocerebral trauma; Head injuries; Closed; Diabetes insipidus; Neurogenic; Hypernatremia; Critical care; Brain Injuries; Traumatic; Diabetes Insipidus	ANTERIOR-PITUITARY INSUFFICIENCY; SUBARACHNOID HEMORRHAGE; HYPOPITUITARISM; DYSFUNCTION; PREVALENCE; PREDICTORS	Background Literature on diabetes insipidus (DI) after severe traumatic brain injury (TBI) is scarce. Some studies have reported varying frequencies of DI and have showed its association with increased mortality, suggesting it as a marker of poor outcome. This knowledge gap in the acute care consequences of DI in severe TBI patients led us to conceive this study, aimed at identifying risk factors and quantifying the effect of DI on short-term functional outcomes and mortality. Methods We assembled a historic cohort of adult patients with severe TBI (Glasgow Coma Scale <= 8) admitted to the intensive care unit (ICU) of a tertiary-care university hospital over a 6-year period. Basic demographic characteristics, clinical information, imaging findings, and laboratory results were collected. We used logistic regression models to assess potential risk factors for the development of DI, and the association of this condition with death and unfavorable functional outcomes [modified Rankin scale (mRS)] at hospital discharge. Results A total of 317 patients were included in the study. The frequency of DI was 14.82%, and it presented at a median of 2 days (IQR 1-3) after ICU admission. Severity according to the Abbreviated Injury Scale (AIS) score of the head, intracerebral hemorrhage, subdural hematoma, and skull base fracture was suggested as risk factors for DI. Diagnosis of DI was independently associated death (OR 4.34, CI 95% 1.92-10.11, p = 0.0005) and unfavorable outcome (modified Rankin Scale = 4-6) at discharge (OR 7.38; CI 95% 2.15-37.21, p = 0.0047). Conclusions Diabetes insipidus is a frequent and early complication in patients with severe TBI in the ICU and is strongly associated with increased mortality and poor short-term outcomes. We provide clinically useful risk factors that will help detect DI early to improve prognosis and therapy of patients with severe TBI.	[Gempeler, Andres; Aristizabal-Mayor, Juan D.; Mejia-Mantilla, Jorge H.] Fdn Valle Lili, Dept Intens Care Med, Carrera 98 18-49, Cali, Colombia; [Gempeler, Andres; Orrego-Gonzalez, Eduardo; Hernandez-Casanas, Andres; Mejia-Mantilla, Jorge H.] Univ ICESI, Fac Med, Cali, Colombia; [Gempeler, Andres; Castro, Andres M.; Aristizabal-Mayor, Juan D.] Fdn Valle Lili, Ctr Invest Clin, Carrera 98 18-49, Cali, Colombia		Mejia-Mantilla, JH (corresponding author), Fdn Valle Lili, Dept Intens Care Med, Carrera 98 18-49, Cali, Colombia.	jorge.mejia@fvl.org.co		Castro Llanos, Andres Mauricio/0000-0003-1821-4739; Orrego Gonzalez, Eduardo Esteban/0000-0002-8406-4153; Gempeler, Andres/0000-0001-9217-9500			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Butcher NE, 2014, J TRAUMA ACUTE CARE, V77, P620, DOI 10.1097/TA.0000000000000404; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Hanley DF, 2017, LANCET, V389, P603, DOI 10.1016/S0140-6736(16)32410-2; Ho CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190683; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lindner G, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.05.001; Peng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134821; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Tan SKR, 2016, CAN J ANESTH, V63, P664, DOI 10.1007/s12630-016-0633-y; van Lieshout JH, 2018, NEUROSURG REV, V41, P917, DOI 10.1007/s10143-017-0827-y	27	3	3	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2020	33	3					718	724		10.1007/s12028-020-00955-x		MAR 2020	7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0WI	WOS:000521716600001	32207035				2022-02-06	
J	Lehman, LL; Maletsky, K; Beaute, J; Rakesh, K; Kapur, K; Rivkin, MJ; Mrakotsky, C				Lehman, Laura L.; Maletsky, Kristin; Beaute, Jeanette; Rakesh, Kshitiz; Kapur, Kush; Rivkin, Michael J.; Mrakotsky, Christine			Prevalence of Symptoms of Anxiety, Depression, and Post-traumatic Stress Disorder in Parents and Children Following Pediatric Stroke	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric stroke; PTSD; anxiety; depression; perinatal stroke	MATERNAL POSTNATAL DEPRESSION; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; NEUROLOGICAL DISORDERS; NATIONAL INSTITUTE; ISCHEMIC-STROKE; OUTCOMES; EPIDEMIOLOGY; ADOLESCENTS; SURVIVORS	Post-traumatic stress disorder (PTSD), anxiety, and depression are seen in parents and children following critical illness. Whether this exists in parents and children following pediatric stroke has not been thoroughly studied. We examined emotional outcomes in 54 mothers, 27 fathers, and 17 children with stroke. Parents of children 0-18 years and children 7-18 years who were within 2 years of stroke occurrence were asked to complete questionnaires to determine their emotional outcomes. Of participating mothers, 28% reported PTSD, 26% depression, and 4% anxiety; in fathers, 15% reported PTSD, 24% depression, and none reported anxiety. Further, children reported significant emotional difficulty, with 24% having depression, 14% anxiety, and 6% PTSD by self-report ratings. Maternal PTSD, anxiety and depression, and paternal anxiety were all negatively associated with the child's functional outcome. Clinically significant anxiety (based on clinical thresholds) was not found in fathers; however, continuous scores were still analyzed for association between subclinical anxiety and functional outcome, which revealed a statistically significant association between more reported symptoms and higher Recovery and Recurrence Questionnaire scores. Prevalence of PTSD and depression are greater in parents compared to the general population in this preliminary study.	[Lehman, Laura L.; Maletsky, Kristin; Beaute, Jeanette; Rakesh, Kshitiz; Kapur, Kush; Rivkin, Michael J.; Mrakotsky, Christine] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Lehman, Laura L.; Rakesh, Kshitiz; Kapur, Kush; Rivkin, Michael J.; Mrakotsky, Christine] Harvard Med Sch, Boston, MA 02115 USA; [Rivkin, Michael J.; Mrakotsky, Christine] Boston Childrens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Rivkin, Michael J.] Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA		Lehman, LL (corresponding author), Boston Childrens Hosp, 300 Longwood Aveneue Fegan 11, Boston, MA 02115 USA.	Laura.Lehman@childrens.harvard.edu	Kapur, Kush/AAQ-3437-2020	Kapur, Kush/0000-0001-9022-913X			Avan B, 2010, ARCH DIS CHILD, V95, P690, DOI 10.1136/adc.2009.164848; Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44; Barakat LP, 1997, J PEDIATR PSYCHOL, V22, P843, DOI 10.1093/jpepsy/22.6.843; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Bemister TB, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0397-5; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Cook N, 2018, J AFFECT DISORDERS, V225, P18, DOI 10.1016/j.jad.2017.07.045; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Davydow DS, 2010, ARCH PEDIAT ADOL MED, V164, P377, DOI 10.1001/archpediatrics.2010.10; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Elbers J, 2014, J CHILD NEUROL, V29, P782, DOI 10.1177/0883073813484358; Elhai JD, 2013, J TRAUMA STRESS, V26, P10, DOI 10.1002/jts.21755; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Goldstein RB, 2016, SOC PSYCH PSYCH EPID, V51, P1137, DOI 10.1007/s00127-016-1208-5; Gordon AL, 2015, INT J STROKE, V10, P1068, DOI 10.1111/ijs.12489; Greene MM, 2018, EARLY HUM DEV, V116, P33, DOI 10.1016/j.earlhumdev.2017.10.008; Greenham M, 2015, DEV NEUROPSYCHOL, V40, P348, DOI 10.1080/87565641.2015.1095191; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Khandelwal S, 2016, J CLIN DIAGN RES, V10, pSC5, DOI 10.7860/JCDR/2016/21666.8549; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; King MLM, 2014, J PEDIATR PSYCHOL, V39, P283, DOI 10.1093/jpepsy/jst074; Lo WD, 2012, NEUROLOGY, V79, P864, DOI 10.1212/WNL.0b013e318266fc9a; Max JE, 2002, J AM ACAD CHILD PSY, V41, P555, DOI 10.1097/00004583-200205000-00013; Merikangas KR, 2011, J AM ACAD CHILD PSY, V50, P32, DOI 10.1016/j.jaac.2010.10.006; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; National Institute of Mental Health, DEF RDOC DOM CONSTR; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; Raju TNK, 2007, PEDIATRICS, V120, P609, DOI 10.1542/peds.2007-0336; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; Steer, 1990, MANUAL BECK ANXIETY; Steinberg AM, 2013, J TRAUMA STRESS, V26, P1, DOI 10.1002/jts.21780; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; van Oers HA, 2014, MATERN CHILD HLTH J, V18, P1993, DOI 10.1007/s10995-014-1445-8; Vernon L, 2017, PSYCHO-ONCOLOGY, V26, P361, DOI 10.1002/pon.4141; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	40	3	3	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2020	35	7					472	479	0883073820909617	10.1177/0883073820909617		MAR 2020	8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	LM6WM	WOS:000523885900001	32202201				2022-02-06	
J	Lyon, I; Fisher, P; Gracey, F				Lyon, Ionie; Fisher, Paul; Gracey, Fergus			"Putting a new perspective on life": a qualitative grounded theory of posttraumatic growth following acquired brain injury	DISABILITY AND REHABILITATION			English	Article						Acceptance; brain injuries; emotional adjustment; post-traumatic growth; qualitative research; shared experiences	SOCIAL IDENTITY; GROUP MEMBERSHIPS; REHABILITATION; PSYCHOLOGY; SELF	Purpose: An acquired brain injury (ABI) is often described as a devastating experience and yet positive changes as a result of this event have been described. This study sought to understand the process of developing posttraumatic growth (PTG) following ABI. Method: Semi-structured interviews were conducted with 10 adults with ABI, recruited from three sites of a community day service for people with ABI. Grounded theory was used to explore the development of positive changes experienced as a result of the injury. Results: PTG appeared to occur in a non-linear way as participants negotiated processes captured in the following themes: "living with a life changing injury," "trying to beat it and acceptance," "identifying with a new you and others," and "meaningful positive change." Intra- and inter-personal comparisons emerged as important in accepting changes and reconnecting with pre-injury identity. This seemed to underpin accessing social and practical opportunities giving rise to connection with strengths and growth. Conclusions: This study extends prior research into the process of adjustment and positive outcomes such as growth, although conclusions are limited to this specific sample and context. Further research and clinical practice development addressing acceptance and community engagement to develop positive change following ABI is required.	[Lyon, Ionie; Fisher, Paul; Gracey, Fergus] Univ East Anglia, Norwich Med Sch, Dept Clin Psychol, Norwich, Norfolk, England		Lyon, I (corresponding author), Little Plumstead Hosp, Norwich NR13 5EW, Norfolk, England.	ionie.lyon@nhs.net		Gracey, Fergus/0000-0002-1416-7894			Ben-Yishay Y, 2000, INT HDB NEUROPSYCHOL, P127, DOI DOI 10.1007/978-1-4757-5569-5_8; Braun V., 2013, SUCCESSFUL QUALITATI; Burr V., 2015, SOCIAL CONSTRUCTIONI; CALHOUN L., 2000, POSTTRAUMATIC STRESS, P135; Charmaz K., 2014, BROKERAGE CLOSURE IN; Conneeley AL., 2003, BRIT J OCCUP THER, V66, P440; Dey I., 2010, SAGE HDB GROUNDED TH, P167; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Fassinger RE, 2005, J COUNS PSYCHOL, V52, P156, DOI 10.1037/0022-0167.52.2.156; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Jones JM, 2012, BRIT J HEALTH PSYCH, V17, P798, DOI 10.1111/j.2044-8287.2012.02074.x; Levine SZ, 2009, J TRAUMA STRESS, V22, P282, DOI 10.1002/jts.20409; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; McGrath JC, 2011, BRAIN IMPAIR, V12, P82, DOI 10.1375/brim.12.2.82; McMillen JC, 2003, REHABIL PSYCHOL, V48, P77, DOI 10.1037/0090-5550.48.2.77; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Pals JL, 2004, PSYCHOL INQ, V15, P65; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Tedeschi R.G., 2015, POSITIVE PSYCHOL PRA, P503, DOI DOI 10.1002/9781118996874.CH30; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Triplett KN, 2012, PSYCHOL TRAUMA-US, V4, P400, DOI 10.1037/a0024204; TURNER JC, 1986, BRIT J SOC PSYCHOL, V25, P237, DOI 10.1111/j.2044-8309.1986.tb00732.x; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	35	3	3	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 23	2021	43	22					3225	3233		10.1080/09638288.2020.1741699		MAR 2020	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WP3GH	WOS:000523996500001	32208033	Green Accepted, Green Submitted			2022-02-06	
J	Sripad, P; Rosenberg, J; Boers, F; Filss, CP; Galldiks, N; Langen, KJ; Clauss, R; Shah, NJ; Dammers, J				Sripad, Praveen; Rosenberg, Jessica; Boers, Frank; Filss, Christian P.; Galldiks, Norbert; Langen, Karl-Josef; Clauss, Ralf; Shah, N. Jon; Dammers, Juergen			Effect of Zolpidem in the Aftermath of Traumatic Brain Injury: An MEG Study	CASE REPORTS IN NEUROLOGICAL MEDICINE			English	Article							FUNCTIONAL CONNECTIVITY; REBOUND INSOMNIA; VEGETATIVE STATE; EEG; ALPHA; MAGNETOENCEPHALOGRAPHY; OSCILLATIONS; DISORDERS; NETWORKS; DYNAMICS	In the past two decades, many studies have shown the paradoxical efficacy of zolpidem, a hypnotic used to induce sleep, in transiently alleviating various disorders of consciousness such as traumatic brain injury (TBI), dystonia, and Parkinson's disease. The mechanism of action of this effect of zolpidem is of great research interest. In this case study, we use magnetoencephalography (MEG) to investigate a fully conscious, ex-coma patient who suffered from neurological difficulties for a few years due to traumatic brain injury. For a few years after injury, the patient was under medication with zolpidem that drastically improved his symptoms. MEG recordings taken before and after zolpidem showed a reduction in power in the theta-alpha (4-12 Hz) and lower beta (15-20 Hz) frequency bands. An increase in power after zolpidem intake was found in the higher beta/lower gamma (20-43 Hz) frequency band. Source level functional connectivity measured using weighted-phase lag index showed changes after zolpidem intake. Stronger connectivity between left frontal and temporal brain regions was observed. We report that zolpidem induces a change in MEG resting power and functional connectivity in the patient. MEG is an informative and sensitive tool to detect changes in brain activity for TBI.	[Sripad, Praveen; Rosenberg, Jessica; Boers, Frank; Filss, Christian P.; Langen, Karl-Josef; Shah, N. Jon; Dammers, Juergen] Forschungszentrum Julich, Inst Neurosci & Med INM 4, Med Imaging Phys, D-52425 Julich, Germany; [Rosenberg, Jessica; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med INM 11, JARA, D-52425 Julich, Germany; [Rosenberg, Jessica; Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Filss, Christian P.; Langen, Karl-Josef] Rhein Westfal TH Aachen, Dept Nucl Med, Aachen, Germany; [Galldiks, Norbert] Forschungszentrum Julich, Inst Neurosci & Med INM 3, D-52425 Julich, Germany; [Galldiks, Norbert] Univ Cologne, Dept Neurol, Cologne, Germany; [Galldiks, Norbert; Langen, Karl-Josef] Univ Cologne, Ctr Integrated Oncol, Cologne, Germany; [Galldiks, Norbert; Langen, Karl-Josef] Univ Bonn, Cologne, Germany; [Clauss, Ralf] Royal Surrey Cty Hosp, Nucl Med Dept, Guildford GU2 7XX, Surrey, England; [Langen, Karl-Josef; Shah, N. Jon] JARA BRAIN Translat Med, Aachen, Germany		Sripad, P (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med INM 4, Med Imaging Phys, D-52425 Julich, Germany.	p.sripad@fz-juelich.de	Galldiks, Norbert/AAG-6896-2019; Dammers, Jurgen/I-1485-2013; Rosenberg, Jessica/P-1868-2016; Sripad, Praveen/ABI-7663-2020; Shah, N. Jon/H-5849-2013	Galldiks, Norbert/0000-0002-2485-1796; Dammers, Jurgen/0000-0003-1526-6592; Rosenberg, Jessica/0000-0003-2688-9410; Sripad, Praveen/0000-0001-6361-2571; Shah, N. Jon/0000-0002-8151-6169			Baillet S, 2017, NAT NEUROSCI, V20, P327, DOI 10.1038/nn.4504; Bomalaski MN, 2017, JAMA NEUROL, V74, P1130, DOI 10.1001/jamaneurol.2017.1133; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Calabro RS, 2015, PSYCHIAT CLIN NEUROS, V69, P122, DOI 10.1111/pcn.12215; Clauss R., 2013, CURRENT PHARM DESIGN, V999, P9, DOI [10.2174/13816128113196660656, DOI 10.2174/13816128113196660656]; Clauss RP, 2004, ARZNEIMITTELFORSCH, V54, P641; Clauss RP, 2000, S AFR MED J, V90, P68; Cohen L, 2004, NEW ENGL J MED, V350, P949, DOI 10.1056/NEJM200402263500922; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Daniele A, 1997, LANCET, V349, P1222, DOI 10.1016/S0140-6736(05)62416-6; de Haas SL, 2010, J PSYCHOPHARMACOL, V24, P1619, DOI 10.1177/0269881109106898; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; Ge S., 2011, WORLD ACAD SCI ENG T, V80, P517; Gillebert CR, 2013, NEUROSCIENTIST, V19, P509, DOI 10.1177/1073858412463168; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Hall SD, 2010, CLIN NEUROPHYSIOL, V121, P549, DOI 10.1016/j.clinph.2009.11.084; Khan S, 2013, P NATL ACAD SCI USA, V110, P3107, DOI 10.1073/pnas.1214533110; LANGTRY HD, 1990, DRUGS, V40, P291, DOI 10.2165/00003495-199040020-00008; Lewine J. D., 1999, AM J AM J NEURORADIO, V20; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Licata SC, 2013, NEUROIMAGE, V70, P211, DOI 10.1016/j.neuroimage.2012.12.055; LLOYD KG, 1988, PHARMACOL BIOCHEM BE, V29, P781, DOI 10.1016/0091-3057(88)90206-7; Machado C, 2014, CURR PHARM DESIGN, V20, P4185; MAHONEY F I, 1965, Md State Med J, V14, P61; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Nasrallah FA, 2017, NEUROIMAGE, V149, P53, DOI 10.1016/j.neuroimage.2017.01.040; Machado VRN, 2012, MEDICC REV, V14, P14, DOI 10.37757/MR2012V14.N4.5; Nutt D, 2015, NEUROPHARMACOLOGY, V88, P155, DOI 10.1016/j.neuropharm.2014.08.017; Nyakale NE, 2012, SAMJ S AFR MED J, V102, P790, DOI [10.7196/samj.5993, 10.7196/SAMJ.5993]; Pang JC, 2018, NEUROIMAGE, V181, P461, DOI 10.1016/j.neuroimage.2018.07.031; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prokic EJ, 2015, NEUROPHARMACOLOGY, V95, P192, DOI 10.1016/j.neuropharm.2015.03.006; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Roehrs TA, 2012, J PSYCHOPHARMACOL, V26, P1088, DOI 10.1177/0269881111424455; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Soldatos CR, 1999, INT CLIN PSYCHOPHARM, V14, P287; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Ware JC, 1997, CLIN NEUROPHARMACOL, V20, P116, DOI 10.1097/00002826-199704000-00002; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157	46	3	3	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-6668	2090-6676		CASE REP NEUROL MED	Case Rep. Neurol. Med.	MAR 20	2020	2020								8597062	10.1155/2020/8597062			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	KZ0FZ	WOS:000522949400001	32257474	Green Published, gold			2022-02-06	
J	Provance, AJ; Howell, DR; Potter, MN; Wilson, PE; D'Lauro, AM; Wilson, JC				Provance, Aaron J.; Howell, David R.; Potter, Morgan N.; Wilson, Pamela E.; D'Lauro, Allison M.; Wilson, Julie C.			Presence of Neck or Shoulder Pain Following Sport-Related Concussion Negatively Influences Recovery	JOURNAL OF CHILD NEUROLOGY			English	Article						pain; cervical spine; mild traumatic brain injury; youth; sports	CERVICAL-SPINE; SYMPTOMS; SCHOOL; DISTURBANCES; CHILDREN; INJURY; SLEEP; BRAIN; RISK	Our objective was to examine the effect of current neck or shoulder pain on concussion outcomes. Variables included symptom resolution and return-to-sport time, symptom severity, amount of school missed, and sleep disturbances. Three hundred twelve patients (37% female; median age = 15.0 years; evaluated median = 9 days postinjury) reported experiencing current neck or shoulder pain at initial evaluation, and 268 did not (31% female; median age = 14.7 years; evaluated median = 8 days postinjury). Neck or shoulder pain was associated with longer symptom resolution time (beta = 6.38, 95% confidence interval [CI] = 2.44, 10.31; P = .002), more severe symptoms (beta = 7.06, 95% CI = 4.91, 9.21; P < .001), and greater odds of missing >5 days of school (adjusted odds ratio [aOR] = 1.89, 95% CI = 1.23, 2.93; P = .004), and postinjury sleep problems (aOR = 2.20, 95% CI = 1.51, 3.21; P < .001). Experiencing neck or shoulder pain during the initial postinjury clinical evaluation was associated with worsened clinical outcomes. Clinicians may consider referral to early rehabilitation following concussion among those who report neck or shoulder pain.	[Provance, Aaron J.; Howell, David R.; Wilson, Julie C.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Provance, Aaron J.; Howell, David R.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Potter, Morgan N.] Univ Delaware, Sch Phys Therapy, Newark, DE USA; [Wilson, Pamela E.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO 80045 USA; [D'Lauro, Allison M.] Childrens Hosp Colorado, Dept Phys Therapy, Aurora, CO USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Univ Colorado, Childrens Hosp Colorado, ATC Sports Med Ctr, Dept Orthoped,Sch Med, 13123 E 16th Ave,B060 Aurora, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu		Howell, David/0000-0002-2955-0191	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03HD094560, R01NS100952, R43NS108823]; MINDSOURCE Brain Injury Network	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Unrelated to this work, DRH has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560), the National Institute of Neurological Disorders and Stroke (R01NS100952, R03HD094560, and R43NS108823), and MINDSOURCE Brain Injury Network. The remaining authors have no conflicts to disclose.	Andreucci A, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx093; Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Childs JD, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0303; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Finning K, 2019, J AFFECT DISORDERS, V245, P928, DOI 10.1016/j.jad.2018.11.055; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Herdman SJ, 2014, VESTIBULAR REHABILIT; Kennedy Ewan, 2019, J Orthop Sports Phys Ther, V49, P845, DOI 10.2519/jospt.2019.8547; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Legault EP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0681-4; Li DE, 2019, MUSCULOSKEL SCI PRAC, V42, P6, DOI 10.1016/j.msksp.2019.04.001; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mikkelsson M, 1997, PAIN, V73, P29, DOI 10.1016/S0304-3959(97)00073-0; Niemi SM, 1997, J ADOLESCENT HEALTH, V20, P238, DOI 10.1016/S1054-139X(96)00219-4; Schlesinger I, 2001, HEADACHE, V41, P586, DOI 10.1046/j.1526-4610.2001.041006586.x; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Shan Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078109; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Tiwari D, 2019, INT J SPORTS PHYS TH, V14, P282, DOI 10.26603/ijspt20190282; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Welton KL, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117745788	32	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2020	35	7					456	462	0883073820909046	10.1177/0883073820909046		MAR 2020	7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	LM6WM	WOS:000523939200001	32192408				2022-02-06	
J	Hurtubise, JM; Gorbet, DJ; Hynes, LM; Macpherson, AK; Sergio, LE				Hurtubise, Johanna M.; Gorbet, Diana J.; Hynes, Loriann M.; Macpherson, Alison K.; Sergio, Lauren E.			White Matter Integrity and Its Relationship to Cognitive-Motor Integration in Females with and without Post-Concussion Syndrome	JOURNAL OF NEUROTRAUMA			English	Article						cognitive-motor integration; post-concussion syndrome; white-matter integrity	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; DIFFUSION TENSOR; SEX-DIFFERENCES; SPATIAL STATISTICS; PREMOTOR CORTEX; SYMPTOMS; CONNECTIVITY; STATEMENT; DIAGNOSIS	Fifteen percent of individuals who sustain a concussion go on to develop post-concussion syndrome (PCS). These persistent symptoms are believed to be attributed to damage to white matter tracts and impaired neurotransmission. Specifically, declines in white matter integrity after concussion have been found along the long-coursing axons underlying the frontoparietal network. This network is essential for the performance of visuomotor transformation tasks requiring cognitive-motor integration (CMI). We have previously observed deficits in performance on CMI-based tasks in those who have a history of concussion, but were asymptomatic. The aim of this study was to investigate performance on a CMI task, as well as white matter integrity differences along frontoparietal-cerebellar white matter tracts, in those with PCS compared to healthy controls. We hypothesized an association between the behavioral and brain structural measures. Twenty-six female participants (13 with PCS for >= 6 months and 13 healthy controls) completed four computer-based visuomotor CMI tasks. In addition, diffusion tensor images (DTIs) were acquired. No statistically significant differences were found in CMI performance between groups (p > 0.05). Further, there were no statistically significant differences between groups on any DTI metrics (p > 0.05). However, examination of the data collapsed across participants revealed significant associations between performance on a CMI task and white matter integrity. Further investigation into additional causes of symptoms in those with PCS (including psychological and cervicogenic factors) will strengthen our understanding of this diverse group. Nonetheless, this study demonstrates that white matter integrity is related to levels of performance in tasks that require rule-based movement control.	[Hurtubise, Johanna M.] Camosun Coll, Ctr Sport & Exercise Educ, Victoria, BC, Canada; [Gorbet, Diana J.; Hynes, Loriann M.; Macpherson, Alison K.; Sergio, Lauren E.] York Univ, Sherman Hlth Sci Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Gorbet, Diana J.; Sergio, Lauren E.] York Univ, Ctr Vis Res, Sherman Hlth Sci Res Ctr, Toronto, ON, Canada		Sergio, LE (corresponding author), York Univ, Norman Bethune Coll, Sch Kinesiol & Hlth Sci, 4700 Keele St,Room 341, Toronto, ON M3J 1P3, Canada.	lsergio@yorku.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-125915]; Donald Sanderson Memorial Trust Fund	This research was supported by a Canadian Institutes for Health Research operating grant to LS (MOP-125915) and the Donald Sanderson Memorial Trust Fund (LS, AM, LH).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chong CD, 2018, HEADACHE, V58, P827, DOI 10.1111/head.13269; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; Della-Maggiore V, 2005, J NEUROPHYSIOL, V93, P2254, DOI 10.1152/jn.00984.2004; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Giza CC, 2015, NEUROSURGERY, V75, pS24, DOI DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gorbet DJ, 2016, BEHAV BRAIN RES, V298, P229, DOI 10.1016/j.bbr.2015.11.012; Gorbet DJ, 2007, EUR J NEUROSCI, V25, P1228, DOI 10.1111/j.1460-9568.2007.05358.x; Gorbet DJ, 2019, EXP BRAIN RES, V237, P57, DOI 10.1007/s00221-018-5395-z; Gorbet DJ, 2011, EXP BRAIN RES, V212, P315, DOI 10.1007/s00221-011-2731-y; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Granek JA, 2015, J NEUROPHYSIOL, V114, P1298, DOI 10.1152/jn.00233.2014; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hawkins KM, 2015, J ALZHEIMERS DIS, V44, P867, DOI 10.3233/JAD-142079; Hawkins KM, 2014, J ALZHEIMERS DIS, V42, P607, DOI 10.3233/JAD-140051; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H., 2014, DIFFUSION MRI QUANTI; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Mori S, 2005, MRI ATLAS HUMAN WHIT; Murray E.A., 2000, EXECUTIVE CONTROL FR, P114; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Rabinowicz T, 1999, J CHILD NEUROL, V14, P98, DOI 10.1177/088307389901400207; Rizzolatti G., 2000, PRINCIPLES NEURAL SC, P865; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; Sergio LE, 2009, CORTICAL MECHANISMS OF VISION, P81; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin YW, 2005, NEUROREPORT, V16, P795, DOI 10.1097/00001756-200505310-00003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song MK, 2013, NURS RES, V62, P45, DOI 10.1097/NNR.0b013e3182741948; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; van Baarsen KM, 2016, NEUROIMAGE, V124, P724, DOI 10.1016/j.neuroimage.2015.09.014; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD 10 CLASSIFICATIO	76	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1528	1536		10.1089/neu.2019.6765		MAR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000525042000001	31928154				2022-02-06	
J	Conway, J; Ilardi, M; Gonzalez, C; Dahan, N; Fallon, S; Moehringer, N; Hasanaj, L; Joseph, B; Serrano, L; Rizzo, JR; Rucker, JC; Feigin, A; Frucht, S; Galetta, SL; Balcer, LJ				Conway, Jenna; Ilardi, Marissa; Gonzalez, Caroline; Dahan, Natalie; Fallon, Samuel; Moehringer, Nicholas; Hasanaj, Lisena; Joseph, Binu; Serrano, Liliana; Rizzo, John-Ross; Rucker, Janet C.; Feigin, Andrew; Frucht, Steven; Galetta, Steven L.; Balcer, Laura J.			Rapid picture naming in Parkinson's disease using the Mobile Universal Lexicon Evaluation System (MULES)	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Parkinson's disease (PD); Picture naming; Mobile Universal Lexicon Evaluation System (MULES); Vision		Objective: The Mobile Universal Lexicon Evaluation System (MULES) is a test of rapid picture naming that captures extensive brain networks, including cognitive, language and afferent/efferent visual pathways. MULES performance is slower in concussion and multiple sclerosis, conditions in which vision dysfunction is common. Visual aspects captured by the MULES may be impaired in Parkinson's disease (PD) including color discrimination, object recognition, visual processing speed, and convergence. The purpose of this study was to compare MULES time scores for a cohort of PD patients with those for a control group of participants of similar age. We also sought to examine learning effects for the MULES by comparing scores for two consecutive trials within the patient and control groups. Methods: MULES consists of 54 colored pictures (fruits, animals, random objects). The test was administered in a cohort of PD patients and in a group of similar aged controls. Wilcoxon rank-sum tests were used to determine statistical significance for differences in MULES time scores between PD patients and controls. Spearman rank-correlation coefficients were calculated to examine the relation between MULES time scores and PD motor symptom severity (UPDRS). Learning effects were assessed using Wilcoxon rank-sum tests. Results: Among 51 patients with PD (median age 70 years, range 52-82) and 20 disease-free control participants (median age 67 years, range 51-90), MULES scores were significantly slower (worse performance) in PD patients (median 63.2 s, range 37.3-296.3) vs. controls (median 53.9 s, range 37.5-128.6, P = .03, Wilcoxon rank-sum test). Slower MULES times were associated with increased motor symptom severity as measured by the Unified Parkinson's Disease Rating Scale, Section III (r(s) = 0.37, P = .02). Learning effects were greater among patients with PD (median improvement of 14.8 s between two MULES trials) compared to controls (median 7.4 s, P = .004). Conclusion: The MULES is a complex test of rapid picture naming that captures numerous brain pathways including an extensive visual network. MULES performance is slower in patients with PD and our study suggests an association with the degree of motor impairment. Future studies will determine the relation of MULES time scores to other modalities that test visual function and structure in PD.	[Conway, Jenna; Ilardi, Marissa; Gonzalez, Caroline; Dahan, Natalie; Fallon, Samuel; Moehringer, Nicholas; Hasanaj, Lisena; Joseph, Binu; Serrano, Liliana; Rucker, Janet C.; Feigin, Andrew; Frucht, Steven; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Neurol, 222 E 41st St,14th Floor, New York, NY 10017 USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Rizzo, John-Ross] NYU, Sch Med, Dept Phys Med, New York, NY USA; [Rizzo, John-Ross] NYU, Sch Med, Dept Rehabil, New York, NY USA		Balcer, LJ (corresponding author), NYU, Sch Med, Dept Neurol, 222 E 41st St,14th Floor, New York, NY 10017 USA.	jenna.conway@nyulangone.org; marissa.ilardi@nyulangone.org; Caroline.E.Gonzalez.19@dartmouth.edu; natalie.dahan.288@my.csun.edu; sfallon@tulane.edu; njm84@cornell.edu; lisena.hasanj@nyulangone.org; binu.joseph@nyulangone.org; liliana.serrano@nyulangone.org; johnross.rizzo@nyulangone.org; janet.rucker@nyulangone.org; andrew.feigin@nyulangone.org; steven.frucht@nyulangone.org; steven.galetta@nyulangone.org; laura.balcer@nyulangone.org		Rizzo, John-Ross/0000-0002-4084-0085; Rucker, Janet/0000-0002-0397-0999; Dahan, Natalie/0000-0002-3834-2693; Frucht, Steven/0000-0002-4653-0491	NYU School of Medicine; NYU Sadder Institute Summer Undergraduate Research Program (SURP)	This study was supported in part by the NYU School of Medicine and the NYU Sadder Institute Summer Undergraduate Research Program (SURP).	Akhand O, 2018, J NEUROL SCI, V387, P199, DOI 10.1016/j.jns.2018.02.031; Armstrong RA, 2017, INT REV NEUROBIOL, V134, P921, DOI [10.1016/bs.im.2017.04.007, 10.1016/bs.irn.2017.04.007]; Bannert MM, 2018, J NEUROSCI, V38, P3657, DOI 10.1523/JNEUROSCI.2307-17.2018; Biundo R, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.18; Brouwer GJ, 2013, J NEUROSCI, V33, P15454, DOI 10.1523/JNEUROSCI.2472-13.2013; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; Conway BR, 2006, CEREB CORTEX, V16, P1604, DOI 10.1093/cercor/bhj099; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Nowacka B, 2014, MED SCI MONITOR, V20, P2243, DOI 10.12659/MSM.890861; Seay M, 2018, J NEUROL SCI, V394, P1, DOI 10.1016/j.jns.2018.08.019; Terao Y, 2011, NEUROPSYCHOLOGIA, V49, P1794, DOI 10.1016/j.neuropsychologia.2011.03.002	12	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2020	410								116680	10.1016/j.jns.2020.116680			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU4GF	WOS:000519667300020	31945624				2022-02-06	
J	Honig, MG; Dorian, CC; Worthen, JD; Micetich, AC; Mulder, IA; Sanchez, KB; Pierce, WF; Del Mar, NA; Reiner, A				Honig, Marcia G.; Dorian, Conor C.; Worthen, John D.; Micetich, Anthony C.; Mulder, Isabelle A.; Sanchez, Katelyn B.; Pierce, William F.; Del Mar, Nobel A.; Reiner, Anton			Progressive long-term spatial memory loss following repeat concussive and subconcussive brain injury in mice, associated with dorsal hippocampal neuron loss, microglial phenotype shift, and vascular abnormalities	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						hippocampus; memory; microglia; neurodegeneration; repeat TBI	CHRONIC TRAUMATIC ENCEPHALOPATHY; POSTTRAUMATIC-STRESS-DISORDER; CEREBRAL-BLOOD-FLOW; MOUSE MODEL; AXONAL INJURY; WHITE-MATTER; WORKING-MEMORY; TAU PATHOLOGY; HEAD-INJURY; MICROVASCULAR INJURY	There is considerable concern about the long-term deleterious effects of repeat head trauma on cognition, but little is known about underlying mechanisms and pathology. To examine this, we delivered four air blasts to the left side of the mouse cranium, a week apart, with an intensity that causes deficits when delivered singly and considered "concussive," or an intensity that does not yield significant deficits when delivered singly and considered "subconcussive." Neither repeat concussive nor subconcussive blast produced spatial memory deficits at 4 months, but both yielded deficits at 14 months, and dorsal hippocampal neuron loss. Hierarchical cluster analysis of dorsal hippocampal microglia across the three groups based on morphology and expression of MHCII, CX3CR1, CD68 and IBA1 revealed five distinct phenotypes. Types 1A and 1B microglia were more common in sham mice, linked to better neuron survival and memory, and appeared mildly activated. By contrast, 2B and 2C microglia were more common in repeat concussive and subconcussive mice, linked to poorer neuron survival and memory, and characterized by low expression levels and attenuated processes, suggesting they were de-activated and dysfunctional. In addition, endothelial cells in repeat concussive mice exhibited reduced CD31 and eNOS expression, which was correlated with the prevalence of type 2B and 2C microglia. Our findings suggest that both repeat concussive and subconcussive head injury engender progressive pathogenic processes, possibly through sustained effects on microglia that over time lead to increased prevalence of dysfunctional microglia, adversely affecting neurons and blood vessels, and thereby driving neurodegeneration and memory decline.	[Honig, Marcia G.; Dorian, Conor C.; Worthen, John D.; Micetich, Anthony C.; Mulder, Isabelle A.; Sanchez, Katelyn B.; Pierce, William F.; Del Mar, Nobel A.; Reiner, Anton] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, 855 Monroe Ave, Memphis, TN 38163 USA; [Reiner, Anton] Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, Memphis, TN 38163 USA		Reiner, A (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, 855 Monroe Ave, Memphis, TN 38163 USA.	areiner@uthsc.edu	Reiner, Anton/AAG-8860-2020	Reiner, Anton/0000-0002-2146-5232	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS081370]; University of Tennessee Neuroscience Institute; University of Tennessee Health Science Center	National Institute of Neurological Disorders and Stroke, Grant/Award Number: NS081370; The University of Tennessee Neuroscience Institute; The University of Tennessee Health Science Center	Agoston DV, 2017, J NEUROTRAUM, V34, pS44, DOI 10.1089/neu.2017.5317; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bachstetter AD, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113180; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chadehumbe MA, 2016, CURR PROB PEDIATR AD, V46, P52, DOI 10.1016/j.cppeds.2015.11.004; Chandra N., 2015, BRAIN NEUROTRAUMA MO, P199; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chen K, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01417; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00119; Cheng H, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104683; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; De Lucia C, 2016, BRAIN BEHAV IMMUN, V55, P179, DOI 10.1016/j.bbi.2015.11.001; Deczkowska A, 2018, NAT NEUROSCI, V21, P779, DOI 10.1038/s41593-018-0145-x; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dubbelaar ML, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01753; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elmore MRP, 2018, AGING CELL, V17, DOI 10.1111/acel.12832; Esopenko C, 2017, CORTEX, V89, P1, DOI 10.1016/j.cortex.2017.01.007; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Frank MG, 2019, SEMIN CELL DEV BIOL, V94, P176, DOI 10.1016/j.semcdb.2019.01.001; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gangolli M, 2019, J NEUROTRAUM, V36, P735, DOI 10.1089/neu.2018.5700; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Go M, 2016, BIOCHEM BIOPH RES CO, V479, P331, DOI 10.1016/j.bbrc.2016.09.073; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Hefendehl JK, 2014, AGING CELL, V13, P60, DOI 10.1111/acel.12149; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Honig MG, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113063; Hoogenboom WS, 2019, PHARMACOL THERAPEUT, V198, P109, DOI 10.1016/j.pharmthera.2019.02.016; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khan AM, 2015, NEUROBIOL AGING, V36, P2164, DOI 10.1016/j.neurobiolaging.2015.03.008; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kunimoto S, 2010, EXP NEUROL, V221, P175, DOI 10.1016/j.expneurol.2009.10.020; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Liu VWT, 2008, CARDIOVASC RES, V77, P19, DOI 10.1016/j.cardiores.2007.06.024; Liu Y, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0387-16.2017; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; McAteer Kelly M, 2017, Concussion, V2, pCNC32, DOI 10.2217/cnc-2016-0031; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mohler E. G., 2007, PSYCHOPHARMACOLOGY B, V220, P687; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Niraula A, 2017, NEUROPSYCHOPHARMACOL, V42, P318, DOI 10.1038/npp.2016.185; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00057; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Park S, 2015, CLIN SCI, V129, P217, DOI 10.1042/CS20140714; Paterno R, 2018, J NEUROTRAUM, V35, P2117, DOI 10.1089/neu.2017.5170; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pluvinage JV, 2019, NATURE, V568, P187, DOI 10.1038/s41586-019-1088-4; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rodriguez-Grande B, 2017, AAPS J, V19, P1615, DOI 10.1208/s12248-017-0123-3; Roy S, 2010, CURR EYE RES, V35, P1045, DOI 10.3109/02713683.2010.514659; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Spittau B, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00194; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y; Stojiljkovic MR, 2019, NEUROBIOL AGING, V74, P56, DOI 10.1016/j.neurobiolaging.2018.10.007; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tan XL, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0020-0; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Thomsen MS, 2017, J CEREBR BLOOD F MET, V37, P3300, DOI 10.1177/0271678X17722436; Tischer J, 2016, GLIA, V64, P1562, DOI 10.1002/glia.23024; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; van Buuren S, 2011, J STAT SOFTW, V45, P1; Verdonk F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0614-7; Walker FR, 2014, BRAIN BEHAV IMMUN, V37, P1, DOI 10.1016/j.bbi.2013.12.010; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Weiner MW, 2014, ALZHEIMERS DEMENT, V10, pS226, DOI 10.1016/j.jalz.2014.04.005; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yamada J, 2013, J COMP NEUROL, V521, P1184, DOI 10.1002/cne.23228; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	179	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	SEP	2021	54	5			SI		5844	5879		10.1111/ejn.14711		MAR 2020	36	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UK5MX	WOS:000563101200001	32090401	Green Published, Green Accepted, hybrid			2022-02-06	
J	Rana, P; Rao, KRV; Ravula, A; Trivedi, R; D'Souza, M; Singh, AK; Gupta, RK; Chandra, N				Rana, Poonam; Rao, Kakulavarapu V.; Ravula, Arunreddy; Trivedi, Richa; D'Souza, Maria; Singh, Ajay K.; Gupta, Raj K.; Chandra, Namas			Oxidative stress contributes to cerebral metabolomic profile changes in animal model of blast-induced traumatic brain injury	METABOLOMICS			English	Article						Apocynin; Amino acid metabolism; Blast-induced neurotrauma; Energy metabolism; Oxidative stress	OXIDASE INHIBITOR APOCYNIN; SPATIAL-LEARNING DEFICITS; ENERGY-METABOLISM; BETA-HYDROXYBUTYRATE; PHOSPHATIDYLETHANOLAMINE; GLUTAMATE; ISCHEMIA; HYPOXIA; MITOCHONDRIAL; HIPPOCAMPUS	Introduction Blast-induced neurotrauma (BINT) has been recognized as the common mode of traumatic brain injury amongst military and civilian personnel due to an increased insurgent activity domestically and abroad. Previous studies from this laboratory have identified three major pathological events following BINT which include blood brain barrier disruption the earliest event, followed by oxidative stress and neuroinflammation as secondary events occurring a few hours following blast. Objectives Our recent studies have also identified an increase in oxidative stress mediated by the activation of superoxide producing enzyme NADPH oxidase (NOX) in different brain regions at varying levels with neurons displaying higher oxidative stress (NOX activation) compared to any other neural cell. Since neurons have higher energy demands in brain and are more prone to oxidative damage, this study evaluated the effect of oxidative stress on blast-blast induced changes in metabolomics profiles in different brain regions. Methods Animals were exposed to mild/moderate blast injury (180 kPa) and examined the metabolites of energy metabolism, amino acid metabolism as well as the profiles of plasma membrane metabolites in different brain regions at different time points (24 h, 3 day and 7 day) after blast using H-1 NMR spectroscopy. Effect of apocynin, an inhibitor of superoxide producing enzyme NADPH oxidase on cerebral metabalomics profiles was also examined. Results Several metabolomic profile changes were observed in frontal cortex and hippocampus with concomitant decrease in energy metabolism. In addition, glutamate/glutamine and other amino acid metabolism as well as metabolites involved in plasma membrane integrity were also altered. Hippocampus appears metabolically more vulnerable than the frontal cortex. A post-treatment of animals with apocynin, an inhibitor of NOX activation significantly prevented the changes in metabolite profiles. Conclusion Together these studies indicate that blast injury reduces both cerebral energy and neurotransmitter amino acid metabolism and that oxidative stress contributes to these processes. Thus, strategies aimed at reducing oxidative stress can have a therapeutic benefit in mitigating metabolic changes following BINT.	[Rana, Poonam; Trivedi, Richa; Singh, Ajay K.] Inst Nucl Med & Allied Sci, Div Behav Neurosci, Metabol Res Facil, Delhi, India; [D'Souza, Maria] Inst Nucl Med & Allied Sci, Dept NMR, Delhi, India; [Gupta, Raj K.; Chandra, Namas] US Army MRMC, US Dept Def Blast Injury Res Program Coordinating, 504 Scott St, Ft Detrick, MD 21702 USA; [Rao, Kakulavarapu V.; Ravula, Arunreddy; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Dept Biomed Engn, Newark, NJ 07102 USA		Gupta, RK; Chandra, N (corresponding author), US Army MRMC, US Dept Def Blast Injury Res Program Coordinating, 504 Scott St, Ft Detrick, MD 21702 USA.; Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Dept Biomed Engn, Newark, NJ 07102 USA.	raj.k.gupta.civ@mail.mil; nama.chandra@njit.edu			Army Medical Research and Materiel Command project Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tube [14059001]; DRDODefence Research & Development Organisation (DRDO) [US-IN-A-16-0002]; DoDUnited States Department of Defense [US-IN-A-16-0002]	This work was supported by Army Medical Research and Materiel Command project Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tube, Grant Number: 14059001 (PI: Namas Chandra) and Indo-U.S Joint DRDO and DoD project (US-IN-A-16-0002 on Experimental and Computational studies in Blunt and Blast induced Traumatic Injuries. PI: Raj Gupta).	Achanta LB, 2017, NEUROCHEM RES, V42, P35, DOI 10.1007/s11064-016-2099-2; Amaral AI, 2010, J NEUROCHEM, V113, P735, DOI 10.1111/j.1471-4159.2010.06636.x; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Cheema AK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113427; Cheema AK, 2018, RADIAT RES, V190, P449, DOI 10.1667/RR15008.1; Choi DH, 2014, ANTIOXID REDOX SIGN, V21, P533, DOI 10.1089/ars.2012.5129; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dang DK, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0478-x; Dawaliby R, 2016, J BIOL CHEM, V291, P3658, DOI 10.1074/jbc.M115.706523; de Lanerolle NC, 2015, SEMIN NEUROL, V35, P12, DOI 10.1055/s-0035-1544240; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Flores RE, 2018, BBA-BIOENERGETICS, V1859, P975, DOI 10.1016/j.bbabio.2018.03.012; Gonzalez-Riano C, 2016, J PHARMACEUT BIOMED, V130, P141, DOI 10.1016/j.jpba.2016.07.008; HINKOVSKAGALCHEVA V, 1988, INT J BIOCHEM, V20, P867, DOI 10.1016/0020-711X(88)90076-6; HIRATA F, 1978, NATURE, V275, P219, DOI 10.1038/275219a0; Hoyer S, 1993, J Geriatr Psychiatry Neurol, V6, P3; Kacso G, 2016, BIOCHEM J, V473, P3463, DOI 10.1042/BCJ20160594; Kapoor M, 2018, BIOMED PHARMACOTHER, V97, P458, DOI 10.1016/j.biopha.2017.10.123; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Li H, 2011, NEUROPHARMACOLOGY, V60, P252, DOI 10.1016/j.neuropharm.2010.09.005; Li QL, 2015, J BIOL CHEM, V290, P8121, DOI 10.1074/jbc.M114.631549; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu X, 2013, J HUAZHONG U SCI-MED, V33, P178, DOI 10.1007/s11596-013-1093-z; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Moore Brenna, 2015, J AM ACAD RELIG, V4, P1; PENNY J E, 1974, Proceedings of the Australian Association of Neurologists, V11, P177; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Rodriguez-Rodriguez P, 2013, NEUROCHEM INT, V62, P750, DOI 10.1016/j.neuint.2013.02.005; Schmidt-Kastner R, 2015, NEUROSCIENCE, V309, P259, DOI 10.1016/j.neuroscience.2015.08.034; Skotak M, 2016, PRIMARY BLAST INJURY, P1; SOKOLOFF L, 1992, CAN J PHYSIOL PHARM, V70, pS107, DOI 10.1139/y92-251; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stewart JD, 2011, ARCH TOXICOL, V85, P3, DOI 10.1007/s00204-010-0635-4; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; TURSKI L, 1993, EXPERIENTIA, V49, P1064, DOI 10.1007/BF01929915; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wallner S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205706; Wolahan SM, 2017, NEUROCRIT CARE, V26, P239, DOI 10.1007/s12028-016-0313-3; Zhang GL, 2013, REPROD TOXICOL, V36, P60, DOI 10.1016/j.reprotox.2012.12.002	50	3	3	2	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1573-3882	1573-3890		METABOLOMICS	Metabolomics	MAR 12	2020	16	3							39	10.1007/s11306-020-1649-4			12	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	KT9PU	WOS:000519346300001	32166461				2022-02-06	
J	Rebchuk, AD; Brown, HJ; Koehle, MS; Blouin, JS; Siegmund, GP				Rebchuk, Alexander D.; Brown, Harrison J.; Koehle, Michael S.; Blouin, Jean-Sebastien; Siegmund, Gunter P.			Using Variance to Explore the Diagnostic Utility of Baseline Concussion Testing	JOURNAL OF NEUROTRAUMA			English	Article						athletic injuries; concussion; football (American); sports medicine	SPORTS-RELATED CONCUSSION; FOOTBALL PLAYERS; HIGH-SCHOOL; NORMATIVE DATA; TEST-PERFORMANCE; KING-DEVICK; COLLEGIATE; RELIABILITY; STATEMENT; IMPACTS	The Graded Symptom Checklist (GSC), Standardized Assessment of Concussion (SAC), Balance Error Scoring System (BESS), and King-Devick Test (KDT) are considered important components of concussion assessment. Whether baseline testing improves the diagnostic utility of these tests remains unclear. We performed an observational cohort study to investigate the within-subject and between-subjects variability of these tests over repeated assessments during two football seasons to examine whether baseline testing reduces variability in test performance. Thirty-five male collegiate football players completed weekly clinical concussion assessments over two seasons. Within-subject (week-to-week) and between-subjects (player-to-player) variability for each test were compared using a bootstrap analysis. Within-subject and between-subjects proportions of overall variance for each test score were calculated. Mixed-model analyses were used to quantify practice effects resulting from repeated testing. For the GSC and BESS, within-subject and between-subjects variability did not significantly differ. For the KDT, the proportion of within-subject variance (20.2%) was significantly less than the between-subjects variance (79.8%). For SAC, however, the proportion of within-subject variance (66.8%) was significantly greater than the between-subjects variance (33.8%). A small, but significant, practice effect was observed for the BESS and KDT tests. When athletes are evaluated during a football season for concussion using the GSC, SAC, and BESS, comparing their scores to baseline performance is likely no more beneficial than comparing them to normative population data for identifying neurological changes associated with concussion. For the KDT, comparison to baseline testing is likely beneficial because of significantly higher between-subjects variability.	[Rebchuk, Alexander D.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Rebchuk, Alexander D.; Brown, Harrison J.; Koehle, Michael S.; Blouin, Jean-Sebastien; Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Koehle, Michael S.] Univ British Columbia, Div Sport & Exercise Med, Vancouver, BC, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC, Canada; [Siegmund, Gunter P.] MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada		Siegmund, GP (corresponding author), MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada.	gunter.siegmund@meaforensic.com	Koehle, Michael S/C-7850-2013; Rebchuk, Alexander/AAZ-3339-2020; Siegmund, Gunter P/B-7003-2013	Koehle, Michael S/0000-0001-7026-8422; Rebchuk, Alexander/0000-0001-5553-346X; 	BC Chiropractic Association; UBC School of Kinesiology; UBC Four Year Doctoral Fellowship; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was funded by the BC Chiropractic Association and UBC School of Kinesiology. Individual funding for graduate students working on this study was provided by the UBC Four Year Doctoral Fellowship and Canadian Institute of Health Research.	Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bower D.M., 2003, 6 SIGMA FORUM AM SOC; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks A, 2014, BR J SPORTS MED, V48, P573, DOI DOI 10.1136/BJSPORTS-2014-093494.38; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davison A.C., 1997, BOOTSTRAP METHODS TH; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Irick E., 2015, STUDENT ATHLETE PART; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Ren SQ, 2010, J APPL STAT, V37, P1487, DOI 10.1080/02664760903046102; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Tsushima WT, 2018, APPL NEUROPSYCH-CHIL, V7, P217, DOI 10.1080/21622965.2017.1290530; Walton S., 2017, BRIT J SPORT MED, V51, pA12	42	3	3	5	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1521	1527		10.1089/neu.2019.6829		MAR 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000525896100001	31928134				2022-02-06	
J	Anderson, V; Davis, GA; Takagi, M; Dunne, K; Clarke, C; Anderson, N; Rausa, VC; Doyle, M; Parkin, G; Truss, K; Thompson, E; Bressan, S; Hearps, S; Babl, FE				Anderson, Vicki; Davis, Gavin A.; Takagi, Michael; Dunne, Kevin; Clarke, Cathriona; Anderson, Nicholas; Rausa, Vanessa C.; Doyle, Melissa; Parkin, Georgia; Truss, Katie; Thompson, Emma; Bressan, Silvia; Hearps, Stephen; Babl, Franz E.			Trajectories and Predictors of Clinician-Determined Recovery after Child Concussion	JOURNAL OF NEUROTRAUMA			English	Article						child; concussion; predictors; recovery	TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; POSTCONCUSSION SYNDROME; SYMPTOMS	By age 16, 20% of children will suffer a concussion. Many experience persisting post-concussive symptoms (PCS), the cause(s) of which remain unclear. We mapped concussion recovery to 3 months post-injury and explored non-modifiable (e.g., age, sex, pre-injury factors, injury mechanism, acute PCS) and modifiable (post-acute child symptoms) predictors of persisting symptoms in order to identify opportunities for early intervention. We conducted a prospective, longitudinal study in the emergency department of a tertiary, pediatric hospital recruiting children within 48 h of concussion (T0), with follow-up at 2 days (T1), 2 weeks (T2), 1 month (T3), and 3 months (T4). Primary outcome was T2 clinician diagnosis. Clinical history, injury mechanism, acute symptoms, and physical and cognitive function were assessed. Parents rated child behavior and fatigue, and their mental health. We enrolled 256 participants, 72% males: 62 (24.3%) were symptomatic at T2. Recovered and symptomatic groups endorsed similar pre-injury PCS, but group differences were found at T1 across all PCS subscales, except Emotional, where symptoms were not evident until T2. By T2, there was significant PCS reduction, steepest in the "Recovered" group, which also had a lower rate of pre-injury psychiatric diagnoses, acute CT scans and less severe parent-rated PCS at T1 than the symptomatic group. They all demonstrated lower parent-rated PCS and less internalizing behaviors (all, p < 0.01). No differences were detected for child age, sex, injury factors, pre-injury parent-rated PCS, or acute physical and cognitive status. Our findings also highlight the importance of considering both pre- and post-injury mental health status in managing post-concussion.	[Anderson, Vicki; Davis, Gavin A.; Takagi, Michael; Dunne, Kevin; Clarke, Cathriona; Anderson, Nicholas; Rausa, Vanessa C.; Doyle, Melissa; Parkin, Georgia; Truss, Katie; Thompson, Emma; Bressan, Silvia; Hearps, Stephen; Babl, Franz E.] Murdoch Childrens Res Inst, Clin Sci Res, Melbourne, Vic, Australia; [Anderson, Vicki; Dunne, Kevin; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Anderson, Vicki; Takagi, Michael; Doyle, Melissa] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Dunne, Kevin; Babl, Franz E.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Level 4 West,50 Flemington Rd, Melbourne, Vic 3052, Australia.	vicki.anderson@mcri.edu.au		Parkin, Georgia/0000-0002-0588-2239; Takagi, Michael/0000-0003-2903-7598; Visser, Melissa/0000-0002-5313-3347; Hearps, Stephen/0000-0003-2984-1172	Royal Children's Hospital Foundation, Melbourne, Australia; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was supported by the Royal Children's Hospital Foundation, Melbourne, Australia. Anderson and Babl are supported by Australian National Health and Medical Research Council practitioner fellowships.	Achenbach TM, 2001, ASEBA SCH AGE FORMS; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Alisic E, 2017, EVID-BASED MENT HEAL, V20, DOI 10.1136/eb-2017-102736; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Marsac ML, 2013, CHILD CARE HLTH DEV, V39, P171, DOI 10.1111/j.1365-2214.2011.01328.x; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Parkin GM, 2019, J NEUROTRAUM, V36, P1768, DOI 10.1089/neu.2018.6042; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Takagi M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022098; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	41	3	3	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1392	1400		10.1089/neu.2019.6683		MAR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000525032900001	31996086				2022-02-06	
J	Callovini, GM; Bolognini, A; Callovini, T; Giordano, M; Gazzeri, R				Callovini, Giorgio M.; Bolognini, Andrea; Callovini, Tommaso; Giordano, Marco; Gazzeri, Roberto			Treatment of CSF leakage and infections of dural substitute in decompressive craniectomy using fascia lata implants and related anatomopathological findings	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Decompressive craniectomy; fascia lata; dural substitute; CSF leak; infection; complication	TRAUMATIC BRAIN-INJURY; AUTOLOGOUS FASCIA; RECONSTRUCTION; COMPLICATIONS; SURGERY; PERICRANIUM; MANAGEMENT; REPAIR; GRAFT; RATES	Purpose: Decompressive craniectomy (DC) is widely used to treat raised intracranial pressure (ICP) in cranial trauma and stroke. It is accompanied by numerous complications. The aim of our study is to assess the surgical treatment of infections related to the use of a dural substitute with concurrent CSF leakage performed at our institution. Material and methods: A retrospective analysis of a series of 72 patients who underwent DC between 2011 and 2017 was performed. Seven cases (9%) showed infection related to the use of xenograft (bovine pericardium) and coexisting CSF leakage. Epidural/subdural empyemas were observed in seven cases; three in conjunction with an intracerebral abscess. For reconstruction, free anterolateral thigh fascia lata flaps were used, based on the size of the defect. Results: After removal of the dural substitute and the implant of free fascia lata, infection and CSF leaks resolved in all. An anatomopathological examination of the implant at the later time of cranioplasty (CP) showed the tissue had become vascularized exhibiting integration with the native dura. No complications related to the harvesting of the fascia lata were observed. Conclusions: Fascia lata is a validated source of autologous grafts; it is cost-free and would appear to be the biological material most similar to the dura mater. The implanted material appears to maintain a lasting vitality when covered over with a well-vascularized scalp, even after a period of months, achieving a successful suppression of infection. Subsequent skull reconstruction is performed safely and easily using artificial bone.	[Callovini, Giorgio M.; Bolognini, Andrea; Callovini, Tommaso; Gazzeri, Roberto] San Giovanni Addolorata Hosp, Dept Neurosurg, Via Amba Aradam 9, I-00100 Rome, Italy; [Giordano, Marco] San Giovanni Addolorata Hosp, Dept Pathol, Rome, Italy		Callovini, GM (corresponding author), San Giovanni Addolorata Hosp, Dept Neurosurg, Via Amba Aradam 9, I-00100 Rome, Italy.	g.callovini@libero.it					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Abuzayed B, 2009, J CRANIOFAC SURG, V20, P435, DOI 10.1097/SCS.0b013e31819b968f; Azzam D, 2018, WORLD NEUROSURG, V113, P244, DOI 10.1016/j.wneu.2018.01.115; BENZEL EC, 1992, NEUROSURGERY, V31, P108; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang DW, 2001, PLAST RECONSTR SURG, V107, P1346, DOI 10.1097/00006534-200105000-00003; Choudhary Niraj Kumar, 2018, Asian J Neurosurg, V13, P314, DOI 10.4103/ajns.AJNS_281_16; Di Rienzo Alessandro, 2016, Surg Neurol Int, V7, pS737; Disa JJ, 1996, PLAST RECONSTR SURG, V97, P801, DOI 10.1097/00006534-199604000-00017; Gok A, 2004, ACTA NEUROCHIR, V146, P53, DOI 10.1007/s00701-003-0175-2; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Khan Farid, 2018, Asian J Neurosurg, V13, P730, DOI 10.4103/ajns.AJNS_6_18; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1; Nakano T, 2014, J CRANIOFAC SURG, V25, P1252, DOI 10.1097/SCS.0000000000000929; Sekhar LN, 2013, WORLD NEUROSURG, V79, P440, DOI 10.1016/j.wneu.2011.12.062; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tachibana E, 2002, J NEUROSURG, V96, P280, DOI 10.3171/jns.2002.96.2.0280; Takagi M, 2006, J CRANIOFAC SURG, V17, P584, DOI 10.1097/00001665-200605000-00035; Vitali M, 2016, CLIN NEUROL NEUROSUR, V144, P59, DOI 10.1016/j.clineuro.2016.03.003; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	24	3	3	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JAN 2	2021	35	1					18	21		10.1080/02688697.2020.1735301		MAR 2020	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QI5DG	WOS:000518721800001	32138540				2022-02-06	
J	Huang, XT; Dai, YN; Ma, XD; Wang, SZ; Xu, XJ; Pei, XL; Li, RL; Wang, HQ				Huang, Xintao; Dai, Yining; Ma, Xiaodong; Wang, Shizhou; Xu, Xinjuan; Pei, Xile; Li, Ruilong; Wang, Hongqin			Different changes in granulocyte-colony stimulating factor and its correlation with inflammatory biomarkers in patients after traumatic brain injury	NEUROREPORT			English	Article						inflammation; granulocyte-colony stimulating factor; traumatic brain injury	COGNITIVE IMPAIRMENT; CELLS; TRANSPLANTATION; MICE	Objective This study analyzed changes in granulocyte-colony stimulating factor (G-CSF) and its correlation with leukocyte and neutrophil counts in patients after traumatic brain injury (TBI). Methods Sixty TBI patients were included retrospectively. The serum levels of G-CSF, tumor necrosis factor-alpha (TNF-alpha), and peripheral leukocyte and neutrophil counts at different time points were measured and analyzed, and the 6-month functional outcomes were monitored. Results The levels of G-CSF in mild and moderate TBI groups were higher than the control at the first three time points. G-CSF in the severe TBI group increased slowly and peaked at day 7, and was only significantly different from the control at day 7 and 14. The leukocyte and neutrophil counts of the mild group gradually decreased, but a second increase after day 4 was observed in the severe group. The cell counts were higher in the severe group compared to other groups. A positive correlation between G-CSF and leukocyte and neutrophil counts was observed in the severe group at day 1. G-CSF positively correlated with TNF-alpha in the severe group at day 4 and 7. In severe patients with a good outcome, G-CSF level at day 7 was significantly higher than those with a poor outcome. Conclusion The G-CSF levels in the severe TBI group exhibited a different pattern from those in the mild and moderate TBI groups, and these levels positively correlated with inflammatory biomarkers. Higher G-CSF levels in severe TBI at day 7 indicated a good outcome at 6 months.	[Huang, Xintao; Wang, Shizhou; Xu, Xinjuan; Pei, Xile; Li, Ruilong; Wang, Hongqin] Shanxi Med Univ, Dept Neurosurg, Hosp 1, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China; [Dai, Yining] Shanxi Eye Hosp, Taiyuan, Shanxi, Peoples R China; [Ma, Xiaodong] Shanxi Ctr Dis Control & Prevent, Dept Occupat Hlth & Poisoning Control, Taiyuan, Shanxi, Peoples R China		Huang, XT (corresponding author), Shanxi Med Univ, Dept Neurosurg, Hosp 1, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China.	xintaoh@hotmail.com			Shanxi Health and Family Planning Commission Research Funds [2015023]; Natural Science Foundation for Young Scientists of Shanxi [201601D202097]; Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi [201802064]; Key Research and Development Projects of Shanxi [201803D31112]; Shanxi Medical University First Hospital Research Funds [YB161709]	The study was supported by the Shanxi Health and Family Planning Commission Research Funds (grant no: 2015023), Natural Science Foundation for Young Scientists of Shanxi (grant no: 201601D202097), Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi (grant no: 201802064) and Key Research and Development Projects of Shanxi (grant no: 201803D31112), Shanxi Medical University First Hospital Research Funds (grant no: YB161709).	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Banks WA, 2016, BRAIN BEHAV IMMUN, V52, P81, DOI 10.1016/j.bbi.2015.10.002; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Corrigan F, 2017, J NEUROTRAUM, V34, P971, DOI 10.1089/neu.2016.4589; Dela Pena I, 2014, J NEUROSURG SCI, V58, P145; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dietel B, 2012, EXP NEUROL, V237, P379, DOI 10.1016/j.expneurol.2012.06.019; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ghorbani M, 2013, DRUG CHEM TOXICOL, V36, P102, DOI 10.3109/01480545.2012.737802; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Liska Michael G, 2017, Brain Circ, V3, P143, DOI 10.4103/bc.bc_19_17; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Sobrino T, 2009, J CEREBR BLOOD F MET, V29, P1968, DOI 10.1038/jcbfm.2009.182; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Sun BL, 2016, MOL NEUROBIOL, V53, P320, DOI 10.1007/s12035-014-8984-2; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Yu SC, 2012, BIOMARKERS, V17, P319, DOI 10.3109/1354750X.2012.668712; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	28	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAR 4	2020	31	4					293	299		10.1097/WNR.0000000000001397			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LH6QM	WOS:000528909300003	31895743				2022-02-06	
J	Palermo, L; Cinelli, MC; Piccardi, L; De Felice, S; Ciurli, P; Incoccia, C; Zompanti, L; Guariglia, C				Palermo, Liana; Cinelli, Maria Cristina; Piccardi, Laura; De Felice, Sara; Ciurli, Paola; Incoccia, Chiara; Zompanti, Laura; Guariglia, Cecilia			Cognitive functions underlying prospective memory deficits: A study on traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Executive functions; prospective memory; speed of processing; traumatic brain injury; working memory	EXECUTIVE FUNCTIONS; INTENTIONS; PERFORMANCE; TIME; INHIBITION; IMPAIRMENT; ADULTS; EVENT; TASKS; STANDARDIZATION	This study investigates prospective memory (PM) deficits as well as the interplay between performance in executive functions (EFs), speed of processing, episodic memory and PM in traumatic brain injury (TBI), differentiating between time based and event based tasks. The Memory for Intentions Screening Test was administrated to a sample of 19 participants with TBI and 50 healthy controls. Tasks probing different EFs (i.e., shifting, updating/working memory, inhibition, and access to long term memory), speed of processing, and episodic memory were also administrated to the TBI group. PM deficits were found in participants with TBI compared to controls. In the role of EFs in PM, only tasks probing updating/working memory and access to the long-term memory showed to play a specific role in PM performance in TBI. However, while updating/working memory was related to both time and event based PM, access to the long term memory was associated to performance on time based PM task only. Speed of processing and retrospective memory abilities do not seem to play a specific role in PM deficit in TBI. Our results provide a better understanding of the PM deficit in TBI, which may contribute to improve existing rehabilitation programs for individuals with TBI.	[Palermo, Liana] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Palermo, Liana; Piccardi, Laura; De Felice, Sara; Ciurli, Paola; Incoccia, Chiara; Guariglia, Cecilia] IRCCS Santa Lucia Fdn, Neuropsychol Unit, Rome, Italy; [Cinelli, Maria Cristina; Zompanti, Laura; Guariglia, Cecilia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Piccardi, Laura] Aquila Univ, Dept Life Hlth & Environm Sci, Laquila, Italy		Palermo, L (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	liana.palermo@unicz.it	Piccardi, laura/AAC-7587-2022; Palermo, Liana/ABG-2726-2021	Palermo, Liana/0000-0001-8047-7201; Piccardi, Laura/0000-0002-1322-5538			ANZAI Y, 1979, PSYCHOL REV, V86, P124, DOI 10.1037/0033-295X.86.2.124; Bauer ME, 2008, T&F SER REMOTE SENS, P3; Benton A., 1976, MULTILINGUAL APHASIA; BRANDIMONTE MA, 1996, PROSPECTIVE MEMORY T; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Capitani E, 1999, CORTEX, V35, P273, DOI 10.1016/S0010-9452(08)70800-1; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Cepeda NJ, 2013, DEVELOPMENTAL SCI, V16, P269, DOI 10.1111/desc.12024; Costa A, 2014, NEUROL SCI, V35, P365, DOI 10.1007/s10072-013-1520-8; De Felice S, 2018, COGN NEUROPSYCHOL, V35, P148, DOI 10.1080/02643294.2017.1422709; Einstein, 2008, PROSPECTIVE MEMORY C, P283; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; GOSCHKE T, 1993, J EXP PSYCHOL LEARN, V19, P1211, DOI 10.1037/0278-7393.19.5.1211; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hagen C, 1997, LEVEL COGNITIVE FUNC; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R.K., 2000, WISCONSIN CARD SORTI; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Kamat R, 2014, ASSESSMENT, V21, P742, DOI 10.1177/1073191114530774; Kardiasmenos KS, 2008, NEUROPSYCHOLOGY, V22, P746, DOI 10.1037/a0013211; Kinch J., 2001, BRAIN IMPAIR, V2, P119, DOI [10.1375/brim.2.2.119, DOI 10.1375/BRIM.2.2.119]; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kopp UA, 2003, INT J PSYCHOL, V38, P229, DOI 10.1080/00207590344000150; KORIAT A, 1990, MEM COGNITION, V18, P568, DOI 10.3758/BF03197099; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levine B., 2002, PRINCIPLES FRONTAL L, P51; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Maylor EA, 2010, Q J EXP PSYCHOL, V63, P442, DOI 10.1080/17470210903469872; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McFarland CP, 2011, AGING NEUROPSYCHOL C, V18, P633, DOI 10.1080/13825585.2011.613449; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Mioni G., 2014, TRAUMATIC BRAIN INJU, P401, DOI [10.5772/5730, DOI 10.5772/57307]; Mioni G, 2015, J INT NEUROPSYCH SOC, V21, P305, DOI 10.1017/S1355617715000211; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Neisser U., 1982, MEMORY OBSERVED REME, P327; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Orsini A., 2003, B PSICOL APPL, V239, P73; Palermo L, 2016, Q J EXP PSYCHOL, V69, P65, DOI 10.1080/17470218.2015.1023734; Pavawalla SP, 2012, NEUROPSYCHOLOGY, V26, P91, DOI 10.1037/a0025866; Paxton J, 2014, J INT NEUROPSYCH SOC, V20, P673, DOI 10.1017/S1355617714000575; Piccardi Laura, 2016, Front Behav Neurosci, V10, P139, DOI 10.3389/fnbeh.2016.00139; Puopolo C, 2013, NEUROSCI BIOBEHAV R, V37, P2638, DOI 10.1016/j.neubiorev.2013.08.013; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Raskin SA, 1996, J HEAD TRAUMA REHAB, V11, P32, DOI 10.1097/00001199-199606000-00007; Raskin SA, 2012, NEUROPSYCHOL REHABIL, V22, P40, DOI 10.1080/09602011.2011.632908; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RICKHAM PP, 1964, BRIT MED J, V2, P173; Romani C, 2018, COGN NEUROPSYCHOL, V35, P171, DOI 10.1080/02643294.2017.1320278; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Taylor SF, 2004, NEUROIMAGE, V21, P1045, DOI 10.1016/j.neuroimage.2003.10.032; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren A. H., 1990, NEUROBEHAVIORAL RECO, P225; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WAIS R WECHSLER ADUL; Wilson B. A., 2013, RBMT 3 RIVERMEAD BEH; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Zarino B, 2014, NEUROL SCI, V35, P1405, DOI 10.1007/s10072-014-1729-1; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	86	3	4	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 3	2020	27	2					158	172		10.1080/23279095.2018.1501374			15	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KS3JZ	WOS:000518208000007	30380921				2022-02-06	
J	Schumm, SN; Gabrieli, D; Meaney, DF				Schumm, Samantha N.; Gabrieli, David; Meaney, David F.			Neuronal Degeneration Impairs Rhythms Between Connected Microcircuits	FRONTIERS IN COMPUTATIONAL NEUROSCIENCE			English	Article						neurodegeneration; microcircuit; network; synchronization; rhythms	TRAUMATIC BRAIN-INJURY; STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE; STRUCTURAL CONNECTIVITY; NETWORK OSCILLATIONS; SYNCHRONIZATION; COMMUNICATION; METASTABILITY; STIMULATION; RETRIEVAL	Synchronization of neural activity across brain regions is critical to processes that include perception, learning, and memory. After traumatic brain injury (TBI), neuronal degeneration is one possible effect and can alter communication between neural circuits. Consequently, synchronization between neurons may change and can contribute to both lasting changes in functional brain networks and cognitive impairment in patients. However, fundamental principles relating exactly how TBI at the cellular scale affects synchronization of mesoscale circuits are not well understood. In this work, we use computational networks of Izhikevich integrate-and-fire neurons to study synchronized, oscillatory activity between clusters of neurons, which also adapt according to spike-timing-dependent plasticity (STDP). We study how the connections within and between these neuronal clusters change as unidirectional connections form between the two neuronal populations. In turn, we examine how neuronal deletion, intended to mimic the temporary or permanent loss of neurons in the mesoscale circuit, affects these dynamics. We determine synchronization of two neuronal circuits requires very modest connectivity between these populations; approximately 10% of neurons projecting from one circuit to another circuit will result in high synchronization. In addition, we find that synchronization level inversely affects the strength of connection between neuronal microcircuits - moderately synchronized microcircuits develop stronger intercluster connections than do highly synchronized circuits. Finally, we find that highly synchronized circuits are largely protected against the effects of neuronal deletion but may display changes in frequency properties across circuits with targeted neuronal loss. Together, our results suggest that strongly and weakly connected regions differ in their inherent resilience to damage and may serve different roles in a larger network.	[Schumm, Samantha N.; Gabrieli, David; Meaney, David F.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Penn Ctr Brain Injury & Repair, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Penn Ctr Brain Injury & Repair, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Schumm, Samantha/0000-0003-4399-5362	Paul G. Allen Foundation; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS088176]	This work was funded by grants from the Paul G. Allen Foundation and the National Institutes of Health (NIH) (RO1 NS088176).	Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bastos AM, 2015, CURR OPIN NEUROBIOL, V31, P173, DOI 10.1016/j.conb.2014.11.001; Betzel RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30770; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bocchio M, 2017, NEURON, V94, P731, DOI 10.1016/j.neuron.2017.03.022; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Card J. P, 2012, FUNDAMENTAL NEUROSCI, P717, DOI [10.1016/B978-0-12-385870-2.00033-0, DOI 10.1016/B978-0-12-385870-2.00033-0]; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Colgin LL, 2015, CURR OPIN NEUROBIOL, V31, P45, DOI 10.1016/j.conb.2014.08.001; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; de Hemptinne C, 2015, NAT NEUROSCI, V18, P779, DOI 10.1038/nn.3997; Deco G, 2016, TRENDS NEUROSCI, V39, P125, DOI 10.1016/j.tins.2016.01.001; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Effenberger F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004420; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; FERSTER D, 1992, J NEUROSCI, V12, P1262; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gabrieli D., 2019, NEURODEGENERATION EX, DOI [10.1101/663187, DOI 10.1101/663187]; Gollo LL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003548; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gu S, 2017, NEUROIMAGE, V148, P305, DOI 10.1016/j.neuroimage.2017.01.003; Gu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9414; Hanslmayr S, 2016, TRENDS NEUROSCI, V39, P16, DOI 10.1016/j.tins.2015.11.004; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Horn A, 2014, NEUROIMAGE, V102, P142, DOI 10.1016/j.neuroimage.2013.09.069; Hummos A, 2014, HIPPOCAMPUS, V24, P1430, DOI 10.1002/hipo.22324; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Ji YP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16000; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim JZ, 2018, NAT PHYS, V14, P91, DOI [10.1038/NPHYS4268, 10.35173/NATR.14.2.5, 10.1038/nphys4268]; Kobayashi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02366-z; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee WH, 2017, NEUROIMAGE, V146, P724, DOI 10.1016/j.neuroimage.2016.08.050; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Muldoon SF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005076; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Narayanan Nandakumar S., 2009, V489, P135, DOI 10.1007/978-1-59745-543-5_7; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Owen SLF, 2006, PAIN, V120, P202, DOI 10.1016/j.pain.2005.09.035; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pang EW, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00170; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Penn Y, 2016, P NATL ACAD SCI USA, V113, P3341, DOI 10.1073/pnas.1515105113; Pevzner A, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00030; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Su YS, 2019, J NEUROTRAUM, V36, P2083, DOI 10.1089/neu.2018.6020; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; Tamura M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02108-9; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Toni R., 2000, FUNCTIONAL ANATOMY H; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vasa F, 2015, NEUROIMAGE, V118, P456, DOI 10.1016/j.neuroimage.2015.05.042; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Wang C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00571; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wheeler DW, 2015, ELIFE, V4, DOI 10.7554/eLife.09960; Wiles L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44006; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845	87	3	3	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5188		FRONT COMPUT NEUROSC	Front. Comput. Neurosci.	MAR 3	2020	14								18	10.3389/fncom.2020.00018			18	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Mathematical & Computational Biology; Neurosciences & Neurology	LE4KD	WOS:000526687200001	32194390	gold, Green Published			2022-02-06	
J	Anderson, J; Patel, M; Forenzo, D; Ai, X; Cai, C; Wade, Q; Risman, R; Cai, L				Anderson, Jeremy; Patel, Misaal; Forenzo, Dylan; Ai, Xin; Cai, Catherine; Wade, Quinn; Risman, Rebecca; Cai, Li			A novel mouse model for the study of endogenous neural stem and progenitor cells after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Closed head injury; Neural stem/progenitor cell; Notch1CR2-GFP; Mouse model; GABAergic neuron	CLOSED-HEAD INJURY; ADULT SUBVENTRICULAR ZONE; GENE-EXPRESSION; NOTCH; PROLIFERATION; NEUROGENESIS; ACTIVATION; MECHANISMS; ASTROCYTES; REGENERATION	Traumatic brain injury (TBI) is a leading cause of death and disability in the US. Neural stem/progenitor cells (NSPCs) persist in the adult brain and represent a potential cell source for tissue regeneration and wound healing after injury. The Notch signaling pathway is critical for embryonic development and adult brain injury response. However, the specific role of Notch signaling in the injured brain is not well characterized. Our previous study has established a Notch1CR2-GFP reporter mouse line in which the Notch1CR2 enhancer directs GFP expression in NSPCs and their progeny. In this study, we performed closed head injury (CHI) in the Notch1CR2-GFP mice to study the response of injury-activated NSPCs. We show that CHI induces neuroinflammation, cell death, and the expression of typical TBI markers (e.g., ApoE, Illb, and Tau), validating the animal model. In addition, CHI induces cell proliferation in GFP + cells expressing NSPC markers, e.g., Notch1 and Nestin. A significant higher percentage of GFP + astrocytes and GABAergic neurons was observed in the injured brain, with no significant change in oligodendrocyte lineage between the CHI and sham animal groups. Since injury is known to activate astrogliosis, our results suggest that injury-induced GFP + NSPCs preferentially differentiate into GABAergic neurons. Our study establishes that Notch1CR2-GFP transgenic mouse is a useful tool for the study of NSPC behavior in vivo after TBI. Unveiling the potential of NSPCs response to TBI (e.g., proliferation and differentiation) will identify new therapeutic strategy for the treatment of brain trauma.	[Anderson, Jeremy; Patel, Misaal; Forenzo, Dylan; Ai, Xin; Cai, Catherine; Wade, Quinn; Risman, Rebecca; Cai, Li] Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA		Cai, L (corresponding author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.	lcai@rutgers.edu		Cai, Li/0000-0003-3344-337X	New Jersey Commission on Spinal Cord Research [08-3074-SCR-E0, 10-3091-SCR-E-0, 15IRG006]; Busch Biomedical Award [659218]; NIH Biotechnology Training Program [NIH]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM00839]; U.S. Department of Education GAANN Precision and Personalized Medicine Pre-Doctoral Training Fellowship [P200A150131]	The authors would like to thank members of the Cai lab for helpful discussion and the Maribel Vasquez lab for imaging analysis. This work was supported by the grants from the New Jersey Commission on Spinal Cord Research [08-3074-SCR-E0; 10-3091-SCR-E-0; 15IRG006] and Busch Biomedical Award [659218]. J.A. and M.N.P. are fellows of the NIH Biotechnology Training Program [NIH T32 GM00839]. M.P. is also a recipient of the U.S. Department of Education GAANN Precision and Personalized Medicine Pre-Doctoral Training Fellowship (P200A150131).	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Artegiani B, 2017, CELL REP, V21, P3271, DOI 10.1016/j.celrep.2017.11.050; Barraud P, 2005, EUR J NEUROSCI, V22, P1555, DOI 10.1111/j.1460-9568.2005.04352.x; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bohrer C., 2016, NEUROGENESIS AUSTIN, V3; Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596; Campolo M, 2018, METHODS MOL BIOL, V1727, P385, DOI 10.1007/978-1-4939-7571-6_30; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Chen CM, 2017, J DATA INFO SCI, V2, P1, DOI 10.1515/jdis-2017-0006; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Dulken BW, 2017, CELL REP, V18, P777, DOI 10.1016/j.celrep.2016.12.060; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao Q, 2018, STEM CELLS DEV, V27, P479, DOI 10.1089/scd.2017.0193; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gardner AJ, 2017, PHYS MED REH CLIN N, V28, P413, DOI 10.1016/j.pmr.2016.12.014; Giachino C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00032; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; LeComte MD, 2016, CYTOKINE, V80, P64, DOI 10.1016/j.cyto.2015.08.259; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Li Y., 2016, SCI REP, V6, P1, DOI DOI 10.1038/srep22755; Lim D.A, 2016, COLD SPRING HARB PER, V8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ludwig PE, 2018, NEURAL REGEN RES, V13, P7, DOI 10.4103/1673-5374.224361; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Makara JK, 2003, MOL CELL NEUROSCI, V23, P521, DOI 10.1016/S1044-7431(03)00080-0; Encinas JM, 2017, ADV DRUG DELIVER REV, V120, P118, DOI 10.1016/j.addr.2017.07.016; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Phipps HW, 2016, METHODS MOL BIOL, V1462, P61, DOI 10.1007/978-1-4939-3816-2_5; Pluta R, 2018, PHARMACOL REP, V70, P881, DOI 10.1016/j.pharep.2018.03.004; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Sibbe M, 2012, EUR J NEUROSCI, V36, P3643, DOI 10.1111/j.1460-9568.2012.08279.x; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01089; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tatsumi K, 2010, J CHEM NEUROANAT, V39, P15, DOI 10.1016/j.jchemneu.2009.09.003; Tu M, 2017, MED SCI MONITOR, V23, P5480, DOI 10.12659/MSM.907160; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Tzatzalos E, 2012, DEV BIOL, V372, P217, DOI 10.1016/j.ydbio.2012.09.015; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Wang XX, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0270-16.2016; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yan YH, 2018, BRAIN BEHAV IMMUN, V67, P118, DOI 10.1016/j.bbi.2017.08.011; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang YM, 2015, NEUROSCI LETT, V603, P12, DOI 10.1016/j.neulet.2015.07.009; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou ZD, 2010, IUBMB LIFE, V62, P618, DOI 10.1002/iub.362	75	3	3	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2020	325								113119	10.1016/j.expneurol.2019.113119			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KH0CW	WOS:000510317000018	31751572				2022-02-06	
J	Bakaeva, ZV; Surin, AM; Lizunova, NV; Zgodova, AE; Krasilnikova, IA; Fisenko, AP; Frolov, DA; Andreeva, LA; Myasoedov, ANF; Pinelis, VG				Bakaeva, Z., V; Surin, A. M.; Lizunova, N., V; Zgodova, A. E.; Krasilnikova, I. A.; Fisenko, A. P.; Frolov, D. A.; Andreeva, L. A.; Myasoedov, Academician N. F.; Pinelis, V. G.			Neuroprotective Potential of Peptides HFRWPGP (ACTH(6-9)PGP), KKRRPGP, and PyrRP in Cultured Cortical Neurons at Glutamate Excitotoxicity	DOKLADY BIOCHEMISTRY AND BIOPHYSICS			English	Article						cultured cortical neurons; glutamate excitotoxicity; survival; intracellular calcium; mitochondrial potential; peptides	CALCIUM HOMEOSTASIS	Glutamate (Glu) excitotoxicity, which accompanies brain ischemia or traumatic brain injury, is the leading mechanism of neuronal death. In the present work, we studied the effects of the peptides HFRWPGP (ACTH(6-9)PGP), KKRRPG, and PyrRP on the survival of cultured cortical neurons on the background of excitotoxic effect of Glu (100 mu M). Biochemical (MTT/WST) and morphometric analyzes showed that, depending on the dose, ACTH(6-9)PGP and KKRRPGP protect neurons from the cells death, while PyrRP, conversely, enhances it. The neuroprotective effect of ACTH(6-9)PGP is accompanied by a slowdown in the development of delayed calcium dysregulation and synchronous mitochondrial depolarization. Among the studied peptides, only ACTH(6-9)PGP significantly increased the number of neurons that restored Ca(2+)homeostasis after Glu was abolished. The influence of KKRRPGP was less pronounced, whereas PyrRP, on the contrary, reduced the number of neurons with low [Ca2+](i). Thus, this study revealed the high therapeutic significance of ACTH(6-9)PGP and allowed assessing the prospects for its possible clinical use.	[Bakaeva, Z., V; Surin, A. M.; Lizunova, N., V; Zgodova, A. E.; Krasilnikova, I. A.; Fisenko, A. P.; Pinelis, V. G.] Minist Hlth Russian Federat, Natl Med Res Ctr Childrens Hlth, Moscow 119296, Russia; [Surin, A. M.] Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia; [Lizunova, N., V] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Zgodova, A. E.] First Sechenov Moscow State Med Univ Minist Hlth, Moscow 119146, Russia; [Frolov, D. A.] MIREA Russian Technol Univ, Moscow 119454, Russia; [Andreeva, L. A.; Myasoedov, Academician N. F.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia		Bakaeva, ZV (corresponding author), Minist Hlth Russian Federat, Natl Med Res Ctr Childrens Hlth, Moscow 119296, Russia.	bakaeva@nczd.ru	Bakaeva, Zanda/AAO-5674-2020; Lizunova, Natalia/AAO-5666-2020; Krasilnikova, Irina/AAO-3767-2020; Zgodova, Arina/AAO-5795-2020; Pinelis, Vsevood/K-5564-2017	Bakaeva, Zanda/0000-0002-2797-3270; Lizunova, Natalia/0000-0002-6644-7716; Krasilnikova, Irina/0000-0001-9453-3040; Zgodova, Arina/0000-0002-8394-3412; Pinelis, Vsevood/0000-0001-8579-605X	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [17-00-00105_COMFI, 17-00-00106_COMFI]	This work was supported by the Russian Foundation for Basic Research (project nos. 17-00-00105_COMFI and 17-00-00106_COMFI).	Bezuglov V.V., 2015, HORIZONS NEUROSCI RE, V21, P151; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Khodorov B, 2004, PROG BIOPHYS MOL BIO, V86, P279, DOI 10.1016/j.pbiomolbio.2003.10.002; Levitskaya N.G., 2019, ROSS FIZIOL ZH IM I, V105, P761, DOI [10.1134/S0869813919060049, DOI 10.1134/S0869813919060049]; Myasoedov N.F., 2016, VESTN ROS AKAD NAUK+, V86, P488, DOI [DOI 10.7868/S0869587316060074, 10.7868/S0869587316060074]; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Pinelis V.G., 2016, IZD PEDIAT, P9; Shevchenko K V, 2013, Bioorg Khim, V39, P320; Storozhevykh TP, 2007, B EXP BIOL MED+, V143, P601, DOI 10.1007/s10517-007-0192-x; Surin A.M., 2014, PATOGENEZ RUS, V12, P40	12	3	3	0	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1607-6729	1608-3091		DOKL BIOCHEM BIOPHYS	Dokl. Biochem. Biophys.	MAR	2020	491	1					62	66		10.1134/S1607672920020040			5	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	LY9VD	WOS:000540874900002	32483752				2022-02-06	
J	Beakey, M; Roe, M; Tiernan, S; Keenan, B; Collins, K				Beakey, Mark; Roe, Mark; Tiernan, Stephen; Keenan, Brian; Collins, Kieran			Cross-Sectional Investigation of Self-Reported Concussions and Reporting Behaviors in 866 Adolescent Rugby Union Players: Implications for Educational Strategies	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						adolescent rugby; sport-related concussion; bell ringer; concussion prevalence; reporting behaviors; educational intervention	SPORT-RELATED CONCUSSION; INJURY; KNOWLEDGE; PREVENTION; MANAGEMENT; DISCLOSURE; ATTITUDES; HISTORY; RISK	Objective: To examine the self-recalled concussion and bell ringer (BR) prevalence, reporting rates, and reporting behaviors in adolescent rugby players. Design: Cross-sectional survey. Setting: School classroom. Participants: Adolescent male rugby players aged 12 to 18 years (n = 866). Main Outcome Measures: Concussion and BR prevalence, reporting rates, and reporting behaviors. Results: The sample reported a concussion and BR prevalence rate of 40% and 69.9%, respectively. Of these athletes with a history, 38.4% and 86.4% suffered recurrent concussions and BRs, respectively. The total reporting rates per 1000 suspected concussions and BRs were 474.8 [95% confidence interval (CI), 415.4-534.3] and 238.7 (95% CI, 217.8-259.5), respectively. The athletes highlighted several barriers which hindered their truthful reporting of concussion, including "not thinking the injury is serious enough to report" (70%), "wanting to win the game" (38%), and "not wanting to miss future games or training" (48%). Conclusions: Educational interventions are an invaluable component within a socioecological framework aimed at improving the concussion reporting rates of adolescent athletes. The self-recalled prevalence, underreporting rates, and behaviors of the sample are alarming, which prompts the need to further explore their motivational beliefs behind their decision to underreport a potential concussion. The information obtained can be used to tailor personalized interventions for specific athlete samples.	[Beakey, Mark; Keenan, Brian; Collins, Kieran] Inst Technol, Dept Sci, Dublin D24 FKT9 24, Ireland; [Roe, Mark] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Hlth Sci Ctr, Dublin, Ireland; [Tiernan, Stephen] Inst Technol Tallaght, Dept Engn, Dublin, Ireland; [Keenan, Brian] Univ Surrey, Sch Hlth Sci, Guildford, Surrey, England		Beakey, M (corresponding author), Inst Technol, Dept Sci, Dublin D24 FKT9 24, Ireland.	mark.beakey@postgrad.ittdublin.ie	Collins, Kieran/AAW-5613-2021	Collins, Kieran/0000-0003-1653-2071	Institute of Technology, Tallaght, Dublin through the President's Research Award Scheme	Supported by the Institute of Technology, Tallaght, Dublin through the President's Research Award Scheme 2016.	[Anonymous], 2017, WORLD RUGBY PLAYER N; Bacon CEW, 2017, J ATHL TRAINING, V52, P937, DOI 10.4085/1062-6050-52.7.02; Beakey M, 2017, EUR J SPORT MED, V3:, P1; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Hislop M, 2017, BRIT J SPORT MED, V51, P331; Hume P, 2017, BRIT J SPORT MED, V51, P333, DOI [10.1136/bjsports-2016-097372.125, DOI 10.1136/BJSPORTS-2016-097372.125]; Irish Rugby Football Union, 2014, GUID CONC RUGB UN SA; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Leung F, 2017, J SCI MED SPORT, V20, pe48; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Quarrie KL, 2017, BRIT J SPORT MED, V51, P1134, DOI 10.1136/bjsports-2017-098013; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wojtowicz M, 2016, J NEUROTRAUM, V6, P1	32	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S75	S81		10.1097/JSM.0000000000000597			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700010	32132481				2022-02-06	
J	Branstetter, JW; Ohman, KL; Johnson, DW; Gilbert, BW				Branstetter, Joshua W.; Ohman, Kelsey L.; Johnson, Donald W.; Gilbert, Brian W.			Management of Paroxysmal Sympathetic Hyperactivity with Dexmedetomidine and Propranolol Following Traumatic Brain Injury in a Pediatric Patient	JOURNAL OF PEDIATRIC INTENSIVE CARE			English	Article						traumatic brain injury; paroxysmal sympathetic hyperactivity; pediatrics; dexmedetomidine; propranolol	CEREBRAL-BLOOD-FLOW; AUTONOMIC DYSFUNCTION; DYSAUTONOMIA; BROMOCRIPTINE	We report a case of pharmacologic management of pediatric paroxysmal sympathetic hyperactivity (PSH) in a patient who experienced symptomatic resolution with dexmedetomidine and propranolol. Following a blunt traumatic subdural hematoma and diffuse axonal injury, an 8-year-old male developed PSH on approximately day 5 of the hospitalization. PSH symptoms identified in this patient were hyperthermia, tachycardia, posturing, and hypertension with associated elevations in intracranial pressure. Episodes of PSH continued to be observed despite appropriate titration of opiates, sedatives, and traditional blood pressure management. Dexmedetomidine and propranolol were subsequently initiated to attenuate acute episodes of PSH. A reduction in sedative requirements and improvement in symptoms followed, which facilitated successful extubation. The combination of propranolol and dexmedetomidine was followed by a decrease in the frequency and severity of acute episodes of PSH. After utilization of multiple treatment modalities to control PSH episodes in our patient, propranolol and dexmedetomidine may have helped attenuate PSH signs and symptoms.	[Branstetter, Joshua W.; Ohman, Kelsey L.; Johnson, Donald W.] UF Hlth Jacksonville, Dept Pharm, Jacksonville, FL USA; [Branstetter, Joshua W.; Ohman, Kelsey L.; Johnson, Donald W.] Univ Florida, Coll Pharm, Jacksonville, FL USA; [Gilbert, Brian W.] Wesley Med Ctr, Dept Pharm, Wichita, KS USA		Branstetter, JW (corresponding author), 1508 4th Ave South,Apartment 220, Birmingham, AL 35233 USA.	joshua.branstetter@childrensal.org	Branstetter, Joshua/ABA-9355-2020				Alofisan TO, 2019, PEDIATR CRIT CARE ME, V20, P252, DOI 10.1097/PCC.0000000000001811; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Constantin JM, 2016, ANAESTH CRIT CARE PA, V35, P7, DOI 10.1016/j.accpm.2015.06.012; Dillon RC, 2017, CLIN AUTON RES, V27, P7, DOI 10.1007/s10286-016-0383-5; Drummond JC, 2008, ANESTHESIOLOGY, V108, P225, DOI 10.1097/01.anes.0000299576.00302.4c; Feng Y, 2015, PEDIATR NEUROSURG, V50, P301, DOI 10.1159/000439282; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hogue CW, 2002, ANESTHESIOLOGY, V97, P592, DOI 10.1097/00000542-200209000-00012; KARLSSON BR, 1990, ANESTH ANALG, V71, P125; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; Peng Y, 2017, ONCOTARGET, V8, P69012, DOI 10.18632/oncotarget.16920; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Raithel Deborah S, 2015, J Pediatr Pharmacol Ther, V20, P335, DOI 10.5863/1551-6776-20.4.335; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; Siefferman JW, 2015, CASE REP NEUROL MED, V2015, DOI 10.1155/2015/421563	26	3	3	7	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2146-4618	2146-4626		J PEDIATR INTENSIVE	J. Pediatr. Intensive Care	MAR	2020	9	1					64	69		10.1055/s-0039-1698758			6	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	KF0BT	WOS:000508915000012	31984161	Green Published			2022-02-06	
J	Buchele, G; Rapp, K; Bauer, JM; Jaensch, A; Becker, C; Benzinger, P				Buechele, G.; Rapp, K.; Bauer, J. M.; Jaensch, A.; Becker, C.; Benzinger, Petra			Risk of traumatic intracranial haemorrhage is increased in older people exposed to oral anticoagulation with phenprocoumon	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Elderly; Anticoagulation; Head injury; Intracranial haemorrhage; Trauma	PREINJURY WARFARIN USE; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; BRAIN-INJURY; FRACTURE RATES; BLEEDING RISK; FALL; THERAPY; ADULTS; OUTCOMES	Background Hospital admissions resulting from traumatic intracranial haemorrhages (TIH) in older people are increasing. There are concerns regarding an increased risk of a TIH in people taking oral anticoagulants (OAC) like phenprocoumon. Aims The aim of this study was to estimate the incremental risk of a TIH associated with OAC in older people. Furthermore, this study explored differences in risk according to functional status. Methods The study took data from a large German health insurance provider and combined hospital diagnoses with data regarding drug dispensing to estimate rates of a TIH in people with and without exposure to phenprocoumon. Analyses were stratified by sex and by severe functional impairment as disclosed by the long-term care insurance provider. Results Overall, exposure to OAC resulted in 2.7 times higher rates of TIH. People with severe functional impairment had a higher baseline risk of TIH than people without severe functional impairment. However, the incremental risk in those exposed to OAC was similar among people with and without severe functional impairment (standardised incidence rate difference 15.73 (95% CI 7.84; 23.61) and 12.10 (95% CI 9.63; 14.57) per 10,000 person-years, respectively). Conclusions OAC increases the risk of TIH considerably. The incremental risk of TIH in those exposed to OAC is comparable between people with and without severe functional impairment. The presence of severe functional impairment per se should not exclude such patients from the potential benefits of OAC. For now, the prescription should be personalized based on individual fall risk factors and risk-taking behaviour.	[Buechele, G.; Rapp, K.; Jaensch, A.] Ulm Univ, Inst Epidemiol & Med Biometry, Helmholtzstr 22, D-89081 Ulm, Germany; [Rapp, K.; Becker, C.; Benzinger, Petra] Robert Bosch Krankenhaus Stuttgart, Dept Clin Gerontol, Auerbachstr 110, D-70376 Stuttgart, Germany; [Bauer, J. M.; Benzinger, Petra] Heidelberg Univ, Ctr Geriatr Med, Bethanien Krankenhaus Heidelberg, Rohrbacher Str 149, D-69126 Heidelberg, Germany; [Benzinger, Petra] Univ Appl Sci Kempten, Fac Social & Hlth Studies, Bahnhofstr 61, D-87435 Kempten, Germany		Benzinger, P (corresponding author), Robert Bosch Krankenhaus Stuttgart, Dept Clin Gerontol, Auerbachstr 110, D-70376 Stuttgart, Germany.; Benzinger, P (corresponding author), Heidelberg Univ, Ctr Geriatr Med, Bethanien Krankenhaus Heidelberg, Rohrbacher Str 149, D-69126 Heidelberg, Germany.; Benzinger, P (corresponding author), Univ Appl Sci Kempten, Fac Social & Hlth Studies, Bahnhofstr 61, D-87435 Kempten, Germany.	pebenzinger@aol.com	Becker, Clemens/ABI-5405-2020				Bai Y, 2018, AGE AGEING, V47, P9, DOI 10.1093/ageing/afx103; Benzinger P, 2013, J AM MED DIR ASSOC, V14, P673, DOI 10.1016/j.jamda.2013.03.012; Bond AJ, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-1; Brazinova A, 2015, AGE AGEING, V44, P502, DOI 10.1093/ageing/afu194; Budnitz D.S., 2012, NEW ENGL J MED, V365, P2002, DOI DOI 10.1056/NEJMsa1103053; Buchele G, 2016, J AM MED DIR ASSOC, V17, P609, DOI 10.1016/j.jamda.2016.02.032; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Devereaux PJ, 2001, BMJ-BRIT MED J, V323, P1218, DOI 10.1136/bmj.323.7323.1218; DiMarco JP, 2005, AM HEART J, V149, P650, DOI 10.1016/j.ahj.2004.11.015; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Gattellari M, 2008, STROKE, V39, P227, DOI 10.1161/STROKEAHA.107.495036; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Klenk J, 2013, Z GERONTOL GERIATR, V46, P720, DOI 10.1007/s00391-013-0554-0; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Lopez-Lopez JA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5058; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Pilote L, 2013, CAN J CARDIOL, V29, P1241, DOI 10.1016/j.cjca.2012.09.021; Poli D, 2011, CIRCULATION, V124, P824, DOI 10.1161/CIRCULATIONAHA.110.007864; Rapp K, 2012, AGE AGEING, V41, P653, DOI 10.1093/ageing/afs044; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Russmann S, 1997, EUR J CLIN PHARMACOL, V52, P31, DOI 10.1007/s002280050245; Scowcroft ACE, 2013, HEART, V99, P127, DOI 10.1136/heartjnl-2012-302843; Staerk L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31477; Torn M, 2005, ARCH INTERN MED, V165, P1527, DOI 10.1001/archinte.165.13.1527; Weitz JI, 2015, CLIN THER, V37, P2506, DOI 10.1016/j.clinthera.2015.09.008	33	3	3	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	MAR	2020	32	3					441	447		10.1007/s40520-019-01215-5			7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	KS7MI	WOS:000518490400010	31102254				2022-02-06	
J	Ciochon, UM; Brandt, EGS; Stavngaard, T				Ciochon, Urszula Maria; Brandt, Erik Gudmann Steuble; Stavngaard, Trine			Acute Tentorial Subdural Hematoma Caused by Rupture of the Posterior Cerebral Artery after Minor Trauma-A Case Report	DIAGNOSTICS			English	Article						traumatic brain aneurysm; pseudoaneurysm; acute subdural hematoma; traumatic brain injury; endovascular coiling	INTRACRANIAL ANEURYSMS; DISTAL; STENTS	Acute subdural hematoma (aSDH) is a common pathology encountered after head trauma. Only a minority of aSDHs have an arterial source. In this article, we report a case of aSDH originating from a traumatic pseudoaneurysm of the distal segment of posterior cerebral artery (PCA), diagnosed several days after the initial minor trauma and successfully treated with endovascular coiling. This case emphasizes the importance of searching for vascular pathology when the localization, severity or relapsing course of the intracranial hemorrhage does not fully correspond to the severity of initial trauma and when the bleeding has a delayed onset. Characteristics, diagnostics and treatment possibilities of traumatic cerebral aneurysms, an important cause of arterial aSDH, are described in the article.	[Ciochon, Urszula Maria; Brandt, Erik Gudmann Steuble; Stavngaard, Trine] Rigshosp, Dept Diagnost Radiol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Brandt, Erik Gudmann Steuble] Holbaek Cent Hosp, Dept Radiol, Smedelundsgade 60, DK-4300 Holbk, Denmark		Ciochon, UM (corresponding author), Rigshosp, Dept Diagnost Radiol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	uciochon@gmail.com; erik.gudmann.steuble.brandt@regionh.dk; trine.stavngaard@regionh.dk		Ciochon, Urszula Maria/0000-0001-7750-7887			Al-Mufti F, 2017, NEUROSURG CLIN N AM, V28, P267, DOI 10.1016/j.nec.2016.11.009; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; Aydin K, 2017, AM J NEURORADIOL, V38, P2131, DOI 10.3174/ajnr.A5362; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Cagnazzo F, 2018, AM J NEURORADIOL, V39, P2064, DOI 10.3174/ajnr.A5804; Chedid MK, 2001, J NEUROSURG, V94, P637, DOI 10.3171/jns.2001.94.4.0637; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Kumar A, 2016, J CLIN NEUROSCI, V25, P90, DOI 10.1016/j.jocn.2015.05.063; Larson P S, 2000, Neurosurg Focus, V8, pe4; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; Murakami M, 2003, NEUROL MED-CHIR, V43, P130, DOI 10.2176/nmc.43.130; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; Turk AS, 2007, AM J NEURORADIOL, V28, P533; YASUI T, 1995, SURG NEUROL, V43, P61, DOI 10.1016/0090-3019(95)80041-E	18	3	3	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	MAR	2020	10	3							175	10.3390/diagnostics10030175			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA9XR	WOS:000524293700027	32210036	Green Published, gold			2022-02-06	
J	Graves, JM; Moore, M; Kehoe, L; Li, M; Chan, A; Conrick, K; Williams-Gilbert, W; Vavilala, MS				Graves, Janessa M.; Moore, Megan; Kehoe, Leanne; Li, Matthew; Chan, Anissa; Conrick, Kelsey; Williams-Gilbert, Wendy; Vavilala, Monica S.			Family Hardship Following Youth Concussion: Beyond the Medical Bills	JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES			English	Article						Mild traumatic brain injury; Concussion; Family; Youth; Adolescents	TRAUMATIC BRAIN-INJURY; CENTERED CARE; CHILDREN; BURDEN; SCHOOL; DISTRESS; RETURN; COSTS; PARENTS; STRESS	Purpose: The costs facing families after pediatric concussion are not limited to medical expenses for treatment and rehabilitation care. The objective of this research was to examine the economic hardship facing families following concussion. Design and methods: Eighteen youth (10-18 years old) with a diagnosed concussion injury and sixteen parents (13 parent/youth dyads) answered open-ended questions regarding experiences associated with concussion care and recovery, specifically as they related to cost. Participants were recruited from a concussion clinic, social media, and via snowball sampling. Interviews were audio recorded, transcribed verbatim, and coded using deductive qualitative content analysis. Results: In addition to direct health care expenses (e.g. copays and deductibles), families of youth with concussion faced indirect costs associated with tutoring and transportation to medical appointments, in some cases over long distances. Financial cost-sharing for concussion care varied widely across participants. Conclusions: Lost productivity included parents missing work to care for their child and for travel to appointments. Research that describes costs of care using claims or survey data lack the experiential perspective of the economic burden on families following concussion. (C) 2019 Elsevier Inc. All rights reserved.	[Graves, Janessa M.] Washington State Univ, Coll Nursing Spokane, Spokane, WA 99210 USA; [Moore, Megan] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Kehoe, Leanne] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Li, Matthew; Vavilala, Monica S.] UW, Harborview Injury Prevent & Res Ctr, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Chan, Anissa] Univ Southern Calif, Dana & David Dornsife Coll Letters Arts & Sci, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Graves, Janessa M.; Moore, Megan; Kehoe, Leanne; Li, Matthew; Chan, Anissa; Conrick, Kelsey; Vavilala, Monica S.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Williams-Gilbert, Wendy] Washington State Univ, Coll Nursing, Pullman, WA 99164 USA; [Kehoe, Leanne] Seattle Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA; [Li, Matthew] Univ Washington, Dept Anaesthesiol & Pain Med, Seattle, WA 98195 USA		Graves, JM (corresponding author), Washington State Univ, Coll Nursing, 412 E Spokane Falls Blvd, Spokane, WA 99210 USA.	janessa.graves@wsu.edu; mm99@uw.edu; lkehoe@uw.edu; mattli@uw.edu; kmc621@u.washington.edu; wendy.buenzli@wsu.edu; vavilala@uw.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634	National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [2KL2TR000421-06]	This research was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (2KL2TR000421-06; PI: Moore). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; [Anonymous], 2017, DED VERS 7 5 17; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Byczkowski TL, 2016, ACAD PEDIATR, V16, P327, DOI 10.1016/j.acap.2015.08.011; Collins Christy L, 2014, Inj Epidemiol, V1, P13; De Young AC, 2014, J CHILD ADOL PSYCHOP, V24, P9, DOI 10.1089/cap.2013.0066; Eichner JM, 2012, PEDIATRICS, V129, P394, DOI 10.1542/peds.2011-3084; Fama JP, 2015, J HUM BEHAV SOC ENVI, V25, P522, DOI 10.1080/10911359.2014.884963; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Graves JM, 2019, HEALTH SERV RES, V54, P337, DOI 10.1111/1475-6773.13096; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Moore M, 2015, PEDIATR CRIT CARE ME, V16, P758, DOI 10.1097/PCC.0000000000000494; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; StataCorp, 2015, STAT STAT SOFTW REL; Thomas Emily, 2013, Pediatr Nurs, V39, P299; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wise AE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01412; WWAMI Rural Health Research Center, RUCA DAT US RUCA DAT RUCA DAT US RUCA DAT	33	3	3	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0882-5963			J PEDIATR NURS	J. Pediatr. Nurs.	MAR-APR	2020	51						15	20		10.1016/j.pedn.2019.11.016			6	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	KU5SR	WOS:000519772900021	31838221	Green Accepted			2022-02-06	
J	Hershaw, JN; Hill-Pearson, CA; Arango, JI; Souvignier, AR; Pazdan, RM				Hershaw, Jamie N.; Hill-Pearson, Candace A.; Arango, Jorge I.; Souvignier, Alicia R.; Pazdan, Renee M.			Semi-Automated Neurofeedback Therapy for Persistent Postconcussive Symptoms in a Military Clinical Setting: A Feasibility Study	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; COMBAT VETERANS; SEVERITY; EEG; DEPRESSION; NEUROPSYCHOLOGY; SATISFACTION; COMPLAINTS; CHECKLIST; SCIENCE	Introduction Neurofeedback therapy (NFT) has demonstrated effectiveness for reducing persistent symptoms following traumatic brain injury (TBI); however, its reliance on NFT experts for administration and high number of treatment sessions limits its use in military medicine. Here, we assess the feasibility of live Z-score training (LZT)-a variant of NFT that requires fewer treatment sessions and can be administered by nonexperts-for use in a military clinical setting. Materials and Methods A single group design feasibility study was conducted to assess acceptability, tolerance, treatment satisfaction, and change in symptoms after a 6-week LZT intervention in 38 Service Members (SMs) with persistent symptoms comorbid with or secondary to mild TBI. Acceptance and feasibility were assessed using treatment completion and patients' satisfaction with treatment. To evaluate changes in symptom status, a battery of self-report questionnaires was administered at baseline, posttreatment, and 3-month follow-up to evaluate changes in psychological, neurobehavioral, sleep, pain, and headache symptoms, as well as self-efficacy in symptom management and life satisfaction. Results Participants tolerated the treatment well and reported a positive experience. Symptom improvement was observed, including depressive, neurobehavioral, and pain-related symptoms, with effects sustained at 3-month follow-up. Conclusion LZT treatment appears to be a feasible, non-pharmacological therapy amenable to SMs. Results from this pilot study promote further investigation of LZT as an intervention for SMs with persistent symptoms following TBI.	[Hershaw, Jamie N.; Hill-Pearson, Candace A.; Arango, Jorge I.; Souvignier, Alicia R.; Pazdan, Renee M.] Def & Vet Brain Injury Ctr, Bldg 7489, Ft Carson, CO 80913 USA; [Souvignier, Alicia R.; Pazdan, Renee M.] Evans Army Community Hosp, Warrior Recovery Ctr, Ft Carson, CO 80913 USA		Hershaw, JN (corresponding author), Def & Vet Brain Injury Ctr, Bldg 7489, Ft Carson, CO 80913 USA.				AMEDD Advanced Technology Initiative, through the Telemedicine and Advanced Technology Research Center [W91YTZ-13-P-0703]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The research reported here was funded by the AMEDD Advanced Technology Initiative, through the Telemedicine and Advanced Technology Research Center (W91YTZ-13-P-0703) with additional support by the Defense and Veterans Brain Injury Center.	Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Center DVBIC, 2017, DOD WORLDW NUMB TBI; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; Choi SW, 2011, NEUROPSYCHOBIOLOGY, V63, P43, DOI 10.1159/000322290; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cohen J., 2013, STAT POWER ANAL BEHA; Collura T., 2010, J NEUROTHERAPY, V14, P22, DOI [DOI 10.1080/10874200903543963, 10.1080/10874200903543963]; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Elliott AM, 2002, BRIT J GEN PRACT, V52, P269; Elrod JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2341-x; Enriquez-Geppert S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00051; Epstein DR, 2012, J REHABIL RES DEV, V49, P867, DOI 10.1682/JRRD.2011.06.0114; Gevensleben H, 2012, EXPERT REV NEUROTHER, V12, P447, DOI [10.1586/ERN.12.22, 10.1586/ern.12.22]; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hammond DC, 2005, J ADULT DEV, V12, P131, DOI 10.1007/s10804-005-7029-5; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroesen K, 2002, FAM PRACT, V19, P57, DOI 10.1093/fampra/19.1.57; Marzbani H, 2016, BASIC CLIN NEUROSCI, V7, P143, DOI 10.15412/J.BCN.03070208; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meyers JE, 2015, APPL NEUROPSYCHOL, V22, P1; Nicholson AA, 2016, NEUROIMAGE-CLIN, V12, P506, DOI 10.1016/j.nicl.2016.07.006; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Sitaram R, 2017, NAT REV NEUROSCI, V18, P86, DOI 10.1038/nrn.2016.164; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stewart WF, 1999, CEPHALALGIA, V19, P107, DOI 10.1046/j.1468-2982.1999.019002107.x; Surmeli T, 2017, CLIN EEG NEUROSCI, V48, P217, DOI 10.1177/1550059416654849; Taylor B, 2015, FISCAL YEAR 2014 VA, P38; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Tinius T. P., 2000, J NEUROTHER, V4, P27, DOI [DOI 10.1300/J184v04n02_05, 10.1300/J184v04n02_05]; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Zotev V, 2018, NEUROIMAGE-CLIN, V19, P106, DOI 10.1016/j.nicl.2018.04.010; [No title captured]	47	3	3	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					E457	E465		10.1093/milmed/usz335			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR7HU	WOS:000535866100022	31603218	Bronze			2022-02-06	
J	Kung, WM; Tzeng, IS; Lin, MS				Kung, Woon-Man; Tzeng, I-Shiang; Lin, Muh-Shi			Three-Dimensional CAD in Skull Reconstruction: A Narrative Review with Focus on Cranioplasty and Its Potential Relevance to Brain Sciences	APPLIED SCIENCES-BASEL			English	Article						decompressive craniectomy; cranioplasty; 3-D CAD; CAM; alloplastic implants	RESORPTION FOLLOWING CRANIOPLASTY; DECOMPRESSIVE CRANIECTOMY; TITANIUM MESH; FLAP RESORPTION; BONE; TECHNOLOGIES; EXPERIENCE; PROSTHESES; CHILDREN; DESIGN	In patients suffering from severe traumatic brain injury and massive stroke (hemorrhagic or ischemic), decompressive craniectomy (DC) is a surgical strategy used to reduce intracranial pressure, and to prevent brainstem compromise from subsequent brain edema. In surviving patients, cranioplasty surgery helps to protect brain tissue, and correct the external deformity. The aesthetic outcome of cranioplasty using an asymmetrical implant can negatively influence patients physically and mentally, especially young patients. Advancements in the development of biomaterials have now made three-dimensional (3-D) computer-assisted design/manufacturing (CAD/CAM)-fabricated implants an optimal choice for the repair of skull defects following DC. Here, we summarize the various materials for cranioplasty, including xenogeneic, autogenous, and alloplastic grafts. The processing procedures of the CAD/CAM technique are briefly outlined, and reflected our experiences to reconstruct skull CAD models using commercial software, published previously, to assess aesthetic outcomes of regular 3-D CAD models without contouring elevation or depression. The establishment of a 3-D CAD model ensures a possibility for better aesthetic outcomes of CAM-derived alloplastic implants. Finally, clinical consideration of the CAD algorithms for adjusting contours and their potential application in prospective healthcare are briefly outlined.	[Kung, Woon-Man; Tzeng, I-Shiang] Chinese Culture Univ, Coll Educ, Dept Exercise & Hlth Promot, Taipei 11114, Taiwan; [Lin, Muh-Shi] Kuang Tien Gen Hosp, Dept Surg, Div Neurosurg, Taichung 43303, Taiwan; [Lin, Muh-Shi] Natl Ilan Univ, Coll Bioresources, Dept Biotechnol & Anim Sci, Yilan 26047, Taiwan; [Lin, Muh-Shi] Hung Kuang Univ, Coll Med & Hlth Care, Dept Biotechnol, Taichung 43302, Taiwan; [Lin, Muh-Shi] Hung Kuang Univ, Coll Med & Hlth Care, Dept Hlth Business Adm, Taichung 43302, Taiwan		Lin, MS (corresponding author), Kuang Tien Gen Hosp, Dept Surg, Div Neurosurg, Taichung 43303, Taiwan.; Lin, MS (corresponding author), Natl Ilan Univ, Coll Bioresources, Dept Biotechnol & Anim Sci, Yilan 26047, Taiwan.; Lin, MS (corresponding author), Hung Kuang Univ, Coll Med & Hlth Care, Dept Biotechnol, Taichung 43302, Taiwan.; Lin, MS (corresponding author), Hung Kuang Univ, Coll Med & Hlth Care, Dept Hlth Business Adm, Taichung 43302, Taiwan.	nskungwm@yahoo.com.tw; istzeng@gmail.com; neurosurgery2005@yahoo.com.tw	Tzeng, I-Shiang/AAD-8063-2019; Kung, Woon-Man/Q-3012-2019; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/U-7004-2019	Tzeng, I-Shiang/0000-0002-9047-8141; Kung, Woon-Man/0000-0001-8311-2902; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/0000-0002-9798-8160			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Azmi A, 2004, Med J Malaysia, V59, P418; Bandyopadhyay T K, 2005, Med J Armed Forces India, V61, P36, DOI 10.1016/S0377-1237(05)80116-9; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bramlet M, 2017, CIRC RES, V120, P904, DOI 10.1161/CIRCRESAHA.116.310546; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Chang S., 2003, BARROW Q, V61, P744; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chen ST, 2015, INJURY, V46, P80, DOI 10.1016/j.injury.2014.09.019; Davidowitz Gary, 2011, Dent Clin North Am, V55, P559, DOI 10.1016/j.cden.2011.02.011; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Huang X, 2010, INT J MED SCI, V7, P385; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Jiao T, 2004, INT J PROSTHODONT, V17, P460; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; KAISER A, 1993, EUR J PEDIATR SURG, V3, P236, DOI 10.1055/s-2008-1063551; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kung WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074267; Kung WM, 2012, BRAIN INJURY, V26, P1737, DOI 10.3109/02699052.2012.698361; Kung WM, 2012, J NEUROTRAUM, V29, P2030, DOI 10.1089/neu.2011.2220; Lakhani RS, 2001, ARCH OTOLARYNGOL, V127, P665, DOI 10.1001/archotol.127.6.665; Leeson D, 2020, DENT MATER, V36, P43, DOI 10.1016/j.dental.2019.10.010; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055; Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012; Nayar S, 2015, J PHARM BIOALLIED SC, V7, pS216, DOI 10.4103/0975-7406.155913; Park SP, 2017, J KOREAN NEUROSURG S, V60, P749, DOI 10.3340/jkns.2017.0203.002; PROLO DJ, 1991, CLIN ORTHOP RELAT R, P270; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Scholz M, 2007, J CRANIO MAXILL SURG, V35, P388, DOI 10.1016/j.jcms.2007.06.006; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108; Zonenshayn M, 2004, J NEUROSURG, V100, P537, DOI 10.3171/ped.2004.100.5.0537	46	3	3	2	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	MAR	2020	10	5							1847	10.3390/app10051847			12	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	LC4MI	WOS:000525298100295		gold			2022-02-06	
J	Lang, SS; Khanna, O; Atkin, NJ; Palma, JE; Yuan, I; Storm, PB; Heuer, GG; Kennedy, B; Waanders, AJ; Li, YM; Huh, JW				Lang, Shih-Shan; Khanna, Omaditya; Atkin, Natalie J.; Palma, Judy E.; Yuan, Ian; Storm, Phillip B.; Heuer, Gregory G.; Kennedy, Benjamin; Waanders, Angela J.; Li, Yimei; Huh, Jimmy W.			Perioperative near-infrared spectroscopy cerebral oxygen saturation in symptomatic pediatric hydrocephalus patients at risk for intracranial hypertension	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						near-infrared spectroscopy; hydrocephalus; intracranial pressure; cerebral hypoxia; neurocritical care; pediatric; neuromonitoring	FLUID SHUNT MALFUNCTION; TRAUMATIC BRAIN-INJURY; TRANSCRANIAL DOPPLER; CARE PATIENTS; BLOOD-FLOW; EMERGENCY; PRESSURE; EPIDEMIOLOGY; MULTICENTER; PERFUSION	OBJECTIVE The lack of a continuous, noninvasive modality for monitoring intracranial pressure (ICP) is a major obstacle in the care of pediatric patients with hydrocephalus who are at risk for intracranial hypertension. Intracranial hypertension can lead to cerebral ischemia and brain tissue hypoxia. In this study, the authors evaluated the use of nearinfrared spectroscopy (NIRS) to measure regional cerebral oxygen saturation (rSO(2)) insymptomatic pediatric patients with hydrocephalus concerning for elevated ICP. METHODS The authors evaluated the NIRS rSO(2) trends in pediatric patients presenting with acute hydrocephalus and clinical symptoms of intracranial hypertension. NIRS rSO(2) values were recorded hourly before and after neurosurgical intervention. To test for significance between preoperative and postoperative values, the authors constructed a linear regression model with the rSO(2) values as the outcome and pre- and postsurgery cohorts as the independent variable, adjusted for age and sex, and used the generalized estimating equation method to account for within-subject correlation. RESULTS Twenty-two pediatric patients underwent NIRS rSO(2) monitoring before and after CSF diversion surgery. The mean durations of NIRS rSO(2) recording pre- and postoperatively were 13.95 and 26.82 hours, respectively. The mean pre- and postoperative rSO(2) values were 73.84% and 80.65%, respectively, and the adjusted mean difference estimated from the regression model was 5.98% (adjusted p < 0.0001), suggestive of improved cerebral oxygenation after definitive neurosurgical CSF diversion treatment. Postoperatively, all patients returned to baseline neurological status with no clinical symptoms of elevated ICP. CONCLUSIONS Cerebral oxygenation trends measured by NIRS in symptomatic pediatric hydrocephalus patients with intracranial hypertension generally improve after CSF diversion surgery.	[Lang, Shih-Shan; Storm, Phillip B.; Heuer, Gregory G.; Kennedy, Benjamin] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Lang, Shih-Shan; Storm, Phillip B.; Heuer, Gregory G.; Kennedy, Benjamin] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Khanna, Omaditya] Thomas Jefferson Univ Hosp, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Atkin, Natalie J.; Yuan, Ian; Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Atkin, Natalie J.; Yuan, Ian; Huh, Jimmy W.] Univ Penn, Dept Anesthesia, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lang, Shih-Shan; Palma, Judy E.; Storm, Phillip B.; Heuer, Gregory G.; Kennedy, Benjamin; Waanders, Angela J.] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed, Philadelphia, PA 19104 USA; [Li, Yimei] Childrens Hosp Philadelphia, Dept Oncol, Philadelphia, PA 19104 USA; [Li, Yimei] Univ Penn, Dept Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Yimei] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Waanders, Angela J.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol & Stem Cell Transplant, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA		Lang, SS (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	chens4@email.chop.edu					Abecasis F, 2018, CHILD NERV SYST, V34, P1465, DOI 10.1007/s00381-018-3877-8; Abramo TJ, 2015, PEDIATR EMERG CARE, V31, P479, DOI 10.1097/PEC.0000000000000141; Bondurant CP, 1995, PEDIATR NEUROSURG, V23, P254, DOI 10.1159/000120968; Boyle TP, 2015, PEDIATR EMERG CARE, V31, P435, DOI 10.1097/PEC.0000000000000462; DASILVA MC, 1995, J CEREBR BLOOD F MET, V15, P1057, DOI 10.1038/jcbfm.1995.132; Drayna PC, 2011, PEDIATR EMERG CARE, V27, P432, DOI 10.1097/PEC.0b013e3182188442; Dunham CM, 2002, J TRAUMA, V52, P40, DOI 10.1097/00005373-200201000-00009; Esnault P, 2015, MINERVA ANESTESIOL, V81, P876; Ferraris A, 2018, J CLIN MONIT COMPUT, V32, P253, DOI 10.1007/s10877-017-0025-z; Figaji AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E4; Friess SH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/361310; Ghanayem NS, 2011, PEDIATR CRIT CARE ME, V12, pS27, DOI 10.1097/PCC.0b013e318221173a; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Kestle JRW, 2019, J NEUROSURG-PEDIATR, V23, P135, DOI 10.3171/2018.10.PEDS18328; Kim TY, 2006, PEDIATR EMERG CARE, V22, P28, DOI 10.1097/01.pec.0000195764.50565.8c; Klinge P, 2002, ACTA NEUROCHIR SUPPL, V81, P55; Kreeger RN, 2012, ANN THORAC SURG, V94, P1527, DOI 10.1016/j.athoracsur.2012.05.096; Lam Sandi, 2015, Surg Neurol Int, V6, pS346, DOI 10.4103/2152-7806.161413; LaRovere KL, 2016, J NEUROTRAUM, V33, P2105, DOI 10.1089/neu.2015.4344; Limbrick DD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172353; Lovett ME, 2019, PEDIATR NEUROL, V94, P3, DOI 10.1016/j.pediatrneurol.2018.12.003; Ballestero MFM, 2017, CHILD NERV SYST, V33, P1517, DOI 10.1007/s00381-017-3475-1; Maslehaty H, 2012, ISRN NEUROL, V2012, P907187; O'Brien NF, 2015, J NEUROSURG-PEDIATR, V16, P420, DOI 10.3171/2015.3.PEDS14521; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; Olbrecht VA, 2018, ANESTHESIOLOGY, V128, P85, DOI 10.1097/ALN.0000000000001920; Park DB, 2016, PEDIATR EMERG CARE, V32, P585, DOI 10.1097/PEC.0000000000000760; Robba C, 2019, CHILDS NERV SYST; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Sharma G, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1039-x; Soul JS, 2004, PEDIATR RES, V55, P872, DOI 10.1203/01.PDR.0000119370.21770.AC; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stone JJ, 2013, J NEUROSURG-PEDIATR, V11, P15, DOI 10.3171/2012.9.PEDS1298; Tasker RC, 2014, SEMIN PEDIATR NEUROL, V21, P255, DOI 10.1016/j.spen.2014.10.004; Topjian AA, 2014, NEUROCRIT CARE, V21, P294, DOI 10.1007/s12028-013-9946-7; Tyree K, 2009, PERFUSION-UK, V24, P325, DOI 10.1177/0267659109353966; Weber F, 2019, PEDIATR ANESTH, V29, P993, DOI 10.1111/pan.13726; Zuluaga MT, 2010, PEDIATR CRIT CARE ME, V11, P514, DOI 10.1097/PCC.0b013e3181c51cf1	39	3	3	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2020	25	3					235	241		10.3171/2019.9.PEDS19457			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	KS6AR	WOS:000518390100005	31783356				2022-02-06	
J	Lohani, S; Bhandari, S; Ranabhat, K; Agrawal, P				Lohani, Subash; Bhandari, Shreeram; Ranabhat, Kajan; Agrawal, Prity			Does Diffuse Axonal Injury MRI Grade Really Correlate with Functional Outcome?	WORLD NEUROSURGERY			English	Article						DAI; GOSE	MAGNETIC-RESONANCE; PROGNOSTIC VALUE; CORPUS-CALLOSUM; HEAD-INJURIES; BRAIN-INJURY; MODERATE	OBJECTIVE: Diffuse axonal injury (DAI) is a common form of primary head injury. This study was done to see the association of DAI grades with extended Glasgow Outcome Scale (GOSE). METHODS: We retrospectively reviewed the charts and radiology reports of a cohort of patients discharged with the diagnosis of diffuse axonal injury. We collected data on variables like age, sex, Glasgow Coma Scale (GCS) at admission, grade of DAI, length of hospital stay, and occurrence of post-traumatic seizures. We contacted the patients after 6 months to assess their GOSE. Outcome analysis was done with SPSS version 23. RESULTS: For 40 patients, DAI and 6-month GOSE were -tillable for analysis. Mean age was 27.8 years, with male to female ratio of 12:1. There were 8 patients with DAI grade I (20.5%),13 patients with DAI grade II (33.3%), and 18 patients with DAI grade III (46.2%). Nine of 39 patients (23.07%) had post-traumatic seizures. Mean GCS at admission was 9.67- Mean length of hospital stay was 24.12 days. Mean GOSE after 6 months was 6.10. There were 5 mortalities. Patients with low mean GCS portended significant unfavorable outcome. Higher DAI grades were not associated with unfavorable outcome. CONCLUSIONS: Mean GCS at presentation is a better predictor of outcome after DAI rather than its grade.	[Lohani, Subash; Bhandari, Shreeram] Upendra Devkota Mem Natl Inst Neurol & Allied Sci, Dept Neurosurg, Kathmandu, Nepal; [Ranabhat, Kajan; Agrawal, Prity] Upendra Devkota Mem Natl Inst Neurol & Allied Sci, Dept Radiol, Kathmandu, Nepal		Lohani, S (corresponding author), Upendra Devkota Mem Natl Inst Neurol & Allied Sci, Dept Neurosurg, Kathmandu, Nepal.	subash.lohani@gmail.com	Ranabhat, Kajan/AAE-4133-2021	Ranabhat, Kajan/0000-0002-3689-3889			Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Vieira RDA, 2018, WORLD NEUROSURG, V109, P140, DOI 10.1016/j.wneu.2017.09.101; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Firsching R, 2017, DTSCH ARZTEBL INT, V114, P313, DOI 10.3238/arztebl.2017.0313; GENTRY LR, 1994, RADIOLOGY, V191, P1; Henninger N, 2018, J TRAUMA ACUTE CARE, V84, P473, DOI 10.1097/TA.0000000000001733; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Matsukawa H, 2011, ACTA NEUROCHIR, V153, P1687, DOI 10.1007/s00701-011-1002-9; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Park SJ, 2009, J KOREAN NEUROSURG S, V46, P205, DOI 10.3340/jkns.2009.46.3.205; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	26	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2020	135									10.1016/j.wneu.2019.12.017			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KR7GS	WOS:000517784600049	31843722				2022-02-06	
J	Miyashita, TL; Ullucci, PA				Miyashita, Theresa L.; Ullucci, Paul A.			Correlation of Head Impact Exposures With Vestibulo-Ocular Assessments	JOURNAL OF SPORT REHABILITATION			English	Article						subconcussion; vision; vestibulo-ocular system	VESTIBULAR SYSTEM; TRAUMA	Context: Managing a concussion injury should involve the incorporation of a multifaceted approach, including a vision assessment. The frontoparietal circuits and subcortical nuclei are susceptible to trauma from a concussion injury, leading to dysfunction of the vestibulo-ocular system. Research investigating the effect of cumulative subconcussive impacts on neurological function is still in its infancy, but repetitive head impacts may result in vestibular system dysfunction. This dysfunction could create visual deficits, predisposing the individual to further head trauma. Objective: The purpose of this study was to investigate the cumulative effect of subconcussive impacts on minimum perception time, static visual acuity, gaze stability, and dynamic visual acuity scores. Design: Prospective cohort. Setting: Division I university. Patients: Thirty-three Division I men's lacrosse players (age = 19.52 [1.20] y). Intervention: Competitive lacrosse season. Main Outcome Measures: At the beginning and end of the season, the players completed a vestibulo-ocular reflex assessment, using the InVision (TM) system by Neurocom (R) to assess perception, static acuity, gaze stability, and dynamic visual acuity. Score differentials were correlated with the head impact exposure data collected via instrumented helmets. Results: A significant correlation was found between change in perception scores and total number of head impacts (r = .54), and between changes in dynamic visual acuity loss scores on the rightside and maximum rotational acceleration (r = .36). No statistical differences were found between preseason and postseason vestibulo-ocular reflex variables. Conclusions: Cumulative subconcussive impacts may negatively affect vestibulo-ocular reflex scores, resulting in decreased visual performance. This decrease in vestibulo-ocular function may place the athlete at risk of sustaining additional head impacts or other injuries.	[Miyashita, Theresa L.] Concordia Univ Chicago, Exercise Sci, River Forest, IL 60305 USA; [Ullucci, Paul A.] Sacred Heart Univ, Fairfield, CT USA		Miyashita, TL (corresponding author), Concordia Univ Chicago, Exercise Sci, River Forest, IL 60305 USA.	theresa.miyashita@cuchicago.edu	Ullucci, Paul A./AAR-1570-2021	Ullucci, Paul A./0000-0003-1930-6520	US Lacrosse Sports Science and Safety Committee	The authors would like to thank the Sacred Heart University men's lacrosse team and coaching staff for their commitment to this project. There are no conflicts of interest to report. This project was funded in part by a grant from the US Lacrosse Sports Science and Safety Committee. The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of US Lacrosse.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Beckerman Stephen, 2003, Optometry, V74, P502; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cohen HS, 2003, J SAFETY RES, V34, P361, DOI 10.1016/j.jsr.2003.09.009; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hitzeman S A, 1993, Optom Clin, V3, P145; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; Peters BT, 2012, J VESTIBUL RES-EQUIL, V22, P145, DOI 10.3233/VES-2012-0440; Raczek J, 2012, COORDINATION MOTOR A; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schubert MC, 2004, PHYS THER, V84, P373, DOI 10.1093/ptj/84.4.373; Ward BK, 2010, J VESTIBUL RES-EQUIL, V20, P363, DOI 10.3233/VES-2010-0371; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	26	3	3	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAR	2020	29	3					310	314		10.1123/jsr.2017-0282			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LX7OX	WOS:000540017800008	30676193				2022-02-06	
J	Morra, JA; Alao, AO				Morra, Joseph A.; Alao, Adekola O.			Role of quetiapine in protection of neurodegeneration after traumatic brain injury	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						TBI; neurogenesis; quetiapine; neuroprotective; schizophrenia	DOPAMINE-D-2 OCCUPANCY	Objective Schizophrenia is a chronic psychotic disorder in which patients experience positive and negative symptoms for over six months. Schizophrenia is associated with early mortality, with 40% of this excess mortality due to suicide. This is a case of patient with schizophrenia who was treated with quetiapine after suffering a traumatic brain injury and recovered enough to be discharged to a rehabilitation unit. This case illustrates the neuroprotective effects of quetiapine in treating neurologic deficits in a patient who recently suffered a traumatic brain injury. Method This is a case report of a patient with schizophrenia treated in the hospital setting. He was placed on quetiapine after suffering a traumatic brain injury due to a suicide attempt in which he shot himself with a nail gun. Results The patient initially presented with neurologic deficits suggestive of traumatic brain injury (inattention, memory loss, muscle weakness) and psychosis from schizophrenia. He was treated with quetiapine and recovered enough to be discharged to a rehabilitation unit. Conclusion Quetiapine, a second-generation antipsychotic, has been shown to significantly decrease blood-brain barrier hyperpermeability by preserving tight junction integrity in small animal models. This anti-inflammatory effect may also help to preserve neurogenesis in patients with traumatic brain injury, as shown in this case. This case may help elucidate the nature of quetiapine's neuroprotective effects in patients who have suffered traumatic brain injury and also highlights the need to further investigate other atypical antipsychotics and their potential neuroprotective role in treating traumatic brain injury.	[Morra, Joseph A.; Alao, Adekola O.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY USA; [Morra, Joseph A.] SUNY Upstate Med Univ, Joseph Morra, 766 Irving Ave, Syracuse, NY 13210 USA		Morra, JA (corresponding author), SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY USA.; Morra, JA (corresponding author), SUNY Upstate Med Univ, Joseph Morra, 766 Irving Ave, Syracuse, NY 13210 USA.	morraj2019@gmail.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; de Greef R, 2011, AAPS J, V13, P121, DOI 10.1208/s12248-010-9247-4; Faul M, 2010, TRAUMATIC BRAIN INJU; Free KE, 2017, EXP NEUROL, V296, P62, DOI 10.1016/j.expneurol.2017.07.004; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Robinson BD, 2018, J TRAUMA ACUTE CARE, V85, P968, DOI 10.1097/TA.0000000000002011; Singh A., 2013, J DENT MED SCI, V3, P75; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	10	3	3	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2174	1541-3527		INT J PSYCHIAT MED	Int. J. Psychiatr. Med.	MAR	2020	55	2					67	73		10.1177/0091217419838105			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KH9TN	WOS:000510991000001	30913942				2022-02-06	
J	Nalbantoglu, M; Tuncer, OG; Acik, ME; Matur, Z; Altunrende, B; Ozgonenel, E; Ozgonenel, L				Nalbantoglu, Mecbure; Tuncer, Ozlem Gungor; Acik, M. Eren; Matur, Zeliha; Altunrende, Burcu; Ozgonenel, Ebru; Ozgonenel, Levent			Neurogenic heterotopic ossification in Guillain-Barre syndrome: a rare case report	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						Neurogenic Heterotopic Ossification; Guillain Barre Syndrome; Prolonged Immobilisation; Mechanical Ventilation; GBS	TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION	Neurogenic heterotopic ossification (NHO) is an abnormal development of bone in extra-skeletal tissues, related to neurological disease. NHO is frequently seen after traumatic brain injury or spinal cord injury. NHO may also occur as a rare complication of Guillain Barre Syndrome (GBS). Here, we present a 39 year old man with an acute onset of GBS who developed NHO around both hips two months after the disease onset. Our patient had a history of mechanical ventilation, incomplete tetraplegia and prolonged immobilisation. The pathogenesis of NHO is unclear. Various risk factors have been associated with the development of NHO; prolonged coma, long-term sedation, spasticity, degree of paralysis. NHO is a rare complication of GBS and physicians should be aware that it can develop especially in patients with severe paralysis and in need of mechanical ventilation. Pain and restriction of movements, especially in the hips, should bring NHO to the mind.	[Nalbantoglu, Mecbure; Tuncer, Ozlem Gungor; Matur, Zeliha; Altunrende, Burcu] Demiroglu Bilim Univ, Neurol Dept, Med Fac, Istanbul, Turkey; [Acik, M. Eren] Demiroglu Bilim Univ, Anesthesiol & Reanimat Dept, Med Fac, Istanbul, Turkey; [Ozgonenel, Ebru] Demiroglu Bilim Univ, Nucl Med Dept, Med Fac, Istanbul, Turkey; [Ozgonenel, Levent] Demiroglu Bilim Univ, Phys Med & Rehabil Dept, Med Fac, Istanbul, Turkey		Nalbantoglu, M (corresponding author), Demiroglu Bilim Univ, Neurol Dept, Med Fac, Istanbul, Turkey.	mecbure03@hotmail.com					Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Brady RD, 2018, BONE, V109, P35, DOI 10.1016/j.bone.2017.05.015; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Chauveau C, 2008, MOL CELL BIOCHEM, V318, P81, DOI 10.1007/s11010-008-9859-5; Chauveau C, 2004, EXP MOL PATHOL, V76, P37, DOI 10.1016/j.yexmp.2003.10.001; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Gil Joseph A, 2015, R I Med J (2013), V98, P32; Grinspan JB, 2015, VITAM HORM, V99, P195, DOI 10.1016/bs.vh.2015.05.005; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Kanda T, 2013, J NEUROL NEUROSUR PS, V84, P208, DOI 10.1136/jnnp-2012-302312; Mukhi PK, 1996, AM J PHYS MED REHABI, V75, P155; Ohnmar H, 2010, CLIN TER, V161, P529; Ponrartana S, 2012, J CLIN ENDOCR METAB, V97, P2693, DOI 10.1210/jc.2012-1589; RUARK CL, 2017, BONE, V12, P49, DOI DOI 10.1371/JOURNAL.PONE.0171514; Ryu SR, 2008, ARCH PHYS MED REHAB, V89, P564, DOI 10.1016/j.apmr.2007.11.004; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1; Zeilig G, 2006, ARCH PHYS MED REHAB, V87, P92, DOI 10.1016/j.apmr.2005.07.308	19	3	3	0	0	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	MAR	2020	20	1					160	164					5	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	KS7FQ	WOS:000518472800018	32131381				2022-02-06	
J	Namdar, I; Feldman, R; Glazer, S; Meningher, I; Shlobin, NA; Rubovitch, V; Bikovski, L; Been, E; Pick, CG				Namdar, I; Feldman, R.; Glazer, S.; Meningher, I; Shlobin, N. A.; Rubovitch, V; Bikovski, L.; Been, E.; Pick, Chaim G.			Motor Effects of Minimal Traumatic Brain Injury in Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Motor activity; Mice; Neuronal survival; Voluntary wheel running	REVERSES BEHAVIORAL IMPAIRMENTS; NECROSIS-FACTOR-ALPHA; MOUSE MODEL; COGNITIVE DEFICITS; GAIT ABNORMALITIES; MEMORY DEFICITS; HEAD TRAUMA; DISORDERS; IMPACT; SLEEP	Traumatic brain injury (TBI) is considered to be the leading cause of disability and death among young people. Up to 30% of mTBI patients report motor impairments, such as altered coordination and impaired balance and gait. The objective of the present study was to characterize motor performance and motor learning changes, in order to achieve a more thorough understanding of the possible motor consequences of mTBI in humans. Mice were exposed to traumatic brain injury using the weight-drop model and subsequently subjected to a battery of behavioral motor tests. Immunohistochemistry was conducted in order to evaluate neuronal survival and synaptic connectivity. TBI mice showed a different walking pattern on the Erasmus ladder task, without any significant impairment in motor performance and motor learning. In the running wheels, mTBI mice showed reduced activity during the second dark phase and increased activity during the second light phase compared to the control mice. There was no difference in the sum of wheel revolutions throughout the experiment. On the Cat-Walk paradigm, the mice showed a wider frontal base of support post mTBI. The same mice spent a significantly greater percent of time standing on three paws post mTBI compared with controls. mTBI mice also showed a decrease in the number of neurons in the temporal cortex compared with the control group. In summary, mTBI mice suffered from mild motor impairments, minor changes in the circadian clock, and neuronal damage. A more in-depth examination of the mechanisms by which mTBI compensate for motor deficits is necessary.	[Namdar, I; Feldman, R.; Glazer, S.; Meningher, I; Shlobin, N. A.; Rubovitch, V; Been, E.; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Meningher, I; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Shlobin, N. A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bikovski, L.] Tel Aviv Univ, Sackler Sch Med, Myers Neurobehav Core Facil, IL-69978 Tel Aviv, Israel; [Been, E.] Ono Acad Coll, Fac Hlth Profess, Dept Sports Therapy, IL-5545001 Kiryat Ono, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel		Pick, CG (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel.	pickc@tauex.tau.ac.il	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Adelson DP, 1998, PATHOPHYSIOLOGY, V5, P235; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Baratz-Goldstein R, 2017, MOL CELL NEUROSCI, V83, P74, DOI 10.1016/j.mcn.2017.06.004; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Benady A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31623-y; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; CHRISTMAS AJ, 1970, NEUROPHARMACOLOGY, V9, P17, DOI 10.1016/0028-3908(70)90044-4; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Cline MM, 2017, BRAIN RES, V1657, P140, DOI 10.1016/j.brainres.2016.11.027; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; De Oliveira PA, 2017, BRAIN RES, V1663, P78, DOI 10.1016/j.brainres.2017.03.002; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Evans TM, 2015, NEUROSCIENCE, V298, P410, DOI 10.1016/j.neuroscience.2015.04.041; Fine MS, 2016, EXP BRAIN RES, V234, P3173, DOI 10.1007/s00221-016-4714-5; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Marques-Aleixo I, 2015, NEUROSCIENCE, V301, P480, DOI 10.1016/j.neuroscience.2015.06.027; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Montilla-Garcia A, 2017, NEUROPHARMACOLOGY, V125, P231, DOI 10.1016/j.neuropharm.2017.07.029; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Ozolins B, 2016, BRAIN INJURY, V30, P937, DOI 10.3109/02699052.2016.1147080; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Thomasy HE, 2019, J NEUROTRAUM, V36, P802, DOI 10.1089/neu.2018.5810; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Veloz MFV, 2015, BRAIN STRUCT FUNCT, V220, P3513, DOI 10.1007/s00429-014-0870-1; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Woytowicz EJ, 2018, BRAIN INJURY, V32, P191, DOI 10.1080/02699052.2017.1403045; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	69	3	3	2	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2020	70	3					365	377		10.1007/s12031-019-01422-9			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KL2RM	WOS:000513276100007	31820347				2022-02-06	
J	O'Brien, KH				O'Brien, Katy H.			Overcoming Knowledge Barriers for Inclusion of School-Based Speech-Language Pathologists in the Management of Students with Mild Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						pediatrics; mild traumatic brain injury; concussion; return to learn; educational settings; implementation	CONCUSSION MANAGEMENT; REHABILITATION; RECOVERY; SPORT; MISCONCEPTIONS; COLLEGIATE; CONFIDENCE; STATEMENT; CHILDREN; SUPPORT	School-based speech-language pathologists (SLPs) can play an important role in the recovery of children who have sustained a mild traumatic brain injury (mTBI). Two types of knowledge barriers are described here that impact the beliefs and ability of SLPs to respond to the needs of these students. Foundational knowledge is relatively stable over time, and encompasses basic definitions and understanding of the injury. In contrast, flexible knowledge addresses clinical management, including assessment and treatment, and should be regularly updated to align with current best practice recommendations. Clinicians are sensitive to this difference, seeking clinically applicable continuing education. However, general poor understanding of pediatric mTBI paired with rapidly advancing research in the field has led to widespread inaccuracies in both foundational and flexible knowledge. Suggestions are provided for educational initiatives and for advocacy of the role of SLPs in the care of students with mTBI.	[O'Brien, Katy H.] Univ Georgia, Dept Commun Sci & Special Educ, 540 Aderhold Hall,110 Carlton St, Athens, GA 30602 USA		O'Brien, KH (corresponding author), Univ Georgia, Dept Commun Sci & Special Educ, 540 Aderhold Hall,110 Carlton St, Athens, GA 30602 USA.	khobrien@uga.edu					Abbassi E, 2017, BRAIN INJURY, V31, P1667, DOI 10.1080/02699052.2017.1357834; American Speech-Language-Hearing Association, 2018, 2018 SCH SURV SLP CA; American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barwick M., 2014, INT ED RES, V2, P1, DOI DOI 10.12735/IER.V2I4P01; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; BrainSTEPS, 2017, BEST PRACT IMPL PENN; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2019, HEADS UP PROV; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Dachtyl SA, 2017, AM J SPEECH-LANG PAT, V26, P716, DOI 10.1044/2017_AJSLP-16-0138; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Douglas N. F., 2019, PERSPECTIVES ASHA SP, V4, P1, DOI [10.1044/2018_PERS-ST-2018-0000, DOI 10.1044/2018_PERS-ST-2018-0000]; Douglas NF, 2015, J SPEECH LANG HEAR R, V58, pS1827, DOI 10.1044/2015_JSLHR-L-15-0302; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Eastman A, 2015, NEUROREHABILITATION, V37, P235, DOI 10.3233/NRE-151256; Ehren Barbara J., 2001, Seminars in Speech and Language, V22, P233, DOI 10.1055/s-2001-16146; Ehren BJ, 2006, TOP LANG DISORD, V26, P42, DOI 10.1097/00011363-200601000-00005; Ehren BJ, 2001, SEMIN SPEECH LANG, V22, P242; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Green LW, 2009, ANNU REV PUBL HEALTH, V30, P151, DOI 10.1146/annurev.publhealth.031308.100049; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Homer Emily M, 2000, Lang Speech Hear Serv Sch, V31, P62, DOI 10.1044/0161-1461.3101.62; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Hux K, 2013, SUPPORT LEARN, V28, P109, DOI 10.1111/1467-9604.12028; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Ketcham C J, 2017, CUR RES CONCUSSION, V4, pe8; Kim S, 2018, J AMATEUR SPORT, V4, P82, DOI DOI 10.17161/jas.v4i1.6664; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Linden MA, 2018, NEUROREHABILITATION, V42, P311, DOI 10.3233/NRE-172357; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1371, DOI 10.1044/2019_AJSLP-18-0295; Maerlender Arthur, 2019, Concussion, V4, pCNC61, DOI 10.2217/cnc-2018-0008; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McAvoy K, 2009, REAP BENEFITS GOOD C; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meyer AND, 2013, JAMA INTERN MED, V173, P1952, DOI 10.1001/jamainternmed.2013.10081; Mullen R, 2005, EVIDENCE BASED PRACT; O'Brien KH, 2019, TOP LANG DISORD, V39, P313, DOI 10.1097/TLD.0000000000000190; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-105; Ratner NB, 2006, LANG SPEECH HEAR SER, V37, P257, DOI 10.1044/0161-1461(2006/029); Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Schellinger SK, 2018, BRAIN INJURY, V32, P1377, DOI 10.1080/02699052.2018.1492737; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Stockbridge MD, 2018, BRAIN INJURY, V32, P506, DOI 10.1080/02699052.2018.1429660; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theadom A, 2019, NEUROPSYCHOLOGY, V33, P560, DOI 10.1037/neu0000516; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	83	3	3	1	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	MAR	2020	41	2					195	207		10.1055/s-0040-1701687			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	LE5NF	WOS:000526765100006	32155654				2022-02-06	
J	Pressman, E; Penn, D; Patel, NJ				Pressman, Elliot; Penn, David; Patel, Nirav J.			Intracranial Hemorrhage from Meningioma: 2 Novel Risk Factors	WORLD NEUROSURGERY			English	Article						Estrogen; Hemorrhage; Hormone replacement therapy; Meningioma; Selective serotonin reuptake inhibitor; Spontaneous; Subarachnoid hemorrhage	SEROTONIN REUPTAKE INHIBITORS; SUBARACHNOID HEMORRHAGE; SUBDURAL-HEMATOMA; BRAIN-TUMOR; ANTIDEPRESSANTS; ASSOCIATION; MECHANISM; THERAPY	BACKGROUND: Meningiomas are the most common benign intracranial tumor. Although meningiomas are slow growing and potentially highly vascularized, hemorrhage of these tumors is rare. We propose 2 novel modifiable risk factors that may provoke intratumoral hemorrhage of a World Health Organization grade I meningioma. CASE DESCRIPTION: We outline the clinical presentation of a 56-year-old female with spontaneous subarachnoid hemorrhage with intraventricular extension in a coma from a petroclival meningioma taking escitalopram for depression and high-dose estrogen replacement therapy for menopause. Pathology confirmed the diagnosis of World Health Organization grade I meningioma. Postoperatively, the patient declined neurologically and developed vasospasm of the basilar artery, as well as seizures, fever, and new-onset atrial fibrillation. CONCLUSIONS: Spontaneous hemorrhage of meningiomas is a rare event. Known risk factors are age older than 70 or younger than 30; intraventricular or convexity location; malignant, fibrous, or angioblastic histopathology; and presence of hypertension, anticoagulation therapy, and traumatic brain injury. We propose 2 new risk factors to be considered that may predispose to hemorrhage of a meningioma: serotonin-modulating therapy and high-dose estrogen-replacement.	[Pressman, Elliot] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Penn, David; Patel, Nirav J.] Harvard Med Sch, Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA		Patel, NJ (corresponding author), Harvard Med Sch, Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA.	npatel40@bwh.harvard.edu		Pressman, Elliot/0000-0002-5160-802X			Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; ASKENASY HM, 1960, NEUROLOGY, V10, P484, DOI 10.1212/WNL.10.5.484; Bambakidis NC, 2008, NEUROSURGERY, V62, P1182, DOI [10.1227/01.NEU.0000280119.36270.BA, 10.1227/01.neu.0000333784.04435.65]; BLOOMGARDEN GM, 1987, NEUROSURGERY, V20, P24, DOI 10.1227/00006123-198701000-00006; Bosnjak R, 2005, J NEUROSURG, V103, P473, DOI 10.3171/jns.2005.103.3.0473; BUDNY JL, 1977, SURG NEUROL, V8, P323; CHASKIS C, 1992, CLIN NEUROL NEUROSUR, V94, P269, DOI 10.1016/0303-8467(92)90103-A; Cheng MH, 1997, J FORMOS MED ASSOC, V96, P116; Cushing H., 1938, MENINGIOMAS THEIR CL; de Almeida JPC, 2009, J CLIN NEUROSCI, V16, P1246, DOI 10.1016/j.jocn.2008.11.017; Douros A, 2018, CNS DRUGS, V32, P321, DOI 10.1007/s40263-018-0507-7; EL-BANHAWY A, 1962, Acta Neurochir (Wien), V10, P194, DOI 10.1007/BF01406544; EVERETT BA, 1979, SURG NEUROL, V11, P233; Globus JH, 1942, J AMER MED ASSOC, V120, P348, DOI 10.1001/jama.1942.02830400022006; GORAN A, 1965, ARCH NEUROL-CHICAGO, V13, P65, DOI 10.1001/archneur.1965.00470010069009; GRUSZKIEWICZ J, 1969, NEUROCHIRURGIA, V12, P107; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Hadidy AM, 2010, NEUROSCIENCES, V15, P11; Halperin Demian, 2007, Dialogues Clin Neurosci, V9, P47; Hambra Di Vitantonio, 2014, Surg Neurol Int, V5, pS469, DOI 10.4103/2152-7806.143724; HAMER J, 1979, NEUROCHIRURGIA, V22, P189; HELLE TL, 1980, J NEUROL NEUROSUR PS, V43, P725, DOI 10.1136/jnnp.43.8.725; HOESSLY GF, 1955, J NEUROSURG, V12, P614, DOI 10.3171/jns.1955.12.6.0614; JONES N R, 1989, British Journal of Neurosurgery, V3, P691, DOI 10.3109/02688698908992693; Kim DG, 2000, ACTA NEUROCHIR, V142, P165, DOI 10.1007/s007010050019; KOHLI CM, 1984, NEUROSURGERY, V15, P237, DOI 10.1227/00006123-198408000-00014; Kouyialis AT, 2004, J CLIN NEUROSCI, V11, P906, DOI 10.1016/j.jocn.2004.02.014; LANG I, 1995, AM J NEURORADIOL, V16, P1378; LAZARO RP, 1981, NEUROSURGERY, V8, P96, DOI 10.1227/00006123-198101000-00018; Lee Heui Seung, 2013, Korean J Spine, V10, P255, DOI 10.14245/kjs.2013.10.4.255; MARTINEZLAGE JF, 1991, ACTA NEUROCHIR, V110, P129, DOI 10.1007/BF01400680; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Miyazawa Takahito, 2008, J Stroke Cerebrovasc Dis, V17, P325, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.009; MODESTI LM, 1976, J NEUROSURG, V45, P437, DOI 10.3171/jns.1976.45.4.0437; Motegi H, 2012, BRAIN TUMOR PATHOL, V29, P240, DOI 10.1007/s10014-012-0088-y; Movig KLL, 2003, ARCH INTERN MED, V163, P2354, DOI 10.1001/archinte.163.19.2354; Nakao N, 1991, No To Shinkei, V43, P589; Niiro M, 2003, ACTA NEUROCHIR, V145, P767, DOI 10.1007/s00701-003-0089-z; Niwa J, 1989, Neurol Med Chir (Tokyo), V29, P927, DOI 10.2176/nmc.29.927; Okuno S, 1999, SURG NEUROL, V52, P180, DOI 10.1016/S0090-3019(97)00028-1; Onesti ST, 1996, ACTA NEUROCHIR, V138, P1250, DOI 10.1007/BF01809756; PLUCHINO F, 1983, ACTA NEUROCHIR, V68, P45, DOI 10.1007/BF01406201; Qureshi AI, 2016, J NEUROSURG, V124, P45, DOI 10.3171/2014.12.JNS142329; Renoux C, 2017, JAMA NEUROL, V74, P173, DOI 10.1001/jamaneurol.2016.4529; Rim NJ, 2008, KOREAN J RADIOL, V9, pS10, DOI 10.3348/kjr.2008.9.s.s10; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Shuangshoti S, 1999, NEUROPATHOLOGY, V19, P150; SPEKTOR S, 1995, ACTA NEUROCHIR, V134, P51, DOI 10.1007/BF01428502; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; WAKAI S, 1982, NEUROSURGERY, V10, P437, DOI 10.1227/00006123-198204000-00004; WANG AM, 1985, J COMPUT ASSIST TOMO, V9, P511, DOI 10.1097/00004728-198505000-00019; Wang HC, 2016, WORLD NEUROSURG, V94, P319, DOI 10.1016/j.wneu.2016.07.042; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673	53	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2020	135									10.1016/j.wneu.2019.10.173			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KR7GS	WOS:000517784600137	31698125				2022-02-06	
J	Ren, R; Dai, JW; Zhi, Y; Xie, FQ; Shi, J				Ren, Rong; Dai, Jiewen; Zhi, Yin; Xie, Fuqiang; Shi, Jun			Comparison of temporomandibular joint function and morphology after surgical and non-surgical treatment in adult condylar head fractures	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Surgical treatment; Conservative treatment; Condylar head fracture; Helkimo index	RESONANCE-IMAGING ASSESSMENT; SOFT-TISSUE INJURIES; MANDIBULAR CONDYLE; INTERNAL-FIXATION; OPEN REDUCTION; INTRACAPSULAR FRACTURES; CLOSED TREATMENT; CLASSIFICATION	Purpose: The aim of this study was to evaluate whether surgical treatment can distinctly improve temporomandibular joint (TMJ) function and morphology in adult patients with condylar head fractures (CHFs) when compared with conservative treatment. Patients and methods: A retrospective study was performed to evaluate surgical and conservative outcomes in all patients who had suffered CHFs. In this study, all patients were divided into a surgical group and a conservative group. In the surgical group patients were treated by open reduction and internal fixation (ORIF) combined disc anchorage, while in the conservative group patients were treated by a removable splint combined with intermaxillary elastics. Clinical and radiological outcomes were evaluated and functional outcomes were assessed using the Helkimo index score. Paired t-tests, Wilcoxon signed rank tests, independent t-tests and chi(2) tests were used to assess inter-group differences. Results: 75 TMJs in 56 patients were included in this study and were divided into a surgical group (56 TMJs in 40 patients) and a conservative group (19 TMJs in 16 patients). The results showed that the Helkimo index score for TMJ in the surgical group was better than in the conservative group (P-Ai = 0.032, P-Di = 0.001, respectively). Ramus height in the surgical group (61.08 +/- 4.04 mm) recovered more than in the conservative group (54.82 +/- 3.06 mm) (p = 0.012). Discs became shorter, moved further forward, and became severely distorted in the conservative group (disc length = 7.32 +/- 1.35 mm). In contrast, discs became longer, retained a normal disc-condyle relationship, and formed a normal shape in the surgical group (disc length = 11.05 +/- 2.07 mm) (p = 0.003). According to the MRI images, joint effusion, retrodiscal tear, and lateral capsular tear were better cured in the surgical group (p = 0.001, p < 0.001, p = 0.012, respectively). Conclusion: Based on these results, it seems that surgical treatment of condylar head fractures should be the preferred approach if there are no contraindications for general anesthesia. (C) 2020 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Ren, Rong; Dai, Jiewen; Zhi, Yin; Shi, Jun] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral & Craniomaxillofacial Sci, Shanghai Key Lab Stomatol,Sch Med, Shanghai, Peoples R China; [Ren, Rong; Xie, Fuqiang] Lanzhou Univ, Dept Oral & Maxillofacial Surg, Hosp 2, 82 Cuiyingmen, Lanzhou 733030, Peoples R China		Xie, FQ (corresponding author), Lanzhou Univ, Dept Oral & Maxillofacial Surg, Hosp 2, 82 Cuiyingmen, Lanzhou 733030, Peoples R China.; Shi, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Craniomaxillofacial Sci, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	xiefq@lzu.edu.com; dr_shijun@163.com			Foundation of Shanghai Jiao Tong University [YG2015QN22]	This work was supported by the Foundation of Shanghai Jiao Tong University (No. YG2015QN22).	Cai BL, 2018, J ORAL MAXIL SURG, V76, P1026, DOI 10.1016/j.joms.2017.12.015; Chen MJ, 2010, J ORAL MAXIL SURG, V68, P2189, DOI 10.1016/j.joms.2009.09.063; Choi BH, 1997, INT J ORAL MAX SURG, V26, P344, DOI 10.1016/S0901-5027(97)80794-1; CHUONG R, 1988, J ORAL MAXIL SURG, V46, P257, DOI 10.1016/0278-2391(88)90003-1; Ellis E 3rd, 2000, Facial Plast Surg, V16, P193, DOI 10.1055/s-2000-12579; Gerhard S, 2007, INT J ORAL MAX SURG, V36, P214, DOI 10.1016/j.ijom.2006.09.013; HE D, 2014, J ORAL MAXILLOFAC SU, V72, P763; He DM, 2009, J ORAL MAXIL SURG, V67, P1672, DOI 10.1016/j.joms.2009.02.012; HELKIMO MI, 1979, ACTA ODONTOL SCAND, V37, P51, DOI 10.3109/00016357909004685; Hlawitschka M, 2005, INT J ORAL MAX SURG, V34, P597, DOI 10.1016/j.ijom.2005.02.004; Hlawitschka M, 2002, J ORAL MAXIL SURG, V60, P784, DOI 10.1053/joms.2002.33246; IIZUKA T, 1991, ORAL SURG ORAL MED O, V72, P400, DOI 10.1016/0030-4220(91)90547-P; Kermer C, 1998, INT J ORAL MAX SURG, V27, P191, DOI 10.1016/S0901-5027(98)80008-8; Kolk A, 2015, J CRANIO MAXILL SURG, V43, P452, DOI 10.1016/j.jcms.2015.02.004; Kommers SC, 2015, J CRANIO MAXILL SURG, V43, P1952, DOI 10.1016/j.jcms.2015.08.031; Landes CA, 2006, INT J ORAL MAX SURG, V35, P115, DOI 10.1016/j.ijom.2005.04.009; Landes CA, 2008, J ORAL MAXIL SURG, V66, P1586, DOI 10.1016/j.joms.2007.06.668; Lee Jong-Sung, 2014, Maxillofac Plast Reconstr Surg, V36, P259, DOI 10.14402/jkamprs.2014.36.6.259; Long X, 2012, CHIN J DENT RES, V15, P17; Loukota RA, 2010, BRIT J ORAL MAX SURG, V48, P477, DOI 10.1016/j.bjoms.2009.08.036; Muller-Richter UDA, 2011, J ORAL MAXIL SURG, V69, P3019, DOI 10.1016/j.joms.2011.02.013; Neff A, 1999, Mund Kiefer Gesichtschir, V3, P24, DOI 10.1007/s100060050088; Neff A, 2000, Mund Kiefer Gesichtschir, V4, P111, DOI 10.1007/s100060050181; Ohnuki T, 2003, ORAL SURG ORAL MED O, V96, P141, DOI 10.1016/S1079-2104(03)00346-9; Pilling E, 2006, J ORAL MAXIL SURG, V64, P868, DOI 10.1016/j.joms.2005.11.049; Ren R, 2018, J CRANIO MAXILL SURG, V46, P2248, DOI 10.1016/j.jcms.2018.10.001; SANTLER G, 1993, J CRANIO MAXILL SURG, V21, P284, DOI 10.1016/S1010-5182(05)80348-8; Schneider M, 2008, J ORAL MAXIL SURG, V66, P2537, DOI 10.1016/j.joms.2008.06.107; Smets LMH, 2003, J CRANIO MAXILL SURG, V31, P162, DOI 10.1016/S1010-5182(03)00025-8; Stegenga B., 1993, Journal of Orofacial Pain, V7, P23; SULLIVAN SM, 1995, J ORAL MAXIL SURG, V53, P763, DOI 10.1016/0278-2391(95)90326-7; Takaku S, 1996, J CRANIO MAXILL SURG, V24, P173, DOI 10.1016/S1010-5182(96)80052-7; Tang YM, 2017, OR SURG OR MED OR PA, V123, pE141, DOI 10.1016/j.oooo.2016.11.019; Vesnaver A, 2008, J ORAL MAXIL SURG, V66, P2123, DOI 10.1016/j.joms.2008.06.010; Yang XJ, 2015, J ORAL MAXIL SURG, V73, P2169, DOI 10.1016/j.joms.2015.05.030; Yu YH, 2013, BRIT J ORAL MAX SURG, V51, P133, DOI 10.1016/j.bjoms.2012.03.019; Zhao YM, 2014, J CRANIO MAXILL SURG, V42, P1078, DOI 10.1016/j.jcms.2012.07.010	37	3	3	0	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	MAR	2020	48	3					323	330		10.1016/j.jcms.2020.01.019			8	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	KU8NL	WOS:000519968900018	32113881				2022-02-06	
J	Sasadai, J; Maeda, N; Shimizu, R; Kobayashi, T; Sakai, S; Komiya, M; Urabe, Y				Sasadai, Junpei; Maeda, Noriaki; Shimizu, Reia; Kobayashi, Takumi; Sakai, Shogo; Komiya, Makoto; Urabe, Yukio			Analysis of team-sport wheelchair falls during the Rio 2016 Summer Paralympic Games: a video-based cross-sectional observational study	BMJ OPEN			English	Article							PROSPECTIVE COHORT; INJURIES; EPIDEMIOLOGY; RUGBY; CONCUSSIONS; BASKETBALL; PLAYERS; USERS; RISK	Objectives To present the fall characteristics of athletes playing wheelchair rugby (WR) and wheelchair basketball (WB) using official videos from the Rio 2016 Paralympic Games and compare the key fall characteristics among the team wheelchair sports event. Methods Eighteen WR and 10 WB game videos for men (MWB) and women (WWB), including 8 teams per sport, were obtained from the official International Paralympic Committee of the Rio 2016 Paralympic Games. The videos were analysed to assess the number of falls, playing time of fall, playing phase, contact with other athletes, the direction of the fall and the body part first in contact with the floor during the fall. Results In total, 359 falls (96 for WR, 172 for MWB and 91 for WWB) occurred with a mean of 5.3, 17.2 and 9.1 falls per match, respectively (p<0.05). Significant differences among the three sports were detected in the playing time (p=0.011), presence of contact (p=0.037), direction (p<0.001) and body part first in contact with the floor (p<0.001). For WR, the falls were primarily lateral and caused by contact, occurring in the second half of the match. WB falls tended to be in the first half for women and the second half for men. Most falls were contact falls in the forward direction. Conclusion By observing the situational details, we described that a number of falls due to contact occurred during these team sports events, especially MWB. In addition, each sport exhibited characteristics attributable to differences in gender, degree of impairment and game rules. The directions of the falls and characteristics of the affected body parts indicate differences in impairments depending on the sport. A fall to the side or back may indicate a risk of injury.	[Sasadai, Junpei; Maeda, Noriaki; Shimizu, Reia; Kobayashi, Takumi; Sakai, Shogo; Komiya, Makoto; Urabe, Yukio] Hiroshima Univ, Dept Sports Rehabil, Hiroshima, Japan		Sasadai, J (corresponding author), Hiroshima Univ, Dept Sports Rehabil, Hiroshima, Japan.	jumpei.sasadai@jpnsport.go.jp	Komiya, Makoto/AAT-8191-2020; Maeda, Noriaki/AAD-7916-2019; shimizu, reia/AAA-9626-2022; Urabe, Yukio/AAS-9779-2021; Sasadai, Junpei/AAE-5964-2019; Komiya, Makoto/AAT-7726-2020	Komiya, Makoto/0000-0003-4183-6114; Maeda, Noriaki/0000-0002-4447-8917; Sasadai, Junpei/0000-0001-6134-4577; 			[Anonymous], 2014, 1964 2012 GAM GROWTH; Blauwet C, 2019, BRIT J SPORT MED, V53, P1391, DOI 10.1136/bjsports-2018-099997; Blauwet CA, 2016, AM J SPORT MED, V44, P1455, DOI 10.1177/0363546516629949; Bradley PS, 2014, HUM MOVEMENT SCI, V33, P159, DOI 10.1016/j.humov.2013.07.024; Derman W, 2016, BRIT J SPORT MED, V50, P1069, DOI 10.1136/bjsports-2016-096214; Derman W, 2020, BRIT J SPORT MED, V54, P38, DOI 10.1136/bjsports-2018-100170; Derman W, 2018, BRIT J SPORT MED, V52, P24, DOI 10.1136/bjsports-2017-098039; Derman W, 2013, BRIT J SPORT MED, V47, P420, DOI 10.1136/bjsports-2013-092375; Forslund EB, 2017, J REHABIL MED, V49, P144, DOI 10.2340/16501977-2177; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Hollander K, 2020, SCAND J MED SCI SPOR, V30, P199, DOI 10.1111/sms.13558; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; *INT WHEELCH BASK, 2002, IWBF PLAYER CLASS WH; International Paralympic Committee, 2017, ANN REPORT; KIRBY RL, 1994, AM J PHYS MED REHAB, V73, P319, DOI 10.1097/00002060-199409000-00004; Mason BS, 2015, MED ENG PHYS, V37, P392, DOI 10.1016/j.medengphy.2015.02.001; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Orr K, 2010, WHEELCHAIR SPORT COM, P151; Rhodes JM, 2015, INT J SPORT PHYSIOL, V10, P318, DOI 10.1123/ijspp.2014-0203; Smith MR, 2016, MED SCI SPORT EXER, V48, P267, DOI 10.1249/MSS.0000000000000762; Sporner ML, 2009, PROSTHET ORTHOT INT, V33, P210, DOI 10.1080/03093640903051816; Tweedy S., 2010, WHEELCHAIR SPORT, P1; Usma-Alvarez CC, 2011, PROCEDIA ENGINEER, V13, P315, DOI 10.1016/j.proeng.2011.05.091; Webborn N, 2018, BRIT J SPORT MED, V52, P1157, DOI 10.1136/bjsports-2016-097236; Webborn N, 2016, PM&R, V8, P545, DOI 10.1016/j.pmrj.2015.09.025; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; Willick SE, 2016, SCAND J MED SCI SPOR, V26, P1233, DOI 10.1111/sms.12554; Willick SE, 2013, BRIT J SPORT MED, V47, P426, DOI 10.1136/bjsports-2013-092374	28	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAR	2020	10	3							e033088	10.1136/bmjopen-2019-033088			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LG0KT	WOS:000527801000075	32152161	Green Published, gold			2022-02-06	
J	Schneider, L; Reichert, E; Faulkner, J; Reichert, B; Sonnen, J; Hawryluk, GWJ				Schneider, Lonnie; Reichert, Ethan; Faulkner, Jenna; Reichert, Brielle; Sonnen, Joshua; Hawryluk, Gregory W. J.			CNS inflammation and neurodegeneration: sequelae of peripheral inoculation with spinal cord tissue in rat	JOURNAL OF NEUROSURGERY			English	Article						spinal cord injury; neurodegeneration; dementia; chronic traumatic encephalopathy; Alzheimer's disease; dementia pugilistica; autoimmunity; neuroinflammation; inoculation	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; SYMPATHETIC OPHTHALMIA; ANTIPITUITARY ANTIBODIES; COGNITIVE IMPAIRMENT; NEUROINFLAMMATION; DEMENTIA; ENCEPHALOPATHY; INVOLVEMENT; RISK	OBJECTIVE Recent research demonstrates that victims of spinal cord injury (SCI) are at increased risk for dementia and that encephalitis can occur as a consequence of isolated SCI. We theorize that autoimmunity to the central nervous system (CNS) could explain these phenomena and undertook this study to determine whether peripheral inoculation with spinal cord homogenate on 1 or 2 occasions is associated with CNS-directed autoimmunity and neurodegeneration in a rat model. METHODS Rats were subcutaneously inoculated with saline or 75 mg of allogeneic spinal cord tissue on 1 or 2 occasions. Animals underwent Morris Water Maze testing, and serial serum samples were collected. Animals were sacrificed 8 weeks following the first inoculation. Autoantibody titers to myelin antigens MAG and GM1 were measured in serum. Immunohistochemistry was used to identify autoantibodies targeting NeuN-labeled neurons and CC1-labeled oligodendrocytes. Quantitative real-time polymerase chain reaction (qPCR) and western blotting were performed for pro-inflammatory cytokines TNF-alpha, IL-1 beta, and IL-6 and the cell death marker caspase 3 as well as the neurodegenerative proteins tau and beta-amyloid in both brain and spinal cord. Fluoro-Jade B was used to stain degenerating neurons, facilitating counting. RESULTS Animals inoculated with spinal cord homogenate exhibited increased titers of autoantibodies to MAG and GM1 and autoantibodies binding to neurons and oligodendrocytes. Double-inoculated animals demonstrated a significant increase in the expression of pro-inflammatory cytokines in the brain (TNF-alpha, p = 0.016; IL-6, p = 0.009) as well as the spinal cord (TNF-alpha, p = 0.024; IL-6, p = 0.002). The number of degenerating neurons was significantly increased in the brain and spinal cord of inoculated animals (p < 0.0001 and p = 0.028, respectively). Elevated expression of tau and beta-amyloid was seen in brain of double-inoculated animals (p = 0.003 and p = 0.009, respectively). Inflammatory marker expression in the brain was positively correlated with anti-myelin autoimmune antibody titers and with tau expression in the brain. Inoculated animals showed impaired memory function in Morris Water Maze testing (p = 0.043). CONCLUSIONS The results of these experiments demonstrate that peripheral exposure to spinal cord antigens is associated with CNS-directed autoimmunity and inflammation in the brain and spinal cord as well as degeneration of CNS cells, memory impairment, and production of neurodegenerative proteins particularly when this exposure is repeated. These data support CNS autoimmunity as a candidate mechanism for the dementia that can follow SCI and perhaps other posttraumatic dementias such as chronic traumatic encephalopathy.	[Schneider, Lonnie] Univ Utah, Dept Phys Med & Rehabil, Salt Lake City, UT USA; [Reichert, Ethan; Faulkner, Jenna; Reichert, Brielle; Hawryluk, Gregory W. J.] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Sonnen, Joshua] Univ Utah, Dept Pathol, Salt Lake City, UT USA		Hawryluk, GWJ (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	gregory.hawryluk@hsc.utah.edu	Sonnen, Joshua/AAT-5788-2021				Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Axelrad J, 1998, MED HYPOTHESES, V50, P259, DOI 10.1016/S0306-9877(98)90027-5; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Chaithanyaa N, 2012, OR SURG OR MED OR PA, V113, P172, DOI 10.1016/j.tripleo.2011.01.036; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Chun H, 2018, NEUROSCI RES, V126, P44, DOI 10.1016/j.neures.2017.11.012; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Coulthart MB, 2016, CAN MED ASSOC J, V188, pE210, DOI 10.1503/cmaj.151257; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gupta SR, 2011, ARCH OPHTHALMOL-CHIC, V129, P250, DOI 10.1001/archophthalmol.2010.358; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P432, DOI 10.1089/scd.2011.0242; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Huang SW, 2017, J NEUROTRAUM, V34, P615, DOI 10.1089/neu.2016.4525; Jure I, 2017, NEURAL REGEN RES, V12, P1044, DOI 10.4103/1673-5374.211177; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Lachance DH, 2010, LANCET NEUROL, V9, P55, DOI 10.1016/S1474-4422(09)70296-0; Lammertse DP, 2012, SPINAL CORD, V50, P661, DOI 10.1038/sc.2012.39; Manandhar A, 2011, NEPAL J OPHTHALMOL, V3, P181, DOI http://dx.doi.org/10.3126/nepjoph.v3i2.5274; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Meeusen JW, 2012, ANN NEUROL, V71, P417, DOI 10.1002/ana.22674; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Obulesu M, 2014, INT J NEUROSCI, V124, P227, DOI 10.3109/00207454.2013.831852; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pimplikar SW, 2014, J CLIN IMMUNOL, V34, pS64, DOI 10.1007/s10875-014-0032-5; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Schwartz M, 2000, PROG BRAIN RES, V128, P259; Seif M, 2018, J NEUROTRAUM, V35, P2941, DOI 10.1089/neu.2017.5522; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Velandia-Romero ML, 2013, J NEUROVIROL, V19, P367, DOI 10.1007/s13365-013-0179-5; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhu BT, 2005, HISTOL HISTOPATHOL, V20, P575, DOI 10.14670/HH-20.575; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	45	3	4	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2020	132	3					933	944		10.3171/2018.10.JNS181517			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KS5YX	WOS:000518385400036	30717048				2022-02-06	
J	Sloan, DM; Marx, BP; Resick, PA; Young-McCaughan, S; Dondanville, KA; Mintz, J; Litz, BT; Peterson, AL				Sloan, Denise M.; Marx, Brian P.; Resick, Patricia A.; Young-McCaughan, Stacey; Dondanville, Katherine A.; Mintz, Jim; Litz, Brett T.; Peterson, Alan L.		STRONG STAR Consortium	Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members: A noninferiority trial	CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS			English	Article						Clinical trial; Posttraumatic stress disorder; Cognitive behavioral therapy; Written exposure therapy	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; ACTIVE-DUTY MILITARY; NICOTINE DEPENDENCE; IMAGINAL EXPOSURE; FAGERSTROM TEST; PRIMARY-CARE; DEPLOYMENT; VALIDITY	Although there are a number of effective treatments for posttraumatic stress disorder (PTSD), there is a need to develop more efficient evidence-based PTSD treatments to address barriers to seeking and receiving treatment. Written exposure therapy (WET) is a potential alternative that is a 5-session treatment without any between-session assignments. WET has demonstrated efficacy, and low treatment dropout rates. However, prior studies with WET have primarily focused on civilian samples. Identifying efficient PTSD treatments for military service members is critical given the high prevalence of PTSD in this population. The current ongoing randomized clinical trial builds upon the existing literature by investigating whether WET is equally efficacious as Cognitive Processing Therapy (CPT) in a sample of 150 active duty military service members diagnosed with PTSD who are randomly assigned to either WET (n = 75) or CPT (n = 75). Participants are assessed at baseline and 10, 20, and 30 weeks after the first treatment session. The primary outcome measure is PTSD symptom severity assessed with the Clinician Administered PTSD Scale for DSM-5. Given the prevalence of PTSD and the aforementioned limitations of currently available first-line PTSD treatments, the identification of a brief, efficacious treatment that is associated with reduced patient dropout would represent a significant public health development.	[Sloan, Denise M.; Marx, Brian P.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Sloan, Denise M.; Marx, Brian P.; Litz, Brett T.] Boston Univ, Dept Psychiat, Sch Med, 72 East Concord St, Boston, MA 02118 USA; [Resick, Patricia A.] Duke Univ, Dept Psychiat & Behav Sci, Sch Med, Durham, NC 27701 USA; [Young-McCaughan, Stacey; Dondanville, Katherine A.; Mintz, Jim; Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Litz, Brett T.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, 150 S Huntington Ave, Boston, MA 02130 USA; Boston Univ, Dept Psychol & Brain Sci, 64 Cummington Mall, Boston, MA 02215 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, Res & Dev Serv, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, One UTSA Circle, San Antonio, TX 78249 USA		Sloan, DM (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD 116B 4, Behav Sci Div, 150 S Huntington Ave, Boston, MA 02130 USA.	denise.sloan@va.gov; brian.marx@va.gov; patricia.resick@duke.edu; youngs1@uthscsa.edu; dondanville@uthscsa.edu; mintz@uthscsa.edu; brett.litz@va.gov; petersona3@uthscsa.edu			U.S. Department of DefenseUnited States Department of Defense [W81XWH-15-1-0391]	This work is supported by an award to Denise M. Sloan (W81XWH-15-1-0391) by the U.S. Department of Defense.	Babor T.F., 2001, AUDIT THE ALCOHOL US; Ben Barnes J, 2019, MIL MED, V184, pE218, DOI 10.1093/milmed/usy226; Borah EV, 2013, MIL MED, V178, P939, DOI 10.7205/MILMED-D-13-00072; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Cigrang JA, 2017, FAM SYST HEALTH, V35, P450, DOI 10.1037/fsh0000315; Cigrang JA, 2015, J ANXIETY DISORD, V36, P110, DOI 10.1016/j.janxdis.2015.10.003; Cohen J., 2013, STAT POWER ANAL BEHA; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Demirtas H, 2003, STAT MED, V22, P2553, DOI 10.1002/sim.1475; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Ebbert JO, 2006, ADDICT BEHAV, V31, P1716, DOI 10.1016/j.addbeh.2005.12.015; Enders C.K., 2010, MODELS NOT MISSING R; Ferketich AK, 2007, ADDICT BEHAV, V32, P1970, DOI 10.1016/j.addbeh.2007.01.005; Finley EP, 2015, PSYCHOL SERV, V12, P73, DOI 10.1037/ser0000014; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 2002, J CONSULT CLIN PSYCH, V70, P1022, DOI 10.1037//0022-006X.70.4.1022; Foa EB, 2018, JAMA-J AM MED ASSOC, V319, P354, DOI 10.1001/jama.2017.21242; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hintze J., 2019, NCSS PASS NUMBER CRU; Hirano K., 2003, ECONOMETRICA, V2003, P71; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Kazis L.E., 2008, VETERANS RAND 12 ITE; Keane TM, 2013, LIFE EVENTS CHECKLIS; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Little R. J. A., 1988, J AM STAT ASSOC, V83, P404, DOI DOI 10.1080/01621459.1988.10478722; Little R, 2009, CH CRC HANDB MOD STA, P409; Mallinckrod CH, 2013, PHARM STAT, V12, P1, DOI 10.1002/pst.1547; Markowitz JC, 2015, AM J PSYCHIAT, V172, P430, DOI 10.1176/appi.ajp.2014.14070908; Marx B. P., 2013, DEV VALIDATION PTSD; Metalsky GI, 1997, COGNITIVE THER RES, V21, P359, DOI 10.1023/A:1021882717784; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Morland LA, 2015, DEPRESS ANXIETY, V32, P811, DOI 10.1002/da.22397; Nacasch N, 2015, BEHAV THER, V46, P328, DOI 10.1016/j.beth.2014.12.002; Nobler MS, 1997, CONVULSIVE THER, V13, P208; Nock MK, 2007, PSYCHOL ASSESSMENT, V19, P309, DOI 10.1037/1040-3590.19.3.309; Resick P. A., 2016, COGNITIVE PROCESSING; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Resick PA, 2017, JAMA PSYCHIAT, V74, P28, DOI 10.1001/jamapsychiatry.2016.2729; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sloan DM, 2007, BEHAV THER, V38, P155, DOI 10.1016/j.beth.2006.06.005; Sloan DM, 2018, JAMA PSYCHIAT, V75, P233, DOI 10.1001/jamapsychiatry.2017.4249; Sloan DM, 2013, J TRAUMA STRESS, V26, P776, DOI 10.1002/jts.21858; Sloan DM, 2012, BEHAV RES THER, V50, P627, DOI 10.1016/j.brat.2012.07.001; Sloan DM, 2011, BEHAV RES THER, V49, P299, DOI 10.1016/j.brat.2011.02.001; Sloan DM, 2005, J CONSULT CLIN PSYCH, V73, P549, DOI 10.1037/0022-006X.73.3.549; Sloan DM, 2004, J CONSULT CLIN PSYCH, V72, P165, DOI 10.1037/0022-006X.72.2.165; Sloan DM, 2019, WRITTEN EXPOSURE THE; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; The US Department of Veterans Affairs and Department of Defense, 2017, VA DOD CLIN PRACT GU; Therneau T.M., 2000, STAT BIOL HEALTH; Thompson-Hollands J, 2018, DEPRESS ANXIETY, V35, P985, DOI 10.1002/da.22825; Tracey T.J., 1989, J CONSULT CLIN PSYCH, V1, P207, DOI [10.1037/1040-3590.1.3.207, DOI 10.1037/1040-3590.1.3.207, 10.1037/1040-3590.1.3.207.]; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Weathers F., 2013, CLINICIAN ADMINISTER; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wilk JE, 2013, PSYCHIATRY, V76, P336, DOI 10.1521/psyc.2013.76.4.336; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266; Yuan Y., SENSITIVITY ANAL MUL	67	3	3	1	4	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA		2451-8654		CONT CLIN TRIAL COMM	Contemp. Clin. Trials Commun.	MAR	2020	17								100507	10.1016/j.conctc.2019.100507			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	MG7QV	WOS:000546224900015	31890987	gold, Green Published			2022-02-06	
J	Sullivan, L; Harvey, HH; Smith, GA; Yang, JZ				Sullivan, Lindsay; Harvey, Hosea H.; Smith, Gary A.; Yang, Jingzhen			Putting Policy Into Practice: School-Level Compliance With and Implementation of State Concussion Laws	JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE			English	Article						compliance; concussion; concussion laws; high schools; implementation	RECURRENT CONCUSSION; LEGISLATION; EDUCATION; SYMPTOMS; CHILDREN	Context: Each year, approximately 2 million US children 18 years or younger sustain a concussion, a type of mild traumatic brain injury (TBI). Concussions can have detrimental effects on physical, cognitive, emotional, or sleep health. Policy: Between 2009 and 2014, all 50 US states and Washington, District of Columbia, enacted state concussion laws aimed to increase awareness about concussion and reduce the prevalence and severity of this injury. Most state laws include the following core tenets: (1) immediate removal from play after an actual or suspected concussion; (2) medical clearance before an athlete can return to play (RTP); and (3) concussion education for athletes, parents, and coaches. Implementation: State concussion laws allow for substantial interpretation at the school level, resulting in considerable variation in the content of school written concussion policies and the level of implementation of state law requirements at the school level. Evaluation: We assessed the degree of high school written concussion policy compliance with the respective state law and examined the relationship between concussion policy compliance and school-level implementation of concussion laws. Seventy-one school officials completed a semistructured telephone interview and submitted their school's written concussion policy. Of the 71 policies analyzed, most complied with the removal-from-play, RTP, and concussion education tenets (90.1%, 97.2%, and 76.1%, respectively). The majority of participants reported that their school implemented the removal-from-play (91.5%), RTP (93.0%), and concussion education (80.6%) tenets well or very well. No significant relationships were found between researcher-rated school policy compliance and school-reported implementation of state law requirements at the school level. Discussion: Our findings suggest that most participating schools complied with their state concussion law and implemented law requirements well or very well. Future studies should identify facilitators and barriers to the implementation of state concussion laws at the school level.	[Sullivan, Lindsay; Smith, Gary A.; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res, 700 Childrens Dr,RBIII WB5403, Columbus, OH 43205 USA; [Harvey, Hosea H.] Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; [Smith, Gary A.; Yang, Jingzhen] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res, 700 Childrens Dr,RBIII WB5403, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org			Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF) [30822]	This work was supported by the Robert Wood Johnson Foundation grant no. 30822.	Andrews EP, 2013, N Y L SCH L REV, V417, P58; Bacon CEW, 2017, J ATHL TRAINING, V52, P937, DOI 10.4085/1062-6050-52.7.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davies S, 2018, J ATHL TRAINING, V53, P873, DOI 10.4085/1062-6050-529-17; Doucette ML, 2016, J LAW MED ETHICS, V44, P503, DOI 10.1177/1073110516667946; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Polacsek M, 2012, PUBLIC HEALTH REP, V127, P216, DOI 10.1177/003335491212700211; Program for Injury Prevention Education & Research (PIPER) Colorado School of Public Health, HIGH SCH RIO REP INF; Sanchez-Vaznaugh EV, 2012, AM J PREV MED, V42, P452, DOI 10.1016/j.amepre.2012.01.008; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Schwartz MB, 2012, J SCHOOL HEALTH, V82, P262, DOI 10.1111/j.1746-1561.2012.00696.x; Smart Growth America-National Complete Streets Coalition, 2015, BEST COMPL STREETS P; Taylor T, 2013, ACCIDENT ANAL PREV, V58, P175, DOI 10.1016/j.aap.2013.02.008; Thompson K, CODEBOOK YOUTH SPORT; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zhang N, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2870	28	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-4659	1550-5022		J PUBLIC HEALTH MAN	J. Public Health Manag. Pract.	MAR-APR	2020	26			2	SI		S84	S92		10.1097/PHH.0000000000001128			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KL0UV	WOS:000513149000011	32004226				2022-02-06	
J	Versteegh, TH; Dickey, JP; Emery, CA; Fischer, LK; MacDermid, JC; Walton, DM				Versteegh, Theodore H.; Dickey, James P.; Emery, Carolyn A.; Fischer, Lisa K.; MacDermid, Joy C.; Walton, David M.			Evaluating the Effects of a Novel Neuromuscular Neck Training Device on Multiplanar Static and Dynamic Neck Strength: A Pilot Study	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						axial rotation; plyometric; centripetal; cervical strengthening	INJURY PREVENTION PROGRAM; FOOTBALL PLAYERS; SPORT; CONCUSSION; RISK; HEAD; BIOMECHANICS; PERFORMANCE; STRATEGIES; RESISTANCE	Versteegh, TH, Dickey, JP, Emery, CA, Fischer, LK, MacDermid, JC, and Walton, DM. Evaluating the effects of a novel neuromuscular neck training device on multiplanar static and dynamic neck strength: A pilot study. J Strength Cond Res 34(3): 708-716, 2020-The neck serves an important function in damping the transference of acceleration forces between the head and the trunk, such as that occurring during contact sports or motor vehicle collisions. An inability to adequately dissipate forces has been proposed as a potential mechanism for clinical conditions such as whiplash or concussion, but current approaches to neck training may not be targeting the correct mechanisms. The purpose of this study was to explore the training effect of a novel neuromuscular strengthening protocol on dynamic and static neck strength. This was a quasiexperimental pilot study design with intervention (n = 8) and control (n = 10) groups. The intervention group was trained (twice/week, similar to 10 minutes, for 7 weeks) on a training device that uses self-generated centripetal force to create a dynamic rotational resistance. This protocol is intended to target the ability of the neck muscles to perform coordinated multiplanar plyometric contractions. Both groups also continued with traditional neck strengthening that included training on a straight-plane, isotonic, 4-way neck machine. Performance on the training device showed improvement after routine practice within 1 week, as evidenced by a trend toward increased peak speed in revolutions per minute (RPM). After 7 weeks, peak RPM increased from 122.8 (95% confidence interval [CI], 91.3-154.4) to 252.3 (95% CI, 241.5-263.1). There was also a large positive effect size (Hedge's d, 0.68) in isometric composite (multiplane) neck strength favoring the intervention group over the control group (difference, 20 N; 95% CI, -8 to 48). The largest magnitude strength improvement in a single plane was in axial rotation and also favored the intervention group over the control group (Hedge's d, 1.24; difference, 46 N; 95% CI, 9-83). Future studies should explore whether the dynamic training presented here could help reduce the risk of sports concussion, whiplash, or other head-neck trauma.	[Versteegh, Theodore H.] Western Univ, Elborn Coll, Sch Phys Therapy, London, ON, Canada; [Dickey, James P.] Western Univ, Sch Kinesiol, London, ON, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Fischer, Lisa K.] Western Univ, Fac Hlth Sci, London, ON, Canada; [MacDermid, Joy C.; Walton, David M.] Western Univ, Sch Phys Therapy, London, ON, Canada		Versteegh, TH (corresponding author), Western Univ, Elborn Coll, Sch Phys Therapy, London, ON, Canada.	tverstee@uwo.ca	Fischer, Lisa K/H-3999-2015; Walton, David M/C-9902-2015; MacDermid, Joy C/H-7837-2013; Dickey, James P/K-6776-2013	Fischer, Lisa K/0000-0001-5992-0176; Walton, David M/0000-0001-9155-3337; MacDermid, Joy C/0000-0001-9311-7379; Dickey, James P/0000-0002-4101-835X	Canadian Institutes of Health Research Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR); Dr. James Roth Chair in Musculoskeletal Measurement and Knowledge Translation	This research received no external funding. J. MacDermid was supported by a Canadian Institutes of Health Research Chair in Gender, Work and Health and the Dr. James Roth Chair in Musculoskeletal Measurement and Knowledge Translation.	Alsalaheen B, 2018, J ELECTROMYOGR KINES, V39, P70, DOI 10.1016/j.jelekin.2018.01.011; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Carlesso LC, 2010, J ORTHOP SPORT PHYS, V40, P455, DOI 10.2519/jospt.2010.3229; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Conley MS, 1997, EUR J APPL PHYSIOL, V75, P443, DOI 10.1007/s004210050186; Dirisala V, 2012, INT J NUMER METH BIO, V28, P472, DOI 10.1002/cnm.1480; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Fremont P, 2015, BRIT J SPORT MED, V49, P88, DOI 10.1136/bjsports-2014-093961; Hagglund M, 2013, BRIT J SPORT MED, V47, P974, DOI 10.1136/bjsports-2013-092644; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Jin X, 2017, J BIOMECH ENG, V139; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Pasanen K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a295; Pelland, 2015, J ATHL ENHANCE, V4, P1; Peterson MD, 2004, J STRENGTH COND RES, V18, P377, DOI 10.1519/00124278-200405000-00031; Rossler R, 2014, SPORTS MED, V44, P1733, DOI 10.1007/s40279-014-0234-2; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Steffen K, 2008, SCAND J MED SCI SPOR, V18, P596, DOI 10.1111/j.1600-0838.2007.00708.x; Steffen K, 2013, BRIT J SPORT MED, V47, P794, DOI 10.1136/bjsports-2012-091886; van Reijen M, 2016, SPORTS MED, V46, P1125, DOI 10.1007/s40279-016-0470-8; Versteegh T, 2015, PHYSIOTHER CAN, V67, P58, DOI 10.3138/ptc.2013-66; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0	29	3	3	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	MAR	2020	34	3					708	716		10.1519/JSC.0000000000003091			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LB0YQ	WOS:000524363800015	30946260				2022-02-06	
J	Wearne, TA; Osborne-Crowley, K; Logan, JA; Wilson, E; Rushby, J; McDonald, S				Wearne, Travis A.; Osborne-Crowley, Katherine; Logan, Jodie A.; Wilson, Emily; Rushby, Jacqueline; McDonald, Skye			Understanding How Others Feel: Evaluating the Relationship Between Empathy and Various Aspects of Emotion Recognition Following Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						emotion recognition; emotion perception; empathy; traumatic brain injury; emotion	IMPAIRED RECOGNITION; HOSPITAL ANXIETY; PERCEPTION; DEPRESSION	Objective: The aim of this study was to use various measures of emotion recognition, such as sensitivity to emotional intensity, accuracy-based emotion labeling, and the ability to differentiate among emotional displays, to examine whether these abilities are associated with emotional and cognitive empathy. We also sought to determine whether these relationships differ between individuals with traumatic brain injury (TBI) and healthy adults. Method: TBI participants (n = 28) and healthy adults (n = 29) matched for age, biological sex, and education, were tested on an emotion intensity rating and recognition task. Self-reported emotional and cognitive empathy questionnaires, together with a neuropsychological battery, were also completed. Results: Participants with TBI reported reduced emotional and cognitive empathy. TBI participants also had reduced overall accuracy in recognizing emotion. specifically for happy and sad emotions, although they had no difficulty identifying the intensity or differentiating among emotional displays. Intensity labeling and sensitivity to differentiate among emotions positively correlated with emotional empathy for healthy adults but not for TBI participants. No facet of emotion recognition correlated with cognitive empathy for healthy adults or 'FBI participants. Conclusions: The ability to identify the intensity and differentiate among emotions is associated with emotional empathy. Although individuals with severe TBI may be able to differentiate emotions, they may be unable to utilize this information to share and understand the emotions of others, or vice versa. These results could have implications for understanding poor interpersonal relationships and impaired social functioning following TBI.	[Wearne, Travis A.; Osborne-Crowley, Katherine; Logan, Jodie A.; Wilson, Emily; Rushby, Jacqueline; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Wearne, Travis A.; Osborne-Crowley, Katherine; Logan, Jodie A.; Wilson, Emily; Rushby, Jacqueline; McDonald, Skye] Ctr Res Excellence Brain Recovery, Brisbane, Qld, Australia		Wearne, TA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	t.wearne@unsw.edu.au	; Rushby, Jacqueline/D-1820-2010; McDonald, Skye/G-4118-2014	Wearne, Travis/0000-0002-7565-9163; Rushby, Jacqueline/0000-0002-5018-638X; Wilson, Emily/0000-0002-1949-7657; Logan, Jodie/0000-0003-1198-487X; McDonald, Skye/0000-0003-0723-6094	Australian Research CouncilAustralian Research Council [DP150100226]	This work was supported by the Australian Research Council under Grant [DP150100226].	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cotter J, 2018, NEUROSCI BIOBEHAV R, V84, P92, DOI 10.1016/j.neubiorev.2017.11.014; Cox CL, 2012, SOC COGN AFFECT NEUR, V7, P727, DOI 10.1093/scan/nsr051; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Mitchell RLC, 2015, NEUROPSYCHOLOGIA, V70, P1, DOI 10.1016/j.neuropsychologia.2015.02.018; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Osborne-Crowley K, 2016, NEUROPSYCHOLOGY, V30, P820, DOI 10.1037/neu0000293; Reitan RM, 1992, TRAIL MAKING TEST; RIGGIO RE, 1989, PERS INDIV DIFFER, V10, P93, DOI 10.1016/0191-8869(89)90184-0; Rosenberg H, 2019, NEUROPSYCHOL REHABIL, V29, P232, DOI 10.1080/09602011.2016.1273118; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Wearne T, 2019, BRAIN INJURY, V33, P12, DOI 10.1080/02699052.2018.1531300; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Zhang F, 2015, J SOC PERS RELAT, V32, P633, DOI 10.1177/0265407514541073; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	3	3	1	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2020	34	3					288	297		10.1037/neu0000609			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KQ1TA	WOS:000516711300004	31804103				2022-02-06	
J	Page, PS; Burkett, DJ; Brooks, NP				Page, Paul S.; Burkett, Daniel J.; Brooks, Nathaniel P.			Association of helmet use with traumatic brain and cervical spine injuries following bicycle crashes	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Cervical spine; bicycle; craniocerebral trauma; neck injuries		Background: The use of bicycle helmets in preventing traumatic brain injuries (TBI) is frequently cited but data remain inconclusive. Additionally, the effects of helmets on cervical spine injuries (CSI) are debated. Methods: We performed a retrospective review of all adult patients with bicycle crashes presenting to one level 1 trauma center in Wisconsin from 2010 to 2016. Patients were divided into two groups: helmeted and un-helmeted. Results: In total 287 patients were included; 149 un-helmeted (51.9%) and 138 helmeted (48.9%). Helmeted riders had radiographic evidence of traumatic brain injury in 20.3% of cases compared to 40.3% of un-helmeted (p < 0.001). On average, helmeted riders had a similar injury severity score of 7.80 (standard deviation (SD) = 7.18) compared with 8.25 (SD = 9.98) in the un-helmeted group (p = 0.68). CSI occurred in 16 (10.7%) un-helmeted patients compared with 15 (10.9%) helmeted patients (p = 0.707). Of the un-helmeted group, four patients (2.7%) were found to have a cervical spine fracture compared with 12 (8.7%) helmeted patients (p = 0.037). Conclusion: Helmet use demonstrated a statistically significant advantage in the prevention of traumatic brain injuries. No significant difference was found regarding the incidence of severity of cervical spine injuries. These results do not demonstrate any statistically significant benefit in the prevention of cervical spine injuries with helmet use. In contrast, helmet use was found to convey a significant protective advantage in the prevention of traumatic brain injuries compared to no helmets.	[Page, Paul S.; Burkett, Daniel J.; Brooks, Nathaniel P.] Univ Wisconsin, Dept Neurol Surg, Neurosurg, 600 Highland Ave, Madison, WI 53792 USA		Page, PS (corresponding author), Univ Wisconsin, Dept Neurol Surg, Neurosurg, 600 Highland Ave, Madison, WI 53792 USA.	paulsamuelpage@gmail.com					Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Dodwell ER, 2010, AM J SPORT MED, V38, P1647, DOI 10.1177/0363546510365532; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Gulack BC, 2015, SURGERY, V158, P556, DOI 10.1016/j.surg.2015.02.025; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Joseph B, 2014, EUR J TRAUMA EMERG S, V40, P729, DOI 10.1007/s00068-014-0453-0; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; Kaushik Ruchi, 2015, Inj Epidemiol, V2, P16; National Center for Statistics and Analysis, 2016, 812318 DOT HS NAT HI; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030	11	3	3	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2020	34	3					276	279		10.1080/02688697.2020.1731425		FEB 2020	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MI0UE	WOS:000517379500001	32106719				2022-02-06	
J	Hu, YL; Liu, SB; Zhu, BM				Hu, Yiling; Liu, Shubao; Zhu, Bing-Mei			CRISPR/Cas9-Induced Loss of Keap1 Enhances Anti-oxidation in Rat Adipose-Derived Mesenchymal Stem Cells	FRONTIERS IN NEUROLOGY			English	Article						gene editing; CRISPR; Cas9; traumatic brain injury; Keap1-Nrf2; anti-oxidation	ACTIVATION; NRF2; MUTATIONS	Stem cells have become a powerful tool in the treatment of many diseases owing to their regenerative ability and rapid promotion of development in regenerative medicine such as in traumatic brain injury. However, the high level of oxidant micro-environment in lesion region leads to more than 99% cells into death. In this study, we used genetic methods to edit Keap1 gene in mesenchymal stem cells, we and observed their antioxidative ability. First, we disturbed the start codon and the 376th amino acid codon of Keap1 in adipose-derived mesenchymal stem cells (Ad-MSCs) with CRISPR/Cas9, respectively, to release Nrf2 from the binding of Keap1. As a result, Nrf2 was activated and localized into nuclei and regulated cellular anti-oxidation. We observed that the cells lacking Keap1 ATG codon showed obvious nuclear localization of Nrf2. Besides lower expression of Bax-1 and lower content of malondialdehyde (MDA) were detected after H2O2 treatment, we also found higher expression of Bcl-2 in Keap1 ATG codon knock-out cells, whereas a higher expression of PCNA was observed only in the Keap1 376th codon-edited cells, whose Bax-1 expression was lower than that in the control cells. Our study revealed that loss of Keap1 resulted in anti-oxidative ability in Ad-MSCs, suggesting that our strategy can hopefully increase the viability of mesenchymal stem cells after grafting. This study is also a frontier exploration to the application of CRISPR/Cas9 in Ad-MSCs.	[Hu, Yiling; Liu, Shubao; Zhu, Bing-Mei] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu, Peoples R China		Zhu, BM (corresponding author), Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu, Peoples R China.	zhubm64@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870224, 81574063, 161170012]	This research was supported by the National Natural Science Foundation of China (Nos. 81870224 and 81574063) and the intramural funding ofWest China Hospital (161170012).	Angelos MG, 2015, CURR OPIN ORGAN TRAN, V20, P663, DOI 10.1097/MOT.0000000000000244; Bateman ME, 2018, STEM CELLS, V36, P1311, DOI 10.1002/stem.2847; Boveia V, 2015, METHODS MOL BIOL, V1314, P115, DOI 10.1007/978-1-4939-2718-0_13; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Maeda K, 2017, EXPERT OPIN BIOL TH, V17, P435, DOI 10.1080/14712598.2017.1293038; Mahmoudifar N, 2015, METHODS MOL BIOL, V1340, P53, DOI 10.1007/978-1-4939-2938-2_4; Noel S, 2015, KIDNEY INT, V88, P1217, DOI 10.1038/ki.2015.328; Pall Martin L., 2015, Shengli Xuebao, V67, P1; Palomares T, 2018, MOL NEUROBIOL, V55, P13, DOI 10.1007/s12035-017-0714-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rio D.C., 2010, COLD SPRING HARB PRO, V2010, ppdb.prot5439, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Rockwell CE, 2012, J IMMUNOL, V188, P1630, DOI 10.4049/jimmunol.1101712; Savitz SI, 2018, STROKE, V49, P1056, DOI 10.1161/STROKEAHA.118.019561; Schmoll Dieter, 2017, Drug Discov Today Technol, V24, P11, DOI 10.1016/j.ddtec.2017.10.001; Danilovic DLS, 2018, HEAD NECK-J SCI SPEC, V40, P1271, DOI 10.1002/hed.25105; Turley AE, 2015, CYTOKINE, V71, P289, DOI 10.1016/j.cyto.2014.11.006; Zhang F, 2019, J CELL BIOCHEM, V120, P19902, DOI 10.1002/jcb.29298; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	20	3	3	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 18	2020	10								1311	10.3389/fneur.2019.01311			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KS9ES	WOS:000518611400001	32132961	Green Published, gold			2022-02-06	
J	Martindale, SL; Konst, MJ; Bateman, JR; Arena, A; Rowland, JA				Martindale, Sarah L.; Konst, Matthew J.; Bateman, James R.; Arena, Alyssa; Rowland, Jared A.			The role of PTSD and TBI in post-deployment sleep outcomes	MILITARY PSYCHOLOGY			English	Article						Veteran; sleep; PTSD; insomnia; TBI	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ALCOHOL-USE; COMBAT VETERANS; DISTURBANCES; SYMPTOMS; QUALITY; IMPACT; RISK; NEED	The purpose of this study was to evaluate the main and interaction effects of PTSD and TBI on sleep outcomes in veterans. Post-deployment combat veterans (N = 293, 87.37% male) completed clinical interviews to determine diagnosis and severity of PTSD and deployment TBI history, as well as subjective measures of sleep quality, sleep duration, and restedness. Sleep-related medical diagnoses were extracted from electronic medical records for all participants. PTSD and TBI were each associated with poorer ratings of sleep quality, restedness, shorter sleep duration, and greater incidence of clinically diagnosed sleep disorders. Analyses indicated main effects of PTSD on sleep quality (p < .001), but no main effects of TBI. PTSD severity was significantly associated with poorer sleep quality (p < .001), restedness (p = .018), and shorter sleep duration (p = .015). TBI severity was significantly associated with restedness beyond PTSD severity (p = .036). There were no interaction effects between diagnostic or severity variables. PTSD severity is a driving factor for subjective ratings of sleep disturbance beyond PTSD diagnosis as well as TBI diagnosis and severity. Despite this, poor sleep was apparent throughout the sample, which suggests post-deployment service members may globally benefit from routine screening of sleep problems and increased emphasis on sleep hygiene.	[Martindale, Sarah L.; Konst, Matthew J.; Bateman, James R.; Rowland, Jared A.] Salisbury VA Med Ctr, Salisbury, NC USA; [Martindale, Sarah L.; Rowland, Jared A.] Midatlantic MIRECC, Durham, NC USA; [Martindale, Sarah L.; Bateman, James R.; Arena, Alyssa; Rowland, Jared A.] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Arena, Alyssa] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA		Martindale, SL (corresponding author), Salisbury VA Med Ctr, Res & Acad Affairs Serv Line, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov	Rowland, Jared A./AAN-3030-2021; Martindale, Sarah L/O-8553-2018	Rowland, Jared A./0000-0002-3655-3411; Martindale, Sarah L/0000-0002-0059-3454; Bateman, James/0000-0002-3646-9148	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and Department of Veterans Affairs CENC Award [I01 CX001135].	Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Belleville G, 2009, J NERV MENT DIS, V197, P126, DOI 10.1097/NMD.0b013e3181961d8e; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; Colvonen PJ, 2015, J CLIN SLEEP MED, V11, P513, DOI 10.5664/jcsm.4692; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P233, DOI 10.1016/j.sleh.2015.10.004; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Khazaie Habibolah, 2016, J Inj Violence Res, V8, P99, DOI 10.5249/jivr.v8i2.808; Koffel E, 2016, PSYCHIAT ANN, V46, P173, DOI 10.3928/00485713-20160125-01; Koffel E, 2013, J ANXIETY DISORD, V27, P512, DOI 10.1016/j.janxdis.2013.07.003; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; Martindale SL, 2017, J NEUROPSYCH CLIN N, V29, pA6, DOI 10.1176/appi.neuropsych.16110307; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meadows SO., 2018, 2015 DEP DEFENSE HLT; Miller MB, 2017, DRUG ALCOHOL DEPEN, V177, P221, DOI 10.1016/j.drugalcdep.2017.03.031; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nakamura Y, 2011, J PSYCHOSOM RES, V70, P335, DOI 10.1016/j.jpsychores.2010.09.007; Orr N., 2010, CHEST, V138, p704A, DOI [10.1378/chest.10975, DOI 10.1378/CHEST.10975]; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Peppard PE, 2013, SLEEP, V36, P7, DOI 10.5665/sleep.2284; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Powell MA, 2015, J TRAUMA STRESS, V28, P322, DOI 10.1002/jts.22027; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Troxel WM, 2015, SLEEP MILITARY PROMO; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Vandekerckhove M, 2010, SLEEP MED REV, V14, P219, DOI 10.1016/j.smrv.2010.01.002; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Weathers F., 2013, CLINICIAN ADMINISTER; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y	47	3	3	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	MAR 3	2020	32	2					212	221		10.1080/08995605.2020.1724595		FEB 2020	10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	KT6KG	WOS:000515305500001					2022-02-06	
J	Neary, JP; Dude, CM; Singh, J; Len, TK; Bhambhani, YN				Neary, J. Patrick; Dude, Carolynn M.; Singh, Jyotpal; Len, Trevor K.; Bhambhani, Yagesh N.			Pre-frontal Cortex Oxygenation Changes During Aerobic Exercise in Elite Athletes Experiencing Sport-Related Concussion	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussion; exercise testing; near-infrared spectroscopy; pre-frontal cortex oxygenation; physiology; athletes	TRAUMATIC BRAIN-INJURY; NEAR-INFRARED SPECTROSCOPY; HEART-RATE-VARIABILITY; CEREBRAL OXYGENATION; ACTIVE REHABILITATION; EPIDEMIOLOGY; RECOVERY; RELIABILITY; ACTIVATION; STATEMENT	Aims: Recent research suggests that aerobic exercise can be performed safely within the first week following a concussion injury and that early initiation of exercise may speed recovery. To better understand the physiological changes during a concussion, we tested the hypothesis that mild-to-intense exercise testing can be performed within days immediately following injury, and can be used to discern differences between the concussed and normal healthy state. Thus, the purpose was to observe the cerebral hemodynamic responses to incremental exercise testing performed acutely post-concussion in high-performance athletes. Methods: This study was a within- and between-experimental design, with seven male university ice hockey teams participating. A subgroup of five players acted as control subjects (CON) and was tested at the same time as the 14 concussed (mTBI) players on Day 2, 4, and 7 post-concussion. A 5-min resting baseline and 5-min exercise bouts of mild (EX1), moderate (EX2), and high (EX3) intensity exercise were performed on a cycle ergometer. Near-infrared spectroscopy was used to monitor pre-frontal cortex oxy-haemoglobin (HbO(2)), deoxy-haemoglobin (HHb), and total blood volume (tHb) changes. Results: ANOVA compared differences between testing days and groups, and although large percentage changes in HbO(2) (20-30%), HHb (30-40%), and tHb (30-40%) were recorded, no significant (p <= 0.05) differences in cerebral hemodynamics occurred between mTBI vs. CON during aerobic exercise testing on any day post-injury. Furthermore, there was a linear relationship between exercise intensity vs. cerebral hemodynamics during testing for each day (r(2) = 0.83-0.99). Conclusion: These results demonstrate two novel findings: (1) mild-to-intense aerobic exercise testing can be performed safely as early as Day 2 post-concussion injury in a controlled laboratory environment; and (2) evidence-based objective measures such as cerebral hemodynamics can easily be collected using near-infrared spectroscopy (NIRS) to monitor physiological changes during the first-week post-injury. This research has important implications for monitoring physiological recovery post-injury and establishing new rehabilitation guidelines.	[Neary, J. Patrick; Singh, Jyotpal; Len, Trevor K.] Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK, Canada; [Bhambhani, Yagesh N.] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada		Neary, JP (corresponding author), Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK, Canada.	patrick.neary@uregina.ca			Canadian Institutes of Health Research, CIHRCanadian Institutes of Health Research (CIHR) [84313]	We are grateful for the financial contribution from external research grants to conduct this research (Canadian Institutes of Health Research, CIHR #84313).	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; BELARDINELLI R, 1995, EUR J APPL PHYSIOL O, V70, P487, DOI 10.1007/BF00634377; Bhambhani Y, 2006, J REHABIL RES DEV, V43, P845, DOI 10.1682/JRRD.2005.09.0151; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P573, DOI 10.1111/cpf.12447; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Collins M. W., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01681; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dech RT, 2019, J SCI MED SPORT, V22, P1090, DOI 10.1016/j.jsams.2019.06.007; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Ellis M.J., 2014, CURR RES CONCUSSION, V1, P33; Ellis MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01115; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Giacalone G, 2017, BIOMED OPT EXPRESS, V8, P4987, DOI 10.1364/BOE.8.004987; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Koike A, 2004, CHEST, V125, P182, DOI 10.1378/chest.125.1.182; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Kozlowski K, 2014, INT J ATHL THER TRAI, V19, P28, DOI DOI 10.1123/ijatt.2014-0007; La Fountaine MF, 2019, MED SCI SPORT EXER, V51, P792, DOI 10.1249/MSS.0000000000001833; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Morissette MP, 2020, MED SCI SPORT EXER, V52, P820, DOI 10.1249/MSS.0000000000002198; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Neary JP, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2010023; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Obrig H, 1996, J APPL PHYSIOL, V81, P1174, DOI 10.1152/jappl.1996.81.3.1174; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sharma A, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00042; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Worts PR, 2019, SPORTS MED, V49, P683, DOI 10.1007/s40279-019-01065-1; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	70	3	3	3	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 12	2020	14								35	10.3389/fnhum.2020.00035			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KR4KT	WOS:000517589100001	32116614	gold, Green Published			2022-02-06	
J	Tu, TQ; Peng, JH; Jiang, Y				Tu, Tianqi; Peng, Jianhua; Jiang, Yong			FNDC5/Irisin: A New Protagonist in Acute Brain Injury	STEM CELLS AND DEVELOPMENT			English	Article						acute brain injury; traumatic brain injury; stroke; FNDC5; Irisin; stem cell therapy	EMBRYONIC STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; REDUCES INFARCT SIZE; HIPPOCAMPAL NEUROGENESIS; IRISIN PROTECTS; MITOCHONDRIAL BIOGENESIS; NEURAL DIFFERENTIATION; INSULIN-RESISTANCE; DIABETES-MELLITUS	Acute brain injury (ABI), including stroke and traumatic brain injury, which accounts for a heavy burden of morbidity and mortality, results in a great loss of productive life and serious health problem worldwide. To improve patients' survival and ameliorate their outcome, effective clinical treatment strategies and new therapeutic targets are urgently needed. Novel therapeutic strategies, especially about stem cell therapy and various targets to enhance the therapeutic effects of stem cell therapy, are emerging all the time. Irisin is a myokine released from cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5). This myokine is closely related to metabolism and neural stem cell differentiation, and it gained attention in recent years. Recent studies reported that FNDC5/Irisin may play a key role in brain injury, for it might be a powerful agent mediating the neural cell response and stem cell therapy. This review aims at understanding the newly discovered myokine "Irisin," discussing the potential role and mechanisms of Irisin in ABI, and shedding light on its potential application in stem cell therapy. Furthermore, we propose that Irisin could be a novel protagonist in the treatment and prevention of ABI.	[Tu, Tianqi; Peng, Jianhua; Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China; [Peng, Jianhua] Southwest Med Univ, Affiliated Hosp, Academician Expert Workstn Sichuan Prov, Luzhou, Peoples R China; [Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Lab Neurol Dis & Brain Funct, Luzhou, Peoples R China; [Peng, Jianhua; Jiang, Yong] Neurosurg Clin Res Ctr Sichuan Prov, Luzhou, Peoples R China		Jiang, Y (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China.	jiangyong@swmu.edu.cn		Peng, Jianhua/0000-0003-3348-9538	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771278, 81801176, 81971132]; Sichuan Science and Technology Program [2018RZ0090, 2019JDTD0004, 19MZGC0003]; Luzhou Science and Technology Program [2016LZXNYD-Z02, 2017-R-74, 2018-JYJ-42]	This work was supported by the National Natural Science Foundation of China (81771278, 81801176, and 81971132), Sichuan Science and Technology Program (2018RZ0090, 2019JDTD0004 and 19MZGC0003), and Luzhou Science and Technology Program (2016LZXNYD-Z02, 2017-R-74, 2018-JYJ-42).	Asadi Y, 2018, NEUROCHEM RES, V43, P1549, DOI 10.1007/s11064-018-2569-9; Askari H, 2018, PHARMACOL RES, V129, P44, DOI 10.1016/j.phrs.2018.01.012; Bailey DM, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5438; Barnett R, 2019, LANCET, V393, P1589, DOI 10.1016/S0140-6736(19)30851-7; Bi JB, 2019, REDOX BIOL, V20, P296, DOI 10.1016/j.redox.2018.10.019; Bluher S, 2014, OBESITY, V22, P1701, DOI 10.1002/oby.20739; Bolanos JP, 2009, ADV DRUG DELIVER REV, V61, P1299, DOI 10.1016/j.addr.2009.05.009; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bostrom PA, 2014, NAT REV ENDOCRINOL, V10, P11, DOI 10.1038/nrendo.2013.230; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894; Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298; Chen ZM, 2018, LANCET GLOB HEALTH, V6, pE630, DOI 10.1016/s2214-109x(18)30216-x; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi SH, 2018, SCIENCE, V361, P991, DOI 10.1126/science.aan8821; Chou SHY, 2017, STROKE, V48, P2231, DOI 10.1161/STROKEAHA.117.017758; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dale CE, 2017, CIRCULATION, V135, P2373, DOI 10.1161/CIRCULATIONAHA.116.026560; Dillen Y, 2020, TRANSL STROKE RES, V11, P60, DOI 10.1007/s12975-019-00717-8; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dobkin BH, 2008, NAT CLIN PRACT NEURO, V4, P76, DOI 10.1038/ncpneuro0709; Drury-Stewart D, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt292; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; Elley CR, 2005, LANCET, V366, P1248; Emami MR, 2017, EUR J INTERN MED, V44, pE22, DOI 10.1016/j.ejim.2017.07.030; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Fan J., 2019, J CELLULAR PHYSL, V235, P1165; Farmer SR, 2019, NEW ENGL J MED, V380, P1480, DOI 10.1056/NEJMcibr1900041; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; Forouzanfar M, 2015, CELL BIOL INT, V39, P629, DOI 10.1002/cbin.10427; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Ghahrizjani FA, 2015, GENE, V557, P123, DOI 10.1016/j.gene.2014.12.010; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; Guan J, 2012, BIOMATERIALS, V33, P1386, DOI 10.1016/j.biomaterials.2011.10.073; Gul-Kahraman K, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12589; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; Hu W, 2016, PLOS ONE, V11, pe0165460; Huang L, 2019, PROG NEUROBIOL, V173, P1, DOI 10.1016/j.pneurobio.2018.05.004; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ikeda R, 2005, NEUROBIOL DIS, V20, P38, DOI 10.1016/j.nbd.2005.01.031; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jin KL, 2004, J CEREBR BLOOD F MET, V24, P399, DOI 10.1097/00004647-200404000-00005; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Kazeminasab F, 2018, APPL PHYSIOL NUTR ME, V43, P651, DOI 10.1139/apnm-2017-0614; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Khacho M, 2019, NAT REV NEUROSCI, V20, P34, DOI 10.1038/s41583-018-0091-3; Khan Karim M, 2012, Lancet, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Kim OY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110407; Kim S, 2019, PFLUG ARCH EUR J PHY, V471, P491, DOI 10.1007/s00424-019-02253-8; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Langdon KD, 2011, NEUROSCIENCE, V182, P82, DOI 10.1016/j.neuroscience.2011.03.028; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Li RL, 2018, J MOL CELL CARDIOL, V121, P242, DOI 10.1016/j.yjmcc.2018.07.250; Li RL, 2019, J CELL PHYSIOL, V234, P17578, DOI 10.1002/jcp.28382; Li XS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00127; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Luo WS, 2019, TRANSL STROKE RES, V10, P342, DOI 10.1007/s12975-018-0648-5; Makimattila S, 2004, J CEREBR BLOOD F MET, V24, P1393, DOI 10.1097/01.WCB.0000143700.15489.B2; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mo J, 2019, REDOX BIOL, V20, P75, DOI 10.1016/j.redox.2018.09.022; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Murphy MP, 2018, NEW ENGL J MED, V378, P391, DOI 10.1056/NEJMe1714638; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pang JW, 2019, CELL TRANSPLANT, V28, P26, DOI 10.1177/0963689718812054; Peng J, 2017, MOL IMMUNOL, V91, P185, DOI 10.1016/j.molimm.2017.09.014; Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Peterson JM, 2014, PEERJ, V2, DOI 10.7717/peerj.605; Piya MK, 2014, AM J PHYSIOL-ENDOC M, V306, pE512, DOI 10.1152/ajpendo.00308.2013; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Rajamani U, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08572-9; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; Ruan QW, 2018, PEPTIDES, V103, P60, DOI 10.1016/j.peptides.2018.03.013; Sarmah D, 2018, TRANSL STROKE RES, V9, P356, DOI 10.1007/s12975-017-0580-0; Sarmah D, 2019, TRANSL STROKE RES, V10, P121, DOI 10.1007/s12975-018-0642-y; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Shao L, 2017, BIOCHEM BIOPH RES CO, V487, P194, DOI 10.1016/j.bbrc.2017.04.020; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Stanne TM, 2016, STROKE, V47, P1943, DOI 10.1161/STROKEAHA.115.012383; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Takagi T, 2017, TRANSL STROKE RES, V8, P515, DOI 10.1007/s12975-017-0556-0; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tari AR, 2019, PROG CARDIOVASC DIS, V62, P94, DOI 10.1016/j.pcad.2019.02.003; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; Tu WJ, 2018, NEUROTHERAPEUTICS, V15, P1158, DOI 10.1007/s13311-018-0651-2; Tu WJ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1177-6; Varela-Rodriguez BM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29898; Villarroya F, 2012, CELL METAB, V15, P277, DOI 10.1016/j.cmet.2012.02.010; Wang H, 2017, J CELL PHYSIOL, V232, P3775, DOI 10.1002/jcp.25857; Wang KX, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9070341; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu HS, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2018.02.017; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu Y, 2017, BRAIN, V140, DOI 10.1093/brain/awx084; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu BJ, 2013, CELL METAB, V18, P612, DOI 10.1016/j.cmet.2013.10.008; Xu S-Z, 2017, PLOS ONE, V12, pe0175498; Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002; Yang T, 2009, CELL TRANSPLANT, V18, P391, DOI 10.3727/096368909788809767; Ye X, 2019, PEPTIDES, V119, DOI 10.1016/j.peptides.2019.170120; Young MF, 2019, PROG CARDIOVASC DIS, V62, P172, DOI 10.1016/j.pcad.2019.02.007; Zhou QC, 2015, MOL CELL ENDOCRINOL, V412, P349, DOI 10.1016/j.mce.2015.05.036; Zhu GX, 2016, J CARDIOVASC PHARM, V68, P67, DOI 10.1097/FJC.0000000000000386	132	3	3	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	MAY 1	2020	29	9					533	543		10.1089/scd.2019.0232		FEB 2020	11	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	LI7SU	WOS:000512964100001	31914844	Bronze			2022-02-06	
J	Yang, CH; Nag, S; Xing, GQ; Aggarwal, NT; Schneider, JA				Yang, Chunhui; Nag, Sukriti; Xing, Guoqiang; Aggarwal, Neelum T.; Schneider, Julie A.			A Clinicopathological Report of a 93-Year-Old Former Street Boxer With Coexistence of Chronic Traumatic Encephalopathy, Alzheimer's Disease, Dementia With Lewy Bodies, and Hippocampal Sclerosis With TDP-43 Pathology	FRONTIERS IN NEUROLOGY			English	Article						Alzheimer's disease; chronic traumatic encephalopathy; dementia; dementia with Lewy bodies; phosphorylated tau; traumatic brain injury; TDP-43 pathology; tauopathy	BRAIN-INJURY; ASSOCIATION; NEUROPATHOLOGY; DISTINCT; DECLINE; RISK	Chronic traumatic encephalopathy (CTE) was recently recognized as a new tauopathy in which multifocal perivascular phosphorylated tau aggregates accumulate in neurons, astrocytes, and neurites at the depths of the cortical sulci. Traumatic brain injury (TBI) in early or mid-life is known to be associated with an increased risk of dementia in late life. This case report describes a 93-year-old former street boxer with a premortem diagnosis of severe dementia, who showed pathological evidence of the coexistence of Alzheimer's disease, CTE, dementia with Lewy bodies, and hippocampal sclerosis with TDP-43 pathology. These findings suggest that TBI may trigger a variety of misfolded proteins leading to dementia. Currently, clear clinical diagnostic criteria for CTE have not been established. Therefore, clinicians should be aware that TBI is a risk factor for dementia and that CTE can overlap with other neurodegenerative diseases.	[Yang, Chunhui; Nag, Sukriti; Aggarwal, Neelum T.; Schneider, Julie A.] Rush Univ, Rush Alzheimer Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Nag, Sukriti; Schneider, Julie A.] Rush Univ, Dept Pathol Neuropathol, Med Ctr, Chicago, IL 60612 USA; [Xing, Guoqiang] North Sichuan Med Coll, Affiliated Hosp, Nanchong, Peoples R China; [Aggarwal, Neelum T.; Schneider, Julie A.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA		Yang, CH (corresponding author), Rush Univ, Rush Alzheimer Dis Ctr, Med Ctr, Chicago, IL 60612 USA.	chunhuiyang2018@gmail.com	Xing, Guoqiang/ABA-8450-2020				Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Buckland ME, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0751-1; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jellinger KA, 2009, BBA-MOL BASIS DIS, V1792, P730, DOI 10.1016/j.bbadis.2008.07.006; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nag S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0531-3; Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Schneider JA, 2012, BRAIN, V135, P3005, DOI 10.1093/brain/aws234; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Wilson RS, 2013, JAMA NEUROL, V70, P1418, DOI 10.1001/jamaneurol.2013.3961; Yuan SH, 2018, CASE REP NEUROL MED, V2018, DOI 10.1155/2018/7890269	32	3	3	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 12	2020	11								42	10.3389/fneur.2020.00042			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KR4AX	WOS:000517561700001	32117011	gold, Green Published			2022-02-06	
J	Bouyer, B; Leroy, F; Rudant, J; Weill, A; Coste, J				Bouyer, Benjamin; Leroy, Fanny; Rudant, Jeremie; Weill, Alain; Coste, Joel			Burden of fractures in France: incidence and severity by age, gender, and site in 2016	INTERNATIONAL ORTHOPAEDICS			English	Article						Fractures; General population; Epidemiology; Incidence; Severity	TRAUMATIC BRAIN-INJURY; HIP-FRACTURES; FOREARM FRACTURES; OLDER WOMEN; EPIDEMIOLOGY; COSTS; ANKLE; SURVIVORSHIP; PREDICTORS; OUTCOMES	Purpose Fractures are common events, but the exact incidence and severity of fractures have not been clearly determined for most anatomical sites. We estimated the incidence and severity of fractures in France regardless of the anatomical site. Methods Observational cross-sectional study in France in 2016 based on the national health data system. All incident fractures in patients 20 years and older were included. We determined the anatomical fracture site (12 sites) and the severity using a 4-point scale (outpatient care, hospitalization, surgery, and in-hospital death). Results We identified 562,094 incident fractures, predominantly occurring in women (319,858: 56.9%); with a mean age of 63.6 years, and an exponential increase after the age of 70 years. Distal upper limb (172,591: 30.7%), distal lower limb (84,602: 15.1%), and femoral neck (78,766: 14.0%) accounted for more than one-half of all fractures. Sex and age of onset distributions varied widely according to fracture sites, with earlier onset for distal lower limb fractures (mean age: 54.2 years) and distal upper limb fractures (mean age: 55.2 years) with a men predominance for skull fractures. Only 105,165 (18.7%) fractures were treated on an outpatient basis; 11,913 (2.1%) in-hospital deaths occurred in patients with a mean age of 79.5 years. High mortality was observed for skull (12.9%), rib (4.9%), and femoral fractures (femoral neck 4.3% and proximal lower limb 4.2%). Conclusion We estimated the incidence of fractures in France by sex and anatomical site. We also showed that fractures remain common and serious life events, especially in older people.	[Bouyer, Benjamin] Hop Europeen Georges Pompidou, Serv Orthopedie, F-75015 Paris, France; [Bouyer, Benjamin; Coste, Joel] Univ Paris, Paris, France; [Leroy, Fanny; Rudant, Jeremie; Weill, Alain] Caisse Natl Assurance Maladie, Paris, France; [Weill, Alain] Grp Interet Sci EPI PHARE, St Denis, France; [Coste, Joel] Hop Cochin, Unite Biostat & Epidemiol, 27 Rue Faubourg St Jacques, F-75014 Paris, France		Coste, J (corresponding author), Univ Paris, Paris, France.; Coste, J (corresponding author), Hop Cochin, Unite Biostat & Epidemiol, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	joel.coste@parisdescartes.fr		Coste, Joel/0000-0001-7674-7192; Weill, Alain/0000-0001-8687-9092	French National Health Insurance Fund (CNAM)	This research was funded by the French National Health Insurance Fund (CNAM). JR, FL, and AWare or were employees of the French National Health Insurance Fund.	Abrahamsen B, 2015, OSTEOPOROSIS INT, V26, P67, DOI 10.1007/s00198-014-2831-1; Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Beck B, 2016, MED J AUSTRALIA, V204, P407, DOI 10.5694/mja15.01369; Beziz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155783; Boddaert J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083795; Bonafede Machaon, 2013, J Med Econ, V16, P169, DOI 10.3111/13696998.2012.737391; Bouyer B, 2018, J THROMB HAEMOST, V16, P1537, DOI 10.1111/jth.14205; Chen FP, 2017, OSTEOPOROSIS INT, V28, P811, DOI 10.1007/s00198-016-3820-3; Colas S, 2017, CLIN ORTHOP RELAT R, V475, P2046, DOI 10.1007/s11999-017-5260-6; Colas S, 2015, JAMA SURG, V150, P979, DOI 10.1001/jamasurg.2015.1325; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; Cummings SR, 1998, OSTEOPOROSIS INT, V8, pS8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Driessen JHM, 2016, OSTEOPOROSIS INT, V27, P2017, DOI 10.1007/s00198-016-3488-8; Guggenbuhl P, 2005, JOINT BONE SPINE, V72, P372, DOI 10.1016/j.jbspin.2004.04.002; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kanis JA, 2008, TECHNICAL REPORT; Lee KM, 2013, OSTEOPOROSIS INT, V24, P2819, DOI 10.1007/s00198-013-2394-6; LEES B, 1993, LANCET, V341, P673, DOI 10.1016/0140-6736(93)90433-H; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; Marques A, 2015, OSTEOPOROSIS INT, V26, P2623, DOI 10.1007/s00198-015-3171-5; Oberlin P, 2016, DREES, V948, P1; Palmer A, 2018, GERIATR ORTHOP SURG, V9, DOI 10.1177/2151459318813976; Papadimitriou N, 2017, LANCET PUBLIC HEALTH, V2, pE239, DOI 10.1016/S2468-2667(17)30046-4; Schwartz AV, 1999, OSTEOPOROSIS INT, V9, P242, DOI 10.1007/s001980050144; Seeley DG, 1996, J BONE MINER RES, V11, P1347; Svedbom A, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0187-y; Thelot B., 2015, B EPIDEMIOLOGIQUE HE, V30, P580; Tuppin P, 2017, REV EPIDEMIOL SANTE, V65, pS149, DOI 10.1016/j.respe.2017.05.004; Van Staa TP, 2001, BONE, V29, P517, DOI 10.1016/S8756-3282(01)00614-7; Williamson S, 2017, OSTEOPOROSIS INT, V28, P2791, DOI 10.1007/s00198-017-4153-6	34	3	3	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	MAY	2020	44	5					947	955		10.1007/s00264-020-04492-2		FEB 2020	9	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	LI5OW	WOS:000515962400001	32036489	Green Published, hybrid			2022-02-06	
J	Hartnell, D; Gillespie-Jones, K; Ciornei, C; Hollings, A; Thomas, A; Harrild, E; Reinhardt, J; Paterson, DJ; Alwis, D; Rajan, R; Hackett, MJ				Hartnell, David; Gillespie-Jones, Kate; Ciornei, Cristina; Hollings, Ashley; Thomas, Alexander; Harrild, Elizabeth; Reinhardt, Juliane; Paterson, David J.; Alwis, Dasuni; Rajan, Ramesh; Hackett, Mark J.			Characterization of Ionic and Lipid Gradients within Corpus Callosum White Matter after Diffuse Traumatic Brain Injury in the Rat	ACS CHEMICAL NEUROSCIENCE			English	Article						Brain injury; ions; white matter; X-ray fluorescence; synchrotron; infrared	MEMBRANE PHOSPHOLIPID DEGRADATION; AXONAL INJURY; ELEMENTAL COMPOSITION; SUBSTANTIA-NIGRA; IMPACT; EPIDEMIOLOGY; NEURONS; PROTEIN; PATHOPHYSIOLOGY; COMPONENTS	There is increased recognition of the effects of diffuse traumatic brain injury (dTBI), which can initiate yet unknown biochemical cascades, resulting in delayed secondary brain degeneration and long-term neurological sequela. There is limited availability of therapies that minimize the effect of secondary brain damage on the quality of life of people who have suffered TBI, many of which were otherwise healthy adults. Understanding the cascade of biochemical events initiated in specific brain regions in the acute phase of dTBI and how this spreads into adjacent brain structures may provide the necessary insight into drive development of improved therapies. In this study, we have used direct biochemical imaging techniques (Fourier transform infrared spectroscopic imaging) and elemental mapping (X-ray fluorescence microscopy) to characterize biochemical and elemental alterations that occur in corpus callosum white matter in the acute phase of dTBI. The results provide direct visualization of differential biochemical and ionic changes that occur in the highly vulnerable medial corpus callosum white matter relative to the less vulnerable lateral regions of the corpus callosum. Specifically, the results suggest that altered ionic gradients manifest within mechanically damaged medial corpus callosum, potentially spreading to and inducing lipid alterations to white matter structures in lateral brain regions.	[Hartnell, David; Hollings, Ashley; Thomas, Alexander; Harrild, Elizabeth; Hackett, Mark J.] Curtin Univ, Curtin Inst Funct Mol & Interfaces, Sch Mol & Life Sci, Perth, WA 6845, Australia; [Hartnell, David; Hollings, Ashley; Thomas, Alexander; Harrild, Elizabeth; Hackett, Mark J.] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia; [Gillespie-Jones, Kate; Ciornei, Cristina; Alwis, Dasuni; Rajan, Ramesh] Monash Univ, Biomed Discovery Inst, Neurosci Program, Clayton, Vic 3168, Australia; [Gillespie-Jones, Kate; Ciornei, Cristina; Alwis, Dasuni; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Reinhardt, Juliane; Paterson, David J.] Australian Nucl Sci & Technol Org, 800 Blackburn Rd, Clayton, Vic 3168, Australia; [Reinhardt, Juliane] La Trobe Univ, ARC Ctr Excellence Adv Mol Imaging, Inst Mol Sci, Dept Chem & Phys, Melbourne, Vic 3086, Australia		Hackett, MJ (corresponding author), Curtin Univ, Curtin Inst Funct Mol & Interfaces, Sch Mol & Life Sci, Perth, WA 6845, Australia.; Hackett, MJ (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia.	mark.j.hackett@curtin.edu.au		Hollings, Ashley/0000-0001-7829-4932; Hartnell, David/0000-0001-9750-3250; hackett, mark/0000-0002-3296-7270	ANSTO; Australian GovernmentAustralian GovernmentCGIAR; National Health and Medical Research Council -NMHRCNational Health and Medical Research Council of Australia [APP 1029311]; Dementia Australia Research Foundation, Mamutil New Investigator Project Grant [11646]	We gratefully acknowledge travel funding provided by ANSTO, funded by the Australian Government. R.R. acknowledges funding support from the National Health and Medical Research Council -NMHRC APP 1029311. MJ.H. is supported by the Dementia Australia Research Foundation, Mamutil New Investigator Project Grant (11646).	Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Barabas ME, 2014, J BIOL CHEM, V289, P34241, DOI 10.1074/jbc.M114.570101; Bishop DP, 2018, CHEM SOC REV, V47, P3770, DOI 10.1039/c7cs00610a; Caine S, 2016, NEUROBIOL DIS, V91, P132, DOI 10.1016/j.nbd.2016.03.006; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Chwiej J, 2011, J BIOL INORG CHEM, V16, P275, DOI 10.1007/s00775-010-0724-0; Chwiej JG, 2019, ACS CHEM NEUROSCI, V10, P628, DOI 10.1021/acschemneuro.8b00471; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Fimognari N, 2018, ACS CHEM NEUROSCI, V9, P2774, DOI 10.1021/acschemneuro.8b00193; Gomez-Fernandez JC, 1998, CHEM PHYS LIPIDS, V96, P41, DOI 10.1016/S0009-3084(98)00079-6; Grubman A, 2014, CHEM SCI, V5, P2503, DOI 10.1039/c4sc00316k; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hackett MJ, 2019, METALLOMICS, V11, P151, DOI 10.1039/c8mt00230d; Hackett MJ, 2019, ACS CHEM NEUROSCI, V10, P2533, DOI 10.1021/acschemneuro.9b00039; Hackett MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500911; Hackett MJ, 2015, ACS CHEM NEUROSCI, V6, P761, DOI 10.1021/acschemneuro.5b00037; Hackett MJ, 2015, ACS CHEM NEUROSCI, V6, P226, DOI 10.1021/cn500157j; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hare DJ, 2016, METALLOMICS, V8, P156, DOI [10.1039/c5mt00288e, 10.1039/C5MT00288E]; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kastyak MZ, 2010, NEUROSCIENCE, V166, P1119, DOI 10.1016/j.neuroscience.2010.01.017; Langlois J. A., 2006, TRAUMATIC BRAIN INJU, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lins BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158152; Malek SA, 2003, J NEUROSCI, V23, P3826; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Pevsner A, 2003, BIOPOLYMERS, V72, P282, DOI 10.1002/bip.10416; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Pushie MJ, 2018, ANALYST, V143, P3761, DOI 10.1039/c7an01904a; Pushie MJ, 2018, ACS CHEM NEUROSCI, V9, P886, DOI 10.1021/acschemneuro.7b00382; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryan CG, 2014, J PHYS CONF SER, V499, DOI 10.1088/1742-6596/499/1/012002; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Summers KL, 2017, BIOCHEMISTRY-US, V56, P4107, DOI 10.1021/acs.biochem.7b00262; Surowka AD, 2016, TALANTA, V161, P368, DOI 10.1016/j.talanta.2016.08.023; Surowka AD, 2015, METALLOMICS, V7, P1522, DOI 10.1039/c5mt00154d; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tsang D, 1997, NEUROCHEM RES, V22, P811, DOI 10.1023/A:1022031825923; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williamson MR, 2017, STROKE, V48, P195, DOI 10.1161/STROKEAHA.116.015404; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045	69	3	3	2	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	FEB 5	2020	11	3					248	257		10.1021/acschemneuro.9b00257			19	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	KJ7FE	WOS:000512222900007	31850738	Green Submitted			2022-02-06	
J	Mercier, LJ; Fung, TS; Harris, AD; Dukelow, SP; Debert, CT				Mercier, Leah J.; Fung, Tak S.; Harris, Ashley D.; Dukelow, Sean P.; Debert, Chantel T.			Improving symptom burden in adults with persistent post-concussive symptoms: a randomized aerobic exercise trial protocol	BMC NEUROLOGY			English	Article						Concussion; Mild traumatic brain injury; Persistent post-concussive symptoms; Aerobic exercise; Randomized controlled trial; Exercise intolerance; Post-concussion syndrome; Quality of life	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; AGREEMENT STATEMENT; DAYTIME SLEEPINESS; HEAD-INJURY; SPORT; VALIDITY; SCALE; QUESTIONNAIRE; IMPACT	Background Persistent post-concussive symptoms (PPCS) affect up to 30% of individuals following mild traumatic brain injury. PPCS frequently includes exercise intolerance. Sub-symptom threshold aerobic exercise has been proposed as a treatment option for symptom burden and exercise intolerance in this population. The primary aim of this study is to evaluate whether a progressive, sub-symptom threshold aerobic exercise program can alleviate symptom burden in adults with PPCS. Methods Fifty-six adults (18-65) with PPCS (>3mos-5 yrs) will be randomized into two groups: an immediate start 12-week aerobic exercise protocol (AEP) or delayed start 6-week placebo-like stretching protocol (SP), followed by AEP. Aerobic or stretching activities will be completed 5x/week for 30 mins during the intervention. Online daily activity logs will be submitted. Exercise prescriptions for the AEP will be 70-80% of heart rate at the point of symptom exacerbation achieved on a treadmill test with heart rate monitoring. Exercise prescription will be updated every 3-weeks with a repeat treadmill test. The Rivermead Post-concussion Symptom Questionnaire will be the primary outcome measure at 6 and 12-weeks of intervention. Secondary outcomes include assessments of specific symptoms (headache, quality of life, mood, anxiety, fatigue, dizziness, sleep parameters, daytime sleepiness) in addition to blood biomarkers and magnetic resonance imaging and spectroscopy data for quantification of brain metabolites including gamma-aminobutyric acid (GABA), glutathione, glutamate and N-acetyl aspartate (NAA) all measured at 6 and 12-weeks of intervention. Discussion This trial will evaluate the use of aerobic exercise as an intervention for adults with PPCS, thus expanding our knowledge of this treatment option previously studied predominantly for adolescent sport-related concussion.	[Mercier, Leah J.; Dukelow, Sean P.; Debert, Chantel T.] Univ Calgary, Dept Clin Neurosci, Div Phys Med & Rehabil, Calgary, AB, Canada; [Fung, Tak S.] Univ Calgary, Informat Technol, Calgary, AB, Canada; [Harris, Ashley D.] Univ Calgary, Dept Radiol, Calgary, AB, Canada		Mercier, LJ (corresponding author), Univ Calgary, Dept Clin Neurosci, Div Phys Med & Rehabil, Calgary, AB, Canada.	leah.mercier@ucalgary.ca		Debert, Chantel/0000-0002-2704-0438	Foundation for Physical Medicine and Rehabilitation; Hotchkiss Brain Institute PFUND award; New Frontiers in Research Fund Exploration award; Integrated Concussion Research Program (ICRP) graduate studentship	This study is funded by the Foundation for Physical Medicine and Rehabilitation, a Hotchkiss Brain Institute PFUND award and a New Frontiers in Research Fund Exploration award. Each of these grants were peer reviewed. Leah J Mercier is supported by an Integrated Concussion Research Program (ICRP) graduate studentship. None of the study's funding sources had a role in study design or implementation. Funding agencies will not have a role in study execution, analysis, results interpretation, manuscript drafting or future publication of results.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Borg G, 1982, CATEGORY SCALE RATIO, P25; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Castien RF, 2012, CEPHALALGIA, V32, P710, DOI 10.1177/0333102412449933; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chekroud SR, 2018, LANCET PSYCHIAT, V5, P739, DOI 10.1016/S2215-0366(18)30227-X; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Dolezal Brett A, 2017, Adv Prev Med, V2017, P1364387, DOI 10.1155/2017/1364387; Falck RS, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz040; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Friedman SD, 2017, NEUROLOGY, V89, P2151, DOI 10.1212/WNL.0000000000004666; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Landry Glenn J, 2015, Front Aging Neurosci, V7, P166, DOI 10.3389/fnagi.2015.00166; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Larun L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub7; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lemmens J, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0961-8; Lowe B, 2006, PSYCHOSOMATICS, V47, P62, DOI 10.1176/appi.psy.47.1.62; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntyre M, 2020, AM J PHYS MED REHAB, V99, P257, DOI 10.1097/PHM.0000000000001340; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Saleh MG, 2016, NEUROIMAGE, V142, P576, DOI 10.1016/j.neuroimage.2016.07.056; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Sebela A, 2019, CHRONOBIOL INT, V36, P1227, DOI 10.1080/07420528.2019.1630631; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00362; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stern Y, 2019, NEUROLOGY, V92; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; World Health Organization, 1993, ICD 10 CLASS MENT BE	59	3	3	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	FEB 5	2020	20	1							46	10.1186/s12883-020-1622-x			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KW5FC	WOS:000521189600001	32024486	Green Published, gold			2022-02-06	
J	Rosenblum, DJ; Walton, SR; Erdman, NK; Broshek, DK; Hart, JM; Resch, JE				Rosenblum, Daniel J.; Walton, Samuel R.; Erdman, Nicholas K.; Broshek, Donna K.; Hart, Joeseph M.; Resch, Jacob E.			If Not Now, When? An Absence of Neurocognitive and Postural Stability Deficits in Collegiate Athletes with One or More Concussions	JOURNAL OF NEUROTRAUMA			English	Article						balance; concussion; cumulative; neurocognitive; postural control	CHRONIC TRAUMATIC ENCEPHALOPATHY; LIFE COGNITIVE IMPAIRMENT; SPORT-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; MUSCULOSKELETAL INJURY; RECURRENT CONCUSSION; BALANCE CONTROL; 1ST EXPOSURE	A history of concussion has been associated with decreased neurocognitive function and postural control. The purpose of our study was to compare neurocognitive function and postural control in collegiate athletes with and without varying histories of concussion. Collegiate athletes were divided into groups based on 0 (n = 129), 1 (n = 91), 2 (n = 52), and 3+ (n = 34) prior concussions. Participants in each group were carefully matched by sport, sex, height, weight, and age. Athletes were administered the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT (TM)) and the Sensory Organization Test (SOT) as part of a standard of care pre-season assessment. Group ImPACT (Verbal and Visual Memory, Visual Motor Speed, and Reaction Time) and SOT (Equilibrium Score and Somatosensory, Visual, and Vestibular sensory ratios) outcome scores were compared using one-way analyses of variance (ANOVAs). Coefficients of variation (CVs) were also calculated for each outcome score and were compared using two-sample tests with 95% confidence intervals (CIs). Participants with and without a history of concussion were not significantly different for any ImPACT or SOT outcome score (p's > 0.10). Groups (0, 1, 2, and 3+ previous concussions) were not different from each other for any ImPACT or SOT outcome score (p's >= 0.11). Likewise, the CVs associated with each ImPACT and SOT outcome score did not vary significantly between outcome scores for any group comparison (p >= 0.09). Our findings suggest that a history of one or more concussions does not influence neurocognitive performance or postural stability in collegiate athletes at their pre-season baseline assessment.	[Rosenblum, Daniel J.; Walton, Samuel R.; Erdman, Nicholas K.; Hart, Joeseph M.; Resch, Jacob E.] Univ Virginia, Dept Kinesiol, Charlottesville, VA USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA		Resch, JE (corresponding author), Univ Virginia, Mem Gymnasium, 210 Emmet St S, Charlottesville, VA 22904 USA.	jer6x@virginia.edu	Erdman, Nicholas/ABA-4554-2020; Broshek, Donna/ABA-4208-2021	Erdman, Nicholas/0000-0001-8109-7585; Broshek, Donna/0000-0002-7175-7815; Walton, Samuel/0000-0003-2647-5701			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Cai W, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00858; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Centers for Disease Control and Prevention. (2017). Getting Answers about Concussion, 2017, GETT ANSW CONC; Chong RKY, 1999, J GERONTOL A-BIOL, V54, pM122, DOI 10.1093/gerona/54.3.M122; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; El-Kahky AM, 2000, ACTA OTO-LARYNGOL, V120, P508, DOI 10.1080/000164800750046018; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harro CC, 2018, PARKINSONS DIS-US, V2018, DOI 10.1155/2018/6142579; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Lovell M. R, 2011, IMMEDIATE POSTCONCUS; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mucha A, 2018, HAND CLINIC, V158, P135, DOI 10.1016/B978-0-444-63954-7.00014-8; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Salthouse TA, 2007, NEUROPSYCHOLOGY, V21, P401, DOI 10.1037/0894-4105.21.4.401; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; Thompson M., 2009, BALANCE MANAGER SYST; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Zaiontz C, 2019, REAL STAT USING EXCE	59	3	3	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2020	37	10					1211	1220		10.1089/neu.2019.6813		FEB 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LL3VP	WOS:000512108100001	31910071				2022-02-06	
J	Corbin-Berrigan, LA; Kowalski, K; Faubert, J; Christie, B; Gagnon, I				Corbin-Berrigan, Laurie-Ann; Kowalski, Kristina; Faubert, Jocelyn; Christie, Brian; Gagnon, Isabelle			Could Neurotracker be used as a clinical marker of recovery following pediatric mild traumatic brain injury? An exploratory study	BRAIN INJURY			English	Article						Neurotracker; perceptual-cognitive training; three-dimensional multiple object tracking; Object tracking; children; pediatrics; mild traumatic brain injury; concussion; return to activities	COGNITIVE FUNCTION; SENSITIVITY; PERFORMANCE; CONCUSSION; MANAGEMENT; TRACKING; CHILDREN; IMPACT	Primary objective: This study aimed to explore the potential for the Neurotracker, a perceptual-cognitive, multiple-object tracking test, and train paradigm, as a marker of functional recovery after mild traumatic brain injury (mTBI). It is hypothesized that Neurotracker could serve as a proxy for assessing cerebral functioning. Research design: A comparative, 6 time points, longitudinal study design was used to compare Neurotracker performance between children and adolescents who were clinically recovered from mTBI and healthy controls. Methods and Procedures: Clinical measures were collected at the initial and final visits. Neurotracker trainings were performed at each of the 6 visits. Speed thresholds (Neurotracker performance) were recorded at each visit. Main Outcomes and Results: A two-way repeated measures ANOVA suggested no differences between the groups but a significant time effect was apparent. Conclusions: Clinically recovered children and adolescents exhibit similar training abilities to control subjects on this task. These results support further investigations using Neurotracker as a marker of recovery following mTBI.	[Corbin-Berrigan, Laurie-Ann] Univ Quebec Trois Rivieres, Dept Sci Activite Phys, 3351 Blvd Forges,Pavillon Albert Tessier 4245, Trois Rivieres, PQ G9A 5H7, Canada; [Corbin-Berrigan, Laurie-Ann; Gagnon, Isabelle] Mcgill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Kowalski, Kristina] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Faubert, Jocelyn] Univ Montreal, Ecole Optometrie, Montreal, PQ, Canada; [Faubert, Jocelyn] Faubert Lab, Dept Psychol, Montreal, PQ, Canada; [Christie, Brian] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Gagnon, Isabelle] Montreal Childrens Hosp, Dept Psychol Trauma, Montreal, PQ, Canada		Corbin-Berrigan, LA (corresponding author), Univ Quebec Trois Rivieres, Dept Sci Activite Phys, 3351 Blvd Forges,Pavillon Albert Tessier 4245, Trois Rivieres, PQ G9A 5H7, Canada.	laurie-ann.corbin-berrigan@uqtr.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by the Canadian Institutes of Health Research.	Canada P, 2019, CONCUSSION; Corbin-Berrigan LA, 2018, NEUROREPORT, V29, P559, DOI 10.1097/WNR.0000000000000988; Deitz Jean C, 2007, Phys Occup Ther Pediatr, V27, P87, DOI 10.1300/J006v27n04_06; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Faubert J, 2012, NEUROTRACKER SYSTEM, V6; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Legault I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00323; Legault I, 2012, NEUROREPORT, V23, P469, DOI 10.1097/WNR.0b013e328353e48a; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Romeas T, 2016, PSYCHOL SPORT EXERC, V22, P1, DOI 10.1016/j.psychsport.2015.06.002; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Tullo D, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12670; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812; Vartanian O, 2016, MIL PSYCHOL, V28, P353, DOI 10.1037/mil0000125; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Williams AM, 2000, J SPORT SCI, V18, P737, DOI 10.1080/02640410050120113; Williams AM, 1999, VISUAL PERCEPTION AC; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	26	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					385	389		10.1080/02699052.2020.1723699		FEB 2020	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000512576800001	32013583				2022-02-06	
J	Austin, AV; Sasser, P; Tanabe, K; MacKnight, JM; Kent, JB				Austin, Ashley V.; Sasser, Phillip; Tanabe, Kawai; MacKnight, John M.; Kent, Jeremy B.			Video Analysis of Concussion Exposures in a National Collegiate Athletic Association Division I Football Team	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						sport-related concussion; football position; collision partner; medical observer; field location	SPORT-RELATED CONCUSSION; PROFESSIONAL FOOTBALL; EPIDEMIOLOGY; DIAGNOSIS; PLAYERS	Background: Research into improving player safety of sport-related concussion (SRC) in American football has been an ongoing endeavor. In an attempt to better understand the incidence of SRCs in American football, research has focused on the characteristics of SRC during gameplay. Determining SRC specifics and assessing them quantitatively can help identify high-risk scenarios and predict exposure risk. Purpose: To identify and assess the incidence of SRCs in a National Collegiate Athletic Association football team by comparing field location, player positions, collision partners, and player cues. Study Design: Descriptive epidemiology study. Methods: We used physician sideline reports of diagnosed concussions from a Division I football team from September 2010 to December 2018. Game videos were analyzed to identify the field location where the SRC occurred, collision partner, and player behavior postconcussion. The incidence of in-game SRCs by position was also assessed. We used the "words of estimative probability" model to categorize each concussion as certain, almost certain, probable, or even on the basis of our confidence in identifying them using game film. Results: This study examined 44 SRCs that occurred over 9 seasons. The SRC incidence was significantly higher in the middle defense (5-20 yards from the line of scrimmage) compared with all other field locations (relative risk, 2.46; 95% CI, 1.14-5.29; P < .05). In-game collision partners were most commonly defensive backs. The most common player cue was a hand to helmet/face mask. The positions with the highest SRC incidence by athlete-exposure, game position, and position play belonged to the defensive backs, wide receivers, and running backs. Conclusion: The middle defense had a significantly higher incidence of SRCs than all other field locations. We pose a new method to categorize concussions during video analysis by using words of estimative probability. Knowledge of SRC gameplay characteristics can potentially guide the medical staff and medical observer to better identify them.	[Austin, Ashley V.] Univ Washington, Sch Med, Dept Family Med, Seattle, WA 98195 USA; [Sasser, Phillip; Tanabe, Kawai; Kent, Jeremy B.] Univ Virginia, Sch Med, Dept Family Med, Charlottesville, VA 22908 USA; [MacKnight, John M.] Univ Virginia, Sch Med, Dept Internal Med, Charlottesville, VA 22908 USA		Kent, JB (corresponding author), POB 800729, Charlottesville, VA 22908 USA.	jbk7y@virginia.edu	Kent, Jeremy B/AAQ-5384-2020				[Anonymous], NFL FOOTB OP; [Anonymous], NY TIMES; [Anonymous], NEW KICKOFF RULE APP; Asplund CA, 2015, BRIT J SPORT MED, V49, P1015, DOI 10.1136/bjsports-2014-h1381rep; Baugh CM, 2016, CONCUSSION, V1, P1; Broome G., ACCS EYES STEP BETT; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Carollo B., 2015, BIG 10 FOOTB MED DAY; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Delaney J, BIG 10 C 2015 MED DA; Dopher M. ACC, 2015, ACC FOOTB GAM WILL I; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Johnson G, 2015, NCAA APPROVES EXPT R; Kekis J, US TODAY; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McGrath B, 2011, NEW YORKER; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; NFL, NFL FANTASY FOOTBALL; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; REAGAN RT, 1989, J APPL PSYCHOL, V74, P433, DOI 10.1037/0021-9010.74.3.433; SECsports, SEC OUTL MED OBS PRO; Tjong VK, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00070; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Williams VB, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0569-5	43	3	3	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	FEB	2020	8	2							2325967120903294	10.1177/2325967120903294			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	KR3HY	WOS:000517510200001	32166091	gold, Green Published			2022-02-06	
J	Beqiri, E; Czosnyka, M; Lalou, AD; Zeiler, FA; Fedriga, M; Steiner, LA; Chieregato, A; Smielewski, P				Beqiri, Erta; Czosnyka, Marek; Lalou, Afroditi D.; Zeiler, Frederick A.; Fedriga, Marta; Steiner, Luzius A.; Chieregato, Arturo; Smielewski, Peter			Influence of mild-moderate hypocapnia on intracranial pressure slow waves activity in TBI	ACTA NEUROCHIRURGICA			English	Article						ICP slow waves; Hypocapnia; TBI; Cerebral autoregulation; Compensatory reserve; RAP	CEREBRAL-BLOOD-FLOW; B-WAVES; CARBON-DIOXIDE; HEAD-INJURY; OSCILLATIONS; REACTIVITY; HYPERVENTILATION; FLUCTUATIONS; ANESTHESIA; DYNAMICS	Background In traumatic brain injury (TBI) the patterns of intracranial pressure (ICP) waveforms may reflect pathological processes that ultimately lead to unfavorable outcome. In particular, ICP slow waves (sw) (0.005-0.05 Hz) magnitude and complexity have been shown to have positive association with favorable outcome. Mild-moderate hypocapnia is currently used for short periods to treat critical elevations in ICP. Our goals were to assess changes in the ICP sw activity occurring following sudden onset of mild-moderate hypocapnia and to examine the relationship between changes in ICP sw activity and other physiological variables during the hypocapnic challenge. Methods ICP, arterial blood pressure (ABP), and bilateral middle cerebral artery blood flow velocity (FV), were prospectively collected in 29 adult severe TBI patients requiring ICP monitoring and mechanical ventilation in whom a minute volume ventilation increase (15-20% increase in respiratory minute volume) was performed as part of a clinical CO2-reactivity test. The time series were first treated using FFT filter (pass-band set to 0.005-0.05 Hz). Power spectral density analysis was performed. We calculated the following: mean value, standard deviation, variance and coefficient of variation in the time domain; total power and frequency centroid in the frequency domain; cerebrospinal compliance (Ci) and compensatory reserve index (RAP). Results Hypocapnia led to a decrease in power and increase in frequency centroid and entropy of slow waves in ICP and FV (not ABP). In a multiple linear regression model, RAP at the baseline was the strongest predictor for the decrease in the power of ICP slow waves (p < 0.001). Conclusion In severe TBI patients, a sudden mild-moderate hypocapnia induces a decrease in mean ICP and FV, but also in slow waves power of both signals. At the same time, it increases their higher frequency content and their morphological complexity. The difference in power of the ICP slow waves between the baseline and the hypocapnia period depends on the baseline cerebrospinal compensatory reserve as measured by RAP.	[Beqiri, Erta; Czosnyka, Marek; Lalou, Afroditi D.; Fedriga, Marta; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Beqiri, Erta] Milan Univ, Dept Physiol & Transplantat, Milan, Italy; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England; [Fedriga, Marta] Spedali Civili Univ Hosp, Dept Anesthesia Crit Care & Emergency, Piazzale Spedali Civili 1, I-25123 Brescia, Italy; [Steiner, Luzius A.] Univ Basel, Univ Hosp Basel, Anesthesiol, Basel, Switzerland; [Steiner, Luzius A.] Univ Basel, Dept Clin Res, Basel, Switzerland; [Chieregato, Arturo] Grande Osped Metropolitano Niguarda, Neurointens Care Unit, Milan, Italy		Beqiri, E (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England.; Beqiri, E (corresponding author), Milan Univ, Dept Physiol & Transplantat, Milan, Italy.	erta.beqiri@gmail.com	; Lalou, Afroditi Despina/D-2938-2017	beqiri, erta/0000-0002-8108-0000; Lalou, Afroditi Despina/0000-0003-3768-8681; Zeiler, Frederick/0000-0003-1737-0510			AUER LM, 1983, ACTA NEUROCHIR, V68, P93, DOI 10.1007/BF01406205; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Carrera E, 2011, J NEUROTRAUM, V28, P889, DOI 10.1089/neu.2010.1377; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; da Costa CS, 2017, J CEREBR BLOOD F MET, V37, P3368, DOI 10.1177/0271678X16687314; Einhaupl KM, 1986, OSCILLATIONS ICP REL, P290; Eklund A, 2001, J NEUROSURG, V94, P392, DOI 10.3171/jns.2001.94.3.0392; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; HARA K, 1990, MED INFORM, V15, P125, DOI 10.3109/14639239008997664; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; Higashi S, 1989, ROLE VASOMOTOR CTR A, P220; HUNDLEY WG, 1988, AM J PHYSIOL, V254, pH67, DOI 10.1152/ajpheart.1988.254.1.H67; JONES SC, 1995, AM J PHYSIOL-HEART C, V268, pH569, DOI 10.1152/ajpheart.1995.268.2.H569; Kasprowicz M, 2010, J NEUROSCI METH, V190, P310, DOI 10.1016/j.jneumeth.2010.05.015; Kay S. M., 1988, MODERN SPECTRAL ESTI; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Lalou DA, 2016, NEUROL RES, V38, P587, DOI 10.1080/01616412.2016.1189200; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Lu CW, 2016, ACTA NEUROCHIR SUPPL, V122, P33, DOI 10.1007/978-3-319-22533-3_6; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MAUTNER-HUPPERT D, 1989, Neurological Research, V11, P194; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosner M., 1986, INTRACRANIAL PRESSUR, P137, DOI [10.1007/978-3-642-70971-5_25, DOI 10.1007/978-3-642-70971-5_25]; Russo G, 2000, NEUROL SCI, V21, P292, DOI 10.1007/s100720070066; Smielewski P, 2018, ACTA NEUROCHIR SUPPL, V126, P139, DOI 10.1007/978-3-319-65798-1_29; Spiegelberg A, 2018, ACTA NEUROCHIR SUPPL, V126, P243, DOI 10.1007/978-3-319-65798-1_49; Steiner LA, 2005, ACTA NEUROCHIR, V147, P477, DOI 10.1007/s00701-005-0510-x; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; VENES JL, 1979, CHILD BRAIN, V5, P352; Walter M, 2002, ACT NEUR S, V81, P161; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386	40	3	3	1	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2020	162	2					345	356		10.1007/s00701-019-04118-6			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KV1ES	WOS:000520167600018	31844989	hybrid, Green Published, Green Submitted			2022-02-06	
J	Black, AM; Miutz, LN; Warriyar, KVV; Schneider, KJ; Yeates, KO; Emery, CA				Black, Amanda M.; Miutz, Lauren N.; Warriyar, Vineetha K. V.; Schneider, Kathryn J.; Yeates, Keith Owen; Emery, Carolyn A.			Baseline Performance of High School Rugby Players on the Sport Concussion Assessment Tool 5	JOURNAL OF ATHLETIC TRAINING			English	Article						student-athletes; mild traumatic brain injuries; rugby union	VALUES; SCALES; SCAT3	Context: Version 5 of the Sport Concussion Assessment Tool (SCAT5) was released in 2017 with an additional 10-word list option in the memory section and additional instructions for completing the symptom scale. Objective: To provide reference scores for high school rugby union players on the SCAT5, including immediate memory using the 10-word list, and examine how age, sex, and concussion history affected performance. Design: Cross-sectional study. Setting: Calgary, Alberta high schools. Patients or Other Participants: High school rugby union players (ages 15-18 years) participating in a 2018 season cohort study (n = 380, males = 210, females = 170). Main Outcome Measure(s): Sport Concussion Assessment Tool 5 scores, including total number of symptoms (of 20), symptom severity (of 132), 10-word immediate memory (of 30), delayed memory (of 10), modified Standardized Assessment of Concussion (of 50), and balance examination (of 30). Results: The median number of symptoms reported at baseline ranged from 5 to 8 across sex and age stratifications. Median symptom severity was lowest in males with no concussion history (7; range, 0-28) and highest in females with a concussion history (13, range = 0-45). Median total scores on immediate memory were 2-3 (range = 0-4) for males and 21 (range = 9-29) for females. Median total scores were 3 (range 0-4) on digits backward and 7 (range = 0-20) on delayed memory (all groups). Based on simultaneous quantile (q) regression at 0.50 and 0.75, adjusted for age and concussion history, being female was associated with a higher total symptoms score (q0.75 beta(female) = 2.85; 99% confidence interval [CI] 0.33, 5.37), higher total symptom severity score (q0.75 beta(female) = 8.00; 99% CI = 2.83, 13.17), and lower number of errors on the balance examination (q0.75 beta(female) = -3.00; 99% CI = -4.85, -1.15). Age and concussion history were not associated with any summary measures. Conclusions: The 10-word list option in the memory section reduced the likelihood of a ceiling effect. A player's sex may be an important consideration when interpreting the SCAT5 after concussion.	[Black, Amanda M.; Miutz, Lauren N.; Warriyar, Vineetha K. V.; Schneider, Kathryn J.; Emery, Carolyn A.] Fac Kinesiol, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Black, Amanda M.; Miutz, Lauren N.; Schneider, Kathryn J.; Emery, Carolyn A.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Black, Amanda M.; Miutz, Lauren N.; Schneider, Kathryn J.; Emery, Carolyn A.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Emery, Carolyn A.] Dept Psychol & Neurosci, Calgary, AB, Canada; [Yeates, Keith Owen; Emery, Carolyn A.] Dept Paediat, Calgary, AB, Canada; [Emery, Carolyn A.] Dept Community Hlth Sci, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Calgary, AB, Canada		Black, AM (corresponding author), Fac Kinesiol, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ablack@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Emery, Carolyn/AAI-2761-2020; Black, Amanda/O-7675-2017	Black, Amanda/0000-0001-5668-9706	International Olympic Committee; Integrated Concussion Research Program at the University of Calgary	This work would not have been possible without the help of the teachers, coaches, and athletes who participated in the study and helped organize the testing sessions. We thank all of the research assistants and coordinators at the Sport Injury Prevention Research Centre for their help with data collection. The Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. Dr Black was supported by a postdoctoral fellowship through the Integrated Concussion Research Program at the University of Calgary.	Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Dessy A, 2014, CLIN NEUROL NEUROSUR, V122, P59, DOI 10.1016/j.clineuro.2014.04.003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Hanninen T, 2014, BRAIN INJURY, V28, P553; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrold GK, 2017, J NEUROL SCI, V379, P312, DOI 10.1016/j.jns.2017.06.038; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	18	3	3	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2020	55	2					116	123		10.4085/1062-6050-123-19			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KM1GV	WOS:000513866900002	31917599	Green Published, gold			2022-02-06	
J	Blanco-Ocampo, D; Cawen, FA; Alamo-Pindado, LA; Negro-Demontel, ML; Peluffo, H				Blanco-Ocampo, Daniela; Cawen, Fabio Andres; Alamo-Pindado, Luis Angel; Negro-Demontel, Maria Luciana; Peluffo, Hugo			Safe and neuroprotective vectors for long-term traumatic brain injury gene therapy	GENE THERAPY			English	Article							CONTROLLED CORTICAL IMPACT; PARKINSONS-DISEASE; DELIVERY	Traumatic brain injury (TBI) is a complex and progressive brain injury with no approved treatments that needs both short- and long-term therapeutic strategies to cope with the variety of physiopathological mechanisms involved. In particular, neuroinflammation is a key process modulating TBI outcome, and the potentiation of these mechanisms by pro-inflammatory gene therapy vectors could contribute to the injury progression. Here, we evaluate in the controlled cortical impact model of TBI, the safety of integrative-deficient lentiviral vectors (IDLVs) or the non-viral HNRK recombinant modular protein/DNA nanovector. These two promising vectors display different tropisms, transduction efficiencies, short- or long-term transduction or inflammatory activation profile. We show that the brain intraparenchymal injection of these vectors overexpressing green fluorescent protein after a CCI is not neurotoxic, and interestingly, can decrease the short-term sensory neurological deficits, and diminish the brain tissue loss at 90 days post lesion (dpl). Moreover, only IDLVs were able to mitigate the memory deficits elicited by a CCI. These vectors did not alter the microglial or astroglial reactivity at 90 dpl, suggesting that they do not potentiate the on-going neuroinflammation. Taken together, these data suggest that both types of vectors could be interesting tools for the design of gene therapy strategies targeting immediate or long-term neuropathological mechanisms of TBI.	[Blanco-Ocampo, Daniela; Alamo-Pindado, Luis Angel; Negro-Demontel, Maria Luciana; Peluffo, Hugo] Univers Republ, Fac Med, Dept Histol, Embryol, Montevideo, Uruguay; [Blanco-Ocampo, Daniela] Univers Republ, Fac Med, Dept Physiopathol, Montevideo, Uruguay; [Cawen, Fabio Andres; Alamo-Pindado, Luis Angel; Negro-Demontel, Maria Luciana; Peluffo, Hugo] Institut Pasteur Montevideo, Gene Therapy Lab, Neuroinflammation, Montevideo, Uruguay		Peluffo, H (corresponding author), Univers Republ, Fac Med, Dept Histol, Embryol, Montevideo, Uruguay.	hugo.peluffo@pasteur.edu.uy		Peluffo, Hugo/0000-0001-6111-8668			Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Burnside ER, 2018, BRAIN, V141, P2362, DOI 10.1093/brain/awy158; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Deverman BE, 2018, NAT REV DRUG DISCOV, V17, P768, DOI 10.1038/nrd.2018.158; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Domingo-Espin J, 2012, NANOMED-NANOTECHNOL, V8, P1263, DOI 10.1016/j.nano.2012.06.005; Domingo-Espin J, 2011, NANOMEDICINE-UK, V6, P1047, DOI [10.2217/NNM.11.28, 10.2217/nnm.11.28]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Hwu WL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003640; Kochanek PM, 2020, J NEUROTRAUM, V37, P2353, DOI 10.1089/neu.2018.6203; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; Negro-Demontel ML, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.47; Niethammer M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau0713; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Palfi S, 2018, HUM GENE THER CL DEV, V29, P148, DOI 10.1089/humc.2018.081; Peluffo H, 2013, GENE THER, V20, P645, DOI 10.1038/gt.2012.78; Peluffo H, 2007, ANN NEUROL, V62, P251, DOI 10.1002/ana.21170; Peluffo H, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-35; Richter Monique, 2018, Curr Protoc Immunol, V120, DOI 10.1002/cpim.42; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stoessl AJ, 2014, LANCET, V383, P1107, DOI 10.1016/S0140-6736(13)62108-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365	29	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	FEB	2020	27	1-2					96	103		10.1038/s41434-019-0073-8			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	KO6NB	WOS:000515664800011	30926962				2022-02-06	
J	Bomyea, J; Simmons, AN; Shenton, ME; Coleman, MJ; Bouix, S; Rathi, Y; Pasternak, O; Coimbra, R; Shutter, L; George, MS; Grant, G; Zafonte, RD; McAllister, TW; Stein, MB				Bomyea, Jessica; Simmons, Alan N.; Shenton, Martha E.; Coleman, Michael J.; Bouix, Sylvain; Rathi, Yogesh; Pasternak, Ofer; Coimbra, Raul; Shutter, Lori; George, Mark S.; Grant, Gerald; Zafonte, Ross D.; McAllister, Thomas W.; Stein, Murray B.		INTRuST Consortium	Neurocognitive markers of childhood abuse in individuals with PTSD: Findings from the INTRuST Clinical Consortium	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						PTSD; Childhood maltreatment; Cortical thickness; Morphology; MRI	EARLY-LIFE STRESS; HIPPOCAMPAL VOLUME; CORTICAL THICKNESS; SEXUAL-ABUSE; ANTERIOR CINGULATE; SENSITIVE PERIODS; BRAIN STRUCTURE; MALTREATMENT; CHILDREN; TRAUMA	To date, few studies have evaluated the contribution of early life experiences to neurocognitive abnormalities observed in posttraumatic stress disorder (PTSD). Childhood maltreatment is common among individuals with PTSD and is thought to catalyze stress-related biobehavioral changes that might impact both brain structure and function in adulthood. The current study examined differences in brain morphology (brain volume, cortical thickness) and neuropsychological performance in individuals with PTSD characterized by low or high self-reported childhood maltreatment, compared with healthy comparison participants. Data were drawn from the INjury and TRaUmatic STress (INTRuST) Clinical Consortium imaging repository, which contains MRI and self-report data for individuals classified as PTSD positive (with and without a history of mild traumatic brain injury [mTBI]), individuals with mTBI only, and healthy comparison participants. The final sample included 36 individuals with PTSD without childhood maltreatment exposure (PTSD, n = 30 with mTBI), 31 individuals with PTSD and childhood maltreatment exposure (PTSD + M, n = 26 with mTBI), and 114 healthy comparison participants without history of childhood maltreatment exposure (HC). The PTSD + M and PTSD groups demonstrated cortical thinning in prefrontal and occipital regions, and poorer verbal memory and processing speed compared to the HC group. PTSD + M participants demonstrated cortical thinning in frontal and cingulate regions, and poorer executive functioning relative to the PTSD and HC groups. Thus, neurocognitive features varied between individuals with PTSD who did versus did not have exposure to childhood maltreatment, highlighting the need to assess developmental history of maltreatment when examining biomarkers in PTSD.	[Bomyea, Jessica; Simmons, Alan N.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Bomyea, Jessica; Simmons, Alan N.; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Shenton, Martha E.; Coleman, Michael J.; Bouix, Sylvain; Rathi, Yogesh; Pasternak, Ofer] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Dept Psychiat, 1249 Boylston St, Boston, MA 02215 USA; [Shenton, Martha E.; Pasternak, Ofer] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA 02301 USA; [Coimbra, Raul] Univ Calif San Diego, Dept Surg, La Jolla, CA 92161 USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; [George, Mark S.] Med Univ South Carolina, Ralph H Johnson VA Med Ctr, Charleston, SC 29401 USA; [George, Mark S.] Ralph H Johnson VA Med Ctr, Charleston, SC 29401 USA; [Grant, Gerald] Stanford Univ, Med Ctr, Palo Alto, CA 94305 USA; [Grant, Gerald] Duke Univ, Durham, NC 90586 USA; [Zafonte, Ross D.] Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Boston, MA 02215 USA; [Zafonte, Ross D.] Harvard Med Sch, Boston, MA 02215 USA; [McAllister, Thomas W.] Geisel Sch Med Dartmouth, Hanover, NH 03755 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Stein, Murray B.] Univ Calif San Diego, San Diego Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA		Bomyea, J (corresponding author), 9500 Gilman Dr,MC 0855, San Diego, CA USA.	jbomyea@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Shutter, Lori A/G-2957-2013; Simmons, Alan/A-9815-2008	Coimbra, Raul/0000-0002-3759-6851; George, Mark/0000-0003-1767-1815; Simmons, Alan/0000-0003-3963-2112; Shutter, Lori/0000-0002-1390-0628	CDMRPUnited States Department of Defense [W81XWH-08-2-0159]; VA Office of Academic Affairs; US Department of Veteran Affairs (CSRD)US Department of Veterans Affairs [CX001600-01A1]	The authors thank the INTRuST consortium contributors for contributions to the study design and execution. This work was supported by the CDMRP award W81XWH-08-2-0159 (Stein et al.), the VA Office of Academic Affairs (J. Bomyea) and a Career Development Award from the US Department of Veteran Affairs (CSR&D CX001600-01A1; J. Bomyea). Thank you to Charles Kim for his assistance with the preparation of this manuscript.	Akiki TJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0840-4; Alvarez MJ, 2011, J NERV MENT DIS, V199, P156, DOI 10.1097/NMD.0b013e31820c751c; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bajaj S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00412; Bauer PM, 2009, BIOL PSYCHIAT, V66, P1100, DOI 10.1016/j.biopsych.2009.06.014; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Benedict R.H., 1997, BRIEF BISUOSPATIAL M; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bomyea J, 2019, PSYCHIAT RES, V272, P531, DOI 10.1016/j.psychres.2018.12.021; Bucker J, 2012, COMPR PSYCHIAT, V53, P758, DOI 10.1016/j.comppsych.2011.12.006; Chaney A, 2014, J PSYCHIATR NEUROSCI, V39, P50, DOI 10.1503/jpn.120208; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; De Bellis MD, 2009, J INT NEUROPSYCH SOC, V15, P868, DOI 10.1017/S1355617709990464; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Dube SR, 2009, PSYCHOSOM MED, V71, P243, DOI 10.1097/PSY.0b013e3181907888; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fonzo GA, 2013, PSYCHIAT RES-NEUROIM, V211, P93, DOI 10.1016/j.pscychresns.2012.08.006; Garfinkel SN, 2009, PSYCHIAT ANN, V39, P370, DOI 10.3928/00485713-20090527-01; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Golier J, 2002, PSYCHIAT CLIN N AM, V25, P295, DOI 10.1016/S0193-953X(01)00004-1; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Grecucci A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00523; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hovens JGFM, 2015, J CLIN PSYCHIAT, V76, P931, DOI 10.4088/JCP.14m09135; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Khalsa SS, 2018, BIOL PSYCHIAT-COGN N, V3, P501, DOI 10.1016/j.bpsc.2017.12.004; Koola MM, 2013, J NERV MENT DIS, V201, P348, DOI 10.1097/NMD.0b013e318288e333; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Landre L, 2010, PSYCHIAT RES-NEUROIM, V183, P181, DOI 10.1016/j.pscychresns.2010.01.015; Lanius RA, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.27313; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lim L, 2014, AM J PSYCHIAT, V171, P854, DOI 10.1176/appi.ajp.2014.13101427; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Majer M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-61; Malarbi S, 2017, NEUROSCI BIOBEHAV R, V72, P68, DOI 10.1016/j.neubiorev.2016.11.004; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; Milad MR, 2014, BEHAV RES THER, V62, P17, DOI 10.1016/j.brat.2014.08.006; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Navalta CP, 2006, J NEUROPSYCH CLIN N, V18, P45, DOI 10.1176/appi.neuropsych.18.1.45; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Nemeroff CB, 2016, NEURON, V89, P892, DOI 10.1016/j.neuron.2016.01.019; Nikulina V, 2013, NEUROPSYCHOLOGY, V27, P417, DOI 10.1037/a0032811; Nolin P, 2007, CHILD ABUSE NEGLECT, V31, P631, DOI 10.1016/j.chiabu.2006.12.009; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ohashi K, 2017, NEUROIMAGE, V150, P50, DOI 10.1016/j.neuroimage.2017.02.037; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paquola C, 2016, NEUROSCI BIOBEHAV R, V69, P299, DOI 10.1016/j.neubiorev.2016.08.011; Pechtel P, 2014, NEUROIMAGE, V97, P236, DOI 10.1016/j.neuroimage.2014.04.025; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Schmidt M., 1996, REY AUDITORY VERBAL; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Tomoda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052528; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Weathers FW, 1993, ANN M INT SOC TRAUMA; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitney KA, 2015, ARCH CLIN NEUROPSYCH, V30, P130, DOI 10.1093/arclin/acu094; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Wolfson, 1993, HALSTEAD REITAN NEUR; Woodward SH, 2009, J INT NEUROPSYCH SOC, V15, P830, DOI 10.1017/S1355617709990476; Xie B, 2013, BRAIN RES, V1490, P225, DOI 10.1016/j.brainres.2012.10.048	93	3	3	3	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	FEB	2020	121						108	117		10.1016/j.jpsychires.2019.11.012			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KE7ZO	WOS:000508769800013	31809943	Green Submitted, Green Accepted			2022-02-06	
J	Bruneau, DA; Cronin, DS				Bruneau, David A.; Cronin, Duane S.			Head and Neck Response of an Active Human Body Model and Finite Element Anthropometric Test Device During a Linear Impactor Helmet Test	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							AMERICAN FOOTBALL HELMETS; PROFESSIONAL FOOTBALL; INJURY; PERFORMANCE; CONCUSSION; METRICS	It has been proposed that neck muscle activation may play a role in head response resulting from impacts in American Football. The importance of neck stiffness and active musculature in the standard linear impactor helmet test was assessed using a detailed head and neck finite element (FE) model from a current human body model (HBM) compared to a validated hybrid III head and neck FE model. The models were assessed for bare-head and helmeted impacts at three speeds (5.5, 7.4, and 9.3 m/s) and three impact orientations. The HBM head and neck was assessed without muscle activation and with a high level of muscle activation representing a braced condition. The HBM and hybrid III had an average cross-correlation rating of 0.89 for acceleration in the primary impact direction, indicating excellent correspondence regardless of muscle activation. Differences were identified in the axial head acceleration, attributed to axial neck stiffness (correlation rating of 0.45), but these differences did not have a large effect on the overall head response using existing head response metrics (head injury criteria, brain injury criteria, and head impact power). Although responses that develop over longer durations following the impact differed slightly, such as the moment at the base of the neck, this occurred later in time, and therefore, did not considerably affect the short-term head kinematics in the primary impact direction. Though muscle activation did not play a strong role in the head response for the test configurations considered, muscle activation may play a role in longer duration events.	[Bruneau, David A.; Cronin, Duane S.] Univ Waterloo, Dept Mech & Mechatron Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada		Bruneau, DA (corresponding author), Univ Waterloo, Dept Mech & Mechatron Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	dbruneau@uwaterloo.ca; duane.cronin@uwaterloo.ca			Football Research, Inc. (FRI); Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Government (Ontario Graduate Scholarship Program)	Football Research, Inc. (FRI; Funder ID: 10.13039/100006425).; Natural Sciences and Engineering Research Council of Canada (NSERC; Funder ID: 10.13039/501100000038).; Ontario Government (Ontario Graduate Scholarship Program; Funder ID: 10.13039/100013873).	Barker JB, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036464; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bruneau D.C., 2018, P IRCOBI C ATH SEPT, P322; Bustamante M., 2019, J DYN BEHAV MAT; Craig M.J, 2007, BIOMECHANICS JAW LOA; Cronin D., 2018, USER MANUAL FINITE E; Cronin D.S., 2018, HUM MOD S BERL ALZ G; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Fice JB, 2011, ANN BIOMED ENG, V39, P2152, DOI 10.1007/s10439-011-0315-4; Funk J.R., 2017, LINEAR IMPACTOR HELM; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GHBMC, 2019, RESOURCES; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Johnson KL, 2016, MATER DESIGN, V111, P108, DOI 10.1016/j.matdes.2016.08.064; Kallieris D., 1995, INT RES COUNC BIOM I, P135; Karton CM, 2014, AM SOC TEST MATER, V1552, P23, DOI 10.1520/STP155220120175; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Morimoto K, 2013, J PHYS THER SCI, V25, P563, DOI 10.1589/jpts.25.563; NOCSAE, 2017, STAND PERF SPEC NEWL; Panzer MB, 2011, MED ENG PHYS, V33, P1147, DOI 10.1016/j.medengphy.2011.05.004; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rush G.A, 2016, DESIGN AM FOOTBALL H; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Thunert, 2012, CORA RELEASE 3 6 USE; Vavalle NA, 2013, TRAFFIC INJ PREV, V14, pS87, DOI 10.1080/15389588.2013.802777; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; White NA, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028133; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	42	3	3	0	4	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	FEB	2020	142	2							021004	10.1115/1.4043667			11	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KS8JF	WOS:000518552200005	31053858				2022-02-06	
J	Din-Lovinescu, C; Parikh, I; Paskhover, B				Din-Lovinescu, Corina; Parikh, Ishan; Paskhover, Boris			How Have Craniofacial Injuries Changed in Adult Bicyclists Over the Past 10 Years?	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							HELMET USE; EMERGENCY-DEPARTMENTS; HEAD-INJURIES; UNITED-STATES; CHILDREN; LEGISLATION; TRENDS	Purpose: As bicycling popularity grows in the United States, it becomes increasingly important to understand and characterize bicycle-related injuries. In this study, we sought to characterize craniofacial injuries in adult cyclists and to evaluate trends in injuries over the past 10 years. Materials and Methods: In this retrospective cohort study, the National Electronic Injury Surveillance System was queried for bicycle-related craniofacial injuries in adults aged 18 to 64 years from January 1, 2008, to December 31, 2017. Variables examined included demographic characteristics, diagnosis, patient disposition, and change in number of injuries and age-adjusted incidence of injuries from 2008 to 2017. Linear regression analysis was performed to evaluate trends in injuries over time, with statistical significance set at P < .05. Results: There were an estimated 573,305 visits to emergency departments across the United States for bicycle-related craniofacial injuries from 2008 to 2017. Male patients (75%), patients aged 18 to 24 years (25%), and white patients (54%) were injured most commonly. The population-adjusted incidence of total injuries increased by 22% from 2008 to 2017 (P = .13). The rates of traumatic brain injury and craniofacial fractures rose by 50% (P = .06) and 63% (P < .01), respectively. Cyclists aged 55 to 64 years had the highest increase in the age-adjusted incidence of injury from 2008 to 2017, by 54% (P < .01). Conclusions: Bicycle-related trauma remains a public health concern, with a steady number of craniofacial injuries presenting to emergency departments across the United States during the past 10 years. Injuries have increased for adults aged 55 to 64 years, and there has been a rise in more severe injuries including traumatic brain injury and craniofacial fractures. (C) 2019 American Association of Oral and Maxillofacial Surgeons	[Din-Lovinescu, Corina; Paskhover, Boris] Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, 90 Bergen St,Ste 8100, Newark, NJ 07103 USA; [Parikh, Ishan] St Barnabas Hosp, Dept Otolaryngol Head & Neck Surg, Livingston, NJ USA		Din-Lovinescu, C (corresponding author), Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, 90 Bergen St,Ste 8100, Newark, NJ 07103 USA.	corina.din-lovinescu@rwjbh.org		Parikh, Ishan/0000-0001-9295-9726			Alliance for Biking and Walking, BIC WALK US 2012 BEN; [Anonymous], OUTD FDN NUMB PART B, VStatista-The Statistics Portal; Bicycle Helmet Safety Institute, BIC HELM LAWS; Boffano P, 2013, OR SURG OR MED OR PA, V116, P275, DOI 10.1016/j.oooo.2013.03.004; Bonander C, 2014, J SAFETY RES, V51, P15, DOI 10.1016/j.jsr.2014.07.001; Breakaway Research Group, US BIC PART BENCHM S; Centers for Disease Control and Prevention, BIC SAF; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Dennis J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2674; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; Fishman E, 2016, TRANSPORT REV, V36, P92, DOI 10.1080/01441647.2015.1033036; Fry R, 2018, MILLENNIALS PROJECTE; Gaither TW, 2018, INJURY PREV, V24, P135, DOI 10.1136/injuryprev-2016-042281; Jacobsen PL, 2015, INJURY PREV, V21, P271, DOI 10.1136/ip.9.3.205rep; Karkhaneh M, 2013, ACCIDENT ANAL PREV, V59, P206, DOI 10.1016/j.aap.2013.05.027; League of American Bicyclists, WE RID AN BIC COMM A; Lee KH, 2008, AUST DENT J, V53, P246, DOI 10.1111/j.1834-7819.2008.00056.x; Lindsay H, 2014, CHRON DIS INJ CAN, V34, P74; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; McAdams RJ, 2018, ACCIDENT ANAL PREV, V118, P11, DOI 10.1016/j.aap.2018.05.019; Mehan TJ, 2009, CLIN PEDIATR, V48, P166, DOI 10.1177/0009922808324952; National Association of City Transportation Officials, BIK SHAR US 2017; National Association of City Transportation Officials, BIK SHAR US 2010 201; National Association of City Transportation Officials, 2016, NACT BIK SHAR EQ PRA; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Pucher J, 2011, TRANSPORT RES A-POL, V45, P451, DOI 10.1016/j.tra.2011.03.001; Sanford T, 2015, JAMA-J AM MED ASSOC, V314, P947, DOI 10.1001/jama.2015.8295; Svider PF, 2016, OTOLARYNG HEAD NECK, V154, P371, DOI 10.1177/0194599815618932; The League of American Bicyclists, GROWTH BIK COMM; The United States Census Bureau, POP HOUS UN EST; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; US Census Bureau, NAT INT TABL 2000 20; US Census Bureau, POP PYR US TOT RES P; US Department of Transportation Federal Highway Administration, DOT POL STAT BIC PED; Walter SR, 2011, ACCIDENT ANAL PREV, V43, P2064, DOI 10.1016/j.aap.2011.05.029; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	36	3	3	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	FEB	2020	78	2							254.e1	10.1016/j.joms.2019.08.006			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	KG5TS	WOS:000510013900016	31518548				2022-02-06	
J	Johnson, B; Dodd, A; Mayer, AR; Hallett, M; Slobounov, S				Johnson, Brian; Dodd, Andrew; Mayer, Andrew R.; Hallett, Mark; Slobounov, Semyon			Are there any differential responses to concussive injury in civilian versus athletic populations: a neuroimaging study	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; Mild traumatic brain injury (mTBI); Resting state functional magnetic resonance imaging (rs-fMRI); Default mode network (DMN)	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; HIPPOCAMPAL VOLUME; CLINICAL-TRIALS; FMRI; ENCEPHALOPATHY; CONSEQUENCES; ACTIVATION; INHIBITION	Accurate identification and classification of patients suffering from mild traumatic brain injury (mTBI) is a significant challenge faced by clinicians and researchers. To examine if there are different pathophysiological responses to concussive injury in different populations, evaluated here comparing collegiate athletes versus age-matched non-athletes. Resting-state fMRI data were acquired in the acute phase of concussion from 30 collegiate athletes and from 30 injury and age matched non-athletes. Resting-state functional connectivity measures revealed group differences with reduced connectivity in the anterior cingulate cortex (p < .05) and posterior cingulate cortex (p < 0.05) hubs of the Default Mode Network in the athletes. Given the known positive effects of exercise on brain functional reserves and neural efficiency concept, we expected less pronounced effect of concussion in athletic population. In contrast, there were significant decreases in functional connectivity in athletes that could be a result of previous repetitive subconcussive impacts and history of concussion.	[Johnson, Brian; Slobounov, Semyon] Penn State Univ, Dept Kinesiol, 276 Recat Bldg, University Pk, PA 16802 USA; [Dodd, Andrew; Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA; [Dodd, Andrew; Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Hallett, Mark] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Slobounov, Semyon] Penn State Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA		Slobounov, S (corresponding author), Penn State Univ, Dept Kinesiol, 276 Recat Bldg, University Pk, PA 16802 USA.; Slobounov, S (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA.	sms18@psu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002667] Funding Source: NIH RePORTER		Ahlskog JE, 2011, NEUROLOGY, V77, P288, DOI 10.1212/WNL.0b013e318225ab66; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bergman K, 2010, J EMERG NURS, V36, P221, DOI 10.1016/j.jen.2009.07.001; Bosnell R, 2008, NEUROIMAGE, V42, P603, DOI 10.1016/j.neuroimage.2008.05.005; Brier MR, 2014, BRAIN CONNECT, V4, P299, DOI 10.1089/brain.2014.0236; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Costafreda Sergi G, 2009, Front Neuroinform, V3, P33, DOI 10.3389/neuro.11.033.2009; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fletcher P, 1999, CEREB CORTEX, V9, P168, DOI 10.1093/cercor/9.2.168; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Gradin V, 2010, PSYCHIAT RES-NEUROIM, V184, P86, DOI 10.1016/j.pscychresns.2010.08.010; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Krajcovicova L, 2012, J NEURAL TRANSM, V119, P443, DOI 10.1007/s00702-011-0723-5; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, DOI 10.1093/brain/awt051; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Ploughman M, 2008, DEV NEUROREHABIL, V11, P236, DOI 10.1080/17518420801997007; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Yoo K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00049; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	63	3	3	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	FEB	2020	14	1					110	117		10.1007/s11682-018-9982-1			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KJ1DP	WOS:000511797100011	30361946				2022-02-06	
J	Jones, M; Collier, G; Reinkensmeyer, DJ; DeRuyter, F; Dzivak, J; Zondervan, D; Morris, J				Jones, Mike; Collier, George; Reinkensmeyer, David J.; DeRuyter, Frank; Dzivak, John; Zondervan, Daniel; Morris, John			Big Data Analytics and Sensor-Enhanced Activity Management to Improve Effectiveness and Efficiency of Outpatient Medical Rehabilitation	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						mobile rehabilitation; disability; rehabilitation; information and communication technology	MACHINE; CLASSIFICATION; ADHERENCE	Numerous societal trends are compelling a transition from inpatient to outpatient venues of care for medical rehabilitation. While there are advantages to outpatient rehabilitation (e.g., lower cost, more relevant to home and community function), there are also challenges including lack of information about how patient progress observed in the outpatient clinic translates into improved functional performance at home. At present, outpatient providers must rely on patient-reported information about functional progress (or lack thereof) at home and in the community. Information and communication technologies (ICT) offer another option-data collected about the patient's adherence, performance and progress made on home exercises could be used to help guide course corrections between clinic visits, enhancing effectiveness and efficiency of outpatient care. In this article, we describe our efforts to explore use of sensor-enhanced home exercise and big data analytics in medical rehabilitation. The goal of this work is to demonstrate how sensor-enhanced exercise can improve rehabilitation outcomes for patients with significant neurological impairment (e.g., from stroke, traumatic brain injury, and spinal cord injury). We provide an overview of big data analysis and explain how it may be used to optimize outpatient rehabilitation, creating a more efficient model of care. We describe our planned development efforts to build advanced analytic tools to guide home-based rehabilitation and our proposed randomized trial to evaluate effectiveness and implementation of this approach.	[Jones, Mike; Collier, George; Morris, John] Virginia C Crawford Res Inst, Shepherd Ctr, Atlanta, GA 30309 USA; [Reinkensmeyer, David J.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92606 USA; [DeRuyter, Frank] Duke Univ, Dept Surg, Durham, NC 27708 USA; [Dzivak, John] Pt Pal, Altadena, CA 91001 USA; [Zondervan, Daniel] Flint Rehabil Devices LLC, Irvine, CA 92614 USA		Jones, M (corresponding author), Virginia C Crawford Res Inst, Shepherd Ctr, Atlanta, GA 30309 USA.	mike_jones@shepherd.org; george.collier@shepherd.org; dreinken@uci.edu; frank.deruyter@duke.edu; john@ptpal.com; dzondervan@flintrehab.com; john.morris@shepherd.org		Morris, John T./0000-0003-3986-1011	National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90REGE0011-01-00]	Preparation of this article and funding for the described research and development is provided by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), grant number 90REGE0011-01-00. The opinions expressed in this article are those of the authors and do not reflect the official position of NIDILRR.	American Academy of Ophthalmology, AI LEARNS DET DIAB E; [Anonymous], 2019, J AM MED ASS; Blevi L, KPMG PROCESS MINING; Bresnick J., HLTH IT ANAL; Carrera I.M, ARTIFICIAL INTELLIGE; CREUTZIG F, 2017, CONCUSSION, V2; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Dey S, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2544-0; Dodakian L, 2017, NEUROREHAB NEURAL RE, V31, P923, DOI 10.1177/1545968317733818; Faroqi-Shah Y, 2016, SEMIN SPEECH LANG, V37, P3, DOI 10.1055/s-0036-1572385; Gordon R, MIT NEWS; Hilbert M, 2011, SCIENCE, V332, P60, DOI 10.1126/science.1200970; Jones M, 2020, INT J ENV RES PUB HE, V17, P381; Kavakiotis I, 2017, COMPUT STRUCT BIOTEC, V15, P104, DOI 10.1016/j.csbj.2016.12.005; Konerman MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208141; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Laney D, APPL DELIVERY STRATE; Lee SK, 2013, HEALTHC INFORM RES, V19, P33, DOI 10.4258/hir.2013.19.1.33; Lo-Ciganic WH, 2015, MED CARE, V53, P720, DOI 10.1097/MLR.0000000000000394; Ottenbacher KJ, 2019, PHYS MED REH CLIN N, V30, P459, DOI 10.1016/j.pmr.2018.12.003; Park JH, 2019, ARCH PHYS MED REHAB, V100, P1907, DOI 10.1016/j.apmr.2019.03.016; Rahimian F, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002695; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Tax N, 2017, LECT NOTES COMPUT SC, V10253, P477, DOI 10.1007/978-3-319-59536-8_30; Tucker CS, 2015, COMPUT BIOL MED, V66, P120, DOI 10.1016/j.compbiomed.2015.08.012; Varadhan R, 2013, DEV PROTOCOL OBSERVA; Wang Q, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0229-y; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zhu M, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-41	29	3	3	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB 1	2020	17	3							748	10.3390/ijerph17030748			13	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	KR7GF	WOS:000517783300073	31991582	Green Submitted, Green Published, gold			2022-02-06	
J	Liu, M; Yang, ZK; Yan, YF; Shen, X; Yao, HB; Fei, L; Wang, ES				Liu, Meng; Yang, Zhi-Kun; Yan, Yu-Feng; Shen, Xiao; Yao, Hui-Bin; Fei, Li; Wang, Er-Song			Optic Nerve Sheath Measurements by Computed Tomography to Predict Intracranial Pressure and Guide Surgery in Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Computed tomography; Intracranial pressure; Optic nerve sheath diameter; Traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; DIAMETER	BACKGROUND: Research has shown that the optic nerve sheath diameter (ONSD) is a good predictor of intracranial pressure (ICP) and may predict the need for surgery in patients with head injury. The objective was to test the value of ONSD in predicting the requirement for surgery in patients with traumatic brain injury (TBI). METHODS: In this retrospective cohort study, we first verified the correlation between ICP and ONSD using data from 62 patients with TBI who had undergone ICP monitoring. Second, we analyzed head computed tomography images from patients with TBI who were admitted to the emergency department where patients had been divided into surgery or conservative treatment groups, dependent on the assessment of a neurosurgeon. The correlation between ICP and ONSD was measured using linear regression analysis. Biologistic and receiver operating characteristic curve analyses were used to test the diagnostic value of ONSD to predict surgery. RESULTS: ONSD was significantly correlated with ICP (r = 0.606; P < 0.01), and there was a significant linear regression equation (<(y)over cap> = 0.071 x ICP + 3.533; P < 0.01), with ONSD predicting the requirement for surgery in patients with TBI (area under the curve, 0.920; P < 0.01; 95% confidence interval, 0.877-0.962). CONCLUSIONS: ONSD measured via head computed tomography correlates with ICP and can predict the requirement for surgery in patients with TBI following admission to the emergency department.	[Liu, Meng; Yang, Zhi-Kun; Yan, Yu-Feng; Shen, Xiao; Yao, Hui-Bin; Fei, Li; Wang, Er-Song] Fudan Univ, Jinshan Hosp, Dept Neurosurg, Shanghai, Peoples R China		Wang, ES (corresponding author), Fudan Univ, Jinshan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	wersong@aliyun.com	INECIKLI, MEHMET FATIH/AAK-5124-2020	INECIKLI, MEHMET FATIH/0000-0002-9796-8223; Liu, Meng/0000-0002-2445-2525			Bekerman I, 2016, AM J EMERG MED, V34, P2336, DOI 10.1016/j.ajem.2016.08.045; Bekerman I, 2016, J CLIN NEUROSCI, V30, P106, DOI 10.1016/j.jocn.2016.01.018; Bekerman I, 2016, J NEUROIMAGING, V26, P309, DOI 10.1111/jon.12322; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Chauvet D, 2010, NEUROSURG REV, V33, P287, DOI 10.1007/s10143-010-0261-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Goel RS, 2008, INJURY, V39, P519, DOI 10.1016/j.injury.2007.09.029; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kazdal H, 2016, WORLD NEUROSURG, V85, P292, DOI [10.1016/j.wneu.2015.10.015, 10.1016/j.WNEU.2015.10.015]; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mehan ND, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0151-4; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Vaiman M, 2016, J CLIN NEUROSCI, V34, P177, DOI 10.1016/j.jocn.2016.06.008; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32	19	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2020	134						E317	E324		10.1016/j.wneu.2019.10.065			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KK6VS	WOS:000512878200039	31629929				2022-02-06	
J	Mattei, TA; Teasdale, GM				Mattei, Tobias A.; Teasdale, Graham M.			The Story of the Development and Adoption of the Glasgow Coma Scale: Part I, The Early Years	WORLD NEUROSURGERY			English	Article						Coma scales; Glasgow Coma Scale; Glasgow Coma Scale Score; GCS; History of neurosurgery; Medical coma; Traumatic brain injury	IMPAIRED CONSCIOUSNESS; BRAIN-DAMAGE; HEAD-INJURY; PREDICTION; PROGNOSIS	The Glasgow Coma Scale and its derived Score have been adopted worldwide for assessing the degree of impaired responsiveness in traumatic brain injury and other kinds of acute brain damage. In this historical vignette, we describe how the foundations for their enduring success were laid during their initial development. To provide a unique additional background and context, the material from interviews with one of the originators of the scale was brought together with information from key publications in the early years after the first description of the scale in 1974. This historical investigation shows how the contents of the eye, verbal, and motor components of the scale were assembled through analysis of previous systems, guided by early clinimetric principles. Its reproducibility as a tool for clinical communication was confirmed through innovative studies of interobserver variability. To test its validity, international collaborations linking units in Britain, the Netherlands, and the United States were pursued. These collaborations were accompanied by the creation of the total Glasgow Coma Score with a 6-point motor subdivision. The observation that outcomes after severe head injury were similar in the different countries, despite marked variations in management, stimulated controversy that promoted further interest in traumatic brain injury research and a recommendation for the worldwide use of the scale as a common severity marker. Inclusion of the scale in major developments such as the Advanced Trauma Life Support (AILS) and the National Traumatic Coma Databank cemented its influential position in clinical care and research for the succeeding decades.	[Mattei, Tobias A.] St Louis Univ, Div Neurosurg, St Louis, MO 63103 USA; [Teasdale, Graham M.] Univ Glasgow, Neurosurg, Glasgow, Lanark, Scotland		Mattei, TA (corresponding author), St Louis Univ, Div Neurosurg, St Louis, MO 63103 USA.	tobias.mattei@health.slu.edu					Ablin G, 1967, WORLD DIRECTORY NEUR; BARLOW P, 1984, J MICROCOMPUT APPL, V7, P271, DOI 10.1016/0745-7138(84)90059-9; BATES D, 1977, ANN NEUROL, V2, P211, DOI 10.1002/ana.410020306; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Collicott P E, 1979, Nebr Med J, V64, P279; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Feinstein AR, 1967, CLIN JUDGEMENT; FISHER CM, 1969, ACTA NEUROL SCAND, VS 45, P5; FOULKES MA, 1991, J NEUROSURG S, V75, pS; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Jennett B, 1975, J R Coll Physicians Lond, V9, P231; Jennett B, 1972, Clin Neurosurg, V19, P200; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1976, LANCET, V1, P1031; Jennett B., 2002, TRAUMA, V4, P91, DOI DOI 10.1191/1460408602TA2330A; JENNETT B, 1984, HIGH TECHNOLOGY MED; JENNETT WB, 1965, BRIT MED J, V1, P1215, DOI 10.1136/bmj.1.5444.1215; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; MacEwen W, 1811, LANCET, V118, P581; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MCKISSOCK W, 1960, LANCET, V2, P167; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MURRAY GD, 1986, STAT MED, V5, P403, DOI 10.1002/sim.4780050504; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Plum F, 1972, Contemp Neurol Ser, V10, P1; Ponce FA, 2014, J NEUROSURG, V120, P1252, DOI 10.3171/2014.2.JNS14358a; REILLY PL, 1975, LANCET, V2, P375; Reith FCM, 2017, NEUROSURGERY, V80, P829, DOI 10.1093/neuros/nyw178; Rowbottham GFR, 1964, ACUTE INJURIES HEAD; SEGATORE M, 1992, HEART LUNG, V21, P548; Styner JK, 2006, SURG-J R COLL SURG E, V4, P163, DOI 10.1016/S1479-666X(06)80087-9; TEASDALE G, 1978, ANESTHESIOLOGY, V49, P225, DOI 10.1097/00000542-197809000-00023; TEASDALE G, 1983, LANCET, V2, P678; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1975, Nurs Times, V71, P972; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; TEASDALE GM, 1974, J NEUROL NEUROSUR PS, V37, P1286; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	51	3	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2020	134						311	322		10.1016/j.wneu.2019.10.193			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KK6VS	WOS:000512878200188	31712114				2022-02-06	
J	Nair, AB; Cohen, MJ; Flori, HR				Nair, Alison B.; Cohen, Mitchell J.; Flori, Heidi R.			Clinical Characteristics, Major Morbidity, and Mortality in Trauma-Related Pediatric Acute Respiratory Distress Syndrome*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						acute respiratory distress syndrome; mortality; organ dysfunction; pediatric; pediatric acute respiratory distress syndrome; trauma	ACUTE LUNG INJURY; ORGAN DYSFUNCTION SYNDROME; SEVERITY SCORE; RISK; RATIO	Objectives: To determine the presence, central characteristics, and impact on major morbidity and mortality of trauma-related pediatric acute respiratory distress syndrome. Design: Retrospective review of a prospective trauma database. Setting: American College of Surgeons verified level 1 trauma center in an urban setting. Patients: Trauma patients age 0 to 18 years old inclusive. Interventions: None. Measurements and Main Results: Of the 7,382 patients presenting within the 10-year study period, 646 met study criteria for inclusion in the analysis. Trauma-related pediatric acute respiratory distress syndrome was present in 9% of the analyzed cohort. On univariate analysis and compared with those without, trauma-related pediatric acute respiratory distress syndrome occurred more commonly among those with traumatic brain injury (77.2% vs 45.5%; p < 0.001), non-accidental trauma (28.8% vs 10.2%; p < 0.001), and an injury severity score greater than 30 (27.1% vs 3.8%; p 0.001). New or progressive multiple organ dysfunction syndrome was significantly higher in trauma-related pediatric acute respiratory distress syndrome patients (86.7% vs 10.4%; p < 0.001) as was mortality (18.3% vs 3.1%; p < 0.001) than in those without. The presence of trauma-related pediatric acute respiratory distress syndrome (odds ratio, 6.98; 95% CI, 2.95-16.5; p < 0.001), younger age (odds ratio, 0.93; 95% CI, 0.87-0.99; p = 0.038), and worse injury severity (odds ratio, 1.19; 95% CI, 1.14-1.24; p < 0.001) were all independent statistical predictors of new or progressive multiple organ dysfunction syndrome in this retrospective cohort. Mortality in patients without trauma-related pediatric acute respiratory distress syndrome increased with increasing injury severity, whereas mortality in patients with trauma-related pediatric acute respiratory distress syndrome was the same regardless of injury severity. On multivariable regression analysis, while age and injury severity were independent statistical predictors of mortality, trauma-related pediatric acute respiratory distress syndrome was not (odds ratio, 2.35; 95% CI, 0.88-6.28; p = 0.087). Conclusions: Pediatric acute respiratory distress syndrome is present in the pediatric trauma population. Trauma-related pediatric acute respiratory distress syndrome is associated with eight times the organ dysfunction and five times the mortality compared with patients without trauma-related pediatric acute respiratory distress syndrome, yet research in this area is lacking. Further prospective, mechanistic evaluations are essential to understand why these patients are at risk and how to effectively intervene to improve outcomes.	[Nair, Alison B.] Univ Calif San Francisco, Dept Pediat, Div Crit Care Med, San Francisco, CA 94143 USA; [Cohen, Mitchell J.] Univ Colorado, Dept Surg, Denver, CO 80202 USA; [Cohen, Mitchell J.] Denver Hlth Med Ctr, Denver, CO USA; [Flori, Heidi R.] Univ Michigan, CS Mott Childrens Hosp, Dept Pediat, Pediat Crit Care Med, Ann Arbor, MI 48109 USA		Nair, AB (corresponding author), Dept Pediat, Div Crit Care Med, 550 16th St,4th Floor,Box 0106, San Francisco, CA 94158 USA.	Alison.Nair@ucsf.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD 49303-10]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department of DefenseUnited States Department of Defense; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); GenentechRoche HoldingGenentech; Society for Critical Care Medicine/European Society for Intensive Care Medicine	This work was performed at University of California, Benioff Children's Hospital Oakland.; Dr. Nair's institution received funding from the National Institutes of Health (NIH) T32 HD 49303-10 (provided salary support for Dr. Nair's 4th year of fellowship 2016-2017). Dr. Cohen's institution received funding from the NIH, and he received other funding from the Department of Defense. Drs. Cohen and Flori received support for article research from the NIH. Dr. Flori's institution received funding from the National Heart, Lung, and Blood Institute, and she received funding from Genentech, Society for Critical Care Medicine/European Society for Intensive Care Medicine, and from expert testimony for a law firm in California.	Alvarez P, 2015, Open Respir Med J, V9, P92, DOI 10.2174/1874306401509010092; [Anonymous], 2017, DEATHS PERC TOT DEAT; [Anonymous], 2016, TABL 75 IN INJ REL V; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bilan N, 2015, J CARDIOVASC THORAC, V7, P28, DOI 10.15171/jcvtr.2014.06; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Bulger EM, 1997, ARCH SURG-CHICAGO, V132, P435; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Cecchetti C, 2013, MINERVA ANESTESIOL, V79, P1140; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Daurat A, 2016, INJURY, V47, P147, DOI 10.1016/j.injury.2015.08.031; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; de Roulet A, 2019, J PEDIATR SURG, V54, P1405, DOI 10.1016/j.jpedsurg.2018.07.005; Driscoll A. K., 2017, TRENDS INFANT MORTAL; Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; GOSSLING HR, 1979, JAMA-J AM MED ASSOC, V241, P2740, DOI 10.1001/jama.241.25.2740; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Khemani RG, 2019, LANCET RESP MED, V7, P115, DOI 10.1016/S2213-2600(18)30344-8; Lin JC, 2017, PEDIATR CRIT CARE ME, V18, P8, DOI 10.1097/PCC.0000000000000978; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Miller TR, 2000, FUTURE CHILD, V10, P137, DOI 10.2307/1602828; Murphy SL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3239; Pfeifer R, 2017, J TRAUMA ACUTE CARE, V83, P496, DOI 10.1097/TA.0000000000001571; Proulx F, 1996, CHEST, V109, P1033, DOI 10.1378/chest.109.4.1033; Pugin J, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-27; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Sharar Sam R, 2012, Int J Crit Illn Inj Sci, V2, P111, DOI 10.4103/2229-5151.100886; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Valadka S, 2000, J PEDIATR SURG, V35, P684, DOI 10.1053/jpsu.2000.5943; Watkins TR, 2012, CRIT CARE MED, V40, P2295, DOI 10.1097/CCM.0b013e3182544f6a; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; WILSON RF, 1973, ARCH SURG-CHICAGO, V106, P395; Wu JS, 2008, AM J EMERG MED, V26, P419, DOI 10.1016/j.ajem.2007.06.032	38	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2020	21	2					122	128		10.1097/PCC.0000000000002175			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	LH6KK	WOS:000528892100006	32032263				2022-02-06	
J	Pantic, I; Jeremic, R; Dacic, S; Pekovic, S; Pantic, S; Djelic, M; Vitic, Z; Brkic, P; Brodski, C				Pantic, Igor; Jeremic, Rada; Dacic, Sanja; Pekovic, Sanja; Pantic, Senka; Djelic, Marina; Vitic, Zagorka; Brkic, Predrag; Brodski, Claude			Gray-Level Co-Occurrence Matrix Analysis of Granule Neurons of the Hippocampal Dentate Gyrus Following Cortical Injury	MICROSCOPY AND MICROANALYSIS			English	Article						dentate gyrus; gray-level co-occurrence matrix analysis; hippocampus; sensorimotor cortex ablation; texture; traumatic brain injury	CHROMATIN TEXTURE; GLUCOCORTICOID-RECEPTOR; HISTONE H3; STRESS; GLCM; ABILITY	Traumatic brain injury (TBI) is a main cause of death and disabilities in young adults. Although learning and memory impairments are a major clinical manifestation of TBI, the consequences of TBI on the hippocampus are still not well understood. In particular, how lesions to the sensorimotor cortex damage the hippocampus, to which it is not directly connected, is still elusive. Here, we study the effects of sensorimotor cortex ablation (SCA) on the hippocampal dentate gyrus, by applying a highly sensitive gray-level co-occurrence matrix (GLCM) analysis. Using GLCM analysis of granule neurons, we discovered, in our TBI paradigm, subtle changes in granule cell (GC) morphology, including textual uniformity, contrast, and variance, which is not detected by conventional microscopy. We conclude that sensorimotor cortex trauma leads to specific changes in the hippocampus that advance our understanding of the cellular underpinnings of cognitive impairments in TBI. Moreover, we identified GLCM analysis as a highly sensitive method to detect subtle changes in the GC layers that is expected to significantly improve further studies investigating the impact of TBI on hippocampal neuropathology.	[Pantic, Igor; Jeremic, Rada; Djelic, Marina; Brkic, Predrag] Univ Belgrade, Inst Med Physiol, Fac Med, Visegradska 26-II, RS-11129 Belgrade, Serbia; [Pantic, Igor] Univ Haifa, 199 Abba Hushi Blvd, IL-3498838 Haifa, Israel; [Dacic, Sanja] Univ Belgrade, Fac Biol, Inst Physiol & Biochem Ivan Djaja, Dept Gen Physiol & Biophys, Studentski Trg 16, Belgrade 11000, Serbia; [Pekovic, Sanja] Univ Belgrade, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Dept Neurobiol, Blvd Despota Stefana 142, Belgrade, Serbia; [Pantic, Senka] Univ Belgrade, Inst Histol & Embryol, Sch Med, Visegradska 26-II, RS-11129 Belgrade, Serbia; [Vitic, Zagorka; Brodski, Claude] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel		Brodski, C (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel.	claude@bgu.ac.il	Pantic, Igor/K-8881-2012	Pantic, Igor/0000-0001-6589-8964	Ministry of Education, Science and technological development, Republic of Serbia [III41014, 175059, III41027]; Mediterranean Society for Metabolic Syndrome, Diabetes and Hypertension in Pregnancy DEGU [92018]	The authors are grateful to The Ministry of Education, Science and technological development, Republic of Serbia (projects III41014, 175059, and III41027), as well as the project 92018 of the Mediterranean Society for Metabolic Syndrome, Diabetes and Hypertension in Pregnancy DEGU (Dr Igor Pantic is the Head of the project). The authors also acknowledge the technical support and advice from the National Institutes of Health (Bethesda, Maryland, USA) regarding the function of ImageJ software.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; [Anonymous], 2015, ONCOLOGY TIMES, V37, P37; Arasi PRE, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1266-9; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Brianezi G, 2015, J EUR ACAD DERMATOL, V29, P809, DOI 10.1111/jdv.12453; Brkic P, 2012, BRAIN INJURY, V26, P1273, DOI 10.3109/02699052.2012.667593; Bustamante C, 2010, INT J DEV NEUROSCI, V28, P605, DOI 10.1016/j.ijdevneu.2010.07.229; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chandramohan Y, 2007, J NEUROCHEM, V101, P815, DOI 10.1111/j.1471-4159.2006.04396.x; Chen X, 2015, CLIN IMAG, V39, P775, DOI 10.1016/j.clinimag.2015.04.003; De Mello MRB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-75; DiIeva A, 2016, SPR SER COMPUT NEURO, P1, DOI 10.1007/978-1-4939-3995-4; Fa MX, 2014, NEUROBIOL LEARN MEM, V112, P53, DOI 10.1016/j.nlm.2014.04.008; Fumagalli S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1401-z; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kleppe M, 2018, CANCER CELL, V33, P785, DOI 10.1016/j.ccell.2018.03.024; Kolarevic D, 2018, J MICROSC-OXFORD, V270, P17, DOI 10.1111/jmi.12645; Kuliffay P, 2010, BRATISL MED J, V111, P4; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Mapayi T, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/597475; Pantic I, 2016, J THEOR BIOL, V406, P124, DOI 10.1016/j.jtbi.2016.07.018; Pantic I, 2016, J THEOR BIOL, V397, P61, DOI 10.1016/j.jtbi.2016.02.038; Pantic I, 2015, J THEOR BIOL, V370, P151, DOI 10.1016/j.jtbi.2015.01.035; Pantic I, 2014, MICROSC MICROANAL, V20, P1373, DOI 10.1017/S1431927614012811; Pantic I, 2013, AN ACAD BRAS CIENC, V85, P1063, DOI 10.1590/S0001-37652013005000045; Paxinos G, 2004, RAT BRAIN STEREOTAXI; Qin YJ, 2004, J NEUROCHEM, V89, P364, DOI 10.1111/j.1471-4159.2003.02332.x; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Shamir L, 2009, BIOINFORMATICS, V25, P3060, DOI 10.1093/bioinformatics/btp571; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Song CI, 2013, LARYNGOSCOPE, V123, pE45, DOI 10.1002/lary.24151; Tan TCY, 2016, MOL REPROD DEV, V83, P701, DOI 10.1002/mrd.22680; Veskovic M, 2018, MICROSC MICROANAL, V24, P132, DOI 10.1017/S1431927617012806; Yang XF, 2012, MED PHYS, V39, P5732, DOI 10.1118/1.4747526; Zhu HL, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3530903	36	3	3	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1431-9276	1435-8115		MICROSC MICROANAL	Microsc. microanal.	FEB	2020	26	1					166	172	PII S143192762000001X	10.1017/S143192762000001X			7	Materials Science, Multidisciplinary; Microscopy	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Microscopy	KQ3QM	WOS:000516841400020	31948501				2022-02-06	
J	Shabany, M; NikbakhtNasrabadi, A; Mohammadi, N; Pruitt, SD				Shabany, Maryam; NikbakhtNasrabadi, Alireza; Mohammadi, Nooredin; Pruitt, Sheri D.			Family-centered empowerment process in individuals with spinal cord injury living in Iran: a grounded theory study	SPINAL CORD			English	Article							ADJUSTMENT; DISABILITY; COMMUNITY; OUTCOMES; QUALITY; PEOPLE; BURDEN; ADULTS; HOPE; HOME	Study design This was a qualitative study using grounded theory method. Objectives To explain the process of family-centered empowerment in a population of individuals with SCI living in Iran. Setting Brain and SCI Research Center, Social Welfare Center, and SCI Association of Tehran; Iran. Methods Participants were 19 persons with traumatic SCI, 13 family member caregivers, and 11 health care providers selected through purposeful sampling. Data were collected using face-to-face, semi-structured interviews, which were continued until data saturation. The interview data were methodically collected and analyzed using Strauss and Corbin's (1998) recommended method for grounded theory. Constant comparative analysis was simultaneously conducted through reviews of the interview statements, observations of behavior, interviewer field notes, and interviewer memos. The analysis was managed in MAXQDA software version 10. Results The process of family-centered empowerment following SCI included five categories: (1) disruption in the existential integrity of the individual; (2) constructive life recovery; (3) inhibitors of family-centered empowerment; (4) facilitators of family-centered empowerment, and (5) back on track. Constructive life recovery was selected as the core variable using the grounded theory method. This core variable identified the strategies most frequently used by the participants to cope with the challenges of SCI-related impairment, disability, and overall life management. Conclusions Family-centered empowerment process in individuals with SCI living in Iran emerged from the data. The model includes early disruptions in the bio-psycho-social and vocational lives of individuals with SCI and their families, strategies for recovery post injury, inhibitors and facilitators of family-centered empowerment, the gradual return to work and daily activities, and the expected social roles for individuals with SCI.	[Shabany, Maryam; NikbakhtNasrabadi, Alireza] Univ Tehran Med Sci, Neurosci Inst, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran; [NikbakhtNasrabadi, Alireza] Univ Tehran Med Sci, Dept Med Surg Nursing, Tehran, Iran; [NikbakhtNasrabadi, Alireza] Univ Tehran Med Sci, Nursing & Midwifery Sch, Int Affairs, Tehran, Iran; [Mohammadi, Nooredin] Iran Univ Med Sci, Dept Crit Care Nursing, Nursing & Midwifery Sch, Tehran, Iran; [Pruitt, Sheri D.] Kaiser Permanente, Permanente Med Grp, Behav Sci Integrat, Sacramento, CA USA		NikbakhtNasrabadi, A (corresponding author), Univ Tehran Med Sci, Neurosci Inst, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran.; NikbakhtNasrabadi, A (corresponding author), Univ Tehran Med Sci, Dept Med Surg Nursing, Tehran, Iran.; NikbakhtNasrabadi, A (corresponding author), Univ Tehran Med Sci, Nursing & Midwifery Sch, Int Affairs, Tehran, Iran.	nikbakht@tums.ac.ir	Nikbakht Nasrabadi, Alireza/F-3768-2014	Nikbakht Nasrabadi, Alireza/0000-0002-3970-4158			Abrams G. M., 2015, NEUROLOGY, V21, P188; Adinolfi P, 2016, J HEALTH MANAG, V18, P117, DOI 10.1177/0972063415625524; [Anonymous], 2011, WORLD REP DIS; Boschen KA, 2003, INT J REHABIL RES, V26, P157, DOI 10.1097/00004356-200309000-00001; Chung BY, 2008, ASIAN NURS RES, V2, P55, DOI 10.1016/S1976-1317(08)60029-8; Dorsett P, 2010, AUST SOC WORK, V63, P83, DOI 10.1080/03124070903464293; Egnew TR, 2005, ANN FAM MED, V3, P255, DOI 10.1370/afm.313; Fitzharris M, 2014, SPINAL CORD, V52, P117, DOI 10.1038/sc.2013.135; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Gajraj-Singh P, 2011, SPINAL CORD, V49, P928, DOI 10.1038/sc.2011.15; Hagen EM, 2011, ACTA NEUROL SCAND, V124, P71, DOI 10.1111/j.1600-0404.2011.01547.x; Hosseinigolafshani Zahra, 2014, Iran J Nurs Midwifery Res, V19, P266; Rodriguez LJ, 2018, SPINAL CORD, V56, P548, DOI 10.1038/s41393-018-0092-0; Kehn M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-168; Kennedy P, 2006, SPINAL CORD, V44, P95, DOI 10.1038/sj.sc.3101787; Kennedy P, 2009, PSYCHOL HEALTH MED, V14, P17, DOI 10.1080/13548500802001801; Khan F, 2015, PHYS MED REHABIL INT, V2, P1070; Khazaeipour Z, 2018, SPINAL CORD, V56, P1184, DOI 10.1038/s41393-018-0162-3; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Lam T, 2008, SPINAL CORD, V46, P246, DOI 10.1038/sj.sc.3102134; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Lofvenmark I, 2016, DISABIL REHABIL, V38, P1483, DOI 10.3109/09638288.2015.1106596; Marini I, 2011, REHABIL COUNS BULL, V54, P82, DOI 10.1177/0034355210368868; MARTIN PY, 1986, J APPL BEHAV SCI, V22, P141, DOI 10.1177/002188638602200207; Matter B, 2009, J SPINAL CORD MED, V32, P545, DOI 10.1080/10790268.2009.11754556; Mbae F. N., 2016, INT J ACAD RES ACCOU, V6, P119; McCann Terence V, 2003, Nurse Res, V11, P7; MCGOWAN MB, 1987, PARAPLEGIA, V25, P357, DOI 10.1038/sc.1987.64; Nikbakht-Nasrabadi A, 2016, IRAN J PUBLIC HEALTH, V45, P867; Olney MF, 2004, J REHABIL, V70, P4; Rahimi-Movaghar V, 2009, J SPINAL CORD MED, V32, P428, DOI 10.1080/10790268.2009.11754572; Reinhard SC., 2012, HOME ALONE FAMILY CA; Rimmer JH, 2008, AM J LIFESTYLE MED, V2, P409, DOI 10.1177/1559827608317397; Rohatinsky N, 2017, HEALTH SOC CARE COMM, V25, P769, DOI 10.1111/hsc.12370; Rolfe G, 2006, J ADV NURS, V53, P304, DOI 10.1111/j.1365-2648.2006.03727.x; Rosland AM, 2010, CHRONIC ILLN, V6, P22, DOI 10.1177/1742395309354608; Sabet FP, 2017, TRAUMA MON, V22, DOI 10.5812/traumamon.38208; Salahi S, 2012, J NURS MIDWIFERY URM, V10, P1; Shields N, 2012, BRIT J SPORT MED, V46, P989, DOI 10.1136/bjsports-2011-090236; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024; Van Buyten JP, 2001, EUR J PAIN-LONDON, V5, P299, DOI 10.1053/eujp.2001.0249; World Health Organization, 2013, SPIN CORD INJ	42	3	3	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	FEB	2020	58	2					174	184		10.1038/s41393-019-0348-3			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KI8KQ	WOS:000511607200006	31477808	Bronze			2022-02-06	
J	Thanacharoenpanich, S; Bixby, S; Breen, MA; Kim, YJ				Thanacharoenpanich, Songkiat; Bixby, Sarah; Breen, Michael A.; Kim, Young-Jo			MRI Is Better Than CT Scan for Detection of Structural Pathologies After Traumatic Posterior Hip Dislocations in Children and Adolescents	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						traumatic hip dislocation; MRI; imaging	ENTRAPMENT; REDUCTION; FRACTURE; IMAGES; WALL	Background:Traumatic posterior hip dislocations in children and adolescents requires emergent closed reduction. Postreduction imaging is necessary to assess the concentricity of reduction and structural injuries to the hip. There is no a consensus for which imaging is a modality of choice in such condition. The purposes of this study are to describe magnetic resonance imaging (MRI) findings of traumatic posterior hip dislocations and to compare the effectiveness of MRI with computerized tomography (CT) in detecting structural abnormalities of the hip that impact patient management.Methods:This study is a retrospective review of imaging in traumatically dislocated hips in patients who were treated at our institution. All CT and MRI imaging were reviewed and specific osseous and soft tissue injuries documented by consensus among 2 musculoskeletal pediatric radiologists who interpreted the MRI and CT scans of each patient in a blinded manner.Results:In total, 27 patients (23 males, 4 females) with mean age of 12.5 years (range, 2 to 19y) with postreduction MRI were evaluated. MRI findings revealed femoral head injuries in 17 (62.9%), posterior labral entrapments in 6 (22.2%), posterior labral tears in 17 (62.9%), posterior wall fractures in 15 (55.5%), fracture of the posterior unossified part of acetabulum in 4 (14.8%), and ligamentum teres injuries in 8 (29.6%). Of 16 patients who had postreduction CT scans, 6 (37.5%) had femoral head fractures, 9 (56.3%) had posterior wall fractures, and 8 (50%) had intra-articular osseous entrapments. All bony fractures and intra-articular entrapment could be seen on MRI imaging. In 16 patients with both CT and MRI, posterior acetabular injury was detected in 10/16 (62.5%) on MRI and 9/16 (56.3%) on CT. Three patients with entrapment of labrums identified on MRI could not be seen on CT scan. One patient with persistently unstable hip after reduction had an entrapped unossified portion of acetabular fracture which was seen on MRI but not on CT.Conclusions:MRI is superior to CT scan for detection of structural injuries in children and adolescents with traumatic hip dislocation. The unique structural injuries included entrapment of posterior labrum and posterior unossified acetabular fractures could be seen only at MRI. These findings will impact surgical decision making of these injuries.Level of evidence:Level IV.	[Thanacharoenpanich, Songkiat; Kim, Young-Jo] Harvard Med Sch, Boston Childrens Hosp, Dept Orthopaed, Boston, MA 02115 USA; [Bixby, Sarah; Breen, Michael A.] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Thanacharoenpanich, Songkiat] Lerdsin Gen Hosp, Inst Orthopaed, Bangkok, Thailand		Kim, YJ (corresponding author), 300 Longwood Ave,Hunnewell 2, Boston, MA 02115 USA.	young-jo.kim@childrens.harvard.edu		Breen, Micheal/0000-0002-9141-8175			Brooks RA, 2000, CLIN ORTHOP RELAT R, P15; Chun KA, 2004, SKELETAL RADIOL, V33, P728, DOI 10.1007/s00256-004-0800-z; Elder G, 2004, CAN J SURG, V47, P290; Fabricant PD, 2013, J BONE JOINT SURG AM, V95A, P230, DOI [10.2106/JBJS.L.00592, 10.2106/JBJS.L.00772]; FUNK FJ, 1962, J BONE JOINT SURG AM, V44, P1135, DOI 10.2106/00004623-196244060-00008; Hearty T, 2011, J ORTHOP TRAUMA, V25, pE68, DOI 10.1097/BOT.0b013e3181f9a7ba; LAORR A, 1995, SKELETAL RADIOL, V24, P239; Mayer SW, 2015, PEDIATR RADIOL, V45, P1355, DOI 10.1007/s00247-015-3317-9; Novais EN, 2016, J PEDIATR ORTHOPED, V36, P673, DOI 10.1097/BPO.0000000000000527; POGGI JJ, 1995, CLIN ORTHOP RELAT R, P249; Price CT, 2002, J ORTHOP TRAUMA, V16, P730, DOI 10.1097/00005131-200211000-00008; Rubel IF, 2002, PEDIATR RADIOL, V32, P435, DOI 10.1007/s00247-001-0634-y; SHEA KP, 1986, J PEDIATR ORTHOPED, V6, P215, DOI 10.1097/01241398-198603000-00017; SLATIS P, 1974, INJURY, V5, P188, DOI 10.1016/S0020-1383(74)80003-3; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; Vialle R, 2004, PEDIATR RADIOL, V34, P970, DOI 10.1007/s00247-004-1299-0	17	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	FEB	2020	40	2					86	92		10.1097/BPO.0000000000001127			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	KB6TK	WOS:000506624900008	31923168				2022-02-06	
J	Zhao, J; Li, Q; Wu, JM; Zhou, CR; Cao, Y; Li, XK; Niu, JL				Zhao, Jing; Li, Qi; Wu, Jiamin; Zhou, Chuanren; Cao, Yu; Li, Xiaokun; Niu, Jianlou			Structure-Based Site-Specific PEGylation of Fibroblast Growth Factor 2 Facilitates Rational Selection of Conjugate Sites	BIOTECHNOLOGY JOURNAL			English	Article						FGF2; FGF2-FGFR-heparin; site-specific PEGylation; structure-based PEGylation	SOLID-PHASE PEGYLATION; TRAUMATIC BRAIN-INJURY; G-CSF; PEG; HORMONE; FGF21	Polyethylene glycol modification (PEGylation) can enhance the pharmacokinetic properties of therapeutic proteins by the attachment of polyethylene glycol (PEG) to the surface of a protein to shield the protein surface from proteolytic degradation and limit aggregation. However, current PEGylation strategies often reduce biological activity, potentially as a result of steric hindrance of PEG. Overall, there are no structure-based guidelines for selection of conjugate sites that retain optimal biological activity with improved pharmacokinetic properties. In this study, site-specific PEGylation based on the FGF2-FGFR1-heparin complex structure is performed. The effects of the conjugate sites on protein function are investigated by measuring the receptor/heparin binding affinities of the modified proteins and performing assays to measure cell-based bio-activity and in vivo stability. Comprehensive analysis of these data demonstrates that PEGylation of FGF2 that avoids the binding sites for fibroblast growth factor receptor 1 (FGFR1) and heparin provides optimal pharmacokinetic enhancement with minimal losses to biological activity. Animal experiments demonstrate that PEGylated FGF2 exhibits greater efficacy in protecting against traumatic brain injury-induced brain damage and neurological functions than the non-modified FGF2. This rational structure-based PEGylation strategy for protein modification is expected to have a major impact in the area of protein-based therapeutics.	[Zhao, Jing; Li, Qi; Wu, Jiamin; Zhou, Chuanren; Cao, Yu; Li, Xiaokun; Niu, Jianlou] Wenzhou Med Univ, Sch Pharm, Wenzhou, Zhejiang, Peoples R China		Li, XK; Niu, JL (corresponding author), Wenzhou Med Univ, Sch Pharm, Wenzhou, Zhejiang, Peoples R China.	proflxk@163.com; niujianlou@126.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81803415] Funding Source: Medline; Natural Science Foundation of ZhejiangNatural Science Foundation of Zhejiang Province [LQ19H300002] Funding Source: Medline; Science and Technology Project of Wenzhou [Y20180176] Funding Source: Medline; Natural Science Foundation of Ningbo [2016A610171] Funding Source: Medline		Bailon P, 2009, EXPERT OPIN DRUG DEL, V6, P1, DOI [10.1517/17425240802650568 , 10.1517/17425240802650568]; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Fruijtier-Polloth C, 2005, TOXICOLOGY, V214, P1, DOI 10.1016/j.tox.2005.06.001; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Goetz R, 2012, J BIOL CHEM, V287, P29134, DOI 10.1074/jbc.M112.342980; Huang ZF, 2017, CELL REP, V20, P1717, DOI 10.1016/j.celrep.2017.06.063; Huang ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036423; Huang ZF, 2012, BIOCONJUGATE CHEM, V23, P740, DOI 10.1021/bc200550f; Huang ZF, 2011, WOUND REPAIR REGEN, V19, P633, DOI 10.1111/j.1524-475X.2011.00722.x; Huang Z, 2009, J BIOTECHNOL, V142, P242, DOI 10.1016/j.jbiotec.2009.05.004; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Lee BK, 2007, BIOCONJUGATE CHEM, V18, P1728, DOI 10.1021/bc060245m; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Niu JL, 2014, J CHROMATOGR A, V1327, P66, DOI 10.1016/j.chroma.2013.12.049; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Pfister D, 2014, J CONTROL RELEASE, V180, P134, DOI 10.1016/j.jconrel.2014.02.002; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Qi FB, 2018, BIOCONJUGATE CHEM, V29, P451, DOI 10.1021/acs.bioconjchem.7b00770; Qiu HW, 2013, BIOCONJUGATE CHEM, V24, P408, DOI 10.1021/bc300519h; Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI 10.1517/17425247.5.4.371 ; Salmaso S, 2009, BIOCONJUGATE CHEM, V20, P1179, DOI 10.1021/bc9000432; Song LT, 2014, BIOMATERIALS, V35, P5206, DOI 10.1016/j.biomaterials.2014.03.023; Veronese FM, 2007, BIOCONJUGATE CHEM, V18, P1824, DOI 10.1021/bc070123+; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066; Zakrzewska M, 2009, J BIOL CHEM, V284, P25388, DOI 10.1074/jbc.M109.001289	35	3	4	1	15	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	FEB	2020	15	2							1900203	10.1002/biot.201900203			11	Biochemical Research Methods; Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	KI6FG	WOS:000511444500013	31556248				2022-02-06	
J	Xiao, X; Bai, P; Cao, SQ; Jiang, YJ; Liang, WB; Wang, T; Luo, XL; Guan, QZ; Gao, LB; Zhang, L				Xiao, Xiao; Bai, Peng; Cao, Shuqiang; Jiang, Youjing; Liang, Weibo; Wang, Tao; Luo, Xiaolei; Guan, Qiaozhi; Gao, Linbo; Zhang, Lin			Integrated Bioinformatics Analysis for the Identification of Key Molecules and Pathways in the Hippocampus of Rats After Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; DEMIs; DEGs; Bioinformatics analysis; Time dependent expression pattern	PROTEIN-INTERACTION NETWORKS; GENE-EXPRESSION PROFILES; MODELS; TIME; GEO	High-throughput and bioinformatics technology have been broadly applied to demonstrate the key molecules involved in traumatic brain injury (TBI), while no study has integrated the available TBI-related datasets for analysis. In this study, four available expression datasets of fluid percussion injury (FPI) and sham samples from the hippocampus of rats were analysed. A total of 248 differentially expressed genes (DEGs) and 10 differentially expressed microRNAs (DEMIs) were identified. Then, functional annotation was performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Most of the DEGs were enriched for the term inflammatory immune response. The MCODE plug-in in the Cytoscape software was applied to build a protein-protein interaction (PPI) network, and 18 hub genes were demonstrated to be enriched in the cell cycle pathway. Besides, time sequence (3 h, 6 h, 12 h, 24 h, and 48 h) profile analysis was performed using short time-series expression miner (STEM). The significantly expressed genes were assigned into 24 pattern clusters with four significant uptrend clusters. Four DEGs, Fcgr2a, Bcl2a1, Cxcl16, and Gbp2, were found to be differentially expressed at all time-points. Fifty-three DEGs and eight DEMIs were identified to form a miRNA-mRNA negative regulatory network using miRWalk3.0 and Cytoscape. Moreover, the mRNA levels of eight hub genes were validated by qRT-PCR. These DEGs, DEMIs, and time-dependent expression patterns facilitate our knowledge of the molecular mechanisms underlying the process of TBI in the hippocampus of rats and have the potential to improve the diagnosis and treatment of TBI.	[Xiao, Xiao] Sichuan Univ, Dept Obstet & Gynecol, West China Univ Hosp 2, Chengdu, Peoples R China; [Xiao, Xiao] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Peoples R China; [Xiao, Xiao; Bai, Peng; Wang, Tao; Luo, Xiaolei; Gao, Linbo; Zhang, Lin] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, West China Univ Hosp 2, Ctr Translat Med,Lab Mol Translat Med,Minist Educ, Chengdu, Peoples R China; [Xiao, Xiao; Bai, Peng; Cao, Shuqiang; Jiang, Youjing; Liang, Weibo; Zhang, Lin] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Forens Genet, Chengdu 610041, Sichuan, Peoples R China; [Guan, Qiaozhi] Macau Univ Sci & Technol, Business Sch, Taipa, Macao, Peoples R China		Gao, LB; Zhang, L (corresponding author), Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, West China Univ Hosp 2, Ctr Translat Med,Lab Mol Translat Med,Minist Educ, Chengdu, Peoples R China.; Zhang, L (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Forens Genet, Chengdu 610041, Sichuan, Peoples R China.	xjx060312@163.com; baipeng@scu.edu.cn; 417980442@qq.com; jiangyoujing@163.com; liangweibo@scu.edu.cn; 1804537328@qq.com; 153634049@qq.com; 1761922966@qq.com; gaolinboscu@163.com; zhanglin@scu.edu.cn	liang, weibo/G-8456-2011	liang, weibo/0000-0002-8487-3575	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81974226]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2018SCUH0053]; Science and Technology Major Projects of Sichuan Province of China [2017SZDZX0013]; Science and Technology Support Program of Sichuan Province of China [2016SZ0013]	This work was supported by the National Natural Science Foundation of China (No. 81974226), the Fundamental Research Funds for the Central Universities (No. 2018SCUH0053), the Science and Technology Major Projects of Sichuan Province of China (No. 2017SZDZX0013), and the Science and Technology Support Program of Sichuan Province of China (No. 2016SZ0013).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Badr R, 2016, BRATISL MED J, V117, P358, DOI 10.4149/BLL_2016_071; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Chen ZH, 2019, EXP NEUROL, V313, P37, DOI 10.1016/j.expneurol.2018.12.003; Chia WJ, 2015, NEUROCHEM INT, V87, P43, DOI 10.1016/j.neuint.2015.04.009; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hop HT, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12813; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karnati HK, 2019, J NEUROTRAUM, V36, P975, DOI 10.1089/neu.2018.5898; Lee BC, 2010, NEUROL RES, V32, pS43, DOI 10.1179/016164109X12537002793922; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Merkel SF, 2017, CELL TRANSPLANT, V26, P1178, DOI 10.1177/0963689717714341; Miao Q, 2017, NEUROCHEM RES, V42, P1515, DOI 10.1007/s11064-017-2208-x; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Ou S, 2014, EUR REV MED PHARMACO, V18, P101; Phipps HW, 2016, METHODS MOL BIOL, V1462, P61, DOI 10.1007/978-1-4939-3816-2_5; Rosito M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00193; Russell NH, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146466; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi WZ, 2017, MOL MED REP, V15, P2129, DOI 10.3892/mmr.2017.6275; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sticht C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206239; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taklimie FR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061271; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Wang L, 2018, J INVEST SURG, V31, P69, DOI 10.1080/08941939.2016.1278057; Wang N, 2018, CELL PHYSIOL BIOCHEM, V45, P78, DOI 10.1159/000486224; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Yang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10201-8; Zhang HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193037	48	3	4	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2020	45	4					928	939		10.1007/s11064-020-02973-9		JAN 2020	12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KV3WQ	WOS:000510110000001	31997105				2022-02-06	
J	Schober, ME; Requena, DF; Maschek, JA; Cox, J; Parra, L; Lolofie, A				Schober, Michelle E.; Requena, Daniela F.; Maschek, J. Alan; Cox, James; Parra, Leonardo; Lolofie, Alyssa			Effects of controlled cortical impact and docosahexaenoic acid on rat pup fatty acid profiles	BEHAVIOURAL BRAIN RESEARCH			English	Article						Developing brain; Traumatic brain injury; Nutrition; Polyunsaturated fatty acids; Neuroprotection	TRAUMATIC BRAIN-INJURY; COGNITIVE FUNCTION; LINOLENIC ACID; SPATIAL MEMORY; SUPPLEMENTATION; MEMBRANE; EXPRESSION; CHILDREN; OUTCOMES; MODEL	Traumatic brain injury (TBI) is the leading cause of acquired neurologic disability in children, particularly in those under four years old. During this period, rapid brain growth demands higher Docosahexaenoic Acid (DHA) intake. DHA is an essential fatty acid and brain cell component derived almost entirely from the diet. DHA improved neurologic outcomes and decreased inflammation after controlled cortical impact (CCI) in 17-day old (P17) rats, our established model of pediatric TBI. In adult rodents, TBI decreases brain DHA. We hypothesized that CCI would decrease rat brain DHA at post injury day (PID) 60, blunted by 0.1% DHA diet. We quantitated fatty acids using Gas Chromatography-Mass Spectrometry. We provided 0.1% DHA before CCI to ensure high DHA in dam milk. We compared brain DHA in rats after 60 days of regular (REG) or DHA diet to SHAM pups on REG diet. Brain DHA decreased in REGCCI, not in DHACCI, relative to SHAMREG. In a subsequent experiment, we gave rat pups DHA or vehicle intraperitoneally after CCI followed by DHA or REG diet for 60 days. REG increased brain Docosapentaenoic Acid (n-6 DPA, a brain DHA deficiency marker) relative to SHAMDHA and DHACCI pups (p < 0.001, diet effect). DHA diet nearly doubled DHA and decreased n-6 DPA in blood but did not increase brain DHA content (p < 0.0001, diet effect). We concluded that CCI or craniotomy alone induces a mild DHA deficit as shown by increased brain DPA.	[Schober, Michelle E.; Requena, Daniela F.; Lolofie, Alyssa] Dept Pediat, Div Crit Care, Salt Lake City, UT 84132 USA; [Cox, James] Dept Biochem, Salt Lake City, UT 84132 USA; [Parra, Leonardo] Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84132 USA; [Cox, James] Diabet & Metab Res Ctr, Salt Lake City, UT 84132 USA; [Maschek, J. Alan; Cox, James] Univ Utah, Metabol Mass Spectrometry & Prote Core, Salt Lake City, UT 84132 USA		Schober, ME (corresponding author), Univ Utah, Sch Med, POB 581289, Salt Lake City, UT 84158 USA.	michelle.schober@hsc.utah.edu; Daniela.requena@hsc.utah.edu; alan.maschek@pharm.utah.edu; jcox@cores.utah.edu; Leonardo.parra.rivas@gmail.com; Alyssa.lolofie@hsc.utah.edu		Parra Rivas, Leonardo/0000-0002-6707-1255	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R21 NS090098-02]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Pediatric Critical Care Medicine at the University of Utah;  [1 S10 OD01623201];  [1 S10 OD021505-01];  [1 U54 DK110858-01]	This work was supported by the NINDS Grant number 5R21 NS090098-02, National Institutes of Health and by Pediatric Critical Care Medicine at the University of Utah. Neither funding agency had any role in the study design, data collection, analysis, and interpretation, writing of the report nor in the decision to submit the article for publication.; Metabolomics Analyses were performed at the University of Utah Metabolomics Core Facility, which is supported by 1 S10 OD01623201, 1 S10 OD021505-01 and 1 U54 DK110858-01.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Ajmone-Cat MA, 2012, J NEUROSCI RES, V90, P575, DOI 10.1002/jnr.22783; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Andruchow ND, 2017, NEUROPSYCHOLOGY, V31, P724, DOI 10.1037/neu0000373; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Attar-Bashi NM, 2007, PROSTAG LEUKOTR ESS, V76, P121, DOI 10.1016/j.plefa.2006.11.002; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Birch EE, 2010, AM J CLIN NUTR, V91, P848, DOI 10.3945/ajcn.2009.28557; Chang HY, 2015, LIFE SCI, V120, P39, DOI 10.1016/j.lfs.2014.10.014; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Domenichiello AF, 2015, PROG LIPID RES, V59, P54, DOI 10.1016/j.plipres.2015.04.002; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Frenguelli BG, 2019, NEUROCHEM RES, V44, P661, DOI 10.1007/s11064-017-2386-6; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Ibarguren M, 2014, BBA-BIOMEMBRANES, V1838, P1518, DOI 10.1016/j.bbamem.2013.12.021; Ikonomidou C, 2011, ANTIOXID REDOX SIGN, V14, P1535, DOI 10.1089/ars.2010.3581; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Joffre C, 2016, PROSTAG LEUKOTR ESS, V114, P1, DOI 10.1016/j.plefa.2016.09.003; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kim H, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0242-9; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lauritzen L, 2002, LIPIDS, V37, P237, DOI 10.1007/s11745-002-0886-2; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Levant B, 2006, PHYSIOL BEHAV, V89, P196, DOI 10.1016/j.physbeh.2006.06.007; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; Martinez M, 1998, J NEUROCHEM, V71, P2528; Moriguchi T, 2001, J LIPID RES, V42, P419; Moriguchi T, 2013, LIPIDS, V48, P343, DOI 10.1007/s11745-013-3775-5; Najm S, 2017, CLIN NUTR ESPEN, V20, P17, DOI 10.1016/j.clnesp.2017.04.004; Ojo JO, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00893; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Potts Mathew B, 2006, NeuroRx, V3, P143; Rapoport SI, 2013, PROSTAG LEUKOTR ESS, V88, P79, DOI 10.1016/j.plefa.2012.05.003; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Rodriguez A, 1998, J LIPID RES, V39, P1825; Rogers LK, 2013, PHARMACOL RES, V70, P13, DOI 10.1016/j.phrs.2012.12.003; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Schober ME, 2014, J NEUROTRAUM, V31, pA65; Schober ME, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112971; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Slovis JC, 2018, PEDIATR CRIT CARE ME, V19, P353, DOI 10.1097/PCC.0000000000001490; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Sugasini D, 2015, NUTR NEUROSCI, V18, P87, DOI 10.1179/1476830514Y.0000000111; Valenzuela A, 2005, ANN NUTR METAB, V49, P325, DOI 10.1159/000087337; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wang Q, 2018, BRAIN RES, V1678, P367, DOI 10.1016/j.brainres.2017.11.008; Wu A., 2013, NEUROREHABIL NEURAL; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yavin E, 2001, J MOL NEUROSCI, V16, P229, DOI 10.1385/JMN:16:2-3:229; Zarate R, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0153-6	76	3	3	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 27	2020	378								112295	10.1016/j.bbr.2019.112295			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	LD5HB	WOS:000526059200040	31618622	Green Accepted			2022-02-06	
J	Cole, WR; Cecchini, AS; Remigio-Baker, RA; Gregory, E; Bailie, JM; Ettenhofer, ML; McCulloch, KL				Cole, Wesley R.; Cecchini, Amy S.; Remigio-Baker, Rosemay A.; Gregory, Emma; Bailie, Jason M.; Ettenhofer, Mark L.; McCulloch, Karen L.			"Return to duty" as an outcome metric in military concussion research: Problems, pitfalls, and potential solutions	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; mild traumatic brain injury; military; return to duty; return to play	TRAUMATIC BRAIN-INJURY; NEUROBEHAVIORAL SYMPTOM INVENTORY; POSTCONCUSSION; PERFORMANCE; STATEMENT; PTSD	Objective: "Return to duty" (RTD) is often used as an outcome metric in military concussion research, but is inconsistently defined across studies and presents several key problems to researchers. Using results from the Defense and Veterans Brain Injury Center's (DVBIC) Progressive Return to Activity (PRA) study, we highlight problems with RTD, and suggest solutions to inform future efforts. Method: 116 service members (SMs) were enrolled in one of two groups (pre-implementation and post-implementation of the PRA Clinical Recommendation [CR]). Data, including the Neurobehavioral Symptom Inventory (NSI-22), was collected within 72-hours of injury (baseline), and at 1-week, 1-month, 3-months, and 6-months post-injury. Our analyses focused on three time points: baseline, approximate RTD date, and post-RTD follow-up, with RTD data captured via self-report and electronic medical record (EMR). Secondary analyses included comparisons across PRA-CR implementation groups. Results: Of those SMs (<50% of the sample) with both self-reported and EMR RTD dates, dates largely did not match (range 1 to 36 days). RTD (either date) also did not indicate symptom recovery, with >50% of SMs reporting "abnormally high" symptom levels (i.e., NSI-22 total >= 75(th) percentile) at RTD, and over 50% of SMs reporting at least one significant symptom (i.e., any NSI-22 item >= 2) after RTD. Conclusions: Our data demonstrate challenges encountered with a RTD outcome metric. Military concussion researchers should strive to use a well-defined RTD outcome metric. We propose defining RTD as a return to deployment readiness. Further, researchers should utilize Department of Defense definitions of Individual Medical Readiness and Deployment Limiting conditions to increase specificity of a RTD outcome metric. Improving the way RTD is captured will improve confidence that tools used after a SM sustains concussion are adequately informing RTD decisions.	[Cole, Wesley R.; Cecchini, Amy S.] Womack Army Med Ctr, Intrepid Spirit, Ft Bragg, NC 28310 USA; [Cecchini, Amy S.] Geneva Fdn, Tacoma, WA USA; [Remigio-Baker, Rosemay A.; Gregory, Emma; Bailie, Jason M.; Ettenhofer, Mark L.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Remigio-Baker, Rosemay A.; Bailie, Jason M.] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA; [Remigio-Baker, Rosemay A.] Henry M Jackson Fdn, Bethesda, MD USA; [Bailie, Jason M.] Gen Dynam Hlth Solut, Falls Church, VA USA; [Ettenhofer, Mark L.] Naval Med Ctr San Diego, San Diego, CA USA; [Ettenhofer, Mark L.] Amer Hosp Serv Grp, Exton, PA USA; [Ettenhofer, Mark L.] Univ Calif San Diego, San Diego, CA 92103 USA; [McCulloch, Karen L.] Univ N Carolina, Chapel Hill, NC 27515 USA		Cole, WR (corresponding author), Womack Army Med Ctr, Intrepid Spirit, Ft Bragg, NC 28310 USA.	wesley.r.cole.civ@mail.mil			Defense Health Program 6.7 [D6.7_14_C2_I_14_J9_1077]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was supported by the Defense Health Program 6.7 (award number: D6.7_14_C2_I_14_J9_1077) and the Defense and Veterans Brain Injury Center.	Bailie JM, 2019, AM J SPORT MED, V47, P3505, DOI 10.1177/0363546519883259; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Defense and Veterans Brain Injury Center, 2019, CONC MAN TOOL REL AU; Defense and Veterans Brain Injury Center, 2014, PROGR RET ACT FOLL M; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Fletcher J. D., 2014, TEACHING MEASURING C; Gregory E, 2017, CONTEMP CLIN TRIALS, V52, P95, DOI 10.1016/j.cct.2016.11.005; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Prim JH, 2019, MIL MED, V184, pE268, DOI 10.1093/milmed/usy425; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Scherer MR, 2018, ARCH PHYS MED REHAB, V99, pS79, DOI 10.1016/j.apmr.2017.04.012; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; U.S. Department of Defense, 2018, DOD POL GUID MAN MIL; U.S. Department of Defense, 2010, DEPL LIM MED COND SE; U.S. Department of Defense, 2014, IND MED READ IMR DOD; Weightman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169104	35	3	3	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1156	1174		10.1080/13854046.2020.1715484		JAN 2020	19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000509450000001	31985338				2022-02-06	
J	Hsia, RY; Mannix, RC; Guo, J; Kornblith, AE; Lin, F; Sokolove, PE; Manley, GT				Hsia, Renee Y.; Mannix, Rebekah C.; Guo, Joanna; Kornblith, Aaron E.; Lin, Feng; Sokolove, Peter E.; Manley, Geoffrey T.			Revisits, readmissions, and outcomes for pediatric traumatic brain injury in California, 2005-2014	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; LONG-TERM; MILD; ADOLESCENTS; SERVICES; CHILDREN; VISITS; COSTS; CARE	Long-term outcomes related to emergency department revisit, hospital readmission, and all-cause mortality, have not been well characterized across the spectrum of pediatric traumatic brain injury (TBI). We evaluated emergency department visit outcomes up to 1 year after pediatric TBI, in comparison to a referent group of trauma patients without TBI. We performed a longitudinal, retrospective study of all pediatric trauma patients who presented to emergency departments and hospitals in California from 2005 to 2014. We compared emergency department visits, dispositions, revisits, readmissions, and mortality in pediatric trauma patients with a TBI diagnosis to those without TBI (Other Trauma patients). We identified 208,222 pediatric patients with an index diagnosis of TBI and 1,314,064 patients with an index diagnosis of Other Trauma. Population growth adjusted TBI visits increased by 5.6% while those for Other Trauma decreased by 40.7%. The majority of patients were discharged from the emergency department on their first visit (93.2% for traumatic brain injury vs. 96.5% for Other Trauma). A greater proportion of TBI patients revisited the emergency department (33.4% vs. 3.0%) or were readmitted to the hospital (0.9% vs. 0.04%) at least once within a year of discharge. The health burden within a year after a pediatric TBI visit is considerable and is greater than that of non-TBI trauma. These data suggest that outpatient strategies to monitor for short-term and longer-term sequelae after pediatric TBI are needed to improve patient outcomes, lessen the burden on families, and more appropriately allocate resources in the healthcare system.	[Hsia, Renee Y.; Guo, Joanna; Kornblith, Aaron E.; Sokolove, Peter E.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Mannix, Rebekah C.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah C.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Lin, Feng] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Hsia, RY (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.; Hsia, RY (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	renee.hsia@ucsf.edu		Kornblith, Aaron/0000-0002-1344-575X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01 NS086090-01]; One Mind	This study was supported in part by NIH 1U01 NS086090-01 (GTM), One Mind (GTM), and a gift from the Fisher Family. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The contents of the article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsors. There was no internal funding and no additional external funding received for this study.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Alpern ER, 2014, ACAD EMERG MED, V21, P365, DOI 10.1111/acem.12347; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Cho CS, 2012, PEDIATR EMERG CARE, V28, P606, DOI 10.1097/PEC.0b013e31825cf7cf; Duseja R, 2015, ANN INTERN MED, V162, P750, DOI 10.7326/M14-1616; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Geiger AA, 2011, J SURG RES, V170, P133, DOI 10.1016/j.jss.2011.03.026; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Huebner ARS, 2018, PM&R, V10, P462, DOI 10.1016/j.pmrj.2017.10.004; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Lumba-Brown A, 2018, JAMA PEDIAT; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McCrea M, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2846; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Center for Injury Prevention and Control, 2014, WISQARS COST INJ REP; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Sabbatini AK, 2016, JAMA-J AM MED ASSOC, V315, P663, DOI 10.1001/jama.2016.0649; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0227981	10.1371/journal.pone.0227981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP8WY	WOS:000534599100090	31978188	gold, Green Published			2022-02-06	
J	Kim, JH; Ahn, JH; Oh, JK; Song, JH; Park, SW; Chang, IB				Kim, Ji Hee; Ahn, Jun Hyong; Oh, Jae Keun; Song, Joon Ho; Park, Seung Woo; Chang, In Bok			Factors associated with the development and outcome of hydrocephalus after decompressive craniectomy for traumatic brain injury	NEUROSURGICAL REVIEW			English	Article						Complication; Decompressive craniectomy; Hydrocephalus; Outcome; Posttraumatic hydrocephalus; Traumatic brain injury	SEVERE HEAD-INJURY; POSTTRAUMATIC HYDROCEPHALUS; RISK-FACTORS; INTERHEMISPHERIC HYGROMA; SUBDURAL HYGROMA; CRANIOPLASTY; MANAGEMENT	Posttraumatic hydrocephalus (PTH) is common in patients undergoing decompressive craniectomy (DC) for traumatic brain injury (TBI), but the incidence, mechanisms, and risk factors have not been fully elucidated. This study aimed to determine the incidence of and the factors associated with PTH. We retrospectively reviewed patients who underwent DC for TBI at our institute between January 2014 and December 2018. We identified and compared the demographic, clinical, and radiological data, and 12-month functional outcome (as assessed by the Glasgow Outcome Scale [GOS]) between patients who developed PTH and those who did not. Logistic regression analyses were performed to identify risk factors for PTH. Additionally, the influence of PTH on unfavorable functional outcome was analyzed. PTH developed in 18 (18.95%) of the 95 patients who survived at 1 month after DC. A multivariate analysis indicated that postoperative intraventricular hemorrhage (odds ratio [OR] 4.493, P = 0.020), postoperative subdural hygroma (OR 4.074, P = 0.021), and postoperative hypothermia treatment (OR 9.705, P = 0.010) were significantly associated with PTH. The 12-month functional outcome significantly differed between the patients who developed PTH and those who did not (P = 0.049). Patients who developed PTH had significantly poorer 12-month functional outcomes than those who did not (P = 0.049). Another multivariate analysis indicated that subdural hemorrhage (OR 6.814, P = 0.031) and the presence of at least one dilated pupil before DC (OR 8.202, P = 0.000) were significantly associated with unfavorable functional outcomes (GOS grades 1-3). Although the influence of PTH (OR 5.122, P = 0.056) was not statistically significant in the multivariate analysis, it had a great impact on unfavorable functional outcomes. PTH considerably affects functional outcomes at 12 months after DC for TBI. Furthermore, postoperative imaging findings such as intraventricular hemorrhage and subdural hygroma can predict the development of PTH; therefore, careful observation is required during the follow-up period.	[Kim, Ji Hee; Ahn, Jun Hyong; Oh, Jae Keun; Song, Joon Ho; Chang, In Bok] Hallym Univ, Dept Neurosurg, Sacred Heart Hosp, 22 Gwanpyeong Ro, Anyang Si 14068, Gyeonggi Do, South Korea; [Park, Seung Woo] Kangwon Natl Univ, Dept Neurosurg, Coll Med, Chunchon, South Korea		Chang, IB (corresponding author), Hallym Univ, Dept Neurosurg, Sacred Heart Hosp, 22 Gwanpyeong Ro, Anyang Si 14068, Gyeonggi Do, South Korea.	nscib71@hanmail.net					Brown DA, 2017, HAND CLINIC, V140, P299, DOI 10.1016/B978-0-444-63600-3.00016-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Cho BR, 2012, KOREAN J NEUROTRAUMA, V8, P110; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di GF, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1179; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Iencean S, 2009, ROMANIAN NEUROSURG, V16, P17; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Khalili Hosseinali, 2017, Bull Emerg Trauma, V5, P190; Khan Farid, 2018, Asian J Neurosurg, V13, P730, DOI 10.4103/ajns.AJNS_6_18; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kim H, 2017, J KOREAN NEUROSURG S, V60, P730, DOI 10.3340/jkns.2017.0210; Kocher T, 1901, HIRNERSCHUTTERUNG HI; Low CYD, 2013, J CLIN NEUROSCI, V20, P867, DOI 10.1016/j.jocn.2012.06.007; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Sun S, 2019, SCAND J SURG, V108, P265, DOI 10.1177/1457496918812210; Takeuchi S, 2013, BRAIN EDEMA, P281; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Woo J-Y, 2006, J KOR NEUROTRAUMA SO, V2, P31, DOI [10.13004/jknts.2006.2.1.31, DOI 10.13004/JKNTS.2006.2.1.31]; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Yu Peng, 2015, J Craniofac Surg, V26, pe635, DOI 10.1097/SCS.0000000000002063; Zhang K, 2016, BRIT J NEUROSURG, V30, P251, DOI 10.3109/02688697.2016.1139052	42	3	3	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	FEB	2021	44	1					471	478		10.1007/s10143-019-01179-0		JAN 2020	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QB1MO	WOS:000507797900005	31953782				2022-02-06	
J	Naidu, PSR; Denham, E; Bartlett, CA; McGonigle, T; Taylor, NL; Norret, M; Smith, NM; Dunlop, SA; Iyer, KS; Fitzgerald, M				Naidu, Priya S. R.; Denham, Eleanor; Bartlett, Carole A.; McGonigle, Terry; Taylor, Nicolas L.; Norret, Marck; Smith, Nicole M.; Dunlop, Sarah A.; Iyer, K. Swaminathan; Fitzgerald, Melinda			Protein corona formation moderates the release kinetics of ion channel antagonists from transferrin-functionalized polymeric nanoparticles	RSC ADVANCES			English	Article							BLOOD-BRAIN-BARRIER; SPINAL-CORD-INJURY; IN-VITRO RELEASE; DRUG-DELIVERY; SECONDARY DEGENERATION; OXIDATIVE STRESS; PLGA NANOPARTICLES; SURFACE-CHARGE; RECEPTOR; METHACRYLATE)	Transferrin (Tf)-functionalized p(HEMA-ran-GMA) nanoparticles were designed to incorporate and release a water-soluble combination of three ion channel antagonists, namely zonampanel monohydrate (YM872), oxidized adenosine triphosphate (oxATP) and lomerizine hydrochloride (LOM) identified as a promising therapy for secondary degeneration that follows neurotrauma. Coupled with a mean hydrodynamic size of 285 nm and near-neutral surface charge of -5.98 mV, the hydrophilic nature of the functionalized polymeric nanoparticles was pivotal in effectively encapsulating the highly water soluble YM872 and oxATP, as well as lipophilic LOM dissolved in water-based medium, by a back-filling method. Maximum loading efficiencies of 11.8 +/- 1.05% (w/w), 13.9 +/- 1.50% (w/w) and 22.7 +/- 4.00% (w/w) LOM, YM872 and oxATP respectively were reported. To obtain an estimate of drug exposure in vivo, drug release kinetics assessment by HPLC was conducted in representative physiological milieu containing 55% (v/v) human serum at 37 degrees C. In comparison to serum-free conditions, it was demonstrated that the inevitable adsorption of serum proteins on the Tf-functionalized nanoparticle surface as a protein corona impeded the rate of release of LOM and YM872 at both pH 5 and 7.4 over a period of 1 hour. While the release of oxATP from the nanoparticles was detectable for up to 30 minutes under serum-free conditions at pH 7.4, the presence of serum proteins and a slightly acidic environment impaired the detection of the drug, possibly due to its molecular instability. Nevertheless, under representative physiological conditions, all three drugs were released in combination from Tf-functionalized p(HEMA-ran-GMA) nanoparticles and detected for up to 20 minutes. Taken together, the study provided enhanced insight into potential physiological outcomes in the presence of serum proteins, and suggests that p(HEMA-ran-GMA)-based therapeutic nanoparticles may be promising drug delivery vehicles for CNS therapy.	[Naidu, Priya S. R.; Taylor, Nicolas L.; Norret, Marck; Smith, Nicole M.; Iyer, K. Swaminathan] Univ Western Australia, Sch Mol Sci, 30 Stirling Highway, Crawley, WA 6009, Australia; [Denham, Eleanor; Bartlett, Carole A.; McGonigle, Terry; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Kent St, Bentley, WA 6102, Australia; [Taylor, Nicolas L.] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, 30 Stirling Highway, Crawley, WA 6009, Australia; [Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, 30 Stirling Highway, Crawley, WA 6009, Australia; [Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Ralph & Sarich Neurosci Res Inst Bldg Verdun St, Nedlands, WA 6009, Australia		Iyer, KS (corresponding author), Univ Western Australia, Sch Mol Sci, 30 Stirling Highway, Crawley, WA 6009, Australia.	swaminatha.iyer@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Smith, Nicole/L-2502-2013	Fitzgerald, Melinda/0000-0002-4823-8179; Smith, Nicole/0000-0002-5519-8152; Dunlop, Sarah/0000-0002-1306-3962	National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia [APP1082403]; NHMRCNational Health and Medical Research Council of Australia [APP1087114]	The authors acknowledge financial support from the National Health and Medical Research Council (NHMRC), Australia (APP1082403). MF was supported by an NHMRC Career Development Fellowship (APP1087114).	Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Barratt, 2000, Pharm Sci Technol Today, V3, P163; Behzadi S, 2014, COLLOID SURFACE B, V123, P143, DOI 10.1016/j.colsurfb.2014.09.009; Bharti C, 2015, INT J PHARM INVESTIG, V5, P124, DOI 10.4103/2230-973X.160844; Bramini M, 2014, ACS NANO, V8, P4304, DOI 10.1021/nn5018523; Caracciolo G, 2017, TRENDS BIOTECHNOL, V35, P257, DOI 10.1016/j.tibtech.2016.08.011; Chang J, 2012, PHARM RES-DORDR, V29, P1495, DOI 10.1007/s11095-011-0624-1; Chang J, 2009, INT J PHARMACEUT, V379, P285, DOI 10.1016/j.ijpharm.2009.04.035; Chen HT, 2019, J MATER CHEM B, V7, P1875, DOI 10.1039/c8tb02968g; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Chouhan Raje, 2009, Journal of Nanobiotechnology, V7, P5, DOI 10.1186/1477-3155-7-5; Chouhan R, 2009, J MATER SCI-MATER M, V20, P1103, DOI 10.1007/s10856-008-3677-x; Corbo C, 2016, NANOMEDICINE-UK, V11, P81, DOI 10.2217/nnm.15.188; Decker C, 2013, J LIPOSOME RES, V23, P154, DOI 10.3109/08982104.2013.770017; Di Bernardo P, 2006, DALTON T, P4711, DOI 10.1039/b604211b; Docter D, 2014, NAT PROTOC, V9, P2030, DOI 10.1038/nprot.2014.139; Doig RLO, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0380-1; Doig RLO, 2016, NEUROSCIENCE, V339, P450, DOI 10.1016/j.neuroscience.2016.10.005; Duan XP, 2013, SMALL, V9, P1521, DOI 10.1002/smll.201201390; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fedoroff S., 2008, PROTOCOLS NEURAL CEL; Ferreira L, 2000, INT J PHARM, V194, P169, DOI 10.1016/S0378-5173(99)00375-0; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Gan CW, 2010, BIOMATERIALS, V31, P7748, DOI 10.1016/j.biomaterials.2010.06.053; Gaumet M, 2008, EUR J PHARM BIOPHARM, V69, P1, DOI 10.1016/j.ejpb.2007.08.001; Grafe C, 2016, INT J BIOCHEM CELL B, V75, P196, DOI 10.1016/j.biocel.2015.11.005; Hara H., 1995, CNS DRUG REV, V1, P204; HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4; Hibino T, 2008, J PHARMACOL SCI, V108, P89, DOI 10.1254/jphs.08058FP; Hinna A, 2014, ANAL BIOANAL CHEM, V406, P7827, DOI 10.1007/s00216-014-7643-9; Hristov DR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17040; Jain P, 2017, BIOTECHNOL ADV, V35, P889, DOI 10.1016/j.biotechadv.2017.08.003; Jo DH, 2015, NANOMED-NANOTECHNOL, V11, P1603, DOI 10.1016/j.nano.2015.04.015; Ke PC, 2017, ACS NANO, V11, P11773, DOI 10.1021/acsnano.7b08008; Khan S, 2013, J PHYS CHEM LETT, V4, P3747, DOI 10.1021/jz401874u; Khor SY, 2018, SMALL, V14, DOI 10.1002/smll.201801702; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Kreuter J, 2014, ADV DRUG DELIVER REV, V71, P2, DOI 10.1016/j.addr.2013.08.008; Langer R, 1998, NATURE, V392, P5; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lee RJ, 1996, BBA-MOL CELL RES, V1312, P237, DOI 10.1016/0167-4889(96)00041-9; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li SD, 2010, J CONTROL RELEASE, V145, P178, DOI 10.1016/j.jconrel.2010.03.016; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Mahmoudi M, 2016, NANO TODAY, V11, P817, DOI 10.1016/j.nantod.2016.10.005; Mao YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113408; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Nag M, 2016, COLLOID SURFACE B, V148, P363, DOI 10.1016/j.colsurfb.2016.08.059; Naidu PSR, 2019, ACS OMEGA, V4, P17083, DOI 10.1021/acsomega.8b02894; Naidu PSR, 2017, LANGMUIR, V33, P12926, DOI 10.1021/acs.langmuir.7b02568; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Oh JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06979-4; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Palchetti S, 2017, COLLOID SURFACE B, V153, P263, DOI 10.1016/j.colsurfb.2017.02.037; Palchetti S, 2016, BBA-BIOMEMBRANES, V1858, P189, DOI 10.1016/j.bbamem.2015.11.012; Panyam J, 2004, J PHARM SCI-US, V93, P1804, DOI 10.1002/jps.20094; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Patel T, 2012, ADV DRUG DELIVER REV, V64, P701, DOI 10.1016/j.addr.2011.12.006; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Pitt D, 2010, BRAIN RES, V1309, P146, DOI 10.1016/j.brainres.2009.10.066; Ritz S, 2015, BIOMACROMOLECULES, V16, P1311, DOI 10.1021/acs.biomac.5b00108; Roese E, 2017, J CONTROL RELEASE, V256, P92, DOI 10.1016/j.jconrel.2017.04.032; Rytkonen J, 2012, J NANOMATER, V2012, DOI 10.1155/2012/896562; Saraiva C, 2016, J CONTROL RELEASE, V235, P34, DOI 10.1016/j.jconrel.2016.05.044; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Service RF, 2010, SCIENCE, V330, P314, DOI 10.1126/science.330.6002.314; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051; Sigma-Aldrich, 2014, AD 5 TRIPH PER OX SO; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Takahashi M, 2002, CNS DRUG REV, V8, P337; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Unagolla JM, 2018, EUR J PHARM SCI, V114, P199, DOI 10.1016/j.ejps.2017.12.012; Visser CC, 2004, J DRUG TARGET, V12, P145, DOI 10.1080/10611860410001701706; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110; Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017; Zanganeh S, 2016, INT J BIOCHEM CELL B, V75, P143, DOI 10.1016/j.biocel.2016.01.005; Zhao RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155953	88	3	4	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND		2046-2069		RSC ADV	RSC Adv.	JAN 15	2020	10	5					2856	2869		10.1039/c9ra09523c			14	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	KJ9YJ	WOS:000512409400047		gold			2022-02-06	
J	Olsen, A; Babikian, T; Dennis, EL; Ellis-Blied, MU; Giza, C; Marion, SD; Mink, R; Johnson, J; Babbitt, CJ; Thompson, PM; Asarnow, RF				Olsen, Alexander; Babikian, Talin; Dennis, Emily L.; Ellis-Blied, Monica U.; Giza, Christopher; Marion, Sarah DeBoard; Mink, Richard; Johnson, Jeffrey; Babbitt, Christopher J.; Thompson, Paul M.; Asarnow, Robert F.			Functional Brain Hyperactivations Are Linked to an Electrophysiological Measure of Slow Interhemispheric Transfer Time after Pediatric Moderate/Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain reserve; EEG; functional magnetic resonance imaging; interhemispheric transfer time; traumatic brain injury	WORKING-MEMORY; FMRI; TBI; CHILDREN; ROBUST; OPTIMIZATION; REGISTRATION; TRAJECTORIES; ACTIVATION; RECOVERY	Increased task-related blood oxygen level dependent (BOLD) activation is commonly observed in functional magnetic resonance imaging (fMRI) studies of moderate/severe traumatic brain injury (msTBI), but the functional relevance of these hyperactivations and how they are linked to more direct measures of neuronal function remain largely unknown. Here, we investigated how working memory load (WML)-dependent BOLD activation was related to an electrophysiological measure of interhemispheric transfer time (IHTT) in a sample of 18 msTBI patients and 26 demographically matched controls from the UCLA RAPBI (Recovery after Pediatric Brain Injury) study. In the context of highly similar fMRI task performance, a subgroup of TBI patients with slow IHTT had greater BOLD activation with higher WML than both healthy control children and a subgroup of msTBI patients with normal IHTT. Slower IHTT treated as a continuous variable was also associated with BOLD hyperactivation in the full TBI sample and in controls. Higher WML-dependent BOLD activation was related to better performance on a clinical cognitive performance index, an association that was more pronounced within the patient group with slow IHTT. Our previous work has shown that a subgroup of children with slow IHTT after pediatric msTBI has increased risk for poor white matter organization, long-term neurodegeneration, and poor cognitive outcome. BOLD hyperactivations after msTBI may reflect neuronal compensatory processes supporting higher-order capacity demanding cognitive functions in the context of inefficient neuronal transfer of information. The link between BOLD hyperactivations and slow IHTT adds to the multi-modal validation of this electrophysiological measure as a promising biomarker.	[Olsen, Alexander; Babikian, Talin; Dennis, Emily L.; Asarnow, Robert F.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Giza, Christopher] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Giza, Christopher] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; Norwegian Univ Sci & Technol, Dept Psychol, NTNU, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Babikian, Talin] UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Dennis, Emily L.] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; Stanford Neurodev Affect & Psychopathol Lab, Stanford, CA USA; [Dennis, Emily L.; Thompson, Paul M.] USC, Keck Sch Med, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Marina Del Rey, CA USA; [Ellis-Blied, Monica U.] Fuller Theol Seminary Sch Psychol, Pasadena, CA USA; [Ellis-Blied, Monica U.] Loma Linda VA Healthcare Syst, Loma Linda, CA USA; [Giza, Christopher] UCLA Mattel Childrens Hosp, Los Angeles, CA USA; [Marion, Sarah DeBoard] Northwest Nazarene Univ, Dept Psychol, Nampa, ID USA; [Marion, Sarah DeBoard] Elks Rehabil Hosp, St Lukes Hlth Syst, Boise, ID USA; [Mink, Richard] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Mink, Richard] Los Angeles Biomed Res Inst, Torrance, CA USA; [Johnson, Jeffrey] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Johnson, Jeffrey] Keck Sch Med, Los Angeles, CA USA; [Babbitt, Christopher J.] Miller Womens & Childrens Hosp Long Beach, Long Beach, CA USA		Olsen, A (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, N-7491 Trondheim, Norway.	alexander.olsen@ntnu.no	Dennis, Emily/AAD-5223-2021; Thompson, Paul M/C-4194-2018	Dennis, Emily/0000-0001-7112-4009; Thompson, Paul M/0000-0002-4720-8867	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54 EB020403] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504, U54 HD087101] Funding Source: Medline		Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BANICH MT, 1990, CORTEX, V26, P77, DOI 10.1016/S0010-9452(13)80076-7; Brown WS, 1999, NEUROPSYCHOLOGIA, V37, P1165, DOI 10.1016/S0028-3932(99)00011-1; Brunner JF, 2015, NEUROPSYCHOLOGIA, V66, P144, DOI 10.1016/j.neuropsychologia.2014.11.019; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Dennis E.L., 2017, 13 INT S MED INF PRO; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Gosselin N., 2010, BRAIN INJURY, V24, P335; Guerriero RM, 2017, NEUROLOGY, V88, P1386, DOI 10.1212/WNL.0000000000003822; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strazzer S, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/104282; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109	35	3	3	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					397	409		10.1089/neu.2019.6532			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000504969600020	31469049	Green Submitted, Green Published, hybrid			2022-02-06	
J	Tegtmeier, F; Schinzel, R; Beer, R; Bulters, D; LeFrant, JY; Sahuquillo, J; Unterberg, A; Andrews, P; Belli, A; Ibanez, J; Lagares, A; Mokry, M; Willschke, H; Fluhe, C; Schmutzhard, E				Tegtmeier, Frank; Schinzel, Reinhard; Beer, Ronny; Bulters, Diederik; LeFrant, Jean-Yves; Sahuquillo, Joan; Unterberg, Andreas; Andrews, Peter; Belli, Antonio; Ibanez, Javier; Lagares, Alfonso; Mokry, Michael; Willschke, Harald; Fluehe, Charlotte; Schmutzhard, Erich		NOSTRA Investigators	Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study	TRIALS			English	Article						Traumatic brain injury; Outcome; Nitric oxide synthase inhibition; Randomised controlled trials	NITRIC-OXIDE; MANAGEMENT; CARE	Background Traumatic brain injury is a leading cause of death and disability worldwide. The nitric oxide synthase inhibitor Ronopterin was shown to improve clinical outcome by enhancing neuroprotection in a phase IIa trial. Methods/design The NOSTRA phase III trial (Ronopterin in traumatic brain injury) is a multi-centre, prospective, randomised, double-blinded, placebo-controlled, phase III trial in Europe. It aims at determining whether the administration of Ronopterin compared to placebo improves neurological outcome in patients with moderate or severe traumatic brain injury at 6 months after injury. The trial is designed to recruit patients between 18 and 60 years of age with moderate or severe traumatic brain injury (Glasgow Coma Scale score >= 3) and requiring insertion of an intracranial pressure probe. Trial patients will receive a 48-h intravenous infusion of either Ronopterin or placebo starting at the earliest 6 h and at the latest 18 h after injury. The primary outcome will be the extended Glasgow Outcome Score (eGOS) at 6 months. Secondary outcomes will include the Quality of Life Index (QOLIBRI) at 6 months after the injury and the eGOS at 3 months after the injury. Additionally, effects on mortality, intracranial pressure and cerebral perfusion pressure are evaluated. Discussion The trial aims to provide evidence on the efficacy and safety of Ronopterin in patients with traumatic brain injury.	[Tegtmeier, Frank; Schinzel, Reinhard] Vasopharm GmbH, Wurzburg, Germany; [Beer, Ronny; Schmutzhard, Erich] Med Univ Innsbruck, Innsbruck, Austria; [Bulters, Diederik] Univ Hosp, Wessex Neurol Ctr, Southampton, Hants, England; [LeFrant, Jean-Yves] Hop Univ Caremeau, Nimes, France; [Sahuquillo, Joan] Vall dHebron Univ Hosp, Barcelona, Spain; [Unterberg, Andreas] Univ Klinikum Heidelberg, Heidelberg, Germany; [Andrews, Peter] Lothian Univ, Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Belli, Antonio] Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Ibanez, Javier] Espases Univ Hosp, Palma De Mallorca, Spain; [Lagares, Alfonso] Hosp Univ 12 Octubre, Madrid, Spain; [Mokry, Michael] LKH Univ Klinikum Graz, Graz, Austria; [Willschke, Harald] Med Univ Wien, Vienna, Austria; [Fluehe, Charlotte] Univ Klinikum Schleswig Holstein, Kiel, Germany		Schinzel, R (corresponding author), Vasopharm GmbH, Wurzburg, Germany.	schinzel@vasopharm.de	Castano-Leon, Ana M/ABF-6322-2020; Sahuquillo, Juan/B-3577-2008; Lagares, Alfonso/B-2969-2011; Keiner, Doerthe/AAK-1195-2020; Belli, Antonio/I-3799-2015; Bulters, Diederik/ABH-3573-2020	Castano-Leon, Ana M/0000-0002-7918-5049; Sahuquillo, Juan/0000-0003-0713-5875; Lagares, Alfonso/0000-0003-3996-0554; Keiner, Doerthe/0000-0003-2975-7704; Belli, Antonio/0000-0002-3211-9933; Ibanez, Javier/0000-0003-3735-8332; Bulters, Diederik/0000-0001-9884-9050	vasopharm GmbH	The study is completely funded by vasopharm GmbH. FT and RS as employees of vasopharm were involved in the design of the study.	BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Lehmacher W, 1999, BIOMETRICS, V55, P1286, DOI 10.1111/j.0006-341X.1999.01286.x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Ott C, 2019, BRIT J CLIN PHARMACO, V85, P900, DOI 10.1111/bcp.13870; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Schinzel R, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P133, DOI 10.1016/B978-0-12-802686-1.00008-0; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076	18	3	3	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JAN 14	2020	21	1							80	10.1186/s13063-019-3965-4			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KN2DO	WOS:000514651700007	31937347	Green Published, gold			2022-02-06	
J	Ozen, I; Ruscher, K; Nilsson, R; Flygt, J; Clausen, F; Marklund, N				Ozen, Ilknur; Ruscher, Karsten; Nilsson, Robert; Flygt, Johanna; Clausen, Fredrik; Marklund, Niklas			Interleukin-1 Beta Neutralization Attenuates Traumatic Brain Injury-Induced Microglia Activation and Neuronal Changes in the Globus Pallidus	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; interleukin-1 beta; inflammation; Parkinson's disease; globus pallidus; axonal injury	FLUID PERCUSSION INJURY; RECEPTOR ANTAGONIST; PARKINSONS-DISEASE; ANIMAL-MODELS; HEAD-INJURY; EXPRESSION; INFLAMMATION; PROTEIN; RISK; ENCEPHALOPATHY	Traumatic brain injury (TBI) increases the risk of delayed neurodegenerative processes, including Parkinson's disease (PD). Interleukin-1beta (IL-1 beta), a key pro-inflammatory cytokine, may promote secondary injury development after TBI. Conversely, neutralizing IL-1 beta was found to improve functional recovery following experimental TBI. However, the mechanisms underlying the behavioral improvements observed by IL-1 beta neutralization are still poorly understood. The present study investigated the role of IL-1 beta on the microglia response and neuronal changes in the globus pallidus in response to diffuse TBI. Mice were subjected to sham injury or the central fluid percussion injury (cFPI) (a model of traumatic axonal injury), and were randomly administered an IL-1 beta neutralizing or a control antibody at 30 min post-injury. The animals were analyzed at 2, 7, or 14 days post-injury. When compared to controls, mice subjected to cFPI TBI had increased microglia activation and dopaminergic innervation in the globus pallidus, and a decreased number of parvalbumin (PV) positive interneurons in the globus pallidus. Neutralization of IL-1 beta attenuated the microglia activation, prevented the loss of PV+ interneurons and normalized dopaminergic fiber density in the globus pallidus of brain-injured animals. These findings argue for an important role for neuro-inflammation in the PD-like pathology observed in TBI.	[Ozen, Ilknur; Ruscher, Karsten; Nilsson, Robert; Marklund, Niklas] Lund Univ, Dept Clin Sci, Lund Brain Injury Lab Neurosurg Res, S-22184 Lund, Sweden; [Ruscher, Karsten; Nilsson, Robert] Lund Univ, Dept Clin Sci, Lab Expt Brain Res, S-22184 Lund, Sweden; [Flygt, Johanna; Clausen, Fredrik; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden; [Marklund, Niklas] Lund Univ, Dept Clin Sci Lund, Neurosurg, S-22185 Lund, Sweden		Marklund, N (corresponding author), Lund Univ, Dept Clin Sci, Lund Brain Injury Lab Neurosurg Res, S-22184 Lund, Sweden.; Marklund, N (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden.; Marklund, N (corresponding author), Lund Univ, Dept Clin Sci Lund, Neurosurg, S-22185 Lund, Sweden.	ilknur.ozen@med.lu.se; karsten.ruscher@med.lu.se; nilsson.f.robert@gmail.com; johanna.flygt@ctc-ab.se; fredrik.clausen@neuro.uu.se; niklas.marklund@med.lu.se		Nilsson, Robert/0000-0001-8007-455X; Marklund, Niklas/0000-0002-9797-5626; ozen, ilknur/0000-0002-5858-864X	Uppsala University Hospital; Skane University Hospital, Lund, Sweden; Parkinson Foundation; Swedish Brain Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Fund; Crafoord Foundation; Sveriges Stroke Riksforbundet; Sparbanksstiftelsen Fars Frosta; Hans-Christian and Alice Wachtmeister Foundation; regional grant-ALF-Skane	This work was funded by grants from Uppsala University Hospital and Skane University Hospital, Lund, Sweden, Parkinson Foundation, the Swedish Brain Foundation and Swedish Research Council under the framework of ERA-NET-NEURON CnsAFlame (to N.M.), The Swedish Brain Fund; the Crafoord Foundation, Sveriges Stroke Riksforbundet, Sparbanksstiftelsen Fars & Frosta, a regional grant-ALF-Skane (to K.R.) and the Hans-Christian and Alice Wachtmeister Foundation (to N.M. and K.R.).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Alten R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2438; ARLUISON M, 1984, BRAIN RES BULL, V13, P269, DOI 10.1016/0361-9230(84)90128-X; Basu A, 2002, J NEUROSCI, V22, P6071; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Cossette M, 1999, NEUROSCI RES, V34, P51, DOI 10.1016/S0168-0102(99)00029-2; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; de Oliveira DV, 2017, ONCOTARGET, V8, P18622, DOI 10.18632/oncotarget.15740; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Fernandez-Suarez D, 2012, J NEUROPATH EXP NEUR, V71, P973, DOI 10.1097/NEN.0b013e3182717cba; Flygt J, 2018, J NEUROTRAUM, V35, P2837, DOI 10.1089/neu.2018.5660; Fogal B, 2008, J NEUROCHEM, V106, P1, DOI 10.1111/j.1471-4159.2008.05315.x; Gagnon D, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00038; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Hardman CD, 1999, MOVEMENT DISORD, V14, P626, DOI 10.1002/1531-8257(199907)14:4<626::AID-MDS1012>3.0.CO;2-U; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kenborg L, 2015, NEUROLOGY, V84, P1098, DOI 10.1212/WNL.0000000000001362; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Kerr N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00309; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; McKee AC, 2017, JAMA-J AM MED ASSOC, V318, P2353, DOI 10.1001/jama.2017.16687; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Monif M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0621-8; Moore RY, 2008, NEUROBIOL DIS, V29, P381, DOI 10.1016/j.nbd.2007.09.004; Nistico R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054666; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; PERCHERON G, 1993, ADV NEUROL, V60, P84; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; ROTHWELL NJ, 1993, CEREBROVAS BRAIN MET, V5, P178; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Tanaka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-143; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008	62	3	3	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN 2	2020	21	2							387	10.3390/ijms21020387			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	KO2KZ	WOS:000515380000017	31936248	Green Published, gold			2022-02-06	
J	Ruge, T; Carlsson, AC; Hellstrom, M; Wihlborg, P; Unden, J				Ruge, Toralph; Carlsson, Axel C.; Hellstrom, Magnus; Wihlborg, Per; Unden, Johan			Is medical urgency of elderly patients with traumatic brain injury underestimated by emergency department triage?	UPSALA JOURNAL OF MEDICAL SCIENCES			English	Article						Elderly patients; emergency department; RETTS-A; traumatic brain injury	OLDER-ADULTS; FRAILTY	Background: Mortality is high among elderly patients with traumatic brain injury (TBI). Recent data suggest that early surgical intervention and aggressive rehabilitation may reduce mortality rates even in elderly patients. Our aim was therefore to study the Rapid Emergency Triage and Treatment System-Adult (RETTS-A) triage of patients with isolated TBI and examine the differences in acute management according to age. Methods: We included 306 adult patients with isolated severe TBI and an abbreviated injury scale (AIS) score >= 3. Using a cut-off of 60 years of age, differences in triage priority according to RETTS-A, time to first computed tomography (CT) scan, length of hospital stay (LOS), and 30-day survival were studied. Results: In patients with an AIS score of 3 and 4, we observed that elderly patients had a longer time from admission to first CT scan. In addition, we observed that elderly patients were less often triaged with the highest priority level, despite similar AIS scores. LOS was significantly higher in elderly patients (median 9 days compared with 3 days for younger patients, p < 0.001). Finally, age, triage priority, and AIS score were independent risk factors for mortality. Conclusion: Elderly patients with isolated TBI are managed differently than younger patients, which could be due to an under-triage of elderly patients by RETTS-A.	[Ruge, Toralph; Wihlborg, Per] Univ Hosp Skane, Dept Clin Sci Malmo, Malmo, Sweden; [Ruge, Toralph] Karolinska Univ Hosp, Dept Emergency Med, S-17176 Stockholm, Sweden; [Carlsson, Axel C.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Care, Huddinge, Sweden; [Carlsson, Axel C.] Uppsala Univ, Dept Med Sci, Cardiovasc Epidemiol, Uppsala, Sweden; [Hellstrom, Magnus] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Unden, Johan] Halmstad Cty Hosp, Dept Operat & Intens Care, Halmstad, Sweden; [Unden, Johan] Lund Univ, Anaesthesiol & Intens Care Med, Lund, Sweden		Ruge, T (corresponding author), Karolinska Univ Hosp, Dept Emergency Med, S-17176 Stockholm, Sweden.	thoralph.ruge@med.lu.se		Carlsson, Axel C/0000-0001-6113-0472			Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Farrohknia N, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-42; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Giannoulis Dionysios, 2016, Eur J Orthop Surg Traumatol, V26, P365, DOI 10.1007/s00590-016-1744-4; Holzmann M, 2015, LAKARTINDINGEN, V41, P112; Hruska K, 2018, EMERG MED CLIN N AM, V36, P219, DOI 10.1016/j.emc.2017.08.014; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P196, DOI 10.1097/TA.0b013e3182a833ac; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Ljunggren M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0213-8; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Phillips S, 1996, J TRAUMA, V40, P278, DOI 10.1097/00005373-199602000-00018; Ruge T, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1157-4; Salvi F, 2007, INTERN EMERG MED, V2, P292, DOI 10.1007/s11739-007-0081-3; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Widgren Bengt R, 2009, Lakartidningen, V106, P746; Wong George K C, 2011, J Emerg Trauma Shock, V4, P346, DOI 10.4103/0974-2700.83861	19	3	3	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-9734	2000-1967		UPSALA J MED SCI	Ups. J. Med. Sci.	JAN 2	2020	125	1					58	63		10.1080/03009734.2019.1706674			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KO4TO	WOS:000515544200008	31986958	Green Published, gold			2022-02-06	
J	Bing, Y; Garcia-Gonzalez, D; Voets, N; Jerusalem, A				Bing, Yun; Garcia-Gonzalez, Daniel; Voets, Natalie; Jerusalem, Antoine			Medical imaging based in silico head model for ischaemic stroke simulation	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Ischaemic stroke; Finite element method; In silico experiment; Midline shift	INTRACRANIAL-PRESSURE; BRAIN-TISSUE; MECHANICAL-PROPERTIES; DEFORMATION; RECOVERY; IMAGES; EDEMA; INFARCTION; PREDICTION; CONNECTIVITY	Stroke is one of the most common causes of death and a leading factor of disability in adults worldwide. It occurs when the blood supply to part of the brain is significantly reduced, potentially leading to the formation of brain oedema. Owing to the rigid nature of the skull, brain expansion results in the shifting of tissue structure, often captured by measurement of the midline shift (MLS). Clinically, MLS has been used in practice as an indication of stroke severity, potential tissue damage and as a way to assess whether decompressive surgery should be performed. However, a growing body of research points towards limitations in such predictive ability. Inspired by the recent progress made in traumatic brain injury simulations, in silico experiments appear as the ideal candidate to elucidate stroke consequences on brain tissues, e.g., morphological changes, in particular in the overarching context of computer model assisted clinical decision making support. To this end, two biologically-informed finite element head models, human and rat, were constructed to support such analysis. The main components of the models include magnetic resonance imaging-derived grey matter, white matter, cerebrospinal fluid and skull, while the human head model also includes the vasculature, additional cerebral components and axonal tractography. Constitutive models representing the mechanical behaviour of each component account in particular for the behaviour of brain tissues during the swelling process accompanying oedema development. The rat model was leveraged for the calibration of the swelling parameters, in turn used for the simulation of human stroke. Human oedema development as a result of stroke was simulated at three frequent locations: basal ganglia, fronto-opercular/anterior insula and temporo-parietal. All three cases exhibit a quadratic MLS evolution with time with the basal ganglia and temporo-parietal showing the largest and smallest values, respectively, at any given time. A proposed injury criterion for axonal tract damage was shown to be larger in the temporoparietal case. Taken together, these results point towards i) the importance of considering stroke location when using the MLS as an indication of stroke severity, and ii) the potential lack of correlation between MLS value and tissue damage. Ultimately, we propose an in silica methodology that may hold promise in predicting stroke evolution based on an estimate of MLS and stroke location at a given time.	[Bing, Yun; Garcia-Gonzalez, Daniel; Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England; [Garcia-Gonzalez, Daniel] Univ Carlos III Madrid, Dept Continuum Mech & Struct Anal, Avda Univ 30, Madrid 28911, Spain; [Voets, Natalie] Univ Oxford, John Radcliffe Hosp, Wellcome Ctr Integrat Neuroimaging FMRIB, Oxford OX3 9DU, England		Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	antoine.jerusalem@eng.ox.ac.uk	Garcia-Gonzalez, Daniel/K-7349-2017	Garcia-Gonzalez, Daniel/0000-0003-4692-3508	Talent Attraction grant from the Comunidad de Madrid [CM 2018 - 2018-T2/IND-9992]; Wellcome TrustWellcome TrustEuropean Commission [203139/Z/16/Z]; EPSRC Healthcare Technologies Challenge AwardUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N020987/1]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N020987/1] Funding Source: UKRI	D.G.-G. acknowledges support from the Talent Attraction grant (CM 2018 - 2018-T2/IND-9992) from the Comunidad de Madrid. The Wellcome Centre for Integrative Neuroimaging is supported by core funding from the Wellcome Trust (203139/Z/16/Z). Finally, A.J. acknowledges funding from the EPSRC Healthcare Technologies Challenge Award EP/N020987/1.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Ay H, 2008, STROKE, V39, P373, DOI 10.1161/STROKEAHA.107.499095; Baird AE, 2001, LANCET, V357, P2095, DOI 10.1016/S0140-6736(00)05183-7; Bakhai A, 2004, PHARMACOECONOMICS, V22, P11, DOI 10.2165/00019053-200422004-00004; Becker E, 2010, BRAIN, V133, P909, DOI 10.1093/brain/awq011; Bivard A, 2017, STROKE, V48, P645, DOI 10.1161/STROKEAHA.116.015143; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Cheng B, 2014, STROKE, V45, P1695, DOI 10.1161/STROKEAHA.114.005152; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Dick AS, 2014, NEUROSCIENTIST, V20, P453, DOI 10.1177/1073858413513502; Donaldson HH, 1910, J COMP NEUROL PSYCHO, V20, P119, DOI 10.1002/cne.920200203; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Ferrant M, 2001, IEEE T MED IMAGING, V20, P1384, DOI 10.1109/42.974933; Fletcher TL, 2016, ANN BIOMED ENG, V44, P3495, DOI 10.1007/s10439-016-1666-7; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; Garcia-Gonzalez D, 2018, J MECH PHYS SOLIDS, V112, P209, DOI 10.1016/j.jmps.2017.12.001; Garcia-Gonzalez D, 2017, J MECH BEHAV BIOMED, V69, P342, DOI 10.1016/j.jmbbm.2017.01.012; Garcia-Gonzalez D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28271-7; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gerner ST, 2017, STROKE, V48, P587, DOI 10.1161/STROKEAHA.116.015890; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Glaister J., 2017, P SPIE INT SOC OPTIC; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Grefkes C, 2014, LANCET NEUROL, V13, P206, DOI 10.1016/S1474-4422(13)70264-3; Herbet G, 2017, BRAIN TOPOGR, V30, P747, DOI 10.1007/s10548-017-0574-y; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Holzapfel G. A., J R SOC INTERFACE, V12; Holzapfel GA, 2006, J THEOR BIOL, V238, P290, DOI 10.1016/j.jtbi.2005.05.006; Hope TMH, 2016, NEUROIMAGE, V125, P1169, DOI 10.1016/j.neuroimage.2015.09.025; Hope TMH, 2013, NEUROIMAGE-CLIN, V2, P424, DOI 10.1016/j.nicl.2013.03.005; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Jeon SB, 2016, J STROKE, V18, P328, DOI 10.5853/jos.2016.00262; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Johnson CL, 2014, MAGN RESON MED, V71, P477, DOI 10.1002/mrm.25065; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kalita P, 2008, ARCH COMPUT METHOD E, V15, P1, DOI 10.1007/s11831-007-9015-5; Karnath HO, 2009, CEREB CORTEX, V19, P2331, DOI 10.1093/cercor/bhn250; Koch S., 2017, JOVE-J VIS EXP, P1; Kummerer D, 2013, BRAIN, V136, P619, DOI 10.1093/brain/aws354; Kyriacou SK, 1998, LECT NOTES COMPUT SC, V1496, P531; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Li X.G., 2009, COMSOL C MIL; Li XG, 2013, COMPUT METHOD BIOMEC, V16, P1330, DOI 10.1080/10255842.2012.670853; Li XG, 2011, ACTA NEUROCHIR, V153, P2057, DOI 10.1007/s00701-011-1078-2; Liew SL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.11; Liu ZS, 2007, J BIOMECH, V40, P861, DOI 10.1016/j.jbiomech.2006.03.022; Miga MI, 1999, LECT NOTES COMPUT SC, V1679, P900; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Mohamed Mokhtarudin M.J., 2016, THESIS; Mokhtarudin M.J Mohamed, 2017, INT MED DEV TECHN C, P223; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Moustafa RR, 2008, BRIT J PHARMACOL, V153, pS44, DOI 10.1038/sj.bjp.0707530; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murthy SB, 2015, STROKE, V46, P3088, DOI 10.1161/STROKEAHA.115.010054; NAGASHIMA T, 1990, Neurologia Medico-Chirurgica, V30, P1, DOI 10.2176/nmc.30.1; OGDEN RW, 1972, PROC R SOC LON SER-A, V328, P567, DOI 10.1098/rspa.1972.0096; Paulsen KD, 1999, IEEE T BIO-MED ENG, V46, P213, DOI 10.1109/10.740884; Pechaud M., 2006, TECH REP; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Puy L, 2018, STROKE, V49, P2666, DOI 10.1161/STROKEAHA.118.021981; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Sander D, 2001, NEUROLOGY, V57, P833, DOI 10.1212/WNL.57.5.833; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stastna M., CAN APPL MATH Q, V7; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2017, LANCET NEUROL, V16, P826, DOI 10.1016/S1474-4422(17)30283-1; Tameem A, 2013, BJA EDUC, V13, P113, DOI 10.1093/bjaceaccp/mkt001; Timpone VM, 2015, AM J NEURORADIOL, V36, P40, DOI 10.3174/ajnr.A4091; Treadwell SD, 2010, POSTGRAD MED J, V86, P235, DOI 10.1136/pgmj.2009.094292; Tse KM, 2015, ACCIDENT ANAL PREV, V79, P13, DOI 10.1016/j.aap.2015.03.012; Vardakis JC, 2016, MED ENG PHYS, V38, P48, DOI 10.1016/j.medengphy.2015.09.006; Weickenmeier J, 2017, J ELASTICITY, V129, P197, DOI 10.1007/s10659-016-9606-1; Wu O, 2015, STROKE, V46, P2438, DOI 10.1161/STROKEAHA.115.009643; Xu W, 2016, CHILD NERV SYST, V32, P1371, DOI 10.1007/s00381-016-3143-x; Yourganov G, 2016, J NEUROSCI, V36, P6668, DOI 10.1523/JNEUROSCI.4396-15.2016; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034; Zhang L, 2001, Stapp Car Crash J, V45, P369	87	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2020	101								103442	10.1016/j.jmbbm.2019.103442			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	JW2IQ	WOS:000502881800044	31604168	hybrid, Green Published			2022-02-06	
J	Boshra, R; Ruiter, KI; Dhindsa, K; Sonnadara, R; Reilly, JP; Connolly, JF				Boshra, Rober; Ruiter, Kyle, I; Dhindsa, Kiret; Sonnadara, Ranil; Reilly, James P.; Connolly, John F.			On the time-course of functional connectivity: theory of a dynamic progression of concussion effects	BRAIN COMMUNICATIONS			English	Article						brain injury; functional connectivity; electroencephalography; theoretical model; progression	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; EEG; HISTORY; INDIVIDUALS; REDUCTION; COHERENCE; SYMPTOMS; NETWORKS; DEFICITS	The current literature presents a discordant view of mild traumatic brain injury and its effects on the human brain. This dissonance has often been attributed to heterogeneities in study populations, aetiology, acuteness, experimental paradigms and/or testing modalities. To investigate the progression of mild traumatic brain injury in the human brain, the present study employed data from 93 subjects (48 healthy controls) representing both acute and chronic stages of mild traumatic brain injury. The effects of concussion across different stages of injury were measured using two metrics of functional connectivity in segments of electroencephalography time-locked to an active oddball task. Coherence and weighted phase-lag index were calculated separately for individual frequency bands (delta, theta, alpha and beta) to measure the functional connectivity between six electrode clusters distributed from frontal to parietal regions across both hemispheres. Results show an increase in functional connectivity in the acute stage after mild traumatic brain injury, contrasted with significantly reduced functional connectivity in chronic stages of injury. This finding indicates a non-linear time-dependent effect of injury. To understand this pattern of changing functional connectivity in relation to prior evidence, we propose a new model of the time-course of the effects of mild traumatic brain injury on the brain that brings together research from multiple neuroimaging modalities and unifies the various lines of evidence that at first appear to be in conflict.	[Boshra, Rober; Ruiter, Kyle, I; Dhindsa, Kiret; Sonnadara, Ranil; Reilly, James P.; Connolly, John F.] McMaster Univ, ARiEAL Res Ctr, Hamilton, ON L8S 4K1, Canada; [Boshra, Rober; Reilly, James P.; Connolly, John F.] McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4K1, Canada; [Boshra, Rober; Dhindsa, Kiret; Sonnadara, Ranil; Reilly, James P.; Connolly, John F.] Vector Inst, Toronto, ON M5G 1M1, Canada; [Ruiter, Kyle, I; Connolly, John F.] McMaster Univ, Linguist & Languages, Hamilton, ON L8S 4K1, Canada; [Dhindsa, Kiret; Sonnadara, Ranil] McMaster Univ, Dept Surg, Hamilton, ON L8S 4K1, Canada; [Sonnadara, Ranil; Connolly, John F.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON L8S 4K1, Canada; [Reilly, James P.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON L8S 4K1, Canada		Boshra, R; Connolly, JF (corresponding author), McMaster Univ, ARiEAL Res Ctr, Hamilton, ON L8S 4K1, Canada.; Connolly, JF (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4K1, Canada.; Connolly, JF (corresponding author), Vector Inst, Toronto, ON M5G 1M1, Canada.; Connolly, JF (corresponding author), McMaster Univ, Linguist & Languages, Hamilton, ON L8S 4K1, Canada.; Connolly, JF (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON L8S 4K1, Canada.	boshrar@mcmaster.ca; jconnol@mcmaster.ca	Sonnadara, Ranil/AAT-4794-2021	Sonnadara, Ranil/0000-0001-8318-5714; Boshra, Rober/0000-0003-2925-199X; Connolly, John/0000-0001-8869-5369	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Hamilton Spectator; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Senator William McMaster Chair in Cognitive Neuroscience of Language; MacDATA fellowship award; Vector Institute postgraduate affiliate award; Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario	This work was supported by the Canadian Institutes of Health Research (JFC), the Natural Sciences and Engineering Research Council of Canada (JPR), The Hamilton Spectator, Canada Foundation for Innovation (JFC), Senator William McMaster Chair in Cognitive Neuroscience of Language (JFC), the MacDATA fellowship award (RB), the Vector Institute postgraduate affiliate award (RB thorn KD) and the Ontario Ministry of Research and Innovation (RB). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; BERNIER RA, 2017, FRONT NEUROL, V8, P1; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Blain-Moraes S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00248; Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; Boshra R, 2019, IEEE T NEUR SYS REH, V27, P1492, DOI 10.1109/TNSRE.2019.2922553; Broglio S.P, 2017, KINES REV, V6, P110; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Davey MP, 2000, CLIN NEUROPHYSIOL, V111, P1949, DOI 10.1016/S1388-2457(00)00435-1; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kay T, 1993, J HEAD TRAUMA REHAB, V7, P267; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Martini DN, 2017, AM J SPORT MED, V45, P1420, DOI 10.1177/0363546516686785; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Ruiter KI, 2019, CLIN NEUROPHYSIOL, V130, P111, DOI 10.1016/j.clinph.2018.10.013; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Trammell JP, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00364; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	62	3	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							fcaa063	10.1093/braincomms/fcaa063			14	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800007	32954320	Green Published, gold			2022-02-06	
J	Buccellato, KH; Nordstrom, M; Murphy, JM; Burdea, GC; Polistico, K; House, G; Kim, N; Grampurohit, N; Sorensen, J; Isaacson, BM; Pasquina, PF				Buccellato, Kiara H.; Nordstrom, Michelle; Murphy, Justin M.; Burdea, Grigore C.; Polistico, Kevin; House, Gregory; Kim, Nam; Grampurohit, Namrata; Sorensen, Jeff; Isaacson, Brad M.; Pasquina, Paul F.			A Randomized Feasibility Trial of a Novel, Integrative, and Intensive Virtual Rehabilitation Program for Service Members Post-Acquired Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	12th International Conference on Disability Virtural Reality and Associated Technologies	SEP 04-06, 2018	Univ Nottingham, Nottingham, ENGLAND		Univ Nottingham		FALSE DISCOVERY RATE; COGNITIVE REHABILITATION; PSYCHOMETRIC EVALUATION; STROKE; REALITY; BENEFITS	Introduction Acquired Brain Injury, whether resulting from Traumatic brain injury (TBI) or Cerebral Vascular Accident (CVA), represent major health concerns for the Department of Defense and the nation. TBI has been referred to as the "signature" injury of recent U.S. military conflicts in Iraq and Afghanistan - affecting approximately 380,000 service members from 2000 to 2017; whereas CVA has been estimated to effect 795,000 individuals each year in the United States. TBI and CVA often present with similar motor, cognitive, and emotional deficits; therefore the treatment interventions for both often overlap. The Defense Health Agency and Veterans Health Administration would benefit from enhanced rehabilitation solutions to treat deficits resulting from acquired brain injuries (ABI), including both TBI and CVA. The purpose of this study was to evaluate the feasibility of implementing a novel, integrative, and intensive virtual rehabilitation system for treating symptoms of ABI in an outpatient clinic. The secondary aim was to evaluate the system's clinical effectiveness. Materials and Methods Military healthcare beneficiaries with ABI diagnoses completed a 6-week randomized feasibility study of the BrightBrainer Virtual Rehabilitation (BBVR) system in an outpatient military hospital clinic. Twenty-six candidates were screened, consented and randomized, 21 of whom completed the study. The BBVR system is an experimental adjunct ABI therapy program which utilizes virtual reality and repetitive bilateral upper extremity training. Four self-report questionnaires measured participant and provider acceptance of the system. Seven clinical outcomes included the Fugl-Meyer Assessment of Upper Extremity, Box and Blocks Test, Jebsen-Taylor Hand Function Test, Automated Neuropsychological Assessment Metrics, Neurobehavioral Symptom Inventory, Quick Inventory of Depressive Symptomatology-Self-Report, and Post Traumatic Stress Disorder Checklist- Civilian Version. The statistical analyses used bootstrapping, non-parametric statistics, and multilevel/hierarchical modeling as appropriate. This research was approved by the Walter Reed National Military Medical Center and Uniformed Services University of the Health Sciences Institutional Review Boards. Results All of the participants and providers reported moderate to high levels of utility, ease of use and satisfaction with the BBVR system (x (x) over bar = 73-86%). Adjunct therapy with the BBVR system trended towards statistical significance for the measure of cognitive function (ANAM [x (x) over bar = -1.07, 95% CI -2.27 to 0.13, p = 0.074]); however, none of the other effects approached significance. Conclusion This research provides evidence for the feasibility of implementing the BBVR system into an outpatient military setting for treatment of ABI symptoms. It is believed these data justify conducting a larger, randomized trial of the clinical effectiveness of the BBVR system.	[Buccellato, Kiara H.; Nordstrom, Michelle; Murphy, Justin M.; Sorensen, Jeff] Henry M Jackson Fdn Adv Mil Med, 6720 A Rockledge Dr, Bethesda, MD 20817 USA; [Buccellato, Kiara H.; Nordstrom, Michelle; Murphy, Justin M.; Sorensen, Jeff; Isaacson, Brad M.] Ctr Rehabil Sci Res, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Nordstrom, Michelle; Isaacson, Brad M.; Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Dept Rehabil Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Nordstrom, Michelle; Pasquina, Paul F.] Walter Reed Natl Mil Med Ctr, Dept Rehabil Med, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Burdea, Grigore C.; Polistico, Kevin; House, Gregory; Kim, Nam; Grampurohit, Namrata] Bright Cloud Int Corp, 675 US Hwy 1, North Brunswick, NJ 08902 USA; [Isaacson, Brad M.] Geneva Fdn, 917 Pacific Ave, Tacoma, WA 98402 USA		Buccellato, KH (corresponding author), Henry M Jackson Fdn Adv Mil Med, 6720 A Rockledge Dr, Bethesda, MD 20817 USA.; Buccellato, KH (corresponding author), Ctr Rehabil Sci Res, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.			Grampurohit, Namrata/0000-0001-9838-8581	AMEDD Advanced Medical Technology Initiative (AAMTI) [HU0001-15-2-0012]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD; Bright Cloud International Corp, Edison, NJ	This research was supported by an award from the AMEDD Advanced Medical Technology Initiative (AAMTI) (HU0001-15-2-0012) to the Center for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences, Bethesda, MD; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD; and Bright Cloud International Corp, Edison, NJ. This funding source did not have any role in the study design, collection, analysis, or interpretation or data, writing of this manuscript, or decision to submit this article for publication.	[Anonymous], 2018, DOD WORLDW NUMB TBI; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bond CM., 2010, BRIT MED J, V2016, P355; Burdea G, 2018, 12 ICDVRAT; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Burdea GC, 2013, FEASIBILITY STUDY NE, DOI [10.1109/ICVR.2013.6662130, DOI 10.1109/ICVR.2013.6662130]; Burdea G, 2015, DISABIL REHABIL-ASSI, V10, P421, DOI 10.3109/17483107.2014.900575; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cai LY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00031; Chen CC, 2011, AM J PHYS MED REHAB, V90, P415, DOI 10.1097/PHM.0b013e318214f5d8; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; De Almeida PMD, 2015, EUR J PHYSIOTHER, V17, P100, DOI 10.3109/21679169.2015.1044466; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gajanan B, 2016, INDIAN J PHYSIOTHER, V10, P47, DOI [10.5958/0973-5674.2016.00011.3, DOI 10.5958/0973-5674.2016.00011.3]; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gamito P, 2017, DISABIL REHABIL, V39, P385, DOI 10.3109/09638288.2014.934925; Han Lee J, 2003, CYBERPSYCHOL BEHAV, V6, P383; Ibarra S, ENCY CLIN NEUROPSYCH; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; LEWIS JR, 1995, INT J HUM-COMPUT INT, V7, P57, DOI 10.1080/10447319509526110; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Lund A.M, 2001, STC USABILITY SIG NE, V8, P2; Manara JR, 2015, J SHOULDER ELB SURG, V24, P823, DOI 10.1016/j.jse.2014.12.003; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; PRAESTGAARD JT, 1995, SCAND J STAT, V22, P305; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; Sixense Entertainment, 2011, RAZ HYDR MAST GUID; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Taub MB, 2012, VISUAL DIAGNOSIS CAR; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Turolla A, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-85; Weathers FW, PTSD CHECKLIST DSM 5; Wilcoxon F., 1970, SELECTED TABLES MATH, V1, P171, DOI DOI 10.1007/SPRINGERREFERENCE_205698	48	3	4	3	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185	1-2					E203	E211		10.1093/milmed/usz150			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KM6BW	WOS:000514224500040	31268524	hybrid, Green Published			2022-02-06	
J	Carr, BW; Severance, SE; Bell, TM; Zarzaur, B				Carr, Bryan W.; Severance, Sarah E.; Bell, Teresa M.; Zarzaur, Ben L.			Perceived loss of social support after non-neurologic injury negatively impacts recovery	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	32nd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 15-19, 2019	Austin, TX	Eastern Assoc Surg Trauma		Quality of life; social support; posttraumatic stress disorder; depression	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; LONG-TERM OUTCOMES; MAJOR TRAUMA; MULTIDIMENSIONAL SCALE; GENERAL HEALTH; RISK-FACTORS; SYMPTOMS; PREDICTORS; DEPRESSION	BACKGROUND Traumatic injury is not only physically devastating, but also psychologically isolating, potentially leading to poor quality of life, depression and posttraumatic stress disorder (PTSD). Perceived social support (PSS) is associated with better outcomes in some populations. What is not known is if changes in PSS influence long-term outcomes following nonneurologic injury. We hypothesized that a single drop in PSS during recovery would be associated with worse quality of life. METHODS This is a post hoc analysis of a prospectively collected database that included patients 18 years or older admitted to a Level I trauma center with Injury Severity Score (ISS) of 10 or higher, and no traumatic brain or spinal cord injury. Demographic and injury data were collected at the initial hospital admission. Screening for depression, PTSD, and Medical Outcomes Study Short Form 36 Mental Composite Score (MCS) were obtained at the initial hospitalization, 1, 2, 4, and 12 months postinjury. The Multidimensional Scale of Perceived Social Support (MSPSS) was obtained at similar time points. Patients with high MSPSS (>5) at baseline were included and grouped by those that ever reported a score <= 5 (DROP), and those that remained high (STABLE). Outcomes were determined at 4 and 12 months. RESULTS Four hundred eleven patients were included with 96 meeting DROP criteria at 4 months, and 97 at 1 years. There were no differences in sex, race, or injury mechanism. The DROP patients were more likely to be single (p = 0.012 at 4 months, p = 0.0006 at 1 year) and unemployed (p = 0.016 at 4 months, and p = 0.026 at 1 year) compared with STABLE patients. At 4 months and 1 year, DROP patients were more likely to have PTSD, depression, and a lower MCS (p = 0.0006, p < 0.0001). CONCLUSION Patients who have a drop in PSS during the first year of recovery have significantly higher odds of poor psychological outcomes. Identifying these socially frail patients provides an opportunity for intervention to positively influence an otherwise poor quality of life.	[Carr, Bryan W.; Severance, Sarah E.; Bell, Teresa M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Zarzaur, Ben L.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA		Zarzaur, B (corresponding author), 600 Highland Ave,G5-335, Madison, WI 53792 USA.	zarzaur@surgery.wisc.edu		Bell, Teresa/0000-0002-6519-4358; Zarzaur, Ben/0000-0001-9988-9572	National Institute of General Medical Science at the National Institute of Health [K23GM084427]	This project was funded by a grant from the National Institute of General Medical Science at the National Institute of Health, award number K23GM084427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitken LM, 2016, CRIT CARE MED, V44, P734, DOI 10.1097/CCM.0000000000001481; [Anonymous], 2016, WEB BAS INJ STAT QUE; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Carlson EB, 2016, COMPR PSYCHIAT, V69, P106, DOI 10.1016/j.comppsych.2016.04.022; Clay FJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-6; Connolly FR, 2014, J ADV NURS, V70, P714, DOI 10.1111/jan.12237; DAHLEM NW, 1991, J CLIN PSYCHOL, V47, P756, DOI 10.1002/1097-4679(199111)47:6<756::AID-JCLP2270470605>3.0.CO;2-L; Davydow DS, 2009, GEN HOSP PSYCHIAT, V31, P428, DOI 10.1016/j.genhosppsych.2009.05.007; Fitzharris M, 2010, AUST NZ J PUBL HEAL, V34, P153, DOI 10.1111/j.1753-6405.2010.00500.x; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Halcomb Elizabeth, 2005, Aust Crit Care, V18, P17, DOI 10.1016/S1036-7314(05)80020-7; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Inaba K, 2003, J TRAUMA, V54, P486, DOI 10.1097/01.TA.0000051588.05542.D6; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; Kent M, 2011, J TRAUMA STRESS, V24, P591, DOI 10.1002/jts.20685; Kiely JM, 2006, J TRAUMA, V61, P791, DOI 10.1097/01.ta.0000239360.29852.1d; Kopjar B, 1996, Inj Prev, V2, P135, DOI 10.1136/ip.2.2.135; Marasco S, 2015, INJURY, V46, P61, DOI 10.1016/j.injury.2014.06.014; Michaels AJ, 2001, J TRAUMA, V50, P389, DOI 10.1097/00005373-200103000-00001; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; O'Donnell ML, 2012, J TRAUMA STRESS, V25, P125, DOI 10.1002/jts.21677; Orwelius L, 2012, J TRAUMA ACUTE CARE, V72, P504, DOI 10.1097/TA.0b013e31821a416a; Osenbach JE, 2014, PSYCHIATRY, V77, P386, DOI 10.1521/psyc.2014.77.4.386; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rainer TH, 2014, INJURY, V45, P902, DOI 10.1016/j.injury.2013.11.006; Richmond TS, 2014, J NURS SCHOLARSHIP, V46, P116, DOI 10.1111/jnu.12064; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Toien K, 2010, J TRAUMA, V69, P1552, DOI 10.1097/TA.0b013e3181e125f3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers F, PTSD CHECKLIST RELIA; Zarzaur BL, 2017, J TRAUMA ACUTE CARE, V82, P939, DOI 10.1097/TA.0000000000001415; Zarzaur BL, 2016, J SURG RES, V202, P103, DOI 10.1016/j.jss.2015.12.038; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	48	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2020	88	1					113	120		10.1097/TA.0000000000002515			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	KB7JL	WOS:000506666700018	31856020	Green Accepted			2022-02-06	
J	Chen, MR; Chen, QL; Tao, T				Chen, Mingrui; Chen, Qiulin; Tao, Tao			Tanshinone IIA Promotes M2 Microglia by ER beta/IL-10 Pathway and Attenuates Neuronal Loss in Mouse TBI Model	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						tanshinone IIA; TNA; traumatic brain injury; TBI; microglia; interleukins; macrophage polarization	TRAUMATIC BRAIN-INJURY; FACTOR-KAPPA-B; MACROPHAGE POLARIZATION; IN-VIVO; CELLS; EXPRESSION; NEURODEGENERATION; ACTIVATION; BETA	Purpose: Traumatic brain injury (TBI) is a major cause of morbidity and mortality worldwide. Increasing evidence indicates that activated microglia play an important role in the inflammatory response in TBI. Inhibiting M1 and stimulating M2 activated microglia have protective effects in several animal models of central nervous system (CNS) disorders. In the present study, we investigated whether tanshinone IIA (TNA) protects neurons by shifting microglia polarization in a mouse TBI model and further investigated the mechanism in vitro. Materials and Methods: Forty C57BL/6 mice were used to investigate the effect of TNA on microglia polarization in TBI. BV-2 cells were used to examine the mechanism of TNA in regulating microglia polarization. Results: Normal saline (NS), TNA and the combination of TNA with ICI 182,780 (ICI, an estrogen receptor antagonist) were used to treat the TBI mice. After TBI, mice from each group demonstrated functional improvement. The improvement rate in mice treated with TNA was faster than other groups. ICI partially reversed the benefits from TNA treatment. TNA treatment significantly reduced TBI-induced neuronal loss. The number of microglia after TBI was not significantly changed by TNA treatment. However, TNA treatment significantly decreased M1 macrophage markers (iNOS, TNF alpha and IL-1 beta) and increased M2 macrophage markers (CD206, arginase 1 and Ym1). This effect was partially abolished by ICI. TNA treatment downregulated M1 macrophage markers and upregulated M2 macrophage markers in BV-2 cells under LPS stimulation. IL-10 was significantly increased by TNA treatment without a significantly change of IL-4 and IL-13 expression. IL-10 knockdown completely abolished the effect of TNA on microglial M2 polarization. Conclusion: Taken together, our data demonstrated that TNA attenuates neuronal loss in mouse TBI model and promotes M2 microglia by ER beta/IL-10 pathway. Thus, TNA could be a potential drug for TBI and/or the disorders that caused by microglial over-activation in CNS.	[Chen, Mingrui; Chen, Qiulin] Chongqing Red Cross Hosp, Peoples Hosp Jiangbei Dist, Dept Neurosurg, Chongqing 400020, Peoples R China; [Tao, Tao] Guizhou Prov Peoples Hosp, Dept Rehabil Med, Guiyang 550002, Guizhou, Peoples R China		Tao, T (corresponding author), Guizhou Prov Peoples Hosp, Dept Rehabil Med, Guiyang 550002, Guizhou, Peoples R China.	13985162824@163.com					Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Cao FL, 2012, PLOS ONE, V7, pe3838; Chen WN, 2019, INT IMMUNOPHARMACOL, V70, P486, DOI 10.1016/j.intimp.2019.02.054; Chen Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/267976; Cheung DWS, 2013, J ETHNOPHARMACOL, V145, P776, DOI 10.1016/j.jep.2012.12.011; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Deng XH, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00777; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Fang J, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01006; Gao HW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26828-0; Gao S, 2014, EXP BIOL MED, V239, P366, DOI 10.1177/1535370213518169; Gong G, 2019, LIFE SCI, V216, P147, DOI 10.1016/j.lfs.2018.11.046; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jin ML, 2020, NEUROPSYCH DIS TREAT, V16, P397, DOI 10.2147/NDT.S238616; Jing Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01215; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Liu R, 2019, MOL IMMUNOL, V112, P30, DOI 10.1016/j.molimm.2019.04.010; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Oishi S, 2016, IMMUNOLOGY, V149, P320, DOI 10.1111/imm.12647; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Shu M, 2016, MOL MED REP, V13, P3036, DOI 10.3892/mmr.2016.4886; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Wang L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52265-8; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Yang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32987; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y	42	3	3	3	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2020	16						3239	3250		10.2147/NDT.S265478			12	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	PN0YJ	WOS:000604213000001	33408474	Green Published, gold			2022-02-06	
J	Chowdhary, S; Garg, P; Sawhney, V; Pandya, A; Sambhav, K; Gupta, S				Chowdhary, Somya; Garg, Pooja; Sawhney, Vivek; Pandya, Abhijit; Sambhav, Kumar; Gupta, Shailesh			Unusual Missed Diagnosis of Foreign Body: A Case Report	INTERNATIONAL MEDICAL CASE REPORTS JOURNAL			English	Article						intraorbital foreign body; IOFB; intracranial foreign body; CT scan; retinal detachment	COMPUTED-TOMOGRAPHY; GLOBE; MANAGEMENT	Background: Penetrating intraorbital foreign body (IOFB) is usually associated with high-velocity trauma forces around the eye. IOFB injury to globe or optic nerve is considered a surgical emergency; an immediate diagnosis and management plan is generally indicated. Methods: A case report (design). The patient was a 78-year-old male presented with diminution of vision of the right eye following a high-velocity injury. The patient was noted to have a closed globe injury with associated retinal detachment and vitreous hemorrhage. An initial orbital CT scan did not reveal any IOFB, despite and intact globe. However, repeat a CT head and orbit scan revealed an intracranial magnetic foreign body lodged in the right frontal lobe. Conclusion: A CT scan of the brain and paranasal sinuses should be obtained along with a CT orbit in case of high-velocity orbital/ocular trauma.	[Chowdhary, Somya] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA; [Garg, Pooja; Sawhney, Vivek; Pandya, Abhijit; Gupta, Shailesh] Specialty Retina Ctr, Coral Springs, FL 33067 USA; [Sambhav, Kumar] Univ Florida, Dept Ophthalmol, Jacksonville, FL USA		Gupta, S (corresponding author), Specialty Retina Ctr, Coral Springs, FL 33067 USA.	sgupta1997@yahoo.com	Sambhav, Kumar/AAR-7929-2021	Sawhney, Vivek/0000-0002-7652-8448			Fulcher TP, 2002, OPHTHALMOLOGY, V109, P494, DOI 10.1016/S0161-6420(01)00982-4; Hamilton A, 2014, INT OPHTHALMOL, V34, P337, DOI 10.1007/s10792-013-9786-7; Hoffstetter P, 2010, ROFO-FORTSCHR RONTG, V182, P151, DOI 10.1055/s-0028-1109659; Kubal WS, 2008, RADIOGRAPHICS, V28, P1729, DOI 10.1148/rg.286085523; Lakits A, 1999, OPHTHALMOLOGY, V106, P2330, DOI 10.1016/S0161-6420(99)90536-5; Patel SN, 2012, EUR J OPHTHALMOL, V22, P259, DOI 10.5301/EJO.2011.8347; Pinto A, 2012, SEMIN ULTRASOUND CT, V33, P392, DOI 10.1053/j.sult.2012.06.004; Sung EK, 2014, RADIOGRAPHICS, V34, P764, DOI 10.1148/rg.343135120; Turkcuoglu P, 2006, CAN J OPHTHALMOL, V41, P504, DOI 10.1016/S0008-4182(06)80017-7; Turliuc DM, 2015, MED-SURG J, V119, P179; Zhou DD, 2015, CASE REP OPHTHALM, V6, P448, DOI 10.1159/000442584	11	3	3	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-142X			INT MED CASE REP J	INT. MED. CASE REP. J.		2020	13						187	190		10.2147/MCRJ.S246924			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LQ9AJ	WOS:000535289000001	32547254				2022-02-06	
J	DeMarco, AL; Chimich, DD; Bonin, SJ; Siegmund, GP				DeMarco, Alyssa L.; Chimich, Dennis D.; Bonin, Stephanie J.; Siegmund, Gunter P.			Impact Performance of Certified Bicycle Helmets Below, On and Above the Test Line	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Helmet; Head injury risk; Safety standards; Traumatic brain injury; Impact attenuation; Head acceleration; Bicycle	INJURIES; DAMAGE	Bicycle helmets are effective in reducing many head injuries, but their effectiveness could be improved if they provided protection over a larger range of impact locations. We sought to quantify the impact performance of 12 helmet models below, on and above the CPSC prescribed test line. All helmets were drop tested at an impact speed of 6.2 m/s. One helmet adequately attenuated impacts below the CPSC limit of 300 g for all impact locations tested below, on and above the test line. Five helmets met this limit for impacts on or above the test line as required in the CPSC standard, but failed to meet it below the test line (not required in the standard). The remaining six helmets failed to meet the criterion on and/or above the test line. Our findings indicate that consumers should not assume that all portions of a helmet provide adequate and equivalent protection. Our findings also suggest that the CPSC's current system of self-regulation and self-testing by manufacturers does not prevent substandard bicycle helmets from being sold. Public availability of manufacturers' impact test data, an independent testing panel, and/or a wider distribution of impact locations are needed to better protect bicyclists.	[DeMarco, Alyssa L.; Chimich, Dennis D.; Siegmund, Gunter P.] MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada; [Bonin, Stephanie J.] MEA Forens Engineers & Scientists, 23281 Vista Grande Dr, Laguna Hills, CA 92653 USA; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, 6081 Univ Blvd, Vancouver, BC V6T 1Z1, Canada		Siegmund, GP (corresponding author), MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada.	gunter.siegmund@meaforensic.com	Siegmund, Gunter P/B-7003-2013	Siegmund, Gunter/0000-0003-2387-941X			American National Standards Institute, 1984, Z9041984 ANZI; American Society for Testing and Materials, 1994, F144794 AM SOC TEST; American Society for Testing and Materials, 1993, F144793 AM SOC TEST; ASTM International, 2008, F144608 ASTM INT; ASTM International, 1999, F144799A ASTM INT; ASTM International, 2006, F204006 ASTM INT; ASTM International, 2018, F144718 ASTM INT; ASTM International, 2002, F144702 ASTM INT; ASTM International, 2008, F149208 ASTM INT; ASTM International, 2012, F144712 ASTM INT; Bland M. L., 2018, STAR METH BIC HELM V; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Cameron M. H., 1994, 59 MON U ACC RES CTR; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; DeMarco AL, 2017, ANN BIOMED ENG, V45, P1974, DOI 10.1007/s10439-017-1842-4; European Committee for Standardization, 2007, 1077 EN CEN; European Committee for Standardization, 1997, 1078 CEN EN; Gilchrist A, 1996, ACCIDENT ANAL PREV, V28, P525, DOI 10.1016/0001-4575(96)00030-9; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Hoye A, 2018, ACCIDENT ANAL PREV, V120, P239, DOI 10.1016/j.aap.2018.08.001; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh A, 1998, ACCIDENT ANAL PREV, V30, P161, DOI 10.1016/S0001-4575(97)00089-4; McIntosh A. S., 1995, P 39 STAPP CAR CRASH, P111; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P274, DOI 10.1177/1754337111435294; Mertz H. J., 1996, P SOC AUT ENG INT C, P1; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Rowson S., VIRGINIA TECH HELMET; Smith T. A., P 37 ANN ASS ADV AUT, P143; Snell Memorial Foundation, SNELL HELM CERT PROG; Society of Automotive Engineers (SAE), 1989, 1989 SAE HDB, V4; Standards Australia and Standards New Zealand, 2008, 20632008 ASNZS NSW; Syed ON, 2008, J NEUROSURG-PEDIATR, V2, P424, DOI 10.3171/PED.2008.2.12.424; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	37	3	3	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2020	48	1					58	67		10.1007/s10439-019-02422-x			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	KI8PN	WOS:000511620300008	31768795				2022-02-06	
J	Diamond, BR; Mac Donald, CL; Frau-Pascual, A; Snider, SB; Fischl, B; Dams-O'Connor, K; Edlow, BL				Diamond, Bram R.; Mac Donald, Christine L.; Frau-Pascual, Aina; Snider, Samuel B.; Fischl, Bruce; Dams-O'Connor, Kristen; Edlow, Brian L.			Optimizing the accuracy of cortical volumetric analysis in traumatic brain injury	METHODSX			English	Article						Traumatic brain injury; Contusion; Mri; FreeSurfer; Neurodegeneration	HUMAN CEREBRAL-CORTEX; COMMON DATA ELEMENTS; SEGMENTATION; MULTICENTER; THICKNESS; MODERATE; OUTCOMES; ATROPHY	Cortical volumetric analysis is widely used to study the anatomic basis of neurological deficits in patients with traumatic brain injury (TBI). However, patients with TBI-related lesions are often excluded from MRI analyses because cortical lesions may compromise the accuracy of reconstructed surfaces upon which volumetric measurements are based. We developed a FreeSurfer-based lesion correction method and tested its impact on cortical volume measures in 87 patients with chronic moderate-to-severe TBI. We reconstructed cortical surfaces from Tl-weighted MRI scans, then manually labeled and removed vertices on the cortical surfaces where lesions caused inaccuracies. Next, we measured the surface area of lesion overlap with seven canonical brain networks and the percent volume of each network affected by lesions. The lesion correction method revealed that cortical lesions in patients with TBI are preferentially located in the limbic and default mode networks (95.7% each), with the limbic network also having the largest average surface area (4.4+/-3.7%) and percent volume affected by lesions (12.7+/-9.7%). The method has the potential to improve the accuracy of cortical volumetric measurements and permit inclusion of patients with lesioned brains in MRI analyses. The method also provides new opportunities to elucidate network-based mechanisms of neurological deficits in patients with TBI. (C) 2020 The Author(s). Published by Elsevier B.V.	[Diamond, Bram R.; Frau-Pascual, Aina; Snider, Samuel B.; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Diamond, Bram R.; Frau-Pascual, Aina; Snider, Samuel B.; Edlow, Brian L.] Harvard Med Sch, Boston, MA 02115 USA; [Diamond, Bram R.; Frau-Pascual, Aina; Fischl, Bruce; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Mac Donald, Christine L.] Harvard Med Sch, Charlestown, MA USA; [Fischl, Bruce] MIT, Harvard MIT Hlth Sci & Technol, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA.; Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.	kristen.dams-oconnor@mountsinai.org		Frau-Pascual, Aina/0000-0001-6311-8426	National Institutes of Health/National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01 NS086625, RF1NS115268]; NIH Director's Office [DP2HD101400]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U24RR021382]; National Institute for Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896, R01EB006758, R01EB019956, R01EB023281]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG022381, R01AG008122, R01AG016495, U01AG006781, R21AG046657, P41RR014075, P50AG005136]; National Center for Alternative Medicine [RC1 AT005728-01]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R21NS109627, R01NS052585, 1R21NS072652, 1R01NS070963, R01NS083534, 5U01NS086625]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651, R01HD071664]; National Institute on Disability Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B040033]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10RR023401, S10RR019307, S10RR023043]; James S. McDonnell Foundation; Nancy and Buster Alvord Endowment; Rappaport Foundation; Tiny Blue Dot Foundation; University of Washington School of Medicine; Seton Brain Research Fund	We thank Cheuk Y. Tang, Ph.D. for assistance with acquisition of MRI data. The LETBI Project is supported by the National Institutes of Health/National Institute for Neurological Disorders and Stroke and National Institute of Child Health and Development (U01 NS086625 and RF1NS115268). This research was also supported by the NIH Director's Office (DP2HD101400), National Center for Research Resources (U24RR021382), the National Institute for Biomedical Imaging and Bioengineering (P41EB015896, R01EB006758, R01EB019956, R01EB023281), the National Institute on Aging (AG022381, R01AG008122, R01AG016495, R01AG008122, U01AG006781, R21AG046657, P41RR014075, P50AG005136), the National Center for Alternative Medicine (RC1 AT005728-01), the National Institute for Neurological Disorders and Stroke (K23NS094538, R21NS109627, R01NS052585, 1R21NS072652, 1R01NS070963, R01NS083534, 5U01NS086625), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K01HD074651, R01HD071664), and the National Institute on Disability Independent Living and Rehabilitation Research (H133B040033). This research also utilized resources provided by National Institutes of Health shared instrumentation grants S10RR023401, S10RR019307, and S10RR023043. Additional support for this project comes from the James S. McDonnell Foundation, the Nancy and Buster Alvord Endowment, the Rappaport Foundation, the Tiny Blue Dot Foundation, institutional funds from the University of Washington School of Medicine, and the Seton Brain Research Fund.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Despotovic I, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/450341; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Edlow BL, 2018, J NEUROTRAUM, V35, P1604, DOI 10.1089/neu.2017.5457; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fox MD, 2018, NEW ENGL J MED, V379, P2237, DOI 10.1056/NEJMra1706158; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hillary FG, 2009, BRAIN IMAGING BEHAV, V3, P111, DOI 10.1007/s11682-008-9053-0; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Ito KL, 2019, HUM BRAIN MAPP, V40, P4669, DOI 10.1002/hbm.24729; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kansagara D., 2013, COMPLICATIONS MILD T; Knight MJ, 2016, MAGN RESON MATER PHY, V29, P833, DOI 10.1007/s10334-016-0573-0; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Lindroth H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47294-2; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Santhanam P, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1161; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	36	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2215-0161		METHODSX	MethodsX		2020	7								100994	10.1016/j.mex.2020.100994			16	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	PS0YW	WOS:000607658900012	32760659	Green Submitted, Green Published, gold			2022-02-06	
J	Duan, LL				Duan, Leo L.			Latent Simplex Position Model: High Dimensional Multi-view Clustering with Uncertainty Quantification	JOURNAL OF MACHINE LEARNING RESEARCH			English	Article						Co-regularized Clustering; Consensus; PAC-Bayes; Random Cluster Graph; Variable Selection	SELECTION	High dimensional data often contain multiple facets, and several clustering patterns can co-exist under different variable subspaces, also known as the views. While multi-view clustering algorithms were proposed, the uncertainty quantification remains difficult - a particular challenge is in the high complexity of estimating the cluster assignment probability under each view, and sharing information among views. In this article, we propose an approximate Bayes approach - treating the similarity matrices generated over the views as rough first-stage estimates for the co-assignment probabilities; in its Kullback-Leibler neighborhood, we obtain a refined low-rank matrix, formed by the pairwise product of simplex coordinates. Interestingly, each simplex coordinate directly encodes the cluster assignment uncertainty. For multi-view clustering, we let each view draw a parameterization from a few candidates, leading to dimension reduction. With high model flexibility, the estimation can be efficiently carried out as a continuous optimization problem, hence enjoys gradient-based computation. The theory establishes the connection of this model to a random partition distribution under multiple views. Compared to single-view clustering approaches, substantially more interpretable results are obtained when clustering brains from a human traumatic brain injury study, using high-dimensional gene expression data.	[Duan, Leo L.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA		Duan, LL (corresponding author), Univ Florida, Dept Stat, Gainesville, FL 32611 USA.	LI.DUAN@UFL.EDU					[Anonymous], 2004, CS0411099 ARXIV; Arthur D, 2007, SOC IND APPL MATH, P1027, DOI DOI 10.1145/1283383.1283494; Blei DM, 2011, J MACH LEARN RES, V12, P2461; Dahl DB, 2017, J AM STAT ASSOC, V112, P721, DOI 10.1080/01621459.2016.1165103; Dilokthanakul N., 2016, ARXIV161102648; Duan Leo L, 2018, ARXIV181008537; El Moselhy TA, 2012, J COMPUT PHYS, V231, P7815, DOI 10.1016/j.jcp.2012.07.022; Fern XZ, 2003, P INT C MACH LEARN, V20, P186; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Ghahramani Z., 1996, TECH REP CRGTR 96 1; Guedj B., 2019, ARXIV190105353; Handcock MS, 2007, J ROY STAT SOC A STA, V170, P301, DOI 10.1111/j.1467-985X.2007.00471.x; Hennig C, 2004, ANN STAT, V32, P1313, DOI 10.1214/009053604000000571; Hoff PD, 2002, J AM STAT ASSOC, V97, P1090, DOI 10.1198/016214502388618906; Hoff PD, 2006, BAYESIAN ANAL, V1, P321, DOI 10.1214/06-BA111; Joshi S, 2016, MACH LEARN, V104, P411, DOI 10.1007/s10994-016-5543-2; Kingma Diederik P, 2014, INT C LEARN REPR, P3455; Kirk P, 2012, BIOINFORMATICS, V28, P3290, DOI 10.1093/bioinformatics/bts595; KUMAR D, 2011, P ADV NEUR INF PROC, P1413; Law MH., 2003, ADV NEURAL INF PROCE, Vvol. 15, P641; Li D, 2011, AISTATS, V15, P443; Lock EF, 2013, BIOINFORMATICS, V29, P2610, DOI 10.1093/bioinformatics/btt425; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Miller JW, 2019, J AM STAT ASSOC, V114, P1113, DOI 10.1080/01621459.2018.1469995; Miller JA, 2017, ELIFE, V6, DOI 10.7554/eLife.31126; Mo QX, 2018, BIOSTATISTICS, V19, P71, DOI 10.1093/biostatistics/kxx017; Niu D., 2010, P 27 INT C MACH LEAR, P831; Niu DL, 2014, IEEE T PATTERN ANAL, V36, P1340, DOI 10.1109/TPAMI.2013.180; Niu Donglin, 2012, P 15 INT C ART INT S, P814; Ohama Iku, 2017, ADV NEURAL INFORM PR, P397; Rasmussen CE, 2000, ADV NEUR IN, V12, P554; Recht B., 2008, ADV NEURAL INFORM PR, V20; Seldin Y, 2010, J MACH LEARN RES, V11, P3595; Tadesse MG, 2005, J AM STAT ASSOC, V100, P602, DOI 10.1198/016214504000001565; Tan A, 2016, NEUROIMAGE, V124, P350, DOI 10.1016/j.neuroimage.2015.08.050; Teh Y. W., 2005, ADV NEURAL INFORM PR, V17, P1385; Wade S, 2018, BAYESIAN ANAL, V13, P559, DOI 10.1214/17-BA1073; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Wu LF, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2506, DOI 10.1145/3219819.3220090; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Yue Guan, 2010, MULTICLUST WORKSH KN; Zelnik-Manor Lihi, 2005, ADV NEURAL INFORM PR, P1601; Zhou Mingyuan, 2014, P NIPS, P3455	43	3	3	0	5	MICROTOME PUBL	BROOKLINE	31 GIBBS ST, BROOKLINE, MA 02446 USA	1532-4435			J MACH LEARN RES	J. Mach. Learn. Res.		2020	21												25	Automation & Control Systems; Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Computer Science	KW1WQ	WOS:000520962000013					2022-02-06	
J	Fu, PF; Yuan, Q; Lv, K; Hu, J				Fu, Pengfei; Yuan, Qiang; Lv, Ke; Hu, Jin			First Intracranial Pressure Monitoring or First Operation: Which One Is Better?	WORLD NEUROSURGERY			English	Article						Cerebral contusion; Intracranial pressure monitoring; Propensity score matching; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MANAGEMENT; GUIDELINES; EPIDEMIOLOGY; PROGRESSION; MORTALITY; HEMATOMA	BACKGROUND: For patients with TBI, traditional methods such as clinical examination and imaging data are the primary references used for deciding whether to operate or not. Intracranial pressure (ICP) monitoring based on lateral ventricles or parenchymal pressure is a more direct reflection of ICP. However, the research on whether the outcome results of ICP monitoring are better than results based on clinical signs and imaging is sparse. Therefore, we compared treatment results for patients with TBI based on ICP monitoring and traditional methods. METHODS: This retrospective study included patients with TBI admitted to our collaborative hospitals between January 1, 2012, and December 31, 2013. All patients enrolled were divided into a traditional methods group and ICP monitoring group. Follow-up treatment was determined by ICP monitoring value or traditional methods in the 2 groups. Propensity matching scores were used to ensure that baseline characteristics of patients in the 2 groups were consistent. RESULTS: A significant association was found between the initial ICP value and neurologic deterioration (odds ratio 1.24; P < 0.001), and nonlinear correlation achieved the best fit (R-2 = 0.547). Both 6-month good recovery rate and favorable outcome rate were higher in the ICP monitoring group than the traditional methods group by propensity score analysis (P < 0.05). CONCLUSIONS: For patients with TBI with cerebral contusion volume >20 ml, both 6-month good recovery rate and favorable outcome rate were significantly higher in the ICP monitoring group than the traditional methods group.	[Fu, Pengfei; Yuan, Qiang; Lv, Ke; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	17317821354@163.com			Shanghai Municipal Science and Technology Commission project [16411955300, 18441903300]; Shanghai Municipal Commission of Health and Family Planning project [201801075]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC81601914]	This work was supported by the Shanghai Municipal Science and Technology Commission project (grant numbers 16411955300 and 18441903300), Shanghai Municipal Commission of Health and Family Planning project (grant number 201801075), and National Natural Science Foundation of China (grant number NSFC81601914).	Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Maas A, 2016, NEUROSURGERY, V78, P368; Marion DW, 2006, NEUROSURGERY, V58, P655; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Yuan Q, 2015, CRIT CARE MED, V43, P1405, DOI 10.1097/CCM.0000000000000965; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	31	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						E105	E114		10.1016/j.wneu.2019.08.166			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700014	31479786				2022-02-06	
J	Gardner, RC; Rivera, E; O'Grady, M; Doherty, C; Yaffe, K; Corrigan, JD; Bogner, J; Kramer, J; Wilson, F				Gardner, Raquel C.; Rivera, Ernesto; O'Grady, Megan; Doherty, Colin; Yaffe, Kristine; Corrigan, John D.; Bogner, Jennifer; Kramer, Joel; Wilson, Fiona			Screening for Lifetime History of Traumatic Brain Injury Among Older American and Irish Adults at Risk for Dementia: Development and Validation of a Web-Based Survey	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Clinical research; cognitive aging; reliability; screening; traumatic brain injury; validation	MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HEAD-INJURY; RELIABILITY; VALIDITY; CONSCIOUSNESS; ASSOCIATION; PREVALENCE; SAMPLE; AGE	Background: Traumatic brain injury (TBI) is an established risk factor for dementia but mechanisms are uncertain. Accurate TBI exposure classification is critical for cognitive aging research studies seeking to discover mechanisms and treatments of post-TBI dementia. Brief TBI screens, commonly used in epidemiological studies of cognitive aging, are insensitive, leading to exposure mis-classification. Comprehensive TBI interviews, while more sensitive, may be impractical. Objective: We aimed to develop and validate a scalable, self-administered, comprehensive, web-based, TBI exposure survey for use in international cognitive aging research. Methods: We adapted a gold-standard comprehensive TBI interview (the Ohio State University TBI Identification Method; OSU TBI-ID) into a self-administered web-based survey for older adults (Older Adult modification of the OSU TBI-ID; OA OSU TBI-ID). We assessed reliability of our web-based survey versus the gold-standard interview among 97 older adults with normal cognition and mild cognitive impairment (MCI). In addition, we assessed sensitivity of the National Alzheimer's Coordinating Center Uniform Data Set (NACC UDS) brief TBI screen versus the interview among 70 older adults with normal cognition. Results: Our OA OSU TBI-ID web-based survey had good to excellent reliability versus the interview (kappa 0.66-0.73; ICCs 0.68-0.81) even among the sub-set with MCI (kappa 0.74-0.88; ICCs 0.76-0.85), except for several age-at-injury variables. The NACC UDS brief TBI screen missed 50% of TBI exposures identified using the OSU TBI-ID interview. Conclusion: The OSU TBI-ID interview and web-based survey may facilitate more accurate TBI exposure classification in cognitive aging research thereby accelerating discovery of targetable mechanisms of post-TBI dementia.	[Gardner, Raquel C.; Rivera, Ernesto; Yaffe, Kristine; Kramer, Joel] Univ Calif San Francisco, Memory & Aging Ctr, Sandler Neurosci Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Gardner, Raquel C.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Gardner, Raquel C.; Yaffe, Kristine; Kramer, Joel] Univ Calif San Francisco, Sandler Neurosci Ctr, Global Brain Hlth Inst, San Francisco, CA 94143 USA; [O'Grady, Megan; Wilson, Fiona] Univ Dublin, Trinity Coll Dublin, Sch Med, Discipline Physiotherapy, Dublin, Ireland; [Doherty, Colin] Univ Dublin, Trinity Coll Dublin, Sch Med, Trinity Inst Neurosci TCIN, Dublin, Ireland; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Rivera, Ernesto] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA		Gardner, RC (corresponding author), San Francisco VA Med Ctr, 4150 Clement St Neurol 127, San Francisco, CA 94121 USA.	Raquel.Gardner@ucsf.edu	Wilson, Fiona/AAZ-1849-2020	Wilson, Fiona/0000-0002-0292-1087; Doherty, Colin/0000-0002-8869-8567	Global Brain Health Institute; American Federation for Aging Research; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS095755]; Larry L. Hillblom Foundation [2014-A-004-NET, 2018-A-006-NET]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0001]	This work was supported by the Global Brain Health Institute (to RCG and FW), The American Federation for Aging Research (to RCG), the National Institute for Neurological Disorders and Stroke (K23 NS095755 to RCG), and the Larry L. Hillblom Foundation (2014-A-004-NET and 2018-A-006-NET to JK). Dr. Corrigan's and Bogner's time was supported by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) to Ohio State University (90DPTB0001). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; Kesmodel US, 2018, ACTA OBSTET GYN SCAN, V97, P417, DOI 10.1111/aogs.13330; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Napoles-Springer AM, 2006, MED CARE, V44, pS21; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nguyen TP, 2018, J ALZHEIMERS DIS, V66, P717, DOI 10.3233/JAD-180586; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	37	3	3	2	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2020	74	2					699	711		10.3233/JAD-191138			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KX5VS	WOS:000521949300027	32065793	Green Accepted			2022-02-06	
J	Gozt, A; Licari, M; Halstrom, A; Milbourn, H; Lydiard, S; Black, A; Arendts, G; Macdonald, S; Song, S; MacDonald, E; Vlaskovsky, P; Burrows, S; Bynevelt, M; Pestell, C; Fatovich, D; Fitzgerald, M				Gozt, Aleksandra; Licari, Melissa; Halstrom, Alison; Milbourn, Hannah; Lydiard, Stephen; Black, Anna; Arendts, Glenn; Macdonald, Stephen; Song, Swithin; MacDonald, Ellen; Vlaskovsky, Philip; Burrows, Sally; Bynevelt, Michael; Pestell, Carmela; Fatovich, Daniel; Fitzgerald, Melinda			Towards the Development of an Integrative, Evidence-Based Suite of Indicators for the Prediction of Outcome Following Mild Traumatic Brain Injury: Results from a Pilot Study	BRAIN SCIENCES			English	Article						persistent post-concussion symptoms; blood-based biomarkers; neuropsychological assessment; MRI; prediction	POST-CONCUSSION SYMPTOMS; FIBRILLARY ACIDIC PROTEIN; EMERGENCY-DEPARTMENT ASSESSMENT; SERUM NEUROFILAMENT LIGHT; SPORT-RELATED CONCUSSION; NEURON-SPECIFIC ENOLASE; HEAD-INJURY; POSTCONCUSSION SYNDROME; HIGH-SCHOOL; COGNITIVE IMPAIRMENT	Background: Persisting post-concussion symptoms (PPCS) is a complex, multifaceted condition in which individuals continue to experience the symptoms of mild traumatic brain injury (mTBI; concussion) beyond the timeframe that it typically takes to recover. Currently, there is no way of knowing which individuals may develop this condition. Method: Patients presenting to a hospital emergency department (ED) within 48 h of sustaining a mTBI underwent neuropsychological assessment and demographic, injury-related information and blood samples were collected. Concentrations of blood-based biomarkers neuron specific enolase, neurofilament protein-light, and glial fibrillary acidic protein were assessed, and a subset of patients also underwent diffusion tensor-magnetic resonance imaging; both relative to healthy controls. Individuals were classified as having PPCS if they reported a score of 25 or higher on the Rivermead Postconcussion Symptoms Questionnaire at 28 days post-injury. Univariate exact logistic regression was performed to identify measures that may be predictive of PPCS. Neuroimaging data were examined for differences in fractional anisotropy (FA) and mean diffusivity in regions of interest. Results: Of n = 36 individuals, three (8.33%) were classified as having PPCS. Increased performance on the Repeatable Battery for the Assessment of Neuropsychological Status Update Total Score (OR = 0.81, 95% CI: 0.61-0.95, p = 0.004), Immediate Memory (OR = 0.79, 95% CI: 0.56-0.94, p = 0.001), and Attention (OR = 0.86, 95% CI: 0.71-0.97, p = 0.007) indices, as well as faster completion of the Trails Making Test B (OR = 1.06, 95% CI: 1.00-1.12, p = 0.032) at ED presentation were associated with a statistically significant decreased odds of an individual being classified as having PPCS. There was no significant association between blood-based biomarkers and PPCS in this small sample, although glial fibrillary acidic protein (GFAP) was significantly increased in individuals with mTBI relative to healthy controls. Furthermore, relative to healthy age and sex-matched controls (n = 8), individuals with mTBI (n = 14) had higher levels of FA within the left inferior frontal occipital fasciculus (t (18.06) = -3.01, p = 0.008). Conclusion: Performance on neuropsychological measures may be useful for predicting PPCS, but further investigation is required to elucidate the utility of this and other potential predictors.	[Gozt, Aleksandra; Black, Anna; Pestell, Carmela; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia; [Gozt, Aleksandra; Black, Anna; Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia; [Licari, Melissa] Telethon Kids Inst, Perth, WA 6005, Australia; [Halstrom, Alison; Milbourn, Hannah; Lydiard, Stephen; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Crawley, WA 6009, Australia; [Arendts, Glenn; Macdonald, Stephen; Fatovich, Daniel] Univ Western Australia, Emergency Med, Crawley, WA 6009, Australia; [Arendts, Glenn; Macdonald, Stephen; MacDonald, Ellen; Fatovich, Daniel] Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Nedlands, WA 6000, Australia; [Macdonald, Stephen; MacDonald, Ellen; Fatovich, Daniel] Royal Perth Hosp, Emergency Dept, Perth, WA 6000, Australia; [Song, Swithin] Royal Perth Hosp, Radiol Dept, Perth, WA 6000, Australia; [Vlaskovsky, Philip; Burrows, Sally] Univ Western Australia, Sch Med, Crawley, WA 6009, Australia; [Bynevelt, Michael] Univ Western Australia, Sch Surg, Crawley, WA 6009, Australia; [Bynevelt, Michael] Sir Charles Gardener Hosp, Neurol Intervent & Imaging Serv Western Australia, Nedlands, WA 6009, Australia; [Pestell, Carmela] Univ Western Australia, Sch Psychol Sci, Crawley, WA 6009, Australia		Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia.; Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia.; Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Crawley, WA 6009, Australia.	a.gozt@postgrad.curtin.edu.au; Melissa.Licari@telethonkids.org.au; allison.halstrom@uwa.edu.au; hm525@bath.ac.uk; stephen.lydiard@bath.edu; ab2458@bath.ac.uk; glenn.arendts@uwa.edu.au; Stephen.Macdonald@health.wa.gov.au; Swithin.Song@health.wa.gov.au; Ellen.MacDonald@health.wa.gov.au; philip.vlaskovsky@uwa.edu.au; sally.burrows@uwa.edu.au; Michael.Bynevelt@health.wa.gov.au; carmela.pestell@uwa.edu.au; Daniel.Fatovich@health.wa.gov.au; lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011; Fatovich, Daniel/J-5510-2013	Fitzgerald, Melinda/0000-0002-4823-8179; Licari, Melissa/0000-0003-3705-5323; Milbourn, Hannah/0000-0003-4479-8635; Pestell, Carmela/0000-0002-1737-7774; Fatovich, Daniel/0000-0001-9414-6905; Arendts, Glenn/0000-0001-7830-7756; Macdonald, Stephen/0000-0001-9921-4620	NHMRC CareerDevelopment FellowshipNational Health and Medical Research Council of Australia [APP1087114]; Perron Institute for Neurological and Translational Sciences Pump-Priming Grant; Neurotrauma Research ProgramW.A.; State Government ofWestern Australia through the Department of Health; RPH Research Foundation	M.F. has been supported by anNHMRC CareerDevelopment Fellowship (APP1087114) and a Perron Institute for Neurological and Translational Sciences Pump-Priming Grant. The funding for this research project was provided by the Neurotrauma Research ProgramW.A. and was funded by the State Government ofWestern Australia through the Department of Health. The funding for statistical support was provided by the RPH Research Foundation.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Andersson J., 2007, TR07JA2 FMRIB CTR; Andersson J.L., 2007, TR07JA1 FMRIB CTR OX; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Faul M., 2010, US DEP HLTH HUM SERV, V113, P399; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-139; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kirsch NL, 2010, ARCH PHYS MED REHAB, V91, P35, DOI 10.1016/j.apmr.2009.09.019; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Krogsrud SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195540; Lannsjo M, 2012, EUROPEAN J NEUROLOGY, V20, P124; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Makris N, 2007, NEUROIMAGE, V37, P1100, DOI 10.1016/j.neuroimage.2007.05.042; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mercier E, 2018, BRAIN INJURY, V32, P29, DOI 10.1080/02699052.2017.1385097; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Nelson LD, 2018, J NEUROTRAUM, V35, P249, DOI 10.1089/neu.2017.4988; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; NSW Institute of Trauma and Injury Management, 2011, MIN HLTH AD TRAUM CL; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pardini D, 2004, BRIT J SPORT MED, V38, P654; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C., 2012, REPEATABLE BATTERY A; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sullivan EV, 2010, NEUROPSYCHOLOGIA, V48, P4155, DOI 10.1016/j.neuropsychologia.2010.10.023; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Walsh M, 2011, BRAIN CONNECT, V1, P317, DOI 10.1089/brain.2011.0037; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	131	3	3	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2020	10	1							23	10.3390/brainsci10010023			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KL0NW	WOS:000513130500054	31906443	gold, Green Published			2022-02-06	
J	Gurney, JM; Loos, PE; Prins, M; Van Wyck, DW; McCafferty, RR; Marion, DW				Gurney, Jennifer M.; Loos, Paul E.; Prins, Mayumi; Van Wyck, David W.; McCafferty, Randall R.; Marion, Donald W.			The Prehospital Evaluation and Care of Moderate/Severe TBI in the Austere Environment	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				TRAUMATIC BRAIN-INJURY; ELECTRICAL-ACTIVITY; MANAGEMENT; BLOOD; PATHOPHYSIOLOGY; NEUROSURGERY; HEMATOMAS; MORTALITY; PRESSURE; SEIZURES	Increased resource constraints secondary to a smaller medical footprint, prolonged evacuation times, or overwhelming casualty volumes all increase the challenges of effective management of traumatic brain injury (TBI) in the austere environment. Prehospital providers are responsible for the battlefield recognition and initial management of TBI. As such, targeted education is critical to efficient injury recognition, promoting both provider readiness and improved patient outcomes. When austere conditions limit or prevent definitive treatment, a comprehensive understanding of TBI pathophysiology can help inform acute care and enhance prevention of secondary brain injury. Field deployable, noninvasive TBI assessment and monitoring devices are urgently needed and are currently undergoing clinical evaluation. Evidence shows that the assessment, monitoring, and treatment in the first few hours and days after injury should focus on the preservation of cerebral perfusion and oxygenation. For cases where medical management is inadequate (eg, evidence of an enlarging intracranial hematoma), guidelines have been developed for the performance of cranial surgery by nonneurosurgeons. TBI management in the austere environment will continue to be a challenge, but research focused on improving evidence-based monitoring and therapeutic interventions can help to mitigate some of these challenges and improve patient outcomes.	[Gurney, Jennifer M.] US Army, Joint Trauma Syst, Inst Surg Res, 3698 Chambers Pass, San Antonio, TX 78234 USA; [Loos, Paul E.] Off Strateg Warfare, Nonstand Med Detachment, 1st Special Forces Command, Ft Bragg, NC 28310 USA; [Prins, Mayumi] Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza Suite 532, Los Angeles, CA 90095 USA; [Van Wyck, David W.] 4-3 SFG A,Bldg Z-4157 South Post Rd, Ft Bragg, NC 28310 USA; [McCafferty, Randall R.] San Antonio Mil Med Ctr, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA; [Marion, Donald W.] Def & Vet Brain Injury Ctr, 1335 East West Hwy, Silver Spring, MD 20910 USA; [Marion, Donald W.] Gen Dynam Informat Technol, 1335 East West Hwy, Silver Spring, MD 20910 USA		Gurney, JM (corresponding author), US Army, Joint Trauma Syst, Inst Surg Res, 3698 Chambers Pass, San Antonio, TX 78234 USA.		Marion, Donald/AAR-5749-2021				[Anonymous], 2018, SYST JT EM LIF SAV C; [Anonymous], 2017, NEUROSURGERY SEVERE; Balanca B, 2017, J CEREBR BLOOD F MET, V37, P1670, DOI 10.1177/0271678X16657571; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Borden Institute, 2018, EMERGENCY WAR SURG; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bruce BB, 2014, J NEURO-OPHTHALMOL, V34, P288, DOI 10.1097/WNO.0000000000000153; Cap AP, 2018, MIL MED, V183, P44, DOI 10.1093/milmed/usy120; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; DeSoucy, 2017, J SPEC OPER MED, V17, P121; Fang Raymond, 2015, J Trauma Acute Care Surg, V79, pS181, DOI 10.1097/TA.0000000000000769; Ganslandt O, 2018, J NEUROSURG, V128, P1653, DOI 10.3171/2016.11.JNS152268; Giannou C., 2013, WAR SURG WORKING LTD, V2; Gilligan J, 2017, ANZ J SURG, V87, P80, DOI 10.1111/ans.13583; Hahn C, 2019, MIL MED, V184, P301, DOI 10.1093/milmed/usy392; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Jensen JL, 2010, CAN J EMERG MED, V12, P135; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Johnson VV, 2007, CURR OPIN HEMATOL, V14, P694, DOI 10.1097/MOH.0b013e3282ef477f; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Liang CY, 2018, MIL MED, V183, pE318, DOI 10.1093/milmed/usx088; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Marion D W, 1995, New Horiz, V3, P439; McCafferty RR, 2018, MIL MED, V183, P67, DOI 10.1093/milmed/usy071; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Rosenfeld JV, 2006, J CLIN NEUROSCI, V13, P986, DOI 10.1016/j.jocn.2005.11.013; Schwartzkroin PA, 2010, EPILEPSY RES, V92, P74, DOI 10.1016/j.eplepsyres.2010.08.009; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Smith S, 2019, WHO ATTENDS SPECIAL; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; SPRINGER MFB, 1988, AM J EMERG MED, V6, P640, DOI 10.1016/0735-6757(88)90110-6; SPURLING RG, 1947, JAMA-J AM MED ASSOC, V135, P473; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Torosyan N, 2018, EXP GERONTOL, V111, P118, DOI 10.1016/j.exger.2018.07.009; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	44	3	3	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			148	153		10.1093/milmed/usz361			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600023	32074372	Bronze			2022-02-06	
J	Hong, CT; Hsieh, YC; Liu, HY; Chiou, HY; Chien, LN				Hong, Chien-Tai; Hsieh, Yi-Chen; Liu, Hung-Yi; Chiou, Hung-Yi; Chien, Li-Nien			Association Between Anemia and Dementia: A Nationwide, Population-based Cohort Study in Taiwan	CURRENT ALZHEIMER RESEARCH			English	Article						Dementia; anemia; population-based cohort study; competing risk analysis; subdistribution hazard ratio; apolipoprotein E4 (ApoE4)	RISK-FACTORS; DISEASE; MODEL	Background: In addition to the traditional risk predictors, whether anemia is an early biomarker of dementia, needs to be confirmed. Objective: This population-based cohort study aimed to investigate the dementia risk in patients with newly diagnosed anemia using data from the Taiwan National Health Insurance Research Database. Methods: All newly diagnosed anemia patients (n = 26,343) with no history of stroke hospitalization, central nervous disease other than dementia, psychiatric disorders, traumatic brain injury, major operations, or blood loss diseases, were enrolled. A group of non-anemic controls, 1:4 matched with anemic patients on the basis of demographics and comorbidities, was also included. A competing risk analysis was used to evaluate the dementia risk in anemic patients compared to that of their matched controls. Results: The adjusted subdistribution hazard ratio (SHR) of dementia risk in anemic patients was 1.14 (95% confidence interval [CI]: 1.08 similar to 1.21, p<0.001). Patients with iron supplements tended to exhibit a lower dementia risk (adjusted SHR: 0.84; 95% CI: 0.750.94, p=0.002) compared to patients without iron supplement. A subgroup analysis showed that a positive association between dementia and anemia existed in females, those aged 70 years and older, and patients without hypertension, diabetes, or hyperlipidemia. Conclusion: The present population-based cohort study identified that newly diagnosed anemia is a risk factor for dementia and also that iron supplementation was able to reduce the risk of dementia in people with iron deficiency anemia.	[Hong, Chien-Tai] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Hong, Chien-Tai] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Hsieh, Yi-Chen] Taipei Med Univ, Coll Med Sci & Technol, Taipei, Taiwan; [Hsieh, Yi-Chen] Taipei Med Univ, Coll Pharm, Biotechnol Res & Dev, Taipei, Taiwan; [Hsieh, Yi-Chen; Chiou, Hung-Yi] Taipei Med Univ, Dept Appl Mol Epidemiol, Coll Publ Hlth, Taipei, Taiwan; [Liu, Hung-Yi] Taipei Med Univ, Coll Publ Hlth, Hlth & Clin Res Data Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan; [Chien, Li-Nien] Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan		Chien, LN (corresponding author), Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan.; Chien, LN (corresponding author), 250 Wuxing St, Taipei 11031, Taiwan.	lnchien@tmu.edu.tw			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 105-2314B-038-021]	This study was supported by a grant (MOST 105-2314B-038-021) from the Ministry of Science and Technology, Taiwan.	Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Bissinger R, 2019, FEBS J, V286, P826, DOI 10.1111/febs.14606; Carmel R, 2001, BLOOD REV, V15, P9, DOI 10.1054/blre.2001.0146; Cevik B, 2017, ADV CLIN EXP MED, V26, P23, DOI 10.17219/acem/61044; Chen JH, 2009, J FORMOS MED ASSOC, V108, P754, DOI 10.1016/S0929-6646(09)60402-2; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiang CJ, 2007, AM J GERIAT PSYCHIAT, V15, P762, DOI 10.1097/JGP.0b013e318050c98f; Chilcot J, 2018, ANN BEHAV MED, V52, P1, DOI 10.1007/s12160-017-9918-9; Chung SD, 2014, J NEUROL SCI, V346, P90, DOI 10.1016/j.jns.2014.07.062; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dyer SM, 2018, INT PSYCHOGERIATR, V30, P295, DOI 10.1017/S1041610217002344; Hong CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep29651; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jeong SM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0322-2; Johnson SR, 2018, RHEUM DIS CLIN N AM, V44, P203, DOI 10.1016/j.rdc.2018.01.002; Lin TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186475; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; McAfee AT, 2006, PHARMACOEPIDEMIOL DR, V15, P444; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Nakabeppu Y, 2004, FREE RADICAL RES, V38, P423, DOI 10.1080/10715760410001688348; Prada-Ramallal G, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0695-y; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Morris MS, 2007, AM J CLIN NUTR, V85, P193, DOI 10.1093/ajcn/85.1.193; Savica R, 2009, NEUROLOGY, V73, P1381, DOI 10.1212/WNL.0b013e3181bd80c1; SMITH JA, 1995, SPORTS MED, V19, P9, DOI 10.2165/00007256-199519010-00002; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315	33	3	3	1	7	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050	1875-5828		CURR ALZHEIMER RES	Curr. Alzheimer Res.		2020	17	2					196	204		10.2174/1567205017666200317101516			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LI9NJ	WOS:000529802800009	32183675				2022-02-06	
J	Huser, M; Kundig, A; Karlen, W; De Luca, V; Jaggi, M				Hueser, Matthias; Kuendig, Adrian; Karlen, Walter; De Luca, Valeria; Jaggi, Martin			Forecasting intracranial hypertension using multi-scale waveform metrics	PHYSIOLOGICAL MEASUREMENT			English	Article						cerebral auto-regulation indices; intracranial hypertension; intracranial pressure; machine learning; ICP pulse morphology	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; CEREBRAL PERFUSION-PRESSURE; SECONDARY INSULTS; SERUM BIOMARKERS; REACTIVITY; MANAGEMENT; OUTCOMES; PATHOPHYSIOLOGY; AUTOREGULATION	Objective: Acute intracranial hypertension is an important risk factor of secondary brain damage after traumatic brain injury. Hypertensive episodes are often diagnosed reactively, leading to late detection and lost time for intervention planning. A pro-active approach that predicts critical events several hours ahead of time could assist in directing attention to patients at risk. Approach: We developed a prediction framework that forecasts onsets of acute intracranial hypertension in the next 8 h. It jointly uses cerebral auto-regulation indices, spectral energies and morphological pulse metrics to describe the neurological state of the patient. One-minute base windows were compressed by computing signal metrics, and then stored in a multi-scale history, from which physiological features were derived. Main results: Our model predicted events up to 8 h in advance with an alarm recall rate of 90% at a precision of 30% in the MIMIC-III waveform database, improving upon two baselines from the literature. We found that features derived from high-frequency waveforms substantially improved the prediction performance over simple statistical summaries of low-frequency time series, and each of the three feature classes contributed to the performance gain. The inclusion of long-term history up to 8 h was especially important. Significance: Our results highlight the importance of information contained in high-frequency waveforms in the neurological intensive care unit. They could motivate future studies on pre-hypertensive patterns and the design of new alarm algorithms for critical events in the injured brain.	[Hueser, Matthias] Swiss Fed Inst Technol, Dept Comp Sci, Inst Machine Learning, Biomed Informat Grp, CH-8092 Zurich, Switzerland; [Kuendig, Adrian] Swiss Fed Inst Technol, Dept Comp Sci, CH-8092 Zurich, Switzerland; [Karlen, Walter] Swiss Fed Inst Technol, Mobile Hlth Syst Lab, Inst Robot & Intelligent Syst, Dept Hlth Sci & Technol, CH-8092 Zurich, Switzerland; [De Luca, Valeria] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Jaggi, Martin] Ecole Polytech Fed Lausanne, Machine Learning & Optimizat Lab, Sch Comp & Commun Sci, CH-1015 Lausanne, Switzerland		Huser, M (corresponding author), Swiss Fed Inst Technol, Dept Comp Sci, Inst Machine Learning, Biomed Informat Grp, CH-8092 Zurich, Switzerland.	matthias.hueser@inf.ethz.ch	Karlen, Walter/AAN-9397-2020	Karlen, Walter/0000-0001-8643-3074; Jaggi, Martin/0000-0003-1579-5558	Gebert-Ruf Stiftung, Switzerland [GRS-025/14]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [150640]; 'Novel Machine Learning Approaches for Data from the Intensive Care Unit' of the Swiss National Science Foundation [205321_176005]	This work was supported by the Gebert-Ruf Stiftung, Switzerland, under Grant agreement GRS-025/14 and the Swiss National Science Foundation, under Grant agreement 150640. MH was partially funded by the Grant No. 205321_176005 'Novel Machine Learning Approaches for Data from the Intensive Care Unit' of the Swiss National Science Foundation (to Gunnar Ratsch). We acknowledge Emanuela Keller, head of the Neurocritical Care Unit at the University Hospital Zurich, Switzerland, for providing indispensible clinical insights and motivation for this work. MH gratefully acknowledges helpful discussions with Panagiotis Farantatos, Viktor Gal, Stephanie Hyland, Xinrui Lyu, Ngoc M Pham and Gunnar Ratsch.	Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Almeida VG, 2013, J PERS MED, V3, P82, DOI 10.3390/jpm3020082; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bardt TF, 1998, ACT NEUR S, V71, P153; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bonds BW, 2015, BRAIN INJURY, V29, P1642, DOI 10.3109/02699052.2015.1075157; Bonds BW, 2015, J TRAUMA ACUTE CARE, V79, P85, DOI 10.1097/TA.0000000000000698; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chambrin MC, 1999, INTENS CARE MED, V25, P1360, DOI 10.1007/s001340051082; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; De Luca V, 2016, 16 INT S INTR PRESS; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Esteller R, 2001, P ANN INT IEEE EMBS, V23, P1707, DOI 10.1109/IEMBS.2001.1020545; Fan JY, 2010, BIOL RES NURS, V11, P317, DOI 10.1177/1099800409349164; Guiza Fabian, 2017, Crit Care Med, V45, pe316, DOI 10.1097/CCM.0000000000002080; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hu X, 2008, PHYSIOL MEAS, V29, P459, DOI 10.1088/0967-3334/29/4/004; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Huser M, 2015, VAS 2015 13 INT C NE; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Kim N, 2016, J CLIN MONIT COMPUT, V30, P821, DOI 10.1007/s10877-015-9779-3; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; Liu, 2017, ADV NEURAL INFORM PR, V30, P3146, DOI DOI 10.5555/3294996.3295074; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Lundberg S.M., 2017, P 31 INT C NEUR INF, P4768; Lundberg S. M., 2018, ARXIV PREPRINT ARXIV; Majdan M, 2014, MINERVA ANESTESIOL, V80, P1261; Marik P, 1999, J EMERG MED, V17, P711, DOI 10.1016/S0736-4679(99)00055-4; McNames J, 2001, P ANN INT IEEE EMBS, V23, P3977, DOI 10.1109/IEMBS.2001.1019715; McNames J, 2002, 4 INT WORKSH BIOS IN, P303; Myers RB, 2016, CRIT CARE MED, V44, P1754, DOI 10.1097/CCM.0000000000001838; NARAEI P, 2017, CAN CON EL COMP EN, P1, DOI DOI 10.1109/CCECE.2017.7946641; Naraei P, 2017, PROCEEDINGS OF THE 2017 INTELLIGENT SYSTEMS CONFERENCE (INTELLISYS), P395, DOI 10.1109/IntelliSys.2017.8324324; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Pace J, 2018, J TRAUMA ACUTE CARE, V85, P380, DOI 10.1097/TA.0000000000001965; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Quachtran B, 2016, INT C PATT RECOG, P2491, DOI 10.1109/ICPR.2016.7900010; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Scalzo F, 2013, IEEE T BIO-MED ENG, V60, P235, DOI 10.1109/TBME.2012.2210042; Scalzo F, 2012, MED ENG PHYS, V34, P1058, DOI 10.1016/j.medengphy.2011.11.010; Scalzo F, 2012, IEEE PULSE, V3, P49, DOI 10.1109/MPUL.2011.2181024; Shieh JS, 2004, NEUROCOMPUTING, V57, P239, DOI 10.1016/j.neucom.2003.10.006; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Wang J, 2013, BIOMED SIGNAL PROCES, V8, P634, DOI 10.1016/j.bspc.2013.06.004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu P, 2013, COMPUT BIOL MED, V43, P425, DOI 10.1016/j.compbiomed.2013.01.022; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zhang F, 2012, INT C PATT RECOG, P37; Zhang F, 2011, IEEE ENG MED BIO, P7111, DOI 10.1109/IEMBS.2011.6091797; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Ziai WC, 2019, CRIT CARE MED, V47, P1125, DOI 10.1097/CCM.0000000000003848; Zong W, 2003, COMPUT CARDIOL, V30, P259, DOI 10.1109/CIC.2003.1291140	72	3	4	1	8	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	JAN	2020	41	1							014001	10.1088/1361-6579/ab6360			17	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	KN1YF	WOS:000514636300001	31851948	Green Submitted			2022-02-06	
J	Jadischke, R; Zendler, J; Lovis, E; Elliott, A; Goulet, GC				Jadischke, Ron; Zendler, Jessica; Lovis, Erik; Elliott, Andrew; Goulet, Grant C.			Quantitative and qualitative analysis of head and body impacts in American 7v7 non-tackle football	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						football; head; injury; biomechanics; protection	YOUTH FOOTBALL; INJURIES; EXPOSURE; PLAYERS; CONCUSSION; JUNIOR; RECONSTRUCTION; EPIDEMIOLOGY; MECHANISMS; SPORTS	ObjectivesNon-tackle American football is growing in popularity, and it has been proposed as a safer alternative for young athletes interested in American football. Little is known about the nature of head contact in the sport, which is necessary to inform the extent to which protective headgear is warranted. The objective of this study was to identify the location, types and frequency of head and body contacts in competitive 7v7 non-tackle American football.MethodsVideo analysis was used to document the type, frequency and mechanism of contacts across a series of under 12, under 14 and high school non-tackle tournament games. A subset of impacts was quantitatively analysed via 3-D model-based image matching to calculate the preimpact and postimpact speed of players' heads and the change in resultant translational and rotational velocities.ResultsThe incidence rate of head contact was found to be low (3.5 contacts per 1000 athlete-plays). Seventy-five per cent of head contacts were caused by a head-to-ground impact. No head-to-head contacts were identified. Most contacts occurred to the rear upper (occiput) or side upper (temporal/parietal) regions. Head-to-ground impact was associated with a maximum preimpact velocity of 5.92.2 m/s and a change in velocity of 3.0 +/- 1.1 m/s.ConclusionNon-tackle football appears to represent a lower contact alternative to tackle football. The distribution of head impact locations, mechanisms and energies found in the present study is different than what has been previously reported for tackle football. The existing tackle football standards are not appropriate to be applied to the sport of non-tackle football, and sport-specific head protection and headgear certification standards must be determined.	[Jadischke, Ron; Zendler, Jessica; Lovis, Erik; Elliott, Andrew; Goulet, Grant C.] Xenith, Detroit, MI 48209 USA; [Zendler, Jessica] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Zendler, J (corresponding author), Xenith, Detroit, MI 48209 USA.; Zendler, J (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.	jzendler@xenith.com		Zendler, Jessica/0000-0003-4295-9917	Xenith	The study was funded by Xenith, a manufacturer of helmets, gear and apparel for American football and related sports.	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Bailey A, 2020, SPORT BIOMECH, V19, P678, DOI 10.1080/14763141.2018.1513059; Barber Foss K, 2018, JSMAHS, V4, P1, DOI DOI 10.25035/JSMAHS.04.01.05; Barden C, 2018, J ATHL TRAINING, V53, P514, DOI 10.4085/1062-6050-311-16; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Burnham BR, 2010, AM J PREV MED, V38, pS141, DOI 10.1016/j.amepre.2009.10.010; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Fuller CW, 2018, J SPORT SCI, V36, P1776, DOI 10.1080/02640414.2017.1418193; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hecimovich M, 2018, J SPORT SCI MED, V17, P547; Hecimovich Mark, 2018, J Sports Med (Hindawi Publ Corp), V2018, P8376030, DOI 10.1155/2018/8376030; Hisaka LI, 1976, P I MECH ENG P-J SPO, V3, P296; Jadischke R, 2019, P IRCOBI C FLOR, P615; Kaplan Y, 2013, CLIN J SPORT MED, V23, P39, DOI 10.1097/JSM.0b013e3182694870; Kent R, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109551; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; KRAUS JF, 1969, AM J PUBLIC HEALTH N, V59, P2144, DOI 10.2105/AJPH.59.12.2144; KRAUS JF, 1970, AM J PUBLIC HEALTH N, V60, P903, DOI 10.2105/AJPH.60.5.903; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Leung FT, 2017, J SPORT SCI, V35, P2088, DOI 10.1080/02640414.2016.1255771; Leung FT, 2017, J SCI MED SPORT, V20, P740, DOI 10.1016/j.jsams.2017.03.006; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; McCarroll John R, 1980, Phys Sportsmed, V8, P93, DOI 10.1080/00913847.1980.11948637; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Patton DA, 2016, P I MECH ENG P-J SPO, V230, P29, DOI 10.1177/1754337115615482; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Sewry N, 2019, J SCI MED SPORT, V22, P54, DOI 10.1016/j.jsams.2018.06.007; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; The Aspen Institute, 2018, WHAT FLAG BEC STAND; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Urban JE, 2019, J NEUROTRAUM, V36, P275, DOI 10.1089/neu.2018.5699; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Whyte T, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043140; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	53	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000638	10.1136/bmjsem-2019-000638			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF6UO	WOS:000599187100001	32095268	gold, Green Published			2022-02-06	
J	Jamous, MA				Jamous, Mohammad Ahmad			The Safety of Early Thromboembolic Prophylaxis in Closed Traumatic Intracranial Hemorrhage	OPEN ACCESS EMERGENCY MEDICINE			English	Article						head injury; traumatic brain injury; intracranial hemorrhage; DVT prophylaxis; enoxaparin; pharmacologic thrombosis prophylaxis	MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; BRAIN-INJURY; PULMONARY-EMBOLISM; COMPLICATIONS; PREVENTION; THERAPY; EDEMA	Background: Venous thromboembolism (VTE) is a major cause of morbidity and mortality in patients with traumatic brain injury (TBI); this study is testing the safety of enoxaparin use for the prevention of venous thromboembolism in this group of patients. Patients and Methods: From January 2016 to May 2018, 46 patients (36 males, 10 females) with closed traumatic intracranial bleeding received early (ie, within 72 hours) venous thromboembolic prophylaxis with 40 mg of enoxaparin. Patients with traumatic intracranial hemorrhage were followed up both clinically and with repeated brain computed tomography to examine the safety of enoxaparin VTE prophylaxis. Results: The age of the patients ranged from 16-91 years (43.9 +/- 25.8 years). Glasgow coma score ranged from 5-15 (9.9 +/- 4.7). Twenty patients had mild TBI (GCS 15-13), 17 patients had moderate TBI (GCS 12-9), and nine patients had severe TBI (GCS <= 8). Brain computed tomography showed variable types of brain injuries. Non-surgical management was applied for 18 patients. Craniotomy and surgical evacuation of significant (>= 1cm in maximum diameter) EDH and/or SDH was carried out in 26 patients. External ventricular drain was inserted in two patients with significant IVH. Thirty-eight patients had good overall outcome, eight patients showed poor outcome. None of the reviewed patients developed clinical deterioration and/or progression of the intracranial bleeding on follow-up brain CT scans. Conclusion: Enoxaparin is a safe prophylaxis against venous thromboembolism in patients with traumatic closed intracranial bleeding.	[Jamous, Mohammad Ahmad] Jordan Univ Sci & Technol, King Abdulla Univ Hosp, Fac Med, Dept Neurosurg, POB 3030, Irbid, Jordan		Jamous, MA (corresponding author), Jordan Univ Sci & Technol, King Abdulla Univ Hosp, Fac Med, Dept Neurosurg, POB 3030, Irbid, Jordan.	mojamous@yahoo.com					Algattas H, 2015, WORLD NEUROSURG, V84, P1372, DOI 10.1016/j.wneu.2015.06.033; Baharvahdat Humain, 2019, Surg Neurol Int, V10, P10, DOI 10.4103/sni.sni_112_18; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Chazova IE, 2004, TERAPEVT ARKH, V76, P74; Cote LP, 2014, CLIN APPL THROMB-HEM, V20, P772, DOI 10.1177/1076029614532008; Couldwell WT., 2004, NEUROSURG FOCUS, V17, P1, DOI [10.3171/foc.2004.17.4.1, DOI 10.3171/F0C.2004.17.4.1]; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Ianosi B, 2019, EUR J NEUROL, V26, P333, DOI 10.1111/ene.13830; Khaldi A, 2011, J NEUROSURG, V114, P40, DOI 10.3171/2010.8.JNS10332; Kimmell KT, 2015, J NEUROSURG, V122, P1004, DOI 10.3171/2014.10.JNS14632; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Menaker J, 2007, J TRAUMA, V63, P620, DOI 10.1097/TA.0b013e31812f60aa; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Selby R, 2009, THROMB RES, V124, P281, DOI 10.1016/j.thromres.2008.10.002; Wu TC, 2011, STROKE, V42, P705, DOI 10.1161/STROKEAHA.110.600593; 2019, INNOV HIGH EDUC TEAC, V16, P1	24	3	3	2	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1500			OPEN ACCESS EMERG M	Open Access Emerg. Med.		2020	12						81	85		10.2147/OAEM.S239881			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	LE4EC	WOS:000526671500001	32341664	Green Published, gold			2022-02-06	
J	Justin, GA; Turnage, WA; Brooks, DI; Davies, BW; Ryan, DS; Eiseman, AS; Weichel, ED; Colyer, MH				Justin, Grant A.; Turnage, Winston A.; Brooks, Daniel I.; Davies, Brett W.; Ryan, Denise S.; Eiseman, Andrew S.; Weichel, Eric D.; Colyer, Marcus H.			Orbital Fractures and Associated Ocular Injuries in Operation Iraqi Freedom and Operation Enduring Freedom Referred to a Tertiary Care Military Hospital and the Effect on Final Visual Acuity	OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							BLOW-OUT FRACTURES; TRAUMA; MANAGEMENT; EPIDEMIOLOGY; SYSTEM; RISK	Orbital fractures occur commonly during combat trauma and a significant number are legally blind despite appropriate treatment. Purpose: To update the incidence of orbital fractures in U.S. Soldiers admitted to the former Walter Reed Army Medical Center from 2001 to 2011 after sustaining combat injuries in Operation Iraqi Freedom and Operation Enduring Freedom. Methods: Data were collected in the Walter Reed Ocular Trauma Database. Inclusion criteria were any U.S. Soldier or Department of Defense civilian with an orbital fracture injured in Operation Iraqi Freedom/Operation Enduring Freedom. Primary outcome measures were final visual acuity and the effect of orbital fracture, number of fractures, and anatomic location of fracture on final visual acuity. Results: Eight-hundred ninety eye injuries occurred in 652 patients evacuated to Walter Reed Army Medical Center between 2001 and 2011. Orbital fractures occurred in 304 eyes (34.2%). A single wall was fractured in 140 eyes (46.05%), 2 in 99 (32.6%) eyes, 3 in 31 (10.2%), 4 in 28 (9.2%), and unknown in 6 (1.9%) eyes. Roof fractures were found in 74 (24.34%), medial wall in 135 (44.41%), lateral wall in 109 (35.9%), and floor fractures in 217 (71.4%). Final visual acuity was analyzed and 140 (46.05%) eyes had greater than 20/40 vision, 17 (5.59%) were 20/50 to 20/200, 26 (8.5%) were count fingers to light perception, and 95 (31.3%) were no light perception. In logistic regression analysis, roof (p = 0.001), medial (p = 0.009), and lateral fractures (p = 0.016) were significantly associated with final visual acuity less than 20/200, while floor fractures were not (p = 0.874). Orbital fracture and all fracture subtypes were significantly associated with traumatic brain injury, retrobulbar hematoma, optic nerve injury, but not for vitreous hemorrhage, commotio, hyphema, and choroidal rupture. Fracture repair was noted in 45 (14.8%). Conclusions: Orbital fractures occurred in a third of Operation Iraqi Freedom/Operation Enduring Freedom eyes of ocular trauma patients referred to one tertiary care military hospital. This resulted in approximately 40% of these eyes remaining legally blind after injury.	[Justin, Grant A.] Brooke Army Med Ctr, Dept Ophthalmol, San Antonio, TX 78234 USA; [Justin, Grant A.; Davies, Brett W.; Colyer, Marcus H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Turnage, Winston A.] 206th Mil Intelligence Battal, Ft Hood, TX USA; [Brooks, Daniel I.] Walter Reed Natl Mil Med Ctr, Dept Res Programs, Bethesda, MD USA; [Davies, Brett W.] Wilford Hall Eye Ctr, Dept Ophthalmol, San Antonio, TX USA; [Ryan, Denise S.] Warfighter Refract Eye Surg Program & Res Ctr, Ft Belvoir, VA USA; [Eiseman, Andrew S.] Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Weichel, Eric D.] Retina Grp Washington DC, Greenbelt, MD USA; [Colyer, Marcus H.] Walter Reed Natl Mil Med Ctr, Dept Ophthalmol, Bethesda, MD USA		Justin, GA (corresponding author), Brooke Army Med Ctr, Dept Ophthalmol, San Antonio, TX 78234 USA.	grant.a.justin@gmail.com	Justin, Grant/AAJ-9830-2020	, Grant/0000-0001-6084-6399	Office of the Assistant Secretary of Defense for Health Affairs under the Broad Agency Announcement for Extramural Medical Research [BAA-16-R-BAA1, W81XWH-17-2-0007]	Supported by the Office of the Assistant Secretary of Defense for Health Affairs under the Broad Agency Announcement for Extramural Medical Research, BAA-16-R-BAA1under Award Number W81XWH-17-2-0007.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Andrews BT, 2016, LARYNGOSCOPE, V126, pS5, DOI 10.1002/lary.25805; Cabalag MS, 2014, J PLAST RECONSTR AES, V67, P183, DOI 10.1016/j.bjps.2013.10.022; Dubois L, 2015, INT J ORAL MAX SURG, V44, P433, DOI 10.1016/j.ijom.2014.12.003; Fox J., 2019, R COMPANION APPL REG, V3 rd; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Harris GJ, 2006, EYE, V20, P1207, DOI 10.1038/sj.eye.6702384; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; Jacobs SM, 2018, OPHTHALMOLOGY, V125, P1100, DOI 10.1016/j.ophtha.2018.01.030; Jamal BT, 2009, J ORAL MAXIL SURG, V67, P986, DOI 10.1016/j.joms.2008.12.035; Kim YS, 2015, J CRANIOFAC SURG, V26, P1581, DOI 10.1097/SCS.0000000000001860; Kittle CP, 2012, J CRANIOFAC SURG, V23, P1587, DOI 10.1097/SCS.0b013e318256514a; Ko MJ, 2013, OPHTHAL PLAST RECONS, V29, P298, DOI 10.1097/IOP.0b013e318295f91d; Kuhn F, 2004, J FR OPHTALMOL, V27, P206, DOI 10.1016/S0181-5512(04)96122-0; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P139, DOI 10.1016/S0896-1549(02)00004-4; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P163, DOI 10.1016/S0896-1549(02)00007-X; Lanigan A, 2017, OTOLARYNG HEAD NECK, V157, P602, DOI 10.1177/0194599817725713; Layton CJ, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/412397; Magarakis M, 2012, PLAST RECONSTR SURG, V129, P227, DOI 10.1097/PRS.0b013e3182362a6d; Malik AH, 2017, J MAXILLOFAC ORAL SU, V16, P243, DOI 10.1007/s12663-016-0907-5; Mellema PA, 2009, OPHTHAL PLAST RECONS, V25, P306, DOI 10.1097/IOP.0b013e3181aa9a73; Pieramici DJ, 1997, AM J OPHTHALMOL, V123, P820, DOI 10.1016/S0002-9394(14)71132-8; PUTTERMAN AM, 1974, AM J OPHTHALMOL, V77, P232, DOI 10.1016/0002-9394(74)90679-5; Richards NQ, 2015, J CRANIOFAC SURG, V26, P1668, DOI 10.1097/SCS.0000000000001743; SMITH B, 1957, AM J OPHTHALMOL, V44, P734; Tahim AS, 2013, EMERG MED J, V30, P949, DOI 10.1136/emermed-2012-201301; Thach AB, 2008, OPHTHALMOLOGY, V115, P377, DOI 10.1016/j.ophtha.2007.04.032; Thurston TE, 2018, J CRANIOFAC SURG, V29, P943, DOI 10.1097/SCS.0000000000004412; Vlasov Anton, 2015, J Trauma Acute Care Surg, V79, pS210, DOI 10.1097/TA.0000000000000666; Ward TP, 2007, OPHTHALMOL TIMES, V32, P8; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Young SM, 2018, OPHTHALMOLOGY, V125, P938, DOI 10.1016/j.ophtha.2017.12.015	33	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0740-9303	1537-2677		OPHTHAL PLAST RECONS	Ophthalmic Plast. Reconstr. Surg.	JAN-FEB	2020	36	1					55	60		10.1097/IOP.0000000000001461			6	Ophthalmology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology; Surgery	KF8ZK	WOS:000509525600026	31567916				2022-02-06	
J	Kim, M; Lee, U				Kim, MinKyung; Lee, UnCheol			Alpha oscillation, criticality, and responsiveness in complex brain networks	NETWORK NEUROSCIENCE			English	Article						Alpha oscillation; Criticality; Responsiveness; Brain network; Coupled oscillator; Periodic perception	PHASE; EXCITABILITY; PERCEPTION; ATTENTION; DYNAMICS; RHYTHM; TMS	Brains in unconsciousness are characterized by significantly limited responsiveness to stimuli. Even during conscious wakefulness, responsiveness is highly dependent on ongoing brain activity, specifically, of alpha oscillations (similar to 10 Hz). We hypothesized that the variety of brain responses to external stimuli result from the interaction between state-specific and transient alpha oscillations and stimuli. To justify this hypothesis, we simulated various alpha oscillations in the human brain network, modulating criticality (a balanced state between order and disorder), and investigated specific alpha oscillation properties (instantaneous amplitude, phase, and global synchronization) that induce a large or small response. As a result, we found that the alpha oscillations near a critical state show a more complex and long-lasting response, which is more prominent when stimuli are given to globally desynchronized and low-amplitude oscillations. We also found specific phases of alpha oscillation that barely respond to stimuli, which implies the presence of temporal windows in the alpha cycle for a large or small response. The results explain why brain responses are so variable across conscious and unconscious states and across time windows even during conscious wakefulness, and emphasize the importance of considering ongoing alpha oscillations for effective brain stimulation. AUTHOR SUMMARY Responsiveness of the brain varies depending on the brain states (wakefulness, sleep, anesthesia, and traumatic injuries) and even during wakefulness, resulting in various responses to the same stimulus. What makes those different responses across brain states and even across time windows in conscious state? What is an effective way to obtain the largest response to external stimulus? To answer those questions, we simulated various alpha oscillations (similar to 10 Hz) in a large-scale brain network and found state-specific alpha oscillation properties that show large or small responsiveness. Notably, the results suggest the presence of temporal windows in alpha cycle that inhibit external information integration and emphasize considering the large/small responsiveness conditions for effective brain stimulation.	[Kim, MinKyung; Lee, UnCheol] Univ Michigan, Dept Anesthesiol, Sch Med, Ann Arbor, MI 48109 USA; [Kim, MinKyung; Lee, UnCheol] Univ Michigan, Sch Med, Ctr Consciousness Sci, Ann Arbor, MI 48109 USA		Lee, U (corresponding author), Univ Michigan, Dept Anesthesiol, Sch Med, Ann Arbor, MI 48109 USA.; Lee, U (corresponding author), Univ Michigan, Sch Med, Ctr Consciousness Sci, Ann Arbor, MI 48109 USA.	uclee@umich.edu		Kim, MinKyung/0000-0002-7050-2511	Foundation for the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 GM098578]	Uncheol Lee, Foundation for the National Institutes of Health (http://dx.doi.org/10.13039/100000009), Award ID: R01 GM098578.	Benedetto A, 2018, EUR J NEUROSCI, V48, P2599, DOI 10.1111/ejn.13791; Bruers S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00279; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; CALLAWAY E, 1960, J GEN PSYCHOL, V62, P293, DOI 10.1080/00221309.1960.9920419; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Cecere R, 2015, CURR BIOL, V25, P231, DOI 10.1016/j.cub.2014.11.034; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Cocchi L, 2017, PROG NEUROBIOL, V158, P132, DOI 10.1016/j.pneurobio.2017.07.002; Deco G, 2018, NEUROIMAGE, V169, P46, DOI 10.1016/j.neuroimage.2017.12.009; Deco G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03073-5; Deco G, 2017, NEUROIMAGE, V152, P538, DOI 10.1016/j.neuroimage.2017.03.023; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Fekete T, 2018, NEUROIMAGE, V183, P919, DOI 10.1016/j.neuroimage.2018.08.026; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Fiebelkorn IC, 2018, NEURON, V99, P842, DOI 10.1016/j.neuron.2018.07.038; Granada A, 2009, METHOD ENZYMOL, V454, P1, DOI 10.1016/S0076-6879(08)03801-9; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Hannay KM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022923; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Helfrich RF, 2018, NEURON, V99, P854, DOI 10.1016/j.neuron.2018.07.032; Huang ZR, 2017, CEREB CORTEX, V27, P1037, DOI 10.1093/cercor/bhv288; Hudetz AG, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00234; Hutt A, 2018, NEUROIMAGE, V179, P414, DOI 10.1016/j.neuroimage.2018.06.043; Jobst BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04522-x; Kim Hyoungkyu, 2018, PLoS Comput Biol, V14, pe1006424, DOI 10.1371/journal.pcbi.1006424; Kim M, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00055; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Ko TW, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016211; Lee UC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18657-4; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Levnajic Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056202; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Milton A, 2016, NEUROIMAGE, V133, P53, DOI 10.1016/j.neuroimage.2016.02.065; Moon JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep46606; Moon JY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004225; NUNN CMH, 1974, PSYCHOPHYSIOLOGY, V11, P294, DOI 10.1111/j.1469-8986.1974.tb00547.x; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Samaha J, 2017, J NEUROSCI, V37, P2824, DOI 10.1523/JNEUROSCI.3413-16.2017; Sarasso S, 2015, CURR BIOL, V25, P3099, DOI 10.1016/j.cub.2015.10.014; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Schaworonkow N., 2018, EEG TRIGGERED TMS RE, DOI [https://doi.org/10.1101/251363, DOI 10.1101/251363]; Shanahan M, 2010, CHAOS, V20, DOI 10.1063/1.3305451; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; VanRullen R, 2018, NEURON, V99, P632, DOI 10.1016/j.neuron.2018.08.006; VanRullen R, 2016, TRENDS COGN SCI, V20, P723, DOI 10.1016/j.tics.2016.07.006; Yoon S, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032814; Zerlaut Y, 2017, NEURON, V94, P1002, DOI 10.1016/j.neuron.2017.04.001; Zhang HH, 2018, NEURON, V98, P1269, DOI 10.1016/j.neuron.2018.05.019; Zrenner C, 2018, BRAIN STIMUL, V11, P374, DOI 10.1016/j.brs.2017.11.016	54	3	3	2	5	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	2472-1751			NETW NEUROSCI	Netw. Neurosci.		2020	4	1					155	173		10.1162/netn_a_00113			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KM0FP	WOS:000513793200007	32043048	Green Published, Green Submitted, gold			2022-02-06	
J	Larsen, SE; Larson, ER; Hunt, JC; Lorber, WG; DeRoon-Cassini, TA				Larsen, Sadie E.; Larson, Eric R.; Hunt, Joshua C.; Lorber, William G.; DeRoon-Cassini, Terri A.			Interaction Between Psychiatric Symptoms and History of Mild TBI When Evaluating Postconcussion Syndrome in Veterans	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				TRAUMATIC BRAIN-INJURY; CHILD-ABUSE; CONCUSSION; INVENTORY; PTSD; ENCEPHALOPATHY; RELIABILITY; VALIDITY; IMPACT; RISK	Introduction: Symptoms of postconcussive syndrome (PCS) after mild TBI (mTBI) have been shown to resolve quickly, yet new research raises questions about possible long-term effects of this condition. It is not clear how best to address assessment and treatment when someone reports lingering symptoms of PCS. One self-report measure used by the VA and the DoD is the Neurobehavioral Symptom Inventory (NSI), but this measure may be affected by underlying psychiatric symptoms. We investigated whether the NSI is sensitive to mTBI after considering a number of psychiatric and demographic factors. Methods: This study examined which factors are associated with NSI scores in a Veteran sample (n = 741) that had recently returned from deployment. Results: Post-traumatic stress disorder (PTSD) and depression accounted for most of the variance on the NSI. Although history of mTBI was initially related to NSI, this association was no longer significant after other covariates were considered. Conclusions: The NSI score was primarily explained by symptoms of PTSD and depression, suggesting that the NSI is not specific to the experience of a brain injury. We recommend cautious interpretation when this measure is used in the chronic phase after mTBI, especially among patients with comorbid depression or PTSD.	[Larsen, Sadie E.; Larson, Eric R.; Lorber, William G.] Milwaukee VA Med Ctr, Div Mental Hlth, 5000 W Natl Ave, Milwaukee, WI 53295 USA; [Larsen, Sadie E.; Larson, Eric R.; Lorber, William G.] Med Coll Wisconsin, Dept Psychiat & Behav Med, 1155 N Mayfair Rd, Wauwatosa, WI 53226 USA; [Hunt, Joshua C.; DeRoon-Cassini, Terri A.] Med Coll Wisconsin, Dept Surg, Div Trauma & Crit Care, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA		Larsen, SE (corresponding author), Milwaukee VA Med Ctr, Div Mental Hlth, 5000 W Natl Ave, Milwaukee, WI 53295 USA.; Larsen, SE (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, 1155 N Mayfair Rd, Wauwatosa, WI 53226 USA.						Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; BEIN L, 2019, MILITARY BEHAV HLTH, V7, P228; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boillat C, 2017, CHILD ABUSE NEGLECT, V68, P44, DOI 10.1016/j.chiabu.2017.03.018; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1097/00000374-199811000-00034; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Klein R, 2011, ARCH CLIN NEUROPSYCH, V26, P500; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Raskin SA, 1997, BRAIN INJURY, V11, P587, DOI 10.1080/026990597123287; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; REYNOLDS WM, 1981, J CONSULT CLIN PSYCH, V49, P306, DOI 10.1037/0022-006X.49.2.306; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein MB, 2018, J CLIN PSYCHIAT, V79, P70, DOI 10.4088/JCP.16m10900; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Weathers F.W., 1993, ANN CONV INT SOC TRA; Whisman MA, 2000, J CLIN PSYCHOL, V56, P545, DOI 10.1002/(SICI)1097-4679(200004)56:4<545::AID-JCLP7>3.0.CO;2-U; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981	40	3	3	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			161	167		10.1093/milmed/usz193			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600025	31498405	Bronze			2022-02-06	
J	Laverse, E; Guo, T; Zimmerman, K; Foiani, MS; Velani, B; Morrow, P; Adejuwon, A; Bamford, R; Underwood, N; George, J; Brooke, D; O'Brien, K; Cross, MJ; Kemp, SPT; Heslegrave, AJ; Hardy, J; Sharp, DJ; Zetterberg, H; Morris, HR				Laverse, Etienne; Guo, Tong; Zimmerman, Karl; Foiani, Martha S.; Velani, Bharat; Morrow, Philip; Adejuwon, Ademola; Bamford, Richard; Underwood, Natasha; George, Jonathan; Brooke, Daniel; O'Brien, Karen; Cross, Matthew J.; Kemp, Simon P. T.; Heslegrave, Amanda J.; Hardy, John; Sharp, David J.; Zetterberg, Henrik; Morris, Huw R.			Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury	BRAIN COMMUNICATIONS			English	Article						mild-TBI; concussion; biomarkers; NFL; GFAP	BLOOD BIOMARKERS; INTRACRANIAL LESIONS; ELEVATED LEVELS; SERUM; PATHOLOGIES; DIAGNOSIS; SYSTEM	Mild traumatic brain injury is a relatively common event in contact sports and there is increasing interest in the long-term neurocognitive effects. The diagnosis largely relies on symptom reporting and there is a need for objective tools to aid diagnosis and prognosis. There are recent reports that blood biomarkers could potentially help triage patients with suspected injury and normal CT findings. We have measured plasma concentrations of glial and neuronal proteins and explored their potential in the assessment of mild traumatic brain injury in contact sport. We recruited a prospective cohort of active male rugby players, who had pre-season baseline plasma sampling. From this prospective cohort, we recruited 25 players diagnosed with mild traumatic brain injury. We sampled post-match rugby players without head injuries as post-match controls. We measured plasma neurofilament light chain, tau and glial fibrillary acidic protein levels using ultrasensitive single molecule array technology. The data were analysed at the group and individual player level. Plasma glial fibrillary acidic protein concentration was significantly increased 1-h post-injury in mild traumatic brain injury cases compared to the non-injured group (P=0.017). Pairwise comparison also showed that glial fibrillary acidic protein levels were higher in players after a head injury in comparison to their pre-season levels at both 1-h and 3- to 10-day post-injury time points (P = 0.039 and 0.040, respectively). There was also an increase in neurofilament light chain concentration in brain injury cases compared to the pre-season levels within the same individual at both time points (P = 0.023 and 0.002, respectively). Tau was elevated in both the non-injured control group and the 1-h post-injury group compared to pre-season levels (P = 0.007 and 0.015, respectively). Furthermore, receiver operating characteristic analysis showed that glial fibrillary acidic protein and neurofilament light chain can separate head injury cases from control players. The highest diagnostic power was detected when biomarkers were combined in differentiating 1-h post-match control players from 1-h post-head injury players (area under curve 0.90, 95% confidence interval 0.79-1.00, P < 0.0002). The brain astrocytic marker glial fibrillary acidic protein is elevated in blood 1 h after mild traumatic brain injury and in combination with neurofilament light chain displayed the potential as a reliable biomarker for brain injury evaluation. Plasma total tau is elevated following competitive rugby with and without a head injury, perhaps related to peripheral nerve trauma and therefore total tau does not appear to be suitable as a blood biomarker.	[Laverse, Etienne; Guo, Tong; Velani, Bharat; Morris, Huw R.] UCL Inst Neurol, Dept Clin & Movement Neurosci, Queen Sq, London, England; [Zimmerman, Karl; Sharp, David J.] Imperial Coll London, Dept Med, Div Brain Sci, London, England; [Foiani, Martha S.; Heslegrave, Amanda J.; Hardy, John; Zetterberg, Henrik] UCL, UK Dementia Res Inst UCL, UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Morrow, Philip; Bamford, Richard; Underwood, Natasha; George, Jonathan] Saracens Rugby Club, London, England; [Adejuwon, Ademola; Brooke, Daniel] Ealing Trailfinders Rugby Club, London, England; [O'Brien, Karen] London Scottish Rugby Club, London, England; [Cross, Matthew J.] Premiership Rugby, London, England; [Kemp, Simon P. T.] Rugby Football Union, London, England; [Kemp, Simon P. T.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Heslegrave, Amanda J.; Hardy, John; Zetterberg, Henrik] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England; [Hardy, John] UCL Queen Sq Inst Neurol, Reta Lila Weston Inst, London WC1N 1PJ, England; [Hardy, John] NIHR Univ Coll London Hosp Biomed Res Ctr, London, England; [Hardy, John] Hong Kong Univ Sci & Technol, Inst Adv Study, Hong Kong, Peoples R China; [Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden		Morris, HR (corresponding author), UCL Queen Sq Inst Neurol, FRCP, London WC1N 3BG, England.	h.morris@ucl.ac.uk	Hardy, John/C-2451-2009; Zimmerman, Karl/S-3406-2016	Hardy, John/0000-0002-3122-0423; , Etienne/0000-0003-4302-9252; Zimmerman, Karl/0000-0003-1239-3414	Drake FoundationSmithsonian InstitutionSmithsonian National Museum of Natural History; UK Dementia Research Institute at UCL; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-1009, UKDRI-1003, UKDRI-7006] Funding Source: UKRI	The study was funded by a grant from The Drake Foundation, a not-for-profit organization committed to improving understanding of brain injury in sport and the UK Dementia Research Institute at UCL.	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; BOYNE LJ, 1995, J COMP NEUROL, V358, P279, DOI 10.1002/cne.903580209; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; di Battista AP, 2016, PLOS ONE, V11, P1; Douglas DB, 2018, CURR OPIN NEUROL, V31, P362, DOI 10.1097/WCO.0000000000000567; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Goedert M, 1992, NEUROBIOLOGY; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003; Zetterberg H, 2009, BRAIN INJURY, V23, P723, DOI 10.1080/02699050903120399	37	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							137	10.1093/braincomms/fcaa137			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800077	33543129	Green Published, gold			2022-02-06	
J	Li, H; Zhang, CG; Yang, CX; Blevins, M; Norris, D; Zhao, R; Huang, MX				Li, Hong; Zhang, Caiguo; Yang, Chunxia; Blevins, Melanie; Norris, David; Zhao, Rui; Huang, Mingxia			C-terminal binding proteins 1 and 2 in traumatic brain injury-induced inflammation and their inhibition as an approach for anti-inflammatory treatment	INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES			English	Article						CtBP; proinflammatory transcription; neuroinflammation; microglia activation; traumatic brain injury	DIFFUSE AXONAL INJURY; TRANSCRIPTIONAL ACTIVATION; POTENTIAL MECHANISMS; ADENOVIRUS E1A; HEAD-INJURY; CTBP; NEUROPROTECTION; DIFFERENTIATION; IDENTIFICATION; ASSOCIATION	Traumatic brain injury (TBI) induces an acute inflammatory response in the central nervous system that involves both resident and peripheral immune cells. The ensuing chronic neuroinflammation causes cell death and tissue damage and may contribute to neurodegeneration. The molecular mechanisms involved in the maintenance of this chronic inflammation state remain underexplored. C-terminal binding protein (CtBP) 1 and 2 are transcriptional coregulators that repress diverse cellular processes. Unexpectedly, we find that the CtBPs can transactivate a common set of proinflammatory genes both in lipopolysaccharide-activated microglia, astrocytes and macrophages, and in a mouse model of the mild form of TBI. We also find that the expression of these genes is markedly enhanced by a single mild injury in both brain and peripheral blood leukocytes in a severity- and time-dependent manner. Moreover, we were able to demonstrate that specific inhibitors of the CtBPs effectively suppress the expression of the CtBP target genes and thus improve neurological outcome in mice receiving single and repeated mild TBIs. This discovery suggests new avenues for therapeutic modulation of the inflammatory response to brain injury.	[Li, Hong; Zhang, Caiguo; Yang, Chunxia; Norris, David; Huang, Mingxia] Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA; [Yang, Chunxia] Shanxi Med Univ, Dept Psychiat, Hosp 1, Taiyuan, Peoples R China; [Blevins, Melanie; Zhao, Rui] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO 80045 USA		Huang, MX (corresponding author), Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA.	mingxia.huang@cuanschutz.edu			Dudley Stem Cell Research Fund of the University of Colorado Cancer Center; VA Eastern Colorado Health Care System [5101BX002370]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01CA2212 82, R01GM126157, R01GM114178]; Lung, Head and Neck Cancer training grant [T32CA174648]; American Lung Association Senior Research Training Fellowship	We thank H. Potter, Y. Shellman, X-J. Wang and D. Xue for comments on the manuscript. This work was supported by the Dudley Stem Cell Research Fund of the University of Colorado Cancer Center to M. H. and a research grant from the VA Eastern Colorado Health Care System (5101BX002370) to D.N. R. Z was supported in part by NIH grants R01CA2212 82, R01GM126157, and R01GM114178. M.B. was supported by the Lung, Head and Neck Cancer training grant T32CA174648 and an American Lung Association Senior Research Training Fellowship.	Achouri Y, 2007, BIOCHEM BIOPH RES CO, V352, P903, DOI 10.1016/j.bbrc.2006.11.111; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; Blevins MA, 2018, MOL ONCOL, V12, P1358, DOI 10.1002/1878-0261.12330; Blevins MA, 2017, MOL CANCER THER, V16, P981, DOI 10.1158/1535-7163.MCT-16-0592; Boxer LD, 2014, GENE DEV, V28, P2013, DOI 10.1101/gad.246579.114; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bruton RK, 2008, J VIROL, V82, P8476, DOI 10.1128/JVI.00248-08; Byun Jung S, 2013, Int J Cell Biol, V2013, P647975, DOI 10.1155/2013/647975; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Dcona MM, 2017, CANCER BIOL THER, V18, P379, DOI 10.1080/15384047.2017.1323586; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lian H, 2016, BIO PROTOC, P6; Madison DL, 2013, J BIOL CHEM, V288, P27836, DOI 10.1074/jbc.M113.493569; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Paliwal Seema, 2012, Genes Cancer, V3, P481, DOI 10.1177/1947601912463695; Patel J, 2014, CELL CYCLE, V13, P3506, DOI 10.4161/15384101.2014.958407; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Ray SK, 2014, MOL CELL BIOL, V34, P2308, DOI 10.1128/MCB.01600-13; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Straza MW, 2010, CELL CYCLE, V9, P3740, DOI 10.4161/cc.9.18.12936; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Vourc'h M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01330; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002	63	3	4	0	4	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-2288			INT J BIOL SCI	Int. J. Biol. Sci.		2020	16	7					1107	1120		10.7150/ijbs.42109			14	Biochemistry & Molecular Biology; Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	KO4CH	WOS:000515494200002	32174788	gold, Green Published, Green Submitted			2022-02-06	
J	LoPresti, MA; Giridharan, N; Pyarali, M; Gadgil, N; Kan, PT; Niedwiekci, C; Lam, SK				LoPresti, Melissa A.; Giridharan, Nisha; Pyarali, Monika; Gadgil, Nisha; Kan, Peter T.; Niedwiekci, Christian; Lam, Sandi K.			Pediatric intracranial arteriovenous malformations: Examining rehabilitation outcomes	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Pediatric arteriovenous malformation; acute inpatient rehabilitation; outcomes; pediatric neurosurgery	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; INPATIENT REHABILITATION; CHILDREN; STROKE; WEEFIM; SECONDARY; COHORT; SCALE; COST	PURPOSE: Arteriovenous malformation (AVM) rupture in children can cause debilitating neurological injury. Rehabilitation is key to recovery, though literature details little regarding rehabilitation outcomes. We examined a single-center experience with pediatric AVMs as related to acute inpatient rehabilitation outcomes. METHODS: At our institution, a retrospective chart review was completed examining all cases of intracranial AVMs in patients age 18 and younger who completed our acute inpatient rehabilitation program between 2012-2018. Patient characteristics, clinical data, treatment modality, and functional outcomes were reviewed. RESULTS: 14 patients with AVMs underwent acute inpatient rehabilitation; nine (64.3%) treated surgically at our institution, two (14.3%) non-surgically at our institution, and three (21.4%) surgically at an outside facility prior to transitioning care at our institution. Eight (57.1%) were male, seven (50.0%) Caucasian, and seven (50.0%) Hispanic. Seven (50.0%) presented with AVM rupture; six (42.9%) were found incidentally on imaging. Clinical courses, treatment outcomes, and post-treatment complications varied. Several patients underwent repeat treatment or additional procedures. Neurological deficits identified included hemiparesis, dystonia, spasticity, epilepsy, hydrocephalus, and ataxia. Inpatient rehabilitation unit length of stay was on average 21 days (SD 9.02, range 9-41). Functional Independence Measure for Children (WeeFIM (R)) scores, including self-care, mobility, and cognition, demonstrated improvement upon discharge. The mean total change was 36.7 points in those treated surgically, 16.5 in those treated non-surgically, and 25.7 in those treated surgically at another facility. CONCLUSION: We found that all pediatric patients with intracranial AVMs, across all treatment modalities, demonstrated improved outcomes across all functional domains after an acute inpatient rehabilitation program.	[LoPresti, Melissa A.; Giridharan, Nisha; Pyarali, Monika; Gadgil, Nisha; Kan, Peter T.] Texas Childrens Hosp, Baylor Coll Med, Dept Neurosurg, Div Pediat Neurosurg, Houston, TX 77030 USA; [Niedwiekci, Christian] Texas Childrens Hosp, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Lam, Sandi K.] Northwestern Univ, Lurie Childrens Hosp, Dept Neurosurg, Div Pediat Neurosurg, Chicago, IL 60611 USA		Lam, SK (corresponding author), Northwestern Univ, Feinberg Sch Med, Lurie Childrens Hosp, Div Pediat Neurosurg, 225 E Chicago Ave,Box 28, Chicago, IL 60611 USA.; Lam, SK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurosurg, 225 E Chicago Ave,Box 28, Chicago, IL 60611 USA.	sandilam@gmail.com		Lam, Sandi/0000-0003-3294-6637			Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Blom I, 2003, DEV MED CHILD NEUROL, V45, P233, DOI 10.1017/S001216220300046X; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Cosan TE, 2005, CHILD NERV SYST, V21, P75, DOI 10.1007/s00381-004-1026-z; Darsaut TE, 2011, NEUROSURGERY, V69, P540, DOI 10.1227/NEU.0b013e3182181c00; Ding D, 2017, J NEUROSURG-PEDIATR, V19, P127, DOI 10.3171/2016.9.PEDS16283; Duong DH, 1999, NEW ENGL J MED, V340, P1812; Fabri TL, 2018, J PEDIATR REHAB MED, V11, P15, DOI 10.3233/PRM-160429; Fuentes MM, 2016, ARCH PHYS MED REHAB, V97, P1407, DOI 10.1016/j.apmr.2016.02.026; Fukuda K, 2017, J NEUROINTERV SURG, V9, P664, DOI 10.1136/neurintsurg-2016-012485; Gordon AL, 2012, PEDIATR NEUROL, V46, P339, DOI 10.1016/j.pediatrneurol.2012.02.029; Gross BA, 2015, J NEUROSURG-PEDIATR, V15, P71, DOI 10.3171/2014.9.PEDS146; Gross BA, 2013, J NEUROSURG, V118, P437, DOI 10.3171/2012.10.JNS121280; HLADKY JP, 1994, CHILD NERV SYST, V10, P328, DOI 10.1007/BF00335172; Kiris T, 2005, CHILD NERV SYST, V21, P69, DOI 10.1007/s00381-004-1025-0; Lantz ER, 2008, NEUROPSYCHOL REV, V18, P167, DOI 10.1007/s11065-008-9060-3; Lawton MT, 2010, NEUROSURGERY, V66, P702, DOI 10.1227/01.NEU.0000367555.16733.E1; Lazar RM, 1999, ARCH NEUROL-CHICAGO, V56, P103, DOI 10.1001/archneur.56.1.103; Lo W, 2008, STROKE, V39, P161, DOI 10.1161/STROKEAHA.107.497420; MAHALICK DM, 1991, NEUROSURGERY, V29, P351, DOI 10.1227/00006123-199109000-00003; Mahler MP, 2008, SWISS MED WKLY, V138, P459, DOI 2008/31/smw-11845; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Patel N, 2012, NEUROSURGERY, V71, P971, DOI 10.1227/NEU.0b013e31826a8a56; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; van Essen MJ, 2018, ACTA NEUROCHIR, V160, P2199, DOI 10.1007/s00701-018-3665-y; Whigham KB, 2007, COGN BEHAV NEUROL, V20, P244, DOI 10.1097/WNN.0b013e31815e6224; Williams KS, 2017, DEV NEUROREHABIL, V20, P443, DOI 10.1080/17518423.2017.1289419; Yagi M, 2017, STROKE, V48, P740, DOI 10.1161/STROKEAHA.116.015147; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91	33	3	3	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2020	13	1					7	15		10.3233/PRM-190609			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	NZ8TF	WOS:000577373200010	32176668				2022-02-06	
J	Maat, SC; Luppino, FS; Schipper, IB; Krijnen, P; Bartlema, KA				Maat, Sanne C.; Luppino, Floriana S.; Schipper, Inger B.; Krijnen, Pieta; Bartlema, Kornelis A.			Injury patterns after skiing and snowboarding sports accidents	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Snow sports; Skiing; Injuries; Risk	RISK-FACTORS; SKIERS; SNOW; FRACTURES; PARKS	BACKGROUND: Alpine sports are associated with risk of serious injuries. To gain insight into factors that may help reduce injury severity, accident characteristics and injury patterns were analyzed in a cohort of injured skiers and snowboarders. METHODS: All patients with Alpine sports-related injuries, reporting the injury to a leading medical assistance organization in the Netherlands in the period of 2013-2016, were contacted. Medical data were collected from the patients' files. Only ski and snowboard incidents were included. Injuries were classified according to the Abbreviated Injury Scale (AIS) and Injury Severity Scale (ISS). Data on the accident conditions, i.e. risk factors, were collected using retrospective patient-reported questionnaires. Risk factors for injuries with ISS >= 9 were analysed by multivariate modelling. RESULTS: Of the 1588 included patients, 421 patients filled out the questionnaire. Skiers (N.=1370) had more knee injuries (20.4% vs. 7.4%, P<0.001), femur fractures (5.3% vs. 0.5%, P=0.002) and lower leg fractures (27.5% vs. 11.5%, P<0.001) compared to snowboarders (N.=218). Skiers were also more seriously injured (ISS>9) (P=0.01). Injured snowboarders sustained more brain concussions (8.8% vs. 15.7%, P=0.003) and lower arm fractures (5.4% vs. 16.1%, P<0.001). Only `a higher skills level' was borderline significant for predicting serious injury (OR: 4.0 95% CI: 0.86-18.50; P=0.08). No additional risk factors were identified. CONCLUSIONS: Injury patterns after skiing and snowboarding accidents differ, injury severity differed not. Preventive measures should therefore aim to protect specific body parts depending on the type of Alpine sport. Experienced skiers and snowboarders may be more at risk for serious injuries.	[Maat, Sanne C.; Schipper, Inger B.; Krijnen, Pieta; Bartlema, Kornelis A.] Leiden Univ, Dept Trauma Surg, Med Ctr, Post Zone K6-R,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Luppino, Floriana S.] Eurocross Assistance, Leiden, Netherlands		Maat, SC (corresponding author), Leiden Univ, Dept Trauma Surg, Med Ctr, Post Zone K6-R,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	s.c.maat@alrijne.nl	Schipper, Inger/ABE-7796-2021	Schipper, Inger/0000-0001-9952-3079			Basques BA, 2018, KNEE SURG SPORT TR A, V26, P1916, DOI 10.1007/s00167-016-4137-7; Bohm H, 2008, J BIOMECH, V41, P498, DOI 10.1016/j.jbiomech.2007.10.019; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Burkner A, 2008, SPORTVERLETZ SPORTSC, V22, P207, DOI 10.1055/s-2008-1027947; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Castellani C, 2019, J SPORT MED PHYS FIT, V59, P648, DOI [10.23736/S0022-4707.18.08665-6, 10.23736/s0022-4707.18.08665-6]; Coury T, 2013, WILD ENVIRON MED, V24, P417, DOI 10.1016/j.wem.2013.07.002; de Roulet Amory, 2017, J Trauma Acute Care Surg, V82, P781, DOI [10.1097/TA.0000000000001358, 10.1097/ta.0000000000001358]; Goulet C, 2007, CAN J PUBLIC HEALTH, V98, P402, DOI 10.1007/BF03405428; Hume PA, 2015, SPORTS MED, V45, P1175, DOI 10.1007/s40279-015-0334-7; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Moore SJ, 2013, J TRAUMA ACUTE CARE, V75, P334, DOI 10.1097/TA.0b013e31829467c9; Muller L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00656; Ogawa H, 2010, AM J SPORT MED, V38, P532, DOI 10.1177/0363546509348763; Patton A, 2010, NEW ZEAL MED J, V123, P20; Ruedl G, 2011, INT J SPORTS MED, V32, P801, DOI 10.1055/s-0031-1279719; Ruedl G, 2011, INT J SPORTS MED, V32, P618, DOI 10.1055/s-0031-1275355; Ruedl G, 2010, SPORTVERLETZ SPORTSC, V24, P150, DOI 10.1055/s-0029-1245578; Ruedl G, 2012, ACCIDENT ANAL PREV, V48, P292, DOI 10.1016/j.aap.2012.01.031; Rust DA, 2013, AM J SPORT MED, V41, P652, DOI 10.1177/0363546512472045; Schneiders W, 2007, J TRAUMA, V62, P996, DOI 10.1097/01.ta.0000222584.48001.a0; Statistics Netherlands (CBS), 2016, TREND REP TOUR RECR; Thomson CJ, 2015, ACCIDENT ANAL PREV, V75, P179, DOI 10.1016/j.aap.2014.11.024; Wijdicks CA, 2014, BRIT J SPORT MED, V48, P11, DOI 10.1136/bjsports-2013-093019; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD	25	3	3	0	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	JAN	2020	60	1					119	124		10.23736/S0022-4707.19.09753-6			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LV4VF	WOS:000538434100016	31640310				2022-02-06	
J	Maddry, JK; Arana, AA; Perez, CA; Medellin, KL; Paciocco, JA; Mora, AG; Holder, WG; Davis, WT; Herson, P; Bebarta, VS				Maddry, Joseph K.; Arana, Allyson A.; Perez, Crystal A.; Medellin, Kimberly L.; Paciocco, Joni A.; Mora, Alejandra G.; Holder, William G.; Davis, William T.; Herson, Paco; Bebarta, Vikhyat S.			Influence of Time to Transport to a Higher Level Facility on the Clinical Outcomes of US Combat Casualties with TBI: A Multicenter 7-Year Study	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; AEROMEDICAL EVACUATION; SECONDARY INSULTS; MANAGEMENT; HYPOBARIA; HYPOXIA; TEAMS	Introduction Traumatic brain injury (TBI) is a leading cause of death and disability worldwide and is associated with mortality rates as high as 30%. Patients with TBI are at high risk for secondary injury and need to be transported to definitive care expeditiously. However, the physiologic effects of aeromedical evacuation are not well understood and may compound these risks. Combat TBI patients may benefit from delayed aeromedical evacuation. The goal of this study was to evaluate the impact of transport timing out of theater via Critical Care Air Transport Teams (CCATT) to a higher level facility on the clinical outcomes of combat casualties with TBI. Materials and Methods We performed a retrospective review of patients with TBI who were evacuated out of theater by CCATT from January 2007 to May 2014. Data abstractors collected flight information, vital signs, procedures, in-flight assessments, and outcomes. Time to transport was defined as the time from injury to CCATT evacuation out of combat theater. We calculated descriptive statistics and constructed regression models to determine the association between time to transport and clinical outcomes. This study was approved by the U.S. Air Force 59th Medical Wing Institutional Review Board. Results We analyzed the records of 438 patients evacuated out of theater via CCATT and categorized them into three groups: patients who were transported in one day or less (n = 165), two days (n = 163), and three or more days (n= 110). We used logistic regression models to compare outcomes among patients who were evacuated in two days or three or more days to those who were transported within one day while adjusting for demographics, injury severity, and injury type. Patients who were evacuated in two days or three or more days had 50% lower odds of being discharged on a ventilator and were twice as likely to return to duty or be discharged home than those who were evacuated within one day. Additionally, patients transported in three or more days were 70% less likely to be ventilated at discharge with a GCS of 8 or lower and had 30% lower odds of mortality than those transported within one day. Conclusions In patients with moderate to severe TBI, a delay in aeromedical evacuation out of the combat theater was associated with improved mortality rates and a higher likelihood of discharge to home and return to duty dispositions. This study is correlational in nature and focused on CCATT transports from Role III to Role IV facilities; as such, care must be taken in interpreting our findings and future studies are needed to establish a causal link between delayed evacuation and improved discharge disposition. Our study suggests that delaying aeromedical evacuation of TBI patients when feasible may confer benefit.	[Maddry, Joseph K.; Arana, Allyson A.; Perez, Crystal A.; Medellin, Kimberly L.; Paciocco, Joni A.; Mora, Alejandra G.; Bebarta, Vikhyat S.] US Air Force Route Care Res Ctr, US Army Inst Surg Res, MDW 59, 3698 Chambers Pass,Bldg 3610, Ft Sam Houston, TX 78234 USA; [Holder, William G.; Davis, William T.] Brooke Army Med Ctr, Dept Emergency Med, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Herson, Paco] Univ Colorado, Dept Anesthesiol, Sch Med, 12401 E 17th Ave 7th Floor, Aurora, CO 80045 USA; [Bebarta, Vikhyat S.] Univ Colorado, Dept Emergency Med, Sch Med, 12401 E 17th Ave 7th Floor, Aurora, CO 80045 USA		Maddry, JK (corresponding author), US Air Force Route Care Res Ctr, US Army Inst Surg Res, MDW 59, 3698 Chambers Pass,Bldg 3610, Ft Sam Houston, TX 78234 USA.				Department of Defense Joint Program Committee-6/Combat Casualty Care Research ProgramUnited States Department of Defense [JPC-6/CCCRP]	This project was supported by the Department of Defense Joint Program Committee-6/Combat Casualty Care Research Program (JPC-6/CCCRP).	Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Carlton PK, 2008, CRIT CARE MED, V36, pS255, DOI 10.1097/CCM.0b013e31817da609; Choi M, 2018, J TRAUMA ACUTE CARE, V85, pS68, DOI 10.1097/TA.0000000000001909; Dukes SF, 2013, MIL MED, V178, P11, DOI 10.7205/MILMED-D-12-00177; Fang R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1043; Galvagno SM, 2014, MIL MED, V179, P612, DOI 10.7205/MILMED-D-13-00474; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Goldberg SA, 2015, HDB CLIN NEUROL, V126; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Ingalls N, 2014, JAMA SURG, V149, P807, DOI 10.1001/jamasurg.2014.621; Johannigman JA, 2015, MIL MED, V180, P50, DOI 10.7205/MILMED-D-14-00381; Krueger Chad A, 2013, J Surg Orthop Adv, V22, P82; Lairet J, 2013, PREHOSP EMERG CARE, V17, P486, DOI 10.3109/10903127.2013.811564; Lew HL, 2013, J REHABIL RES DEV, V50, pXI, DOI 10.1682/JRRD.2013.09.0212; McCafferty R, JOINT TRAUMA SYSTEM; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Mora AG, 2014, J TRAUMA ACUTE CARE, V77, P724, DOI 10.1097/TA.0000000000000446; Proctor JL, 2017, J TRAUMA ACUTE CARE, V83, pS35, DOI 10.1097/TA.0000000000001478; Ritenour AE, 2010, J SURG RES, V160, P253, DOI 10.1016/j.jss.2009.03.037; Savell SC, 2019, MIL MED, V184, pE288, DOI 10.1093/milmed/usy426; Scultetus AH, 2019, J TRAUMA ACUTE CARE, V86, P116, DOI 10.1097/TA.0000000000002014; Scultetus AH, 2016, J TRAUMA ACUTE CARE, V81, P101, DOI 10.1097/TA.0000000000001048; Skovira JW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0769-2; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Tanielian T, INVISIBLE WOUNDS WAR, P492; Tanielian T, 2008MG7201CCF RAND C, P64; Van Wyck D, JOINT TRAUMA SYSTEM; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; Worster A, 2005, ANN EMERG MED, V45, P448, DOI 10.1016/j.annemergmed.2004.11.021	32	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185	1-2					E138	E145		10.1093/milmed/usz178			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KM6BW	WOS:000514224500031	31334769	hybrid			2022-02-06	
J	Merryman, MB; Synovec, C				Merryman, M. Beth; Synovec, Caitlin			Integrated Care: Provider referrer perceptions of occupational therapy services for homeless adults in an integrated primary care setting	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Federally qualified health centers; primary care; integrated care; team-based care; complex comorbidity	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; MENTAL-ILLNESS; PERSPECTIVES; PEOPLE; EXPERIENCES; INPATIENT; OUTCOMES	BACKGROUND: Occupational therapists have a long history of addressing community performance and participation challenges faced by individuals with complex, chronic conditions, including those with serious mental illnesses (SMI) and cognitive issues that present with a traumatic brain injury (TBI). Healthcare reform has shifted incentives to support practices that promote successful community life for people with complex medical conditions. Community based care models emphasizing integrated primary care, such as Federally Qualified Health Centers (FQHC) are emerging, and a generalist role for occupational therapy is being defined. Those with complex comorbid conditions such as mental illness, substance abuse and traumatic brain injury are at risk for negative health outcomes that are further compounded by homelessness. There is a critical need to understand effective treatment options for this population to reduce the negative effects of chronic health conditions. As occupational therapists further define a role serving traditional clients in less traditional settings, such as the FQHC, it is helpful to explore the perceptions of the utility of OT services on the part of provider referrers. OBJECTIVE: This study explored provider referrer perceptions of a new occupational therapy service for homeless adults in an FQHC to assist effective allocation of scarce resources. METHODS: Twelve provider referrers at an FQHC were interviewed regarding their perception of the role and utility of occupational therapy in this setting. Interviews were then coded for themes. RESULTS: Providers identified the unique value of occupational therapy, emphasizing critical information gleaned from the performance-based assessment of functional cognition, and the positive impact on team interactions and subsequent care decisions. CONCLUSION: Occupational therapy provides a distinct perspective on client performance in FQHC settings indicating benefit for inclusion of services.	[Merryman, M. Beth] Towson Univ, Dept Occupat Therapy & Occupat Sci, 8000 York Rd, Towson, MD 21252 USA; [Synovec, Caitlin] Hlth Care Homeless, Baltimore, MD USA		Merryman, MB (corresponding author), Towson Univ, Dept Occupat Therapy & Occupat Sci, 8000 York Rd, Towson, MD 21252 USA.	bmerryman@towson.edu					Allen C. K., 2007, MANUAL ALLEN COGNITI; Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Baum CM, EXECUTIVE FUNCTION P; Bradley DM, 2011, OCCUP THER MENT HEAL, V27, P26, DOI 10.1080/0164212X.2010.518311; Chapleau A, 2011, PROF CASE MANAG, V16, P71, DOI 10.1097/NCM.0b013e3181f0555b; Cohen D., 2006, QUALITATIVE RES GUID; Creswell J. W, RES DESIGN QUALITATI, V4th; Dahl-Popolizio S, 2016, FAM SYST HEALTH, V34, P270, DOI 10.1037/fsh0000208; Donnelly CA, 2014, CAN J OCCUP THER, V81, P51, DOI 10.1177/0008417414520683; Dubuc N, 2013, INT J INTEGR CARE, V13; Dufour SP, 2014, J INTERPROF CARE, V28, P460, DOI 10.3109/13561820.2014.915210; Eichler J, 2016, FAM SYST HEALTH, V34, P289, DOI 10.1037/fsh0000226; Ellis H, 2016, ARCH PSYCHIAT NURS, V30, P432, DOI 10.1016/j.apnu.2016.01.004; Engineer CY, 2015, INT J INTEGR CARE, V15, P35; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gibson RW, 2011, AM J OCCUP THER, V65, P247, DOI 10.5014/ajot.2011.001297; Halle AD, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.723001; Heasman D, 2012, BRIT J OCCUP THER, V75, P522, DOI 10.4276/030802212X13522194760011; Helfrich CA, 2011, AM J OCCUP THER, V65, P277, DOI 10.5014/ajot.2011.001321; Herzberg G., 2001, OCCUPATIONAL THERAPY, V13, P133, DOI DOI 10.1300/J003V13N03_11; Herzberg GL, 2006, OCCUP THER HEALTH CA, V20, P1, DOI [10.1300/J003v20n03_01, 10.1080/J003v20n03_01]; Jeyaraj JA, 2013, BRAIN INJURY, V27, P1338, DOI 10.3109/02699052.2013.823650; Koverman B, 2017, OPEN J OCCUPATIONAL, V5; Lebrun-Harris LA, 2013, HEALTH SERV RES, V48, P992, DOI 10.1111/1475-6773.12009; Liu Hao, 2006, N Am J Sports Phys Ther, V1, P10; Livescribe, 2005, SMARTP; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Marlowe D, 2014, CONTEMP FAM THER, V36, P162, DOI 10.1007/s10591-013-9283-1; Montenegro H, 2011, J INTEGR CARE, V19, P5, DOI 10.1108/14769011111176707; Muir S, 2012, AM J OCCUP THER, V66, P506, DOI 10.5014/ajot.2012.665001; Munoz JP, 2006, OCCUP THER HEALTH CA, V20, P135, DOI [10.1300/J003v20n03_09, 10.1080/J003v20n03_09]; Murphy AD, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.712001; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Parmenter V, 2013, BRIT J OCCUP THER, V76, P242, DOI 10.4276/030802213X13679275042807; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Raphael-Greenfield E, 2012, OCCUP THER INT, V19, P135, DOI 10.1002/oti.1328; Roy L, J OCCUPATIONAL THERA, V84, P98; Rumball-Smith J, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-149; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Smith E, 2011, AUST OCCUP THER J, V58, P251, DOI 10.1111/j.1440-1630.2011.00944.x; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Thomas Y, 2011, OCCUP THER HEALTH CA, V25, P38, DOI 10.3109/07380577.2010.528554; Topolovec-Vranic J, 2013, BRAIN INJURY, V27, P1600, DOI 10.3109/02699052.2013.823666	43	3	3	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2020	65	2					321	330		10.3233/WOR-203084			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KX1JN	WOS:000521639000012	32007976				2022-02-06	
J	Miles, SR; Brenner, LA; Neumann, D; Hammond, FM; Ropacki, S; Tang, XY; Eapen, BC; Smith, A; Nakase-Richardson, R				Miles, Shannon R.; Brenner, Lisa A.; Neumann, Dawn; Hammond, Flora M.; Ropacki, Susan; Tang, Xinyu; Eapen, Blessen C.; Smith, Austin; Nakase-Richardson, Risa			Posttraumatic Stress Disorder Symptoms Contribute to Staff Perceived Irritability, Anger, and Aggression After TBI in a Longitudinal Veteran Cohort: A VA TBI Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Aggression; Anger; Brain injuries; traumatic; Rehabilitation; Stress disorders; post-traumatic; Veterans	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; BEHAVIOR; PREVALENCE; PTSD; HOSTILITY; VIOLENCE; VIETNAM; IRAQ	Objective: To examine the relationship between staff perceived irritability, anger, and aggression and posttraumatic stress disorder (PTSD) in veterans with traumatic brain injury (TBI) of all severity levels. Design: Longitudinal cohort design. Setting: Veterans Affairs Polytrauma Transitional Rehabilitation Programs. Participants: Veterans and service members with TBI of all severity levels enrolled in the Veterans Affairs Polytrauma Rehabilitation Centers' Traumatic Brain Injury Model System national database (N=240). Interventions: Not applicable. Main Outcome Measure: Univariable and multivariable logistic regression modeling was used to examine the association between irritability, anger, and aggression and potential risk factors, including PTSD symptoms. Irritability, anger, and aggression was measured as a single construct using an item from the Mayo-Portland Adaptability Inventory-4 that was rated by program staff at admission and discharge from the inpatient rehabilitation program. PTSD symptoms were assessed using the PTSD Checklist-Civilian Version. Results: PTSD symptoms uniquely predicted program staff-rated irritability, anger, and aggression at discharge even after controlling for severity of TBI, age, male sex, education, and annual earnings. The model explained 19% of the variance in irritability, anger, and aggression. Conclusions: When TBI severity and PTSD symptoms were considered simultaneously in a sample of veterans, only PTSD symptoms predicted staff-rated irritability, anger, and aggression. Given the negative outcomes linked with irritability, anger, and aggression, veterans may benefit from assessment and treatment of PTSD symptoms within rehabilitation settings. Published by Elsevier Inc.	[Miles, Shannon R.; Nakase-Richardson, Risa] James Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL USA; [Miles, Shannon R.] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsani Coll Med, Tampa, FL 33620 USA; [Brenner, Lisa A.] VHA Rocky Mt Mental Illness Res Educ & Clin Ctr, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Neumann, Dawn; Hammond, Flora M.] Indiana Univ, Sch Med, Indianapolis, IN USA; [Neumann, Dawn; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Ropacki, Susan] Palomar Med Ctr, Escondido, CA USA; [Tang, Xinyu] Tampa VA Res & Educ Fdn Inc, Tampa, FL USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Smith, Austin] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Smith, Austin] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Div Pulm & Sleep Med, Morsani Coll Med, Tampa, FL 33620 USA		Miles, SR (corresponding author), JAHVH, 13000 Bruce B Downs Blvd 117, Tampa, FL 33612 USA.	shannon.miles@va.gov	Miles, Shannon/AAS-2173-2021	Miles, Shannon/0000-0001-8925-1321	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position or any other federal agency, policy, or decision unless so designated by other official documentation. The participating agencies' institutional review boards approved this study, and informed consent was obtained after the details of the study were thoroughly explained to participants.	Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P314, DOI 10.1097/HTR.0b013e3182562f04; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Elbogen EB, 2014, BRIT J PSYCHIAT, V204, P368, DOI 10.1192/bjp.bp.113.134627; Foa E.B., 2007, PROLONGED EXPOSURE T; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hundt Natalie E, 2015, Psychol Trauma, V7, P539, DOI 10.1037/tra0000035; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Kelly G, 2008, BRAIN IMPAIR, V9, P293, DOI 10.1375/brim.9.3.293; Kim E, 2002, NEUROREHABILITATION, V17, P297; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lee TW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203753; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; Miles SR, 2017, AGGRESS VIOLENT BEH, V34, P147, DOI 10.1016/j.avb.2017.01.017; Miles SR, 2016, PSYCHOL SERV, V13, P170, DOI 10.1037/ser0000071; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Resick PA, 2010, COGNITIVE PROCESSING; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Rueve Marie E, 2008, Psychiatry (Edgmont), V5, P34; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; Weathers F.W., 1993, 9 ANN C ISTSS; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	42	3	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					81	88		10.1016/j.apmr.2019.07.018			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300009	31513779	Green Submitted			2022-02-06	
J	Moayeri, A; Niazi, H; Darvishi, M				Moayeri, Ardeshir; Niazi, Hedieh; Darvishi, Marzieh			Effect of Biocanin A in the Acute Phase of Diffuse Traumatic Brain Injury	INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH			English	Article						Phytoestrogens; Biochanin A; Diffuse Traumatic Brain Injury (DTBI); Astrogliosis	PROTECTS DOPAMINERGIC-NEURONS; INFLAMMATORY RESPONSE; SOY PHYTOESTROGENS; SPINAL-CORD; INHIBITION; BIOCHANIN; ESTROGEN; CORTEX; DAMAGE; RATS	Introduction: In various studies, administration of Biochanin A (BCA), aneuroprotective anticancer, anti-oxidant, anti-inflammatory, anti-allergic, anti-hyperglycemic and nti-hyperlipidemic effects Significantly decrease the injury in the brain associated with cell death and enhanced neurotransmitter release and activity. Biochanin A, the predominant phytoestrogens in the plant, mainly include isoflavones. Reports about the effect of phytoestrogens on the central nervous system, especially behavioral assessments, have been controversial. Thus, the aim of this study was to determine the neuroprotective and behavioral effects of Biochanin A in the acute phase following diffuse traumatic brain injury (DTBI) in male rats. Material & method: Male rats were given either Biochanin A or an equal volume of vehicle (DMSO; 50 mg/kg) at 1h after DTBI. Non-injured controls (three groups: with dimethyl sulfoxide (DMSO), and Biochanin A and one group that was untreated sham group) and DTBI (with DTBI and without treatment) animals were also included. The animals at 24h post trauma were evaluated daily over 12 days for motor and cognitive outcomes. After two weeks, the animals were perfused with 0.9% saline followed by 10% phosphate-buffered formalin. The whole brain was dissected and removed, sliced, and stained with Cresyl Fast Violet (dark cell) and immunohistochemistry (GFAP and caspase-3 positive cells). Result: Biochanin A decreased dark cell numbers (P<0.01) and reduced cerebral cortical levels of GFAF arid caspase-3 positive staining (respectively, P<0.0001 and P<0.0001). The researchers investigated the levels of brain edema in the injured animals and found that Biochanin A significantly increased the wet weight/dry weight ratios after brain injury (P<0.01). This increase was associated with an increase in permeability of the blood-brain barrier and was present up to 4 h post-injury, assessed using Evans blue dye (P<0.01). Conclusion: Biochanin A given acutely after injury decreased apoptotic-mediated cell death, dark cells and secondary injury with reduced astrogliosis. These results suggested that phytoestrogens such as Biochanin A might afford protection to those suffering from DTBI.	[Moayeri, Ardeshir; Niazi, Hedieh; Darvishi, Marzieh] Ilam Univ Med Sci, Fac Med, Dept Anat, Ilam, Iran		Darvishi, M (corresponding author), Ilam Univ Med Sci, Fac Med, Dept Anat, Ilam, Iran.	Darvish-m@medilam.ac.ir			Ilam University of Medical Sciences [951031/156]	This study was supported by Ilam University of Medical Sciences (951031/156) for the Study of Diffuse Traumatic Brain Injury and, the authors would like to thank the Biotechnology and Medicinal Plants Research Center of Ilam University of Medical Sciences, for their kind cooperation.	Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Chen HQ, 2007, NEUROSCI LETT, V417, P112, DOI 10.1016/j.neulet.2006.11.045; Chung MJ, 2013, LIFE SCI, V93, P401, DOI 10.1016/j.lfs.2013.07.019; Cruz MN, 2008, ATHEROSCLEROSIS, V196, P49, DOI 10.1016/j.atherosclerosis.2007.01.038; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Darvishi M, 2014, NEUROCHEM RES, V39, P2319, DOI 10.1007/s11064-014-1429-5; Deer RR, 2016, AM J PHYSIOL-HEART C, V310, pH1285, DOI 10.1152/ajpheart.00645.2015; Frink M, 2007, AM J PHYSIOL-LUNG C, V292, pL585, DOI 10.1152/ajplung.00364.2006; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Glushakov AO, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103151; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Hara Y, 2018, NEUROSCIENCE, V394, P303, DOI 10.1016/j.neuroscience.2018.09.021; Heberden C, 2017, BIOCHEM PHARMACOL, V141, P56, DOI 10.1016/j.bcp.2017.05.019; Hildebrand F, 2006, J LEUKOCYTE BIOL, V80, P759, DOI 10.1189/jlb.0406254; Jalaludeen A. M., 2015, ENV TOXICOLOGY PHARM, V39, P1231; Johnson RT, 2013, J COMP NEUROL, V521, P2298, DOI 10.1002/cne.23286; Khaksari M, 2005, IRAN J MED SCI, V30, P128; Khanna S, 2017, FASEB J, V31, P4533, DOI 10.1096/fj.201700353; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P258; Liu JYH, 2019, GEN COMP ENDOCR, V272, P63, DOI 10.1016/j.ygcen.2018.11.016; Liu YX, 2003, J PHARMACOL EXP THER, V305, P212, DOI 10.1124/jpet.102.043166; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mauvais-Jarvis F, 2016, TRENDS ENDOCRIN MET, V27, P844, DOI 10.1016/j.tem.2016.08.008; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Mulherkar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11113-3; Naghdi M, 2009, CYTOTHERAPY, V11, P137, DOI 10.1080/14653240802716582; Narita Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35303-9; Ozbek Z, 2017, TURK NEUROSURG, V27, P816, DOI 10.5137/1019-5149.JTN.18549-16.1; Pan Y, P SOC EXP BIOL MED, V221, P118; Pan YL, 1999, NEUROSCI LETT, V261, P17, DOI 10.1016/S0304-3940(98)00994-X; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Qiu L, 2012, MOL MED REP, V5, P222; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Sadri H, 2017, BRAZ ARCH BIOL TECHN, V60, DOI 10.1590/1678-4324-2017160741; Sayeed I, 2019, NEUROPHARMACOLOGY, V145, P292, DOI 10.1016/j.neuropharm.2018.09.013; Schreihofer DA, 2009, NEUROSCIENCE, V158, P602, DOI 10.1016/j.neuroscience.2008.10.003; Shimizu S, 1997, NEUROSCI LETT, V239, P125, DOI 10.1016/S0304-3940(97)00915-4; Strom JO, 2011, INT J MOL SCI, V12, P1533, DOI 10.3390/ijms12031533; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Topuridze M L, 2007, Georgian Med News, P38; TOUNY LHE, 2010, REJUV RES, V13, P527; van Duursen MBM, 2017, TOXICOL RES-UK, V6, P772, DOI 10.1039/c7tx00184c; Wang WB, 2015, J NEUROL SCI, V348, P121, DOI 10.1016/j.jns.2014.11.018; Wolf B, 1994, J BIOL CHEM, V274, P30651; Wu L, 2018, BEHAV NEUROL, V1960106, P1; Yarim M, 2004, ANAT HISTOL EMBRYOL, V33, P151, DOI 10.1111/j.1439-0264.2004.00525.x; Yu LJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00657; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001	54	3	3	0	1	INT JOURNAL PHARMACEUTICAL & PHYTOPHARMACOLOGICAL RESEARCH	MAHARASTRA	C/O MRS. ANJALI HARSHAL PAWAR, 613-E, MATRU-AMI APT, BEHIND NEW HIGH SCHOOL, KALYAN WEST, MAHARASTRA, 421 301, INDIA	2250-1029	2249-6084		INT J PHARM PHYTOPHA	Int. J. Pharm. Phytopharm. Res.		2020	10	1					77	86					10	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	LJ0IL	WOS:000529858000010					2022-02-06	
J	Morrison, TR; Kulkarni, P; Cai, XZ; Iriah, S; Aggarwal, D; Lu, SF; Simon, NG; Madularu, D; Ferrisa, CF				Morrison, Thomas R.; Kulkarni, Praveen; Cai, Xuezhu; Iriah, Sade; Aggarwal, Dipak; Lu, Shi-Fang; Simon, Neal G.; Madularu, Dan; Ferrisa, Craig F.			Treating head injury using a novel vasopressin 1a receptor antagonist	NEUROSCIENCE LETTERS			English	Article						Momentum exchange TBI; Neuroimaging; Resting state functional connectivity; Brain edema	TRAUMATIC BRAIN-INJURY; ARGININE-VASOPRESSIN; FUNCTIONAL CONNECTIVITY; AQP4 EXPRESSION; EDEMA FORMATION; AQUAPORIN-4; DAMAGE; V-1A; MODEL; BLOOD	Arginine vasopressin (AVP) is a chemical signal in the brain that influences cerebral vascular resistance and brain water permeability. Increases in AVP contribute to the pathophysiology of brain edema following traumatic brain injury (TBI). These effects are mediated through AVP V1a receptors that are expressed in cortical and subcortical brain areas. This exploratory study characterizes the effects of a novel, V1a receptor antagonist, AVN576, on behavioral and magnetic resonance imaging (MRI) measures after severe TBI. Male Sprague Dawley rats were impacted twice producing contusions in the forebrain, putative cerebral edema, and cognitive deficits. Rats were treated with AVN576 after initial impact for 5 days and then tested for changes in cognition. MRI was used to assess brain injury, enlargement of the ventricles, and resting state functional connectivity. Vehicle treated rats had significant deficits in learning and memory, enlarged ventricular volumes, and hypoconnectivity in hippocampal circuitry. AVN576 treatment eliminated the enlargement of the lateral ventricles and deficits in cognitive function while increasing connectivity in hippocampal circuitry. These data corroborate the extensive literature that drugs selectively targeting the AVP V1 a receptor could be used to treat TBI in the clinic.	[Morrison, Thomas R.; Kulkarni, Praveen; Cai, Xuezhu; Iriah, Sade; Aggarwal, Dipak; Madularu, Dan; Ferrisa, Craig F.] Northeastern Univ, Ctr Translat NeuroImaging, Boston, MA 02115 USA; [Ferrisa, Craig F.] Dept Psychol & Pharmaceut Sci, Boston, MA USA; [Lu, Shi-Fang; Simon, Neal G.] Azevan Pharmaceut, Bethlehem, PA USA; [Lu, Shi-Fang; Simon, Neal G.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA		Ferrisa, CF (corresponding author), Northeastern Univ, Dept Psychol, Ctr Translat NeuroImaging, Boston, MA 02115 USA.	c.ferrris@northeastern.edu		Kulkarni, Praveen/0000-0002-8876-4544	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH063663, MH087001]; Azevan Pharmaceuticals, Inc.	The authors wish to thank Simone Grant for her help during behavior data collection and analysis in the completion of this document. We also want to thank Drs. Gary Koppel and Fred Bruns for the original development and optimization of the beta lactam platform. Development of AVN567 was funded by grants MH063663 and MH087001 from the National Institutes of Health. This work is also funded in part by Azevan Pharmaceuticals, Inc.	Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Brody David L, 2015, Handb Clin Neurol, V127, P267, DOI 10.1016/B978-0-444-52892-6.00017-9; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Cai XZ, 2019, BRAIN RES, V1706, P58, DOI 10.1016/j.brainres.2018.10.033; Carney NA, 2016, PEDIATR CRIT CARE ME, V17, P658, DOI 10.1097/PCC.0000000000000772; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Fabio KM, 2013, J PHARM SCI-US, V102, P2033, DOI 10.1002/jps.23495; Filippidis AS, 2014, J NEUROTRAUM, V31, P1258, DOI 10.1089/neu.2013.3063; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Guillon CD, 2007, BIOORGAN MED CHEM, V15, P2054, DOI 10.1016/j.bmc.2006.12.031; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Huang WD, 2008, J ENDOCRINOL INVEST, V31, P996, DOI 10.1007/BF03345638; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Kozniewska E, 2008, J PHYSIOL PHARMACOL, V59, P109; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2003, ACT NEUR S, V86, P7; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Morrison Thomas R, 2014, Curr Top Behav Neurosci, V17, P189, DOI 10.1007/7854_2014_283; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rossi-Mossuti F, 2016, J NEUROL SURG PART A, V77, P36, DOI 10.1055/s-0035-1563556; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Samadani U., 2017, AANS NEUROSURGEON, V26, P1; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079328; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Tang Q, 2016, PROCEEDINGS 2016 THIRD INTERNATIONAL CONFERENCE ON TRUSTWORTHY SYSTEMS AND THEIR APPLICATIONS (TSA), P17, DOI 10.1109/TSA.2016.13; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xu Miao, 2007, Chin J Traumatol, V10, P90; Young LJ, 1999, J NEUROENDOCRINOL, V11, P291; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	76	3	3	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 1	2020	714								134565	10.1016/j.neulet.2019.134565			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW2JU	WOS:000502884800018	31639422				2022-02-06	
J	Ojo, JO; Crynen, G; Algamal, M; Vallabhaneni, P; Leary, P; Mouzon, B; Reed, JM; Mullan, M; Crawford, F				Ojo, Joseph O.; Crynen, Gogce; Algamal, Moustafa; Vallabhaneni, Prashanti; Leary, Paige; Mouzon, Benoit; Reed, Jon M.; Mullan, Michael; Crawford, Fiona			Unbiased Proteomic Approach Identifies Pathobiological Profiles in the Brains of Preclinical Models of Repetitive Mild Traumatic Brain Injury, Tauopathy, and Amyloidosis	ASN NEURO			English	Article						TBI; proteomics; molecular pathobiology; amyloidosis; tauopathy; neurodegeneration	ALZHEIMERS-DISEASE BRAIN; OXIDATIVELY MODIFIED PROTEINS; SEVERE HEAD-INJURY; KNOCK-IN MICE; PRECURSOR-PROTEIN; MOUSE MODEL; COGNITIVE IMPAIRMENT; NITRATED PROTEINS; RISK-FACTOR; BETA	No concerted investigation has been conducted to explore overlapping and distinct pathobiological mechanisms between repetitive mild traumatic brain injury (r-mTBI) and tau/amyloid proteinopathies considering the long history of association between TBI and Alzheimer's disease. We address this problem by using unbiased proteomic approaches to generate detailed time-dependent brain molecular profiles of response to repetitive mTBI in C57BL/6 mice and in mouse models of amyloidosis (with amyloid precursor protein KM670/671NL (Swedish) and Presenilin 1 M146L mutations [PSAPP]) and tauopathy (hTau). Brain tissues from animals were collected at different timepoints after injuries (24 hr-12 months post-injury) and at different ages for tau or amyloid transgenic models (3, 9, and 15 months old), encompassing the pre-, peri-, and post-"onset" of cognitive and pathological phenotypes. We identified 30 hippocampal and 47 cortical proteins that were significantly modulated over time in the r-mTBI compared with sham mice. These proteins identified TBI-dependent modulation of phosphatidylinositol-3-kinase/AKT signaling, protein kinase A signaling, and PPAR alpha/RXR alpha activation in the hippocampus and protein kinase A signaling, gonadotropin-releasing hormone signaling, and B cell receptor signaling in the cortex. Previously published neuropathological studies of our mTBI model showed a lack of amyloid and tau pathology. In PSAPP mice, we identified 19 proteins significantly changing in the cortex and only 7 proteins in hTau mice versus wild-type littermates. When we explored the overlap between our r-mTBI model and the PSAPP/hTau models, a fairly small coincidental change was observed involving only eight significantly regulated proteins. This work suggests a very distinct TBI neurodegeneration and also that other factors are needed to drive pathologies such as amyloidosis and tauopathy postinjury.	[Ojo, Joseph O.; Crynen, Gogce; Algamal, Moustafa; Vallabhaneni, Prashanti; Leary, Paige; Mouzon, Benoit; Reed, Jon M.; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Expt Neuropathol & Prote Lab, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Ojo, Joseph O.; Mouzon, Benoit; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Ojo, Joseph O.; Crynen, Gogce; Algamal, Moustafa; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England; [Reed, Jon M.] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA		Ojo, JO (corresponding author), Roskamp Inst, Expt Neuropathol & Prote Lab, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	jojo@roskampinstitute.org		Algamal, Moustafa/0000-0002-6215-0122	Congressionally Directed Medical Research Program (CDMRP)United States Department of Defense [DOD/W81XWH-13-1-0253]; Roskamp Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by the Congressionally Directed Medical Research Program (CDMRP) award to Fiona Crawford (DOD/W81XWH-13-1-0253) and by the Roskamp Foundation. The content presented does not express the views of the Department of Defense or Veteran Affairs or the United States Government.	Abdul HM, 2008, FREE RADICAL BIO MED, V45, P1420, DOI 10.1016/j.freeradbiomed.2008.08.012; Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Begcevic I, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-5; Boyd-Kimball D, 2005, NEUROSCIENCE, V132, P313, DOI 10.1016/j.neuroscience.2004.12.022; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Butterfield DA, 2003, CELL MOL BIOL, V49, P747; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0; Chang SH, 2013, BIOCHEM BIOPH RES CO, V430, P670, DOI 10.1016/j.bbrc.2012.11.093; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Di Francesco L, 2012, PROTEOMICS, V12, P124, DOI 10.1002/pmic.201100113; Ding J, 2015, ARQ NEURO-PSIQUIAT, V73, P342, DOI 10.1590/0004-282X20150006; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Evans Teresa M, 2014, Transl Proteom, V3, P10; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Foldi Istvan, 2011, J Neurochem, V117, P691, DOI 10.1111/j.1471-4159.2011.07238.x; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; HARRIS ME, 1995, EXP NEUROL, V131, P193, DOI 10.1016/0014-4886(95)90041-1; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon B, 2018, BRAIN INJURY, V32, P1285, DOI 10.1080/02699052.2018.1486457; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Neuner SM, 2017, BEHAV BRAIN RES, V322, P288, DOI 10.1016/j.bbr.2016.06.002; Ojo JO, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00405; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Robinson RAS, 2011, NEUROSCIENCE, V177, P207, DOI 10.1016/j.neuroscience.2011.01.005; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Shi X, 2011, NEUROSCI LETT, V500, P87, DOI 10.1016/j.neulet.2011.06.009; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Song H, 2018, J PROTEOME RES, V17, P858, DOI 10.1021/acs.jproteome.7b00618; Song HL, 2019, J NEUROTRAUM, V36, P1591, DOI 10.1089/neu.2018.6114; Standring OJ, 2019, ACTA NEUROPATHOL, V138, P401, DOI 10.1007/s00401-019-02031-x; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004; Sultana R, 2007, J ALZHEIMERS DIS, V11, P153; Sultana R, 2006, J NEUROSCI RES, V84, P409, DOI 10.1002/jnr.20876; Sultana R, 2011, J PROTEOMICS, V74, P2430, DOI 10.1016/j.jprot.2011.06.015; Sultana R, 2009, J BIOENERG BIOMEMBR, V41, P441, DOI 10.1007/s10863-009-9241-7; Sultana R, 2009, ACTA NEUROPATHOL, V118, P131, DOI 10.1007/s00401-009-0517-0; Swomley AM, 2015, ARCH TOXICOL, V89, P1669, DOI 10.1007/s00204-015-1556-z; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048; Woltjer RL, 2005, FASEB J, V19, P1923, DOI 10.1096/fj.05-4263fje; Yatin Servet M., 2000, Journal of Alzheimer's Disease, V2, P123; Yatin SM, 1999, NEUROBIOL AGING, V20, P325; Zakirova Z., 2017, PROTEOM CLIN APPL, V11, P9	81	3	3	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	JAN	2020	12								1759091420914768	10.1177/1759091420914768			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LA1EQ	WOS:000523698500001	32241177	Green Published, Green Accepted, gold			2022-02-06	
J	Pieper, J; Chang, DLG; Mahasin, SZ; Swan, AR; Quinto, AA; Nichols, SL; Diwakar, M; Huang, CL; Swan, J; Lee, RLR; Baker, DG; Huang, MX				Pieper, Joel; Chang, Douglas G.; Mahasin, Sarah Z.; Swan, Ashley Robb; Quinto, Annemarie Angeles; Nichols, Sharon L.; Diwakar, Mithun; Huang, Charles; Swan, James; Lee, Roland R.; Baker, Dewleen G.; Huang, Mingxiong			Brain Amygdala Volume Increases in Veterans and Active-Duty Military Personnel With Combat-Related Posttraumatic Stress Disorder and Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amygdala; brain concussion; brain injuries; magnetic resonance imaging; neuroanatomy; posttraumatic; stress disorders; traumatic	POSTCONCUSSIVE SYMPTOMS; INTRACRANIAL VOLUME; MANUAL SEGMENTATION; SCORING RULES; PTSD; RISK; NORMALIZATION; CONNECTIVITY; METAANALYSIS; HIPPOCAMPAL	Objective: To identify amygdalar volumetric differences associated with posttraumatic stress disorder (PTSD) in individuals with comorbid mild traumatic brain injury (mTBI) compared with those with mTBI-only and to examine the effects of intracranial volume (ICV) on amygdala volumetric measures. Setting: Marine Corps Base and VA Healthcare System. Participants: A cohort of veterans and active-duty military personnel with combat-related mTBI (N = 89). Design: Twenty-nine participants were identified with comorbid PTSD and mTBI. The remaining 60 formed the mTBI-only control group. Structural images of brains were obtained with a 1.5-T MRI scanner using a T1-weighted 3D-IR-FSPGR pulse sequence. Automatic segmentation was performed in Freesurfer. Main Measures: Amygdala volumes with/without normalizations to ICV. Results: The comorbid mTBI/PTSD group had significantly larger amygdala volumes, when normalized to ICV, compared with the mTBI-only group. The right and left amygdala volumes after normalization to ICV were 0.122% +/- 0.012% and 0.118% +/- 0.011%, respectively, in the comorbid group compared with 0.115% +/- 0.012% and 0.112% +/- 0.009%, respectively, in the mTBI-only group (corrected P < .05). Conclusions: The ICV normalization analysis performed here may resolve previous literature discrepancies. This is an intriguing structural finding, given the role of the amygdala in the challenging neuroemotive symptoms witnessed in casualties of combat-related mTBI and PTSD.	[Pieper, Joel] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Chang, Douglas G.] Univ Calif San Diego, Dept Orthopaed Surg, San Diego, CA 92103 USA; [Swan, Ashley Robb; Quinto, Annemarie Angeles; Lee, Roland R.; Baker, Dewleen G.; Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, Res & Psychiat Serv, San Diego, CA 92103 USA; [Swan, Ashley Robb; Quinto, Annemarie Angeles; Lee, Roland R.; Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Nichols, Sharon L.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Mahasin, Sarah Z.] King Saud Univ, Coll Med, Riyadh, Saudi Arabia; [Diwakar, Mithun] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Huang, Charles] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Swan, James] San Diego State Univ, Dept Management Informat Syst, San Diego, CA 92182 USA; [Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu	Baker, Dewleen/O-4957-2019; Mahasin, Sarah/O-5182-2019	Baker, Dewleen/0000-0002-1736-9838; Mahasin, Sarah/0000-0003-2914-7279	Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX000499, MHBA-010-14F, I01-RX001988, B1988-I, NURC-022-10F, NEUC-044-06S]; Naval Medical Research Center's Advanced Medical Development program (Naval Medical Logistics Command) [N62645-11-C-4037]; NIH Short Term Research Training Grant (NHLBI) [T35 HL007491]; University of California, San Diego, Health Sciences International program	This work was supported in part by Merit Review Grants from the Department of Veterans Affairs (I01-CX000499, MHBA-010-14F, I01-RX001988, B1988-I, NURC-022-10F, and NEUC-044-06S) and Naval Medical Re-search Center's Advanced Medical Development program (Naval Medical Logistics Command Contract #N62645-11-C-4037, for MRS-II). This research was also supported by the NIH Short Term Research Training Grant (NHLBI) T35 HL007491. The authors thank staff at the VA Healthcare System and the Veterans Medical Research Foundation (VRMF). The authors also thank the participating military and veteran volunteers for their military service and participation in this study, as well as the University of California, San Diego, Health Sciences International program for their support.	Bajaj S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00412; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett MR, 2014, PROG NEUROBIOL, V112, P80, DOI 10.1016/j.pneurobio.2013.10.005; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cacciaglia R, 2017, PSYCHONEUROENDOCRINO, V76, P19, DOI 10.1016/j.psyneuen.2016.11.012; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cui H, 2008, NEUROSCIENCE, V152, P703, DOI 10.1016/j.neuroscience.2007.12.028; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Eritaia J, 2000, MAGN RESON MED, V44, P973, DOI 10.1002/1522-2594(200012)44:6<973::AID-MRM21>3.0.CO;2-H; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howlett JR, 2016, TRANSLATIONAL RES TR; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Kuo JR, 2012, ARCH GEN PSYCHIAT, V69, P1080, DOI 10.1001/archgenpsychiatry.2012.73; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; McIntyre C.K., 2007, NEURAL PLASTICITY ME, DOI DOI 10.1201/9781420008418.CH13; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Padival MA, 2013, NEUROSCIENCE, V246, P230, DOI 10.1016/j.neuroscience.2013.04.061; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Renshaw KD, 2011, J AFFECT DISORDERS, V128, P321, DOI 10.1016/j.jad.2010.07.022; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Saygin ZM, 2017, NEUROIMAGE, V155, P370, DOI 10.1016/j.neuroimage.2017.04.046; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Spadoni AD, 2018, CURR TOP BEHAV NEURO, V38, P163, DOI 10.1007/7854_2017_35; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2002, J NEUROSCI, V22, P6810; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Whitwell JL, 2001, AM J NEURORADIOL, V22, P1483; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Yehuda R, 2013, PSYCHONEUROENDOCRINO, V38, P1912, DOI 10.1016/j.psyneuen.2013.06.009; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	65	3	4	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		E1	E9		10.1097/HTR.0000000000000492			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300001	31033749	Green Accepted			2022-02-06	
J	Popescu, M; Popescu, EA; DeGraba, TJ; Hughes, JD				Popescu, Mihai; Popescu, Elena-Anda; DeGraba, Thomas J.; Hughes, John D.			Altered modulation of beta band oscillations during memory encoding is predictive of lower subsequent recognition performance in post-traumatic stress disorder	NEUROIMAGE-CLINICAL			English	Article						Post-traumatic stress disorder; Memory encoding; Beta band oscillations; Magnetoencephalography	TRAUMATIC BRAIN-INJURY; PARAHIPPOCAMPAL PLACE AREA; SLEEP ONSET PERIOD; GAMMA OSCILLATIONS; NEURAL ACTIVITY; PSYCHIATRIC-DISORDERS; COGNITIVE PERFORMANCE; ORBITOFRONTAL CORTEX; ENTORHINAL CORTEX; COMBAT VETERANS	We studied the relationship between electrophysiological markers of memory encoding, subsequent recognition performance, and severity of PTSD symptoms in service members with combat exposure (n. = 40, age: 41.2 +/- 7.2 years) and various levels of PTSD symptom severity assessed using the PTSD Check List for DSM V version (PCL-5). Brain activity was recorded using magnetoencephalography during a serial presentation of 86 images of outdoor scenes that were studied by participants for an upcoming recognition test. In a second session, the original images were shown intermixed with an equal number of novel images while participants performed the recognition task. Participants recognized 76.0% +/- 12.1% of the original images and correctly categorized as novel 89.9% +/- 7.0% of the novel images. A negative correlation was present between PCL-5 scores and discrimination performance (Spearman r(s) = -0.38, p = 0.016). PCL-5 scores were also negatively correlated with the recognition accuracy for original images (r(s) = -0.37, p = 0.02). Increases in theta and gamma power and decreases in alpha and beta power were observed over distributed brain networks during memory encoding. Higher PCL-5 scores were associated with less suppression of beta band power in bilateral ventral and medial temporal regions and in the left orbitofrontal cortex. These regions also showed positive correlations between the magnitude of suppression of beta power during encoding and subsequent recognition accuracy. These findings indicate that the lower recognition performance in participants with greater PTSD symptom severity may be due in part to ineffective encoding reflected in altered modulation of beta band oscillatory activity.	[Popescu, Mihai; Popescu, Elena-Anda; DeGraba, Thomas J.; Hughes, John D.] Natl Intrepid Ctr Excellence, Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Hughes, John D.] Walter Reed Army Inst Res, Behav Biol Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Hughes, JD (corresponding author), Walter Reed Army Inst Res, Behav Biol Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	john.d.hughes4.ctr@mail.mil					Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Association A.P., 2013, DIAGN STAT MAN MENT, P271; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Bangasser DA, 2015, HORM BEHAV, V76, P125, DOI 10.1016/j.yhbeh.2015.04.003; Bastin J, 2013, J NEUROSCI, V33, P10123, DOI 10.1523/JNEUROSCI.4646-12.2013; Baxter MG, 2007, J NEUROSCI, V27, P11327, DOI 10.1523/JNEUROSCI.3369-07.2007; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Breakspear M, 2004, J COMPUT NEUROSCI, V16, P49, DOI 10.1023/B:JCNS.0000004841.66897.7d; Bremner JD, 2004, J NERV MENT DIS, V192, P643, DOI 10.1097/01.nmd.0000142027.52893.c8; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Colombo MA, 2016, SLEEP, V39, P1015, DOI 10.5665/sleep.5744; Corsi-Cabrera M, 2012, SLEEP, V35, P501, DOI 10.5665/sleep.1734; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickie EW, 2008, NEUROPSYCHOLOGIA, V46, P1522, DOI 10.1016/j.neuropsychologia.2008.01.007; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Donner TH, 2007, J NEUROPHYSIOL, V98, P345, DOI 10.1152/jn.01141.2006; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Etkin A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aal3236; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; FREEDMAN RR, 1986, ELECTROEN CLIN NEURO, V63, P408, DOI 10.1016/0013-4694(86)90122-7; Frey S, 2000, P NATL ACAD SCI USA, V97, P8723, DOI 10.1073/pnas.140543497; Frey S, 2002, NEURON, V36, P171, DOI 10.1016/S0896-6273(02)00901-7; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Guez J, 2011, J TRAUMA STRESS, V24, P260, DOI 10.1002/jts.20635; Haegens S, 2014, P NATL ACAD SCI USA, V111, pE1797, DOI 10.1073/pnas.1405516111; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Hanslmayr S, 2011, J NEUROSCI, V31, P15674, DOI 10.1523/JNEUROSCI.3140-11.2011; Hanslmayr S, 2009, CEREB CORTEX, V19, P1631, DOI 10.1093/cercor/bhn197; Hoffman RE, 2001, NEUROSCIENTIST, V7, P441, DOI 10.1177/107385840100700513; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Insausti R, 2008, J COMP NEUROL, V509, P608, DOI 10.1002/cne.21753; Jaycox, 2008, INVISIBLE WOUNDS WAR; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Kamps FS, 2016, NEUROIMAGE, V132, P417, DOI 10.1016/j.neuroimage.2016.02.062; Kay DB, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7030023; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khanna MM, 2017, PSYCHOL MED, V47, P2017, DOI 10.1017/S0033291717000460; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P47, DOI 10.1016/S0167-8760(96)00054-2; Kondo H, 2005, J COMP NEUROL, V493, P479, DOI 10.1002/cne.20796; Kopell N, 2011, P NATL ACAD SCI USA, V108, P3779, DOI 10.1073/pnas.1019676108; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamarche CH, 1997, SLEEP, V20, P724; Liu Y, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-6; Long NM, 2014, NEUROIMAGE, V84, P488, DOI 10.1016/j.neuroimage.2013.08.052; MERICA H, 1992, PHYSIOL BEHAV, V52, P199, DOI 10.1016/0031-9384(92)90258-4; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Meyer T, 2017, J BEHAV THER EXP PSY, V54, P120, DOI 10.1016/j.jbtep.2016.07.010; Meyer T, 2013, COGN AFFECT BEHAV NE, V13, P186, DOI 10.3758/s13415-012-0123-9; Michael T, 2005, BEHAV RES THER, V43, P613, DOI 10.1016/j.brat.2004.04.006; Misic B, 2016, J NEUROSCI, V36, P419, DOI 10.1523/JNEUROSCI.1506-15.2016; Morton NW, 2017, NEUROIMAGE, V147, P692, DOI 10.1016/j.neuroimage.2016.12.049; Mueller-Pfeiffer C, 2013, NEUROIMAGE-CLIN, V3, P531, DOI 10.1016/j.nicl.2013.08.009; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; Ohayon MM, 2000, COMPR PSYCHIAT, V41, P469, DOI 10.1053/comp.2000.16568; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Piantoni G, 2010, J VISION, V10, DOI 10.1167/10.13.18; Popescu M, 2019, CLIN NEUROPHYSIOL, V130, P1869, DOI 10.1016/j.clinph.2019.06.227; Popescu M, 2017, NEUROIMAGE-CLIN, V15, P741, DOI 10.1016/j.nicl.2017.06.029; Popescu M, 2016, CLIN NEUROPHYSIOL, V127, P3075, DOI 10.1016/j.clinph.2016.06.004; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Spitzer B, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0170-17.2017; Spitzer B, 2010, J NEUROSCI, V30, P4496, DOI 10.1523/JNEUROSCI.6041-09.2010; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Waldhauser GT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31400-x; Wolynczyk-Gmaj D, 2011, ACTA NEUROBIOL EXP, V71, P387; Yehuda R, 2005, J CLIN EXP NEUROPSYC, V27, P504, DOI 10.1080/138033990520223; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	108	3	3	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	25								102154	10.1016/j.nicl.2019.102154			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU2JR	WOS:000519535200002	31951934	Green Published, gold			2022-02-06	
J	Prince, J; Schussler, E; McCann, R				Prince, Janelle; Schussler, Eric; McCann, Ryan			Rehabilitation Utilizing Controlled Aerobic Activity in Patients With a Concussion: A Critically Appraised Topic	JOURNAL OF SPORT REHABILITATION			English	Article						postconcussion syndrome; mild traumatic brain injury; submaximal exercise; rest; therapeutic exercise	EXERCISE; EPIDEMIOLOGY; BENEFITS; CHILDREN; QUALITY; IMPACT	Clinical Scenario: A sport-related concussion is a common injury to the brain that may cause a variety of symptoms ranging in duration and severity. The mainstay of treatment for concussion has been rest, followed by a stepwise return to activity. This recovery process may be lengthy when symptoms persist. Aerobic exercise conducted at subsymptom and submaximal intensities has been proposed as a potential intervention for symptoms following a concussion. Therefore, the purpose of this critically appraised topic is to examine the safety of varying aerobic exercise intensities in patients with a concussion. Focused Clinical Question: Are subsymptom and submaximal exercise programs safe when implemented in a population with a symptomatic sports-related concussion when compared with traditional rest? Summary of Key Findings: Four randomized controlled trials were included for critical appraisal. The 4 studies investigated supervised and controlled aerobic exercise as early as within 1 week of with a concussion; all studies conclude that exercise is safe and may be of benefit to individuals with a concussion. Two studies support the use of submaximal exercise as a therapeutic intervention for adolescents with persistent concussion symptoms. Clinical Bottom Line: The authors conclude that controlled exercise performed within the symptom or exertion threshold of patients with concussion is safe compared with rest. It was noted that symptom changes may occur; however, the changes did not have a negative impact on long-term recovery. This research should ease concerns about prescribing physical activity when an athlete with concussion is still experiencing lingering symptoms. While specific parameters of the activity performed have not been described in detail, the individualization of each exercise program was stressed. Strength of Recommendation: Grade A.	[Prince, Janelle; Schussler, Eric; McCann, Ryan] Old Dominion Univ, Sch Rehabil Sci, Norfolk, VA 23529 USA		McCann, R (corresponding author), Old Dominion Univ, Sch Rehabil Sci, Norfolk, VA 23529 USA.	rmccann@odu.edu		Schussler, Eric/0000-0002-0101-0986			Balady GJ, 2000, ACSMS GUIDELINES EXE; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Cotman CW, 2002, EXERC SPORT SCI REV, V30, P75, DOI 10.1097/00003677-200204000-00006; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Maher CG, 2003, PHYS THER REHABIL J, V83, P713, DOI 10.1093/ptj/83.8.713; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeag DB, 2009, CLIN J SPORT MED, V19, P343, DOI 10.1097/JSM.0b013e3181b2c114; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	24	3	3	5	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2020	29	1					122	126		10.1123/jsr.2018-0224			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LX7LQ	WOS:000540009300017	31094622	Bronze			2022-02-06	
J	Quintana, C; Heebner, NR; Olson, AD; Abt, JP; Hoch, MC				Quintana, C.; Heebner, N. R.; Olson, A. D.; Abt, J. P.; Hoch, M. C.			Sport-specific differences in dynamic visual acuity and gaze stabilization in division-I collegiate athletes	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article							HIGH-SCHOOL; CONCUSSION; DIZZINESS; RELIABILITY; DISORDERS; STABILITY; INJURY; CHART	BACKGROUND: The vestibular-ocular reflex (VOR) integrates the vestibular and ocular systems to maintain gaze during head motion. This reflex is often negatively affected following sport-related concussion. Objective measures of gaze stability, a function mediated by the VOR, such as the computerized dynamic visual acuity test (DVAT) and gaze stabilization test (GST), may have utility in concussion management. However, normative data specific to sport, sex, or concussion history have not been established in collegiate athletes. OBJECTIVE: The objective of this study was to establish normative values for the DVAT and GST in collegiate athletes and explore the effect of sport, sex, and concussion history on VOR assessments. METHODS: The DVAT and GST were completed by 124 collegiate athletes (72 male, 52 female, mean +/- SD, age: 19.71 +/- 1.74 years, height: 173.99 +/- 13.97 cm, weight: 80.06 +/- 26.52 kg) recruited from Division-I athletic teams (foot-ball, soccer and cheerleading). The DVAT and GST were performed in the rightward and leftward directions during a single session in a standardized environment. Normative values for DVAT and GST measures were expressed as percentiles. Non-parametric statistics were used to compare differences between groups based on sex, sport, and concussion history. Alpha was set a-priori at 0.05. RESULTS: Overall, the median LogMAR unit for 124 athletes completing the DVAT was 0 (IQR = 0.17) for both leftward and rightward. The median velocities achieved on the GST were 145 degrees/sec and 150 degrees/sec (IQR = 45 and 40) for the leftward and rightward directions respectively. Significant differences were observed between sports (p = 0.001-0.17) for the GST with cheerleading demonstrating higher velocities than the other sports. However, no significant differences were identified based on sex (p >= 0.09) or history of concussion (p >= 0.15). CONCLUSIONS: Normative estimates for the DVAT and GST may assist in the clinical interpretation of outcomes when used in post-concussion evaluation for collegiate athletes. Although sex and previous concussion history had no effect on the DVAT or GST, performance on these measures may be influenced by type of sport. Sport-related differences in the GST may reflect VOR adaptations based on individual sport-specific demands.	[Quintana, C.] Calif State Univ Fresno, Coll Hlth & Human Serv, Dept Kinesiol, 5275 N Campus Dr M-S SG28, Fresno, CA 93740 USA; [Heebner, N. R.; Hoch, M. C.] Univ Kentucky, Coll Hlth Sci, Sports Med Res Inst, Lexington, KY USA; [Olson, A. D.] Univ Kentucky, Coll Hlth Sci, Dept Commun Sci & Disorders, Lexington, KY USA; [Abt, J. P.] Childrens Hlth Andrews Inst Orthopaed & Sports Me, Plano, TX USA		Quintana, C (corresponding author), Calif State Univ Fresno, Coll Hlth & Human Serv, Dept Kinesiol, 5275 N Campus Dr M-S SG28, Fresno, CA 93740 USA.	quintana@csufresno.edu					Alpini D, 2009, SPORT SCI HLTH, V5, P129, DOI DOI 10.1007/S11332-009-0088-4; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Dancey CP, 2004, STAT MATHS PSYCHOL U; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hain TC., 2007, VESTIBULAR REHABILIT, V3, P2; Hazel CA, 2002, OPTOMETRY VISION SCI, V79, P788, DOI 10.1097/00006324-200212000-00011; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Holladay JT, 1997, J REFRACT SURG, V13, P388; ISHIGAKI H, 1993, PERCEPT MOTOR SKILL, V77, P835, DOI 10.2466/pms.1993.77.3.835; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pritcher MR, 2008, OTOL NEUROTOL, V29, P982, DOI 10.1097/MAO.0b013e31818457fb; Rosser DA, 2001, BRIT J OPHTHALMOL, V85, P432, DOI 10.1136/bjo.85.4.432; Tascioglu A. B., 2005, NEUROANATOMY, V4, P24	26	3	3	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2020	30	4					249	257		10.3233/VES-200710			9	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	OH6PS	WOS:000582717000003	32925127	Green Published			2022-02-06	
J	Ralston, JD; Raina, A; Benson, BW; Peters, RM; Roper, JM; Ralston, AB				Ralston, John D.; Raina, Ashutosh; Benson, Brian W.; Peters, Ryan M.; Roper, Joshua M.; Ralston, Andreas B.			Physiological Vibration Acceleration (Phybrata) Sensor Assessment of Multi-System Physiological Impairments and Sensory Reweighting Following Concussion	MEDICAL DEVICES-EVIDENCE AND RESEARCH			English	Article						wearable sensor; physiological vibration acceleration; concussion; multi-system impairment; sensory reweighting	TRAUMATIC BRAIN-INJURY; WHOLE-BODY VIBRATION; GALVANIC VESTIBULAR STIMULATION; SPORTS-RELATED CONCUSSION; CENTER-OF-MASS; POSTURAL CONTROL; BALANCE CONTROL; MUSCLE VIBRATION; BLOOD BIOMARKERS; OPEN-LOOP	Objective: To assess the utility of a head-mounted wearable inertial motion unit (IMU)-based physiological vibration acceleration ("phybrata") sensor to support the clinical diagnosis of concussion, classify and quantify specific concussion-induced physiological system impairments and sensory reweighting, and track individual patient recovery trajectories. Methods: Data were analyzed from 175 patients over a 12-month period at three clinical sites. Comprehensive clinical concussion assessments were first completed for all patients, followed by testing with the phybrata sensor. Phybrata time series data and spatial scatter plots, eyes open (Eo) and eyes closed (Ec) phybrata powers, average power (Eo+Ec)/2, Ec/Eo phybrata power ratio, time-resolved phybrata spectral density (TRPSD) distributions, and receiver operating characteristic (ROC) curves are compared for individuals with no objective impairments and those clinically diagnosed with concussions and accompanying vestibular impairment, other neurological impairment, or both vestibular and neurological impairments. Finally, pre- and post-injury phybrata case report results are presented for a participant who was diagnosed with a concussion and subsequently monitored during treatment, rehabilitation, and return-to-activity clearance. Results: Phybrata data demonstrate distinct features and patterns for individuals with no discernable clinical impairments, diagnosed vestibular pathology, and diagnosed neurological pathology. ROC curves indicate that the average power (Eo+Ec)/2 may be utilized to support clinical diagnosis of concussion, while Eo and Ec/Eo may be utilized as independent measures to confirm accompanying neurological and vestibular impairments, respectively. All 3 measures demonstrate area under the curve (AUC), sensitivity, and specificity above 90% for their respective diagnoses. Phybrata spectral analyses demonstrate utility for quantifying the severity of concussion-induced physiological impairments, sensory reweighting, and subsequent monitoring of improvements throughout treatment and rehabilitation. Conclusion: Phybrata testing assists with objective concussion diagnosis and provides an important adjunct to standard concussion assessment tools by objectively ascertaining neurological and vestibular impairments, guiding targeted rehabilitation strategies, monitoring recovery, and assisting with return-to-sport/work/learn decision-making.	[Ralston, John D.; Roper, Joshua M.; Ralston, Andreas B.] PROTXX Inc, Menlo Pk, CA 94025 USA; [Raina, Ashutosh] Ctr Excellence Pediat Neurol, Rocklin, CA 95765 USA; [Raina, Ashutosh] Concuss Med Clin, Rocklin, CA 95765 USA; [Benson, Brian W.] Benson Concuss Inst, Calgary, AB T3B 6B7, Canada; [Benson, Brian W.] Canadian Sport Inst Calgary, Calgary, AB T3B 5R5, Canada; [Peters, Ryan M.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Peters, Ryan M.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada		Ralston, JD (corresponding author), PROTXX Inc, Menlo Pk, CA 94025 USA.	john.ralston@protxx.com		Ralston, John/0000-0002-8092-9076			Agostini JV, 2004, J AM GERIATR SOC, V52, P1719, DOI 10.1111/j.1532-5415.2004.52467.x; Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Amblard B, 1997, EXP BRAIN RES, V114, P214, DOI 10.1007/PL00005630; [Anonymous], 1995, GAIT POSTURE; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Baloh RW, 1998, ARCH NEUROL-CHICAGO, V55, P649, DOI 10.1001/archneur.55.5.649; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Baruch Martin, 2016, J Rehabil Res Dev, V53, P959, DOI 10.1682/JRRD.2015.06.0120; Bass RI, 1939, RES QUART, V10, P33, DOI 10.1080/10671188.1939.10625750; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bensoussan L, 2007, ARCH PHYS MED REHAB, V88, P1009, DOI 10.1016/j.apmr.2007.05.009; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Blaszczyk JW, 2014, ACTA NEUROBIOL EXP, V74, P433; Bose P, 2015, BRAIN NEUROTRAUMA MO; Boyle J, 2009, BRIT J CLIN PHARMACO, V67, P180, DOI 10.1111/j.1365-2125.2008.03331.x; Broch JT, 2020, MECH VIBRATION SHOCK; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Caccese JB, 2021, CLIN J SPORT MED, V31, P266, DOI 10.1097/JSM.0000000000000709; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Caron O, 2000, J APPL BIOMECH, V16, P234, DOI 10.1123/jab.16.3.234; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Castillo ER, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.177949; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Chakshu NK, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3180; Cheung B, 2006, 2006229 TR DEF R D C; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Cloak R, 2010, INT J SPORTS MED, V31, P894, DOI 10.1055/s-0030-1265151; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Colnaghi S, 2017, CEREBELLUM, V16, P1, DOI 10.1007/s12311-015-0758-5; Curthoys IS, 2010, CLIN NEUROPHYSIOL, V121, P132, DOI 10.1016/j.clinph.2009.09.027; Da He D, 2015, IEEE T BIO-MED ENG, V62, P2547, DOI 10.1109/TBME.2015.2459061; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dakin CJ, 2011, EXP BRAIN RES, V209, P345, DOI 10.1007/s00221-011-2549-7; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Dambinova SA, 2013, MIL MED, V178, P285, DOI 10.7205/MILMED-D-12-00368; Day BL, 1999, J PHYSIOL-LONDON, V517, P631, DOI 10.1111/j.1469-7793.1999.0631s.x; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Delignieres D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001089; DIENER HC, 1984, ELECTROEN CLIN NEURO, V57, P134, DOI 10.1016/0013-4694(84)90172-X; Dlugaiczyk J, 2019, J NEUROPHYSIOL, V121, P2237, DOI 10.1152/jn.00035.2019; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; ElJaroudi A, 1996, P IEEE, V84, P1312, DOI 10.1109/5.535249; Engel D, 2020, EXP BRAIN RES, V238, P1177, DOI 10.1007/s00221-020-05782-2; Erdodi L, 2021, J HEAD TRAUMA REHAB, V36, P103, DOI 10.1097/HTR.0000000000000576; Ferdjallah M, 1997, P 19 INT C IEEE EMBS; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Flatters I, 2014, BEHAV RES METHODS, V46, P950, DOI 10.3758/s13428-013-0419-x; Forbes PA, 2015, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00094; Fujimoto C, 2014, OTOL NEUROTOL, V35, pE317, DOI 10.1097/MAO.0000000000000554; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Galetta KM, 2015, CONCUSSION; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Games KE, 2015, J ATHL TRAINING, V50, P542, DOI 10.4085/1062-6050-50.2.09; Garcia -G-GP, 2020, NEUROSURGERY, DOI [10.1093/neuros/nyaa150154., DOI 10.1093/NEUR0S/NYAA150]; Gauchard GC, 2013, GAIT POSTURE, V37, P82, DOI 10.1016/j.gaitpost.2012.06.011; Gera G, 2018, MIL MED, V183, P327, DOI 10.1093/milmed/usx162; Goffredo M, 2006, MED ENG PHYS, V28, P719, DOI 10.1016/j.medengphy.2005.10.007; Gojanovic B, 2012, J SPORT SCI, V30, P1397, DOI 10.1080/02640414.2012.710756; Grafton ST, 2019, MED DEVICES-EVID RES, V12, P151, DOI 10.2147/MDER.S205357; GRANAT MH, 1990, MED BIOL ENG COMPUT, V28, P601, DOI 10.1007/BF02442615; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gunther M, 2009, J BIOMECH, V42, P2739, DOI 10.1016/j.jbiomech.2009.08.014; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hajiaghamemar M, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046393; Hanas JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215762; Hauenstein A, 2019, P IEEE EMBS 2019 INT; Heick JD, 2017, INT J SPORTS PHYS TH, V12, P581; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; HLAVACKA F, 1995, NEUROSCI LETT, V189, P9, DOI 10.1016/0304-3940(95)11436-Z; Honegger F., 2013, THESIS, DOI [10.5451/unibas-006225247113, DOI 10.5451/UNIBAS-006225247]; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; HUANG KY, 2017, PLOS ONE, V12; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Jahn K, 2003, BRAIN, V126, P1579, DOI 10.1093/brain/awg163; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Khezrian M, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2040036; Kincl Laurel D, 2002, Appl Occup Environ Hyg, V17, P256, DOI 10.1080/10473220252826565; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kitazaki S, 1998, J BIOMECH, V31, P143; Kouli A, 2018, PARKINSONS DIS PATHO, DOI [10.15586/codonpublications.parkin- sonsdisease.2018.ch17., DOI 10.15586/CODONPUBLICATIONS.PARKIN-SONSDISEASE.2018.CH1]; Kouzaki M, 2012, GAIT POSTURE, V35, P11, DOI 10.1016/j.gaitpost.2011.03.028; Kuwabara S, 1999, ANN NEUROL, V45, P533, DOI 10.1002/1531-8249(199904)45:4<533::AID-ANA19>3.0.CO;2-H; Lam B, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt155; Lanska DJ, 2000, NEUROLOGY, V55, P1201, DOI 10.1212/WNL.55.8.1201; Le Flao E, 2018, ISBS PROC ARCH, V36, P257; Lin IS, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0564-2; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Maalouf N, 2017, ROBOT AUTON SYST, V94, P208, DOI 10.1016/j.robot.2017.04.009; Macdonald M. J, 2008, THESIS; Mahboobin A, 2009, MED BIOL ENG COMPUT, V47, P921, DOI 10.1007/s11517-009-0477-5; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; Mang CS, 2019, J NEUROTRAUM, V36, P308, DOI 10.1089/neu.2017.5587; Manor B, 2010, NEUROLOGY, V74, P458, DOI 10.1212/WNL.0b013e3181cef647; Martinez-Mendez R, 2012, COMPUT METHOD BIOMEC, V15, P899, DOI 10.1080/10255842.2011.565753; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Masani K, 2014, GAIT POSTURE, V39, P946, DOI 10.1016/j.gaitpost.2013.12.008; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mayton AG, 2014, INT J HEAVY VEH SYST, V21, P241, DOI 10.1504/IJHVS.2014.066080; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Mercer C, 2006, PROSIG SIGNAL PROCES; Mergner T, 2018, FRONT NEUROROBOTICS, V12, DOI 10.3389/fnbot.2018.00021; Mergner T, 2009, J PHYSIOL-PARIS, V103, P178, DOI 10.1016/j.jphysparis.2009.08.002; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Miyashita TL, 2020, SPORT BIOMECH, V19, P180, DOI 10.1080/14763141.2018.1458892; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Najafi Bijan, 2010, J Diabetes Sci Technol, V4, P780; NASHNER LM, 1971, ACTA OTO-LARYNGOL, V72, P429, DOI 10.3109/00016487109122504; NASHNER LM, 1988, PROG BRAIN RES, V76, P243; Nashner LM, 1989, PROG BRAIN RES, V80, P395; Nazarahari M, 2020, ANN BIOMED ENG, V48, P2310, DOI 10.1007/s10439-020-02504-1; Neville C, 2015, MED DEVICES-EVID RES, V8, P447, DOI 10.2147/MDER.S91719; Nicholas SC, 1998, J VESTIBUL RES-EQUIL, V8, P187; Noamani A, 2020, MED ENG PHYS, V77, P53, DOI 10.1016/j.medengphy.2019.10.018; Noohi F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221954; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Oba N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140235; Paillard T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891390; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Pan T, 2015, GAIT POSTURE, V42, P550, DOI 10.1016/j.gaitpost.2015.08.012; Perera T, 2018, BRAIN, V141, P3009, DOI 10.1093/brain/awy216; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Peterka R J, 1990, J Vestib Res, V1, P49; Peters RM, 2015, J NEUROPHYSIOL, V114, P264, DOI 10.1152/jn.00114.2015; Peterson BW, 1982, DOC OPHTHALMOL, V34, P351; Petrova D, 2017, NEUROCHEM NEUROPHA S, V2, DOI [10.4172/2469-9780-C1-00672., DOI 10.4172/2469-9780-C1-006]; Pietro VDi, 2018, FRONT MOL NEUROSCI, V9, P1, DOI DOI 10.3389/FNM0L.2018.00290; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; Quek J, 2014, GAIT POSTURE, V39, P1069, DOI 10.1016/j.gaitpost.2014.01.009; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Reynard F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211051; Rhea CK, 2015, GAIT POSTURE, V41, P731, DOI 10.1016/j.gaitpost.2015.01.008; Rivera L. F., 2019, P 29 ANN INT C COMP, P329; Rosengren SM, 2019, CLIN NEUROPHYS PRACT, V4, P47, DOI 10.1016/j.cnp.2019.01.005; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Salisbury JP, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8478; Salisbury JP, 2017, BIORXIV, DOI [10.1101/149831141, DOI 10.1101/149831]; Samadani U, 2015, CONCUSSION, V1, pCNC3; Sankarpandi SK, 2017, BMC EAR NOSE THROAT, V17, DOI 10.1186/s12901-017-0034-z; Sawacha Z, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-95; Scinicariello AP, 2001, BIOL CYBERN, V84, P475, DOI 10.1007/PL00007991; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Seimetz Christina, 2012, Biomed Sci Instrum, V48, P386; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shaikh AG, 2016, CURR OPIN NEUROL, V29, P94, DOI 10.1097/WCO.0000000000000277; Sim T, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0395-6; Singh NB, 2012, J ELECTROMYOGR KINES, V22, P131, DOI 10.1016/j.jelekin.2011.10.007; Spauschus A, 1999, EXP BRAIN RES, V126, P556, DOI 10.1007/s002210050764; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; Subbian V, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2424224; Suleiman A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15487-2; Supej M, 2019, J SCI MED SPORT, V22, pS71, DOI 10.1016/j.jsams.2019.02.005; Suzuki Y, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00618; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Tanabe H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22446; Taskin Y, 2019, INT J OCCUP SAF ERGO, V25, P530, DOI 10.1080/10803548.2017.1418487; Teel EF, 2016, CLIN J SPORT MED, V26, P162, DOI 10.1097/JSM.0000000000000210; Thompson TL, 2009, OCHSNER J, V9, P20; Toosizadeh N, 2015, GERONTOLOGY, V61, P51, DOI 10.1159/000362549; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; van der Kooij H, 2011, GAIT POSTURE, V34, P19, DOI 10.1016/j.gaitpost.2011.02.025; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P768, DOI 10.1002/jmri.21679; Vial F, 2019, CLIN NEUROPHYS PRACT, V4, P134, DOI 10.1016/j.cnp.2019.06.002; Vuillerme N, 2002, NEUROSCI LETT, V333, P131, DOI 10.1016/S0304-3940(02)00999-0; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wang JJ, 2019, INT J PROD RES, V57, P3920, DOI 10.1080/00207543.2018.1552032; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Williams HG, 1997, ARCH PHYS MED REHAB, V78, P737, DOI 10.1016/S0003-9993(97)90082-4; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Yamamoto T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12329; Ye S, 2020, DETECTION MTBI PEDIA, DOI [10.1101/2020.04.29.20085274153., DOI 10.1101/2020.04.29.20085274]; Yu E, 2008, ARCH PHYS MED REHAB, V89, P1133, DOI 10.1016/j.apmr.2007.10.047; Yuan P, 2018, HUM BRAIN MAPP, V39, P2753, DOI 10.1002/hbm.24037; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	201	3	3	1	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1470			MED DEVICES-EVID RES	MED. DEVICES-EVID. RES.		2020	13						411	438		10.2147/MDER.S279521			28	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	PC9FG	WOS:000597302600001	33324120	gold, Green Published			2022-02-06	
J	Ram, P; Miah, FT; Wyrick, JM; Kalosza, BA; Coritsidis, GN				Ram, Payal; Miah, Fardina T.; Wyrick, Jonathan M.; Kalosza, Brittany A.; Coritsidis, George N.			Outcomes in Critically Ill Patients With Traumatic Brain Injury: Ethnicity, Documentation, and Insurance Status	CRITICAL CARE MEDICINE			English	Article						documentation; ethnicity; insurance; mortality; traumatic brain injury	UNITED-STATES; UNDOCUMENTED IMMIGRANTS; BINGE DRINKING; DISPARITIES; CARE; ASSOCIATION; DISCHARGE; RACE	Objectives: Disparities in traumatic brain injury outcomes for ethnic minorities and the uninsured have previously been demonstrated; however, outcomes in undocumented immigrants have not been examined. We wanted to determine whether ethnicity, insurance, and documentation status served as risk factors for disparities in traumatic brain injury outcomes between undocumented immigrants and documented residents. Design: Retrospective study. Setting: Patients diagnosed with traumatic brain injury admitted to the surgical/trauma ICU at a level 1 trauma center serving a large immigrant population in New York City from 2009 to 2016. Patients: Four-hundred seventy-one traumatic brain injury patients requiring surgical/trauma ICU admission. Interventions: None. Measurements and Main Results: Undocumented immigrants constituted 29% of the population, were younger (39 vs 57 yr old, respectively; p < 0.0001), Hispanic (83%; p < 0.0001), and uninsured (87%; p < 0.0001). Falls resulted in the majority of traumatic brain injuries in the total population, however, undocumented immigrants were almost twice as likely to be assaulted (p = 0.0032). There was no difference in presence of midline shifts, Injury Severity Score, Glasgow Coma Score, hypotension, hypoxia, and pupillary reactions between undocumented immigrants and documented residents. Undocumented immigrants presented with significantly more effaced basilar cisterns (p = 0.0008). There was no difference in hospital care between undocumented immigrants and documented residents as determined by emergency department to surgical/trauma ICU transfer times (p = 0.967). Undocumented immigrants were more likely to be discharged home (53% vs 33%, respectively; p = 0.0009) and less likely to be sent to rehabilitation (25% vs 32%, respectively; p = 0.0009). After adjusting length of stay and mortality for covariates, undocumented immigrants had shorter length of stay (p < 0.05) and there was no difference in hospital mortality between undocumented immigrants and documented residents. Conclusions: Undocumented immigrants with traumatic brain injuries were more likely to be younger, have shorter length of stay, and experience similar mortality rates to documented residents. Social economic status may play a role in events prior to hospitalization and likely does in disposition outcomes.	[Ram, Payal; Miah, Fardina T.; Wyrick, Jonathan M.; Kalosza, Brittany A.] Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Surg, Elmhurst, NY 11373 USA; [Wyrick, Jonathan M.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Coritsidis, George N.] Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY 11373 USA		Coritsidis, GN (corresponding author), Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Med, Elmhurst, NY 11373 USA.	coritsg@nychhc.org					[Anonymous], 2014, TRAUM BRAIN INJ CONC; Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa; Berk M L, 2001, J Immigr Health, V3, P151; Berlinger N, 2013, HASTINGS CENT REP, V43, P14, DOI 10.1002/hast.126; Budnick HC, 2017, J SURG RES, V215, P231, DOI 10.1016/j.jss.2017.03.062; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; Chikani V, 2015, WEST J EMERG MED, V16, P408, DOI 10.5811/westjem.2015.1.23560; Chong VE, 2014, J SURG RES, V191, P251, DOI 10.1016/j.jss.2014.05.008; Coritsidis GN, 2004, AM J KIDNEY DIS, V43, P424, DOI 10.1053/j.ajkd.2003.11.004; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Englum BR, 2016, AM SURGEON, V82, P281; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Fernandez A, 2017, JAMA INTERN MED, V177, P536, DOI 10.1001/jamainternmed.2016.9209; Garfield R., 2016, NEW ESTIMATES ELIGIB; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Linden EA, 2012, AM J KIDNEY DIS, V60, P354, DOI 10.1053/j.ajkd.2012.05.016; Lopez Gustavo, 2017, KEY FINDINGS US IMMI; Maldonado CZ, 2013, ACAD EMERG MED, V20, P155, DOI 10.1111/acem.12079; Mayor's Office of Immigrant Affairs, 2018, STAT OUR IMM CIT ANN; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; New York City Health and Hospitals Corporation, 2013, 2013 COMM HLTH NEEDS; New York City Health and Hospitals Corporation, 2016, CORP 2016 COMM HLTH; Nichols H, 2018, TOP 10 LEADING CAUSE; Passel Jeffrey S, 2014, UNAUTHORIZED IMMIGRA; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The Henry J. Kaiser Family Foundation, 2017, HLTH COV IMM; Watkins JR, 2014, AM J SURG, V208, P969, DOI 10.1016/j.amjsurg.2014.07.002; Wyrick JM, 2017, J SURG RES, V214, P145, DOI 10.1016/j.jss.2017.02.006	37	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2020	48	1					31	40		10.1097/CCM.0000000000004043			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JW0SY	WOS:000502770900009	31567403				2022-02-06	
J	Sheth, SB; Anandayuvaraj, D; Patel, SS; Sheth, BR				Sheth, Suril B.; Anandayuvaraj, Dharun; Patel, Saumil S.; Sheth, Bhavin R.			Orthopaedic and brain injuries over last 10 seasons in the National Football League (NFL): number and effect on missed playing time	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						American football; concussion; contact sports; injuries	CHRONIC TRAUMATIC ENCEPHALOPATHY	ObjectiveTo examine trends in number and seriousness of major injuries in the National Football League (NFL) over seasons 2010-2019 and the effect of rule changes to injuries to the leg, back, arm and head.MethodsWe calculated, from publicly available weekly injury reports, the number of players that were injured and playing time missed, that is, the number of weeks on average that an injured player had to sit out, as a function of injury to a specific body part. Using classical time series analysis techniques, we fitted injury data with linear and non-linear functions.ResultsThe number of major injuries to the leg, back, arm and head has not declined over the last 10 years. During this time period, time missed because of injuries to the head has shown a significantly increasing trend. Rule changes designed specifically to protect arm or head have, respectively, succeeded in shortening the time that the injured player misses, but the impact lasts only over a single season.ConclusionsOverall, our data support the argument that new, well-intentioned rules adopted every season by the NFL have been proven to be too weak to make the NFL game safer. Broad-based management of brain and orthopaedic injuries and adoption of preventative measures to reduce the number of players injured and the seriousness of their injuries are required in the modern NFL.	[Sheth, Suril B.] Univ Calif Irvine, Irvine, CA USA; [Anandayuvaraj, Dharun; Sheth, Bhavin R.] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77030 USA; [Patel, Saumil S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA		Sheth, BR (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77030 USA.	brsheth@uh.edu					[Anonymous], FFTODAY; Barnwell B, 2009, NY TIMES; Biagioli M, 2016, NATURE, V535, P201, DOI 10.1038/535201a; Bowen M, 2016, NFL PLAYERS PLAY PAI; Campbell R, 2016, REPORTED CONCUSSIONS; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Erickson BJ, 2014, ORTHOPEDICS, V37, DOI 10.3928/01477447-20140728-59; Goodhart C, 1981, INFLATION DEPRESSION, P111; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Lillibridge M, 2012, INJURED HURT FORMER; McCrea M, 2019, BR J SPORTS MED; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Myer GD, 2011, J ORTHOP SPORT PHYS, V41, P377, DOI 10.2519/jospt.2011.3547; NFL.com, NFL; NFL.com, 2016, NFL; NFLFootballOperations, 2018, EV NFL PLAYER; Norman J., 2018, FOOTBALL STILL AM FA; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pompei D, 2017, INSIDE NFLS SECRET W; Schwellnus MP, 2019, BRIT J SPORT MED, V53, P620, DOI 10.1136/bjsports-2018-099105; SportingCharts, 2009, TEAM TOT OFF DEF PLA; SportingCharts, 2016, TEAM TOT OFF DEF PLA; Strathern M., 1997, EUROPEAN REV, V5, P305, DOI DOI 10.1017/S1062798700002660; Veltman N, 2014, NFL PLAYERS HEIGHT W; Vrentas J, 2015, SPORTS ILLUSTRATED; Wagner L, 2016, NFL REPORT CONCUSSIO	27	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000684	10.1136/bmjsem-2019-000684			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF7ZV	WOS:000599268800001	32341797	gold, Green Published			2022-02-06	
J	Sihag, S; Naze, S; Taghdiri, F; Tator, C; Wennberg, R; Mikulis, D; Green, R; Colella, B; Tartaglia, MC; Kozloski, JR				Sihag, Saurabh; Naze, Sebastien; Taghdiri, Foad; Tator, Charles; Wennberg, Richard; Mikulis, David; Green, Robin; Colella, Brenda; Tartaglia, Maria Carmela; Kozloski, James R.			Multimodal Dynamic Brain Connectivity Analysis Based on Graph Signal Processing for Former Athletes With History of Multiple Concussions	IEEE TRANSACTIONS ON SIGNAL AND INFORMATION PROCESSING OVER NETWORKS			English	Article						Brain; Functional magnetic resonance imaging; Signal processing; History; Tools; Frequency control; Brain modeling; graphical models; signal processing	FUNCTIONAL NETWORK CONNECTIVITY; TIME-VARYING CONNECTIVITY; AUTISM SPECTRUM DISORDER; STRUCTURAL CONNECTIVITY; FOOTBALL PLAYERS; INJURY; CLASSIFICATION; CHILDREN; SIZE	The study of structure-function relationships in the brain has been an active area of research in neuroscience. The availability of brain imaging data that captures the structural connectivity and functional co-activation of the brain regions has led to the study of multimodal technical frameworks that can help disentangle the mechanisms linking cognitive abilities and brain structural alterations. This paper analyzes the diffusion and resting state functional magnetic resonance imaging (dMRI and rs-fMRI) data collected from a population consisting of former athletes with a history of multiple concussions and healthy controls with no reported history of concussion. For each subject, the structural connectome is represented by a graph with its nodes associated with cortical brain regions and the adjacency matrix derived from dMRI. Each cortical brain region is associated with a blood oxygen level dependent (BOLD) signal derived from fMRI. This paper uses the tools from graph signal processing (GSP) to select the brain regions of interest (ROIs) that have significant statistical differences in the extracted high and low graph frequency components of the region specific BOLD signal across former athletes and healthy controls, where the graph frequencies represent the extent of spatial variations of the BOLD signal across the brain. The selected ROIs have also been previously identified to be affected in the existing clinical studies on traumatic brain injuries (TBI). Furthermore, the dynamic functional connectivity profiles of the selected ROIs are determined by leveraging the high and low graph frequency components of the BOLD signal and a sliding window based approach. Interestingly, the graph frequency functional connectivity profiles reveal unique characteristics that are not apparent in the unimodal dynamic functional connectivity profiles based on fMRI. Our analysis reveals statistically significant differences in the dwell times in multiple dynamic graph frequency functional connectivity states for the two groups of subjects. Therefore, the results presented in this paper underline the significance of graph signal processing tools for multimodal analysis of brain imaging data and also provide promising direction for applications in clinical research and medical diagnosis.	[Sihag, Saurabh; Naze, Sebastien; Kozloski, James R.] TJ Watson Ibm Res Ctr, Computat Biol Ctr, Ossining, NY 10562 USA; [Taghdiri, Foad; Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S, Canada; [Tator, Charles; Wennberg, Richard; Mikulis, David; Green, Robin; Colella, Brenda; Tartaglia, Maria Carmela] Univ Hlth Network, Toronto Western Hosp, Canadian Concuss Ctr, Neurosci Ctr, Toronto, ON M5G 2C4, Canada; [Tator, Charles; Mikulis, David; Green, Robin] Univ Toronto, Inst Med Sci, Toronto, ON M5S, Canada; [Tator, Charles] Univ Hlth Network, Toronto Western Hosp, Krembil Brain Inst, Div Neurosurg, Toronto, ON M5G 2C4, Canada; [Wennberg, Richard] Univ Hlth Network, Toronto Western Hosp, Div Neurol, Toronto, ON M5G 2C4, Canada; [Mikulis, David] Univ Hlth Network, Joint Dept Med Imaging, Div Neuroradiol, Toronto, ON M5G 2C4, Canada; [Green, Robin; Colella, Brenda] Univ Toronto, Dept Rehabil Sci, Toronto, ON M5S, Canada		Sihag, S (corresponding author), TJ Watson Ibm Res Ctr, Computat Biol Ctr, Ossining, NY 10562 USA.	sihags@rpi.edu; naze@us.ibm.com; foad.taghdiri@mail.utoronto.ca; charles.tator@uhn.ca; r.wennberg@utoronto.ca; david.mikulis@uhn.ca; robin.green@uhn.ca; brenda.colella@uhn.ca; carmela.tartaglia@uhn.ca; kozloski@us.ibm.com		Tartaglia, Carmela/0000-0002-5944-8497; Naze, Sebastien/0000-0003-0367-402X; Tator, Charles/0000-0001-7335-4246; Sihag, Saurabh/0000-0001-9209-7943			Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Atasoy S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10340; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Brahim A, 2019, COMM COM INF SC, V1089, P45, DOI 10.1007/978-3-030-29930-9_5; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Cai BA, 2019, IEEE T BIO-MED ENG, V66, P1852, DOI 10.1109/TBME.2018.2880428; Calhoun Vince D, 1800, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P230; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Calinski TT., 1974, COMMUN STAT, V3, P1, DOI 10.1080/03610927408827101; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Cordova-Palomera A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40268; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dimitriadis S. I., 2019, MULTIPLEXITY GRAPH S; Engels G, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00388; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Furtado CP, 2008, PSYCHIAT RES-NEUROIM, V163, P133, DOI 10.1016/j.pscychresns.2007.11.005; Gibbons J. D., 2011, NONPARAMETRIC STAT I; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goldsberry L, 2017, INT CONF ACOUST SPEE, P851, DOI 10.1109/ICASSP.2017.7952276; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; Heffelfinger JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005002; Hou WS, 2019, BRAIN CONNECT, V9, P475, DOI 10.1089/brain.2018.0629; Hu CH, 2016, NEUROIMAGE, V125, P587, DOI 10.1016/j.neuroimage.2015.10.026; Huang WY, 2018, P IEEE, V106, P868, DOI 10.1109/JPROC.2018.2798928; Huang WY, 2016, IEEE J-STSP, V10, P1189, DOI 10.1109/JSTSP.2016.2600859; Itahashi T, 2015, NEUROIMAGE-CLIN, V7, P155, DOI 10.1016/j.nicl.2014.11.019; Itani S., 2019, ARXIV190411296; Kaiser RH, 2016, NEUROPSYCHOPHARMACOL, V41, P1822, DOI 10.1038/npp.2015.352; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Koh KB, 2010, J CLIN PSYCHIAT, V71, P1576, DOI 10.4088/JCP.09m05061blu; Kudela M, 2017, NEUROIMAGE, V149, P165, DOI 10.1016/j.neuroimage.2017.01.056; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Li R, 2018, HUM BRAIN MAPP, V39, P1207, DOI 10.1002/hbm.23910; Liem F, 2017, NEUROIMAGE, V148, P179, DOI 10.1016/j.neuroimage.2016.11.005; Liu AP, 2016, IEEE J-STSP, V10, P1172, DOI 10.1109/JSTSP.2016.2594949; Luo C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028196, 10.1371/journal.pone.0044847]; Ma S, 2014, NEUROIMAGE, V90, P196, DOI 10.1016/j.neuroimage.2013.12.063; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McClure-Tone EB, 2011, DEV NEUROPSYCHOL, V36, P453, DOI 10.1080/87565641.2010.549876; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medaglia J. D., 2017, NATURE HUMAN BEHAV, V2, P156; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Menoret M, 2017, IEEE GLOB CONF SIG, P618, DOI 10.1109/GlobalSIP.2017.8309033; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Mokhtari F, 2019, NEUROIMAGE, V189, P655, DOI 10.1016/j.neuroimage.2019.02.001; Mokhtari F, 2018, NEUROIMAGE, V173, P421, DOI 10.1016/j.neuroimage.2018.02.025; Mortaheb S, 2019, IEEE ENG MED BIO, P4549, DOI 10.1109/EMBC.2019.8856436; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Ortega A, 2018, P IEEE, V106, P808, DOI 10.1109/JPROC.2018.2820126; Ozdemir A, 2017, IEEE T SIGNAL INF PR, V3, P669, DOI 10.1109/TSIPN.2017.2668146; Pedersen M, 2018, NEUROIMAGE, V181, P85, DOI 10.1016/j.neuroimage.2018.06.020; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Preti MG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12765-7; Proix T, 2016, NEUROIMAGE, V142, P135, DOI 10.1016/j.neuroimage.2016.06.016; Reinen JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03462-y; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sporns O., 2010, NETWORKS BRAIN; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Tagliazucchi E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00010; Tarazi A, 2018, J NEUROTRAUM, V35, P1003, DOI 10.1089/neu.2017.5290; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Vul E., 2010, FDN ISSUES HUMAN BRA, P71, DOI DOI 10.7551/MITPRESS/9780262014021.003.0007; Warnick R, 2018, J AM STAT ASSOC, V113, P134, DOI 10.1080/01621459.2017.1379404; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yu QB, 2018, P IEEE, V106, P886, DOI 10.1109/JPROC.2018.2825200; Yu QB, 2015, NEUROIMAGE, V107, P345, DOI 10.1016/j.neuroimage.2014.12.020; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zafar R, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON POWER SYSTEM TECHNOLOGY (POWERCON); Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	87	3	3	4	11	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2373-776X			IEEE T SIGNAL INF PR	IEEE Trans. Signal Inf. Proc. Netw.		2020	6						284	299		10.1109/TSIPN.2020.2982765			16	Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Telecommunications	LL2EE	WOS:000531366500001					2022-02-06	
J	Strohle, M; Beeretz, I; Rugg, C; Woyke, S; Rauch, S; Paal, P				Stroehle, Mathias; Beeretz, Ina; Rugg, Christopher; Woyke, Simon; Rauch, Simon; Paal, Peter			Canyoning Accidents in Austria from 2005 to 2018	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						canyoning; accidents; emergency medical service; search and rescue; epidemiology; trauma and injuries	TRAUMATIC BRAIN-INJURY; LEPTOSPIROSIS	Canyoning has become a popular recreational sport. Nevertheless, little is known about injuries or diseases associated with canyoning. The aim of this study was to examine accident causes, injury patterns, out-of-hospital and in-hospital treatment and outcomes. For this purpose, national out-of-hospital data from the Austrian Alpine Safety Board and regional in-hospital data from Innsbruck Medical University Hospital were analysed for the period from November 1, 2005 to October 31, 2018. Nationally, 471 persons were involved in such accidents; 162 (34.4%) were severely injured, nine of whom died. Jumping (n = 110, 23.4%), rappelling (n = 51, 10.8%), sliding (n = 41, 8.7%) and stumbling (n = 26, 5.5%) were the most common causes of canyoning accidents. A large proportion of injuries were documented for the lower extremities (n = 133, 47.5%), followed by the upper extremities (n = 65, 23.2%) and the spine (n = 44, 15.7%). Death was mainly caused by drowning. Overall mortality was 1.9% (n = 9), and the absolute risk was 0.02 deaths per 1000 hrs of canyoning. Many uninjured persons required evacuation (n = 116, 24.6%), which resulted in a substantial expense and workload for emergency medical services. Increased safety precautions are required to reduce accidents while jumping and rappelling and fatalities caused by drowning.	[Stroehle, Mathias; Rugg, Christopher] Med Univ Innsbruck, Dept Gen & Surg Crit Care Med, Anichstr 35, A-6020 Innsbruck, Austria; [Beeretz, Ina] Social Serv Vienna, Ctr Paediat Dev, A-1220 Vienna, Austria; [Woyke, Simon; Rauch, Simon] EURAC Res, Inst Mt Emergency Med, Via Ipazia 1, I-39100 Bolzano, Italy; [Paal, Peter] Paracelsus Med Univ Salzburg, Hosp Bros Hosp, Dept Anaesthesiol & Intens Care Med, Kajetanerpl 1, A-5010 Salzburg, Austria		Strohle, M (corresponding author), Med Univ Innsbruck, Dept Gen & Surg Crit Care Med, Anichstr 35, A-6020 Innsbruck, Austria.	mathias.stroehle@tirol-kliniken.at; inabeeretz@icloud.com; christopher.rugg@tirol-kliniken.at; simon.Woyke@eurac.edu; simon.Rauch@eurac.edu; peter.paal@icloud.com		Paal, Peter/0000-0002-2939-4782; Rauch, Simon/0000-0002-3264-6303; Strohle, Mathias/0000-0002-6623-7823; Rugg, Christopher/0000-0002-7150-7357			Ballesteros Pena S, 2013, ARCH MED DEPORTE, V30, P91; Beasley H, 2016, WILDERNESS ENV MED, V27, P430; BONATTI J, 1995, RESUSCITATION, V30, P133, DOI 10.1016/0300-9572(95)00883-U; Brown DJA, 2012, NEW ENGL J MED, V367, P1930, DOI 10.1056/NEJMra1114208; Descamps V, 2002, CONTACT DERMATITIS, V47, P363; Ernstbrunner L, 2018, INJURY, V49, P792, DOI 10.1016/j.injury.2018.03.003; Gatterer H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203920; Hennebique A, 2019, EMERG MICROBES INFEC, V8, P1027, DOI 10.1080/22221751.2019.1638734; Hochedez P, 2013, EUROSURVEILLANCE, V18, P14; Michot JM, 2007, REV MED INTERNE, V28, P566, DOI 10.1016/j.revmed.2007.03.008; Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Soteras I, 2015, INJURY, V46, P585, DOI 10.1016/j.injury.2014.12.030; Stephanides SL, 2007, WILD ENVIRON MED, V18, P16, DOI 10.1580/1080-6032(2007)18[16:IPAFAT]2.0.CO;2; Strapazzon G, 2018, WILD ENVIRON MED, V29, P252, DOI 10.1016/j.wem.2017.12.002; Strohle M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010103; Strohle M, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0543-9	19	3	3	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-7827	1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JAN	2020	17	1							102	10.3390/ijerph17010102			13	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	KF7AG	WOS:000509391500102	31877835	gold, Green Published			2022-02-06	
J	Tucker, R; Falvey, E; Fuller, G; Brown, JC; Raftery, M				Tucker, Ross; Falvey, Eanna; Fuller, Gordon; Brown, James Craig; Raftery, Martin			Effect of a concussion on subsequent baseline SCAT performance in professional rugby players: a retrospective cohort study in global elite Rugby Union	BMJ OPEN			English	Article						sports medicine; neurological injury; physiology	SELF-REPORTED CONCUSSIONS; NEUROCOGNITIVE PERFORMANCE; VIDEO ANALYSIS; SYMPTOMS; SEX; HISTORY; VALUES; AGE	Objectives This study assessed whether concussion affects subsequent baseline performance in professional rugby players. Annual baseline screening tests are used to guide return-to-play decisions and concussion diagnosis during subsequent screens. It is important that baseline performances are appropriate and valid for the duration of a season and unaffected by factors unrelated to the current head impact event. One such factor may be a concussion following baseline assessment. Setting The World Rugby concussion management database for global professional Rugby Union. Participants 501 professional rugby players with two baseline Sports Concussion Assessment Tools (SCATs) and an intervening concussion (CONC) were compared with 1190 control players with successive annual SCAT5s and no diagnosed concussion (CONT). Primary and secondary outcome measures Symptom endorsement, cognitive and balance performance during annual SCAT baseline assessments. Results Players with a diagnosed concussion (CONC) endorsed fewer symptoms (change -0.42, 95% CI -0.75 to -0.09), and reported lower symptom severity scores during their second assessment (T2, p<0.001) than non-concussed players (CONT). Concussed players also improved Digits Backward and Final Concentration scores in T2 (p<0.001). Tandem gait time was improved during T2 in CONT. No other sub-mode differences were observed in either group. Conclusions Reduced symptom endorsement and improved cognitive performance after concussion may be the result of differences in the motivation of previously concussed players to avoid exclusion from play, leading to under-reporting of symptoms and greater effort in cognitive tests. Improved cognitive performance may be the result of familiarity with the tests as a result of greater exposure to concussion screening. The changes are small and unlikely to have clinical significance in most cases, though clinicians should be mindful of possible reasons, possibly repeating sub-modes and investigating players whose baseline scores change significantly after concussion. The findings do not necessitate a change in the sport's concussion management policy.	[Tucker, Ross; Raftery, Martin] World Rugby Pty Ltd, Dublin, Ireland; [Falvey, Eanna] Sports Surg Clin, Dept Sports Med, Dublin, Ireland; [Falvey, Eanna] Univ Coll Cork, Dept Med, Cork, Ireland; [Fuller, Gordon] Univ Sheffield, Sch Hlth & Related Res, Sect Publ Hlth, Sheffield, S Yorkshire, England; [Brown, James Craig] Stellenbosch Univ, Inst Sport & Exercise Med, Dept Orthopaed, Cape Town, Western Cape, South Africa		Tucker, R (corresponding author), World Rugby Pty Ltd, Dublin, Ireland.	Ross.tucker@mweb.co.za		Fuller, Gordon Ward/0000-0001-8532-3500; Falvey, Eanna/0000-0003-3961-1805	World Rugby	There was no specific funding for the research study, though the research was supported by World Rugby, which employs some of the author group, as described in Competing Interests.	Asken BM, 2020, ARCH CLIN NEUROPSYCH, V35, P291, DOI 10.1093/arclin/acz007; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bruce JM, 2004, NEUROLOGY, V63, P1516; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller GW, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0231-y; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Fuller GW, 2020, CLIN J SPORT MED, V30, pE150, DOI 10.1097/JSM.0000000000000713; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044	23	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	8							e036894	10.1136/bmjopen-2020-036894			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NH0DY	WOS:000564351500109	32792442	Green Accepted, gold, Green Published			2022-02-06	
J	Walsh, RS; Crawley, L; Dagnall, N; Fortune, DG				Walsh, R. Stephen; Crawley, Lorraine; Dagnall, Neil; Fortune, Donal G.			The man who used to shrug - one man's lived experience of TBI	NEUROREHABILITATION			English	Article						IPA; TBI; rehabilitation; phenomenology; brain injury; social cure; relational	TRAUMATIC BRAIN-INJURY; SOCIAL IDENTITY; UNCERTAINTY; REHABILITATION; STRESS; THREAT; MODEL	BACKGROUND: Stress is common to the experience of TBI. Stressors challenge physical and psychological coping abilities and undermine wellbeing. Brain injury constitutes a specific chronic stressor. An issue that hinders the usefulness of a stress-based approach to brain injury is a lack of semantic clarity attaching to the term stress. A more precise conceptualisation of stress that embraces experienced uncertainty is allostasis. OBJECTIVE: An emerging body of research, collectively identifiable as 'the social cure' literature, shows that the groups that people belong to can promote adjustment, coping, and well-being amongst individuals confronted with injuries, illnesses, traumas, and stressors. The idea is deceptively simple, yet extraordinarily useful: the sense of self that individuals derive from belonging to social groups plays a key role in determining health and well-being. The objective of this research was to apply a social cure perspective to a consideration of an individual's lived experience of TBI. METHODS: In a novel application of interpretative phenomenological analysis (IPA) this research has investigated one person's lived experience in a single case study of traumatic brain injury. RESULTS: Paradox, shifting perspectives and self under stress, linked by uncertainty, were the themes identified. CONCLUSIONS: A relational approach must be key to TBI rehabilitation.	[Walsh, R. Stephen; Dagnall, Neil] Manchester Metropolitan Univ, Manchester, Lancs, England; [Crawley, Lorraine] Acquired Brain Injury ABI, Dublin, Ireland; [Fortune, Donal G.] Univ Limerick, Limerick, Ireland		Walsh, RS (corresponding author), Manchester Metropolitan Univ, Dept Psychol, 53 Bonsall St, Birley M15 6GX, England.	r.walsh@mmu.ac.uk					BADDELEY A, 1993, NEUROPSYCHOL REHABIL, V3, P235, DOI 10.1080/09602019308401438; Bakewell, 2016, EXISTENTIALIST CAFE; Bandura A., 1995, SELF EFFICACY CHANGI; Bowen C., 2010, RELATIONAL APPROACH; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Cole M., 1978, MIND SOC; Cole M., 2010, AUTOBIOGRAPHY A LURI; Daniels H, 2007, CAMBRIDGE COMPANION TO VYGOTSKY, P1; Daniels H., 2008, VYGOTSKY RES; Echterhoff G, 2011, GROUNDING SOCIALITY: NEURONS, MIND, AND CULTURE, P115; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Folkman S., 1984, STRESS; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gaudiano BA, 2008, EVID-BASED MENT HEAL, V11, P5, DOI 10.1136/ebmh.11.1.5; Greenaway KH, 2015, J PERS SOC PSYCHOL, V109, P53, DOI 10.1037/pspi0000019; Greenaway KH, 2014, BRIT J SOC PSYCHOL, V53, P422, DOI 10.1111/bjso.12049; Haslam, 2004, PSYCHOL ORG SOCIAL I; Haslam C., 2018, NEW PSYCHOL HLTH UNL, DOI [10.4324/9781315648569, DOI 10.4324/9781315648569]; Hogg MA, 2007, ADV EXP SOC PSYCHOL, V39, P69, DOI 10.1016/S0065-2601(06)39002-8; Hogg MA, 2016, PEACE PSYCHOL BOOK S, P3, DOI 10.1007/978-3-319-29869-6_1; Hogg MA, 2014, CURR DIR PSYCHOL SCI, V23, P338, DOI 10.1177/0963721414540168; Hoofien D, 2001, BRAIN INJURY, V15, P189; Langdridge D., 2007, PHENOMENOLOGICAL PSY; Lieberman MatthewD., 2013, SOCIAL WHY OUR BRAIN; Luders A, 2016, PEACE PSYCHOL BOOK S, P33, DOI 10.1007/978-3-319-29869-6_3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacPherson S.E., 2019, CASES AMNESIA CONTRI; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Muldoon OT, 2012, POLIT PSYCHOL, V33, P259, DOI 10.1111/j.1467-9221.2012.00874.x; Muldoon OT, 2009, APPL PSYCHOL-INT REV, V58, P129, DOI 10.1111/j.1464-0597.2008.00385.x; Newby G., 2013, PRACTICAL NEUROPSYCH; Peters A, 2017, PROG NEUROBIOL, V156, P164, DOI 10.1016/j.pneurobio.2017.05.004; Platt PG, 2001, RENAISSANCE QUART, V54, P121, DOI 10.2307/1262222; Qureshi KL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-021675; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shallice T, 2019, CASES AMNESIA CONTRI, P1; Simon B., 2004, IDENTITY MODERN SOC; Smith J.A., 2009, INTERPRETATIVE PHENO; Smith J.A., 2003, APA HDB RES METHODS, P51, DOI [DOI 10.1037/13620-005, 10.1037/13620-005]; TAJFEL H, 1974, SOC SCI INFORM, V13, P65, DOI 10.1177/053901847401300204; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Vygotsky L.S., 1978, MIND SOC; Walsh RS, 2014, HEALTH PSYCHOL REV, V8, P458, DOI 10.1080/17437199.2012.733914; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	48	3	3	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	47	1					11	24		10.3233/NRE-203079			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NE7EM	WOS:000562764300002	32675423	Green Accepted, Bronze			2022-02-06	
J	Wei, LJ; Zhang, JB; Zhang, B; Geng, JJ; Tan, Q; Wang, L; Chen, Z; Feng, H; Zhu, G				Wei, Linjie; Zhang, Jianbo; Zhang, Bo; Geng, Junjun; Tan, Qiang; Wang, Ling; Chen, Zhi; Feng, Hua; Zhu, Gang			Complement C3 participates in the function and mechanism of traumatic brain injury at simulated high altitude	BRAIN RESEARCH			English	Article						Complement component 3; Traumatic brain injury; Secondary injury; High altitude	COBRA VENOM FACTOR; MEMBRANE ATTACK COMPLEX; BASIC-PROTEIN ISOFORMS; RAT MODEL; ACTIVATION; BARRIER; INHIBITION; RECOVERY; DEGRADATION; NEUROTRAUMA	Bacicgrowtd" Traumatic brain injury (TBI) leads to severe mortality and disability, in which secondary injury induced by complement activation plays an important role. TBI tends to be associated with more severe cerebral edema and worse neurological functional recovery if it occurs in high-altitude areas than in low-altitude areas. However, the underlying mechanism of this difference is unknown. Thus, we used cobra venom factor (CVF) to deplete complement C3 in simulated high-altitude areas to explore whether the differences in outcome at different altitudes are related to secondary injury caused by complement C3. Methods: The weight-drop model was adopted to induce TBI in rats. Rats were randomly divided into the following groups: sham + saline (sham), high altitude + TBI + saline (HAT), high altitude + TBI + CVF (H-CVF), low altitude + TBI + saline (LAT), and low altitude + TBI + CVF (L-CVF). Brain contusion and edema volumes, brain water content, myelin basic protein (MBP) expression, tumor necrosis factor alpha (TNF-alpha) expression, interleukin 1 beta (IL1B) expression, mortality rate, neurological function, and complement component 3 (C3) mRNA expression were measured by techniques such as Evans blue fluorescence, Perk staining, TUNEL staining, ELISA, immunohistochemistry and Western blotting to evaluate correlations between complement activation and secondary injury. Results: The activation of complement after TBI was significantly higher at high altitude than at low altitude. High-altitude TBI resulted in a leakier blood-brain barrier, more severe cerebral edema and higher mortality than low-altitude TBI did. In addition, high-altitude TBI tended to be associated with more MBP degradation, ferric iron deposition, neuronal apoptosis, and inflammatory factor deposition than low-altitude TBI. All of these effects of TBI were partially reversed by inhibiting complement activation using CVF. Conclusion: Our study provided evidence that TBI at high altitude leads to severe edema and high mortality and disability rates. Complement C3 activation is one of the important factors contributing to secondary brain injury.	[Wei, Linjie; Zhang, Jianbo; Zhang, Bo; Geng, Junjun; Tan, Qiang; Wang, Ling; Chen, Zhi; Feng, Hua; Zhu, Gang] Army Med Univ, Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, 30 Gaotanyan St, Chongqing 400038, Peoples R China		Zhu, G (corresponding author), Army Med Univ, Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	zhugang6666@126.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217	First Affiliated Hospital of Army Medical University "Science and Technology Innovation Program" [SWH2017JSZD07]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81873754, 81,273,030]	This work was supported by Grant No. SWH2017JSZD07 (Linjie Wei) from The First Affiliated Hospital of Army Medical University "Science and Technology Innovation Program", Grant No. 81873754 (Zhu Gang) and 81,273,030 (Zhu Gang), from the National Natural Science Foundation of China.	Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116007; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Alexander J.J, 2018, MOL IMMUNOL; Alexander JJ, 2018, MOL IMMUNOL, V102, P26, DOI 10.1016/j.molimm.2018.06.267; ALPER CA, 1976, SCIENCE, V191, P1275, DOI 10.1126/science.56780; Badaut J, 2019, J NEUROSCI RES; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Bauer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028578; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Chang HH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28724-z; Chen D, 2016, MICROVASC RES, V105, P23, DOI 10.1016/j.mvr.2015.12.006; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; De Blasio D, 2018, J CEREB BLOOD FLOW M; Fabian RH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00199; Figueroa E, 2005, NEUROSCI LETT, V380, P48, DOI 10.1016/j.neulet.2005.01.027; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gong H, 2017, TRANSL EPIGENET SER, P141, DOI 10.1016/B978-0-12-800226-1.00008-3; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1097-5; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Hew BE, 2012, TOXICON, V60, P632, DOI 10.1016/j.toxicon.2012.05.004; Hua Y, 2000, J NEUROSURG, V92, P1016, DOI 10.3171/jns.2000.92.6.1016; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Khalaf S, 2019, J NEUROTRAUM, V36, P43, DOI 10.1089/neu.2017.5617; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Li F, 2019, J CELLULAR BIOCH UND; Lim-Hing K, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00074; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mao YF, 2013, EUR REV MED PHARMACO, V17, P2207; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Portbury SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183683; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tan Q, 2017, J NEUROSURG, V126, P548, DOI 10.3171/2016.1.JNS152287; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Vogel CW, 2007, CURR PHARM DESIGN, V13, P2916, DOI 10.2174/138161207782023748; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wei G, 2017, NEUROIMMUNOMODULAT, V24, P348, DOI 10.1159/000487998; Wei LJ, 2016, WORLD NEUROSURG, V86, P181, DOI 10.1016/j.wneu.2015.09.070; Wu W, 2009, TRANSPL P, V41, P4321, DOI 10.1016/j.transproceed.2009.08.062; Yang S, 2013, J MOL NEUROSCI, V51, P352, DOI 10.1007/s12031-013-9990-y; You Y, 2011, BRAIN RES, V1381, P208, DOI 10.1016/j.brainres.2011.01.011; Yu AY, 2014, NEUROREPORT, V25, P1272, DOI 10.1097/WNR.0000000000000259; Zuo SL, 2015, NEUROSCI LETT, V609, P216, DOI 10.1016/j.neulet.2015.10.056	55	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 1	2020	1726								146423	10.1016/j.brainres.2019.146423			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW8WN	WOS:000503327300006	31654641				2022-02-06	
J	Westwood, C; Killelea, C; Faherty, M; Sell, T				Westwood, Caroline; Killelea, Carolyn; Faherty, Mallory; Sell, Timothy			Postural Stability Under Dual-Task Conditions: Development of a Post-Concussion Assessment for Lower-Extremity Injury Risk	JOURNAL OF SPORT REHABILITATION			English	Article						brain concussion; reliability; return-to-play; sport management	VARIABILITY; PERFORMANCE; BALANCE; FORCE	Context: Concussions are consequence of sports participation. Recent reports indicate there is an increased risk of lower-extremity musculoskeletal injury when returning to sport after concussion suggesting that achieving "normal" balance may not fully indicate the athlete is ready for competition. The increased risk of injury may indicate the need to refine a screening tool for clearance. Objective: Assess the between-session reliability and the effects of adding a cognitive task to static and dynamic postural stability testing in a healthy population. Setting: Clinical laboratory. Participants: Twelve healthy subjects (6 women; age 22.3 [2.9] y, height 174.4 [7.5] cm, weight 70.1 [12.7] kg) participated in this study. Design: Subjects underwent static and dynamic postural stability testing with and without the addition of a cognitive task (Stroop test). Test battery was repeated 10 days later. Dynamic postural stability testing consisted of a forward jump over a hurdle with a 1-legged landing. A stability index was calculated. Static postural stability was also assessed with and without the cognitive task during single-leg balance. Variability of each ground reaction force component was averaged. Main Outcome Measures: Interclass correlation coefficients (ICC2,1) were computed to determine the reliability. Standard error of measure, mean standard error, mean detectable change, and 95% confidence interval were all calculated. Results: Mean differences between sessions were low, with the majority of variables having moderate to excellent reliability (static .583-.877, dynamic .581-.939). The addition of the dual task did not have any significant effect on reliability of the task; however, generally, the ICC values improved (eyes open .583-.770, dual task .741-.808). Conclusions: The addition of a cognitive load to postural stability assessments had moderate to excellent reliability in a healthy population. These results provide initial evidence on the feasibility of dual-task postural stability testing when examining risk of lower-extremity musculoskeletal injury following return to sport in a concussed population.	[Westwood, Caroline; Killelea, Carolyn; Faherty, Mallory; Sell, Timothy] Duke Sports Sci Inst, Michael W Krzyzewski Human Performance Lab, K Lab, Durham, NC 27705 USA		Westwood, C (corresponding author), Duke Sports Sci Inst, Michael W Krzyzewski Human Performance Lab, K Lab, Durham, NC 27705 USA.	cgw12@duke.edu					Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Floria P, 2014, J APPL BIOMECH, V30, P679, DOI 10.1123/jab.2014-0043; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Portney LG, 2015, FDN CLIN RES APPL PR; Sell TC, 2012, PHYS THER SPORT, V13, P80, DOI 10.1016/j.ptsp.2011.06.006; Talarico MK, 2017, J SPORT SCI, V35, P1118, DOI 10.1080/02640414.2016.1211307; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Wikstrom EA, 2005, J ATHL TRAINING, V40, P305	10	3	3	1	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2020	29	1					131	133		10.1123/jsr.2018-0358			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LX7LQ	WOS:000540009300019	31034337	Bronze			2022-02-06	
J	Whiten, DR; Brownjohn, PW; Moore, S; De, SM; Strano, A; Zuo, YK; Haneklaus, M; Klenerman, D; Livesey, FJ				Whiten, Daniel R.; Brownjohn, Philip W.; Moore, Steven; De, Suman; Strano, Alessio; Zuo, Yukun; Haneklaus, Moritz; Klenerman, David; Livesey, Frederick J.			Tumour necrosis factor induces increased production of extracellular amyloid-beta- and alpha-synuclein-containing aggregates by human Alzheimer's disease neurons	BRAIN COMMUNICATIONS			English	Article						inflammation; protein aggregation; tumour necrosis factor; induced pluripotent stem cells; presenilin-1	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; A-BETA; SYSTEMIC INFLAMMATION; INTERFERON-GAMMA; CA2+ INFLUX; TNF-ALPHA; PROTEIN; TAU; MECHANISM	In addition to increased aberrant protein aggregation, inflammation has been proposed as a key element in the pathogenesis and progression of Alzheimer's disease. How inflammation interacts with other disease pathways and how protein aggregation increases during disease are not clear. We used single-molecule imaging approaches and membrane permeabilization assays to determine the effect of chronic exposure to tumour necrosis factor, a master proinflammatory cytokine, on protein aggregation in human-induced pluripotent stem cell-derived neurons harbouring monogenic Alzheimer's disease mutations. We report that exposure of Alzheimer's disease neurons, but not control neurons, to tumour necrosis factor induces substantial production of extracellular protein aggregates. Aggregates from Alzheimer's disease neurons are composed of amyloid-beta and alpha-synuclein and induce significant permeabilization of lipid membranes in an assay of pathogenicity. These findings provide support for a causal relationship between two crucial processes in Alzheimer's disease pathogenesis and suggest that targeting inflammation, particularly tumour necrosis factor, may have beneficial downstream effects on ameliorating aberrant protein aggregation and accumulation.	[Whiten, Daniel R.; De, Suman; Zuo, Yukun; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Brownjohn, Philip W.; Moore, Steven; Strano, Alessio; Haneklaus, Moritz; Livesey, Frederick J.] UCL Great Ormond St Inst Child Hlth, Zayed Ctr Res Rare Dis Children, 20 Guilford St, London WC1N 1DZ, England; [Klenerman, David] Univ Cambridge, UK Dementia Res Inst, Cambridge CB2 0XY, England		Klenerman, D (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.; Livesey, FJ (corresponding author), UCL Great Ormond St Inst Child Hlth, Zayed Ctr Res Rare Dis Children, 20 Guilford St, London WC1N 1DZ, England.	dk10012@cam.ac.uk; r.livesey@ucl.ac.uk		Strano, Alessio/0000-0002-7364-6553; Whiten, Daniel/0000-0002-7853-3566	Dementias Platform UK [MR/N013255/1]; StemBANCC [115439]; Alzheimer's Research UKAlzheimer's Research UK (ARUK) [ARUK-SCRC2017-1]; Wellcome TrustWellcome TrustEuropean Commission [101052/Z/13/Z, 105358/Z/14/Z, 203144]; Cancer Research UKCancer Research UK [C6946/A24843]; European Research CouncilEuropean Research Council (ERC)European Commission [669237]; Royal SocietyRoyal Society of LondonEuropean Commission; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/L023784/2, UKDRI-2003, MR/L023784/1] Funding Source: UKRI	This work was supported by grants to F.J.L. from Dementias Platform UK (MR/N013255/1), StemBANCC (115439), Alzheimer's Research UK (ARUK-SCRC2017-1), the Wellcome Trust (101052/Z/13/Z, 105358/Z/14/Z and 203144) and Cancer Research UK (C6946/A24843) and to D.K. from the European Research Council (Grant Number 669237) and the Royal Society.	Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bermejo P, 2008, IMMUNOL LETT, V117, P198, DOI 10.1016/j.imlet.2008.02.002; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Colvin BA, 2017, J NEUROCHEM, V143, P736, DOI 10.1111/jnc.14211; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; De S, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0777-4; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Drews A, 2017, CELL REP, V21, P3310, DOI 10.1016/j.celrep.2017.11.057; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P91, DOI 10.1097/01.wad.0000165511.52746.1f; Ekert JO, 2018, INT J GERIATR PSYCH, V33, P688, DOI 10.1002/gps.4871; Evans LD, 2018, CELL REP, V22, P3612, DOI 10.1016/j.celrep.2018.03.021; Flagmeier P, 2017, ANGEW CHEM INT EDIT, V56, P7750, DOI 10.1002/anie.201700966; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Ge Y, 2018, CYTOKINE GROWTH F R, V43, P38, DOI 10.1016/j.cytogfr.2018.07.001; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Horrocks MH, 2016, ACS CHEM NEUROSCI, V7, P399, DOI 10.1021/acschemneuro.5b00324; Hu NW, 2018, CELL REP, V23, P1932, DOI 10.1016/j.celrep.2018.04.040; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Hung COY, 2018, CELL REP, V25, P3647, DOI 10.1016/j.celrep.2018.11.095; Iljina M, 2018, ACS NANO, V12, P10855, DOI 10.1021/acsnano.8b03575; Iljina M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0390-6; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kyrkanides S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-112; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Mhatre SD, 2015, TRENDS NEUROSCI, V38, P621, DOI 10.1016/j.tins.2015.08.006; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Moore S, 2015, CELL REP, V11, P689, DOI 10.1016/j.celrep.2015.03.068; Novo M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19961-3; Paranjape GS, 2013, J NEUROIMMUNE PHARM, V8, P312, DOI 10.1007/s11481-012-9424-6; Paraschiv G, 2013, J MOL RECOGNIT, V26, P1, DOI 10.1002/jmr.2210; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Roberts BR, 2017, BRAIN, V140, P1486, DOI 10.1093/brain/awx057; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; Selkoe DJ, 2019, NAT REV NEUROL, V15, P365, DOI 10.1038/s41582-019-0205-1; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Terrill-Usery SE, 2016, ARCH BIOCHEM BIOPHYS, V597, P1, DOI 10.1016/j.abb.2016.03.017; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; WAAGE A, 1989, J EXP MED, V170, P1859, DOI 10.1084/jem.170.6.1859; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Whiten DR, 2018, CHEMBIOCHEM, V19, P2033, DOI 10.1002/cbic.201800209; Whiten DR, 2018, CELL REP, V23, P3492, DOI 10.1016/j.celrep.2018.05.074; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378	60	3	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							146	10.1093/braincomms/fcaa146			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800086	33543132	Green Published, gold			2022-02-06	
J	Wu, CX; Ning, B; Xu, P; Song, J; Wang, DH				Wu, Chunxing; Ning, Bo; Xu, Ping; Song, Jun; Wang, Dahui			Efficacy and complications after delayed fixation of femoral neck fractures in children	JOURNAL OF ORTHOPAEDIC SURGERY			English	Article						avascular necrosis; delayed reduction fixation; pediatric femoral neck fractures	INTERNAL-FIXATION; METAANALYSIS; ADOLESCENTS; FEMUR	Objective: This study evaluated the efficacy of surgery for femoral neck fractures in children after a 24-h delay and the factors affecting the risk of complications. Methods: The study included 16 children who underwent surgery after the first 24 h for femoral neck fractures. According to Delbet's classification, there were 2 type I, 11 type II, and 3 (four hips) type III cases. The mean time from injury to surgery was 85 h (range 27-240 h). According to Garden's classification, there were 1 type II, 14 type III, and 1 type IV (two hips) cases. Initial surgery consisted of closed reduction and hematocele drainage with a 20-mL needle tube. If the procedure failed, open reduction was performed. Internal fixation (K-wire pinning, screw) was performed after closed (n = 9) or open (n = 8) reduction. The results were assessed using the Ratliff criteria after a mean follow-up of 23.2 months. Patient age, type of fracture, complications, treatment, and avascular necrosis (AVN) were evaluated. Results: The results were good in 15 hips (88.2%) and fair in 2 hips (11.8%, one type II case with closed reduction and one type I case with open reduction). The most frequent complication was AVN (4 of 17; 23.5%; three Ratliff good and one fair), which was significantly related to poor outcomes. AVN occurred in one hip in the closed reduction group (Delbet's type II, 12.5%) and in three in the open reduction group (one Delbet's type I, 50%; two Delbet's type II, 66.7%). There were no significant differences in the time from injury to operation (27, 54, 64, and 116 h) and AVN incidence or Ratliff criteria. Conclusions: The efficacy of delayed reduction fixation of the femoral neck was better in the closed reduction group than in the open reduction group. Fracture location closer to the femoral head and older age affected the incidence of AVN.	[Wu, Chunxing; Ning, Bo; Xu, Ping; Song, Jun; Wang, Dahui] Fudan Univ, Dept Pediat Orthoped, Childrens Hosp, Shanghai 201102, Peoples R China		Wang, DH (corresponding author), Fudan Univ, Dept Pediat Orthoped, Childrens Hosp, Shanghai 201102, Peoples R China.	wangdahui@fudan.edu.cn					Colonna PC, 1928, ANN SURG, V88, P902, DOI 10.1097/00000658-192811000-00012; Crock HV, 2001, J BONE JOINT SURG BR, V83B, P149, DOI 10.1302/0301-620X.83B1.0830149; Dendane MA, 2010, ORTHOP TRAUMATOL-SUR, V96, P161, DOI [10.1016/j.rcot.2010.02.004, 10.1016/j.otsr.2009.11.007]; Eberl R, 2010, ACTA ORTHOP, V81, P442, DOI 10.3109/17453674.2010.501744; FRANDSEN PA, 1988, J BONE JOINT SURG BR, V70, P588, DOI 10.1302/0301-620X.70B4.3403602; Han YH, 2019, NUCL MED COMMUN, V40, P199, DOI 10.1097/MNM.0000000000000963; Ju L, 2016, J PEDIATR ORTHOP B, V25, P459, DOI 10.1097/BPB.0000000000000339; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Moon NH, 2019, INJURY, V50, P713, DOI 10.1016/j.injury.2019.01.018; Nayeemuddin M, 2009, J PEDIATR ORTHOP B, V18, P314, DOI 10.1097/BPB.0b013e32832d5d5f; Palocaren T, 2018, INDIAN J ORTHOP, V52, P501, DOI 10.4103/ortho.IJOrtho_404_17; Papakostidis C, 2015, INJURY, V46, P459, DOI 10.1016/j.injury.2014.12.025; Pavone V, 2019, INJURY, V50, pS40, DOI 10.1016/j.injury.2019.01.043; Qi BW, 2008, MICROSURG, V28, P21, DOI 10.1002/micr.20439; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528, DOI 10.1302/0301-620X.44B3.528; Scott B, 2017, J PEDIATR ORTHOP B, V26, P350, DOI 10.1097/BPB.0000000000000375; Spence D, 2016, J PEDIATR ORTHOPED, V36, P111, DOI 10.1097/BPO.0000000000000424; Stockton DJ, 2019, ACTA ORTHOP, V90, P21, DOI 10.1080/17453674.2018.1558380; Upasani VV, 2018, J PEDIAT ORTHOP; Venkatadass K, 2018, J PEDIATR ORTHOP B, V27, P274, DOI 10.1097/BPB.0000000000000460; Yeranosian M, 2013, BONE JOINT J, V95B, P135, DOI 10.1302/0301-620X.95B1.30161	21	3	4	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1022-5536	2309-4990		J ORTHOP SURG-HONG K	J. Orthop. Surg.	JAN	2020	28	1							2309499019889682	10.1177/2309499019889682			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	JW0BD	WOS:000502723500001	31833450	gold			2022-02-06	
J	Xu, ZX; Albayar, A; Dolle, JP; Hansel, G; Bianchini, J; Sullivan, PZ; Cullen, DK; Smith, DH; Ozturk, AK				Xu, Zi-Xing; Albayar, Ahmed; Dolle, Jean-Pierre; Hansel, Gisele; Bianchini, Justin; Sullivan, Patricia Zadnik; Cullen, D. Kacy; Smith, Douglas H.; Ozturk, Ali K.			Dorsal root ganglion axons facilitate and guide cortical neural outgrowth: In vitro modeling of spinal cord injury axonal regeneration	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); central nervous system regeneration; spinal cord injury (SCI); dorsal root ganglia (DRG) transplantation; cortical neuron aggregates (CNAs); experimental modeling; axonal guidance; axonal bridging	NERVOUS-TISSUE CONSTRUCTS; GLIAL SCAR FORMATION; LONG-TERM SURVIVAL; STEM-CELLS; THERAPY; GROWTH; TRANSPLANTATION; STRATEGY; NEURONS; BIOLOGY	Background: Spinal cord injury (SCI) patients represent a heterogeneous group, with injuries ranging from partial compression to complete transection. Patients with complete injuries are unlikely to exhibit recovery and suffer from paralysis as well as the loss of bowel and bladder function. One treatment option is the formation of a bridge through a lesion site, whereby transplanted cells or biocompatible scaffolds guide the regenerating axons across the site of injury. Moreover, the viability of transplanted dorsal root ganglia (DRGs) into rat spinal cord has been previously demonstrated. Objective: We aim to demonstrate the feasibility of using DRG axons as a bridging tool to help guide the axonal growth of cortical neurons. Methods: Cortical neurons were isolated from embryonic rats and two aggregated populations were cultured at increasing distances in isolation and in a co-culture with DRG explants. Growth rates of the sprouting axons and connections between the two populations were observed over a period of twelve days. Results: DRG explants demonstrated the ability to grow robust axonal connections that can connect two explants separated by up to 10 mm, however, CNAs could not achieve connections in distances greater than 2mm The co-culture of CNAs with DRG explants facilitated axonal growth between two populations of CNAs at distances they cannot otherwise traverse. Conclusions: Our findings support the use of DRG axons to facilitate the growth of cortical neurons in a process of axon-facilitated axon regeneration. We believe these results could have implications for the treatment of SCI.	[Xu, Zi-Xing] Fujian Med Univ, Dept Spinal Surg, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Albayar, Ahmed; Dolle, Jean-Pierre; Hansel, Gisele; Bianchini, Justin; Cullen, D. Kacy; Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Sullivan, Patricia Zadnik; Ozturk, Ali K.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Cullen, D. Kacy] Corporal Michael J Crescenz VA Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA		Albayar, A (corresponding author), Room 283,220 S33rd St, Philadelphia, PA 19104 USA.	ahmed.albayar@pennmedicine.upenn.edu	Hansel, Gisele/A-9150-2015	Hansel, Gisele/0000-0001-5048-1293	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401008]; Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C [2012-149]; U.S. Department of Defense (CDMRP/JPC8-CRMRP )United States Department of Defense [W81XWH-16-1-0796]	The authors thank Kritika Katiyar and Dayo Adewole for technical assistance. This studywas supported by the National Natural Science Foundation of China (No. 81401008), Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C (No. 2012-149) and U.S. Department of Defense (CDMRP/JPC8-CRMRP #W81XWH-16-1-0796).	Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Bernhard M, 2005, RESUSCITATION, V66, P127, DOI 10.1016/j.resuscitation.2005.03.005; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chung J, 2014, J NEUROSURG-SPINE, V21, P966, DOI 10.3171/2014.8.SPINE131090; Dalamagkas K, 2018, NEURAL REGEN RES, V13, P35, DOI 10.4103/1673-5374.224360; Eberli D, 2006, METHOD ENZYMOL, V420, P287, DOI 10.1016/S0076-6879(06)20013-2; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Huang JH, 2008, J NEUROSURG, V108, P343, DOI 10.3171/JNS/2008/108/2/0343; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101; Jacobs S, 2010, SPRINGER PROTOC HAND, P269, DOI 10.1007/978-1-60761-292-6_16; Kapfhammer JP, 1997, ANAT EMBRYOL, V196, P417, DOI 10.1007/s004290050109; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Pfister BJ, 2006, J NEUROSCI METH, V153, P95, DOI 10.1016/j.jneumeth.2005.10.012; Regala C, 2005, EXP NEUROL, V193, P326, DOI 10.1016/j.expneurol.2004.12.027; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5014, DOI 10.1166/jnn.2009.GR04; Smith DH, 2001, TISSUE ENG, V7, P131, DOI 10.1089/107632701300062714; Smith DH, 2009, PROG NEUROBIOL, V89, P231, DOI 10.1016/j.pneurobio.2009.07.006; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Struzyna LA, 2017, JOVE-J VIS EXP, DOI 10.3791/55609; Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Middendorp JJ, 2011, GLOB SPINE J, V1, P1, DOI 10.1055/s-0031-1296049; Wang Y, 2014, NEURAL REGEN RES, V9, P2182, DOI 10.4103/1673-5374.147951; Wang YT, 2015, CURR PHARM BIOTECHNO, V16, P492, DOI 10.2174/138920101606150407112646; Wiliams RR, 2012, PROG BRAIN RES, V201, P295, DOI 10.1016/B978-0-444-59544-7.00014-7; WOOD P, 1980, BRAIN RES, V196, P247, DOI 10.1016/0006-8993(80)90732-5; Yang EZ, 2017, ACTA PHARMACOL SIN, V38, P623, DOI 10.1038/aps.2017.11; Yuan JC, 2017, BRAIN RES, V1655, P90, DOI 10.1016/j.brainres.2016.11.002; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3	38	3	3	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2020	38	1					1	9		10.3233/RNN-190933			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KM4PO	WOS:000514112900001	31594262				2022-02-06	
J	Yuksen, C; Sricharoen, P; Puengsamran, N; Saksobhavivat, N; Sittichanbuncha, Y; Sawanyawisuth, K				Yuksen, Chaiyaporn; Sricharoen, Pungkawa; Puengsamran, Nipa; Saksobhavivat, Nitima; Sittichanbuncha, Yuwares; Sawanyawisuth, Kittisak			Diagnostic properties of a portable near-infrared spectroscopy to detect intracranial hematoma in traumatic brain injury patients	EUROPEAN JOURNAL OF RADIOLOGY OPEN			English	Article						Sensitivity; Specificity; Predictive value; Likelihood ratio	HEMORRHAGE; DEVICE	Traumatic brain injury (TBI) is a major public health issue worldwide. A portable near-infrared spectroscopy (NIRS) is a non-invasive device to detect intracranial hematoma. The advantages of the NIRS include real time results and non-radiation exposure. However, sensitivity and specificity of the NIRS for intracranial hematoma are varied. This study aimed to evaluate the diagnostic properties of the NIRS in TBI patients to detect intracranial hematoma. This study was a diagnostic and prospective study conducted at the Emergency Department. The inclusion criteria were adult patients (age of 18 years or over) with moderate to high risk of all degrees of traumatic brain injury within 24 h after the injury. The primary endpoint of the study was a description of diagnostic properties of the NIRS compared with the CT brain. There were 47 patients enrolled in the study. Most of patients had Glasgow Coma Scale of 15 (44 patients; 93.62 %). Of those, 11 patients (23.40 %) had intracranial hematoma: subdural hematoma (n = 9), epidural hematoma (n = 1), intracerebral hematoma (n = 1), and subarachnoid hemorrhage (n = 3). One patient had subdural hematoma, epidural hematoma, intracerebral hematoma and subarachnoid hemorrhage. There were 31 patients had abnormal findings by the NIRS but only 11 patients had bleeding detected by the CT brain. There were 16 patients had negative results on both the NIRS and the CT brain. The sensitivity and specificity of the NIRS compared with the CT brain was 100 % and 44.4 %, respectively. The area under the ROC curve of the NIRS was 0.722. The median time to complete the NIRS examination was 3 min. In conclusion, the NIRS has high sensitivity and negative predictive value for intracranial hematoma detection in mild TBI patients with extra-axial hematomas.	[Yuksen, Chaiyaporn; Sricharoen, Pungkawa; Puengsamran, Nipa; Saksobhavivat, Nitima; Sittichanbuncha, Yuwares] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Emergency Med, Bangkok, Thailand; [Sawanyawisuth, Kittisak] Khon Kaen Univ, Fac Med, Dept Med, Sleep Apnea Res Grp, Khon Kaen, Thailand		Sawanyawisuth, K (corresponding author), Khon Kaen Univ, Fac Med, Dept Med, Sleep Apnea Res Grp, Khon Kaen, Thailand.	chaipool0634@hotmail.com; pungkawa@hotmail.com; beau_friends@hotmail.com; nitimasak@gmail.com; yuwares.sit@mahidol.ac.th; kittisak@kku.ac.th		Yuksen, Chaiyaporn/0000-0002-4890-7176			Albertsson P, 2005, ACCIDENT ANAL PREV, V37, P225, DOI 10.1016/j.aap.2004.03.006; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; HIGUCHI K, 2017, ASIA PAC J SCI TECHN, V22, DOI DOI 10.3390/MOLECULES22030502; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Liang CY, 2018, MIL MED, V183, pE318, DOI 10.1093/milmed/usx088; Osakwe O., 2013, ASIA PAC J SCI TECHN, V22, P227; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peters J, 2017, PREHOSP DISASTER MED, V32, P414, DOI 10.1017/S1049023X17006367; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Wongwiriya P., 2017, ASIA PAC J SCI TECHN, V22, pAPST; Xu L, 2017, J CLIN NEUROSCI, V40, P136, DOI 10.1016/j.jocn.2017.02.056; Yuksen C, 2018, THER CLIN RISK MANAG, V14, P213, DOI 10.2147/TCRM.S147079	12	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2352-0477		EUR J RADIOL OPEN	Eur. J. Radiol. Open		2020	7								100246	10.1016/j.ejro.2020.100246			4	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	PH7OP	WOS:000600597400036	32775555	Green Published, gold			2022-02-06	
J	Huang, MX; Swan, AR; Quinto, AA; Huang, JW; De-la-garza, BG; Huang, CW; Hesselink, JR; Bigler, ED; Wilde, EA; Max, JE				Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles; Huang, Jeffrey W.; De-la-garza, Bianca G.; Huang, Charles W.; Hesselink, John R.; Bigler, Erin D.; Wilde, Elisabeth A.; Max, Jeffrey E.			Resting-State Magnetoencephalography Source Imaging Pilot Study in Children with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						MEG; mild traumatic brain injury; pediatric; post-concussion symptoms; psychiatric disorder	MIDLINE THETA-RHYTHM; FUNCTIONAL CONNECTIVITY; DELTA WAVES; GAMMA RHYTHMS; MEG; EEG; MECHANISMS; TUMOR; SYNCHRONIZATION; SCHIZOPHRENIA	Mild traumatic brain injury (mTBI) accounts for the vast majority of all pediatric TBI. An important minority of children who have suffered an mTBI have enduring cognitive and emotional symptoms. However, the mechanisms of chronic symptoms in children with pediatric mTBI are not fully understood. This is in part due to the limited sensitivity of conventional neuroimaging technologies. The present study examined resting-state magnetoencephalography (rs-MEG) source images in 12 children who had mTBI and 12 age-matched control children. The rs-MEG exams were performed in children with mTBI 6 months after injury when they reported no clinically significant post-injury psychiatric changes and few if any somatic sensorimotor symptoms but did report cognitive symptoms. MEG source magnitude images were obtained for different frequency bands in alpha (8-12 Hz), beta (15-30 Hz), gamma (30-90 Hz), and low-frequency (1-7 Hz) bands. In contrast to the control participants, rs-MEG source imaging in the children with mTBI showed: 1) hyperactivity from the bilateral insular cortices in alpha, beta, and low-frequency bands, from the left amygdala in alpha band, and from the left precuneus in beta band; 2) hypoactivity from the bilateral dorsolateral prefrontal cortices (dlPFC) in alpha and beta bands, from the ventromedial prefrontal cortex (vmPFC) in beta band, from the ventrolateral prefrontal cortex (vlPFC) in gamma band, from the anterior cingulate cortex (ACC) in alpha band, and from the right precuneus in alpha band. The present study showed that MEG source imaging technique revealed abnormalities in the resting-state electromagnetic signals from the children with mTBI.	[Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles; Hesselink, John R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [De-la-garza, Bianca G.; Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles] VA San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Huang, Ming-Xiong; Swan, Ashley Robb; Quinto, Annemarie Angeles] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA USA; [Huang, Jeffrey W.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Huang, Charles W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Bigler, Erin D.; Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Max, Jeffrey E.] Rady Childrens Hosp, Dept Psychiat, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA		Max, JE (corresponding author), Rady Childrens Hosp, Dept Psychiat, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu			National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD068432-01A1, 1R-01 HD088438-01A1]; Merit Review Grants from the Department of Veterans AffairsUS Department of Veterans Affairs [I01CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, NEUC-044-06S]	This work was supported in part by the National Institute of Child Health and Development grants 1R01HD068432-01A1 and 1R-01 HD088438-01A1 (PI: J.E. Max), and by Merit Review Grants from the Department of Veterans Affairs (PI: M.X. Huang): I01CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, and NEUC-044-06S.	Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Augustine G., 2001, NEUROSCIENCE; Baayen JC, 2003, BRAIN TOPOGR, V16, P85, DOI 10.1023/B:BRAT.0000006332.71345.b7; Babiloni C, 2013, CLIN NEUROPHYSIOL, V124, P837, DOI 10.1016/j.clinph.2012.09.017; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Cohen D, 2002, P 13 INT C BIOM, P919; daSilva FHL, 1997, INT J PSYCHOPHYSIOL, V26, P237; de Jongh A, 2003, NEUROIMAGE, V20, P2291, DOI 10.1016/j.neuroimage.2003.07.030; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; DECKER DA, 1972, ELECTROEN CLIN NEURO, V33, P303, DOI 10.1016/0013-4694(72)90157-5; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P759, DOI 10.1017/S1355617718000437; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hindriks R, 2013, NEUROIMAGE, V70, P150, DOI 10.1016/j.neuroimage.2012.12.018; Hinkley LBN, 2011, BIOL PSYCHIAT, V70, P1134, DOI 10.1016/j.biopsych.2011.06.029; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2017, BRAIN INJURY, V31, P1951, DOI 10.1080/02699052.2017.1363409; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jaiswal MK, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00148; Ju YE, 2017, BRAIN, V140, P2104, DOI 10.1093/brain/awx148; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V5th; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lozano-Soldevilla D, 2018, FRONT COMPUT NEUROSC, V12, DOI 10.3389/fncom.2018.00023; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; MIZUKI Y, 1980, ELECTROEN CLIN NEURO, V49, P345, DOI 10.1016/0013-4694(80)90229-1; MIZUKI Y, 1992, INT J PSYCHOPHYSIOL, V12, P169, DOI 10.1016/0167-8760(92)90008-Y; MIZUKI Y, 1984, FOLIA PSYCHIAT NEU J, V38, P451; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; NAGATA K, 1985, NEUROSURGERY, V17, P613, DOI 10.1227/00006123-198510000-00014; Naviaux RK, 2019, MITOCHONDRION, V46, P278, DOI 10.1016/j.mito.2018.08.001; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Schaul N, 1998, ELECTROEN CLIN NEURO, V106, P101, DOI 10.1016/S0013-4694(97)00111-9; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Scheeringa R, 2012, BRAIN CONNECT, V2, P254, DOI 10.1089/brain.2012.0088; Scholvinck ML, 2013, NEUROIMAGE, V80, P297, DOI 10.1016/j.neuroimage.2013.04.010; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song T, 2009, J CLIN NEUROPHYSIOL, V26, P392, DOI 10.1097/WNP.0b013e3181c29896; Sponheim SR, 2000, BIOL PSYCHIAT, V48, P1088, DOI 10.1016/S0006-3223(00)00907-0; Takahashi N, 1997, CLIN ELECTROENCEPHAL, V28, P49, DOI 10.1177/155005949702800109; Tartaglione A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-145; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; TEASDALE G, 1974, LANCET, V2, P81; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; Wechsler D., 2011, WESCHLER ABBREVIATED; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491	77	3	3	1	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					994	1001		10.1089/neu.2019.6417		DEC 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000505208700001	31724480	Green Published			2022-02-06	
J	Das Gupta, S; Lipponen, A; Paldanius, KMA; Puhakka, N; Pitkanen, A				Das Gupta, Shalini; Lipponen, Anssi; Paldanius, Kaisa M. A.; Puhakka, Noora; Pitkanen, Asla			Dynamics of clusterin protein expression in the brain and plasma following experimental traumatic brain injury	SCIENTIFIC REPORTS			English	Article							CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; BIOMARKERS; APOPTOSIS; MODEL; EPILEPTOGENESIS; EPIDEMIOLOGY; PROGRESSION; DEPOSITION; APOE	Progress in the preclinical and clinical development of neuroprotective and antiepileptogenic treatments for traumatic brain injury (TBI) necessitates the discovery of prognostic biomarkers for post-injury outcome. Our previous mRNA-seq data revealed a 1.8-2.5 fold increase in clusterin mRNA expression in lesioned brain areas in rats with lateral fluid-percussion injury (FPI)-induced TBI. On this basis, we hypothesized that TBI leads to increases in the brain levels of clusterin protein, and consequently, increased plasma clusterin levels. For evaluation, we induced TBI in adult male Sprague-Dawley rats (n = 80) by lateral FPI. We validated our mRNA-seq findings with RT-qPCR, confirming increased clusterin mRNA levels in the perilesional cortex (FC 3.3, p < 0.01) and ipsilateral thalamus (FC 2.4, p < 0.05) at 3 months post-TBI. Immunohistochemistry revealed a marked increase in extracellular clusterin protein expression in the perilesional cortex and ipsilateral hippocampus (7d to 1 month post-TBI), and ipsilateral thalamus (14d to 12 months post-TBI). In the thalamus, punctate immunoreactivity was most intense around activated microglia and mitochondria. Enzyme-linked immunoassays indicated that an acute 15% reduction, rather than an increase in plasma clusterin levels differentiated animals with TBI from sham-operated controls (AUC 0.851, p < 0.05). Our findings suggest that plasma clusterin is a candidate biomarker for acute TBI diagnosis.	[Das Gupta, Shalini; Lipponen, Anssi; Paldanius, Kaisa M. A.; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Lipponen, Anssi/0000-0002-4403-9084	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 2285733-9]; European UnionEuropean Commission [602102]	We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance. We are also grateful to Mr. Juha Kekalainen, for his excellent help in bioinformatics analysis, and to Dr. Xavier Ekolle Ndode Ekane for his expert comments regarding the figure preparation. This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249, 273909, and 2285733-9) and by the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 602102 (EPITARGET).	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Bellander B.-M., 2009, J NEUROSURG, V85, P468; Chang L, 2012, J IMMUNOL METHODS, V378, P102, DOI 10.1016/j.jim.2012.02.011; Corrigan J. D., 2010, J HEAD TRAUMA REHAB, V25; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; DANIK M, 1991, P NATL ACAD SCI USA, V88, P8577, DOI 10.1073/pnas.88.19.8577; Debure L, 2003, J CELL SCI, V116, P3109, DOI 10.1242/jcs.00619; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Foster EM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00164; Gil SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2896; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Jongbloed W, 2015, J ALZHEIMERS DIS, V46, P1103, DOI 10.3233/JAD-150036; Jongbloed W, 2014, ANN CLIN BIOCHEM, V51, P557, DOI 10.1177/0004563213503456; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; KIDA E, 1995, BRAIN RES, V685, P211, DOI 10.1016/0006-8993(95)00482-6; Kim N, 2012, J CELL PHYSIOL, V227, P1157, DOI 10.1002/jcp.22836; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Kroksveen AC, 2013, J PROTEOMICS, V78, P312, DOI 10.1016/j.jprot.2012.09.037; Lidstrom AM, 2001, J ALZHEIMERS DIS, V3, P435, DOI 10.3233/JAD-2001-3501; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15546; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Mukaetova-Ladinska EB, 2015, INT J GERIATR PSYCH, V30, P368, DOI 10.1002/gps.4145; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Oh SB, 2019, BRAIN PATHOL, V29, P217, DOI 10.1111/bpa.12660; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Rao GSU, 2017, J NEUROANAESTHESIOL, V4, P2; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Shin MS, 2013, NEUROENDOCRINOLOGY, V98, P233, DOI 10.1159/000355625; Silajdzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050237; Song H., 2018, TRANSL STROKE RES, P1; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Troakes C, 2017, NEUROPATHOLOGY, V37, P12, DOI 10.1111/neup.12320; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Vishnu VY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166369; Weinstein Galit, 2016, Alzheimers Dement (Amst), V3, P103, DOI 10.1016/j.dadm.2016.06.005; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114; Xiao F, 2009, BRAIN RES, V1255, P180, DOI 10.1016/j.brainres.2008.12.008; Yu WH, 2014, J MOL NEUROSCI, V54, P1, DOI 10.1007/s12031-014-0237-3; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	60	3	3	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 27	2019	9								20208	10.1038/s41598-019-56683-6			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KF6KF	WOS:000509347900013	31882899	Green Published, gold			2022-02-06	
J	Stiekema, APM; Nijsse, B; de Kort, PLM; Spikman, JM; Visser-Meily, JMA; van Heugten, CM				Stiekema, Annemarie P. M.; Nijsse, Britta; de Kort, Paul L. M.; Spikman, Jacoba M.; Visser-Meily, Johanna M. A.; van Heugten, Caroline M.			The relationship between social cognition and participation in the long term after stroke	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Theory of mind; Empathy; Emotion recognition; Participation	TRAUMATIC BRAIN-INJURY; EMOTION RECOGNITION; FUNCTIONAL OUTCOMES; UTRECHT SCALE; SCHIZOPHRENIA; IMPAIRMENTS; LESIONS; MIND; INDIVIDUALS; DEFICITS	Social cognitive impairments may play a role in participation restrictions after stroke. Understanding their relationship could inform treatment approaches to improve participation. We investigated the relationship between social cognition and participation in the long term after stroke. Of 395 patients participating in a large prospective cohort study, cross-sectional data were available at 3-4 years post-stroke of 118 patients on tests for emotion recognition, theory of mind, empathy, and behaviour regulation. Participation was assessed with the Utrecht Scale for Evaluation of Rehabilitation - Participation (USER-P). Bivariate and multivariate regression analysis were used to examine the relationship between social cognitive domains and participation. The majority suffered from minor stroke (83.1% scored NIHSS 0-4). Only behaviour regulation was related to participation restrictions in bivariate analysis, but social cognitive impairments did not predict participation restrictions in multivariate regression in this group. To conclude, in a sample of minor stroke patients with mild impairments in theory of mind, emotion recognition and behavioural control, there were no associations with restrictions in participation. Research should examine whether a relationship is present in patients with more severe stroke. In addition, measuring social aspects of participation is necessary to further unravel this relationship, to determine treatment targets for improving participation.	[Stiekema, Annemarie P. M.; van Heugten, Caroline M.] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Tanslaan 12,POB 616,UNS40 Box 34, NL-6200 MD Maastricht, Netherlands; [Stiekema, Annemarie P. M.; van Heugten, Caroline M.] Maastricht Univ, Limburg Brain Injury Ctr, Maastricht, Netherlands; [Stiekema, Annemarie P. M.] Maastricht Univ, Alzheimer Ctr Limburg, Maastricht, Netherlands; [Nijsse, Britta; de Kort, Paul L. M.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Subdept Neuropsychol, Dept Neurol, Groningen, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Hoogstraat Rehabil, Utrecht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Tanslaan 12,POB 616,UNS40 Box 34, NL-6200 MD Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl		Spikman, Jacoba/0000-0002-6477-0763; Stiekema, Annemarie/0000-0002-6739-3772	VSBfonds (the Dutch Organization to support Dutch society with money, knowledge and networks) [89000004]	The Restore4Stroke study was funded by the VSBfonds (the Dutch Organization to support Dutch society with money, knowledge and networks; grant number 89000004), and coordinated by ZonMw (Dutch Organization for Health Research and Development).	Abbott JD, 2014, LATERALITY, V19, P455, DOI 10.1080/1357650X.2013.862256; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Baldo JV, 2016, NEUROPSYCHOLOGIA, V80, P133, DOI 10.1016/j.neuropsychologia.2015.11.001; Bergstrom A, 2017, SCAND J OCCUP THER, V24, P339, DOI 10.1080/11038128.2016.1245782; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burgess P.W., 1997, HAYLING BRIXTON TEST; Collin C, 1988, Int Disabil Stud, V10, P61; Cooper CL, 2014, BRAIN INJURY, V28, P122, DOI 10.3109/02699052.2013.848379; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; de Graaf JA, 2018, DISABIL REHABIL, V40, P637, DOI 10.1080/09638288.2016.1271466; Desrosiers J, 2006, DISABIL REHABIL, V28, P221, DOI 10.1080/09638280500158372; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Ezekiel L, 2019, ARCH PHYS MED REHAB, V100, P945, DOI 10.1016/j.apmr.2018.06.017; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Fride Y, 2015, TOP STROKE REHABIL, V22, P317, DOI 10.1179/1074935714Z.0000000013; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gonzalez C, 2013, REHABIL NURS, V38, P202, DOI 10.1002/rnj.85; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Groeneveld IF, 2019, J STROKE CEREBROVASC, V28, P499, DOI 10.1016/j.jstrokecerebrovasdis.2018.10.033; Hamilton J, 2017, ARCH CLIN NEUROPSYCH, V32, P507, DOI 10.1093/arclin/acx035; Happe F., 1999, ACQUIRED THEORY MIND; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Leite M, 2017, ACTA NEUROPSYCHOL, V15, P127, DOI 10.5604/01.3001.0010.2405; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; Mehrabian A, 2000, GENET SOC GEN PSYCH, V126, P133; Meijer R, 2006, INT J REHABIL RES, V29, P1, DOI 10.1097/01.mrr.0000175269.59788.41; Narme P, 2017, AGING NEUROPSYCHOL C, V24, P80, DOI 10.1080/13825585.2016.1171291; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nijsse B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213725; Nijsse B, 2019, ARCH PHYS MED REHAB, V100, P1300, DOI 10.1016/j.apmr.2019.01.023; Pendergrass A, 2017, REHABIL PSYCHOL, V62, P81, DOI 10.1037/rep0000118; Pijnenborg GHM, 2009, J INT NEUROPSYCH SOC, V15, P239, DOI 10.1017/S1355617709090341; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; Rai AT, 2019, STROKE, V50, P1902, DOI 10.1161/STROKEAHA.119.025112; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; van der Zee CH, 2013, TOP STROKE REHABIL, V20, P52, DOI 10.1310/tsr2001-52; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; Verhage F, 1964, INTELLIGENTIE LEEFTI; Westerhof-Evers HJ, 2019, BRAIN INJURY, V33, P78, DOI 10.1080/02699052.2018.1531303; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Wolf TJ, 2012, BRAIN IMPAIR, V13, P16, DOI 10.1017/BrImp.2012.1; Wood JP, 2010, CLIN REHABIL, V24, P1045, DOI 10.1177/0269215510375901; Yeh ZT, 2015, J CLIN EXP NEUROPSYC, V37, P128, DOI 10.1080/13803395.2014.992864; Yeh ZT, 2014, PSYCHIAT CLIN NEUROS, V68, P612, DOI 10.1111/pcn.12173; Young A., 2002, FACIAL EXPRESSIONS E; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440; Zupan B, 2015, BRAIN INJURY, V29, P877, DOI 10.3109/02699052.2015.1011233	54	3	3	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2021	31	2					278	292		10.1080/09602011.2019.1692670		DEC 2019	15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QA9MZ	WOS:000503953000001	31854264	Green Published, hybrid			2022-02-06	
J	Bailey, ZS; Cardiff, K; Yang, XF; Gilsdorf, J; Shear, D; Rasmussen, TE; Leung, LY				Bailey, Zachary S.; Cardiff, Katherine; Yang, Xiaofang; Gilsdorf, Janice; Shear, Deborah; Rasmussen, Todd E.; Leung, Lai Yee			The Effects of Balloon Occlusion of the Aorta on Cerebral Blood Flow, Intracranial Pressure, and Brain Tissue Oxygen Tension in a Rodent Model of Penetrating Ballistic-Like Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						resuscitative endovascular balloon occlusion of the aorta; penetrating brain injury; intracranial pressure; cerebral blood flow; brain tissue oxygen tension	HEMORRHAGE CONTROL; RETE-MIRABILE; DEATH; REBOA; SHOCK; BARORECEPTORS; HYPERTENSION; DYSFUNCTION; MANAGEMENT; OUTCOMES	Trauma is among the leading causes of death in the United States. Technological advancements have led to the development of resuscitative endovascular balloon occlusion of the aorta (REBOA) which offers a pre-hospital option to non-compressible hemorrhage control. Due to the prevalence of concomitant traumatic brain injury (TBI), an understanding of the effects of REBOA on cerebral physiology is critical. To further this understanding, we employed a rat model of penetrating ballistic-like brain injury (PBBI). PBBI produced an injury pattern within the right frontal cortex and striatum that replicates the pathology from a penetrating ballistic round. Aortic occlusion was initiated 30 min post-PBBI and maintained continuously (cAO) or intermittently (iAO) for 30 min. Continuous measurements of mean arterial pressure (MAP), intracranial pressure (ICP), cerebral blood flow (CBF), and brain tissue oxygen tension (PbtO(2)) were recorded during, and for 60 min following occlusion. PBBI increased ICP and decreased CBF and PbtO(2). The arterial balloon catheter effectively occluded the descending aorta which augmented MAP in the carotid artery. Despite this, CBF levels were not changed by aortic occlusion. iAO caused sustained adverse effects to ICP and PbtO(2) while cAO demonstrated no adverse effects on either. Temporary increases in PbtO(2) were observed during occlusion, along with restoration of sham levels of ICP for the remainder of the recordings. These results suggest that iAO may lead to prolonged cerebral hypertension following PBBI. Following cAO, ICP, and PbtO(2) levels were temporarily improved. This information warrants further investigation using TBI-polytrauma model and provides foundational knowledge surrounding the non-hemorrhage applications of REBOA including neurogenic shock and stroke.	[Bailey, Zachary S.; Cardiff, Katherine; Yang, Xiaofang; Gilsdorf, Janice; Shear, Deborah; Leung, Lai Yee] Walter Reed Army Inst Res, Brain Trauma Neuroprotect, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Rasmussen, Todd E.; Leung, Lai Yee] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Bailey, ZS (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	zachary.s.bailey5.ctr@mail.mil	Rasmussen, Todd/Y-2122-2019	Rasmussen, Todd/0000-0003-1120-4116	Combat Casualty Care Research Program, United States Army Medical Research and Materiel Command	This work was supported by Combat Casualty Care Research Program, United States Army Medical Research and Materiel Command.	Abe T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1577-x; Abou El Fadl MH, 2017, NEUROL CLIN, V35, P641, DOI 10.1016/j.ncl.2017.06.003; Avaro JP, 2011, J TRAUMA, V71, P720, DOI 10.1097/TA.0b013e318221a94a; Bell ED, 2017, J MECH BEHAV BIOMED, V65, P627, DOI 10.1016/j.jmbbm.2016.09.028; Bonds BW, 2015, BRAIN INJURY, V29, P1642, DOI 10.3109/02699052.2015.1075157; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Burbridge B, 2004, CAN ASSOC RADIOL J, V55, P326; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; Chaudery M, 2015, J TRAUMA ACUTE CARE, V78, P153, DOI 10.1097/TA.0000000000000472; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Daley J, 2017, AM J EMERG MED, V35, P731, DOI 10.1016/j.ajem.2017.01.010; DANIEL PM, 1953, PHILOS T ROY SOC B, V237, P173, DOI 10.1098/rstb.1953.0003; Davidson AJ, 2018, J TRAUMA ACUTE CARE, V84, P192, DOI 10.1097/TA.0000000000001711; Eastridge BJ, 2019, TRANSFUSION, V59, P1423, DOI 10.1111/trf.15161; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Gajavelli S, 2015, J CEREBR BLOOD F MET, V35, P773, DOI 10.1038/jcbfm.2014.243; GILFOIL TM, 1958, AM J PHYSIOL, V194, P155, DOI 10.1152/ajplegacy.1958.194.1.155; GILFOIL TM, 1958, CIRC RES, V6, P501, DOI 10.1161/01.RES.6.4.501; GILLILAN LA, 1974, J COMP NEUROL, V153, P275, DOI 10.1002/cne.901530305; GILPIN C. M., 2005, THESIS; Gray S, 2018, CUREUS, V10, DOI 10.7759/cureus.2637; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Jha RM, 2017, HAND CLINIC, V141, P633, DOI 10.1016/B978-0-444-63599-0.00034-X; Johnson MA, 2017, J TRAUMA ACUTE CARE, V83, P61, DOI [10.1097/TA.0000000000001372, 10.1097/TA.0000000000001518]; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kougias P, 2010, MED SCI MONITOR, V16, pRA1; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Liebeskind David S, 2008, Curr Cardiol Rep, V10, P31, DOI 10.1007/s11886-008-0007-3; LLUCH S, 1985, AM J PHYSIOL, V249, pR482, DOI 10.1152/ajpregu.1985.249.4.R482; Moore LJ, 2016, AM J SURG, V212, P1222, DOI 10.1016/j.amjsurg.2016.09.027; Morrison JJ, 2014, SURG-J R COLL SURG E, V12, P119, DOI 10.1016/j.surge.2013.10.004; Morrison JJ, 2014, SHOCK, V41, P130, DOI 10.1097/SHK.0000000000000085; MUNCH PA, 1983, AM J PHYSIOL, V244, pH672, DOI 10.1152/ajpheart.1983.244.5.H672; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nunez RM, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0142-5; Rasmussen TE, 2017, JAMA SURG, V152, P1072, DOI 10.1001/jamasurg.2017.3428; Rich JA, 2017, BMJ CASE REP, V2017, DOI 10.1136/bcr-2017-22088528716775; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; SHACKFORD SR, 1990, J TRAUMA, V30, P768, DOI 10.1097/00005373-199007000-00002; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; SLEIGHT P, 1977, CIRC RES, V41, P750, DOI 10.1161/01.RES.41.6.750; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Williams AM, 2019, J TRAUMA ACUTE CARE, V86, P415, DOI 10.1097/TA.0000000000002149; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	52	3	3	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 18	2019	10								1309	10.3389/fneur.2019.01309			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JZ3BU	WOS:000504978200001	31920932	gold, Green Published			2022-02-06	
J	Belanger, HG; Wortzel, HS; Vanderploeg, RD; Cooper, DB				Belanger, Heather G.; Wortzel, Hal S.; Vanderploeg, Rodney D.; Cooper, Douglas B.			A model for intervening with veterans and service members who are concerned about developing Chronic Traumatic Encephalopathy (CTE)	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; CTE; neuropsychological; postconcussive; mild TBI; intervention	POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; POSTCONCUSSION SYMPTOMS; DIAGNOSIS THREAT; COMBAT VETERANS; CONCUSSION; HISTORY; METAANALYSIS; OUTCOMES	Objective: This paper briefly reviews what is unknown about chronic traumatic encephalopathy (CTE), highlights understandable concerns by individuals with a history of mild traumatic brain injuries who present to neuropsychologists with fears about a deteriorating course and eventual dementia due to CTE, and proposes a three-phased model for intervening with such individuals. Method: The proposed model includes three phases - (1) assessment and education, (2) targeted interventions for specific symptoms and comorbidities (e.g., sleep disturbance, headache, depression), and (3) psychotherapy to address mental health issues. While this is generally the order in which they will occur, the approach is not necessarily linear but rather provides a recommended schema. Conclusion: Media attention on concussion has greatly increased in the last several years, as interest in the possible contribution of concussion(s) to CTE grows. This media attention has some adverse effects in that it creates a false perception about the current state of the science and may engender iatrogenic effects. The proposed model is offered as one approach to engage patients within this context.	[Belanger, Heather G.; Cooper, Douglas B.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33613 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, 3500 E Fletcher,Ste 207, Tampa, FL 33613 USA; [Belanger, Heather G.] 9Line LLC, James A Haley Vet Hosp, US Special Operat Command, Tampa, FL USA; [Wortzel, Hal S.] Rocky Mt Reg Med Ctr, Rocky Mt MIRECC, Aurora, CO USA; [Wortzel, Hal S.] Univ Colorado, Dept Psychiat, Aurora, CO USA; [Wortzel, Hal S.] Univ Colorado, Dept Neurol, Aurora, CO USA; [Wortzel, Hal S.] Univ Colorado, Dept PM&R, Aurora, CO USA; [Cooper, Douglas B.] Audie Murphy Mem VA Hosp, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA		Belanger, HG (corresponding author), Univ S Florida, Dept Psychol, 3500 E Fletcher,Ste 207, Tampa, FL 33613 USA.	heather.belanger.ctr@socom.mil			Department of Veterans Affairs, Veterans Health Administration (VHA), the Department of Defense (DoD); 9 Line LLC; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [MDA 905-03-2-0003]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Veterans Affairs, Department of Defense, or U.S. Government. The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration (VHA), the Department of Defense (DoD), and 9 Line LLC. Further support was provided by the Defense and Veterans Brain Injury Center, Grant number MDA 905-03-2-0003, and the James A. Haley Veterans' Hospital. Drs. Belanger, Cooper, and Vanderploeg earn part of their income from independent practice, which includes work for the National Football League and the NFL Concussion Settlement. Dr. Wortzel maintains a private practice in forensic neuropsychiatry.	Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Armistead-Jehle P, 2018, ARCH CLIN NEUROPSYCH, V33, P120, DOI 10.1093/arclin/acx031; Barsky AJ, 2004, JAMA-J AM MED ASSOC, V291, P1464, DOI 10.1001/jama.291.12.1464; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Belanger H. G., 2017, TXB CLIN NEUROPSYCHO, P411; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernardy K, 2018, EUR J PAIN, V22, P242, DOI 10.1002/ejp.1121; Bidari A, 2019, DARU, V27, P149, DOI 10.1007/s40199-019-00257-4; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Callahan ML, 2019, APPL NEUROPSYCH-ADUL, V26, P365, DOI 10.1080/23279095.2018.1433179; Carone DA, 2017, APPL NEUROPSYCH-ADUL, V24, P160, DOI 10.1080/23279095.2015.1116074; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Gilron I, 2016, PAIN, V157, P1532, DOI 10.1097/j.pain.0000000000000558; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hoge CW, 2011, JAMA-J AM MED ASSOC, V306, P549, DOI 10.1001/jama.2011.1096; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jing L, 2019, J AFFECT DISORDERS, V245, P98, DOI 10.1016/j.jad.2018.10.114; Karr JE, 2019, J CLIN EXP NEUROPSYC, V41, P680, DOI 10.1080/13803395.2019.1611740; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrea M, 2014, PROG NEUROL SURG, V28, P112, DOI 10.1159/000358769; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Peters KD, 2011, J ABNORM PSYCHOL, V120, P168, DOI 10.1037/a0021899; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ribeiro JD, 2018, BRIT J PSYCHIAT, V212, P279, DOI 10.1192/bjp.2018.27; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Russo AC, 2017, ARCH CLIN NEUROPSYCH, V32, P184, DOI 10.1093/arclin/acw093; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silver J. M., 2013, MANAGEMENT ADULTS TR; Silverberg ND, 2019, NEUROREHABILITATION, V44, P523, DOI 10.3233/NRE-192708; Silverberg ND, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00362; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000095; Ward J., 2017, NY TIMES; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344	77	3	3	2	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1105	1123		10.1080/13854046.2019.1699166		DEC 2019	19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000503557200001	31847694				2022-02-06	
J	Gangloff, C; Mingant, F; Theron, M; Galinat, H; Grimault, O; Ozier, Y; Pichavant-Rafini, K				Gangloff, Cedric; Mingant, Fanny; Theron, Michael; Galinat, Hubert; Grimault, Ollivier; Ozier, Yves; Pichavant-Rafini, Karine			New considerations on pathways involved in acute traumatic coagulopathy: the thrombin generation paradox	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Trauma; Coagulation; Shock; Thrombin; Platelet; Model	DISSEMINATED INTRAVASCULAR COAGULATION; EARLY PLATELET DYSFUNCTION; MULTIPLE ORGAN FAILURE; HEMORRHAGIC-SHOCK; VENOUS THROMBOEMBOLISM; POTASSIUM CHANNELS; IMMUNE-RESPONSE; BRAIN-INJURY; ACTIVATION; MORTALITY	Background: An acute traumatic coagulopathy (ATC) is observed in about one third of severely traumatized patients. This early, specific, and endogenous disorder is triggered by the association of trauma and hemorrhage. The early phase of this condition is characterized by the expression of a bleeding phenotype leading to hemorrhagic shock and the late phase by a prothrombotic profile leading to multiple organ failure. The physiopathology of this phenomenon is still poorly understood. Hypotheses of disseminated intravascular coagulation, activated protein C-mediated fibrinolysis, fibrinogen consumption, and platelet functional impairment were developed by previous authors and continue to be debated. The objective of this study was to observe general hemostasis disorders in case of ATC to confront these hypotheses. Method: Four groups of 15 rats were compared: C, control; T, trauma; H, hemorrhage; and TH, trauma and hemorrhage. Blood samples were drawn at baseline and 90 min. Thrombin generation tests, platelet aggregometry, and standard hemostasis tests were performed. Results: Significant differences were observed between the baseline and TH groups for aPTT (17.9 +/- 0.8 s vs 24.3 +/- 1.4 s, p < 0.001, mean +/- SEM), MAP (79.7 +/- 1.3 mmHg vs 43.8 +/- 1.3 mmHg, p < 0.001, mean +/- SEM), and hemoglobin (16.5 +/- 0.1 g/dL vs 14.1 +/- 0.3 g/dL, p < 0.001, mean +/- SEM), indicating the presence of an hemorrhagic shock due to ATC. Compared to all other groups, coagulation factor activities were decreased in the TH group, but endogenous thrombin potential was (paradoxically) higher than in group C (312 +/- 17 nM/min vs. 228 +/- 23 nM/min; p = 0.016; mean +/- SEM). We also observed a subtle decrease in platelet count and function in case of ATC and retrieved an inversed linear relationship between fibrinogen concentration and aPTT (intercept, 26.53 +/- 3.16; coefficient, - 3.40 +/- 1.26; adjusted R-2: 0.1878; p = 0.0123). Conclusions: The clinical-biological profile that we observed, combining normal thrombin generation, fibrinogen depletion, and a hemorrhagic phenotype, reinforced the hypothesis of activated protein C mediated-fibrinolysis. The key role of fibrinogen, but not of the platelets, was confirmed in this study. The paradoxical preservation of thrombin generation suggests a protective mechanism mediated by rhabdomyolysis in case of major trauma. Based on these results, we propose a new conception concerning the pathophysiology of ATC.	[Gangloff, Cedric; Theron, Michael; Grimault, Ollivier; Ozier, Yves; Pichavant-Rafini, Karine] Univ Bretagne Occidentale, ORPHY Lab EA4324, Brest, France; [Gangloff, Cedric] CHU Pontchaillou, Dept Emergency Med, Rennes, France; [Mingant, Fanny; Galinat, Hubert] CHRU Cavale Blanche, Dept Biol & Hemostasis, Brest, France; [Grimault, Ollivier] Hop Cavale Blanche, Dept Emergency Med, Brest, France; [Ozier, Yves] Hop Cavale Blanche, Dept Anaesthesiol, Brest, France		Gangloff, C (corresponding author), Univ Bretagne Occidentale, ORPHY Lab EA4324, Brest, France.; Gangloff, C (corresponding author), CHU Pontchaillou, Dept Emergency Med, Rennes, France.	cedric.gangloff@chu-rennes.fr		Theron, Michael/0000-0002-3338-5205			Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Buckley JF, 2006, CARDIOVASC RES, V72, P220, DOI 10.1016/j.cardiores.2006.07.011; Campbell JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099181; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute to Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Davenport RA, 2017, ANESTHESIOLOGY, V126, P115, DOI 10.1097/ALN.0000000000001428; David JS, 2016, CRIT CARE MED, V44, pE106, DOI 10.1097/CCM.0000000000001408; De Cristofaro R, 2003, J THROMB THROMBOLYS, V15, P151, DOI 10.1023/B:THRO.0000011370.80989.7b; Deguchi H, 2016, BLOOD, V128, P1870, DOI 10.1182/blood-2016-03-707679; Dibiasi C, 2018, CLIN HEMORHEOL MICRO, V69, P515, DOI 10.3233/CH-189203; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Duchemin J, 2008, THROMB HEAMOST; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Evgenov OV, 2003, CRIT CARE MED, V31, P2429, DOI 10.1097/01.CCM.0000089639.84344.A7; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Frith D, 2012, THROMB RES, V129, P551, DOI 10.1016/j.thromres.2011.11.053; Furay EJ, 2018, J TRAUMA ACUTE CARE, V1; Gando S, 2018, THROMB J, V16, DOI 10.1186/s12959-018-0167-3; Gando S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.37; Gando S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0735-x; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; George MJ, 2018, TRANSFUSION MED, V28, P224, DOI 10.1111/tme.12473; Girish A, 2019, J THROMB HAEMOST, V17, P1632, DOI 10.1111/jth.14552; Guerrero M, 2008, BRIT J SPORT MED, V42, P695, DOI 10.1136/bjsm.2007.037945corr1; Hagemo JS, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-56; Harr JN, 2011, J SURG RES; Hemker H, 2008, THROMBIN GENERATION; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Howard BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150930; Howard BM, 2015, J TRAUMA ACUTE CARE, V79, P1009, DOI 10.1097/TA.0000000000000707; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; Iwamoto S, 2010, J TRAUMA, V68, P669, DOI 10.1097/TA.0b013e3181a0fbb3; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Johansson PI, 2011, CRIT CARE, V15, DOI 10.1186/cc10553; Kawasugi Kazuo, 2011, Rinsho Byori, VSuppl 147, P62; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lance MD, 2012, VOX SANG, V103, P25, DOI 10.1111/j.1423-0410.2011.01575.x; Lance MD, 2015, THROMB J, V13, DOI 10.1186/1477-9560-13-1; Lange M, 2008, CURR OPIN ANESTHESIO, V21, P105, DOI 10.1097/ACO.0b013e3282f3ad74; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; LOFBERG M, 1995, ARCH NEUROL-CHICAGO, V52, P1210, DOI 10.1001/archneur.1995.00540360090020; Lupu C, 2013, J THROMB HAEMOST, V11, P142, DOI 10.1111/jth.12044; Martini WZ, 2012, J TRAUMA ACUTE CARE, V73, P640, DOI 10.1097/TA.0b013e318253b693; Matijevic N, 2014, THROMB RES, V134, P652, DOI 10.1016/j.thromres.2014.07.023; Morris RS, 2017, BLOOD COAGULATION FI, V1; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; Ninivaggi M, 2012, CLIN CHEM, V58, P1252, DOI 10.1373/clinchem.2012.184077; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Oshiro A, 2014, CRIT CARE, V18, DOI 10.1186/cc13816; Owen HC, 2015, J TRAUMA ACUTE CARE, V79, P766, DOI 10.1097/TA.0000000000000850; Park MS, 2017, J TRAUMA ACUTE CARE, V83, P381, DOI 10.1097/TA.0000000000001466; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Rocha JA, 2010, J TRAUMA, V68, P1335, DOI 10.1097/TA.0b013e3181dbbb36; Rocksen D, 2012, INJURY, V43, P632, DOI 10.1016/j.injury.2010.10.002; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Seshadri A, 2017, CRIT CARE MED, V45, P1523, DOI 10.1097/CCM.0000000000002577; Terkildsen JR, 2007, AM J PHYSIOL-HEART C, V293, pH3036, DOI 10.1152/ajpheart.00771.2007; Tripodi A, 2016, CLIN CHEM, V62, P699, DOI 10.1373/clinchem.2015.248625; van Zyl N, 2015, SHOCK; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yanagida Y, 2013, SURGERY, V154, P48, DOI 10.1016/j.surg.2013.02.004	66	3	3	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	DEC 12	2019	14	1							57	10.1186/s13017-019-0276-8			10	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	JV9YN	WOS:000502716100001	31857822	Green Published, gold			2022-02-06	
J	Kesavan, C; Bajwa, NM; Watt, H; Mohan, S				Kesavan, Chandrasekhar; Bajwa, Nikita M.; Watt, Heather; Mohan, Subburaman			Growth Hormone Effects on Bone Loss-Induced by Mild Traumatic Brain Injury and/or Hind Limb Unloading	SCIENTIFIC REPORTS			English	Article							ANABOLIC RESPONSE; FACTOR-I; IGF-I; CONDITIONAL DISRUPTION; PROFESSIONAL FOOTBALL; NEGATIVE IMPACT; GENE-EXPRESSION; OSTEOBLASTS; RECEPTOR; HYPOPITUITARISM	Growth hormone (GH) deficiency and loss of physical activity are common features in traumatic brain injury (TBI) patients that may contribute to bone loss. Therefore, we tested the hypothesis that GH treatment will rescue the hind limb unloading (UL)-induced skeletal deficit in TBI mice. Mild TBI was induced once per day for four consecutive days. UL (right hind limb) and treatment (3 mg/day GH or vehicle) began two weeks after the first TBI episode and lasted for four weeks. GH treatment increased femur BMD and lean body mass but decreased the %fat measured by DXA in the Control group. Micro-CT analysis revealed that the TBI, UL and TBI-UL groups showed reduced tibia trabecular (Tb) bone mass by 15%, 70%, and 75%, respectively compared to Control mice and that GH treatment significantly increased Tb. bone mass in all four groups. Vertebra also showed reduced Tb. bone mass in TBI, UL and TBI-UL groups. GH treatment increased vertebral Tb. bone mass in Control and UL groups but not in the TBI or TBI-UL group. GH treatment increased serum IGF-I levels similarly in TBI, UL and TBI-UL groups at day 14, suggesting the GH effect on liver IGF-I production was unaffected by skeletal UL. In contrast, GH effect on expression of ALP, IGFBP5 and axing in bone were compromised by UL. In conclusion, skeletal UL caused a greater Tb. bone deficit than mild TBI alone and that GH anabolic effects in the TBI and UL groups vary depending on the skeletal site.	[Kesavan, Chandrasekhar; Bajwa, Nikita M.; Watt, Heather; Mohan, Subburaman] VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Kesavan, Chandrasekhar; Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Sch Med, Div Biochem, Dept Basic Sci, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Orthoped, Loma Linda, CA 92354 USA		Mohan, S (corresponding author), VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Div Biochem, Dept Basic Sci, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Orthoped, Loma Linda, CA 92354 USA.	subburaman.mohan@va.gov			Veterans Administration BLR&D merit review grant [1-101-BX-002717]	The research work was performed at facilities provided by the Department of Veterans Affairs. This study was supported by funding from a Veterans Administration BLR&D merit review grant 1-101-BX-002717 to SM. Salary support for SM is provided by a Senior Research Career Scientist Award from the US Department of Veterans Affairs. We thank Nancy Lowen for technical assistance and Dr. Donna Strong for proof reading the manuscript. The contents of this manuscript do not represent the views of VA or United States Government.	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Govoni KE, 2006, AM J PHYSIOL-ENDOC M, V291, pE128, DOI 10.1152/ajpendo.00592.2005; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hari Kumar K V S, 2016, Indian J Endocrinol Metab, V20, P772; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Kasukawa Y, 2003, ENDOCRINOLOGY, V144, P3950, DOI 10.1210/en.2002-0123; Kesavan C, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.42; Kesavan C, 2011, AM J PHYSIOL-ENDOC M, V301, pE1191, DOI 10.1152/ajpendo.00440.2011; Lang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038910; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Long RK, 2011, J BONE MINER RES, V26, P2948, DOI 10.1002/jbmr.511; Madaro L, 2008, BASIC APPL MYOL, V18, P149; Mohan S, 2015, PHYSIOL GENOMICS, V47, P33, DOI 10.1152/physiolgenomics.00107.2014; Mormando M, 2016, CLIN ENDOCRINOL, V85, P717, DOI 10.1111/cen.13161; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Reijnders CMA, 2007, J ENDOCRINOL, V192, P131, DOI 10.1677/joe.1.06880; Rodriguez-Arnao J, 1998, CLIN ENDOCRINOL, V48, P455; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Triplett Jason W., 2007, Molecular & Cellular Biomechanics, V4, P13; van Varsseveld NC, 2016, PITUITARY, V19, P381, DOI 10.1007/s11102-016-0716-3; Wang YM, 2006, J BONE MINER RES, V21, P1350, DOI 10.1359/JBMR.060610; Wergedal JE, 2015, ENDOCRINOLOGY, V156, P1023, DOI 10.1210/en.2014-1702; Yu HR, 2014, J REHABIL RES DEV, V51, P1427, DOI 10.1682/JRRD.2014.04.0095; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735; Yu HR, 2013, STRESS, V16, P564, DOI 10.3109/10253890.2013.806908; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	39	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 12	2019	9								18995	10.1038/s41598-019-55258-9			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW4QZ	WOS:000503039200002	31831786	gold, Green Published			2022-02-06	
J	Hunter, LE; Freudenberg-Hua, Y; Davies, P; Kim, M; Fleysher, R; Stewart, WF; Lipton, RB; Lipton, ML				Hunter, Liane E.; Freudenberg-Hua, Yun; Davies, Peter; Kim, Mimi; Fleysher, Roman; Stewart, Walter F.; Lipton, Richard B.; Lipton, Michael L.			BDNF Val(66)Met Positive Players Demonstrate Diffusion Tensor Imaging Consistent With Impaired Myelination Associated With High Levels of Soccer Heading: Indication of a Potential Gene-Environment Interaction Mechanism	FRONTIERS IN NEUROLOGY			English	Article						BDNF Val(66)Met; diffusion tensor imaging; myelination and re-myelination; soccer heading; mild traumatic brain injury	BRAIN; FREQUENCY; EXPOSURE; MRI	The purpose of this study was to examine the potential effect modifying role of the BDNF Val(66)Met polymorphism on the association of soccer heading with white matter microstructure. We studied 312 players enrolled in the ongoing Einstein Soccer Study, a longitudinal study of amateur soccer player in New York City and surrounding areas. At enrollment and 2 years later, total heading in the prior 12 months (12-mo.) was estimated using an established self-report instrument and diffusion tensor imaging (DTI) was performed. Generalized Estimating Equations (GEE) logistic regression models were employed to test effect modification by the BDNF Val(66)Met polymorphism on the association between 12-mo. heading exposure and DTI. We identified a significant interaction of 12-mo heading*BDNF Val(66)Met genotype on the presence of low Radial Diffusivity, a DTI marker associated with myelination. Only Met (+) players demonstrated significantly reduced odds of low RD [OR (95 % CI): -2.36 (-3.53, -1.19)] associated with the highest vs. lowest quartile of 12-mo heading exposure. BDNF Val(66)Met (+) soccer players with long-term exposure to high levels of heading exhibit less low Radial Diffusivity, suggesting impaired re-myelination may be a substrate of the previously reported association between heading and poor functional outcomes in soccer players.	[Hunter, Liane E.; Fleysher, Roman; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA; [Hunter, Liane E.; Kim, Mimi; Fleysher, Roman; Lipton, Richard B.; Lipton, Michael L.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Freudenberg-Hua, Yun; Davies, Peter] Northwell Hlth, Div Geriatr Psychiat, Glen Oaks, NY USA; [Freudenberg-Hua, Yun] Northweii Hlth, Feinstein Inst Med Res, Litwin Zucker Ctr Study Alzheimers Dis, Manhasset, NY USA; [Kim, Mimi; Lipton, Richard B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Fleysher, Roman; Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Stewart, Walter F.] Sutter Hlth Res Ctr, Walnut Creek, CA USA; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lipton, Richard B.; Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard Bruce/AAY-2818-2021		NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432, F31 NS098799-04]; Dana Foundation David Mahoney Neuroimaging Program; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08AG054727] Funding Source: NIH RePORTER	This study was funded by NINDS (R01 NS082432 and F31 NS098799-04) and The Dana Foundation David Mahoney Neuroimaging Program.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Aung Wint Yan, 2013, Imaging Med, V5, P427; Bankston AN, 2019, GLIA, V67, P1745, DOI 10.1002/glia.23646; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen BW, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00167; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Hardin J., 2012, GEN ESTIMATING EQUAT, V99, DOI [10.1002/0470013192.bsa250, DOI 10.1002/0470013192.BSA250]; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Nikoletopoulou V, 2017, CELL METAB, V26, P230, DOI 10.1016/j.cmet.2017.06.005; Ou XW, 2009, NMR BIOMED, V22, P480, DOI 10.1002/nbm.1358; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Suri AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142288; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tsiperson V, 2015, ASN NEURO, V7, DOI 10.1177/1759091414566878; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	36	3	3	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 11	2019	10								1297	10.3389/fneur.2019.01297			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY2FW	WOS:000504237300001	31920921	Green Published, gold			2022-02-06	
J	Di Battista, AP; Rhind, SG; Churchill, N; Richards, D; Lawrence, DW; Hutchison, MG				Di Battista, Alex P.; Rhind, Shawn G.; Churchill, Nathan; Richards, Doug; Lawrence, David W.; Hutchison, Michael G.			Peripheral blood neuroendocrine hormones are associated with clinical indices of sport-related concussion	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; DEHYDROEPIANDROSTERONE-SULFATE; HIPPOCAMPAL-NEURONS; ACUTE RECOVERY; CELL-DEATH; PROGESTERONE; PROLACTIN; DHEA; DYSFUNCTION; RESPONSES	The purpose of this study was to evaluate the relationship between neuroendocrine hormones and clinical recovery following sport-related concussion (SRC). Ninety-five athletes (n = 56 male, n = 39 female) from a cohort of 11 interuniversity sport teams at a single institution provided blood samples; twenty six athletes with SRC were recruited 2-7 days post-injury, and 69 uninjured athletes recruited prior to the start of their competitive season. Concentrations of seven neuroendocrine hormones were quantitated in either plasma or serum by solid-phase chemiluminescent immunoassay. The Sport Concussion Assessment Tool version 5 (SCAT-5) was used to evaluate symptoms at the time of blood sampling in all athletes. Multivariate partial least squares (PLS) analyses were used to evaluate the relationship between blood hormone concentrations and both (1) time to physician medical clearance and (2) initial symptom burden. A negative relationship was observed between time to medical clearance and both dehydroepiandrosterone sulfate (DHEA-S) and progesterone; a positive relationship was found between time to medical clearance and prolactin. Cognitive, somatic, fatigue and emotion symptom clusters were associated with distinct neuroendocrine signatures. Perturbations to the neuroendocrine system in athletes following SRC may contribute to initial symptom burden and longer recovery times.	[Di Battista, Alex P.; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Di Battista, Alex P.; Rhind, Shawn G.] Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada; [Churchill, Nathan] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Neurosci Program, Toronto, ON, Canada; [Richards, Doug; Lawrence, David W.; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, David L MacIntosh Sport Med Clin, Toronto, ON, Canada; [Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada		Di Battista, AP (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.; Di Battista, AP (corresponding author), Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada.	alex.dibattista@utoronto.ca		Rhind, Shawn/0000-0003-2300-0620	Defence Research & Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR)	We thank Ingrid Smith, Sarah Watling and Maria Shiu for their technical assistance. This research was funded by Defence Research & Development Canada (DRDC) and the Canadian Institutes of Military and Veterans Health (CIMVHR). This study was approved by the Canadian Forces Surgeon General's Health Research Program. In accordance with the Department of National Defence policy, the paper was reviewed and approved for submission without modification by the DRDC Publications Office.	Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Ben Dor R, 2015, PSYCHOPHARMACOLOGY, V232, P3375, DOI 10.1007/s00213-015-3991-1; Birketvedt GS, 2012, APPETITE, V59, P688, DOI 10.1016/j.appet.2012.07.015; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bosch OG, 2015, PSYCHONEUROENDOCRINO, V62, P1, DOI 10.1016/j.psyneuen.2015.07.167; Brand JM, 2004, EUR CYTOKINE NETW, V15, P99; Cardounel A, 1999, P SOC EXP BIOL MED, V222, P145, DOI 10.1046/j.1525-1373.1999.d01-124.x; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Di Battista A. P., 2018, J NEUROINFLAMMATION; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Di Battista AP, 2018, BRAIN INJURY, V32, P575, DOI 10.1080/02699052.2018.1432892; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Khandelwal D, 2012, DRUGS, V72, P17, DOI 10.2165/11598070-000000000-00000; Kimonides VG, 1998, P NATL ACAD SCI USA, V95, P1852, DOI 10.1073/pnas.95.4.1852; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903; La Fountaine MF, 2016, J NEUROTRAUM, V33, P904, DOI 10.1089/neu.2015.3968; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Suarez ALP, 2015, ADV EXP MED BIOL, V846, P243, DOI 10.1007/978-3-319-12114-7_11; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Rhodes ME, 1996, BRAIN RES, V733, P284, DOI 10.1016/0006-8993(96)00751-2; Ritchie EV, 2018, BRAIN INJURY, V32, P523, DOI 10.1080/02699052.2018.1429662; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sripada RK, 2013, NEUROPSYCHOPHARMACOL, V38, P1798, DOI 10.1038/npp.2013.79; Tandon A, 2009, ACTA NEUROCHIR, V151, P1411, DOI 10.1007/s00701-009-0444-9; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; van der Zwan JE, 2015, APPL PSYCHOPHYS BIOF, V40, P257, DOI 10.1007/s10484-015-9293-x; van Kerkhof LWM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135652; Vincent K, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00413; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P1483, DOI 10.1210/jc.81.4.1483; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	69	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 9	2019	9								18605	10.1038/s41598-019-54923-3			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JU5ZC	WOS:000501753800004	31819094	gold, Green Published			2022-02-06	
J	Gurusamy, J; Gandhi, S; Amudhan, S; Veerabhadraiah, KB; Narayanasamy, P; Sreenivasan, ST; Palaniappan, M				Gurusamy, Jothimani; Gandhi, Sailaxmi; Amudhan, Senthil; Veerabhadraiah, Kathyayani B.; Narayanasamy, Padmavathi; Sreenivasan, Sunitha T.; Palaniappan, Marimuthu			Misconceptions about traumatic brain injury among nursing students in India: implications for nursing care and curriculum	BMC NURSING			English	Article						Misconceptions; Traumatic Brain Injury; Prevention; Educational Intervention; Nursing Education; Nursing Care	COMMON MISCONCEPTIONS; ETHNIC-MINORITIES; KNOWLEDGE; PROFESSIONALS; EPIDEMIOLOGY; PERCEPTIONS; EXPERIENCE; SURVIVORS; BELIEFS; IMPACT	Background: Despite the devastating consequences of Traumatic brain injuries (TBIs), TBI misconceptions are common among healthcare professionals. As an essential member of multi-professional team providing TBI care, it is important that nurses have correct information and adequate skills to achieve the best possible outcomes for TBI. For example, some common misconceptions about TBIs are that a second blow to the head can improve memory functioning and wearing seatbelts can cause as many brain injuries as it prevents. In India, perhaps such misconceptions towards TBI among nursing professionals were not yet documented. As nursing students form the future health workforce, understanding TBI misconceptions among nursing students in resource-limited settings like India will provide useful information for strengthening the nursing curricula for improved care and rehabilitation of TBIs. Methods: We used a cross-sectional survey to study the TBI misconceptions among nursing students in India. A Common Misconceptions about Traumatic Brain Injury (CM-TBI) questionnaire was administered to 154 nursing students from a nursing college of a tertiary care neuro-centre in India. The mean percentage of misconceptions were calculated for 7-domains of CM-TBI. T-test for independent samples and ANOVA were used to study the association of misconception with socio-demographic variables using total score for each respondent. Results: Of the 143 nursing students who completed the survey, majority of them were female (97%) and in the 19-20 year age-group (95.1%). Domain on brain damage (81.1%) had highest rate, while amnesia domain (42.0%) had lowest rate of misconception. The overall mean-score was 22.73 (Standard Deviation: 4.69) which was significantly higher than the median score of 19.5. The study did not show significant differences on overall misconceptions about TBI for any of the socio-demographic characteristics. Conclusions: Misconceptions about TBIs were common among nursing students and it was pervasive irrespective of age, gender, place of residence and year of education. A need to strengthen nursing curriculum in the area of TBIs has been emphasized for improved care and management of TBIs. The study findings also suggest the need for understanding such misconceptions among other healthcare professionals involved in TBI care.	[Gurusamy, Jothimani; Veerabhadraiah, Kathyayani B.; Narayanasamy, Padmavathi; Sreenivasan, Sunitha T.] NIMHANS, Coll Nursing, Bangalore 560029, Karnataka, India; [Gandhi, Sailaxmi] NIMHANS, Dept Nursing, Bangalore 560029, Karnataka, India; [Amudhan, Senthil] NIMHANS, Dept Epidemiol, Bangalore, Karnataka, India; [Palaniappan, Marimuthu] NIMHANS, Dept Biostat, Bangalore, Karnataka, India		Gurusamy, J (corresponding author), NIMHANS, Coll Nursing, Bangalore 560029, Karnataka, India.	jothisrinivas.jothi@gmail.com	Gurusamy, Jothimani/P-6729-2019; Amudhan, Senthil/AAN-6572-2020	Gurusamy, Jothimani/0000-0002-3844-6038; Amudhan, Senthil/0000-0001-8361-9623			Bharati Vidyapeeth University approved by Indian Nursing Council, 2017, B SC NURS CURR IND; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bradford LS, 2015, REHABIL PSYCHOL, V60, P344, DOI 10.1037/rep0000057; Burton Adrian, 2016, Lancet Neurol, V15, P1011, DOI 10.1016/S1474-4422(16)30131-4; Cao R, 2018, INT NURS REV, V65, P131, DOI 10.1111/inr.12399; Chow SKY, 2017, BMC NURS, V16, DOI 10.1186/s12912-017-0241-3; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Ernst WJ, 2016, EXCEPTIONALITY, V24, P123, DOI 10.1080/09362835.2015.1107832; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Logue S., 2006, INT EDUC J, V7, P553; Mckinlay A, 2019, DISABIL REHABIL, V41, P1419, DOI 10.1080/09638288.2018.1429500; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; O'Rourke C, 2018, DISABIL REHABIL, V40, P1119, DOI 10.1080/09638288.2017.1288274; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Pappadis MR, 2017, ARCH PHYS MED REHAB, V98, P751, DOI 10.1016/j.apmr.2016.11.016; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Pretorius C, 2013, SAJP-S AFR J PSYCHI, V19, P75, DOI 10.7196/SAJP.436; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Schellinger SK, 2018, BRAIN INJURY, V32, P1377, DOI 10.1080/02699052.2018.1492737; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	37	3	3	15	17	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6955			BMC NURS	BMC Nurs.	DEC 9	2019	18	1							64	10.1186/s12912-019-0388-1			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	KW6TE	WOS:000521306400001	31827390	Green Published, gold			2022-02-06	
J	Brown, JC; Starling, LT; Stokes, K; Viviers, P; Jordaan, E; Surmon, S; Derman, EW				Brown, James Craig; Starling, Lindsay Toyah; Stokes, Keith; Viviers, Pierre; Jordaan, Esme; Surmon, Sean; Derman, Elton Wayne			High Concussion Rate in Student Community Rugby Union Players During the 2018 Season: Implications for Future Research Directions	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						non-professional; injury surveillance; football; Stellenbosch; video	INJURY; METAANALYSIS; SPORT	Collision sports, such as Rugby Union ("Rugby") have a particularly high risk of injury. Of all injuries common to collision sports, concussions have received the most attention due to the potentially negative cognitive effects in the short- and long-term. Despite non-professional Rugby players comprising the majority of the world's playing population, there is relatively little research in this population. Stellenbosch Rugby Football Club ("Maties"), the official rugby club of Stellenbosch University, represents one of the world's largest non-professional Rugby clubs, making this an ideal cohort for community-level injury surveillance. The aim of this study was to describe the incidence and events associated with concussion in this cohort. Baseline demographics were obtained on the 807 male student Rugby non-professional players who registered for the 10-week long 2018 season, which comprised 101 matches and 2,915 of exposure hours. All match-related injuries were captured by the medical staff of Stellenbosch Campus Health Service on an electronic form developed from the consensus statement for injury recording in Rugby. The mean age, height and weight of this cohort were 20 +/- 2 years, 182 +/- 7 cm and 88 +/- 14 kg, respectively. Overall, there were 89 time-loss injuries, which equated to an injury rate of 30.6 per 1,000 match hours [95% confidence intervals (CIs): 24.2-36.9], or about one injury per match. The most common injury diagnosis was "concussion" (n = 27 out of 90 injuries, 30%), at a rate of 9.3 per 1,000 match hours (95% CIs: 5.8-12.8). The three most common mechanisms of concussion in the present study were performing a tackle (33%), accidental collision (30%) and being tackled (11%). Concussion was the most common injury in this population, at a rate that was six times higher than the most comparable study from the UK, which had far more exposure time over six seasons and wider range of player ability, from recreational to semi-professional. This might be explained by the training and vigilance of the club's first aiders observing all matches for concussion. Future studies should try to explain this high rate and subsequently reduce these concussions. The addition of video surveillance data would assist in identifying the etiology of these concussions injuries in order to develop specific targeted interventions.	[Brown, James Craig; Starling, Lindsay Toyah; Viviers, Pierre; Surmon, Sean; Derman, Elton Wayne] Stellenbosch Univ, Dept Surg Sci, Div Orthopaed, Inst Sport & Exercise Med, Cape Town, South Africa; [Brown, James Craig; Starling, Lindsay Toyah; Viviers, Pierre; Surmon, Sean; Derman, Elton Wayne] IOC Res Ctr, Cape Town, South Africa; [Stokes, Keith] Univ Bath, Dept Hlth, Bath, Avon, England; [Stokes, Keith] Rugby Football Union, Twickenham, England; [Jordaan, Esme] MRC, Biostat Unit, Cape Town, South Africa; [Jordaan, Esme] Univ Western Cape, Stat & Populat Studies Dept, Cape Town, South Africa; [Surmon, Sean] Stellenbosch Univ, Maties Sport, Stellenbosch, South Africa		Brown, JC (corresponding author), Stellenbosch Univ, Dept Surg Sci, Div Orthopaed, Inst Sport & Exercise Med, Cape Town, South Africa.; Brown, JC (corresponding author), IOC Res Ctr, Cape Town, South Africa.	jamesbrown06@gmail.com	Derman, Wayne/ABD-6557-2020; Stokes, Keith/C-2605-2009	Stokes, Keith/0000-0002-5049-2838	World Rugby (International Governing Body of Rugby); Medical Research Council of South Africa (SA-MRC)	The research costs involved in producing the data for this study were partially funded by World Rugby (the International Governing Body of Rugby) and the Medical Research Council of South Africa (SA-MRC; through their Self-Initiated Research Programme grant, SIR grant).	Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fraas MR, 2016, EUR J SPORT SCI, V16, P1212, DOI 10.1080/17461391.2016.1170207; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; King D, 2017, SPORTS MED, V47, P197, DOI 10.1007/s40279-016-0576-z; Mathewson E, 2015, SA J. Sports Med., V27, P72, DOI 10.7196/SAJSM.8091; Project Steering Group, 2018, ENGL PROF RUGB INJ S; Puren M., 2007, S AFR J SPORTS MED, V19, P125, DOI [10.17159/2078-516x/2007/v19i5a254, DOI 10.17159/2078-516X/2007/V19I5A254]; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Schwellnus MP, 2019, BRIT J SPORT MED, V53, P620, DOI 10.1136/bjsports-2018-099105; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Viviers PL, 2018, SPORTS HEALTH, V10, P223, DOI 10.1177/1941738118757178; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, 2018, WORLD RUGB PLAYER NU; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4	26	3	3	0	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 4	2019	13								423	10.3389/fnhum.2019.00423			7	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	JW7ZE	WOS:000503265700001	31866844	gold, Green Published			2022-02-06	
J	Esnault, P; Mathais, Q; D'Aranda, E; Montcriol, A; Cardinale, M; Cungi, PJ; Goutorbe, P; Joubert, C; Dagain, A; Meaudre, E				Esnault, Pierre; Mathais, Quentin; D'Aranda, Erwan; Montcriol, Ambroise; Cardinale, Mickael; Cungi, Pierre-Julien; Goutorbe, Philippe; Joubert, Christophe; Dagain, Arnaud; Meaudre, Eric			Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Severe traumatic brain injury; Fibrin monomers; Progressive hemorrhagic injury; Trauma-induced coagulopathy; Glasgow Outcome Scale	INTRACEREBRAL HEMORRHAGE; COAGULATION DISORDERS; RISK-FACTORS; COAGULOPATHY; DIAGNOSIS; MICROPARTICLES; MANAGEMENT; MARKERS; PARAMETERS; IMPACT	Background Progressive hemorrhagic injury (PHI) is common in patients with severe traumatic brain injury (TBI) and is associated with poor outcomes. TBI-associated coagulopathy is frequent and has been described as risk factor for PHI. This coagulopathy is a dynamic process involving hypercoagulable and hypocoagulable states either one after the other either concomitant. Fibrin monomers (FMs) are a direct marker of thrombin action and thus reflect coagulation activation. This study sought to determine the ability of FM to predict PHI after severe TBI. Methods We conducted a prospective, observational study including all severe TBI patients admitted in the trauma center. Between September 2011 and September 2016, we enrolled patients with severe TBI into the derivation cohort. Between October 2016 and December 2018, we recruited the validation cohort on the same basis. Study protocol included FM measurements and standard coagulation test at admission and two computed tomography (CT) scans (upon arrival and at least 6 h thereafter). A PHI was defined by an increment in size of initial lesion (25% or more) or the development of a new hemorrhage in the follow-up CT scan. Multivariate logistic regression analysis was applied to identify predictors of PHI. Results Overall, 106 patients were included in the derivation cohort. Fifty-four (50.9%) experienced PHI. FM values were higher in these patients (151 [136.8-151] vs. 120.5 [53.3-151], p < 0.0001). The ROC curve demonstrated that FM had a fair accuracy to predict the occurrence of PHI with an area under curve of 0.7 (95% CI [0.6-0.79]). The best threshold was determined at 131.7 mu g/ml. In the validation cohort of 54 patients, this threshold had a negative predictive value of 94% (95% CI [71-100]) and a positive predictive value of 49% (95% CI [32-66]). The multivariate logistic regression analysis identified 2 parameters associated with PHI: FM >= 131.7 (OR 6.8; 95% CI [2.8-18.1]) and Marshall category (OR 1.7; 95% CI [1.3-2.2]). Coagulopathy was not associated with PHI (OR 1.3; 95% CI [0.5-3.0]). The proportion of patients with an unfavorable functional neurologic outcome at 6-months follow-up was higher in patients with positive FM: 59 (62.1%) versus 16 (29.1%), p < 0.0001. Conclusions FM levels at admission had a fair accuracy to predict PHI in patients with severe TBI. FM values >= 131.7 mu g/ml are independently associated with the occurrence of PHI.	[Esnault, Pierre; Mathais, Quentin; D'Aranda, Erwan; Montcriol, Ambroise; Cardinale, Mickael; Cungi, Pierre-Julien; Goutorbe, Philippe; Meaudre, Eric] St Anne Mil Hosp, Intens Care Unit, Toulon, France; [Joubert, Christophe; Dagain, Arnaud] St Anne Mil Hosp, Dept Neurosurg, Toulon, France; [Dagain, Arnaud; Meaudre, Eric] Ecole Val de Grace, French Mil Hlth Serv Acad Unit, Paris, France		Esnault, P (corresponding author), St Anne Mil Hosp, Intens Care Unit, Toulon, France.	pierre.esnault@gmail.com	Joubert, Christophe/AAU-4807-2020; Esnault, Pierre/AAN-5792-2020				Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Atefi G, 2016, SHOCK, V46, P83, DOI 10.1097/SHK.0000000000000675; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Foley JH, 2016, CIRC RES, V118, P1392, DOI 10.1161/CIRCRESAHA.116.306853; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gando S, 2016, SEMIN THROMB HEMOST, V42, P155, DOI 10.1055/s-0035-1564831; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Gris J-C, 2018, BRIT J HAEMATOL, V11, P1644; Hamano A, 2002, CLIN CHIM ACTA, V318, P25, DOI 10.1016/S0009-8981(01)00779-3; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hasegawa M, 2018, CLIN APPL THROMB-HEM, V24, P107, DOI 10.1177/1076029616674824; Hatada T, 2012, CLIN APPL THROMB-HEM, V18, P495, DOI 10.1177/1076029611429786; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; JENNETT B, 1975, LANCET, V1, P480; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Mooberry MJ, 2016, CYTOM PART A, V89A, P111, DOI 10.1002/cyto.a.22647; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Palazon-Bru A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176726; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Rao A, 2017, NEUROSURGERY, V64, P182, DOI 10.1093/neuros/nyx210; Refaai MA, 2018, THROMB HAEMOSTASIS, V118, P1856, DOI 10.1055/s-0038-1673684; Singh N, 2017, CLIN APPL THROMB-HEM, V23, P460, DOI 10.1177/1076029615615959; SORENSEN JV, 1993, HAEMOSTASIS, V23, P91; Stolla M, 2019, TRANSFUSION, V59, P1522, DOI 10.1111/trf.15169; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Wada H, 2008, SEMIN THROMB HEMOST, V34, P33, DOI 10.1055/s-2008-1066021; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wan XY, 2017, ACTA NEUROCHIR, V159, P227, DOI 10.1007/s00701-016-3043-6; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011774	56	3	5	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2020	33	1					182	195		10.1007/s12028-019-00882-6		DEC 2019	14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MT1KH	WOS:000500287800004	31797276				2022-02-06	
J	Armstead, WM; Vavilala, MS				Armstead, William M.; Vavilala, Monica S.			Cerebral Perfusion Pressure Directed-Therapy Modulates Cardiac Dysfunction After Traumatic Brain Injury to Influence Cerebral Autoregulation in Pigs	NEUROCRITICAL CARE			English	Article						Cerebral autoregulation; Traumatic brain injury; Creatine kinase; Catecholamines	MODERATE; CHILDREN	Background Traumatic brain injury (TBI) is an important contributor to morbidity and mortality. Low cerebral perfusion pressure (CPP, mean arterial pressure [MAP] minus intracranial pressure) after TBI is associated with cerebral ischemia, impaired cerebral autoregulation, and poor outcomes. Normalization of CPP and limitation of cerebral autoregulation impairment is a key therapeutic goal. However, some vasoactive agents used to elevate MAP such as phenylephrine (Phe) improve outcome in females but not male piglets after TBI while dopamine (DA) does so in both sexes. Clinical evidence has implicated neurological injuries as a cause of cardiac dysfunction, and we recently described cardiac dysfunction after TBI. Cardiac dysfunction may, in turn, influence brain health. One mechanism of myocyte injury may involve catecholamine excess. We therefore tested the hypothesis that TBI caused cardiac dysfunction and catecholamine excess which may reciprocally be modulated by vasoactive agent choice to normalize CPP and prevent impairment of cerebral autoregulation after injury. Methods TBI was produced in anesthetized pigs equipped with a closed cranial window, and Phe or DA administered to normalize CPP. Results Plasma cardiac enzymes troponin and creatine kinase and catecholamines epinephrine and norepinephrine were elevated by TBI, such release potentiated by Phe in males but blocked in female piglets and blocked in both sexes after DA. Cerebral autoregulation was impaired after TBI, worsened by Phe in males but protected in females and males treated with DA. Papaverine-induced dilation was unchanged by fluid percussion brain injury, DA, and Phe. Conclusions These data indicate that pressor choice in elevation of CPP is important in limiting cardiac dysfunction and suggest that DA protects cerebral autoregulation in both sexes via reduction of cardiac biomarkers of injury and catecholamines released after TBI.	[Armstead, William M.] Univ Penn, Dept Anesthesiol, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.; Armstead, WM (corresponding author), Univ Penn, Dept Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.; Armstead, WM (corresponding author), Univ Penn, Pharmacol, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS090998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090998] Funding Source: NIH RePORTER	These studies were supported by NIH R01 NS090998.	Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Curvello V, 2019, NEUROCRIT CARE, V30, P467, DOI 10.1007/s12028-018-0638-1; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Krishnamoorthy Vijay, 2015, Int J Crit Illn Inj Sci, V5, P103, DOI 10.4103/2229-5151.158409; Krishnamoorthy V, 2015, PEDIATR CRIT CARE ME, V16, pE107, DOI 10.1097/PCC.0000000000000397; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P482, DOI 10.4103/0972-5229.136086; Lee VH, 2006, NEUROCRIT CARE, V5, P243, DOI 10.1385/NCC:5:3:243; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9	24	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2019	31	3					476	485		10.1007/s12028-019-00735-2			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JU5FK	WOS:000501700900005	31115824	Green Accepted			2022-02-06	
J	Baig, MR; Tapia, RN; Meraj, A; Pugh, JA; Roache, JD; Finley, EP				Baig, Muhammad R.; Tapia, Rebecca N.; Meraj, Adeel; Pugh, Jacqueline A.; Roache, John D.; Finley, Erin P.			Enhancing Access to Psychiatric Care for Posttraumatic Stress Disorder in Veterans with Mild Traumatic Brain Injury through Integrated Services	PSYCHIATRIC QUARTERLY			English	Article						Mental healthcare; Rehabilitation program; Integrated care; Access to care; Engagement in treatment	COGNITIVE PROCESSING THERAPY; PROLONGED EXPOSURE; COMBAT VETERANS; IRAQ; NIGHTMARES; SYMPTOMS; PRAZOSIN; PTSD; MEMBERS; WAR	(i) To describe an integrated model of psychiatric care for the treatment of posttraumatic stress disorder (PTSD) in veterans with mild traumatic brain injury (mTBI). (ii) To evaluate access to and engagement in psychiatric care among veterans with comorbid PTSD and mTBI after implementation of an Integrated Care (IC) model compared to the previous Usual Care (UC). 100 randomly selected charts, 50 from each of UC and IC were reviewed in this non-concurrent case- control study. Polytrauma Network Site (PNS), an outpatient rehabilitation clinic, for veterans who suffered from brain and other traumatic injuries at an urban VA Polytrauma Rehabilitation Center. Veterans receiving treatment for mTBI symptoms by the rehabilitation team were referred for medication management for PTSD to UC and IC. Co-located access to psychiatric care for medication management as part of the interdisciplinary team with the goal of expediting rehabilitation and functional recovery. Number of consults for psychiatric care for medication management scheduled and completed within 30 days, and number of veterans offered, initiating, and completing evidence-based psychotherapies for PTSD in UC compared to IC. After implementation of IC there were significant improvements in timely completion of consults and patient engagement with a psychiatrist. There also were improvements in number of referrals, initiation, and completion of evidence-based psychotherapies for the treatment of PTSD. IC within the PNS shows promise as an effective care model for increasing access and engagement in care for veterans with comorbid PTSD/mTBI. Future research is needed to examine the utility of this model in other sites.	[Baig, Muhammad R.; Meraj, Adeel] South Texas Vet Healthcare Syst, Mental Hlth, Mail Code A116,7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Baig, Muhammad R.; Tapia, Rebecca N.] Polytrauma Rehabil Ctr, Mail Code A116,7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Baig, Muhammad R.; Roache, John D.; Finley, Erin P.] Univ Texas San Antonio, Dept Psychiat, Hlth Sci Ctr San Antonio, Mail Code A116,7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Pugh, Jacqueline A.; Finley, Erin P.] South Texas Vet Hlth Care Syst, Res, San Antonio, TX USA; [Pugh, Jacqueline A.; Finley, Erin P.] Univ Texas San Antonio, Hlth Sci Ctr, Dept Med, Div Gen,Hosp Med, San Antonio, TX 78284 USA		Baig, MR (corresponding author), South Texas Vet Healthcare Syst, Mental Hlth, Mail Code A116,7400 Merton Minter Blvd, San Antonio, TX 78229 USA.; Baig, MR (corresponding author), Polytrauma Rehabil Ctr, Mail Code A116,7400 Merton Minter Blvd, San Antonio, TX 78229 USA.; Baig, MR (corresponding author), Univ Texas San Antonio, Dept Psychiat, Hlth Sci Ctr San Antonio, Mail Code A116,7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	muhammad.baig@va.gov	Pugh, Jacqueline/I-6199-2013	Pugh, Jacqueline/0000-0003-4933-141X; Roache, John/0000-0002-7010-8119	Department of Veterans AffairsUS Department of Veterans Affairs	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We thank Eric A. Townsend and Edward A. Martinez for their help with accessing the data from electronic medical records. Dr. Baig's salary was supported by the Department of Veterans Affairs.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2014, TREATM POSTT STRESS; [Anonymous], 2017, CLIN PRACT GUID; Asnis GM, 2004, DRUGS, V64, P383, DOI 10.2165/00003495-200464040-00004; Berger W, 2009, PROG NEURO-PSYCHOPH, V33, P169, DOI 10.1016/j.pnpbp.2008.12.004; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Corrigan PW, 2008, J PSYCHOSOC NURS MEN, V46, P42, DOI 10.3928/02793695-20080101-04; Duff J, 2011, WORLDV EVID-BASED NU, V8, P30, DOI 10.1111/j.1741-6787.2010.00209.x; Finley EP, 2017, MED CARE, V55, pS61, DOI 10.1097/MLR.0000000000000668; Fortney JC, 2011, J GEN INTERN MED, V26, pS639, DOI 10.1007/s11606-011-1806-6; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Jensen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179546; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Krystal JH, 2017, BIOL PSYCHIAT, V82, pE51, DOI 10.1016/j.biopsych.2017.03.007; Mott JM, 2014, J TRAUMA STRESS, V27, P265, DOI 10.1002/jts.21927; Patricia A, 2014, COGNITIVE PROCESSING; Peskind ER, 2003, J GERIATR PSYCH NEUR, V16, P165, DOI 10.1177/0891988703256050; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Raskind MA, 2002, J CLIN PSYCHIAT, V63, P565, DOI 10.4088/JCP.v63n0705; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Shiner B, 2013, ADM POLICY MENT HLTH, V40, P311, DOI 10.1007/s10488-012-0421-0; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tarrier N, 1999, J CONSULT CLIN PSYCH, V67, P13, DOI 10.1037/0022-006X.67.1.13; Tsan JY, 2012, PSYCHOL SERV, V9, P336, DOI 10.1037/a0028308	35	3	4	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-2720	1573-6709		PSYCHIAT QUART	Psychiatr. Q.	DEC	2019	90	4					815	827		10.1007/s11126-019-09668-7			13	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	JT9KH	WOS:000501299700012	31446544				2022-02-06	
J	Bodanapally, UK; Shanmuganathan, K; Gunjan, YP; Schwartzbauer, G; Kondaveti, R; Feiter, TR				Bodanapally, U. K.; Shanmuganathan, K.; Gunjan, Y. P.; Schwartzbauer, G.; Kondaveti, R.; Feiter, T. R.			Quantification of Iodine Leakage on Dual-Energy CT as a Marker of Blood-Brain Barrier Permeability in Traumatic Hemorrhagic Contusions: Prediction of Surgical Intervention for Intracranial Pressure Management	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							COMPUTED-TOMOGRAPHY; INJURY; DETERIORATION; PROGRESSION; EDEMA	BACKGROUND AND PURPOSE: Hemorrhagic contusions are associated with iodine leakage. We aimed to identify quantitative iodine-based dual-energy CT variables that correlate with the type of intracranial pressure management. MATERIALS AND METHODS: Consecutive patients with contusions from May 2016 through January 2017 were retrospectively analyzed. Radiologists, blinded to the outcomes, evaluated CT variables from unenhanced admission and short-term follow-up head dual-energy CT scans obtained after contrast-enhanced whole-body CT. Treatment intensity of intracranial pressure was broadly divided into 2 groups: those managed medically and those managed surgically. Univariable analysis followed by logistic regression was used to develop a prediction model. RESULTS: The study included 65 patients (50 men; median age, 48 years; Q(1) to Q(3), 25?65.5 years). Twenty-one patients were managed surgically (14 by CSF drainage, 7 by craniectomy). Iodine-based variables that correlated with surgical management were higher iodine concentration, pseudohematoma volume, iodine quantity in pseudohematoma, and iodine quantity in contusions. The regression model developed after inclusion of clinical variables identified 3 predictor variables: postresuscitation Glasgow Coma Scale (adjusted OR = 0.55; 95% CI, 0.38?0.79; P = .001), age (adjusted OR = 0.9; 95% CI, 0.85?0.97; P = .003), and pseudohematoma volume (adjusted OR = 2.05; 95% CI, 1.1?3.77; P = .02), which yielded an area under the curve of 0.96 in predicting surgical intracranial pressure management. The 2 predictors for craniectomy were age (adjusted OR = 0.89; 95% CI, 0.81?0.99; P = .03) and pseudohematoma volume (adjusted OR = 1.23; 95% CI, 1.03?1.45; P = .02), which yielded an area under the curve of 0.89. CONCLUSIONS: Quantitative iodine-based parameters derived from follow-up dual-energy CT may predict the intensity of intracranial pressure management in patients with hemorrhagic contusions.	[Bodanapally, U. K.; Shanmuganathan, K.; Feiter, T. R.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Gunjan, Y. P.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Neurol, Baltimore, MD 21201 USA; [Schwartzbauer, G.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Neurosurg, Baltimore, MD 21201 USA; [Kondaveti, R.] Kasturba Med Coll & Hosp, Mangaluru, India		Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol & Nucl Med, 22 S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu	Parikh, Gunjan/AAS-1375-2020	Parikh, Gunjan/0000-0002-8447-1349; Fleiter, Thorsten/0000-0001-6255-9027; Kondaveti, Rahul/0000-0002-8137-8050			Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Bodanapally UK, 2018, AM J NEURORADIOL, V39, P658, DOI 10.3174/ajnr.A5558; Bodanapally UK, 2017, AM J NEURORADIOL, V38, P1946, DOI 10.3174/ajnr.A5318; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Bonatti M, 2018, AM J NEURORADIOL, V39, P441, DOI 10.3174/ajnr.A5513; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Letourneau-Guillon L, 2013, AM J NEURORADIOL, V34, P773, DOI 10.3174/ajnr.A3309; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Orito K, 2018, J NEUROTRAUM, V35, P760, DOI 10.1089/neu.2017.5247; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rosa M, 2016, J NEUROTRAUM, V33, P1015, DOI 10.1089/neu.2015.4062; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181	28	3	3	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	DEC	2019	40	12					2059	2065		10.3174/ajnr.A6316			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	JV9VW	WOS:000502708500018	31727752	hybrid, Green Published			2022-02-06	
J	Bustamante, MC; Cronin, DS				Bustamante, M. C.; Cronin, D. S.			Cavitation threshold evaluation of porcine cerebrospinal fluid using a Polymeric Split Hopkinson Pressure Bar-Confinement chamber apparatus	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Cavitation; Porcine cerebrospinal fluid; Polymeric split Hopkinson pressure bar; Mild traumatic brain injury; Negative intracranial pressure	TIME-DEPENDENT CHANGES; BRAIN-INJURY; ULTRASONIC CAVITATION; TENSILE-STRENGTH; BIOMARKER LEVELS; BLAST; MODEL; EXPOSURE; BLOOD; WATER	Studies investigating mild Traumatic Brain Injury (mTBI) in the military population using experimental head surrogates and Finite Element (FE) head models have demonstrated the existence of transient negative pressures occurring within the head at the contrecoup location to the blast wave impingement. It has been hypothesized that this negative pressure may cause cavitation of cerebrospinal fluid (CSF) and possibly lead to brain tissue damage from cavitation bubble collapse. The cavitation pressure threshold of human CSF is presently unknown, although existing FE studies in the literature have assumed a value of -100 kPa. In the present study, the cavitation threshold of degassed porcine CSF at body temperature (37 degrees C) was measured using a unique modified Polymeric Split Hopkinson Pressure Bar apparatus, and compared to thresholds of distilled water at various conditions. The loading pulse generated in the apparatus was comparable to experimentally measured pressures resulting from blast exposure, and those predicted by an FE model. The occurrence of cavitation was identified using high-speed imaging and the corresponding pressures were determined using a computational model of the apparatus that was previously developed and validated. The probability of cavitation was calculated (ISO/TS, 18506) from forty-one experimental tests on porcine CSF, representing an upper bound for in vivo CSF. The 50% probability of cavitation for CSF (-0.467 MPa +/- 7%) was lower than that of distilled water (-1.37 MPa +/- 16%) under the same conditions. The lesser threshold of CSF could be related to the constituents such as blood cells and proteins. The results of this study can be used to inform FE head models subjected to blast exposure and improve prediction of the potential for CSF cavitation and response of brain tissue.	[Bustamante, M. C.; Cronin, D. S.] Univ Waterloo, Dept Mech Engn, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada		Cronin, DS (corresponding author), Univ Waterloo, Dept Mech Engn, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	mcbustam@uwaterloo.ca; duane.cronin@uwaterloo.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	The authors would like to acknowledge: the Defence Research and Development Canada, Suffield Research Centre for supplying materials; the Natural Sciences and Engineering Research Council of Canada for financial support; and Compute Canada and Sharcnet for providing the necessary computing resources.	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Altman PL., 1961, BLOOD OTHER BODY FLU, V1 ed.; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bir C., 2011, MEASURING BLAST RELA; Bo C, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011110052; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; BRADLEY RD, 1962, J PHYSIOL-LONDON, V160, P381, DOI 10.1113/jphysiol.1962.sp006853; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; BULL TH, 1956, BRIT J APPL PHYS, V7, P416, DOI 10.1088/0508-3443/7/11/308; Bustamante MC, 2018, EXP MECH, V58, P55, DOI 10.1007/s11340-017-0323-x; Bustamante MC, 2019, C PROC SOC EXP MECH, P95, DOI 10.1007/978-3-319-95062-4_21; Canchi S, 2017, J MECH BEHAV BIOMED, V74, P261, DOI 10.1016/j.jmbbm.2017.06.018; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Chahine K.K.G., 2014, ADV EXPT NUMERICAL T, V106, P71, DOI [10.1007/978-94-017-8539-6, DOI 10.1007/978-94-017-8539-6]; CHESTERMAN WD, 1952, P PHYS SOC LOND B, V65, P846, DOI 10.1088/0370-1301/65/11/302; Conn P. M., 2008, NEUROSCIENCE MED; COUZENS DCF, 1969, NATURE, V222, P473, DOI 10.1038/222473a0; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Finnemore E.J., 2001, FLUID MECH ENG APPL, P816; FRY FJ, 1995, ULTRASOUND MED BIOL, V21, P1227, DOI 10.1016/0301-5629(96)89519-6; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S., 2009, ASME 2009 INT MECH E, P8; Gehre C., 2009, ENHANCED SAFETY VEHI; Ginsberg HJ, 2001, ULTRASON, P1381, DOI 10.1109/ULTSYM.2001.991978; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Haniff S, 2017, SHOCK WAVES, V27, P929, DOI 10.1007/s00193-017-0765-1; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; ISO, 1999, 9790 ISOTR; ISO/TS, 2014, 18506 ISOTS; Jurado R., 1990, CEREBROSPINAL FLUID; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KENNER VH, 1980, EXP MECH, V20, P226, DOI 10.1007/BF02327705; KENNER VH, 1980, J BIOMECH ENG-T ASME, V102, P151, DOI 10.1115/1.3138212; Kolsky H., 1949, Proceedings of the Physical Society. Section B, V62, P676, DOI 10.1088/0370-1301/62/11/302; LEE CS, 1988, ULTRASOUND MED BIOL, V14, P735, DOI 10.1016/0301-5629(88)90029-4; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marieb EN, 2010, HUMAN ANATOMY PHYSL, V8th; Mates S, 2018, DYNAMIC BEHAV MAT, P67; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nie X, 2013, INT J IMPACT ENG, V53, P56, DOI 10.1016/j.ijimpeng.2012.07.012; OVERTON GDN, 1984, J PHYS D APPL PHYS, V17, P979, DOI 10.1088/0022-3727/17/5/012; OVERTON GDN, 1982, J PHYS D APPL PHYS, V15, pL3, DOI 10.1088/0022-3727/15/2/001; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer M.B., 2010, PERS ARM SYST S QUEB, P11; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Richmond DR., 1968, ESTIMATE MANS TOLERA; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; SEDGEWICK SA, 1978, J PHYS D APPL PHYS, V11, P2517, DOI 10.1088/0022-3727/11/18/010; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; SKINHOJ E, 1965, ACTA NEUROL SCAND, VS 41, P313; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Strand O., 2004, SPIE P, V5580, P593, DOI [10.1063/5.0004363, DOI 10.1063/5.0004363]; Thunert, 2012, CORA RELEASE 3 6 USE; Tsaklis P, 2010, HUMAN MOV SCI, V11, P91, DOI [10.2478/v10038-009-0025-z, DOI 10.2478/V10038-009-0025-Z]; U.S. Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Venkatesh B, 1997, J NEUROL SCI, V147, P5, DOI 10.1016/S0022-510X(96)05304-X; White M, 2003, ICASUALTIES IRAQ COA; Williams PR, 1999, P ROY SOC A-MATH PHY, V455, P3311, DOI 10.1098/rspa.1999.0452; Williams PR, 2004, MOL PHYS, V102, P2091, DOI 10.1080/00268970412331292786; Williams PR, 1998, PHYS MED BIOL, V43, P3101, DOI 10.1088/0031-9155/43/10/028; Zhang C, 2014, CANCER LETT, V347, P105, DOI 10.1016/j.canlet.2014.01.022; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhu Feng, 2010, Stapp Car Crash J, V54, P211; Zhu Y, 2016, TRIBOL INT, V102, P419, DOI 10.1016/j.triboint.2016.06.007	78	3	3	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	DEC	2019	100								103400	10.1016/j.jmbbm.2019.103400			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	JN3XE	WOS:000496832200032	31476553				2022-02-06	
J	Dunbar, KE; Raboy, AL; Kirby, ZM; Taylor, PL; Roy, MJ				Dunbar, Kerri E.; Raboy, Annabel Lee; Kirby, Zena M.; Taylor, Patricia L.; Roy, Michael J.			Distinguishing the Relative Impact of Post-Traumatic Stress Disorder and Traumatic Brain Injury on iPad-Measured Cognitive Function	CYBERPSYCHOLOGY BEHAVIOR AND SOCIAL NETWORKING			English	Article						traumatic brain injury; post-traumatic stress disorder; cognition	NIH TOOLBOX; VALIDITY; RELIABILITY; PAIN; DEPRESSION; PREVALENCE; VALIDATION; SYMPTOMS; VETERANS; PTSD	Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) are highly prevalent, and frequently comorbid, among active and retired military service members. Both TBI and PTSD may contribute to impaired cognitive function, but it remains insufficiently clear what the relative impact of each is on overall cognition and whether multiple TBIs may further impair cognitive function. To understand the relative impact of TBI and symptoms of PTSD on cognitive function we examined data from 326 active or retired military service members, or dependents, either with or without a history of TBI, using questionnaires and the NIH Toolbox Cognitive Battery (NIH-TB), a brief iPad-based assessment that measures the cognitive domains most important to daily functioning. The NIH-TB was developed for use as a "common currency" among research studies, and was more recently adapted to the iPad for ease of use. To our knowledge, this is the first report of its application to evaluate the relative impact of TBI and PTSD. Our results indicate that cognitive function remains largely intact after multiple TBIs if symptoms of PTSD are not evident, and that measures of literacy and overall intelligence are relatively impervious to both TBI and PTSD. When cognitive impairment is observed after TBI, it is predominantly associated with the presence of significant symptoms of PTSD in most domains. However, TBI alone may impair some aspects of executive function. These findings need to be validated in other populations.	[Dunbar, Kerri E.; Raboy, Annabel Lee; Kirby, Zena M.; Taylor, Patricia L.; Roy, Michael J.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Dunbar, Kerri E.; Raboy, Annabel Lee; Kirby, Zena M.; Taylor, Patricia L.] Henry M Jackson Fdn, Rockville, MD USA; [Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Roy, MJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	michael.roy@usuhs.edu			Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This study was funded by the Center for Neuroscience and Regenerative Medicine.	Brearly TW, 2019, ARCH CLIN NEUROPSYCH, V34, P524, DOI 10.1093/arclin/acy070; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Buckley RF, 2017, JPAD-J PREV ALZHEIM, V4, P3, DOI 10.14283/jpad.2017.1; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen BE, 2013, J CLIN PSYCHIAT, V74, P1063, DOI 10.4088/JCP.12m08291; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crocker LD, 2019, J INT NEUROPSYCH SOC, V25, P79, DOI 10.1017/S1355617718000851; Failla MD, 2015, BRAIN NEUROTRAUMA MO, P505; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lunter CM, 2019, EMERG MED AUSTRALAS, V31, P355, DOI 10.1111/1742-6723.13163; Onoda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109931; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Rao SM, 2017, MULT SCLER J, V23, P1929, DOI 10.1177/1352458516688955; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Shura RD, 2019, PSYCHOL SERV, V16, P312, DOI 10.1037/ser0000208; Steel JL, 2011, INJURY, V42, P288, DOI 10.1016/j.injury.2010.11.045; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Weathers F.W., 1993, 9 ANN C ISTSS; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Willer L, 2016, EUR STROKE J, V1, P294, DOI 10.1177/2396987316665233	27	3	3	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-2715	2152-2723		CYBERPSYCH BEH SOC N	Cyberpsychology Behav. Soc. Netw.	DEC	2019	22	12					761	765		10.1089/cyber.2019.0296			5	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	KM1YB	WOS:000513916400003	31841649				2022-02-06	
J	Hoskinson, KR; Bigler, ED; Abildskov, TJ; Dennis, M; Taylor, HG; Rubin, K; Gerhardt, CA; Vannatta, K; Stancin, T; Yeates, KO				Hoskinson, Kristen R.; Bigler, Erin D.; Abildskov, Tracy J.; Dennis, Maureen; Taylor, H. Gerry; Rubin, Kenneth; Gerhardt, Cynthia A.; Vannatta, Kathryn; Stancin, Terry; Yeates, Keith Owen			The mentalizing network and theory of mind mediate adjustment after childhood traumatic brain injury	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						acquired brain injury; MRI; social cognition; social adjustment; sequelae	ADULT SURVIVORS; HEAD-INJURY; CHILDREN; BEHAVIOR; OUTCOMES; ADOLESCENTS; PREDICTORS; MODERATE; EMOTION; TERM	Childhood traumatic brain injury (TBI) affects over 600 000 children per year in the United States. Following TBI, children are vulnerable to deficits in psychosocial adjustment and neurocognition, including social cognition, which persist long-term. They are also susceptible to direct and secondary damage to related brain networks. In this study, we examine whether brain morphometry of the mentalizing network (MN) and theory of mind (ToM; one component of social cognition) mediates the effects of TBI on adjustment. Children with severe TBI (n = 15, M-age =10.32), complicated mild/moderate TBI (n = 30, M-age =10.81) and orthopedic injury (OI; n = 42, M-age = 10.65) completed measures of ToM and executive function and underwent MRI; parents rated children's psychosocial adjustment. Children with severe TBI demonstrated reduced right-hemisphere MN volume, and poorer ToM, vs children with OI. Ordinary least-squares path analysis indicated that right-hemisphere MN volume and ToM mediated the association between severe TBI and adjustment. Parallel analyses substituting the central executive network and executive function were not significant, suggesting some model specificity. Children at greatest risk of poor adjustment after TBI could be identified based in part on neuroimaging of social brain networks and assessment of social cognition and thereby more effectively allocate limited intervention resources.	[Hoskinson, Kristen R.; Taylor, H. Gerry; Gerhardt, Cynthia A.; Vannatta, Kathryn] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Hoskinson, Kristen R.; Taylor, H. Gerry; Gerhardt, Cynthia A.; Vannatta, Kathryn] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Bigler, Erin D.; Abildskov, Tracy J.] Brigham Young Univ, Dept Psychol Sci, Provo, UT 84602 USA; [Bigler, Erin D.; Abildskov, Tracy J.] Brigham Young Univ, Neurosci Ctr Brigham, Provo, UT 84602 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Rubin, Kenneth] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Hoskinson, KR (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Biobehav Hlth, 700 Childrens Dr, Columbus, OH 43205 USA.	Kristen.hoskinson@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Hoskinson, Kristen/AAL-9162-2020	Hoskinson, Kristen/0000-0003-4044-9753	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 R01 HD048946]	This work was supported in part by grant 5 R01 HD048946 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to K.O.Y.	Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V., 2012, DEV SOCIAL NEUROSCIE, P3; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; DEEGAN J, 1978, EDUC PSYCHOL MEAS, V38, P873, DOI 10.1177/001316447803800404; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DROTAR D, 1995, J CLIN CHILD PSYCHOL, V24, P184, DOI 10.1207/s15374424jccp2402_6; Griffin R, 2006, LATERALITY, V11, P195, DOI 10.1080/13576500500450552; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hayes A.F., 2017, INTRO MEDIATION MODE; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Howard I, 2005, ETHNIC DIS, V15, pS51; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Manly T, 1999, TEA CH TEST EVERYDAY; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mossad SI, 2016, NEUROIMAGE, V134, P320, DOI 10.1016/j.neuroimage.2016.03.053; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Root AE, 2016, J APPL DEV PSYCHOL, V42, P1, DOI 10.1016/j.appdev.2015.10.002; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Save-Pedebos J, 2016, EPILEPSY BEHAV, V55, P139, DOI 10.1016/j.yebeh.2015.12.013; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Siegal M, 1996, BRAIN LANG, V53, P40, DOI 10.1006/brln.1996.0035; Sodian B, 2011, CHILD DEV PERSPECT, V5, P39, DOI 10.1111/j.1750-8606.2010.00152.x; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Verger K, 2001, BRAIN INJURY, V15, P211; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Zaitchik D, 2010, NEUROPSYCHOLOGIA, V48, P2528, DOI 10.1016/j.neuropsychologia.2010.04.031	67	3	3	4	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	DEC	2019	14	12					1285	1295		10.1093/scan/nsaa006			11	Neurosciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LS7AZ	WOS:000536534300004	31993655	Green Published, gold			2022-02-06	
J	Jodoin, M; Rouleau, DM; Therrien, E; Chauny, JM; Sandman, E; Larson-Dupuis, C; Leduc, S; Gosselin, N; De Beaumont, L				Jodoin, Marianne; Rouleau, Dominique M.; Therrien, Erik; Chauny, Jean-Marc; Sandman, Emilie; Larson-Dupuis, Camille; Leduc, Stephane; Gosselin, Nadia; De Beaumont, Louis			Investigating the incidence and magnitude of heterotopic ossification with and without joints involvement in patients with a limb fracture and mild traumatic brain injury	BONE REPORTS			English	Article						Mild traumatic brain injury; Isolated limb fracture; Heterotopic ossification; Orthopedic complications; Return to work		Objectives: This study seeks to evaluate the incidence rate of heterotopic ossification (HO) formation in patients afflicted by an isolated limb fracture (ILF) and a concomitant mild traumatic brain injury (mTBI). Methods: The current study is an observational study including ILF patients with or without a concomitant mTBI recruited from an orthopedic clinic of a Level 1 Trauma Hospital. Patients were diagnosed with a mTBI according to the American Congress of Rehabilitation Medicine (ACRM) criteria. Radiographs taken on average 3 months post-trauma were analyzed separately by two distinct specialists for the presence of HO proximally to the fracture site (joints or extra joints). Both raters referred to Brooker's and Della's Valle's classification to establish signs of HO. First, analyses were conducted for the full sample. Secondly, a matched cohort was used in order to control for specific factors, namely age, sex, type of injury, and time elapsed between the accident and the analyzed radiograph. Results: The full sample included a total of 183 patients with an ILF (94 females; 47.5 years old), of which 50 had a concomitant mTBI and 133 without. Radiographic evidence of HO was significantly higher in patients with an ILF and a mTBI compared to ILF patients (X-2 = 6.50; p = 0.01). The matched cohort consisted of 94 participants (i.e.; 47 patients from the ILF + mTBI group and 47 patients from the ILF group). Again, ILF + mTBI patients presented significantly higher rates of HO signs in comparison to ILF patients (X-2 = 3.69; p = 0.04). Presence of HO was associated with prolonged delays to return to work (RTW) only in ILF + mTBI patients (F = 4.055; p = 0.05) but not in ILF patients (F = 0.823; p = 0.37). Conclusions: Study findings suggest that rates of HO are significantly higher proximally to fracture sites when ILF patients sustain a concomitant mTBI, even after controlling for factors known to influence HO. Moreover, results show that HO is associated with a prolonged RTW only in ILF patients with a concomitant mTBI but not in ILF-only patients. The impact of mTBI on HO formation warrants further attention to detect early signs of HO, to identify shared physiopathological mechanisms and, ultimately, to design targeted therapies.	[Jodoin, Marianne; Rouleau, Dominique M.; Therrien, Erik; Chauny, Jean-Marc; Sandman, Emilie; Larson-Dupuis, Camille; Leduc, Stephane; Gosselin, Nadia; De Beaumont, Louis] Hop Sacre Coeur Montreal, Ctr Rech, Montreal, PQ, Canada; [Jodoin, Marianne; Larson-Dupuis, Camille; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Rouleau, Dominique M.; Therrien, Erik; Sandman, Emilie; Leduc, Stephane; De Beaumont, Louis] Univ Montreal, Dept Chirurg, Montreal, PQ, Canada		De Beaumont, L (corresponding author), 5400 Gouin Ouest,Suite E-1340, Montreal, PQ, Canada.	marianne.jodoin@umontreal.ca; erik.therrien@umontreal.ca; jean-marc.chauny@umontreal.ca; emilie.sandman@umontreal.ca; camille.larson-dupuis@umontreal.ca; stephaneleduc@hotmail.com; nadia.gosselin@umontreal.ca; louis.de.beaumont@umontreal.ca					Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Clay FJ, 2010, J REHABIL MED, V42, P162, DOI 10.2340/16501977-0495; Coelho CVC, 2009, ARQ NEURO-PSIQUIAT, V67, P382, DOI 10.1590/S0004-282X2009000300002; Convente MR, 2015, CURR OSTEOPOROS REP, V13, P116, DOI 10.1007/s11914-015-0258-z; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Eisenstein N, 2018, J ORTHOP RES, V36, P1061, DOI 10.1002/jor.23808; Evans KN, 2012, J ORTHOP TRAUMA, V26, pE204, DOI 10.1097/BOT.0b013e31825d60a5; Firoozabadi R, 2017, J AM ACAD ORTHOP SUR, V25, P117, DOI 10.5435/JAAOS-D-15-00366; Forsberg JA, 2014, CLIN ORTHOP RELAT R, V472, P2845, DOI 10.1007/s11999-014-3694-7; Foruria AM, 2014, BONE JOINT J, V96B, P1681, DOI 10.1302/0301-620X.96B12.34091; Foruria Antonio M, 2013, J Bone Joint Surg Am, V95, pe66, DOI 10.2106/JBJS.K.01533; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Jodoin M, 2017, BRAIN INJURY, V31, P1683, DOI 10.1080/02699052.2017.1341644; Jodoin M, 2017, INJURY, V48, P1927, DOI 10.1016/j.injury.2017.06.025; Jodoin M, 2016, INJURY, V47, P1835, DOI 10.1016/j.injury.2016.05.036; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Kraft CT, 2016, J TRAUMA ACUTE CARE, V80, P156, DOI 10.1097/TA.0000000000000883; Nauth A, 2012, J ORTHOP TRAUMA, V26, P684, DOI 10.1097/BOT.0b013e3182724624; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Toom A, 2005, INT ORTHOP, V29, P156, DOI 10.1007/s00264-004-0603-9; Undurti A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00072; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Winkler S, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0764-2	33	3	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-1872			BONE REP	Bone Rep.	DEC	2019	11								100222	10.1016/j.bonr.2019.100222			7	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	VJ8QB	WOS:000639894100011	31463337	Green Published, gold			2022-02-06	
J	Juengst, SB; Hart, T; Sander, AM; Nalder, EJ; Pappadis, MR				Juengst, Shannon B.; Hart, Tessa; Sander, Angelle M.; Nalder, Emily J.; Pappadis, Monique R.			Mobile Health Interventions for Traumatic Brain Injuries	CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS			English	Article						Traumatic brain injuries; Mobile health; Technology; Telerehabilitation; Intervention; Rehabilitation		Purpose of ReviewMobile health (mHealth) interventions may be useful for individuals with traumatic brain injury (TBI), but there is minimal knowledge regarding how mHealth technology is currently being used for TBI treatment or rehabilitation. The purpose of this review is to examine the extant literature on the use of mHealth for intervention delivery in order to identify considerations for using mHealth with the TBI population, and to provide recommendations for further study.Recent FindingsConsistent with recent literature in other disability populations, mHealth shows promise for people with TBI as a compensatory strategy for cognitive impairment, a method for monitoring and reducing symptoms, and a means of addressing goals in social and educational spheres.SummaryIn this review article, we summarize the results of 16 articles on mHealth interventions for individuals with TBI, highlighting relevant findings for clinical application and discussing challenges unique to the use of mHealh post-TBI.	[Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Harris Hlth Syst, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Beth K & Stuart C Yudofsky Div Neuropsychiat, Dept Psychiat, Houston, TX 77030 USA; [Sander, Angelle M.; Pappadis, Monique R.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Nalder, Emily J.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Nalder, Emily J.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Pappadis, Monique R.] Univ Texas Med Branch, Div Rehabil Sci, Sch Hlth Profess, Galveston, TX 77555 USA; [Pappadis, Monique R.] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu					[Anonymous], 2017, MOBILE FACT SHEET; Anthes E, 2016, NATURE, V532, P20, DOI 10.1038/532020a; Archer KR, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0775-1; Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Baldwin VN, 2015, NEUROPSYCHOL REHABIL, V25, P617, DOI 10.1080/09602011.2014.956764; Bedell GM, 2017, DEV NEUROREHABIL, V20, P408, DOI 10.1080/17518423.2016.1237584; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Beratarrechea A, 2014, TELEMED E-HEALTH, V20, P75, DOI 10.1089/tmj.2012.0328; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bowles KH, 2009, J TELEMED TELECARE, V15, P344, DOI 10.1258/jtt.2009.090118; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Bulaj G, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00126; Charters E, 2015, NEUROPSYCHOL REHABIL, V25, P82, DOI 10.1080/09602011.2014.942672; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Cikajlo I, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.6849; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cruz G, 2016, BRIT J OCCUP THER, V79, P598, DOI 10.1177/0308022616640299; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Daudet L, 2017, IEEE J BIOMED HEALTH, V21, P496, DOI 10.1109/JBHI.2016.2633509; Davis GA, 2015, J PAEDIATR CHILD H, V51, P830, DOI 10.1111/jpc.12879; de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2; De Joode EA, 2013, NEUROPSYCHOL REHABIL, V23, P133, DOI 10.1080/09602011.2012.726632; Dicianno BE, 2015, PHYS THER, V95, P397, DOI 10.2522/ptj.20130534; Donker T, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2791; Edwards CM, 2015, NEUROREHAB NEURAL RE, V29, P897, DOI 10.1177/1545968315570326; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evald L., 2017, DISABIL REHABIL, P1; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Fairman AD, 2016, INT J TELEREHABILITA, V8, P11, DOI 10.5195/ijt.2016.6194; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Ferguson S, 2015, BRAIN INJURY, V29, P583, DOI 10.3109/02699052.2014.1002109; Firth J, 2016, SCHIZOPHRENIA BULL, V42, P448, DOI 10.1093/schbul/sbv132; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Groussard P-Y., 2015, NEUROPSYCHOL REHABIL, P1; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T., 2017, BRAIN INJURY, P1; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hendricks DJ, 2015, NEUROREHABILITATION, V37, P449, DOI 10.3233/NRE-151273; How TV, 2017, DISABIL REHABIL-ASSI, V12, P244, DOI 10.3109/17483107.2015.1129457; Huguet A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154248; Hunkin NM, 1998, NEUROPSYCHOLOGIA, V36, P25, DOI 10.1016/S0028-3932(97)00106-1; Iorio-Morin C, 2016, CLIN NEUROL NEUROSUR, V142, P48, DOI 10.1016/j.clineuro.2016.01.021; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Kitsiou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173160; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Kr A, 2015, TRIALS ELECT RESOUR; Lamontagne ME, 2011, BRAIN INJURY, V25, P1188, DOI 10.3109/02699052.2011.608211; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lannin N, 2014, CLIN REHABIL, V28, P470, DOI 10.1177/0269215513512216; Larsen ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152285; Lee H, 2015, BRIT J SPORT MED, V49, P500, DOI 10.1136/bjsports-2013-092930; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Morris JT., 2016, SUNSPOT WIRELESS DEV; Narad ME., 2017, DEV NEUROREHABILITAT, P1; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Powell LE, 2015, NEUROREHABILITATION, V37, P437, DOI 10.3233/NRE-151272; Powell LE, 2019, DISABIL REHABIL-ASSI, V14, P21, DOI 10.1080/17483107.2017.1389999; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Rodriguez MTS, 2018, NEUROLOGIA, V33, P313, DOI 10.1016/j.nrl.2015.10.005; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Scherer MJ., 2005, CRIT REV PHYS REHABI, V17; Schopp LH, 2005, PROF PSYCHOL-RES PR, V36, P158, DOI 10.1037/0735-7028.36.2.158; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; Smith B, 2012, HEALTH INFORM J, V18, P294, DOI 10.1177/1460458212445349; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Sundararaman LV, 2017, REGION ANESTH PAIN M, V42, P488, DOI 10.1097/AAP.0000000000000621; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thomas L., 2015, STATE TELEMEDICINE G; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841; Vuletic S, 2016, J HEAD TRAUMA REHAB, V31, P147, DOI 10.1097/HTR.0000000000000221; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2017, IN PRESS; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; Worthen-Chaudhari L., 2017, BRAIN INJURY, P1; Yepes M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5592	91	3	3	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4833		CURR PHYS MED REHAB	Curr. Phys. Med. Rehabil. Rep.	DEC	2019	7	4					341	356		10.1007/s40141-019-00240-9			16	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VK2QF	WOS:000670357000006					2022-02-06	
J	Koskinen, LOD; Sundstrom, N; Hagglund, L; Eklund, A; Olivecrona, M				Koskinen, Lars-Owe D.; Sundstrom, Nina; Hagglund, Linda; Eklund, Anders; Olivecrona, Magnus			Prostacyclin Affects the Relation Between Brain Interstitial Glycerol and Cerebrovascular Pressure Reactivity in Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Pressure reactivity; Autoregulation; Glycerol; Cerebral microdialysis; Prostacyclin	CEREBRAL-BLOOD-FLOW; AUTOREGULATION; MICRODIALYSIS; PRINCIPLES; VASOSPASM; ARTERIAL; IMPACT	Background Cerebral injury may alter the autoregulation of cerebral blood flow. One index for describing cerebrovascular state is the pressure reactivity (PR). Little is known of whether PR is associated with measures of brain metabolism and indicators of ischemia and cell damage. The aim of this investigation was to explore whether increased interstitial levels of glycerol, a marker of cell membrane damage, are associated with PR, and if prostacyclin, a membrane stabilizer and regulator of the microcirculation, may affect this association in a beneficial way. Materials and Methods Patients suffering severe traumatic brain injury (sTBI) were treated according to an intracranial pressure (ICP)-targeted therapy based on the Lund concept and randomized to an add-on treatment with prostacyclin or placebo. Inclusion criteria were verified blunt head trauma, Glasgow Coma Score <= 8, age 15-70 years, and a first measured cerebral perfusion pressure of >= 10 mmHg. Multimodal monitoring was applied. A brain microdialysis catheter was placed on the worst affected side, close to the penumbra zone. Mean (glycerol(mean)) and maximal glycerol (glycerol(max)) during the 96-h sampling period were calculated. The mean PR was calculated as the ICP/mean arterial pressure (MAP) regression coefficient based on hourly mean ICP and MAP during the first 96 h. Results Of the 48 included patients, 45 had valid glycerol and PR measurements available. PR was higher in the placebo group as compared to the prostacyclin group (p = 0.0164). There was a positive correlation between PR and the glycerol(mean) (rho = 0.503, p = 0.01) and glycerol(max) (rho = 0.490, p = 0.015) levels in the placebo group only. Conclusions PR is correlated to the glycerol level in patients suffering from sTBI, a relationship that is not seen in the group treated with prostacyclin. Glycerol has been associated with membrane degradation and may support glycerol as a biomarker for vascular endothelial breakdown. Such a breakdown may impair the regulation of cerebrovascular PR.	[Koskinen, Lars-Owe D.; Hagglund, Linda; Olivecrona, Magnus] Umea Univ, Dept Pharmacol & Clin Neurosci, Neurosurg, S-90185 Umea, Sweden; [Sundstrom, Nina; Eklund, Anders] Umea Univ, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Olivecrona, Magnus] Orebro Univ, Fac Hlth & Med, Dept Anaesthesia & Intens Care, Dept Med Sci,Sect Neurosurg, Orebro, Sweden		Koskinen, LOD (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Neurosurg, S-90185 Umea, Sweden.	Lars-Owe.Koskinen@umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Eklund, Anders/0000-0002-2031-722X; Olivecrona, Magnus/0000-0001-8457-4711	Umea Clinical Neuroscience research fund; Tore Nilsson foundation; Kempe foundation; Capio foundation; Umea University	The source of funding for the study was from Umea Clinical Neuroscience research fund, Tore Nilsson, Kempe and Capio foundations and Umea University.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; De-Lima-Oliveira M, 2018, WORLD NEUROSURG, V113, P110, DOI 10.1016/j.wneu.2018.01.194; Edvinsson L., 1993, CEREBRAL BLOOD FLOW; FITZGERALD GA, 1979, LIFE SCI, V25, P665, DOI 10.1016/0024-3205(79)90507-1; Fog M, 1938, J NEUROL PSYCHIATRY, V1, P187, DOI 10.1136/jnnp.1.3.187; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; KONTOS HA, 1977, STROKE, V8, P226, DOI 10.1161/01.STR.8.2.226; Koskinen LOD, 2015, NEUROCRIT CARE, V22, P26, DOI 10.1007/s12028-014-0030-8; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lazaridis C, 2014, NEUROCRIT CARE, V21, P345, DOI 10.1007/s12028-014-0007-7; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MONCADA S, 1979, FED PROC, V38, P66; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MONCADA S, 1977, LANCET, V1, P18; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; MRAOVITCH S, 1996, NEUROPHYSIOLOGICAL B; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; Rasmussen R, 2015, STROKE, V46, P37, DOI 10.1161/STROKEAHA.114.007470; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Santos Edgar, 2012, Acta Neurochir Suppl, V114, P363, DOI 10.1007/978-3-7091-0956-4_70; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Ungerstedt U, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P361; Wahlstrom MR, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-98; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Yokobori S, 2011, J TRAUMA, V71, P1235, DOI 10.1097/TA.0b013e3182140dd7; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1	41	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2019	31	3					494	500		10.1007/s12028-019-00741-4			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JU5FK	WOS:000501700900007	31123992	Green Published, hybrid			2022-02-06	
J	Li, ZG; Wang, GL; Ji, C; Jiang, JZ; Wang, JW; Wang, J				Li, Zhigang; Wang, Guangliang; Ji, Cheng; Jiang, Jinzhong; Wang, Jiawei; Wang, Jian			Characterization of the mechanical properties for cranial bones of 8-week-old piglets: the effect of strain rate and region	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Pediatric head injury; Piglet cranium; Mechanical properties; Cranium region; Strain rate; Computational modeling	INFANT SKULL; HEAD IMPACT; SIMULATIONS; VALIDATION; PARAMETERS; SUTURE; MODEL	Due to ethical reasons, piglets have often been employed as surrogates for children in biomechanics studies. To our knowledge, no public data detailing the mechanical properties of cranial bones for 8-week-old piglets are available. In this study, tensile tests were conducted on frontal, parietal, and occipital bone specimens derived from 8-week-old piglets at different strain rates. The cranial bone specimens exhibit obvious linear elastic behavior and an insignificant plastic stage prior to failure. The mechanical property of the parietal bone is very close to that of the frontal bone, and the property differs significantly from that of the occipital bone. The average elastic modulus and ultimate stress of the parietal/frontal bone are 4.19 times and 2.75 times as high as occipital bone, respectively, whereas the average ultimate strain is about 25% times lower than that of the occipital bone. In addition, the cranial bone exhibits significant strain-rate characteristics. As the strain rate increases from 0.001 to 10 s(-1), the average elastic modulus and ultimate stress of the parietal/frontal and occipital bone increase by about 88% and 59%, and 94% and 96%, respectively. In contrast, the average ultimate strain of the parietal/frontal and occipital bone decreases by about 32% and about 17%, respectively. The quantitative relationship between the mechanical parameters of the cranial bone and the strain rate based on the experimental data is established. A strain-rate-dependent elastic constitutive model was developed through user material subroutine and implemented into LS-DYNA. Simulation results using the self-developed material subroutine code showed that this constitutive model can be used to predict the responses of cranial bone specimens under different tensile speeds.	[Li, Zhigang; Wang, Guangliang; Ji, Cheng; Wang, Jiawei; Wang, Jian] Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing 100044, Peoples R China; [Jiang, Jinzhong] Cangzhou Hosp Integrated Tradit & Western Med Heb, Cangzhou 061001, Hebei, Peoples R China		Li, ZG (corresponding author), Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing 100044, Peoples R China.	zgli@bjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51505024]	This work was supported by the National Natural Science Foundation of China (Grant No. 51505024). The authors thank Xiaoming Wang from TA Instruments for his assistance in tensile testing.	Auperrin A, 2014, J BIOMECH, V47, P1180, DOI 10.1016/j.jbiomech.2013.10.060; Baumer TG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000081; Biswas S, 2017, J MECH BEHAV BIOMED, V65, P688; Boruah S, 2017, J MECH BEHAV BIOMED, V65, P688, DOI 10.1016/j.jmbbm.2016.09.041; COATS B, 2003, P IRCOBI C LISB, P57; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Couper Z, 2008, BIOMECH MODEL MECHAN, V7, P105, DOI 10.1007/s10237-007-0079-9; Davis MT, 2012, J BIOMECH, V45, P2493, DOI 10.1016/j.jbiomech.2012.07.001; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; Irwin A., 1997, 973317 SAE; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Li ZG, 2016, J MECH BEHAV BIOMED, V60, P557, DOI 10.1016/j.jmbbm.2016.03.021; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Mertz HJ., 1984, 840884 SAE; Motherway JA, 2010, IFMBE PROC, V31, P776, DOI 10.1007/978-3-642-14515-5_197; Pasquesi SA, 2017, ANN BIOMED ENG, V45, P1877, DOI 10.1007/s10439-017-1833-5; Peterson J, 2003, ANAT REC PART A, V274A, P785, DOI 10.1002/ar.a.10096; Rahmoun J, 2014, MECH RES COMMUN, V60, P7, DOI 10.1016/j.mechrescom.2014.04.001; Roth S, 2007, International Journal of Vehicle Safety, V2, P404, DOI 10.1504/IJVS.2007.016750; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; [阮世捷 Ruan Shijie], 2012, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V31, P502; Sahli F, 2015, COMPUT METHOD BIOMEC, V18, P890, DOI 10.1080/10255842.2013.855728; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Thibault KL, 1999, INT IRCOBI C P, P73; Wang JW, 2014, MED SCI MONITOR, V20, P1808, DOI 10.12659/MSM.892278; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhou Z, 2016, COMPUT METH PROG BIO, V131, P13, DOI 10.1016/j.cmpb.2016.04.013	38	3	3	1	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	DEC	2019	18	6					1697	1707		10.1007/s10237-019-01169-7			11	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	JI7RD	WOS:000493661200010	31119413				2022-02-06	
J	McCarty, AK; Zhang, L; Hansen, S; Jackson, WJ; Bentil, SA				McCarty, Annastacia K.; Zhang, Ling; Hansen, Sarah; Jackson, William J.; Bentil, Sarah A.			Viscoelastic properties of shock wave exposed brain tissue subjected to unconfined compression experiments	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury; Blast; Viscoelastic; Fractional zener; Shock wave; Absorption	MECHANICAL-BEHAVIOR; DIFFUSION TENSOR; POSTMORTEM TIME; WHITE-MATTER; INJURY; SHEAR; EQUATIONS; MODELS; LIVER	Traumatic brain injuries (TBI) affect millions of people each year. While research has been dedicated to determining the mechanical properties of the uninjured brain, there has been a lack of investigation on the mechanical properties of the brain after experiencing a primary blast-induced TBI. In this paper, whole porcine brains were exposed to a shock wave to simulate blast-induced TBI. First, ten (10) brains were subjected to unconfined compression experiments immediately following shock wave exposure. In addition, 22 brains exposed to a shock wave were placed in saline solution and refrigerated between 30 minutes and 6.0 hours before undergoing unconfined compression experiments. This study aimed to investigate the effect of a time delay on the viscoelastic properties in the event that an experiment cannot be completed immediately. Samples from both soaked and freshly extracted brains were subjected to compressive rates of 5, 50, and 500 mm/min during the unconfined compression experiments, The fractional Zener (FZ) viscoelastic model was applied to obtain the brain's material properties. The length of time in the solution statistically influenced three of the four FZ coefficients, E-0 (instantaneous elastic response), tau(0) (relaxation time), and alpha (fractional order). Further, the compressive rate statistically influenced tau(0) and alpha.	[McCarty, Annastacia K.; Zhang, Ling; Hansen, Sarah; Jackson, William J.; Bentil, Sarah A.] Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA		Bentil, SA (corresponding author), Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA.	sbentil@iastate.edu			Roy J. Carver Charitable Trust [18-5021]	This research was financially supported by the Roy J. Carver Charitable Trust under Grant #18-5021 and is acknowledged gratefully.	Agoston DV, 2017, J NEUROTRAUM, V34, pS44, DOI 10.1089/neu.2017.5317; Ayyildiz M, 2014, BIORHEOLOGY, V51, P47, DOI 10.3233/BIR-14007; BAGLEY RL, 1983, AIAA J, V21, P741, DOI 10.2514/3.8142; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bentil S.A, 2013, THESIS; Bentil SA, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aab990; Bentil SA, 2014, J MECH BEHAV BIOMED, V30, P83, DOI 10.1016/j.jmbbm.2013.10.020; BLAIR GWS, 1947, J COLL SCI IMP U TOK, V2, P21; Boudjema F, 2017, J PHYS CONF SER, V790, DOI 10.1088/1742-6596/790/1/012002; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Courtney E, 2015, ARXIV150206112; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Davis GB, 2006, MED ENG PHYS, V28, P455, DOI 10.1016/j.medengphy.2005.07.023; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Garo A, 2007, BIORHEOLOGY, V44, P51; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guthkelch A N, 1979, Acta Neurochir Suppl (Wien), V28, P120; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; JMP, 2015, VERS 12 2 0; Johnston R, 2013, NATURE NEWS; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Kleiven S, 2007, J STAPP CAR CRASH, V51; Kohandel M, 2005, PHYS MED BIOL, V50, P2799, DOI 10.1088/0031-9155/50/12/005; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; McCarty AK, 2019, J MECH BEHAV BIOMED, V97, P355, DOI 10.1016/j.jmbbm.2019.05.028; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nicolle S, 2010, J MECH BEHAV BIOMED, V3, P630, DOI 10.1016/j.jmbbm.2010.07.010; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, ASME 2012 INT MECH E; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Schiessel H, 1995, J PHYS A-MATH GEN, V28, P6567, DOI 10.1088/0305-4470/28/23/012; Takhounts E.G, 1999, INJ BIOM RES P 27 IN, P141; The Mathworks Inc, 2016, MATLAB; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tirella A, 2014, J BIOMED MATER RES A, V102, P3352, DOI 10.1002/jbm.a.34914; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005	52	3	3	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	DEC	2019	100								103380	10.1016/j.jmbbm.2019.103380			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	JN3XE	WOS:000496832200019	31446342	Green Submitted			2022-02-06	
J	Morris, MC; Kassam, F; Bercz, A; Beckmann, N; Schumacher, F; Gulbins, E; Makley, AT; Goodman, MD				Morris, Mackenzie C.; Kassam, Farzaan; Bercz, Aron; Beckmann, Nadine; Schumacher, Fabian; Gulbins, Erich; Makley, Amy T.; Goodman, Michael D.			The Role of Chemoprophylactic Agents in Modulating Platelet Aggregability After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Traumatic brain injury; Venous thromboembolism; Chemoprophylaxis; Sphingolipids	VENOUS THROMBOEMBOLISM CHEMOPROPHYLAXIS; UNFRACTIONATED HEPARIN; SPHINGOSINE 1-PHOSPHATE; LUNG INJURY; PROPHYLAXIS; ACTIVATION; ENOXAPARIN; MODEL; ACID; AGGREGATION	Background: The pathophysiology behind the subacute but persistent hypercoagulable state after traumatic brain injury (TBI) is poorly understood but contributes to morbidity induced by venous thromboembolism. Because platelets and their microvesicles have been hypothesized to play a role in post-traumatic hypercoagulability, administration of commonly used agents may ameliorate this coagulability. We hypothesized that utilization of aspirin, ketorolac, amitriptyline, unfractionated heparin, or enoxaparin would modulate the platelet aggregation response after TBI. Methods: Concussive TBI was induced by weight drop. Mice were then randomized to receive aspirin, ketorolac, amitriptyline, heparin, enoxaparin, or saline control at 2 and 8 h after TBI. Mice were sacrificed at 6 or 24 h after injury to determine coagulability by rotational thromboelastometry (ROTEM), platelet function testing with impedance aggregometry, and microvesicle enumeration. Platelet sphingolipid metabolites were analyzed by mass spectrometry. Results: ROTEM demonstrated increased platelet contribution to maximum clot firmness at 6 h after TBI in mice that received aspirin or amitriptyline, but this did not persist at 24 h. By contrast, adenosine diphosphate- and arachidonic acid-induced platelet aggregation at 6 h was significantly lower in mice receiving ketorolac, aspirin, and amitriptyline compared with mice receiving saline at 6 h after injury and only arachidonic acid-initiated platelet aggregation was decreased by aspirin at 24 h. There were no differences in microvesicle production at either time point. Platelet sphingosine-1-phosphate levels were decreased at 6 h in the group receiving amitriptyline and increased at 24 h along with platelet ceramide levels at 24 h in the amitriptyline group. Conclusion: After TBI, amitriptyline decreased platelet aggregability and increased contribution to clot in a manner similar to aspirin. The amitriptyline effects on platelet function and sphingolipid metabolites may represent a possible role of the acid sphingomyelinase in the hypercoagulability observed after injury. In addition, inhibition of platelet reactivity may be an underappreciated benefit of low molecular weight heparins, such as enoxaparin. (C) 2019 Elsevier Inc. All rights reserved.	[Morris, Mackenzie C.; Kassam, Farzaan; Bercz, Aron; Beckmann, Nadine; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Schumacher, Fabian; Gulbins, Erich] Univ Duisburg Essen, Univ Hosp Essen, Dept Mol Biol, Essen, Germany; [Schumacher, Fabian] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Sect Gen Surg, 231 Albert Sabin Way,ML 0558m, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu	Schumacher, Fabian/ABC-1750-2020	Schumacher, Fabian/0000-0001-8703-3275; Bercz, Aron/0000-0002-4259-2644	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 GM124156-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM124156] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health R01 GM124156-01A1 (MDG).	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Aggarwal A, 2004, NEPHROL DIAL TRANSPL, V19, P1559, DOI 10.1093/ndt/gfh209; Aggarwal A, 2002, J THROMB THROMBOLYS, V13, P161, DOI 10.1023/A:1020478923794; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Depew AJ, 2008, AM SURGEON, V74, P906; Dunne E, 2016, CLIN CHEM LAB MED, V54, P1269, DOI 10.1515/cclm-2015-0802; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Frisoli FA, 2017, NEUROSURGERY, V81, P1016, DOI 10.1093/neuros/nyx164; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gulbins A, 2018, MOL PSYCHIATR, V23, P2324, DOI 10.1038/s41380-018-0090-9; Hamada SR, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0315-0; Johnson BL, 2016, SHOCK, V46, P541, DOI 10.1097/SHK.0000000000000648; Kachler K, 2017, CANCER RES, V77, P5963, DOI 10.1158/0008-5472.CAN-16-3313; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Knudson MM, 2004, ANN SURG, V240, P6; Macchi L, 2002, THROMB RES, V107, P45, DOI 10.1016/S0049-3848(02)00210-4; Malhotra S, 2001, INT J CLIN PHARM TH, V39, P110; Martin GE, 2018, SHOCK, V50, P551, DOI 10.1097/SHK.0000000000001056; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Munzer P, 2014, AM J PHYSIOL-CELL PH, V307, pC920, DOI 10.1152/ajpcell.00029.2014; Munzer P, 2014, ARTERIOSCL THROM VAS, V34, P61, DOI 10.1161/ATVBAHA.112.300210; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Onuma T, 2017, THROMB RES, V156, P91, DOI 10.1016/j.thromres.2017.06.001; Prakash PS, 2012, J TRAUMA ACUTE CARE, V73, P401, DOI 10.1097/TA.0b013e31825a776d; Rauch BH, 2014, CELL PHYSIOL BIOCHEM, V34, P185, DOI 10.1159/000362994; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Simon CG, 1999, THROMB RES, V94, P13, DOI 10.1016/S0049-3848(98)00186-8; Strollo BP, 2018, J CRIT CARE, V43, P75, DOI 10.1016/j.jcrc.2017.08.012; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tuinman PR, 2013, SHOCK, V40, P334, DOI 10.1097/SHK.0b013e3182a384f0; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zapata-Morales JR, 2016, DRUG DEVELOP RES, V77, P187, DOI 10.1002/ddr.21310	38	3	3	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2019	244						1	8		10.1016/j.jss.2019.06.022			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JG3EL	WOS:000491957000001	31279258	Green Accepted			2022-02-06	
J	Peterson, AB; Sarmiento, K; Xu, LK; Haileyesus, T				Peterson, Alexis B.; Sarmiento, Kelly; Xu, Likang; Haileyesus, Tadesse			Traumatic brain injury-related hospitalizations and deaths among American Indians and Alaska natives - United States, 2008-2014	JOURNAL OF SAFETY RESEARCH			English	Article						Traumatic brain injury; American Indian; Alaskan native; nonfatal and fatal injury	OUTCOMES	Introduction: Despite progress, injury remains the leading cause of preventable death for American Indian and Alaska Natives (Al/AN), aged 1 to 44. There are few publications on injuries among the Al/ AN population, especially those on traumatic brain injury (TBI). A TBI can cause short- or long-term changes in cognition, communication, and/or emotion. Method: To describe changes over time in TBI incidence by mechanism of injury, injury intent, and age group among Al/ANs, the CDC analyzed hospitalization and death data from the 2008-2014 Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) and the National Vital Statistics System (NVSS), respectively. Results: From 2008-2014, the incidence of TBI-related hospitalizations increased by 32% (1,477 in 2008 to 1,945 in 2014) and resulted in a 21% increase in age-adjusted rates of people hospitalized with TBI. TBI-related deaths increased in number (569 in 2008 to 644 in 2014) and age-adjusted rate (22.7 in 2008 to 25.4 in 2014) by approximately 13% and 12%, respectively. Motor-vehicle crashes were the leading cause of TBI-related deaths among Al/ANs aged 0-54 years. Practical application: Prevention efforts should focus on increasing motor-vehicle safety and advancing prevention strategies for other leading causes of TBI, including: falls, intentional self-harm, and assaults. (C) 2019 National Safety Council and Elsevier Ltd. All rights reserved.	[Peterson, Alexis B.; Sarmiento, Kelly] CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Xu, Likang; Haileyesus, Tadesse] CDC, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Peterson, AB (corresponding author), 4770 Buford Highway,Mail Stop S106-9, Atlanta, GA 30341 USA.	APeterson4@cdc.gov					[Anonymous], 2018, IND HLTH FOC INJ 201; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arias Elizabeth, 2016, Vital Health Stat 2, P1; Bigback KM, 2015, HEALTH SERV RES, V50, P1390, DOI 10.1111/1475-6773.12331; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Fuentes MM, 2016, J PEDIATR REHAB MED, V9, P133, DOI 10.3233/PRM-160376; Healthcare Cost and Utilization Project, 2017, OV NAT NAT NAT IMP S; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; National Center for Health Statistics, 2017, US CENS POP BRIDG RA; National Center for Health Statistics, 2016, NAT VIT STAT SYST; National Center for Injury Prevention and Control, 2019, STOPP ELD ACC DEATHS; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	15	3	3	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	DEC	2019	71						315	318		10.1016/j.jsr.2019.09.017			4	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	KB8FB	WOS:000506723600030	31862042				2022-02-06	
J	Rau, CS; Wu, SC; Hsu, SY; Liu, HT; Huang, CY; Hsieh, TM; Chou, SE; Su, WT; Liu, YW; Hsieh, CH				Rau, Cheng-Shyuan; Wu, Shao-Chun; Hsu, Shiun-Yuan; Liu, Hang-Tsung; Huang, Chun-Ying; Hsieh, Ting-Min; Chou, Sheng-En; Su, Wei-Ti; Liu, Yueh-Wei; Hsieh, Ching-Hua			Concurrent Types of Intracranial Hemorrhage are Associated with a Higher Mortality Rate in Adult Patients with Traumatic Subarachnoid Hemorrhage: A Cross-Sectional Retrospective Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; subarachnoid hemorrhage (SAH); subdural hematoma (SDH); epidural hematoma (EDH); intracerebral hemorrhage (ICH); mortality	CARE-UNIT ADMISSION; 2 BODY REGIONS; HEAD-INJURY; INTRAPARENCHYMAL HEMORRHAGE; CLINICAL-SIGNIFICANCE; BRAIN-INJURY; RISK-FACTORS; PROGRESSION; LEVEL; CT	Traumatic subarachnoid hemorrhage (SAH) is the second most frequent intracranial hemorrhage and a common radiologic finding in computed tomography. This study aimed to estimate the risk of mortality in adult trauma patients with traumatic SAH concurrent with other types of intracranial hemorrhage, such as subdural hematoma (SDH), epidural hematoma (EDH), and intracerebral hemorrhage (ICH), compared to the risk in patients with isolated traumatic SAH. We searched our hospital's trauma database from 1 January, 2009 to 31 December, 2018 to identify hospitalized adult patients >= 20 years old who presented with a trauma abbreviated injury scale (AIS) of >= 3 in the head region. Polytrauma patients with an AIS of >= 3 in any other region of the body were excluded. A total of 1856 patients who had SAH were allocated into four exclusive groups: (Group I) isolated traumatic SAH, n = 788; (Group II) SAH and one diagnosis, n = 509; (Group III) SAH and two diagnoses, n = 493; and (Group IV) SAH and three diagnoses, n = 66. One, two, and three diagnoses indicated occurrences of one, two, or three other types of intracranial hemorrhage (SDH, EDH, or ICH). The adjusted odds ratio with a 95% confidence interval (CI) of the level of mortality was calculated with logistic regression, controlling for sex, age, and pre-existing comorbidities. Patients with isolated traumatic SAH had a lower rate of mortality (1.8%) compared to the other three groups (Group II: 7.9%, Group III: 12.4%, and Group IV: 27.3%, all p < 0.001). When controlling for sex, age, and pre-existing comorbidities, we found that Group II, Group III, and Group IV patients had a 4.0 (95% CI 2.4-6.5), 8.9 (95% CI 4.8-16.5), and 21.1 (95% CI 9.4-47.7) times higher adjusted odds ratio for mortality, respectively, than the patients with isolated traumatic SAH. In this study, we demonstrated that compared to patients with isolated traumatic SAH, traumatic SAH patients with concurrent types of intracranial hemorrhage have a higher adjusted odds ratio for mortality.	[Rau, Cheng-Shyuan] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 83301, Taiwan; [Hsu, Shiun-Yuan; Liu, Hang-Tsung; Huang, Chun-Ying; Hsieh, Ting-Min; Chou, Sheng-En; Su, Wei-Ti] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Trauma Surg, Kaohsiung 83301, Taiwan; [Liu, Yueh-Wei] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Gen Gurgery, Kaohsiung 83301, Taiwan; [Hsieh, Ching-Hua] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan		Liu, YW (corresponding author), Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Gen Gurgery, Kaohsiung 83301, Taiwan.; Hsieh, CH (corresponding author), Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan.	ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; ah.lucy@hotmail.com; htl1688@yahoo.com.tw; junyinhaung@yahoo.com.tw; hs168hs168@gmail.com; athenechou@gmail.com; s101132@adm.cgmh.org.tw; anthony0612@adm.cgmh.org.tw; m93chinghua@gmail.com		WU, Shaochun/0000-0002-0984-6921; Hsieh, Ching-Hua/0000-0002-0945-2746	 [CMRPG8F1711];  [CMRPG8F1712];  [CMRPG8F1713]	This research was supported by a grant from CMRPG8F1711, CMRPG8F1712, and CMRPG8F1713 to Y.-W.L.	Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Boesiger BM, 2005, J EMERG MED, V29, P23, DOI 10.1016/j.jemermed.2005.02.002; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chartrain AG, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17448; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Diaz B, 2019, J EMERG TRAUMA SHOCK, V12, P173, DOI 10.4103/JETS.JETS_123_18; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Farion K, 2010, J MED SYST, V34, P551, DOI 10.1007/s10916-009-9268-7; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Hsieh CH, 2018, BIOMED J, V41, P321, DOI 10.1016/j.bj.2018.08.007; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Lee VH, 2014, NEUROCRIT CARE, V21, P14, DOI 10.1007/s12028-013-9952-9; Lin TK, 2012, J TRAUMA ACUTE CARE, V73, P131, DOI 10.1097/TA.0b013e31824aff74; Modi NJ, 2016, NEUROL INDIA, V64, P8, DOI 10.4103/0028-3886.178030; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Subic A, 2017, J INTERN MED, V281, P348, DOI 10.1111/joim.12588; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Witiw CD, 2018, CRIT CARE MED, V46, P430, DOI 10.1097/CCM.0000000000002931; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109	36	3	3	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2019	16	23							4787	10.3390/ijerph16234787			9	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	KC6HG	WOS:000507275700023	31795322	Green Published, gold			2022-02-06	
J	Solomon, D; Kaminski, O; Schrier, I; Kashtan, H; Stein, M				Solomon, Daniel; Kaminski, Oleg; Schrier, Ilan; Kashtan, Hanoch; Stein, Michael			Isolated Traumatic Brain Injury in the Very Old	ISRAEL MEDICAL ASSOCIATION JOURNAL			English	Article						decompressive craniectomy; epidural hematoma; octogenarians; subdural hematoma; traumatic brain injury	ELDERLY-PATIENTS; UNITED-STATES; MORTALITY; AGE; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; HEMATOMAS; ADULTS	Background: Older age is an independent predictor of worse outcome from traumatic brain injury (TB)). No clear guidelines exist for the management of TBI in elderly patients. Objectives: To describe the outcomes of elderly patients presenting with TBI and intracranial bleeding (ICB), comparing a very elderly population (>= 80 years of age) to a younger one (70-79). Methods: Retrospective analysis of the outcomes of elderly patients presenting with TBI with ICB admitted to a level I trauma center. Results: The authors analyzed 100 consecutive patients aged 70-79 and 100 patients aged 80 and older. In-hospital mortality rates were 9% and 21% for groups 70-79 and >= 80 years old, respectively (P = 0.017). Patients 70-79 years old showed a 12-month survival rate of 73% and a median survival of 47 months. In patients >= 80 years old, 12-month survival was 63% and median survival was 27 months (P = NS). In patients presenting with a Glasgow Coma Scale score of >= 8, the in-hospital mortality rates were 41% (n=5/12) and 100% (n=8/8). Among patients >= 80 years old undergoing emergent surgical decompression, in-hospital mortality was 66% (n=12/18). Survivors presented with a severe drop in their functional score. Survival was dismal in patients 80 years old who were treated conservatively despite recommended operative guidelines. Conclusions: There is a lack of reliable means to evaluate the outcome in patients with poor functional status at baseline. The negative prognostic impact of severe TB) is profound, regardless of treatment choices.	[Solomon, Daniel; Kaminski, Oleg; Schrier, Ilan; Kashtan, Hanoch; Stein, Michael] Rabin Med Ctr, Dept Surg, Beilinson Campus, IL-49100 Petah Tiqwa, Israel; [Solomon, Daniel; Kaminski, Oleg; Schrier, Ilan; Kashtan, Hanoch; Stein, Michael] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Solomon, D (corresponding author), Rabin Med Ctr, Dept Surg, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.	daniel.s985@gmail.com	Kashtan, Hanoch/AAU-4441-2021; Solomon, Daniel/AAK-5101-2020				Bouzat P, 2019, J NEUROTRAUM, V36, P2506, DOI 10.1089/neu.2019.6432; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; CDC Injury Center, 2016, TBI DAT STAT CONC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Marincowitz C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-028912; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Valadka AB, 2012, WORLD NEUROSURG, V78, P231, DOI 10.1016/j.wneu.2011.12.067; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084	23	3	3	0	0	ISRAEL MEDICAL ASSOC JOURNAL	RAMAT GAN	2 TWIN TOWERS, 11TH FL, 35 JABOTINSKY ST, PO BOX 3604, RAMAT GAN 52136, ISRAEL	1565-1088			ISR MED ASSOC J	Isr. Med. Assoc. J.	DEC	2019	21	12					779	784					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB8DV	WOS:000506720400002	31814339				2022-02-06	
J	Stephens, S; Campbell, R; Chaseling, R; Ma, N				Stephens, Sean; Campbell, Robert; Chaseling, Raymond; Ma, Norman			Traumatic brain injuries in a paediatric neurosurgical unit: A Queensland experience	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Hospitals; Paediatric; Skull fractures; Neurosurgery; Falls; Traffic injuries	HEAD TRAUMA; CHILDREN; EPIDEMIOLOGY	Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in children with a broad injury spectrum and associated continuum in the level of care required. A dearth of data exists regarding children requiring inpatient neurosurgical admission following TBI. A retrospective study of children 016 years-old admitted to the neurosurgical unit of a level-1 paediatric trauma hospital in Queensland, Australia following TBI was conducted focusing on the demographics, clinical characteristics, and management of these patients to guide those involved in their management, and identify areas for improvement in injury prevention and trauma system management. Over 48 months, 671 patients were identified (62.6% male) with median age 5.0 years, the majority transferred from peripheral centres. Falls (47.2%) and traffic accidents (21.5%) were the most common mechanisms. Non-displaced skull fracture was the most common injury. Moderate or severe TBI (GCS 3-12) was seen in 14.8% of whom were more likely to require surgery, intensive care, or suffer polytrauma. Clinically significant TBI, defined as moderate/severe TBI, polytrauma, death, requiring neurosurgery, intensive care admission, intubation, or admission three or more nights was detected in 57.97% with higher rates in transferred patients (62.9%) versus primary presentations (50.6%). Mechanisms involving low kinetic forces especially low-height falls and children with non-surgical pathology were less likely to meet criteria for clinically significant TBI. Opportunity exists to optimise triage and transfer practices within the trauma network to minimise the economic and social implications of over-triage with many children requiring only brief observation. Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.	[Stephens, Sean; Campbell, Robert; Chaseling, Raymond; Ma, Norman] Queensland Childrens Hosp, Neurosurg Dept, 501 Stanley St, South Brisbane, Qld 4101, Australia; [Stephens, Sean] Royal Brisbane & Womens Hosp, Neurosurg Dept, Herston, Qld, Australia		Stephens, S (corresponding author), 11 Arinya Rd, Ashgrove, Qld 4060, Australia.	seanchristopher.stephens@health.qld.gov.au					Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Collins NC, 2013, EMERG MED J, V30, P675, DOI 10.1136/emermed-2011-200496; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Gill PJ, 2015, CAN MED ASSOC J, V187, P1189, DOI 10.1503/cmaj.150949; Hewes HA, 2017, J TRAUMA ACUTE CARE, V83, P662, DOI 10.1097/TA.0000000000001560; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Tallapragada K, 2018, ANZ J SURG, V88, P202, DOI 10.1111/ans.14175; Tay EL, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0590-1; Yoon SY, 2017, J KOREAN NEUROSURG S, V60, P584, DOI 10.3340/jkns.2016.0707.008	16	3	4	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2019	70						27	32		10.1016/j.jocn.2019.09.008			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JS5QM	WOS:000500360600005	31537459				2022-02-06	
J	Sundaram, V; Ding, VY; Desai, M; Lumba-Brown, A; Little, J				Sundaram, Vandana; Ding, Victoria Y.; Desai, Manisha; Lumba-Brown, Angela; Little, Jessica			Reliable sideline ocular-motor assessment following exercise in healthy student athletes	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head injuries/concussion; Student athletes; Diagnostic; Dynamic visual schronization; Portable	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; CONCUSSION; EPIDEMIOLOGY; SPORTS; SYNCHRONIZATION	Objectives: To assess the reliability and effect of exercise on sideline dynamic visual performance measures of ocular-motor function using a portable visual assessment system (EYE-SYNC (R)). Design: Prospective cohort study. Methods: Healthy student athletes, ages 18-25 years, performed eye-tracking six times-three times consecutively prior to and after practice-using EYE-SYNC (R) goggles. Ocular-motor performance was assessed by calculating five gaze error outcomes between target position and actual gaze position to inform dynamic visual synchronization. We assessed reliability by calculating the intraclass correlation coefficient (ICC) for each outcome (we defined the standard deviation of tangential error (SDTE) as our primary outcome) and calculated differences in mean pre- and post-practice scores. Results: ICCs for the SDTE score were 0.86 (95% confidence interval, CI: 0.82-0.9) and 0.88 (0.84-0.91) at pre- and post-practice, respectively. 133 (89%) and 135 (90%) of 150 athletes had at least one measurement at pre- and post-practice, respectively. 117 (78%) and 122 (81%) athletes had more than one SDTE score at pre- and post-practice, respectively. The absolute mean (SD) differences between pre- and post-practice mean scores ranged from 0.02 (0.05) for horizontal gain to 0.1 (0.5) for SDTE. Conclusions: We observed high ICC scores indicating excellent reliability of visual synchronization measurements, suggesting that one measurement would be sufficient. Most athletes had similar scores before and after practice, indicating little change in visual performance following exercise. EYE-SYNC (R) goggles have the potential for use in obtaining objective visual performance measures of ocular-motor function for sideline assessment of concussion and return to play decisions. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd.	[Sundaram, Vandana; Ding, Victoria Y.; Desai, Manisha] Stanford Univ, Sch Med, Dept Med, Quantitat Sci Unit, Stanford, CA 94305 USA; [Lumba-Brown, Angela] Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA 94305 USA; [Little, Jessica] Stanford Univ, Sch Med, Dept Neurosurg, Stanford Concuss & Brain Performance Ctr, Stanford, CA 94305 USA		Sundaram, V (corresponding author), Stanford Univ, Sch Med, Dept Med, Quantitat Sci Unit, Stanford, CA 94305 USA.	sund@stanford.edu			U.S. Department of DefenseUnited States Department of Defense [W911QY-12-C-0005, W911QY-14-C-0086]; Department of DefenseUnited States Department of Defense; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 TR001085]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001085]	This work was supported by U.S. Department of Defense contracts W911QY-12-C-0005 and W911QY-14-C-0086. Dr Jamshid Ghajar MD, PhD is the Principal Investigator on both contracts. The Department of Defense had no involvement in the study design, the collection, analysis and interpretation of the data, the writing of the report or in the decision to submit the paper for publication. Dr. Ghajar was involved in the study design and review of the manuscript.; All authors received funding support from the Department of Defense and declare no other conflict of interest. Ms. Sundaram's spouse was a part-time paid consultant from November 2017 to March 2018 with SyncThink, Inc.; The REDCap platform services are made possible by Stanford School of Medicine Research Office. The REDCap platform services at Stanford are subsidized by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1 TR001085. The data content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lippman H., CONCUSSION PUBLIC HL; Maruta J, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00640; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Patel DR, 2017, TRANSL PEDIATR, V6, P114, DOI 10.21037/tp.2017.03.08; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; R Core Team, 2019, R LANG ENV STAT COMP; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	3	3	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	DEC	2019	22	12					1287	1291		10.1016/j.jsams.2019.07.015			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JT2OD	WOS:000500834200003	31445952	hybrid			2022-02-06	
J	Tate, RL				Tate, Robyn L.			Measuring outcomes and monitoring progress in the era of evidence-based clinical practice	BRAIN IMPAIRMENT			English	Article						Measurement; evidence-based assessment; International Classification of Functioning; Disability and Health; COSMIN; single-case methods; neurorehabilitation	TRAUMATIC BRAIN-INJURY; ICF CORE SETS; INTERNATIONAL CLASSIFICATION; METHODOLOGICAL QUALITY; SYSTEMATIC REVIEWS; COSMIN CHECKLIST; INSTRUMENTS; DISABILITY	Health outcome measurement is a growth industry. Thousands of behavioural assessment instruments, developed for neurological populations alone, are available for diagnosis, prediction and evaluation of interventions. The task of selecting the best instrument for the purpose at hand is thus a daunting one for the clinician and researcher. Fortunately, there are guides that make the task easier. This presidential address covers three interrelated themes that inform assessment in neurorehabilitation: First, it reviews current concepts and the status of behavioural assessment in neurorehabilitation. It then examines evidence-based clinical practice as applied to assessment of function, along with methods to benchmark the scientific quality of assessment instruments. Finally, the article considers the need to move beyond outcome measurement in the neurorehabilitation setting.	[Tate, Robyn L.] Univ Sydney, Fac Med & Hlth, John Walsh Ctr Rehabil Res, Kolling Inst Med Res, Sydney, NSW, Australia		Tate, RL (corresponding author), Univ Sydney, Fac Med & Hlth, John Walsh Ctr Rehabil Res, Kolling Inst Med Res, Sydney, NSW, Australia.	robyn.tate@sydney.edu.au					Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Coenen M, 2011, J NEUROL, V258, P1477, DOI 10.1007/s00415-011-5963-7; Evans JJ, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P49; Finger ME, 2012, DISABIL REHABIL, V34, P429, DOI 10.3109/09638288.2011.608145; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Grill E, 2011, J REHABIL MED, V43, P131, DOI 10.2340/16501977-0641; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Hunsley J, 2007, ANNU REV CLIN PSYCHO, V3, P29, DOI 10.1146/annurev.clinpsy.3.022806.091419; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Manolov R., 2015, RESOURCES GUIDELINES; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; Mokkink LB, 2018, QUAL LIFE RES, V27, P1171, DOI 10.1007/s11136-017-1765-4; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Pfaff A., 2004, MANUAL MODIFIE UNPUB; Rosenkoetter U, 2018, BRAIN IMPAIR, V19, P103, DOI 10.1017/BrImp.2017.29; Schellingerhout JM, 2012, QUAL LIFE RES, V21, P659, DOI 10.1007/s11136-011-9965-9; Scherer MJ, 2012, AGEING INT, V37, P414, DOI 10.1007/s12126-010-9093-9; Spoorenberg SLW, 2015, DISABIL REHABIL, V37, P2337, DOI 10.3109/09638288.2015.1024337; Tate R. L., BRAIN IMPAIRMENT; Tate R.L., 2019, SINGLE CASE EXPT DES; Tate R. L., 2014, UNDERSTANDING TRAUMA, P163; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Tate RL, 2020, NEUROPSYCHOL REHABIL, V30, P641, DOI 10.1080/09602011.2018.1488746; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Tate RL, 2008, BRAIN IMPAIR, V9, P282, DOI 10.1375/brim.9.3.282; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Wearne T, 2020, NEUROPSYCHOL REHABIL, V30, P973, DOI 10.1080/09602011.2018.1531768; World Health Organization, 2001, ICF INT CLASS FUNCT	31	3	3	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2019	20	3					276	288	PII S1443964619000287	10.1017/BrImp.2019.28			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	JX0OC	WOS:000503442500006					2022-02-06	
J	Manor, B; Zhou, JH; Lo, OY; Zhu, H; Gouskova, NA; Yu, WT; Zafonte, R; Lipsitz, LA; Travison, TG; Pascual-Leone, A				Manor, Brad; Zhou, Junhong; Lo, On-Yee; Zhu, Hao; Gouskova, Natalia A.; Yu, Wanting; Zafonte, Ross; Lipsitz, Lewis A.; Travison, Thomas G.; Pascual-Leone, Alvaro			Self-Reported Head Trauma Predicts Poor Dual Task Gait in Retired National Football League Players	ANNALS OF NEUROLOGY			English	Article							COGNITIVE RESERVE; OLDER-ADULTS; WALKING; VARIABILITY; ATTENTION	Objective Symptomatic head trauma associated with American-style football (ASF) has been linked to brain pathology, along with physical and mental distress in later life. However, the longer-term effects of such trauma on objective metrics of cognitive-motor function remain poorly understood. We hypothesized that ASF-related symptomatic head trauma would predict worse gait performance, particularly during dual task conditions (ie, walking while performing an additional cognitive task), in later life. Methods Sixty-six retired professional ASF players aged 29 to 75 years completed a health and wellness questionnaire. They also completed a validated smartphone-based assessment in their own homes, during which gait was monitored while they walked normally and while they performed a verbalized serial-subtraction cognitive task. Results Participants who reported more symptomatic head trauma, defined as the total number of impacts to the head or neck followed by concussion-related symptoms, exhibited greater dual task cost (ie, percentage increase) to stride time variability (ie, the coefficient of variation of mean stride time). Those who reported >= 1 hit followed by loss of consciousness, compared to those who did not, also exhibited greater dual task costs to this metric. Relationships between reported trauma and dual task costs were independent of age, body mass index, National Football League career duration, and history of musculoskeletal surgery. Symptomatic head trauma was not correlated with average stride times in either walking condition. Interpretation Remote, smartphone-based assessments of dual task walking may be utilized to capture meaningful data sensitive to the long-term impact of symptomatic head trauma in former professional ASF players and other contact sport athletes. ANN NEUROL 2019	[Manor, Brad; Zhou, Junhong; Lo, On-Yee; Zhu, Hao; Gouskova, Natalia A.; Yu, Wanting; Lipsitz, Lewis A.; Travison, Thomas G.; Pascual-Leone, Alvaro] Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, Boston, MA 02131 USA; [Manor, Brad; Zhou, Junhong; Lo, On-Yee; Gouskova, Natalia A.; Lipsitz, Lewis A.; Travison, Thomas G.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gerontol, Boston, MA 02215 USA; [Manor, Brad; Zhou, Junhong; Lo, On-Yee; Gouskova, Natalia A.; Zafonte, Ross; Lipsitz, Lewis A.; Travison, Thomas G.; Pascual-Leone, Alvaro] Harvard Med Sch, Boston, MA 02115 USA; [Zafonte, Ross] Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Autonomous Univ Barcelona, Guttmann Neurorehabil Inst, Badalona, Spain		Manor, B; Zhou, JH (corresponding author), Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, Boston, MA 02131 USA.	bradmanor@hsl.harvard.edu; junhongzhou@hsl.harvard.edu	Lo, On-Yee/AAE-6460-2019	Lo, On-Yee/0000-0002-7964-7717; Zhou, Junhong/0000-0002-7931-7646	FPHS at Harvard University; Harvard Catalyst j Harvard Clinical and Translational Science Center (NIH/National Center for Research Resources); Harvard Catalyst j Harvard Clinical and Translational Science Center (National Center for Advancing Translation Sciences) [UL1 RR025758]; NIH/NIA Boston Claude D. Pepper Older Americans Independence Center (OAIC) [P30 AG03167]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG059089-01]; United States-Israel Binational Science FoundationUS-Israel Binational Science Foundation; Marcus-Applebaum Foundation at Hebrew SeniorLife; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Science FoundationNational Science Foundation (NSF); Sidney R. Baer, Jr. Foundation; Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [HR001117S0030]	This work was primarily supported by the FPHS at Harvard University, the Harvard Catalyst j Harvard Clinical and Translational Science Center (NIH/National Center for Research Resources and National Center for Advancing Translation Sciences, UL1 RR025758), and the NIH/NIA Boston Claude D. Pepper Older Americans Independence Center (OAIC) (P30 AG031679). B.M. and J.Z. were also supported by grants from the NIH/NIA (R01 AG059089-01), the United States-Israel Binational Science Foundation, and the Marcus-Applebaum Foundation at Hebrew SeniorLife. A.P.-L. was also supported by grants from the NIH, National Science Foundation, Sidney R. Baer, Jr. Foundation, and Defense Advanced Research Projects Agency (DARPA; HR001117S0030). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Institutes of Health, NeuroNEXT, the Sidney R. Baer, Jr. Foundation, the FPHS, or DARPA.	Allali G, 2019, J GERONTOL A-BIOL, V74, P705, DOI 10.1093/gerona/gly123; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Beauchet O, 2017, GEROSCIENCE, V39, P439, DOI 10.1007/s11357-017-9992-8; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Grotz C, 2017, INT PSYCHOGERIATR, V29, P123, DOI 10.1017/S1041610216001745; Hamacher D, 2014, EXP BRAIN RES, V232, P3509, DOI 10.1007/s00221-014-4039-1; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Jor'dan AJ, 2020, J GERONTOL A-BIOL, V75, P1516, DOI 10.1093/gerona/glz006; Lee J, 2018, J EXERC REHABIL, V14, P993, DOI 10.12965/jer.1836402.201; Lo OY, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00390; Malcolm BR, 2015, NEUROIMAGE, V117, P230, DOI 10.1016/j.neuroimage.2015.05.028; Manor B, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8815; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mirelman A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-85; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Montero-Odasso M, 2019, J GERONTOL A-BIOL, V74, P897, DOI 10.1093/gerona/gly148; Montero-Odasso MM, 2017, JAMA NEUROL, V74, P857, DOI 10.1001/jamaneurol.2017.0643; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Ruffieux J, 2015, SPORTS MED, V45, P1739, DOI 10.1007/s40279-015-0369-9; Slater LV, 2017, J ATHL TRAINING, V52, P847, DOI 10.4085/1062-6050-52.6.06; Stern Y, 2018, ALZHEIMER DEMENT; Strike SC, 2009, GAIT POSTURE, V29, P597, DOI 10.1016/j.gaitpost.2008.12.015; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	31	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JAN	2020	87	1					75	83		10.1002/ana.25638		NOV 2019	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LS0BE	WOS:000499297400001	31693765	Green Published, hybrid			2022-02-06	
J	Taylor, MS; Zelinkova, V; Plancikova, D; Melichova, J; Sivco, P; Rusnak, M; Majdan, M				Taylor, M. S.; Zelinkova, V.; Plancikova, D.; Melichova, J.; Sivco, P.; Rusnak, M.; Majdan, M.			Seasonal patterns of traumatic brain injury deaths due to traffic-related incidents in the Slovak Republic	TRAFFIC INJURY PREVENTION			English	Article						TBI; Slovakia; season; traffic	EPIDEMIOLOGY; MORTALITY	Objective: Traumatic Brain Injuries (TBIs) are an important type of injury in terms of both morbidity and mortality. Road Traffic Incidents are one of the most frequent causes of TBI. This analysis seeks to quantify the number of such injuries occurring in the Slovak Republic, and examine patterns of TBI according to mode of transport and seasonality. Methods: Data concerning total numbers of TBIs occurring from the years 1996-2015 were obtained from the Statistical Office of the Slovak Republic. The events caused by road incidents were examined separately according the external cause stated on death certification. Events were classified into seasons according to the month of death. Summary statistics were produced concerning numbers of deaths according to sex, mode of transport and season. Analyses were performed to examine trends in TBI by season and type of road user. Results: During a period of 20 years from 1996, there were 17,047 recorded deaths involving TBI in the Slovak Republic. Of these, 5,370 were caused by road traffic incidents (RTIs). Age standardized rates tended to decrease from 8.3/100,000/year (1996) to 2.5/100,000/year (2015). Males made up approximately 79% of road traffic-caused TBIs. Summer and autumn showed significantly more events than any other season, with motorcyclists and cyclists in particular being more frequently injured at this time of year. Conclusions: The results show that Slovakia, like many countries, suffers a considerable burden of TBI and that RTIs are a major contributor to this, especially among young adults. Rates of TBI vary by season in Slovakia, and users of different modes of transport appear more or less likely to suffer such injury during different seasons. Considerable variability in rates of injury exists between road users and times of year. Improved understanding of the timing and sufferers of injuries may allow better planning of response and care services. Further research into transport modes and policies aimed at safer driving should be explored.	[Taylor, M. S.; Zelinkova, V.; Plancikova, D.; Melichova, J.; Sivco, P.; Rusnak, M.; Majdan, M.] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Univ Namestie 1, Trnava 91701, Slovakia		Taylor, MS (corresponding author), Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Univ Namestie 1, Trnava 91701, Slovakia.	marktrnava@gmail.com		Sivco, Patrik/0000-0002-3663-326X	European UnionEuropean Commission [602150]	MT, VZ, MM were employed as part of CENTER-TBI (Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury) supported by the European Union Seventh Framework program under grant agreement number 602150. No other funding or sponsorship was received in preparing this work.	Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Brazinova A, 2016, EUR J PUBLIC HEALTH, V26; Brazinova A, 2016, TRAFFIC INJ PREV, V17, P692, DOI 10.1080/15389588.2016.1143095; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Eurostat, 2013, REV EUR STAND POP; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; LYSHOLM J, 1987, AM J SPORT MED, V15, P168, DOI 10.1177/036354658701500213; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Shinsugi C, 2015, ENVIRON HEALTH PREV, V20, P36, DOI 10.1007/s12199-014-0421-7; Statisticky urad Slovenskej republiky, 2018, DAT CUB; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; WALTER SD, 1977, BRIT J PREV SOC MED, V31, P137; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; WorldHealthOrganization(WHO), 2019, GLOB HLTH OBS	20	3	3	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	JAN 2	2020	21	1					55	59		10.1080/15389588.2019.1666981		NOV 2019	5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	KK3UL	WOS:000500116400001	31790603				2022-02-06	
J	Avila, JA; Kiprowska, M; Jean-Louis, T; Rockwell, P; Figueiredo-Pereira, ME; Serrano, PA				Avila, Jorge A.; Kiprowska, Magdalena; Jean-Louis, Teneka; Rockwell, Patricia; Figueiredo-Pereira, Maria E.; Serrano, Peter A.			PACAP27 mitigates an age-dependent hippocampal vulnerability to PGJ2-induced spatial learning deficits and neuroinflammation in mice	BRAIN AND BEHAVIOR			English	Article						aging; CA1; CA3; Fluoro-Jade C; microglia; radial arm maze	TRAUMATIC BRAIN-INJURY; CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; MEDIATED FUNCTIONAL IMPROVEMENT; ALZHEIMERS-DISEASE; CYCLOPENTENONE PROSTAGLANDINS; MEMORY DEFICITS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); NEURODEGENERATIVE DISEASES; UBIQUITINATED PROTEINS	Background Inflammation in the brain is mediated by the cyclooxygenase pathway, which leads to the production of prostaglandins. Prostaglandin (PG) D2, the most abundant PG in the brain, increases under pathological conditions and is spontaneously metabolized to PGJ2. PGJ2 is highly neurotoxic, with the potential to transition neuroinflammation into a chronic state and contribute to neurodegeneration as seen in many neurological diseases. Conversely, PACAP27 is a lipophilic peptide that raises intracellular cAMP and is an anti-inflammatory agent. The aim of our study was to investigate the therapeutic potential of PACAP27 to counter the behavioral and neurotoxic effects of PGJ2 observed in aged subjects. Methods PGJ2 was injected bilaterally into the hippocampal CA1 region of 53-week-old and 12-week-old C57BL/6N male mice, once per week over 3 weeks (three total infusions) and included co-infusions of PACAP27 within respective treatment groups. Our behavioral assessments looked at spatial learning and memory performance on the 8-arm radial maze, followed by histological analyses of fixed hippocampal tissue using Fluoro-Jade C and fluorescent immunohistochemistry focused on IBA-1 microglia. Results Aged mice treated with PGJ2 exhibited spatial learning and long-term memory deficits, as well as neurodegeneration in CA3 pyramidal neurons. Aged mice that received co-infusions of PACAP27 exhibited remediated learning and memory performance and decreased neurodegeneration in CA3 pyramidal neurons. Moreover, microglial activation in the CA3 region was also reduced in aged mice cotreated with PACAP27. Conclusions Our data show that PGJ2 can produce a retrograde spread of damage not observed in PGJ2-treated young mice, leading to age-dependent neurodegeneration of hippocampal neurons producing learning and memory deficits. PACAP27 can remediate the behavioral and neurodegenerative effects that PGJ2 produces in aged subjects. Targeting specific neurotoxic prostaglandins, such as PGJ2, offers great promise as a new therapeutic strategy downstream of cyclooxygenases, to combat the neuronal deficits induced by chronic inflammation.	[Avila, Jorge A.; Serrano, Peter A.] CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA; [Avila, Jorge A.; Kiprowska, Magdalena; Jean-Louis, Teneka; Rockwell, Patricia; Figueiredo-Pereira, Maria E.; Serrano, Peter A.] CUNY, Grad Sch, New York, NY USA; [Kiprowska, Magdalena; Jean-Louis, Teneka; Rockwell, Patricia; Figueiredo-Pereira, Maria E.] CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA		Serrano, PA (corresponding author), CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA.; Figueiredo-Pereira, ME (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu; serrano@genectr.hunter.cuny.edu		Avila, Jorge A./0000-0003-4692-6645	NIH-NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MD007599, 1R21 MH109779]; Graduate Center, City University of New York; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RISE 5R25GM060665]	This project was supported in part by NIH-NIMH grant MD007599 to Hunter College, grant 1R21 MH109779 to PAS, NIH Training Grant RISE 5R25GM060665 to JAA and TJL, and the Graduate Center, City University of New York.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Ago Y, 2011, NEUROSCIENCE, V172, P554, DOI 10.1016/j.neuroscience.2010.10.044; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Avila JA, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00509; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; BEATTY WW, 1985, NEUROBIOL AGING, V6, P219, DOI 10.1016/0197-4580(85)90053-3; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Brelstaff J, 2018, CELL REP, V24, P1939, DOI 10.1016/j.celrep.2018.07.072; Brifault C, 2015, STROKE, V46, P520, DOI 10.1161/STROKEAHA.114.006864; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chivet M, 2013, BIOCHEM SOC T, V41, P241, DOI 10.1042/BST20120266; Corwin C, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1305-3; Cudaback E, 2014, BIOCHEM PHARMACOL, V88, P565, DOI 10.1016/j.bcp.2013.12.014; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Daumas S, 2008, LEARN MEMORY, V15, P625, DOI 10.1101/lm.990208; Dejda A, 2011, PEPTIDES, V32, P1207, DOI 10.1016/j.peptides.2011.04.003; Delgado M, 1999, J BIOL CHEM, V274, P31930, DOI 10.1074/jbc.274.45.31930; Delgado M, 1999, J IMMUNOL, V162, P1707; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; Figueiredo-Pereira ME, 2016, ANN NY ACAD SCI, V1363, P125, DOI 10.1111/nyas.12987; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Han PC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00180; Han PC, 2015, JAMA NEUROL, V72, P333, DOI 10.1001/jamaneurol.2014.3625; Han PC, 2014, NEUROBIOL AGING, V35, P2064, DOI 10.1016/j.neurobiolaging.2014.03.022; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Heckman P. R., 2017, AGE RELATED COGNITIV, P135; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hou Y, 2014, PROG NEURO-PSYCHOPH, V54, P92, DOI 10.1016/j.pnpbp.2014.03.015; Iadecola C, 2005, STROKE, V36, P182, DOI 10.1161/01.STR.0000153797.33611.d8; IWAMOTO N, 1989, J NEUROL, V236, P80, DOI 10.1007/BF00314401; JARRARD LE, 1978, J COMP PHYSIOL PSYCH, V92, P1119, DOI 10.1037/h0077516; Joo KM, 2004, J COMP NEUROL, V476, P388, DOI 10.1002/cne.20231; Kerfoot EC, 2007, LEARN MEMORY, V14, P581, DOI 10.1101/lm.627007; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kiprowska MJ, 2017, BBA-MOL BASIS DIS, V1863, P1157, DOI 10.1016/j.bbadis.2017.03.017; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Lee DR, 2009, TOXICOLOGY, V258, P17, DOI 10.1016/j.tox.2009.01.001; Lee S, 2018, KOREAN J ANESTHESIOL, V71, P353, DOI 10.4097/kja.d.18.00242; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; Li ZM, 2004, BIOCHEM BIOPH RES CO, V319, P1171, DOI 10.1016/j.bbrc.2004.05.098; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Liu H, 2013, NEUROTOX RES, V24, P191, DOI 10.1007/s12640-013-9377-4; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Luo WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11161; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MacDonald JF, 2007, BBA-BIOMEMBRANES, V1768, P941, DOI 10.1016/j.bbamem.2006.12.006; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Merlo S, 2017, EUR J PHARMACOL, V817, P51, DOI 10.1016/j.ejphar.2017.05.059; Metcalfe MJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.70; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; Moody TW, 2011, CURR OPIN ENDOCRINOL, V18, P61, DOI 10.1097/MED.0b013e328342568a; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P500; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ogata K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120526; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Paulitschke V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046103; Paxinos G., 2001, MOUSE BRAIN STEREOTA, P160; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierre SR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-18; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; Roberto M, 2001, LEARN MEMORY, V8, P265, DOI 10.1101/lm.40501; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Schwab JM, 2004, CELL DEATH DIFFER, V11, P1245, DOI 10.1038/sj.cdd.4401487; Sebastian V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081121; Sebastian V, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00038; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Sevenich L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00697; Shivers KY, 2014, BBA-MOL BASIS DIS, V1842, P1707, DOI 10.1016/j.bbadis.2014.06.020; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Smith BM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00142; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; Stephens ML, 2011, NEUROBIOL AGING, V32, P811, DOI 10.1016/j.neurobiolaging.2009.05.009; STEWART J, 1989, NEUROBIOL AGING, V10, P669, DOI 10.1016/0197-4580(89)90003-1; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; SUZUKI F, 1986, BRAIN RES, V385, P321, DOI 10.1016/0006-8993(86)91079-6; Tanaka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-143; Tsukiyama N, 2011, STRESS, V14, P368, DOI 10.3109/10253890.2010.544345; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; WALLACE JE, 1980, J GERONTOL, V35, P355, DOI 10.1093/geronj/35.3.355; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Yagami T, 2006, CURR NEUROPHARMACOL, V4, P87, DOI 10.2174/157015906775203011; Yang RQ, 2015, CELL MOL BIOL LETT, V20, P265, DOI 10.1515/cmble-2015-0008; Zhang F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0529-3; Zhang JF, 2014, NEURON, V82, P195, DOI 10.1016/j.neuron.2014.01.043; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011	120	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JAN	2020	10	1							e01465	10.1002/brb3.1465		NOV 2019	18	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	KC0AM	WOS:000499061200001	31769222	gold, Green Published			2022-02-06	
J	Ma, GX; Liu, CY; Hashim, J; Conley, G; Morriss, N; Meehan, WP; Qiu, JH; Mannix, R				Ma, Guixian; Liu, Changyun; Hashim, Jumana; Conley, Grace; Morriss, Nicholas; Meehan, William P.; Qiu, Jianhua; Mannix, Rebekah			Memantine Mitigates Oligodendrocyte Damage after Repetitive Mild Traumatic Brain Injury	NEUROSCIENCE			English	Article						traumatic brain injury; oligodendrocytes; white matter injury; NMDAR	NEUROFILAMENT LIGHT PROTEIN; GLUTATHIONE-S-TRANSFERASE; WHITE-MATTER; NMDA RECEPTORS; AXONAL INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; MYELIN; GLUTAMATE; NEURODEGENERATION	Repetitive mild traumatic brain injury (rmTBI; e.g., sports concussions) is common and results in significant cognitive impairment, white matter injury and increased risk of neurodegeneration. Targeted therapies for rmTBI are lacking, though evidence from other injury models indicates that targeting N-methyl-D-aspartate (NMDA) receptor (NMDAR)-mediated glutamatergic toxicity might mitigate rmTBI-induced injury. We have previously shown that the NMDAR antagonist memantine lessens axonal injury and restores long term potentiation after rmTBI. Here, we evaluated whether the protective effects of memantine include oligodendrocyte specific mechanisms, as prior studies suggest that oligodendrocytes are particularly vulnerable to glutamatergic toxicity. Mice were subjected to rmTBI injury (5 injuries in 5 days) and randomized to treatment with memantine or with vehicle (n = 32/group). At the molecular level, oligodendrocyte counts and function (myelin basic protein, MBP) were assessed by immunohistochemistry and western blot at days 3, 7 and 28 days after the last injury. Axon integrity was assessed by neurofilament light chain (NF-l) expression and axonal ultrastructure was evaluated by electron microscopy. Compared to vehicle-treated mice, memantine-treated mice were protected against oligodendrocyte loss and decreased MBP expression at subacute time points after injury. Memantine treatment also protected against axon damage assessed by NF-l expression. These data suggest that the therapeutic effects of post-concussive NMDAR antagonism may in part work through oligodendrocyte specific mechanisms, which may have implications for long term neurodegenerative sequelae after multiple concussions. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Ma, Guixian] Guangdong Prov Peoples Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Ma, Guixian] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Hashim, Jumana; Conley, Grace; Morriss, Nicholas; Qiu, Jianhua; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Meehan, William P.; Qiu, Jianhua; Mannix, Rebekah] Harvard Med Sch, Boston, MA 02115 USA; [Liu, Changyun] Fujian Med Univ, Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China; [Meehan, William P.] Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Mannix, Rebekah/0000-0003-3608-2792	CHB IDDRC; National Football League; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament	This work was supported in part by funding from the CHB IDDRC and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and the National Football League.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Beconi Maria G, 2011, PLoS Curr, V3, pRRN1291, DOI 10.1371/currents.RRN1291; Bonfanti E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.256; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Burzomato V, 2010, J PHYSIOL-LONDON, V588, P3403, DOI 10.1113/jphysiol.2010.195503; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Campana WM, 2017, FASEB J, V31, P1744, DOI 10.1096/fj.201601121R; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Coman L, 2005, J NEUROL SCI, V233, P67, DOI 10.1016/j.jns.2005.03.029; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Fehily B, 2019, J NEUROCHEM, V149, P660, DOI 10.1111/jnc.14673; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Fournier AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131617; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kirkcaldie MTK, 2016, J CHEM NEUROANAT, V76, P9, DOI 10.1016/j.jchemneu.2016.05.006; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Liu XX, 2017, J NEUROTRAUM, V34, P2445, DOI 10.1089/neu.2016.4823; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lopez-Valdes HE, 2014, STROKE, V45, P2093, DOI 10.1161/STROKEAHA.113.004476; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Ma JY, 2015, NEUROBIOL AGING, V36, P2544, DOI 10.1016/j.neurobiolaging.2015.05.017; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; Mannix R, 2014, J NEUROSURG, P1; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mei Z, 2017, BEHAV BRAIN RES; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Noel A, 2016, LIFE SCI, V158, P14, DOI 10.1016/j.lfs.2016.06.020; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Saab BJ, 2011, PHARMACOLOGY, V88, P284, DOI 10.1159/000332829; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sukhanov IM, 2004, BEHAV PHARMACOL, V15, P263, DOI 10.1097/01.fbp.0000137212.03247.f1; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Swiatkowski P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01826-w; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; TANSEY FA, 1991, J NEUROCHEM, V57, P95, DOI 10.1111/j.1471-4159.1991.tb02104.x; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wang YC, 2017, J CEREBR BLOOD F MET, V37, P980, DOI 10.1177/0271678X16648971; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8	72	3	3	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 21	2019	421						152	161		10.1016/j.neuroscience.2019.10.016			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JQ1DR	WOS:000498694400014	31682950				2022-02-06	
J	Karr, JE; Luoto, TM; Gilman, IG; Berghem, K; Kotilainen, AK; Iverson, GL				Karr, Justin E.; Luoto, Teemu M.; Gilman, Isabelle G.; Berghem, Ksenia; Kotilainen, Anna-Kerttu; Iverson, Grant L.			Age, symptoms, and functional outcome after mild traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						aged; brain concussion; head injuries: closed; outcome assessment (health care); post-concussion syndrome	CLOSED-HEAD INJURY; GLASGOW COMA SCALE; OLDER-ADULTS; NEUROBEHAVIORAL CONSEQUENCES; COGNITIVE IMPAIRMENT; FALL RISK; QUESTIONNAIRE; MODERATE; PEOPLE; EPIDEMIOLOGY	ObjectivesPrevious older adult studies have examined outcome from moderate-to-severe traumatic brain injury (TBI), but fewer have focused on the effects of milder brain injuries. This study examined age-related differences in symptom reporting and whether symptoms are differentially related to functional outcome based on age. Materials & MethodsPatients presenting with a head injury at the Tampere University Hospital emergency department (N = 325, aged 18-100) were evaluated at 1 week post injury on the Modified Rankin Scale and Rivermead Post Concussion Symptoms Questionnaire (RPQ). ResultsA quarter of participants had missing RPQ data, with missingness associated with greater age and strongly associated with pre-existing functional impairment, dementia, and/or neurological conditions. Among participants with complete data, participants <65 years old endorsed headaches, noise/light sensitivity, irritability, and frustration/impatience at a greater frequency than participants >= 65 years old. However, no differences were found in the number of symptoms endorsed or the total symptom severity score. The correlations between the severity of symptoms and change in function were similar between the two age groups. ConclusionsOlder adults tended to report fewer symptoms, but symptoms had a roughly equivalent relationship with declines in functioning across age groups. A large percentage of older adults in this study had pre-injury dementia or neurological disease that contributed to missing data on the 1-week outcome measures. The results provide insight into the impact of mild spectrum TBI on older adults compared to younger patients.	[Karr, Justin E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Boston, MA 02129 USA; [Karr, Justin E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Karr, Justin E.; Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Karr, Justin E.; Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Karr, Justin E.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland; [Gilman, Isabelle G.] Villanova Univ, Dept Psychol & Brain Sci, Villanova, PA 19085 USA; [Berghem, Ksenia] Tampere Univ Hosp, Med Imaging Ctr, Dept Radiol, Tampere, Finland; [Kotilainen, Anna-Kerttu] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland		Karr, JE (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Boston, MA 02129 USA.	jkarr1@mgh.harvard.edu	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Iverson, Grant/0000-0001-7348-9570; Karr, Justin/0000-0003-3653-332X	Finnish State Research Funding; Finnish Medical Society Duodecim	The study was financially supported by the Finnish State Research Funding and the Finnish Medical Society Duodecim.	AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Harlein J, 2009, J ADV NURS, V65, P922, DOI 10.1111/j.1365-2648.2008.04950.x; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hu TN, 2017, CAN J NEUROL SCI, V44, P384, DOI 10.1017/cjn.2016.441; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Kojima G, 2015, J AM MED DIR ASSOC, V16, P1027, DOI 10.1016/j.jamda.2015.06.018; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RANKIN J, 1957, Scott Med J, V2, P200; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111378; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; World Health Organization, 1992, ICD 10 CLASSIFICATIO	36	3	3	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	FEB	2020	141	2					183	190		10.1111/ane.13190		NOV 2019	8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JZ9ZM	WOS:000497329100001	31693184				2022-02-06	
J	Kelman, JC; Hodge, C; Stanwell, P; Mustafic, N; Fraser, CL				Kelman, Julian C.; Hodge, Christopher; Stanwell, Peter; Mustafic, Nina; Fraser, Clare L.			Retinal nerve fibre changes in sports-related repetitive traumatic brain injury	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						concussive trauma; imaging system; neuro-imaging; neuro-ophthalmic disease; retinal degeneration	MILD COGNITIVE IMPAIRMENT; WHITE-MATTER; LAYER THICKNESS; OPTIC-NERVE; HEAD TRAUMA; CONCUSSION; ENCEPHALOPATHY; PLAYERS; IMPACT	Importance There is limited literature on the use of optical coherence tomography in the assessment of retinal nerve fibre layer (RNFL) thickness in sports-related repetitive mild traumatic brain injury. Background To evaluate RNFL thickness in professional rugby league players. RNFL thinning may serve as a proxy for wider white matter degeneration. Design Cross-sectional observational study. Participants Thirteen retired Australian professional rugby league players were recruited. Methods Participants underwent binocular optical coherence tomography to measure RNFL thickness. Each participant underwent a complete ophthalmic assessment to exclude concurrent disease. Main Outcome Measures RNFL thickness of each eye were compared with a normative database. Results Participants had played professional Rugby League for 18 years on average and reported sustaining 15 sports-related concussions throughout their career. The RNFL in participants was four micrometres thinner than that of matched normative data. Cohort average RNFL thickness was reduced in 12 out of 14 optical coherence testing parameters. These findings were statistically significant in the left inferonasal [P = .013] and left nasal [P = .006] sectors. There was no statistically significant relationship between RNFL thickness and other visual measures. Conclusions and Relevance This study is the first to demonstrate RNFL thinning in a cohort of retired Australian professional Rugby League players. RNFL changes have been shown to correlate with cerebral white matter loss and neurodegeneration. Optical coherence tomography may serve as a safe and economical means of screening for repetitive traumatic brain injury related neurodegeneration in contact sport athletes.	[Kelman, Julian C.; Hodge, Christopher; Mustafic, Nina; Fraser, Clare L.] Univ Sydney, Save Sight Inst, Fac Med & Hlth, Sydney, NSW, Australia; [Hodge, Christopher] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia; [Stanwell, Peter] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW, Australia		Kelman, JC (corresponding author), Univ Sydney, Save Sight Inst, Fac Med & Hlth, Sydney, NSW, Australia.	julian.kelman@icloud.com	Stanwell, Peter/F-9136-2012	Stanwell, Peter/0000-0002-4780-0393; Fraser, Clare/0000-0002-0379-7743; Mustafic, Nina/0000-0002-5756-0506; Kelman, Julian/0000-0002-4362-4302			Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Chan VTT, 2019, OPHTHALMOLOGY, V126, P497, DOI 10.1016/j.ophtha.2018.08.009; Childs C, 2018, EYE BRAIN, V10, P101, DOI 10.2147/EB.S183042; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Debacker J, 2018, HAND CLINIC, V158, P145, DOI 10.1016/B978-0-444-63954-7.00015-X; FDA, 2010, SPECTR HRA OCT 510K; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Ko F, 2018, JAMA NEUROL, V75, P1198, DOI 10.1001/jamaneurol.2018.1578; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Leong D, 2018, J NEURO-OPHTHALMOL, V38, P285, DOI 10.1097/WNO.0000000000000572; Liao H, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00188; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miller G, 2009, SCIENCE, V325, P670, DOI 10.1126/science.325_670; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mutlu U, 2018, JAMA NEUROL, V75, P1256, DOI 10.1001/jamaneurol.2018.1563; Mutlu U, 2017, NEUROBIOL AGING, V60, P183, DOI 10.1016/j.neurobiolaging.2017.09.003; O'Caoimh R, 2012, AGE AGEING, V41, P624, DOI 10.1093/ageing/afs059; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Perrine K, 2017, WORLD NEUROSURG, V102, P533, DOI 10.1016/j.wneu.2017.02.084; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shi ZY, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00069; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014	43	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1442-6404	1442-9071		CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	MAR	2020	48	2					204	211		10.1111/ceo.13673		NOV 2019	8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	KU2CW	WOS:000497286800001	31691473				2022-02-06	
J	Manderino, LM; Zachman, AM; Gunstad, J				Manderino, Lisa M.; Zachman, Angela M.; Gunstad, John			Novel ImPACT validity indices in collegiate student-athletes with and without histories of ADHD or academic difficulties	CLINICAL NEUROPSYCHOLOGIST			English	Article						Assessment; head injury; traumatic brain injury; malingering; symptom validity testing	TEST-PERFORMANCE; CONCUSSION; INJURY; MTBI	Objective: Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) assesses neurocognitive functioning in sports-related concussion. Previous work demonstrates ImPACT?s validity indices detect poor effort at disproportionately higher rates in athletes with histories of attention deficit hyperactivity disorder (ADHD) or academic difficulties. The present study examines whether previously suggested ?dormant? validity indices, Word Memory Correct Distractors (WMCD), and Design Memory Correct Distractors (DMCD), reduce disproportionate invalidity in collegiate athletes with such histories.Method: Six seasons of ImPACT protocols were examined (n?=?1727). Athletes were grouped by self-reported histories of ADHD, academic difficulties, or comorbid ADHD and academic difficulties. Chi-square analyses compared invalidity rates using existing validity indices and both standard and conservative cutoffs for WMCD and DMCD.Results: Using standard cutoffs for dormant indices (WMCD?<?22, DMCD?<?16) produced significant differences in rates of athletes identified as having an invalid protocol, with the comorbid group exhibiting the highest invalidity rate (63.2%) and the no history group producing the lowest (42.0%), ?(2) (3)?=?11.57, p?<?.01, Cramer?s V?=?0.08. This difference remained when utilizing conservative cutoffs (WMCD?<?18, DMCD?<?10), with the comorbid group again producing the highest (26.3%) and the no history group producing the lowest (10.4%), ?(2) (3)?=?15.64, p?<? .005, Cramer?s V?=?0.10.Conclusions: Student-athletes with self-reported histories of ADHD and academic difficulties are more likely to produce invalid protocols, even with dormant indices. These findings emphasize the difficulty in assessing validity in special populations of athletes and encourage further work in this area.	[Manderino, Lisa M.; Zachman, Angela M.; Gunstad, John] Kent State Univ, Dept Psychol Sci, 144 Kent Hall, Kent, OH 44242 USA		Manderino, LM (corresponding author), Kent State Univ, Dept Psychol Sci, 144 Kent Hall, Kent, OH 44242 USA.	lmanderi@kent.edu					Bayley PJ, 2008, J COGNITIVE NEUROSCI, V20, P505, DOI 10.1162/jocn.2008.20038; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Dan O, 2015, J ATTEN DISORD, V19, P231, DOI 10.1177/1087054712454571; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Johnson E, 2014, ARCH CLIN NEUROPSYCH, V29, P590; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M. R., 2016, IMPACT ADM INTERPRET; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Manderino LM, 2018, ARCH CLIN NEUROPSYCH, V33, P596, DOI 10.1093/arclin/acx102; Manderino L. M., 2017, CLIN J SPORT MED, V28, P1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schindler Sebastian, 2013, BMC Psychol, V1, P12, DOI 10.1186/2050-7283-1-12; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732	20	3	3	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 17	2019	33	8			SI		1455	1466		10.1080/13854046.2018.1539191			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JH1IM	WOS:000492525700009	30516427				2022-02-06	
J	Langevin, P; Fait, P; Fremont, P; Roy, JS				Langevin, Pierre; Fait, Philippe; Fremont, Pierre; Roy, Jean-Sebastien			Cervicovestibular rehabilitation in adult with mild traumatic brain injury: a randomised controlled trial protocol	BMC SPORTS SCIENCE MEDICINE AND REHABILITATION			English	Article						Mild traumatic brain injury; Neck pain; Dizziness; Cervical spine; Vestibular system; Function; Persistent post-concussion symptoms; Gradual activation	SPORTS-RELATED CONCUSSION; NECK DISABILITY INDEX; PSYCHOMETRIC PROPERTIES; POSTURAL CONTROL; TASK-FORCE; DIZZINESS; RELIABILITY; SYMPTOMS; DISORDERS; SCALES	BackgroundMild traumatic brain injury (mTBI) is an acknowledged public health problem. Up to 25% of adult with mTBI present persistent symptoms. Headache, dizziness, nausea and neck pain are the most commonly reported symptoms and are frequently associated with cervical spine and vestibular impairments. The most recent international consensus statement (2017 Berlin consensus) recommends the addition of an individualized rehabilitation approach for mTBI with persistent symptoms. The addition of an individualized rehabilitation approach including the evaluation and treatment of cervical and vestibular impairments leading to symptoms such as neck pain, headache and dizziness is, however, recommended based only on limited scientific evidence. The benefit of such intervention should therefore be further investigated.ObjectiveTo compare the addition of a 6-week individualized cervicovestibular rehabilitation program to a conventional approach of gradual sub-threshold physical activation (SPA) alone in adults with persistent headache, neck pain and/or dizziness-related following a mTBI on the severity of symptoms and on other indicators of clinical recovery. We hypothesize that such a program will improve all outcomes faster than a conventional approach (between-group differences at 6-week and 12-week).MethodsIn this single-blind, parallel-group randomized controlled trial, 46 adults with subacute (3 to12 weeks post-injury) persistent mTBI symptoms will be randomly assigned to: 1) a 6-week SPA program or 2) SPA combined with a cervicovestibular rehabilitation program. The cervicovestibular rehabilitation program will include education, cervical spine manual therapy and exercises, vestibular rehabilitation and home exercises. All participants will take part in 4 evaluation sessions (baseline, week 6, 12 and 26) performed by a blinded evaluator. The primary outcome will be the Post-Concussion Symptoms Scale. The secondary outcomes will be time to clearance to return to function, number of recurrent episodes, Global Rating of Change, Numerical Pain Rating Scale, Neck Disability Index, Headache Disability Inventory and Dizziness Handicap Inventory. A 2-way ANOVA and an intention-to-treat analysis will be used.DiscussionControlled trials are needed to determine the best rehabilitation approach for mTBI with persistent symptoms such as neck pain, headache and dizziness. This RCT will be crucial to guide future clinical management recommendations.	[Langevin, Pierre; Fait, Philippe] Clin Cortex & Physio Interact, 205-1035 Ave Wilfrid Pelletier, Quebec City, PQ G1W 0C5, Canada; [Langevin, Pierre; Fremont, Pierre; Roy, Jean-Sebastien] Univ Laval, Fac Med, Dept Rehabil, Pavillon Ferdinand Vandry,1050,Ave Med,Bur 4431, Quebec City, PQ G1R 1P5, Canada; [Langevin, Pierre; Fait, Philippe; Roy, Jean-Sebastien] Quebec Rehabil Inst CIRRIS, Ctr Interdisciplinary Res Rehabil & Social Integr, 525 Blvd Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Human Kinet, 3351 Blvd Forges, Trois Rivieres, PQ G8Z 4M3, Canada; [Fait, Philippe] Res Ctr Neuropsychol & Cognit CERNEC, Pavillon Marie Victorin,90,Rue Vincent dIndy, Montreal, PQ H2V 2S9, Canada		Langevin, P (corresponding author), Clin Cortex & Physio Interact, 205-1035 Ave Wilfrid Pelletier, Quebec City, PQ G1W 0C5, Canada.; Langevin, P (corresponding author), Univ Laval, Fac Med, Dept Rehabil, Pavillon Ferdinand Vandry,1050,Ave Med,Bur 4431, Quebec City, PQ G1R 1P5, Canada.	pierre.langevin@fmed.ulaval.ca	Langevin, Pierre/AAH-1937-2021	Langevin, Pierre/0000-0003-4339-3687; Fremont, Pierre/0000-0003-2810-8382; Roy, Jean-Sebastien/0000-0003-2853-9940	Reseau Provincial de Recherche en Adaptation-Readaptation (REPAR); Ordre Professionnel de la physiotherapie du Quebec (OPPQ)	Funding was provided by the Reseau Provincial de Recherche en Adaptation-Readaptation (REPAR) and by the Ordre Professionnel de la physiotherapie du Quebec (OPPQ). Trial sponsors are REPAR(repar.irglm@ssss.gouv.qc.ca) and OPPQ (physio@oppq.qc.ca).The funding agency/sponsor had no role in the study design, writing the manuscript, or in the decision to submit for publication.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Belley AF, 2018, J ORTHOP SPORT PHYS, V48, P541, DOI 10.2519/jospt.2018.7871; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Blanpied Peter R, 2017, J Orthop Sports Phys Ther, V47, pA1, DOI 10.2519/jospt.2017.0302; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cleland JA, 2008, ARCH PHYS MED REHAB, V89, P69, DOI 10.1016/j.apmr.2007.08.126; Cook C, 2005, PHYSIOTHER RES INT, V10, P59, DOI 10.1002/pri.27; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Esculier JF, 2018, BRIT J SPORT MED, V52, P659, DOI 10.1136/bjsports-2016-096988; Gross AR, 2004, SPINE, V29, P1541, DOI 10.1097/01.BRS.0000131218.35875.ED; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Herdman SJ, 2007, ARCH OTOLARYNGOL, V133, P383, DOI 10.1001/archotol.133.4.383; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JACOBSON GP, 1995, HEADACHE, V35, P534, DOI 10.1111/j.1526-4610.1995.hed3509534.x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kontos AP, 2004, J APPL SPORT PSYCHOL, V16, P220, DOI 10.1080/10413200490485568; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Langevin P, 2015, J ORTHOP SPORT PHYS, V45, P4, DOI 10.2519/jospt.2015.5211; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDonnell MN, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub4; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Miller J, 2010, MANUAL THER, V15, P334, DOI 10.1016/j.math.2010.02.007; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Sara RPA, 2006, MANUAL THER, V11, P321, DOI 10.1016/j.math.2005.09.001; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Roos M, 2018, CLIN REHABIL, V32, P1656, DOI 10.1177/0269215518785000; Schneider GM, 2013, ARCH PHYS MED REHAB, V94, P1628, DOI 10.1016/j.apmr.2013.02.015; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Shaked D, 2020, APPL NEUROPSYCH-ADUL, V27, P478, DOI 10.1080/23279095.2019.1570199; Treleaven J, 2006, AUST J PHYSIOTHER, V52, P67, DOI 10.1016/S0004-9514(06)70070-8; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Varatharajan S, 2016, EUR SPINE J, V25, P1971, DOI 10.1007/s00586-016-4376-9; von Piekartz H, 2011, CRANIO, V29, P43, DOI 10.1179/crn.2011.008; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weschsler D, 1995, MEASUREMENT ADULT IN; Wlodyka-Demaille S, 2002, ARCH PHYS MED REHAB, V83, P376, DOI 10.1053/apmr.2002.30623; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	3	3	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-1847			BMC SPORTS SCI MED R	BMC Sports Sci. Med. Rehabil.	NOV 11	2019	11	1							25	10.1186/s13102-019-0139-3			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JL7SX	WOS:000495730200001	31737275	Green Published, gold			2022-02-06	
J	Register-Mihalik, JK; Guskiewicz, KM; Marshall, SW; McCulloch, KL; Mihalik, JP; Mrazik, M; Murphy, I; Naidu, D; Ranapurwala, SI; Schneider, K; Gildner, P; McCrea, M; Mrazik, M; Salmon, D; Auton, B; Ketcham, CJ; Hall, EE; Bowman, TG; Wesley, CA; Jewell, E; Hynes, L				Register-Mihalik, Johna K.; Guskiewicz, Kevin M.; Marshall, Stephen W.; McCulloch, Karen L.; Mihalik, Jason P.; Mrazik, Martin; Murphy, Ian; Naidu, Dhiren; Ranapurwala, Shabbar, I; Schneider, Kathryn; Gildner, Paula; McCrea, Michael; Mrazik, Marty; Salmon, Danielle; Auton, Brandon; Ketcham, Caroline J.; Hall, Eric E.; Bowman, Thomas G.; Wesley, Caroline A.; Jewell, Elizabeth; Hynes, Loriann		Active Rehab Study Consortium Inve	Methodology and Implementation of a Randomized Controlled Trial (RCT) for Early Post-concussion Rehabilitation: The Active Rehab Study	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; exercise; clinical intervention; post-concussion activity; return to play	SPORT-RELATED CONCUSSION; CERVICOVESTIBULAR REHABILITATION; INTERNATIONAL-CONFERENCE; DUAL-TASK; EXERCISE; RELIABILITY; ADOLESCENTS; BALANCE; MEMBERS; ZURICH	Background: Sports-related concussion (SRC) is a complex injury with heterogeneous presentation and management. There are few studies that provide guidance on the most effective and feasible strategies for recovery and return to sports participation. Furthermore, there have been no randomized studies of the feasibility, safety, and efficacy of early rehabilitation strategies across multiple sports and age groups. This international cluster-randomized pragmatic trial evaluates the effectiveness of early multi-dimensional rehabilitation integrated with the current return to sport strategy vs. the current return to sport strategy alone. Methods: The study is a cluster-randomized pragmatic trial enrolling male and female athletes from 28 sites. The sites span three countries, and include multiple sports, levels of play (high school, college, and professional), and levels of contact. The two study arms are Enhanced Graded Exertion (EGE) and Multidimensional Rehabilitation (MDR). The EGE arm follows the current return to sport strategy and the MDR arm integrates early, MDR strategies in the context of the current return to sport strategy. Each arm employs a post-injury protocol that applies to all athletes from that site in the event they sustain a concussion during their study enrollment. Participants are enrolled at pre-season baseline. Assessment timepoints include pre-season baseline, time of injury (concussion), 24-48 h post-injury, asymptomatic, and 1-month post-injury. Symptoms and activity levels are tracked post injury through the return to play process and beyond. Injury and recovery characteristics are obtained for all participants. Primary endpoints include time to medical clearance for full return to sport and time to become asymptomatic. Secondary endpoints include symptom, neurocognitive, mental status, balance, convergence insufficiency, psychological distress, and quality of life trajectories post-injury. Discussion: Outputs from the trial are expected to inform both research and clinical practice in post-concussion rehabilitation across all levels of sport and extend beyond civilian medicine to care for military personnel. Ethics and Dissemination: The study is approved by the data coordinating center Institutional Review Board and registered at . Dissemination will include peer-reviewed publications, presentation to patients and public groups, as well as dissemination in other healthcare and public venues of interest. Trial Funding: National Football League.	[Register-Mihalik, Johna K.; Guskiewicz, Kevin M.; Marshall, Stephen W.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Marshall, Stephen W.; Ranapurwala, Shabbar, I; Gildner, Paula] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.; Ranapurwala, Shabbar, I] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [McCulloch, Karen L.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Div Phys Therapy, Chapel Hill, NC 27515 USA; [Mrazik, Martin; Naidu, Dhiren] Univ Alberta, Fac Educ, Edmonton, AB, Canada; [Mrazik, Martin; Naidu, Dhiren] Canadian Football League, Toronto, ON, Canada; [Murphy, Ian] New Zealand Rugby, Wellington, New Zealand; [Schneider, Kathryn] Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Hotchkiss Brain Inst, Res Inst, Cummings Sch Med,Alberta Childrens Hosp, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Sport Med Ctr, Acute Sport Concuss Clin Sport, Calgary, AB, Canada; [McCrea, Michael] Med Coll Wisconsin, Ctr Neurotrauma Res, Dept Neurosurg, Milwaukee, WI 53226 USA; [Mrazik, Martin; Naidu, Dhiren; Mrazik, Marty] Canadian Football League, Montreal, PQ, Canada; [Mrazik, Martin; Naidu, Dhiren; Mrazik, Marty] Univ Alberta, Edmonton, AB, Canada; [Murphy, Ian; Salmon, Danielle] New Zealand Rugby, Dip Sport Med, Auckland, New Zealand; [Auton, Brandon] Catawba Coll, Salisbury, CT USA; [Ketcham, Caroline J.; Hall, Eric E.] Elon Univ, Elon, NC USA; [Bowman, Thomas G.; Wesley, Caroline A.] Univ Lynchburg, Lynchburg, VA USA; [Jewell, Elizabeth] North Carolina Cent Univ, Durham, NC USA; [Hynes, Loriann] York Univ, N York, ON, Canada		Register-Mihalik, JK (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.; Register-Mihalik, JK (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA.	johnakay@email.unc.edu	Bowman, Tom/AAU-6473-2020; Bowman, Thomas/AAA-3036-2020	Bowman, Thomas/0000-0002-0034-2946; Ketcham, Caroline/0000-0002-6713-130X	National Football League (NFL)	The current study was funded by the National Football League (NFL). The NFL plays no role in the study design, data collection, or interpretation of study findings.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; COX DR, 1972, J R STAT SOC B, V34, P187; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kozlowski AJ, 2016, ARCH PHYS MED REHAB, V97, P650, DOI 10.1016/j.apmr.2015.12.010; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Perez Lori, 2007, J Neurosci Nurs, V39, P342; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tang E, 2019, QUAL LIFE RES, V28, P815, DOI 10.1007/s11136-018-2058-2; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	36	3	3	0	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 8	2019	10								1176	10.3389/fneur.2019.01176			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JQ5DG	WOS:000498965500001	31781021	Green Published, gold			2022-02-06	
J	Pradeep, T; Bray, MJC; Arun, S; Richey, LN; Jahed, S; Bryant, BR; LoBue, C; Lyketsos, CG; Kim, P; Peters, ME				Pradeep, Tejus; Bray, Michael J. C.; Arun, Siddharth; Richey, Lisa N.; Jahed, Sahar; Bryant, Barry R.; LoBue, Christian; Lyketsos, Constantine G.; Kim, Paul; Peters, Matthew E.			History of traumatic brain injury interferes with accurate diagnosis of Alzheimer's dementia: a nation-wide case-control study	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Traumatic brain injury; Alzheimer's disease; dementia; chronic traumatic encephalopathy; diagnostic accuracy; neuropathology; neurodegeneration; acquired brain injury; neurology	COGNITIVE RESERVE; DISEASE; ONSET; INSTITUTE; DISTINCT; RISK	Traumatic brain injury (TBI) and Alzheimer's disease (AD) bear a complex relationship, potentially increasing risk of one another reciprocally. However, recent evidence suggests post-TBI dementia exists as a distinct neurodegenerative syndrome, confounding AD diagnostic accuracy in clinical settings. This investigation sought to evaluate TBI's impact on the accuracy of clinician-diagnosed AD using gold standard neuropathological criteria. In this preliminary analysis, data were acquired from the National Alzheimer's Coordinating Centre (NACC), which aggregates clinical and neuropathologic information from Alzheimer's disease centres across the United States. Modified National Institute on Aging-Reagan criteria were applied to confirm AD by neuropathology. Among participants with clinician-diagnosed AD, TBI history was associated with misdiagnosis (false positives) (OR = 1.351 [95% CI: 1.091-1.674], p = 0.006). Among participants without clinician-diagnosed AD, TBI history was not associated with false negatives. TBI moderates AD diagnostic accuracy. Possible AD misdiagnosis can mislead patients, influence treatment decisions, and confound research study designs. Further work examining the influence of TBI on dementia diagnosis is warranted.	[Pradeep, Tejus; Bray, Michael J. C.; Arun, Siddharth; Richey, Lisa N.; Jahed, Sahar; Bryant, Barry R.; Lyketsos, Constantine G.; Kim, Paul; Peters, Matthew E.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [LoBue, Christian] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA; [LoBue, Christian] UT Southwestern Med Ctr, Dept Neurol Surg, Dallas, TX USA		Peters, ME (corresponding author), 5300 Alpha Commons Dr,Off 446, Baltimore, MD 21224 USA.	mpeter42@jhmi.edu	Bray, Michael Johnathan Charles/AAL-8925-2020; LoBue, Christian/M-4584-2017	Bray, Michael Johnathan Charles/0000-0003-4650-1313; Peters, Matthew/0000-0002-5668-4566; LoBue, Christian/0000-0001-9671-5526; Bryant, Barry/0000-0002-3627-7824; Richey, Lisa/0000-0001-8050-1240; Pradeep, Tejus/0000-0002-0506-069X	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017];  [P30 AG010161];  [P50 AG047366];  [P30 AG010129];  [P50 AG016573];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG053760];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P30 AG049638];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]	NACC data are contributed by the NIA funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P121, DOI 10.1016/j.jalz.2017.10.009; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Faul M., 2013, TRAUMATIC BRAIN INJU; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gottlieb S., 2006, BRIT MED J, V321, P1100, DOI [10.1016/S0140-6736(06)67, DOI 10.1016/S0140-6736(06)67]; Grant DA, 2018, J NEUROTRAUM, V35, P94, DOI 10.1089/neu.2017.5042; Head E., 2016, ALZHEIMERS DEMENTI S, V12, P293, DOI [10.1016/j.jalz.2016.06.528, DOI 10.1016/J.JALZ.2016.06.528]; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoenig MC, 2017, NEUROBIOL AGING, V57, P1, DOI 10.1016/j.neurobiolaging.2017.05.004; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Krch D, 2019, J HEAD TRAUMA REHAB, V34, pE57, DOI 10.1097/HTR.0000000000000472; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Mendez MF, 2006, INT J PSYCHIAT MED, V36, P401, DOI 10.2190/Q6J4-R143-P630-KW41; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P166, DOI 10.1176/appi.neuropsych.22.2.166; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Veras Renato Peixoto, 2007, Arch. Clin. Psychiatry (São Paulo), V34, P5; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Webber D, 2013, APPL NEUROPSYCH-ADUL, V20, P145, DOI 10.1080/09084282.2012.670161	36	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		61	70		10.1080/09540261.2019.1682529		NOV 2019	10	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000495526200001	31707905	Green Accepted			2022-02-06	
J	Brunner, M; Togher, L; Palmer, S; Dann, S; Hemsley, B				Brunner, Melissa; Togher, Leanne; Palmer, Stuart; Dann, Stephen; Hemsley, Bronwyn			Rehabilitation professionals' views on social media use in traumatic brain injury rehabilitation: gatekeepers to participation	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; social media; rehabilitation; health professionals	COMMUNICATION; DISABILITY; PEOPLE; INTERVENTIONS; NETWORKING	Purpose: Rehabilitation professionals support people with traumatic brain injury (TBI) to return to meaningful participation in life and society - which now includes the use of social media. However, the role of health professionals in supporting the use of social media by adults with TBI is not yet known. This study aimed to investigate the experiences and views of rehabilitation professionals on the use of social media by people with TBI during rehabilitation. Method: Two focus groups were conducted and analysed qualitatively for content themes. Results: Eleven rehabilitation professionals, including allied health, recreational therapy, and service management, took part in this study. Participants identified potential benefits to people with TBI using social media, including reduced social isolation. However, they expressed concerns about social media risks relating to the vulnerability, exploitation, and reputation management for people with TBI. Rehabilitation professionals viewed their role as being to protect people from these risks of harm, either through imposing restrictions on social media use or responding to problems after these occurred. Conclusion: A knowledge translation approach might help guide and support rehabilitation professionals in enabling adults with TBI to safely access and experience the benefits of meaningful engagement in social media during rehabilitation.	[Brunner, Melissa; Hemsley, Bronwyn] Univ Technol Sydney, Grad Sch Hlth, Speech Pathol, Ultimo, NSW, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Speech Pathol, Sydney, NSW, Australia; [Togher, Leanne] Univ New South Wales, NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [Palmer, Stuart] Univ Melbourne, Melbourne Ctr Study Higher Educ, Melbourne, Vic, Australia; [Dann, Stephen] Australian Natl Univ, Coll Business & Econ, Canberra, ACT, Australia; [Hemsley, Bronwyn] Univ Newcastle, Fac Educ & Arts, Newcastle, NSW, Australia		Brunner, M (corresponding author), UTS, Grad Sch Hlth, Speech Pathol, POB 123, Broadway, NSW 2007, Australia.	melissa.brunner@uts.edu.au	Brunner, Melissa/AAS-5965-2020; Togher, Leanne/AAC-7083-2019; Dann, Stephen/H-2505-2011; Hemsley, Bronwyn/A-7427-2010	Dann, Stephen/0000-0001-7946-3494; Hemsley, Bronwyn/0000-0002-6255-3140; Palmer, Stuart/0000-0002-2517-0597; Brunner, Melissa/0000-0001-6823-5189	Australian Government Research Training Program scholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; Australian Research CouncilAustralian Research Council	This research was funded through an Australian Government Research Training Program scholarship (first author) and a Discovery Early Career Research Award from the Australian Research Council (last author).	Ashby Gillian Alice, 2015, Pract Neurol, V15, P361, DOI 10.1136/practneurol-2014-000957; Baier CK, 2018, APHASIOLOGY, V32, P1336, DOI 10.1080/02687038.2017.1409870; Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Blackburn E, 2018, CAN J BIOETHICS REV, V1, P22; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; Brunner M, 2019, SUPPORTING PEO UNPUB; Brunner M, 2019, PROCEEDINGS OF THE 52ND ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, P4329; Brunner M, 2020, BRAIN IMPAIR, V21, P1, DOI 10.1017/BrImp.2019.12; Brunner M, 2019, INT J LANG COMM DIS, V54, P221, DOI 10.1111/1460-6984.12405; Brunner M, 2018, BRAIN INJURY, V32, P49, DOI 10.1080/02699052.2017.1403047; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Creswell JW., 2014, RES DESIGN QUALITATI; Douglas JM, 2018, BRAIN IMPAIR, V19, P258, DOI 10.1017/BrImp.2018.17; Douglas JM, 2017, BRAIN IMPAIR, V18, P321, DOI 10.1017/BrImp.2017.20; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Grace E, 2014, CHILD LANG TEACH THE, V30, P141, DOI 10.1177/0265659013518565; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Haegele JA, 2016, QUEST, V68, P193, DOI 10.1080/00336297.2016.1143849; Hemsley B, 2018, INT J SPEECH-LANG PA, V20, P50, DOI 10.1080/17549507.2017.1413137; Hemsley B, 2017, AUGMENT ALTERN COMM, V33, P1, DOI 10.1080/07434618.2017.1280082; Humpage L, 2007, SOC POLICY ADMIN, V41, P215, DOI 10.1111/j.1467-9515.2007.00549.x; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P15, DOI 10.1007/s12152-014-9213-4; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Montgomery B., 2018, FRONT DIGIT HUMANIT, V5, P1, DOI [10.3389/fdigh.2018.00022., DOI 10.3389/FDIGH.2018.00022]; Newman L, 2017, INFORM SYST J, V27, P559, DOI 10.1111/isj.12106; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Raghavendra P, 2013, ENHANCING SOCIAL PAR; Ripley DL, 2019, PM&R, V11, P76, DOI 10.1002/pmrj.12041; Ross PE, 2018, DISABIL REHABIL, V40, P757, DOI 10.1080/09638288.2016.1274341; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schellinger S, 2015, THESIS; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Stolwyk RJ, 2019, DISABIL REHABIL, V41, P1313, DOI 10.1080/09638288.2018.1424955; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	48	3	3	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 3	2021	43	14					1955	1964		10.1080/09638288.2019.1685604		NOV 2019	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	TD5HG	WOS:000494904900001	31694430				2022-02-06	
J	Piastra, M; Caresta, E; Massimi, L; Picconi, E; Luca, E; Morena, TC; Conti, G; Eaton, S				Piastra, M.; Caresta, E.; Massimi, L.; Picconi, E.; Luca, E.; Morena, T. C.; Conti, G.; Eaton, S.			Lipid Peroxidation and Antioxidant Consumption as Early Markers of Neurosurgery-Related Brain Injury in Children	NEUROCRITICAL CARE			English	Article						Pediatric neurosurgery; Pediatric intensive care; Antioxidant activity; Lipid peroxidation; Brain injury	FREE-RADICAL SCAVENGER; OXIDATIVE STRESS; CEREBROSPINAL-FLUID; INFANTS	Background and Aims Lipid peroxidation represents a marker of secondary brain injury both in traumatic and in non-traumatic conditions-as in major neurosurgical procedures-eventually leading to brain edema amplification and further brain damage. Malondialdehyde (MDA), a lipid peroxidation marker, and ascorbate, a marker of antioxidant status, can represent early indicators of this process within the cerebrospinal fluid (CSF). We hypothesized that changes in cerebral lipid peroxidation can be measured ex vivo following neurosurgery in children. Methods Thirty-six children (M:F = 19/17, median age 32.9 months; IQR 17.6-74.6) undergoing neurosurgery for brain tumor removal were admitted to the pediatric intensive care unit (PICU) in the postoperative period with an indwelling intraventricular catheter for intracranial pressure monitoring and CSF drainage. Plasma and CSF samples were obtained for serial measurement of MDA, ascorbate, and cytokines. Results An early brain-limited increase in lipid peroxidation was measured, with a significant increase from baseline of MDA in CSF (p = 0.007) but not in plasma. In parallel, ascorbate in CSF decreased (p = 0.05). Systemic inflammatory response following brain surgery was evidenced by plasma IL-6/IL-8 increase (p 0.0022 and 0.0106, respectively). No correlation was found between oxidative response and tumor site or histology (according to World Health Organization grading). Similarly, lipid peroxidation was unrelated to the length of surgery (mean 321 +/- 73 min), or intraoperative blood loss (mean 20.9 +/- 16.8% of preoperative volemia, 44% given hemotransfusions). Median PICU stay was 3.5 days (IQL range 2-5.5 d.), and postoperative ventilation need was 24 h (IQL range 20-61.5 h). The elevation in postoperative MDA in CSF compared with preoperative values correlated significantly with postoperative ventilation need (P = 0.05, r(2) 0168), while no difference in PICU stay was recorded. Conclusions Our results indicate that lipid peroxidation increases consistently following brain surgery, and it is accompanied by a decrease in antioxidant defences; intraventricular catheterization offers a unique chance of oxidative process monitoring. Further studies are needed to evaluate whether monitoring post-neurosurgical oxidative stress in CSF is of prognostic utility.	[Piastra, M.; Caresta, E.; Picconi, E.; Luca, E.; Morena, T. C.; Conti, G.] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Emergency Anesthesia & Intens Care, Pediat Intens Care Unit, Lgo Gemelli 8, I-00168 Rome, Italy; [Massimi, L.] Fdn Policlin Gemelli IRCCS, Pediat Neurosurg, Dept Neurosurg, Rome, Italy; [Caresta, E.; Eaton, S.] UCL Great Ormond St Inst Child Hlth, Dept Pediat Surg, 30 Guilford St, London WC1N 1EH, England; [Piastra, M.; Conti, G.] Univ Cattolica Sacro Cuore, Inst Anesthesia Intens Care, Rome, Italy; [Picconi, E.; Luca, E.; Morena, T. C.; Conti, G.] Fdn Policlin Univ Agostino Gemelli IRCCS, Pediat Intens Care Unit, Rome, Italy; [Caresta, E.] Sapienza Univ, Pediat, Rome, Italy		Morena, TC (corresponding author), Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Emergency Anesthesia & Intens Care, Pediat Intens Care Unit, Lgo Gemelli 8, I-00168 Rome, Italy.; Morena, TC (corresponding author), Fdn Policlin Univ Agostino Gemelli IRCCS, Pediat Intens Care Unit, Rome, Italy.	tony.cmds@gmail.com	Conti, Giorgio/AAB-9546-2022; Picconi, Enzo/AAD-5876-2022	Conti, Giorgio/0000-0002-8566-9365; Eaton, Simon/0000-0003-0892-9204; Picconi, Enzo/0000-0002-1808-0665			Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Borg A, 2016, WORLD NEUROSURG, V95, P383, DOI 10.1016/j.wneu.2015.12.105; Bujok G, 1996, CHILD NERV SYST, V12, P97, DOI 10.1007/BF00819504; Caresta E, 2007, PEDIATR RES, V61, P228, DOI 10.1203/01.pdr.0000252441.91671.e5; Cirak B, 1999, PEDIATR NEUROSURG, V31, P298, DOI 10.1159/000028879; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Deletis V, 2001, ANN NY ACAD SCI, V939, P137; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Jadhav V, 2007, SURG NEUROL, V67, P15, DOI 10.1016/j.surneu.2006.07.014; Kastenbauer S, 2002, NEUROLOGY, V58, P186, DOI 10.1212/WNL.58.2.186; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Piastra M, 2008, J NEURO-ONCOL, V90, P191, DOI 10.1007/s11060-008-9643-0; Piastra M, 2017, NEUROCRIT CARE, V26, P388, DOI 10.1007/s12028-016-0344-9; Pietrini D, 2009, J NEURO-ONCOL, V93, P361, DOI 10.1007/s11060-008-9784-1; Sherchan Prativa, 2013, Acta Neurochir Suppl, V118, P129, DOI 10.1007/978-3-7091-1434-6_23; Spentzas T, 2010, PEDIATR CRIT CARE ME, V11, P718, DOI 10.1097/PCC.0b013e3181d907fa; Srivastava R, 2013, J TROP PEDIATRICS, V59, P305, DOI 10.1093/tropej/fmt013; Velayutham PK, 2013, J SURG RES, V179, P125, DOI 10.1016/j.jss.2012.09.005; Yilmaz N, 2006, INT J NEUROSCI, V116, P937, DOI 10.1080/00207450600553141; Zengin E, 2009, CLIN NEUROL NEUROSUR, V111, P345, DOI 10.1016/j.clineuro.2008.11.008	25	3	3	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2020	33	1					124	131		10.1007/s12028-019-00870-w		NOV 2019	8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MT1KH	WOS:000494931600001	31696410	Green Submitted			2022-02-06	
J	Avcu, P; Sinha, S; Pang, KCH; Servatius, RJ				Avcu, Pelin; Sinha, Swamini; Pang, Kevin C. H.; Servatius, Richard J.			Reduced avoidance coping in male, but not in female rats, after mild traumatic brain injury: Implications for depression	BEHAVIOURAL BRAIN RESEARCH			English	Article						Acoustic startle; Delay eyeblink; Instrumental learning; Sex differences; Depression; Lateral fluid percussion, concussion	POSTTRAUMATIC-STRESS-DISORDER; CORTICOTROPIN-RELEASING HORMONE; ACOUSTIC STARTLE RESPONSE; LATERAL HABENULA; ACTIVE-AVOIDANCE; ANIMAL-MODEL; MODULATION; ACTIVATION; ANXIETY; DEFICITS	Although there is evidence that traumatic brain injury (mTBI) induces emotional sequelae in rats, it is unclear whether the phenotype is reminiscent of major depressive disorder (MDD) or posttraumatic stress disorder (PTSD). Three behavioral protocols with oppositional indicators for MDD or PTSD were assessed: acoustic startle responses (ASRs), eyeblink conditioning, and instrumental escape/avoidance (E/A) learning. Female and male rats were exposed to lateral fluid percussion injury (LFPi) consistent with mild TBI (mTBI) or sham (SHAM) surgery. Experiment 1 suggested that the acquisition of the classically conditioned eyeblink responses was unaffected by mTBI infemale and male rats. In Experiment 2, male and female mTBI rats acquired instrumental escape responses similar to their SHAM counterparts. Avoidance expression of female mTBI rats did not differ appreciably from female SHAM rats. However, male mTBI rats expressed avoidance at a lower rate than male SHAM rats over training. Poor coping in male rats emerged with repeated exposure to stress, suggesting that depressive behaviors in mTBI develop over time and with continued demand from stress. Severely attenuated ASRs were evident in female and male mTBI rats compared to respective SHAM rats throughout testing across the two experiments. Overall, signs among the three bidirectional assessments during the subacute period after mTBI were more indicative of MDD-like, than PTSD-like sequelae.	[Avcu, Pelin; Sinha, Swamini; Pang, Kevin C. H.] New Jersey Hlth Care Syst, Neurobehav Res Lab, Dept Vet Affairs, E Orange, NJ USA; [Avcu, Pelin; Sinha, Swamini; Pang, Kevin C. H.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Rutgers Biomed & Hlth Sci, Newark, NJ USA; [Avcu, Pelin; Sinha, Swamini; Pang, Kevin C. H.; Servatius, Richard J.] Rutgers State Univ, Grad Sch Biomed Sci, Newark, NJ USA; [Servatius, Richard J.] Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, Syracuse, NY USA; [Servatius, Richard J.] Upstate Med Univ, Dept Psychiat, New York, NY 13210 USA		Servatius, RJ (corresponding author), Syracuse Vet Affairs Med Ctr, Stress & Motivated Behav Inst, 800 Irving Ave, Syracuse, NY 13210 USA.	Richard.servatius@va.gov			Stress and Motivated Behavior Institute; VA Merit Grant [I01 BX000132]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS044373]; NJ Commission on Brain Injury Research [CBIR11PJT003, CBIR14FEL014]; Veterans AffairsUS Department of Veterans Affairs [I01BX000132] Funding Source: NIH RePORTER	This research was supported by; the Stress and Motivated Behavior Institute; VA Merit Grant: I01 BX000132; NIH Grant: NS044373; and NJ Commission on Brain Injury Research: CBIR11PJT003 and CBIR14FEL014.	Allen NB, 1999, BIOL PSYCHIAT, V46, P542, DOI 10.1016/S0006-3223(99)00025-6; Amo R, 2014, NEURON, V84, P1034, DOI 10.1016/j.neuron.2014.10.035; ANISMAN H, 1979, PSYCHOPHARMACOLOGY, V64, P163, DOI 10.1007/BF00496057; ARCHER T, 1982, J COMP PHYSIOL PSYCH, V96, P476, DOI 10.1037/h0077896; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Avcu P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00334; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Caulfield MD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00348; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; DAVIS M, 1982, J NEUROSCI, V2, P791; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fragale JEC, 2016, EXP NEUROL, V275, P59, DOI 10.1016/j.expneurol.2015.11.002; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Freeman JH, 2015, BRAIN RES, V1621, P260, DOI 10.1016/j.brainres.2014.09.062; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Greer TL, 2005, J AFFECT DISORDERS, V86, P235, DOI 10.1016/j.jad.2005.02.006; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; GROVES PM, 1974, BEHAV BIOL, V10, P391, DOI 10.1016/S0091-6773(74)91975-0; Handy J.D., 2017, ANN M PAVL SOC OCT; Handy JD, 2018, BEHAV BRAIN RES, V339, P106, DOI 10.1016/j.bbr.2017.11.014; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Heldt SA, 2009, BEHAV PHARMACOL, V20, P584, DOI 10.1097/FBP.0b013e32832ec594; Holloway JL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00076; IIango A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00132; Ilango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065684; Jacobson NS, 2001, CLIN PSYCHOL-SCI PR, V8, P255, DOI 10.1093/clipsy/8.3.255; Jiao XL, 2011, BEHAV BRAIN RES, V221, P98, DOI 10.1016/j.bbr.2011.02.029; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Karamustafalioglu OK, 2006, J CLIN PSYCHIAT, V67, P882, DOI 10.4088/JCP.v67n0604; Kaviani H, 2004, J AFFECT DISORDERS, V83, P21, DOI 10.1016/j.jad.2004.04.007; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Larrauri JA, 2015, PSYCHOPHARMACOLOGY, V232, P3009, DOI 10.1007/s00213-015-3940-z; Lee Y., 1997, J NEUROSCI, V17; Lee YL, 1997, J NEUROSCI, V17, P6434; LEVISON PK, 1967, ARCH INT PHARMACOD T, V170, P31; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Miller MW, 2004, J ABNORM PSYCHOL, V113, P451, DOI 10.1037/0021-843x.113.3.451; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Myers CE, 2012, STRESS, V15, P31, DOI 10.3109/10253890.2011.578184; Netrakanti PR, 2015, CEREBELLUM, V14, P264, DOI 10.1007/s12311-015-0645-0; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; North C S, 2001, Mil Med, V166, P51; North CS, 2009, AM J PSYCHIAT, V166, P34, DOI 10.1176/appi.ajp.2008.08050644; O'Brien-Simpson L, 2009, J AFFECT DISORDERS, V112, P243, DOI 10.1016/j.jad.2008.03.022; O'Donnell ML, 2007, BEHAV RES THER, V45, P601, DOI 10.1016/j.brat.2006.03.015; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Ottenbreit ND, 2004, BEHAV RES THER, V42, P293, DOI 10.1016/S0005-7967(03)00140-2; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Pang KCH, 2011, HIPPOCAMPUS, V21, P835, DOI 10.1002/hipo.20799; Ranaivo HR, 2011, J NEUROTRAUM, V28, P1757, DOI 10.1089/neu.2011.1799; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; SEIDEN LS, 1968, J PHARMACOL EXP THER, V159, P422; Servatius RJ, 2008, BEHAV BRAIN RES, V192, P191, DOI 10.1016/j.bbr.2008.04.006; Servatius RJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00379; Servatius RJ, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00015; Servatius RJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00168; SERVATIUS RJ, 1994, BEHAV NEUROSCI, V108, P1101, DOI 10.1037/0735-7044.108.6.1101; Servatius RJ, 2000, J NEUROSCI METH, V102, P35, DOI 10.1016/S0165-0270(00)00276-4; Servatius RJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1483, DOI 10.1038/sj.npp.1300691; Servatius RJ, 2005, BIOL PSYCHIAT, V57, P865, DOI 10.1016/j.biopsych.2005.01.015; SERVATIUS RJ, 1994, PHYSIOL BEHAV, V56, P945, DOI 10.1016/0031-9384(94)90328-X; SERVATIUS RJ, 1995, BIOL PSYCHIAT, V38, P539, DOI 10.1016/0006-3223(94)00369-E; Shalev AY, 1997, PSYCHIAT RES, V69, P1, DOI 10.1016/S0165-1781(96)03001-6; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Sinha SP, 2017, BRAIN BEHAV IMMUN, V61, P353, DOI 10.1016/j.bbi.2017.01.006; Sloan DM, 2010, BIOL PSYCHOL, V84, P368, DOI 10.1016/j.biopsycho.2010.04.004; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; THOMPSON RF, 1991, NEUROPSYCHOLOGIA, V29, P571, DOI 10.1016/0028-3932(91)90011-V; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066; Wright W.G., 2017, MIL HLTH SYST RES S; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196	89	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	NOV 5	2019	373								112064	10.1016/j.bbr.2019.112064			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	LD5EX	WOS:000526053200016	31278968				2022-02-06	
J	Zanin, AC; Kamrath, JK; Corman, SR				Zanin, Alaina C.; Kamrath, Jessica K.; Corman, Steven R.			Agentic Denial: How Athletic Teams Sustain Divergent Structures During Concussion Events	SMALL GROUP RESEARCH			English	Article						athletic health care teams; structurational divergence theory; concussion reporting	STRUCTURATIONAL DIVERGENCE; COMMUNICATION; MEMBERSHIP; BOUNDARIES; COHESION; AGENCY; MODEL; WORK	This study reveals how athletic health care teams, embedded within large bureaucratic organizations and complex social systems, negotiate and sustain multiple divergent structures. An iterative analysis of 69 in-depth interviews with National Collegiate Athletic Association (NCAA) Division I athletes' certified athletic trainers (ATCs) and coaches from four high-contact sports (i.e., women's lacrosse, men's wrestling, men's soccer, and men's football) revealed that team members coconstructed and negotiated multiple conflicting structures during concussion events. The divergent macro-, meso-, and micro-level structures include (a) formal versus hidden authority structures, (b) prevention versus inevitability discourse, (c) assigned versus enacted roles, and (d) authentic versus inauthentic injury performance. The analysis also revealed how a specific speech act, termed agentic denial, enabled members to obscure their agency within concussion events. Theoretical implications and practical recommendations are discussed.	[Zanin, Alaina C.] Arizona State Univ, Org & Hlth Commun, Tempe, AZ 85287 USA; [Kamrath, Jessica K.] Calif State Univ Fullerton, Org Commun, Fullerton, CA 92634 USA; [Corman, Steven R.] Arizona State Univ, Ctr Strateg Commun, Tempe, AZ 85287 USA		Zanin, AC (corresponding author), Arizona State Univ, Hugh Downs Sch Human Commun, 950 S Forest Mall, Tempe, AZ 85281 USA.; Zanin, AC (corresponding author), Arizona State Univ, Coll Liberal Arts & Sci, 950 S Forest Mall, Tempe, AZ 85281 USA.	Alaina.Zanin@asu.edu		Zanin, Alaina/0000-0001-8463-9853	United States National Collegiate Athletic Association Mind Matters Research Challenge program	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors received funding for this research from the United States National Collegiate Athletic Association Mind Matters Research Challenge program.	Alvesson M, 2000, HUM RELAT, V53, P1125, DOI 10.1177/0018726700539002; Apker J, 2005, J APPL COMMUN RES, V33, P93, DOI 10.1080/00909880500044620; Ashforth BE, 2000, ACAD MANAGE REV, V25, P472, DOI 10.2307/259305; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Austin JL., 1962, DO THINGS WORDS, V2; Baker D. P., 2005, MED TEAMWORK PATIENT; Berteotti C. R., 1994, GROUP COMMUNICATION, P107; Bisel RS, 2014, MANAGE COMMUN Q, V28, P625, DOI 10.1177/0893318914549952; Carmack H. J., 2010, QUALITATIVE RES REPO, V11, P6, DOI [10.1080/17459430903413432, DOI 10.1080/17459430903413432]; Carmack HJ, 2010, QUAL HEALTH RES, V20, P1393, DOI 10.1177/1049732310372618; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; French JR., 1959, STUDIES SOCIAL POWER, P150, DOI DOI 10.1007/BF00228551; Giddens A., 1984, CONSTITUTION SOC OUT; Giddens A., 1979, CENTRAL PROBLEMS SOC; Kramer MW, 2004, COMMUN MONOGR, V71, P311, DOI 10.1080/0363452042000288292; Lammers JC, 1997, J APPL COMMUN RES, V25, P17, DOI 10.1080/00909889709365463; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Lindlof TR, 2017, QUALITATIVE COMMUNIC; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; MOORHEAD G, 1991, HUM RELAT, V44, P539, DOI 10.1177/001872679104400601; Mortensen M, 2018, ORGAN SCI, V29, P341, DOI 10.1287/orsc.2017.1198; Mortensen M, 2014, ORGAN SCI, V25, P909, DOI 10.1287/orsc.2013.0881; National Collegiate Athletic Association Membership Affairs Staff, 2018, NCAA DIV 1 MAN; Nicotera A. M., 2018, AGENCY ORG PERSPECTI, P66; Nicotera AM, 2015, MANAGE COMMUN Q, V29, P493, DOI 10.1177/0893318915585143; Nicotera AM, 2015, HEALTH COMMUN, V30, P371, DOI 10.1080/10410236.2013.863139; Nicotera AM, 2013, MANAGE COMMUN Q, V27, P90, DOI 10.1177/0893318912458214; Nicotera AM, 2010, J APPL COMMUN RES, V38, P362, DOI 10.1080/00909882.2010.514001; Nicotera AM, 2010, HEALTH COMMUN, V25, P32, DOI 10.1080/10410230903473516; Pescosolido AT, 2012, SMALL GR RES, V43, P744, DOI 10.1177/1046496412465020; POOLE MS, 1999, HDB GROUP COMMUNICAT, P37; Propp KM, 2010, QUAL HEALTH RES, V20, P15, DOI 10.1177/1049732309355289; Rabol L.I., 2012, J COMMUN HEALTHC, V5, P129, DOI [DOI 10.1179/1753807612Y.0000000009, 10.1179/1753807612Y.0000000009]; Real K, 2011, ROUTL COMMUN SER, P100; Reddy MC, 2008, INFORM PROCESS MANAG, V44, P256, DOI 10.1016/j.ipm.2006.12.010; Reichertz J., 2007, SAGE HDB GROUNDED TH, P214, DOI DOI 10.4135/9781848607941.N10; Rost, 1992, MANAGEMENT COMMUNICA, V5, DOI [https://doi.org/10.1177/0893318992005003001, DOI 10.1177/0893318992005003001]; Rovio E, 2009, SMALL GR RES, V40, P421, DOI 10.1177/1046496409334359; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Searle John R., 1969, SPEECH ACTS ESSAY PH; SEWELL WH, 1992, AM J SOCIOL, V98, P1, DOI 10.1086/229967; Stohl, 1990, COMMUNICATION STUDIE, V41, P248, DOI [https://doi.org/10.1080/10510979009368307, DOI 10.1080/10510979009368307]; Stohl C., 2002, NEW DIRECTIONS GROUP, P237; STOHL C, 2003, COMMUNICATION CONTEX, P399; Tracy S.J., 2013, QUALITATIVE RES METH; Tracy SJ, 2004, J APPL COMMUN RES, V32, P119, DOI 10.1080/0090988042000210025; VAUGHAN D, 1990, ADMIN SCI QUART, V35, P225, DOI 10.2307/2393390; Wallace Ruth, 1999, CONT SOCIOLOGICAL TH, V5th; Weick KE, 2005, ORGAN SCI, V16, P409, DOI 10.1287/orsc.1050.0133; Zanin AC, 2020, HEALTH COMMUN, V35, P935, DOI 10.1080/10410236.2019.1598742; Zanin AC, 2018, J APPL COMMUN RES, V46, P267, DOI 10.1080/00909882.2018.1465578; [No title captured]	53	3	3	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1046-4964	1552-8278		SMALL GR RES	Small Group Res.	JUN	2020	51	3					342	374	1046496419883948	10.1177/1046496419883948		NOV 2019	33	Psychology, Applied; Management; Psychology, Social	Social Science Citation Index (SSCI)	Psychology; Business & Economics	LM6ME	WOS:000495550500001					2022-02-06	
J	Adediran, T; Drumheller, BC; McCunn, M; Stein, DM; Albrecht, JS				Adediran, Timileyin; Drumheller, Byron C.; McCunn, Maureen; Stein, Deborah M.; Albrecht, Jennifer S.			Sex Differences in In-hospital Complications Among Older Adults After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Older adults; Sex differences; In-hospital complications	ACUTE KIDNEY INJURY; EXTRACRANIAL COMPLICATIONS; GENDER-DIFFERENCES; UNITED-STATES; LUNG INJURY; PROGESTERONE; MORTALITY; SURVEILLANCE; MODERATE; OUTCOMES	Background: Older adults have the highest rates of hospitalization and mortality after traumatic brain injury (TBI) and suffer poorer outcomes compared with younger adults with similar injuries. Non-neurological complications can significantly impact outcomes. Evidence suggests that women may have better outcomes after TBI. However, sex differences in in-hospital complications among older adults after TBI have not been studied. The objective of this study was to assess sex differences in in-hospital complications after TBI among adults aged 65 y and older. Methods: We conducted a retrospective cohort study of adults aged >= 65 y treated for isolated moderate to severe TBI at the R Adams Cowley Shock Trauma Center between 1996 and 2012. Using the Shock Trauma Center registry, we identified TBI using the International Classification of Disease, Ninth Revision, Clinical Modification codes and required an abbreviated injury scale head score >= 3, abbreviated injury scale scores for other body regions <= 2, and a blunt injury mechanism. We searched the Shock Trauma Center registry for the International Classification of Disease, Ninth Revision, Clinical Modification codes representing in-hospital complications. Results: Of 2511 patients meeting inclusion criteria, 1283 (51.1%) were men and 635 (25.1%) developed an in-hospital complication. Men were more likely than women to develop an in-hospital complication (28.1% versus 22.0, P < 0.001). In an adjusted analysis, men were at increased risk of any in-hospital complication (hazards ratio 1.23; 95% confidence interval 1.05, 1.44) compared with women. Conclusions: Older men were more likely to have any in-hospital complications than women. (C) 2019 Elsevier Inc. All rights reserved.	[Adediran, Timileyin; Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Drumheller, Byron C.; Stein, Deborah M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Program Trauma,Dept Surg, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, Dept Anesthesiol, R Adams Cowley Shock Trauma Ctr,Div Trauma Anesth, Baltimore, MD 21201 USA		Adediran, T (corresponding author), Univ Maryland, Sch Med, 10 South Pine St,MSTF 360, Baltimore, MD 21201 USA.	tadedir1@umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274; Adediran, Timileyin/0000-0002-7872-4338; Stein, Deborah/0000-0003-3683-3963	AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01 HS024560] Funding Source: Medline		Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Allison PD, 2010, SURVIVAL ANAL USING, V2nd; American College of Surgeons, 2015, NAT TRAUM DAT STAND; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Haydel M, 2018, BMJ BEST PRACT; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Marr A, 2002, CENTRAL NERVOUS SYST; Maryland Institute for Emergency Medical Services Systems (MIEMS), 2017, MED I EM MED SERV SY; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Prin M, 2016, INJ EPIDEMIOL, V3, P1; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rothman K.J., 2008, Modern epidemiology, V3rd; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	41	3	3	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2019	243						427	433		10.1016/j.jss.2019.05.053			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JA7SF	WOS:000488045900058	31279269				2022-02-06	
J	Arciniega, H; Kilgore-Gomez, A; Harris, A; Peterson, DJ; McBride, J; Fox, E; Berryhill, ME				Arciniega, Hector; Kilgore-Gomez, Alexandrea; Harris, Alison; Peterson, Dwight J.; McBride, Jaclyn; Fox, Emily; Berryhill, Marian E.			Visual working memory deficits in undergraduates with a history of mild traumatic brain injury	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Visual working memory; Chronic mTBI; Mild TBI; Concussion	CONTRALATERAL DELAY ACTIVITY; MILITARY SERVICE MEMBERS; NEURAL MEASURE; PSYCHOPHYSICS; SYMPTOMS; REPRESENTATIONS; CONCUSSION; CAPACITY; RISK	We investigated whether a history of mild traumatic brain injury (mTBI), or concussion, has any effect on visual working memory (WM) performance. In most cases, cognitive performance is thought to return to premorbid levels soon after injury, without further medical intervention. We tested this assumption in undergraduates, among whom a history of mTBI is prevalent. Notably, participants with a history of mTBI performed worse than their colleagues with no such history. Experiment 1 was based on a change detection paradigm in which we manipulated visual WM set size from one to three items, which revealed a significant deficit at set size 3. In Experiment 2 we investigated whether feedback could rescue WM performance in the mTBI group, and found that it failed. In Experiment 3 we manipulated WM maintenance duration (set size 3, 500-1,500 ms) to investigate a maintenance-related deficit. Across all durations, the mTBI group was impaired. In Experiment 4 we tested whether retrieval demands contributed to WM deficits and showed a consistent deficit across recognition and recall probes. In short, even years after an mTBI, undergraduates perform differently on visual WM tasks than their peers with no such history. Given the prevalence of mTBI, these data may benefit other researchers who see high variability in their data. Clearly, further studies will be needed to determine the breadth of the cognitive deficits in those with a history of mTBI and to identify relevant factors that contribute to positive cognitive outcomes.	[Arciniega, Hector; Kilgore-Gomez, Alexandrea; McBride, Jaclyn; Fox, Emily; Berryhill, Marian E.] Univ Nevada, Dept Psychol, Program Cognit & Brain Sci, Program Integrat Neurosci, Reno, NV 89557 USA; [Harris, Alison] Claremont Mckenna Coll, Dept Psychol, Claremont, CA 91711 USA; [Peterson, Dwight J.] Concordia Coll, Dept Psychol, Moorhead, MN USA		Arciniega, H (corresponding author), Univ Nevada, Dept Psychol, Program Cognit & Brain Sci, Program Integrat Neurosci, Reno, NV 89557 USA.	harciniega@unr.edu		Berryhill, Marian/0000-0002-8218-6587; Kilgore-Gomez, Alexandrea/0000-0002-7537-0386	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103650] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM103650] Funding Source: Medline; NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM103650] Funding Source: Medline; NSFNational Science Foundation (NSF) [OIA 1632849] Funding Source: Medline		Adam KCS, 2017, ATTEN PERCEPT PSYCHO, V79, P1506, DOI 10.3758/s13414-017-1331-8; Bajaj S, 2018, HUM BRAIN MAPP, V39, P1886, DOI 10.1002/hbm.23951; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; De Monte VE., 2005, BRAIN IMPAIR, V6, P109, DOI [10.1375/brim.2005.6.2.109, DOI 10.1375/BRIM.2005.6.2.109]; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Gozenman F, 2014, J EXP PSYCHOL HUMAN, V40, P1748, DOI 10.1037/a0037474; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hudac CM, 2018, INT J PSYCHOPHYSIOL, V132, P135, DOI 10.1016/j.ijpsycho.2017.09.020; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jones KT, 2015, NEUROIMAGE, V105, P238, DOI 10.1016/j.neuroimage.2014.11.012; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P231; Lotan E, 2018, AM J NEURORADIOL, V39, P1222, DOI 10.3174/ajnr.A5688; Luck SJ, 2013, TRENDS COGN SCI, V17, P391, DOI 10.1016/j.tics.2013.06.006; Luria R, 2016, NEUROSCI BIOBEHAV R, V62, P100, DOI 10.1016/j.neubiorev.2016.01.003; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Miranda AT, 2014, BEHAV RES METHODS, V46, P159, DOI 10.3758/s13428-013-0357-7; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Stockbridge M. D, 2018, THESIS; Tate DF, 2012, BRAIN IMAGING BEHAV, V6, P103, DOI 10.1007/s11682-012-9185-0; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004	51	3	3	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	NOV	2019	81	8					2597	2603		10.3758/s13414-019-01774-9			7	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	JN0NC	WOS:000496600300003	31218600	Bronze, Green Accepted			2022-02-06	
J	Baker, JG; Willer, BS; Leddy, JJ				Baker, John G.; Willer, Barry S.; Leddy, John J.			Integrating Neuropsychology Services in a Multidisciplinary Concussion Clinic	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild traumatic brain injury (mTBI); multidisciplinary clinic; neuropsychologist; primary care behavioral health model; rehabilitation	SPORTS-RELATED CONCUSSIONS; BEHAVIORAL HEALTH; CARE; REHABILITATION; RELIABILITY; ADOLESCENTS; MANAGEMENT; RECOVERY; SYMPTOMS	Objective: To describe the integration of neuropsychology services in a multidisciplinary concussion clinic and provide descriptive information on patients, services, and initial health status. Setting: A university-based outpatient sports medicine concussion clinic. Participants: A consecutive sample of 338 patients ages 8 to 84 years (median 23.5 years, 35% 13-18 years), 49.1% male, seen between 2014 and 2018. Patients' injuries included sports 42%, work 28.4%, and vehicular 12.1% and 48.5% were students. Design: Descriptive statistics with group comparisons. Main Measures: 12-Item Short Form Health Survey (SF-12) T scores (mean = 50, SD = 10) referenced to US population. Results: Half of the patients were seen within 24 days of their injury and showed reduced physical functioning (40.2) and average mental (emotional) functioning (48.8). Patients seen after 24 days showed even more reduced physical functioning (33.9) and reduced mental functioning (41.0), both P < .0001. Average treatment time was also longer, 88.1 (173.9) versus 186.8 (211.1) days, P < .0001. Two-thirds of patients were referred for cervical or vestibular physical therapy at their initial visit. Conclusion: Early referral for specialized care, including neuropsychology services, may be beneficial.	[Baker, John G.; Leddy, John J.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Orthopaed, Buffalo, NY USA; [Baker, John G.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Nucl Med, Buffalo, NY 14214 USA; [Willer, Barry S.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Baker, JG (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Nucl Med, Buffalo, NY 14214 USA.; Baker, JG (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Orthopaed & Sports Med, Buffalo, NY 14214 USA.	jgbaker@buffalo.edu					Ahmed OH, 2017, PROG BRAIN RES, V234, P205, DOI 10.1016/bs.pbr.2017.06.014; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Baker JG, 2011, BRAIN INJ PROF, V9, P28; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Haider Mohammad N, 2017, Concussion, V2, pCNC40, DOI 10.2217/cnc-2017-0001; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Kessler R., 2008, FAMILIES SYSTEMS HLT, V26, P207, DOI DOI 10.1037/A0011918; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; O'Keefe KA, 2018, PEDIATR EMERG CARE, V34, P322, DOI 10.1097/PEC.0000000000001476; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Robinson PJ, 2009, J CLIN PSYCHOL MED S, V16, P58, DOI 10.1007/s10880-009-9145-z; Rose SC, 2016, SPORTS HEALTH, V8, P37, DOI 10.1177/1941738115591948; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Vogel ME, 2017, J BEHAV MED, V40, P69, DOI 10.1007/s10865-016-9798-7; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241	28	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					419	424		10.1097/HTR.0000000000000541			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200013	31688378				2022-02-06	
J	Bekker, W; Smith, MTD; Kong, VY; Bruce, JL; Laing, G; Manchev, V; Clarke, DL				Bekker, W.; Smith, M. T. D.; Kong, V. Y.; Bruce, J. L.; Laing, G.; Manchev, V; Clarke, D. L.			Isolated free fluid on computed tomography for blunt abdominal trauma - A South African Experience	ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND			English	Article						Blunt abdominal trauma; Isolated free fluid; Abdominal computed tomography	INTRAABDOMINAL FREE FLUID; MULTIDETECTOR CT; INJURY; LAPAROTOMY	INTRODUCTION The clinical significance of isolated free fluid on abdominal computed tomography (CT) in patients with blunt abdominal trauma is unclear. This audit reviews our unit's experience with isolated free fluid and attempts to refine our clinical algorithms for the assessment of patients with blunt abdominal trauma. MATERIALS AND METHODS All patients who sustained blunt abdominal trauma between December 2012 and December 2017 who were subjected to multidetector CT of the abdomen as part of their initial investigation were included in this study. RESULTS During the five-year period under review, a total of 1066 patients underwent abdominal CT following blunt poly trauma. A total of 84 (7.9%) patients died. There were 148 (14%) patients with CT finding of isolated free fluid. Of these, 128 (67%) were selected for non-operative management, which included a period of serial abdominal examinations. In this non-operative group, five patients failed their abdominal observations and underwent laparotomy. Findings in these five cases were negative (1), non-therapeutic (1), splenic injury (1), Pancreatic and splenic injury (1) and bladder injury (1). Thirteen patients (10%) died, none of whom had surgery. The causes of death were exsanguination from a major traumatic lower limb injury (1), multiple organ failure (1), traumatic brain injury (10) and spinal cord injury (1). The remaining 20 patients underwent laparotomy. The indications were failed non-operative management (5), abdominal distension (1) and suspicion of a missed hollow viscus injury (14). In this group there were 11 therapeutic and 6 non-therapeutic surgeries and three negative laparotomies. For the 15 patients selected for operative management, the findings were as follows: hollow viscus injury (3), mesenteric bleeds (2), splenic and pancreatic injury (1), liver and bladder injury (1), splenic and bladder injury (1), non-therapeutic (4), negative (3). The finding of isolated free fluid on CT is 98% sensitive and 96% specific for true isolated free fluid (chi square 331.598; P= 0.000). This finding predicts successful non-operative management with a positive predictive value of 93% and a negative predictive value of 96%. DISCUSSION In patients with blunt abdominal trauma, the finding of isolated free fluid on abdominal CT alone is no longer an indication for laparotomy. Other clinical factors must be taken into account when deciding on the need for laparotomy, such as haemodynamic status, clinical abdominal findings and the ability to reliably assess the abdomen. In the absence of a clinical indication for urgent laparotomy, patients with isolated free fluid may be observed.	[Bekker, W.; Smith, M. T. D.; Kong, V. Y.; Bruce, J. L.; Laing, G.; Manchev, V; Clarke, D. L.] Univ KwaZulu Natal, Dept Surg, Durban, South Africa; [Kong, V. Y.; Clarke, D. L.] Univ Witwatersrand, Dept Surg, Johannesburg, South Africa		Bekker, W (corresponding author), Univ KwaZulu Natal, Dept Surg, Durban, South Africa.	bekkerwanda@yahoo.com		Clarke, Damian/0000-0002-8467-1455; Laing, Grant/0000-0001-8075-0386			Atri M, 2008, RADIOLOGY, V249, P524, DOI 10.1148/radiol.2492072055; Banz Vanessa M, 2009, J Trauma Manag Outcomes, V3, P10, DOI 10.1186/1752-2897-3-10; Chen ZB, 2009, HEPATOB PANCREAT DIS, V8, P597; Drasin TE, 2008, AM J ROENTGENOL, V191, P1821, DOI 10.2214/AJR.07.3347; Howes N, 2012, S AFR J SURG, V50, P30; Joseph DK, 2013, AM J SURG, V205, P414, DOI 10.1016/j.amjsurg.2012.12.003; Mahmood I, 2014, WORLD J SURG, V38, P1411, DOI 10.1007/s00268-013-2427-5; Park MH, 2013, CLIN IMAG, V37, P884, DOI 10.1016/j.clinimag.2013.06.005; Valcarcel CR, 2009, CIR ESPAN, V86, P17, DOI 10.1016/j.ciresp.2009.01.015; Rodriguez C, 2002, J TRAUMA, V53, P79, DOI 10.1097/00005373-200207000-00016; Yu JX, 2010, RADIOLOGY, V256, P799, DOI 10.1148/radiol.10091903	11	3	3	1	1	ROYAL COLL SURGEONS ENGLAND	LONDON	35-43 LINCOLN'S INN FIELDS, LONDON WC2A 3PN, ENGLAND	0035-8843	1478-7083		ANN ROY COLL SURG	Ann. R. Coll. Surg. Engl.	NOV	2019	101	8					552	557		10.1308/rcsann.2019.0078			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JJ1YW	WOS:000493959100008	31219321	Green Published			2022-02-06	
J	Chaikittisilpa, N; Vavilala, MS; Lele, AV; Moore, AE; Bethel, J; Krishnamoorthy, V				Chaikittisilpa, Nophanan; Vavilala, Monica S.; Lele, Abhijit V.; Moore, Anne E.; Bethel, Justin; Krishnamoorthy, Vijay			Early cardiovascular function and associated hemodynamics in adults with isolated moderate-severe traumatic brain injury: A pilot study	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Cardiac function; Hemodynamic; Echocardiography	STANDARDS COMMITTEE; CARDIAC DYSFUNCTION; EARLY MANAGEMENT; TASK-FORCE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; QUANTIFICATION; CATECHOLAMINES; GUIDELINES	Background: While cardiac dysfunction has been described following traumatic brain injury (TBI), its association with systemic and cerebral hemodynamics is not known. We examined the contemporaneous relationship between early cardiac function with systemic and cerebral hemodynamic parameters after moderate-severe TBI. Methods: Bedside transthoracic echocardiography (TTE) and transcranial Doppler (TCD) ultrasonography were performed within 24 h in patients > 18 years with isolated moderate-severe TBI. Systemic hemodynamic parameters were quantified using routine monitoring [heart rate and mean arterial pressures (MAP)] and calculation from echocardiographic data [stroke volume index (SVI), cardiac index (CI), and systemic vascular resistance index (SVRI)]. Systolic dysfunction was defined using TTE as global longitudinal strain (GLS) > -16%. Mean middle cerebral artery velocity (FVm) was the measure of cerebral hemodynamics and quantified using TCD. Results: Among 15 patients [mean age 43 +/- 13 years, GCS 5 +/- 3, 73% male], 15 TTE and 15 TCD exams were performed simultaneously. Five (33%) patients had systolic dysfunction, with significantly worse GLS (median [IQR] -12.1% [-14.1, -12] vs. -19.1% [-19.9, -17.7], p = 0.004). Median (IQR) MAP was 97 (89, 107) mmHg, SVI (29.0 [20.5, 31.0] mL m(-2)), and CI (2.83 [2.05, 3.10] L/min m(-2)) were low to normal, while SVRI (2704 dyne sec/cm(5) m(-2) [2210, 4084]) was normal to high. None of the patients had abnormal TCDs. Higher GLS (reduced systolic function) was associated with lower SVI (r(2) = 0.274, p = 0.03) but not other parameters. Conclusion: Systemic hemodynamic parameters were consistent with an early catecholamine-excess state. While reduced systolic function was associated with lower SVI, there was no relationship with reduced cerebral perfusion, possibly due to normal MAP. (C) 2019 Published by Elsevier Ltd.	[Chaikittisilpa, Nophanan] Mahidol Univ, Siriraj Hosp, Dept Anesthesiol, 2 Prannok Rd, Bangkok 10110, Thailand; [Chaikittisilpa, Nophanan; Vavilala, Monica S.; Lele, Abhijit V.; Bethel, Justin; Krishnamoorthy, Vijay] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Vavilala, Monica S.; Lele, Abhijit V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Moore, Anne E.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC USA		Chaikittisilpa, N (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Anesthesiol, 2 Prannok Rd, Bangkok 10110, Thailand.	Nophanan.chi@mahidol.edu					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bentzer P, 2017, NEUROCRIT CARE, V26, P450, DOI 10.1007/s12028-016-0348-5; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, REP C TRAUM BRAIN IN; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cinotti R, 2016, INTENS CARE MED, V42, P173, DOI 10.1007/s00134-015-4106-5; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Giuseppe Citerio, 2014, NEUROCRIT CARE, V21, P38, DOI [10.1007/s12028-014-0033-5, DOI 10.1007/S12028-014-0033-5]; Gregory T, 2012, BJA EDUC, V12, P67, DOI 10.1093/bjaceaccp/mkr058; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HUNT D, 1972, AM HEART J, V83, P232, DOI 10.1016/0002-8703(72)90142-1; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Krishnamoorthy V, 2020, J NEUROSURG ANESTH, V32, P156, DOI 10.1097/ANA.0000000000000578; Krishnamoorthy V, 2018, CRIT CARE MED, V46, P965, DOI 10.1097/CCM.0000000000003052; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leitman IM, 2012, J SURG RES, V173, pE33, DOI 10.1016/j.jss.2011.10.040; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rzheutskaya RE, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/606179; Sivakumar S, 2017, J CRIT CARE, V39, P40, DOI 10.1016/j.jcrc.2017.01.005; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Varon J, 2014, ACUTE CRITICAL CARE, P1; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Zaroff JG, 2006, STROKE, V37, P1680, DOI 10.1161/01.STR.0000226461.52423.dd	37	3	3	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2019	69						97	103		10.1016/j.jocn.2019.08.024			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JP5SV	WOS:000498325100017	31477465				2022-02-06	
J	Chen, YF; Herrold, AA; Gallagher, VT; Reilly, JL; Parrish, T; Breiter, HC				Chen, Yufen; Herrold, Amy A.; Gallagher, Virginia T.; Reilly, James L.; Parrish, Todd; Breiter, Hans C.			Cutting to the Pathophysiology Chase: Translating Cutting-Edge Neuroscience to Rehabilitation Practice in Sports-Related Concussion Management	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						eye movement tracking; female athletes; magnetic resonance imaging; mild traumatic brain injury; neuroscience	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; DEFAULT-MODE NETWORK; COLLEGIATE FOOTBALL PLAYERS; MENSTRUAL-CYCLE PHASE; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY; RISK-FACTORS; LONGITUDINAL ASSESSMENT; ACTIVATION PATTERNS	SYNOPSIS: Mild traumatic brain injury, or concussion, is a common sports injury. Concussion involves physical injury to brain tissue and vascular and axonal damage that manifests as transient and often nonspecific clinical symptoms. Concussion diagnosis is challenging, and the relationship between brain injury and clinical symptoms is unclear. The purpose of this commentary was to translate cutting-edge neuroscience to rehabilitation practice. We (1) highlight potential biomarkers that may improve our understanding of concussion and its recovery, (2) explain why researchers must address the paucity of concussion research in female athletes, and (3) present female-specific factors that should be accounted for in future studies. Integrating objective, quantitative measures of concussion pathophysiology with concussion history, genetics, and genomics will help caregivers identify concussed athletes, tailor recovery protocols, and protect athletes from potential long-term effects of cumulative head impact.	[Chen, Yufen; Parrish, Todd] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Ctr Translat Imaging, Chicago, IL 60611 USA; [Herrold, Amy A.; Gallagher, Virginia T.; Reilly, James L.; Breiter, Hans C.] Concuss Neuroimaging Consortium, Chicago, IL 60611 USA; [Herrold, Amy A.; Gallagher, Virginia T.; Reilly, James L.; Breiter, Hans C.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, Chicago, IL 60611 USA; [Herrold, Amy A.] Edward Hines Jr VA Hosp, Hines, IL USA		Chen, YF (corresponding author), Northwestern Univ, Ctr Translat Imaging, 710 North Fairbanks Court,LC 0-300, Chicago, IL 60611 USA.	yfchen@northwestern.edu		Parrish, Todd/0000-0002-1184-1572	Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER; RRD VA [IK2 RX000949] Funding Source: Medline		Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Allen AM, 2016, EXP CLIN PSYCHOPHARM, V24, P1, DOI 10.1037/pha0000057; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andreano JM, 2010, NEUROIMAGE, V53, P1286, DOI 10.1016/j.neuroimage.2010.07.011; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Craig MC, 2008, HORM BEHAV, V53, P503, DOI 10.1016/j.yhbeh.2007.11.005; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daniels Kimberly, 2013, Natl Health Stat Report, P1; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; De Bondt T, 2013, EUR RADIOL, V23, P57, DOI 10.1007/s00330-012-2572-5; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Dietrich T, 2001, NEUROIMAGE, V13, P425, DOI 10.1006/nimg.2001.0703; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Gingnell M, 2012, HORM BEHAV, V62, P400, DOI 10.1016/j.yhbeh.2012.07.005; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Herrold AA, 2019, MIL MED, V184, P138, DOI 10.1093/milmed/usy306; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Joseph JE, 2012, NEUROIMAGE, V59, P2923, DOI 10.1016/j.neuroimage.2011.09.067; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klein C, 2001, EXP BRAIN RES, V139, P1; Koch KM, 2018, AM J NEURORADIOL, V39, P1215, DOI 10.3174/ajnr.A5692; Konrad C, 2008, J NEURAL TRANSM, V115, P1327, DOI 10.1007/s00702-008-0073-0; KWONG KK, 1995, MAGNET RESON MED, V34, P878, DOI 10.1002/mrm.1910340613; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Linnstaedt SD, 2016, J ORTHOP SPORT PHYS, V46, P911, DOI 10.2519/jospt.2016.6944; Mac Donald CL, 2019, J NEUROTRAUM, V36, P264, DOI 10.1089/neu.2018.5629; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Petersen N, 2014, NEUROIMAGE, V90, P24, DOI 10.1016/j.neuroimage.2013.12.016; Pletzer B, 2014, BRAIN RES, V1543, P128, DOI 10.1016/j.brainres.2013.11.007; Reichenbach JR, 2015, CLIN NEURORADIOL, V25, P225, DOI 10.1007/s00062-015-0432-9; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rumberg B, 2010, NEUROSCI RES, V66, P366, DOI 10.1016/j.neures.2009.12.011; Schisterman EF, 2014, EPIDEMIOL REV, V36, P71, DOI 10.1093/epirev/mxt007; Schoning S, 2007, NEUROPSYCHOLOGIA, V45, P3203, DOI 10.1016/j.neuropsychologia.2007.06.011; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shirley E, 2018, J AM ACAD ORTHOP SUR, V26, pE279, DOI 10.5435/JAAOS-D-16-00684; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Simon LM, 2016, CURR SPORT MED REP, V15, P161, DOI 10.1249/JSR.0000000000000268; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Terrell TR, 2018, BRIT J SPORT MED, V52, P192, DOI 10.1136/bjsports-2016-097419; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Tremblay S, 2017, EUR J NEUROSCI, V46, P1956, DOI 10.1111/ejn.13583; Walter A, 2019, J NEUROTRAUM, V36, P1115, DOI 10.1089/neu.2017.5622; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Weber AM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00575; Weis S, 2008, J NEUROSCI, V28, P13401, DOI 10.1523/JNEUROSCI.4392-08.2008; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	114	3	3	3	8	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					811	818		10.2519/jospt.2019.8884			8	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100006	31154951	Bronze			2022-02-06	
J	Chien, YJ; Chien, YC; Liu, CT; Wu, HC; Chang, CY; Wu, MY				Chien, Yung-Jiun; Chien, Yung-Chen; Liu, Chien-Ting; Wu, Hsin-Chi; Chang, Chun-Yu; Wu, Meng-Yu			Effects of Methylphenidate on Cognitive Function in Adults with Traumatic Brain Injury: A Meta-Analysis	BRAIN SCIENCES			English	Article						methylphenidate; traumatic brain injury; adult; meta-analysis	DOUBLE-BLIND; RELEASE METHYLPHENIDATE; SUSTAINED ATTENTION; PLACEBO; ADOLESCENTS; ENHANCEMENT; ACTIVATION; EFFICACY; SEQUELAE; DEFICITS	This meta-analysis evaluated the effects of methylphenidate (MPH) on cognitive outcome and adverse events in adults with traumatic brain injuries (TBI). We searched PubMed, EMBASE, and PsycINFO for randomized controlled trials (RCTs) published before July 2019. Studies that compared the effects of MPH and placebos in adults with TBI were included. The primary outcome was cognitive function, while the secondary outcome was adverse events. Meta-regression and sensitivity analysis were conducted to evaluate heterogeneity. Seventeen RCTs were included for qualitative analysis, and ten RCTs were included for quantitative analysis. MPH significantly improved processing speed, measured by Choice Reaction Time (standardized mean difference (SMD): -0.806; 95% confidence interval (CI): -429 to -0.182, p = 0.011) and Digit Symbol Coding Test (SMD: -0.653; 95% CI: -1.016 to -0.289, p < 0.001). Meta-regression showed that the reaction time was inversely associated with the duration of MPH. MPH administration significantly increased heart rate (SMD: 0.553; 95% CI: 0.337 to 0.769, p < 0.001), while systolic or diastolic blood pressure did not exhibit significant differences. Therefore, MPH elicited better processing speed in adults with TBI. However, MPH use could significantly increase heart rate. A larger study is required to evaluate the effect of dosage, age, or optimal timing on treatment of adults with TBI.	[Chien, Yung-Jiun; Liu, Chien-Ting; Wu, Hsin-Chi] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Phys Med & Rehabil, New Taipei 231, Taiwan; [Chien, Yung-Chen] Taipei Med Univ Hosp, Dept Med Educ, Taipei 110, Taiwan; [Chien, Yung-Jiun; Liu, Chien-Ting; Wu, Hsin-Chi; Chang, Chun-Yu] Tzu Chi Univ, Sch Med, Hualien 970, Taiwan; [Wu, Meng-Yu] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Emergency Med, New Taipei 231, Taiwan; [Wu, Meng-Yu] Tzu Chi Univ, Sch Med, Dept Emergency Med, Hualien 970, Taiwan		Chang, CY (corresponding author), Tzu Chi Univ, Sch Med, Hualien 970, Taiwan.; Wu, MY (corresponding author), Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Emergency Med, New Taipei 231, Taiwan.; Wu, MY (corresponding author), Tzu Chi Univ, Sch Med, Dept Emergency Med, Hualien 970, Taiwan.	jessica.kan.48@gmail.com; 102311050@gms.tcu.edu.tw; ctliu242@gmail.com; hsinchiwu@gmail.com; paulchang1231@gmail.com; skyshangrila@gmail.com	Wu, Meng Yu/J-8772-2019	Wu, Meng Yu/0000-0002-8773-1847; Chang, Chun-Yu/0000-0002-6958-4425; Chien, Yung Jiun/0000-0002-7750-1466	Taipei Tzu Chi Hospital [TCRD-TPE-108-5]	This study was funded by grants of Taipei Tzu Chi Hospital (TCRD-TPE-108-5).	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Andersen SL, 2004, INT J DEV NEUROSCI, V22, P423, DOI 10.1016/j.ijdevneu.2004.06.002; Andrews GD, 2006, NEUROPSYCHOPHARMACOL, V31, P594, DOI 10.1038/sj.npp.1300818; [Anonymous], 2013, COMPREHENSIVE META A; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Busardo FP, 2016, CURR NEUROPHARMACOL, V14, P17, DOI 10.2174/1570159X13666150407225902; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; Dorer CL, 2018, BRAIN INJURY, V32, P1040, DOI 10.1080/02699052.2018.1469166; Dymowski AR, 2017, CLIN REHABIL, V31, P733, DOI 10.1177/0269215516655590; Eme R, 2012, EXPERT REV NEUROTHER, V12, P475, DOI [10.1586/ERN.12.15, 10.1586/ern.12.15]; FARAJ BA, 1974, J PHARMACOL EXP THER, V191, P535; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Frankel T, 2007, APHASIOLOGY, V21, P1039, DOI 10.1080/02687030701198395; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hammerness P, 2014, CHILD NEUROPSYCHOL, V20, P319, DOI 10.1080/09297049.2013.790359; HINDMARCH I, 1977, BRIT J CLIN PHARMACO, V4, pS167, DOI 10.1111/j.1365-2125.1977.tb05747.x; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Jaeger J, 2018, J CLIN PSYCHOPHARM, V38, P513, DOI 10.1097/JCP.0000000000000941; Jenkins P, 2015, J NEUROL NEUROSUR PS, V86, DOI 10.1136/jnnp-2015-312379.166; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kolb Bryan, 2011, J Can Acad Child Adolesc Psychiatry, V20, P265; Lamberti M, 2015, CLIN THER, V37, pE47, DOI 10.1016/j.clinthera.2015.05.143; Laviola G, 1999, NEUROSCI BIOBEHAV R, V23, P993, DOI 10.1016/S0149-7634(99)00032-9; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Liang EF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081789; Lonn EM, 2014, CLIN RES CARDIOL, V103, P149, DOI 10.1007/s00392-013-0644-4; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; MAXWELL RA, 1958, J PHARMACOL EXP THER, V123, P22; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Motaghinejad M, 2016, NEUROSCI LETT, V619, P106, DOI 10.1016/j.neulet.2015.12.015; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Schrantee A, 2016, JAMA PSYCHIAT, V73, P955, DOI 10.1001/jamapsychiatry.2016.1572; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Storebo OJ, 2016, JAMA-J AM MED ASSOC, V315, P2009, DOI 10.1001/jama.2016.3611; Valentine JC, 2010, J EDUC BEHAV STAT, V35, P215, DOI 10.3102/1076998609346961; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960	62	3	3	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2019	9	11							291	10.3390/brainsci9110291			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3NV	WOS:000502273900002	31653039	Green Published, gold			2022-02-06	
J	Elbourn, E; Kenny, B; Power, E; Togher, L				Elbourn, Elise; Kenny, Belinda; Power, Emma; Togher, Leanne			Psychosocial Outcomes of Severe Traumatic Brain Injury in Relation of Discourse Recovery: A Longitudinal Study up to 1 Year Post-Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TROBE COMMUNICATION QUESTIONNAIRE; QUALITY-OF-LIFE; SELF-AWARENESS; NARRATIVE DISCOURSE; PSYCHOMETRIC PROPERTIES; FACIAL EXPRESSION; MAIN CONCEPTS; HEAD-INJURY; FOLLOW-UP; DEFICITS	Purpose: The interrelationship between psychosocial outcomes and discourse after severe traumatic brain injury remains largely unknown. This study examines outcomes relating to work, relationships, and independence within the context of discourse recovery across the 1st year post-injury. Method: An inception cohort comprising 57 participants with severe traumatic brain injury was assessed at 3, 6, 9, and 12 months post-injury. Outcomes were measured with the Sydney Psychosocial Reintegration Scale-2 (Tate et al., 2012; Tate, Simpson, Loo, & Lane-Brown, 2011), and discourse was evaluated with Main Concept Analysis of a narrative retell. Correlation and linear regression analyses were utilized. Results: Significant correlations were found between psychosocial outcomes reported by relatives and discourse performance across the 1st year. The 6-month discourse scores significantly predicted the 12-month psychosocial outcomes reported by relatives. Initial discourse severity and recovery pattern also informed outcomes. Conclusions: Discourse disorders have a strong relationship with everyday outcomes relating to work, relationships, and independence as reported by relatives. Six months post-injury is a beneficial time for assessment, education, and service planning. Age, years of education, and aphasia may mediate recovery and outcomes. A clinical decision tree is offered to support goal setting.	[Elbourn, Elise; Kenny, Belinda; Togher, Leanne] Univ Sydney, Discipline Speech Pathol, Sydney, NSW, Australia; [Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia		Elbourn, E (corresponding author), Univ Sydney, Discipline Speech Pathol, Sydney, NSW, Australia.	elise.elbourn@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406	National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia [GNT1056000, 632681]	This research was supported by National Health and Medical Research Council (Australia) Scholarship Grant GNT1056000 and National Health and Medical Research Council (Australia) Grant 632681, awarded to Leanne Togher, Robyn Tate, Skye McDonald, Lyn Illustrator, Audrey Holland, and Brian MacWhinney.	Armstrong E, 2006, CLIN APHASIOLOGY FUT; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Brassel S, 2016, BRAIN INJURY, V30, P1329, DOI 10.1080/02699052.2016.1187288; Campbell M., 2000, REHABILITATION TRAUM; Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Coolican H., 2014, RES METHODS STAT PSY, V6th Edn; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cupit J, 2010, APHASIOLOGY, V24, P1486, DOI 10.1080/02687031003615235; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; DAMICO JS, 1991, COMMUNICATION SKILLS, P125; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Evans JD, 1996, STRAIGHTFORWARD STAT; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1996, BRAIN INJURY, V10, P1; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Grimes N., 2005, WALT DISNEYS CINDERE; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; International Business Machines, 2016, IBM SPSS STAT MAC VE; Isaki E, 2000, BRAIN INJURY, V14, P441; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joanette Y, 2004, PROTOCOLE MONTREAL E; Jones CA, 2011, BRAIN INJURY, V25, P844, DOI 10.3109/02699052.2011.585507; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kertesz A., 2012, W APHASIA BATTERY RE; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kong APH, 2011, J SPEECH LANG HEAR R, V54, P148, DOI 10.1044/1092-4388(2010/09-0240); Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; Levack WMM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009727.pub2; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Meulenbroek P, 2013, CLIN APH C TUCS AZ; Meulenbroek P, 2016, J VOCAT REHABIL, V44, P15, DOI 10.3233/JVR-150777; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; NICHOLAS LE, 1995, J SPEECH HEAR RES, V38, P146, DOI 10.1044/jshr.3801.145; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Richardson C, 2014, BRAIN INJURY, V28, P1711, DOI 10.3109/02699052.2014.954270; Richardson JD, 2016, APHASIOLOGY, V30, P45, DOI 10.1080/02687038.2015.1057891; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Snow PC, 2000, BRAIN INJURY, V14, P397; Stark JA, 2010, APHASIOLOGY, V24, P709, DOI 10.1080/02687030903524729; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Tran S, 2018, BRAIN INJURY, V32, P1700, DOI 10.1080/02699052.2018.1537006; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; [No title captured]	86	3	3	1	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2019	28	4					1463	1478		10.1044/2019_AJSLP-18-0204			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	JP0ML	WOS:000497966200006	31487472				2022-02-06	
J	Euteneuer, J; Gosch, A; Cachee, P; Courts, C				Euteneuer, Jan; Gosch, Annica; Cachee, Philipp; Courts, Cornelius			Evaluation of the backspatter generation and wound profiles of an anatomically correct skull model for molecular ballistics	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Molecular ballistics; Backspatter; Ballistic head model; Blank gun	BLOOD-SPATTER PATTERNS; CLOSE-RANGE SHOTS; BIOLOGICAL TRACES; BRAIN SIMULANTS; GUNSHOT WOUNDS; GUN BARRELS; HEAD; FIREARM; TRAUMA; INJURY	Molecular ballistics connects the molecular genetic analysis of biological traces with the wounding events and complex forensic traces investigated in terminal ballistics. Backspatter, which originates from a projectile hitting a biological target when blood and/or tissue is propelled back into the direction of the gun, is of particular interest; those traces can consolidate and persist on the outer and inner surfaces of firearms and serve as evidence in criminal investigations. Herein, we are the first to present an anatomically correct head model for molecular ballistic research based on a polyurethane skull replica enclosing tissue-simulating sponge material that is doped with "triple-contrast" mixture (EDTA-blood, acrylic paint, and an x-ray contrast agent). Ten percent ballistic gelatin was used as brain simulant. We conducted contact and intermediate-range shots with a Glock 19 pistol (9 mm Luger), a pump-action shotgun (12/70 slugs), and blank cartridge handguns. Each shot was documented by a high-speed camera at 35,000 fps. Apart from the blank cartridge guns, all gunshots penetrated the skull model and created backspatter, which was recovered from the distal part of the barrels and analyzed. The pistol contact shots and one of three shotgun shots yielded full STR profiles. While the shotgun slugs destroyed the skulls, the remaining models could be used for radiological and optical fracture and wound channel evaluation. Known backspatter mechanisms and their respective timing could be confirmed visually by video analysis. Our complete model setup proved to be well applicable to molecular ballistic research as well as wound channel and fracture pattern investigation.	[Euteneuer, Jan; Gosch, Annica; Courts, Cornelius] Univ Med Ctr Schleswig Holstein, Inst Forens Med, Kiel, Germany; [Cachee, Philipp] Sachverstandigenburo Cachee, Pistoriusstr 6a, D-13086 Berlin, Germany		Courts, C (corresponding author), Univ Med Ctr Schleswig Holstein, Inst Forens Med, Kiel, Germany.	cornelius.courts@uksh.de	Cachee, Philipp/AAH-8904-2021	Gosch, Annica/0000-0002-3315-7587; Courts, Cornelius/0000-0002-9811-8482; Euteneuer, Jan/0000-0001-7800-3509	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [CO 992/7-1]	This project was funded by the Deutsche Forschungsgemeinschaft (DFG) (CO 992/7-1).	Bir C, 2016, FORENSIC SCI INT, V261, P1, DOI 10.1016/j.forsciint.2016.01.023; Bolliger SA, 2014, J FORENSIC RADIOL IM, V2, P17, DOI 10.1016/j.jofri.2013.12.001; BUTLER EG, 1945, J NEUROSURG, V2, P358, DOI 10.3171/jns.1945.2.4.0358; Buyuk Y, 2009, J FORENSIC LEG MED, V16, P354, DOI 10.1016/j.jflm.2009.01.011; Carr D, 2015, INT J LEGAL MED, V129, P505, DOI 10.1007/s00414-014-1073-2; Courts C, 2014, J FORENSIC SCI, V59, P1129, DOI 10.1111/1556-4029.12434; Courts C, 2012, INT J LEGAL MED, V126, P391, DOI 10.1007/s00414-011-0655-5; De Boer HH, 2016, INT J LEGAL MED, V130, P1371, DOI 10.1007/s00414-016-1324-5; Demirci S, 2011, J FORENSIC LEG MED, V18, P237, DOI 10.1016/j.jflm.2011.05.005; FACKLER ML, 1988, AM J FOREN MED PATH, V9, P218, DOI 10.1097/00000433-198809000-00008; Falland-Cheung L, 2018, J MECH BEHAV BIOMED, V77, P609, DOI 10.1016/j.jmbbm.2017.10.026; Falland-Cheung L, 2017, J MECH BEHAV BIOMED, V65, P665, DOI 10.1016/j.jmbbm.2016.09.034; Freitas CJ, 2014, INT J MED SCI, V11, P409, DOI 10.7150/ijms.8079; Giese A, 2002, SURG NEUROL, V57, P268, DOI 10.1016/S0090-3019(02)00643-2; Grabmuller M, 2016, FORENSIC SCI INT, V258, P11, DOI 10.1016/j.forsciint.2015.10.030; Grabmuller M, 2015, FORENSIC SCI MED PAT, V11, P365, DOI 10.1007/s12024-015-9695-3; HORI H, 1972, J INVEST DERMATOL, V58, P396, DOI 10.1111/1523-1747.ep12540633; Jussila J, 2005, FORENSIC SCI INT, V150, P63, DOI 10.1016/j.forsciint.2004.06.039; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 2002, INT J LEGAL MED, V116, P273, DOI 10.1007/s00414-002-0325-8; Karger B, 1997, INT J LEGAL MED, V110, P27; Karger B, 1997, INT J LEGAL MED, V110, P323, DOI 10.1007/s004140050096; Karger B, 2009, FORENSIC PATHOLOGY R, P139; Kronlein RU, 1899, ARCH KLIN CHIR, V59, P67; Kunz SN, 2013, FORENSIC SCI INT, V228, pE54, DOI 10.1016/j.forsciint.2013.02.012; Kunz SN, 2015, J FORENSIC SCI, V60, P166, DOI 10.1111/1556-4029.12572; Lazarjan MS, 2014, FORENSIC SCI INT, V239, P73, DOI 10.1016/j.forsciint.2014.03.022; Lux C, 2014, FORENSIC SCI INT, V237, P62, DOI 10.1016/j.forsciint.2014.01.016; MADEA B, 1988, J FORENSIC SCI SOC, V28, P321, DOI 10.1016/S0015-7368(88)72858-3; Mahoney PF, 2017, INT J LEGAL MED, V131, P1043, DOI 10.1007/s00414-017-1557-y; Mahoney P, 2019, INT J LEGAL MED, V133, P151, DOI 10.1007/s00414-018-1802-z; Mahoney P, 2018, INT J LEGAL MED, V132, P519, DOI 10.1007/s00414-017-1737-9; Pang B. C. M., 2007, Legal Medicine, V9, P181, DOI 10.1016/j.legalmed.2006.12.003; Peschel O, 2011, FORENSIC SCI MED PAT, V7, P257, DOI 10.1007/s12024-010-9198-1; Radford GE, 2016, INT J LEGAL MED, V130, P985, DOI 10.1007/s00414-015-1219-x; Reardon PK, 2018, SCIENCE, V360, P1222, DOI 10.1126/science.aar2578; Rossi C, 2018, J FORENSIC SCI, V63, P1526, DOI 10.1111/1556-4029.13713; Schyma C, 2017, FORENSIC SCI INT, V273, P64, DOI 10.1016/j.forsciint.2017.01.031; Schyma C, 2012, INT J LEGAL MED, V126, P607, DOI 10.1007/s00414-012-0704-8; Schyma C, 2012, FORENSIC SCI INT, V214, P82, DOI 10.1016/j.forsciint.2011.07.021; Schyma C, 2017, FORENSIC SCI MED PAT, V13, P188, DOI 10.1007/s12024-017-9868-3; Schyma C, 2015, INT J LEGAL MED, V129, P1027, DOI 10.1007/s00414-015-1151-0; Schyma C, 2013, FORENSIC SCI INT-GEN, V7, P22, DOI 10.1016/j.fsigen.2012.05.008; Schyma CWA, 2010, FORENSIC SCI INT, V197, P114, DOI 10.1016/j.forsciint.2010.01.002; Sellier K, 1982, ARBEITSMETHODEN MED, V8; Smith MJ, 2015, LEGAL MED-TOKYO, V17, P427, DOI 10.1016/j.legalmed.2015.06.007; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; Taylor SC, 2018, FORENSIC SCI INT, V282, P157, DOI 10.1016/j.forsciint.2017.11.032; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Viel G, 2009, FORENSIC SCI MED PAT, V5, P22, DOI 10.1007/s12024-008-9062-8; Weimann W., 1931, DTSCH Z GERICHTL MED, V17, P92, DOI DOI 10.1007/BF02252047; Wiethold, 1934, DTSCH Z GERICHTL MED, V23, P71, DOI 10.1007/BF01771912; Wood I, 2017, FORENS SCI INT-GEN S, V6, pE153, DOI 10.1016/j.fsigss.2017.09.022; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335; Zwirner J, 2017, INT J LEGAL MED, V131, P1581, DOI 10.1007/s00414-017-1580-z	58	3	3	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	NOV	2019	133	6					1839	1850		10.1007/s00414-019-02120-2			12	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	JG4IP	WOS:000492038100023	31338573				2022-02-06	
J	Gardner, JE; Teramoto, M; Hansen, C				Gardner, James E.; Teramoto, Masaru; Hansen, Colby			Factors Associated With Degree and Length of Recovery in Children With Mild and Complicated Mild Traumatic Brain Injury	NEUROSURGERY			English	Article						Degree and length of recovery; Complicatedmild traumatic brain injury; Concussion; Pediatric mild traumatic brain injury; Computed tomography	POSTCONCUSSION SYNDROME; OUTCOMES; RECOMMENDATIONS; ADOLESCENTS; PREVALENCE; CONCUSSION	BACKGROUND: A complicated mild traumatic brain injury (C-mTBI) is an mTBI with some form of intracranial abnormality identified radiographically. The lack of knowledge in recovery patterns and no clear guidelines on return to activity in children with C-mTBI provide unique challenges to physicians. OBJECTIVE: To examine recovery patterns among three cohorts: mTBI, mTBI with skull fracture only (mTBI-SF), and C-mTBI via a cross-sectional survey. METHODS: Caregivers of children with mTBI (from hospital database queries 2010-2013) were mailed a questionnaire on preinjury health, postinjury recovery, and activity patterns before and after injury. We examined degree (0-10 with 10 being complete recovery) and length (in months) of recovery in children with mTBI, and associations of potential risk factors to these variables. RESULTS: Of the 1777 surveyed, a total of 285 complete responses were analyzed for this study. Data included 175 (61.4%) children with mTBI, 33 (11.6%) children with mTBI-SF, and 77 (27.0%) children with C-mTBI. Older age and C-mTBI (vs mTBI) were significantly associated with a lower degree and longer period of recovery (P < .05). Predicted probabilities of complete recovery for children with mTBI, those with mTBI-SF, and those with C-mTBI were 65.5%, 52.7%, and 40.0%, respectively. Predicted probabilities of not yet completely recovered after more than a year since injury for these groups were 11.3%, 24.4%, and 37.6%, respectively. CONCLUSION: These results demonstrate significant differences in children with different forms of mTBI, and argue for further investigation of treatment plans individualized for each form of mTBI.	[Gardner, James E.] Univ Utah, Sch Med, Salt Lake City, UT 84108 USA; [Teramoto, Masaru; Hansen, Colby] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84108 USA		Hansen, C (corresponding author), Univ Utah, Div Phys Med & Rehabil, Sch Med, 590 Wakara Way, Salt Lake City, UT 84108 USA.	Colby.Hansen@hsc.utah.edu	Hansen, Colby/AAP-7680-2021	Hansen, Colby/0000-0002-8012-2483			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2017, BRIT J SPORT MED, V51, P862, DOI [10.1136/bjsports-2016-097270.223, DOI 10.1136/BJSPORTS-2016-097270.223]; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Hansen C, 2019, PEDIATR NEUROL, V90, P31, DOI 10.1016/j.pediatrneurol.2018.09.015; Iverson GL, 2000, BRAIN INJURY, V14, P1057; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Ma H-P, 2017, J NEUROL NEUROSCI, V8; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Valier AR, 2016, ARCH PHYS MED REHAB, V97, P1202, DOI 10.1016/j.apmr.2015.11.015; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Veeramuthu V, 2017, WORLD NEUROSURG, V97, P416, DOI 10.1016/j.wneu.2016.10.041; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	37	3	3	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2019	85	5					E842	E850		10.1093/neuros/nyz140			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	JI6HX	WOS:000493569500014	31058994				2022-02-06	
J	Guo, D; Verweel, L; Reed, N				Guo, David; Verweel, Lee; Reed, Nick			Exploring Gaps in Concussion Knowledge and Knowledge Translation Among Coaches of Youth Female Hockey	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; pediatric; female; coaches; knowledge; knowledge translation	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; ANXIETY DISORDERS; HEAD-INJURY; SYMPTOMS; PREDICTORS; MANAGEMENT; CHILDREN; IMPACT	Objective: To better understand the level of concussion knowledge of youth female hockey coaches and to identify preferred methods of knowledge translation for this population. Design: Cross-sectional survey. Setting: Participants independently completed written surveys before in-person concussion information sessions or online surveys through link provided in emails. Participants: Convenience sampling yielded 130 coaches of youth female hockey from Canada. Main Outcome Measures: Knowledge level on concussion, resources from which coaches obtained information on concussion, opinions on the current level of concussion knowledge, and knowledge translation. Results: Coaches demonstrated adequate knowledge on concussion, achieving 84% correct on true-false questions and 92% correct on symptom identification accuracy. However, coaches showed limited awareness of concussion specific to mechanisms for injury (identification) and postconcussion symptoms. Internet resources were rated as the most used resources for concussion yet were not rated very helpful. Nonetheless, coaches indicated online courses and web sites as the most preferred method for concussion knowledge translation. Conclusions: Youth female hockey coaches have overall adequate knowledge of concussion; however, gaps in knowledge do exist. Future efforts to raise the concussion knowledge among coaches of female youth hockey should include information specific to the mechanism of injury, along with sign and symptom identification, with particular attention paid to emotional symptoms. Given the reported preferences and the widespread availability of the Internet, further exploration and research validation of online courses and web sites tailored to the youth female hockey community is encouraged.	[Guo, David; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Verweel, Lee; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Verweel, Lee; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada		Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	nreed@hollandbloorview.ca			University of Toronto, Department of Occupational Science and Occupational Therapy; Concussion Research Centre at Bloorview Research Institute	The authors thank the University of Toronto, Department of Occupational Science and Occupational Therapy, the Concussion Research Centre at Bloorview Research Institute, and all participants involved in the research study for their support of this project.	Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Canadian Radio-Television and Telecommunications Commission, 2015, CAN RAD TEL TEL COMM, P1; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, HEADS; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hockey Canada, 2007, 2007 ANN REP; Hockey Canada, 2014, 2014 ANN REP; Hockey Canada, 2011, 2011 ANN REP; Hockey Canada, 2015, 2015 ANN REP; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lella A, 2016, 2015 US MOBILE APP R, P1; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McLeod JD, 2012, J HEALTH SOC BEHAV, V53, P482, DOI 10.1177/0022146512462888; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Moore DS, 2009, INTRO PRACTICE STAT, P339; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Pew Research Center, 2013, INT US DEM; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Smith A, 2015, PEW RES CENT, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Statistista, 2016, NUMB APPS AV LEAD AP; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; Van Ameringen M, 2003, J ANXIETY DISORD, V17, P561, DOI 10.1016/S0887-6185(02)00228-1; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	50	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2019	29	6					486	493		10.1097/JSM.0000000000000542			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	KG1IB	WOS:000509694100017	31688180				2022-02-06	
J	Jackson, S; Baity, MR; Bobb, K; Swick, D; Giorgio, J				Jackson, Sarah; Baity, Matthew R.; Bobb, Kailyn; Swick, Diane; Giorgio, Jeannette			Stress Inoculation Training Outcomes Among Veterans With PTSD and TBI	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						stress inoculation training; veterans; PTSD	TRAUMATIC BRAIN-INJURY; COGNITIVE PROCESSING THERAPY; AFGHANISTAN WAR VETERANS; PSYCHOMETRIC PROPERTIES; DISORDER; MILITARY; PSYCHOTHERAPY; CHECKLIST; IRAQ; PERFORMANCE	Objective: Stress inoculation training (SIT) is a cognitive-behavioral treatment that has demonstrated potential as a nontrauma based intervention for veterans with pasttratimatic stress disorder (PTSD). The purpose of this study was to explore the efficacy of a novel 3-phase group formulation of SIT applied to a naturalistic population of veterans with PTSD and traumatic brain injury (TBI). The goals were to reduce symptoms of PTSD and depression. improve perceived functioning. and increase treatment initiation among veterans who were reticent to initiate established evidence-based and trauma-focused therapies. Method: A program development and evaluation archival analysis of 65 veterans engaged in SIT over an 18-month period at an outpatient VA PTSD clinic was conducted. Participants completed baseline self-report measures of PTSD and depression symptoms, substance use. and perceived performance. Results: Paired samples I tests were used to evaluate pre- to posttreatment gains and demonstrated significant reductions in PTSD (PTSD Checklist, d = 0.66) and depression symptoms (Beck Depression Inventory. d = 0.67), increases in aspects of perceived stress tolerance and performance in multiple life domains, as well as improvements in both social and occupational functioning (Situational Adaptation to Stress Scale, d = 1.26). Eighty-eight percent of the intent-to-treat sample followed through with the recommended follow-up treatment. Conclusions: The results of this study provide preliminary support for the use of this SIT protocol in reducing symptoms of PTSD and depression, improving performance, and increasing rates of treatment initiation in evidence-based and trauma-focused treatments.	[Jackson, Sarah; Giorgio, Jeannette] Vet Affairs Northern Calif Hlth Care Syst, Mather, CA 95655 USA; [Baity, Matthew R.; Bobb, Kailyn] Alliant Int Univ, San Diego, CA USA; [Swick, Diane] Univ Calif Davis, Davis, CA 95616 USA; [Swick, Diane] Vet Affairs Northern Calif Hlth Care Syst, Martinez, CA USA		Jackson, S (corresponding author), Vet Affairs Northern Calif Hlth Care Syst, Mather, CA 95655 USA.	sarah.jackson6@va.gov			CSRD VA [I01 CX000566] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [I01CX000566] Funding Source: NIH RePORTER		Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Barwood MJ, 2006, AVIAT SPACE ENVIR MD, V77, P1136; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Blake DD, 1990, BEHAV THERAP, V13, P187; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Bryan CJ, 2011, PROF PSYCHOL-RES PR, V42, P16, DOI 10.1037/a0022290; Cacciola JS, 2013, J SUBST ABUSE TREAT, V44, P256, DOI 10.1016/j.jsat.2012.07.013; Cohen J., 2013, STAT POWER ANAL BEHA; DeViva JC, 2017, PSYCHOL TRAUMA-US, V9, P35, DOI 10.1037/tra0000189; Drisekll JE, 2001, HUM FACTORS, V43, P99, DOI 10.1518/001872001775992471; FOA EB, 1991, J CONSULT CLIN PSYCH, V59, P715, DOI 10.1037/0022-006X.59.5.715; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2018, JAMA-J AM MED ASSOC, V319, P354, DOI 10.1001/jama.2017.21242; Hamblen JL, 2015, PROF PSYCHOL-RES PR, V46, P90, DOI 10.1037/a0038535; Harmon AL, 2014, PSYCHOL SERV, V11, P295, DOI 10.1037/a0035846; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hourani L, 2016, MIL MED, V181, P1151, DOI 10.7205/MILMED-D-15-00192; Hundt NE, 2018, PSYCHOL SERV, V15, P536, DOI 10.1037/ser0000212; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Jones KD, 2010, J COUNS DEV, V88, P372, DOI 10.1002/j.1556-6678.2010.tb00036.x; Lu MW, 2016, J BEHAV HEALTH SER R, V43, P71, DOI 10.1007/s11414-013-9372-9; Mayer R.E., 2005, CAMBRIDGE HDB MULTIM, DOI DOI 10.1017/CBO9780511816819.004; Mayer RE., 2011, APPL SCI LEARNING; Mayer RE, 2009, MULTIMEDIA LEARNING, 2ND EDITION, P1; McClernon CK, 2011, HUM FACTORS, V53, P207, DOI 10.1177/0018720811405317; Meichenbaum, 1985, STRESS INOCULATION T; MEICHENBAUM D, 1976, BEHAV MANAGEMENT ANX, P1; Meichenbaum D., 2007, PRINCIPLES PRACTICE, P497; MEICHENBAUM DH, 1972, J CONSULT CLIN PSYCH, V39, P370, DOI 10.1037/h0033896; Meichenbaum Donald, 2011, TREATING PTSD MILITA, P325, DOI DOI 10.1016/J.SOCSCIMED.2009.06.022; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Mott JM, 2014, J TRAUMA STRESS, V27, P265, DOI 10.1002/jts.21927; Mott JM, 2014, MIL MED, V179, P143, DOI 10.7205/MILMED-D-13-00363; Resick PA, 2017, JAMA PSYCHIAT, V74, P28, DOI 10.1001/jamapsychiatry.2016.2729; Rizzo A., 2006, NOVEL APPROACHES DIA, V6, P235, DOI DOI 10.1109/VR.2006.23]; Robson S., 2014, RR750AF RAND CORP; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scheiner DL, 2014, J TRAUMA STRESS, V27, P291, DOI 10.1002/jts.21921; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Sozda CN, 2014, NEUROPSYCHOLOGY, V28, P347, DOI 10.1037/neu0000043; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Stetz MC, 2006, ANN REV CYBERTHERAPY, V4, P51; Stetz MC, 2007, ANN REV CYBERTHERAPY, V5, P192; SWELLER J, 1988, COGNITIVE SCI, V12, P257, DOI 10.1207/s15516709cog1202_4; Sweller J., 1994, LEARN INSTR, V4, P295, DOI [DOI 10.1016/0959-4752(94)90003-5, 10.1016/0959-4752(94)90003-5]; Swick D, 2015, PSYCHIAT RES-NEUROIM, V234, P227, DOI 10.1016/j.pscychresns.2015.09.016; Taylor BC, 2014, J REHABIL RES DEV, V51, pVII, DOI 10.1682/JRRD.2014.06.0155; The US Department of Veterans Affairs and Department of Defense, 2017, VA DOD CLIN PRACT GU; Turner D, 2008, J CYBERTHERAPY REHAB, V1, P239; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wiederhold B. K., 2004, CYB 9 C SAN DIEG CA; Wiederhold M. D., 2006, VIRTUAL REALITY TRAI; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	59	3	3	0	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	NOV	2019	11	8					842	850		10.1037/tra0000432			9	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	JH5BT	WOS:000492784800005	30896224				2022-02-06	
J	Kayhanian, S; Young, AMH; Mangla, C; Jalloh, I; Fernandes, HM; Garnett, MR; Hutchinson, PJ; Agrawal, S				Kayhanian, Saeed; Young, Adam M. H.; Mangla, Chaitanya; Jalloh, Ibrahim; Fernandes, Helen M.; Garnett, Matthew R.; Hutchinson, Peter J.; Agrawal, Shruti			Modelling outcomes after paediatric brain injury with admission laboratory values: a machine-learning approach	PEDIATRIC RESEARCH			English	Article							HEAD TRAUMA; CHILDREN; LACTATE; HYPERGLYCEMIA; MORTALITY; CARE	BACKGROUND: Severe traumatic brain injury (TBI) is a leading cause of mortality in children, but the accurate prediction of outcomes at the point of admission remains very challenging. Admission laboratory results are a promising potential source of prognostic data, but have not been widely explored in paediatric cohorts. Herein, we use machine-learning methods to analyse 14 different serum parameters together and develop a prognostic model to predict 6-month outcomes in children with severe TBI. METHODS: A retrospective review of patients admitted to Cambridge University Hospital's Paediatric Intensive Care Unit between 2009 and 2013 with a TBI. The data for 14 admission serum parameters were recorded. Logistic regression and a support vector machine (SVM) were trained with these data against dichotimised outcomes from the recorded 6-month Glasgow Outcome Scale. RESULTS: Ninety-four patients were identified. Admission levels of lactate, H+, and glucose were identified as being the most informative of 6-month outcomes. Four different models were produced. The SVM using just the three most informative parameters was the best able to predict favourable outcomes at 6 months (sensitivity = 80%, specificity = 99%). CONCLUSIONS: Our results demonstrate the potential for highly accurate outcome prediction after severe paediatric TBI using admission laboratory data.	[Kayhanian, Saeed; Young, Adam M. H.; Jalloh, Ibrahim; Fernandes, Helen M.; Garnett, Matthew R.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Kayhanian, Saeed; Mangla, Chaitanya] Univ Cambridge, Fitzwilliam Coll, Cambridge, England; [Mangla, Chaitanya] Univ Cambridge, Dept Comp Sci & Technol, Cambridge, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Paediat Intens Care, Cambridge, England		Kayhanian, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.; Kayhanian, S (corresponding author), Univ Cambridge, Fitzwilliam Coll, Cambridge, England.	sk776@cam.ac.uk			Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme); National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Brain Injury and Repair Theme); National Institute for Health Research (NIHR) Academic Clinical FellowshipNational Institute for Health Research (NIHR); National Institute for Health ResearchNational Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); European Union Seventh Framework Programme grant (CENTRE-TBI) [602150]; Royal College of Surgeons of England; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277, G0600986] Funding Source: UKRI	Research support-the Medical Research Council (MRC, Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). A.M.H.Y. is supported by a National Institute for Health Research (NIHR) Academic Clinical Fellowship. P.J.H. is supported by a Research Professorship from the National Institute for Health Research, the NIHR Cambridge Biomedical Research Centre, a European Union Seventh Framework Programme grant (CENTRE-TBI; grant no. 602150), and the Royal College of Surgeons of England.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Hermanides J, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1883-y; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Kan CH, 2009, MALAYS J MED SCI, V16, P25; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034	26	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	NOV	2019	86	5					641	645		10.1038/s41390-019-0510-9			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	JM9DI	WOS:000496506400019	31349360	Green Published			2022-02-06	
J	Lenski, M; Biczok, A; Neufischer, K; Tonn, JC; Briegel, J; Thon, N				Lenski, Markus; Biczok, Annamaria; Neufischer, Katrin; Tonn, Joerg-Christian; Briegel, Josef; Thon, Niklas			Significance of cerebrospinal fluid inflammatory markers for diagnosing external ventricular drain-associated ventriculitis in patients with severe traumatic brain injury	NEUROSURGICAL FOCUS			English	Article						ventriculitis; external ventricular drain; cerebrospinal fluid; IL-6; traumatic brain injury; inflammatory marker; ventriculostomy	CELL INDEX; INTERLEUKIN-6; MENINGITIS; INFECTIONS; IL-6; MANAGEMENT; ONSET	OBJECTIVE The aim of this study was to investigate the diagnostic potential of the inflammatory markers interleukin-6 (IL-6), total leukocyte count (TLC), and protein in the CSF and IL-6, C-reactive protein, and white blood cell count in the serum for the early diagnosis of ventriculitis in patients with traumatic brain injury (TBI) and an external ventricular drain compared with patients without ventriculitis. METHODS Retrospective data from 40 consecutive patients with TBI and an external ventricular drain treated in the authors' intensive care unit between 2013 and 2017 were analyzed. For all markers, arithmetical means and standard deviations, area under the curve (AUC), cutoff values, sensitivity, specificity, positive likelihood ratio (LR), and negative LR were calculated and correlated with presence or absence of ventriculitis. RESULTS There were 35 patients without ventriculitis and 5 patients with ventriculitis. The mean +/- SD IL-6 concentration in CSF was significantly increased, with 6519 +/- 4268 pg/mL at onset of ventriculitis compared with 1065 +/- 1705 pg/mL in patients without ventriculitis (p = 0.04). Regarding inflammatory markers in CSF, IL-6 showed the highest diagnostic potential for differentiation between the presence and absence of ventriculitis (AUC 0.938, cutoff 4064 pg/mL, sensitivity 100%, specificity 92.3%, positive LR 13, and negative LR 0), followed by TLC (AUC 0.900, cutoff 64.5 /mu L, sensitivity 100%, specificity 80%, positive LR 5.0, and negative LR 0) and protein (AUC 0.876, cutoff 31.5 mg/dL, sensitivity 100%, specificity 62.5%, positive LR 2.7, and negative LR 0). CONCLUSIONS The level of IL-6 in CSF has the highest diagnostic value of all investigated inflammatory markers for detecting ventriculitis in TBI patients at an early stage. In particular, CSF IL-6 levels higher than the threshold of 4064 pg/mL were significantly associated with the probability of ventriculitis.	[Lenski, Markus; Biczok, Annamaria; Neufischer, Katrin; Tonn, Joerg-Christian; Thon, Niklas] Ludwig Maximilian Univ Munchen, Neurochirurg Klin & Poliklin, Munich, Germany; [Briegel, Josef] Ludwig Maximilian Univ Munchen, Anasthesiol Klin, Klinikum Grosshadern, Munich, Germany		Lenski, M (corresponding author), Klinikum Univ Munchen, Neurochirurg Klin & Poliklin, Munich, Germany.	markus.lenski@med.uni-muenchen.de	Briegel, Josef/AAG-3774-2019; Tonn, Joerg/AAK-8509-2021; Josef, Briegel/ABF-3522-2021; Thon, Niklas/AAI-9069-2021	Thon, Niklas/0000-0003-0011-5281			Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; BOHR V, 1984, ARCH NEUROL-CHICAGO, V41, P1045, DOI 10.1001/archneur.1984.04050210043012; Chen L, 2016, BRAIN INJURY, V30, P318, DOI 10.3109/02699052.2015.1113565; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Eftekhar B, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-2; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gordon M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0567-0; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Hoogmoed J, 2017, NEUROCRIT CARE, V26, P362, DOI 10.1007/s12028-016-0345-8; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Pinto VLL, 2011, BRAZ J INFECT DIS, V15, P156, DOI 10.1590/S1413-86702011000200011; Lenski M, 2019, J NEUROSURG ANESTH, V31, P227, DOI 10.1097/ANA.0000000000000496; Lenski M, 2017, WORLD NEUROSURG, V99, P132, DOI 10.1016/j.wneu.2016.11.131; Lenski M, 2014, J ARTHROPLASTY, V29, P1105, DOI 10.1016/j.arth.2014.01.014; Liu ZH, 2015, CRIT CARE MED, V43, P2416, DOI 10.1097/CCM.0000000000001188; Lunardi LW, 2017, WORLD NEUROSURG, V106, P504, DOI 10.1016/j.wneu.2017.07.012; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Miller JM, 2018, CLIN INFECT DIS, V67, P813, DOI 10.1093/cid/ciy584; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Prasad R, 2014, PEDIATR NEUROL, V50, P60, DOI 10.1016/j.pediatrneurol.2013.08.016; Rumalla K, 2018, PEDIATR NEUROL, V80, P70, DOI 10.1016/j.pediatrneurol.2017.11.015; SAKAI H, 1984, Neurological Surgery, V12, P205; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Seule M, 2015, FACIAL PLAST SURG, V31, P325, DOI 10.1055/s-0035-1562884; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; STEUDEL WI, 1986, ACTA NEUROCHIR, V80, P93, DOI 10.1007/BF01812281; Takahashi W, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.02.020; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Walti LN, 2013, J INFECTION, V66, P424, DOI 10.1016/j.jinf.2012.12.010; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	35	3	3	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E15	10.3171/2019.8.FOCUS19407			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900015	31675710	gold			2022-02-06	
J	Lin, SY; Chen, WS; Harnod, T; Lin, CL; Hsu, WH; Lin, CC; Chang, YL; Wang, IK; Kao, CH				Lin, Shih-Yi; Chen, Weishan; Harnod, Tomor; Lin, Cheng-Li; Hsu, Wu-Huei; Lin, Cheng-Chieh; Chang, Yun-Lun; Wang, I-Kuan; Kao, Chia-Hung			Sleep apnea and risk of traumatic brain injury and associated mortality and healthcare costs: a population-based cohort study	ANNALS OF TRANSLATIONAL MEDICINE			English	Article						Sleep apnea; traumatic brain injury; hypnotic	DISEASE; STROKE	Background: The objective of this study was aimed to investigate whether sleep apnea patients had a higher risk of traumatic brain injury. Methods: Data were collected from the Taiwan Longitudinal Health Insurance Database during the period of 2000-2012. The study cohort comprised 6,456 patients aged >= 20 years with a first diagnosis of sleep apnea. The primary outcome was the incidence of traumatic brain injury. Kaplan-Meier survival analysis and Cox proportional-hazards modeling were used. Results: After adjustments for associated comorbidities and hypnotic medications, sleep apnea patients were associated with a 1.19-fold higher risk of traumatic brain injury (95% CI, 1.07-1.33) compared with patients without sleep apnea. Sleep apnea patients who took benzodiazepine (BZD) had a 1.30-fold increased risk of traumatic brain injury compared with patients without sleep apnea (95% CI, 1.14-1.49). However, this risk was not statistically significant, with a 1.03-fold risk of traumatic brain injury in sleep apnea patients without BZD use (95% CI, 0.84-1.25) compared with patients without sleep apnea. Compared with patients without sleep apnea, the risk of traumatic brain injury in sleep apnea patients aged 65-79 years old was higher (adjusted hazard ratio, 1.36; 95% CI, 1.06-1.74). Conclusions: Sleep apnea patients, regardless of hypnotic use, had a higher risk of traumatic brain injury compared with patients without sleep apnea.	[Lin, Shih-Yi; Hsu, Wu-Huei; Lin, Cheng-Chieh; Chang, Yun-Lun; Wang, I-Kuan; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Biomed Sci, 2 Yuh Der Rd, Taichung 40447, Taiwan; [Lin, Shih-Yi; Chang, Yun-Lun; Wang, I-Kuan] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Lin, Shih-Yi; Chang, Yun-Lun; Wang, I-Kuan] China Med Univ Hosp, Kidney Inst, Taichung, Taiwan; [Chen, Weishan; Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Weishan; Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Harnod, Tomor] Hualien Tzu Chi Gen Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Hualien, Taiwan; [Harnod, Tomor] Tzu Chi Univ, Coll Med, Hualien, Taiwan; [Hsu, Wu-Huei] China Med Univ, China Med Univ Hosp, Div Pulm & Crit Care Med, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Ctr Augmented Intelligence Healthcare, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan		Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Biomed Sci, 2 Yuh Der Rd, Taichung 40447, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, 2 Yuh Der Rd, Taichung 40447, Taiwan.	d10040@mail.cmuh.org.tw			Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133004]; China Medical University Hospital [CMU106-ASIA-12, DMR-107-192]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039-004]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW108-TDU-B-212-133004), China Medical University Hospital (CMU106-ASIA-12, DMR-107-192); Academia Sinica Stroke Biosignature Project (BM10701010021); MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039-004); Tseng-Lien Lin Foundation, Taichung, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Burks SV, 2016, SLEEP, V39, P967, DOI 10.5665/sleep.5734; daLuz P., 2018, ENDOTHELIUM CARDIOVA; Hargens TA, 2013, NAT SCI SLEEP, V5, P27, DOI 10.2147/NSS.S34838; Harnod T, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000001506, 10.1097/MD.0000000000001571]; Huang WS, 2014, PSYCHIAT CLIN NEUROS, V68, P255, DOI 10.1111/pcn.12117; Jean-Louis G, 2008, J CLIN SLEEP MED, V4, P261; Jennings LA, 2015, AM J MANAG CARE, V21, pE519; Egea-Guerrero JJ, 2018, J HEAD TRAUMA REHAB, V33, P46, DOI 10.1097/HTR.0000000000000292; Jullian-Desayes I, 2015, SLEEP MED REV, V21, P23, DOI 10.1016/j.smrv.2014.07.004; Karimi M, 2015, SLEEP, V38, P341, DOI 10.5665/sleep.4486; Lavie L, 2001, CHEST, V120, P900, DOI 10.1378/chest.120.3.900; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Lee YC, 2015, SLEEP, V38, P213, DOI 10.5665/sleep.4400; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Liu J, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/234129; Mazza S, 2005, EUR RESPIR J, V25, P75, DOI 10.1183/09031936.04.00011204; Mendelson WB, 1996, SLEEP, V19, P698; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Riefkohl EZ, 2003, PHARMACOL THERAPEUT, V28, P724; Shen TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128461; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SOROCK GS, 1988, ARCH INTERN MED, V148, P2441, DOI 10.1001/archinte.148.11.2441; Surman CBH, 2009, J CLIN PSYCHIAT, V70, P1523, DOI 10.4088/JCP.08m04514; Tan A, 1996, MOVEMENT DISORD, V11, P214, DOI 10.1002/mds.870110216; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Wang SF, 2020, FRONT ONCOL, V9, DOI [10.3389/fphar.2018.01513, 10.3389/fonc.2019.01513]; Wu CS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001568; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104	29	3	3	0	0	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2305-5839	2305-5847		ANN TRANSL MED	ANN. TRANSL. MED.	NOV	2019	7	22							644	10.21037/atm.2019.10.88			12	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	JS7BX	WOS:000500459400034	31930045	Green Published, gold			2022-02-06	
J	Lipponen, A; Natunen, T; Hujo, M; Ciszek, R; Hamalainen, E; Tohka, J; Hiltunen, M; Paananen, J; Poulsen, D; Kansanen, E; Ndode-Ekane, XE; Levonen, AL; Pitkanen, A				Lipponen, Anssi; Natunen, Teemu; Hujo, Mika; Ciszek, Robert; Hamalainen, Elina; Tohka, Jussi; Hiltunen, Mikko; Paananen, Jussi; Poulsen, David; Kansanen, Emilia; Ekolle Ndode-Ekane, Xavier; Levonen, Anna-Liisa; Pitkanen, Asla			In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury-Lessons Learned	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						adverse event; common data element; LINCS analysis; machine-learning; traumatic brain injury; neuroinflammation; neuroprotection	TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; CONNECTIVITY MAP; SMALL MOLECULES; RAT-BRAIN; ACTIVATION; CLOMIPRAMINE; EXPRESSION; INHIBITION; PATHWAY	We developed a pipeline for the discovery of transcriptomics-derived disease-modifying therapies and used it to validate treatments in vitro and in vivo that could be repurposed for TBI treatment. Desmethylclomipramine, ionomycin, sirolimus and trimipramine, identified by in silico LINCS analysis as candidate treatments modulating the TBI-induced transcriptomics networks, were tested in neuron-BV2 microglial co-cultures, using tumour necrosis factor alpha as a monitoring biomarker for neuroinflammation, nitrite for nitric oxide-mediated neurotoxicity and microtubule associated protein 2-based immunostaining for neuronal survival. Based on (a) therapeutic time window in silico, (b) blood-brain barrier penetration and water solubility, (c) anti-inflammatory and neuroprotective effects in vitro (p < 0.05) and (d) target engagement of Nrf2 target genes (p < 0.05), desmethylclomipramine was validated in a lateral fluid-percussion model of TBI in rats. Despite the favourable in silico and in vitro outcomes, in vivo assessment of clomipramine, which metabolizes to desmethylclomipramine, failed to demonstrate favourable effects on motor and memory tests. In fact, clomipramine treatment worsened the composite neuroscore (p < 0.05). Weight loss (p < 0.05) and prolonged upregulation of plasma cytokines (p < 0.05) may have contributed to the worsened somatomotor outcome. Our pipeline provides a rational stepwise procedure for evaluating favourable and unfavourable effects of systems-biology discovered compounds that modulate post-TBI transcriptomics.	[Lipponen, Anssi; Ciszek, Robert; Hamalainen, Elina; Tohka, Jussi; Kansanen, Emilia; Ekolle Ndode-Ekane, Xavier; Levonen, Anna-Liisa; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland; [Natunen, Teemu; Hiltunen, Mikko; Paananen, Jussi] Univ Eastern Finland, Inst Biomed, POB 1627, FIN-70211 Kuopio, Finland; [Hujo, Mika] Univ Eastern Finland, Sch Comp, POB 1627, FIN-70211 Kuopio, Finland; [Paananen, Jussi] Univ Eastern Finland, Bioinformat Ctr, POB 1627, FIN-70211 Kuopio, Finland; [Poulsen, David] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, 875 Ellicott St,6071 CTRC, Buffalo, NY 14203 USA		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland.	anssi.lipponen@uef.fi; teemu.natunen@uef.fi; mika.hujo@uef.fi; robert.ciszek@uef.fi; elina.hamalainen@uef.fi; jussi.tohka@uef.fi; mikko.hiltunen@uef.fi; jussi.paananen@uef.fi; davidpou@buffalo.edu; emilia.kansanen@uef.fi; xavier.ekollendode-ekane@uef.fi; anna-liisa.levonen@uef.fi; asla.pitkanen@uef.fi	Tohka, Jussi/D-2385-2013	Tohka, Jussi/0000-0002-1048-5860; Levonen, Anna-Liisa/0000-0002-6575-2137; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Lipponen, Anssi/0000-0002-4403-9084; Kansanen, Emilia/0000-0001-6029-8097	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909]; European Union's Seventh Framework Programme (FP7/2007-2013) [nffi 602102]; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; North-Savo Regional Fund; Doctoral Program of Molecular Medicine (UEF)	This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249 and 273909) (A.P.), the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement nffi 602102 (EPITARGET) (A.P.), The Finnish Cultural Foundation, North-Savo Regional Fund (A.L.) and Doctoral Program of Molecular Medicine (UEF) (A.L.).	Aitchison K, 2010, J PSYCHOPHARMACOL, V24, P1261, DOI 10.1177/0269881109105789; Albrecht JS, 2015, J NEUROTRAUM, V32, P1223, DOI 10.1089/neu.2014.3651; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Azim K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000698; BALANTGORGIA AE, 1991, CLIN PHARMACOKINET, V20, P447, DOI 10.2165/00003088-199120060-00002; BALK SD, 1984, P NATL ACAD SCI-BIOL, V81, P6418, DOI 10.1073/pnas.81.20.6418; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Buttini M, 1997, BRIT J PHARMACOL, V122, P1483, DOI 10.1038/sj.bjp.0701502; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Calegari L, 2007, BIOL PHARM BULL, V30, P1541, DOI 10.1248/bpb.30.1541; Cardamone L, 2013, BRIT J PHARMACOL, V168, P1531, DOI 10.1111/bph.12052; COOKSON J, 1993, BRIT J PSYCHIAT, V163, P20, DOI 10.1192/S0007125000292325; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Delahaye-Duriez A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1097-7; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Faissner S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02119-6; Foltz CJ, 1999, LAB ANIMAL, V28, P28; FRIEDMAN E, 1983, J PHARMACOL EXP THER, V225, P387; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Fu ES, 2005, J NEUROSURG ANESTH, V17, P82, DOI 10.1097/01.ana.0000163199.10365.38; Gallorini M, 2015, BIOMATERIALS, V56, P114, DOI 10.1016/j.biomaterials.2015.03.047; Gao L, 2014, FEBS J, V281, P1110, DOI 10.1111/febs.12672; GARCIAMARQUEZ C, 1987, PSYCHOPHARMACOLOGY, V93, P77, DOI 10.1007/BF02439590; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gex-Fabry M, 2000, THER DRUG MONIT, V22, P701, DOI 10.1097/00007691-200012000-00009; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Hutter-Paier B, 2000, CELL TISSUE RES, V302, P39, DOI 10.1007/s004410000258; Huttunen H, 2013, MACH VISION APPL, V24, P1311, DOI 10.1007/s00138-012-0464-y; Hwang J, 2008, NEUROPHARMACOLOGY, V55, P826, DOI 10.1016/j.neuropharm.2008.06.045; Jacunski A, 2013, CLIN PHARMACOL THER, V94, P659, DOI 10.1038/clpt.2013.168; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Johnstone AL, 2012, MOL CELL NEUROSCI, V50, P125, DOI 10.1016/j.mcn.2012.04.008; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kazuyuki F., 1991, EUR J PHARMACOL, V204, P227, DOI [10.1016/0014-2999(91)90846-I, DOI 10.1016/0014-2999(91)90846-I]; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; KOELLA WP, 1979, BIOL PSYCHIAT, V14, P485; Kolodkin A, 2012, EUR J PHARM SCI, V46, P190, DOI 10.1016/j.ejps.2011.06.006; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Lee AF, 2004, J NEUROSCI, V24, P9174, DOI 10.1523/JNEUROSCI.1588-04.2004; Lipponen A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0519-z; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; LIU CM, 1978, J BIOL CHEM, V253, P5892; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Martiskainen H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0991-6; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Mirza N, 2017, HUM MOL GENET, V26, P527, DOI 10.1093/hmg/ddw410; MUSA MN, 1989, J CLIN PHARMACOL, V29, P746, DOI 10.1002/j.1552-4604.1989.tb03410.x; Natunen T, 2016, NEUROBIOL DIS, V85, P187, DOI 10.1016/j.nbd.2015.11.005; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Ojala M, 2010, J MACH LEARN RES, V11, P1833; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; R Core Team, 2018, STATS PACK LANG ENV; Rau TF, 2014, INT J MOL SCI, V15, P1402, DOI 10.3390/ijms15011402; Regenthal R, 1999, J CLIN MONITOR COMP, V15, P529, DOI 10.1023/A:1009935116877; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SALZMANN MM, 1965, BRIT J PSYCHIAT, V111, P1105, DOI 10.1192/bjp.111.480.1105; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shekh-Ahmad T, 2018, BRAIN, V141, P1390, DOI 10.1093/brain/awy071; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Siavelis JC, 2016, BRIEF BIOINFORM, V17, P322, DOI 10.1093/bib/bbv048; Silverman EK, 2013, CLIN PHARMACOL THER, V93, P26, DOI 10.1038/clpt.2012.207; Smalley JL, 2016, J MOL MED, V94, P235, DOI 10.1007/s00109-015-1344-5; So HC, 2017, NAT NEUROSCI, V20, P1342, DOI 10.1038/nn.4618; Stenton SB, 2005, CLIN PHARMACOKINET, V44, P769, DOI 10.2165/00003088-200544080-00001; STERN RS, 1980, BRIT J PSYCHIAT, V136, P161, DOI 10.1192/bjp.136.2.161; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Usher LC, 2010, J NEUROSCI, V30, P4693, DOI 10.1523/JNEUROSCI.0302-10.2010; van Vliet EA, 2017, EPILEPSIA, V58, P2013, DOI 10.1111/epi.13915; Weigmann H, 2000, EUR NEUROPSYCHOPHARM, V10, P401, DOI 10.1016/S0924-977X(00)00098-5; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wheaton P, 2011, J PSYCHOPHARMACOL, V25, P1581, DOI 10.1177/0269881110388331; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yang A, 2016, EUR NEUROPSYCHOPHARM, V26, P591, DOI 10.1016/j.euroneuro.2015.12.025; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Yau JLW, 2007, NEUROPSYCHOPHARMACOL, V32, P2520, DOI 10.1038/sj.npp.1301389; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	110	3	3	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2019	20	21							5395	10.3390/ijms20215395			31	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	JQ4VU	WOS:000498946100153	31671916	gold, Green Published			2022-02-06	
J	McAllister, PJ; Khatkova, SE; Faux, SG; Picaut, P; Raymond, R; Gracies, JM				McAllister, Peter J.; Khatkova, Svetlana E.; Faux, Steven G.; Picaut, Philippe; Raymond, Romain; Gracies, Jean-Michel			EFFECTS ON WALKING OF SIMULTANEOUS UPPER/LOWER LIMB ABOBOTULINUMTOXINA INJECTIONS IN PATIENTS WITH STROKE OR BRAIN INJURY WITH SPASTIC HEMIPARESIS	JOURNAL OF REHABILITATION MEDICINE			English	Article						muscle spasticity; paresis; botulinum toxin; type A; walking speed; stroke; traumatic brain injury	BOTULINUM TOXIN; A TREATMENT; GAIT	Objective: To compare walking speed in patients with spastic hemiparesis who received abobotulinumtoxinA either in the lower limb or simultaneously in both the lower and upper limbs. Design: Post hoc analysis from a phase 3 study of abobotulinumtoxinA (Dysport (R), NCT01251367). Patients: Adult patients with spastic hemiparesis causing gait dysfunction. Methods: Comfortable barefoot walking speed over 10 m was evaluated in 127 patients receiving lower limb vs lower and upper limb injections over <= 4 treatment cycles; 1,000 U or 1,500 U in lower limb for cycle 1/2; optional upper limb injections from cycle 3 (500 U: upper limb, 1,000 U: lower limb). Results: Mean (standard deviation; SD) lower limb cycle 3/4 doses were lower in the lower plus upper limb group vs lower limb only (1,000 U (SD 50), 1,000 U (SD 50) vs 1,380 U (SD 210), 1,360 U (SD 220). Baseline comfortable barefoot walking speed was similar between groups. Changes at cycle 3 week 4, in m/s, were: lower and upper limb: +0.063 (SD 0.131); lower limb only: +0.078 (SD 0.114), and cycle 4 week 4: lower and upper limb: +0.086 (SD 0.166); lower limb only: +0.086 (SD 0.123). Conclusion: Simultaneous lower and upper limb abobotulinumtoxinA treatment does not hamper improvement in walking speed compared with lower limb treatment alone. Thus, physicians may split the 1,500 U abobotulinumtoxinA dose as needed to best treat patients with spastic paresis.	[McAllister, Peter J.] New England Inst Neurol & Headache, 30 Buxton Farm Rd,Ste 230, Stamford, CT 06905 USA; [Khatkova, Svetlana E.] Ctr Minist Hlth & Social Dev Russian Federat, Neurol Dept, Fed State Hosp, Treatments & Rehabil, Moscow, Russia; [Faux, Steven G.] St Vincents Hosp, Darlinghurst, NSW, Australia; [Faux, Steven G.] Univ New South Wales, Sydney, NSW, Australia; [Picaut, Philippe] Ipsen Pharma, Les Ulis, France; [Raymond, Romain] Ividata, Levallois Perret, France; [Gracies, Jean-Michel] Univ Paris Est, EA BIOTN 7377, Hosp Albert Chenevier Henri Mondor, Dept Neurorehabil, Creteil, France		McAllister, PJ (corresponding author), New England Inst Neurol & Headache, 30 Buxton Farm Rd,Ste 230, Stamford, CT 06905 USA.	peter@neinh.com			IpsenIpsen	Y The phase 3 study and post hoc analysis were funded by Ipsen.	Barnes M, 2017, DISABIL REHABIL, V39, P1428, DOI 10.1080/09638288.2016.1198432; BOHANNON RW, 1988, INT J REHABIL RES, V11, P181, DOI 10.1097/00004356-198806000-00012; Carmo AA, 2012, BRAZ J MED BIOL RES, V45, P537, DOI 10.1590/S0100-879X2012007500051; Dashtipour K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002468; Dashtipour K, 2015, AM J PHYS MED REHAB, V94, P229, DOI 10.1097/PHM.0000000000000208; Eng Janice J, 2007, Expert Rev Neurother, V7, P1417, DOI 10.1586/14737175.7.10.1417; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; Falso M, 2012, NEUROL INT, V4, P32, DOI 10.4081/ni.2012.e8; Gracies JM, 2018, MUSCLE NERVE, V57, P245, DOI 10.1002/mus.25721; Gracies JM, 2017, NEUROLOGY, V89, P2245, DOI 10.1212/WNL.0000000000004687; Hefter H, 2017, CLIN BIOMECH, V43, P15, DOI 10.1016/j.clinbiomech.2017.01.018; Hirsch MA, 2005, MOVEMENT DISORD, V20, P1014, DOI 10.1002/mds.20499	12	3	4	2	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2019	51	10					813	816		10.2340/16501977-2604			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JH4HV	WOS:000492730500012	31529136	gold			2022-02-06	
J	Miller, MB; Metrik, J; Borsari, B; Jackson, KM				Miller, Mary Beth; Metrik, Jane; Borsari, Brian; Jackson, Kristina M.			Longitudinal Associations between Sleep, Intrusive Thoughts, and Alcohol Problems Among Veterans	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Alcohol; Drinking; Posttraumatic Stress Disorder; Mental Health; Veterans	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; TRAUMATIC BRAIN-INJURY; CANNABIS USE; US VETERANS; INSOMNIA; PTSD; SYMPTOMS; IRAQ; PREVALENCE	Background Research suggests bidirectional associations between symptoms of posttraumatic stress disorder (PTSD) and sleep disturbance, both of which have been associated with alcohol problems. However, few studies have examined the interplay of these conditions in predicting alcohol problems over time. This study tested 2 competing models: (i) sleep disturbance as a mediator of the association between intrusive thoughts about trauma and alcohol problems and (ii) intrusion symptoms as the mediator of the sleep/alcohol problem association. Methods Veterans (N = 325, 93% male, 81% White) completed assessments at baseline, 6 months, and 12 months as part of a larger observational study. Zero-inflated-negative binomial models were used to examine indirect effects of baseline predictors on (i) yes/no likelihood and (ii) number of 12-month alcohol problems through 6-month mediators. Models controlled for past-year cannabis use and drinks consumed per week at baseline. Results The only significant predictor of alcohol problem likelihood was baseline drinking quantity. Baseline PTSD intrusions had a direct effect on number of alcohol problems at 12 months, with no indirect (mediated) effect through 6-month sleep disturbance. In the competing model, baseline sleep disturbance had a marginally significant direct effect on 12-month alcohol problems, with a significant indirect effect through 6-month PTSD intrusions. Conclusions PTSD intrusions are associated with more alcohol problems and help explain the long-term association between sleep and alcohol problems among veterans. Because sleep disturbances are associated with more intrusive thoughts about trauma, we recommend that treatments targeting sleep in the context of PTSD and alcohol use include a cognitive component.	[Miller, Mary Beth] Univ Missouri, Dept Psychiat, 1 Hosp Dr DC067-00, Columbia, MO 65212 USA; [Miller, Mary Beth; Metrik, Jane; Jackson, Kristina M.] Brown Univ, Sch Publ Hlth, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Metrik, Jane] Providence VA Med Ctr, Providence, RI USA; [Borsari, Brian] San Francisco VA Hlth Care Syst, Mental Hlth Serv 116B, San Francisco, CA USA; [Borsari, Brian] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA		Miller, MB (corresponding author), Univ Missouri, Dept Psychiat, 1 Hosp Dr DC067-00, Columbia, MO 65212 USA.	millmary@health.missouri.edu		BORSARI, BRIAN/0000-0002-1491-7771; Jackson, Kristina/0000-0001-5449-5473	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02AA021761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA040880] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02 AA021761, K02AA13938, K23 AA026895] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA033425] Funding Source: Medline		Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Alterman AI, 2009, J STUD ALCOHOL DRUGS, V70, P304, DOI 10.15288/jsad.2009.70.304; Atkins DC, 2013, PSYCHOL ADDICT BEHAV, V27, P166, DOI 10.1037/a0029508; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Berking M, 2011, J CONSULT CLIN PSYCH, V79, P307, DOI 10.1037/a0023421; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boden MT, 2018, J STUD ALCOHOL DRUGS, V79, P853, DOI 10.15288/jsad.2018.79.853; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calhoun PS, 2016, AM J DRUG ALCOHOL AB, V42, P269, DOI 10.3109/00952990.2015.1051185; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Chaudhary NS, 2015, ADDICT BEHAV, V50, P165, DOI 10.1016/j.addbeh.2015.06.021; Cox RC, 2018, PSYCHOL TRAUMA-US, V10, P508, DOI 10.1037/tra0000336; Fuehrlein B, 2014, ADDICT BEHAV, V39, P374, DOI 10.1016/j.addbeh.2013.08.026; Gaher RM, 2014, PSYCHOL ADDICT BEHAV, V28, P1013, DOI 10.1037/a0037257; Germain A, 2007, BEHAV RES THER, V45, P627, DOI 10.1016/j.brat.2006.04.009; Gilpin NW, 2017, GENES BRAIN BEHAV, V16, P15, DOI 10.1111/gbb.12349; Grant S, 2016, J STUD ALCOHOL DRUGS, V77, P509, DOI 10.15288/jsad.2016.77.509; Gutner CA, 2018, PSYCHIAT RES, V263, P108, DOI 10.1016/j.psychres.2018.02.045; Hall M, 2000, PSYCHOSOM MED, V62, P227, DOI 10.1097/00006842-200003000-00014; Harvey AG, 2005, J COGN PSYCHOTHER, V19, P41, DOI 10.1891/jcop.19.1.41.66332; Harvey AG, 2014, J CONSULT CLIN PSYCH, V82, P670, DOI 10.1037/a0036606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu MC, 2011, AM J DRUG ALCOHOL AB, V37, P367, DOI 10.3109/00952990.2011.597280; Jenkins MM, 2015, SLEEP, V38, P1547, DOI 10.5665/sleep.5044; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; King PR, 2017, J PSYCHOSOM RES, V96, P60, DOI 10.1016/j.jpsychores.2017.03.012; Kliewer W, 2015, J YOUTH ADOLESCENCE, V44, P507, DOI 10.1007/s10964-014-0184-x; Langdon KJ, 2016, J AFFECT DISORDERS, V196, P234, DOI 10.1016/j.jad.2016.02.048; Lehavot K, 2018, AM J PREV MED, V54, pE1, DOI 10.1016/j.amepre.2017.09.008; Lind MJ, 2017, J CLIN SLEEP MED, V13, P291, DOI 10.5664/jcsm.6466; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Metrik J, 2016, PSYCHOL ADDICT BEHAV, V30, P743, DOI 10.1037/adb0000210; Miller MB, 2017, ADDICT BEHAV, V75, P59, DOI 10.1016/j.addbeh.2017.06.020; Miller SM, 2017, ADDICT BEHAV, V66, P90, DOI 10.1016/j.addbeh.2016.11.011; Miller W., 1995, DRINKER INVENTORY CO; Muthen B. O., 2017, MPLUS USERS GUIDE, V8th; Nilsson JP, 2005, J SLEEP RES, V14, P1, DOI 10.1111/j.1365-2869.2005.00442.x; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Robinson SM, 2014, PSYCHOL ADDICT BEHAV, V28, P154, DOI 10.1037/a0030992; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Short NA, 2017, BEHAV RES THER, V97, P146, DOI 10.1016/j.brat.2017.07.014; Sobell L. C., 2003, NIH PUBLICATION, V03-3745; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Swinkels CM, 2013, SLEEP, V36, P1019, DOI 10.5665/sleep.2800; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Watson D, 2008, PSYCHOL ASSESSMENT, V20, P248, DOI 10.1037/a0012570; Watson D, 2007, PSYCHOL ASSESSMENT, V19, P253, DOI 10.1037/1040-3590.19.3.253; Witkiewitz K, 2015, J CONSULT CLIN PSYCH, V83, P1044, DOI 10.1037/ccp0000033; Wright CE, 2010, BEHAV MED, V36, P85, DOI 10.1080/08964280903521305; Wright KM, 2011, STRESS HEALTH, V27, P325, DOI 10.1002/smi.1373; Zayfert C, 2004, J TRAUMA STRESS, V17, P69, DOI 10.1023/B:JOTS.0000014679.31799.e7	55	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	NOV	2019	43	11					2438	2445		10.1111/acer.14191			8	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	JI8TV	WOS:000493737100018	31560410	Green Accepted			2022-02-06	
J	Northam, W; Chandran, A; Quinsey, C; Abumoussa, A; Flores, A; Elton, S				Northam, Weston; Chandran, Avinash; Quinsey, Carolyn; Abumoussa, Andrew; Flores, Alex; Elton, Scott			Pediatric nonoperative skull fractures: delayed complications and factors associated with clinic and imaging utilization	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						skull fracture; nonoperative; outpatient; complications; imaging; follow-up; trauma	TRAUMATIC BRAIN-INJURY; SINUS THROMBOSIS; CHILDREN; MANAGEMENT; INSURANCE; ACCESS; CARE	OBJECTIVE Skull fractures represent a common source of morbidity in the pediatric trauma population. This study characterizes the type of follow-up that these patients receive and discusses predictive factors for follow-up. METHODS The authors reviewed cases of nonoperative pediatric skull fractures at a single academic hospital between 2007 and 2017. Clinical patient and radiological fractures were recorded. Recommended neurosurgical follow-up, follow-up appointments, imaging studies, and fracture-related complications were recorded. Statistical analyses were performed to identify predictors for outpatient follow-up and imaging. RESULTS The study included 414 patients, whose mean age was 5.2 years; 37.2% were female, and the median length of stay was 1 day (IQR 0.9-4 days). During 438 clinic visits and a median follow-up period of 8 weeks (IQR 4-12, range 1-144 weeks), 231 imaging studies were obtained, mostly head CT scans (55%). A total of 283 patients were given recommendations to attend follow-up in the clinic, and 86% were seen. Only 12 complications were detected, including 7 growing skull fractures, 2 traumatic encephaloceles, and 3 cases of hearing loss. Primary care physician (PCP) status and insurance status were associated with a recommendation of follow-up, actual follow-up compliance, and the decision to order outpatient imaging in patients both with and without intracranial hemorrhage. PCP status remained an independent predictor in each of these analyses. Follow-up compliance was not associated with a patient's distance from home. Among patients without intracranial hemorrhage, a follow-up recommendation and actual follow-up compliance were associated with pneumocephalus and other polytraumatic injuries, and outpatient imaging was associated with a bilateral fracture. No complications were found in patients with linear fractures above the skull base in those without an intracranial hemorrhage. CONCLUSIONS Pediatric nonoperative skull fractures drive a large expenditure of clinic and imaging resources to detect a relatively small profile of complications. Understanding the factors underlying the decision for clinic follow-up and additional imaging can decrease future costs, resource utilization, and radiation exposure. Factors related to injury severity and socioeconomic indicators were associated with outpatient imaging, the decision to follow up patients in the clinic, and patients' subsequent attendance. Socioeconomic status (PCP and insurance) may affect access to appropriate neurosurgical follow-up and deserves future research attention. Patients with no intracranial hemorrhage and with a linear fracture above the skull base do not appear to be at risk for delayed complications and could be candidates for reduced follow-up and imaging.	[Northam, Weston; Quinsey, Carolyn; Abumoussa, Andrew; Elton, Scott] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA; [Chandran, Avinash] Univ N Carolina, Matthew Gfeller Sport Related TBI Res Ctr, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Flores, Alex] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA		Elton, S (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	scott_elton@med.unc.edu					Adepoju A, 2017, J NEUROSURG-PEDIATR, V20, P598, DOI 10.3171/2017.6.PEDS16702; Antonelli V, 2002, SURG NEUROL, V57, P117, DOI 10.1016/S0090-3019(01)00667-X; Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; Awad Al-Wala, 2014, Surg Neurol Int, V5, P53, DOI 10.4103/2152-7806.130908; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Brodie HA, 1997, AM J OTOL, V18, P188; Ersahin Y, 1996, CHILD NERV SYST, V12, P323, DOI 10.1007/BF00301021; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenwald M J, 1987, J Pediatr Ophthalmol Strabismus, V24, P141; Gupta SK, 1997, ACTA NEUROCHIR, V139, P928, DOI 10.1007/BF01411301; Hassan SF, 2014, J TRAUMA ACUTE CARE, V77, P166, DOI 10.1097/TA.0000000000000256; Hersh DS, 2018, J NEUROSURG-PEDIATR, V21, P258, DOI 10.3171/2017.9.PEDS17311; Johnson F, 2008, OTOLARYNG CLIN N AM, V41, P597, DOI 10.1016/j.otc.2008.01.006; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LENDE RA, 1961, J NEUROSURG, V18, P479, DOI 10.3171/jns.1961.18.4.0479; Liu XS, 2012, J NEUROSURG-PEDIATR, V9, P670, DOI 10.3171/2012.2.PEDS11538; MCGUIRT WF, 1992, CLIN PEDIATR, V31, P12, DOI 10.1177/000992289203100103; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; MUHONEN MG, 1995, SURG NEUROL, V43, P367, DOI 10.1016/0090-3019(95)80066-P; Mulroy MH, 2012, FORENSIC SCI INT, V214, P167, DOI 10.1016/j.forsciint.2011.07.050; Newacheck PW, 1996, PEDIATRICS, V97, P26; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Skaggs DL, 2001, PEDIATRICS, V107, P1405, DOI 10.1542/peds.107.6.1405; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; White IK, 2016, J NEUROSURG-PEDIATR, V17, P602, DOI 10.3171/2015.9.PEDS15352	31	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2019	24	5					489	497		10.3171/2019.5.PEDS18739			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	JJ2IN	WOS:000493985200002	31470399				2022-02-06	
J	Stockbridge, MD; Newman, R				Stockbridge, Melissa D.; Newman, Rochelle			Enduring Cognitive and Linguistic Deficits in Individuals With a History of Concussion	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; SPORTS-RELATED CONCUSSION; NARRATIVE DISCOURSE; NEUROPSYCHOLOGICAL OUTCOMES; MULTIDIMENSIONAL SCALE; PARKINSONS-DISEASE; YOUNG-ADULTS; SELF-REPORTS; CHILDREN	Purpose: The purpose of this research is to determine whether individuals with a history of concussion retain enduring differences in narrative writing tasks, which necessitate rapid and complex integration of both cognitive and linguistic faculties. Method: Participants aged 12-40 years old, who did or did not have a remote history of concussion, were recruited to take an online survey that included writing both a familiar and a novel narrative. They also were asked to complete multiple tasks targeting word-level and domain general cognitive skills, so that their performance could be interpreted across these dimensions. Results: Participants with a concussion history were largely similar to participants with no history of brain injury across tasks that targeted a single skill in isolation. However, participants with prior concussions demonstrated difficulty in providing both key content and details when presented with a novel video and asked to provide a summary of what they had just seen. Number of lifetime concussions predicted the inclusion of key content when summarizing the video. Thus, differences in cognitive and linguistic skills required for written narrative language may continue to be present far after concussion, despite average normative levels of performance on tasks targeting these skills in isolation. Conclusions: These findings suggest that individuals with a concussion history, particularly a history of multiple concussions, may continue to experience difficulties for a long period after injury and are likely to benefit from more complex and ecologically valid assessment prior to discharge. Individuals with a concussion history who return to full participation in work, school, and recreational activities may continue to benefit from assistance when asked to rapidly acquire and distill novel information, as is often required in academic and professional environments.	[Stockbridge, Melissa D.; Newman, Rochelle] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA		Stockbridge, MD (corresponding author), Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA.	melissadawn.stockbridge@gmail.com	Stockbridge, Melissa/AAP-7382-2020	Stockbridge, Melissa/0000-0001-9069-1236			Angold A, 2000, J AM ACAD CHILD PSY, V39, P975, DOI 10.1097/00004583-200008000-00009; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barak A., 2002, Journal of Technology in Human Services, V19, P65, DOI 10.1300/J017v19n02_06; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Berisha V, 2017, BRAIN LANG, V169, P57, DOI 10.1016/j.bandl.2017.02.003; Bernard CO, 2017, J HEAD TRAUMA REHAB, V32, P413, DOI 10.1097/HTR.0000000000000298; Bialunska A, 2017, ARCH PHYS MED REHAB, V98, pe22; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bretz F, 2009, STAT MED, V28, P586, DOI 10.1002/sim.3495; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Bruwer B, 2008, COMPR PSYCHIAT, V49, P195, DOI 10.1016/j.comppsych.2007.09.002; Buchanan T, 2005, EUR J PSYCHOL ASSESS, V21, P115, DOI 10.1027/1015-5759.21.2.115; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Chuah SC, 2006, J RES PERS, V40, P359, DOI 10.1016/j.jrp.2005.01.006; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cole W. R., 2016, TRANSLATIONAL RES TR; Crewe-Brown SJ, 2011, S AFR J COMMUN DISOR, V58, P48; Cummings JL, 1999, INT J GERIATR PSYCH, V14, P711, DOI 10.1002/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fueger C., 2017, THESIS; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GLOSSER G, 1992, J GERONTOL, V47, pP266, DOI 10.1093/geronj/47.4.P266; Green SL, 2018, BRAIN INJURY, V32, P182, DOI 10.1080/02699052.2017.1358396; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harvey J, 2016, SPEECH LANGUAGE HEAR, V38; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Illingworth AJ, 2015, J BUS PSYCHOL, V30, P325, DOI 10.1007/s10869-014-9363-8; International Narcotics Control Board, 1998, REP INT NARC CONTR B; James S, 2009, INT J SPEECH-LANG PA, V11, P34, DOI 10.1080/17549500802588179; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kovach S. E., 2015, NARRATIVE DISCOURSE; Labov William, 2003, NARRATIVE ANAL ORAL; Leadholm B., 1992, LANGUAGE SAMPLE ANAL; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Lewandowski L, 2009, ARCH CLIN NEUROPSYCH, V24, P791, DOI 10.1093/arclin/acp087; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MacWhinney B., 2000, CHILDES PROJECT TOOL, V1; MacWhinney B., 2000, CHILDES PROJECT TOOL, V2; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; MENZA MA, 1993, BIOL PSYCHIAT, V34, P465, DOI 10.1016/0006-3223(93)90237-8; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Research Council & Committee on sports- related concussions in youth, 2014, SPORTS RELATED CONCU; Nishiguchi S, 2015, J CLIN GERONTOL GERI, V6, P9, DOI 10.1016/j.jcgg.2014.08.003; Norman R. S., 2017, THESIS; Nuti A, 2004, EUR J NEUROL, V11, P315, DOI 10.1111/j.1468-1331.2004.00781.x; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Petley L, 2018, BRAIN INJURY, V32, P464, DOI 10.1080/02699052.2018.1429022; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rahman A, 2005, AM J EPIDEMIOL, V162, P491, DOI 10.1093/aje/kwi215; ROTH FP, 1986, J SPEECH HEAR DISORD, V51, P8, DOI 10.1044/jshd.5101.08; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Seignourel PJ, 2008, CLIN PSYCHOL REV, V28, P1071, DOI 10.1016/j.cpr.2008.02.008; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; Shahar G, 2003, ANXIETY STRESS COPIN, V16, P119, DOI 10.1080/1061580021000057077; Shapiro L., 1991, DEVELOPING NARRATIVE, P89; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smith B, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-37; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soto CJ, 2017, J PERS SOC PSYCHOL, V113, P117, DOI 10.1037/pspp0000096; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stark JA, 2010, APHASIOLOGY, V24, P709, DOI 10.1080/02687030903524729; Stockbridge M. D, 2018, THESIS, DOI [10.13016/M21Z41X14, DOI 10.13016/M21Z41X14]; Stockbridge M. D., 2019, WRITTEN NARRAT UNPUB; Stockbridge MD, 2018, BRAIN INJURY, V32, P506, DOI 10.1080/02699052.2018.1429660; Stoet G, 2017, TEACH PSYCHOL, V44, P24, DOI 10.1177/0098628316677643; Templer KJ, 2008, COMPUT HUM BEHAV, V24, P1216, DOI 10.1016/j.chb.2007.04.006; Thompson EC, 2018, BRAIN INJURY, V32, P763, DOI 10.1080/02699052.2018.1447686; Thordardottir ET, 2001, INT J LANG COMM DIS, V36, P221, DOI 10.1080/13682820152410872; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	124	3	3	0	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2019	28	4					1554	1570		10.1044/2019_AJSLP-18-0196			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	JP0ML	WOS:000497966200012	31487473				2022-02-06	
J	Taipale, J				Taipale, Jaakko			Predefined criteria and interpretative flexibility in legal courts' evaluation of expertise	PUBLIC UNDERSTANDING OF SCIENCE			English	Article						Daubert; DTI; expertise; fMRI; interpretative flexibility; law and science; practice; scientific literacy; traumatic brain injury	SCIENCE; JUDGES; LAW; CREDIBILITY	This study examines two different approaches in empirical analysis of judges' evaluation of expertise in court: first, an analyst-based approach that employs predefined normative criteria to measure judges' performance, and second, an actor-based approach that emphasizes interpretative flexibility in judges' evaluation practice. I demonstrate how these different approaches to investigating judges' adjudication lead to differing understandings about judges' abilities to evaluate scientific evidence and testimonial. Although the choice of analytical approach might depend on context and purpose in general, I contend that in assessing judges' competence, an actor-based approach that adequately describes the way in which judges relate to and handle expertise is required to properly understand and explain how judges evaluate expertise. The choice of approach is especially important if the resulting understanding of judges' competence is subsequently used as a basis for making normative and prescriptive claims with potential consequences for trial outcomes.	[Taipale, Jaakko] Univ Helsinki, Helsinki, Finland		Taipale, J (corresponding author), Univ Helsinki, Fac Social Sci, POB 18,Unioninkatu 35, FIN-00014 Helsinki, Finland.	jaakko.taipale@helsinki.fi		Taipale, Jaakko/0000-0003-1590-2499			Baker JD, 2011, SOC STUD SCI, V41, P361, DOI 10.1177/0306312710395341; Bal R, 2005, SCI TECHNOL HUM VAL, V30, P52, DOI 10.1177/0162243904270722; Bartlett A, 2018, BIG DATA SOC, V5, DOI 10.1177/2053951718768831; Bauer MW, 2007, PUBLIC UNDERST SCI, V16, P79, DOI 10.1177/0963662506071287; Chin JM, 2014, PSYCHOL PUBLIC POL L, V20, P225, DOI 10.1037/law0000012; Cole S, 1992, MAKING SCI NATURE SO; Cole SA, 2017, ANNU REV LAW SOC SCI, V13, P351, DOI 10.1146/annurev-lawsocsci-110316-113550; Collins H., 2007, RETHINKING EXPERTISE; Collins H, 2007, STUD HIST PHILOS SCI, V38, P657, DOI 10.1016/j.shpsa.2007.09.003; Collins H, 2014, SOC STUD SCI, V44, P786, DOI 10.1177/0306312714546242; Collins H, 2011, SOC STUD SCI, V41, P271, DOI 10.1177/0306312711399665; Collins Harry M., 1985, CHANGING ORDER REPLI; COLLINS HM, 1981, SOC STUD SCI, V11, P3, DOI 10.1177/030631278101100101; Daston L., 2007, OBJECTIVITY; Edmond G, 2002, SOC STUD SCI, V32, P371, DOI 10.1177/0306312702032003002; Edmond G, 1997, PUBLIC UNDERST SCI, V6, P329, DOI 10.1088/0963-6625/6/4/003; Edmond G., 2000, MOD LAW REV, V63, P251, DOI DOI 10.1111/MLR.2000.63.ISSUE-2; Filippi C.G., 2014, AM J BIOETHICS AJOB, V5, P9; Fleck Ludwik, 1986, COGNITION FACT MAT L, P59; Gatowski SI, 2001, LAW HUMAN BEHAV, V25, P433, DOI 10.1023/A:1012899030937; Haack S, 2005, AM J PUBLIC HEALTH, V95, pS66, DOI [10.2105/AJPH.2004.044529, 10.2102/AJPH.2004.044529]; Israel-Jost V, 2014, SCI PRACTICE TURN PH, P114; Jasanoff S, 2005, AM J PUBLIC HEALTH, V95, pS49, DOI 10.2105/AJPH.2004.045732; Jasanoff S, 2015, TEX LAW REV, V93, P1723; Jones OD, 2013, J NEUROSCI, V33, P17624, DOI 10.1523/JNEUROSCI.3254-13.2013; Kirkland A, 2012, SOC STUD SCI, V42, P237, DOI 10.1177/0306312711435832; Kovera MB, 2000, J APPL PSYCHOL, V85, P574, DOI 10.1037//0021-9010.85.4.574; Kritzer HM, 2007, SOC LEGAL STUD, V16, P321, DOI 10.1177/0964663907079762; Law J, 2008, SOCIOL REV, V56, P623, DOI 10.1111/j.1467-954X.2008.00808.x; Loiva J, 2012, DEFENSOR LEGIS, V5/2012, P639; Lynch M, 2014, SCI PRACTICE TURN PH, P93; Rask R, 2011, ASIANTUNTEMUSTIETO J, P11; Tadei A, 2016, NORD PSYCHOL, V68, P204, DOI 10.1080/19012276.2015.1125303; Taipale J, 2019, SOC STUD SCI, V49, P310, DOI 10.1177/0306312719854538; Turner S, 2001, SOC STUD SCI, V31, P123, DOI 10.1177/030631201031001007; Uusitalo K, 2013, LAPSEN ASEMA KANSAIN, P11; Vaisanen T, 2014, DEFENSOR LEGIS, V5/2014, P721; Wingate PH, 2004, LAW HUMAN BEHAV, V28, P97, DOI 10.1023/B:LAHU.0000015005.29504.14	38	3	3	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0963-6625	1361-6609		PUBLIC UNDERST SCI	Public Underst. Sci.	NOV	2019	28	8					883	896		10.1177/0963662519881338			14	Communication; History & Philosophy Of Science	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Communication; History & Philosophy of Science	JK8WL	WOS:000495120500002	31694499	Green Accepted			2022-02-06	
J	Varshneya, K; Rodrigues, AJ; Medress, ZA; Stienen, MN; Grant, GA; Ratliff, JK; Veeravagu, A				Varshneya, Kunal; Rodrigues, Adrian J.; Medress, Zachary A.; Stienen, Martin N.; Grant, Gerald A.; Ratliff, John K.; Veeravagu, Anand			Risks, costs, and outcomes of cerebrospinal fluid leaks after pediatric skull fractures: a MarketScan analysis between 2007 and 2015	NEUROSURGICAL FOCUS			English	Article						CSF leak; pediatric; traumatic brain injury; skull fracture	CLINICAL-SIGNIFICANCE; CHILDREN; MANAGEMENT; COMPLICATIONS; ADMISSION; NEED	OBJECTIVE Skull fractures are common after blunt pediatric head trauma. CSF leaks are a rare but serious complication of skull fractures; however, little evidence exists on the risk of developing a CSF leak following skull fracture in the pediatric population. In this epidemiological study, the authors investigated the risk factors of CSF leaks and their impact on pediatric skull fracture outcomes. METHODS The authors queried the MarketScan database (2007-2015), identifying pediatric patients (age < 18 years) with a diagnosis of skull fracture and CSF leak. Skull fractures were disaggregated by location (base, vault, facial) and severity (open, closed, multiple, concomitant cerebral or vascular injury) Descriptive statistics and hypothesis testing were used to compare baseline characteristics, complications, quality metrics, and costs. RESULTS The authors identified 13,861 pediatric patients admitted with a skull fracture, of whom 1.46% (n = 202) developed a CSF leak. Among patients with a skull fracture and a CSF leak, 118 (58.4%) presented with otorrhea and 84 (41.6%) presented with rhinorrhea. Patients who developed CSF leaks were older (10.4 years vs 8.7 years, p < 0.0001) and more commonly had skull base (n = 183) and multiple (n = 22) skull fractures (p < 0.05). These patients also more frequently underwent a neurosurgical intervention (24.8% vs 9.6%, p < 0.0001). Compared with the non-CSF leak population, patients with a CSF leak had longer average hospitalizations (9.6 days vs 3.7 days, p < 0.0001) and higher rates of neurological deficits (5.0% vs 0.7%, p < 0.0001; OR 7.0; 95% CI 3.6-13.6), meningitis (5.5% vs 0.3%, p < 0.0001; OR 22.4; 95% CI 11.2-44.9), nonroutine discharge (6.9% vs 2.5%, p < 0.0001; OR 2.9; 95% CI 1.7-5.0), and readmission (24.7% vs 8.5%, p < 0.0001; OR 3.4; 95% CI 2.5-4.7). Total costs at 90 days for patients with a CSF leak averaged $81,206, compared with $32,831 for patients without a CSF leak (p < 0.0001). CONCLUSIONS The authors found that CSF leaks occurred in 1.46% of pediatric patients with skull fractures and that skull fractures were associated with significantly increased rates of neurosurgical intervention and risks of meningitis, hospital readmission, and neurological deficits at 90 days. Pediatric patients with skull fractures also experienced longer average hospitalizations and greater healthcare costs at presentation and at 90 days.	[Varshneya, Kunal; Rodrigues, Adrian J.; Medress, Zachary A.; Stienen, Martin N.; Grant, Gerald A.; Ratliff, John K.; Veeravagu, Anand] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA		Veeravagu, A (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	anandv2@stanford.edu					Adepoju A, 2017, J NEUROSURG-PEDIATR, V20, P598, DOI 10.3171/2017.6.PEDS16702; Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Arneitz C, 2016, J CLIN IMAG SCI, V6, DOI 10.4103/2156-7514.194261; Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; BECKHARDT RN, 1991, OTOLARYNG HEAD NECK, V104, P425, DOI 10.1177/019459989110400402; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bressan S, 2018, ANN EMERG MED, V71, P714, DOI 10.1016/j.annemergmed.2017.10.014; Donaldson K, 2019, PEDIATR EMERG CARE, V35, P301, DOI 10.1097/PEC.0000000000001814; Ersahin Y, 1996, CHILD NERV SYST, V12, P323, DOI 10.1007/BF00301021; Friedman J A, 2000, Neurosurg Focus, V9, pe1, DOI 10.3171/foc.2000.9.1.1; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Leibu S, 2017, WORLD NEUROSURG, V103, P315, DOI 10.1016/j.wneu.2017.04.068; MANN KS, 1986, CHILD NERV SYST, V2, P258; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; McCutcheon BA, 2013, OTOLARYNG HEAD NECK, V149, P931, DOI 10.1177/0194599813508539; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; NELSON EL, 1984, NEUROSURGERY, V15, P318, DOI 10.1227/00006123-198409000-00005; Olshaker Jonathan S., 1993, Emergency Medicine Clinics of North America, V11, P165; Perheentupa U, 2010, INT J PEDIATR OTORHI, V74, P1245, DOI 10.1016/j.ijporl.2010.07.023; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Sivanandapanicker J, 2018, J NEUROSCI RURAL PRA, V9, P370, DOI 10.4103/jnrp.jnrp_38_18; Tunik MG, 2016, ANN EMERG MED, V68, P431, DOI 10.1016/j.annemergmed.2016.04.058; Williams DC, 2017, PEDIATR EMERG CARE, V33, pE146, DOI 10.1097/PEC.0000000000001329; Yellinek S, 2016, J CLIN NEUROSCI, V25, P111, DOI 10.1016/j.jocn.2015.10.012; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3; Ziu M, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.4.FOCUS1244	29	3	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E10	10.3171/2019.8.FOCUS19543			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900010	31675705	gold			2022-02-06	
J	Yuhas, PT; Shorter, PD; McDaniel, CE; Earley, MJ; Hartwick, ATE				Yuhas, Phillip T.; Shorter, Patrick D.; McDaniel, Catherine E.; Earley, Michael J.; Hartwick, Andrew T. E.			Observer-perceived light aversion behaviour in photophobic subjects with traumatic brain injury	CLINICAL AND EXPERIMENTAL OPTOMETRY			English	Article						photophobia; pupil; retinal ganglion cells; traumatic brain injury	RETINAL GANGLION-CELLS; SYMPTOMS; RESPONSES; MILITARY; SOUND; TIME; TBI	Background Photophobia is a common sequela of traumatic brain injury (TBI). Diagnostic tools for this debilitating condition are lacking. This investigation sought to determine whether masked observers can distinguish subjects with TBI-associated photophobia from matched controls based on video recordings of their ocular responses to light stimulation. Methods Cohorts of students (n = 20), photophobic TBI subjects (n = 28) and their matched control subjects (n = 12) were recruited. A custom pupillometer delivered bright (10(13)-10(14) photons/s/cm(2)), flashing (0.10 Hz) red (625 nm) and blue (470 nm) light stimuli to subjects, and consensual pupil light responses were recorded. Using a five-point scale, masked observers later graded light aversion behaviour in the pupil video recordings obtained from the student cohort based on observed blinking, tearing and squinting. A grading scale was developed and used by masked observers to grade light aversion behaviour in videos obtained from subjects with post-TBI photophobia and the matched controls. These subjects also scored their perceived discomfort during each light pulse using a five-point scale. Results The subjects in the TBI cohort scored both the blue and red flashing stimuli as evoking more discomfort, relative to control subjects, consistent with their reported photophobia. There was strong agreement among the masked observers for their grades of light aversion behaviour in the videos of ocular light stimulation (interclass correlation co-efficient = 0.78; 29 per cent perfect concordance). However, the median grades for the videos obtained from the TBI subject cohort were not significantly different from those for the control group. Conclusions Clinicians cannot diagnose TBI-related photophobia based solely on video recordings of ocular responses to light. The need remains for an objective test to diagnose and manage this prevalent post-TBI symptom.	[Yuhas, Phillip T.; Shorter, Patrick D.; McDaniel, Catherine E.; Earley, Michael J.; Hartwick, Andrew T. E.] Ohio State Univ, Coll Optometry, 338 W 10th Ave, Columbus, OH 43210 USA; [Shorter, Patrick D.] US Air Force, Res Lab, Directed Energy Bioeffects Div, San Antonio, TX USA		Hartwick, ATE (corresponding author), Ohio State Univ, Coll Optometry, 338 W 10th Ave, Columbus, OH 43210 USA.	hartwick.4@osu.edu		Yuhas, Phillip/0000-0002-5956-4957	NIH Loan Repayment ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [L30 EY024749]; National Center For Advancing Translational Sciences Grant [8KL2TR00011 2-05]; Department of Defense TATRC GrantUnited States Department of Defense [W81XWH-12-1-0434]	NIH Loan Repayment Program L30 EY024749, National Center For Advancing Translational Sciences Grant 8KL2TR00011 2-05 and the Department of Defense TATRC Grant W81XWH-12-1-0434.	Aboshiha J, 2017, INVEST OPHTH VIS SCI, V58, P3537, DOI 10.1167/iovs.17-21935; BAILEY IL, 1991, INVEST OPHTH VIS SCI, V32, P422; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; DAROUGAR S, 1985, BRIT J OPHTHALMOL, V69, P2, DOI 10.1136/bjo.69.1.2; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; DRUMMOND PD, 1986, HEADACHE, V26, P465, DOI 10.1111/j.1526-4610.1986.hed2609465.x; Efron N, 2001, OPHTHAL PHYSL OPT, V21, P17, DOI 10.1046/j.1475-1313.2001.00575.x; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Evans RW, 2008, HEADACHE, V48, P395, DOI 10.1111/j.1526-4610.2007.00920.x; Feuer WJ, 2002, AM J OPHTHALMOL, V133, P19, DOI 10.1016/S0002-9394(01)01338-1; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; GRIFFIN JR, 1989, POSTGRAD MED, V86, P117; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Katz BJ, 2016, SURV OPHTHALMOL, V61, P466, DOI 10.1016/j.survophthal.2016.02.001; LEBENSOHN JE, 1951, AM J OPHTHALMOL, V34, P1294, DOI 10.1016/0002-9394(51)91866-1; Lin YD, 2015, INVEST OPHTH VIS SCI, V56, P1649, DOI 10.1167/iovs.14-15963; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Maleki N, 2012, HUM BRAIN MAPP, V33, P75, DOI 10.1002/hbm.21194; Matynia A, 2012, EXP EYE RES, V105, P60, DOI 10.1016/j.exer.2012.09.012; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Nahar NK, 2007, OPTOMETRY VISION SCI, V84, P620, DOI 10.1097/OPX.0b013e3180dc99a8; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Stringham JM, 2003, J OPT SOC AM A, V20, P1852, DOI 10.1364/JOSAA.20.001852; STURR JF, 1982, PERCEPT PSYCHOPHYS, V31, P402, DOI 10.3758/BF03202668; TEASDALE G, 1974, LANCET, V2, P81; Truong JQ, 2014, BRAIN INJURY, V28, P1283, DOI 10.3109/02699052.2014.915989; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Yuhas PT, 2017, OPTOMETRY VISION SCI, V94, P108, DOI 10.1097/OPX.0000000000000934; Yuhas PT, 2016, INVEST OPHTH VIS SCI, V57; Zele AJ, 2018, J OPT SOC AM A, V35, pB19, DOI 10.1364/JOSAA.35.000B19	40	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0816-4622	1444-0938		CLIN EXP OPTOM	Clin. Exp. Optom.	NOV	2019	102	6					621	626		10.1111/cxo.12896			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	JH5OX	WOS:000492819000014	31037766				2022-02-06	
J	Zeeshan, M; Hamidi, M; O'Keeffe, T; Bae, EH; Hanna, K; Friese, RS; Kulvatunyou, N; Zakaria, E; Gries, L; Tang, A; Joseph, B				Zeeshan, Muhammad; Hamidi, Mohammad; O'Keeffe, Terence; Bae, Esther H.; Hanna, Kamil; Friese, Randall S.; Kulvatunyou, Narong; Zakaria, El Rasheid; Gries, Lynn; Tang, Andrew; Joseph, Bellal			Propranolol attenuates cognitive, learning, and memory deficits in a murine model of traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	49th Annual Meeting of the Western-Trauma-Association	MAR 03-09, 2019	Snowmass, CO	Western Trauma Assoc		Traumatic brain injury; propranolol; beta blockers	BETA-BLOCKERS; EXCITOTOXICITY; CONSEQUENCES; MODERATE	BACKGROUND beta-blockers have been shown to improve survival after traumatic brain injury (TBI); however, the impact of continuous dosage of beta-blockers on cognitive function has not been elucidated. We hypothesized that a daily dose of propranolol can improve memory, learning, and cognitive function following TBI. STUDY DESIGN Twenty male C57BL mice were subjected to a cortical-controlled moderate TBI. Two hours after TBI, animals were randomly allocated to either the beta-blocker group (n = 10) or the placebo group (n = 10). Mice in the beta-blocker group received intraperitoneal 4 mg/kg propranolol every 24 hours for 7 days while the placebo group received 4 mg/kg normal saline. Baseline novel object recognition and classic maze tests were done prior to TBI and then daily from Day 1 through 7 after TBI. Animals were sacrificed on Day 7. Serum biomarkers were measured using ELISA and brain sections were analyzed using western blot and hematoxylin and eosin staining. RESULTS Both the beta-blocker and placebo groups had lower recognition index scores compared with the baseline following TBI. beta-blocker mice had significantly higher novel object recognition scores compared with placebo mice 2 days after TBI. The beta-blocker group required less time to complete the maze-test compared to placebo group after Day 4. There was no difference regarding the serum levels of IL-1 beta, IL-6, and TNF-alpha. The beta-blocker group had lower levels of UCHL-1 and higher levels of Hsp-70 in brain lysate. Hematoxylin and eosin staining revealed that more neurons in the hippocampal-CA1 area underwent apoptosis in the placebo group compared with the beta-blocker group. CONCLUSION Postinjury propranolol administration results in improved memory, learning and cognitive functions in a murine model of moderate TBI. Propranolol increases the expression of antiapoptotic protein (Hsp-70) and decreases cell death in the hippocampal-CA1 area compared with the placebo.	[Zeeshan, Muhammad; Hamidi, Mohammad; O'Keeffe, Terence; Bae, Esther H.; Hanna, Kamil; Friese, Randall S.; Kulvatunyou, Narong; Zakaria, El Rasheid; Gries, Lynn; Tang, Andrew; Joseph, Bellal] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Coll Med, Tucson, AZ USA		Joseph, B (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room Kk5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu					Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CERNE R, 1993, NEUROSCI LETT, V161, P124, DOI 10.1016/0304-3940(93)90275-P; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Dekker SE, 2018, J NEUROSCI RES, V96, P711, DOI 10.1002/jnr.24125; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Genet GF, 2018, J TRAUMA ACUTE CARE, V84, P89, DOI 10.1097/TA.0000000000001708; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Jain KK, 2011, HANDBOOK OF NEUROPROTECTION, P217, DOI 10.1007/978-1-61779-049-2_4; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Lokhandwala A, 2018, J AM COLL SURGEONS, V227, pS272, DOI 10.1016/j.jamcollsurg.2018.07.561; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Michael S, 1986, NEUROSURGERY, V18, P136; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pandit V, 2018, J TRAUMA ACUTE CARE, V85, P48, DOI 10.1097/TA.0000000000001835; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Roy S, 2017, MMWR SURVEILL SUMM, V66, P1; Sandweiss AJ, 2017, J TRAUMA ACUTE CARE; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Ye CI, 2000, BIOPHYS J, V79, P2547, DOI 10.1016/S0006-3495(00)76495-2; Zhang R, 2013, TSLP, V10, P1, DOI [10.1145/2442076.2442078, DOI 10.1145/2442076.2442078]	39	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2019	87	5					1140	1147		10.1097/TA.0000000000002484			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	JZ1YN	WOS:000504900200029	31425494				2022-02-06	
J	Tiruneh, A; Siman-Tov, M; Givon, A; Peleg, K; Bahouth, H; Becker, A; Hadary, A; Jeroukhimov, I; Karawani, M; Kessel, B; Klein, Y; Lin, G; Merin, O; Miklush, B; Mnouskin, Y; Rivkind, A; Shaked, G; Sibak, G; Soffer, D; Stein, M; Wais, M; Pharan, H; Garbetzev, I				Tiruneh, Abebe; Siman-Tov, Maya; Givon, Adi; Peleg, Kobi; Bahouth, H.; Becker, A.; Hadary, A.; Jeroukhimov, I; Karawani, M.; Kessel, B.; Klein, Y.; Lin, G.; Merin, O.; Miklush, B.; Mnouskin, Y.; Rivkind, A.; Shaked, G.; Sibak, G.; Soffer, D.; Stein, M.; Wais, M.; Pharan, H.; Garbetzev, I		Israel Trauma Grp	Comparison between traumatic brain injury with and without concomitant injuries: an analysis based on a national trauma registry 2008-2016	BRAIN INJURY			English	Article						Traumatic brain injury; concomitant injuries; hospitalization; mortality; National Trauma Registry	EXTRACRANIAL INJURIES; HEAD-INJURY; MORTALITY; IMPACT; ETHNICITY; CHILDREN; SURVIVAL; SYSTEM; RISK	Objective: To compare demographic, injury and hospitalization characteristics and mortality between Isolated and Non-Isolated traumatic brain injury. Methods: A retrospective study based on the Israeli National Trauma Registry of patients hospitalized for traumatic brain injury (TBI) between 2008 and 2016. Isolated TBI was defined as no other anatomic region was having concomitant injury with AIS >= 2. X-2 test and multivariate logistic regression analysis were used for data analysis. Results: Of the 23566-study population, 40.4% were admitted for isolated TBI. Isolated TBI was significantly more frequent in elderly aged >= 65 years, female, Jews, and injuries sustained at home or in residential institution. The Non-isolated TBI was greater in road traffic injuries, particularly among pedestrians and motor cyclists, and in violence injuries. The Non-isolated TBI group had greater injury severity and hospital resource utilization. In-hospital mortality was higher in the patients with Non-isolated TBI [OR: 1.56(95% CI: 1.33-1.83)], particularly in patients with GCS 13-15; elderly aged 65+ years; and patients with concomitant injuries to abdomen, spine or external body regions. Conclusion: In a patient with TBI, concomitant injuries with AIS >= 2 matter, and awareness of the identified factors has relevance for guiding injury prevention efforts and indeed for potentially improving care and outcome.	[Tiruneh, Abebe; Siman-Tov, Maya; Givon, Adi; Peleg, Kobi; Bahouth, H.; Becker, A.; Hadary, A.; Jeroukhimov, I; Karawani, M.; Kessel, B.; Klein, Y.; Lin, G.; Merin, O.; Miklush, B.; Mnouskin, Y.; Rivkind, A.; Shaked, G.; Sibak, G.; Soffer, D.; Stein, M.; Wais, M.; Pharan, H.; Garbetzev, I; Israel Trauma Grp] Israel Natl Ctr Trauma & Emergency Med, Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Peleg, Kobi] Tel Aviv Univ, Sch Publ Hlth, Dept Disaster Management, Tel Aviv, Israel		Peleg, K (corresponding author), Sheba Med Ctr, IL-52621 Tel Aviv, Israel.; Peleg, K (corresponding author), Gertner Inst Hlth Policy & Epidemiol, IL-52621 Tel Aviv, Israel.; Peleg, K (corresponding author), Natl Ctr Trauma & Emergency Med Res, IL-52621 Tel Aviv, Israel.; Peleg, K (corresponding author), Tel Aviv Univ, Disaster Med Dept, IL-52621 Tel Aviv, Israel.	kobi.peleg@gmail.com					Abdel-Rahman N, 2013, ETHNIC HEALTH, V18, P391, DOI 10.1080/13557858.2012.754405; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; [Anonymous], DEC TRAUM INJ ISR 20; [Anonymous], 2008, ADV TRAUM LIF SUPP D; Association for the Advancement of Automotive Medicine, 1990, ABBREVIATED INJURY S; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Goldman S, 2015, TRAFFIC INJ PREV, V16, P368, DOI 10.1080/15389588.2014.940458; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Israel Central of Intelligence Agency, WORLD FACTBOOK; Jonsdottir GM, 2017, ACTA ANAESTH SCAND, V61, P408, DOI 10.1111/aas.12869; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Magid A, 2015, TRAFFIC INJ PREV, V16, P42, DOI 10.1080/15389588.2014.908289; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Moran M, 2010, TRANSPORT RES F-TRAF, V13, P377, DOI 10.1016/j.trf.2010.07.001; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Peden M., 2004, WORLD REPORT ROAD TR; Peleg K, 2004, ARCH SURG-CHICAGO, V139, P1231, DOI 10.1001/archsurg.139.11.1231; Peleg K, 2004, AM J EMERG MED, V22, P164, DOI 10.1016/j.ajem.2004.02.003; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2015, INJURY, V46, P86, DOI 10.1016/j.injury.2014.08.026; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Shibahashi K, 2018, WORLD NEUROSURG, V110, pE1078, DOI 10.1016/j.wneu.2017.12.002; Siman-Tov M, 2016, BRAIN INJURY, V30, P83, DOI 10.3109/02699052.2015.1104551; Siman-Tov M, 2013, INJURY, V44, P1448, DOI 10.1016/j.injury.2012.08.054; Soffer D, 2006, ISR MED ASSOC J, V8, P98; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; TEASDALE G, 1974, LANCET, V2, P81; Tiruneh A, 2017, ETHNIC HEALTH, V22, P49, DOI 10.1080/13557858.2016.1196647; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; WHO, 2002, WORLD REP VIOL HLTH; World Health Organization, 2007, WHO GLOB REP FALLP; World Health Organization, 2014, INJ VIOL FACTS 2014; World Health Organization, 2015, GLOB STAT REP ROAD S	43	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					213	223		10.1080/02699052.2019.1683893		OCT 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000493149100001	31661634				2022-02-06	
J	Asselstine, J; Kristman, VL; Armstrong, JJ; Dewan, N				Asselstine, Jennifer; Kristman, Vicki L.; Armstrong, Joshua J.; Dewan, Neha			The Rivermead Post-Concussion Questionnaire score is associated with disability and self-reported recovery six months after mild traumatic brain injury in older adults	BRAIN INJURY			English	Article						mTBI; mild traumatic brain injury; prognosis; older adults; recovery	GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; CES-D; SYMPTOMS QUESTIONNAIRE; CONSTRUCT-VALIDITY; VALIDATION; DEPRESSION	Background/Objectives: Post-concussion syndrome refers to the adverse group of symptoms following a mild traumatic brain injury (mTBI). The Rivermead post-concussion syndrome questionnaire (RPQ) is a common clinical tool for assessing baseline post-concussion syndrome symptomology; however, it is unknown if scores on this questionnaire are associated with future disability. Therefore, the goal of this study was to determine the association between baseline RPQ scores and future disability in older adults with mTBI. Methods and Findings: This study used a prospective cohort design, using the RPQ to measure baseline post-concussion syndrome symptomatology. Disability at 6 months was measured using the Glasgow Outcome Scale-Extended (GOSE; disability), short-form 12 (SF-12; physical and mental quality of life), and self-reported recovery. Linear and logistic models adjusted for confounding factors were estimated using 200 bootstrapped samples. Individuals with higher levels of baseline symptomatology were more likely to have poor GOSE scores (RR = 2.13, 95% CI [1.51, 2.31]) and self-reported recovery (RR = 2.64, 95% CI [1.31, 8.98]) 6 months later. Conclusions: High levels of baseline symptomatology may be associated with overall disability and individual perceptions of recovery 6 months post-MTBI. While the RPQ is valid in assessing a patient's post-concussive symptoms following mTBI, it may not predict long-term physical or mental health in older adults.	[Asselstine, Jennifer; Kristman, Vicki L.; Armstrong, Joshua J.; Dewan, Neha] Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada; [Asselstine, Jennifer] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Kristman, Vicki L.] Lakehead Univ, Northern Ontario Sch Med, Div Human Sci, Thunder Bay, ON, Canada; [Kristman, Vicki L.; Armstrong, Joshua J.; Dewan, Neha] Lakehead Univ, EPID Work Res Inst, Thunder Bay, ON, Canada		Kristman, VL (corresponding author), Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	vkristman@lakeheadu.ca		Asselstine, Jennifer/0000-0001-7254-032X	Ontario Neurotrauma Foundation [2012-ABI-MTBI-EP-950]; CIHR New Investigator Award in Community-based Primary Health CareCanadian Institutes of Health Research (CIHR)	This project was funded by the Ontario Neurotrauma Foundation, grant reference number 2012-ABI-MTBI-EP-950. Dr. Vicki Kristman is supported by a CIHR New Investigator Award in Community-based Primary Health Care.	Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kristman VL, 2016, THE JOURNAL OF HEAD; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Maruish M., 2004, USE PSYCHOL TESTING, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; ORME JG, 1986, J CLIN PSYCHOL, V42, P28, DOI 10.1002/1097-4679(198601)42:1<28::AID-JCLP2270420104>3.0.CO;2-T; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Pettit T, 2001, INT J GERIATR PSYCH, V16, P1061, DOI 10.1002/gps.479; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Salmi L Rachid, 2014, Arch Phys Med Rehabil, V95, pS95, DOI 10.1016/j.apmr.2013.10.026; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; StataCorp, 2014, STAT STAT SOFTW REL; Umegaki Y, 2017, PSYCHOL ASSESSMENT, V29, P354, DOI 10.1037/pas0000351; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	41	3	3	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					195	202		10.1080/02699052.2019.1682670		OCT 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000493170000001	31661628				2022-02-06	
J	Huang, APH; Lai, DM; Hsu, YH; Kung, Y; Lan, C; Yeh, CS; Tsai, HH; Lin, CF; Chen, WS				Huang, Abel Po-Hao; Lai, Dar-Ming; Hsu, Yi-Hua; Kung, Yi; Lan, Chiang; Yeh, Chia-Shan; Tsai, Hsin-Han; Lin, Chih-Feng; Chen, Wen-Shiang			Cavitation-induced traumatic cerebral contusion and intracerebral hemorrhage in the rat brain by using an off-the-shelf clinical shockwave device	SCIENTIFIC REPORTS			English	Article							CONTROLLED CORTICAL IMPACT; FOCUSED ULTRASOUND; INJURY; BARRIER; MICROBUBBLES; MODEL; MICE	Traumatic cerebral contusion and intracerebral hemorrhages (ICH) commonly result from traumatic brain injury and are associated with high morbidity and mortality rates. Current animal models require craniotomy and provide less control over injury severity. This study proposes a highly reproducible and controllable traumatic contusion and ICH model using non-invasive extracorporeal shockwaves (ESWs). Rat heads were exposed to ESWs generated by an off-the-shelf clinical device plus intravenous injection of microbubbles to enhance the cavitation effect for non-invasive induction of injury. Results indicate that injury severity can be effectively adjusted by using different ESW parameters. Moreover, the location or depth of injury can be purposefully determined by changing the focus of the concave ESW probe. Traumatic contusion and ICH were confirmed by H&E staining. Interestingly, the numbers of TUNEL-positive cells (apoptotic cell death) peaked one day after ESW exposure, while Iba1-positive cells (reactive microglia) and GFAP-positive cells (astrogliosis) respectively peaked seven and fourteen days after exposure. Cytokine assay showed significantly increased expressions of IL-1 beta, IL-6, and TNF-alpha. The extent of brain edema was characterized with magnetic resonance imaging. Conclusively, the proposed non-invasive and highly reproducible preclinical model effectively simulates the mechanism of closed head injury and provides focused traumatic contusion and ICH.	[Huang, Abel Po-Hao; Lai, Dar-Ming; Hsu, Yi-Hua; Yeh, Chia-Shan; Tsai, Hsin-Han] Natl Taiwan Univ Hosp & Coll Med, Dept Surg, Taipei, Taiwan; [Kung, Yi; Lan, Chiang; Chen, Wen-Shiang] Natl Taiwan Univ Hosp & Coll Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lin, Chih-Feng] Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan		Chen, WS (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Phys Med & Rehabil, Taipei, Taiwan.	wenshiang@gmail.com	Wen-shiang, Chen/B-4794-2009	Wen-shiang, Chen/0000-0003-1488-5164; HUANG, ABEL PO-HAO/0000-0002-5689-6761	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 106-2314-B-002-090]; National Taiwan University HospitalNational Taiwan University [NTUH 106-M3732]; Seventh Core Laboratory of NTUH	This work was supported by Ministry of Science and Technology (MOST 106-2314-B-002-090), Taiwan and National Taiwan University Hospital (NTUH 106-M3732). We appreciate research support from the Seventh Core Laboratory of NTUH. We also thank 7 T animal MRI Core Lab of the Neurobiology and Cognitive Science Center, NTU for technical and facility support. We thank Taiwan Lung Foundation for the suggestions for statistics and histology.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alhelfi A, 2016, J THERM SCI ENG APPL, V8, DOI 10.1115/1.4034056; Angstman NB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28910-z; Angstman NB, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00012; Bolanos JP, 2009, ADV DRUG DELIVER REV, V61, P1299, DOI 10.1016/j.addr.2009.05.009; Chen JQ, 2014, ASIAN PAC J TROP MED, V7, P991, DOI 10.1016/S1995-7645(14)60174-7; Conti AC, 1998, J NEUROSCI, V18, P5663; Cortes MDP, 2005, AM J NEURORADIOL, V26, P1218; Csaszar NBM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140541; Divani AA, 2018, J ULTRAS MED, V37, P2925, DOI 10.1002/jum.14656; Divani AA, 2015, J NEUROTRAUM, V32, P1109, DOI 10.1089/neu.2014.3686; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2014, VET RES COMMUN, V38, P297, DOI 10.1007/s11259-014-9616-z; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hatano B, 2011, PROC SPIE, V7897, DOI 10.1117/12.875909; Huang YX, 2017, RADIOLOGY, V282, P123, DOI 10.1148/radiol.2016152154; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Konofagou EE, 2012, CURR PHARM BIOTECHNO, V13, P1332; Kung Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20672-y; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Liu HL, 2014, THERANOSTICS, V4, P432, DOI 10.7150/thno.8074; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Lohse-Busch H, 2014, NEUROREHABILITATION, V35, P235, DOI 10.3233/NRE-141115; Marion DW, 2006, NEUROSURGERY, V58, P655; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Ohl SW, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0019; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; Prieur F, 2015, ULTRASON SONOCHEM, V26, P193, DOI 10.1016/j.ultsonch.2015.03.011; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sternecker K, 2018, BIOL OPEN, V7, DOI 10.1242/bio.033258; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; Tao CY, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00422; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037	44	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 30	2019	9								15614	10.1038/s41598-019-52117-5			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JI2EP	WOS:000493276600045	31666607	Green Published, gold			2022-02-06	
J	Johansson, B; Andrell, P; Ronnback, L; Mannheimer, C				Johansson, Birgitta; Andrell, Paulin; Ronnback, Lars; Mannheimer, Clas			Follow-up after 5.5 years of treatment with methylphenidate for mental fatigue and cognitive function after a mild traumatic brain injury	BRAIN INJURY			English	Article						Methylphenidate; mild TBI; mental fatigue; cognition	EXCESSIVE DAYTIME SLEEPINESS; DOUBLE-BLIND; ATTENTION DEFICITS; DIVIDED ATTENTION; NETWORK; (-)-OSU6162; MODAFINIL; SYMPTOMS; MODERATE; TRIAL	Objective: Prolonged mental fatigue and cognitive impairments are common after a mild traumatic brain injury (TBI). This sets limits for rehabilitation and for regaining the capacity for work and participation in social life. Method: This follow-up study, over a period of approximately 5.5 years was designed to evaluate the effect and safety of methylphenidate treatment for mental fatigue after a mild TBI. A comparison was made between those who had continued, and those who had discontinued the treatment. The effect was also evaluated after a four-week treatment break. Results: Significant improvement in mental fatigue, depression, and anxiety for the group treated with methylphenidate (p < .001) was found, while no significant change was found for the group without methylphenidate. The methylphenidate treatment group also improved their processing speed (p = .008). Withdrawal produced a pronounced and significant deterioration in mental fatigue, depression, and anxiety and a slower processing speed. This indicates that the methylphenidate effect is reversible if discontinued and that continued methylphenidate treatment can be a prerequisite for long-term improvement. The effect was found to be stable and safe over the years. Conclusion: We suggest methylphenidate to be a possible treatment option for patients with post-TBI symptoms including mental fatigue and cognitive symptoms.	[Johansson, Birgitta; Ronnback, Lars] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Andrell, Paulin] Gothenburg Univ, Sahlgrenska Univ Hosp, Inst Med, Dept Mol & Clin Med,Multidisciplinary Pain Ctr, Gothenburg, Sweden; [Mannheimer, Clas] Kungalv Hosp, Multidisciplinary Pain Ctr, Kungalv, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Bla Straket 7,V3, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se			Research and Development Centre, Gothenburg; Sodra Bohuslan [VGFOUGSB-804271]	This work was supported by grants from The Research and Development Centre, Gothenburg and Sodra Bohuslan VGFOUGSB-804271.	Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Berginstrom N, 2018, J HEAD TRAUMA REHAB, V33, P266, DOI 10.1097/HTR.0000000000000340; Berginstrom N, 2017, J HEAD TRAUMA REHAB, V32, pE46, DOI 10.1097/HTR.0000000000000236; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Dorer CL, 2018, BRAIN INJURY, V32, P1040, DOI 10.1080/02699052.2018.1469166; Faraone SV, 2018, NEUROSCI BIOBEHAV R, V87, P255, DOI 10.1016/j.neubiorev.2018.02.001; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hosomi S, 2018, NEUROIMAGE-CLIN, V20, P946, DOI 10.1016/j.nicl.2018.09.031; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2018, J CLIN PSYCHOPHARM, V38, P164, DOI 10.1097/JCP.0000000000000854; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PATRICK KS, 1987, PSYCHOPHARMACOLOGY 3, P1387; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reitan R, 1985, HALSTEAD REITAN NEUR; Ronnback L, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-22; Skau S, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00145; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Wechsler D., 2010, WECHSLER ADULT INTEL; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	50	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					229	235		10.1080/02699052.2019.1683898		OCT 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000492890100001	31657646	hybrid			2022-02-06	
J	Preethi, J; Bidkar, PU; Cherian, A; Dey, A; Srinivasan, S; Adinarayanan, S; Ramesh, AS				Preethi, Jayakumar; Bidkar, Prasanna Udupi; Cherian, Anusha; Dey, Ankita; Srinivasan, Swaminathan; Adinarayanan, Sethuramachandran; Ramesh, Andy Sadanand			Comparison of total intravenous anesthesia vs. inhalational anesthesia on brain relaxation, intracranial pressure, and hemodynamics in patients with acute subdural hematoma undergoing emergency craniotomy: a randomized control trial	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						TIVA; Inhalational agents; Traumatic brain injury; ICP	SEVOFLURANE-FENTANYL; PROPOFOL-FENTANYL; NITROUS-OXIDE; ISOFLURANE; SURGERY; TUMORS	Background The major goals of anesthesia in patients with severe traumatic brain injury (TBI) are-maintenance of hemodynamic stability, optimal cerebral perfusion pressure, lowering of ICP, and providing a relaxed brain. Although both inhalational and intravenous anesthetics are commonly employed, there is no clear consensus on which technique is better for the anesthetic management of severe TBI. Methods Ninety patients, 18-60 years of age, of either gender, with GCS < 8, posted for emergency evacuation of acute subdural hematoma were enrolled in this prospective trial, and they were randomized into two groups of 45 each. Patients in group P received propofol infusion at 100-150 mg/kg/min for maintenance of anesthesia and those in group I received <= 1 MAC of isoflurane. Hemodynamic parameters were monitored in all patients. ICP was measured at the dural opening and brain relaxation was assessed by the operating surgeon on a four-point scale (1-perfectly relaxed, 2-satisfactorily relaxed, 3-firm brain, and 4-bulging brain) at the dural opening. It was reassessed at dural closure. Results Brain relaxation, both at dural opening and closure, was significantly better in patients who received propofol compared to those who received isoflurane. ICP was significantly lower (25.47 +/- 3.72 mmHg vs. 23.41 +/- 3.97 mmHg) in the TIVA group. Hemodynamic parameters were well maintained in both groups. Conclusions In patients with severe TBI, total intravenous (Propofol)-based anesthesia provided better brain relaxation, maintained a lower ICP along with better hemodynamics when compared to inhalational anesthesia.	[Preethi, Jayakumar; Cherian, Anusha; Dey, Ankita; Srinivasan, Swaminathan; Adinarayanan, Sethuramachandran] JIPMER, Dept Anaesthesiol & Crit Care, Pondicherry, India; [Bidkar, Prasanna Udupi] JIPMER, Charge Neuroanaesthesiol Div, Dept Anaesthesiol & Crit Care, Pondicherry, India; [Ramesh, Andy Sadanand] JIPMER, Dept Neurosurg, Pondicherry, India		Bidkar, PU (corresponding author), JIPMER, Charge Neuroanaesthesiol Div, Dept Anaesthesiol & Crit Care, Pondicherry, India.	drprasannabidkar@gmail.com; anushacherian@gmail.com; ankitadeyslg@gmail.com; adinarayanans@gmail.com	Bidkar, Prasanna/AAQ-4198-2021	Bidkar, Prasanna/0000-0002-4497-6772; swaminathan, srinivasan/0000-0002-4919-215X			Bastola P, 2015, INDIAN J ANAESTH, V59, P287, DOI 10.4103/0019-5049.156868; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; Bundgaard H, 2000, BRIT J NEUROSURG, V14, P229; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cenic A, 2002, ANESTH ANALG, V94, P661, DOI 10.1097/00000539-200203000-00033; Deiner S, 2010, SEMIN CARDIOTHORAC V, V14, P51, DOI 10.1177/1089253210362792; Fiset P, 1999, J NEUROSCI, V19, P5506; Folino TB, 2019, STATPEARLS; Hans P, 2006, CURR OPIN ANESTHESIO, V19, P498, DOI 10.1097/01.aco.0000245274.69292.ad; Hassan WMNW, 2017, MALAYS J MED SCI, V24, P73, DOI 10.21315/mjms2017.24.5.8; Jorgensen HA, 1999, BRIT J NEUROSURG, V13, P449; Kannabiran N, 2018, J NEUROANESTHESIOL C, V5, P141, DOI [10.1055/s-0038-1673544, DOI 10.1055/S-0038-1673544]; Magni G, 2005, J NEUROSURG ANESTH, V17, P134, DOI 10.1097/01.ana.0000167447.33969.16; McCulloch TJ, 2007, ANESTHESIOLOGY, V106, P56, DOI 10.1097/00000542-200701000-00012; Mishra LD, 2008, J ANAESTH CLIN PHARM, V24, P399; Motayagheni N, 2017, AM J NEPHROL, V46, P380, DOI 10.1159/000482014; Petersen KD, 2003, ANESTHESIOLOGY, V98, P329, DOI 10.1097/00000542-200302000-00010; Prabhakar H, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010467.pub2; Raghava A, 2015, Surg Neurol Int, V6, P73, DOI 10.4103/2152-7806.156771; RAVUSSIN P, 1991, J NEUROSURG ANESTH, V3, P85, DOI 10.1097/00008506-199106000-00002; RD Miller, 2015, MILLERS ANESTHESIA, P920; Sakabe T, 2010, COTTRELL YOUNGS NEUR, P78; Santra S, 2009, INDIAN J ANAESTH, V53, P44; Sneyd JR, 2005, BRIT J ANAESTH, V94, P778, DOI 10.1093/bja/aei141; Talke P, 2002, ANESTH ANALG, V95, P430, DOI 10.1097/00000539-200208000-00036; TODD MM, 1993, ANESTHESIOLOGY, V78, P1005, DOI 10.1097/00000542-199306000-00002; Van Hemelrijck J, 1989, Acta Anaesthesiol Belg, V40, P95	27	3	3	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2021	47	3			SI		831	837		10.1007/s00068-019-01249-4		OCT 2019	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SO8AZ	WOS:000493264400001	31664468				2022-02-06	
J	Lindfors, M; Lindblad, C; Nelson, DW; Bellander, BM; Siironen, J; Raj, R; Thelin, EP				Lindfors, Matias; Lindblad, Caroline; Nelson, David W.; Bellander, Bo-Michael; Siironen, Jari; Raj, Rahul; Thelin, Eric P.			Prognostic performance of computerized tomography scoring systems in civilian penetrating traumatic brain injury: an observational study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Penetrating traumatic brain injury; Computerized tomography; Prognosis; Outcome prediction	CRANIOCEREBRAL GUNSHOT WOUNDS; HEAD-INJURY; CLASSIFICATION; MORTALITY; PREDICTORS; MANAGEMENT; SURVIVAL; MARSHALL	Background The prognosis of penetrating traumatic brain injury (pTBI) is poor yet highly variable. Current computerized tomography (CT) severity scores are commonly not used for pTBI prognostication but may provide important clinical information in these cohorts. Methods All consecutive pTBI patients from two large neurotrauma databases (Helsinki 1999-2015, Stockholm 2005-2014) were included. Outcome measures were 6-month mortality and unfavorable outcome (Glasgow Outcome Scale 1-3). Admission head CT scans were assessed according to the following: Marshall CT classification, Rotterdam CT score, Stockholm CT score, and Helsinki CT score. The discrimination (area under the receiver operating curve, AUC) and explanatory variance (pseudo-R-2) of the CT scores were assessed individually and in addition to a base model including age, motor response, and pupil responsiveness. Results Altogether, 75 patients were included. Overall 6-month mortality and unfavorable outcome were 45% and 61% for all patients, and 31% and 51% for actively treated patients. The CT scores' AUCs and pseudo-R(2)s varied between 0.77-0.90 and 0.35-0.60 for mortality prediction and between 0.85-0.89 and 0.50-0.57 for unfavorable outcome prediction. The base model showed excellent performance for mortality (AUC 0.94, pseudo-R-2 0.71) and unfavorable outcome (AUC 0.89, pseudo-R-2 0.53) prediction. None of the CT scores increased the base model's AUC (p > 0.05) yet increased its pseudo-R-2 (0.09-0.15) for unfavorable outcome prediction. Conclusion Existing head CT scores demonstrate good-to-excellent performance in 6-month outcome prediction in pTBI patients. However, they do not add independent information to known outcome predictors, indicating that a unique score capturing the intracranial severity in pTBI may be warranted.	[Lindfors, Matias; Siironen, Jari; Raj, Rahul] Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland; [Lindfors, Matias; Siironen, Jari; Raj, Rahul] Univ Helsinki, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland; [Lindblad, Caroline; Bellander, Bo-Michael; Thelin, Eric P.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Nelson, David W.] Karolinska Inst, Sect Perioperat Med & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Nelson, David W.] Karolinska Univ Hosp, Funct Perioperat Med & Intens Care, Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Thelin, Eric P.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus, Cambridge, England; [Bellander, Bo-Michael; Thelin, Eric P.] Karolinska Univ Hosp, Theme Neuro, Stockholm, Sweden		Lindfors, M (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland.; Lindfors, M (corresponding author), Univ Helsinki, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland.	matias.lindfors@helsinki.fi	Lindblad, Caroline/AAJ-7911-2021; Raj, Rahul/K-7693-2012; Thelin, Eric Peter/K-2144-2012	Lindblad, Caroline/0000-0003-4952-8597; Raj, Rahul/0000-0003-4243-9591; Thelin, Eric Peter/0000-0002-2338-4364; Nelson, David/0000-0003-2530-8207	University of Helsinki; Paivikki ja Sakari Sohlbergin Saatio; Karolinska Institute Funds Clinical Scientist Training Programme, Research Internship, Karolinska Institutet Resebidrag; Swedish Society for Medical Research Travel Grant; Stockholm County Council (ALF)Stockholm County Council; Maire Taposen Saatio; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv Halsa; Svenska Sallskapet for Medicinsk Forskning; Helsinki University Central Hospital	Open access funding provided by University of Helsinki including Helsinki University Central Hospital. The study did not receive specific funding. MLhas received personal research grants from Maire Taposen Saatio and Paivikki ja Sakari Sohlbergin Saatio. CL has received personal grants from the Karolinska Institute Funds Clinical Scientist Training Programme, Research Internship, Karolinska Institutet Resebidrag, and the Swedish Society for Medical Research Travel Grant. DWN and BMB have received funding from Stockholm County Council (ALF). JS has received funding from Maire Taposen Saatio. RR has received personal grants from Finska Lakaresallskapet and Medicinska Understodsforeningen Liv & Halsa. EPT is supported by postdoctoral grants from Svenska Sallskapet for Medicinsk Forskning.	Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; de Holanda LF, 2016, WORLD NEUROSURG, V90, P420, DOI 10.1016/j.wneu.2016.03.015; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Glapa M, 2009, AM SURGEON, V75, P223; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; Khan MB, 2014, WORLD NEUROSURG, V82, P14, DOI 10.1016/j.wneu.2013.01.026; Kochanek KD, 2012, NATL VITAL STAT REPO, V60, P1; LILLARD PL, 1978, SURG NEUROL, V9, P79; Lindfors M, 2018, ACTA NEUROCHIR, V160, P2107, DOI 10.1007/s00701-018-3670-1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Maragkos GA, 2018, J NEUROTRAUM, V35, P2605, DOI 10.1089/neu.2018.5682; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Murano T, 2005, AM SURGEON, V71, P1009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Skarupa DJ, 2019, AM J SURG, V218, P255, DOI 10.1016/j.amjsurg.2018.11.034; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Turco L, 2017, WORLD NEUROSURG, V104, P653, DOI 10.1016/j.wneu.2017.05.068; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072	47	3	3	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2019	161	12					2467	2478		10.1007/s00701-019-04074-1		OCT 2019	12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JV4VQ	WOS:000492918100001	31659439	Green Published, hybrid			2022-02-06	
J	White-Schwoch, T; Krizman, J; McCracken, K; Burgess, JK; Thompson, EC; Nicol, T; LaBella, CR; Kraus, N				White-Schwoch, Travis; Krizman, Jennifer; McCracken, Kristi; Burgess, Jamie K.; Thompson, Elaine C.; Nicol, Trent; LaBella, Cynthia R.; Kraus, Nina			Performance on auditory, vestibular, and visual tests is stable across two seasons of youth tackle football	BRAIN INJURY			English	Article						Concussion; children; sports; athletes; neurosensory function	CHRONIC TRAUMATIC ENCEPHALOPATHY; HEAD IMPACT EXPOSURE; ERROR SCORING SYSTEM; KING-DEVICK TEST; SCREENING TOOL; CONCUSSION; DEFICITS; PLAYERS; SPORTS; RELIABILITY	Objective: Few studies have tracked neurologic function in youth football players longitudinally. This study aimed to determine whether changes in tests of auditory, vestibular, and/or visual functions are evident after participation in one or two seasons of youth tackle football. Study Design: Prospective cohort study. Subjects and Methods: Before their 2017 and/or 2018 seasons, male tackle football players (ages 7-14 yrs) completed three tests that tend to exhibit acute disruptions following a concussion: (1) the FFR (frequency-following response), aphysiologic test of auditory function, (2) the BESS (Balance Error Scoring System), a test of vestibular function, and (3) the King-Devick, a test of oculomotor function. We planned to repeat these on all subjects at the end of each season. Results: Performance on neurosensory tests was stable, with no changes observed in FFR or King-Devick and a slight improvement observed in BESS performance across each season. Performance was also stable over two years for the subjects who participated both years. Across-season test-retest reliability correlations were high. Conclusions: In the absence of concussion, young athletes' performance on the FFR, King-Devick, and BESS is stable across one or two seasons of youth tackle football.	[White-Schwoch, Travis; Krizman, Jennifer; Thompson, Elaine C.; Nicol, Trent; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL USA; [White-Schwoch, Travis; Krizman, Jennifer; Thompson, Elaine C.; Nicol, Trent; Kraus, Nina] Northwestern Univ, Dept Commun Sci, Evanston, IL USA; [McCracken, Kristi; Burgess, Jamie K.; LaBella, Cynthia R.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Orthopaed Surg & Sports Med, 225 East Chicago Ave,Box 69, Chicago, IL 60611 USA; [LaBella, Cynthia R.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Evanston, IL USA		LaBella, CR (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Orthopaed Surg & Sports Med, 225 East Chicago Ave,Box 69, Chicago, IL 60611 USA.	clabella@luriechildrens.org		, Jamie/0000-0001-6630-8495	Knowles Hearing Centre; Ann & Robert H. Lurie Children's Hospital of Chicago	This work was supported by the Knowles Hearing Centre;Ann & Robert H. Lurie Children's Hospital of Chicago;	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2018, CLIN J SPORT MED, V28, P130, DOI 10.1097/JSM.0000000000000420; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hornickel J, 2012, HEARING RES, V284, P52, DOI 10.1016/j.heares.2011.12.005; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Kraus N, 2017, NEUROSCI LETT, V646, P21, DOI 10.1016/j.neulet.2017.03.008; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Krizman J, 2019, HEARING RES, V382, DOI 10.1016/j.heares.2019.107779; Krizman J, 2015, CLIN NEUROPHYSIOL, V126, P2348, DOI 10.1016/j.clinph.2015.01.026; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Linder SM, 2018, MED SCI SPORT EXER, V50, P1998, DOI 10.1249/MSS.0000000000001660; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McDonald B, 2018, 3 INT C PAED ACQ BRA; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Murray NG, 2018, INT J PSYCHOPHYSIOL, V132, P81, DOI 10.1016/j.ijpsycho.2017.09.018; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Song JH, 2011, CLIN NEUROPHYSIOL, V122, P346, DOI 10.1016/j.clinph.2010.07.009; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Thompson EC, 2018, BRAIN INJURY, V32, P763, DOI 10.1080/02699052.2018.1447686; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423	44	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					236	244		10.1080/02699052.2019.1683899		OCT 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000493150100001	31661641				2022-02-06	
J	Anke, A; Roe, C; Sigurdardottir, S; Norup, A; Soberg, HL; Arango-Lasprilla, JC; Manskow, US				Anke, Audny; Roe, Cecilie; Sigurdardottir, Solrun; Norup, Anne; Soberg, Helene L.; Arango-Lasprilla, Juan Carlos; Manskow, Unn Sollid			Family needs at one and two years after severe traumatic brain injury: a prospective study of changes and predictors	BRAIN INJURY			English	Article						Traumatic brain injury; relatives; family; support systems; chronic	BURDEN 1 YEAR; INTERVENTION IMPACT; LIFE SATISFACTION; CAREGIVER BURDEN; MULTICENTER; EFFICACY; IMPROVE; NORWAY; HEALTH; CARE	Objective: To assess changes in family needs between the first and second years after severe traumatic brain injury (sTBI) and to identify factors predicting unmet family needs. Design: Prospective Norwegian multicenter cohort study. Participants: The family members of 110 patients with sTBI were followed up at one year, and family members of 70 patients also at two years after trauma. Main measure: The Family Needs Questionnaire-Revised (FNQ-R). Results: Mean ratings of met family needs changed with a small decline between one year and two years post-injury on the FNQ-R subscales of Health Information and of Community Support Network. Proportions of needs met at one and two years ranged between 28% and 55%. Family needs most often met were from the Health Information subscale, and needs most often unmet were from the Emotional Support subscale. Caring for older patients, patients with more functional disabilities, female patients and being a spouse of a patient were associated with statistically significantly greater unmet family needs. Conclusion: Family members of survivors of traumatic brain injuries experience high levels of unmet needs, and rating of met needs tends to decline from one to two years post-injury. The identified predictors of unmet needs can contribute to guiding services following sTBI.	[Anke, Audny] Univ Hosp North Norway, Dept Rehabil, N-9038 Tromso, Norway; [Anke, Audny] Arctic Univ Norway, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Anke, Audny] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa, Spain; [Roe, Cecilie; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Norup, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Soberg, Helene L.] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway; [Arango-Lasprilla, Juan Carlos] Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain; [Arango-Lasprilla, Juan Carlos] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Arango-Lasprilla, Juan Carlos; Manskow, Unn Sollid] Univ Hosp North Norway, Norwegian Ctr E Hlth Res, Tromso, Norway		Anke, A (corresponding author), Univ Hosp North Norway, Dept Rehabil, N-9038 Tromso, Norway.	audny.anke@uit.no		Norup, Anne/0000-0002-5598-6116	Norwegian ExtraFoundation for Health and Rehabilitation; North Norwegian Health Authorities	This study was conducted with grants from the Norwegian ExtraFoundation for Health and Rehabilitation and the North Norwegian Health Authorities.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Moules S, 1999, BRAIN INJURY, V13, P983; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Niemeier JP, 2019, ARCH PHYS MED REHAB, V100, pS65, DOI 10.1016/j.apmr.2018.07.422; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; TEASDALE G, 1974, LANCET, V2, P81; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Tverdov AH, 2016, BRAIN INJURY, V30, P324, DOI 10.3109/02699052.2015.1113566; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	45	3	3	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					89	97		10.1080/02699052.2019.1682191		OCT 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000492316900001	31647690				2022-02-06	
J	Ratka, J; Cheever, K; Mansell, JL; Tierney, RT				Ratka, Jenna; Cheever, Kelly; Mansell, Jamie L.; Tierney, Ryan T.			The effect of an interval fatigue protocol on Vestibular/Ocular Motor Screening (VOMS) performance	BRAIN INJURY			English	Article						Concussion; sport-related concussion; sideline assessment; exertional fatigue	AEROBIC EXERCISE; SPORT; CONCUSSION; MANAGEMENT	Objective: The purpose of this study was to examine the effect of a fatigue protocol on Vestibular/Ocular Motor Screening (VOMS) performance. Design: Within subjects, repeated measures, crossover. Methods: Fifteen healthy, physically-active participants (22.20 +/- 1.424 years) completed 2 sessions under 2 conditions. A pretest VOMS, condition protocol, and a posttest VOMSwere performed. The control condition consisted of rest, while the experimental consisted of a fatigue protocol. Results: The primary outcome measures were VOMS performance scores and Near Point of Convergence (NPC) measurements. Statistically significant interaction effects for NPC, F(1,14) = 9.38, p = .008, and total VOMS score, F(1,14) = 10.96, p = .005 were observed. For NPC, posttest (9.12 +/- 4.99 cm) was significantly different, t(14) = -2.60, p = .021, than pretest scores (7.12 +/- 3.19 cm). For total VOMS score, posttest experimental scores (4.93 +/- 5.12) were significantly different, t(14) = -3.06, p = .009, than pretest severity scores (1.73 +/- 3.67). Conclusions: Significant increases were found in total VOMS and NPC scores following exertional fatigue. Exertional fatigue affects symptoms associated with vestibular, and/or ocular motor system assessments. Clinicians should use the VOMS with caution immediately following activity and allow time for recovery from acute fatigue.	[Ratka, Jenna; Mansell, Jamie L.; Tierney, Ryan T.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Cheever, Kelly] Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA		Ratka, J (corresponding author), Temple Univ, Philadelphia, PA 19122 USA.	jennaratka@gmail.com		Cheever, Kelly/0000-0001-8381-3426			Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Connell CJW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26614; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Fery YA, 1997, PERCEPT MOTOR SKILL, V84, P291, DOI 10.2466/pms.1997.84.1.291; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; Lindsey J., 2017, ATHLETIC TRAINING SP, V9, P177, DOI [10.3928/19425864-20170420-03, DOI 10.3928/19425864-20170420-03]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Morissette MP, 2014, CURR RES CONCUSSION, V1, P19; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nielsen BB, 1999, AM PHYSL SOC, V277, P45; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Scherr J, 2013, EUR J APPL PHYSIOL, V113, P147, DOI 10.1007/s00421-012-2421-x; Shibuya K, 2004, J SPORT MED PHYS FIT, V44, P215; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; WILLIAMS SJ, 1994, BRIT J SPORT MED, V28, P96, DOI 10.1136/bjsm.28.2.96	28	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					110	114		10.1080/02699052.2019.1682194		OCT 2019	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000492101000001	31645131				2022-02-06	
J	Krueger, EM; Putty, M; Young, M; Gaynor, B; Omi, E; Farhat, H				Krueger, Evan M.; Putty, Matthew; Young, Michael; Gaynor, Brandon; Omi, Ellen; Farhat, Hamad			Neurosurgical Outcomes of Isolated Hemorrhagic Mild Traumatic Brain Injury	CUREUS			English	Article						mild traumatic brain injury; subdural hematoma; neurosurgical intervention; epidural hematoma; neurocritical care	CARE-UNIT ADMISSION; SUBARACHNOID HEMORRHAGE; LOW-RISK; INTRACRANIAL HEMORRHAGE; STATES; COST; SAFE	Introduction Mild traumatic brain injury (TBI) is common but its management is variable. Objectives To describe the acute natural history of isolated hemorrhagic mild TBI. Methods This was a single-center, retrospective chart review of 661 patients. Inclusion criteria were consecutive patients with hemorrhagic mild TBI. Exclusion criteria were any other acute traumatic injury and significant comorbidities. Variables recorded included neurosurgical intervention and timing, mortality, emergency room disposition, intensive care unit (ICU) length of stay (LOS), discharge disposition, repeat computed tomography head (CTH) indications and results, neurologic exam, age, sex, Glasgow Coma Scale (GCS) score, and hemorrhage type. Results Overall intervention and unexpected delayed intervention rates were 9.4% and 1.5%, respectively. The mortality rate was 2.4%. A 10-year age increase had 26% greater odds of intervention (95% CI, 9.6-45%; P<.001) and 53% greater odds of mortality (95% CI, 11-110%; P=.009). A one-point GCS increase had 49% lower odds of intervention (95% CI, 25-66%; P<.001) and 50% lower odds of mortality (95% CI, 1-75%; P=.047). Subdural and epidural hemorrhages were more likely to require intervention (P=.02). ICU admission was associated with discharge to an acute care facility (OR, 2.9; 95% CI, 1.4-6.0; P=.003). Neurologic exam changes were associated with a worsened CTH scan (OR, 12.3; 95% CI, 7.0-21.4; P<.001) and intervention (OR, 15.1; 95% CI, 8.4-27.2; P<.001). Conclusions Isolated hemorrhagic mild TBI patients are at a low, but not clinically insignificant, risk of intervention and mortality.	[Krueger, Evan M.] Advocate Hlth Care, Neurosurg, Downers Grove, IL USA; [Putty, Matthew] Advocate Hlth Care, Neurosurg, Normal, IL USA; [Young, Michael] Advocate Bromenn Med Ctr, Neurosurg, Normal, IL 61761 USA; [Gaynor, Brandon; Farhat, Hamad] Advocate Christ Med Ctr, Neurosurg, Oak Lawn, IL USA; [Omi, Ellen] Advocate Hlth Care, Trauma Surg, Oak Lawn, IL USA		Young, M (corresponding author), Advocate Bromenn Med Ctr, Neurosurg, Normal, IL 61761 USA.	mmyoung2251@gmail.com		Young, Michael/0000-0002-9771-0572			Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2015, C TRAUM BRAIN INJ US; Bardes JM, 2016, AM SURGEON, V82, P36; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2010, DAT STAT WISQARS COS; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Lamb LC, 2018, EUR J TRAUMA EMERG S, V44, P897, DOI 10.1007/s00068-017-0867-6; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Milbrandt EB, 2008, CRIT CARE MED, V36, P2504, DOI 10.1097/CCM.0b013e318183ef84; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Witiw CD, 2018, CRIT CARE MED, V46, P430, DOI 10.1097/CCM.0000000000002931; Yun BJ, 2018, ACAD EMERG MED, V25, P769, DOI 10.1111/acem.13350	25	3	3	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	OCT 24	2019	11	10							e5982	10.7759/cureus.5982			12	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JG6AG	WOS:000492153400005	31808447	Green Published, gold			2022-02-06	
J	Moran, RN; Wallace, J; Murray, NG; Covassin, T				Moran, Ryan N.; Wallace, Jessica; Murray, Nicholas G.; Covassin, Tracey			Effects of attention deficit hyperactivity disorder and learning disability on vestibular and ocular baseline concussion assessment in pediatric athletes	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						ADHD; concussion; learning disability; vestibular	MOTOR SCREENING VOMS; SPORTS-RELATED CONCUSSION; EYE-MOVEMENTS; RISK-FACTORS; PERFORMANCE; RECOVERY; RELIABILITY; SCORES; YOUTH; ADHD	Vestibular and ocular motor assessment has gained popularity as a tool for sport-related concussion among healthcare professionals. With awareness of premorbid risk factors, such as attentional problems, it is imperative to understand their effects at baseline. The purpose of this study was to examine the effects of attention deficit/hyperactivity disorder (ADHD) and diagnosed learning disability (LD) on vestibular and oculomotor baseline concussion assessment in pediatrics. Pediatric athletes between the ages of 8 and 14 years with ADHD/LD (n = 30) and match controls without ADHD/LD (n = 30) completed baseline concussion testing, consisting of symptom provocation on the Vestibular/Ocular Motor Screening (VOMS) and oculomotor performance on near point of convergence (NPC) and King-Devick (K-D) tools. Those diagnosed with ADHD/LD performed worse on baseline saccades (p range = .02-.10), convergence (p = .04), vestibular ocular reflex (VOR) (p = .03) and visual motion sensitivity (VMS) (p = .04) of the VOMS. Base rate analyses revealed that 26% of athletes in the ADHD/LD group had >= 1 and 13.3% had >= 2 VOMS domains over clinical cutoff levels, compared to 3.3% (>= 1 domain) and 0 (>= 2 domains) of controls. Individuals with ADHD/LD also performed worse on K-D assessment (p = .005). However, no differences were reported on NPC distance (p = .19). These findings suggest worse baseline concussion assessment scores on vestibular/ocular motor assessment domains in pediatric athletes diagnosed with ADHD/LD. Additional research is needed on assessment outcomes to determine if special consideration to those diagnosed with ADHD/LD is warranted.	[Moran, Ryan N.; Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, 2103 Capital Hall,Box 870325, Tuscaloosa, AL 35487 USA; [Murray, Nicholas G.] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, Sport Injury Res Lab, E Lansing, MI 48824 USA		Moran, RN (corresponding author), Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, 2103 Capital Hall,Box 870325, Tuscaloosa, AL 35487 USA.	rnmoran@ua.edu			Michigan State University College of Education; Michigan State University Graduate School Research Fellowship Award	This study was funded by the Michigan State University College of Education and the Graduate School Research Fellowship Award (authors: RNM and TC).	Akinbami Lara J, 2011, NCHS Data Brief, P1; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; CDC, 2014, CDCP DIAGN MED TREAT; Chacko A, 2013, CHILD ADOL PSYCH CL, V22, P457, DOI 10.1016/j.chc.2013.03.006; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Jonkman LM, 2000, PSYCHOPHYSIOLOGY, V37, P334; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kristjansson A, 2007, SCAND J PSYCHOL, V48, P97, DOI 10.1111/j.1467-9450.2007.00537.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2019, J NEUROSURG-PEDIATR, V23, P465, DOI 10.3171/2018.10.PEDS18425; Moran RN, 2018, SCAND J MED SCI SPOR, V28, P2686, DOI 10.1111/sms.13286; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mrazik M, 2019, J NEUROL SCI, V399, P140, DOI 10.1016/j.jns.2019.02.020; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mueller B., 2015, NEUROLOGY S, V84; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Salinas CM, 2016, APPL NEUROPSYCH-CHIL, V5, P264, DOI 10.1080/21622965.2015.1052814; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	38	3	3	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2021	10	3					276	282		10.1080/21622965.2019.1683453		OCT 2019	7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TW4CZ	WOS:000492503900001	31650856				2022-02-06	
J	Washington, PM; Lee, C; Dwyer, MKR; Konofagou, EE; Kernie, SG; Morrison, B				Washington, Patricia M.; Lee, Changhee; Dwyer, Mary Kate R.; Konofagou, Elisa E.; Kernie, Steven G.; Morrison, Barclay, III			Hyaluronidase reduced edema after experimental traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Blood-brain barrier; edema; hyaluronan; magnetic resonance imaging; traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; HEAD-INJURY; PERMEABILITY; BARRIER; MODEL; ACCUMULATION; HYPERTENSION; HIPPOCAMPUS; MORTALITY	Cerebral edema and the subsequent increased intracranial pressure are associated with mortality and poor outcome following traumatic brain injury. Previous in vitro studies have shown that the Gibbs-Donnan effect, which describes the tendency of a porous, negatively charged matrix to attract positive ions and water, applies to brain tissue and that enzymatic reduction of the fixed charge density can prevent tissue swelling. We tested whether hyaluronidase, an enzyme that degrades the large, negatively charged glycosaminoglycan hyaluronan, could reduce brain edema after traumatic brain injury. In vivo, intracerebroventricular injection of hyaluronidase after controlled cortical impact in mice reduced edema in the ipsilateral hippocampus at 24 h by both the wet-weight/dry-weight method (78.15 +/- 0.65% vs. 80.4 +/- 0.46%; p < 0.01) and T-2-weighted magnetic resonance imaging (13.88 +/- 3.09% vs. 29.23 +/- 6.14%; p < 0.01). Hyaluronidase did not adversely affect blood-brain-barrier-integrity measured by dynamic contrast-enhanced magnetic resonance imaging, nor did hyaluronidase negatively affect functional recovery after controlled cortical impact measured with the rotarod or Morris water maze tasks. Reduction of fixed charge density by hyaluronidase was confirmed in cortical explants in vitro (5.46 +/- 1.15 mu g/mg vs. 7.76 +/- 1.87 mu g/mg; p < 0.05). These data demonstrate that targeting the fixed charge density with hyaluronidase reduced edema in an in vivo mouse model of traumatic brain injury.	[Washington, Patricia M.; Kernie, Steven G.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Washington, Patricia M.; Lee, Changhee; Dwyer, Mary Kate R.; Konofagou, Elisa E.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,Mail Code 8904, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,Mail Code 8904, New York, NY 10027 USA.	Bm2119@columbia.edu	Kernie, Steven/AAT-9912-2020; Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	Columbia University's Research Initiatives for Science and Engineering (RISE) program - Columbia University's Office of the Executive Vice President for Research; Taub Institute MRI Platform Pilot Scan/Analysis Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R56NS089523]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by Columbia University's Research Initiatives for Science and Engineering (RISE) program sponsored by Columbia University's Office of the Executive Vice President for Research (S.G. Kernie and B. Morrison III), the Taub Institute MRI Platform Pilot Scan/Analysis Award (B. Morrison III), and NIH 1R56NS089523 (S.G. Kernie).	Angeli S, 2017, J BIOMECH, V56, P42, DOI 10.1016/j.jbiomech.2017.02.028; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BHATTACHARYA J, 1989, J APPL PHYSIOL, V66, P2595, DOI 10.1152/jappl.1989.66.6.2595; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elkin BS, 2011, J NEUROTRAUM, V28, P2277, DOI 10.1089/neu.2010.1603; Elkin BS, 2010, PHILOS T R SOC A, V368, P585, DOI 10.1098/rsta.2009.0223; Finan John D, 2016, BMC Res Notes, V9, P160, DOI 10.1186/s13104-016-1968-8; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; FUXE K, 1994, NEUROSCI LETT, V169, P25, DOI 10.1016/0304-3940(94)90348-4; Hunger J, 2012, BIOPHYS J, V103, pL10, DOI 10.1016/j.bpj.2012.05.028; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hylin MJ, 2013, LEARN MEMORY, V20, P267, DOI 10.1101/lm.030197.112; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McConnell ED, 2016, J CEREBR BLOOD F MET, V36, P1537, DOI 10.1177/0271678X15608389; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NETTELBLADT O, 1989, AM J PHYSIOL, V257, pL379, DOI 10.1152/ajplung.1989.257.6.L379; Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165; Sherman Larry S, 2015, Int J Cell Biol, V2015, P368584, DOI 10.1155/2015/368584; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Solis MA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/346972; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Thomas DL, 2006, MAGN RESON MED, V55, P943, DOI 10.1002/mrm.20823; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; WALDENSTROM A, 1991, J CLIN INVEST, V88, P1622, DOI 10.1172/JCI115475; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	44	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2020	40	10					2026	2037	0271678X19882780	10.1177/0271678X19882780		OCT 2019	12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	NV8EM	WOS:000492626800001	31648593	Green Published			2022-02-06	
J	Mitrushina, M; Tomaszewski, R				Mitrushina, Maura; Tomaszewski, Robert			Factors associated with return to work in patients with long-term disabilities due to neurological and neuropsychiatric disorders	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Long-term disability; Return to work; Cognitive remediation; Psychotherapy; Vocational rehabilitation	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; FOLLOW-UP; INDIVIDUAL PLACEMENT; NATIONAL INSTITUTE; EMPLOYMENT; PREDICTORS; PRODUCTIVITY; DEPRESSION; OUTCOMES	The current study explores factors predicting return to work in a sample of patients with neurological and neuropsychiatric disorders who have attended a prevocational readiness and social skills training programme many years after trauma. Participants were community-dwelling adults with long-term disabilities (N = 67). Results of univariate analyses followed by multivariate logistic regression analysis revealed that both pre-injury (prior) and post-injury (current) factors influenced the likelihood of employment in our sample: prior employment, current employment readiness, current cognitive competence (particularly memory and executive functioning) and emotional adjustment. Our findings demonstrate that both pre-trauma and current factors interact in predicting return to work not only for individuals with traumatic brain injury (TBI), but also for a broader group of patients with long-term disabilities due to a variety of neurological and neuropsychiatric conditions. Thus, our findings provide preliminary support for ongoing long-term management of individuals with long-term disabilities and warrant close attention of future investigators to potential benefits of cognitive remediation, psychotherapy and vocational rehabilitation in terms of maintenance of initial gains and increased probability of return to work many years after trauma.	[Mitrushina, Maura; Tomaszewski, Robert] Calif State Univ Northridge, Dept Psychol, Northridge, CA 91330 USA; [Mitrushina, Maura; Tomaszewski, Robert] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA		Mitrushina, M (corresponding author), Calif State Univ Northridge, Dept Psychol, Northridge, CA 91330 USA.; Mitrushina, M (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	maura.mitrushina@csun.edu					Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; [Anonymous], 2007, NEUR DIS PUBL HLTH C; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Army Individual Test Battery, 1944, MAN DIR SCOR; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Becker DR, 1993, WORKING LIFE INDIVID; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dahm J, 2015, BRAIN INJURY, V29, P1539, DOI 10.3109/02699052.2015.1075141; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Delman J, 2017, PSYCHIATR REHABIL J, V40, P179, DOI 10.1037/prj0000264; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Drake RE, 2017, ADM POLICY MENT HLTH, V44, P309, DOI 10.1007/s10488-017-0803-4; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Nutzi M, 2017, REHABIL PSYCHOL, V62, P45, DOI 10.1037/rep0000119; Ottomanelli L, 2017, ARCH PHYS MED REHAB, V98, P1567, DOI 10.1016/j.apmr.2016.12.010; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Riches V. C., 1993, STANDARDS WORK PERFO; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Viering S., 2015, FRONT PUBLIC HEALTH, V16, P1; Villotti P, 2017, COMMUNITY MENT HLT J, V53, P864, DOI 10.1007/s10597-016-0068-5; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Watanabe TK, 2003, ARCH PHYS MED REHAB, V84, pS23, DOI 10.1053/apmr.2003.50054; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 1993, INT CLASS IMP DIS HA; World Health Organization, 2007, INT CLASS FUNCT DIS	60	3	3	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT 21	2019	29	9					1313	1331		10.1080/09602011.2017.1395746			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IT5UV	WOS:000482933600001	29125015				2022-02-06	
J	Yu, XC; Ghajari, M				Yu, Xiancheng; Ghajari, Mazdak			An assessment of blast modelling techniques for injury biomechanics research	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article							TRAUMATIC BRAIN-INJURY; HEAD; RESPONSES	Blast-induced traumatic brain injury (TBI) has been affecting combatants and civilians. The blast pressure wave is thought to have a significant contribution to blast-related TBI. Due to the limitations and difficulties of conducting blast tests on surrogates, computational modelling has been used as a key method for exploring this field. However, the blast wave modelling methods reported in current literature have drawbacks. They either cannot generate the desirable blast pressure wave history or they are unable to accurately simulate the blast wave/structure interaction. In addition, boundary conditions, which can have significant effects on model predictions, have not been described adequately. Here, we critically assess the commonly used methods for simulating blast wave propagation in air (open-field blast) and its interaction with the human body. We investigate the predicted blast wave time history, blast wave transmission, and the effects of various boundary conditions in three-dimensional (3D) models of blast prediction. We propose a suitable meshing topology, which enables accurate prediction of blast wave propagation and interaction with the human head and significantly decreases the computational cost in 3D simulations. Finally, we predict strain and strain rate in the human brain during blast wave exposure and show the influence of the blast wave modelling methods on the brain response. The findings presented here can serve as guidelines for accurately modelling blast wave generation and interaction with the human body for injury biomechanics studies and design of prevention systems.	[Yu, Xiancheng; Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, South Kensington Campus, London SW7 2AZ, England; [Yu, Xiancheng; Ghajari, Mazdak] Imperial Coll London, Ctr Blast Injury Studies, South Kensington Campus, London, England		Yu, XC (corresponding author), Imperial Coll London, Dyson Sch Design Engn, South Kensington Campus, London SW7 2AZ, England.	x.yu16@imperial.ac.uk		Yu, Xiancheng/0000-0003-4002-3912	Royal British Legion Centre for Blast Injury Studies at Imperial College London; Royal British Legion	This work was conducted under the auspices of the Royal British Legion Centre for Blast Injury Studies at Imperial College London. The authors would like to acknowledge the financial support of the Royal British Legion.	Alia A, 2006, APPL THERM ENG, V26, P1032, DOI 10.1016/j.applthermaleng.2005.10.018; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Benson DJ, 1997, COMPUT METHOD APPL M, V140, P59, DOI 10.1016/S0045-7825(96)01050-X; Borvik T, 2009, COMPUT STRUCT, V87, P507, DOI 10.1016/j.compstruc.2009.02.005; Bouamoul A, 2008, HIGH EXPLOSIVE SIMUL; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi MS, 2009, INT J IMPACT ENG, V36, P1269, DOI 10.1016/j.ijimpeng.2009.03.007; Chafi MS, 2009, BIOMECHANICAL ANAL B; Dewey JM, 2016, SHOCK WAVE SCI TECHN, V9, P53, DOI 10.1007/978-3-319-23745-9_2; Donea J., 2004, ENCY COMPUTATIONAL M; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gilson L., 2012, EPJ Web of Conferences, V26, DOI 10.1051/epjconf/20122604018; Glasstone S., 1977, EFFECTS NUCL WEAPONS, V3; Han YZ, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/631493; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaycox, 2008, INVISIBLE WOUNDS WAR; Jeon D, 2017, COMPUTATION, V5, DOI 10.3390/computation5030041; Kingery C, 1984, AIRBLAST PARAMETERS; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Lockhart PA, 2010, THESIS; Lockhart PA, 2015, COMPUT METHOD BIOMEC, V18, P635, DOI 10.1080/10255842.2013.829460; Manual L-DK, 2007, MAN L DK US I VOL VE, P354; Merkle A, 2009, ASME 2009 INT MECH E; Moghaddam H., 2014, EXAMINATION BLAST IN; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Ngo T, 2004, P 51 C DEV MECH STRU; Nicolle S, 2004, SHEAR PROPERTIES BRA; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Rigby S. E., 2014, THESIS; Salimi Jazi M, 2015, THESIS; Sarvghad-Moghaddam H, 2017, SHOCK WAVES, V27, P919, DOI 10.1007/s00193-017-0749-1; Sarvghad-Moghaddam H, 2017, COMPUT METHOD BIOMEC, V20, P16, DOI 10.1080/10255842.2016.1193597; Schwer L, 2010, LS DYNA FORUM; Sharma S, 2011, BIOMECHANICAL ANAL B; Singh D, 2012, EVALUATION HEAD RESP; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Slavik TP, 2010, IOP CONF SER-MAT SCI, V10, DOI 10.1088/1757-899X/10/1/012146; Slavik TP, 2012, BLAST LOADING LS DYN; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Toma M, 2018, BRAIN INJURY, V32, P1576, DOI 10.1080/02699052.2018.1502470; Toussaint G, 2012, INTERNAL BLAST COM 1; Wu J, 2018, MULTILAYER PAVEMENT; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	49	3	3	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	DEC	2019	35	12							e3258	10.1002/cnm.3258		OCT 2019	15	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	KA0PV	WOS:000491106100001	31518061				2022-02-06	
J	Li, SL; Dong, XL; Sun, WM; Zhao, N; Yu, GH; Shuai, L				Li, Shilin; Dong, Xiangli; Sun, Weiming; Zhao, Na; Yu, Guohua; Shuai, Lang			Effects of transcranial direct current stimulation on patients with disorders of consciousness after traumatic brain injury: study protocol for a randomized, double-blind controlled trial	TRIALS			English	Article						Transcranial direct current stimulation; Disorders of consciousness; Traumatic brain injury; Randomized controlled trial	OF-THE-ART; NERVE ELECTRICAL-STIMULATION; SPINAL-CORD STIMULATION; VEGETATIVE STATE; CORTICAL STIMULATION; EVOKED-POTENTIALS; PREFRONTAL CORTEX; DC STIMULATION; COMA; TDCS	Background Disorders of consciousness (DOC) after traumatic brain injury (TBI) raise the mortality of patients, restrict the rehabilitation of patients with TBI, and increase the physical and economic burden that TBI imposes on patients and their families. Thus, treatment to promote early awakening in DOC after TBI is of vital importance. Various treatments have been reported, but there is no advanced evidence base to support them. Transcranial direct current stimulation (tDCS) has shown great potential in promoting neuroelectrochemical effects. This protocol is for a double-blind, randomized, controlled, clinical trial aiming to research the effects and safety of conventional rehabilitation combined with tDCS therapy in patients with DOC after TBI. Methods/design Eighty patients with DOC after TBI will be randomized into one of two groups receiving conventional rehabilitation combined with sham tDCS or conventional rehabilitation combined with active tDCS. The intervention period in each of the two groups will last 4 weeks (20 min per day, 6 days per week). Primary outcomes (Glasgow Outcome Scale (GOS)) will be measured at baseline and the end of every week from the first to the fourth week. Secondary outcomes will be measured at baseline and the end of the fourth week. Adverse events and untoward effects will be measured during each treatment. Discussion Patients with central nervous system lesions have received tDCS as a painless, non-invasive, easily applied and effective therapy for several decades, and there has been some evidence in recent years showing partial improvement on the level of consciousness of partial patients with DOC. However, reports mainly focus on the patients in a minimally conscious state (MCS), and there is a lack of large-sample clinical trials. This protocol presents an objective design for a randomized controlled trial that aims to study the effectiveness of conventional rehabilitation combined with tDCS therapy for DOC after TBI, to evaluate its safety, and to explore effective and economical therapeutic methods.	[Li, Shilin; Sun, Weiming; Zhao, Na; Yu, Guohua; Shuai, Lang] Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China; [Li, Shilin; Sun, Weiming; Zhao, Na; Yu, Guohua; Shuai, Lang] Nanchang Univ, Clin Med Sch 1, Nanchang 330006, Jiangxi, Peoples R China; [Dong, Xiangli] Nanchang Univ, Dept Psychosomat Med, Affiliated Hosp 2, Nanchang 330006, Jiangxi, Peoples R China		Sun, WM (corresponding author), Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.; Sun, WM (corresponding author), Nanchang Univ, Clin Med Sch 1, Nanchang 330006, Jiangxi, Peoples R China.	sunweiming08@126.com		sun, wei ming/0000-0002-2041-0328	Youth Foundation of Science and Technology Research of Jiangxi Educational Committee, China [GJJ160245]; Jiangxi Province Natural Science Foundation for Youths, China [20171BAB215025]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260295]	The Youth Foundation of Science and Technology Research of Jiangxi Educational Committee, China (No. GJJ160245); Jiangxi Province Natural Science Foundation for Youths, China (No. 20171BAB215025). National Natural Science Foundation of China (No. 81260295).	Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310; Bai Y, 2018, INT J NEUROSCI, V128, P587, DOI 10.1080/00207454.2017.1403440; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Boggio PS, 2008, DRUG ALCOHOL DEPEN, V92, P55, DOI 10.1016/j.drugalcdep.2007.06.011; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Fertonani A, 2017, NEUROSCIENTIST, V23, P109, DOI 10.1177/1073858416631966; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.v69n0105; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, J HEAD TRAUMA REHAB, V19, P254, DOI 10.1097/00001199-200405000-00006; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; Groppa S, 2010, NEUROSCIENCE, V166, P1219, DOI 10.1016/j.neuroscience.2010.01.019; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; HALL JW, 1982, LARYNGOSCOPE, V92, P883; Hongling L, 2018, ANN PHYS REHABIL MED, V61, pe226, DOI 10.1016/j.rehab.2018.05.524; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-73; JONES C, 1979, AM J NURS, V79, P1551; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Lei J, 2015, J NEUROTRAUM, V32, P1584, DOI 10.1089/neu.2014.3768; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Lin C.-Y., 2017, THESIS; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; Mattogno PP, 2017, ACTA NEUROCHIR SUPPL, V124, P19, DOI 10.1007/978-3-319-39546-3_4; McAlees E, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2689-1; Nitsche MA, 2004, CLIN NEUROPHYSIOL, V115, P2419, DOI 10.1016/j.clinph.2004.05.001; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Rango M, 2008, MAGN RESON MED, V60, P782, DOI 10.1002/mrm.21709; Rizzo V, 2014, BRAIN STIMUL, V7, P113, DOI 10.1016/j.brs.2013.10.002; Sankaran R, 2019, NEUROL INDIA, V67, P728, DOI 10.4103/0028-3886.263236; Schiff Nicholas D, 2013, Handb Clin Neurol, V116, P295, DOI 10.1016/B978-0-444-53497-2.00024-3; Soldner F, 2001, ACTA NEUROCHIR, V143, P873, DOI 10.1007/s007010170017; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wilson WJ, 2002, J NEUROSURG, V97, P1062, DOI 10.3171/jns.2002.97.5.1062; Wu X, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2045-x; Yamamoto T, 2017, ACTA NEUROCHIR SUPPL, V124, P37, DOI 10.1007/978-3-319-39546-3_6; Yamamoto T, 2012, NEUROL MED-CHIR, V52, P475, DOI 10.2176/nmc.52.475; Yu YT, 2017, BRAIN STIMUL, V10, P328, DOI 10.1016/j.brs.2016.12.004	51	3	4	4	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	OCT 17	2019	20	1							596	10.1186/s13063-019-3680-1			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JE8WJ	WOS:000490970200001	31623656	Green Published, gold			2022-02-06	
J	Catlin, J; Leclerc, JL; Shukla, K; Marini, SM; Dore, S				Catlin, James; Leclerc, Jenna L.; Shukla, Krunal; Marini, Sarah M.; Dore, Sylvain			Role of the PGE(2) receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						concussion; eicosanoids; EP receptors; prostanoids; repetitive head injury	CONTROLLED CORTICAL IMPACT; MOUSE MODEL; ACTIVATION; NEURODEGENERATION; EXCITOTOXICITY; INFLAMMATION; CONTRIBUTES; MICROGLIA; ISCHEMIA; DEFICITS	Aims The goal was to explore the signaling pathways of PGE(2) to investigate therapeutic effects against secondary injuries following TBI. Methods Young (4.9 +/- 1.0 months) and aged (20.4 +/- 1.4 months) male wild type (WT) C57BL/6 and PGE(2) EP1, 2, and 3 receptor knockout mice were selected to either receive sham or repetitive concussive head injury. Immunohistochemistry protocols with Iba1 and GFAP were performed to evaluate microgliosis and astrogliosis in the hippocampus, two critical components of neuroinflammation. Passive avoidance test measured memory function associated with the hippocampus. Results No differences in hippocampal microgliosis were found when aged EP2(-/-) and EP3(-/-) mice were compared with aged WT mice. However, the aged EP1(-/-) mice had 69.2 +/- 7.5% less hippocampal microgliosis in the contralateral hemisphere compared with WT aged mice. Compared with aged EP2(-/-) and EP3(-/-), EP1(-/-) aged mice had 78.9 +/- 5.1% and 74.7 +/- 6.2% less hippocampal microgliosis in the contralateral hemisphere. Within the EP1(-/-) mice, aged mice had 90.7 +/- 2.7% and 81.1 +/- 5.6% less hippocampal microgliosis compared with EP1(-/-) young mice in the contralateral and ipsilateral hemispheres, respectively. No differences were noted in all groups for astrogliosis. There was a significant difference in latency time within EP1(-/-), EP2(-/-), and EP3(-/-) on day 1 and day 2 in aged and young mice. Conclusion These findings demonstrate that the PGE(2) EP receptors may be potential therapeutic targets to treat repetitive concussions and other acute brain injuries.	[Catlin, James; Leclerc, Jenna L.; Shukla, Krunal; Marini, Sarah M.; Dore, Sylvain] Univ Florida, Dept Anesthesiol, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Dept Neurol Psychiat & Pharmaceut, Gainesville, FL 32610 USA; [Leclerc, Jenna L.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA		Dore, S (corresponding author), Univ Florida, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, 1275 Ctr Dr, Gainesville, FL 32610 USA.	sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020	Dore, Sylvain/0000-0003-3771-5109; Catlin, James/0000-0002-8376-3454; Shukla, Krunal/0000-0002-5607-3036	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS046400, R21NS103036]	National Institutes of Health, Grant/Award Number: R01NS046400 and R21NS103036	Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad Muzamil, 2010, Exp Transl Stroke Med, V2, P12, DOI 10.1186/2040-7378-2-12; Anglada-Huguet M, 2014, MOL NEUROBIOL, V49, P784, DOI 10.1007/s12035-013-8556-x; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Chizzolini C, 2009, IMMUNOL CELL BIOL, V87, P510, DOI 10.1038/icb.2009.56; Cimino PJ, 2008, CURR MED CHEM, V15, P1863, DOI 10.2174/092986708785132915; Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63; Conde JR, 2006, NEUROBIOL AGING, V27, P1451, DOI 10.1016/j.neurobiolaging.2005.07.012; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dore S, 2006, TRENDS PHARMACOL SCI, V27, P458, DOI 10.1016/j.tips.2006.07.001; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Ho CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190683; Ikeda-Matsuo Y, 2011, J NEUROIMMUNOL, V238, P34, DOI 10.1016/j.jneuroim.2011.06.014; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lebender LF, 2018, PULM PHARMACOL THER, V49, P75, DOI 10.1016/j.pupt.2018.01.008; Leclerc JL, 2015, ASN NEURO, V7, DOI 10.1177/1759091415578713; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mohan Shekher, 2012, Front Neurol, V3, P145, DOI 10.3389/fneur.2012.00145; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017	44	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUN	2020	26	6			SI		628	635		10.1111/cns.13228		OCT 2019	8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	LQ8CX	WOS:000490303200001	31617678	Green Published, gold			2022-02-06	
J	Benou, I; Veksler, R; Friedman, A; Raviv, TR				Benou, Itay; Veksler, Ronel; Friedman, Alon; Raviv, Tammy Riklin			Combining white matter diffusion and geometry for tract-specific alignment and variability analysis	NEUROIMAGE			English	Article						Diffusion MRI; White matter; Fiber bundle; Tract-specific analysis; Tractography registration; Mild traumatic brain injury	SPATIAL STATISTICS; TENSOR IMAGE; REGISTRATION; DENSITY; IMPACT; DTI	We present a framework for along-tract analysis of white matter (WM) fiber bundles based on diffusion tensor imaging (DTI) and tractography. We introduce the novel concept of fiber-flux density for modeling fiber tracts' geometry, and combine it with diffusion-based measures to define vector descriptors called Fiber-Flux Diffusion Density (FFDD). The proposed model captures informative features of WM tracts at both the microscopic (diffusion-related) and macroscopic (geometry-related) scales, thus enabling improved sensitivity to subtle structural abnormalities that are not reflected by either diffusion or geometrical properties alone. A key step in this framework is the construction of an FFDD dissimilarity measure for sub-voxel alignment of fiber bundles, based on the fast marching method (FMM). The obtained aligned WM tracts enable meaningful inter-subject comparisons and group-wise statistical analysis. Moreover, we show that the FMM alignment can be generalized in a straight forward manner to a single-shot co-alignment of multiple fiber bundles. The proposed alignment technique is shown to outperform a well-established, commonly used DTI registration algorithm. We demonstrate the FFDD framework on the Human Connectome Project (HCP) diffusion MRI dataset, as well as on two different datasets of contact sports players. We test our method using longitudinal scans of a basketball player diagnosed with a traumatic brain injury, showing compatibility with structural MRI findings. We further perform a group study comparing mid- and post-season scans of 13 active football players exposed to repetitive head trauma, to 17 non-player control (NPC) subjects. Results reveal statistically significant FFDD differences (p-values<0.05) between the groups, as well as increased abnormalities over time at spatially-consistent locations within several major fiber tracts of football players.	[Benou, Itay; Raviv, Tammy Riklin] Ben Gurion Univ Negev, Dept Elect & Comp Engn, Beer Sheva, Israel; [Veksler, Ronel; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Benou, Itay; Veksler, Ronel; Friedman, Alon; Raviv, Tammy Riklin] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Friedman, Alon] Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS, Canada; [Friedman, Alon] Dalhousie Univ, Fac Med, Brain Repair Ctr, Halifax, NS, Canada		Raviv, TR (corresponding author), Ben Gurion Univ Negev, Dept Elect & Comp Engn, Beer Sheva, Israel.	tammy@csail.mit.edu	Raviv, Tammy Riklin/A-3462-2013	, Alon/0000-0003-4780-8456	Israel Science FoundationIsrael Science Foundation [1638/16]; Israel Defense Forces (IDF) Medical Corps; Directorate of Defense Research & Development, Israel Ministry of Defense (IMOD DDRD)	This study was partially supported by The Israel Science Foundation (1638/16); The Israel Defense Forces (IDF) Medical Corps and Directorate of Defense Research & Development, Israel Ministry of Defense (IMOD DDR&D).	Andersson J, 2007, TR07JA2 FMRIB U OXF, V2, P1; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benou I., 2018, CDMRI MICCAI WORKSH, P191; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P105, DOI 10.1016/j.ijpsycho.2017.09.006; Borja MJ, 2018, NEUROIMAG CLIN N AM, V28, P117, DOI 10.1016/j.nic.2017.09.009; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Chung MK, 2010, STAT INTERFACE, V3, P69; COHEN I, 1992, LECT NOTES COMPUT SC, V588, P458; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Corouge I, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P344; Corouge I, 2006, MED IMAGE ANAL, V10, P786, DOI 10.1016/j.media.2006.07.003; de Groot M, 2013, NEUROIMAGE, V76, P400, DOI 10.1016/j.neuroimage.2013.03.015; Descoteaux M, 2012, COMPREHENSIVE BIOMED, V3, P81; Fan QY, 2016, NEUROIMAGE, V124, P1108, DOI 10.1016/j.neuroimage.2015.08.075; Frenkel M, 2003, LECT NOTES COMPUT SC, V2683, P35; Garyfallidis E, 2015, NEUROIMAGE, V117, P124, DOI 10.1016/j.neuroimage.2015.05.016; Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175; Glozman T, 2018, NEUROIMAGE, V167, P466, DOI 10.1016/j.neuroimage.2017.11.052; Gorodissky OA, 2018, IEEE IMAGE PROC, P376, DOI 10.1109/ICIP.2018.8451669; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Heimer L., 2012, HUMAN BRAIN SPINAL C; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK., 2010, IMAGING MED, V2, P341, DOI 10.2217/iim.10.21; Khatami M, 2017, PATTERN RECOGN, V63, P593, DOI 10.1016/j.patcog.2016.09.020; Klein J., 2007, BILDVERARBEITUNG MED, P272, DOI DOI 10.1007/978-3-540-71091-2_55; Martensson J, 2013, MAGN RESON MATER PHY, V26, P527, DOI 10.1007/s10334-013-0368-5; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; O'Donnell LJ, 2015, SCHIZOPHR RES, V161, P133, DOI 10.1016/j.schres.2014.09.007; O'Donnell LJ, 2012, LECT NOTES COMPUT SC, V7512, P123, DOI 10.1007/978-3-642-33454-2_16; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Olivetti E, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00554; Prasad G, 2014, NEUROIMAGE, V97, P284, DOI 10.1016/j.neuroimage.2014.04.033; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Sebastian TB, 2003, IEEE T PATTERN ANAL, V25, P116, DOI 10.1109/TPAMI.2003.1159951; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tagliasacchi A, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531377; Wang DF, 2016, NEUROIMAGE, V125, P301, DOI 10.1016/j.neuroimage.2015.10.032; Wang Y, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-016-0299-2; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Yap PT, 2009, NEUROIMAGE, V47, P549, DOI 10.1016/j.neuroimage.2009.04.055; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Yeo BTT, 2009, IEEE T MED IMAGING, V28, P1914, DOI 10.1109/TMI.2009.2025654; Younes L, 1998, SIAM J APPL MATH, V58, P565, DOI 10.1137/S0036139995287685; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang H, 2010, MED IMAGE ANAL, V14, P666, DOI 10.1016/j.media.2010.05.002; Zhang ZW, 2018, NEUROIMAGE, V172, P130, DOI 10.1016/j.neuroimage.2017.12.064; Zvitia O, 2010, IEEE T MED IMAGING, V29, P132, DOI 10.1109/TMI.2009.2029097	58	3	3	1	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT 15	2019	200						674	689		10.1016/j.neuroimage.2019.05.003			16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IR6VU	WOS:000481579300058	31096057				2022-02-06	
J	Helmich, I; Lausberg, H				Helmich, Ingo; Lausberg, Hedda			Nonverbal Hand Movement Durations Indicate Post-Concussion Symptoms of Athletes	JOURNAL OF NEUROTRAUMA			English	Article						hand movement behavior; hand movement duration; mild traumatic brain injury (mTBI); nonverbal behavior; sport-related concussions	RECURRENT CONCUSSION; FOOTBALL PLAYERS; BEHAVIOR; DEPRESSION; GESTURES; DEFICITS; DISEASE; MOTOR; LIMB	Methods of post-concussion diagnosis are still under debate with regard to sensitivity, objectivity, reliability, and costs. Spontaneous displays of nonverbal hand movement behavior during interaction are indicative of psychopathology and are relatively simple to record and analyze. Increased continuous (irregular) body-focused hand movement activity in particular indicates psychopathologies that overlap in symptomatology with those of sport-related concussions (SRCs). We therefore hypothesized that the duration of "irregular," "on body," and "act on each other" hand movements is increased in athletes with SRC who suffer from post-concussion symptoms. Three matched groups of 40 athletes were investigated: 14 symptomatic athletes with a concussion, 14 asymptomatic athletes with a concussion, and 12 non-concussed athletes. Using the Neuropsychological Gesture (NEUROGES)-Elan analysis system, four certified raters analyzed all nonverbal hand movements that were displayed during a videotaped standardized anamnesis about concussion history, incidence, course of action, and post-concussion symptoms. The duration of irregular Structure units among symptomatic athletes was significantly longer compared with asymptomatic athletes. Irregular, on body, and act on each other hand movement durations correlated with post-concussion symptoms. Whereas the duration of irregular units significantly predicted the post-concussion symptom score, working memory performances showed only marginal effects. Increased duration of irregular hand movement units indicates post-concussion symptoms in athletes with SRC. Because the recording of spontaneous displays of nonverbal hand movement behavior is relatively simple and cost efficient, we suggest using the neuropsychological analysis of hand movement behavior as a future diagnostic parameter of concussion management protocols.	[Helmich, Ingo; Lausberg, Hedda] German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany		Helmich, I (corresponding author), German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany.	i.helmich@dshs-koeln.de					Bailon O, 2010, DEMENT GERIATR COGN, V29, P388, DOI 10.1159/000305095; BARROSO F, 1978, J EXP PSYCHOL HUMAN, V4, P321, DOI 10.1037/0096-1523.4.2.321; Broglio SP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00252; Buyukdura JS, 2011, PROG NEURO-PSYCHOPH, V35, P395, DOI 10.1016/j.pnpbp.2010.10.019; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Freedman N., 1972, STUDIES DYADIC COMMU, P153; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Helmich I, 2014, J COGN PSYCHOL, V26, P740, DOI 10.1080/20445911.2014.961925; Helmich I, 2014, EXP BRAIN RES, V232, P3159, DOI 10.1007/s00221-014-4006-x; Helmich I, 2015, J NEUROPSYCH CLIN N, V27, P287, DOI 10.1176/appi.neuropsych.14100276; Holle H, 2015, BEHAV RES METHODS, V47, P837, DOI 10.3758/s13428-014-0506-7; HORAK FB, 1984, J NEUROL NEUROSUR PS, V47, P1020, DOI 10.1136/jnnp.47.9.1020; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009008; Koop MM, 2008, MOVEMENT DISORD, V23, P1262, DOI 10.1002/mds.22077; Kreyenbrink I, 2017, Z PSYCHOSOM MED PSYC, V63, P297, DOI 10.13109/zptm.2017.63.3.297; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lausberg H, 2003, BRAIN, V126, P343, DOI 10.1093/brain/awg042; Lausberg H., 2019, NEUROGES ANAL SYSTEM; Lausberg H, 2011, PSYCHOTHER WISS, V1, P41; Lausberg H., 1995, 42 ARB DTSCH K UNPUB, P1995; Lausberg H., 2013, UNDERSTANDING BODY M; Lausberg H, 2009, BEHAV RES METHODS, V41, P841, DOI 10.3758/BRM.41.3.841; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Sousa-Poza Joaquin F., 1977, HUM COMMUN RES, V4, P19, DOI [10.1111/j.1468-2958.1977.tb00592.x, DOI 10.1111/J.1468-2958.1977.TB00592.X]; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; ULRICH G, 1985, J AFFECT DISORDERS, V9, P63, DOI 10.1016/0165-0327(85)90011-4; Uvnas-Moberg K, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01529	41	3	3	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2019	36	20					2913	2921		10.1089/neu.2019.6385			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JC0JD	WOS:000488964400008	30963809				2022-02-06	
J	Hosseini-Farid, M; Ramzanpour, M; McLean, J; Ziejewski, M; Karami, G				Hosseini-Farid, Mohammad; Ramzanpour, Mohammadreza; McLean, Jayse; Ziejewski, Mariusz; Karami, Ghodrat			Rate-dependent constitutive modeling of brain tissue	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain tissue; Constitutive modeling; Strain rate; Parallel rheological framework; Compressibility; Finite element	MECHANICAL CHARACTERIZATION; DEFORMATION; BEHAVIOR; BIOMECHANICS; FALLS	In this paper, the dynamic behavior of bovine brain tissue, measured from a set of in vitro experiments, is investigated and represented through a nonlinear viscoelastic constitutive model. The brain samples were tested by employing unconfined compression tests at three different deformation rates of 10, 100, and 1000 mm/s. The tissue exhibited a significant rate-dependent behavior with different compression speeds. Based on the parallel rheological framework approach, a nonlinear viscoelastic model that captures the key aspects of the rate dependency in large-strain behavior was introduced. The proposed model was numerically calibrated to the tissue test data from three different deformation rates. The determined material parameters provided an excellent constitutive representation of tissue response in comparison with the test results. The obtained material parameters were employed in finite element simulations of tissue under compression loadings and successfully verified by the experimental results, thus demonstrating the computational compatibility of the proposed material model. The results of this paper provide groundwork in developing a characterization framework for large-strain and rate-dependent behavior of brain tissue at moderate to high strain rates which is of the highest importance in biomechanical analysis of the traumatic brain injury.	[Hosseini-Farid, Mohammad; Ramzanpour, Mohammadreza; McLean, Jayse; Ziejewski, Mariusz; Karami, Ghodrat] North Dakota State Univ, Dept Mech Engn, Fargo, ND 58104 USA		Karami, G (corresponding author), North Dakota State Univ, Dept Mech Engn, Fargo, ND 58104 USA.	g.karami@ndsu.edu	Farid, Mohammad H./AAC-1370-2020	Farid, Mohammad H./0000-0001-9342-8644; Karami, Ghodrat/0000-0002-0815-0850			Anderson PSL, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.187294; Bergstrom J, 2015, MECH SOLID POLYM THE; Bergstrom JS, 2001, MECH MATER, V33, P523, DOI 10.1016/S0167-6636(01)00070-9; BOYCE MC, 1989, J MECH PHYS SOLIDS, V37, P647, DOI 10.1016/0022-5096(89)90033-1; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; DAFALIAS YF, 1986, J APPL MECH-T ASME, V53, P290, DOI 10.1115/1.3171753; Dalrymple T, 2015, CONST MODELS RUBBER, VIX, P189, DOI [10.1201/b18701-35, DOI 10.1201/B18701-35]; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; El Sayed T, 2008, J BIOMECH, V41, P1458, DOI 10.1016/j.jbiomech.2008.02.023; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Eslaminejad A, 2018, SCI IRAN, V25, P3141, DOI 10.24200/sci.2018.20888; Eslaminejad A, 2018, ASME 2018 INT MECH E; Farid M. H., 2019, MECH CHARACTERIZATIO; Farid MH, 2017, ASME 2017 INT MECH E; Farid MH, 2018, ASME 2018 INT MECH E; Faul M, 2010, TRAUMATIC BRAIN INJU; Forte AE, 2017, BIOMECH MODEL MECHAN, V16, P907, DOI 10.1007/s10237-016-0860-8; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Ghoreishy MHR, 2018, POLYM TEST, V70, P135, DOI 10.1016/j.polymertesting.2018.06.035; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Haldar K, 2018, J MECH BEHAV BIOMED, V81, P178, DOI 10.1016/j.jmbbm.2017.12.021; Holbourn AHS, 1943, LANCET, V2, P438; Hosseini-Farid M, 2019, SCI IRAN, V26, P2047, DOI 10.24200/sci.2019.21314; Hosseini-Farid M., 2018, BIOMEDICAL SCI INSTR, V54, P369; Hosseini-Farid M, 2019, INT J NONLIN MECH, V116, P147, DOI 10.1016/j.ijnonlinmec.2019.06.008; Hoursan H, 2020, SCI IRAN, V27, P784, DOI 10.24200/sci.2018.50940.1928; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2009, INT J CRASHWORTHINES, V14, P245, DOI 10.1080/13588260802440290; Hurtado JA, 2013, CONSTITUTIVE MODELS FOR RUBBER VIII, P95; Jahani B, 2018, J COMPOS MATER, V52, P609, DOI 10.1177/0021998317712569; Jaishankar A, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0284; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; LEE EH, 1969, J APPL MECH, V36, P1, DOI 10.1115/1.3564580; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; OGDEN RW, 1986, RUBBER CHEM TECHNOL, V59, P361, DOI 10.5254/1.3538206; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; PAMIDI MR, 1978, J BIOMECH ENG-T ASME, V100, P44, DOI 10.1115/1.3426188; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Quintavalla SJ, 2004, RUBBER CHEM TECHNOL, V77, P972, DOI 10.5254/1.3547863; Ramazanian T, 2018, J SHOULDER ELB SURG, V27, P1785, DOI 10.1016/j.jse.2018.05.022; Ramzanpour M., 2018, BIOMEDICAL SCI INSTR, V54, P76; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Ratajczak M, 2019, MATERIALS, V12, DOI 10.3390/ma12020271; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Saboori P, 2019, ANN BIOMED ENG, V47, P1982, DOI 10.1007/s10439-019-02199-z; Shojaeiarani J, 2019, MECH MATER, V135, P77, DOI 10.1016/j.mechmat.2019.05.003; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; Viano D. C., 1999, J CRASH PREVENTION I, V1, P35; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	60	3	3	3	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	APR	2020	19	2					621	632		10.1007/s10237-019-01236-z		OCT 2019	12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KY4RL	WOS:000489937400001	31612343				2022-02-06	
J	Lu, XCM; Browning, J; Liao, ZL; Cao, Y; Yang, WH; Shear, DA				Lu, Xi-Chun M.; Browning, Jenny; Liao, Zhilin; Cao, Ying; Yang, Weihong; Shear, Deborah A.			Post-Traumatic Epilepsy and Seizure Susceptibility in Rat Models of Penetrating and Closed-Head Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						closed-head brain injury; penetrating brain injury; PTE; PTZ; seizure susceptibility	PENTYLENETETRAZOLE-INDUCED SEIZURES; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; PTZ-INDUCED SEIZURES; ANIMAL-MODELS; NONCONVULSIVE SEIZURES; RISK; ANTICONVULSANT; EPIDEMIOLOGY; PROGRESSION	Traumatic brain injury (TBI) carries a risk of developing post-traumatic epilepsy (PTE). Currently, animal models that replicate clinical PTE (delayed spontaneous and recurrent seizures) are limited, which hinders pre-clinical research. In this study, we used two rat models of penetrating ballistic-like brain injury (PBBI) and closed-head injury (CHI) to induce spontaneous seizures and also measure changes in seizure susceptibility. In the PBBI model, two trajectories (frontal and lateral) and two injury severities for each trajectory, were evaluated. In the CHI model, a single projectile impact to the dorsal/lateral region of the head was tested. Continuous video-electroencephalographic (EEG) recordings were collected for 10 days at 1 or 6 month(s) post-injury. After EEG recording, all rats were given a sub-convulsant dose of pentylenetetrazole (PTZ) to challenge the seizure susceptibility. The video-EEG recording did not detect PTE following the PBBI. Only one CHI rat demonstrated persistent and recurrent non-convulsive seizures detected at 6 months post-injury. However, after PTZ challenge, 50-100% of the animals across different TBI groups experienced seizures. Seizure susceptibility increased over time from 1 to 6 months post-injury across the majority of TBI groups. Injury severity effects were not apparent within the PBBI model, but were evident between PBBI and CHI models. These results demonstrated the difficulties in detecting delayed spontaneous post-traumatic seizures even in a high-risk model of penetrating brain injury. The PTZ-induced increase in seizure susceptibility indicated the existence of vulnerable risk of epileptogenesis following TBI, which may be considered as an alternative research tool for pre-clinical studies of PTE.	[Lu, Xi-Chun M.; Browning, Jenny; Liao, Zhilin; Cao, Ying; Yang, Weihong; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Lu, XCM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	xi-chun.m.lu.civ@mail.mil			Canbat Casualty Care Research Program of the Department of Army [H_029_2014_WRAIR]	This study was funded by Canbat Casualty Care Research Program of the Department of Army (H_029_2014_WRAIR).	Agoston DV, 2019, NEUROBIOL DIS, V123, P59, DOI 10.1016/j.nbd.2018.07.017; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Anaeigoudari A, 2016, AVICENNA J PHYTOMEDI, V6, P223; Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gerbatin RR, 2019, PROG NEURO-PSYCHOPH, V92, P328, DOI 10.1016/j.pnpbp.2019.02.004; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gu F, 2018, NEUROBIOL DIS, V113, P45, DOI 10.1016/j.nbd.2018.01.018; HABERER LJ, 1991, BIOPHARM DRUG DISPOS, V12, P59, DOI 10.1002/bdd.2510120107; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Jyoti A, 2009, NEUROSCI LETT, V453, P86, DOI 10.1016/j.neulet.2009.01.082; Kalantaripour TP, 2016, BIOMED PHARMACOTHER, V84, P258, DOI 10.1016/j.biopha.2016.09.048; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kendirli MT, 2014, EPILEPSIA, V55, P1969, DOI 10.1111/epi.12854; Keret A, 2018, SEIZURE-EUR J EPILEP, V58, P29, DOI 10.1016/j.seizure.2018.03.018; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Klioueva IA, 2001, PHYSIOL BEHAV, V72, P421, DOI 10.1016/S0031-9384(00)00425-X; Leone M, 1997, NEUROLOGY, V48, P614, DOI 10.1212/WNL.48.3.614; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Lu DC, 2011, J NEUROTRAUM; Lu XCM, 2017, J TRAUMA ACUTE CARE, V83, pS25, DOI 10.1097/TA.0000000000001470; Lu XCM, 2015, J NEUROTRAUM, V32, P1621, DOI 10.1089/neu.2014.3766; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Malow Beth A, 2004, Epilepsy Curr, V4, P193, DOI 10.1111/j.1535-7597.2004.04509.x; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Reeta KH, 2016, BEHAV PHARMACOL, V27, P623, DOI 10.1097/FBP.0000000000000257; Sacks J, 1941, J PHARMACOL EXP THER, V73, P289; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Samsonsen C, 2016, EPILEPSY RES, V127, P260, DOI 10.1016/j.eplepsyres.2016.09.014; Schreiner A, 2003, CLIN ELECTROENCEPHAL, V34, P140, DOI 10.1177/155005940303400307; Scorza FA, 2003, NEUROSCI RES, V47, P323, DOI 10.1016/S0168-0102(03)00220-7; Sejima H, 1997, BRAIN DEV-JPN, V19, P171, DOI 10.1016/S0387-7604(96)00492-5; Setkowicz Z, 2016, BRAIN RES, V1642, P20, DOI 10.1016/j.brainres.2016.03.008; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Viggiano A, 2016, BRAIN RES BULL, V125, P168, DOI 10.1016/j.brainresbull.2016.07.001; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	62	3	3	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					236	247		10.1089/neu.2019.6573		OCT 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000489734900001	31530242				2022-02-06	
J	Joyce, JM; Monchi, O; Ismail, Z; Kibreab, M; Cheetham, J; Kathol, I; Sarna, J; Martino, D; Debert, CT				Joyce, Julie M.; Monchi, Oury; Ismail, Zahinoor; Kibreab, Mekale; Cheetham, Jenelle; Kathol, Iris; Sarna, Justyna; Martino, Davide; Debert, Chantel T.			The impact of traumatic brain injury on cognitive and neuropsychiatric symptoms of Parkinson?s disease	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Parkinson?s disease; traumatic brain injury; mild cognitive impairment; brain injury screening questionnaire	HEAD-INJURY; NONMOTOR SYMPTOMS; ALPHA-SYNUCLEIN; DIAGNOSTIC-CRITERIA; RATING-SCALE; DEPRESSION; DEMENTIA; RISK; IMPAIRMENT; ANXIETY	The objective was to determine whether a history of traumatic brain injury (TBI) was associated with Parkinson?s Disease (PD) and specific cognitive, motor, and neuropsychiatric symptoms. A cross-sectional cohort study of 120 participants aged 60?85?years old (48 females) were recruited (69 PD and 51 healthy controls). Assessments included demographic information, neuropsychological tests, a motor evaluation, neuropsychiatric questionnaires, and the Brain Injury Screening Questionnaire. A history of TBI or number of TBIs was not significantly related to an increased risk of developing PD or poorer motor scores on the United Parkinson Disease Rating Scale part 3. There was a significant negative correlation between number of TBI?s and mean z-scores of global cognition (r(s)(69) = ?0.338, p?=?0.004), executive function (r(s)(69) = ?0.251, p?=?0.038), memory (r(s)(69) = ?0.262, p?=?0.029), and language (r(s)(69) = ?0.245, p?=?0.042), and a significant positive correlation on the Beck Depression Inventory II (r(s)(69) = 0.285, p?=?0.018) and the Patient Health Questionnaire?9 (PHQ-9) (r(s)(69) = 0.326, p?=?0.006) in the PD group only. In conclusion, a history of TBI was negatively associated with cognition and positively associated with depressive symptoms in patients with PD, but not with motor symptoms.	[Joyce, Julie M.; Monchi, Oury; Ismail, Zahinoor; Kibreab, Mekale; Cheetham, Jenelle; Kathol, Iris; Sarna, Justyna; Martino, Davide; Debert, Chantel T.] Univ Calgary, Dept Clin Neurosci, 1403 29th St NW, Calgary, AB T2N 1N4, Canada; [Monchi, Oury; Ismail, Zahinoor; Kibreab, Mekale; Cheetham, Jenelle; Kathol, Iris; Sarna, Justyna; Martino, Davide; Debert, Chantel T.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Monchi, Oury] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Ismail, Zahinoor] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Ismail, Zahinoor] Univ Calgary, Community Hlth Sci, Calgary, AB, Canada; [Debert, Chantel T.] Univ Calgary, Dept Kinesiol, Calgary, AB, Canada		Debert, CT (corresponding author), Univ Calgary, Dept Clin Neurosci, 1403 29th St NW, Calgary, AB T2N 1N4, Canada.	chantel.debert@ahs.ca		Kibreab, Mekale/0000-0001-8813-6006; Debert, Chantel/0000-0002-2704-0438	Branch out Neurological Foundation; Hotchkiss Brain Institute, University of Calgary; Cumming School of Medicine, Department of Clinical Neurosciences, University of Calgary; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-126017]; Department of Canadian National Defense; Tourmaline Oil Chair in Parkinson's Disease; Canada Research Chair in non-motor symptoms of Parkinson's disease; Parkinson Canada; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Immunitat und Seele foundation; Parkinson's Association of Alberta; CHDI; Brain Canada Foundation; AbbvieAbbVie; Centre for Aging and Brain Health Innovation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); JanssenJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; Brain Canada; Alberta Canada	Julie Joyce was funded by the Branch out Neurological Foundation, Alberta Canada. Dr. Debert was funded by the Hotchkiss Brain Institute, University of Calgary, Cumming School of Medicine, Department of Clinical Neurosciences, University of Calgary, the Canadian Institute of Health Research, and the Department of Canadian National Defense. Dr. Monchi was funded by an operating grant from the Canadian Institutes of Health Research (MOP-126017), the Tourmaline Oil Chair in Parkinson's Disease, The Canada Research Chair in non-motor symptoms of Parkinson's disease, Brain Canada, Parkinson Canada and the Natural Sciences and Engineering Research Council of Canada. Dr. Martino has received research support from the Immunitat und Seele foundation (Research Project Grant) and from Parkinson's Association of Alberta (Fellowship supervision grant). Dr. Martino received royalties from Springer Verlag. Dr. Sarna received an Honoraria from Allergan, Abbvie, and Paladin. She is also involved in multi-center clinical trials funded by CHDI (non-profit), Brain Canada Foundation, and Abbvie. Iris Kathol, Jenelle Cheetham, and Mekale Kibreab have no disclosures. Dr. Zahinoor Ismail has received research funding from Brain Canada, Centre for Aging and Brain Health Innovation, Canadian Institutes of Health Research, and Janssen, and has received consulting fees/honoraria from Lundbeck, Otsuka, and Janssen.	Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Belaus A, 2015, REV CHIL NEUROPSICOL, V10, P8, DOI 10.5839/rcnp.2015.10.01.03; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Chen JJ, 2014, THER ADV NEUROL DISO, V7, P52, DOI 10.1177/1756285613495723; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Debert CT, 2019, CAN J NEUROL SCI, V46, P311, DOI 10.1017/cjn.2019.18; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Dobkin RD, 2014, J NEUROPSYCH CLIN N, V26, P57, DOI 10.1176/appi.neuropsych.12120381; Evans IEM, 2019, AGING MENT HEALTH, V23, P1691, DOI 10.1080/13607863.2018.1506742; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Gardner RC, 2017, J GERONTOL A-BIOL, V72, P1233, DOI 10.1093/gerona/glw341; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman JG, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0055-3; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hanganu A, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0907-6; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hiseman JP, 2017, INT REV NEUROBIOL, V133, P479, DOI [10.1016/bs.irn.2017.05.035, 10.1016/bs.im.2017.05.035]; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Ismail Z, 2019, INT PSYCHOGERIATR, V31, P157, DOI 10.1017/S1041610218000637; Ismail Z, 2017, J ALZHEIMERS DIS, V56, P929, DOI 10.3233/JAD-160979; Ismail Z, 2017, JAMA PSYCHIAT, V74, P58, DOI 10.1001/jamapsychiatry.2016.3162; Ismail Z, 2016, ALZHEIMERS DEMENT, V12, P195, DOI 10.1016/j.jalz.2015.05.017; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jellinger KA, 2015, J NEURAL TRANSM, V122, P505, DOI 10.1007/s00702-014-1288-x; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kirsch-Darrow L, 2006, NEUROLOGY, V67, P33, DOI 10.1212/01.wnl.0000230572.07791.22; Laar A.D.V., 2004, NEUROLOGIST, V10, P185; Lawson RA, 2014, PARKINSONISM RELAT D, V20, P1071, DOI 10.1016/j.parkreldis.2014.07.004; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Massano J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008870; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McMurtray AM, 2013, INT J PSYCHIAT MED, V45, P227, DOI 10.2190/PM.45.3.b; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Plancher KD, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114550623; Prakash KM, 2016, EUR J NEUROL, V23, P854, DOI 10.1111/ene.12950; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Research and Training Center on Community Integration of Individuals with Traumatic Brain Injury, 2011, BRAIN INJ SCREEN QUE; Rumalla K, 2017, INT J NEUROSCI, V127, P326, DOI 10.1080/00207454.2016.1239196; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P435, DOI 10.1038/nrn.2017.62; Schiehser DM, 2016, PARKINSONISM RELAT D, V30, P58, DOI 10.1016/j.parkreldis.2016.05.024; Schirinzi T, 2019, PARKINSONISM RELAT D, V61, P203, DOI 10.1016/j.parkreldis.2018.10.018; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Weil RS, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0823-9; Williams LM, 2017, DEPRESS ANXIETY, V34, P9, DOI 10.1002/da.22556; Williams LM, 2016, LANCET PSYCHIAT, V3, P472, DOI 10.1016/S2215-0366(15)00579-9; Worthington A, 2018, NEUROPSYCHOLOGIA, V118, P40, DOI 10.1016/j.neuropsychologia.2018.04.012; Yoon EJ, 2019, NEUROLOGY, V93, pE766, DOI 10.1212/WNL.0000000000007968	62	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		46	60		10.1080/09540261.2019.1656177		OCT 2019	15	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000491741200001	31631720				2022-02-06	
J	Edlow, BL; Threlkeld, ZD; Fehnel, KP; Bodien, YG				Edlow, Brian L.; Threlkeld, Zachary D.; Fehnel, Katie P.; Bodien, Yelena G.			Recovery of Functional Independence After Traumatic Transtentorial Herniation With Duret Hemorrhages	FRONTIERS IN NEUROLOGY			English	Article						Duret hemorrhage; coma; traumatic brain injury; brainstem; herniation	ASCENDING AROUSAL SYSTEM; BRAIN-STEM HEMORRHAGES; INJURY; COMA; CONSCIOUSNESS; SCALE; IMMEDIATE; DAMAGE	Historically, Duret hemorrhages have conferred a devastating prognosis. However, recent case reports suggest that cognitive and functional recovery are possible after Duret hemorrhages. Here, we describe a patient who recovered consciousness, communication, and functional independence after Duret hemorrhages caused by traumatic transtentorial herniation. We performed prospective, standardized behavioral assessments, structural MRI scans and stimulus-based functional MRI (fMRI) scans during the first 2 years of recovery. The multimodal assessments revealed reintegration of neural networks mediating language and consciousness, concurrent with the reemergence of functional independence. These observations provide insights into network-based mechanisms of recovery from coma and add to a growing body of evidence indicating that Duret hemorrhages are not invariably associated with a poor prognosis.	[Edlow, Brian L.; Bodien, Yelena G.] Harvard Med Sch, Ctr Neurotechnol & Neurorecovery, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Threlkeld, Zachary D.] Stanford Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Fehnel, Katie P.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA		Edlow, BL (corresponding author), Harvard Med Sch, Ctr Neurotechnol & Neurorecovery, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.; Edlow, BL (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	bedlow@mgh.harvard.edu		Bodien, Yelena/0000-0003-4858-2903	NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538]; James S. McDonnell Foundation; Rappaport Foundation; Tiny Blue Dot Foundation	This study was supported by the NIH National Institute of Neurological Disorders and Stroke (K23NS094538), the James S. McDonnell Foundation, the Rappaport Foundation, and the Tiny Blue Dot Foundation.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ALEXANDER E, 1982, SURG NEUROL, V17, P107, DOI 10.1016/S0090-3019(82)80031-1; Beier AD, 2014, J NEUROSURG-PEDIATR, V14, P421, DOI 10.3171/2014.7.PEDS13376; Bermudez G, 2015, ACTA NEUROCHIR, V157, P1337, DOI 10.1007/s00701-015-2486-5; Bodien YG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00688; Bonow RH, 2016, J NEUROSURG-SPINE, V24, P389, DOI 10.3171/2015.6.SPINE1521; Chew KL, 2012, FORENSIC SCI MED PAT, V8, P436, DOI 10.1007/s12024-012-9329-y; Duret H., 1874, ARCH PHYSL NORM PATH, V1, P60; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fujimoto Y, 2000, NEUROL MED-CHIR, V40, P508, DOI 10.2176/nmc.40.508; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Nguyen HS, 2016, INT MED CASE REP J, V9, P15, DOI 10.2147/IMCRJ.S95809; HASSLER O, 1967, NEUROLOGY, V17, P368, DOI 10.1212/WNL.17.4.368; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS173, DOI 10.1016/j.apmr.2015.03.027; Ishizaka S, 2014, BRAIN INJURY, V28, P374, DOI 10.3109/02699052.2013.864422; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kamijo Y, 2005, AM J EMERG MED, V23, P908, DOI 10.1016/j.ajem.2005.07.014; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Kowalski RG, 2015, ANN NEUROL, V77, P804, DOI 10.1002/ana.24381; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Posner JB, 2007, PLUM POSNERS DIAGNOS; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Wijdicks EFM., 2014, COMATOSE PATIENT, VSecond edition; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	39	3	3	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 9	2019	10								1077	10.3389/fneur.2019.01077			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO6BN	WOS:000497661900001	31649617	Green Published, gold			2022-02-06	
J	Henne, K; Ventresca, M				Henne, Kathryn; Ventresca, Matt			A criminal mind? A damaged brain? Narratives of criminality and culpability in the celebrated case of Aaron Hernandez	CRIME MEDIA CULTURE			English	Article						Aaron Hernandez; celebrated criminality; masculinity; neuroscience; sport; traumatic brain injury	SCIENCE; TRUTH	This article examines the media discourse surrounding the life and death of former National Football League player Aaron Hernandez, who died by suicide while incarcerated for first-degree murder. As a postmortem analysis found evidence of notable degenerative brain disease, differing explanations and speculations remain about the causes of his criminal behavior. This analysis illustrates how journalistic narratives attribute Hernandez's criminality to either the material composition of his damaged brain or how his tumultuous background affected psychological makeup, minimizing the structural and political economic conditions that enabled this particular case of celebrated criminality. Cultural criminological and socio-legal insights aid in elucidating how notions of racialized masculinity and neurocriminology come to constitutively inform framings of Hernandez's crimes, motivations, and actions while also directing critical attention away from the influence of relevant institutions, particularly sport, and instrumentalizing the role of violence. This article concludes with a reflection on the underpinning tensions revealed through depictions of Hernandez, his mind, and his brain, arguing that they surpass news and media stories and actually implicate debates about the growing influence of neuroscience in understandings of social problems, including crime.	[Henne, Kathryn] Australian Natl Univ, Sch Regulat & Global Governance RegNet, HC Coombs Extens Bldg 8,Fellows Rd, Canberra, ACT 2601, Australia; [Henne, Kathryn] Univ Waterloo, Biogovernance Law & Soc, Waterloo, ON, Canada; [Ventresca, Matt] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada		Henne, K (corresponding author), Australian Natl Univ, Sch Regulat & Global Governance RegNet, HC Coombs Extens Bldg 8,Fellows Rd, Canberra, ACT 2601, Australia.	kathryn.henne@anu.edu.au		Ventresca, Matt/0000-0003-2863-5692; Henne, Kathryn/0000-0001-7369-3002	Australian Research CouncilAustralian Research Council [DE170100819]; Canada Research Chairs programCanada Research Chairs	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Kathryn Henne received funding from the Australian Research Council (DE170100819) and the Canada Research Chairs program.	Abi- Rached Joelle M., 2013, NEURO NEW BRAIN SCI; [Anonymous], 2017, GUARDIAN; Aronson JD, 2009, LAW SOCIAL INQUIRY, V34, P603, DOI 10.1111/j.1747-4469.2009.01159.x; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Biber K, 2019, CRIME MEDIA CULT, V15, P401, DOI 10.1177/1741659018780191; Bishop G, 2013, NY TIMES; Bonnett A, 2003, HDB CULTURAL GEOGRAP, P300, DOI DOI 10.4135/9781848608252.N21; Borges R, 2013, ROLLING STONE; Breer Albert, 2017, SPORTS ILLUSTRATED; Brody E, 2019, J SPORT SOC ISSUES, V43, P296, DOI 10.1177/0193723519840504; Brown M, 2013, BRIT J CRIMINOL, V53, P1017, DOI 10.1093/bjc/azt043; Calavita Kitty, 2010, INVITATION LAW SOC I; Carrington B., 2010, RACE SPORT POLITICS; Cavender G, 2010, CRIME MEDIA CULT, V6, P251, DOI 10.1177/1741659010382329; CRENSHAW KW, 1988, HARVARD LAW REV, V101, P1331, DOI 10.2307/1341398; de la Tierra AL, 2016, FEM CRIMINOL, V11, P375, DOI 10.1177/1557085116662313; de Oca JM, 2012, SOCIOL SPORT J, V29, P131, DOI 10.1123/ssj.29.2.131; Dillard JA, 2017, NY TIMES; Dolloff M, 2016, CBS BOSTON      0201; Dominguez P, 2017, BUZZFEED; Doyle A, 2017, HARTFORD COURANT; Dumit J, 2004, PICTURING PERSONHOOD; Dunning E, 1999, SPORT MATTERS SOCIOL; ELLIS A, 2016, MEN MASCULINITIES VI; Ericson R, 2000, ECON SOC, V29, P532; Fallin M, 2019, BIOSOCIETIES, V14, P438, DOI 10.1057/s41292-018-0135-y; Faulk K, 2017, PLAYERS TRIBUNE 0113; Finn C, 2017, BOSTONCOM       0419; Gregory S., 2017, TIME; Han S, 2006, FEMINIST INTERPRETAT, P173; Healy B, 2018, BOSTON GLOBE; Henne K, 2013, THEOR CRIMINOL, V17, P455, DOI 10.1177/1362480613494990; Hochman A, 2019, ETHNIC RACIAL STUD, V42, P1245, DOI 10.1080/01419870.2018.1527937; Hohler B, 2018, BOSTON GLOBE; Hughes L, 2012, NESN            1108; Kahler K, 2017, SPORTS ILLUSTRATED; Kilgore A, 2017, WASH POST; Kounang Nadia, 2017, CNN; LEONARD DJ, 2017, PLAYING WHITE PRIVIL; McCann M, 2017, SPORTS ILLUSTRATED; McCann Michael, 2018, SPORTS ILLUSTRATED; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McMullan J, 2007, CAN J LAW SOC, V22, P21, DOI 10.1017/S0829320100009108; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Mowers R.L., 2014, COMMODIFIED CRIMINAL, P119; Oates T.P., 2017, FOOTBALL MANLINESS U; PenfoldMounce R, 2010, CULT CRIMINOL, P1, DOI 10.1057/9780230248304; Pennington B., 2017, NY TIMES; Perez A.J., 2018, US TODAY; Pfeiffer S, 2018, BOSTON GLOBE; Pitts-Taylor V., 2016, BRAINS BODY NEUROSCI; RAFTER N, 2008, CRIMINAL BRAIN UNDER; Reiss M, 2013, ESPN; Rose Nikolas., 1999, GOVERNING SOUL SHAPI; Rosenberg M., 2017, SPORTS ILLUSTRATED; Rosenberg M, 2016, SPORTS ILLUSTRATED; Schwarz A, 2017, DEADSPIN        0926; SHERWIN RK, 1994, STANFORD LAW REV, V47, P39, DOI 10.2307/1229221; Spivak R, 2018, CRIMINAL LAW B, V54, P1279; Tomase J, 2017, WEEI RADIO      0922; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Venturelli M, 2020, SPORT SCI HLTH, V16, P601, DOI 10.1007/s11332-020-00694-8; Volin B, 2013, BOSTON GLOBE; Wetzel D, 2017, YAHOO SPORTS    0505; Whitley D, 2017, ORLANDO SENTINEL; Whitlock J, 2013, FOX SPORTS      0626; Woolgar S, 2013, SOC STUD SCI, V43, P321, DOI 10.1177/0306312713488820; Young A., 1996, IMAGINING CRIME TEXT; Young K, 2019, SPORT VIOLENCE SOC	69	3	3	3	13	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1741-6590	1741-6604		CRIME MEDIA CULT	Crime Media Cult.	DEC	2020	16	3					395	413	1741659019879888	10.1177/1741659019879888		OCT 2019	19	Criminology & Penology; Sociology	Social Science Citation Index (SSCI)	Criminology & Penology; Sociology	NK8YJ	WOS:000490228800001		hybrid			2022-02-06	
J	Kolk, A; Saard, M; Pertens, L; Kallakas, T; Sepp, K; Kornet, K				Kolk, Anneli; Saard, Marianne; Pertens, Lisanna; Kallakas, Triin; Sepp, Kirsi; Kornet, Kai			Structured Model of Neurorehab: A Pilot Study of Modern Multitouch Technology and Virtual Reality Platforms for Training Sociocognitive Deficit in Children with Acquired Brain Injury	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Children with acquired brain injury; multitouch rehabilitation technology; pediatric neurorehabilitation; social competence rehabilitation; sociocognitive deficit	SOCIAL COMPETENCE; REHABILITATION; COGNITION	Social competence is often impaired in children with acquired brain injury (ABI), but evidence-based rehabilitation has remained undeveloped. This pilot-study aimed to create a structured model for sociocognitive rehabilitation for children with ABI. A total of 32 children aged 8?13?years participated: 22 with ABI -epilepsy, traumatic brain injury, or tic disorder and 10 healthy controls. Interactive computer-based applications were implemented into rehabilitation design using multitouch-multiuser tabletop (MMT) devices: Snowflake MultiTeach (MT) and Diamond Touch Table (DTT), plus MediqVR virtual reality (VR) platform. At baseline, patients demonstrated social incompetence compared to healthy controls. Post-training evaluations showed that rehabilitation on Snowflake MT improved children?s executive and cooperation skills. DTT developed new communication and language skills, metacognitive skills, and coping with difficult social situations. This structured model for social competence rehabilitation helps therapists to understand the objectives and tools for improving social and cooperation skills in children with ABI. We provide practical recommendations using next-generation devices, which are effective and motivating for children.	[Kolk, Anneli; Saard, Marianne; Kornet, Kai] Univ Tartu, Fac Med, Tartu, Estonia; [Kolk, Anneli; Saard, Marianne; Pertens, Lisanna] Tartu Univ Hosp Childrens Clin, Lunini 6, EE-51014 Tartu, Estonia; [Kallakas, Triin] Tallinn Childrens Hosp, Psychiat Clin, Tallinn, Estonia; [Sepp, Kirsi] Univ Tartu, Inst Social Studies, Dept Special Educ, Tartu, Estonia		Kolk, A (corresponding author), Tartu Univ Hosp Childrens Clin, Lunini 6, EE-51014 Tartu, Estonia.	anneli.kolk@kliinikum.ee					Anderson V., 2014, SOCIAL COMMUNICATION, P161; Bauminger N., 2005, FRIENDSHIP OBSERVATI; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Didehbani N, 2016, COMPUT HUM BEHAV, V62, P703, DOI 10.1016/j.chb.2016.04.033; Gioia GA., 1996, BEHAV RATING INVENTO; Gresham FM., 1990, SOCIAL SKILLS RATING; Harris Amanda, 2009, CSCL, P335; Jakobson A, 2014, SENTENCE COMPLETION; KORKMAN M, 2008, NEPSY 2 LASTEN NEURO; Larson EB, 2014, NEUROREHABILITATION, V34, P759, DOI 10.3233/NRE-141078; Martinez W, 2011, J PEDIATR PSYCHOL, V36, P878, DOI 10.1093/jpepsy/jsr035; Parsons S, 2002, J INTELL DISABIL RES, V46, P430, DOI 10.1046/j.1365-2788.2002.00425.x; Raud T, 2015, EPILEPSY BEHAV, V52, P93, DOI 10.1016/j.yebeh.2015.08.028; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Saltzman-Benaiah J, 2007, CLIN NEUROPSYCHOL, V21, P294, DOI 10.1080/13854040500473760; Smith TEC, 2015, TEACHING STUDENTS SP; Spence SH, 2003, J ANXIETY DISORD, V17, P605, DOI 10.1016/S0887-6185(02)00236-0; Wang M, 2011, NEUROEPIDEMIOLOGY, V36, P2, DOI 10.1159/000320847; Zancanaro M., 2014, PLAYFUL USER INTERFA, P209, DOI [10.1007/978-981-4560-96-2_10, DOI 10.1007/978-981-4560-96-2_10]	20	3	3	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	OCT 2	2019	8	4					326	332		10.1080/21622965.2018.1486193			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JB9EN	WOS:000488884300004	30295544				2022-02-06	
J	Arimitsu, N; Takai, K; Fujiwara, N; Shimizu, J; Ueda, Y; Wakisaka, S; Hirotsu, C; Murayama, MA; Suzuki, T; Suzuki, N				Arimitsu, Nagisa; Takai, Kenji; Fujiwara, Naruyoshi; Shimizu, Jun; Ueda, Yuji; Wakisaka, Sueshige; Hirotsu, Chieko; Murayama, Masanori A.; Suzuki, Tomoko; Suzuki, Noboru			Roles of Reelin/Disabled1 pathway on functional recovery of hemiplegic mice after neural cell transplantation; Reelin promotes migration toward motor cortex and maturation to motoneurons of neural grafts	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Neural stem/progenitor cells; Neurosphere; Neural transplantation; Graft migration; Reelin pathway; Disabled1; Ctip2; Foxp2; Integrin beta 1	DISABLED 1; NEURONAL MIGRATION; MESSENGER-RNA; DAB1; MOUSE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; PHENOTYPE; RECEPTOR	Reelin is a large glycoprotein which regulates central nervous system (CNS) development. Dysfunctions of Reelin were reported on certain neuropsychiatric diseases. We examined involvement of Reelin pathway in functional recovery of hemiplegic mice after neural transplantation. Reelin was expressed 1 day after cryogenic injury of right motor cortex. We transplanted neural stem/progenitor cells (NSPCs) from wild-type mice into ipsilateral striatum of hemiplegic mice. The grafts migrated from the striatum and reached the injured cortex 14 days after transplantation. The transplantation significantly improved their motor functions (P < .05). The NSPCs migrating toward the cortex expressed Reelin receptors, Apoer and Vldlr, and phosphorylated Disabled1 (Dab1), a downstream signaling molecule of Reelin. The grafts expressed Ncadherin and active form of Integrin beta 1, both of which were known to become active with Reelin stimulation. At day 28, the grafts expressed Ctip2, Criml, Foxp2, and Fezf2, all of which were forebrain motoneuron associated markers, and Nfm and Synapsin1 on the damaged cortex. We then transplanted NSPCs of yotari mice (yot/yot genotype) having nonfunctional Dabl by a mutation of its gene. Majority of the grafts from yotari mice ( > 80%) did not migrate and thus remained at the striatum. The grafts did not express the forebrain motoneuron associated markers nor the cell adhesion molecules including Ncadherin and active Integrin beta 1. Reelin pathway was involved in graft migration by regulating certain adhesion molecules and in their differentiation to functional motoneurons accompanying synapse formation. We suggested involvement of Reelin pathway for neural regeneration and functional recovery of hemiplegic mice in adulthood after neural transplantation.	[Arimitsu, Nagisa; Takai, Kenji; Fujiwara, Naruyoshi; Shimizu, Jun; Ueda, Yuji; Wakisaka, Sueshige; Hirotsu, Chieko; Murayama, Masanori A.; Suzuki, Tomoko; Suzuki, Noboru] St Marianna Univ, Dept Immunol & Med, St Marianna Grad Sch Med, Sch Med,Dept Regenerat Med,Miyamae Ku, Sugao 2-16-1, Kawasaki, Kanagawa 2168511, Japan		Suzuki, N (corresponding author), St Marianna Univ, Dept Immunol & Med, St Marianna Grad Sch Med, Sch Med,Dept Regenerat Med,Miyamae Ku, Sugao 2-16-1, Kawasaki, Kanagawa 2168511, Japan.	n3suzuki@marianna-u.ac.jp		Murayama, Masanori/0000-0002-0049-0316	JSPS KAKENHI from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [16 K10744, 26462172, 25505007, 16 K11334, 17 K10852]; SRF	This work was supported by JSPS KAKENHI Grant Numbers [16 K10744, 26462172, 25505007, 16 K11334, and 17 K10852] from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT) and in part by the grant from SRF.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Arimitsu N, 2012, INT J MOL SCI, V13, P2636, DOI 10.3390/ijms13032636; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Ballout N, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00055; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brai E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00447; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Chiba S, 2003, CELL TRANSPLANT, V12, P457, DOI 10.3727/000000003108747019; Cocito C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00141; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Gallagher E, 1998, J COMP NEUROL, V402, P238; Hazama Y, 2010, INFLAMM REGEN, V30, P193; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Ikeda R, 2005, NEUROBIOL DIS, V20, P38, DOI 10.1016/j.nbd.2005.01.031; Ikeda R, 2004, EXP NEUROL, V189, P280, DOI 10.1016/j.expneurol.2004.05.040; Imai H, 2017, CEREB CORTEX, V27, P3485, DOI 10.1093/cercor/bhv334; Ishii K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00229; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Katyal S, 2004, EMBO J, V23, P1878, DOI 10.1038/sj.emboj.7600185; Kojima T, 2000, MOL BRAIN RES, V75, P121, DOI 10.1016/S0169-328X(99)00313-7; Kono T, 2013, J ST MARIANNA U, V4, P31; Kwon IS, 2009, MOL CELL NEUROSCI, V40, P50, DOI 10.1016/j.mcn.2008.08.012; Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271; Matsubayashi Y, 2008, J NEUROSCI METH, V174, P71, DOI 10.1016/j.jneumeth.2008.07.003; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Pacey L., 2006, PROTOCOL EXCHANGE, DOI [DOI 10.1038/NPROT.2006.215, 10.1038/nprot.2006.215]; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Pramatarova A, 2003, MOL CELL BIOL, V23, P7210, DOI 10.1128/MCB.23.20.7210-7221.2003; Pujadas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4443; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Sekine K, 2012, NEURON, V76, P353, DOI 10.1016/j.neuron.2012.07.020; Suzuki N, 2017, CELL TRANSPLANT, V26, P1355, DOI 10.1177/0963689717720280; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; Wang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43760; Yoneshima H, 1997, NEUROSCI RES, V29, P217, DOI 10.1016/S0168-0102(97)00088-6; Zhang JH, 2018, CELL REP, V22, P3598, DOI 10.1016/j.celrep.2018.03.005; Zhao Y, 2012, GENE THER, V19, P189, DOI 10.1038/gt.2011.82	48	3	3	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2019	320								112970	10.1016/j.expneurol.2019.112970			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IU2OR	WOS:000483420200017	31185198				2022-02-06	
J	Bader, F; Kochen, WR; Kraus, M; Wiener, M				Bader, Farah; Kochen, William R.; Kraus, Marilyn; Wiener, Martin			The dissociation of temporal processing behavior in concussion patients: Stable motor and dynamic perceptual timing	CORTEX			English	Article						Timing perception; Interval timing; Implicit timing; Traumatic brain injury; Concussion	TRAUMATIC BRAIN-INJURY; TIME PERCEPTION; ATTENTION DEFICITS; EYE-MOVEMENTS; DOPAMINE; INFORMATION; DYSFUNCTION; MEMORY; SPEED; INHIBITION	Temporal processing is an integral aspect of human cognition and perception. Recent studies have suggested that patients suffering from concussion exhibit a deficit in temporal processing, characterized by poor performance on a variety of timing tasks. However, the majority of studies focusing on temporal processing deficits in concussion have focused on visual timing mechanisms. As temporal processing may be dominant for auditory-based processing, and so less susceptible to noise, we investigated patients with TBI and compared them to normal healthy controls on a battery of temporal processing tasks, including paced finger tapping and temporal bisection with sub-second intervals. The results of our investigation found that traumatic brain patients were unimpaired on the paced finger tapping task, suggesting that temporal processing deficits do not extend into motor timing and rhythmicity domain. In the temporal bisection task, TBI patients maintained precision but had a significantly higher bisection point, characterized by a greater propensity to judge stimuli as "short" and were significantly slower than controls. Analysis with a drift-diffusion model of perceptual decision-making revealed that TBI patients were specifically impaired in evidence accumulation, suggesting a smaller signal to noise ratio. Specifically, it demonstrated that patients had higher decision threshold and slower drift rates for accumulating evidence in order to arrive at a decision. Patients had to surmount higher evidence thresholds to reach a decision and were slower than controls in their rate of evidence accumulation. These results suggest specific deficits in temporal perceptual decision-making may predict the neural temporal pathways that may be compromised or unaffected, paving the way for designing targeted therapies to address these impairments. (C) 2019 Elsevier Ltd. All rights reserved.	[Bader, Farah; Kochen, William R.; Wiener, Martin] George Mason Univ, Dept Psychol, 2055 David King Hall, Fairfax, VA 22030 USA; [Bader, Farah] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Kraus, Marilyn] George Washington Univ, Med Ctr, Concuss Clin, Washington, DC 20037 USA		Wiener, M (corresponding author), George Mason Univ, Dept Psychol, 2055 David King Hall, Fairfax, VA 22030 USA.	mwiener@gmu.edu		Kochen, William/0000-0003-4797-8754			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Anderson JW, 2011, NEUROPSYCHOLOGY, V25, P36, DOI 10.1037/a0020333; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Balci F, 2014, ACTA PSYCHOL, V149, P157, DOI 10.1016/j.actpsy.2014.03.005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bavassi L, 2017, PSYCHOL RES-PSYCH FO, V81, P143, DOI 10.1007/s00426-015-0721-6; Bolbecker AR, 2011, BIPOLAR DISORD, V13, P99, DOI 10.1111/j.1399-5618.2011.00895.x; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bowman NE, 2012, NEURON, V75, P916, DOI 10.1016/j.neuron.2012.06.035; Breska A, 2018, P NATL ACAD SCI USA, V115, P12283, DOI 10.1073/pnas.1810596115; Bueti D, 2012, NEURON, V75, P725, DOI 10.1016/j.neuron.2012.07.019; Bueti D, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00034; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Carroll CA, 2009, BRAIN COGNITION, V71, P345, DOI 10.1016/j.bandc.2009.06.009; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Coslett HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010324; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; DUBE L, 1988, J COMP NEUROL, V267, P455, DOI 10.1002/cne.902670402; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Faul M, 2010, TRAUMATIC BRAIN INJU; Freeman J S, 1996, Parkinsonism Relat Disord, V2, P81, DOI 10.1016/1353-8020(96)00009-0; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goel A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0460; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hawkins GE, 2015, J NEUROSCI, V35, P2476, DOI 10.1523/JNEUROSCI.2410-14.2015; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Helmbold N, 2007, J PERS, V75, P985, DOI 10.1111/j.1467-6494.2007.00463.x; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Kanabus M, 2002, ACTA NEUROBIOL EXP, V62, P263; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konigs M, 2017, NEUROPSYCHOLOGY, V31, P137, DOI 10.1037/neu0000302; Kopec CD, 2010, BRAIN COGNITION, V74, P262, DOI 10.1016/j.bandc.2010.08.006; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lenhard W, 2016, COMPUTATION EFFECT S; Levy JM, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00044; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Matthews WJ, 2016, PSYCHOL BULL, V142, P865, DOI 10.1037/bul0000045; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Mioni G, 2013, BRAIN COGNITION, V81, P305, DOI 10.1016/j.bandc.2012.12.005; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Obeso I, 2014, BRAIN, V137, P1470, DOI 10.1093/brain/awu058; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; Peirce J. W, 2007, J NEUROSCIENCE METHO, V162; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Piras F, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00217; Pogarell O, 2007, PSYCHIAT RES-NEUROIM, V156, P251, DOI 10.1016/j.pscychresns.2007.05.002; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roseboom W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08194-7; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Simen P, 2009, BRAIN RES, V1299, P95, DOI 10.1016/j.brainres.2009.07.017; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Tipples J, 2018, EMOTION, V18, P237, DOI 10.1037/emo0000342; Vorberg D., 1996, HDB PERCEPTION ACTIO, V2nd; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wiecki TV, 2015, CLIN PSYCHOL SCI, V3, P378, DOI 10.1177/2167702614565359; Wiecki TV, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00014; Wiener M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26385-6; Wiener M, 2015, NEUROIMAGE, V113, P268, DOI 10.1016/j.neuroimage.2015.03.054; Wiener M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100803; Wiener M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00031; Wiener M, 2011, J COGNITIVE NEUROSCI, V23, P2811, DOI 10.1162/jocn.2011.21626; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025	94	3	3	0	6	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	OCT	2019	119						215	230		10.1016/j.cortex.2019.04.019			16	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	JC1JZ	WOS:000489035600017	31158558				2022-02-06	
J	Beaulieu, CL; Peng, J; Hade, EM; Corrigan, JD; Seel, RT; Dijkers, MP; Hammond, FM; Horn, SD; Timpson, ML; Swan, M; Bogner, J				Beaulieu, Cynthia L.; Peng, Juan; Hade, Erinn M.; Corrigan, John D.; Seel, Ronald T.; Dijkers, Marcel P.; Hammond, Flora M.; Horn, Susan D.; Timpson, Misti L.; Swan, Melanie; Bogner, Jennifer			Level of Effort and 3 Hour Rule Compliance.	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	4th Federal Interagency Conference on Traumatic Brain Injury (TBI)	JUN 11-13, 2018	Washington, DC				TRAUMATIC BRAIN-INJURY; PARTICIPATION ASSESSMENT; PATIENT; SATISFACTION; OUTCOMES; SEVERITY; VALIDITY; THERAPY; TIME	Objective: To determine if patients' level of effort (LOE) in therapy sessions during traumatic brain injury (TBI) rehabilitation modifies the effect of compliance with the 3-Hour Rule of the Centers for Medicare & Medicaid Services. Design: Propensity score methodology applied to the TBI Practice-Based Evidence database, consisting of multisite, prospective, longitudinal observational data. Setting: Acute inpatient rehabilitation facilities (IRF). Participants: Patients (N=1820) who received their first IRF admission for TBI in the United States and were enrolled for 3- and 9-month follow-up. Main Outcome Measures: Participation Assessment with Recombined Tools-Objective-17, FIM Motor and Cognitive scores, Satisfaction with Life Scale, and Patient Health Questionnaire-9. Results: When the full cohort was examined, no strong main effect of compliance with the 3-Hour Rule was identified and LOE did not modify the effect of compliance with the 3-Hour Rule. In contrast, LOE had a strong positive main effect on all outcomes, except depression. When the sample was stratified by level of disability, LOE modified the effect of compliance, particularly on the outcomes of participants with less severe disability. For these patients, providing 3 hours of therapy for 50% or more of therapy days in the context of low effort resulted in poorer performance on select outcome measures at discharge and up to 9 months postdischarge compared to patients with <50% of 3-hour therapy days. Conclusions: LOE is an active ingredient in inpatient TBI rehabilitation, while compliance with the 3-Hour Rule was not found to have a substantive effect on the outcomes. The results support matching time in therapy during acute TBI rehabilitation to patients' LOE in order to optimize long-term benefits on outcomes. (C) 2019 by the American Congress of Rehabilitation Medicine	[Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Peng, Juan; Hade, Erinn M.; Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Seel, Ronald T.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Sch Med, Richmond, VA USA; [Dijkers, Marcel P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Dijkers, Marcel P.] Wayne State Univ, Detroit, MI USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Horn, Susan D.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Horn, Susan D.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Timpson, Misti L.] Rocky Mt Univ Hlth Profess, Provo, UT USA; [Swan, Melanie] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA		Bogner, J (corresponding author), 480 Med Ctr Dr, Columbus, OH 43210 USA.	bogner.1@osu.edu		Corrigan, John/0000-0002-7591-5622	Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-1403-13476]; National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]	Supported by the Patient-Centered Outcomes Research Institute (grant no. CER-1403-13476), the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525). The statements presented in this work are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors, or Methodology Committee.	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Bode RK, 2004, STROKE, V35, P2537, DOI 10.1161/01.STR.0000145200.02380.a3; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Centers for Medicare and Medicaid Medicare Learning Network, 2017, MLN MATTERS; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2015, ARCH PHYS MED REHAB, V96; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; JOHNSTON MV, 1986, ARCH PHYS MED REHAB, V67, P581; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Nagai S., 2011, APANESE J COMPREHENS, V2, P77; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Wang H, 2013, PM&R, V5, P122, DOI 10.1016/j.pmrj.2012.08.013; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Williams RT, 2016, ARCH PHYS MED REHAB, V97, P929, DOI 10.1016/j.apmr.2016.01.017	25	3	3	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1827	1836		10.1016/j.apmr.2019.01.014			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000004	30796920	Green Submitted			2022-02-06	
J	Benko, MJ; Abdulla, SG; Cuoco, JA; Dhiman, N; Klein, BJ; Guilliams, EL; Marvin, EA; Howes, GA; Collier, BR; Hamill, ME				Benko, Michael J.; Abdulla, Sarah G.; Cuoco, Joshua A.; Dhiman, Nitasha; Klein, Brendan J.; Guilliams, Evin L.; Marvin, Eric A.; Howes, Gregory A.; Collier, Bryan R.; Hamill, Mark E.			Short- and Long-Term Geriatric Mortality After Acute Traumatic Subdural Hemorrhage	WORLD NEUROSURGERY			English	Article						Closed head injury; Elderly; Geriatric; Subdural hematoma; Subdural hemorrhage; Trauma; Traumatic brain injury	SEVERE HEAD-INJURY; BRAIN-INJURY; PROGNOSTIC-FACTORS; PATIENTS OLDER; HEMATOMA; AGE; MORBIDITY; OUTCOMES; LESION; RISK	BACKGROUND: Acute subdural hemorrhage often occurs in those >= 65 years of age after trauma and tends to yield poor clinical outcomes. Previous studies have demonstrated a propensity toward high in-hospital mortality rates in this population; however, postdischarge mortality data are limited. The objective of the present study was to analyze short- and long-term mortality data after acute traumatic subdural hemorrhage in the geriatric population as well as review the impact of associated clinical variables including mechanism of injury, pre-morbid antithrombotic use, and need for surgical decompression on mortality rates. METHODS: We retrospectively reviewed 455 patients who presented with an isolated traumatic acute subdural hemorrhage to our level-1 trauma center over a 5 year period using our data registry. Patients were then cross-referenced in the National Social Security Death Index for postdischarge mortality rates. United States life tables were used for peer-controlled actuarial comparisons. RESULTS: Acute traumatic subdural hemorrhage is often a fatal injury in the geriatric population, especially if taking antithrombotics or requiring surgical decompression. Specifically, they have greater in-hospital mortality rates than adults with similar injuries and have significantly lower survival rates for several years following discharge compared with their peer-matched controls. CONCLUSIONS: Here, we found that age is a significant predictor of both short- and long-term survival after acute traumatic subdural hemorrhage. Moreover, the present study corroborates that the need for surgical decompression or the use of pre-morbid antithrombotic medications is associated with increased overall mortality.	[Benko, Michael J.; Cuoco, Joshua A.; Klein, Brendan J.; Guilliams, Evin L.; Marvin, Eric A.; Howes, Gregory A.] Carilion Clin, Div Neurosurg, Roanoke, VA 24014 USA; [Collier, Bryan R.; Hamill, Mark E.] Carilion Clin, Div Trauma Surg, Roanoke, VA 24014 USA; [Benko, Michael J.; Cuoco, Joshua A.; Klein, Brendan J.; Guilliams, Evin L.; Marvin, Eric A.; Howes, Gregory A.] Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA; [Benko, Michael J.; Cuoco, Joshua A.; Klein, Brendan J.; Guilliams, Evin L.; Marvin, Eric A.; Howes, Gregory A.] Virginia Tech, Carilion Sch Med, Roanoke, VA USA; [Benko, Michael J.; Cuoco, Joshua A.; Klein, Brendan J.; Guilliams, Evin L.; Marvin, Eric A.; Howes, Gregory A.] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Abdulla, Sarah G.] Harbor Univ Calif Los Angeles, Torrance, CA USA; [Dhiman, Nitasha] Columbia Univ, Dept Radiol, New York, NY USA		Benko, MJ (corresponding author), Carilion Clin, Div Neurosurg, Roanoke, VA 24014 USA.; Benko, MJ (corresponding author), Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA.; Benko, MJ (corresponding author), Virginia Tech, Carilion Sch Med, Roanoke, VA USA.; Benko, MJ (corresponding author), Edward Via Coll Osteopath Med, Blacksburg, VA USA.	mjbenko@carilionclinic.org	Hamill, Mark/I-5919-2019	Hamill, Mark/0000-0001-9566-0009			AMACHER AL, 1987, NEUROSURGERY, V20, P954; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Baraniskin A, 2014, J NEUROL SURG PART A, V75, P31, DOI 10.1055/s-0032-1325629; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; El-Fiki M, 2012, WORLD NEUROSURG, V78, P228, DOI 10.1016/j.wneu.2012.02.049; FELL DA, 1975, J NEUROSURG, V42, P37, DOI 10.3171/jns.1975.42.1.0037; Frontera JA, 2011, NEUROCRIT CARE, V14, P260, DOI 10.1007/s12028-010-9418-2; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Lee JJ, 2018, J NEUROSURG, V128, P236, DOI 10.3171/2016.5.JNS16255; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Marion DW, 2006, NEUROSURGERY, V58, P655; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Prasad GL, 2018, WORLD NEUROSURG, V111, pE221, DOI 10.1016/j.wneu.2017.12.034; Prevention C. F. D. C. a., 2019, TRAUM BRAIN INJ CONC; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tallon JM, 2008, CAN J SURG, V51, P339; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Whitehouse KJ, 2016, WORLD NEUROSURG, V94, P493, DOI 10.1016/j.wneu.2016.07.057; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; World Health Organization, 1998, 50 FACTS GLOB HLTH S; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	44	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2019	130						E350	E355		10.1016/j.wneu.2019.06.086			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JB0MH	WOS:000488248200042	31229743				2022-02-06	
J	Chrostek, MR; Fellows, EG; Guo, WL; Swanson, WJ; Crane, AT; Cheeran, MC; Low, WC; Grande, AW				Chrostek, Matthew R.; Fellows, Emily G.; Guo, Winston L.; Swanson, William J.; Crane, Andrew T.; Cheeran, Maxim C.; Low, Walter C.; Grande, Andrew W.			Efficacy of Cell-Based Therapies for Traumatic Brain Injuries	BRAIN SCIENCES			English	Article						traumatic brain injury; stem cells; inflammation; neuroregeneration; mesenchymal stem cells; neural stem cells	MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; IMPROVES NEUROLOGICAL FUNCTION; FUNCTIONAL RECOVERY; BARRIER DISRUPTION; RAT MODEL; TRANSPLANTATION; STROKE; INFLAMMATION; ACTIVATION	Traumatic brain injuries (TBIs) are a leading cause of death and disability. Additionally, growing evidence suggests a link between TBI-induced neuroinflammation and neurodegenerative disorders. Treatments for TBI patients are limited, largely focused on rehabilitation therapy, and ultimately, fail to provide long-term neuroprotective or neurorestorative benefits. Because of the prevalence of TBI and lack of viable treatments, new therapies are needed which can promote neurological recovery. Cell-based treatments are a promising avenue because of their potential to provide multiple therapeutic benefits. Cell-based therapies can promote neuroprotection via modulation of inflammation and promote neurorestoration via induction of angiogenesis and neurogenesis. Neural stem/progenitor cell transplantations have been investigated in preclinical TBI models for their ability to directly contribute to neuroregeneration, form neural-like cells, and improve recovery. Mesenchymal stem cells (MSCs) have been investigated in clinical trials through multiple different routes of administration. Intravenous administration of MSCs appears most promising, demonstrating a robust safety profile, correlation with neurological improvements, and reductions in systemic inflammation following TBI. While still preliminary, evidence suggests cell-based therapies may become a viable treatment for TBI based on their ability to promote neuroregeneration and reduce inflammation.	[Chrostek, Matthew R.; Fellows, Emily G.; Guo, Winston L.; Swanson, William J.; Crane, Andrew T.; Low, Walter C.; Grande, Andrew W.] Univ Minnesota, Dept Neurosurg, Med Sch, Minneapolis, MN 55455 USA; [Cheeran, Maxim C.] Univ Minnesota, Dept Vet Populat Med, Coll Vet Med, St Paul, MN 55108 USA; [Low, Walter C.; Grande, Andrew W.] Univ Minnesota, Stem Cell Inst, Med Sch, Minneapolis, MN 55455 USA		Grande, AW (corresponding author), Univ Minnesota, Dept Neurosurg, Med Sch, Minneapolis, MN 55455 USA.; Grande, AW (corresponding author), Univ Minnesota, Stem Cell Inst, Med Sch, Minneapolis, MN 55455 USA.	chros005@umn.edu; fello064@umn.edu; guoxx838@umn.edu; swan2166@umn.edu; atcrance@umn.edu; cheeran@umn.edu; lowwalt@umn.edu; grande@umn.edu	Cheeran, Maxim C-J/C-2135-2009	Cheeran, Maxim C-J/0000-0002-5331-4746; Guo, Winston/0000-0003-0082-0511; Grande, Andrew/0000-0002-6474-7969; Chrostek, Matthew/0000-0002-9457-1431; Crane, Andrew/0000-0003-3452-2766	Minnesota Department of Higher Education	This research was supported through a grant from the Minnesota Department of Higher Education.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Bjarnadottir K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34594; Centers for Disease Control and Prevention, 2015, CTR DIS CONTR PREV R; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Devetzi M, 2018, INT J MOL MED, V41, P1177, DOI 10.3892/ijmm.2018.3361; Feng Y, 2017, MOL MED REP, V16, P654, DOI 10.3892/mmr.2017.6619; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Guo SW, 2017, NEUROPSYCH DIS TREAT, V13, P2757, DOI 10.2147/NDT.S141534; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hu JN, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1210-4; Hu W, 2018, FOLIA NEUROPATHOL, V56, P112, DOI 10.5114/fn.2018.76615; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Laskowitz DT, 2018, STEM CELL TRANSL MED, V7, P521, DOI 10.1002/sctm.18-0008; Li Y, 2001, CELL TRANSPLANT, V10, P31; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Savitz SI, 2016, STEM CELLS, V34, P537, DOI 10.1002/stem.2253; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Sirbulescu RF, 2019, J NEUROTRAUM, V36, P2579, DOI 10.1089/neu.2018.6368; Sirbulescu RF, 2017, WOUND REPAIR REGEN, V25, P774, DOI 10.1111/wrr.12584; Stone LLH, 2016, CELL TRANSPLANT, V25, P1473, DOI 10.3727/096368916X691277; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; van Velthoven CTJ, 2014, MOL THER, V22, P645, DOI 10.1038/mt.2013.260; Walker PA, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/369578; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Watanabe TK, 2018, PM&R, V10, pS151, DOI 10.1016/j.pmrj.2018.07.008; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Xiao J, 2005, STEM CELLS DEV, V14, P722, DOI 10.1089/scd.2005.14.722; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	63	3	3	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2019	9	10							270	10.3390/brainsci9100270			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI5NX	WOS:000493515400020	31658732	gold, Green Published			2022-02-06	
J	Cogan, AM; Huang, J; Philip, J				Cogan, Alison M.; Huang, Janice; Philip, Joyce			Military Service Member Perspectives About Occupational Therapy Treatment in a Military Concussion Clinic	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						brain injury; occupational therapy; qualitative research; veterans; client-centered practice	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; REHABILITATION; COMBAT; INTERVENTION; STRATEGIES; PERSONNEL; SYMPTOMS; FAMILY; NEEDS	The purpose of this study is to describe important features of occupational therapy practice for treatment of military service members with chronic symptoms and a history of mild traumatic brain injury (mTBI) in a military concussion care clinic from service members' perspectives with support from occupational therapy practitioners. Two series of focus groups were conducted with service members with chronic mTBI-related symptoms (n = 6) and practitioners (n = 5). Data were analyzed concurrently with collection. We identified five main themes: therapeutic relationship, consistent inclusion of family members, combat versus noncombat injuries, loss of military identity, and assessment against population norms. The findings of this study suggest that service members' evaluations of occupational therapy are based on the overall experience of the encounter, centered by the therapeutic relationship, rather than specific intervention strategies or technology.	[Cogan, Alison M.] Washington DC VA Med Ctr, 50 Irving St NW, Washington, DC 20422 USA; [Huang, Janice; Philip, Joyce] Naval Hosp Camp Pendleton, Salt Lake City, UT USA		Cogan, AM (corresponding author), Washington DC VA Med Ctr, 50 Irving St NW, Washington, DC 20422 USA.	alison.cogan@va.gov	Cogan, Alison/AAS-3101-2021	Cogan, Alison/0000-0002-6800-1988			Agee J, 2009, INT J QUAL STUD EDUC, V22, P431, DOI 10.1080/09518390902736512; American Occupational Therapy Association, 2014, AMERICAN JOURNAL OF, V68, pS1, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJ0T.2014.682006]; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Classen S, 2014, OTJR-OCCUP PART HEAL, V34, P176, DOI 10.3928/15394492-20141006-01; Cogan AM, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.027599; Cogan AM, 2014, OTJR-OCCUP PART HEAL, V34, P150, DOI 10.3928/15394492-20140617-01; Conroy SA, 2014, ACAD MANAGE REV, V39, P67, DOI 10.5465/amr.2011.0396; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; Donoho CJ, 2017, AM J EPIDEMIOL, V186, P1310, DOI 10.1093/aje/kwx318; Eakman AM, 2017, BRIT J OCCUP THER, V80, P350, DOI 10.1177/0308022617691538; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Hammell KRW, 2013, SCAND J OCCUP THER, V20, P174, DOI 10.3109/11038128.2012.752032; Hartmann M, 2010, PSYCHOTHER PSYCHOSOM, V79, P136, DOI 10.1159/000286958; Krueger RA, 2015, FOCUS GROUPS PRACTIC, V5th; Law M, 1990, Can J Occup Ther, V57, P82; Libin AV, 2017, AM J ORTHOPSYCHIAT, V87, P129, DOI 10.1037/ort0000253; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Merriam SB., 2016, QUALITATIVE RES GUID, V4; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; PELOQUIN SM, 1990, AM J OCCUP THER, V44, P13, DOI 10.5014/ajot.44.1.13; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Taylor RR, 2008, INTENTIONAL RELATION; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742	29	3	3	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	OCT	2019	39	4					232	238		10.1177/1539449218813849			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	JA5VP	WOS:000487911200007	30465460				2022-02-06	
J	Carneiro, AMC; Poiani, GC; Zaninnoto, AL; Osorio, RL; Oliveira, MD; Paiva, WS; Zangaro, RA				Costa Carneiro, Ana Maria; Poiani, Guilherme Cruz; Zaninnoto, Ana Luiza; Osorio, Rodrigo Lazo; Oliveira, Marcelo de Lima; Paiva, Wellingson Silva; Zangaro, Renato Amaro			Transcranial Photobiomodulation Therapy in the Cognitive Rehabilitation of Patients with Cranioencephalic Trauma	PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY			English	Article						photobiomodulation; traumatic brain injury; neurological rehabilitation		Objective: This research evaluated the hemodynamic conditions before and after the transcranial photobiomodulation therapy (PBMT) and investigated neurocognitive changes before and after treatment. Background: Traumatic brain injury (TBI) is the major cause of morbidity and mortality among individuals 21-60 years old and causes similar to 500,000 people to be hospitalized in Brazil annually. Some survivors develop an irreversible decrease in neurological function, and the mortality rate is as high as 70% in severe cases. PBMT is an alternative to treat secondary injuries due to TBI. Methods: This multidisciplinary clinical study was carried out on 10 chronic adult patients with severe TBI, who were treated with PBMT with an optical device containing 13 sets of 4 light emitting diodes, and underwent hemodynamic transcranial Doppler and neuropsychological evaluation at three different times: pre-PBMT, post-PBMT (after a week), and late-PBMT, which occurred 3 months after the last session. The patients received PBMTs three times a week, for 6 weeks. PBMTs were performed for 18 sessions for 6 weeks and 30min per session. Results: The results found an alteration in the cerebral blood flow (CBF) as well as a consequent increase of the cerebral oxygenation that helped to improve the cerebral function. Conclusions: The PBMT contributed to increased CBF, evidenced mainly by the increased left peak systolic velocity, which consequently increased the hemodynamic response after the PBMT and impacts on the peripheral cerebral perfusion contributing to improved cerebral function.	[Costa Carneiro, Ana Maria; Osorio, Rodrigo Lazo; Zangaro, Renato Amaro] Anhembi Morumbi Univ, Stricto Sensu Program Master & Doctorate Biomed E, BR-12247016 Sao Jose Dos Campos, SP, Brazil; [Poiani, Guilherme Cruz; Oliveira, Marcelo de Lima; Paiva, Wellingson Silva] Univ Sao Paulo Med Sch, Hosp Clin, Div Neurosurg, Sao Paulo, Brazil; [Zaninnoto, Ana Luiza] MGH Inst Hlth Profess, Speech & Feeding Disorders Lab, Marion, IN USA; [Osorio, Rodrigo Lazo; Zangaro, Renato Amaro] Anhembi Morumbi Univ, CITE, Sao Jose Dos Campos, SP, Brazil		Carneiro, AMC (corresponding author), Anhembi Morumbi Univ, Stricto Sensu Program Master & Doctorate Biomed E, BR-12247016 Sao Jose Dos Campos, SP, Brazil.	amcostac@gmail.com	; Zangaro, Renato/K-5961-2015; PAIVA, WELLINGSON/G-5517-2013	de-Lima-Oliveira, Marcelo/0000-0002-7418-1516; Zangaro, Renato/0000-0001-6962-3001; PAIVA, WELLINGSON/0000-0002-5165-7040				0	3	3	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2578-5478		PHOTOBIOMOD PHOTOMED	Photobiomodulation Photomed. Laser Surg.	OCT 1	2019	37	10					657	666		10.1089/photob.2019.4683			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XQ8BK	WOS:000731767700014	31647777	Green Published, hybrid			2022-02-06	
J	Deighton, S; Durish, CL; Taylor, HG; Rubin, K; Dennis, M; Bigler, ED; Vannatta, K; Gerhardt, CA; Stancin, T; Yeates, KO				Deighton, Stephanie; Durish, Christianne Laliberte; Taylor, H. Gerry; Rubin, Kenneth; Dennis, Maureen; Bigler, Erin D.; Vannatta, Kathryn; Gerhardt, Cynthia A.; Stancin, Terry; Yeates, Keith Owen			Theory of Mind and Parental Nurturance as Predictors of Peer Relationships After Childhood Traumatic Brain Injury: A Test of Moderated Mediation	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Pediatrics; Traumatic brain injury; Social outcomes; Reciprocated friendships; Peer rejection; victimization; Theory of mind; Parenting	BEHAVIOR PROBLEMS; FRIENDSHIP QUALITY; EMOTION SOCIALIZATION; PSYCHOSOCIAL OUTCOMES; EXECUTIVE FUNCTIONS; SOCIAL-ADJUSTMENT; CHILDREN; COMPETENCE; RESPONSIVENESS; VICTIMIZATION	Objective: Traumatic brain injury (TBI) sustained in childhood is associated with poor social outcomes. This study investigated the role of theory of mind (ToM) as a mediator of the relation between TBI and peer rejection/victimization and reciprocated friendships, as well as the moderating effect of parental nurturance on those relationships. Method: Participants were children of 8-13 years old (M = 10.45, SD = 1.47), including 13 with severe TBI, 39 with complicated mild/moderate TBI, and 32 children with orthopedic injuries. Data on peer rejection/victimization and friendship were collected in school classrooms using the Extended Class Play and friendship nominations. Parents rated parental nurturance using the Child-Rearing Practices Report. Finally, ToM was measured based on children's average performance across three tasks measuring different aspects of ToM. Results: Severe TBI was associated with poorer ToM, greater peer rejection/victimization, and fewer reciprocated friendships. ToM mediated the relation between severe TBI and peer rejection/victimization (i.e., severe TBI predicted poorer ToM, which in turn predicted greater rejection/victimization). Parental nurturance significantly moderated this relation, such that the mediating effect of ToM was significant only at low and average levels of parental nurturance, for both severe and complicated mild/moderate TBI groups. Neither the mediating effect of ToM nor the moderating effect of parental nurturance was significant for reciprocated friendships. Conclusion: High parental nurturance may mitigate the negative effects of ToM deficits on risk of peer rejection/victimization among children with TBI. Interventions designed to increase parental nurturance or ToM may promote better social outcomes among children with TBI.	[Deighton, Stephanie; Durish, Christianne Laliberte; Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Taylor, H. Gerry; Vannatta, Kathryn; Gerhardt, Cynthia A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Taylor, H. Gerry; Vannatta, Kathryn; Gerhardt, Cynthia A.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Taylor, H. Gerry; Vannatta, Kathryn; Gerhardt, Cynthia A.] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Rubin, Kenneth] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT 84602 USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Psychiat, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Deighton, S (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	smdeight@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Rubin, Kenneth H/M-5276-2018	Rubin, Kenneth H/0000-0002-2608-2484	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 R01 HD048946]; Ronald and Irene Ward Chair in Pediatric Brain Injury; Alberta Innovates Graduate Studentship; Canadian Institute of Health Research Doctoral AwardCanadian Institutes of Health Research (CIHR)	This work was supported by the National Institute of Child Health and Human Development (Grant 5 R01 HD048946). Keith Yeates is supported by the Ronald and Irene Ward Chair in Pediatric Brain Injury. Preparation of this manuscript was supported by an Alberta Innovates Graduate Studentship to Ms. Deighton and Ms. Laliberte Durish; and a Canadian Institute of Health Research Doctoral Award to Ms. Laliberte Durish.	Anderson V., 2012, DEV SOCIAL NEUROSCIE; Booth-LaForce C, 2006, ATTACH HUM DEV, V8, P309, DOI 10.1080/14616730601048209; BORDALO A. A., 2006, REV PARAENSE MED BEL, V20, P5; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; Brand AE, 2010, NEW DIR CHILD ADOLES, V128, P85, DOI 10.1002/cd.270; Brophy-Herb HE, 2011, SOC DEV, V20, P73, DOI 10.1111/j.1467-9507.2009.00570.x; BUKOWSKI WM, 1994, J SOC PERS RELAT, V11, P471, DOI 10.1177/0265407594113011; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Farrant BM, 2012, INFANT CHILD DEV, V21, P175, DOI 10.1002/icd.740; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Haskett ME, 2007, CHILD CARE HLTH DEV, V33, P67, DOI 10.1111/j.1365-2214.2006.00627.x; Hayes A.F., 2017, INTRO MEDIATION MODE; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hayes Andrew F., 2012, CISC VIS NETW IND GL; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kingery JN, 2011, MERRILL PALMER QUART, V57, P215; Klimes-Dougan B, 2007, SOC DEV, V16, P326, DOI 10.1111/j.1467-9507.2007.00387.x; Ladd GW, 2001, CHILD DEV, V72, P1579, DOI 10.1111/1467-8624.00366; Ladd GW, 1998, DEV PSYCHOL, V34, P1450, DOI 10.1037/0012-1649.34.6.1450; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Malcolm KT, 2006, J SOC PERS RELAT, V23, P721, DOI 10.1177/0265407506068260; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Mezulis AH, 2004, J FAM PSYCHOL, V18, P575, DOI 10.1037/0893-3200.18.4.575; Nangle DW, 2003, J CLIN CHILD ADOLESC, V32, P546, DOI 10.1207/S15374424JCCP3204_7; NEWCOMB AF, 1995, PSYCHOL BULL, V117, P306, DOI 10.1037/0033-2909.117.2.306; Park J., 2005, EARLY EDUC DEV, V16, P233, DOI [DOI 10.1080/10409289.2005.10472869, 10.1080/10409289.2005.10472869]; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; RICKEL AU, 1982, J CLIN PSYCHOL, V38, P129, DOI 10.1002/1097-4679(198201)38:1<129::AID-JCLP2270380120>3.0.CO;2-3; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Root AE, 2016, J APPL DEV PSYCHOL, V42, P1, DOI 10.1016/j.appdev.2015.10.002; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ross KA, 2011, BRAIN INJURY, V25, P1206, DOI 10.3109/02699052.2011.609519; Rubin K. H., 2015, HDB CHILD PSYCHOL DE, V4, P175, DOI [10.1002/9781118963418.childpsy405, DOI 10.1002/9781118963418.CHILDPSY405]; Rubin KH, 2006, J ABNORM CHILD PSYCH, V34, P143, DOI 10.1007/s10802-005-9017-4; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sodian B, 2011, CHILD DEV PERSPECT, V5, P39, DOI 10.1111/j.1750-8606.2010.00152.x; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wechsler D., 2011, WECHSLER ABBREVIATED; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	52	3	3	1	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2019	25	9					931	940	PII S135561771900064X	10.1017/S135561771900064X			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	JB3VM	WOS:000488484800004	31317863	Green Accepted			2022-02-06	
J	Donnelly, KZ; Baker, K; Pierce, R; St Ivany, AR; Barr, PJ; Bruce, ML				Donnelly, Kyla Z.; Baker, Kim; Pierce, Ramsay; St Ivany, Amanda R.; Barr, Paul J.; Bruce, Martha L.			A retrospective study on the acceptability, feasibility, and effectiveness of LoveYourBrain Yoga for people with traumatic brain injury and caregivers	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; yoga; resilience; meditation; community-based rehabilitation; caregiver; quality of life	QUALITY-OF-LIFE; COGNITIVE REHABILITATION; COMMUNITY INTEGRATION; SELF-AWARENESS; EMOTION REGULATION; COPING STRATEGIES; FAMILY; TBI; INTERVENTION; INDIVIDUALS	Purpose: To conduct a mixed methods, pre-post, retrospective study on the feasibility, acceptability, and effectiveness of the LoveYourBrain Yoga program. Materials and Methods: People were eligible if they were a traumatic brain injury survivor or caregiver, age 15?70, ambulatory, and capable of gentle exercise and group discussion. We analyzed attendance, satisfaction, and mean differences in scores on Quality of Life After Brain Injury Overall scale (QOLIBRI-OS) and four TBI-QOL/Neuro-QOL scales. Content analysis explored perceptions of benefits and areas of improvement. Results: 1563 people (82.0%) participated ?1 class in 156 programs across 18 states and 3 Canadian provinces. Mean satisfaction was 9.3 out of 10 (SD 1.0). Mixed effects linear regression found significant improvements in QOLIBRI-OS (B 9.70, 95% CI: 8.51, 10.90), Resilience (B 1.30, 95% CI: 0.60, 2.06), Positive Affect and Well-being (B 1.49, 95% CI: 1.14, 1.84), and Cognition (B 1.48, 95% CI: 0.78, 2.18) among traumatic brain injury survivors (n?=?705). No improvement was found in Emotional and Behavioral Dysregulation, however, content analysis revealed better ability to regulate anxiety, anger, stress, and impulsivity. Caregivers perceived improvements in physical and psychological health. Conclusions: LoveYourBrain Yoga is feasible and acceptable and may be an effective mode of community-based rehabilitation.	[Donnelly, Kyla Z.; St Ivany, Amanda R.; Bruce, Martha L.] Dartmouth Coll, Geisel Sch Med, Dept Psychiat, Lebanon, NH 03766 USA; [Donnelly, Kyla Z.; Baker, Kim; Pierce, Ramsay] LoveYourBrain Fdn, Windsor, VT USA; [Barr, Paul J.] Dartmouth Coll, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA		Donnelly, KZ (corresponding author), Dartmouth Coll, Dartmouth Ctr Hlth, 35 Centerra Pkwy, Lebanon, NH 03766 USA.; Donnelly, KZ (corresponding author), Dartmouth Coll, Dartmouth Ctr Aging, 35 Centerra Pkwy, Lebanon, NH 03766 USA.	kyla.z.donnelly@dartmouth.edu	St Ivany, Amanda/AAC-6228-2019		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 MH073553]	The preparation of this manuscript research was supported by funding from a T32 NIH grant [#T32 MH073553] and received no other funding from the public, commercial or not-for-profit sectors.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Adams D, 2016, NEUROREHABILITATION, V39, P223, DOI 10.3233/NRE-161353; [Anonymous], 2015, C TRAUM BRAIN INJ US; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Azulay J, 2016, PHYS MED REHABIL INT, V3, P1101; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; Breitenstein SM, 2010, RES NURS HEALTH, V33, P164, DOI 10.1002/nur.20373; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Combs MA, 2018, REHABIL PSYCHOL, V63, P182, DOI 10.1037/rep0000179; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Creswell JW., 2014, RES DESIGN QUALITATI; Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18; Dahl CJ, 2015, TRENDS COGN SCI, V19, P515, DOI 10.1016/j.tics.2015.07.001; Donnelly KZ, 2020, DISABIL REHABIL, V42, P2482, DOI 10.1080/09638288.2018.1563638; Donnelly KZ, 2017, BRAIN INJURY, V31, P208, DOI 10.1080/02699052.2016.1225988; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Ekhtiari H, 2017, PROG BRAIN RES, V235, P239, DOI 10.1016/bs.pbr.2017.08.013; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Fouladbakhsh Judith M, 2010, Oncol Nurs Forum, V37, pE7, DOI 10.1188/10.ONF.E7-E15; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; Gimbel MA, 1998, NURS PRACT FORUM, V9, P243; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Laura AGOTR, 2017, INT J COMPLEMENT ALT, V8; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Maoz S, 2016, ARCH PHYS MED REHAB, V97, pe26; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Martin AC, 2014, ONCOL NURS FORUM, V41, P257, DOI 10.1188/14.ONF.257-264; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 2007, BRAIN IMPAIR, V8, P238, DOI DOI 10.1375/BRIM.8.3.238; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P286, DOI 10.1097/HTR.0000000000000277; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Patel NK, 2011, ACT ADAPT AGING, V35, P151, DOI 10.1080/01924788.2011.574256; Patterson F, 2019, PATIENT EDUC COUNS, V102, P148, DOI 10.1016/j.pec.2018.08.001; Patterson F, 2016, DISABIL REHABIL, V38, P1961, DOI 10.3109/09638288.2015.1111436; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Poritz JMP, 2020, ARCH PHYS MED REHAB, V101, P54, DOI 10.1016/j.apmr.2017.11.018; Prasad K, 2013, EXPLORE-NY, V9, P219, DOI 10.1016/j.explore.2013.04.001; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Robinson-Smith G, 2000, ARCH PHYS MED REHAB, V81, P460, DOI 10.1053/mr.2000.3863; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sasse N, 2014, DISABIL REHABIL, V36, P2152, DOI 10.3109/09638288.2014.893029; Schmid AA, 2016, DISABIL REHABIL, V38, P914, DOI 10.3109/09638288.2015.1062927; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schoonenboom J, 2017, KOLNER Z SOZIOL SOZ, V69, P107, DOI 10.1007/s11577-017-0454-1; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shepherd-Banigan ME, 2018, J GEN INTERN MED, V33, P1177, DOI 10.1007/s11606-018-4417-7; Sherman KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/143271; Silverthorne Colin, 2012, Int J Yoga Therap, P47; Simeonsson RJ, 2009, J POLICY PRACT INTEL, V6, P70, DOI 10.1111/j.1741-1130.2009.00215.x; Skoro-Kondza L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-33; Southwick SM, 2012, RESILIENCE: THE SCIENCE OF MASTERING LIFE'S GREATEST CHALLENGES, P1, DOI 10.1017/CBO9781139013857; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thiese MS, 2014, BIOCHEM MEDICA, V24, P199, DOI 10.11613/BM.2014.022; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; TOSELAND RW, 1990, SOC WORK, V35, P209; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Tsaousides T, 2017, J HEAD TRAUMA REHAB, V32, P354, DOI 10.1097/HTR.0000000000000345; Tucker JA, 2006, ADDICTION, V101, P918, DOI 10.1111/j.1360-0443.2006.01396.x; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Upchurch DM, 2019, J WOMENS HEALTH, V28, P135, DOI 10.1089/jwh.2018.7178; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Wright CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156826	106	3	3	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 5	2021	43	12					1764	1775		10.1080/09638288.2019.1672109		OCT 2019	12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	SV2CL	WOS:000488501000001	31577456				2022-02-06	
J	Fournier, N; Gariepy, C; Prevost, JF; Belhumeur, V; Fortier, E; Carmichael, PH; Gariepy, JL; Le Sage, N; Emond, M				Fournier, Nicolas; Gariepy, Charles; Prevost, Jean-Francois; Belhumeur, Vincent; Fortier, Emile; Carmichael, Pierre-Hugues; Gariepy, Jean-Luc; Le Sage, Natalie; Emond, Marcel			Adapting the Canadian CT head rule age criteria for mild traumatic brain injury	EMERGENCY MEDICINE JOURNAL			English	Article								Objective With the ageing population, the prevalence of mild traumatic brain injury (mTBI) among older patients is increasing, and the age criteria of the Canadian CT head rule (CCHR) is challenged by many emergency physicians. We modified the age criteria of the CCHR to evaluate its predictive capacity. Methods We conducted a retrospective cohort study at a level 1 trauma centre ED of all mTBI patients 65 years old and over with an mTBI between 2010 and 2014. Main outcome was a clinically important brain injury (CIBI) reported on CT. The clinical and radiological data collection was standardised. Univariate analyses were performed to measure the predictive capacities of different age cut-offs at 70, 75 and 80 years old. Results 104 confirmed mTBI were included; CT scan identified 32 (30.8%) CIBI. Sensitivity and specificity (95% CI) of the CCHR were 100% (89.1 to 100) and 4.2% (0.9 to 11.7) for a modified criteria of 70 years old; 100% (89.1 to 100) and 13.9% (6.9 to 24.1) for 75 years old; and 90.6% (75.0 to 98.0) and 23.6% (14.4 to 35.1) for 80 years old. Furthermore, modifying the age criteria to 75 years old showed a reduction of CT up to 25% (n=10/41) among the individuals aged 65-74 without missing CIBI. Conclusion Adjusting the age criteria of the Canadian CT head rule to 75 years old could be safe while reducing radiation and ED resources. A future prospective study is suggested to confirm the proposed modification.	[Fournier, Nicolas; Gariepy, Charles; Prevost, Jean-Francois; Belhumeur, Vincent; Fortier, Emile; Le Sage, Natalie; Emond, Marcel] Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [Fournier, Nicolas; Gariepy, Charles; Prevost, Jean-Francois; Belhumeur, Vincent; Fortier, Emile; Le Sage, Natalie; Emond, Marcel] Univ Laval, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada; [Carmichael, Pierre-Hugues] Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Ctr Excellence Vieillissement Quebec, Quebec City, PQ, Canada; [Gariepy, Jean-Luc] Univ Laval, CHU Quebec, Dept Radiol, Quebec City, PQ, Canada; [Emond, Marcel] Univ Laval, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada		Emond, M (corresponding author), Univ Laval, CHU Quebec, Quebec City, PQ, Canada.	marcelemond1@me.com	Emond, Marcel/G-5804-2014; Le Sage, Natalie/G-7063-2016	Emond, Marcel/0000-0001-7158-8110; Le Sage, Natalie/0000-0003-4762-8156; Fournier, Nicolas/0000-0001-6484-3056	Fondation du CHU de Quebec - Universite Laval	This study was funded by the Fondation du CHU de Quebec - Universite Laval.	Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Park N., 2017, POPULATION ESTIMATES; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Statistic Canada, 2017, ANN DEM EST CAN PROV; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	10	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	OCT	2019	36	10					617	+		10.1136/emermed-2018-208153			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JG3BS	WOS:000491949900009	31326953				2022-02-06	
J	Gallego, M; Villaluenga, E				Gallego, M.; Villaluenga, E.			Coxofemoral luxation in pet rabbits: nine cases	JOURNAL OF SMALL ANIMAL PRACTICE			English	Article							FEMORAL-HEAD; DOGS; EXCISION; CATS	Of the pet rabbits presented at one private practice between August 2011 and August 2016 (n=1369), 5 center dot 6% presented with a traumatic orthopaedic injury. Of these, 7 center dot 8% (n=6) presented with traumatic coxofemoral luxation, the most frequently observed type of luxation. Three cases of non-traumatic coxofemoral luxation in pet rabbits are also discussed. Eight rabbits presented with craniodorsal luxation and one with caudoventral luxation. Five rabbits were initially treated using closed reduction and an Ehmer sling under sedation. Two rabbits responded satisfactorily to closed reduction; their bandages remained in place for 10 and 14 days, and movement was cage-limited for 1 month after bandage placement. The bandage did not prevent re-luxation in three cases. Therefore, two rabbits received iliofemoral nylon sutures, and three rabbits received a femoral neck and head ostectomy. One rabbit was treated directly using open reduction and an iliofemoral nylon suture due to fractures in the same limb. One rabbit was presented in shock, coxofemoral luxation was noticed as an incidental finding and euthanasia was elected by the owner. In conclusion, of the three rabbits treated via femoral neck and head ostectomy one rabbit had an unsatisfactory outcome and two rabbits have non-assessable outcomes. The three rabbits treated with iliofemoral sutures showed satisfactory long-term outcomes and the two rabbits treated with closed reduction and an Ehmer sling showed satisfactory medium and long-term outcomes.	[Gallego, M.; Villaluenga, E.] Ctr Vet Madrid Exot, Madrid 28015, Spain		Gallego, M (corresponding author), Ctr Vet Madrid Exot, Madrid 28015, Spain.	miguel.galego@gmail.com		Gallego, Miguel/0000-0002-8348-5909			Ash K, 2012, VET COMP ORTHOPAED, V25, P54, DOI 10.3415/VCOT-11-02-0019; Barone R., 1989, ANATOMIE COMP MAMIFE, P239; BASHER AWP, 1986, VET SURG, V15, P356, DOI 10.1111/j.1532-950X.1986.tb00243.x; BERZON JL, 1980, VET SURG, V9, P88, DOI 10.1111/j.1532-950X.1980.tb01661.x; BONE DL, 1984, VET SURG, V13, P263, DOI 10.1111/j.1532-950X.1984.tb00807.x; Coleman KA, 2015, J EXOT PET MED, V24, P178, DOI 10.1053/j.jepm.2015.04.006; Dean PW, 2014, CURRENT TECHNIQUES IN SMALL ANIMAL SURGERY, 5TH EDITION, P1120; FOX SM, 1991, COMP CONT EDUC PRACT, V13, P381; Harcourt-Brown N., 2013, BSAVA MANUAL RABBIT, P308; JOHNSON JA, 1994, VET COMP ORTHOPAED, V7, P56; Knudsen CS, 2010, VET REC, V166, P462, DOI 10.1136/vr.b4815; Martini FM, 2001, VET SURG, V30, P468, DOI 10.1053/jvet.2001.25875; MCLAUGHLIN RM, 1994, VET SURG, V23, P21, DOI 10.1111/j.1532-950X.1994.tb00438.x; Off W, 2010, VET COMP ORTHOPAED, V23, P297; Owiny JR, 2001, COMPARATIVE MED, V51, P85; TANGNER SH, 1992, VET MED-US, V87, P314; Tomlinson JL, 2014, CURRENT TECHNIQUES IN SMALL ANIMAL SURGERY, 5TH EDITION, P991; Yap FW, 2015, J FELINE MED SURG, V17, P704, DOI 10.1177/1098612X14556848	18	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4510	1748-5827		J SMALL ANIM PRACT	J. Small Anim. Pract.	OCT	2019	60	10					631	635		10.1111/jsap.12866			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	JC0VA	WOS:000488996700008	29920673				2022-02-06	
J	Irvine, KA; Sahbaie, P; Ferguson, AR; Clark, JD				Irvine, Karen-Amanda; Sahbaie, Peyman; Ferguson, Adam R.; Clark, J. David			Enhanced descending pain facilitation in acute traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Pain; Serotonin; Acute brain injury; Neuroinflammation	5-HT3 RECEPTORS; NEUROPATHIC PAIN; NERVE INJURY; RAT MODEL; SENSITIZATION; MODULATION; HEADACHE; NEURONS; ROLES; STIMULATION	Acute and persistent pain are recognized consequences of TBI that can enhance suffering and significantly impair rehabilitative efforts. Both experimental models and clinical studies suggest that TBI may result in an imbalance between descending pain facilitatory and inhibitory pathways. The aim of this study was to assess the role of enhanced descending serotonin-mediated pain facilitation in a rat TBI model using selective spinal serotonergic fiber depletion with 5, 7-dihydroxytryptamine (DHT). We observed significant hindpaw allodynia in TBI rats that was reduced after DHT but not vehicle treatment. Immunohistochemical studies demonstrated profound spinal serotonin depletion in DHT-treated rats. Furthermore, lumbar intrathecal administration of the 5-HT3 receptor antagonist ondansetron at 7 days post-injury (DPI), when hindpaw allodynia was maximal, also attenuated nociceptive sensitization. Additional immunohistochemical analyses of the lumbar spinal cord at 7 DPI revealed a robust bilateral microglial response in the superficial dorsal horns that was significantly reduced with DHT treatment. Furthermore, serotonin depletion also prevented the TBI-induced bilateral increase in c-Fos positive cells within the Rexed laminae I and II of the dorsal horns. These results indicate that in the weeks following TBI, pain may be responsive to 5-HT3 receptor antagonists or other measures which rebalance descending pain modulation.	[Irvine, Karen-Amanda; Sahbaie, Peyman; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Irvine, Karen-Amanda; Sahbaie, Peyman; Clark, J. David] VA Palo Alto Hlth Care Syst, Anesthesiol Serv, 3801 Miranda Ave E4-220, Palo Alto, CA 94304 USA; [Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurosurg, Brain & Spinal Injury Ctr, 1001 Potrero Ave, San Francisco, CA 94110 USA; [Ferguson, Adam R.] San Francisco VA Hlth Care Syst, 4150 Clement St, San Francisco, CA 94121 USA		Irvine, KA (corresponding author), VA Palo Alto HCS, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	kairvine@stanford.edu; psahbaie@stanford.edu; adam.ferguson@ucsf.edu; djclark@stanford.edu		Irvine, Karen-amanda/0000-0001-5259-1824; Ferguson, Adam/0000-0001-7102-1608	U.S. Dept. of DefenseUnited States Department of Defense [MR130295]; Dept. of Veterans AffairsUS Department of Veterans Affairs [RX001776]	This work was supported by grants from the U.S. Dept. of Defense (MR130295) and the Dept. of Veterans Affairs (RX001776).	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Boyer N, 2014, PAIN, V155, P1196, DOI 10.1016/j.pain.2014.03.001; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001; DosSantos MF, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/2368386; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Guo W, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-35; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Inoue A, 1999, J NEUROCHEM, V73, P2206; Irvine KA, 2018, J NEUROTRAUM, V35, P1495, DOI 10.1089/neu.2017.5411; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Liang DY, 2017, IBRO REP, V2, P14, DOI 10.1016/j.ibror.2016.12.001; Liang DY, 2017, MOL PAIN, V13, DOI 10.1177/1744806917730212; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Ling G.S., 2004, CURR PROTOC NEUROSCI, V9, pUnit; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Machu TK, 2011, PHARMACOL THERAPEUT, V130, P338, DOI 10.1016/j.pharmthera.2011.02.003; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Moisset X, 2016, EUR J PAIN, V20, P689, DOI 10.1002/ejp.811; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nasirinezhad F, 2016, J SPINAL CORD MED, V39, P212, DOI 10.1179/2045772315Y.0000000047; Nichols JN, 2017, J NEUROTRAUM, V34, P2481, DOI 10.1089/neu.2017.4998; Okubo M, 2013, J NEUROSCI, V33, P5152, DOI 10.1523/JNEUROSCI.3390-12.2013; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Patel R, 2018, NEUROPHARMACOLOGY, V143, P29, DOI 10.1016/j.neuropharm.2018.09.028; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Proudfit HK, 2002, J PAIN, V3, P350, DOI 10.1054/jpai.2002.127777; Rahman Wahida, 2011, Rev Pain, V5, P21, DOI 10.1177/204946371100500204; Rajkovic O, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00734; Ruff R. L, 2016, F1000RES, V5; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Southall MD, 1998, PAIN, V78, P39, DOI 10.1016/S0304-3959(98)00113-4; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Suri P, 2019, J PAIN, V20, P97, DOI 10.1016/j.jpain.2018.08.002; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thomas TC, 2015, BRAIN NEUROTRAUMA MO; Todd AJ, 2017, MOL PAIN, V13, P1, DOI 10.1177/1744806917693003; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; TYERS MB, 1992, SEMIN ONCOL, V19, P1; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Urban MO, 1999, P NATL ACAD SCI USA, V96, P7687, DOI 10.1073/pnas.96.14.7687; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Viisanen H, 2010, NEUROSCI LETT, V476, P133, DOI 10.1016/j.neulet.2010.04.014; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Wang X, 2018, CNS NEUROSCI THER, V24, P1100, DOI 10.1111/cns.13077; Watkins LR, 2000, ANNU REV PSYCHOL, V51, P29, DOI 10.1146/annurev.psych.51.1.29; Young NA, 2014, NEUROSURG CLIN N AM, V25, P819, DOI 10.1016/j.nec.2014.07.007	69	3	3	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2019	320								112976	10.1016/j.expneurol.2019.112976			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IU2OR	WOS:000483420200013	31185197				2022-02-06	
J	Li, ZJ; Du, ZB; You, XC; Liu, ZL; Cheng, J; Luo, CC; Chu, DY; Ning, SW; Kang, Y; Yang, C; Zhuang, Z				Li, Zhijie; Du, Zhibo; You, Xiaochuan; Liu, Zhanli; Cheng, Jian; Luo, Chengcheng; Chu, Dongyang; Ning, Shaowu; Kang, Yue; Yang, Ce; Zhuang, Zhuo			Numerical study on dynamic mechanism of brain volume and shear deformation under blast loading	ACTA MECHANICA SINICA			English	Article						Blast-induced traumatic brain injury; Numerical head model; Fluid-structure coupling model; Diffuse axonal injury; Brain contusion	POSSIBLE DAMAGE MECHANISM; FINITE-ELEMENT-ANALYSIS; HUMAN HEAD; INJURY; CAVITATION; RESPONSES; TISSUE	Blast-induced traumatic brain injury (b-TBI) is a kind of significant injury to soldiers in the current military conflicts. However, the mechanism of b-TBI has not been well understood, and even there are some contradictory conclusions. It is crucial to reveal the dynamic mechanism of brain volume and shear deformations under blast loading for better understanding of b-TBI. In this paper, the numerical simulation method is adopted to carry out comprehensive and in-depth researches on this issue for the first time. Based on the coupled Eulerian-Lagrangian method, the fluid-structure coupling model of the blast wave and human head is developed to simulate two situations, namely the head subjected to the frontal and lateral impacts. The simulation results are analyzed to obtain the underlying dynamic mechanisms of brain deformation. The brain volume deformation is dominated by the local bending vibration of the skull, and the corresponding frequency for the forehead skull under the frontal impact and the lateral skull faced to the lateral impact is as high as 8 kHz and 5 kHz, respectively. This leads to the high-frequency fluctuation of brain pressure and the large pressure gradient along the skull, totally different from the dynamic response of brain under head collisions. While the brain shear deformation mainly depends on the relative tangential displacement between the skull and brain and the anatomical structure of inner skull, being not related to the brain pressure and its gradient. By further comparing the medical statistics, it is inferred that diffuse axonal injury and brain contusion, the two most common types of b-TBI, are mainly attributed to brain shear deformations. And the von Mises stress can be adopted as the indicator for these two brain injuries. This study can provide theoretical guidance for the diagnosis of b-TBI and the development of protective equipment.	[Li, Zhijie; Du, Zhibo; You, Xiaochuan; Liu, Zhanli; Cheng, Jian; Luo, Chengcheng; Chu, Dongyang; Ning, Shaowu; Zhuang, Zhuo] Tsinghua Univ, Sch Aerosp Engn, Beijing 100084, Peoples R China; [Kang, Yue] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Yang, Ce] Army Med Univ, Daping Hosp, Chongqing 400038, Peoples R China		You, XC; Liu, ZL (corresponding author), Tsinghua Univ, Sch Aerosp Engn, Beijing 100084, Peoples R China.	youxiaochuan@tsinghua.edu.cn; liuzhanli@tsinghua.edu.cn		Liu, Zhanli/0000-0003-3599-4909			Bayly P. V., 2012, APPL IMAGING TECHNIQ, V4, P117; Belingardi G, 2005, 19 INT TECHN C ENH S; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Dixit P, 2017, ARCH COMPUT METHOD E, V24, P979, DOI 10.1007/s11831-016-9196-x; Felten DL., 2015, NETTERS ATLAS NEUROS, V3; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Franck Christian, 2017, Concussion, V2, pCNC47, DOI 10.2217/cnc-2017-0011; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Garcia-Gonzalez D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28271-7; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gupta RK, 2017, DEF LIFE SCI J, V2, P3, DOI DOI 10.14429/dlsj.2.10369; Hardy W., 2001, 2001220016 SAE; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nahum A, 1977, 770922 SAE; Newman J.A, 1986, P INT RES COUNC BIOM, P21; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Sadovsky MA, 2004, GEOPHYS PHYS EXPLOSI; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Singh D, 2019, ANN BIOMED ENG, V47, P1993, DOI 10.1007/s10439-018-02193-x; Smith JE, 2019, J ROY ARMY MED CORPS, V165, P57, DOI 10.1136/jramc-2018-001058; Song S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16959; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Ward C., 1980, SAE T, V89, P3867; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Willinger R., 2000, INT RES COUNC BIOM I; Zhou C., 1995, 952714 SAE	41	3	3	5	20	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0567-7718	1614-3116		ACTA MECH SINICA-PRC	Acta Mech. Sin.	OCT	2019	35	5					1104	1119		10.1007/s10409-019-00875-w			16	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	JU7KO	WOS:000501851500015					2022-02-06	
J	Liu, QM; Liu, J; Wu, XF; Han, X; Guan, FJ				Liu, Qiming; Liu, Jie; Wu, Xingfu; Han, Xu; Guan, Fengjiao			Evaluation and prediction of diffuse axonal injury based on optimization strategy in vehicle collision accidents	STRUCTURAL AND MULTIDISCIPLINARY OPTIMIZATION			English	Article						Traumatic brain injuries; Brain injury index; Prediction model; Kinematic parameters; Strain-based measures; Correlation enhancement; Artificial neural network learning	INTRACRANIAL-PRESSURE; BRAIN; MILD; ACCELERATION; MODEL	The brain is one of the most critical parts of the human body, and it is vulnerable in vehicle collision accidents. Statistically, traumatic brain injuries (TBIs) account for about half of the 1.3 million deaths and 50 million injuries in annual road traffic accidents around the world. However, there are currently no universally accepted and specialized criteria for the different types of brain injuries, even though a series of injury criteria has been presented using mathematical combinations of kinematic parameters. To reduce TBIs and improve the safety performance of vehicles, we established a new brain injury index (BII) by maximizing the correlation between the kinematic parameters and strain-based measures such as cumulative strain damage measure (CSDM) and maximum principal strain (MPS), which employed 218 crash test data and the simulated injury monitor (SIMon) model from the National Highway Traffic Safety Administration website. In the process of establishing the BII, we combined the K-Nearest Neighbor with quadratic regression to enhance the correlation between the kinematic metrics and CSDM/MPS by eliminating the influence of some outlier data and used the genetic algorithm to obtain the optimal weight ratios of several kinematic parameters with strong correlations. The assessment capability of the proposed BII was more superior and reliable than other indexes when compared with 15 existing kinematic-based criteria. Finally, we developed a simple BII (SBII), which ignored the influence of the translational velocity and acceleration, and used it to establish three prediction models of brain injury based on artificial neural network learning, which achieved the quantitative description of the relationship between the kinematic parameters and CSDM/MPS.	[Liu, Qiming] Hebei Univ Technol, Sch Elect Engn, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin 300401, Peoples R China; [Liu, Jie; Wu, Xingfu; Han, Xu] Hunan Univ, Coll Mech & Vehicle Engn, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China; [Han, Xu] Hebei Univ Technol, Sch Mech Engn, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin 300401, Peoples R China; [Guan, Fengjiao] Natl Univ Def Technol, Sci & Technol Integrated Logist Support Lab, Changsha 410073, Hunan, Peoples R China		Liu, QM (corresponding author), Hebei Univ Technol, Sch Elect Engn, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin 300401, Peoples R China.; Liu, J; Han, X (corresponding author), Hunan Univ, Coll Mech & Vehicle Engn, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China.; Han, X (corresponding author), Hebei Univ Technol, Sch Mech Engn, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin 300401, Peoples R China.	logemen@hebut.edu.cn; liujie@hnu.edu.cn; xhan@hebut.edu.cn		Han, Xu/0000-0002-8967-4372	National Key R&D Program of China [2017YFB1301300]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51621004, 11832011]; independent research project of State Key Laboratory of Reliability and Intelligence Electrical Equipment, Hebei University of Technology [EERIZZ2018001]	This work is supported by the National Key R&D Program of China (2017YFB1301300), the National Science Foundation of China (51621004, 11832011) and the independent research project of State Key Laboratory of Reliability and Intelligence Electrical Equipment, Hebei University of Technology (EERIZZ2018001).	Ackerman MJ, 1998, P IEEE, V86, P504, DOI 10.1109/5.662875; Antona-Makoshi J, 2012, P 2012 INT IRCOBI C, V2012, P441; Antona-Makoshi J., 2016, THESIS, pTechnology; Antona-Makoshi J., 2016, IJAE, V7, P69; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deng ZY, 2016, NEUROCOMPUTING, V195, P143, DOI 10.1016/j.neucom.2015.08.112; Ding SF, 2014, NEURAL PROCESS LETT, V40, P245, DOI 10.1007/s11063-013-9326-5; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gadd CW, 1966, SAE TECHNICAL PAPER, DOI [10.4271/660793, DOI 10.4271/660793]; Gajera V, 2016, PROCEEDINGS OF THE 2016 2ND INTERNATIONAL CONFERENCE ON APPLIED AND THEORETICAL COMPUTING AND COMMUNICATION TECHNOLOGY (ICATCCT), P812, DOI 10.1109/ICATCCT.2016.7912111; Golman AJ, 2014, ACCIDENT ANAL PREV, V64, P1, DOI 10.1016/j.aap.2013.10.026; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Kimpara, 2011, INT J AUTOMOT ENG, V2, P13, DOI [10.20485/jsaeijae.2.2_13, DOI 10.20485/JSAEIJAE.2.2_13]; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2002, THESIS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Leone N, 2015, P ESV, V15-0310; Li F, 2017, CURR PHARM DESIGN, V23, P2177, DOI 10.2174/1381612823666161118144829; Lili Qu, 2010, 2010 International Conference on Computer Application and System Modeling (ICCASM 2010), P267, DOI 10.1109/ICCASM.2010.5623211; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; McElhaney James H, 2005, Stapp Car Crash J, V49, pv; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman JA, 1986, P 2012 INT IRCOBI C; NHTSA, SIMON SOFTW PACK; NHTSA, VEH CRASH TEST DAT; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Patrick LM, 1966, SAE T, P785, DOI [10.4271/650171, DOI 10.4271/650171]; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Schmitt KU, 2010, TRAUMA BIOMECHANICS: ACCIDENTAL INJURY IN TRAFFIC AND SPORTS, THIRD EDITION, P1, DOI 10.1007/978-3-642-03713-9; Sminkey ML, 2011, GLOBAL PLAN DECADE A; Takahashi Y., 2015, 2015011439 SAE, DOI DOI 10.4271/2015-01-1439; Takhounts EG, 2011, P P 22 ENH SAF VEH C, P1; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Willinger R, 1995, P IRCOBI, V23, P245; World Health Organization, 2015, GLOB STAT REP ROAD S; Xiong F, 2018, STRUCT MULTIDISCIP O, V57, P441, DOI 10.1007/s00158-017-1749-6; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	53	3	3	1	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1615-147X	1615-1488		STRUCT MULTIDISCIP O	Struct. Multidiscip. Optim.	OCT	2019	60	4					1491	1508		10.1007/s00158-019-02277-9			18	Computer Science, Interdisciplinary Applications; Engineering, Multidisciplinary; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mechanics	JI8MR	WOS:000493718200012					2022-02-06	
J	Parmontree, P; Tunthanathip, T; Doungngern, T; Rojpitbulstit, M; Kulviwat, W; Ratanalert, S				Parmontree, Porntip; Tunthanathip, Thara; Doungngern, Thitima; Rojpitbulstit, Malee; Kulviwat, Wattanachai; Ratanalert, Sanguansin			Predictive Risk Factors for Early Seizures in Traumatic Brain Injury	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						posttraumatic seizure; predictive model; risk factors; traumatic brain injury	LATE POSTTRAUMATIC SEIZURES; HEAD-INJURY; EPIDEMIOLOGY; MULTICENTER	Background Early posttraumatic seizure (PTS) is a significant cause of unfavorable outcomes in traumatic brain injury (TBI). This study was aimed to investigate the incidence and determine a predictive model for early PTS. Materials and Methods A prospective cohort study of 484 TBI patients was conducted. All patients were evaluated for seizure activities within 7 days after the injury. Risk factors for early PTS were identified using univariate analysis. The candidate risk factors with p < 0.1 were selected into multivariable logistic regression analysis to identify predictors of early PTS. The fitting model and the power of discrimination with the area under the receiver operating characteristic (AUROC) curve were demonstrated. The nomogram for prediction of early PTS was developed for individuals. Results There were 27 patients (5.6%) with early PTS in this study. The final model illustrated chronic alcohol use (odds ratio [OR]: 4.06, 95% confidence interval [CI]: 1.64-10.07), epidural hematoma (OR: 3.98, 95% CI: 1.70-9.33), and Glasgow Coma Scale score 3-8 (OR: 3.78, 95% CI: 1.53-9.35) as predictors of early PTS. The AUROC curve was 0.77 (95% CI: 0.66-0.87). Conclusions The significant predictors for early PTS were chronic alcohol use, epidural hematoma, and severe TBI. Our nomogram was considered as a reliable source for prediction.	[Parmontree, Porntip; Doungngern, Thitima; Rojpitbulstit, Malee] Prince Songkla Univ, Fac Pharmaceut Sci, Hat Yai, Thailand; [Tunthanathip, Thara] Prince Songkla Univ, Songklanagarind Hosp, Fac Med, Dept Surg,Div Neurosurg, Hat Yai, Thailand; [Kulviwat, Wattanachai] Hatyai Hosp, Dept Neurosurg, Songkhla, Songkhla, Thailand; [Ratanalert, Sanguansin] Mae Fah Luang Univ, Sch Med, Chiang Rai, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Songklanagarind Hosp, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand.	tsus4@hotmail.com		Tunthanathip, Thara/0000-0002-6303-836X	Faculty of Pharmaceutical Sciences and Graduate school, Prince of Songkla University, Thailand	The research funds were supported from the Faculty of Pharmaceutical Sciences and Graduate school, Prince of Songkla University, Thailand.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chan H K, 2010, J MED SCI, V17, P36; Chen F, 2018, J CANCER, V9, P2543, DOI 10.7150/jca.24431; Ding K., 2016, TRANSLATIONAL RES TR; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Hillbom M, 2003, CNS DRUGS, V17, P1013, DOI 10.2165/00023210-200317140-00002; Majidi S, 2017, NEUROCRIT CARE, V27, P90, DOI 10.1007/s12028-016-0363-6; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Najafi Mohammad Reza, 2015, Adv Biomed Res, V4, P82, DOI 10.4103/2277-9175.156640; Phuenpathom N, 2000, J CLIN NEUROSCI, V7, P223, DOI 10.1054/jocn.1999.0203; Prathep Sumidtra, 2017, Journal of the Medical Association of Thailand, V100, P843; Rabiu TB, 2017, WORLD NEUROSURG, V104, P367, DOI 10.1016/j.wneu.2017.04.133; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Tunthanathip T, 2017, J NEUROSCI RURAL PRA, V8, P601, DOI 10.4103/jnrp.jnrp_381_17; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P9	28	3	3	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT	2019	10	4					582	587		10.1055/s-0039-1700791			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	JV4II	WOS:000502328400004	31831975	gold, Green Published			2022-02-06	
J	Ravin, R; Morgan, NY; Blank, PS; Ravin, N; Guerrero-Cazares, H; Quinones-Hinojosa, A; Zimmerberg, J				Ravin, Rea; Morgan, Nicole Y.; Blank, Paul S.; Ravin, Nitay; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Zimmerberg, Joshua			Response to Blast-like Shear Stresses Associated with Mild Blast-Induced Brain Injury	BIOPHYSICAL JOURNAL			English	Article							IN-VITRO; MODEL; WAVE	Toward the goal of understanding the pathophysiology of mild blast-induced traumatic brain injury and identifying the physical forces associated with the primary injury phase, we developed a system that couples a pneumatic blast to a microfluidic channel to precisely and reproducibly deliver shear transients to dissociated human central nervous system (CNS) cells, on a timescale comparable to an explosive blast but with minimal pressure transients. Using fluorescent beads, we have characterized the shear transients experienced by the cells and demonstrate that the system is capable of accurately and reproducibly delivering uniform shear transients with minimal pressure across the cell culture volume. This system is compatible with high-resolution, time-lapse optical microscopy. Using this system, we demonstrate that blast-like shear transients produced with minimal pressure transients and submillisecond rise times activate calcium responses in dissociated human CNS cultures. Cells respond with increased cytosolic free calcium to a threshold shear stress between 8 and 21 Pa; the propagation of this calcium response is a result of purinergic signaling. We propose that this system models, in vitro, the fundamental injury wave produced by shear forces consequent to blast shock waves passing through density inhomogeneity in human CNS cells.	[Ravin, Rea; Ravin, Nitay] Celoptics Inc, Rockville, MD USA; [Morgan, Nicole Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA; [Blank, Paul S.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, Div Basic & Translat Biophys, NIH, Bethesda, MD 20892 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA		Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, Div Basic & Translat Biophys, NIH, Bethesda, MD 20892 USA.	zimmerbj@mail.nih.gov		Guerrero-Cazares, Hugo/0000-0003-1307-719X	Intramural Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland; National Institutes of Health Extramural ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS070024]; Defense Advanced Research Project AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); Space and Naval Warfare Systems Center (SPAWARSYSCEN Pacific) [N66001-14-C-4056]	This work was supported by the Intramural Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, and of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, as well as the National Institutes of Health Extramural Program under award number R01NS070024 (A.Q.H.); this material is also based upon work supported by the Defense Advanced Research Project Agency and Space and Naval Warfare Systems Center (SPAWARSYSCEN Pacific) under contract no. N66001-14-C-4056 (Celoptics).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BRODE HL, 1959, PHYS FLUIDS, V2, P217, DOI 10.1063/1.1705911; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Shin HS, 2009, J NANOSCI NANOTECHNO, V9, P7330, DOI 10.1166/jnn.2009.1769; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765	24	3	3	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	OCT 1	2019	117	7					1167	1178		10.1016/j.bpj.2019.07.052			12	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	JB3LA	WOS:000488457600001	31495447	Bronze, Green Published			2022-02-06	
J	Sattayasoonthorn, P; Suthakorn, J; Chamnanvej, S				Sattayasoonthorn, Preedipat; Suthakorn, Jackrit; Chamnanvej, Sorayouth			On the feasibility of a liquid crystal polymer pressure sensor for intracranial pressure measurement	BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK			English	Article						hydrostatic experiment; intracranial pressure (ICP); liquid crystal polymer (LCP); MEMS; moist environment; piezoresistive pressure sensor; strain gauge; Wheatstone bridge	SYSTEM; WIRELESS; IMPLANT; BRAIN; MEMS; ICP	Intracranial pressure (ICP) monitoring is crucial in determining the appropriate treatment in traumatic brain injury. Minimally invasive approaches to monitor ICP are subject to ongoing research because they are expected to reduce infections and complications associated with conventional devices. This study aims to develop a wireless ICP monitoring device that is biocompatible, miniature and implantable. Liquid crystal polymer (LCP) was selected to be the main material for the device fabrication. This study considers the design, fabrication and testing of the sensing unit of the proposed wireless ICP monitoring device. A piezoresistive pressure sensor was designed to respond to 0-50 mm Hg applied pressure and fabricated on LCP by standard microelectromechanical systems (MEMS) procedures. The fabricated LCP pressure sensor was studied in a moist environment by means of a hydrostatic pressure test. The results showed a relative change in voltage and pressure from which the sensor's sensitivity was deduced. This was a proof-of-concept study and based on the results of this study, a number of recommendations for improving the considered sensor performance were made. The limitations are discussed, and future design modifications are proposed that should lead to a complete LCP package with an improved performance for wireless, minimally invasive ICP monitoring.	[Sattayasoonthorn, Preedipat; Suthakorn, Jackrit] Mahidol Univ, Fac Engn, Ctr Biomed & Robot Technol BART LAB, Dept Biomed Engn, Salaya, Nakhon Pathom, Thailand; [Chamnanvej, Sorayouth] Mahidol Univ, Ramathibodi Hosp, Dept Surg, Neurosurg Div,Fac Med, Bangkok, Thailand		Suthakorn, J (corresponding author), Mahidol Univ, Fac Engn, Ctr Biomed & Robot Technol BART LAB, Dept Biomed Engn, Salaya, Nakhon Pathom, Thailand.	jackrit.sut@mahidol.ac.th		Suthakorn, Jackrit/0000-0003-1333-3982	Thesis Grant for Doctoral Degree Student under National Research Council of Thailand (NRCT) through Mahidol University	FY2016 Thesis Grant for Doctoral Degree Student under National Research Council of Thailand (NRCT) through Mahidol University.	[Anonymous], 2007, J NEUROSURG S212, V24, pS1; Bee M, 2013, BIOMED ENG-BIOMED TE, V58, P24; Bhattacharya SK, 2007, 6TH INTERNATIONAL IEEE CONFERENCE ON POLYMERS AND ADHESIVES IN MICROELECTRONICS AND PHOTONICS, PROCEEDINGS 2007, P159, DOI 10.1109/POLYTR.2007.4339159; Boresi AP, 2001, J STRUCT ENG, V127, P598, DOI [10.1061/%28asce%290733-9445%282001%29127%3a5%28598%29, DOI 10.1061/%28ASCE%290733-9445%282001%29127%3A5%28598%29]; Chang WY, 2008, IEEE SENS J, V8, P495, DOI 10.1109/JSEN.2008.918749; Chow EY, 2010, IEEE ENG MED BIO, P6429, DOI 10.1109/IEMBS.2010.5627324; Clausen I, 2014, SENSORS-BASEL, V14, P17686, DOI 10.3390/s140917686; Dean R, 2004, PROC SPIE, V5515, P88, DOI 10.1117/12.559831; Fonseca M., 2007, THESIS; Ghannad-Rezaie M, 2012, J MICROELECTROMECH S, V21, P23, DOI 10.1109/JMEMS.2011.2171322; Ginggen A, 2008, IEEE T BIO-MED ENG, V55, P1374, DOI 10.1109/TBME.2007.913908; Hodgins D, 2008, IEEE PERVAS COMPUT, V7, P14, DOI 10.1109/MPRV.2008.8; Hou S. M.-C., 2012, THESIS; Iron Boar Labs Ltd, LIQ CRYST POL LCP; James T, 2008, SENSORS-BASEL, V8, P6077, DOI 10.3390/s8096077; Kawoos U, 2009, THESIS; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kawoos U, 2015, IEEE MICROW MAG, V16, P39, DOI 10.1109/MMM.2014.2377585; Kiefer M, 2011, IEEE ENG MED BIO, P2246, DOI 10.1109/IEMBS.2011.6090426; Ko HS, 2007, J MICROMECH MICROENG, V17, P1640, DOI 10.1088/0960-1317/17/8/030; Kottapalli AGP, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/8/085006; Kottapalli A G P, 2012, SMART MATER STRUCT, V11, P1; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Lee SE, 2012, IEEE T BIO-MED ENG, V59, P2085, DOI 10.1109/TBME.2012.2196274; Liu C, 2007, ADV MATER, V19, P3783, DOI 10.1002/adma.200701709; Loffler S, 2012, BIOMED ENG-BIOMED TE, V57, P858, DOI 10.1515/bmt-2012-4437; Loffler S, 2012, BIOMED ENG-BIOMED TE, V57, P104, DOI 10.1515/bmt-2012-4434; Masi BC, 2012, BIOMATERIALS, V33, P5768, DOI 10.1016/j.biomaterials.2012.04.048; Min KS, 2014, NEUROMODULATION, V17, P160, DOI 10.1111/ner.12093; Nader N, 2013, Patent No. [US8,343,068B2, 8343068]; Rao JS, 2017, SIMULATION BASED ENGINEERING IN FLUID FLOW DESIGN, P23, DOI 10.1007/978-3-319-46382-7_2; Rogers Corporation, ULTRALAM 3000 FLEX C; Roytowski D, 2013, CME, V31, P390; Sattayasoonthorn P, 2013, IEEE INT CONF NANO, P63, DOI 10.1109/NANOMED.2013.6766317; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Senturia SD., 2002, MICROSYSTEM DESIGN, DOI [10.1007/b117574, DOI 10.1007/B117574]; Shu Y, 2015, SENSORS-BASEL, V15, P3224, DOI 10.3390/s150203224; Stehlin E, 2013, J APPL PHYSIOL, V115, P1672, DOI 10.1152/japplphysiol.00683.2013; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Vyas R, 2007, IEEE ANTENNAS PROP, P1586; Wang K, 2009, IEEE T BIO-MED ENG, V56, P6, DOI 10.1109/TBME.2008.926691; Wang XF, 2003, J MICROMECH MICROENG, V13, P628, DOI 10.1088/0960-1317/13/5/314; Xue N, 2012, J MICROELECTROMECH S, V21, P1338, DOI 10.1109/JMEMS.2012.2206072; Yu L, 2014, SENSORS-BASEL, V14, P20620, DOI 10.3390/s141120620; Zeiser R, 2014, J SENS SENS SYST, V3, P77, DOI 10.5194/jsss-3-77-2014; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661; Zou G, 2002, IEEE T ADV PACKAGING, V25, P503, DOI 10.1109/TADVP.2002.807593; 2000, J NEUROTRAUMA, V17, P497	49	3	3	0	27	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0013-5585	1862-278X		BIOMED ENG-BIOMED TE	Biomed. Eng.-Biomed. Tech.	OCT	2019	64	5					543	553		10.1515/bmt-2018-0029			11	Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Medical Informatics	JB0HH	WOS:000488232700005	30875314				2022-02-06	
J	Solla, F; Carboni, J; Fernandez, A; Dupont, A; Chivoret, N; Brezac, G; Rampal, V; Breaud, J				Solla, Federico; Carboni, Joseph; Fernandez, Arnaud; Dupont, Audrey; Chivoret, Nathalie; Brezac, Gilles; Rampal, Virginie; Breaud, Jean			Severe casualties from Bastille Day Attack in Nice, France	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Terror attack; Mass casualty incident; Children; Trauma; Pediatric hospital	TERRORIST ATTACK; DISASTER; CHILDREN	Purpose To describe the most severe casualties from the July 14th, 2016 terror attack in Nice that were treated at the Lenval University Children's Hospital (LUCH) of Nice (France). Methods Retrospective study about casualties treated at LUCH from Bastille Day Attack with injuries resulting in the need for surgery, resuscitation, or death. The type of lesions and surgery, duration of hospitalizations, complications, psychological status, and outcome at discharge were collected. Results Eleven patients presented severe traumas including three adults. They were triaged and managed first by the Critical Care Physician on duty and by emergency room nurses with no additional staff. Six pediatric casualties needed surgery; seven patients were hospitalized in Pediatric Intensive Care Unit (PICU). Five deaths were reported. The most relevant injuries were: pelvic disjunction, lower limb fracture, vascular injuries, and head or trunk crush. As soon as it was possible, two surgeons attended the emergency room (ER) to help carry out the triage. Overall we performed twenty-eight surgeries, including two neurological, one vascular, and five orthopedic. We performed closed reduction and internal fixation (CRIF) in three cases of limb fractures. A compartment syndrome was observed. Stress disorders were observed in three patients, which merited psychiatric support and treatment. Conclusion We faced uncommon situations with severe casualties without pre-hospital management. The presence of adult patients and unusual lesions increased the complexity. The presence of surgeons in the ER seemed useful for effective clinical decision-making. CRIF has been a valid option for damage control. Competence in vascular, neurological, major trauma surgery and psychic trauma should be available in any pediatric trauma center.	[Solla, Federico; Carboni, Joseph; Chivoret, Nathalie; Rampal, Virginie; Breaud, Jean] Lenval Univ, Pediat Surg Dept, Childrens Hosp, 57 Ave Calif, F-06200 Nice, France; [Carboni, Joseph; Fernandez, Arnaud; Breaud, Jean] Univ Nice, Med Sch, 28 Ave Valombrose, F-06107 Nice, France; [Fernandez, Arnaud] Lenval Univ, Child Psychiat, Childrens Hosp, F-06200 Nice, France; [Dupont, Audrey] Lenval Univ, Pediat Intens Care Unit, Childrens Hosp, F-06200 Nice, France; [Brezac, Gilles] Lenval Univ, Pediat Anesthesiol, Childrens Hosp, F-06200 Nice, France		Solla, F (corresponding author), Lenval Univ, Pediat Surg Dept, Childrens Hosp, 57 Ave Calif, F-06200 Nice, France.	fedesolla@hotmail.com	fernandez, arnaud/ABE-2929-2020	fernandez, arnaud/0000-0002-6326-9096			Allen GM, 2007, PREHOSP DISASTER MED, V22, P537, DOI 10.1017/S1049023X00005392; Carles M, 2016, LANCET, V388, P2349, DOI 10.1016/S0140-6736(16)32128-6; Chrisman AK, 2014, CHILD ADOL PSYCH CL, V23, P257, DOI 10.1016/j.chc.2013.12.004; Gregory TM, 2016, INJURY, V47, P2122, DOI 10.1016/j.injury.2016.08.014; Haas H, 2017, LANCET, V389, P1007, DOI 10.1016/S0140-6736(17)30655-4; Harjai M M, 2005, Med J Armed Forces India, V61, P330, DOI 10.1016/S0377-1237(05)80056-5; Heldenberg E, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00047; Holton CS, 2015, ORTHOPAEDICS TRAUMA, V29, P337, DOI [10.1016/j.mporth.2015.10.010, DOI 10.1016/J.MPORTH.2015.10.010]; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Slone M, 2016, CHILD PSYCHIAT HUM D, V47, P950, DOI 10.1007/s10578-016-0626-7; Solla F, 2018, ACAD PEDIAT; Tobert Daniel, 2015, J Orthop Trauma, V29 Suppl 10, pS7, DOI 10.1097/BOT.0000000000000413; Trudeau MO, 2016, SEMIN PEDIATR SURG, V25, P23, DOI 10.1053/j.sempedsurg.2015.09.006	13	3	3	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2019	45	5					857	864		10.1007/s00068-018-0901-3			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JD5FT	WOS:000490009600011	29318344				2022-02-06	
J	Timpson, M; Hade, EM; Beaulieu, C; Horn, SD; Hammond, FM; Peng, J; Montgomery, E; Giuffrida, C; Gilchrist, K; Lash, A; Dijkers, M; Corrigan, JD; Bogner, J				Timpson, Misti; Hade, Erinn M.; Beaulieu, Cynthia; Horn, Susan D.; Hammond, Flora M.; Peng, Juan; Montgomery, Erin; Giuffrida, Clare; Gilchrist, Kamie; Lash, Aubrey; Dijkers, Marcel; Corrigan, John D.; Bogner, Jennifer			Advanced Therapy in Traumatic Brain Injury Inpatient Rehabilitation: Effects on Outcomes During the First Year After Discharge	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	4th Federal Interagency Conference on Traumatic Brain Injury (TBI)	JUN 11-13, 2018	Washington, DC				PATIENT HEALTH QUESTIONNAIRE-9; STROKE REHABILITATION; PARTICIPATION ASSESSMENT; PHYSICAL-THERAPY; DEPRESSION; SATISFACTION; ASSOCIATION; INTENSITY; VALIDITY; WALKING	Objective: To use causal inference methods to determine if receipt of a greater proportion of inpatient rehabilitation treatment focused on higher level functions, for example, executive functions, ambulating over uneven surfaces (advanced therapy [AdvTx]), results in better rehabilitation outcomes. Design: A cohort study using propensity score methods applied to the traumatic brain injury practice-based evidence (TBI-PBE) database, a database consisting of multisite, prospective, longitudinal observational data. Setting: Acute inpatient rehabilitation facilities. Participants: Patients enrolled in the TBI-PBE study (N = 1843), aged 14 years or older, who sustained a severe, moderate, or complicated mild TBI, receiving their first inpatient rehabilitation facility admission to 1 of 9 sites in the United States, and consented to follow-up 3 and 9 months postdischarge from inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Participation Assessment with Recombined Tools-Objective-17, FIM motor and cognitive scores, Satisfaction with Life Scale, and Patient Health Questionnaire-9. Results: Controlling for measured potential confounders, increasing the percentage of AdvTx during inpatient TBI rehabilitation was found to be associated with better community participation, functional independence, life satisfaction, and decreased likelihood of depression during the year after discharge from inpatient rehabilitation. Participants who began rehabilitation with greater disability experienced larger gains on some outcomes than those who began rehabilitation with more intact abilities. Conclusions: Increasing the proportion of treatment targeting higher level functions appears to have no detrimental and a small, beneficial effect on outcome. Caution should be exercised when inferring causality given that a large number of potential confounders could not be completely controlled with propensity score methods. Further, the extent to which unmeasured confounders influenced the findings is not known and could be of particular concern due to the potential for the patient's recovery trajectory to influence therapists' decisions to provide a greater amount of AdvTx. (C) 2018 by the American Congress of Rehabilitation Medicine	[Timpson, Misti] Rocky Mt Univ Hlth Profess, Provo, UT USA; [Hade, Erinn M.; Peng, Juan; Montgomery, Erin; Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Beaulieu, Cynthia] Brooks Rehabil Hosp, Jacksonville, FL USA; [Horn, Susan D.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Giuffrida, Clare] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Gilchrist, Kamie] Intermt Med Ctr, Murray, UT USA; [Lash, Aubrey] Cleveland VA Med Ctr, Cleveland, OH USA; [Dijkers, Marcel] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Dijkers, Marcel] Wayne State Univ, Detroit, MI USA		Bogner, J (corresponding author), Ohio State Univ, Coll Med, Phys Med & Rehabil Dept, 480 Med Ctr Dr, Columbus, OH 43210 USA.	bogner.1@osu.edu			Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-1403-13476]; National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; Administration for Community Living. National Institute on Disability, Independent Living and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]	Supported by Patient-Centered Outcomes Research Institute (award no. CER-1403-13476). The statements presented in this work are solely the responsibility of the author(s) and do not necessarily represent the views of PCORI, its Board of Governors, or its Methodology Committee. Funding for the database used in this study came from the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the Administration for Community Living. National Institute on Disability, Independent Living and Rehabilitation Research (grant no. H133A080023). and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96; BOBATH B, 1979, PRACTITIONER, V223, P793; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2015, REHABIL PSYCHOL, V60, P211, DOI 10.1037/rep0000042; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hatfield B, 2005, ARCH PHYS MED REHAB, V86, pS61, DOI 10.1016/j.apmr.2005.08.111; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Horn SD, 2013, ARCH PHYS MED REHAB, V94, pS75, DOI 10.1016/j.apmr.2012.10.036; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Institute of Medicine, 2011, COGN REH THER TRAUM; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lanza ST, 2013, AM J COMMUN PSYCHOL, V52, P380, DOI 10.1007/s10464-013-9604-4; Latham NK, 2005, ARCH PHYS MED REHAB, V86, pS41, DOI 10.1016/j.apmr.2005.08.128; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Malis K, RECOMMENDATIONS BEST; Naimi AI, 2014, EPIDEMIOLOGY, V25, P292, DOI 10.1097/EDE.0000000000000053; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Tang QP, 2014, TOP STROKE REHABIL, V21, P120, DOI 10.1310/tsr2102-120; Nguyen TL, 2017, PHARMACOEPIDEM DR S, V26, P1513, DOI 10.1002/pds.4325; Nguyen TL, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0338-0; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Winstein CJ, 2015, PROG BRAIN RES, V218, P331, DOI 10.1016/bs.pbr.2015.01.004	43	3	3	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1818	1826		10.1016/j.apmr.2018.11.015			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000003	30578774	Green Submitted			2022-02-06	
J	Tse, KM; Tan, LB; Bin Sapingi, MA; Franklyn, M; Lee, PVS; Tan, VBC; Lee, HP				Tse, Kwong Ming; Tan, Long Bin; Bin Sapingi, Mohamad Ali; Franklyn, Melanie; Lee, Peter Vee Sin; Tan, Vincent Beng Chye; Lee, Heow Pueh			The role of a composite polycarbonate-aerogel face shield in protecting the human brain from blast-induced injury: A fluid-structure interaction (FSI) study	JOURNAL OF SANDWICH STRUCTURES & MATERIALS			English	Article						Face shield design; aerogel; polycarbonate; finite element head model; traumatic brain injury; composite helmet	FINITE-ELEMENT MODEL; COMBAT HELMET; HUMAN HEAD; IMPACT; MITIGATION; TRANSMISSION; RESPONSES; POLYUREA; BEHAVIOR; WAVES	Background Blast-induced traumatic brain injury is the most prevalent injury sustained by combat soldiers at the frontline. The current study aims to investigate the effectiveness of composite polycarbonate-aerogel face shields with different configurations in mitigating blast-induced brain injuries. Method A series of dynamic fluid-structure interaction simulations of a helmeted head subjected to a frontal free field blast was performed, to evaluate the effectiveness of the current conventional polycarbonate face shield and three other composite face shields with different configurations when exposed to a frontal free-field blast. Results The simulation results demonstrated that the sandwiched structured face shields of polycarbonate and aerogel provided superior blast attenuation than a single-layered polycarbonate face shield. The alternate multi-layered transparent materials of high and low densities provided the best attenuation of blast pressure transmission to the head, with the polycarbonate exterior shell casing contributing to the structural integrity of the face shield, while the lower dense aerogel filler providing high acoustic impedance to blast wave transmission. Conclusion This study provides further insights on future development and design of personal protective equipment in mitigating blast-induced injuries to the head.	[Tse, Kwong Ming; Tan, Long Bin; Bin Sapingi, Mohamad Ali; Tan, Vincent Beng Chye; Lee, Heow Pueh] Natl Univ Singapore, Dept Mech Engn, Singapore, Singapore; [Tse, Kwong Ming; Franklyn, Melanie; Lee, Peter Vee Sin] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia; [Lee, Heow Pueh] Natl Univ Singapore Suzhou, Res Inst, Suzhou, Peoples R China		Lee, HP (corresponding author), Natl Univ Singapore, Dept Mech Engn, Singapore, Singapore.; Tse, KM (corresponding author), Natl Univ Singapore, Singapore, Singapore.; Tse, KM (corresponding author), Univ Melbourne, Melbourne, Vic 3010, Australia.	mpeleehp@nus.edu.sg	Tan, Vincent/R-8040-2019; Lee, Heow Pueh/I-7834-2014; Tse, Kwong Ming/D-8669-2011	Tan, Vincent/0000-0003-1436-5337; Lee, Heow Pueh/0000-0002-4380-3888; Tse, Kwong Ming/0000-0002-8170-0775; Franklyn, Melanie/0000-0003-0090-9161			Aerogel.org, WHAT IS AER; Agoston DV, 2015, BRAIN NEUROTRAUMA MO, P687; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bhardwaj R, 2014, BIOMECH MODEL MECHAN, V13, P123, DOI 10.1007/s10237-013-0490-3; Boccia E, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2900; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chan M., 1980, P 24 STAPP CAR CRASH, P347; City Plastics Polycarbonate, POL TECHN DAT INF; CLEMEDSON C, 1961, J APPL PHYSIOL, V16, P426, DOI 10.1152/jappl.1961.16.3.426; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; Cooper GJ, 1996, J TRAUMA, V40, pS105, DOI 10.1097/00005373-199603001-00024; Dewey JM., 2010, 21 INT S MIL ASP BLA; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ganpule S, 2010, 16 US NAT C THEOR AP, P1; Ganpule SG, 2013, THESIS, P289; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P297, DOI 10.1108/15736101211269122; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; Huang, 2011, WICOM 2011 23 25 SEP, P1; Israeli-Weapons, IWEAPONS PROT FAC VI; Karimi A, 2016, INJURY, V47, P1042, DOI 10.1016/j.injury.2016.01.030; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lee HP, 2010, COMPUT METHOD BIOMEC, V13, P537, DOI 10.1080/10255840903337848; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 2010, ACTA BIOENG BIOMECH, V12, P25; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; NICKELL RE, 1974, J ENG IND-T ASME, V96, P490, DOI 10.1115/1.3438355; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Nyein MK., 2013, THESIS, P167; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Petr K, 2012, J COMPUT NONLIN DYN, V7; Pinnoji PK, 2010, MATER DESIGN, V31, P3716, DOI 10.1016/j.matdes.2010.03.011; Reimer-Kirkham S, 2011, HEALTH INEQUITIES IN CANADA: INTERSECTIONAL FRAMEWORKS AND PRACTICES, P112; RICHMOND DR, 1968, ANN NY ACAD SCI, V152, P103, DOI 10.1111/j.1749-6632.1968.tb11970.x; Rodriguez-Millan M, 2016, MATER DESIGN, V110, P391, DOI 10.1016/j.matdes.2016.08.015; Sahoo D, 2016, INJURY, V47, P2424, DOI 10.1016/j.injury.2016.09.004; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Sharma S, 2011, NANOTECHNOLOGY AND BIOSENSORS, P24; Tamiami International Equipment Inc., HELM FAC SHIELDS MIA; Tan LB, 2013, 9TH INTERNATIONAL CONFERENCE ON COMPOSITE SCIENCE AND TECHNOLOGY: 2020 - SCIENTIFIC AND INDUSTRIAL CHALLENGES, P523; Tan LB, 2012, PERFORMANCE EVALUATI; TAN LB, 2012, INT J IMPACT ENG, V50, P99, DOI DOI 10.1016/j.ijimpeng.2012.06.003; Tan LB, 2014, INT J NUMER METH BIO, V30, P1476, DOI 10.1002/cnm.2668; Tse KM, 2017, MED BIOL ENG COMPUT, V55, P641, DOI 10.1007/s11517-016-1536-3; Vechart A, 2011, THESIS, P128; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; WARD CC, 1975, P 19 STAPP CAR CRASH, P641; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhou XY, 2010, ACM T ARCHIT CODE OP, V7, DOI 10.1145/1746065.1736070; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	61	3	4	4	20	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1099-6362	1530-7972		J SANDW STRUCT MATER	J. Sandw. Struct. Mater.	OCT	2019	21	7					2484	2511		10.1177/1099636217733369			28	Engineering, Mechanical; Materials Science, Characterization & Testing; Materials Science, Composites	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	IV8MX	WOS:000484520700014					2022-02-06	
J	Vos, L; Whiteneck, GG; Ngan, E; Leon-Novelo, L; Sherer, M				Vos, Leia; Whiteneck, Gale G.; Ngan, Esther; Leon-Novelo, Luis; Sherer, Mark			Rasch Analysis of Postconcussive Symptoms: Development of Crosswalks and the Brain Injury Symptom Scale	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							POST-CONCUSSION SYMPTOMS; FUNCTIONAL INDEPENDENCE MEASURE; CONSTRUCT-VALIDITY; OUTCOME MEASURES; QUESTIONNAIRE; PREDICTION; VETERANS; MODERATE	Objective: The first aim of this study was to develop a Rasch-based crosswalk between 2 postconcussive symptom measures, the Neurobehavioral Symptom Inventory (NSI) and the Rivermead Postconcussive Symptom Questionnaire (RPQ). The second goal was to utilize Rasch analysis to formulate a new proposed scale containing the best theoretical and psychometric items. Design: Prospective cohort observational study. Setting: Three acute inpatient rehabilitation hospitals in the United States. Participants: Community-dwelling persons (N=497) who were previously hospitalized and were diagnosed with mild to severe traumatic brain injury. Participants were (1) 18-64 years old; (2) could give informed consent; (3) able to complete study measures in English; (4) did not have an interfering medical or psychiatric condition. Interventions: Not applicable. Main Outcome Measures: NSI, RPQ. Results: Rasch analysis revealed 4 subdimensions across the 2 scales: cognitive, affective, physical, and visual. Crosswalk tables were generated for the first 3. Visual items were too few to generate a crosswalk. Iterative Rasch analysis produced a new scale with items rated from none to severe including the best items in each of these dimensions. Conclusions: The NSI and RPQ have considerable overlap and measure the same overarching constructs. Crosswalk tables may be helpful for clinicians and researchers to convert scores from 1 measure to the other. A more psychometrically sound scale, the Brain Injury Symptom Scale, composed of items from the NSI and RPQ, is proposed and will need further validation. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Vos, Leia; Sherer, Mark] Brain Injury Res Ctr, TIRR Mem Hermann, Houston, TX USA; [Vos, Leia; Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Vos, Leia] Zabolocki VA Med Ctr, 41277 5000 W Natl Ave, Milwaukee, WI 53295 USA; [Whiteneck, Gale G.] Craig Hosp, Res Dept, Englewood, CO USA; [Ngan, Esther; Leon-Novelo, Luis] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA		Vos, L (corresponding author), Zabolocki VA Med Ctr, 41277 5000 W Natl Ave, Milwaukee, WI 53295 USA.	Leia.Vos@va.gov	Vos, Leia/AAJ-8364-2020	Vos, Leia/0000-0003-1253-9129; Whiteneck, Gale/0000-0003-3609-5104; Sherer, Mark/0000-0003-1784-7008	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90RT5007, 90DP0013]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant no. 90RT5007; 90DP0013). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume Endorsement by the Federal Government.	Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bomyea J, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000278; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Bulson R, 2012, J REHABIL RES DEV, V49, P1075, DOI 10.1682/JRRD.2011.02.0017; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chan RCK, 2005, BRAIN INJURY, V19, P1117, DOI 10.1080/026990500150088; Cicerone K, 1994, ARCH PHYS MED REHAB, V75, P723; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fisher Jr WP, 2007, RASCH MEAS TRANS, V21, P1095, DOI DOI 10.1111/J.1600-0528.2012.00694.X; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hong I, 2018, DISABIL REHABIL, V40, P217, DOI 10.1080/09638288.2016.1247468; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Linacre J M, 1999, J Outcome Meas, V3, P103; Linacre J M, 1998, J Outcome Meas, V2, P266; Linacre J. M., DIMENSIONALITY CONTR; LINACRE JM, 2000, RASCH MEASUREMENT T, V14, P768; Linacre John M, 2002, J Appl Meas, V3, P85; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; NINDS Common Data Elements, TRAUMATIC BRAIN INJU; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Raiche G., 2005, RASCH MEASUREMENT T, V19, P1012, DOI DOI 10.1016/B978-012471352-9/50004-3; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sullivan KA, 2017, APPL NEUROPSYCH-ADUL, V24, P522, DOI 10.1080/23279095.2016.1216433; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Velozo CA, 2007, J REHABIL RES DEV, V44, P467, DOI 10.1682/JRRD.2006.06.0068; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wright B, 1994, MEASUREMENT T, V8, P370; Yu CH, 2005, PRACTICAL ASSESSMENT, V10, P2	40	3	3	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1844	1852		10.1016/j.apmr.2019.04.013			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000006	31129144				2022-02-06	
J	Wang, HC; Lin, YT; Hsu, SY; Tsai, NW; Lai, YR; Su, BYJ; Kung, CT; Lu, CH				Wang, Hung-Chen; Lin, Yu-Tsai; Hsu, Shih-Yuan; Tsai, Nai-Wen; Lai, Yun-Ru; Su, Ben Yu-Jih; Kung, Chia-Te; Lu, Cheng-Hsien			Serial plasma DNA levels as predictors of outcome in patients with acute traumatic cervical spinal cord injury	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						Traumatic spinal cord injury; Plasma DNA; Outcome; Japanese Orthopaedic Association score	CELL-FREE DNA; DEOXYRIBONUCLEIC-ACID LEVELS; MITOCHONDRIAL-DNA; QUANTITATIVE-ANALYSIS; PROGNOSTIC MARKER; MATERNAL PLASMA; BRAIN-INJURY; FETAL DNA; INFLAMMATION; DYSFUNCTION	Background Acute traumatic cervical spinal cord injury (SCI) is a leading cause of disability in adolescents and young adults worldwide. Evidence from previous studies suggests that circulating cell-free DNA is associated with severity following acute injury. The present study determined whether plasma DNA levels in acute cervical SCI are predictive of outcome. Methods In present study, serial plasma nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) levels were obtained from 44 patients with acute traumatic cervical SCI at five time points from day 1 to day 180 post-injury. Control blood samples were obtained from 66 volunteers. Results Data showed a significant increase in plasma nDNA and mtDNA concentrations at admission in SCI patients compared to the control group. Plasma nDNA levels at admission, but not plasma mtDNA levels, were significantly associated with the Japanese Orthopaedic Association (JOA) score and Injury Severity Score in patients with acute traumatic cervical SCI. In patients with non-excellent outcomes, plasma nDNA increased significantly at days 1, 14 and 30 post-injury. Furthermore, its level at day 14 was independently associated with outcome. Higher plasma nDNA levels at the chosen cutoff point (> 45.6 ng/ml) predicted poorer outcome with a sensitivity of 78.9% and a specificity of 78.4%. Conclusions These results indicate JOA score performance and plasma nDNA levels reflect the severity of spinal cord injury. Therefore, the plasma nDNA assays can be considered as potential neuropathological markers in patients with acute traumatic cervical SCI.	[Wang, Hung-Chen; Hsu, Shih-Yuan] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Wang, Hung-Chen; Lin, Yu-Tsai; Hsu, Shih-Yuan; Tsai, Nai-Wen; Lai, Yun-Ru; Su, Ben Yu-Jih; Kung, Chia-Te; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, 123 Ta Pei Rd, Kaohsiung, Taiwan; [Lin, Yu-Tsai] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Tsai, Nai-Wen; Lai, Yun-Ru; Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Su, Ben Yu-Jih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Kaohsiung, Taiwan; [Kung, Chia-Te] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Xiamen Chang Gung Mem Hosp, Dept Neurol, Xiamen, Fujian, Peoples R China		Lu, CH (corresponding author), Chang Gung Univ, Coll Med, 123 Ta Pei Rd, Kaohsiung, Taiwan.; Lu, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan.; Lu, CH (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.; Lu, CH (corresponding author), Xiamen Chang Gung Mem Hosp, Dept Neurol, Xiamen, Fujian, Peoples R China.	chlu99@ms44.url.com.tw		Su, Yu-Jih/0000-0002-7274-3458	Chang Gung Memorial Hospital Research ProjectChang Gung Memorial Hospital [CMRPG8D1391]	This study was supported by grants from the Chang Gung Memorial Hospital Research Project (CMRPG8D1391).	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Arnalich F, 2013, CRIT CARE, V17, DOI 10.1186/cc12735; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bao F, 2004, J NEUROCHEM, V90, P1194, DOI 10.1111/j.1471-4159.2004.02580.x; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; Breitbach S, 2014, J APPL PHYSIOL, V117, P119, DOI 10.1152/japplphysiol.00002.2014; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du W, 2013, EUR SPINE J, V22, P1594, DOI 10.1007/s00586-013-2741-5; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Fatouros IG, 2006, CLIN CHEM, V52, P1820, DOI 10.1373/clinchem.2006.070417; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; FOURNIE GJ, 1993, GERONTOLOGY, V39, P215; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Jiang N, 2005, J LEUKOCYTE BIOL, V77, P296, DOI 10.1189/jlb.0704411; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Li G, 2015, NEUROCHEM RES, V40, P1379, DOI 10.1007/s11064-015-1604-3; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lu CH, 2010, QJM-INT J MED, V103, P169, DOI 10.1093/qjmed/hcp201; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Medalha CC, 2012, CELL MOL NEUROBIOL, V32, P949, DOI 10.1007/s10571-012-9825-3; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rainer TH, 2007, CLIN CHIM ACTA, V376, P190, DOI 10.1016/j.cca.2006.08.025; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rodrigues EM, 2014, J NEUROTRAUM, V31, P1639, DOI 10.1089/neu.2013.3178; Soares HD, 1995, J NEUROSCI, V15, P8223; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; TSUMITA T, 1963, NATURE, V198, P1088, DOI 10.1038/1981088a0; Ulndreaj A, 2017, J NEUROTRAUM, V34, P1209, DOI 10.1089/neu.2016.4498; Wang HC, 2012, EUR J NEUROL, V19, P1532, DOI 10.1111/j.1468-1331.2012.03761.x; Wang HC, 2014, J NEUROTRAUM, V31, P1039, DOI 10.1089/neu.2013.3070; Wang HC, 2013, J NEUROSURG, V118, P13, DOI 10.3171/2012.8.JNS112093; Wang QQ, 2019, J NEUROTRAUM, V36, P1949, DOI 10.1089/neu.2018.5966; Wang Y, 2015, NEUROSCIENCE, V289, P224, DOI 10.1016/j.neuroscience.2014.12.061; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; Yu SCY, 2013, CLIN CHEM, V59, P1228, DOI 10.1373/clinchem.2013.203679; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160	50	3	3	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	OCT 1	2019	17	1							329	10.1186/s12967-019-2084-z			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JE1ZF	WOS:000490493900004	31570098	Green Published, gold			2022-02-06	
J	Stoica, T; Knight, LK; Naaz, F; Ramic, M; Depue, BE				Stoica, Teodora; Knight, Lindsay Kathleen; Naaz, Farah; Ramic, Melina; Depue, Brendan E.			Cortical morphometry and structural connectivity relate to executive function and estradiol level in healthy adolescents	BRAIN AND BEHAVIOR			English	Article						adolescent; anisotropy; estradiol; executive function; gray matter; white matter	WHITE-MATTER INTEGRITY; WORKING-MEMORY PERFORMANCE; POPULATION-BASED SAMPLE; TRAUMATIC BRAIN-INJURY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; PREFRONTAL CORTEX; GRAY-MATTER; NIH MRI; GEOMETRICALLY ACCURATE	Introduction Emotional and behavioral control is necessary self-regulatory processes to maintain stable goal-driven behavior. Studies indicate that variance in these executive function (EF) processes is related to morphological features of the brain and white matter (WM) differences. Furthermore, sex hormone level may modulate circuits in the brain important for cognitive function. Methods We aimed to investigate the structural neural correlates of EF behavior in gray matter (GM) and WM while taking into account estradiol level, in an adolescent population. The present study obtained neuroimaging behavioral and physiological data from the National Institute of Health's Pediatric Database (NIHPD). We analyzed the relationship between cortical morphometry and structural connectivity (N = 55), using a parent-administered behavioral monitoring instrument (Behavior Rating Inventory of Executive Function-BRIEF), estradiol level, as well as their interaction. Results Executive function behavior and estradiol level related to bidirectional associations with cortical morphometry in the right posterior dorsolateral prefrontal cortex (pDLPFC) and primary motor cortex (PMC), as well as fractional anisotropy (FA) in the forceps major and minor. Lastly, the interaction of EF behavior and estradiol level related to decreased volume in the right PMC and was linked to altered FA in the right inferior fronto-occipital fasciculus (iFOF). Conclusions The study provides evidence that the relationship between EF behavior and estradiol level related to bidirectional GM and WM differences, implying estradiol level has an influence on the putative structural regions underlying EF behavior. The findings represent a crucial link between EF behavior and hormonal influence on brain structure in adolescence.	[Stoica, Teodora; Knight, Lindsay Kathleen] Univ Louisville, Interdisciplinary Program Translat Neurosci, Louisville, KY 40292 USA; [Naaz, Farah] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Ramic, Melina] Univ Miami, Dept Psychiat, Coral Gables, FL 33124 USA; [Depue, Brendan E.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Depue, Brendan E.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA		Depue, BE (corresponding author), Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA.	brendan.depue@louisville.edu	Stoica, Teodora/AAU-6256-2021	Stoica, Teodora/0000-0003-1797-7443; Depue, Brendan/0000-0001-6665-5833; Knight, Lindsay/0000-0002-0120-5556	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-HD02-3343, N01-MH9-0002, N01-NS-9-2314, N01-NS-9-2315, N01-NS-9-2316, N01-NS-9-2317, N01-NS-9-2319, N01-NS-9-2320]	National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke, Grant/Award Number: N01-HD02-3343, N01-MH9-0002, N01-NS-9-2314, N01-NS-9-2315, N01-NS-9-2316, N01-NS-9-2317, N01-NS-9-2319 and N01-NS-9-2320	Almey A, 2015, HORM BEHAV, V74, P125, DOI 10.1016/j.yhbeh.2015.06.010; Antshel KM, 2005, PSYCHIAT RES-NEUROIM, V138, P235, DOI 10.1016/j.pscychresns.2005.02.003; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Ashtari M, 2012, DEV MED CHILD NEUROL, V54, P6, DOI 10.1111/j.1469-8749.2011.04122.x; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biesbroek JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166261; Bimonte HA, 1999, PSYCHONEUROENDOCRINO, V24, P161, DOI 10.1016/S0306-4530(98)00068-7; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Caballero A, 2016, NEUROSCI BIOBEHAV R, V70, P4, DOI 10.1016/j.neubiorev.2016.05.013; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Clark CAC, 2010, DEV PSYCHOL, V46, P1176, DOI 10.1037/a0019672; Cooke PS, 2017, PHYSIOL REV, V97, P995, DOI 10.1152/physrev.00018.2016; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P825, DOI 10.1111/j.1467-7687.2009.00918.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Depue BE, 2016, CEREB CORTEX, V26, P1634, DOI 10.1093/cercor/bhu324; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ducharme S, 2015, DATA BRIEF, V5, P929, DOI 10.1016/j.dib.2015.10.044; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Faridi N, 2015, NEUROPSYCHOLOGY, V29, P82, DOI 10.1037/neu0000079; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Garic D, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12744; Gautam P, 2015, HUM BRAIN MAPP, V36, P2318, DOI 10.1002/hbm.22772; Genova HM, 2013, J CLIN EXP NEUROPSYC, V35, P631, DOI 10.1080/13803395.2013.806649; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Hampson E, 2013, PSYCHONEUROENDOCRINO, V38, P2897, DOI 10.1016/j.psyneuen.2013.07.020; Herting MM, 2014, HUM BRAIN MAPP, V35, P5633, DOI 10.1002/hbm.22575; Herting MM, 2012, CEREB CORTEX, V22, P1979, DOI 10.1093/cercor/bhr246; Hidalgo-Lopez E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00403; Holmes MM, 2002, BEHAV NEUROSCI, V116, P928, DOI 10.1037//0735-7044.116.5.928; Karbach J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00390; Kharitonova M, 2013, DEV COGN NEUROS-NETH, V6, P61, DOI 10.1016/j.dcn.2013.07.002; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhn C, 2010, HORM BEHAV, V58, P122, DOI 10.1016/j.yhbeh.2009.10.015; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Lewis JG, 2002, MATURITAS, V41, P1, DOI 10.1016/S0378-5122(01)00250-X; Mahone EM, 2009, J INT NEUROPSYCH SOC, V15, P31, DOI 10.1017/S1355617708090164; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Peper JS, 2015, HUM BRAIN MAPP, V36, P1043, DOI 10.1002/hbm.22684; Peper JS, 2011, PSYCHONEUROENDOCRINO, V36, P1101, DOI 10.1016/j.psyneuen.2011.05.004; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Perez-Iglesias R, 2010, AM J PSYCHIAT, V167, P451, DOI 10.1176/appi.ajp.2009.09050716; Prasad KM, 2015, SCHIZOPHR RES, V161, P119, DOI 10.1016/j.schres.2014.09.043; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044826; Santiago C, 2015, AM J GERIAT PSYCHIAT, V23, P754, DOI 10.1016/j.jagp.2014.09.008; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smolker HR, 2015, BRAIN STRUCT FUNCT, V220, P1291, DOI 10.1007/s00429-014-0723-y; Solso S, 2016, BIOL PSYCHIAT, V79, P676, DOI 10.1016/j.biopsych.2015.06.029; Sommer T, 2018, PSYCHOPHARMACOLOGY, V235, P3465, DOI 10.1007/s00213-018-5061-y; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P3646, DOI 10.1002/hbm.22427; Tamm L, 2012, PSYCHIAT RES-NEUROIM, V202, P150, DOI 10.1016/j.pscychresns.2012.04.001; Tamura I, 2007, NEUROCASE, V13, P178, DOI 10.1080/13554790701448812; Taylor R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01295; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Waber DP, 2012, J INT NEUROPSYCH SOC, V18, P179, DOI 10.1017/S1355617711001536; Wide JK, 2004, BEHAV BRAIN RES, V155, P45, DOI 10.1016/j.bbr.2004.04.001; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu YP, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00088; Yamagata T, 2012, J NEUROSCI, V32, P12934, DOI 10.1523/JNEUROSCI.2398-12.2012; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009	89	3	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2019	9	12							e01413	10.1002/brb3.1413		SEP 2019	15	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	KF6ME	WOS:000488572800001	31568680	Green Published, gold			2022-02-06	
J	Lanzillo, B; Piscosquito, G; Marcuccio, L; Lanzillo, A; Vitale, DF				Lanzillo, Bernardo; Piscosquito, Giuseppe; Marcuccio, Laura; Lanzillo, Anna; Vitale, Dino Franco			Prognosis of severe acquired brain injury: Short and long-term outcome determinants and their potential clinical relevance after rehabilitation. A comprehensive approach to analyze cohort studies	PLOS ONE			English	Article							MODELS; PREDICTION	Background Accurate prognostic evaluation is a key factor in the clinical management of patients affected by severe acute brain injury (ABI) and helps planning focused therapies, better caregiver's support and allocation of resources. Aim of the study was to assess factors independently associated with both the short and long-term outcomes after rehabilitation in patients affected by ABI in the setting of a single Rehabilitation Unit specifically allocated to these patients. Methods and findings In all patients (567) with age. 18 years discharged from the Unit in the period 2006/2015 demographic, etiologic, comorbidity indicators, and descriptors of the disability burden (at hospital admission and discharge) were evaluated as potential prognostic factors of both short-term (4 classes of disability status at discharge) and long-term (mortality) outcomes. A comprehensive analytical method was adopted to combine several tasks. Select the factors with a significant independent association with the outcome, assess the relative weights and the "stability" (by bootstrap resampling) of them and estimate the role of the prognostic models in the clinical framework considering "cost" and "benefits". The generalized ordered logistic model for ordinal dependent variables was used for the short-term outcome while the Cox proportional hazard model was used for the long-term outcome. The final shortterm model identified 7 factors that independently account for 37% of the outcome variability as shown by pseudo R-2 (pR(2)) = 0.37. The disability status descriptors show the strongest association since they account for more than 60% of the pR(2), followed by age (14.8%), the presence of percutaneous endoscopic gastrostomy or nasogastric intubation (14.4%), a longer stay in the acute ward (5.9%) and concomitant coronary disease (1.3%). The final multivariable Cox model identified 4 factors that independently account for 52% of the outcome variability (R-2 = 0.52). The disability extent and the disability recovered lead the long-term mortality since they account for the 53% of the global R-2. The relevant effect of age (42%) is appreciable only after 2 years given the significant interaction with time. A longer stay in the acute ward explains the remaining fraction (5%). Considering 'cost and benefits', the decision curve analysis shows that the clinical benefit achieved by using both prognostic models is greater than the other possible action strategies, namely 'treat all' and 'treat none. Several less obvious characteristics of the prognostic models are appreciated by integrating the results of multiple analytical methods. Conclusion The comprehensive analytical tool aimed to integrate statistical significance, weight, "stability" and clinical "net" benefit, gives back a prognostic framework explaining a relevant portion of both outcomes' variability in which the strong association of the disability status with both outcomes is comparable to and followed by a time modulated role of age. Our data do not support a differentiated association of traumatic vs non-traumatic etiology. The results encourage the use of integrated approach to analyze cohort data.	[Lanzillo, Bernardo; Piscosquito, Giuseppe; Marcuccio, Laura; Lanzillo, Anna; Vitale, Dino Franco] IRCCS Telese Terme, Ist Clin Maugeri, Via Bagni Vecchi 1, Telese T, BN, Italy; [Vitale, Dino Franco] Casa Cura San Michele, Via Montella 16, Maddaloni, CE, Italy		Vitale, DF (corresponding author), IRCCS Telese Terme, Ist Clin Maugeri, Via Bagni Vecchi 1, Telese T, BN, Italy.; Vitale, DF (corresponding author), Casa Cura San Michele, Via Montella 16, Maddaloni, CE, Italy.	dinofranco.vitale@fastwebnet.it	Lanzillo, Anna/ABF-5999-2021; bernardo, lanzillo/F-1496-2019; piscosquito, giuseppe/A-9053-2018	Lanzillo, Anna/0000-0003-2385-401X; bernardo, lanzillo/0000-0001-5473-0701; piscosquito, giuseppe/0000-0001-6768-8936			Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Lanzillo B, 2015, EUR J PHYS REHAB MED, V51, P587; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Rengo G, 2016, CIRC RES, V118, P1116, DOI 10.1161/CIRCRESAHA.115.308207; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2008, MULTIVARIATE MODEL B, P183; Royston P, 2011, FLEXIBLE PARAMETRIC, P275; Sauerbrei W, 2007, BIOMETRICAL J, V49, P453, DOI 10.1002/bimj.200610328; Shorrocks AF, 2013, J ECON INEQUAL, V11, P99, DOI 10.1007/s10888-011-9214-z; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vickers AJ, 2008, AM STAT, V62, P314, DOI 10.1198/000313008X370302; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0216507	10.1371/journal.pone.0216507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	WOS:000532345500005	31557186	Green Published, gold			2022-02-06	
J	Suleiman, A; Lithgow, BJ; Anssari, N; Ashiri, M; Moussavi, Z; Mansouri, B				Suleiman, Abdelbaset; Lithgow, Brian J.; Anssari, Neda; Ashiri, Mehrangiz; Moussavi, Zahra; Mansouri, Behzad			Correlation between Ocular and Vestibular Abnormalities and Convergence Insufficiency in Post-Concussion Syndrome	NEURO-OPHTHALMOLOGY			English	Article						Mild traumatic brain injury; mTBI; concussion; post-concussion syndrome; PCS; electrovestibulography; EVestG; vergence eye movement; convergence insufficiency; depression	TRAUMATIC BRAIN-INJURY; EYE-MOVEMENTS; VERGENCE; SYMPTOMS; NEURONS; DEFICITS; AREA; RELIABILITY; IMPAIRMENT; PREDICTORS	The vestibular and oculomotor/visual systems are commonly affected in post-concussion syndrome (PCS). Convergence insufficiency (CI) is the most common ocular abnormality after concussion. Electrovestibulography (EVestG) is a relatively new non-invasive method that measures the peripheral vestibular responses; it has shown abnormal vestibular responses in a PCS. Here, we report the results of investigating the correlation between the vestibular and oculomotor systems in PCS population using EVestG and CI measures. Forty-eight PCS patients were tested using EVestG, out of which 20 also completed the Rivermead post-concussion questionnaire (RPQ). An EVestG feature (Field Potential (FP)-area) was extracted from the stationary part of the EVestG signals. A neuro-ophthalmologist (author BM) measured participants? CI at near vision using cross-cover examination and a prism-bar. Results indicate: (1) vestibular abnormality (i.e. FP-area) and CI values are significantly correlated in PCS (R = 0.68, p < .01), and (2) there are significant correlations between severity of concussion (i.e. RPQ3) and CI (R = 0.70, p < .01) and between RPQ3 and FP-area (R = ?0.56, p < .02). To the best of our knowledge, this is the first study that objectively demonstrates a significant positive correlation between the CI and vestibular systems? abnormality. These findings are scientifically important as they help localise the pathology of PCS, and are clinically valuable as they help physicians in their decision-making about PCS diagnosis and rehabilitation strategies.	[Suleiman, Abdelbaset; Lithgow, Brian J.; Ashiri, Mehrangiz; Moussavi, Zahra; Mansouri, Behzad] Univ Manitoba, Biomed Engn Program, Winnipeg, MB, Canada; [Lithgow, Brian J.] Monash Univ, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Anssari, Neda; Mansouri, Behzad] Univ Manitoba, Dept Internal Med, Sect Neurol, Winnipeg, MB, Canada; [Anssari, Neda] Univ Toronto, Dept Internal Med, Div Neurol, Toronto, ON, Canada; [Mansouri, Behzad] Univ Manitoba, Dept Ophthalmol, Winnipeg, MB, Canada; [Mansouri, Behzad] iScope Concuss & Pain Clin, Toronto, ON, Canada		Mansouri, B (corresponding author), Univ Manitoba, Biomed Engn Program, Winnipeg, MB, Canada.	behzad.mansouri@gmail.com					Alkan Y, 2011, VISUAL NEUROSCI, V28, P247, DOI 10.1017/S0952523811000125; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blakley B, 2019, J MED BIOL ENG, V39, P213, DOI 10.1007/s40846-018-0398-6; Brown DJ, 2010, HEARING RES, V267, P12, DOI 10.1016/j.heares.2010.03.091; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHARPIER S, 1994, J NEUROPHYSIOL, V72, P531, DOI 10.1152/jn.1994.72.2.531; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Daroff R.B., 2015, BRADLEYS NEUROLOGY C; Das VE, 2012, INVEST OPHTH VIS SCI, V53, P3858, DOI 10.1167/iovs.11-9145; Davis, 2001, DIAGNOSIS MANAGEMENT; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; GAMLIN PDR, 1989, J NEUROPHYSIOL, V62, P70, DOI 10.1152/jn.1989.62.1.70; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Jury MA, 2001, NEW ZEAL MED J, V114, P286; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Lithgow B, 2012, ANN BIOMED ENG, V40, P1835, DOI 10.1007/s10439-012-0526-3; Lithgow BJ, 2019, WORLD J BIOL PSYCHIA, V20, P799, DOI 10.1080/15622975.2019.1599143; Lithgow BJ, 2019, EUR ARCH PSY CLIN N, V269, P761, DOI 10.1007/s00406-018-0935-x; Lithgow BJ, 2015, WORLD J BIOL PSYCHIA, V16, P334, DOI 10.3109/15622975.2015.1014410; MARLINSKY VV, 1995, NEUROSCIENCE, V69, P661, DOI 10.1016/0306-4522(95)00231-7; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00611; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McGregor ML, 2014, PEDIATR CLIN N AM, V61, P621, DOI 10.1016/j.pcl.2014.03.010; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Moller A. R, 2000, HEARING ITS PHYSL PA; MOLLER AR, 1983, EXP NEUROL, V80, P633, DOI 10.1016/0014-4886(83)90313-8; Moussavi Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41923-6; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; OHTSUKA K, 1988, AM J OPHTHALMOL, V106, P60, DOI 10.1016/S0002-9394(14)76389-5; Pallus AC, 2018, J NEUROPHYSIOL, V119, P585, DOI 10.1152/jn.00193.2017; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rambold H, 2004, NEUROLOGY, V62, P1850, DOI 10.1212/01.WNL.0000125331.95849.62; Reeves SR, 2016, DISORD NERV SYST, P1; Samadani Uzma, 2016, Concussion, V1, pCNC2, DOI 10.2217/cnc.15.2; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; SCHILLER PH, 1980, J NEUROPHYSIOL, V44, P1175, DOI 10.1152/jn.1980.44.6.1175; Searle A, 2016, NEURO-OPHTHALMOLOGY, V40, P209, DOI 10.1080/01658107.2016.1217028; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Squire L, 2013, FUNDAMENTAL NEUROSCI; Squire R, 2012, SCHOLARPEDIA, V7, P5341, DOI [10.4249/scholarpedia.5341, DOI 10.4249/SCHOLARPEDIA.5341]; Suleiman A, 2015, IEEE ENG MED BIO, P3375, DOI 10.1109/EMBC.2015.7319116; Suleiman A, 2019, APPL ELECTROVESTIBUL; Suleiman A, 2019, J MED BIOL ENG, V39, P218, DOI 10.1007/s40846-018-0405-y; Suleiman A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32808-1; Suleiman A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15487-2; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Taghdiri F, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000286; Tyler CW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00173; VAINA LM, 1989, BIOL CYBERN, V61, P347, DOI 10.1007/BF00200800; Van Horn MR, 2013, J NEUROSCI, V33, P7274, DOI 10.1523/JNEUROSCI.2268-12.2013; WALLS GL, 1962, VISION RES, V2, P69, DOI 10.1016/0042-6989(62)90064-0	68	3	4	1	8	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	0165-8107	1744-506X		NEURO-OPHTHALMOLOGY	Neuro-Ophthalmol.	MAY 3	2020	44	3					157	167		10.1080/01658107.2019.1653325		SEP 2019	11	Clinical Neurology; Ophthalmology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Ophthalmology	LT6ZJ	WOS:000490554200001	32395167	Green Published			2022-02-06	
J	Richey, LN; Rao, V; Roy, D; Narapareddy, BR; Wigh, S; Bechtold, KT; Sair, HI; Van Meter, TE; Falk, H; Leoutsakos, JM; Yan, HJ; Lyketsos, CG; Korley, FK; Peters, ME				Richey, Lisa N.; Rao, Vani; Roy, Durga; Narapareddy, Bharat R.; Wigh, Shreya; Bechtold, Kathleen T.; Sair, Haris, I; Van Meter, Timothy E.; Falk, Hayley; Leoutsakos, Jeannie-Marie; Yan, Haijuan; Lyketsos, Constantine G.; Korley, Frederick K.; Peters, Matthew E.			Age differences in outcome after mild traumatic brain injury: results from the HeadSMART study	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Mild traumatic brain injury; mTBI; age differences; older adults; outcomes research	OLDER-ADULTS; HEAD-INJURY; ELDERLY-PATIENTS; DEPRESSION; MORTALITY; VALIDITY; RISK	This study longitudinally examined age differences across multiple outcome domains in individuals diagnosed with acute mild traumatic brain injury (mTBI). A sample of 447 adults meeting VA/DoD criteria for mTBI was dichotomized by age into older (>= 65 years; n = 88) and younger (n = 359) sub-groups. All participants presented to the emergency department within 24 hours of sustaining a head injury, and outcomes were assessed at 1-, 3-, and 6-month intervals. Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9), post-concussive symptoms (PCS) were ascertained with the Rivermead Post-Concussion Questionnaire (RPQ), and functional recovery from the Extended Glasgow Outcome Scale (GOSE). Mixed effects logistic regression models showed that the rate of change over time in odds of functional improvement and symptom alleviation did not significantly differ between age groups (p = 0.200-0.088). Contrary to expectation, older adults showed equivalent outcome trajectories to younger persons across time. This is a compelling finding when viewed in light of the majority opinion that older adults are at risk for significantly worse outcomes. Future work is needed to identify the protective factors inherent to sub-groups of older individuals such as this.	[Richey, Lisa N.; Rao, Vani; Roy, Durga; Narapareddy, Bharat R.; Leoutsakos, Jeannie-Marie; Yan, Haijuan; Lyketsos, Constantine G.; Peters, Matthew E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Wigh, Shreya] Univ New Mexico, Albuquerque, NM 87131 USA; [Bechtold, Kathleen T.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Sair, Haris, I] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Van Meter, Timothy E.] ImmunArray Inc, Program Neurol Dis, Richmond, VA USA; [Falk, Hayley] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Korley, Frederick K.] Univ Michigan, Sch Med, Dept Emergency Med, North Campus Res Complex,026-333N2800 Plymouth Rd, Ann Arbor, MI 48105 USA		Korley, FK (corresponding author), Univ Michigan, Sch Med, Dept Emergency Med, North Campus Res Complex,026-333N2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	korley@med.umich.edu		Richey, Lisa/0000-0001-8050-1240			Abdulle AE, 2018, J HEAD TRAUMA REHAB, V33, pE59, DOI 10.1097/HTR.0000000000000368; Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jaoda A., 2008, ANN EMERG MED, V52, P14; JENNETT B, 1975, LANCET, V1, P480; Kansagara D., 2013, COMPLICATIONS MILD T; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Peters ME, 2018, BRAIN INJURY, V32, P1725, DOI 10.1080/02699052.2018.1520301; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; StataCorp, 2013, STATA STAT SOFTW REL; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Yu F, 2005, J NURS SCHOLARSHIP, V37, P229, DOI 10.1111/j.1547-5069.2005.00040.x	32	3	3	2	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		22	30		10.1080/09540261.2019.1657076		SEP 2019	9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000487509500001	31549522				2022-02-06	
J	Moran, RN; Meek, J; Allen, J; Robinson, J				Moran, Ryan N.; Meek, Jeff; Allen, Jeff; Robinson, James			Sex differences and normative data for the m-CTSIB and sensory integration on baseline concussion assessment in collegiate athletes	BRAIN INJURY			English	Article						Concussion; balance; postural stability; vestibular	ERROR SCORING SYSTEM; POSTURAL STABILITY; NEUROCOGNITIVE PERFORMANCE; RISK-FACTORS; BALANCE; SPORT; RELIABILITY; SYMPTOMS; AGE	Primary objective: To investigate sex differences on baseline m-CTSIB and sensory integration function between male and female collegiate athletes and develop preliminary normative data for this population. Methods and procedures: Baseline data were retrospectively analyzed for 591 National Collegiate Athletic Association (NCAA) athletes between 2015 and 2018 on the modified Clinical Test for Sensory Interaction and Balance (m-CTSIB). A series of Mann-Whitney U tests were conducted to determine sex differences on m-CTSIB and individual sensory integration performance. Main outcomes and results: Female athletes performed significantly better than male athletes on baseline m-CTSIB composite scores (p < .001). Females also performed better on the eyes open-firm surface (p < .001), eyes closed-firm surface (p = .001), eyes open-foam surface (p < .001), and eyes closed-foam surface (p = .001) tasks as compared to male athletes. Conclusions: Male and female athletes exhibit differences on baseline m-CTSIB and sensory integration test performance. The m-CTSIB normative data are presented for the total sample and by sex. These normative data provide a frame of reference for interpreting m-CTSIB performance in collegiate athletes as part of concussion assessment.	[Moran, Ryan N.; Meek, Jeff; Allen, Jeff; Robinson, James] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL 35487 USA		Moran, RN (corresponding author), Univ Alabama, 478 Russell Hall,Box 870311, Tuscaloosa, AL 35487 USA.	rnmoran@ua.edu					Anderson SL, 2019, CLIN J SPORT MED, V29, P413, DOI 10.1097/JSM.0000000000000545; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brett BL, 2020, CLIN J SPORT MED, V30, P458, DOI 10.1097/JSM.0000000000000632; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Linder SM, 2018, MED SCI SPORT EXER, V50, P1998, DOI 10.1249/MSS.0000000000001660; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2019, J ATHL TRAINING, V54, P445, DOI 10.4085/1062-6050-220-18; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mummareddy N, 2020, CLIN J SPORT MED, V30, P451, DOI 10.1097/JSM.0000000000000626; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Pawlowski B, 2003, AM J HUM BIOL, V15, P144, DOI 10.1002/ajhb.10136; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Skibba K, 2013, RESEARCH PERSPECTIVES AND BEST PRACTICES IN EDUCATIONAL TECHNOLOGY INTEGRATION, P1, DOI 10.4018/978-1-4666-2988-2.ch001; Smith AW, 2012, J HUM KINET, V33, P25, DOI 10.2478/v10078-012-0041-5; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Whitney SL, 1998, AM J OCCUP THER, V52, P666, DOI 10.5014/ajot.52.8.666; Zajac FE., 1993, PROG BRAIN RES, P349; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	31	3	3	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					20	25		10.1080/02699052.2019.1669824		SEP 2019	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000487312800001	31542961				2022-02-06	
J	Hoffman, H; Jalal, MS; Chin, LS				Hoffman, Haydn; Jalal, Muhammad S.; Chin, Lawrence S.			The risk factors, outcomes, and costs associated with venous thromboembolism after traumatic brain injury: a nationwide analysis	BRAIN INJURY			English	Article						Traumatic brain injury; venous thromboembolism; venous thrombosis; pulmonary embolism	INTRACRANIAL HEMORRHAGE; MORTALITY; CHEMOPROPHYLAXIS; EPIDEMIOLOGY; IMPACT	Objective: We sought to identify risk factors for VTE following traumatic brain injury (TBI) and determine how venous thromboembolism (VTE) affects outcomes and costs using a national database. Methods: The Nationwide Inpatient Sample (NIS) was used to identify patients with TBI between 2002 and 2014. VTE was identified as any occurrence of deep venous thrombosis or pulmonary embolism. We investigated putative risk factors for VTE and determined the effect of VTE on outcomes including mortality and disposition. Results: 424,929 patients met the inclusion criteria. There were 16,690 (3.9%) patients who developed a VTE. The annual incidence of VTE increased from 2.2% in 2002 to 5.4% in 2014 (R-2 = 0.992, p < .001). Older age, increasing number of comorbidities, craniotomy or craniectomy, and more severe injuries were associated with increased odds of developing VTE (p < .001 for all). Patients with VTE had decreased odds of in-hospital mortality (OR 0.53; 95% CI 0.50-0.57) and increased odds of non-routine disposition (OR 2.05; 95% CI 1.97-2.14), tracheostomy, and gastrostomy. Conclusion: To our knowledge, we provide the largest analysis of VTE in TBI. This entity appears to be increasing in frequency, which may merit new strategies for prevention.	[Hoffman, Haydn; Jalal, Muhammad S.; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA.	hoffmanh@upstate.edu		Hoffman, Haydn/0000-0002-2967-6528			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cucchiara BL, 2004, CRIT CARE MED, V32, P241, DOI 10.1097/01.CCM.0000104113.36384.81; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Foreman PM, 2014, CLIN NEUROL NEUROSUR, V123, P109, DOI 10.1016/j.clineuro.2014.05.017; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Grosse SD, 2016, THROMB RES, V137, P3, DOI 10.1016/j.thromres.2015.11.033; Harris DA, 2014, J NEUROSURG-PEDIATR, V13, P448, DOI 10.3171/2014.1.PEDS13479; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Hoffman H, 2018, WORLD NEUROSURG, V118, pE880, DOI 10.1016/j.wneu.2018.07.089; Kim KS, 2009, NEUROCRIT CARE, V11, P28, DOI 10.1007/s12028-009-9201-4; Kornblith LZ, 2015, J TRAUMA ACUTE CARE, V78, P30, DOI 10.1097/TA.0000000000000490; Kshettry VR, 2014, J CLIN NEUROSCI, V21, P282, DOI 10.1016/j.jocn.2013.07.003; Lai JM, 1997, BRAIN INJURY, V11, P331, DOI 10.1080/026990597123485; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCutcheon BA, 2015, J NEUROSURG, V123, P406, DOI 10.3171/2015.3.JNS131356; Meizoso JP, 2017, J SURG RES, V207, P138, DOI 10.1016/j.jss.2016.08.072; Ogunlade J, 2018, CUREUS, V10, DOI 10.7759/cureus.3042; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; Proctor MC, 2006, J TRAUMA, V60, P147, DOI 10.1097/01.ta.0000197180.79965.bc; Ray WZ, 2009, J NEUROSURG, V110, P1010, DOI 10.3171/2008.9.JNS08107; Samuel AM, 2018, SPINE, V43, P1289, DOI 10.1097/BRS.0000000000002634; Sanches Jose Eduardo Arantes, 2012, Open Orthop J, V6, P590, DOI 10.2174/1874325001206010590; Seifi A, 2018, J CLIN NEUROSCI, V57, P46, DOI 10.1016/j.jocn.2018.08.042; Semrad TJ, 2007, J NEUROSURG, V106, P601, DOI 10.3171/jns.2007.106.4.601; Senders JT, 2018, J NEURO-ONCOL, V136, P135, DOI 10.1007/s11060-017-2631-5; Skaf E, 2005, AM J CARDIOL, V96, P1731, DOI 10.1016/j.amjcard.2005.07.097; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Strollo BP, 2018, J CRIT CARE, V43, P75, DOI 10.1016/j.jcrc.2017.08.012; Sumislawski JJ, 2018, J TRAUMA ACUTE CARE, V85, P907, DOI 10.1097/TA.0000000000002048; Tanweer O, 2013, J NEUROSURG, V119, P1309, DOI 10.3171/2013.7.JNS13313; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; Wagner RH, 1999, J HEAD TRAUMA REHAB, V14, P558, DOI 10.1097/00001199-199912000-00004; Yang Genyan, 2012, Open J Prev Med, V2, P499, DOI 10.4236/ojpm.2012.24069	38	3	3	8	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1671	1678		10.1080/02699052.2019.1667536		SEP 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000486952700001	31526026				2022-02-06	
J	Newman, SD; Grantz, JG; Brooks, K; Gutierrez, A; Kawata, K				Newman, Sharlene D.; Grantz, Jesse G.; Brooks, Kelsie; Gutierrez, Arianna; Kawata, Keisuke			Association between History of Concussion and Substance Use Is Mediated by Mood Disorders	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						alcohol; anxiety; cannabis; concussion; depression; panic disorder	TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; DEPRESSIVE SYMPTOMS; PRIME-MD; SPORTS; COMORBIDITY; PREVALENCE; ALCOHOL; RISK; INDIVIDUALS	Understanding the impact of concussion history on mental health-mood disorders and substance use-is an essential step in characterizing the psychological and behavioral consequences of concussion and in developing effective treatments. The objective of this study was to examine the association between the history of concussion and substance abuse by investigating both its direct and indirect association via mood disorder. A secondary objective was to determine whether gender moderates the association. A comprehensive survey was administered to 4849 college-age adults that assessed history of concussion; depression, anxiety, and panic disorders using the Patient Health Questionnaire (PHQ); and substance use using the Alcohol Use Disorders Identification Test (AUDIT) (alcohol) and Cannabis Use Disorders Identification Test-Revised (CUDIT) (cannabis). Regression models were used to examine the association between concussion history and substance use. Mood disorders were entered into the model as mediators and gender as a moderator variable. Those with a history of concussion had higher panic, AUDIT, and CUDIT scores than those with no history of concussion, and AUDIT and CUDIT scores showed an interaction between concussion history and gender. The regression models revealed significant direct and indirect (via depression and panic disorder) effects of concussion history on alcohol and cannabis use, which was moderated by gender. Concussion can have long-term psychological consequences and appears to affect both mood and substance use. The results presented demonstrate that the relationship between concussion and substance use is complex with mood disorder mediating the effect.	[Newman, Sharlene D.; Grantz, Jesse G.; Brooks, Kelsie; Gutierrez, Arianna] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Newman, Sharlene D.; Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN USA; [Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA		Newman, SD (corresponding author), Indiana Univ, Coll Arts & Sci, Dept Psychol & Brain Sci, 1101 E 10th St, Bloomington, IN 47405 USA.	sdnewman@indiana.edu			Indiana Clinical and Translational Sciences Institute - National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR002529]	This publication was funded by the Indiana Clinical and Translational Sciences Institute, funded in part by grant #UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson SJ, 2010, DRUG ALCOHOL DEPEN, V110, P137, DOI 10.1016/j.drugalcdep.2010.02.017; Alcock Bradey, 2018, Addict Behav Rep, V7, P58, DOI 10.1016/j.abrep.2018.02.001; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Bersani G, 2016, EUR REV MED PHARMACO, V20, P547; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P45; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davis LL, 2005, COMPR PSYCHIAT, V46, P81, DOI 10.1016/j.comppsych.2004.07.025; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hayes A.F., 2017, INTRO MEDIATION MODE; Hutchison MG, 2018, INT J PSYCHOPHYSIOL, V132, P55, DOI 10.1016/j.ijpsycho.2017.11.006; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khadrawy YA, 2017, BEHAV BRAIN RES, V324, P41, DOI 10.1016/j.bbr.2017.02.015; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Martin R, 2018, ENV DES GUIDE, P1; Martin RJ, 2018, SUBST USE MISUSE, V53, P446, DOI 10.1080/10826084.2017.1334068; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McHugh RK, 2018, CLIN PSYCHOL REV, V66, P12, DOI 10.1016/j.cpr.2017.10.012; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; McVige J., 2018, NEUROLOGY, DOI [10.1212/01.wnl.0000550692.23055, DOI 10.1212/01.WNL.0000550692.23055]; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152118; Morales D., 2007, BRAIN CONTUSION IMAG; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Scheutzow MH, 1999, BRAIN INJURY, V13, P705; Seney ML, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0017-3; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; Zilberman ML, 2003, CAN J PSYCHIAT, V48, P5, DOI 10.1177/070674370304800103	47	3	3	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6550		SEP 2019	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IZ0OK	WOS:000486790100001	31359826	Green Published			2022-02-06	
J	Kavi, T; Abdelhady, A; DeChiara, J; Lubas, E; Abdelhady, K; Daci, R; Roman, JS; Patel, UK				Kavi, Tapan; Abdelhady, Ahmed; DeChiara, James; Lubas, Emily; Abdelhady, Khodeja; Daci, Rrita; Roman, Janika San; Patel, Urvish K.			Association of Patterns of Mild Traumatic Brain Injury with Neurologic Deterioration: Experience at a Level I Trauma Center	CUREUS			English	Article						mild traumatic brain injury; neurologic deterioration; glasgow coma score; subdural hematoma; contusion; subarachnoid hemorrhage	REPEAT HEAD CT; SUBARACHNOID HEMORRHAGE; CLINICAL-SIGNIFICANCE; PROGRESSION; TRIAGE	Introduction: There are about 2.5 million emergency room visits for traumatic brain injury (TBI) every year and 75%-95% of all TBI patients have mild TBI. Previous studies have suggested that a large proportion of mild TBI patients can be treated in a non-aggressive manner, but they have not differentiated mild TBI as per radiological patterns to help in the selection of these patients. Our study aimed to identify different patterns of mild TBI to determine if certain injuries make patients more prone to neurologic worsening than others, and thus require more intensive monitoring. We also studied the factors associated with neurologic deterioration. Methods: We conducted a retrospective study using an institutional trauma database to identify TBI patients between the years of 2015 and 2016 with admission Glasgow Coma Score (GCS) of 13 to 15, through chart review by the investigators. Radiological and neurological worsening was determined through computed tomography (CT) scan results, GCS scores, and the requirement for neurosurgical intervention. We identified the prevalence of demographic characteristics, radiological patterns, and risk factors. We studied neurologic deterioration (decline in GCS to less than 13 at 48 hours or earlier after admission) and surgical intervention among patients with different radiological patterns of TBI. We further studied the cohort of isolated subdural hematoma (SDH) patients requiring surgery to evaluate the associated risk factors. Results: Out of 374 patients with mild TBI (mean age was 63 years), 59% were male, 77% were Caucasian, the median GCS was 15, majority of patients had isolated SDH (45%), and mixed pattern of hemorrhage (39%); the use of antiplatelet (33%) was the most commonly identified risk factors. Overall 7% of patients were found to have neurologic deterioration (GCS to less than 13) and 9% required surgical intervention at 48 hours or earlier after admission. The most common pattern of TBI requiring surgical intervention was isolated SDH (85%). Among the cohort of patients with isolated SDH, 17% required surgical intervention and 69% of those isolated SDH patients requiring surgery had neurologic deterioration. The most common risk factor in isolated SDH patients requiring surgery was antiplatelet use (34%), anticoagulant use (20%), alcohol abuse (17%), severe renal failure (17%), and thrombocytopenia (7%). Mean size of SDH in patients requiring surgery was 1.6 cm with 0.8 cm of midline shift. Conclusion: This study identified the pattern of mild TBI associated with neurological worsening at our Level I Trauma Center. Among patients with mild TBI, SDH patients seem to be at highest risk for deterioration and requirement for surgery. If these results can be externally validated through a multi-center study, these patients could be selectively identified for aggressive monitoring in the intensive care unit (ICU) and repeat CT scans.	[Kavi, Tapan] Cooper Univ Hosp, Neurol, Cooper Neurol Inst, Camden, NJ USA; [Abdelhady, Ahmed; DeChiara, James; Lubas, Emily] Rowan Univ, Neurol, Cooper Med Sch, Camden, NJ USA; [Abdelhady, Khodeja] Washington Univ Hlth & Sci, Internal Med, San Pedro, Brazil; [Daci, Rrita] Univ Massachusetts, Neurosurg, Worcester, MA 01605 USA; [Roman, Janika San] Cooper Univ Hosp, Trauma, Camden, NJ USA; [Patel, Urvish K.] Icahn Sch Med Mt Sinai, Neurol, New York, NY 10029 USA		Patel, UK (corresponding author), Icahn Sch Med Mt Sinai, Neurol, New York, NY 10029 USA.	dr.urvish.patel@gmail.com		Patel, Urvish/0000-0002-6702-298X			af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Albertine P, 2016, AM J EMERG MED, V34, P521, DOI 10.1016/j.ajem.2015.12.035; Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; [Anonymous], 2019, CDC RELEASES GUIDELI; [Anonymous], 2014, TRIAGE ASSESSMENT IN; [Anonymous], 2019, TBI RELATED EMERGENC; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Rosen CB, 2018, J TRAUMA ACUTE CARE, V3; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	19	3	3	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 17	2019	11	9							e5677	10.7759/cureus.5677			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	IY1JD	WOS:000486147700001	31723486	Green Published, gold			2022-02-06	
J	Kokhan, VS; Anokhin, PK; Belov, OV; Gulyaev, MV				Kokhan, Viktor S.; Anokhin, Petr K.; Belov, Oleg, V; Gulyaev, Mikhail, V			y Cortical Glutamate/GABA Imbalance after Combined Radiation Exposure: Relevance to Human Deep-Space Missions	NEUROSCIENCE			English	Article						ionizing radiation; carbon nuclei; glutamate; GABA; anxiety; spatial learning	TRAUMATIC BRAIN-INJURY; IONIZING-RADIATION; MEMORY FORMATION; HIPPOCAMPAL NEUROGENESIS; MONOAMINE METABOLISM; SYNAPTIC PLASTICITY; RECEPTOR SUBUNITS; SPATIAL MEMORY; HZE PARTICLES; MICE LACKING	Ionizing radiation (IR) is one of the major biological limiting factors of human deep-space missions. Despite the dominant paradigm about the negative effects of IR on the CNS, the anxiolytic, antidepressant, anti-aggressive, and pro-cognitive effects have recently been discovered. The mechanisms of these phenomena remain undisclosed. Here, we study the effects of combined IR exposure (gamma-rays and C-12 nuclei) on the psychoemotional state, cognitive abilities, and the metabolism of glutamate and GABA in Wistar rats, with an emphasis on the age factor. Irradiation resulted in the anxiogenic effect, reversing during maturation, and the sustained increase in spatial learning performance. A persistent decrease in the content of GABA was observed, which confirmed the hypothesis of disinhibition of the CNS under irradiation with moderate doses, proposed earlier. Glutamate/GABA imbalance was accompanied by an increase in the metabolism of these neurotransmitters: an increase in expression level of GLT-1, GAD65, GABAT and GAT1. Besides, a decrease in the expression level of NR1 subunit of the NMDA receptor was noted. Notably, the maturation of rats led not only to the rebalancing of the glutamate/GABA ratio by reducing the glutamate content, but also to leveling the differences in the expression levels of the analyzing biomolecules. Thus, the combined action of IR at moderate doses resulted in long-term changes in psycho-emotional status and, surprisingly, an increase in the efficiency of spatial learning performance. We suggest that IR (within the range of composition and doses used) can be relatively safe for the functions of the CNS. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kokhan, Viktor S.; Anokhin, Petr K.] VP Serbsky Fed Med Res Ctr Psychiat & Narcol, Moscow, Russia; [Belov, Oleg, V] Joint Inst Nucl Res, Dubna, Russia; [Gulyaev, Mikhail, V] Moscow MV Lomonosov State Univ, Moscow, Russia		Kokhan, VS (corresponding author), Fed Med Res Ctr Psychiat & Narcol, Malyi Mogiltsevskii Pereulok 3, Moscow 123007, Russia.	viktor_kohan@hotmail.com	Kokhan, Viktor S/E-9478-2017; Anokhin, Petr/F-4026-2017; Belov, Oleg V./E-8961-2017; Belov, Oleg/AAD-6691-2020; Gulyaev, Mikhail/A-6163-2014	Kokhan, Viktor S/0000-0002-5512-4356; Anokhin, Petr/0000-0002-7974-5077; Belov, Oleg V./0000-0002-9429-3793; Belov, Oleg/0000-0002-9429-3793; Gulyaev, Mikhail/0000-0003-4684-2484	RFBRRussian Foundation for Basic Research (RFBR) [17-04-00598]	The study was funded by the RFBR, the research projects no. 17-04-00598.	ABUELFAILAT RR, 1983, RADIAT RES, V93, P62; Arias-Carrion Oscar, 2010, Int Arch Med, V3, P24, DOI 10.1186/1755-7682-3-24; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Balentova S, 2015, INT J MOL SCI, V16, P27796, DOI 10.3390/ijms161126068; Belov OV, 2016, PHYS MEDICA, V32, P1088, DOI 10.1016/j.ejmp.2016.08.006; Belov OV, 2015, J THEOR BIOL, V366, P115, DOI 10.1016/j.jtbi.2014.09.024; Belyaeva AG, 2017, NEUROCHEM J+, V11, P168, DOI 10.1134/S1819712417010032; Bevelacqua J J, 2018, J Biomed Phys Eng, V8, P153; Blaszczyk JW, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00269; Budd JML, 2005, P ROY SOC B-BIOL SCI, V272, P101, DOI 10.1098/rspb.2004.2927; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cacao E, 2016, RADIAT RES, V186, P624, DOI 10.1667/RR14569.1; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; CHA Y, 1989, SCIENCE, V243, P1325, DOI 10.1126/science.2646716; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Chiapponi C, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00061; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Dieb W, 2015, EUR J PAIN, V19, P85, DOI 10.1002/ejp.525; Eom HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147538; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Feijo FD, 2011, REV ASSOC MED BRAS, V57, P74, DOI 10.1590/S0104-42302011000100020; Finlay JM, 2015, BRAIN RES, V1600, P70, DOI 10.1016/j.brainres.2014.10.037; Fuss J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012769; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gong X, 2015, EXP THER MED, V10, P653, DOI 10.3892/etm.2015.2577; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Haley GE, 2013, RADIAT RES, V179, P590, DOI 10.1667/RR2946.1; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hassler DM, 2014, SCIENCE, V343, DOI 10.1126/science.1244797; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hsu WL, 2014, NEUROPSYCHOPHARMACOL, V39, P746, DOI 10.1038/npp.2013.263; Jewell JS, 2018, RADIAT RES, V190, P565, DOI 10.1667/RR15085.1; Jinno S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.013.2009; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Klinman JP, 2013, ANNU REV BIOCHEM, V82, P471, DOI 10.1146/annurev-biochem-051710-133623; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kokhan VS, 2019, BEHAV BRAIN RES, V362, P311, DOI 10.1016/j.bbr.2019.01.024; Kokhan VS, 2017, BEHAV BRAIN RES, V320, P473, DOI 10.1016/j.bbr.2016.10.032; Kokhan VS, 2019, LIFE SCI SPACE RES, V20, P12, DOI 10.1016/j.lssr.2018.11.003; Kokhan VS, 2016, NEUROSCI BIOBEHAV R, V71, P621, DOI 10.1016/j.neubiorev.2016.10.006; Kolata SM, 2018, NEUROPSYCHOPHARMACOL, V43, P1445, DOI 10.1038/npp.2017.296; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lazarev A O, 2011, Aviakosm Ekolog Med, V45, P54; Letzkus JJ, 2015, NEURON, V88, P264, DOI 10.1016/j.neuron.2015.09.024; Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4; Lonart G, 2012, RADIAT RES, V178, P289, DOI 10.1667/RR2862.1; Machida M, 2010, RADIAT RES, V174, P618, DOI 10.1667/RR1988.1; Marty VN, 2014, RADIAT RES, V182, P653, DOI 10.1667/RR13647.1; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; Miyachi Y, 1996, BEHAV BRAIN RES, V81, P135, DOI 10.1016/S0166-4328(96)89076-0; Parihar VK, 2018, EXP NEUROL, V305, P44, DOI 10.1016/j.expneurol.2018.03.009; Parihar VK, 2015, ANTIOXID REDOX SIGN, V22, P78, DOI 10.1089/ars.2014.5929; Park Y, 2013, J CEREBR BLOOD F MET, V33, P1642, DOI 10.1038/jcbfm.2013.121; PARKER BR, 1971, CHEM PHYS LETT, V8, P94, DOI 10.1016/0009-2614(71)80586-9; Pecaut MJ, 2004, RADIAT RES, V162, P148, DOI 10.1667/RR3205; Peissner W, 1999, MOL BRAIN RES, V71, P61, DOI 10.1016/S0169-328X(99)00170-9; Pooters T, 2015, BRAIN RES, V1621, P294, DOI 10.1016/j.brainres.2015.01.015; Povysheva NV, 2016, NEUROBIOL DIS, V96, P75, DOI 10.1016/j.nbd.2016.08.006; Qume M, 1997, BRIT J PHARMACOL, V122, P539, DOI 10.1038/sj.bjp.0701383; Raber J, 2014, RADIAT RES, V181, P362, DOI 10.1667/RR13347.1; Rabin BM, 2007, RADIAT ENVIRON BIOPH, V46, P173, DOI 10.1007/s00411-006-0071-2; Rabin BM, 2011, ADV SPACE RES, V48, P370, DOI 10.1016/j.asr.2011.03.008; RABIN BM, 1994, ADV SPACE RES, V14, P457, DOI 10.1016/0273-1177(94)90500-2; Regue-Guyon M, 2018, PROG MOL BIOL TRANSL, V158, P159, DOI 10.1016/bs.pmbts.2018.03.002; Rice OV, 2009, RADIAT ENVIRON BIOPH, V48, P215, DOI 10.1007/s00411-009-0220-5; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Rosas-Vidal LE, 2014, NEUROPSYCHOPHARMACOL, V39, P2161, DOI 10.1038/npp.2014.64; Sajja BR, 2009, NEUROIMAG CLIN N AM, V19, P45, DOI 10.1016/j.nic.2008.08.002; Sanchez MC, 2010, RADIAT RES, V174, P669, DOI 10.1667/RR2106.1; Sanchez MC, 2009, RADIAT RES, V171, P41, DOI 10.1667/RR1361.1; Sharma NK, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00134; Shi L, 2008, INT J RADIAT ONCOL, V71, P526, DOI 10.1016/j.ijrobp.2008.02.015; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Shtemberg A S, 2013, Aviakosm Ekolog Med, V47, P54; Skvortsova VI, 2018, ACTA NATURAE, V4, P54; Tan YF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00059; Tellez R, 2012, NEUROBIOL LEARN MEM, V97, P189, DOI 10.1016/j.nlm.2011.12.002; Trixler F, 2013, CURR ORG CHEM, V17, P1758, DOI 10.2174/13852728113179990083; Vazquez J, 2004, J NEUROPHYSIOL, V92, P2198, DOI 10.1152/jn.00099.2004; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Wang DY, 2007, BEHAV BRAIN RES, V178, P262, DOI 10.1016/j.bbr.2007.01.003; Wu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033200; Xie Y, 2014, PHARMACOL BIOCHEM BE, V126, P181, DOI 10.1016/j.pbb.2014.08.005; Zhukova N. A., 1996, Radiatsionnaya Biologiya Radioekologiya, V36, P371	90	3	5	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 15	2019	416						295	308		10.1016/j.neuroscience.2019.08.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JF4JZ	WOS:000491355300027	31401184				2022-02-06	
J	Putnam, LJ; Willes, AM; Kalata, BE; Disher, ND; Brusich, DJ				Putnam, Lauren J.; Willes, Ashley M.; Kalata, Brooke E.; Disher, Nathaniel D.; Brusich, Douglas J.			Expansion of a fly TBI model to four levels of injury severity reveals synergistic effects of repetitive injury for moderate injury conditions	FLY			English	Article						Traumatic brain injury; TBI; repetitive injury; mortality; geotaxis; Drosophila; injury severity	TRAUMATIC BRAIN-INJURY; COLLABORATING-CENTER; UNITED-STATES; TASK-FORCE; VULNERABILITY; EPIDEMIOLOGY; ASSOCIATION; CONCUSSION; GLIOSIS; AGE	Several million traumatic brain injury (TBI) events are reported in the United States annually. However, mild TBI events often go unreported, and mild and repetitive mild TBI conditions are challenging to model. Fruit flies (Drosophila melanogaster) have gained traction for the study of TBI. The best-characterized fly TBI model is the high-impact trauma (HIT) method. We replicated the HIT method and confirmed several previous findings at the standard level of injury severity. We then expanded upon the HIT model by characterizing mortality across three reduced levels of injury severity. Importantly, we found reduced mortality with reduced injury severity and synergistic effects on mortality in response to repetitive TBI by our moderate injury conditions. Last, we compared moderate, repetitive TBI to a single severe TBI via assessment of the pattern of mortality and geotaxis performance in the 24 h following TBI. We found the number and severity of injuries could result in different patterns of death, while all TBI conditions led to impaired geotaxis compared to uninjured flies at 0.5 h and 6 h post-TBI. Thus, we have extended a well-characterized model of TBI in flies, and shown the utility of this model for making unique insights into TBI across various severities, injury numbers, and time-points post-injury.	[Putnam, Lauren J.; Willes, Ashley M.; Kalata, Brooke E.; Disher, Nathaniel D.; Brusich, Douglas J.] Univ Wisconsin, Human Biol, Coll Sci Engn & Technol, Green Bay, WI 54302 USA		Brusich, DJ (corresponding author), Univ Wisconsin, Human Biol, Coll Sci Engn & Technol, Green Bay, WI 54302 USA.	brusichd@uwgb.edu			Medical College of WisconsinGeneral Electric; University of Wisconsin - Green Bay	This work was supported by University of Wisconsin - Green Bay Start-Up Funds, University of Wisconsin - Green Bay Summer Scholar Grant; Medical College of Wisconsin [N/A]; University of Wisconsin - Green Bay [N/A - Start-Up]; University of Wisconsin - Green Bay [N/A -Summer Scholar].	Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Linderman JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041907; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Podratz JL, 2013, FLY, V7, P187, DOI 10.4161/fly.24789; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	39	3	3	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1933-6934	1933-6942		FLY	Fly	OCT 2	2019	13	1-4					1	11		10.1080/19336934.2019.1664363		SEP 2019	11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP2DC	WOS:000486698600001	31524048	Green Submitted, Bronze, Green Published			2022-02-06	
J	Koo, HW; Oh, M; Kang, HK; Park, YK; Lee, BJ; Han, SR; Yoon, SW; Choi, CY; Sohn, MJ; Lee, CH				Koo, Hae-Won; Oh, Minkyung; Kang, Hyung Koo; Park, Yung Ki; Lee, Byung-Jou; Han, Seong Rok; Yoon, Sang Won; Choi, Chan Young; Sohn, Moon-Jun; Lee, Chae Heuck			High-degree centrum semiovale-perivascular spaces are associated with development of subdural fluid in mild traumatic brain injury	PLOS ONE			English	Article							SMALL VESSEL DISEASE; BASAL GANGLIA; BLOOD-PRESSURE; RISK-FACTORS; HEMATOMA; HYGROMA; AGE	Background Severe centrum semiovale perivascular spaces (CSO-PVSs) are associated with the onset of brain atrophy and dementia. This study explored the relationship between severity of CSO-PVS and development of subdural fluid (SDF) in patients with mild traumatic brain injury (TBI), with the aim of investigating independent radiological risk factors for development of SDF. Methods The study cohort comprised 222 patients with a mean age of 51 years (64.0% men) who presented with mild TBI from January 2013 to November 2016. In this study, mild TBI was defined as a Glasgow Coma Scale (GCS) of. 13, Post-Traumatic Amnesia (PTA) of < 1 day, and Loss of Consciousness (LOC) of < 30 minutes. The severity of CSO-PVS was categorized as low or high-degree. Results Among the 222 enrolled patients, 38 (17.1%) and 90 (40.5%) had high-degree PVS in the basal ganglia (BG) and centrum semiovale, respectively. Compared with patients who did not develop SDF, the mean age of patients who developed SDF was significantly higher (47.41 years versus 60.33 years, P < 0.0001). The incidence of de novo SDF was significantly higher in men than in women (77.8% versus 59.5%, P = 0.0151). Patients who showed SDF on brain computed tomography at admission more frequently developed de novo SDF (68.5% versus 38.1%, P < 0.0001). In multivariate logistic regression analysis of risk factors, high-degree CSO-PVS, male sex, initial SDF on admission, and old age were independently associated with development of de novo SDF after mild TBI. In Cox proportional hazards models of risk factors for SDF-development free survival rate, high-degree CSO-PVS, old age, and initial subdural hemorrhage showed statistically significant differences. Conclusions Our study might help neurosurgeons determine the frequency of brain CT or the duration of follow-up for patients who present with mild TBI with high-degree CSO-PVS.	[Koo, Hae-Won; Park, Yung Ki; Lee, Byung-Jou; Han, Seong Rok; Yoon, Sang Won; Choi, Chan Young; Sohn, Moon-Jun; Lee, Chae Heuck] Inje Univ, Neurosci Radiosurg & Adapt Hybrid Neurosurg Res C, Dept Neurosurg, Ilsan Paik Hosp,Coll Med, Goyang, South Korea; [Oh, Minkyung] Inje Univ, Busan Paik Hosp, Coll Med, Dept Pharmacol, Busan, South Korea; [Oh, Minkyung] Inje Univ, Busan Paik Hosp, Clin Trial Ctr, Busan, South Korea; [Kang, Hyung Koo] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea		Koo, HW (corresponding author), Inje Univ, Neurosci Radiosurg & Adapt Hybrid Neurosurg Res C, Dept Neurosurg, Ilsan Paik Hosp,Coll Med, Goyang, South Korea.	hwkoo@paik.ac.kr		Koo, Hae-Won/0000-0001-7014-3005; Kang, Hyung Koo/0000-0001-9671-0944	Bio & Medical department of Hanmi medical company; Hanmi corporation research fund	This work was funded by the Bio & Medical department of Hanmi medical company. Only H.W.K. received the fund (Hanmi corporation research fund). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahn JH, 2016, J KOREAN NEUROSURG S, V59, P622, DOI 10.3340/jkns.2016.59.6.622; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Berkowitz AL, 2014, NEUROLOGY, V83, P1004, DOI 10.1212/WNL.0000000000000779; Burnett MS, 2014, JAMA NEUROL, V71, P735, DOI 10.1001/jamaneurol.2014.286; Del Brutto OH, 2018, EUR NEUROL, V79, P86, DOI 10.1159/000486308; Del Brutto OH, 2017, ATHEROSCLEROSIS, V267, P34, DOI 10.1016/j.atherosclerosis.2017.10.024; Ding J, 2017, JAMA NEUROL, V74, P1105, DOI 10.1001/jamaneurol.2017.1397; Edlmann E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0881-y; Holl DC, 2018, WORLD NEUROSURG, V116, P402, DOI 10.1016/j.wneu.2018.05.037; Jang SH, 2018, AM J PHYS MED REHAB, V97, P892, DOI 10.1097/PHM.0000000000000996; Ko BS, 2008, J KOREAN NEUROSURG S, V43, P11, DOI 10.3340/jkns.2008.43.1.11; Koo HW, 2016, J NEUROL SCI, V367, P89, DOI 10.1016/j.jns.2016.05.040; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; Liang Y, 2018, J AFFECT DISORDERS, V228, P166, DOI 10.1016/j.jad.2017.11.080; MacLullich AMJ, 2004, J NEUROL NEUROSUR PS, V75, P1519, DOI 10.1136/jnnp.2003.030858; Miyata M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12966-4; OHNO K, 1986, Bulletin of Tokyo Medical and Dental University, V33, P99; OHNO K, 1987, J NEUROL NEUROSUR PS, V50, P1694, DOI 10.1136/jnnp.50.12.1694; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Okada Y, 2002, SURG NEUROL, V57, P405, DOI 10.1016/S0090-3019(02)00720-6; PARK CK, 1994, ACTA NEUROCHIR, V127, P41, DOI 10.1007/BF01808545; Park SH, 2008, J CLIN NEUROSCI, V15, P868, DOI 10.1016/j.jocn.2007.08.003; Potter GM, 2015, CEREBROVASC DIS, V39, P224, DOI 10.1159/000375153; Potter GM, 2015, INT J STROKE, V10, P376, DOI 10.1111/ijs.12054; Riba-Llena I, 2018, STROKE, V49, P1279, DOI 10.1161/STROKEAHA.118.020163; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; Sousa EB, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-5; SPALLONE A, 1989, EUR NEUROL, V29, P18, DOI 10.1159/000116370; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; TANAKA Y, 1987, SURG NEUROL, V27, P353, DOI 10.1016/0090-3019(87)90010-3; Taniguchi D, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0997-9; TEASDALE G, 1974, LANCET, V2, P81; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Yakushiji Y, 2014, NEUROLOGY, V83, P2116, DOI 10.1212/WNL.0000000000001054; Yang S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16358-6; Yang SN, 2017, NEUROL RES, V39, P787, DOI 10.1080/01616412.2017.1324552; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc; Zhang XE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155490; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2019	14	9							e0221788	10.1371/journal.pone.0221788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY3SM	WOS:000486313000045	31483820	Green Published, gold, Green Submitted			2022-02-06	
J	Amissah, J; Agyei-Baffour, P; Badu, E; Agyeman, JK; Badu, ED				Amissah, John; Agyei-Baffour, Peter; Badu, Eric; Agyeman, John Kwaku; Badu, Eunice Darkowaa			The Cost of Managing Occupational Injuries Among Frontline Construction Workers in Ghana	VALUE IN HEALTH REGIONAL ISSUES			English	Article						cost burden; indirect cost; occupational injury; frontline construction workers		Background: The cost burden of occupational injuries has significant effects on the social well-being of workers. Although there seems to be growing evidence on the cost burden on other public health issues, little is known about occupational injuries, especially in low- to middle-income countries including Ghana. Objective: This study, therefore, sought to estimate the cost burden of managing occupational injuries among frontline construction workers. Methods: A prevalence-based cost of illness approach was used to estimate the cost burden of construction injuries. A structured questionnaire was used to collect cost-related data from 640 frontline construction workers. Descriptive statistics were used to estimate direct and indirect cost of injuries using Microsoft Excel and STATA version 14. Results: Overall, a worker spends an average of GHC 104.84 ($24.52) and GHC 180.89 ($42.31) as direct and indirect costs, respectively. Compared with other injuries, fracture had the highest average cost, GHS 343.33 ($80.30), and concussion and internal injury recorded the lowest cost. Also, compared with other trade specialties, carpenters had the highest average cost burden and laborers had the lowest burden. Conclusion: There is high direct and indirect cost for managing occupational injury among construction workers. Advocacy and awareness about workplace insurance and regulatory policies should adequately be strengthened and prioritized through periodic monitoring and evaluations.	[Amissah, John; Agyei-Baffour, Peter; Agyeman, John Kwaku] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Hlth Policy Planning Management & Econ, Kumasi, Ghana; [Badu, Eric] Univ Newcastle, Sch Nursing & Midwifery, Newcastle, NSW, Australia; [Agyeman, John Kwaku] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Internal Audit Dept, Kumasi, Ghana; [Badu, Eunice Darkowaa] Kwame Nkrumah Univ Sci & Technol, Coll Humanities & Social Sci, Dept English, Kumasi, Ghana		Amissah, J (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Hlth Policy Planning Management & Econ, Kumasi, Ghana.	pinnochkio@gmail.com	; Badu, Eric/C-9482-2018	AMISSAH, JOHN/0000-0003-4472-9074; Badu, Eric/0000-0002-0593-3550			Akazili J., 2007, AFR J HLTH SCI, V14, P70; American Cancer Society, CANC FACTS FIG 2011; [Anonymous], 2016, 5 INJ STOR BUILD CON; [Anonymous], 2015, GRAPHIC ONLINE  0725; Asante F.A., 2003, EC BURDEN MALARIA GH; Asante FA, 2005, EC IMPACT BURDDEN MA; Cochran WG., 2007, SAMPLING TECHNIQUES; Dement J M, 1999, Appl Occup Environ Hyg, V14, P97, DOI 10.1080/104732299303269; Ghana Labour Department, 2000, ANN LAB REP, V114, P286; Ghana Statistical Services, 2010, GHAN LAB STAT EC ACT; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Gyedu A, 2015, INJURY PREV, V21, pE71, DOI 10.1136/injuryprev-2013-040950; Hamalainen P, 2006, SAFETY SCI, V44, P137, DOI 10.1016/j.ssci.2005.08.017; Hrymak V, COSTS EFFECTS WORKPL; Institute for Health Metrics and Evaluation, 2016, GHAN; JeffreyCoker F, OPEN DATA KIT IMPLIC; Kudebong M, 2011, Ghana Med J, V45, P135; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Lee S, 2006, CAN J CIVIL ENG, V33, P219, DOI 10.1139/L05-026; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; Leigh JP, 1997, J OCCUP ENVIRON MED, V39, P1170; Leigh JP, 1998, OCCUP HLTH IND MED, V4, P205; Lipscomb Hester J, 2003, Appl Occup Environ Hyg, V18, P479, DOI 10.1080/10473220301422; Mock CN, 2003, ACCIDENT ANAL PREV, V35, P81, DOI 10.1016/S0001-4575(01)00092-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Ostlin P, 2005, B WORLD HEALTH ORGAN, V83, P948; *SAF WORK AUSTR, 2013, WORK REL INJ FAT INV; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Takala J, 2014, J OCCUP ENVIRON HYG, V11, P326, DOI 10.1080/15459624.2013.863131; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Waehrer GM, 2007, ACCIDENT ANAL PREV, V39, P1258, DOI 10.1016/j.aap.2007.03.012; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zaney GD, 2016, PREVENTION OCCUPATIO	35	3	3	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2212-1099			VALUE HEALTH REG ISS	Value Health Reg. Iss.	SEP	2019	19						104	111		10.1016/j.vhri.2019.06.002			8	Health Care Sciences & Services; Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	VJ8WC	WOS:000641760200014	31377654	Bronze			2022-02-06	
J	Baumann, RM; Hamilton-Wright, S; Riley, DL; Brown, K; Hunt, C; Michalak, A; Matheson, FI				Baumann, Rebekah M.; Hamilton-Wright, Sarah; Riley, Dana Lee; Brown, Karen; Hunt, Cindy; Michalak, Alicja; Matheson, Flora I.			Experiences of Violence and Head Injury Among Women and Transgender Women Sex Workers	SEXUALITY RESEARCH AND SOCIAL POLICY			English	Article						Traumatic brain injury; Head injury; Sex work; Transgender; Violence; Women; Qualitative	TRAUMATIC BRAIN-INJURY; HEALTH; RELIABILITY; VALIDITY; STIGMA	Women and transgender women sex workers have similar experiences of housing instability, childhood trauma, and victimization to populations with high rates of traumatic brain injury (TBI), such as people experiencing homelessness and incarceration; yet, there is little research on TBI among sex workers. We conducted a mixed method study using qualitative interviews and the Ohio State University TBI Identification Method to understand experiences of violence and head injury with 10 participants recruited from Elizabeth Fry Toronto. Head injuries which resulted in loss of consciousness, or a change in conscious state, a report of feeling dazed or a gap in memory, were classified as traumatic brain injuries. All other injuries to the head which did not meet these criteria were classified as head injuries. Ninety percent of participants reported at least one lifetime TBI, and all participants reported at least one head injury related to violence in sex work. Findings indicate the need to educate sex workers on the seriousness of head injuries and the importance of treatment. Participants spoke of widespread stigma and discrimination as barriers to care, which may be mitigated by enhanced training with an anti-oppressive framework in the health care sector and in law enforcement. Participants felt that peer support workers could best deliver education and create awareness of TBI among people involved in sex work. The magnitude of violence and TBI in this population indicates the need for future research to determine actual prevalence of TBI and appropriate screening tools combined with educational programs.	[Baumann, Rebekah M.; Hamilton-Wright, Sarah; Matheson, Flora I.] St Michaels Hosp, Ctr Urban Hlth Solut, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Baumann, Rebekah M.] Univ Toronto, Human Biol, 300 Huron St,Room 105, Toronto, ON M5S 3J6, Canada; [Riley, Dana Lee; Brown, Karen] Elizabeth Fry Toronto, 215 Wellesley St East, Toronto, ON M4X 1G1, Canada; [Hunt, Cindy; Matheson, Flora I.] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada; [Hunt, Cindy; Matheson, Flora I.] Univ Toronto, Ctr Criminol & Sociolegal Studies, 155 Coll St, Toronto, ON M5T 3M7, Canada; [Hunt, Cindy; Michalak, Alicja] St Michaels Hosp, Trauma & Neurosurg Program, Head Injury Clin, 30 Bond St, Toronto, ON M5B 1W8, Canada		Matheson, FI (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Matheson, FI (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.; Matheson, FI (corresponding author), Univ Toronto, Ctr Criminol & Sociolegal Studies, 155 Coll St, Toronto, ON M5T 3M7, Canada.	mathesonf@smh.ca		Hamilton-Wright, Sarah/0000-0001-5573-7112			Ackerman R., 2003, S 20 ANN INT FALL C; Amnesty International Canada, 2014, VIOL IND WOM GIRLS C; Bodkin K, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0156-0; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Browne AJ, 2009, NURS PHILOS, V10, P167, DOI 10.1111/j.1466-769X.2009.00406.x; Centers for Disease Control, 2016, TBI GET FACTS; Chabot F., 2012, TOOLBOX WHAT WORKS S; Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davis J., 2004, STREETS TACKLING HOM; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Deering KN, 2011, DRUG ALCOHOL DEPEN, V113, P46, DOI 10.1016/j.drugalcdep.2010.07.007; Ditmore, 2003, REVOLVING DOOR ANAL; Dominelli L, 1996, BRIT J SOC WORK, V26, P153; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fitzgerald Erin., 2015, MEANINGFUL WORK TRAN; Hampton, 2004, CANADIAN WOMAN STUDI, V24, P23; Hudon Eileen, 2011, GARDEN TRUTH PROSTIT; Hughto JMW, 2015, SOC SCI MED, V147, P222, DOI 10.1016/j.socscimed.2015.11.010; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Kubik W., 2009, HUMANITY SOC, V33, P18, DOI 10.1177/016059760903300103; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCarthy B, 2014, ARCH SEX BEHAV, V43, P1379, DOI 10.1007/s10508-014-0281-7; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Muldoon KA, 2015, AIDS CARE, V27, P512, DOI 10.1080/09540121.2014.978732; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Orchard T, 2012, SEX RES SOC POLICY, V9, P350, DOI 10.1007/s13178-012-0097-y; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Schepel E., 2011, COMP STUDY ADULT TRA; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sinha M., 2013, MEASURING VIOLENCE W; Stout M. D., 2001, ABORIGINAL WOMENS HL; Stout M. D., 1998, ABORIGINAL WOMEN CAN; Surratt HL, 2004, CRIME DELINQUENCY, V50, P43, DOI 10.1177/0011128703258875; Topolovec-Vranic J, 2017, J PSYCHIATR RES, V87, P53, DOI 10.1016/j.jpsychires.2016.12.004; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Varcoe C, 2017, RES NURS HEALTH, V40, P237, DOI 10.1002/nur.21795; Young TK, 2003, BMJ-BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419	43	3	3	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1868-9884	1553-6610		SEX RES SOC POLICY	Sex. Res. Soc. Policy	SEP	2019	16	3					278	288		10.1007/s13178-018-0334-0			11	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	IM6KC	WOS:000478100800003					2022-02-06	
J	Bigler, ED; Abildskov, TJ; Eggleston, B; Taylor, BA; Tate, DF; Petrie, JA; Newsome, MR; Scheibel, RS; Levin, H; Walker, WC; Goodrich-Hunsaker, N; Tustison, NJ; Stone, JR; Mayer, AR; Duncan, TD; York, GE; Wilde, EA				Bigler, Erin D.; Abildskov, Tracy J.; Eggleston, Barry; Taylor, Brian A.; Tate, David F.; Petrie, Jo Ann; Newsome, Mary R.; Scheibel, Randall S.; Levin, Harvey; Walker, William C.; Goodrich-Hunsaker, Naomi; Tustison, Nicholas J.; Stone, James R.; Mayer, Andrew R.; Duncan, Timothy D.; York, Gerry E.; Wilde, Elisabeth A.			Structural neuroimaging in mild traumatic brain injury: A chronic effects of neurotrauma consortium study	INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH			English	Article						automated image analysis; cognitive assessment; mild traumatic brain injury; neuroimaging quantification; veterans	BODY-MASS INDEX; COGNITIVE PERFORMANCE; CORTICAL THICKNESS; SERVICE MEMBERS; MRI VOLUMETRY; CARE; BMI; HYPOPITUITARISM; PREDICTORS; SYMPTOMS	Objectives: The chronic effects of neurotrauma consortium (CENC) observational study is a multisite investigation designed to examine the long-term longitudinal effects of mild traumatic brain injury (mTBI). All participants in this initial CENC cohort had a history of deployment in Operation Enduring Freedom (Afghanistan), Operation Iraqi Freedom (Iraq), and/or their follow-on conflicts (Operation Freedom's Sentinel). All participants undergo extensive medical, neuropsychological, and neuroimaging assessments and either meet criteria for any lifetime mTBI or not. These assessments are integrated into six CENC core studies-Biorepository, Biostatistics, Data and Study Management, Neuroimaging, and Neuropathology. Methods: The current study outlines the quantitative neuroimaging methods managed by the Neuroimaging Core using FreeSurfer automated software for image quantification. Results: At this writing, 319 participants from the CENC observational study have completed all baseline assessments including the imaging protocol and tertiary data quality assurance procedures. Conclusions/Discussion: The preliminary findings of this initial cohort are reported to describe how the Neuroimaging Core manages neuroimaging quantification for CENC studies.	[Bigler, Erin D.; Abildskov, Tracy J.; Petrie, Jo Ann] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Abildskov, Tracy J.; Petrie, Jo Ann] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Eggleston, Barry] RTI Int, Biostat & Epidemiol, Durham, NC USA; [Taylor, Brian A.; Walker, William C.] Virginia Commonwealth Univ, Biomed Engn, Richmond, VA USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Newsome, Mary R.; Scheibel, Randall S.; Levin, Harvey; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Newsome, Mary R.; Scheibel, Randall S.; Levin, Harvey; Wilde, Elisabeth A.] Baylor Coll Med, Houston, TX 77030 USA; [Abildskov, Tracy J.; Petrie, Jo Ann; Goodrich-Hunsaker, Naomi; Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Goodrich-Hunsaker, Naomi; Tustison, Nicholas J.; Stone, James R.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Mayer, Andrew R.] Univ New Mexico, Neurol & Brain & Behav Hlth Inst, Albuquerque, NM 87131 USA; [Duncan, Timothy D.] VA Portland Hlth Care Syst, Med Imaging & Radiol, Portland, OR USA; [York, Gerry E.] TBI Imaging & Res, Alaska Radiol Associates, Anchorage, AK USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.; Bigler, ED (corresponding author), Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA.	erin_bigler@byu.edu	; Tate, David/G-5166-2011	TUSTISON, NICHOLAS/0000-0001-9418-5103; Eggleston, Barry/0000-0003-0472-9707; Tate, David/0000-0003-0213-1920	CENC Neuroimaging Core [1I0RX001062, PT120517, I01RX002174]; U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-132-0095]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	CENC Neuroimaging Core, Grant/Award Numbers: 1I0RX001062, PT120517 and I01RX002174; U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium, Grant/Award Number: W81XWH-132-0095; U.S. Army Medical Research and Material Command	Albanese Emiliano, 2017, Alzheimers Dement (Amst), V8, P165, DOI 10.1016/j.dadm.2017.05.007; Arvanitakis Z, 2018, J GERONTOL A-BIOL, V73, P198, DOI 10.1093/gerona/glx152; Astafiev SV, 2016, NEUROIMAGE-CLIN, V11, P10, DOI 10.1016/j.nicl.2016.01.004; Bajaj S, 2018, HUM BRAIN MAPP, V39, P1886, DOI 10.1002/hbm.23951; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; Cifu DX, 2016, BRAIN INJURY, V30, P1397, DOI 10.1080/02699052.2016.1219065; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Czorlich P, 2017, WORLD NEUROSURG, V107, P515, DOI 10.1016/j.wneu.2017.08.010; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; Fedor A, 2013, OBESITY FACTS, V6, P185, DOI 10.1159/000351138; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Garcia-Ptacek S, 2014, EUR J CLIN NUTR, V68, P1204, DOI 10.1038/ejcn.2014.199; Gavriilidou NN, 2015, EUR J CLIN NUTR, V69, P1066, DOI 10.1038/ejcn.2015.73; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greve DN, 2018, NEUROIMAGE, V171, P6, DOI 10.1016/j.neuroimage.2017.12.072; Hagenaars SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02837-3; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kirton JW, 2016, AGING NEUROPSYCHOL C, V23, P253, DOI 10.1080/13825585.2015.1082531; Klose M, 2015, J CLIN MED, V4, P1480, DOI 10.3390/jcm4071480; Lee YM, 2016, PHYSICIAN SPORTSMED, V44, P217, DOI 10.1080/00913847.2016.1216718; LEONARD WR, 1994, AM J HUM BIOL, V6, P77, DOI 10.1002/ajhb.1310060111; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Mills KL, 2016, NEUROIMAGE, V141, P273, DOI 10.1016/j.neuroimage.2016.07.044; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Pereira VH, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00217; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Singh-Manoux A, 2011, ANN NEUROL, V70, P296, DOI 10.1002/ana.22391; Stelmokas J, 2017, J ALZHEIMERS DIS, V60, P1499, DOI 10.3233/JAD-170306; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Trexler ET, 2018, MED SCI SPORT EXER, V50, P684, DOI [10.1249/mss.0000000000001492, 10.1249/MSS.0000000000001492]; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Wang C, 2016, J NEUROL NEUROSUR PS, V87, P754, DOI 10.1136/jnnp-2015-312304; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; West RK, 2015, J ALZHEIMERS DIS, V44, P927, DOI 10.3233/JAD-142049; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Wilde EA, 2016, BRAIN INJURY, V30, P1442, DOI 10.1080/02699052.2016.1219063; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000	58	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8931	1557-0657		INT J METH PSYCH RES	Int. J. Methods Psychiatr. Res.	SEP	2019	28	3							e1781	10.1002/mpr.1781			15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	JH4EK	WOS:000492720900010	31608535	Green Published			2022-02-06	
J	Brungart, DS; Kruger, SE; Kwiatkowski, T; Heil, T; Cohen, J				Brungart, Douglas S.; Kruger, Sarah E.; Kwiatkowski, Tricia; Heil, Thomas; Cohen, Julie			The Effect of Walking on Auditory Localization, Visual Discrimination, and Aurally Aided Visual Search	HUMAN FACTORS			English	Article						dual task; time sharing; task switching; cognition; multisensory integration; sensory and perceptual processes; kinesthesis; proprioception; orientation; balance; virtual environments; simulation; virtual reality	TRAUMATIC BRAIN-INJURY; DUAL-TASK PERFORMANCE; VIRTUAL-REALITY; HEARING-LOSS; AUDIO; FIELD; HEAD; SOUND; INTERFERENCE; SIMULATION	Objective: The present study was designed to examine the impact that walking has on performance in auditory localization, visual discrimination, and aurally aided visual search tasks. Background: Auditory localization and visual search are critical skills that are frequently conducted by moving observers, but most laboratory studies of these tasks have been conducted on stationary listeners who were either seated or standing during stimulus presentation. Method: Thirty participants completed three different tasks while either standing still or while walking at a comfortable self-selected pace on a treadmill: (1) an auditory localization task, where they identified the perceived location of a target sound; (2) a visual discrimination task, where they identified a visual target presented at a known location directly in front of the listener; and (3) an aurally aided visual search task, where they identified a visual target that was presented in the presence of multiple visual distracters either in isolation or in conjunction with a spatially colocated auditory cue. Results: Participants who were walking performed auditory localization and aurally aided visual search tasks significantly faster than those who were standing, with no loss in accuracy. Conclusion: The improved aurally aided visual search performance found in this experiment may be related to enhanced overall activation caused by walking. It is also possible that the slight head movements required may have provided auditory cues that enhanced localization accuracy. Application: The results have potential applications in virtual and augmented reality displays where audio cues might be presented to listeners while walking.	[Brungart, Douglas S.; Kruger, Sarah E.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Kwiatkowski, Tricia; Cohen, Julie] Henry M Jackson Fdn, Bethesda, MD USA; [Heil, Thomas] Keaki Technol, Orlando, FL USA		Brungart, DS (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Mil Audiol & Speech Ctr, Bldg 19,Room 5600,4954 North Palmer Rd, Bethesda, MD 20889 USA.	douglas.s.brungart.civ@mail.mil		Heil, Thomas/0000-0003-4427-4591; Cohen, Julie/0000-0001-6774-9874	Army Medical Research and Material Command Grant [W81XWH-12-2-0068]	This work was completed under Army Medical Research and Material Command Grant W81XWH-12-2-0068. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, the Department of the Navy, the Department of the Air Force, the Department of Defense, nor the U.S. Government.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Bliss JP, 1997, PRESENCE-TELEOP VIRT, V6, P73, DOI 10.1162/pres.1997.6.1.73; Bolia RS, 1999, HUM FACTORS, V41, P664, DOI 10.1518/001872099779656789; Brungart D. S., 1999, Proceedings of the 1999 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics. WASPAA'99 (Cat. No.99TH8452), P171, DOI 10.1109/ASPAA.1999.810877; Brungart DS, 2006, J AUDIO ENG SOC, V54, P32; Duncan MJ, 2016, BEHAV BRAIN RES, V302, P100, DOI 10.1016/j.bbr.2016.01.020; Gilkey R. H., 2007, P HUM FACT ERG SOC A, V51, P1349; Harma A, 2004, J AUDIO ENG SOC, V52, P618; HARTMANN WM, 1983, J ACOUST SOC AM, V74, P1380, DOI 10.1121/1.390163; Helton W.S., 2013, P HUM FACTOR ERGON S, V57, No. 1, P1244, DOI [10.1177/1541931213571276, DOI 10.1177/1541931213571276]; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Kapralos B, 2008, PRESENCE-VIRTUAL AUG, V17, P527, DOI 10.1162/pres.17.6.527; LAU S, 2012, CAN ACOUST, V40, P118; Lau ST, 2016, J AM ACAD AUDIOL, V27, P567, DOI 10.3766/jaaa.15115; Lim J, 2015, GAIT POSTURE, V42, P466, DOI 10.1016/j.gaitpost.2015.07.060; Lu Y, 2010, THESIS; McMorris T, 2000, INT J SPORT PSYCHOL, V31, P66; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Onakomaiya MM, 2017, MIL MED, V182, P128, DOI 10.7205/MILMED-D-16-00054; Pedersen J., 2005, HUMAN FACTORS ERGONO, V98, P2542; Perrett S, 1997, J ACOUST SOC AM, V102, P2325, DOI 10.1121/1.419642; PERROTT DR, 1991, HUM FACTORS, V33, P389, DOI 10.1177/001872089103300402; Perrott DR, 1996, HUM FACTORS, V38, P702, DOI 10.1518/001872096778827260; Romigh GD, 2015, IEEE J-STSP, V9, P943, DOI 10.1109/JSTSP.2015.2421874; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Schwab KA, 2006, NEUROLOGY, V66, pA235; Speigle J. M., 1993, Proceedings IEEE 1993 Symposium on Research Frontiers in Virtual Reality (Cat. No.93TH0585-0), P92, DOI 10.1109/VRAIS.1993.378257; Szturm T, 2013, GAIT POSTURE, V38, P596, DOI 10.1016/j.gaitpost.2013.02.004; Tomporowski PD, 2014, J AGING PHYS ACTIV, V22, P557, DOI [10.1123/japa.2012-0241, 10.1123/JAPA.2012-0241]; Vazquez-Alvarez Y, 2012, PERS UBIQUIT COMPUT, V16, P987, DOI 10.1007/s00779-011-0459-0; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; Weatherless RA, 2013, HUM FACTORS, V55, P285, DOI 10.1177/0018720812453465; Wightman FL, 1999, J ACOUST SOC AM, V105, P2841, DOI 10.1121/1.426899; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; Wolfe J., 2008, VISUAL SEARCH, V3, P3325	35	3	3	1	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0018-7208	1547-8181		HUM FACTORS	Hum. Factors	SEP	2019	61	6					976	991		10.1177/0018720819831092			16	Behavioral Sciences; Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Engineering; Psychology	IN3YK	WOS:000478612100008	30870052	hybrid			2022-02-06	
J	Crocker, LD; Jurick, SM; Thomas, KR; Keller, AV; Sanderson-Cimino, M; Hoffman, SN; Boyd, B; Rodgers, C; Norman, SB; Lang, AJ; Twamley, EW; Jak, AJ				Crocker, Laura D.; Jurick, Sarah M.; Thomas, Kelsey R.; Keller, Amber, V; Sanderson-Cimino, Mark; Hoffman, Samantha N.; Boyd, Briana; Rodgers, Carie; Norman, Sonya B.; Lang, Ariel J.; Twamley, Elizabeth W.; Jak, Amy J.			Mild traumatic brain injury characteristics do not negatively influence cognitive processing therapy attendance or outcomes	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						PTSD; Mild traumatic brain injury; Treatment response; Treatment attendance; Veterans	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; PROLONGED EXPOSURE; POSTCONCUSSION SYNDROME; RECURRENT CONCUSSION; US VETERANS; DSM-IV; PTSD; PREVALENCE; AFGHANISTAN	Some providers have expressed hesitation about the appropriateness of PTSD treatment for veterans with a history of mild traumatic brain injury (mTBI), given concerns that TBI-related sequelae may negatively affect PTSD treatment and/or should be the focus of treatment instead. However, research suggests that those with a history of mTBI can benefit from evidence-based PTSD treatment. To extend these findings, we examined whether specific mTBI injury markers were associated with PTSD treatment attendance and response. Iraq/ Afghanistan-era veterans with PTSD and history of mTBI (N = 88) all received Cognitive Processing Therapy (CPT; either standard CPT without the trauma account or SMART-CPT, a modified version of CPT that included cognitive rehabilitation strategies). Analyses examined whether time since injury, presence of loss of consciousness (LOC) or posttraumatic amnesia (PTA), and number and mechanism of mTBIs were associated with treatment attendance or response. None of the five injury variables examined were associated with number of treatment sessions attended. Multilevel modeling indicated that injury variables did not moderate treatment response (across treatment conditions) in terms of change in PTSD and depression symptoms. There was a three-way interaction showing that individuals who denied ever experiencing LOC exhibited a greater decrease in PTSD and depression symptoms in standard CPT relative to those in the SMART-CPT. Thus, a history of mTBI should not preclude individuals from receiving standard CPT, regardless of injury characteristics. In fact, PTSD treatment should often be a first line of treatment for these veterans, given evidence of a mental health etiology to persistent post-concussive symptoms.	[Crocker, Laura D.; Keller, Amber, V; Hoffman, Samantha N.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Crocker, Laura D.; Jurick, Sarah M.; Norman, Sonya B.; Lang, Ariel J.; Twamley, Elizabeth W.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jurick, Sarah M.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Thomas, Kelsey R.; Norman, Sonya B.; Lang, Ariel J.; Twamley, Elizabeth W.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Sanderson-Cimino, Mark] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Boyd, Briana] Vet Med Res Fdn, San Diego, CA USA; [Rodgers, Carie] PsychArmor Inst, San Diego, CA USA; [Norman, Sonya B.] Natl Ctr PTSD, White River Jct, VT USA		Crocker, LD (corresponding author), 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	laura.crocker@va.gov		Thomas, Kelsey/0000-0003-4277-8876; Hoffman, Samantha/0000-0002-2792-8576; Keller, Amber/0000-0002-2972-784X	Department of Defense awardUnited States Department of Defense [W81XWH-11-1-0641]; VA Rehabilitation RD Service [IK2 RX002459]	Funding for the clinical trial was provided by Department of Defense award W81XWH-11-1-0641. The funding agency had no involvement in the study design, data collection, data analysis, interpretation of data, writing of the report, and in the decision to submit the article for publication. Laura Crocker received salary support during this work from the VA Interprofessional Polytrauma and TBI Fellowship and Career Development Award Number IK2 RX002459 from the VA Rehabilitation R&D Service. Special thanks to Liljana Trenova and Henry Orff. The authors declare no conflict of interest.	Ackland PE, 2019, J AFFECT DISORDERS, V252, P493, DOI 10.1016/j.jad.2019.04.066; American Psychological Association, 2017, CLIN PRACT GUID TREA; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cook JM, 2014, PROF PSYCHOL-RES PR, V45, P136, DOI 10.1037/a0036183; Cook JM, 2013, PSYCHIATRY, V76, P18, DOI 10.1521/psyc.2013.76.1.18; Crawford EF, 2017, J NERV MENT DIS, V205, P140, DOI 10.1097/NMD.0000000000000594; Crocker LD, 2018, BEHAV RES THER, V108, P68, DOI 10.1016/j.brat.2018.07.004; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TRAU; Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Doran JM, 2019, PSYCHIAT QUART, V90, P11, DOI 10.1007/s11126-018-9604-5; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jak A, 2017, CURR TREAT OPTIONS P, V4, P231, DOI [10.1007/s40501-017-0119-8, DOI 10.1007/s40501-017-0119-8]; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Maguen S, 2019, PSYCHIAT RES, V274, P112, DOI 10.1016/j.psychres.2019.02.027; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Osei-Bonsu PE, 2017, J BEHAV HEALTH SER R, V44, P213, DOI 10.1007/s11414-015-9489-0; Ragsdale KA, 2016, J TRAUMA STRESS, V29, P474, DOI 10.1002/jts.22130; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Raza Gina T, 2015, Psychol Trauma, V7, P547, DOI 10.1037/tra0000059; Resick PA, 2017, JAMA PSYCHIAT, V74, P28, DOI 10.1001/jamapsychiatry.2016.2729; Rosen CS, 2019, J ANXIETY DISORD, V62, P53, DOI 10.1016/j.janxdis.2018.11.003; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Sripada RK, 2018, GEN HOSP PSYCHIAT, V54, P12, DOI 10.1016/j.genhosppsych.2018.07.001; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Weathers F.W., 1993, 9 ANN C ISTSS; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Woodard JL, 2017, NEUROPSYCHOLOGY, V31, P1020, DOI 10.1037/neu0000386; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260	61	3	3	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	SEP	2019	116						7	13		10.1016/j.jpsychires.2019.05.022			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	IJ6FC	WOS:000475996500002	31174014	Bronze			2022-02-06	
J	Dise-Lewis, JE; Forster, JE; McAvoy, K; Stearns-Yoder, KA; Bahraini, NH; Laker, SR; Brenner, LA				Dise-Lewis, Jeanne E.; Forster, Jeri E.; McAvoy, Karen; Stearns-Yoder, Kelly A.; Bahraini, Nazanin H.; Laker, Scott R.; Brenner, Lisa A.			The Natural History of Postconcussion Recovery Among High School Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						athletes; concussion; high school; mild traumatic brain injury; recovery	RISK-FACTORS; NECK PAIN; CONCUSSION; SPORTS; PLAY; RETURN; EPIDEMIOLOGY; DEPRESSION; DIZZINESS; SYMPTOMS	Objective: Evaluate postconcussive symptom reporting and recovery. Setting: Public high school. Participants: Unmatched controls (n = 760); students who sustained a sports-related concussion (n = 77); matched controls (gender, grade, sport) (n = 77). Design: Prospective longitudinal cohort study. Outcome measure: Immediate Postconcussion Assessment and Cognitive Testing. Results: At baseline, athletes who went on to sustain concussions were more likely than unmatched controls to be younger (P = .02), male (P = .001), and participate in different sports (P < .0001) such as football (concussed = 52%, unmatched controls = 20%). Differences were also noted regarding a previous history of concussion (P = .045; concussed athletes = 26%; unmatched control athletes = 16%) and lifetime number of concussions (P = .05). At baseline, those whose sustained concussions during the study period were more likely than matched controls to report numbness (P = .01) and concentration problems (P = .01) and more likely than unmatched controls to report dizziness (P = .02), sensitivity to light (P = .01), sensitivity to noise (P = .002), and numbness (P = .02). However, when data were reanalyzed and those with a previous history of concussion were removed, differences between those who sustained concussions during the study period and matched controls were no longer significant; when compared to unmatched controls, sensitivity to light (P = .01) and vision problems (P = .04) remained significant. Among those who sustained concussions, median time to recovery was 6 days (95% confidence interval: 4-9), and 71 out of 77 (92%) recovered by the fourth postinjury evaluation (median: 20 days postinjury). Conclusions: Course and time frame of recovery were variable. Data also suggest that a previous history of concussion may be contributing to baseline symptom reporting and highlight the potential enduring impact of history of concussion on sensorimotor function. However, further research as to whether preinjury measures of sensorimotor function may increase understanding regarding concussion risk is warranted.	[Dise-Lewis, Jeanne E.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Bahraini, Nazanin H.; Laker, Scott R.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Phys Med & Rehabil, Aurora, CO USA; [Dise-Lewis, Jeanne E.; Bahraini, Nazanin H.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Neurol, Aurora, CO USA; [Stearns-Yoder, Kelly A.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Marcus Inst Brain Hlth, Aurora, CO USA; [Forster, Jeri E.; Stearns-Yoder, Kelly A.; Bahraini, Nazanin H.; Brenner, Lisa A.] VHA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 N Wheeling St, Aurora, CO 80045 USA; [McAvoy, Karen] Cherry Creek Sch Dist, Aurora, CO USA; [McAvoy, Karen] Rocky Mt Hosp Children, Denver, CO USA		Brenner, LA (corresponding author), VHA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 N Wheeling St, Aurora, CO 80045 USA.	lisa.2.brenner@ucdenver.edu	Laker, Scott/ABE-7455-2021; Brenner, Lisa A./AAG-2442-2019		Centers for Disease Control and Prevention National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE000394-03]; VHA Rocky Mountain Mental Illness Research Education and Clinical Center; Marcus Institute for Brain Health; University of Colorado Anschutz Medical Campus; Department of Physical Medicine Rehabilitation	This study was funded by the Centers for Disease Control and Prevention National Center for Injury Prevention and Control, R49 CE000394-03, and supported by the VHA Rocky Mountain Mental Illness Research Education and Clinical Center, University of Colorado Anschutz Medical Campus, Department of Physical Medicine& Rehabilitation, and Marcus Institute for Brain Health.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barth JT, 1989, MILD HEAD INJURY, P257; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Manderino LM, 2018, ARCH CLIN NEUROPSYCH, V33, P596, DOI 10.1093/arclin/acx102; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Taylor AM, 2012, CURR OPIN PEDIATR, V24, P717, DOI 10.1097/MOP.0b013e32835a279b; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	35	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		E36	E44		10.1097/HTR.0000000000000469			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100005	30829818				2022-02-06	
J	Drews, JD; Shi, JX; Papandria, D; Wheeler, KK; Sribnick, EA; Thakkar, RK				Drews, Joseph D.; Shi, Junxin; Papandria, Dominic; Wheeler, Krista K.; Sribnick, Eric A.; Thakkar, Rajan K.			Prehospital Versus Trauma Center Glasgow Coma Scale in Pediatric Traumatic Brain Injury Patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Glasgow coma scale; Pediatric; Agreement	HEAD-INJURY; CHILDREN; PERFORMANCE; AGREEMENT; SEVERITY; MODERATE; SCORE	Background: Traumatic brain injury (TBI) is a major source of morbidity and mortality in children. The Glasgow Coma Scale (GCS) can be challenging to calculate in pediatric patients. Our objective was to determine its reproducibility between prehospital providers and pediatric trauma hospital personnel. Materials and methods: The institutional trauma database for a level 1 pediatric trauma center was queried for patients aged <= 18 y who presented with a TBI. Demographics, mechanism, prehospital GCS, and trauma center GCS were collected. Agreement was evaluated with weighted kappa (kappa) coefficients (0 = agreement no better than that expected by chance alone, 1 = perfect agreement). Results: The inclusion criteria were met by 1711 patients, 263 of whom were aged <3 y. Prehospital GCS and trauma center GCS differed in 766 patients (44.8%). Agreement between prehospital GCS and trauma center GCS was moderate for all patients (kappa = 0.61, 95% confidence interval [CI] 0.57-0.64). Agreement was slightly better than chance alone in patients with trauma center GCS between 9 and 12 y (kappa = 0.09, 95% CI 0.03-0.15) and was lower for children aged 0-2 y (kappa = 0.51, 95% CI 0.42-0.61) than for those aged between 3 and 18 y (kappa = 0.63, 95% CI 0.59-0.66). Younger children were more likely to have score differences of at least 3 points (21.3% versus 13.6% of 3- to 18-y-olds, P < 0.001). Conclusions: Prehospital and trauma center GCS scores frequently disagree in children, particularly in TBI patients aged <3 y and those with moderate TBI. Centers should consider the inconsistency of the pediatric GCS when triaging TBI patients. (C) 2019 Elsevier Inc. All rights reserved.	[Drews, Joseph D.; Papandria, Dominic; Sribnick, Eric A.; Thakkar, Rajan K.] Nationwide Childrens Hosp, Dept Surg, Columbus, OH 43205 USA; [Drews, Joseph D.; Thakkar, Rajan K.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Shi, Junxin; Wheeler, Krista K.; Sribnick, Eric A.; Thakkar, Rajan K.] Nationwide Childrens Hosp, Ctr Pediat Trauma Res, Res Inst, Columbus, OH 43205 USA; [Sribnick, Eric A.] Nationwide Childrens Hosp, Dept Neurosurg, Columbus, OH 43205 USA; [Papandria, Dominic] Emory Univ, Sch Med, Dept Surg, 1364 Clifton Rd NE, Atlanta, GA 30322 USA		Thakkar, RK (corresponding author), Nationwide Childrens Hosp, Dept Pediat Surg, 700 Childrens Dr,FOB 6C, Columbus, OH 43205 USA.	Rajan.Thakkar@nationwidechildrens.org	Sribnick, Eric/AAH-6693-2020				Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Cicchetti D. V., 1971, American Journal of EEG Technology, V11, P101; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; DiBrito SR, 2018, J PEDIATR SURG, V53, P1789, DOI 10.1016/j.jpedsurg.2017.12.027; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; McHugh Mary L., 2012, BIOCHEM MEDICA, V22, P282; National Center for Injury Prevention and Control CDC, 2018, 10 LEAD CAUS DEATH A; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; REILLY PL, 1988, CHILD NERV SYST, V4, P30; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81	24	3	3	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2019	241						112	118		10.1016/j.jss.2019.03.038			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IC7EX	WOS:000471137000018	31022676				2022-02-06	
J	Dunn, MS; Beck, B; Simpson, PM; Cameron, PA; Kennedy, M; Maiden, M; Judson, R; Gabbe, BJ				Dunn, Matthew S.; Beck, Ben; Simpson, Pam M.; Cameron, Peter A.; Kennedy, Marcus; Maiden, Matthew; Judson, Rodney; Gabbe, Belinda J.			Comparing the outcomes of isolated, serious traumatic brain injury in older adults managed at major trauma centres and neurosurgical services: A registry-based cohort study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; TBI; Older adult; Trauma systems; Functional outcome	VICTORIA; PATIENT; SCALE; COMA; CARE	Background: The incidence of older adult traumatic brain injury (TBI) is increasing in both high and middle to low-income countries. It is unknown whether older adults with isolated, serious TBI can be safely managed outside of major trauma centres. This registry based cohort study aimed to compare mortality and functional outcomes of older adults with isolated, serious TBI who were managed at specialised Major Trauma Services (MTS) and Metropolitan Neurosurgical Services (MNS). Method: Older adults (65 years and over) who sustained an isolated, serious TBI following a low fall (from standing or <= 1 m) were extracted from the Victorian State Trauma Registry from 2007 to 2016. Multivariable models were fitted to assess the association between hospital designation (MTS vs. MNS) and the two outcomes of interest: in-hospital mortality and functional outcome, adjusting for potential confounders. Functional outcomes were measured using the Glasgow Outcome Scale Extended at six months post-injury. Results: From 2007-2016, there were 1904 older adults who sustained an isolated, serious TBI from a low fall who received definitive care at an MTS (n = 1124) or an MNS (n = 780). After adjusting for confounders, there was no mortality benefit for patients managed at an MTS over an MNS (OR = 0.84; 95% CI: 0.65,1.08; P = 0.17) or improvement in functional outcome six months post-injury (OR = 1.13; 95% CI: 0.94, 1.36; P = 0.21). Conclusion: For older adults with isolated, serious TBI following a low fall, there was no difference in mortality or functional outcome based on definitive management at an MTS or an MNS. This confirms that MNS without the added designation of a major trauma centre are a suitable destination for the management of isolated, serious TBI in older adults. (C) 2019 Elsevier Ltd. All rights reserved.	[Dunn, Matthew S.; Beck, Ben; Simpson, Pam M.; Cameron, Peter A.; Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Kennedy, Marcus] Ambulance Victoria, Adult Retrieval Victoria, Melbourne, Vic, Australia; [Maiden, Matthew] Geelong Univ Hosp, Dept Intens Care, Geelong, Vic, Australia; [Maiden, Matthew] Royal Adelaide Hosp, Dept Intens Care, Adelaide, SA, Australia; [Judson, Rodney] Royal Melbourne Hosp, Dept Gen Surg, Melbourne, Vic, Australia; [Judson, Rodney] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Gabbe, Belinda J.] Swansea Univ, Med Sch, Hlth Data Res UK, Swansea, W Glam, Wales		Dunn, MS (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Emergency & Trauma Res, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	matthew.dunn@monash.edu	Beck, Ben/ABD-5556-2020	Beck, Ben/0000-0003-3262-5956; Dunn, Matthew/0000-0001-6971-5248	Department of Health and Human Services, State Government of Victoria; Transport Accident Commission; Australian Research CouncilAustralian Research Council [DE180100825, FT170100048]; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [545926]	The Victorian State Trauma Registry (VSTR) is a Department of Health and Human Services, State Government of Victoria and Transport Accident Commission funded project. Ben Beck was supported by an Australian Research Council Discovery Early Career Researcher Award Fellowship (DE180100825). Peter Cameron was supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#545926). Belinda Gabbe was supported by an Australian Research Council Future Fellowship (FT170100048).	Aarli JA, 2006, NEUR DIS PUBL HLTH C, P233; Agresti A., 2010, ANAL ORDINAL CATEGOR, V2nd; [Anonymous], 2008, ABBREVIATED INJURY S; Atkin C, 2005, INJURY, V36, P1277, DOI 10.1016/j.injury.2005.05.011; Beck B, 2016, MED J AUSTRALIA, V204, P407, DOI 10.5694/mja15.01369; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gabbe BJ, 2005, ACAD EMERG MED, V12, P751, DOI 10.1197/j.aem.2005.03.527; Guzman JM, 2012, AGEING 21 CENTURY CE; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kaufman EJ, 2018, J AM COLL SURGEONS, V226, P741, DOI 10.1016/j.jamcollsurg.2018.01.055; Kupas DF, 2016, ANN EMERG MED, V68, P744, DOI 10.1016/j.annemergmed.2016.06.017; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prasad GL, 2018, WORLD NEUROSURG, V111, pE221, DOI 10.1016/j.wneu.2017.12.034; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	31	3	3	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2019	50	9					1534	1539		10.1016/j.injury.2019.06.012			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	IV6GN	WOS:000484367000008	31204027				2022-02-06	
J	Fisher, M; Tierney, R; Russ, A; Mansell, J				Fisher, Mindi; Tierney, Ryan; Russ, Anne; Mansell, Jamie			Current Evidence in Management of Concussion Baseline Testing in ADHD and Learning Difficulties Patients: A Critically Appraised Topic	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						adolescent; clinical evaluation; functional performance; neurophysiology	DEFICIT HYPERACTIVITY DISORDER	Clinical Question: In concussed patients, will having attention deficit hyperactivity disorder (ADHD) or learning difficulties (LD) versus not having ADHD or LD cause higher symptom severity scores or invalid baseline protocols? Clinical Bottom Line: Research supports the concept that there is a difference at baseline for individuals with ADHD and/or LD compared with those who do not.	[Fisher, Mindi] Calif Univ Penn, California, PA 15419 USA; [Tierney, Ryan; Russ, Anne; Mansell, Jamie] Temple Univ, Philadelphia, PA 19122 USA		Fisher, M (corresponding author), Calif Univ Penn, California, PA 15419 USA.	mindi.dauria@gmail.com					Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Collings LJ, 2017, BRAIN INJURY, V31, P1479, DOI 10.1080/02699052.2017.1377351; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Czamara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063859; Huang F, 2016, CHINESE MED J-PEKING, V129, P1922, DOI 10.4103/0366-6999.187861; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Manderino L, 2018, CLIN J SPORT MED, V28, P111, DOI 10.1097/JSM.0000000000000433; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207	8	3	3	2	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	SEP	2019	24	5					181	185		10.1123/ijatt.2018-0089			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	IX4MB	WOS:000485659200001		Bronze			2022-02-06	
J	Frassanito, P; Bianchi, F; Stifano, V; Fraschetti, F; Massimi, L; Tamburrini, G; Caldarelli, M				Frassanito, Paolo; Bianchi, Federico; Stifano, Vito; Fraschetti, Flavia; Massimi, Luca; Tamburrini, Gianpiero; Caldarelli, Massimo			Craniocerebral disproportion after decompressive craniectomy in infants: The hidden enemy of cranial repair?	CHILDS NERVOUS SYSTEM			English	Article						Cranial growth; Cranial repair; Cranioplasty; Craniocerebral disproportion; Pediatric head injury; Personalized medicine	CRANIOPLASTY; SUCTION; DEATH	Introduction Cranioplasty aims at restoring the physiological integrity and volume of the skull. Any disproportion between the intracranial content and the volume of the container may favor the occurrence of complications. A classification of volume mismatches is proposed. A negative mismatch, consisting of intracranial content minor to skull volume, is well represented by the sinking flap. On the other side, a positive mismatch, consisting of intracranial content higher than skull volume, usually depends on CSF collection or hydrocephalus once the brain edema is regressed. Though, in children, this condition may result from physiological brain growth after decompressive craniectomy. Treatment algorithm based on this classification is presented. Illustrative case A 1-year-old boy with a severe traumatic brain injury underwent right decompressive craniectomy, evacuation of subdural hematoma, and dural expansion at another institution. After failure of autologous bone-assisted cranioplasty for infection, a helmet was recommended in order to postpone the cranial repair. Patient was admitted to our institution 3 years later. CT scan showed brain herniation through the cranial defect, associated to a condition of acquired craniocerebral disproportion, due to the condition of "open skull". Augmented hydroxyapatite cranioplasty (CustomBone, Finceramica, Faenza, Italy) was performed in order to manage this rare condition of positive volume mismatch. Subsequent course was uneventful and no complication was recorded at 30-month follow-up. Conclusions This illustrative case highlights the possible occurrence of a positive structural mismatch between the skull and the intracranial content after decompressive craniectomy, thus configuring a condition of acquired craniocerebral disproportion, aside of other brain or CSF complications. We firstly recognize this condition in the literature and propose it as a possible factor affecting the outcome of cranioplasty in infants and young children.	[Frassanito, Paolo; Bianchi, Federico] Fdn Policlin Univ A Gemelli IRCCS, Pediat Neurosurg, Largo Agostino Gemelli 8, I-00168 Rome, Italy; [Stifano, Vito; Fraschetti, Flavia; Massimi, Luca; Tamburrini, Gianpiero; Caldarelli, Massimo] Univ Cattolica Sacro Cuore, Pediat Neurosurg, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy		Frassanito, P (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Pediat Neurosurg, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	paolo.frassanito@gmail.com	Stifano, Vito/I-9032-2019; FRASSANITO, Paolo/K-4099-2018	Stifano, Vito/0000-0002-5509-9592; FRASSANITO, Paolo/0000-0003-0071-3126			Di Rocco C, 2015, COMPLICATIONS CSF SH, P233; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312; Robles LA, 2018, WORLD NEUROSURG, V111, P99, DOI 10.1016/j.wneu.2017.12.061; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Van Roost D, 2003, NEUROSURGERY, V53, P1315, DOI 10.1227/01.NEU.0000093498.08913.9E; Yu KKH, 2016, J NEUROSURG, V125, P1610, DOI 10.3171/2016.5.JNS161142	7	3	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2019	35	9					1467	1471		10.1007/s00381-019-04166-4			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	IR9HA	WOS:000481753100009	31134339				2022-02-06	
J	Haag, H; Biscardi, M; Smith, N; MacGregor, N; Colantonio, A				Haag, Halina (Lin); Biscardi, Melissa; Smith, Noel (Natalia); MacGregor, Nneka; Colantonio, Angela		Pauktuutit Inuit Women Canada	Traumatic brain injury and intimate partner violence: Addressing knowledge and service gaps among indigenous populations in Canada	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury (TBI); intimate partner violence (IPV); Indigenous women; women's health	INTERPERSONAL VIOLENCE; HEALTH-CARE; CHALLENGES; AMERICAN; OUTCOMES; IMPACT	Background Traumatic brain injury (TBI) is a serious consequence of intimate partner violence (IPV) that is often overlooked. In the case of Indigenous women in Canada the challenges are broad, multidimensional, and left almost entirely unexplored. Given the elevated rates of violence and injury experienced by women exposed to IPV and the increased levels of physical assault among Indigenous women in Canada, it is important to understand the unique experiences and service needs of these women. This study sought to identify barriers and facilitating factors for TBI-sensitive service provision for Indigenous women experiencing IPV. Method: As part of a larger national stakeholder consultation process to develop a TBI educational toolkit for IPV service providers, input from Indigenous stakeholders was specifically sought to allow for insights into unique challenges and strengths related to this population. Interviews and focus groups were conducted with IPV direct-service providers, support professionals, and advocates working with Canadian First Nations and Inuit women. Findings: Findings suggest that multiple intersections of marginalization, shame and stigma, and colonization, coupled with significant barriers to service provision in remote communities are such that solutions generated for urban-based settler populations are ineffective. Conclusions: Recommendations include a widespread educational campaign to raise awareness of the seriousness of TBI among Indigenous women exposed to IPV. Education is particularly important among healthcare and direct service providers, survivors and their families and communities, legal professionals and child protection agencies, and Indigenous and settler government bodies. Future research should focus on expanding our understanding of this complex issue and developing culturally sensitive, community-based supports.	[Haag, Halina (Lin)] Wilfrid Laurier Univ, Waterloo, ON, Canada; [Biscardi, Melissa; Smith, Noel (Natalia); Colantonio, Angela] Univ Toronto, Toronto, ON, Canada; [MacGregor, Nneka] WomenatthecentrE, N York, ON, Canada; [Colantonio, Angela] Toronto Rehab UHN, Kite, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto, ON, Canada.; Colantonio, A (corresponding author), Toronto Rehab UHN, Kite, Toronto, ON, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Department of Justice Canada [8858055]; Canadian Institutes of Health Research Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario	This work was supported by the Department of Justice Canada (A.C. file number 8858055); the Canadian Institutes of Health Research Chair in Gender, Work and Health (A.C. grant number CGW-126580); and The Ontario Ministry of Health and Long-Term Care (H.H. Ontario Women's Health Scholar Award).	Akter S, 2019, INT J PUBLIC HEALTH, V64, P343, DOI 10.1007/s00038-018-1177-4; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brennan S., 2011, VIOLENT VICTIMIZATIO; Brownridge DA, 2017, J FAM VIOLENCE, V32, P607, DOI 10.1007/s10896-016-9880-5; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Car M., 2000, BRAIN INJURY ASS AM, V4, P1; Crown-Indigenous Relations and Northern Affairs Canada, 2017, IND PEOPL COMM; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Keightley M, 2011, BRAIN INJURY, V25, P142, DOI 10.3109/02699052.2010.541898; Keightley ML, 2011, CAN J OCCUP THER, V78, P237, DOI 10.2182/cjot.2011.78.4.5; Keightley ML, 2009, BRAIN INJURY, V23, P250, DOI 10.1080/02699050902748331; Kronfli N, 2017, AIDS CARE, V29, P1235, DOI 10.1080/09540121.2017.1338658; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Linton KF, 2017, SOC WORK PUBLIC HLTH, V32, P202, DOI 10.1080/19371918.2016.1247403; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Linton KF, 2015, BRAIN INJURY, V29, P639, DOI 10.3109/02699052.2014.989406; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metis Nation, WHO AR MET; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Office of the Auditor General of Canada, 2017, 2017 MARCH REP AUD G; Patrick K, 2016, CAN MED ASSOC J, V188, pE78, DOI 10.1503/cmaj.160117; Puchala C, 2010, J ALTERN COMPLEM MED, V16, P89, DOI 10.1089/acm.2009.0213; Saturviit Inuit Women's Association of Nunavik, 2015, BRING HOP REST PEAC; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Statistics Canada, 2016, FAM VIOL CAN STAT PR; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; WHO, 2017, VIOL WOM GLOB PICT H; World Health Organization, 2016, UND ADDR VIOL WOM IN	34	3	3	2	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2019	20	2			SI		197	210	PII S1443964619000160	10.1017/BrImp.2019.16			14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	IU7UQ	WOS:000483789200008					2022-02-06	
J	Hawkins, LG; Eggleston, D; Brown, CC				Hawkins, Lindsey G.; Eggleston, Dane; Brown, Cameron C.			Utilizing a Narrative Therapy Approach with Couples Who Have Experienced a Traumatic Brain Injury to Increase Intimacy	CONTEMPORARY FAMILY THERAPY			English	Article						Traumatic brain injury (TBI); Narrative therapy; Intimacy; Couples	EMOTION RECOGNITION DEFICITS; NEUROBEHAVIORAL SEQUELAE; DEPRESSIVE SYMPTOMS; CHRONIC STRESS; HEAD-INJURY; MODERATE; TBI; ADJUSTMENT; ILLNESS; IMPACT	More individuals within the U.S. suffer from traumatic brain injuries (TBI) than breast cancer or HIV/aids and is one of the leading causes of disability. Due to the prevalence and severity of TBIs, it is essential for couple, marriage, and family therapists to understand TBIs common symptoms and treatment options for couples struggling with intimacy post diagnosis. Despite the need for further discussion and guidance, minimal literature presently exists incorporating a systemic approach for couples where one partner has encountered a TBI. In an effort to address this gap, the present article aims to provide, (1) awareness and contextual understanding on how TBI's shape couples experiences and (2) a suggested approach for treating couples to enhance their intimacy through a narrative lens. Those who experience a TBI can face many symptoms including increased impulsivity, disinhibition, aggression, lack of communication, depression, and sexual dysfunction. Narrative therapy may be uniquely equipped to assist couples experiencing these symptoms from a TBI by allowing couples to externalize the problem, create new experiences around this problem, and strengthen their new experiences. This suggested approach is delineated, applied to a clinical example, and discussed.	[Hawkins, Lindsey G.; Eggleston, Dane; Brown, Cameron C.] Texas Tech Univ, Coll Human Sci, Couple Marriage & Family Therapy Program, 1301 Akron Ave Room 271, Lubbock, TX 79409 USA		Hawkins, LG (corresponding author), Texas Tech Univ, Coll Human Sci, Couple Marriage & Family Therapy Program, 1301 Akron Ave Room 271, Lubbock, TX 79409 USA.	lindsey.g.hawkins@ttu.edu					Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Aniciete D, 2011, J FEM FAM THER, V23, P103, DOI 10.1080/08952833.2011.576233; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Ashworth F, 2011, BRAIN IMPAIR, V12, P128, DOI 10.1375/brim.12.2.128; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bay E, 2012, ARCH PSYCHIAT NURS, V26, P477, DOI 10.1016/j.apnu.2012.06.002; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bay EH, 2012, J MARITAL FAM THER, V38, P556, DOI 10.1111/j.1752-0606.2011.00231.x; BERMAN EM, 1975, AM J PSYCHIAT, V132, P583; Bermudez JM, 2010, FAM THER COUNSEL, P271; BERMUDEZ L, 2009, MULTICULTURAL COUPLE, P319; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowen C., 2010, RELATIONAL APPROACH; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Butera-Prinzi F, 2014, AUST NZ J FAM THER, V35, P81, DOI 10.1002/anzf.1046; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Combs, 1996, NARRATIVE THERAPY SO; Coner-Edwards AF, 1988, BLACK FAMILIES CRISI, P37; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Courville C. B., 1945, PATHOLOGY NERVOUS SY; Crocker LD, 2018, BEHAV RES THER, V108, P68, DOI 10.1016/j.brat.2018.07.004; DRIGOTAS SM, 1992, J PERS SOC PSYCHOL, V62, P62, DOI 10.1037/0022-3514.62.1.62; ELKAIM M, 1985, FAM PROCESS, V24, P151, DOI 10.1111/j.1545-5300.1985.00151.x; Epston, 1990, NARRATIVE MEANS THER; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Faul M, 2010, TRAUMATIC BRAIN INJU; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Freedman J, 2014, AUST NZ J FAM THER, V35, P20, DOI 10.1002/anzf.1043; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hogan BA, 1999, NEUROREHABILITATION, V13, P21; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Kowal J, 2003, J MARITAL FAM THER, V29, P299, DOI 10.1111/j.1752-0606.2003.tb01208.x; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McAdams D. P., 1988, HDB PERSONAL RELATIO, P7; MCADAMS DP, 1982, J PERS ASSESS, V46, P586, DOI 10.1207/s15327752jpa4606_5; Merscham C., 2000, FAM J, V8, P282; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Moreno JA, 2015, SEX RELATSH THER, V30, P448, DOI 10.1080/14681994.2015.1039937; Moreno JA, 2015, SEX DISABIL, V33, P483, DOI 10.1007/s11195-015-9414-8; National Institute of Neurological Disorders and Stroke, 2015, 152478 NINDS; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; PALAZZOLI MS, 1978, PARADOX COUNTERPARAD; Perecman E., 1987, FRONTAL LOBES REVISI; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; Porter S, 1989, PHY MED REHAB, P3143; Prager K. J., 1995, PSYCHOL INTIMACY; Reis H.T., 1988, HDB PERSONAL RELATIO, P367; Robins N, 2012, THESIS; ROLLAND JS, 1994, J MARITAL FAM THER, V20, P327, DOI 10.1111/j.1752-0606.1994.tb00125.x; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Shilts L. G., 1991, J STRATEGIC SYSTEMIC, V10, P92; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Stith SM, 2004, J MARITAL FAM THER, V30, P305, DOI 10.1111/j.1752-0606.2004.tb01242.x; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Vromans PL, 2009, J PSYCHOTHERAPY RES, V21, P4; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; WARING EM, 1981, CAN J PSYCHIAT, V26, P167, DOI 10.1177/070674378102600306; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; White M., 2007, MAPS NARRATIVE PRACT, V1st; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zimmerman J., 2017, J SYSTEMIC THERAPIES, V36, P12, DOI [10.1521/jsyt.2017.36.2.12, DOI 10.1521/JSYT.2017.36.2.12]	83	3	3	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-2764	1573-3335		CONTEMP FAM THER	Contemp. Fam. Ther.	SEP	2019	41	3					304	315		10.1007/s10591-018-9484-8			12	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	IJ0HT	WOS:000475581800009					2022-02-06	
J	Jacovides, CL; Ahmed, S; Suto, Y; Paris, AJ; Leone, R; McCarry, J; Christofidou-Solomidou, M; Kaplan, LJ; Smith, DH; Holena, DN; Schwab, CW; Pascual, JL				Jacovides, Christina L.; Ahmed, Syed; Suto, Yujin; Paris, Andrew J.; Leone, Ryan; McCarry, Jordan; Christofidou-Solomidou, Melpo; Kaplan, Lewis J.; Smith, Douglas H.; Holena, Daniel N.; Schwab, C. William; Pascual, Jose L.			An inflammatory pulmonary insult post-traumatic brain injury worsens subsequent spatial learning and neurological outcomes	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	32nd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 15-19, 2019	Austin, TX	Eastern Assoc Surg Trauma		Traumatic brain injury; Murine model; Lung infection; Morris Water Maze; Learning; Memory	MORRIS WATER MAZE; CONTROLLED CORTICAL IMPACT; MODEL; RATS; DEFICITS; LUNG	BACKGROUND Severe traumatic brain injury (TBI) patients are at high risk for early aspiration and pneumonia. How pneumonia impacts neurological recovery after TBI is not well characterized. We hypothesized that, independent of the cerebral injury, pneumonia after TBI delays and worsens neurological recovery and cognitive outcomes. METHODS Fifteen CD1 male mice were randomized to sham craniotomy or severe TBI (controlled cortical impact [CCI] - velocity 6 m/s, depth 1.0 mm) +/- intratracheal lipopolysaccharide (LPS-2 mg/kg in 0.1 mL saline) as a pneumonia bioeffector. Neurological functional recovery by Garcia Neurologic Testing (GNT) and body weight loss were recorded daily for 14 days. On Days 6-14, animals underwent Morris Water Maze learning and memory testing with cued trials (platform visible), spatial learning trials (platform invisible, spatial cues present), and probe (memory) trials (platform removed, spatial clues present). Intergroup differences were assessed by the Kruskal-Wallis test with Bonferroni correction (p < 0.05). RESULTS Weight loss was greatest in the CCI + LPS group (maximum 24% on Day 3 vs. 8% [Sham], 7% [CCI], both on Day 1). GNT was lowest in CCI + LPS during the first week. Morris Water Maze testing demonstrated greater spatial learning impairment in the CCI + LPS group vs. Sham or CCI counterparts. Cued learning and long-term memory were worse in CCI + LPS and CCI as compared to Sham. CONCLUSION A pneumonia bioeffector insult after TBI worsens weight loss and mortality in a rodent model. Not only is spatial learning impaired, but animals are more debilitated and have worse neurologic performance. Understanding the adverse effects of pneumonia on TBI recovery is the first step d patients.	[Jacovides, Christina L.; Ahmed, Syed; Leone, Ryan; McCarry, Jordan; Kaplan, Lewis J.; Holena, Daniel N.; Schwab, C. William; Pascual, Jose L.] Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Perelman Sch Med, Rm 108,1st Floor Suite,51 N 39th St, Philadelphia, PA 19104 USA; [Suto, Yujin] Tokyo Med Univ, Hachioji Med Ctr, Dept Emergency & Crit Care Med, Tokyo, Japan; [Paris, Andrew J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Christofidou-Solomidou, Melpo] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA		Pascual, JL (corresponding author), Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Perelman Sch Med, Rm 108,1st Floor Suite,51 N 39th St, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Leone, Ryan/ABC-1848-2020	Leone, Ryan/0000-0003-0549-9990; Ahmed, Syed Moiz/0000-0003-3922-5525; Holena, Daniel/0000-0003-3424-5754	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398] Funding Source: Medline		Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Baldwin G, 2015, C TRAUM BRAIN INJ US; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Gomez-Cabrera MC, 2017, J GERONTOL A-BIOL, V72, P885, DOI 10.1093/gerona/glw337; Chen GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729831; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Jacovides CL, DOES LUNG INFECT BRA; Lee JC, 2010, RADIAT RES, V173, P590, DOI 10.1667/RR1522.1; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagata K, 2018, J TRAUMA ACUTE CARE, V84, P727, DOI 10.1097/TA.0000000000001819; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Pardon MC, 2015, ROM J MORPHOL EMBRYO, V56, P903; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Suto Y, 2019, J NEUROTRAUM, V36, P609, DOI 10.1089/neu.2018.5812; Suto Y, 2018, J TRAUMA ACUTE CARE, V85, P275, DOI 10.1097/TA.0000000000001957; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116	25	3	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2019	87	3					552	558		10.1097/TA.0000000000002403			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	IU8KC	WOS:000483829500012	31205212				2022-02-06	
J	Karic, S; DesRosiers, M; Mizrahi, B; Zevallos, J; Rodriguez, P; Barengo, NC				Karic, Semir; DesRosiers, Michael; Mizrahi, Briana; Zevallos, Juan; Rodriguez, Pura; Barengo, Noel C.			The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs	CHILD CARE HEALTH AND DEVELOPMENT			English	Article						attention deficit hyperactivity disorder; children; concussion; head injury; traumatic brain injury	DEFICIT/HYPERACTIVITY DISORDER; ADHD; NEUROBIOLOGY; CHILDHOOD	Background As children with attention deficit hyperactivity disorder (ADHD) have shown to be at higher risk of accidents and injury, one may assume that they may also bear a higher likelihood of mild traumatic brain injuries (mTBI). However, the current scientific evidence whether ADHD severity is associated with traumatic brain injuries is controversial. The objective of this study was too assess the association between the severity of ADHD and prevalence of mTBI in 0- to 18-year-old children with ADHD in the United States. Methods Cross-sectional study using secondary data gathered in 2009/10 from the National Survey of Children with Special Healthcare Needs. After excluding comorbidity and those with nonspecific attention deficits, the final study population consisted of 10,739 children with ADHD from 40,052 households. The main exposure variable was self-reported ADHD severity (mild, moderate, or severe). The main outcome was mTBI, defined as head injury, traumatic brain injury, and/or concussion). Covariates included age, gender and race, medication status. Unadjusted and adjusted logistic regression analysis were used. Results Children with more severe ADHD had consistently increased incidences of mTBI. Adjusted logistic regression analysis revealed a statistically significant association between severity of ADHD and occurrence of mTBI. The corresponding odds ratios were 1.57 (95% confidence interval (CI) [1.13, 2.18] for moderate, and 1.79 (95% CI [1.18, 2.72]) for severe ADHD, respectively, compared with mild ADHD. In males, children with moderate and severe ADHD had increased odds of mTBI. The corresponding odds ratio for mTBI in those with moderate ADHD was 1.60 (95% CI [1.07, 2.39]) and 1.86 (95% CI [1.15, 3.00]) for severe ADHD, respectively. No associations between severity and mTBI were found in girls. Conclusions As ADHD severity was associated with incidence of mTBI, it is important to identify those who need increased attention and counselling to prevent injury.	[Karic, Semir; DesRosiers, Michael; Mizrahi, Briana; Zevallos, Juan; Rodriguez, Pura; Barengo, Noel C.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Med & Populat Hlth Sci Res, 11200 SW 8th St,AHC2, Miami, FL 33199 USA		Barengo, NC (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Med & Populat Hlth Sci Res, 11200 SW 8th St,AHC2, Miami, FL 33199 USA.	nbarengo@fiu.edu		Barengo, Noel C/0000-0003-0660-3091			Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Bramlett Matthew D, 2014, Vital Health Stat 1, P1; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; Byrne JM, 2003, CHILD NEUROPSYCHOL, V9, P142, DOI 10.1076/chin.9.2.142.14501; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Harvey WJ, 2009, ADAPT PHYS ACT Q, V26, P131, DOI 10.1123/apaq.26.2.131; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lindemann C, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00220; Lingineni RK, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-50; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; National Center for Health Statistics, 2016, STAT NCFH; PELHAM WE, 1990, J CONSULT CLIN PSYCH, V58, P130, DOI 10.1037/0022-006X.58.1.130; Raman SR, 2013, INJURY PREV, V19, P164, DOI 10.1136/injuryprev-2012-040483; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; StataCorp, 2015, STAT 14 BAS REF MAN; Turic D, 2010, PHARMACOGEN PERS MED, V3, P61, DOI 10.2147/PGPM.S6800; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Zametkin AJ, 1998, J CLIN PSYCHIAT, V59, P17	27	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1862	1365-2214		CHILD CARE HLTH DEV	Child Care Health Dev.	SEP	2019	45	5					688	693		10.1111/cch.12684			6	Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics	IR5BS	WOS:000481448600009	31049988				2022-02-06	
J	Kisala, PA; Bushnik, T; Boulton, AJ; Hanks, RA; Kolakowsky-Hayner, SA; Tulsky, DS				Kisala, Pamela A.; Bushnik, Tamara; Boulton, Aaron J.; Hanks, Robin A.; Kolakowsky-Hayner, Stephanie A.; Tulsky, David S.			Measuring Fatigue in TBI: Development of the TBI-QOL Fatigue Item Bank and Short Form	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; fatigue; health-related quality of life; patient-reported outcome measures; psychometrics	TRAUMATIC BRAIN-INJURY; RESPONSE THEORY; MENTAL FATIGUE; DEPRESSION; MODERATE; QUALITY; SLEEP; FIT; RELIABILITY; PREVALENCE	Objective: To develop a traumatic brain injury (TBI)-specific, item response theory (IRT)-calibrated Fatigue item bank, short form, and computer adaptive test (CAT) as part of the Traumatic Brain Injury-Quality of Life (TBI-QOL) measurement system. Setting: Five TBI Model Systems rehabilitation centers in the US Participants: Adults with complicated mild, moderate, or severe TBI confirmed by medical record review. Design: Cross-sectional field testing via phone or in-person interview. Main Measures: TBI-QOL Fatigue item bank, short form, and CAT. Results: A total of 590 adults with TBI completed 95 preliminary fatigue items, including 86 items from the Patient-Reported Outcomes Measurement Information System (PROMIS) and 9 items from the Quality of Life in Neurological Disorders (Neuro-QOL) system. Through 4 iterations of factor analysis, 22 items were deleted for reasons such as local item dependence, misfit, and low item-total correlations. Graded response model IRT analyses were conducted on the 73-item set, and Stocking-Lord equating was used to transform the item parameters to the PROMIS (general population) metric. A short form and CAT, which demonstrate similar reliability to the full item bank, were developed. Test-retest reliability of the CAT was established in an independent sample (Pearson's r and intraclass correlation coefficient = 0.82 [95% confidence interval: 0.72-0.88]). Conclusions: The TBI-QOL Fatigue item bank, short form, and CAT provide rehabilitation researchers and clinicians with TBI-optimized tools for assessment of the patient-reported experience and impact of fatigue on individuals with TBI.	[Kisala, Pamela A.; Boulton, Aaron J.; Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA; [Bushnik, Tamara] NYU, Langone Med Ctr, Rusk Rehabil, New York, NY USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Kolakowsky-Hayner, Stephanie A.] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA		Tulsky, DS (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu		Tulsky, David/0000-0002-4335-4509; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038]; NIDILRRUnited States Department of Health & Human Services [H133A120100]	This study was supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of this manuscript was provided by NIDILRR grant number H133A120100.	Barroso Julie, 2002, J Assoc Nurses AIDS Care, V13, P66, DOI 10.1016/S1055-3290(06)60242-2; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; BELZA BL, 1995, J RHEUMATOL, V22, P639; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner J, 2007, IRTFIT MACRO ITEM FI; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bormann J, 2001, J Assoc Nurses AIDS Care, V12, P75, DOI 10.1016/S1055-3290(06)60146-5; Brown M.W., 1993, SOCIOL METHOD RES, P136; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B, 2012, BRAIN INJURY FUNCTIO; Johansson B, 2017, NEUROPSYCHOL REHABIL, V27, P1047, DOI 10.1080/09602011.2017.1292921; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kim SH, 2007, J EDUC MEAS, V44, P93, DOI 10.1111/j.1745-3984.2007.00029.x; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Kolakowsky-Hayner SA, 2017, NEUROPSYCHOL REHABIL, V27, P1002, DOI 10.1080/09602011.2016.1229680; Kolen M., 2014, TEST EQUATING SCALIN, V3rd Edn; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Lequerica A, 2012, J HEAD TRAUMA REHAB, V27, pE28, DOI 10.1097/HTR.0b013e31826fe574; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Muthen B. O., 1998, MPLUS USERS GUIDE, V7th; Neurology Task Force, 2013, TBI EDGE OUTC MEAS I; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; PRICE RK, 1992, PUBLIC HEALTH REP, V107, P514; PROMIS, 2013, PROMIS INSTR DEV PSY; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Samejima F, 1969, PSYCHOMETRIKA MONO S, V17; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; STOCKING ML, 1983, APPL PSYCH MEAS, V7, P201, DOI 10.1177/014662168300700208; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; THISSEN D, 2003, MULTILOG VERSION 7 C; Tomar Sachin, 2018, Asian J Neurosurg, V13, P1061, DOI 10.4103/ajns.AJNS_89_17; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P281, DOI 10.1097/HTR.0000000000000531; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X	54	3	3	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		289	297		10.1097/HTR.0000000000000530			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100010	31498228				2022-02-06	
J	McCarron, KK; Dasgupta, MK; Campbell, CA; Hull, AE; Namazi, S; Adams, AH; Allen, NJ; Bloeser, KJ; Thomas, LA; Reinhard, MJ; Scholten, JD; Schwartz, BL				McCarron, Kelly K.; Dasgupta, Megan K.; Campbell, Celeste A.; Hull, Amanda E.; Namazi, Salya; Adams, Alyssa H.; Allen, Nathaniel J.; Bloeser, Katharine J.; Thomas, Laura A.; Reinhard, Matthew J.; Scholten, Joel D.; Schwartz, Barbara L.			Social Rehabilitation for Military Veterans With Traumatic Brain Injury, Psychological Trauma, and Chronic Neuropsychiatric Symptoms: Intervention Development and Initial Outcomes	PSYCHIATRIC REHABILITATION JOURNAL			English	Article						traumatic brain injury; psychological trauma; polytrauma; social participation; veterans	POSTTRAUMATIC-STRESS-DISORDER; EMOTION PERCEPTION DEFICITS; QUALITY-OF-LIFE; FOLLOW-UP; DEPRESSION; HEALTH; COGNITION; PTSD	Objective: A subset of military veterans who have experienced both traumatic brain injury and psychological trauma present with chronic neuropsychiatric symptoms and experience persistent obstacles to social reintegration. This project aimed to develop a novel treatment targeting the unmet social rehabilitation needs of these veterans. Initial intervention development, feasibility, and outcome data are explored. Method: Four treatment groups were conducted (n = 20). A treatment workbook was developed during Groups 1 and 2 (n = 10) and research data were collected from Groups 3 and 4 (n = 10). Results: There was a 0% attrition rate across all groups with unanimous requests for additional sessions. T test effect sizes were analyzed with bias-corrected Hedges'g. Improvements were observed on measures of depression (p = .026, g = 0.73), empathic perspective taking (p = .007, g = 0.94), social cognition (p = .002-.678, g = 0.27-1.30 across multiple measures), social relationships (p = .007, g = 1.50). traumatic brain injury-related quality of life (social: p = .014, g = 0.68, emotional: p = .009, g = 1.28) and nonsocial executive functioning (p = .006. g = 0.54). Conclusions and Implications for Practice: Preliminary evidence from this exploratory study suggests that targeting multiple layers of social competence using a combined psychotherapy and cognitive rehabilitation approach holds promise. Larger, controlled studies are needed to further evaluate the feasibility and efficacy of this intervention.	[McCarron, Kelly K.; Dasgupta, Megan K.; Campbell, Celeste A.; Scholten, Joel D.] Vet Affairs Med Ctr, Polytrauma Network Site, Washington, DC USA; [Hull, Amanda E.; Namazi, Salya; Adams, Alyssa H.; Allen, Nathaniel J.; Bloeser, Katharine J.; Thomas, Laura A.; Reinhard, Matthew J.] Vet Affairs Med Ctr, War Related Illness & Injury Study Ctr, Washington, DC USA; [Schwartz, Barbara L.] Vet Affairs Med Ctr, Mental Hlth Serv, Washington, DC USA; [Dasgupta, Megan K.] Adventist Hlth Care, Rockville, MD USA; [Hull, Amanda E.] Vet Affairs Portland Hlth Care Syst, Off Patient Ctr Care & Cultural Transformat, Portland, OR USA; [Namazi, Salya] Stixrud Grp, Silver Spring, MD USA; [Adams, Alyssa H.] Dept Vet Affairs, Natl Vet Sports Programs & Special Events, Washington, DC USA; [Thomas, Laura A.] Natl Inst Environm Hlth Sci, NIH, Durham, NC USA; [McCarron, Kelly K.] Dept Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, 385 Tremont Ave,Mail Stop 129, E Orange, NJ 07018 USA		McCarron, KK (corresponding author), Dept Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, 385 Tremont Ave,Mail Stop 129, E Orange, NJ 07018 USA.	kelly.mccarron@va.gov		Allen, Nathaniel/0000-0002-7783-8464	Institute for Clinical Research, Inc., Washington, DC Veterans Affairs Medical Center	The clinical, intellectual, and administrative leadership of Pamela Harman, PhD, CCC-SLP, and Howard Schulman, PhD was essential to this project's completion. This work was supported by the Institute for Clinical Research, Inc., the non-profit affiliate of the Washington, DC Veterans Affairs Medical Center. The authors report no conflicts of interest.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1993, BECK ANXIETY INVENTO; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cloitre M, 2016, MIL MED, V181, pE183, DOI 10.7205/MILMED-D-15-00209; Cloitre M, 2010, AM J PSYCHIAT, V167, P915, DOI 10.1176/appi.ajp.2010.09081247; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Erickson TM, 2007, BEHAV THER, V38, P364, DOI 10.1016/j.beth.2006.10.005; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Grant DM, 2008, J ABNORM PSYCHOL, V117, P662, DOI 10.1037/a0012591; Green CA, 2015, ADM POLICY MENT HLTH, V42, P508, DOI 10.1007/s10488-014-0552-6; Greig TC, 2007, SCHIZOPHR RES, V96, P156, DOI 10.1016/j.schres.2007.07.003; Hedges L.V., 1985, STAT METHODS META AN; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Ladegaard N, 2014, PSYCHIAT RES, V216, P37, DOI 10.1016/j.psychres.2013.12.010; Lezak, 2008, MANUAL MAYO PORTLAND; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Malec J., 2005, MAYO PORTLAND ADAPTA; McCarron K, 2014, SOCIAL COGNITION REH; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Neietlisbach G., 2009, J AGGRESSION MALTREA, V18, P382, DOI [10.1080/10926770902881489, DOI 10.1080/10926770902881489]; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Pearson, 2009, ADV CLIN SOL WAIS 4; Plana I, 2014, J ANXIETY DISORD, V28, P169, DOI 10.1016/j.janxdis.2013.09.005; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Schnurr PR, 2011, WOMEN HEALTH ISS, V21, pS169, DOI 10.1016/j.whi.2011.04.013; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	58	3	3	1	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1095-158X	1559-3126		PSYCHIATR REHABIL J	Psychiatr. Rehabil. J.	SEP	2019	42	3					296	304		10.1037/prj0000361			9	Psychiatry; Rehabilitation	Social Science Citation Index (SSCI)	Psychiatry; Rehabilitation	IT7PQ	WOS:000483068600011	31070444				2022-02-06	
J	Morleo, B; Teresinski, G; Rousseau, G; Tse, R; Tettamanti, C; Augsburger, M; Palmiere, C				Morleo, Bastien; Teresinski, Gregor; Rousseau, Guillaume; Tse, Rexson; Tettamanti, Camilla; Augsburger, Marc; Palmiere, Cristian			Biomarkers of Cerebral Damage in Fatal Hypothermia Preliminary Results	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						autopsy; biomarkers; hypothermia; postmortem biochemistry	NEURON-SPECIFIC ENOLASE; POSTMORTEM COMPUTED-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; BIOCHEMISTRY; DIAGNOSIS; S100B; PROTEIN; PATHOPHYSIOLOGY; MARKERS	The identification of hypothermia as the cause of death remains challenging in forensic pathology because of unspecific radiological, morphological, and biochemical results. Hyperemia, edema, and petechial hemorrhages within the cerebral parenchyma were described in cases of death by hypothermia. On the other hand, the effect of low temperatures in the brain has been speculated to cause local injuries on a cellular level with potential occurrences of necrosis and inflammation. In the study herein described, endocan, alkaline phosphatase, neuron-specific enolase, S100 protein subunit B, glial fibrillary acidic protein, and C-reactive protein were measured in postmortem serum from femoral blood and cerebrospinal fluid in a series of hypothermia fatalities and control cases. The combination of data collected failed to identify a specific biochemical profile for death by hypothermia in postmortem serum and/or the cerebrospinal fluid, thus suggesting that an alternative panel of brain damage biomarkers indicative of diffuse hypoxic brain injury needs to be defined in hypothermia fatalities.	[Morleo, Bastien; Augsburger, Marc; Palmiere, Cristian] Lausanne Univ Hosp, CURML, Chemin La Vulliette 4, CH-1000 Lausanne, Switzerland; [Teresinski, Gregor] Med Univ Lublin, Dept Forens Med, Lublin, Poland; [Rousseau, Guillaume] CHU Angers, Dept Biochim & Genet, Angers, France; [Rousseau, Guillaume] CHU Angers, Serv Med Legale & Penitentiaire, Angers, France; [Tse, Rexson] Auckland City Hosp, LabPLUS, Dept Forens Pathol, Auckland, New Zealand; [Tettamanti, Camilla] Univ Genoa, Dept Sect Forens & Legal Med, Genoa, Italy; [Tettamanti, Camilla] Univ Genoa, Sch Specializat Legal Med, Genoa, Italy		Morleo, B (corresponding author), Lausanne Univ Hosp, CURML, Chemin La Vulliette 4, CH-1000 Lausanne, Switzerland.	bastien.morleo@gmail.com	Tse, Rexson/Y-1939-2019	Tse, Rexson/0000-0002-1388-9537; Augsburger, Marc/0000-0002-5606-3831; Tettamanti, Camilla/0000-0002-7410-3198; Teresinski, Grzegorz/0000-0002-4184-9305			Castellani JW, 2016, AUTON NEUROSCI-BASIC, V196, P63, DOI 10.1016/j.autneu.2016.02.009; Faa A, 2012, CLINICS, V67, P821, DOI 10.6061/clinics/2012(07)19; Gos T, 2013, J PSYCHIATR RES, V47, P1694, DOI 10.1016/j.jpsychires.2013.07.005; Hyodoh H, 2013, FORENSIC SCI INT, V231, P190, DOI 10.1016/j.forsciint.2013.05.011; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jeican Ionut Isaia, 2014, Clujul Med, V87, P54, DOI 10.15386/cjm.2014.8872.871.iij1; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Kawasumi Y, 2013, EUR J RADIOL, V82, P361, DOI 10.1016/j.ejrad.2012.11.017; Kinoshita Akiyoshi, 2015, Hepatogastroenterology, V62, P966; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2009, Leg Med (Tokyo), V11 Suppl 1, pS273, DOI 10.1016/j.legalmed.2009.02.042; Liu Y, 2019, J STROKE CEREBROVASC, V28, P21, DOI 10.1016/j.jstrokecerebrovasdis.2018.09.011; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Mallet ML, 2002, QJM-INT J MED, V95, P775, DOI 10.1093/qjmed/95.12.775; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; Nogami M, 1998, ACTA HISTOCHEM, V100, P371, DOI 10.1016/S0065-1281(98)80034-2; Nogami M, 1998, FORENSIC SCI INT, V94, P97, DOI 10.1016/S0379-0738(98)00060-7; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2017, ROM J LEG MED, V25, P301, DOI 10.4323/rjlm.2017.301; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Palmiere C, 2014, INT J LEGAL MED, V128, P607, DOI 10.1007/s00414-014-0977-1; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Rousseau G, 2018, INT J LEGAL MED; Rousseau G, 2018, CLIN CHEM LAB MED, V56, P1819, DOI 10.1515/cclm-2018-0153; Sahu Seelora, 2017, World J Biol Chem, V8, P21, DOI 10.4331/wjbc.v8.i1.21; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Scherpereel A, 2006, CRIT CARE MED, V34, P532, DOI 10.1097/01.CCM.0000198525.82124.74; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Turk EE, 2010, FORENSIC SCI MED PAT, V6, P106, DOI 10.1007/s12024-010-9142-4; Watt DG, 2015, SURGERY, V157, P362, DOI 10.1016/j.surg.2014.09.009	33	3	3	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2019	40	3					242	245		10.1097/PAF.0000000000000484			4	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	IS8LU	WOS:000482402100007	31033490	Green Submitted			2022-02-06	
J	Pritchard, E; Tsindos, T; Ayton, D				Pritchard, Elizabeth; Tsindos, Tess; Ayton, Darshini			Practitioner perspectives on the nexus between acquired brain injury and family violence	HEALTH & SOCIAL CARE IN THE COMMUNITY			English	Article						acquired brain injury; domestic violence; family violence; practitioner attitudes; qualitative study	CHILD-ABUSE; MENTAL-HEALTH; CONSEQUENCE; VICTIMS; TRENDS; WOMEN	Family violence has been highlighted by the World Health Organization as a major public health concern. Although family violence occurs to all genders, a higher prevalence of victims are female. Estimates report around 30% of all women experience intimate partner violence worldwide. Experiencing assault in the family violence context can lead to an acquired brain injury (ABI); however, the connection between these two phenomena has not been well established. The aim of this qualitative study was to explore the extent of, and factors contributing to, ABI and family violence. We conducted 22 semi-structured interviews and one focus group (n = 4) with practitioners working with family violence victims and/or perpetrators. Thematic data analysis utilised inductive and deductive coding approaches. The Social Determinants of Health Framework was used to guide analysis. Practitioners estimated 30%-40% of the clients on their caseloads had a suspected or diagnosed ABI. They identified that contributing factors were extremely complex. These included acquiring an ABI through assault (past family violence or other criminal act), and transport crashes. Complicating factors of ABI were identified as mental health conditions, alcohol and drug use, and post-traumatic stress disorder. Additional factors contributing to family violence were recognised as biological (age of parent, twin births, pregnancy, premature births, and children with congenital abnormalities), relationships (intimate partner, father, boyfriend, mother and siblings), previous trauma (family violence), and life stressors (unemployment, financial, and lack of housing). Social determinants of health included cultural (ethnicity, societal attitudes, values, and beliefs) and organisational (legislation and policy) factors which influenced behaviours and outcomes across all sectors. A model of Brain injury Family violence Nexus (BFN) was created to understand the interaction between these phenomena. Utilising the BFN model to understand the interaction can enhance the methods used within health and social services for a more efficacious approach.	[Pritchard, Elizabeth; Tsindos, Tess; Ayton, Darshini] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Hlth Serv Res Unit,Div Hlth Serv, Melbourne, Vic, Australia		Ayton, D (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Hlth Serv Res Unit,Div Hlth Serv, Melbourne, Vic, Australia.	Darshini.Ayton@monash.edu		Ayton, Darshini/0000-0002-2754-2024	Department of Health and Human Services, Victoria, Aust Funding Source: Medline		Ayton D, 2021, TRAUMA VIOLENCE ABUS, V22, P3, DOI 10.1177/1524838018821951; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Birdsey E., 2013, REPORTING VIOLENCE P; Boyatzis R. E., 1998, TRANSFORMING QUALITA; Brain Injury Australia, 2016, PREV ACQ BRAIN INJ V; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Brewer-Smyth K, 2015, J FORENSIC NURS, V11, P4, DOI 10.1097/JFN.0000000000000062; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Carty H, 2002, EUR RADIOL, V12, P2919, DOI 10.1007/s00330-002-1436-9; Chien WC, 2013, VIOLENCE VICTIMS, V28, P403, DOI 10.1891/0886-6708.11-00142; Corrigan FM, 2011, J PSYCHOPHARMACOL, V25, P17, DOI 10.1177/0269881109354930; Corvo K., 2006, J AGGRESS MALTREAT T, V13, P49; Davidson LL, 2015, NATURE, V527, pS161, DOI 10.1038/nature16030; Ennis Elaine, 2004, Pediatr Rehabil, V7, P205, DOI 10.1080/13638490410001703316; Gagnon KL, 2017, J TRAUMA DISSOCIATIO, V18, P635, DOI 10.1080/15299732.2016.1252001; Hansen JB, 2017, ACAD PEDIATR, V17, P362, DOI 10.1016/j.acap.2016.10.002; Helps Y, 2008, INJURY RES STAT SERI, V45; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Jackson H, 2004, AP PRA H PS, P233; Jackson M., 2011, AQUIRED BRAIN INJURY; Jarvis M, 2010, RELIABILITY, RISK AND SAFETY: THEORY AND APPLICATIONS VOLS 1-3, P25; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Liamputtong P., 2009, QUALITATIVE RES METH; Linton KF, 2015, BRAIN INJURY, V29, P639, DOI 10.3109/02699052.2014.989406; MARCANTONIS E, 2004, DISS ABSTR INT B, V64, P3532; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; McFadgion A., 2014, DISS ABSTR INT A, V75; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Parrish J, 2013, INT J CIRCUMPOL HEAL, V72, P472, DOI 10.3402/ijch.v72i0.21216; Perez-Arjona E, 2002, NEUROL RES, V24, P29, DOI 10.1179/016164102101199512; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; State of Victoria, 2014, 132201416 STAT VICT, VIV; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Vasterling J. J., 2012, UNDERSTANDING INTERF, P3; Walling SM, 2012, J MARITAL FAM THER, V38, P471, DOI 10.1111/j.1752-0606.2011.00226.x; Wood JN, 2016, ACAD PEDIATR, V16, P224, DOI 10.1016/j.acap.2015.05.008; Wood JN, 2012, PEDIATRICS, V130, pE358, DOI 10.1542/peds.2011-3755; World Health Organization, 2017, VIOL WOM; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	44	3	3	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0410	1365-2524		HEALTH SOC CARE COMM	Health Soc. Care Community	SEP	2019	27	5					1283	1294		10.1111/hsc.12770			12	Public, Environmental & Occupational Health; Social Work	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Work	IS9EU	WOS:000482452200047	31140672				2022-02-06	
J	Rattray, NA; True, G; Natividad, DM; Salyers, MP; Frankel, RM; Kukla, M				Rattray, Nicholas A.; True, Gala; Natividad, Diana M.; Salyers, Michelle P.; Frankel, Richard M.; Kukla, Marina			The Long an Winding Road to Postsecondary Education for US Veterans With Invisible Injuries	PSYCHIATRIC REHABILITATION JOURNAL			English	Article						Veterans; reintegration; mixed methods; mental health; education	STUDENT SERVICE MEMBERS/VETERANS; COMMUNITY REINTEGRATION; MILITARY SERVICE; DISABILITIES; CHALLENGES; COLLEGE; COMBAT; NEEDS; PTSD	Objective: Veterans with "invisible injuries" (a mental health diagnosis or a traumatic brain injury) often pursue higher education to enhance employment and community reintegration, but frequently experience challenges to success. This mixed methods study examined how the educational experiences of Veterans with invisible injuries become intertwined with broader transitions between military and civilian life and the resulting implications for rehabilitation services. Method: Thirty-eight Veterans with mental illness or a traumatic brain injury who served in a post-9/11 conflict and attended a postsecondary institution within the past 60 months completed in-depth interviews and questionnaires. We used a constant comparative approach to analyze barriers and facilitators to educational functioning and community reintegration. Results: Managing school-specific challenges, coping with mental and physical health problems, forming a new sense of self, and forging new career pathways were major factors influencing education experiences and reintegration. Participants discussed the challenges of balancing these processes while progressing toward an academic degree, which often resulted in a longer, nonlinear educational pathway. While some participants attempted to "compartmentalize" educational goals, separate from health and family concerns, these aims were inevitably interlaced. In addition, multiple and longer military deployments tended to lengthen the time to degree completion. Conclusions and Implications for Practice: Many Veterans with invisible injuries face complex challenges stemming from military experiences, the family dynamics to which they return. and reintegration issues that demand novel forms of resilience. Collaboration between university staff and health practitioners may be important in enhancing support for student Veterans coping with invisible disabilities.	[Rattray, Nicholas A.; Natividad, Diana M.; Frankel, Richard M.; Kukla, Marina] Roudebush VAMC, VA HSR&D Ctr Hlth Informat & Commun, Indianapolis, IN USA; [Rattray, Nicholas A.] Indiana Univ Purdue Univ Indianapolis, Dept Anthropol, Indianapolis, IN USA; [Rattray, Nicholas A.; Frankel, Richard M.] Ctr Hlth Serv Res, Regenstrief Inst Inc, Indianapolis, IN USA; [True, Gala] South Cent MIRECC Southeast Louisiana Vet Hlth Ca, New Orleans, LA USA; [True, Gala] Louisiana State Univ, Sch Med, Sect Community & Populat Med, Baton Rouge, LA 70803 USA; [Salyers, Michelle P.; Kukla, Marina] Indiana Univ Purdue Univ Indianapolis, Dept Psychol, Indianapolis, IN USA; [Salyers, Michelle P.; Kukla, Marina] ACT Ctr Indiana, Indianapolis, IN USA; [Frankel, Richard M.] Indiana Univ, Sch Med, Dept Gen Internal Med, Bloomington, IN 47405 USA		Rattray, NA (corresponding author), Roudebush VA Med Ctr, HSR&D Mail Code 11H,1481 West 10th St, Indianapolis, IN 46202 USA.	nrattray@iupui.edu		Rattray, Nicholas/0000-0002-9683-889X	Center for Health Information and Communication, Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development ServiceUS Department of Veterans Affairs [CIN 13-416]; Indiana Institute for Medical Research; Veterans AffairsUS Department of Veterans Affairs [IK2RX002642] Funding Source: NIH RePORTER	The views expressed in this article do not necessarily represent the official views of the U.S. Department of Veterans Affairs. The research was funded by the Center for Health Information and Communication, Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development Service (CIN 13-416), and the Indiana Institute for Medical Research.	Ackerman R., 2009, NEW DIRECTIONS STUDE, V126, P5, DOI [https://doi.org/10.1002/ss.311, DOI 10.1002/SS.311]; Ahern J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128599; Averill JB, 2002, QUAL HEALTH RES, V12, P855, DOI 10.1177/104973230201200611; Barry AE, 2015, J AM COLL HEALTH, V63, P415, DOI 10.1080/07448481.2015.1072777; Barry AE, 2014, J STUD AFF RES PRACT, V51, P30, DOI 10.1515/jsarp-2014-0003; Borsari B, 2017, AM J ORTHOPSYCHIAT, V87, P166, DOI 10.1037/ort0000199; Branker C, 2009, J POSTSECOND EDUC DI, V22, P59; Buckley K.K, 2010, VETERANS LAW REV, V2, P1; Burnett SE, 2009, J POSTSECOND EDUC DI, V22, P53; Cate C.A., 2014, MILLION RECORDS PROJ; Corbin J., 2008, BASICS QUALITATIVE R, DOI [10.4135/9781452230153, DOI 10.4135/9781452230153]; Crocker T, 2014, J REHABIL RES DEV, V51, pXI, DOI [10.1682/JRRD.2014.01.00111, 10.1682/JRRD.2014.01.0011]; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; Dichter ME, 2015, AFFILIA J WOM SOC WO, V30, P187, DOI 10.1177/0886109914555219; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Ellison ML, 2012, PSYCHIATR REHABIL J, V35, P209, DOI 10.2975/35.3.2012.209.217; Elnitsky CA, 2018, ARCH PHYS MED REHAB, V99, pS58, DOI 10.1016/j.apmr.2017.10.008; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Glover-Graf N., 2010, REHABILITATION ED, V24, P43, DOI DOI 10.1891/088970110805029921; Hammond S., 2017, NEW DIRECTIONS I RES, V2016, P11, DOI [10.1002/ir.20191, DOI 10.1002/IR.20191]; Hamrick F. A., 2013, CALLED SERVE HDB STU; Harmon C, 2003, J ECON SURV, V17, P115, DOI 10.1111/1467-6419.00191; Kraus A, 2013, CALLED SERVE HDB STU; Kukla M, 2015, J VOCAT REHABIL, V43, P51, DOI 10.3233/JVR-150754; Kukla M, 2015, J REHABIL RES DEV, V52, P477, DOI 10.1682/JRRD.2014.11.0289; Livingston WG, 2011, J STUD AFF RES PRACT, V48, P315, DOI 10.2202/1949-6605.6292; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; McCaslin S, 2014, CAREER PLANN ADULT D, V30, P191; Mikelson J.D, 2014, AM DISABILITIES ACT, P85; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Norman SB, 2015, J REHABIL RES DEV, V52, P701, DOI 10.1682/JRRD.2015.01.0013; Plano Clark, 2018, DESIGNING CONDUCTING; QSR International Pty Ltd, 2012, NVIVO QUAL DAT AN SO; Reisinger HS, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110116; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Rumann CB, 2010, J HIGH EDUC, V81, P431, DOI 10.1353/jhe.0.0103; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Shackelford AL, 2009, J POSTSECOND EDUC DI, V22, P36; Smith-Osborne A, 2012, J REHABIL, V78, P4; Smith-Osborne Alexa, 2009, J SOCIOLOGY SOCIAL W, V36, P111; Spradley J.P., 1979, ETHNOGRAPHIC INTERVI; Tamborini CR, 2015, DEMOGRAPHY, V52, P1383, DOI 10.1007/s13524-015-0407-0; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teachman J, 2007, SOCIOL EDUC, V80, P359, DOI 10.1177/003804070708000404; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; U.S. Department of Veterans Affairs, 2016, ANN BEN REP FISC YEA; Willis G. B., 2005, COGNITIVE INTERVIEWI, DOI [10.4135/9781412983655, DOI 10.4135/9781412983655]	50	3	3	4	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1095-158X	1559-3126		PSYCHIATR REHABIL J	Psychiatr. Rehabil. J.	SEP	2019	42	3					284	295		10.1037/prj0000375			12	Psychiatry; Rehabilitation	Social Science Citation Index (SSCI)	Psychiatry; Rehabilitation	IT7PQ	WOS:000483068600010	31246076	Green Accepted, Green Submitted			2022-02-06	
J	Ryan, NP; Noone, K; Godfrey, C; Botchway, EN; Catroppa, C; Anderson, V				Ryan, Nicholas P.; Noone, Kate; Godfrey, Celia; Botchway, Edith N.; Catroppa, Cathy; Anderson, Vicki			Young adults' perspectives on health-related quality of life after paediatric traumatic brain injury: A prospective cohort study	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Cohort study; Traumatic brain injury; Quality of life; Outcome; Young adulthood	NEUROCOGNITIVE OUTCOMES; EXTERNALIZING BEHAVIOR; COGNITIVE DYSFUNCTION; WHOQOL-BREF; PREDICTORS; CHILDHOOD; RECOVERY; SURVIVORS; CHILDREN; MILD	Background: Quality of life (QoL) is commonly affected in children and families living with traumatic brain injury (TBI). Despite the established link between childhood TBI and reduced health-related QoL (HRQoL), there is a dearth of longitudinal, prospective research to determine the prevalence and predictors of impaired HRQoL in the very long term post-injury. Objectives: We evaluated HRQoL in young adult survivors of paediatric TBI at 15 years post-injury. We aimed to identify the prevalence of impaired HRQoL and the respective contribution of pre-injury, environmental, injury-related, cognitive and mood-based factors to various dimensions of HRQoL at 15 years post-injury. Methods: This prospective study involved 52 young adult survivors of mild to severe TBI included from consecutive hospital admissions to the Royal Children's Hospital Melbourne, Australia between 1993 and 1997. Participants underwent neuropsychological evaluation and completed self-report measures of HRQoL, psychological functioning and social communication at 15 years post-injury. Results: As compared with an age-matched Australian normative sample, the TBI group reported significantly poorer physical HRQoL at 15 years post-injury. Although group differences in other HRQoL domains did not reach statistical significance, 52% of the TBI group reported impaired functioning in at least one HRQoL domain. Contrary to expectations, HRQoL was not associated with injury severity, socioeconomic status, or pre-injury functioning. Instead, poorer HRQoL was linked to more severe depression symptoms, greater perceived social communication difficulty and reduced cognitive flexibility at 15 years post-injury. Conclusions: A substantial proportion of young adult survivors of childhood TBI experience poor HRQoL in at least one domain of functioning at 15 years post-injury. These findings suggest that, even in the very long term post-injury, the identification and treatment of modifiable risk factors has potential to improve very-long-term HRQoL outcomes in this vulnerable population. (C) 2019 Elsevier Masson SAS. All rights reserved.	[Ryan, Nicholas P.; Noone, Kate; Godfrey, Celia; Botchway, Edith N.; Catroppa, Cathy; Anderson, Vicki] Murdoch Childrens Res Inst, Brain & Mind Clin Sci Theme, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Psychol Sci, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Godfrey, Celia; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Ryan, Nicholas P.] Deakin Univ, Cognit Neurosci Unit, Geelong, Vic, Australia		Ryan, NP (corresponding author), Deakin Univ, Cognit Neurosci Unit, 221 Burwood Highway, Burwood, Vic 3125, Australia.	nicholas.ryan@mcri.edu.au; kate.noone@mcri.edu.au; celia.godrey@mcri.edu.au; edith.botchway@mcri.edu.au; cathy.catroppa@mcri.edu.au; vicki.anderson@rch.org.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Botchway, Edith N/0000-0002-0075-3382; Ryan, Nicholas/0000-0002-0878-8889	Victoria Neurotrauma Initiative, Australia [CO6E1]; Victorian Government Operational Infrastructure Support Program; Australian Postgraduate AwardAustralian Government; NHMRC Moving Ahead Centre for Research Excellence in Brain Injury Recovery Seed GrantNational Health and Medical Research Council of Australia; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia; MCRI PhD scholarship	This work was supported by a grant from the Victoria Neurotrauma Initiative (CO6E1), Australia; the Victorian Government Operational Infrastructure Support Program; an Australian Postgraduate Award, MCRI PhD scholarship, and NHMRC Moving Ahead Centre for Research Excellence in Brain Injury Recovery Seed Grant to NR; and an NHMRC Senior Practitioner Fellowship to VA. The funding bodies did not play a role in the design of the study, collection, analysis and interpretation of the data, or writing of the manuscript.	Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Arrington-Sanders R, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-5; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Biglia N, 2012, EUR J CANCER CARE, V21, P485, DOI 10.1111/j.1365-2354.2011.01320.x; Camara-Costa H, 2017, NEURO-ONCOL PRACT, V4, P161, DOI 10.1093/nop/npw028; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Daniel A., 1983, POWER PRIVILEGE PRES; Davis JC, 2010, BMC GERIATR, V10; Delis DC., 2001, DELIS KAPLAN EXECUTI; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Farrington D. P., 1992, THE SCH YEARS, P123; Felder-Puig R, 2008, MED CARE, V46, P432, DOI 10.1097/MLR.0b013e3181648e95; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; NOLLER P, 1992, J ADOLESCENCE, V15, P101, DOI 10.1016/0140-1971(92)90041-3; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Skevington SM, 2004, SOC PSYCH PSYCH EPID, V39, P1, DOI 10.1007/s00127-004-0700-5; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; WHO, 1996, INTR ADM SCOR GEN VE; Yang Z, 2018, BIOL PSYCHIAT-COGN N, V3, P311, DOI 10.1016/j.bpsc.2017.12.006; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	57	3	3	1	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	SEP	2019	62	5					342	350		10.1016/j.rehab.2019.06.014			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IY8EO	WOS:000486627100006	31352061	Bronze			2022-02-06	
J	Su, XH; Ye, YQ; Yang, YX; Zhang, KL; Bai, W; Chen, HJ; Kang, EM; Kong, CG; He, XS				Su, Xinhong; Ye, Yuqin; Yang, Yongxiang; Zhang, Kailiang; Bai, Wei; Chen, Huijun; Kang, Enming; Kong, Chuiguang; He, Xiaosheng			The Effect of SPTLC2 on Promoting Neuronal Apoptosis is Alleviated by MiR-124-3p Through TLR4 Signalling Pathway	NEUROCHEMICAL RESEARCH			English	Article						miR-124-3p; SPTLC2; Apoptosis; TLR4	TRAUMATIC BRAIN-INJURY; SERINE PALMITOYLTRANSFERASE; IN-VITRO; CERAMIDE; CELLS; DIFFERENTIATION; PROLIFERATION; SURVIVAL; SUBUNIT; MODEL	To investigate the role and mechanism of microRNA-124-3p (miR-124-3p) and serine palmitoyltransferase long chain base subunit 2 (SPTLC2) in neuronal apoptosis induced by mechanical injury. Transient transfection was used to modify the expression of miR-124-3p and SPTLC2. After transfection, neuronal apoptosis was evaluated in an in vitro injury model of primary neurons using TUNEL staining and western blot. The correlation between miR-124-3p and SPTLC2 was identified through a dual luciferase reporter assay in HEK293 cells. A rescue experiment in primary neurons was performed to further confirm the result. To explore the downstream mechanisms, co-immunoprecipitation was performed to identify proteins that interact with SPTLC2 in toll-like receptor 4 (TLR4) signalling pathway. Subsequently, the relative expression levels of TLR4 pathway molecules were measured by western blot. Our results showed that increased miR-124-3p can inhibit neuronal apoptosis, which is opposite to the effect of SPTLC2. In addition, miR-124-3p was proved to negatively regulate SPTLC2 expression and suppress the apoptosis-promoting effect of SPTLC2 via the TLR4 signalling pathway.	[Su, Xinhong; Yang, Yongxiang; Bai, Wei; Chen, Huijun; Kang, Enming; Kong, Chuiguang; He, Xiaosheng] Air Force Mil Med Univ, Xijing Hosp, Dept Neurosurg, 169 Changle Western Rd, Xian 710032, Shanxi, Peoples R China; [Ye, Yuqin] PLA 921rd Hosp, Dept Neurosurg, Changsha 410000, Hunan, Peoples R China; [Zhang, Kailiang] Air Force Mil Med Univ, Tangdu Hosp, Inst Chinese PLA, Dept Orthoped Surg Orthoped Oncol, Xian 710032, Shaanxi, Peoples R China		He, XS (corresponding author), Air Force Mil Med Univ, Xijing Hosp, Dept Neurosurg, 169 Changle Western Rd, Xian 710032, Shanxi, Peoples R China.	hexiaos@fmmu.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471264]	This study was supported by the Natural Science Foundation of China (No. 81471264).	Bastianetto S, 1999, MOL BRAIN RES, V66, P35, DOI 10.1016/S0169-328X(99)00002-9; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Deng DN, 2016, CANCER SCI, V107, P899, DOI 10.1111/cas.12946; Dickson RC, 2000, METHOD ENZYMOL, V311, P3; Dong RF, 2018, J CELL BIOCHEM, V119, P269, DOI 10.1002/jcb.26170; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Geng LJ, 2017, EXP BIOL MED, V242, P1757, DOI 10.1177/1535370217734492; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hu LL, 2017, GRAEF ARCH CLIN EXP, V255, P2199, DOI 10.1007/s00417-017-3772-0; Huang S, 2018, FASEB J, V32, P2315, DOI 10.1096/fj.201700673RERR; Jain A, 2017, J CELL SCI, V130, P360, DOI 10.1242/jcs.194191; Jembrek MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/346783; Kang QM, 2017, ONCOTARGET, V8, P24314, DOI 10.18632/oncotarget.15149; Lang F, 2011, EXPERT OPIN THER TAR, V15, P1061, DOI 10.1517/14728222.2011.588209; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Li C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43834; Li W, 2013, J SURG RES, V180, P133, DOI 10.1016/j.jss.2012.10.928; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Maeng HJ, 2017, BMB REP, V50, P144, DOI 10.5483/BMBRep.2017.50.3.197; Pan Y, 2018, DOMEST ANIM ENDOCRIN, V65, P17, DOI 10.1016/j.domaniend.2018.05.002; Papagiannakopoulos T, 2009, CELL STEM CELL, V4, P375, DOI 10.1016/j.stem.2009.04.007; Periyasamy P, 2018, MOL NEUROBIOL, V55, P3196, DOI 10.1007/s12035-017-0584-5; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Wang JR, 2019, CANCER BIOMARK, V24, P159, DOI 10.3233/CBM-182000; Yang YX, 2019, NEUROCHEM RES, V44, P811, DOI 10.1007/s11064-018-02714-z; Yu NZ, 2018, TRANSL NEUROSCI, V9, P175, DOI 10.1515/tnsci-2018-0026; Yuan QY, 2017, CANCER BIOMARK, V19, P93, DOI 10.3233/CBM-160427; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou LJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44822; Zhou YJ, 2019, J ALZHEIMERS DIS, V67, P571, DOI 10.3233/JAD-181053	40	3	4	1	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2019	44	9					2113	2122		10.1007/s11064-019-02849-7			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	IW0AP	WOS:000484625100008	31372925				2022-02-06	
J	Sufaro, Y; Avraham, E; Alguyn, F; Azriel, A; Melamed, I				Sufaro, Yuval; Avraham, Elad; Alguyn, Farouq; Azriel, Amit; Melamed, Israel			Unfavorable functional outcome is expected for elderly patients suffering from acute subdural hematoma even when presenting with preserved level of consciousness	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Acute subdural hematoma; Age; Elderly; Glasgow coma scale; Neurologic deficits; Functional outcome	TRAUMATIC BRAIN-INJURY; MORTALITY; EPIDEMIOLOGY; AGE	Alongside an increase in life expectancy, median age of patients presenting with traumatic acute subdural hematomas (ASDH) has increased as well. Treatment guidelines are based on studies performed on relatively young patients. The optimal management of elderly (>70 years old) patients with ASDH, specifically those with relatively preserved level of consciousness, was not thoroughly investigated so far. We retrospectively examined elderly patients presented to our medical center between the years 2006-2016 with traumatic convexity ASDH and GCS of 13-15. 773 patients were included in the initial cohort and 54 patients were included in the final analysis. The mean age at presentation was 81.5 years and the means of hematoma thickness and midline shift were 15.5 mm and 6.6 mm, respectively. Patients in our cohort had an overall unfavorable outcome (mRS 5-6) of 28% and 56% at discharge and at 1 year following injury, respectively. The results were not significantly different for the subgroups of patients older than 80 years and patients with high ASA-PS. Surgical evacuation of the ASDH was undertaken in 28 patients with focal neurologic deficit and/or worsening on subsequent brain scans. At 1 year, 64% (18 patients) in the surgery group had unfavorable outcome compared to 48% (12 patients) in the conservative group. We believe that these numbers should be taken under consideration when assessing elderly patients with convexity ASDH and relatively preserved level of consciousness. (C) 2019 Elsevier Ltd. All rights reserved.	[Sufaro, Yuval; Avraham, Elad; Alguyn, Farouq; Azriel, Amit; Melamed, Israel] Soroka Univ Med Ctr, Dept Neurosurg, 151 Rager Ave, Beer Sheva, Israel; [Sufaro, Yuval; Avraham, Elad; Alguyn, Farouq; Azriel, Amit; Melamed, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel		Avraham, E (corresponding author), Soroka Univ Med Ctr, Dept Neurosurg, 151 Rager Ave, Beer Sheva, Israel.	eladavr@clalit.org.il					Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; [Anonymous], 2001, MAN GUID GER TRAUM E; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Codd PJ, 2013, J CLIN NEUROSCI, V20, P1751, DOI 10.1016/j.jocn.2013.02.019; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kuge A, 2017, ACUTE MED SURG, V4, P451, DOI 10.1002/ams2.295; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryota Tamura, 2016, CASE REP NEUROL MED, V2016; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Sinha VD, 2008, INDIAN J NEUROTRAUM, V5, P69; Skaga NO, 2007, J TRAUMA, V63, P972, DOI 10.1097/TA.0b013e31804a571c; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x	24	3	5	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2019	67						167	171		10.1016/j.jocn.2019.05.015			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IU2MD	WOS:000483413600030	31262452				2022-02-06	
J	Zhang, F; Huang, LH; Singichetti, B; Li, HL; Sullivan, L; Yang, JG				Zhang, Fang; Huang, Lihong; Singichetti, Bhavna; Li, Huiling; Sullivan, Lindsay; Yang, Jingzhen Ginger			Sex and age differences in hospitalized pediatric traumatic brain injury	PEDIATRICS INTERNATIONAL			English	Article						China; epidemiology; pediatric; traumatic brain injury	LONG-TERM DISABILITY; BICYCLE HELMET USE; UNITED-STATES; EPIDEMIOLOGY; CHILDREN; POPULATION; PREVALENCE; DEATHS; VISITS; US	Background The aim of this study was to investigate the epidemiological characteristics of pediatric traumatic brain injury (TBI) requiring hospitalization in Chinese children <= 17 years of age according to sex and age group. Methods This study retrospectively analyzed pediatric TBI inpatient data obtained via electronic health records from one children's hospital in China. Patients aged <= 17 years admitted to the hospital due to TBI between 1 January 2013 and 31 December 2015 were identified using International Classification of Diseases (ICD) -9 and ICD-10 codes. The demographic, injury, and hospitalization characteristics were analyzed by sex and age groups. Results The subject consisted of 1,087 pediatric TBI patients admitted to the hospital (61.5% boys). The highest proportion of hospitalization was observed in the 1-3 years age group. For both boys and girls, the most common diagnosis was "traumatic epidural hematoma" and the leading mechanism of TBI was "fall". The median length of hospital stay was 8.5 days and the median hospitalization cost was 7,977.4 Chinese yuan (approximately $US 1,140). Conclusions Boys and children aged 1-3 years incurred more pediatric TBI requiring hospitalization than their counterparts. Prevention of falls, the most common injury mechanism in both boys and girls, is an important strategy to reduce pediatric TBI and related hospitalizations.	[Zhang, Fang] Soochow Univ, Childrens Hosp, Suzhou, Jiangsu, Peoples R China; [Huang, Lihong; Singichetti, Bhavna] Fudan Univ, Zhongshan Hosp, Dept Biostat, Shanghai, Peoples R China; [Huang, Lihong; Sullivan, Lindsay; Yang, Jingzhen Ginger] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res Inst, Columbus, OH USA; [Li, Huiling] Soochow Univ, Sch Nursing, Suzhou, Jiangsu, Peoples R China; [Yang, Jingzhen Ginger] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Yang, JG (corresponding author), Ohio State Univ, Abigail Wexner Res Inst, Nationwide Childrens Hosp, Ctr Injury Res & Policy,Dept Pediat,Coll Med, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA.	ginger.yang@nationwidechildrens.org		Singichetti, Bhavna/0000-0002-2188-3979			Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cheung F.M., 1996, GROWING CHINESE WAY, P45; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; Efron B., 1986, STAT SCI, V1, P54, DOI 10.1214/ss/1177013815; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gielen AC, 2002, ARCH PEDIAT ADOL MED, V156, P33, DOI 10.1001/archpedi.156.1.33; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LeBlanc JC, 2006, CAN MED ASSOC J, V175, P883, DOI 10.1503/cmaj.050592; Li Y.L, 2017, GEOSCIENCE, V31, P1; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; PARKIN PC, 1993, PEDIATRICS, V91, P772; Peden M, 2008, WORLD REPORT CHILD I; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; US Consumer Product Safety Commission, 2010, PUBL PLAYGR SAF HDB; Wang B, 2015, CONT EC, V20, P116; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang YH, 2007, INT J MED INFORM, V76, P614, DOI 10.1016/j.ijmedinf.2006.05.003; Zhi D, 2000, CHIN J NEUROSURG, V16, P239; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493	43	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	SEP	2019	61	9					904	912		10.1111/ped.13946			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	JE7UU	WOS:000490896300009	31287612				2022-02-06	
J	Mumbower, R; Childs, G; Vance, DE; Dreer, LE; Novack, T; Heaton, K				Mumbower, Rachael; Childs, Gwendolyn; Vance, David E.; Dreer, Laura E.; Novack, Thomas; Heaton, Karen			Sleep following traumatic brain injury (TBI): experiences and influencing factors	BRAIN INJURY			English	Article						Traumatic brain injury; sleep; health education; qualitative	QUALITY INDEX; DISTURBANCES; CANNABIS; DYSFUNCTION; RECOVERY; METAANALYSIS; COMPLAINTS; DISORDERS; VETERANS; PATTERNS	Objective: This study aimed to 1) describe and explore the experiences of sleep following a moderate or severe traumatic brain injury (TBI) in community-dwelling adults, 2) elicit factors that positively or negatively impact the sleep experience, and 3) understand sleep-related education provided to survivors. Design: Qualitative description. Methods: Face-to-face interviews with 16 individuals using a semi-structured interview guide. Transcripts were systematically coded and common themes were identified. The final sample consisted of primarily Caucasian men with average age of 32.4 years (SD = 9.9), and average of 2.6 years (SD = .89) years post injury. Results: Community-dwelling survivors of TBI experienced poor sleep quality and quantity post-injury and described a variety of approaches to manage their sleep. Survivors described coping with sleep changes and using sleep as a coping mechanism for TBI. Additionally, survivors' responses indicated perceived lack of resources and preference for receiving education from knowledgeable, familiar clinicians during face-to-face encounters. Conclusions: This study provides a description of reported sleep experiences following TBI and adds new knowledge regarding sleep management strategies and preferences for resources. The findings suggest a need for education regarding sleep for rehabilitation professionals and long-term sleep support after discharge from rehabilitation.	[Mumbower, Rachael; Heaton, Karen] UAB, Sch Nursing, Birmingham, AL 35294 USA; [Childs, Gwendolyn] UAB, Undergrad & Prelicensure Programs, Sch Nursing, Birmingham, AL USA; [Vance, David E.] UAB, Res & Scholarship, Sch Nursing, Birmingham, AL USA; [Dreer, Laura E.] UAB, Dept Ophthalmol & Visual Sci, Birmingham, AL USA; [Novack, Thomas] UAB, Dept Phys Med & Rehabil, Birmingham, AL USA		Mumbower, R (corresponding author), UAB, Sch Nursing, Birmingham, AL 35294 USA.	rmumbower@ua.edu	Mumbower, Rachael/AAP-4635-2020; Vance, David/AAE-6047-2020	Novack, Thomas/0000-0003-3043-7900; Vance, David/0000-0002-0498-6263; Childs, Gwendolyn/0000-0002-1328-4239; Heaton, Karen/0000-0002-9532-1573			Adams D, 2016, NEUROREHABILITATION, V39, P223, DOI 10.3233/NRE-161353; Andreae MH, 2015, J PAIN, V16, P1221, DOI 10.1016/j.jpain.2015.07.009; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Babson KA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0775-9; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chen PY, 2015, J HEAD TRAUMA REHAB, V30, pE50, DOI 10.1097/HTR.0000000000000086; Coffey Nathan T, 2016, J Patient Exp, V3, P88, DOI 10.1177/2374373516667007; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Donders J, 2017, BRAIN INJURY, V31, P1871, DOI 10.1080/02699052.2017.1334962; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Fereday J., 2006, INT J QUAL METHODS, V5, P80, DOI [10.1177/160940690600500107, DOI 10.1177/160940690600500107]; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gates P, 2016, SUBST ABUS, V37, P255, DOI 10.1080/08897077.2015.1023484; Hawley LA, 2018, ARCH PHYS MED REHAB, V99, P1584, DOI 10.1016/j.apmr.2018.02.003; Hobson JA, 2002, CONSCIOUS COGN, V11, P377, DOI 10.1016/S1053-8100(02)00011-9; Huang TY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/378726; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Karadag E, 2017, NURS CRIT CARE, V22, P105, DOI 10.1111/nicc.12198; Katona I, 2015, HANDB EXP PHARMACOL, V231, P285, DOI 10.1007/978-3-319-20825-1_10; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Lequerica A, 2014, NEUROREHABILITATION, V35, P485, DOI 10.3233/NRE-141141; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lillehei AS, 2015, J ALTERN COMPLEM MED, V21, P430, DOI 10.1089/acm.2014.0327; Lincoln Y. S, 1986, NEW DIRECTIONS PROGR, V30, P73, DOI [DOI 10.1002/EV.1427, 10.1002/ev.1427]; Littlewood DL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012113; Lu W, 2015, BRAIN INJURY, V29, P1342, DOI 10.3109/02699052.2015.1043947; Lytle J, 2014, AM J CRIT CARE, V23, P24, DOI 10.4037/ajcc2014958; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Martin-Sanchez E, 2009, PAIN MED, V10, P1353, DOI 10.1111/j.1526-4637.2009.00703.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matthews EE, 2016, J HEAD TRAUMA REHAB, V31, P126, DOI 10.1097/HTR.0000000000000216; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; Munhall P., 2012, NURSING RES; MURRI L, 1984, ARCH NEUROL-CHICAGO, V41, P183, DOI 10.1001/archneur.1984.04050140081031; Nguyen BM, 2014, AM SURGEON, V80, P979; Nishida Masaki, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.09.2011.4845; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Paterson B, 2001, Rehabil Nurs, V26, P48; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Reddy DS, 2016, J PHARMACOL EXP THER, V357, P45, DOI 10.1124/jpet.115.230151; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Saldana J., 2015, CODING MANUAL QUALIT; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Szaflarski JP, 2014, EPILEPSY BEHAV, V41, P277, DOI 10.1016/j.yebeh.2014.08.135; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663	64	3	3	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1624	1632		10.1080/02699052.2019.1658133		AUG 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000483974700001	31462085				2022-02-06	
J	Santos, ME; Agrela, N				Santos, Maria Emilia; Agrela, Nicole			Traumatic brain injury in Portugal: progress in incidence and mortality	BRAIN INJURY			English	Article						Epidemiology; traumatic brain injury; incidence; mortality	EPIDEMIOLOGY; TRENDS; NORWAY; IMPACT	Objectives: Traumatic brain injury continue to be a public health issue, mainly as a result of road accidents and falls. Current epidemiological studies appear to be necessary for a better understanding and monitoring of this problem. This paper analyzes the evolution of these cases in Portugal from the late 1990s to 2014. Methods: The number of hospital admissions and of total mortality in the country were analyzed regarding 2011 and 2014. The results were compared with values obtained previously, for 1997. Results: Incidence rate decreased, being 137/100 000 in 1997 and 65/100 000 in 2014. The mortality rate has also decreased from 17/100 000 to 10/100 000. However, between 2011 and 2014, there was a trend to increase the total number of cases. The incidence rate by age group also differs, with fewer cases in the young adult population in 2014 contrasting with a very high mortality among people aged 80 or older, of 57/100 000. Men continue to show a greater incidence, presenting more hospitalization cases (1.4:1), and higher mortality (2.3:1). Conclusions: The results are consistent with other studies, revealing a decrease in cases, but a high mortality in the elderly population, and the need of more preventive measures.	[Santos, Maria Emilia] Univ Catolica Portuguesa, Ringgold Stand Inst, Ctr Interdisciplinary Res Hlth CIIS, Inst Hlth Sci, P-1649023 Lisbon, Portugal; [Agrela, Nicole] Univ Catolica Portuguesa, Ringgold Stand Inst, Inst Hlth Sci, Lisbon, Portugal		Santos, ME (corresponding author), Univ Catolica Portuguesa, Ringgold Stand Inst, Ctr Interdisciplinary Res Hlth CIIS, Inst Hlth Sci, P-1649023 Lisbon, Portugal.	me.psantos@ics.lisboa.ucp.pt					Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Dias C, 2014, ACTA MEDICA PORT, V27, P349, DOI 10.20344/amp.4892; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Miller WG, 1986, NEUROPSYCHOLOGY HDB, P347; Oliveira E, 2012, ACTA MEDICA PORT, V25, P179; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Santos Maria Emilia, 2003, Acta Med Port, V16, P71; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Szarpak Lukasz, 2011, Pol Przegl Chir, V83, P646, DOI 10.2478/v10035-011-0103-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; World Health Organization, 2002, PROJ MORT BURD DIS 2	21	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2019	33	12					1552	1555		10.1080/02699052.2019.1658227		AUG 2019	4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ8NK	WOS:000483226800001	31442091				2022-02-06	
J	Holmes, G; Clacy, A; Salmon, PM				Holmes, Glenn; Clacy, Amanda; Salmon, Paul M.			Sports-related concussion management as a control problem: using STAMP to examine concussion management in community rugby	ERGONOMICS			English	Article						Concussion; sports-related concussion; SRC; systems theory	INJURY; PREVENTION; DEPRESSION; SCHOOLBOY; SYSTEM; MODEL	The effective management of sports-related concussion is an on-going problem in amateur sport due to a number of systemic issues. These factors have often been studied in isolation with minimal consideration for the interactions between them, or the overall system in which they occur. The aim of this research was to model the actors, controls, and feedback mechanisms influencing the management of concussion in community rugby union using the Systems-Theoretic Accident Model and Processes (STAMP) method. Findings show that there are currently many inadequate controls, that are directly and indirectly impacting effective concussion management. The practical implications of these findings are discussed (e.g. improved guideline education, mandatory medical presence, rule amendments). Additionally, the model provides a sound framework similar team sports can use to inform research into injury management and prevention (e.g. rugby league, hockey, AFL). Practitioner Summary: Research shows that concussion management in regional sport is inconsistent due to contextual limitations. Systems-Theoretic Accident Model and Processes was applied to identify the systemic factors currently influencing concussion management practices in community sport. Findings show inadequate controls precipitate concussion management gaps. Practical implications of the findings are discussed.	[Holmes, Glenn; Clacy, Amanda] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Sippy Downs, Qld, Australia; [Salmon, Paul M.] Univ Sunshine Coast, Ctr Human Factors & Sociotech Syst, Sippy Downs, Qld, Australia; [Clacy, Amanda] Sunshine Coast Mind & Neurosci Thompson Inst, TI 2-40,12 Innovat Pkwy, Birtinya, Qld 4575, Australia		Holmes, G (corresponding author), Univ Sunshine Coast, 90 Sippy Downs Dr, Sippy Downs, Qld 4556, Australia.	gholmes1@usc.edu.au		Holmes, Glenn/0000-0003-2801-5522; Salmon, Paul/0000-0001-7403-0286	ARCAustralian Research Council [FT140100681]	Paul Salmon's contribution to this research was supported by an ARC Future Fellowship (FT140100681). We would like to thank the anonymous reviewers for their helpful comments on the original manuscript.	Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Boone SD, 2016, SUICIDE LIFE-THREAT, V46, P625, DOI 10.1111/sltb.12240; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Bremer E, 2018, AM J LIFESTYLE MED, V12, P148, DOI 10.1177/1559827616640196; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Clacy A, 2019, APPL ERGON, V80, P256, DOI 10.1016/j.apergo.2017.06.010; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Clacy A, 2015, PROCEDIA MANUF, V3, P1173, DOI 10.1016/j.promfg.2015.07.195; Clacy A, 2013, J BIOETHIC INQ, V10, P127, DOI 10.1007/s11673-012-9421-8; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Dawson K., 2017, P 13 INT C NAT DEC M, P48; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hollnagel E, 2012, FRAM: THE FUNCTIONAL RESONANCE ANALYSIS METHOD: MODELLING COMPLEX SOCIO-TECHNICAL SYSTEMS, P1; Hsu C., 2007, PRACTICAL ASSESSMENT, V12, P1, DOI DOI 10.1016/S0169-2070(99)00018-7; Hulme A, 2017, THEOR ISS ERGON SCI, V18, P338, DOI 10.1080/1463922X.2016.1274455; Hulme A, 2017, APPL ERGON, V65, P345, DOI 10.1016/j.apergo.2017.07.005; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Leveson N, 2004, SAFETY SCI, V42, P237, DOI 10.1016/S0925-7535(03)00047-X; Leveson NG, 2011, SAFETY SCI, V49, P55, DOI 10.1016/j.ssci.2009.12.021; List Mark, 2014, S D Med, V67, P370; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Salmon PM, 2016, ACCIDENT ANAL PREV, V96, P140, DOI 10.1016/j.aap.2016.05.025; Salmon PM, 2012, SAFETY SCI, V50, P1158, DOI 10.1016/j.ssci.2011.11.009; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910	40	3	3	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0014-0139	1366-5847		ERGONOMICS	Ergonomics	NOV 2	2019	62	11					1485	1494		10.1080/00140139.2019.1654134		AUG 2019	10	Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Psychology	JA5ZL	WOS:000482361100001	31390942				2022-02-06	
J	Davies, SC; Bernstein, ER; Daprano, CM				Davies, Susan C.; Bernstein, Elana R.; Daprano, Corinne M.			A Qualitative Inquiry of Social and Emotional Support for Students with Persistent Concussion Symptoms	JOURNAL OF EDUCATIONAL AND PSYCHOLOGICAL CONSULTATION			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; CHILDREN; CONSULTATION; ADOLESCENTS; DEPRESSION; SPORTS	Students who sustain concussions often struggle with social and emotional symptoms. Such symptoms can interfere with students' academic performance, relationships, and overall sense of well-being. This qualitative study involved interviews with eight adolescents and young adults who sustained concussions as youths and experienced significant social and emotional symptoms; six of the participants' parents were also interviewed. Grounded theory methodology was used to code the data, construct categories and identify themes, and develop a theoretical model of students' post-concussion social and emotional issues and potential sources of support. Categories of issues emerging from the interviews included anxiety/stress, depression/sadness, interpersonal difficulties/isolation, and irritability/moodiness. An exploration of barriers and facilitators of recovery revealed themes related to: factors at school, factors at home, medical care, and level of involvement with sports and athletic personnel. The theoretical model highlights important areas for development in school-based consultation to ameliorate students' post-concussion social and emotional symptoms.	[Davies, Susan C.; Bernstein, Elana R.] Univ Dayton, Sch Psychol, Dayton, OH 45469 USA; [Daprano, Corinne M.] Univ Dayton, Sch Educ & Hlth Sci, Dayton, OH 45469 USA; [Daprano, Corinne M.] Univ Dayton, Hlth & Sport Sci, Dayton, OH 45469 USA		Davies, SC (corresponding author), Univ Dayton, Dept Counselor Educ, 300 Coll Pk, Dayton, OH 45469 USA.	sdavies1@udayton.edu		Davies, Susan/0000-0003-4027-2310	Ohio Department of Public Safety, Division of Emergency Medical Services	This project was supported by funding from the Ohio Department of Public Safety, Division of Emergency Medical Services.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Charmaz K., 2014, BROKERAGE CLOSURE IN; Corbin J., 2014, BASICS QUALITATIVE R; Cover R, 2018, J ATHL TRAINING, V53, P646, DOI 10.4085/1062-6050-338-17; Davies S., 2016, MANAGING CONCUSSIONS; Dey, 1999, GROUNDING GROUNDED T; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Dreer LE, 2017, HEALTH PROMOT PRACT, V18, P428, DOI 10.1177/1524839916650865; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glang A., 2018, EXCEPTIONALITY ED IN, V27, P94; Glaser B., 1967, DISCOVERY GROUNDED T; Gould KR, 2019, NEUROPSYCHOL REHABIL, V29, P376, DOI 10.1080/09602011.2017.1307767; Graff DM, 2016, J CHILD NEUROL, V31, P1569, DOI 10.1177/0883073816666205; Grier BC, 2011, J EDUC PSYCHOL CONS, V21, P88, DOI 10.1080/10474412.2011.571522; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Marshall C., 2016, DESIGNING QUALITATIV; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Minney MJ, 2019, BRAIN INJURY, V33, P168, DOI 10.1080/02699052.2018.1540794; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Power TJ, 2013, ADV SCH MENT HEALTH, V6, P68, DOI 10.1080/1754730X.2013.749089; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Shaw SR, 2011, J EDUC PSYCHOL CONS, V21, P106, DOI 10.1080/10474412.2011.571479; Sheridan SM, 2009, J EDUC PSYCHOL CONS, V19, P106, DOI 10.1080/10474410902888566; SHIELDS JD, 1995, EDUC TREAT CHILD, V18, P184; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Truscott SD, 2011, J EDUC PSYCHOL CONS, V21, P169, DOI 10.1080/10474412.2011.574583; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152	37	3	3	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1047-4412	1532-768X		J EDUC PSYCHOL CONS	J. Educ. Psychol. Consult.	APR 2	2020	30	2					156	182		10.1080/10474412.2019.1649598		AUG 2019	27	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	LF0MY	WOS:000480570100001					2022-02-06	
J	Giorgi-Coll, S; Thelin, EP; Lindblad, C; Tajsic, T; Carpenter, KLH; Hutchinson, PJA; Helmy, A				Giorgi-Coll, Susan; Thelin, Eric Peter; Lindblad, Caroline; Tajsic, Tamara; Carpenter, Keri L. H.; Hutchinson, Peter J. A.; Helmy, Adel			Dextran 500 Improves Recovery of Inflammatory Markers: An In Vitro Microdialysis Study	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						chemokines; cytokines; Dextran 500; in vitro; microdialysis; recovery	TRAUMATIC BRAIN-INJURY; CYTOKINES; TRANSPORT; QUANTIFICATION; AGENTS; FLUIDS	Cerebral microdialysis (CMD) is used in severe traumatic brain injury (TBI) in order to recover metabolites in brain extracellular fluid (ECF). To recover larger proteins and avoid fluid loss, albumin supplemented perfusion fluid (PF) has been utilized, but because of regulatory changes in the European Union, this is no longer practicable. The aim with this study was to see whether fluid, absolute (AR), and relative (RR) recovery for the novel carrier, Dextran 500, was better than conventional PF for a range of cytokines and chemokines. An in vitro setup mimicking conditions observed in the neurocritical care of TBI patients was used, utilizing 100-kDa molecular-weight cut-off CMD catheters inserted through a triple-lumen bolt cranial access device into an external solution with diluted cytokine standards in known concentrations for 48 h (divided into 6-h epochs). Samples were run on a 39-plex Luminex (Luminex Corporation, Austin, TX) assay to assess cytokine concentrations. We found that fluid recovery was inadequate in 50% of epochs with conventional PF, whereas Dextran PF overcame this limitation. The AR was higher in the Dextran PF samples for a majority of cytokines, and RR was significantly increased for macrophage colony-stimulating factor and transforming growth factor-alpha. In summary, Dextran PF improved fluid and cytokine recovery as compared to conventional PF and is a suitable alternative to albumin supplemented PF for protein microdialysis.	[Giorgi-Coll, Susan; Thelin, Eric Peter; Tajsic, Tamara; Carpenter, Keri L. H.; Hutchinson, Peter J. A.; Helmy, Adel] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Carpenter, Keri L. H.; Hutchinson, Peter J. A.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Thelin, Eric Peter; Lindblad, Caroline] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric Peter] Karolinska Univ Hosp, Theme Neuro, Stockholm, Sweden		Thelin, EP (corresponding author), Karolinska Univ Sjukhuset Solna, BioClinicum J5 20, Tema Neuro, Forskargrp Svensson, S-17176 Stockholm, Sweden.	eric.thelin@ki.se	Helmy, Adel/AAS-3084-2020; Thelin, Eric Peter/K-2144-2012; Lindblad, Caroline/AAJ-7911-2021	Helmy, Adel/0000-0002-0531-0556; Thelin, Eric Peter/0000-0002-2338-4364; Lindblad, Caroline/0000-0003-4952-8597	National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); National Institute for Health Research (NIHR) ProfessorshipNational Institute for Health Research (NIHR); Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; Royal College of Surgeons of England; Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, 79068]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251, G0600986] Funding Source: UKRI	The work was supported by funding for S.G.C. and K.L.H.C. from the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). P.J.H. is funded by a National Institute for Health Research (NIHR) Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship, and the National Institute for Health Research Biomedical Research Centre, Cambridge. E.P.T. has received salary support from Swedish Society for Medical Research. A.H. is supported by the Royal College of Surgeons of England and the National Institute for Health Research Biomedical Research Centre, Cambridge. The study consumables were purchased through the NIHR Research Professorship (Peter Hutchinson), and the Luminex 200 analyzer was purchased with Medical Research Council (MRC) funding (G0600986 ID79068).	Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; Ao XP, 2004, ANAL CHEM, V76, P3777, DOI 10.1021/ac035536s; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; Chu JT, 2014, ANAL BIOANAL CHEM, V406, P7601, DOI 10.1007/s00216-014-8192-y; Chu JT, 2014, BIOMED MICRODEVICES, V16, P301, DOI 10.1007/s10544-013-9833-1; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Dahlin AP, 2014, ANAL CHEM, V86, P8671, DOI 10.1021/ac501880u; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Duo J, 2006, BIOSENS BIOELECTRON, V22, P449, DOI 10.1016/j.bios.2006.05.004; Giorgi-Coll S, 2017, ANAL BIOANAL CHEM, V409, P5031, DOI 10.1007/s00216-017-0447-y; Hamrin K, 2002, J APPL PHYSIOL, V92, P385, DOI 10.1152/jappl.2002.92.1.385; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00245; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Keeler GD, 2014, EUR J PHARM SCI, V57, P60, DOI 10.1016/j.ejps.2013.11.005; Khan F, 2015, SCAND J IMMUNOL, V82, P467, DOI 10.1111/sji.12332; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; R Core Team, 2018, STATS PACK LANG ENV; Sarkar D, 2008, USE R, P1; Schutte RJ, 2004, ANAL CHEM, V76, P6058, DOI 10.1021/ac0493626; Sjogren S, 2002, BRIT J DERMATOL, V146, P375, DOI 10.1046/j.1365-2133.2002.04621.x; Thelin EP, 2017, AAPS J, V19, P367, DOI 10.1208/s12248-016-0027-7; Trickler W, 2003, J PHARM SCI-US, V92, P1419, DOI 10.1002/jps.10410; Waelgaard L, 2006, SCAND J IMMUNOL, V64, P345, DOI 10.1111/j.1365-3083.2006.01826.x; West B., 2015, LINEAR MIXED MODELS; Wilke C O, 2018, COWPLOT STREAMLINED; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E	36	3	3	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6513		AUG 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IP6AN	WOS:000480133200001	31298609	Green Submitted, Green Published, hybrid			2022-02-06	
J	Gornall, A; Takagi, M; Clarke, C; Babl, FE; Davis, GA; Dunne, K; Anderson, N; Hearps, SJC; Demaneuf, T; Rausa, V; Anderson, V				Gornall, Alice; Takagi, Michael; Clarke, Cathriona; Babl, Franz E.; Davis, Gavin A.; Dunne, Kevin; Anderson, Nicholas; Hearps, Stephen J. C.; Demaneuf, Thibaut; Rausa, Vanessa; Anderson, Vicki			Behavioral and Emotional Difficulties after Pediatric Concussion	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						behavior problems; CBCL; concussion recovery; pediatrics	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; CHILDREN; SYMPTOMS; ADOLESCENTS; OUTCOMES; STATEMENT; SEVERITY; HISTORY; SPORTS	Pediatric concussion is a major public health concern. Despite the prevalence of behavior problems following concussion and their potential role in prolonged symptoms, little is known about how child and adolescent behavior may impact post-concussion recovery. We sought to examine change in behavioral and emotional functioning in a sample of children ages 5 to <18 years with concussion. This study reports on data collected as part of a larger single-site prospective longitudinal cohort study. Participants were recruited from the Emergency Department (ED) of a tertiary children's hospital and completed the Child Behavior Checklist (CBCL) at 2 weeks (acute; T2) and 3 months (post-acute; T4) post-injury. Children with concussion (n = 231) showed a significant reduction in internalizing (p < 0.001, d = 0.27), externalizing (p < 0.001, d = 0.23), and total behavior problems (p < 0.001, d = 0.36) at 3 months compared with 2 weeks post-injury. Multiple regression models found a significant interaction between age and sex with higher rates of internalizing (p = 0.048, eta(2)(p) = 0.02) and total (p = 0.040, eta(2)(p) = 0.02) behavior problems as age increased in females. The results show that pediatric concussion is associated with temporary behavioral disturbances that are likely to improve considerably in the months following injury. Nonetheless, as age increases, females may be at increased risk for experiencing ongoing internalizing problems several months after concussion and may require targeted clinical intervention.	[Gornall, Alice; Takagi, Michael; Clarke, Cathriona; Babl, Franz E.; Davis, Gavin A.; Dunne, Kevin; Anderson, Nicholas; Hearps, Stephen J. C.; Demaneuf, Thibaut; Rausa, Vanessa; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Takagi, Michael; Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Dunne, Kevin; Anderson, Vicki] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Gornall, Alice] Monash Univ, Psychol Sci, Melbourne, Vic, Australia		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Brain & Mind, Level 4 West,50 Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Hearps, Stephen/L-6853-2016	Gornall, Alice/0000-0002-0406-3266; Hearps, Stephen/0000-0003-2984-1172; Takagi, Michael/0000-0003-2903-7598	Royal Children's Hospital Research Foundation; Victorian Government Operational Infrastructure Scheme; Australian National Health and Medical Research Council (NHMRC) Development GrantNational Health and Medical Research Council of Australia; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia; Australian Government Research Training Program (RTP) ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science	The authors would like to thank the participating families and ED staff at the Royal Children's Hospital in Melbourne, Australia, for their support of this study. The authors also extend their gratitude to the dedicated volunteers and research assistants without whom this study would not have been possible.; This study was funded by the Royal Children's Hospital Research Foundation and the Victorian Government Operational Infrastructure Scheme. Hearps was funded by an Australian National Health and Medical Research Council (NHMRC) Development Grant, Babl was funded by the Royal Children's Hospital Research Foundation and NHMRC Practitioner Fellowship, and Anderson by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.; Gornall was supported by an Australian Government Research Training Program (RTP) Scholarship.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Brooks BL, 2019, J NEUROTRAUM, V36, P679, DOI 10.1089/neu.2018.5792; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Cohen J., 2013, STAT POWER ANAL BEHA; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Gagner C., 2017, PSYCHOL MED, V48, P1; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Rescorla L.A., 2001, RATINGS RELATIONS DS; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sawyer MG, 2000, AUST NZ J PSYCHIAT, V34, P214, DOI 10.1046/j.1440-1614.2000.00729.x; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Takagi M., 2017, SPORTS CONCUSSIONS C; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Wiener, 2006, ESSENTIALS CHILD ADO; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	40	3	3	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2018.6235		AUG 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IP3DF	WOS:000479937400001	31072265				2022-02-06	
J	LaGree, D; Wilbur, D; Cameron, GT				LaGree, Danielle; Wilbur, Douglas; Cameron, Glen T.			A strategic approach to sports crisis management Assessing the NFL concussion crisis from marketing and public relations perspectives	INTERNATIONAL JOURNAL OF SPORTS MARKETING & SPONSORSHIP			English	Article						Emotion; Media; Sports marketing; Reputation; Crisis communication	NATIONAL FOOTBALL LEAGUE; NEGATIVE EMOTIONS; COMMUNICATION; INFORMATION; MEDIA; MODEL; ANGER; FACE	Purpose Using the National Football League (NFL) concussion crisis context, the purpose of this paper is to provide sports marketers with a strategic approach to sports crisis management through consideration of crisis media coverage and organizational reputation. Design/methodology/approach An online experiment assessed the impact of two crisis response strategies, fan involvement and exposure to crisis media coverage on emotional response, corporate message credibility, crisis perception and perceived corporate reputation. Findings The accident response strategy was associated with more favorable perceptions of the NFL and corporate message credibility. Sports fan involvement facilitated more favorable perceptions of the NFL's reputation, while exposure to media coverage of the NFL's crisis created negative perceptions of the NFL's reputation. Exposure to media coverage of the NFL concussion crisis increased feelings of anger, which in turn decreased perceptions of corporate message credibility. Originality/value This paper addresses sports crisis strategy from both marketing and public relations perspectives. It describes how strategic efforts protect a sports organization's reputation, thus increasing marketing effectiveness.	[LaGree, Danielle] Kansas State Univ, AQ Miller Sch Journalism & Mass Commun, Coll Arts & Sci, Manhattan, KS 66506 USA; [Wilbur, Douglas; Cameron, Glen T.] Univ Missouri, Missouri Sch Journalism, Columbia, MO USA		LaGree, D (corresponding author), Kansas State Univ, AQ Miller Sch Journalism & Mass Commun, Coll Arts & Sci, Manhattan, KS 66506 USA.	DaniLaGree@k-state.edu					[Anonymous], 2013, ASS PRESS; [Anonymous], 2015, ASS PRESS; Barca J., 2018, FORBES; Bedard P., 2018, NFL SEEKS CRISIS COM; BEE CC, 2010, INTERNATIONAL JOURNA, V2, P37; BILLINGS RS, 1980, ADMIN SCI QUART, V25, P300, DOI 10.2307/2392456; Borah P, 2018, J HEALTH COMMUN, V23, P399, DOI 10.1080/10810730.2018.1455770; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cancel AE, 1999, PUBLIC RELAT REV, V25, P171, DOI 10.1016/S0363-8111(99)80161-1; Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009; Claeys AS, 2013, J APPL COMMUN RES, V41, P293, DOI 10.1080/00909882.2013.806991; Concussion Legacy Foundation, 2018, WHAT IS CTE; Coombs WT, 2007, CORP REPUT REV, V10, P163, DOI 10.1057/palgrave.crr.1550049; Coombs W. T., 2006, J PROMOTION MANAGEME, V12, P241, DOI DOI 10.1300/J057V12N03_13; Coombs WT, 2005, RES EMOTION ORGAN, V1, P263; Coombs WT., 1996, J PUBLIC RELATIONS R, V8, P279; Dawar N, 2000, J MARKETING RES, V37, P215, DOI 10.1509/jmkr.37.2.215.18729; de Oca JM, 2016, POP COMMUN, V14, P3, DOI 10.1080/15405702.2015.1084623; Ezell L., 2013, PBS FRONTLINE; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Fearn-Banks K., 2002, CRISIS COMMUNICATION, V2nd ed.; Fombrun C.J., 2000, CORP REPUT REV, V3, P13, DOI DOI 10.1057/PALGRAVE.CRR.1540095; Fortunato JA, 2000, PUBLIC RELAT REV, V26, P481, DOI 10.1016/S0363-8111(00)00060-6; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Gaines C., 2015, BUSINESS INSIDER; Gold J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-792; GONZALEZHERRERO A, 2008, J CONTING CRISIS MAN, V16, P143, DOI DOI 10.1111/J.1468-5973.2008.00543.X; Guo SJ, 2017, PUBLIC RELAT REV, V43, P755, DOI 10.1016/j.pubrev.2017.07.003; Hallahan K, 2000, PUBLIC RELAT REV, V26, P499, DOI 10.1016/S0363-8111(00)00061-8; Hayes A.F., 2017, INTRO MEDIATION MODE; Heinze KL, 2017, J SPORT MANAGE, V31, P497, DOI 10.1123/jsm.2016-0309; Huddleston T., 2017, FORTUNE; Ioakimidis M., 2010, INT J SPORT MARK SPO, V11, P2, DOI DOI 10.1108/IJSMS-11-04-2010-B002; IZARD CE, 1993, PSYCHOL REV, V100, P68; Jin Y., 2007, SPHERA PUBLICA, V7, P81; Jin Y, 2012, J PUBLIC RELAT RES, V24, P266, DOI 10.1080/1062726X.2012.676747; Jin Y, 2010, CORP COMMUN, V15, P428, DOI 10.1108/13563281011085529; Jin Y, 2010, J PUBLIC RELAT RES, V22, P429, DOI 10.1080/10627261003801420; Jin Y, 2010, COMMUN RES, V37, P522, DOI 10.1177/0093650210368256; Jin Y, 2010, PUBLIC RELAT REV, V36, P63, DOI 10.1016/j.pubrev.2009.08.015; Johansen W, 2012, PUBLIC RELAT REV, V38, P270, DOI 10.1016/j.pubrev.2011.11.008; Kelly E., 2017, YOUNG RES, V1, P27; Kemp E, 2014, PSYCHOL MARKET, V31, P933, DOI 10.1002/mar.20744; Kim HJ, 2011, COMMUN RES, V38, P826, DOI 10.1177/0093650210385813; King J., 2017, FALLOUT CONTINUES NF; Koesters TC, 2017, SPORT MARKET Q, V26, P121; Laros FJM, 2005, J BUS RES, V58, P1437, DOI 10.1016/j.jbusres.2003.09.013; Laskas J., 2009, GQ; Lazarus R. S., 1991, EMOTION AND ADAPTION; Lerner JS, 2006, J BEHAV DECIS MAKING, V19, P115, DOI 10.1002/bdm.515; Lim C. H., 2010, International Journal of Sport Communication, V3, P49; McCarthy M., 2016, SPORTING NEWS; Mondello M, 2017, J SPORT MANAGE, V31, P562, DOI 10.1123/jsm.2016-0222; Morgan R., 2017, NEW YORK POST; Nabi RL, 1999, COMMUN THEOR, V9, P292, DOI 10.1111/j.1468-2885.1999.tb00172.x; Nabi RL, 2002, COMMUN MONOGR, V69, P204, DOI 10.1080/03637750216541; Nabi RL, 2003, COMMUN RES, V30, P224, DOI 10.1177/0093650202250881; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Nichols B.S., 2016, LETS GET ENGAGED CRO, P71; O'Reilly N, 2008, INT J SPORT FINANC, V3, P79; OHANIAN R, 1990, J ADVERTISING, V19, P39, DOI 10.1080/00913367.1990.10673191; Orr T., 2015, J BUSINESS EC, V6, P1735, DOI 10.15341/jbe(2155-7950)/10.06.2015/008; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pasqualicchio G., 2017, CASE STUDIES SPORT M, V6, P1; Poels K, 2006, J ADVERTISING RES, V46, P18, DOI 10.2501/S0021849906060041; Pulver A., 2015, CONCUSSION MEDIC DID; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Richards O, 2017, PUBLIC RELAT REV, V43, P615, DOI 10.1016/j.pubrev.2017.02.015; Scherer K. R., 2001, APPRAISAL PROCESSES; Seifert K., 2018, WHATS REALLY CHANGED; Thorson E, 2012, J MASS COMMUN Q, V89, P112, DOI 10.1177/1077699011430066; Utz S, 2013, PUBLIC RELAT REV, V39, P40, DOI 10.1016/j.pubrev.2012.09.010; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Ward J., 2017, NY TIMES; Wilbur D, 2016, J US CHINA PUBLIC AD, V13, P181; Yannopoulou N, 2011, J MARKET MANAG-UK, V27, P530, DOI 10.1080/0267257X.2010.498141; ZAICHKOWSKY JL, 1985, J CONSUM RES, V12, P341, DOI 10.1086/208520; 2018, FORBES, V2018, P7; [No title captured]; 2018, CNN, V2018, P8	80	3	3	5	26	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1464-6668	2515-7841		INT J SPORT MARK SPO	Int. J. Sports Mark. Spons.	AUG 5	2019	20	3					407	429		10.1108/IJSMS-05-2018-0045			23	Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	JF6CM	WOS:000491475500003					2022-02-06	
J	Bakhtiarydavijani, A; Murphy, MA; Mun, S; Jones, MD; Bammann, DJ; LaPlaca, MC; Horstemeyer, MF; Prabhu, RK				Bakhtiarydavijani, A.; Murphy, M. A.; Mun, S.; Jones, M. D.; Bammann, D. J.; LaPlaca, M. C.; Horstemeyer, M. F.; Prabhu, R. K.			Damage biomechanics for neuronal membrane mechanoporation	MODELLING AND SIMULATION IN MATERIALS SCIENCE AND ENGINEERING			English	Article						mechanoporation; traumatic brain injury; multiscale modeling; molecular dynamics; mechano-physiological damage modeling; internal state variable theory	MOLECULAR-DYNAMICS SIMULATIONS; TRAUMATIC BRAIN-INJURY; CELL-DEATH MECHANISMS; TRANSIENT PORES; LIPID-BILAYERS; STRAIN; MODEL; DEFORMATION; STRESS; DISRUPTIONS	In this paper, mechano-physiological damage evolution equations are developed to capture the disruption of neuronal membrane integrity and quantify neuronal cell death in the brain during mechanical insult. Traumatic brain injury involves multiscale structure-property relations where the mechanical behavior of the brain is phenomenologically characterized at the macroscale. However, damage largely occurs at the cellular level (microscale and nanoscale) due to the loss of ion homeostasis. To measure this neuronal death mechanism, molecular dynamics simulations were performed on a representative neuronal membrane, a 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) bilayer structures. Pore density and pore growth due to membrane deformation were then quantified. The results showed that the pore growth and pore density rates were a function of stress state, but only the pore growth rate was a function of the strain rate. Mechano-physiological damage evolution equations were developed to capture the damage biomechanics of the POPC bilayer based on the pore density and growth rate responses. The proposed damage evolution equations were combined with the Nernst-Planck diffusion equation to produce a criterion based on the change of intracellular calcium ion concentration.	[Bakhtiarydavijani, A.; Prabhu, R. K.] Mississippi State Univ, Dept Agr & Biol Engn, 130 Creelman St, Mississippi State, MS 39762 USA; [Bakhtiarydavijani, A.; Murphy, M. A.; Mun, S.; Bammann, D. J.; Horstemeyer, M. F.; Prabhu, R. K.] Mississippi State Univ, Ctr Adv Vehicular Syst, 200 Res Blvd, Starkville, MS 39759 USA; [Jones, M. D.] Cardiff Univ, Inst Med Engn & Med Phys, Cardiff Sch Engn, Queens Bldg, Cardiff CF24 3AA, S Glam, Wales; [Bammann, D. J.; Horstemeyer, M. F.] Mississippi State Univ, Dept Mech Engn, Box 9552, Mississippi State, MS 39762 USA; [LaPlaca, M. C.] Georgia Inst Technol, Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA		Prabhu, RK (corresponding author), Mississippi State Univ, Dept Agr & Biol Engn, 130 Creelman St, Mississippi State, MS 39762 USA.; Prabhu, RK (corresponding author), Mississippi State Univ, Ctr Adv Vehicular Syst, 200 Res Blvd, Starkville, MS 39759 USA.	rprabhu@abe.msstate.edu		Bakhtiarydavijani, Amirhamed/0000-0002-1483-5346; Murphy, Michael/0000-0001-9158-1709; Mun, Sungkwang/0000-0002-3347-2587	NSF through a subcontract with Mississippi State University; EPSCoR research program [EPS_0903787]; NSFNational Science Foundation (NSF); Bagley College of Engineering; Center for Advanced Vehicular Systems at Mississippi State University	This material is based upon work supported by the NSF through a subcontract with Mississippi State University and was performed through the EPSCoR research program (EPS_0903787). Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF. The authors would like to express their gratitude to the NSF, and the Bagley College of Engineering and the Center for Advanced Vehicular Systems at Mississippi State University for supporting this work.	BAMMANN DJ, 1989, NUCL ENG DES, V116, P355, DOI 10.1016/0029-5493(89)90095-2; Bear M. F., 2006, NEUROSCIENCE; Bier M, 1999, BIOELECTROMAGNETICS, V20, P194, DOI 10.1002/(SICI)1521-186X(1999)20:3<194::AID-BEM6>3.0.CO;2-0; Brochard-Wyart F, 2000, PHYSICA A, V278, P32, DOI 10.1016/S0378-4371(99)00559-2; Cajigal S., 2007, NEUROLOGY TODAY, V7, P1; Calvo B, 2009, J BIOMECH, V42, P642, DOI 10.1016/j.jbiomech.2008.12.002; Cardenas AE, 2000, BIOPHYS J, V79, P80, DOI 10.1016/S0006-3495(00)76275-8; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; COLEMAN BD, 1967, J CHEM PHYS, V47, P597, DOI 10.1063/1.1711937; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; DRESNER L, 1972, DESALINATION, V10, P27, DOI 10.1016/S0011-9164(00)80245-3; El Sayed T, 2008, COMPUT METHODS APPL, V197, P4470; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Evans E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095010; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Francis DK, 2014, INT J SOLIDS STRUCT, V51, P2765, DOI 10.1016/j.ijsolstr.2014.03.025; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gozen I, 2014, EUR PHYS J-SPEC TOP, V223, P1813, DOI 10.1140/epjst/e2014-02228-5; Horstemeyer MF, 2010, INT J PLASTICITY, V26, P1310, DOI 10.1016/j.ijplas.2010.06.005; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Horstemeyer MF, 1999, INT J SOLIDS STRUCT, V36, P5029, DOI 10.1016/S0020-7683(98)00239-X; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Ingolfsson HI, 2017, BIOPHYS J, V113, P2271, DOI 10.1016/j.bpj.2017.10.017; Johnson KL, 2016, MATER DESIGN, V111, P108, DOI 10.1016/j.matdes.2016.08.064; Kirby B, 2010, MICRO NANOSCALE FLUI; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Koshiyama K, 2011, J BIOMECH, V44, P2053, DOI 10.1016/j.jbiomech.2011.05.014; Koshiyama K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018105; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7; Maher E, 2012, J MECH BEHAV BIOMED, V12, P9, DOI 10.1016/j.jmbbm.2012.03.001; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Melikov KC, 2001, BIOPHYS J, V80, P1829, DOI 10.1016/S0006-3495(01)76153-X; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Murphy MA, 2019, J BIOMOL STRUCT DYN, V37, P1346, DOI 10.1080/07391102.2018.1453376; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Ovalle-Garcia E, 2011, J PHYS CHEM B, V115, P4826, DOI 10.1021/jp111985z; Pena E, 2014, COMPUT STRUCT, V130, P57, DOI 10.1016/j.compstruc.2013.10.002; Picas L, 2012, BIOPHYS J, V102, pL1, DOI 10.1016/j.bpj.2011.11.4001; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Schwenk CF, 2004, PURE APPL CHEM, V76, P37, DOI 10.1351/pac200476010037; Shinoda W, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134103; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; The MathWorks Inc, 2015, MATLAB IM PROC TOOLB; Tieleman DP, 2006, J PHYS-CONDENS MAT, V18, pS1221, DOI 10.1088/0953-8984/18/28/S07; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Tomasini MD, 2010, EXP BIOL MED, V235, P181, DOI 10.1258/ebm.2009.009187; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082	64	3	3	0	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0965-0393	1361-651X		MODEL SIMUL MATER SC	Model. Simul. Mater. Sci. Eng.	AUG	2019	27	6							065004	10.1088/1361-651X/ab1efe			22	Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Physics	IC1GG	WOS:000470706700001					2022-02-06	
J	Barnes, SM; Monteith, LL; Forster, JE; Nazem, S; Borges, LM; Stearns-Yoder, KA; Bahraini, NH				Barnes, Sean M.; Monteith, Lindsey L.; Forster, Jeri E.; Nazem, Sarra; Borges, Lauren M.; Stearns-Yoder, Kelly A.; Bahraini, Nazanin H.			Developing Predictive Models to Enhance Clinician Prediction of Suicide Attempts Among Veterans With and Without PTSD	SUICIDE AND LIFE-THREATENING BEHAVIOR			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SELF-INJURIOUS THOUGHTS; TRAUMATIC BRAIN-INJURY; RISK-ASSESSMENT; HEALTH-CARE; BEHAVIORS; METAANALYSIS; IDEATION; VALIDITY; ANXIETY	The limitations of self-report confine clinicians' ability to accurately predict suicides and suicide attempts (SAs). Behavioral assessments (e.g., Death Implicit Association Test [IAT]) may be a means of supplementing self-report and clinician prediction. Objective The authors aimed to build and test a predictive model of SAs that included established risk factors and measures of suicide risk, and Death IAT scores. The authors also sought to test the predictive validity of the SA model among subgroups of Veterans with and without PTSD. Method Participants included 166 psychiatrically hospitalized Veterans. Results A model that included patient prediction, age, and Death IAT scores improved upon clinician prediction of SAs during the six-month follow-up (C-statistic for clinician prediction = 73.6, 95% CI [62.9, 84.4] and C-statistic for model = 82.8, 95% CI [74.6, 91.0]). The model was tested in subgroups of Veterans with and without PTSD. Among Veterans without PTSD, the Death IAT and patient prediction predicted SAs above and beyond clinician prediction, while these variables did not significantly improve prediction among Veterans with PTSD (C-statistic for no-PTSD = 91.3, 95% CI [80.6, 1.00]; C-statistic for PTSD = 86.8, 95% CI [76.8, 96.8]). Building a separate model for Veterans with PTSD did not improve upon clinician prediction. Conclusions Findings indicate that predictive models may bolster clinician prediction of SAs and that predictors may differ for Veterans with PTSD.	[Barnes, Sean M.; Monteith, Lindsey L.; Forster, Jeri E.; Nazem, Sarra; Borges, Lauren M.; Stearns-Yoder, Kelly A.; Bahraini, Nazanin H.] Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 North Wheeling St, Aurora, CO 80045 USA; [Barnes, Sean M.; Monteith, Lindsey L.; Nazem, Sarra; Borges, Lauren M.; Bahraini, Nazanin H.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Forster, Jeri E.; Nazem, Sarra; Stearns-Yoder, Kelly A.; Bahraini, Nazanin H.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Forster, Jeri E.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA		Barnes, SM (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 North Wheeling St, Aurora, CO 80045 USA.	sean.barnes2@va.gov	Monteith, Lindsey L./X-3658-2019	Monteith, Lindsey L./0000-0002-8104-5280	Military Suicide Research Consortium, through the Office of the Assistant Secretary of Defense for Health Affairs; Rocky Mountain Mental Illness, Research, Education, and Clinical Center; Denver VA Medical Center [W81XWH-10-2-0178]	This research was funded by the Military Suicide Research Consortium, through the Office of the Assistant Secretary of Defense for Health Affairs, and the Rocky Mountain Mental Illness, Research, Education, and Clinical Center. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Military Suicide Research Consortium, Department of Defense, Department of Veterans Affairs, or the US Government. Denver VA Medical Center Grant Number: W81XWH-10-2-0178.	Barnes SM, 2017, SUICIDE LIFE-THREAT, V47, P67, DOI 10.1111/sltb.12265; Beck AT., 1991, MANUAL BECK SCALE SU; Bolton JM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4978; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Cole-King A., 2013, ADV PSYCHIAT TREAT, V19, P276, DOI [10.1192/apt.bp.110.008763, DOI 10.1192/APT.BP.110.008763]; Denneson LM, 2010, PSYCHIAT SERV, V61, P1192, DOI 10.1176/ps.2010.61.12.1192; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Fawcett J, 2001, ANN NY ACAD SCI, V932, P94, DOI 10.1111/j.1749-6632.2001.tb05800.x; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Freedenthal S, 2011, J CLIN PSYCHOL, V67, P609, DOI 10.1002/jclp.20782; Ganzini L, 2013, J GEN INTERN MED, V28, P1215, DOI 10.1007/s11606-013-2412-6; Guerra VS, 2011, J ANXIETY DISORD, V25, P12, DOI 10.1016/j.janxdis.2010.06.025; Holowka DW, 2014, J CONSULT CLIN PSYCH, V82, P569, DOI 10.1037/a0036347; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; King's College of London, 2017, STIGM BARR CAR SERV; Kleiman EM, 2017, J ABNORM PSYCHOL, V126, P726, DOI 10.1037/abn0000273; Matarazzo BB, 2013, SUICIDE LIFE-THREAT, V43, P235, DOI 10.1111/j.1943-278x.2012.00131.x; McKinney JM, 2017, J AFFECT DISORDERS, V214, P100, DOI 10.1016/j.jad.2017.03.008; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2007, PSYCHOL ASSESSMENT, V19, P309, DOI 10.1037/1040-3590.19.3.309; Nock MK, 2010, PSYCHOL SCI, V21, P511, DOI 10.1177/0956797610364762; Nock MK, 2009, J ABNORM PSYCHOL, V118, P816, DOI 10.1037/a0016948; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Panagioti M, 2012, COMPR PSYCHIAT, V53, P915, DOI 10.1016/j.comppsych.2012.02.009; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Popovic D, 2015, BIPOLAR DISORD, V17, P795, DOI 10.1111/bdi.12338; Randall JR, 2013, PSYCHOL ASSESSMENT, V25, P714, DOI 10.1037/a0032391; Ringer FB, 2018, PSYCHOL ASSESSMENT, V30, P767, DOI 10.1037/pas0000519; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Smith EG, 2013, J CLIN PSYCHIAT, V74, P226, DOI 10.4088/JCP.12m07853; Suris A, 2011, J TRAUMA STRESS, V24, P605, DOI 10.1002/jts.20674; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Weiner J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-374; Wenzel A, 2008, APPL PREV PSYCHOL, V12, P189, DOI 10.1016/j.appsy.2008.05.001; Wortzel HS, 2017, J PSYCHIATR PRACT, V23, P436, DOI 10.1097/PRA.0000000000000263; Wortzel HS, 2013, J PSYCHIATR PRACT, V19, P323, DOI 10.1097/01.pra.0000432603.99211.e8	39	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-0234	1943-278X		SUICIDE LIFE-THREAT	Suicide Life-Threat. Behav.	AUG	2019	49	4					1094	1104		10.1111/sltb.12511			11	Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	IQ3GV	WOS:000480640600015	30206955				2022-02-06	
J	Braeckman, K; Descamps, B; Vanhove, C				Braeckman, Kim; Descamps, Benedicte; Vanhove, Christian			Advanced Diffusion Imaging in The Hippocampus of Rats with Mild Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 150; traumatic brain injury; agnetic resonance imaging; diffusion tensor imaging; preclinical; rat; hippocampus		Mild traumatic brain injury (mTBI) is the most common type of acquired brain injury. Since patients with traumatic brain injury show a tremendous variability and heterogeneity (age, gender, type of trauma, other possible pathologies, etc.), animal models play a key role in unraveling factors that are limitations in clinical research. They provide a standardized and controlled setting to investigate the biological mechanisms of injury and repair following TBI. However, not all animal models mimic the diffuse and subtle nature of mTBI effectively. For example, the commonly used controlled cortical impact (CCI) and lateral fluid percussion injury (LFPI) models make use of a craniotomy to expose the brain and induce widespread focal trauma, which are not commonly seen in mTBI. Therefore, these experimental models are not valid to mimic mTBI. Thus, an appropriate model should be used to investigate mTBI. The Marmarou weight drop model for rats induces similar microstructurel alterations and cognitive impairments as seen in patients who sustain mild trauma; therefore, this model was selected for this protocol. Conventional computed tomography and magnetic resonance imaging (MRI) scans commonly show no damage following a mild injury, because mTBI induces often only subtle and diffuse injuries. With diffusion weighted MRI, it is possible to investigate microstructurel properties of brain tissue, which can provide more insight into the microscopic alterations following mild trauma. Therefore, the goal of this study is to obtain quantitative information of a selected region-of-interest (i.e., hippocampus) to follow up disease progression after obtaining a mild and diffuse brain injury.	[Braeckman, Kim; Descamps, Benedicte; Vanhove, Christian] Univ Ghent, Infin Lab, Med Imaging & Signal Proc Grp, Ghent, Belgium		Braeckman, K (corresponding author), Univ Ghent, Infin Lab, Med Imaging & Signal Proc Grp, Ghent, Belgium.	Kim.Braeckman@ugent.be		Vanhove, Christian/0000-0002-3988-5980	Research Foundation - Flanders (FWO)FWO [G027815N]	The authors would like to thank Research Foundation - Flanders (FWO) for supporting this work (Grant number: G027815N).	[Anonymous], 2019, MATLAB CODE DKI WMTI; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Leemans A., 2019, EXPLORE DTI; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lyeth B. G., 2016, FRONT NEUROL, V7, P1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Wallace E. J, 2018, BRAIN IMAGING BEHAV, P1; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	25	3	3	0	7	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	AUG	2019		150							e60012	10.3791/60012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY7QI	WOS:000486589800106	31475983	Green Published			2022-02-06	
J	Cecchi, NJ; Oros, TJ; Ringhofer, JJ; Monroe, DC				Cecchi, Nicholas J.; Oros, Theophil J.; Ringhofer, Justin J.; Monroe, Derek C.			Comparison of head impact attenuation capabilities between a standard American football helmet and novel protective equipment that couples a helmet and shoulder pads	SPORTS ENGINEERING			English	Article						Concussion; Helmet; Headgear; Head kinematics; Neck injury	HIGH-SCHOOL FOOTBALL; PROFESSIONAL FOOTBALL; GAME IMPACTS; BRAIN-INJURY; CONCUSSION; COLLEGIATE; PERFORMANCE; EPIDEMIOLOGY; PLAYERS	Concussive and subconcussive sports-related head impacts are common in the United States, particularly in American football. Football helmets are constantly improving upon their predecessors and are proven to reduce head impact kinematics and the risk of sports-related head injury. All football helmets are required to pass certification testing overseen by the National Operating Committee on Standards for Athletic Equipment (NOCSAE) before they are permitted for use. A new advance in protective equipment involves coupling a helmet and shoulder pads as one connected piece of protective equipment. These protective gears cannot be tested using the standard NOCSAE method as they are worn over a user's head, neck, and upper torso. We aimed to test the effectiveness of a prototype of a coupled, one-piece design, relative to a standard football helmet, using a custom drop tower method of testing. Relative to the standard football helmet, the coupled design reduced measures of peak linear acceleration at front, side, and rear impacts (p < .001) and peak rotational acceleration at all tested head locations (p < .004). The coupled design was also more effective than the standard helmet in attenuating the resultant upper neck force (p < .004) at all tested head impact locations and resultant upper neck moment at rear and side impact locations (p < .048). Future iterations of coupled, one-piece designs should use the results of this study to make improvements to the device, and further investigations on the effectiveness and safety implications of the protective gear are necessary.	[Cecchi, Nicholas J.; Oros, Theophil J.; Ringhofer, Justin J.] Impact Sports Co LLC, Anaheim, CA 92805 USA; [Monroe, Derek C.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA		Cecchi, NJ (corresponding author), Impact Sports Co LLC, Anaheim, CA 92805 USA.	nick.cecchi@impactsportsco.com	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163; Monroe, Derek/0000-0003-3885-6878	Popejoy Family Trust	NJC, TJO, and JJR have a financial interest in Popejoy Sports LLC. Funding for study expenses was provided by the Popejoy Family Trust.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; BISHOP PJ, 1990, AM J SPORT MED, V18, P201, DOI 10.1177/036354659001800215; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Delaney JS, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.015735; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; NOCSAE, 2017, STAND PERF SPEC NEWL; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson B, 2018, P I MECH ENG P-J SPO, V232, P94, DOI 10.1177/1754337117707859; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Zanetti K, 2013, INT RES COUNCIL BIOM	27	3	3	1	8	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	AUG	2019	22	3-4							16	10.1007/s12283-019-0311-8			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	IV7QS	WOS:000484462300001					2022-02-06	
J	Gao, J; Wei, LM; Xu, GJ; Ren, CG; Zhang, ZW; Liu, YC				Gao, Jian; Wei, Limin; Xu, Guangjun; Ren, Chunguang; Zhang, Zongwang; Liu, Yanchao			Effects of dexmedetomidine vs sufentanil during percutaneous tracheostomy for traumatic brain injury patients A prospective randomized controlled trial	MEDICINE			English	Article						dexmedetomidine; monitored anesthesia care; percutaneous tracheostomy; sufentanil; traumatic brain injury	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; MANAGEMENT; PROPOFOL; SEDATION; CHALLENGES; DIAGNOSIS; RECOVERY; EFFICACY; SAFETY	Background: Percutaneous tracheostomy, almost associated with cough reflex and hemodynamic fluctuations, is a common procedure for traumatic brain injury (TBI) patients, especially those in neurosurgery intensive care units (NICUs). However, there are currently a lack of effective preventive measures to reduce the risk of secondary brain injury. The aim of this study was to compare the effect of dexmedetomidine (DEX) vs sufentanil during percutaneous tracheostomy in TBI patients. Methods: The 196 TBI patients who underwent percutaneous tracheostomy were randomized divided into 3 groups: group D1 (n= 62, DEX infusion at 0.5 mu g.kg(-1) for 10minutes, then adjusted to 0.2-0.7 mu g.kg(-1).hour(-1)), group D2 (n= 68, DEX infusion at 1 mu g.kg(-1) for 10 minutes, then adjusted to 0.2-0.7 mu g.kg(-1).hour(-1)), and groupS(n= 66, sufentanil infusion 0.3 mu g.kg(-1) for 10minutes, then adjusted to 0.2-0.4 mu g.kg(-1).hour(-1)). The bispectral index (BIS) of all patients was maintained at 50 to 70 during surgery. Anesthesia onset time, hemodynamic variables, total cumulative dose of DEX/sufentanil, total doses of rescue propofol and fentanyl, time to first dose of rescue propofol and fentanyl, number of intraoperative patient movements and cough reflexes, adverse events, and surgeon satisfaction score were recorded. Results: Anesthesia onset time was significantly lower in group D2 than in both other groups(14.35 +/- 3.23vs12.42 +/- 2.12vs13.88 +/- 3.51 minutes in groups D1, D2, and S, respectively; P<. 001). Both heart rate and mean arterial pressure during percutaneous tracheostomy were more stable in group D2. Total doses of rescue propofol and fentanyl were significantly lower in group D2 than in group D1(P<. 001). The time to first dose of rescue propofol and fentanyl were significantly longer in group D2 than in both other groups (P<. 001). The number of patient movements and cough reflexes during percutaneous tracheostomy were lower in group D2 than in both other groups (P<. 001). The overall incidences of tachycardia and hypertension (which required higher doses of esmolol and urapidil, respectively) were also lower in group D2 than in both other groups (P<.05). Three patients in group Shad respiratory depression compared to X in the D1 group and X in the D2 group. The surgeon satisfaction score was significantly higher in group D2 than in both other groups (P<. 05). Conclusions: During percutaneous tracheostomy, compared with sufentanil, DEX (1 mu g.kg(-1) for 10minutes, then adj usted to 0.2-0.7 mu g.kg(-1).hour(-1)) can provide the desired attenuation of the hemodynamic response without increased adverse events. Consequently, DEX could be used safely and effectively during percutaneous tracheostomy in TBI patients.	[Gao, Jian; Wei, Limin; Xu, Guangjun; Ren, Chunguang; Zhang, Zongwang; Liu, Yanchao] Liaocheng Peoples Hosp, Dept Anaesthesiol, Liaocheng, Shandong, Peoples R China		Liu, YC (corresponding author), Liaocheng Peoples Hosp, Liaocheng, Shandong, Peoples R China.	289048370@qq.com					Alofisan TO, 2019, PEDIATR CRIT CARE ME, V20, P252, DOI 10.1097/PCC.0000000000001811; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bang SA, 2016, J NEUROTRAUM, V33, P1005, DOI 10.1089/neu.2015.4051; Buki A, 2017, IDEGGYOGY SZEMLE, V70, P223, DOI 10.18071/isz.70.0223; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Cho JS, 2016, AM J THER, V23, pE369, DOI 10.1097/MJT.0000000000000074; D'Aragon F, 2013, CAN J ANESTH, V60, P370, DOI 10.1007/s12630-013-9896-8; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; De Guzman E, 2017, CRIT CARE CLIN, V33, P423, DOI 10.1016/j.ccc.2017.03.011; Devlin JW, 2014, CHEST, V145, P1204, DOI 10.1378/chest.13-1448; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Farrell Deacon, 2018, Curr Anesthesiol Rep, V8, P279, DOI 10.1007/s40140-018-0286-1; Fernandez-Ortega JF, 2015, J HEAD TRAUMA REHAB, V30, P364, DOI 10.1097/HTR.0000000000000116; Freeman BD, 2017, CRIT CARE CLIN, V33, P311, DOI 10.1016/j.ccc.2016.12.007; Gaither JB, 2015, J EMERG MED, V49, P375, DOI 10.1016/j.jemermed.2015.01.038; Graves JM, 2016, PEDIATR CRIT CARE ME, V17, P438, DOI 10.1097/PCC.0000000000000698; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Gu JW, 2014, J CRIT CARE, V29, P287, DOI 10.1016/j.jcrc.2013.10.021; Hall AM, 2008, SPINAL CORD, V46, P753, DOI 10.1038/sc.2008.18; Isley MR, 2009, J CLIN MONIT COMPUT, V23, P369, DOI 10.1007/s10877-009-9191-y; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Kakkar A, 2016, J CLIN ANESTH, V33, P283, DOI 10.1016/j.jclinane.2016.04.026; Khan Abdul Alim, 2017, Anesth Essays Res, V11, P964, DOI 10.4103/aer.AER_103_17; Kim SY, 2009, BRIT J ANAESTH, V103, P750, DOI 10.1093/bja/aep263; Kleffmann J, 2012, NEUROCRIT CARE, V17, P85, DOI 10.1007/s12028-012-9709-x; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Levin R, 2001, LARYNGOSCOPE, V111, P1169, DOI 10.1097/00005537-200107000-00008; MacLaren R, 2014, ANN PHARMACOTHER, V48, P17, DOI 10.1177/1060028013511228; Prielipp RC, 2002, ANESTH ANALG, V95, P1052, DOI 10.1097/00000539-200210000-00048; Rana S, 2005, MAYO CLIN PROC, V80, P1632, DOI 10.4065/80.12.1632; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Schomer KJ, 2019, J INTENSIVE CARE MED, V34, P62, DOI 10.1177/0885066616689555; Schultz MJ, 2007, CRIT CARE MED, V35, P676, DOI 10.1097/01.CCM.0000254051.16396.60; Sifringer M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/530371; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Su X, 2016, LANCET, V388, P1893, DOI 10.1016/S0140-6736(16)30580-3; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Tang QL, 2017, PEERJ, V5, DOI 10.7717/peerj.2986; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Vollmer JP, 2018, CRIT CARE MED, V46, pE91, DOI 10.1097/CCM.0000000000002802; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Wang SL, 2017, BIOMED PHARMACOTHER, V93, P1337, DOI 10.1016/j.biopha.2017.06.051; Wang WM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00410; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Yaghoobi Siamak, 2014, Glob J Health Sci, V6, P221, DOI 10.5539/gjhs.v6n4p221; Young AMH, 2018, PEDIATR RES, V83, P41, DOI 10.1038/pr.2017.215; Zhang HQ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005815	48	3	4	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	AUG	2019	98	35							e17012	10.1097/MD.0000000000017012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY2RU	WOS:000486239900072	31464960	Green Published, gold			2022-02-06	
J	Jones, NS; Wieschhaus, K; Martin, B; Tonino, PM				Jones, Nathaniel S.; Wieschhaus, Kyle; Martin, Brendan; Tonino, Pietro M.			Medical Supervision of High School Athletics in Chicago: A Follow-up Study	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						medical aspects of sports; athletic training; injury prevention; medical supervision; football (American); head injuries (concussion)	ASSOCIATION POSITION STATEMENT; EMERGENCY PREPAREDNESS; SECONDARY-SCHOOLS; TRAINER SERVICES; CARDIAC-ARREST; SUDDEN-DEATH; TASK-FORCE; MANAGEMENT; FOOTBALL; RECOMMENDATIONS	Background: High school sports participation in the United States has increased dramatically over the past 25 years. A corresponding increase in the number of injuries has been noted, particularly in contact sports such as football. This has led medical and sports organizations nationwide to advocate for proper medical supervision of athletes at games and practices. Purpose: To gather information from Chicago public high schools to gauge how medical supervision for high school sports has changed in 2017 compared with 2003. Study Design: Cross-sectional study. Methods: Survey questionnaires were sent to the athletic directors of all 99 Chicago public high schools to complete via email. The questionnaire survey contained the same questions as in a survey conducted in 2003 by Tonino and Bollier, with the addition of 4 novel questions relating to emergency action plans (EAPs), automated external defibrillators, concussion management policy, and tackling progression drills. Results: The response rate was 66.67% (66/99 schools). Of the 66 responding schools, all with football programs, no school had a physician on the sideline at home games (decrease from 10.6% in 2003), 37.9% had an athletic trainer present (increase from 8.5% in 2003), and 63.6% had a paramedic available (decrease from 89.4% in 2003). In 2017, 65.6% of responding schools had a coach certified in cardiopulmonary resuscitation (CPR) available at practice to handle medical problems, compared with 89.4% in 2003 (P < .001). Regarding the 4 novel questions, 93.9% of the responding schools had proper tackling progression drills in place, followed by 89.1% who had appropriate EAPs and 93.9% with concussion management protocols, including return-to-play and return-to-learn protocols. Conclusion: Although significant improvement was found in athletic trainer coverage, especially at games, physician coverage was lacking and fewer coaches were certified in CPR in 2017 compared with 2003. EAPs and concussion management protocols were present in most Chicago public high schools. Overall, greater medical supervision is needed, which we believe should come in the form of increased athletic training and physician involvement and coverage, given that expert, expedited medical care saves lives.	[Jones, Nathaniel S.; Wieschhaus, Kyle; Martin, Brendan; Tonino, Pietro M.] Loyola Univ Med Ctr, Maywood, IL 60153 USA; [Jones, Nathaniel S.; Tonino, Pietro M.] Loyola Univ Chicago, Stritch Sch Med, Dept Orthopaed Surg & Rehabil, Maywood, IL USA; [Wieschhaus, Kyle] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA; [Martin, Brendan] Loyola Univ Chicago, Maywood, IL USA		Jones, NS (corresponding author), Loyola Univ Med Ctr, Dept Orthopaed Surg & Rehabil, 2160 S First Ave,Maguire Bldg,Suite 1700, Maywood, IL 60153 USA.	jonen@lumc.edu	Martin, Brendan/AAG-6147-2020; Shaheen, Ahmed/AAP-4054-2021	Shaheen, Ahmed/0000-0002-2216-1951; Jones, Nathaniel/0000-0002-7618-9431			Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; Andersen JC, 2002, J ATHL TRAINING, V37, P99; Aukerman DF, 2006, SOUTH MED J, V99, P132, DOI 10.1097/01.smj.0000199749.22741.5e; Binkley HM, 2002, J ATHL TRAINING, V37, P329; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Casa DJ., 2008, J ATHL TRAINING, V43, P416; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Drezner JA, 2007, J ATHL TRAINING, V42, P143; Fincham JE, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720243; Geijer JR, 2009, INTERNET J ALLIED HE, V7; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harer Matthew W, 2014, WMJ, V113, P144; Heck JF, 2004, J ATHL TRAINING, V39, P101; Holmberg M, 2000, RESUSCITATION, V44, P7, DOI 10.1016/S0300-9572(99)00155-0; Johnson ST, 2017, SPORTS HEALTH, V9, P181, DOI 10.1177/1941738116686782; Lear A, 2015, J ATHL TRAINING, V50, P1054, DOI 10.4085/1062-6050-50.8.01; Mazerolle SM, 2015, J ATHL TRAINING, V50, P1059, DOI 10.4085/1062-6050-50.10.01; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; National Federation of State High School Associations, 2014, REC GUID MIN HEAD IM; National Federation of State High School Associations, 2016, HIGH SCH SPORTS PART; National Federation of State High School Associations Sports Medicine Advisory Committee, 2018, HEAT ACCL HEAT ILLN; Pike A, 2016, J ATHL TRAINING, V51, P717, DOI 10.4085/1062-6050-51.11.04c; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Porter Marianne, 1980, Phys Sportsmed, V8, P95, DOI 10.1080/00913847.1980.11948564; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Pryor RR, 2014, PEDIATR EXERC SCI, V26, P124, DOI 10.1123/pes.2014-0014; Ransone J, 1999, J ATHL TRAINING, V34, P267; Salzman GA, 2015, J PEDIATR SURG, V50, P1192, DOI 10.1016/j.jpedsurg.2014.10.058; Scarneo SE, 2019, J ATHL TRAINING, V54, P99, DOI 10.4085/1062-6050-82-18; Schneider K, 2017, RURAL REMOTE HEALTH, V17; Tonino PM, 2004, PHYSICIAN SPORTSMED, V32, P37, DOI 10.3810/psm.2004.02.123; Travers AH, 2010, CIRCULATION, V122, pS676, DOI 10.1161/CIRCULATIONAHA.110.970913	34	3	3	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	AUG	2019	7	8							2325967119862503	10.1177/2325967119862503			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	IS8ES	WOS:000482382900001	31448300	Green Published, gold			2022-02-06	
J	Karakilic, E; Ahci, S				Karakilic, Ersen; Ahci, Serhat			Permanent central diabetes insipidus after mild head injury	BMJ CASE REPORTS			English	Article						pituitary disorders; neurological injury; neuroendocrinology; trauma Cns; pns		We report a case of a patient with mild traumatic brain injury (TBI) who was diagnosed with permanent central diabetes insipidus (DI). A 21-year-old man was admitted to our outpatient clinic with polyuria and polydipsia 1week after a mild head injury. He was well, except for these complaints. The initial laboratory workup was consistent with DI. There was no abnormality with other laboratory and hormone values. MRI showed lack of neurohypophyseal hyperintensity with no other abnormal findings. The patient responded well to desmopressin therapy. At the first year of the diagnosis, the patient still needed to use desmopressin treatment as we concluded that DI is permanent. DI is not uncommon after TBI, but it is often seen after severe TBI. We present here an extraordinary case of developing permanent DI after mild TBI with the absence of neurohypophyseal bright spot on MRI with no other abnormal findings.	[Karakilic, Ersen] Canakkale Onsekiz Mart Univ, Tip Fak, Endocrinol & Metab, Canakkale, Turkey; [Ahci, Serhat] Canakkale Onsekiz Mart Univ, Tip Fak, Internal Med, Canakkale, Turkey		Karakilic, E (corresponding author), Canakkale Onsekiz Mart Univ, Tip Fak, Endocrinol & Metab, Canakkale, Turkey.	ersenkarakilic@comu.edu.tr		KARAKILIC, ERSEN/0000-0003-3590-2656			Adams NC, 2018, NEURORADIOLOGY, V60, P995, DOI 10.1007/s00234-018-2072-7; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Garrahy A, 2019, CLIN ENDOCRINOL, V90, P23, DOI 10.1111/cen.13866; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Robertson GL, 2016, BEST PRACT RES CL EN, V30, P205, DOI 10.1016/j.beem.2016.02.007; ROBERTSON GL, 1995, ENDOCRIN METAB CLIN, V24, P549, DOI 10.1016/S0889-8529(18)30031-8; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Tudor RM, 2019, PITUITARY, V22, P296, DOI 10.1007/s11102-018-0917-z	11	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	AUG	2019	12	5							e228737	10.1136/bcr-2018-228737			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VK1LS	WOS:000661395200099	31142487	Green Published			2022-02-06	
J	Lang, SS; Zhang, BQ; Yver, H; Palma, J; Kirschen, MP; Topjian, AA; Kennedy, B; Storm, PB; Heuer, GG; Mensinger, JL; Huh, JW				Lang, Shih-Shan; Zhang, Bingqing; Yver, Hugues; Palma, Judy; Kirschen, Matthew P.; Topjian, Alexis A.; Kennedy, Benjamin; Storm, Phillip B.; Heuer, Gregory G.; Mensinger, Janell L.; Huh, Jimmy W.			Reduction of ventriculostomy-associated CSF infection with antibiotic-impregnated catheters in pediatric patients: a single-institution study	NEUROSURGICAL FOCUS			English	Article						external ventricular drain; externalized shunt; CSF infection; pediatric; neurocritical care; ventriculitis; ventriculostomy	NEUROCRITICAL CARE; DRAINS; EFFICACY	OBJECTIVE External ventricular drains (EVDs) are commonly used in the neurosurgical population. However, very few pediatric neurosurgery studies are available regarding EVD-associated infection rates with antibiotic-impregnated EVD catheters. The authors previously published a large pediatric cohort study analyzing nonantibiotic-impregnated EVD catheters and risk factors associated with infections. In this study, they aimed to analyze the EVD-associated infection rate after implementation of antibiotic-impregnated EVD catheters. METHODS A retrospective observational cohort of pediatric patients (younger than 18 years of age) who underwent a burr hole for antibiotic-impregnated EVD placement and who were admitted to a quaternary care ICU between January 2011 and January 2019 were reviewed. The ventriculostomy-associated infection rate in patients with antibiotic-impregnated EVD catheters was compared to the authors' historical control of patients with nonantibiotic-impregnated EVD catheters. RESULTS Two hundred twenty-nine patients with antibiotic-impregnated EVD catheters were identified. Neurological diagnostic categories included externalization of an existing shunt (externalized shunt) in 34 patients (14.9%); brain tumor (tumor) in 77 patients (33.6%); intracranial hemorrhage (ICH) in 27 patients (11.8%), traumatic brain injury (TBI) in 6 patients (2.6%); and 85 patients (37.1%) were captured in an "other" category. Two of 229 patients (0.9% of all patients) had CSF infections associated with EVD management, totaling an infection rate of 0.99 per 1000 catheter days. This is a significantly lower infection rate than was reported in the authors' previously published analysis of the use of nonantibiotic-impregnated EVD catheters (0.9% vs 6%, p = 0.00128). CONCLUSIONS In their large pediatric cohort, the authors demonstrated a significant decline in ventriculostomy-associated CSF infection rate after implementation of antibiotic-impregnated EVD catheters at their institution.	[Lang, Shih-Shan; Kennedy, Benjamin; Storm, Phillip B.; Heuer, Gregory G.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lang, Shih-Shan; Palma, Judy; Kennedy, Benjamin; Storm, Phillip B.; Heuer, Gregory G.] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed, Philadelphia, PA 19104 USA; [Zhang, Bingqing; Kirschen, Matthew P.; Topjian, Alexis A.; Huh, Jimmy W.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Yver, Hugues] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Mensinger, Janell L.] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA		Lang, SS (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	chens4@email.chop.edu	Mensinger, Janell/AAR-3375-2021				Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ifeachor AP, 2015, PEDIATR DRUGS, V17, P239, DOI 10.1007/s40272-015-0127-3; Jamjoom AAB, 2018, J NEUROL NEUROSUR PS, V89, P120, DOI 10.1136/jnnp-2017-316415; Kestle JRW, 2016, J NEUROSURG-PEDIATR, V17, P391, DOI 10.3171/2015.8.PEDS15253; LaRovere KL, 2013, PEDIATR NEUROL, V48, P206, DOI 10.1016/j.pediatrneurol.2012.12.006; Mikhaylov Y, 2014, J CLIN NEUROSCI, V21, P765, DOI 10.1016/j.jocn.2013.09.002; Muttaiyah S, 2010, J CLIN NEUROSCI, V17, P296, DOI 10.1016/j.jocn.2009.06.016; Root BK, 2016, WORLD NEUROSURG, V86, P306, DOI [10.1016/J.WNEU.2015.09.032, 10.1016/j.wneu.2015.09.032]; Shekhar H, 2016, BRIT J NEUROSURG, V30, P64, DOI 10.3109/02688697.2015.1096903; Sheppard JP, 2018, NEUROSURGERY; Sonabend AM, 2011, NEUROSURGERY, V68, P996, DOI 10.1227/NEU.0b013e3182096d84; Talibi S, 2016, BRIT J NEUROSURG, V30, P560, DOI 10.1080/02688697.2016.1181150; Tamburrini G, 2008, ACTA NEUROCHIR, V150, P1049, DOI 10.1007/s00701-008-0022-6; Topjian AA, 2014, NEUROCRIT CARE, V21, P294, DOI 10.1007/s12028-013-9946-7; Verberk JDM, 2016, J HOSP INFECT, V92, P401, DOI 10.1016/j.jhin.2015.12.018; Wright K, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12271	17	3	3	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	AUG	2019	47	2							E4	10.3171/2019.5.FOCUS19279			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IN4LX	WOS:000478647700004	31370025	gold			2022-02-06	
J	Lansade, L; Bonneau, C; Parias, C; Biau, S				Lansade, Lea; Bonneau, Coralie; Parias, Celine; Biau, Sophie			Horse's emotional state and rider safety during grooming practices, a field study	APPLIED ANIMAL BEHAVIOUR SCIENCE			English	Article						Equus caballus; Welfare; Emotion; Accidents; Riding activity	ANIMAL-WELFARE; HEART-RATE; BEHAVIOR; STRESS	Care given to animals, such as grooming for horses, can be a source of well-being when carried out correctly. However, it can cause discomfort when badly perceived and lead to potentially dangerous reactions. This study aimed to describe how grooming is conducted in the field, in terms of the horse's emotional state and also rider safety. Our observations carried out on 69 horses in riding centres and sports stables show that grooming produces more negative than positive emotions. Indeed, only 5% of horses showed mutual grooming, approach or relaxed behaviour, whereas four times more horses expressed avoidance and threatening behaviours. These results have consequences for handler safety. Regarding threatening behaviours, nine incidents (a hoof or teeth passing within 10 cm of the rider's body or head) were recorded. Concerning riders, 100% behaved in a risky way at least once: passing behind or under the head of the horse without keeping it in the field of view (97%) or squatting by its feet (42%). On average, riders carried out 6.7 + 0.49 dangerous behaviours per session, and sometimes up to 19. Moreover, only 7% of them wore a hard hat when preparing their horse, while the risk of concussion is just as high on foot as in the saddle. Finally, 88% of them showed posture which was risky for their backs when picking out hooves. Surprisingly, riders' experience had no effect on the parameters recorded. In particular, horse professionals were just as exposed to risky situations, did not protect their backs, and their horses showed similar levels of defensive behaviours or signs of discomfort as the less experienced riders (P > 0.05). This result is undoubtedly linked to the lack of importance granted to this practice and little teaching about reading horse signals indicating comfort and discomfort. We hope that our results will make riders aware of how important grooming is for the horse's welfare as much as for their own health and safety.	[Lansade, Lea; Bonneau, Coralie; Parias, Celine] Univ Tours, PRC, CNRS, INRA,IFCE, F-37380 Nouzilly, France; [Biau, Sophie] IFCE Ecole Natl Equitat, BP 207, F-49411 Saumur, France		Lansade, L (corresponding author), INRA, PRC, Ctr Val Loire, F-37380 Nouzilly, France.	lea.lansade@inra.fr			IFCE (French Horse and Riding Institute)	IFCE (French Horse and Riding Institute) funded this experiment. This funding source had no role in study design, data collection or analysis, or preparation or submission of the manuscript	Ahloy-Dallaire J, 2018, BEHAV PROCESS, V156, P3, DOI 10.1016/j.beproc.2017.11.011; Biau S, 2016, 12 INT EQ SCI C UND; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Broom DM, 1998, ADV STUD BEHAV, V27, P371; Carmichael SP, 2014, INJURY, V45, P1479, DOI 10.1016/j.injury.2014.03.016; Christensen JW, 2012, APPL ANIM BEHAV SCI, V140, P44, DOI 10.1016/j.applanim.2012.05.003; Corr PJ, 2013, EMOT REV, V5, P285, DOI 10.1177/1754073913477507; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; FEH C, 1993, ANIM BEHAV, V46, P1191, DOI 10.1006/anbe.1993.1309; Fortin M, 2018, J COMP PSYCHOL, V132, P130, DOI 10.1037/com0000091; Fraser D, 2009, APPL ANIM BEHAV SCI, V118, P108, DOI 10.1016/j.applanim.2009.02.020; GIEBEL G, 1993, CHIRURG, V64, P938; Hall C, 2018, APPL ANIM BEHAV SCI, V205, P183, DOI 10.1016/j.applanim.2018.03.006; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Hintze S, 2016, PLOS ONE, V11; Lansade L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32993-z; McBride SD, 2004, J EQUINE VET SCI, V24, P76, DOI 10.1016/j.jevs.2004.01.014; Mellor DJ, 2015, ANIM WELFARE, V24, P241, DOI 10.7120/09627286.24.3.241; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Nielsen BL, 2018, APPL ANIM BEHAV SCI, V205, P175, DOI 10.1016/j.applanim.2018.04.013; Reefmann N, 2009, ANIM BEHAV, V78, P651, DOI 10.1016/j.anbehav.2009.06.015; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Schmied C, 2008, APPL ANIM BEHAV SCI, V109, P25, DOI 10.1016/j.applanim.2007.01.013; Silver J R, 1991, Br J Sports Med, V25, P105; Valenchon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170783; Wolyncewicz GEL, 2018, INJURY, V49, P933, DOI 10.1016/j.injury.2017.12.003	26	3	3	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0168-1591	1872-9045		APPL ANIM BEHAV SCI	Appl. Anim. Behav. Sci.	AUG	2019	217						43	47		10.1016/j.applanim.2019.04.017			5	Agriculture, Dairy & Animal Science; Behavioral Sciences; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Behavioral Sciences; Veterinary Sciences	IR6PM	WOS:000481561200006		Green Published, Bronze			2022-02-06	
J	Maia, PD; Raj, A; Kutz, JN				Maia, Pedro D.; Raj, Ashish; Kutz, J. Nathan			Slow-gamma frequencies are optimally guarded against effects of neurodegenerative diseases and traumatic brain injuries	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Slow-gamma; Neurodegenerative disease; Alzheimer; Traumatic brain injury; Focal axonal swelling; Demyelination; Spike-train robustness	AXONAL-INJURY; MULTIPLE-SCLEROSIS; AUTOIMMUNE ENCEPHALOMYELITIS; NEURONAL-ACTIVITY; WORKING-MEMORY; SYNCHRONIZATION; OSCILLATIONS; DYSFUNCTION; MODELS; DEGENERATION	We introduce a computational model for the cellular level effects of firing rate filtering due to the major forms of neuronal injury, including demyelination and axonal swellings. Based upon experimental and computational observations, we posit simple phenomenological input/output rules describing spike train distortions and demonstrate that slow-gamma frequencies in the 38-41 Hz range emerge as the most robust to injury. Our signal-processing model allows us to derive firing rate filters at the cellular level for impaired neural activity with minimal assumptions. Specifically, we model eight experimentally observed spike train transformations by discrete-time filters, including those associated with increasing refractoriness and intermittent blockage. Continuous counterparts for the filters are also obtained by approximating neuronal firing rates from spike trains convolved with causal and Gaussian kernels. The proposed signal processing framework, which is robust to model parameter calibration, is an abstraction of the major cellular-level pathologies associated with neurodegenerative diseases and traumatic brain injuries that affect spike train propagation and impair neuronal network functionality. Our filters are well aligned with the spectrum of dynamic memory fields including working memory, visual consciousness, and other higher cognitive functions that operate in a frequency band that is - at a single cell level - optimally guarded against common types of pathological effects. In contrast, higher-frequency neural encoding, such as is observed with short-term memory, are susceptible to neurodegeneration and injury.	[Maia, Pedro D.; Raj, Ashish] Weill Cornell Med, Dept Radiol, New York, NY 10065 USA; [Maia, Pedro D.; Raj, Ashish] Weill Cornell Med, Brain & Mind Res Inst, New York, NY 10065 USA; [Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA		Maia, PD (corresponding author), Weill Cornell Med, Dept Radiol, New York, NY 10065 USA.; Maia, PD (corresponding author), Weill Cornell Med, Brain & Mind Res Inst, New York, NY 10065 USA.	pedro.doria.maia@gmail.com; asr2004@med.cornell.edu; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257			Adalbert R, 2009, BRAIN, V132, P402, DOI 10.1093/brain/awn312; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Crick F., 1990, Seminars in the Neurosciences, V2, P263; CRICK F, 1992, SCI AM, V267, P153, DOI 10.1038/scientificamerican0992-152; CRICK F, 1990, COLD SPRING HARB SYM, V55, P953; Daianu M., 2016, SPIE P, V9784, P1; Dayan P, 2001, THEORETICAL NEUROSCI; DeStefano N, 1995, ANN NEUROL, V38, P901, DOI 10.1002/ana.410380610; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Edlow BL, 2016, NEUROCRIT CARE, V24, P342, DOI 10.1007/s12028-015-0216-8; Fan JQ, 1998, SCAND J STAT, V25, P359, DOI 10.1111/1467-9469.00109; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gold I, 1999, CONSCIOUS COGN, V8, P186, DOI 10.1006/ccog.1999.0399; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hellman A. N., 2010, LAB CHIP, P16; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; HENRY GH, 1974, J NEUROPHYSIOL, V37, P1394, DOI 10.1152/jn.1974.37.6.1394; Herwerth M, 2016, ANN NEUROL, V79, P794, DOI 10.1002/ana.24630; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Karlsson P, 2016, SCAND J PAIN, V10, P28, DOI 10.1016/j.sjpain.2015.08.007; Kirk M, 2017, NEUROPSYCHOLOGIA; Koch C, 1994, SOME FURTHER IDEAS R; Kolaric KV, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.59; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Lachance M, 2014, J COMPUT NEUROSCI, V37, P523, DOI 10.1007/s10827-014-0521-9; Laukka J. J., 2016, NEUROSCIENCE LETT; Louis ED, 2009, MOVEMENT DISORD, V24, P1600, DOI 10.1002/mds.22567; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia PD, 2017, J COMPUT NEUROSCI, V42, P323, DOI 10.1007/s10827-017-0643-y; Maia PD, 2015, J NEUROSCI METH, V253, P233, DOI 10.1016/j.jneumeth.2015.06.022; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; Middleton SJ, 2008, NEURON, V58, P763, DOI 10.1016/j.neuron.2008.03.030; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; POGGIO GF, 1981, J PHYSIOL-LONDON, V315, P469, DOI 10.1113/jphysiol.1981.sp013759; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reich DS, 1998, J NEUROSCI, V18, P10090; Rieke FM, 1995, SPIKES EXPLORING NEU; Rocca MA, 2015, LANCET NEUROL, V14, P302, DOI 10.1016/S1474-4422(14)70250-9; Rudy S., 2016, J SYSTEMS INTEGRATIV; Saleem AB, 2017, NEURON, V93, P315, DOI 10.1016/j.neuron.2016.12.028; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; SMITH KJ, 1994, EYE, V8, P224, DOI 10.1038/eye.1994.51; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Verden D, 2016, J NEUROSCI RES, V94, P1411, DOI 10.1002/jnr.23923; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wandell B. A., 1995, FDN VISION; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Zlochiver S, 2010, BIOL CYBERN, V102, P181, DOI 10.1007/s00422-009-0361-2	80	3	3	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	AUG	2019	47	1					1	16		10.1007/s10827-019-00714-8			16	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	IU7WR	WOS:000483794500001	31165337				2022-02-06	
J	Nguyen, CN; Clements, RN; Porter, LA; Clements, NE; Gray, MD; Killian, DJ; Baker, RT				Nguyen, Cindy N.; Clements, Reuben N.; Porter, Lucas A.; Clements, Nicole E.; Gray, Matthew D.; Killian, Dustin J.; Baker, Russell T.			Examining Practice and Learning Effects With Serial Administration of the Clinical Reaction Time Test in Healthy Young Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; learning effect; practice effect	CONCUSSION; SPORT	Context: The clinical reaction time (RTclin) test has been recommended as a valid test for assessing concussion and determining recovery of reaction time function following concussion. However, it is unknown whether repeat assessment, as is used in postconcussion testing, is affected by learning or practice phenomena. Objective: To determine if a practice or learning effect is present with serial administration of the RTclin test. Design: Randomized control trial. Setting: University athletic training clinics. Participants: A total of 112 healthy collegiate athletes (age = 19.46 [1.34] y). Interventions: The control group completed the RTclin test on days 1 and 60. The experimental group completed the RTclin test on days 1, 2, 3, 7, and 60. Main Outcome Measure: Reaction time as measured with the RTclin test. Results: The difference in RTclin test performance from day 1 to day 60 was not significant (mean change = -2.77 [14.46] ms, P = .42, 95% confidence intervals, -6.40 to 0.862) between groups. The experimental group experienced significant improvement (lambda = 0.784, F-4,F-49 = 3.365, P = .02, eta(2) = .216, power = 0.81) with acute repeat testing. However, post hoc analysis did not reveal a significant difference between scores during the 5 test periods. Conclusions: The results suggest serial administration of the RTclin test does not produce a practice or learning effect. Clinicians, however, should be cautious as the results do provide evidence patients may demonstrate improved scores when testing occurs on repetitive days after initial exposure to the test.	[Nguyen, Cindy N.; Clements, Reuben N.; Porter, Lucas A.; Clements, Nicole E.; Gray, Matthew D.; Killian, Dustin J.; Baker, Russell T.] Univ Idaho, Moscow, ID 83843 USA		Baker, RT (corresponding author), Univ Idaho, Moscow, ID 83843 USA.	russellb@uidaho.edu	Baker, Russell/W-1898-2019	Baker, Russell/0000-0003-3352-9632			[Anonymous], 2008, NAT COUNC YOUTH SPOR; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Del Rossi G, 2014, J ATHL TRAINING, V49, P356, DOI 10.4085/1062-6059-49.2.04; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Faul M, 2010, TRAUMATIC BRAIN INJU; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Thomas W, 2010, ELECTRON PROC THEOR, P6	27	3	3	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2019	28	6					558	563		10.1123/jsr.2017-0340			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	IW7SI	WOS:000485193900005	29584536				2022-02-06	
J	Pappacena, S; Bailey, M; Cabrini, L; Landoni, G; Udy, A; Pilcher, DV; Young, P; Bellomo, R				Pappacena, Simone; Bailey, Michael; Cabrini, Luca; Landoni, Giovanni; Udy, Andrew; Pilcher, David, V; Young, Paul; Bellomo, Rinaldo			Early dysglycemia and mortality in traumatic brain injury and subarachnoid hemorrhage	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries, traumatic; Subarachnoid hemorrhage; Diabetes mellitus; Hyperglycemia; Hypoglycemia	NEW-ZEALAND RISK; CEREBRAL GLUCOSE; GLYCEMIC CONTROL; HYPERGLYCEMIA; VALIDATION; MANAGEMENT; ADMISSION; IMPACT	BACKGROUND: Traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) are the most common causes of severe acute brain injury in younger Intensive Care Unit (ICU) patients. Dysglycemia (abnormal peak glycemia, glycemic variability, mean glycemia, nadir glycemia) is common in these patients but its comparative outcome associations are unclear. METHODS: In a retrospective, cross-sectional, study of adults admitted to Australian and New Zealand ICUs with TBI and SAH from 2005 to 2015, we studied the relationship between multiple aspects of early (first 24 hours) dysglycemia and mortality and compared TBI and SAH patients with the general ICU population and with each other. RESULTS : Among 670,301 patients, 11,812 had TBI and 6,098 had SAH. After adjustment for illness severity, we found that the mortality rate increased with each quintile of glycemia for each aspect of early dysglycemia (peak glycemia, glycemic variability, mean glycemia, nadir glycemia; P<0.0001 for all). This increased risk of death was greater in TBI and SAH patients than in the general ICU population. Moreover, it was stronger for mean glycemia (increase in mortality from 9.2% in the lowest quintile to 15.1% in general ICU patients compared with an increase in mortality from 4.4% to 49.0% for TBI and SAH patients; P<0.0001). Finally, in TBI patients, this relationship was significantly stronger than in SAH patients (P<0.0001). CONCLUSIONS: In TBI and SAH patients, greater dysglycemia is associated with greater mortality. This association is significantly stronger than in the general population and it is significantly stronger in patients with TBI compared with SAH.	[Pappacena, Simone; Cabrini, Luca; Landoni, Giovanni] Osped San Raffaele, Dept Anesthesiol & Intens Care, Milan, Italy; [Bailey, Michael; Udy, Andrew; Pilcher, David, V; Bellomo, Rinaldo] Monash Univ, ANZIC RC, Melbourne, Vic, Australia; [Udy, Andrew; Pilcher, David, V] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Young, Paul] Med Res Inst New Zealand, Wellington, New Zealand; [Bellomo, Rinaldo] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Melbourne, Vic, Australia		Bellomo, R (corresponding author), Austin Hosp, Dept Intens Care, Heidelberg, Vic 3084, Australia.	rinaldo.bellomo@austin.org.au	Giovanni, Landoni/AAH-1881-2019	Giovanni, Landoni/0000-0002-8594-5980; Pappacena, Simone/0000-0003-2495-7512; Young, Paul/0000-0002-3428-3083			Bilotta F, 2012, WORLD J DIABETES, V3, P130, DOI 10.4239/wjd.v3.i7.130; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Di Muzio F, 2016, CRIT CARE MED, V44, P1683, DOI 10.1097/CCM.0000000000001742; Egi M, 2006, J CRIT CARE, V21, P197, DOI 10.1016/j.jcrc.2006.03.003; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kafaki SB, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMEDED.S40330; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC11, DOI 10.7860/JCDR/2016/17208.7686; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Krinsley JS, 2013, CRIT CARE, V17, DOI 10.1186/cc12547; Kruyt ND, 2009, STROKE, V40, pE424, DOI 10.1161/STROKEAHA.108.529974; Latorre JGS, 2009, STROKE, V40, P1644, DOI 10.1161/STROKEAHA.108.535534; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Paul E, 2017, ANAESTH INTENS CARE, V45, P326, DOI 10.1177/0310057X1704500308; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111420; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schmutzhard E, 2011, NEUROCRIT CARE, V15, P281, DOI 10.1007/s12028-011-9601-0; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Suh S, 2015, DIABETES METAB J, V39, P273, DOI 10.4093/dmj.2015.39.4.273; Terzioglu B, 2015, J RES MED SCI, V20, P1166, DOI 10.4103/1735-1995.172984	32	3	3	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	AUG	2019	85	8					830	839		10.23736/S0375-9393.19.13307-X			10	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	IK9LD	WOS:000476915600007	30735020				2022-02-06	
J	Parsons, JT; Anderson, SA; Casa, DJ; Hainline, B				Parsons, John T.; Anderson, Scott A.; Casa, Douglas J.; Hainline, Brian			Preventing Catastrophic Injury and Death in Collegiate Athletes: Interassociation Recommendations Endorsed by 13 Medical and Sports Medicine Organisations	JOURNAL OF ATHLETIC TRAINING			English	Article						American football; concussion; exertional heat stress; heat acclimatisation; injury prevention	ASSOCIATION TASK-FORCE; SUDDEN CARDIAC-ARREST; HIGH-SCHOOL; TEAM RHABDOMYOLYSIS; AMERICAN FOOTBALL; NCAA FOOTBALL; FATALITIES	The Second Safety in College Football Summit resulted in interassociation consensus recommendations for three paramount safety issues in collegiate athletics: (1) independent medical care for collegiate athletes; (2) diagnosis and management of sport-related concussion; and (3) year-round football practice contact for collegiate athletes. This document, the fourth arising from the 2016 event, addresses the prevention of catastrophic injury, including traumatic and nontraumatic death, in collegiate athletes. The final recommendations in this document are the result of presentations and discussions on key items that occurred at the summit. After those presentations and discussions, endorsing organisation representatives agreed on 18 foundational statements that became the basis for this consensus paper that has been subsequently reviewed by relevant stakeholders and endorsing organisations. This is the final endorsed document for preventing catastrophic injury and death in collegiate athletes. This document is divided into the following components. (1) Background-this section provides an overview of catastrophic injury and death in collegiate athletes. (2) Interassociation recommendations: preventing catastrophic injury and death in collegiate athletes-this section provides the final recommendations of the medical organisations for preventing catastrophic injuries in collegiate athletes. (3) Interassociation recommendations: checklist-this section provides a checklist for each member school. The checklist statements stem from foundational statements voted on by representatives of medical organisations during the summit, and they serve as the primary vehicle for each member school to implement the prevention recommendations. (4) References-this section provides the relevant references for this document. (5) Appendices-this section lists the foundational statements, agenda, summit attendees and medical organisations that endorsed this document.	[Parsons, John T.; Hainline, Brian] Natl Collegiate Athlet Assoc, Sport Sci Inst, Indianapolis, IN 46206 USA; [Anderson, Scott A.] Univ Oklahoma, Athlet, Norman, OK 73019 USA; [Casa, Douglas J.] Univ Connecticut, Kinesiol, Storrs, CT USA		Hainline, B (corresponding author), NCAA, Indianapolis, IN 46206 USA.	bhainline@ncaa.org			NCAA Committee on Competitive Safeguards and Medical Aspects of Sports	The authors thank the participants in the 2016 Second Safety in College Football Summit and the organisations who have endorsed and/or given affirmation of value to this document. Finally, the authors are grateful to the NCAA Committee on Competitive Safeguards and Medical Aspects of Sports; Board of Governors; and the membership for their support in guiding this document to become NCAA Association-wide policy.	Adams WM, 2016, J ATHL TRAINING, V51, P358, DOI 10.4085/1062-6050-51.4.14; Anderson S, 2017, J ATHL TRAINING, V52, P145, DOI 10.4085/1062-6050-52.3.02; Anderson SA, 2012, J STRENGTH COND RES, V26, P1179, DOI 10.1519/JSC.0b013e31824f2091; Andres K., 2018, 2018 2019 NCAA MENS; ASTM International, 2016, SPORTS EQ PLAYING SU, V15; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Casa DJ, 2012, J ATHL TRAINING, V47, P477, DOI 10.4085/1062-6050-47.4.08; Casa DJ, 2012, CURR SPORT MED REP, V11, P115, DOI 10.1249/JSR.0b013e31825615cc; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Cooper ER, 2016, J ATHL TRAINING, V51, P593, DOI 10.4085/1062-6050-51.8.08; DeMartini JK, 2011, J STRENGTH COND RES, V25; Drezner JA, 2008, HEART RHYTHM, V5, P794, DOI 10.1016/j.hrthm.2008.03.001; Drezner JA, 2007, J ATHL TRAINING, V42, P143; Eichner ER, 2018, CURR SPORT MED REP, V17, P142, DOI 10.1249/JSR.0000000000000484; Eichner ER, 2016, CURR SPORT MED REP, V15, P378, DOI 10.1249/JSR.0000000000000311; Eichner ER, 2016, CURR SPORT MED REP, V15, P122, DOI 10.1249/JSR.0000000000000251; Garrett AT, 2011, SPORTS MED, V41, P757, DOI 10.2165/11587320-000000000-00000; Hainline B, 2016, J AM COLL CARDIOL, V67, P2981, DOI 10.1016/j.jacc.2016.03.527; Harmon KG, 2012, BRIT J SPORT MED, V46, P325, DOI 10.1136/bjsports-2011-090896; Harris KM, 2012, AM J CARDIOL, V110, P1185, DOI 10.1016/j.amjcard.2012.06.004; Hsu AC, 2012, MED SCI SPORT EXER, V44, P178, DOI 10.1249/MSS.0b013e318275044f; Hyland A., 2018, NCAA MENS BASKETBALL; IOM (Institute of Medicine), 2012, STRATEGIES IMPROVE C; Kucera KL, 2018, ANN SURVEY FOOTBALL; Kucera KL, 2019, INJURY PREV, V25, P83, DOI 10.1136/injuryprev-2017-042642; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; McGrew CA, 2010, CURR SPORT MED REP, V9, P185, DOI 10.1249/JSR.0b013e3181e7c9c4; Mueller FO, 2001, J ATHL TRAINING, V36, P312; National Operating Committee on Standards for Athletic Equipment, 2015, STAND PERF SPEC NEWL; Parsons JT, 2014, 2014 2015 NCAA SPORT; Redding R., 2017, NCAA FOOTBALL RULES; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; TORG JS, 1991, AM J SPORT MED, V19, P6, DOI 10.1177/036354659101900103; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; Yau R. K., 2018, CATASTROPHIC SPORTS	37	3	3	4	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2019	54	8					843	851		10.4085/1062-6050-54.085			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IY7YK	WOS:000486610900002	31536387	gold, Green Published			2022-02-06	
J	Sima, AP; Yu, H; Marwitz, JH; Kolakowsky-Hayner, SA; Felix, ER; Bergquist, TF; Whiteneck, G; Kreutzer, JS; Johnson-Greene, D				Sima, Adam P.; Yu, Hao; Marwitz, Jennifer H.; Kolakowsky-Hayner, Stephanie A.; Felix, Elizabeth R.; Bergquist, Thomas F.; Whiteneck, Gale; Kreutzer, Jeffrey S.; Johnson-Greene, Douglas			Outcome Prediction From Post-Injury Resilience in Patients With TBI	REHABILITATION PSYCHOLOGY			English	Article						resilience traumatic brain injury; depressive symptoms; anxiety; return to work	TRAUMATIC BRAIN-INJURY; CONNOR-DAVIDSON RESILIENCE; QUALITY-OF-LIFE; PARTICIPATION ASSESSMENT; SCALE; DEPRESSION; SATISFACTION; VALIDATION; MODERATE; QOL	Purpose/Objective: The objective of the study was to evaluate the extent to which 1- and 2-year outcomes after traumatic brain injury (FBI) are predicted by resilience. Research Method/Design: This was an observational, longitudinal study of persons (n = 158) with moderate or severe TBI who completed both 1-and 2-year outcome assessments. Outcomes included anxiety (Generalized Anxiety Disorder-7), depression (Patient Health Questionnaire-9), life satisfaction (Satisfaction with Life Scale), substance misuse, and return-to-work measures. The Connor-Davidson Resilience Scale was used to assess resilience at 3 or 6 months after injury. Results: Greater resilience predicted less anxiety, depression, and substance use and better satisfaction with life and return to work at 1 year after injury for both adjusted and unadjusted models. Standardized regression coefficients were all greater than 0.38 for continuous outcomes, whereas odds ratios were 1.34 and 0.81 for the return to work and substance misuse outcomes, respectively (p < .05). Similar but weaker trends were found at 2 years after injury. with statistical significance no longer met for all outcomes. Conclusions/Implications: Resilience was shown to have predictive ability for outcomes at 1 and 2 years after TBI. Resilience appears to be a salient and important variable for long-term outcomes in person with TBI after adjusting for injury and demographic characteristics.	[Sima, Adam P.; Yu, Hao] Virginia Commonwealth Univ, Dept Biostat, POB 980032, Richmond, VA 23298 USA; [Marwitz, Jennifer H.; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Kolakowsky-Hayner, Stephanie A.] Icahn Sch Med, Dept Rehabil Med, New York, NY USA; [Felix, Elizabeth R.; Johnson-Greene, Douglas] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med, Dept Psychiat, Rochester, MN USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med, Dept Psychol, Rochester, MN USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med, Dept Phys Med & Rehabil, Rochester, MN USA; [Whiteneck, Gale] Craig Hosp, Res Dept, Englewood, CO USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA 23284 USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23284 USA; [Yu, Hao] Purdue Univ, Grad Sch, W Lafayette, IN 47907 USA		Sima, AP (corresponding author), Virginia Commonwealth Univ, Dept Biostat, POB 980032, Richmond, VA 23298 USA.	adam.sima@vcuhealth.org	Felix, Elizabeth/AAD-6356-2021	Sima, Adam/0000-0001-8426-9987	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0009, 90DP0030, 90DP0033, 90DP0034, 90DP0046]	The contents of this article were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (90DP0009, 90DP0030, 90DP0033, 90DP0034, 90DP0046). The National Institute on Disability, Independent Living, and Rehabilitation Research is a center within the Administration for Community Living, Department of Health and Human Services.	Bertholet N, 2010, ADDICTION, V105, P2106, DOI [10.1111/j.1360-0443.2010.03081.x, 10.1111/j.1360-0443.2010.03167.x]; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Hosmer DW., 2000, APPL LOGISTIC REGRES, DOI [10.1002/0471722146, DOI 10.1002/0471722146, 10. 1002/0471722146]; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Laird KT, 2018, INT J GERIATR PSYCH, V33, P1596, DOI 10.1002/gps.4953; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Pakalniskiene V, 2016, COMPR PSYCHIAT, V69, P88, DOI 10.1016/j.comppsych.2016.05.010; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Sheerin CM, 2018, DEPRESS ANXIETY, V35, P140, DOI 10.1002/da.22700; Shi XL, 2016, J ADOLESCENCE, V53, P55, DOI 10.1016/j.adolescence.2016.08.015; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	38	3	3	1	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2019	64	3					320	327		10.1037/rep0000263			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IE7MX	WOS:000472559200008	30973246	Bronze			2022-02-06	
J	Wilde, EA; Newsome, MR; Ott, SD; Hunter, JV; Dash, P; Redell, J; Spruiell, M; Diaz, M; Chu, ZD; Goodrich-Hunsaker, N; Petrie, J; Li, RS; Levin, H				Wilde, Elisabeth A.; Newsome, Mary R.; Ott, Summer D.; Hunter, Jill V.; Dash, Pramod; Redell, John; Spruiell, Matthew; Diaz, Marlene; Chu, Zili D.; Goodrich-Hunsaker, Naomi; Petrie, JoAnn; Li, Ruosha; Levin, Harvey			Persistent Disruption of Brain Connectivity after Sports-Related Concussion in a Female Athlete	JOURNAL OF NEUROTRAUMA			English	Article						female athlete; functional connectivity; sports-related concussion; structural connectivity; traumatic brain injury	WHITE-MATTER; FUNCTIONAL CONNECTIVITY; CORPUS-CALLOSUM; SEX-DIFFERENCES; INJURY; ABNORMALITIES; INTEGRITY; MODERATE	Structural and functional connectivity (FC) after sports-related concussion (SRC) may remain altered in adolescent athletes despite symptom resolution. Little is known, however, about how alterations in structural connectivity and FC co-present in female athletes whose symptom recovery tends to be prolonged. Despite resolution of symptoms, one month after her second SRC, an 18-year-old female athlete had decreased structural connectivity in the corpus callosum and cingulum, with altered FC near those regions, compared with other SRC and orthopedically injured athletes. Findings show persistent effects of SRC on advanced brain imaging and the possibility of greater vulnerability of white matter tracts in females.	[Wilde, Elisabeth A.; Newsome, Mary R.; Diaz, Marlene; Levin, Harvey] Michael E De Bakey Vet Affairs Med Ctr, Houston, TX USA; [Wilde, Elisabeth A.; Newsome, Mary R.; Hunter, Jill V.; Spruiell, Matthew; Diaz, Marlene; Chu, Zili D.; Levin, Harvey] Baylor Coll Med, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Goodrich-Hunsaker, Naomi; Petrie, JoAnn] Univ Utah, Salt Lake City, UT USA; [Wilde, Elisabeth A.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Ott, Summer D.; Dash, Pramod; Redell, John; Li, Ruosha] Univ Texas Hlth Sci Ctr Houston UTHlth, Houston, TX USA; [Hunter, Jill V.] Texas Childrens Hosp, Houston, TX 77030 USA; [Goodrich-Hunsaker, Naomi] Brigham Young Univ, Provo, UT 84602 USA		Levin, H (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, One Baylor Plaza, Houston, TX 77030 USA.	hlevin@bcm.edu		Spruiell, Matthew/0000-0001-5311-7956	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS086714]	We acknowledge support from the National Institute of Neurological Disorders and Stroke (NINDS) grant R21 NS086714 and the cooperation of the athletes and their families. The South Central Mental Illness Research, Education, and Clinical Center (SCMIRECC) at the Michael E. DeBakey VA Medical Center provided facilities for analysis of the fMRI data. We also gratefully acknowledge assistance from James Montier, Coy VanValkenburgh, Qisheng Liu, MD, David Ress, PhD, and the Core for Advanced Magnetic Resonance Imaging at Baylor College of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of Baylor College of Medicine or UTHealth McGovern Medical School. We would also like to thank Tracy J. Abildskov for his kind assistance with the figures.	Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Slobounov S, 2014, CLIN NEUROPHYSIOL, V125, P1291, DOI 10.1016/j.clinph.2013.12.107; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212	29	3	3	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2019	36	22					3164	3171		10.1089/neu.2019.6377		AUG 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JI6MG	WOS:000479854300001	31119974	Green Published			2022-02-06	
J	Wu, XQ; Li, ZB; Chen, WX; Wen, DL; Zhang, ZH; Xiong, XM				Wu, X-Q; Li, Z-B; Chen, W-X; Wen, D-L; Zhang, Z-H; Xiong, X-M			The influence of different resuscitation solution on lactic acid accumulation after hemorrhagic shock: a network meta-analysis	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Hemorrhagic shock; Lactic acid accumulation; Network meta-analysis (NMA)	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; RAT MODEL; RINGERS SOLUTION; BLOOD LACTATE; PYRUVATE; APOPTOSIS; INDICATORS; MORTALITY	OBJECTIVE: To compare the effect of various fluid resuscitation procedures after hemorrhagic shock on the lactic acid accumulation by network meta-analysis. MATERIALS AND METHODS: A number of articles were obtained by searching the databases. Randomized control trials (RCT) were selected by two literature quality assessors; the extracted experimental data were then summarized to compare and analyze the effect of various kinds of infusion procedures at different time points on the concentration of lactic acid in the internal environment of rat models. RESULTS: 9 articles containing 25 independent reports were enrolled. Results revealed that the accumulation of lactic acid generated in the resuscitation using hydroxyethyl starch solution or gelofusine was significantly different from the one using Ringer solution, hypertonic saline or normal salt solution (p<0.05). Compared to the colloidal, the aqueous solution of pyruvate showed a slightly weaker effect in reducing the accumulation of lactic acid. The accumulation of lactic acid is severely affected by hypertonic saline. Ringer lactate solution, and balanced salt solution, i.e., the concentration of lactic acid is increasing with an augment of concentration or prolongation of treatment time. CONCLUSIONS: In terms of the management of lactic acid accumulation after hemorrhagic shock, the effect of colloidal solution was remarkably better than a crystalloid solution, and hypertonic saline and normal salt solution were not recommended as preferable drugs in the treatment of hemorrhagic shock.	[Wu, X-Q] Guangzhou First Peoples Hosp, Dept Crit Care Med, Guangzhou, Guangdong, Peoples R China; [Li, Z-B; Chen, W-X; Wen, D-L; Zhang, Z-H; Xiong, X-M] Guangzhou Med Univ, Affiliated Hosp 2, Dept Crit Care Med, Guangzhou, Guangdong, Peoples R China		Wen, DL (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Dept Crit Care Med, Guangzhou, Guangdong, Peoples R China.	wendeliang@tutanota.com					Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Bergeron JW, 2012, J FORENSIC LEG MED, V19, P113, DOI 10.1016/j.jflm.2011.06.001; Catala-Lopez F, 2014, RHEUMATOL INT, V34, P1489, DOI 10.1007/s00296-014-2994-2; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; D'Alessandro A, 2016, SHOCK, V46, P173, DOI 10.1097/SHK.0000000000000588; Dimitriou R, 2011, EUR J TRAUMA EMERG S, V37, P539, DOI 10.1007/s00068-011-0137-y; Duan CY, 2015, INT J CLIN EXP MED, V8, P11645; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Freimuth J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-94; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Hanon C, 2015, J STRENGTH COND RES, V29, P942, DOI 10.1519/JSC.0000000000000736; Hirano Elcio Shiyoiti, 2006, Acta Cir. Bras., V21, P31, DOI 10.1590/S0102-86502006000100008; Hu S, 2013, J EMERG MED, V45, P885, DOI 10.1016/j.jemermed.2013.04.062; Jaskille A, 2006, J AM COLL SURGEONS, V202, P25, DOI 10.1016/j.jamcollsurg.2005.08.027; Jiang LL, 2016, SHOCK, V45, P441, DOI 10.1097/SHK.0000000000000515; Jouffroy R, 2014, RESUSCITATION, V85, P1764, DOI 10.1016/j.resuscitation.2014.10.012; Koustova E, 2003, SURGERY, V134, P267, DOI 10.1067/msy.2003.245; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Liu ZQ, 2018, J NEUROSURG SCI, V62, P24, DOI 10.23736/S0390-5616.17.03953-4; Monteiro De Barros CL, 2016, J SPORT MED PHYS FIT, V56, P27; Puffer RC, 2016, WORLD NEUROSURG, V92, P166, DOI 10.1016/j.wneu.2016.05.003; Qin LB, 2018, EUR REV MED PHARMACO, V22, P1812, DOI 10.26355/eurrev_201803_14600; Sharma P, 2005, ANESTHESIOLOGY, V103, P65, DOI 10.1097/00000542-200507000-00013; Sharma Pushpa, 2012, J Emerg Trauma Shock, V5, P309, DOI 10.4103/0974-2700.102372; Soller B, 2015, SHOCK, V44, P90, DOI 10.1097/SHK.0000000000000307; Subrato D, 2000, J TRAUMA, V49, P47, DOI 10.1097/00005373-200007000-00007; Yi JS, 2007, NEUROBIOL DIS, V26, P94, DOI 10.1016/j.nbd.2006.12.007; Zhang JJ, 2014, SHOCK, V42, P464, DOI 10.1097/SHK.0000000000000230; Zhang Y, 2012, TIANJIN MED J, V40, P254; 易汉, 2015, [中国老年学杂志, Chinese Journal of Gerontology], V35, P7038	31	3	3	0	4	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	AUG	2019	23	15					6707	+		10.26355/eurrev_201908_18562			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IN5OM	WOS:000478726400039	31378914				2022-02-06	
J	Yakoub, KM; Davies, DJ; Su, ZJ; Bentley, C; Forcione, M; Toman, E; Hammond, D; Watson, CN; Bishop, J; Cooper, L; Barbey, AK; Sawlani, V; Di Pietro, V; Grey, MJ; Belli, A				Yakoub, Kamal M.; Davies, David J.; Su, Zhangjie; Bentley, Conor; Forcione, Mario; Toman, Emma; Hammond, Douglas; Watson, Callum N.; Bishop, Jon; Cooper, Lauren; Barbey, Aron K.; Sawlani, Vijay; Di Pietro, Valentina; Grey, Michael J.; Belli, Antonio			Investigation into repetitive concussion in sport (RECOS): study protocol of a prospective, exploratory, observational cohort study	BMJ OPEN			English	Article							ACUTE-PANCREATITIS; ATLANTA CLASSIFICATION; ACUPUNCTURE; REVISION; SYSTEM; PAIN	Introduction Sport-related concussion management remains a diagnostic dilemma to clinicians in all strata of care, coaching staff and players alike. The lack of objective diagnostic and prognostic biomarkers and over-reliance on subjective clinical assessments carries a significant health risk of undiagnosed concussive episodes and early return to play before full recovery increasing the risk of sustaining additional concussion, and leading to long-term sequelae and/or unfavourable outcome. Objective To identify a set of parameters (neuroimaging with neurophysiological, biological and neuropsychological tests) that may support pitch-side and outpatient clinical decision-making in order to objectively diagnose concussion, determine the severity of injury, guide a safe return to play and identify the potential predictors of the long-term sequelae of concussion. Methods and analysis An exploratory, observational, prospective, cohort study recruiting between 2017 and 2020. The participants will have a baseline preseason screening (brain imaging, neuropsychological assessments, serum, urine and saliva sampling). If a screened player later suffers a concussion and/or multiple concussions then he/she will be assessed again with the same protocol within 72 hours, and their baseline data will be used as internal control as well as normative data. Inferential statistical analysis will be performed to determine correlations between biological, imaging techniques and neuropsychological assessments. Ethics and dissemination This study was approved by the East of England-Essex Research Ethics Committee on 22 September 2017-REC 17/EE/0275; IRAS 216703. The results of this study will be presented at national and international conferences and submitted for publication in peer reviewed journals.	[Yakoub, Kamal M.; Davies, David J.; Su, Zhangjie; Bentley, Conor; Forcione, Mario; Bishop, Jon; Cooper, Lauren; Sawlani, Vijay; Di Pietro, Valentina; Belli, Antonio] Tianjin Gong An Hosp, Dept Acupuncture & Moxibust, Tianjin, Peoples R China; [Yakoub, Kamal M.; Davies, David J.; Bentley, Conor; Forcione, Mario; Watson, Callum N.; Di Pietro, Valentina; Belli, Antonio] Minist Educ, Key Lab Chinese Internal Med, Beijing, Peoples R China; [Yakoub, Kamal M.; Davies, David J.; Bentley, Conor; Forcione, Mario; Watson, Callum N.; Di Pietro, Valentina; Belli, Antonio] Beijing Univ Chinese Med, Affiliated Dongzhimen Hosp, Beijing, Peoples R China; [Toman, Emma; Hammond, Douglas] Tianjin Med Univ, Tianjin Inst Gen Surg, Gen Hosp, Tianjin, Peoples R China; [Barbey, Aron K.; Di Pietro, Valentina] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Sawlani, Vijay] Tianjin Univ Tradit Chinese Med, Grad Coll, Tianjin, Peoples R China; [Grey, Michael J.] Tianjin Univ Tradit Chinese Med, Inst Tradit Chinese Med, Tianjin, Peoples R China		Yakoub, KM (corresponding author), Tianjin Gong An Hosp, Dept Acupuncture & Moxibust, Tianjin, Peoples R China.; Yakoub, KM (corresponding author), Minist Educ, Key Lab Chinese Internal Med, Beijing, Peoples R China.; Yakoub, KM (corresponding author), Beijing Univ Chinese Med, Affiliated Dongzhimen Hosp, Beijing, Peoples R China.	k.yakoub@bham.ac.uk	Belli, Antonio/I-3799-2015; Forcione, Mario/K-2852-2018	Belli, Antonio/0000-0002-3211-9933; Forcione, Mario/0000-0002-4045-8011; Watson, Callum Nicholas/0000-0003-2511-5501; Toman, Emma/0000-0003-2142-1923; Bentley, Conor/0000-0003-3021-4838			ANDERSSON S, 1995, MED HYPOTHESES, V45, P271, DOI 10.1016/0306-9877(95)90117-5; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Ona XB, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009179.pub2; Chandler J. H. J., 2017, COCHRANE HDB SYSTEMA; Chen YL, 2018, TRADIT MED RES, V3, P106, DOI 10.12032/TMR201810069; Cosen-Binker LI, 2003, PANCREATOLOGY, V3, P445, DOI 10.1159/000074972; Diehl DL, 1999, J ALTERN COMPLEM MED, V5, P27, DOI 10.1089/acm.1999.5.27; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; Forsmark CE, 2016, NEW ENGL J MED, V375, P1972, DOI 10.1056/NEJMra1505202; Halonen KI, 2002, CRIT CARE MED, V30, P1274, DOI 10.1097/00003246-200206000-00019; Huang WQ, 2018, TRADIT MED RES, V3, P95, DOI 10.12032/TMR201810068; Kumar AH, 2018, GASTROENTEROL REP, V6, P127, DOI 10.1093/gastro/gox029; Lankisch PG, 2015, LANCET, V386, P85, DOI 10.1016/S0140-6736(14)60649-8; Li L, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010001; Li YY, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013206; Luo Yan-Hong, 2011, Zhongguo Zhen Jiu, V31, P105; McKay CJ, 2003, PANCREATOLOGY, V3, P111, DOI 10.1159/000070078; Minozzi S, 2013, ADDICTION, V108, P688, DOI 10.1111/j.1360-0443.2012.04005.x; Munigala S, 2017, PANCREATOLOGY, V17, P534, DOI 10.1016/j.pan.2017.05.391; Pooran N, 2003, J CLIN GASTROENTEROL, V37, P263, DOI 10.1097/00004836-200309000-00013; Rathnakar SK, 2017, J CLIN DIAGN RES, V11, pPC10, DOI 10.7860/JCDR/2017/23168.9375; Sarr MG, 2013, POL ARCH MED WEWN, V123, P118, DOI 10.20452/pamw.1627; Sarri G, 2019, BMJ OPEN GASTROENTER, V6, DOI 10.1136/bmjgast-2018-000248; Singh VK, 2009, CLIN GASTROENTEROL H, V7, P1247, DOI 10.1016/j.cgh.2009.08.012; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; van Dijk SM, 2017, GUT, V66, P2024, DOI 10.1136/gutjnl-2016-313595; VanderPloeg K, 2009, J ACUPUNCT MERIDIAN, V2, P26, DOI 10.1016/S2005-2901(09)60012-1; Waller A, 2018, J EMERG MED, V55, P769, DOI 10.1016/j.jemermed.2018.08.009; Wang Cheng-Wei, 2010, Zhen Ci Yan Jiu, V35, P375; Wang Xin-yu, 2007, Zhongguo Zhen Jiu, V27, P421; Wang XP, 2003, J GASTROEN HEPATOL, V18, P57, DOI 10.1046/j.1440-1746.2003.02898.x; Winso O, 2018, UPSALA J MED SCI, V123, P207, DOI 10.1080/03009734.2018.1539054; Xu WB, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1261; Xue QM, 2015, ACUPUNCT MED, V33, P299, DOI 10.1136/acupmed-2014-010609; Xue Qi-ming, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P658; Zeng Xiantao, 2015, J Evid Based Med, V8, P2, DOI 10.1111/jebm.12141; Zhao Yu-pei, 2007, Zhonghua Wai Ke Za Zhi, V45, P721; Zhu SF, 2015, ACUPUNCT MED, V33, P115, DOI 10.1136/acupmed-2014-010646	38	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2019	9	7							e029883	10.1136/bmjopen-2019-029883			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IW8US	WOS:000485269700352	31278105	gold, Green Published, Green Accepted			2022-02-06	
J	Ziliotto, N; Marchetti, G; Straudi, S; Tisato, V; Lavezzi, S; Manfredini, F; Basaglia, N; Bernardi, F				Ziliotto, Nicole; Marchetti, Giovanna; Straudi, Sofia; Tisato, Veronica; Lavezzi, Susanna; Manfredini, Fabio; Basaglia, Nino; Bernardi, Francesco			Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation	CLINICA CHIMICA ACTA			English	Article						Soluble NCAM; Traumatic brain injury; Minimally conscious state; tDCS	BRAIN; TDCS	Background: Transcranial direct current stimulation (tDCS) is used for therapeutic purpose in severely brain-injured patients. The relationship between the recovery after tDCS and potential biomarkers in plasma has been limitedly investigated in patients with minimal conscious state (MCS). Objective. To investigate soluble neuronal adhesion molecule (sNCAM) plasma levels in relation to tDCS and recovery processes in MCS. Methods: sNCAM was measured in plasma before (T-1,T-0), during (T-1) and after (T-2, T-3) tDCS sessions in eight patients with a post traumatic etiology and at least one year of chronic state. Results: While sNCAM levels were highly correlated overtime, no significant difference was observed in relation to tDCS. An inverse relation was observed between sNCAM levels at baseline and the tDCS long-lasting effects (T-1, r = -0.852, p = 0.007; T-0, r = -0.787, p = 0.020). Conclusions: This exploratory research suggests the sNCAM levels, potentially associated with tDCS outcomes, as a candidate biomarker of neurobiological after-effects in MCS patients.	[Ziliotto, Nicole; Bernardi, Francesco] Univ Ferrara, Dept Life Sci & Biotechnol, Via Fossato Mortara 74, I-44100 Ferrara, Italy; [Marchetti, Giovanna; Manfredini, Fabio; Basaglia, Nino] Univ Ferrara, Dept Biomed & Specialty Surg Sci, Ferrara, Italy; [Straudi, Sofia; Lavezzi, Susanna; Basaglia, Nino] Ferrara Univ Hosp, Dept Neurosci & Rehabil, Ferrara, Italy; [Tisato, Veronica] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Tisato, Veronica] Univ Ferrara, LTTA Ctr, Ferrara, Italy		Ziliotto, N (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Via Fossato Mortara 74, I-44100 Ferrara, Italy.	zltncl1@unife.it	Tisato, Veronica/K-4525-2016; Ziliotto, Nicole/V-2532-2019; Manfredini, Fabio/ABG-2372-2020; bernardi, francesco/F-5443-2013; Straudi, Sofia/AAI-6971-2021	Ziliotto, Nicole/0000-0003-1007-7266; Manfredini, Fabio/0000-0001-9476-6434; Straudi, Sofia/0000-0002-2061-9922; Tisato, Veronica/0000-0001-8448-066X	Emilia Romagna Region, ItalyRegione Emilia Romagna [1786/2012]	This work was supported by the Emilia Romagna Region, Italy [grant numbers 1786/2012].	Antal A, 2017, CLIN NEUROPHYSIOL, V128, P1774, DOI 10.1016/j.clinph.2017.06.001; Chu CY, 2018, NEUROCHEM RES, V43, P1714, DOI 10.1007/s11064-018-2594-8; Cirillo G, 2017, BRAIN STIMUL, V10, P1, DOI 10.1016/j.brs.2016.11.009; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giorli E, 2015, J NEUROIMAGING, V25, P571, DOI 10.1111/jon.12162; Gnanapavan S, 2013, MULT SCLER RELAT DIS, V2, P13, DOI 10.1016/j.msard.2012.08.002; Kong XD, 2014, NEUROSCI BULL, V30, P903, DOI 10.1007/s12264-014-1481-9; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Marchetti G, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0043-4; Niezgoda A, 2017, IMMUNOL LETT, V185, P93, DOI 10.1016/j.imlet.2017.03.011; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Secher T, 2010, ADV EXP MED BIOL, V663, P227, DOI 10.1007/978-1-4419-1170-4_15; Straudi S., 2019, BRAIN INJURY, P1; Thibaut A, 2015, BRAIN STIMUL, V8, P1116, DOI 10.1016/j.brs.2015.07.024; Tomar GS, 2018, CLIN CHIM ACTA, V487, P325, DOI 10.1016/j.cca.2018.10.025; Trofimov AO, 2018, ADV EXP MED BIOL, V1072, P59, DOI 10.1007/978-3-319-91287-5_10; Wang HC, 2013, CLIN CHIM ACTA, V423, P122, DOI 10.1016/j.cca.2013.04.023	17	3	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2019	495						374	376		10.1016/j.cca.2019.05.008			3	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	IL0CR	WOS:000476964200057	31077650				2022-02-06	
J	Green, G; D'Angelo, J; Coyles, J; Penny, I; Golfinos, JG; Valadka, A				Green, Gary; D'Angelo, John; Coyles, Jon; Penny, Ian; Golfinos, John G.; Valadka, Alex			Association Between a Rule Change to Reduce Home Plate Collisions and Mild Traumatic Brain Injury and Other Injuries in Professional Baseball Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; baseball; rule changes in sports; catchers	FOOTBALL	Background: Improved player safety is an important goal of professional baseball. Prevention of mild traumatic brain injury (concussion) is an area of emphasis because of the potential for long-term as well as short-term sequelae. Hypothesis: A rule change can lower the incidence of concussions and other injuries in professional baseball. Study Design: Cohort study; Level of evidence, 3. Methods: This study included a retrospective review of data entered concurrently into professional baseball's electronic medical record system. All minor and major league teams are required to use this system. All injuries are captured by creation of a new record in the system at the time of the injury. All active minor and major league players from 2011 to 2017 were included. The 30 major league clubs have 1200 roster players and play 162 games per season. The approximately 200 minor league clubs have about 7500 active players and play 56 to 144 games annually that combine for approximately 330,000 athlete-exposures per season. Before the 2014 season, Major League Baseball, in conjunction with its players association, instituted a rule limiting home plate collisions between base runners and catchers that applied to both Major League Baseball and Minor League Baseball. All concussions and other injuries at home plate from 2011 to 2017 were analyzed by mechanism and player position. Results: From 2011 to 2013, an annual mean of 100 injuries occurred from home plate collisions in the minor and major leagues, resulting in a mean loss of 2148 days annually. After the rule change, there was a mean 55 home plate collision injuries with 936 days lost per season (P < .0001 for injuries and days lost). A mean 11 concussions attributed to these collisions occurred annually in the minor and major leagues before the rule change, as compared with 2.3 per year after (P = .0029). There were no major league concussions from these collisions after the rule change. The mean annual number of days missed because of concussions at home plate dropped from 276 before 2014 to 36 per year after 2014 (P = .0001). Conclusion: This rule change was associated with significant reductions in the numbers of concussions and other injuries caused by collisions at home plate as well as significant decreases in time lost from play.	[Green, Gary; D'Angelo, John; Coyles, Jon; Penny, Ian; Golfinos, John G.; Valadka, Alex] Major League Baseball, New York, NY USA; [Green, Gary; D'Angelo, John; Coyles, Jon; Penny, Ian; Golfinos, John G.; Valadka, Alex] Major League Baseball Players Assoc, New York, NY USA; [Green, Gary] Univ Calif Los Angeles, Los Angeles, CA USA; [Golfinos, John G.] NYU, Sch Med, Dept Neurosurg, New York, NY USA; [Valadka, Alex] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA		Green, G (corresponding author), Pacific Palisades Med Grp, 15200 Sunset Blvd,Suite 107, Pacific Palisades, CA 90272 USA.	gary.green@mlb.com					Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Green GA, 2021, CLIN J SPORT MED, V31, pE1, DOI 10.1097/JSM.0000000000000679; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; MUELLER FO, 1987, CLIN SPORT MED, V6, P185; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348; Salfino M., 2018, FIVETHIRTYEIGHT; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165	8	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2019	47	11					2704	2708	0363546519861525	10.1177/0363546519861525		JUL 2019	5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	IV8UI	WOS:000480096800001	31336057				2022-02-06	
J	Fallon, S; Akhand, O; Hernandez, C; Galetta, MS; Hasanaj, L; Martone, J; Webb, N; Drattell, J; Amorapanth, P; Rizzo, JR; Nolan-Kenney, R; Serrano, L; Rucker, JC; Cardone, D; Galetta, SL; Balcer, LJ				Fallon, Samuel; Akhand, Omar; Hernandez, Christopher; Galetta, Matthew S.; Hasanaj, Lisena; Martone, John; Webb, Nikki; Drattell, Julia; Amorapanth, Prin; Rizzo, John-Ross; Nolan-Kenney, Rachel; Serrano, Liliana; Rucker, Janet C.; Cardone, Dennis; Galetta, Steven L.; Balcer, Laura J.			MULES on the sidelines: A vision-based assessment tool for sports-related concussion	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Sports; Picture naming; Mobile Universal Lexicon Evaluation System (MULES); Vision	EVALUATION SYSTEM MULES; AUTOMATIZED NAMING RAN; EXECUTIVE FUNCTIONS; ADOLESCENT BRAIN; MATURATION	Objective: The Mobile Universal Lexicon Evaluation System (MULES) is a test of rapid picture naming under investigation. Measures of rapid automatic naming (RAN) have been used for over 50 years to capture aspects of vision and cognition. MULES was designed as a series of 54 grouped color photographs (fruits, random objects, animals) that integrates saccades, color perception and contextual object identification. We examined MULES performance in youth, collegiate and professional athletes at pre-season baseline and at the sidelines following concussion. Methods: Our study teams administered the MULES to youth, collegiate and professional athletes during pre-season baseline testing. Sideline post-concussion time scores were compared to pre-season baseline scores among athletes with concussion to determine degrees and directions of change. Results: Among 681 athletes (age 17 +/- 4 years, range 6-37, 38% female), average test times at baseline were 41.2 +/- 11.2 s. The group included 280 youth, 357 collegiate and 44 professional athletes; the most common sports were ice hockey (23%), soccer (17%) and football (11%). Age was a predictor of MULES test times, with longer times noted for younger participants (P < .001, linear regression). Consistent with other timed performance measures, significant learning effects were noted for the MULES during baseline testing with trial 1 test times (mean 49.2 +/- 13.1 s) exceeding those for trial 2 (mean 41.3 +/- 11.2 s, P <.0001, paired t-test). Among 17 athletes with concussion during the sports seasons captured to date (age 18 +/- 3 years), all showed increases (worsening) of MULES time scores from pre-season baseline (median increase 11.2 s, range 0.6-164.2, P =.0003, Wilcoxon signed-rank test). The Symptom Severity Score from the SCATS Symptom Evaluation likewise worsened from pre-season baseline following injury among participants with concussion (P = .002). Conclusions: Concussed athletes demonstrate worsening performance on the MULES test compared to their baseline time scores. This test samples a wide network of brain pathways and complements other vision-based measures for sideline concussion assessment. The MULES test demonstrates capacity to identify athletes with sports-related concussion.	[Fallon, Samuel; Akhand, Omar; Hernandez, Christopher; Galetta, Matthew S.; Hasanaj, Lisena; Martone, John; Rizzo, John-Ross; Nolan-Kenney, Rachel; Serrano, Liliana; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Neurol, 222 E 41st St,14th Floor, New York, NY 10017 USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Drattell, Julia; Amorapanth, Prin; Rizzo, John-Ross] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Cardone, Dennis] NYU, Sch Med, Primary Care Sports Med, Dept Orthoped, New York, NY USA; [Webb, Nikki] NYU, Dept Recreat & Athlet, New York, NY USA		Balcer, LJ (corresponding author), NYU, Sch Med, Dept Neurol, 222 E 41st St,14th Floor, New York, NY 10017 USA.	samuel.fallon@nyulangone.org; omar.akhand@nyulangone.org; christopher.hemandez@nyulangone.org; mgaletta@sas.upenn.edu; lisena.hasanj@nyulangone.org; john.martone@nyulangone.org; nikki.webb@nyu.edu; julia.drattell@nyulangone.org; amorapanth@nyulangone.org; johnross.rizzo@nyulangone.org; rachel.nolan@nyulangone.org; liliana.serrano@nyulangone.org; janet.rucker@nyulangone.org; dennis.cardone@nyulangone.org; steven.galetta@nyulangone.org; laura.balcer@nyulangone.org		Rizzo, John-Ross/0000-0002-4084-0085; Amorapanth, Prin/0000-0002-4260-7826; Rucker, Janet/0000-0002-0397-0999	NYU School of Medicine, New York, NY; Empire Clinical Research Investigator Program (ECRIP), New York State Department of Health, Albany, NY	This study was supported in part by the NYU School of Medicine, New York, NY; and the Empire Clinical Research Investigator Program (ECRIP), New York State Department of Health, Albany, NY.	Akhand O, 2019, CURR OPIN NEUROL, V32, P68, DOI 10.1097/WCO.0000000000000654; Akhand O, 2018, J NEUROL SCI, V387, P199, DOI 10.1016/j.jns.2018.02.031; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Cummine J, 2014, BEHAV BRAIN RES, V275, P157, DOI 10.1016/j.bbr.2014.08.038; Denckla M.B., 1974, CORTEX, V10, P185; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; Denckla MB, 1999, ANN DYSLEXIA, V49, P29, DOI 10.1007/s11881-999-0018-9; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; GESCHWIND N, 1966, ARCH NEUROL-CHICAGO, V15, P137, DOI 10.1001/archneur.1966.00470140027004; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Kandel Eric, 2012, AGE INSIGHT; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; LaRocca NG, 2018, MULT SCLER J, V24, P1469, DOI 10.1177/1352458517723718; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Norman Geschwind, 1967, CORTEX, V3, P97; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; Seay M, 2018, J NEUROL SCI, V394, P1, DOI 10.1016/j.jns.2018.08.019; Silverio A., 2017, J SPORTS MED THER, V2, P9; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Wells F.L., 1945, MENTAL EXAMINERS HDB	27	3	3	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUL 15	2019	402						52	56		10.1016/j.jns.2019.04.036			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IF3MK	WOS:000472984700008	31103959				2022-02-06	
J	Caccese, JB; Johns, KE; Langdon, JL; Shaver, GW; Buckley, TA				Caccese, Jaclyn B.; Johns, Kassandra E.; Langdon, Jody L.; Shaver, George W.; Buckley, Thomas A.			Does baseline concussion testing aid in identifying future concussion risk?	RESEARCH IN SPORTS MEDICINE			English	Article						Prevention; mild Traumatic Brain Injury (mTBI); ImPACT; neuromuscular control		The purpose was to determine differences in pre-season baseline performance between student-athletes who suffered a future sport-related concussion (fSRC) and those who did not. Collegiate student-athletes (82 fSRC, 82 matched control, age = 18.4 +/- 0.8years, height = 172.7 +/- 10.3 cm, mass = 80.1 +/- 20.9 kg) completed baseline Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Balance Error Scoring System (BESS), and Standardized Assessment of Concussion (SAC). Results of the independent t-tests suggested there were no differences between the fSRC and the control groups for ImPACT composite scores (95% confidence intervals, Visual Memory: fSRC 70.4-75.9, Control 73.4-78.5, p = 0.134; Verbal Memory: fSRC 83.8-87.7, Control 85.7-89.9, p = 0.155; Reaction Time: fSRC 0.562-0.591, Control 0.580-0.614, p = 0.071; Visual Motor Speed: fSRC 38.5-41.1, Control 38.2-40.9, p = 0.757), BESS total errors (fSRC 11.3-13.7, Control 11.8-14.4, p = 0.483), or SAC (fSRC 26.6-27.4, Control 26.9-27.6, p = 0.394). Receiver operating characteristic (ROC) areas-under-the-curve were 0.417-0.515. Our findings suggest that baseline concussion assessments cannot be used to predict individuals who may sustain a fSRC.	[Caccese, Jaclyn B.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 100 Discovery Blvd, Newark, NJ 19713 USA; [Johns, Kassandra E.; Langdon, Jody L.] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA 30460 USA; [Shaver, George W.] Georgia Southern Univ, Regents Ctr Learning Disorders, Statesboro, GA 30460 USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Biomech & Movement Sci Program, Newark, GA USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 100 Discovery Blvd, Newark, NJ 19713 USA.	tbuckley@udel.edu	Caccese, Jaclyn B./AAH-4571-2020; Langdon, Jody/AAY-4638-2021; Buckley, Thomas A/B-7525-2016	Caccese, Jaclyn B./0000-0003-2329-3603; Buckley, Thomas A/0000-0002-0515-0150	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS070744-01A1]	This work was supported by the National Institute of Neurological Disorders and Stroke [1R15NS070744-01A1].	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Chandran A, 2020, RES SPORTS MED, V28, P42, DOI 10.1080/15438627.2019.1590834; Craig DI, 2020, RES SPORTS MED, V28, P181, DOI 10.1080/15438627.2019.1586706; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Wasserman E. B., 2018, CLIN J SPORT MED, V1	15	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	OCT 1	2020	28	4					594	599		10.1080/15438627.2019.1641500		JUL 2019	6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NY9PV	WOS:000478333800001	31287331	Green Accepted			2022-02-06	
J	Taylor, K; Post, A; Hoshizaki, TB; Gilchrist, MD				Taylor, Karen; Post, Andrew; Hoshizaki, Thomas Blaine; Gilchrist, Michael D.			The effect of a novel impact management strategy on maximum principal strain for reconstructions of American football concussive events	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Brain injury; impact management; helmet decoupling technology; dominant coordinate component of acceleration; maximum principal strain (MPS); University of College Dublin Brain Trauma Model (UCDBTM)	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; HIGH-SCHOOL FOOTBALL; PROFESSIONAL FOOTBALL; ANGULAR-ACCELERATION; HEAD IMPACTS; ACCIDENT RECONSTRUCTION; UNIVERSITY FOOTBALL; CORPUS-CALLOSUM; ELEMENT	The purpose of this study was to test the effectiveness of a helmet to reduce maximum principal strain by decoupling the head-helmet interface in reconstructions of head-to-head concussive impacts in American football. The primary goal of the American football helmet has been protection of players against skull fractures and other traumatic brain injuries. The modern-day helmet has evolved and been designed to mitigate traumatic brain injury, but it does not offer optimized protection against concussive injury. Studies to determine the influence of decoupling strategies on changes to brain motion and the resulting influence on maximum principal strain, a metric associated with concussive injury, have not yet been examined under concussive impact conditions. In this study, 19 helmet-to-helmet concussive events from professional American football were reconstructed using a pneumatically driven linear impactor to determine the components (resultant and dominant) of linear and rotational acceleration. The University of College Dublin Brain Trauma Model was used to determine maximum principal strain values. A prototype helmet with a decoupling liner strategy was shown to significantly reduce maximum principal strain in seven of the head-to-head concussive impact reconstructions. In each case, the prototype helmet significantly reduced the dominant coordinate component of rotational acceleration. The results of this study indicate the potential of a helmet liner decoupling system in reducing maximum principal strain for reconstructions of concussive events in American football.	[Taylor, Karen; Post, Andrew; Hoshizaki, Thomas Blaine; Gilchrist, Michael D.] Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Taylor, K (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	ktayl078@uottawa.ca		Post, Andrew/0000-0002-5960-5552; Taylor, Karen/0000-0003-1578-2343	Ontario Graduate Scholarship in Science and Technology (OGSST) from Fluid Protection Technology	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The author received funding through an Ontario Graduate Scholarship in Science and Technology (OGSST) from Fluid Protection Technology.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Caccese V, 2013, COMPOS STRUCT, V100, P404, DOI 10.1016/j.compstruct.2012.12.034; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Fowler JN, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029982; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1970, J BIOMECH, V3, P239, DOI 10.1016/0021-9290(70)90025-4; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2017, P I MECH ENG P-J SPO, V231, P83, DOI 10.1177/1754337116633376; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kendall M., 2016, THESIS; Kleiven S., 2002, 20229 ROYAL I TECHN; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krzeminski DE, 2016, POLYM TEST, V55, P190, DOI 10.1016/j.polymertesting.2016.08.019; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Liao S, 2016, MED SCI SPORT EXER, V48, P1239, DOI 10.1249/MSS.0000000000000896; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; Mills NJ, 2003, COMPOS SCI TECHNOL, V63, P2389, DOI 10.1016/S0266-3538(03)00272-0; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Nahum AM, 1977, 21 ANN STAPP CAR CRA; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ouckama R, 2011, J BIOMECH, V44, P904, DOI 10.1016/j.jbiomech.2010.11.035; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, INT RES COUNC BIOM I; Post A, 2013, P 1 INT C HELM PERF; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X, 1992, 36 STAPP CAR CRASH C; UNTERHARNSCHEIDT F, 1969, TEX REP BIOL MED, V27, P127; Versace J., 1971, 710881 SAE; VETTER L, 1987, POLYM ENG SCI, V27, P1113, DOI 10.1002/pen.760271502; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Walsh ES, 2012, P I MECH ENG P-J SPO, V226, P220, DOI 10.1177/1754337112442299; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Willinger R., 1995, P IRCOBI C BRUNN SWI, P245; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L, 2001, THESIS; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	81	3	3	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2019	233	4					503	513	1754337119857434	10.1177/1754337119857434		JUL 2019	11	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IY2BJ	WOS:000476415600001					2022-02-06	
J	Meng, SY; Cernicchi, A; Kleiven, S; Halldin, P				Meng, Shiyang; Cernicchi, Alessandro; Kleiven, Svein; Halldin, Peter			The biomechanical differences of shock absorption test methods in the US and European helmet standards	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Helmet; shock absorption test; finite element analysis; skull fracture; traumatic brain injury	CEREBRAL CONCUSSION; SAFETY HELMETS; HEAD-INJURIES; MODEL; BODY; ACCELERATION	Nowadays crash helmets are tested by dropping a free or unrestrained headform in Europe but a guided or restrained headform in the United States. It remains unclear whether the free fall and the guided fall produce similar impact kinematics that cause head injury. A ?nite element helmet model is developed and compared with experimental tests. The resulting head kinematics from virtual tests are input for a ?nite element head model to compute the brain tissue strain. The guided fall produces higher peak force and linear acceleration than the free fall. Eccentric impact in the free fall test induces angular head motion which directs some of the impact energy into rotational kinetic energy. Consequently, the brain tissue strain in the free fall test is up to 6.3 times more than that in the guided fall. This study recommends a supplemental procedure that records angular head motion in the free fall test.	[Meng, Shiyang; Cernicchi, Alessandro] Dainese SpA, R&D Dept, Via Artigianato 35, Molvena, Italy; [Meng, Shiyang; Kleiven, Svein; Halldin, Peter] Royal Inst Technol KTH, Neuron Engn, Stockholm, Sweden		Meng, SY (corresponding author), Dainese SpA, R&D Dept, Via Artigianato 35, Molvena, Italy.; Meng, SY (corresponding author), Royal Inst Technol KTH, Neuron Engn, Stockholm, Sweden.	shiyangm@kth.se		Meng, Shiyang/0000-0002-9206-5404	European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie [642662]	This work was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie [grant number 642662].	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; [Anonymous], 1984, 218 DOT FMVSS NAT HI; [Anonymous], 2002, 2205 UN ECE; Becker EB, 2012, P 9 INT MOT C COL GE, P424; Bourdet N., 2016, P IRCOBI C MAL SPAIN, P479; Cairns H, 1941, BRIT MED J, V1941, P465, DOI 10.1136/bmj.2.4213.465; Cernicchi A, 2008, INT J CRASHWORTHINES, V13, P451, DOI 10.1080/13588260802055460; Chan P, 2007, 20 INT TECHN C ENCH; Chinn B., 2001, COST 327 MOTORCYCLE; Connor TA, 2016, CURRENT STANDARDS SP; Delye H, 2007, J NEUROTRAUM, V24, P1576, DOI 10.1089/neu.2007.0283; Deshpande VS, 2000, J MECH PHYS SOLIDS, V48, P1253, DOI 10.1016/S0022-5096(99)00082-4; Deshpande VS, 2001, ACTA MATER, V49, P1859, DOI 10.1016/S1359-6454(01)00058-1; Ebrahimi I, 2015, TRAFFIC INJ PREV, V16, P404, DOI 10.1080/15389588.2014.937804; Fahlstedt M., 2016, P 2016 IRCOBI C INT, P459; Fenner Jr H, 2005, HIC WORKSH FIN REP W; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 2015, IRCOBI NOCSAE PDB SN; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Ghajari M, 2011, INT J CRASHWORTHINES, V16, P285, DOI 10.1080/13588265.2011.559798; GILCHRIST A, 1994, INT J IMPACT ENG, V15, P201, DOI 10.1016/S0734-743X(05)80013-2; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hallquist JO, 2007, LS DYNA KEYW US MAN; Hallquist JO, 2006, LS DYNA THEORY MANUA; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MATZENMILLER A, 1995, MECH MATER, V20, P125, DOI 10.1016/0167-6636(94)00053-0; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Mellor A, 2007, MOTORCYCLISTS HELMET; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Mohan P, 2010, 11 INT LS DYNA US C, P53; National Highway Traffic Safety Administration (NHTSA), 1972, OCC CRASH PROT HEAD; Newman JA, 2015, ACCIDENTAL INJURY, P755; Nusholtz GS, 1996, STAPP CAR C, VP-30, P95; Ommaya A, 1981, HEAD NECK INJ CRIT C; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; S. T. I. S. Comm, 2003, INSTR IMP TEST 1; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Thibault L.E., 1990, P INT C BIOM IMP LYO, P191; Thom D., 1998, P 16 ESV C 31 WINDS, P2310; Thom DR, 1997, FEASIBILITY STUDY UP; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Vander Vorst Michael, 2003, Annu Proc Assoc Adv Automot Med, V47, P363; Vander Vorst Michael, 2004, Annu Proc Assoc Adv Automot Med, V48, P181; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Yoganandan N, 2018, J NEUROTRAUM, V35, P1272, DOI 10.1089/neu.2017.5356	60	3	3	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness	JUL 4	2019	24	4					399	412		10.1080/13588265.2018.1464545			14	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HY9JY	WOS:000468457900004					2022-02-06	
J	Shepherd, D; Landon, J; Kalloor, M; Theadom, A				Shepherd, Daniel; Landon, Jason; Kalloor, Mathew; Theadom, Alice		BIONIC Res Grp	Clinical correlates of noise sensitivity in patients with acute TBI	BRAIN INJURY			English	Article						TBI; Noise sensitivity; anxiety; symptom reporting	TRAUMATIC BRAIN-INJURY; ROAD TRAFFIC NOISE; ACOUSTIC HYPERESTHESIA; HEAD-INJURY; NEW-ZEALAND; SYMPTOMS; CONCUSSION; ANXIETY; HEALTH; POPULATION	Primary objective: The impact of noise sensitivity (NS) on the daily functioning of people who have experienced a traumatic brain injury (mTBI) is an understudied area, particularly following mTBI. The primary objective of this cross-sectional study was to investigate clinical markers of NS in a sample of New Zealand adults following mTBI.Research design: Cross-sectional study.Methods and procedures: A community-based sample of 151 adults who had experienced a brain injury in the last two weeks completed assessments estimating cognitive functioning, postconcussion symptoms (including NS), and affective state.Results: Over half the sample (59%) reported some degree of NS. Exploratory statistical analyses indicated that NS was associated with being female, living in a rural area, number of previous brain injuries, cognitive flexibility scores, reaction time, perceptions of recovery, anxiety, and depression. Regression analyses revealed that anxiety was the dominant correlate of NS (B = .120, p < .001, 95% CI [0.069, 1.71]).Conclusions: As the first study to explore the correlates of NS following mild TBI, the findings have important clinical and research implications. The present findings suggest that treatment approaches targeting anxiety may be effective in reducing NS in people who have experienced a brain injury. Moreover, evidence is presented suggesting that NS is unlikely to reflect malingering, and should be treated as a genuine somatic symptom of brain injury.	[Shepherd, Daniel; Landon, Jason; Kalloor, Mathew; Theadom, Alice; BIONIC Res Grp] Auckland Univ Technol, Dept Psychol, Private Bag 92006, Auckland 1142, New Zealand		Shepherd, D (corresponding author), Auckland Univ Technol, Dept Psychol, Private Bag 92006, Auckland 1142, New Zealand.	daniel.shepherd@aut.ac.nz	Landon, Jason/AAD-3951-2019				[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Armann E, 2007, INTER NOISE NOISE CO, V2007, P1167; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Belojevic G, 2003, Noise Health, V6, P77; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; BOHNEN N, 1991, BRIT J PSYCHIAT, V159, P860, DOI 10.1192/bjp.159.6.860; Broadbent DE., 1972, SOUND, V6, P56; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brunger H, 2014, BRAIN INJURY, V28, P71, DOI 10.3109/02699052.2013.857788; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; DSM-5 American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Fann JR, 2013, MANAGEMENT ADULTS TR; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; Fyhri A, 2010, SCI TOTAL ENVIRON, V408, P4935, DOI 10.1016/j.scitotenv.2010.06.057; Grillon C, 2008, PSYCHOPHARMACOLOGY, V199, P421, DOI 10.1007/s00213-007-1019-1; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Heinonen-Guzejev M, 2011, NOISE HEALTH, V13, P51, DOI [10.4103/1463-1741.74000, 10.4103/1463-1741.74002]; Hughes R. W., 2011, P 11 INT C NOIS PUBL; IWATA O, 1984, JPN PSYCHOL RES, V26, P75, DOI 10.4992/psycholres1954.26.75; Job R.F. Soames, 1999, Noise Health, V1, P57; Kahkonen S, 2007, J PSYCHIATR NEUROSCI, V32, P316; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kliuchko M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39236; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; McGarrigle R, 2014, INT J AUDIOL, V53, P433, DOI 10.3109/14992027.2014.890296; Miedema HME, 2003, J ACOUST SOC AM, V113, P1492, DOI 10.1121/1.1547437; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Novak CC, 2010, J CULIN SCI TECHNOL, V8, P191, DOI 10.1080/15428052.2010.535756; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Paunovic K, 2014, SCI TOTAL ENVIRON, V481, P479, DOI 10.1016/j.scitotenv.2014.02.092; Pryor J, 2004, DISABIL REHABIL, V26, P974, DOI 10.1080/09638280410001702397; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; Rijnen SJM, 2020, ASSESSMENT, V27, P373, DOI 10.1177/1073191117727346; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; Sawamura D, 2014, BRAIN INJURY, V28, P1455, DOI 10.3109/02699052.2014.919531; Sax Leonard, 2010, ADV GENDER ED, V2, P13; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shepherd D, 2016, J CLIN EXP NEUROPSYC, V38, P900, DOI 10.1080/13803395.2016.1176995; Shepherd D, 2015, INT J ENV RES PUB HE, V12, P5284, DOI 10.3390/ijerph120505284; Shepherd D, 2015, NOISE HEALTH, V17, P165, DOI 10.4103/1463-1741.155850; Shepherd D, 2011, NOISE HEALTH, V13, P333, DOI 10.4103/1463-1741.85502; Somerville LH, 2010, BIOL PSYCHIAT, V68, P416, DOI 10.1016/j.biopsych.2010.04.002; Stansfeld S.A, 1992, PSYCHOL MED        S, V22S, P1, DOI DOI 10.1017/S0264180100001119; STANSFELD SA, 1993, PSYCHOL MED, V23, P977, DOI 10.1017/S0033291700026441; Stansfeld SA, 2015, INT J ENV RES PUB HE, V12, P12735, DOI 10.3390/ijerph121012735; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Uomoto JM, 2004, REHABIL PSYCHOL, V49, P334, DOI 10.1037/0090-5550.49.4.334; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Kamp I, 2004, J ACOUST SOC AM, V116, P3471, DOI 10.1121/1.1810291; WEINSTEIN ND, 1980, J SOUND VIB, V68, P241, DOI 10.1016/0022-460X(80)90468-X; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wright B, 2014, NOISE HEALTH, V16, P166, DOI 10.4103/1463-1741.134917; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	67	3	3	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1050	1058		10.1080/02699052.2019.1606443			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000478089800011	31007081				2022-02-06	
J	Tornas, S; Stubberud, J; Solbakk, AK; Evans, J; Schanke, AK; Lovstad, M				Tornas, Sveinung; Stubberud, Jan; Solbakk, Anne-Kristin; Evans, Jonathan; Schanke, Anne-Kristine; Lovstad, Marianne			Moderators, mediators and nonspecific predictors of outcome after cognitive rehabilitation of executive functions in a randomised controlled trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive function; goal management training; cognitive rehabilitation; randomised controlled trial; predictors of outcome	TRAUMATIC BRAIN-INJURY; BEHAVIOR RATING INVENTORY; FUNCTION-ADULT VERSION; GOAL MANAGEMENT; EMOTIONAL REGULATION; SELF-REPORT; DYSFUNCTION; INTEGRATION; ATTENTION; INTERVENTION	Moderators, mediators and nonspecific predictors of treatment after cognitive rehabilitation of executive functions in a randomised controlled trial Objective: To explore moderators, mediators and nonspecific predictors of executive functioning after cognitive rehabilitation in a randomised controlled trial, comparing Goal Management Training (GMT) with an active psycho-educative control-intervention, in patients with chronic acquired brain injury. Methods: Seventy patients with executive dysfunction were randomly allocated to GMT (n = 33) or control (n = 37). Outcome measures were established by factor-analysis and included cognitive executive complaints, emotional dysregulation and psychological distress. Results: Higher age and IQ emerged as nonspecific predictors. Verbal memory and planning ability at baseline moderated cognitive executive complaints, while planning ability at six-month follow-up mediated all three outcome measures. Inhibitory cognitive control emerged as a unique GMT specific mediator. A general pattern regardless of intervention was identified; higher levels of self-reported cognitive-and executive-symptoms of emotional dysregulation and psychological distress at six-month follow-up mediated less improvement across outcome factors. Conclusions: The majority of treatment effects were nonspecific to intervention, probably underscoring the variables' general contribution to outcome of cognitive rehabilitation interventions. Interventions targeting specific cognitive domains, such as attention or working memory, need to take into account the patients' overall cognitive and emotional self-perceived functioning. Future studies should investigate the identified predictors further, and also consider other predictor candidates.	[Tornas, Sveinung; Stubberud, Jan; Schanke, Anne-Kristine; Lovstad, Marianne] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Solbakk, Anne-Kristin] Rigshosp, Oslo Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Oslo, Norway; [Solbakk, Anne-Kristin; Schanke, Anne-Kristine; Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway; [Evans, Jonathan] Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, Dept Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Solbakk, Anne-Kristin] Helgeland Hosp, Dept Neuropsychol, Mosjoen, Norway		Tornas, S (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.	sveinung.tornaas@sunnaas.no	Stubberud, Jan/ABE-6922-2021		Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds [2011/2/0204]	This work was supported by the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds under grant number 2011/2/0204.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Beck AT, 2009, DEPRESSION: CAUSES AND TREATMENT, SECOND EDITION, P1; Becker F, 2014, NEUROREHABILITATION, V34, P87, DOI 10.3233/NRE-131015; Bertens D, 2016, ARCH PHYS MED REHAB, V97, P97, DOI 10.1016/j.apmr.2015.07.021; Bertens D, 2015, J INT NEUROPSYCH SOC, V21, P639, DOI 10.1017/S1355617715000764; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chorpita BF, 2011, CLIN PSYCHOL-SCI PR, V18, P154, DOI 10.1111/j.1468-2850.2011.01247.x; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; Conners C. K., 2000, CONNORS CPT 2 CONTIN; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming J, 1999, BRAIN INJURY, V13, P417; Gioia GA IP, 2000, BEHAV RATING INVENTO; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Logan DE, 2008, PAIN, V136, P366, DOI 10.1016/j.pain.2007.07.015; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McCambridge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039116; Metzler-Baddeley C, 2010, APPL NEUROPSYCHOL, V17, P299, DOI 10.1080/09084282.2010.523394; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Robertson I., 1996, GOAL MANAGEMENT TRAI; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 2013, PRINCIPLES FRONTAL L, P742; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Schmid M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00633; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stuss DT, 2007, J INT NEUROPSYCH SOC, V13, P120, DOI 10.1017/S1355617707070154; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tornas S, 2016, ARCH PHYS MED REHAB, V97, P1841, DOI 10.1016/j.apmr.2016.06.014; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Wechsler D., 1999, MANUAL WECHLER ABBRE; Winocur G, 2007, J INT NEUROPSYCH SOC, V13, P153, DOI 10.1017/S135561770707018X; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	68	3	3	1	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 3	2019	29	6					844	865		10.1080/09602011.2017.1338587			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HU3MB	WOS:000465176100002	28651477	Green Accepted			2022-02-06	
J	Vakil, E; Aviv, O; Mishael, M; Ashkenazi, SS; Sacher, Y				Vakil, Eli; Aviv, Or; Mishael, Moral; Ashkenazi, Simone Schwizer; Sacher, Yaron			Direct and indirect measures of context in patients with mild-to-severe traumatic brain injury (TBI): The additive contribution of eye tracking	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Context effect; eye tracking; TBI	RECOGNITION MEMORY; DEPENDENT MEMORY; ATTENTION; FAMILIARITY; RETRIEVAL	Introduction: The facilitation of memory for target stimuli due to the similarity of context in the learning and testing phases is known as the Context-Effect (CE). Previous studies reported that TBI affects memory for contextual information when tested directly. However, the indirect effect of contextual information on memory of target (i.e., CE) is preserved. Several studies have demonstrated that CE is composed of multiple, distinct cognitive processes. The present study includes four context conditions to enable identification of the exact process affected by TBI. In addition, eye movements were monitored to test three hypotheses: first, that the TBI group's dwell time on target (DTOT) at encoding would be less than that of controls. Second, that DTOT at encoding would be more highly associated with recognition at test for the control group than for the TBI group. Third, that overall DTOT at encoding on new, as compared to old items (repetition effect), would be less pronounced for the TBI group as compared to controls.Methods: Twenty-four patients with mild-to-severe TBI and 23 matched controls participated in this study. We presented participants with photographs of male faces shown wearing distinctive, trial-unique hats (yielding specific Target-Context pairing). Eye movements were recorded throughout the test task.Results: Memory for faces following TBI is impaired compared to that of controls. The magnitude and pattern of CE are the same for both groups. The TBI group has a lower DTOT compared to that of controls. However, the relative length of DTOT in the various conditions is similar in both groups.Conclusions: Behavioral results indicate that although the TBI group has impaired memory for faces, the CE pattern is similar to that of controls. Similarly, in terms of eye movements, although the TBI group focuses less on target, relations between the various conditions are similar in both groups.	[Vakil, Eli; Aviv, Or; Mishael, Moral; Ashkenazi, Simone Schwizer] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Vakil, Eli; Aviv, Or; Mishael, Moral; Ashkenazi, Simone Schwizer] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Sacher, Yaron] Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; [Sacher, Yaron] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	vakile@mail.biu.ac.il		Schwizer Ashkenazi, Simone/0000-0002-8211-9624	Israeli Ministry of Defense, Rehabilitation Department [203003-846]	This work was supported by the Israeli Ministry of Defense, Rehabilitation Department under Grant number 203003-846.	Barak O, 2013, Q J EXP PSYCHOL, V66, P2008, DOI 10.1080/17470218.2013.772647; Canty A. L., 2014, UNDERSTANDING TRAUMA; Chanon VW, 2008, VIS COGN, V16, P325, DOI 10.1080/13506280701459026; CHRISTIE J, 1995, MEM COGNITION, V23, P547, DOI 10.3758/BF03197256; DALTON P, 1993, MEM COGNITION, V21, P223, DOI 10.3758/BF03202735; Fernandez A, 2001, PSICOLOGICA, V22, P253; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Hannula DE, 2010, BIOL PSYCHIAT, V68, P610, DOI 10.1016/j.biopsych.2010.06.001; Heisz JJ, 2013, PSYCHOL SCI, V24, P1157, DOI 10.1177/0956797612468281; Kafkas A, 2011, Q J EXP PSYCHOL, V64, P1971, DOI 10.1080/17470218.2011.588335; Levy DA, 2008, Q J EXP PSYCHOL, V61, P1620, DOI 10.1080/17470210802134767; MEMON A, 1985, Current Psychological Research and Reviews, V4, P349, DOI 10.1007/BF02686589; Messer K., 1999, P 2 C AUD VID BAS BI; Murnane K, 1999, J EXP PSYCHOL GEN, V128, P403, DOI 10.1037/0096-3445.128.4.403; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2007, MEMORY, V15, P508, DOI 10.1080/09658210701391022; Smith SM, 2001, PSYCHON B REV, V8, P203, DOI 10.3758/BF03196157; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 1996, NEUROPSY NEUROPSY BE, V9, P176; Vakil E, 1997, NEUROPSYCHOLOGY, V11, P545, DOI 10.1037/0894-4105.11.4.545; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Vakil E, 2007, Q J EXP PSYCHOL, V60, P916, DOI 10.1080/17470210701357568; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225	24	3	3	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL 3	2019	41	6					644	652		10.1080/13803395.2019.1604946			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IK8LC	WOS:000476845600008	31018765				2022-02-06	
J	Zhu, YL; Howard, JT; Edsall, PR; Morris, RB; Lund, BJ; Cleland, JM				Zhu, Yanli; Howard, Jeffrey T.; Edsall, Peter R.; Morris, Ryan B.; Lund, Brian J.; Cleland, Jeffery M.			Blast Exposure Induces Ocular Functional Changes with Increasing Blast Over-pressures in a Rat Model	CURRENT EYE RESEARCH			English	Article						Blast; ocular; dysfunction; overpressure; electroretinography	EXPERIMENTAL RODENT MODEL; TRAUMATIC BRAIN-INJURY; GANGLION-CELL DAMAGE; INTRAOCULAR-PRESSURE; VISUAL DYSFUNCTION; MOUSE MODEL; GLAUCOMA; EYE	Purpose: Blast-related brain and ocular injuries can lead to acute and chronic visual dysfunction. The chronic visual consequences of blast exposure and its progression remain unclear. The goal of this study is to analyze ocular functional response to four levels of blast exposure and identify a threshold of blast exposure leading to acute and chronic visual dysfunction. Methods: Anesthetized adult male Long-Evans rats received a single-blast exposure at a peak overpressure of 78, 117, 164 or 213 kPa, delivered by a compressed air-driven shock tube. Clinical eye examination, intraocular pressure (IOP), flash electroretinography (fERG) and spectral-domain optical coherence tomography (SD-OCT) images were assessed prior to, and at multiple time points post exposure. Results: No abnormal fERG were observed for the two lowest-level blast groups (78 kPa or 117 kPa). For the 164 kPa group, the a- and b-wave amplitudes of the fERG were decreased at 3 days postexposure (p = 0.009 for a-wave, p = 0.010 for b-wave), but recovered to baseline levels by 7 days post-exposure. The IOP was unchanged for the 117 kPa and 164 kPa groups. The 78 kPa group demonstrated a small transient increase during week one (p = 0.046). For the highest blast group (213 kPa), the IOP was significantly elevated immediately post-exposure (p = 0.0001), but recovered by 24 hr. A bimodal depression in the fERG a- and b-wave amplitudes was observed for this group: the amplitudes were depressed at day 3 post-exposure (p = 0.007 for a-wave, p = 0.012 for b-wave), and recovered by day 7 post-exposure. However, the fERG amplitudes were once again depressed at week 8 post-exposure, suggesting a chronic retinal dysfunction. All retinae appeared normal in SD-OCT images. Conclusions: Our study demonstrates that a single-blast exposure may result in acute and chronic fERG deficit, and traumatic IOP elevation. Noninvasive functional tests may hold promise for identifying individuals with a risk for developing chronic visual deficits, and indicating a time window for early clinical diagnosis, rehabilitation, and treatment.	[Zhu, Yanli; Howard, Jeffrey T.; Edsall, Peter R.; Morris, Ryan B.; Lund, Brian J.; Cleland, Jeffery M.] US Army, Ocular Trauma Div, Inst Surg Res, Joint Base San Antonio, San Antonio, TX USA		Cleland, JM (corresponding author), US Army, Ocular Trauma Div, Inst Surg Res, 3698 Chambers Rd, San Antonio, TX 78234 USA.	jeffery.m.cleland@gmail.com					Bojikian KD, 2015, EYE, V29, P1579, DOI 10.1038/eye.2015.173; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Chalioulias K, 2007, J R Army Med Corps, V153, P124; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Clark Molly E, 2012, Methods Mol Biol, V884, P265, DOI 10.1007/978-1-61779-848-1_19; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Hardin James W., 2003, GEN ESTIMATING EQUAT, DOI [10.1201/b13880, DOI 10.1201/B13880]; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lund BJ, 2014, INVEST OPHTH VIS SCI, V55, P1348, DOI 10.1167/iovs.13-13337; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Mao Z, 2016, OPHTHALMIC RES, V56, P92, DOI 10.1159/000445352; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0_1; Notghi B, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037072; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781; Weaver AA, 2017, BIOMECH MODEL MECHAN, V16, P463, DOI 10.1007/s10237-016-0830-1; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; World Health Organization (WHO), PRIOR EYE DIS CORN O; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1735, DOI 10.1167/iovs.06-1037; Zhu YL, 2012, MOL MED, V18, P697, DOI 10.2119/molmed.2012.00050; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	33	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0271-3683	1460-2202		CURR EYE RES	Curr. Eye Res.	JUL 3	2019	44	7					770	780		10.1080/02713683.2019.1567791			11	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	OP0ID	WOS:000587758200012	30947563				2022-02-06	
J	Abhilash, KPP; Tephilah, R; Pradeeptha, S; Gunasekaran, K; Chandy, GM				Abhilash, Kundavaram Paul Prabhakar; Tephilah, R.; Pradeeptha, Sharon; Gunasekaran, Karthik; Chandy, Gina Maryann			Injury Patterns and Outcomes of Trauma in the Geriatric Population Presenting to the Emergency Department in a Tertiary Care Hospital of South India	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Accidents; emergency department; geriatric; injury patterns; trauma		Background: The geriatric population is more prone for injuries with complications due to their associated comorbidities. This study was done to understand the mode, severity, and outcome of injuries among geriatric patients presenting to the emergency department (ED). Materials and Methods: This retrospective study included all patients >60 years who presented with trauma between October 2014 and March 2015. Details of the incident, injuries, and hospital outcome were noted. Results: Among 8563 geriatric patients, who presented to the ED during the study, 427 (4.9%) patients were trauma related. The mean age was 69 (standard deviation: 6.76) years with 87.6% being young-old (60-79 years) and 12.4% being old-old (>80 years). Majority (63.2%) were Priority 2 patients. The median time between the incident and ED arrival among Priority 1 patients was 3 h (interquartile range: 2-5). Common modes of injuries were slip and fall (37.4%), two-wheeler accidents (25.8%), fall from height (9.1%), and pedestrian (8.9%). The ED team alone managed 25.8% of patients. Specialty departments referred to included orthopedics (48%), neurosurgery (18.3%), plastic surgery (4.2%), HLRS (4%), and others. Injuries due to slip and fall were significantly more among the old-old (P = 0.001), and two-wheeler accidents were more among the young-old (P = 0.001), respectively. Superficial head injuries (28.8%), extremity (24.8%), facial (18.7%), and traumatic brain injuries (17.8%) were common presentations. Thoracic injuries were significantly more among the old-old (P < 0.001). Half (46.3%) of the young-old were discharged stable (P = 0.017). In-hospital mortality rate was 0.7% (3/427), while 12.9% (55/427) left against medical advice due to poor prognosis. Conclusion: Our study demonstrates the pattern of injury seen in the elderly in an urban setting in India. From this, we perceive the need for a prospective study evaluating the causes for geriatric trauma, which would help work on ways to prevent and minimize injuries in the elderly.	[Abhilash, Kundavaram Paul Prabhakar; Tephilah, R.; Pradeeptha, Sharon; Chandy, Gina Maryann] Christian Med Coll & Hosp, Dept Emergency Med, Vellore 632004, Tamil Nadu, India; [Gunasekaran, Karthik] Christian Med Coll & Hosp, Dept Gen Med, Vellore, Tamil Nadu, India		Chandy, GM (corresponding author), Christian Med Coll & Hosp, Dept Emergency Med, Vellore 632004, Tamil Nadu, India.	ginachandy@gmail.com	Abhilash, Kundavaram Paul Prabhakar/ABH-7163-2020	Abhilash, Kundavaram Paul Prabhakar/0000-0002-2382-4411			ARFAOUI W, 2014, B SOC SCI MED GRAND, P69; Aschkenasy MT, 2006, EMERG MED CLIN N AM, V24, P413, DOI 10.1016/j.emc.2006.01.005; Betz ME, 2014, J AM GERIATR SOC, V62, P1317, DOI 10.1111/jgs.12877; Brown JB, 2015, J TRAUMA ACUTE CARE, V78, P352, DOI 10.1097/TA.0000000000000523; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; DEVAS MB, 1974, BRIT MED J, V1, P190, DOI 10.1136/bmj.1.5900.190; Dries DJ, 2008, CRITICAL CARE MED; Gowing R, 2007, CAN J SURG, V50, P437; Hsia RY, 2011, ARCH SURG-CHICAGO, V146, P585, DOI 10.1001/archsurg.2010.311; Kara H, 2014, CLIN INTERV AGING, V9, P17, DOI 10.2147/CIA.S56542; Rau CS, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0063-1; Rich MW, 2016, CIRCULATION, V133, P2103, DOI [10.1161/CIR.0000000000000380, 10.1016/j.jacc.2016.03.004]; Salvi F, 2007, INTERN EMERG MED, V2, P292, DOI 10.1007/s11739-007-0081-3; Schroll M, 1992, Ugeskr Laeger, V154, P2889; Wang Hao, 2013, J Clin Med Res, V5, P75, DOI 10.4021/jocmr1227w; Wilson MS, 2016, J ORTHOP TRAUMA, V30, pE299, DOI 10.1097/BOT.0000000000000615	16	3	3	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock	JUL-SEP	2019	12	3					198	202		10.4103/JETS.JETS_79_18			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	IV4JF	WOS:000484238700008	31543643	gold, Green Published			2022-02-06	
J	Berthold Lindstedt, M; Johansson, J; Ygge, J; Borg, K				Berthold Lindstedt, Marta; Johansson, Jan; Ygge, Jan; Borg, Kristian			VISION-RELATED SYMPTOMS AFTER ACQUIRED BRAIN INJURY AND THE ASSOCIATION WITH MENTAL FATIGUE, ANXIETY AND DEPRESSION	JOURNAL OF REHABILITATION MEDICINE			English	Article						vision disorder; mental fatigue; anxiety; depression; traumatic brain injury; stroke	VISUAL DYSFUNCTION; ISCHEMIC-STROKE; 1ST YEAR; ASTIGMATISM; DISORDERS; QUALITY; BALANCE	Background: Brain injury causes multiple symptoms. Among these, visual disturbances are common; 50-70% of patients experience some change in vision after injury/illness. Other very common and disabling symptoms are fatigue, anxiety and depression. This study examines whether levels of fatigue, anxiety and depression are increased if the patients also experience vision disorders. Materials and Methods: A total of 123 patients enrolled in day care rehabilitation unit for medium-to-severe brain injury completed questionnaires about self-experienced fatigue, anxiety, depression and self-experienced level and type of visual disturbances. Symptoms of fatigue, anxiety and depression were compared with the occurrence of visual disturbances. Analyses were performed using binary logistic regression. Results: An association was found between visual symptoms and fatigue, but not between visual symptoms and anxiety/depression. However, some visual symptoms, such as glare, blurred vision and reading difficulties, showed great differences between patients with or without anxiety/depression. Conclusion: Vision rehabilitation may be a tool for mitigating fatigue after acquired brain injury.	[Berthold Lindstedt, Marta; Borg, Kristian] Karolinska Inst, Dept Clin Sci, Div Rehabil Med, Danderyd Hosp, Stockholm, Sweden; [Johansson, Jan; Ygge, Jan] Karolinska Inst, Dept Clin Neurosci Eye & Vis, Stockholm, Sweden		Berthold Lindstedt, M (corresponding author), Danderyd Hosp, Div Rehabil Med, Blg 60 Fl 3, SE-18288 Stockholm, Sweden.	marta.berthold-lindstedt@sll.se					Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Berthold-Lindstedt M, 2017, J REHABIL MED, V49, P327, DOI 10.2340/16501977-2218; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broomfield NM, 2015, INT J STROKE, V10, P897, DOI 10.1111/ijs.12109; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Coubard OA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01035; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gall C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00051; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; GRISHAM JD, 1993, OPTOMETRY VISION SCI, V70, P384, DOI 10.1097/00006324-199305000-00008; Holmqvist A, 2018, J REHABIL MED, V50, P725, DOI 10.2340/16501977-2365; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson P, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.3512.3512; KERKHOFF G, 1990, NERVENARZT, V61, P711; Lenzi GL, 2008, REV NEUROL-FRANCE, V164, P837, DOI 10.1016/j.neurol.2008.07.010; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Maaijwee NAMM, 2016, EUR J NEUROL, V23, P1262, DOI 10.1111/ene.13009; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Meeren HKM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24831; Padula WV, 2017, BRAIN INJURY, V31, P589, DOI 10.1080/02699052.2017.1291991; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Rosenfield M, 2012, OPHTHAL PHYSL OPT, V32, P142, DOI 10.1111/j.1475-1313.2011.00887.x; Rowe F, 2016, DISABIL REHABIL, V38, P813, DOI 10.3109/09638288.2015.1061604; Rowe FJ, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.771; Sand KM, 2016, EUR J NEUROL, V23, P1, DOI 10.1111/ene.12848; Schow T, 2017, TOP STROKE REHABIL, V24, P41, DOI 10.1080/10749357.2016.1188475; Schow T, 2016, NEUROREHABILITATION, V38, P331, DOI 10.3233/NRE-161324; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Trachtman JN, 2010, OPTOMETRY, V81, P240, DOI 10.1016/j.optm.2009.07.017; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; Wolffsohn JS, 2011, J CATARACT REFR SURG, V37, P454, DOI 10.1016/j.jcrs.2010.09.022; Wright F, 2017, STROKE RES TREAT, V2017, DOI 10.1155/2017/2124743; Wu SM, 2014, STROKE, V45, P1778, DOI 10.1161/STROKEAHA.113.004584; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	3	3	0	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUL	2019	51	7					499	505		10.2340/16501977-2570			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	IF4KO	WOS:000473050400004	31165172	gold			2022-02-06	
J	Bressan, S; Kochar, A; Oakley, E; Borland, M; Phillips, N; Dalton, S; Lyttle, MD; Hearps, S; Cheek, JA; Furyk, J; Neutze, J; Dalziel, S; Babl, FE; Gilhotra, Y; Donath, S				Bressan, Silvia; Kochar, Amit; Oakley, Ed; Borland, Meredith; Phillips, Natalie; Dalton, Sarah; Lyttle, Mark D.; Hearps, Stephen; Cheek, John Alexander; Furyk, Jeremy; Neutze, Jocelyn; Dalziel, Stuart; Babl, Franz E.; Gilhotra, Yuri; Donath, Susan		Paediat Res Emergency Dept Int	Traumatic brain injury in young children with isolated scalp haematoma	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							MINOR HEAD-INJURY; INTRACRANIAL INJURY; COMPUTED-TOMOGRAPHY; SKULL FRACTURES; DECISION RULES; PECARN; PREDICTION; MANAGEMENT; CHALICE; VISITS	Objective Despite high-quality paediatric head trauma clinical prediction rules, the management of otherwise asymptomatic young children with scalp haematomas (SH) can be difficult. We determined the risk of intracranial injury when SH is the only predictor variable using definitions from the Pediatric Emergency Care Applied Research Network (PECARN) and Children's Head Injury Algorithm for the Prediction of Important Clinical Events (CHALICE) head trauma rules. Design Planned secondary analysis of a multicentre prospective observational study. Setting Ten emergency departments in Australia and New Zealand. Patients Children <2 years with head trauma (n=5237). Interventions We used the PECARN (any non-frontal haematoma) and CHALICE (>5 cm haematoma in any region of the head) rule-based definition of isolated SH in both children <1 year and <2 years. Main outcome measures Clinically important traumatic brain injury (ciTBI; ie, death, neurosurgery, intubation >24 hours or positive CT scan in association with hospitalisation >= 2 nights for traumatic brain injury). Results In children <1 year with isolated SH as per PECARN rule, the risk of ciTBI was 0.0% (0/109; 95% CI 0.0% to 3.3%); in those with isolated SH as defined by the CHALICE, it was 20.0% (7/35; 95% CI 8.4% to 36.9%) with one patient requiring neurosurgery. Results for children <2 years and when using rule specific outcomes were similar. Conclusions In young children with SH as an isolated finding after head trauma, use of the definitions of both rules will aid clinicians in determining the level of risk of ciTBI and therefore in deciding whether to do a CT scan.	[Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Kochar, Amit] Womens & Childrens Hosp Adelaide, Pediat Emergency, Womens & Babies Div, Adelaide, SA, Australia; [Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Oakley, Ed; Cheek, John Alexander; Babl, Franz E.] Royal Childrens Hosp Melbourne, Emergency Dept, Parkville, Vic, Australia; [Oakley, Ed; Hearps, Stephen; Babl, Franz E.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Borland, Meredith] Perth Childrens Hosp, Emergency Med, Perth, WA, Australia; [Borland, Meredith] Univ Western Australia, Div Paediat, Crawley, WA, Australia; [Borland, Meredith] Univ Western Australia, Div Emergency Med, Crawley, WA, Australia; [Phillips, Natalie] Queensland Childrens Hosp, Emergency Dept, South Brisbane, Qld, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Westmead, NSW, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England; [Furyk, Jeremy] Univ Hosp Geelong, Emergency Dept, Geelong, Vic, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Med, Otahuhu, New Zealand; [Dalziel, Stuart] Starship Childrens Hlth, Emergency Dept, Auckland, New Zealand; [Gilhotra, Yuri] Queensland Childrens Hosp, Emergency Dept, Brisbane, Qld, Australia; [Donath, Susan] Murdoch Childrens Res Inst, Melbourne, Vic, Australia		Babl, FE (corresponding author), Royal Childrens Hosp, Emergency Dept, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Lyttle, Mark/0000-0002-8634-7210; Hearps, Stephen/0000-0003-2984-1172	National Health and Medical Research Council, Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation [3112011]; WA Health Targeted Research Funds 2013, Perth, Australia; National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1058560]; A + Trust (Auckland District Health Board), Auckland, New Zealand; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation; Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB's time was part funded by a grant from the Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia, and an NHMRC Practitioner Fellowship, Canberra, Australia. StD's time was part funded by the Health Research Council of New Zealand (HRC13/556).	Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bin SS, 2010, PEDIATR EMERG CARE, V26, P633, DOI 10.1097/PEC.0b013e3181ef0440; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2018, ANN EMERG MED, V71, P714, DOI 10.1016/j.annemergmed.2017.10.014; Bressan S, 2017, EUR J EMERG MED, V24, P308, DOI 10.1097/MEJ.0000000000000459; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Burke K, 2014, ARCH DIS CHILD, V99, P958, DOI 10.1136/archdischild-2014-306159; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Magana JN, 2017, ACAD EMERG MED, V24, P382, DOI 10.1111/acem.13155; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCabe AM, 2015, ACAD EMERG MED, V22, P1372, DOI 10.1111/acem.12819; National Clinical Guideline C, 2014, NIH CLIN EXC GUID HE; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Parri N, 2018, J PEDIATR-US, V196, P230, DOI 10.1016/j.jpeds.2017.12.057; Pfeiffer H, 2018, ARCH DIS CHILD, V103, P776, DOI 10.1136/archdischild-2017-313748; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reid SR, 2012, CLIN PEDIATR, V51, P745, DOI 10.1177/0009922812446009; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983	32	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	JUL	2019	104	7					664	669		10.1136/archdischild-2018-316066			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IH6FF	WOS:000474588500014	30833284				2022-02-06	
J	Cooper, L; Harper, R; Wham, GS; Cates, J; Chafin, SJ; Cohen, RP; Dompier, TP; Huggins, RA; Newman, D; Peterson, B; McLeod, TCV				Cooper, Larry; Harper, Ronnie; Wham, George S., Jr.; Cates, Jason; Chafin, Scott J., Jr.; Cohen, Randy P.; Dompier, Thomas P.; Huggins, Robert A.; Newman, Dan; Peterson, Bart; McLeod, Tamara C. Valovich			Appropriate Medical Care Standards for Organizations Sponsoring Athletic Activity for the Secondary School-Aged Athlete: A Summary Statement	JOURNAL OF ATHLETIC TRAINING			English	Article						safety; adolescents; athletic injuries; high school; injury and illness prevention; concussion; heat illness; sudden death	ASSOCIATION POSITION STATEMENT; PREVENTING SUDDEN-DEATH; CLINICAL-OUTCOMES ASSESSMENT; EXERTIONAL HEAT ILLNESS; TRAINING PRACTICE; DISABLEMENT MODELS; TASK-FORCE; MANAGEMENT	Objective: To present the appropriate medical care standards for organizations that sponsor athletic activities for secondary school-aged athletes. Data Sources: To develop the current standards and identify current best-practices evidence, the task force used a multistep process that included reviewing the existing 2004 Appropriate Medical Care for Secondary School-Aged Athletes consensus points and cross-referencing of National Athletic Trainers' Association (NATA) statements and official documents from the strategic alliance (the NATA, NATA Foundation, Board of Certification, and Commission on Accreditation of Athletic Training Education). Gaps in the recommendations from the 2004 Appropriate Medical Care for Secondary School-Aged Athletes document were identified by the task force, and the new appropriate medical care standards were developed and refined. Conclusions and Recommendations: Twelve standards, with supporting substandards, were developed that encompassed readiness to participate in activity; facilities; equipment; protective materials; environmental policies; nutrition, hydration, and dietary supplementation; wellness and long-term health; comprehensive emergency action plans; on-site immediate care; on-site therapeutic interventions; psychological concerns; and athletic health care administration. Collectively, these standards describe a comprehensive approach to providing appropriate health care to secondary school-aged athletes and should serve as a framework with which organizations can evaluate and improve the medical care supplied to adolescent athletes.	[Cooper, Larry] Penn Trafford High Sch, Harrison City, PA USA; [Harper, Ronnie] Dutchtown High Sch, Geismar, LA USA; [Wham, George S., Jr.] Pelion High Sch, Pelion, SC, Brazil; [Cates, Jason] Cabot Publ Sch, Cabot, AR USA; [Chafin, Scott J., Jr.] Gregorio Chafin Johnson Poolson & Tabor LLC, Shreveport, LA USA; [Cohen, Randy P.] Univ Arizona, Dept Intercollegiate Athlet, Tucson, AZ USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Huggins, Robert A.] Univ Connecticut, Korey Stringer Inst, Dept Kinesiol, Storrs, CT USA; [Newman, Dan] Union High Sch, Dept Athlet, Tulsa, OK USA; [Peterson, Bart] Palo Verde High Magnet Sch, Tucson, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, 5850 East Still Circle, Mesa, AZ 85206 USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, 5850 East Still Circle, Mesa, AZ 85206 USA		McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Programs, 5850 East Still Circle, Mesa, AZ 85206 USA.; McLeod, TCV (corresponding author), AT Still Univ, Sch Osteopath Med Arizona, 5850 East Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Huggins, Robert/0000-0003-2174-8088			Almquist J, 2004, APPROPRIATE MED COVE; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; American Academy of Family Physicians American Academy of Pediatrics American College of Sports Medicine American Medical Society for Sports Medicine American Orthopaedic Society for Sports Medicine American Osteopathic Academy of Sports Medicine, 2010, PREP PHYS EV; Andersen JC, 2002, J ATHL TRAINING, V37, P99; [Anonymous], BOC FAC PRINC; [Anonymous], H 470 995 ATHL SPORT; [Anonymous], APPR MED CAR SEC SCH; [Anonymous], TECHN ASS DOC REP DA; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Binkley HM, 2002, J ATHL TRAINING, V37, P329; Bonci CM, 2008, J ATHL TRAINING, V43, P80, DOI 10.4085/1062-6050-43.1.80; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; Buell JL, 2013, J ATHL TRAINING, V48, P124, DOI 10.4085/1062-6050-48.1.16; Cappaert TA, 2008, J ATHL TRAINING, V43, P640, DOI 10.4085/1062-6050-43.6.640; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Casa DJ, 2012, J ATHL TRAINING, V47, P477, DOI 10.4085/1062-6050-47.4.08; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Castellani JW, 2006, MED SCI SPORT EXER, V38, P2012, DOI 10.1249/01.mss.0000241641.75101.64; Conley KM, 2014, J ATHL TRAINING, V49, P102, DOI 10.4085/1062-6050-48.6.05; Cooper L, 2018, APPROPRIATE MED CARE; Cotton D, 1997, SPORTS LAW; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Houglum P.A., 2001, THERAPEUTIC EXERCISE; Kaminski TW, 2013, J ATHL TRAINING, V48, P528, DOI 10.4085/1062-6050-48.4.02; Kerr ZY, 2014, MED SCI SPORT EXER, V46, P124, DOI 10.1249/MSS.0b013e3182a11f45; Lam KC, 2016, J ATHL TRAINING, V51, P435, DOI 10.4085/1062-6050-51.8.03; Lloyd RS, 2016, J STRENGTH COND RES, V30, P1491, DOI 10.1519/JSC.0000000000001387; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Neal TL, 2015, J ATHL TRAINING, V50, P231, DOI 10.4085/1062-6050-50.3.03; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Stovitz SD, 2010, BRIT J SPORT MED, V44, P4, DOI 10.1136/bjsm.2009.069195; Turocy PS, 2011, J ATHL TRAINING, V46, P322; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; Walsh KM, 2000, J ATHL TRAINING, V35, P471; Wasilko SM, 2013, SPORTS HEALTH, V5, P548, DOI 10.1177/1941738113484250; Yeo BK, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-31	37	3	3	1	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2019	54	7					741	748		10.4085/1062-6050-544-18			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IT4PV	WOS:000482843900001	31135211	Green Published, gold			2022-02-06	
J	das Nair, R; Bradshaw, LE; Day, FEC; Drummond, A; Harris, SRS; Fitzsimmons, D; Montgomery, AA; Newby, G; Sackley, C; Lincoln, NB				das Nair, Roshan; Bradshaw, Lucy E.; Day, Florence E. C.; Drummond, Avril; Harris, Shaun R. S.; Fitzsimmons, Deborah; Montgomery, Alan A.; Newby, Gavin; Sackley, Catherine; Lincoln, Nadina B.			Clinical and cost effectiveness of memory rehabilitation following traumatic brain injury: a pragmatic cluster randomized controlled trial	CLINICAL REHABILITATION			English	Article						Traumatic brain injury; memory rehabilitation; randomized controlled trial	OF-THE-LITERATURE; COGNITIVE REHABILITATION; NEUROLOGICAL DISABILITIES; MULTIPLE-SCLEROSIS; EVERYDAY MEMORY; IMPAIRMENT; PEOPLE; REMIND; TREAT; TBI	Objective: To evaluate the clinical and cost effectiveness of a group-based memory rehabilitation programme for people with traumatic brain injury. Design: Multicentre, pragmatic, observer-blinded, randomized controlled trial in England. Setting: Community. Participants: People with memory problems following traumatic brain injury, aged 18-69 years, able to travel to group sessions, communicate in English, and give consent. Interventions: A total of 10 weekly group sessions of manualized memory rehabilitation plus usual care (intervention) vs. usual care alone (control). Main measures: The primary outcome was the patient-reported Everyday Memory Questionnaire (EMQ-p) at six months post randomization. Secondary outcomes were assessed at 6 and 12 months post randomization. Results: We randomized 328 participants. There were no clinically important differences in the primary outcome between arms at six-month follow-up (mean EMQ-p score: 38.8 (SD 26.1) in intervention and 44.1 (SD 24.6) in control arms, adjusted difference in means: -2.1, 95% confidence interval (CI): -6.7 to 2.5, p = 0.37) or 12-month follow-up. Objectively assessed memory ability favoured the memory rehabilitation arm at the 6-month, but not at the 12-month outcome. There were no between-arm differences in mood, experience of brain injury, or relative/friend assessment of patient's everyday memory outcomes, but goal attainment scores favoured the memory rehabilitation arm at both outcome time points. Health economic analyses suggested that the intervention was unlikely to be cost effective. No safety concerns were raised. Conclusion: This memory rehabilitation programme did not lead to reduced forgetting in daily life for a heterogeneous sample of people with traumatic brain injury. Further research will need to examine who benefits most from such interventions.	[das Nair, Roshan] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England; [das Nair, Roshan] Univ Nottingham, Inst Mental Hlth, B19, Nottingham NG7 2TU, England; [Bradshaw, Lucy E.; Day, Florence E. C.; Montgomery, Alan A.] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham, England; [Drummond, Avril] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Harris, Shaun R. S.; Fitzsimmons, Deborah] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Newby, Gavin] Newby Psychol Serv Ltd, Northwich, England; [Sackley, Catherine] Kings Coll London, Sch Populat Hlth & Environm Sci, London, England; [Lincoln, Nadina B.] Univ Nottingham, Div Rehabil & Ageing, Nottingham, England		das Nair, R (corresponding author), Univ Nottingham, Inst Mental Hlth, B19, Nottingham NG7 2TU, England.	roshan.dasnair@nottingham.ac.uk		sackley, catherine/0000-0002-8580-6622; Montgomery, Alan/0000-0003-0450-1606; Drummond, Avril/0000-0003-1220-8354; das Nair, Roshan/0000-0001-8143-7893	National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Health Technology Assessment ProgrammeNational Institute for Health Research (NIHR) [10/57/24]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was funded by the National Institute for Health Research (NIHR) and Health Technology Assessment Programme (project no. 10/57/24) and will be published in full in Health Technology Assessment. Further information available at: https://www.journalslibrary.nihr.ac.uk/programmes/hta/105724/#/.The funder had no role in study design, data collection, analysis, interpretation, or writing of the report. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bateman A, 2009, NEUROPSYCHOL REHABIL, V19, P941, DOI 10.1080/09602010903021170; Bowen A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007039.pub2; Byrne C, 2017, NEUROREHABILITATION, V41, P501, DOI 10.3233/NRE-162015; Carr SE, 2014, CLIN REHABIL, V28, P552, DOI 10.1177/0269215513512336; Chiaravalloti ND, 2016, NEUROREHAB NEURAL RE, V30, P539, DOI 10.1177/1545968315604395; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Das Nair R, HLTH TECHNOL ASSESS; das Nair R, 2015, TRIALS, V16, DOI 10.1186/1745-6215-16-6; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; DASNAIR R, 2016, COCHRANE DB SYST REV, V9; Devlin NJ, 2018, HEALTH ECON, V27, P7, DOI 10.1002/hec.3564; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Goldberg RJ, 1988, USERS GUIDE GEN HLTH; Goodwin RA, 2020, NEUROPSYCHOL REHABIL, V30, P15, DOI 10.1080/09602011.2018.1447973; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martin KJ, 2014, INT J THER REHABIL, V21, P590, DOI 10.12968/ijtr.2014.21.12.590; National Institute for Health and Care Excellence (NICE), 2014, QUAL STAT 7 COMM REH; Ossher L, 2013, AGING NEUROPSYCHOL C, V20, P220, DOI 10.1080/13825585.2012.690365; Pearson Assessment, RIV BEH MEM TEST; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raudenbush S.W., 2011, OPTIMAL DESIGN SOFTW; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sander AM, 2018, CLIN NEUROPSYCHOL, V32, P495, DOI 10.1080/13854046.2017.1368714; Scottish Intercollegiate Guidelines Network (SIGN), 2013, BRAIN INJ REH AD; Shrier I, 2014, CLIN TRIALS, V11, P28, DOI 10.1177/1740774513504151; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Syder D, 1993, SHEFFIELD SCREENING; Thames Valley Strategic Clinical Network, 2016, TRANSF COMM NEUR WHA; Trigg E., 2018, THESIS; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; World Health Organization, 2007, INT CLASS FUNCT DIS	39	3	3	1	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUL	2019	33	7					1171	1184		10.1177/0269215519840069			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	ID9WW	WOS:000472038900008	30977398	hybrid, Green Published			2022-02-06	
J	Dong, WW; Sun, YF; Cheng, H; Yang, B; Wang, LL; Jiang, ZF; Li, BX; Wen, SH; Guo, XS; Guan, DW; Zhao, R				Dong, Wenwen; Sun, Yingfu; Cheng, Hao; Yang, Bei; Wang, Linlin; Jiang, Zhenfei; Li, Bingxuan; Wen, Shuheng; Guo, Xiangshen; Guan, Dawei; Zhao, Rui			Dynamic cell type-specific expression of Nrf2 after traumatic brain injury in mice	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						astrocytes; microglia; neurons; NG2 glia; nuclear factor erythroid 2-related factor 2; traumatic brain injury	TRANSCRIPTION FACTOR NRF2; ASTROCYTE-SPECIFIC OVEREXPRESSION; OXIDATIVE STRESS; NF-E2-RELATED FACTOR-2; THERAPEUTIC TARGET; ACTIVATION; NEURONS; PATHWAY; NEUROPROTECTION; GLUTATHIONE	Nrf2 plays a pivotal role in antioxidant response and anti-inflammation after traumatic brain injury (TBI), and its deletion aggravates TBI-induced brain damage. Previous studies have demonstrated that Nrf2 is activated post TBI, but dynamic changes in expression and cell type-specific characteristics remain unclear. In this study, the Feeney weight-drop contusion model was conducted to mimic TBI, and the ipsilateral cerebral cortex was collected at 1, 3, 7 and 14 days post TBI (dpi). Nrf2 protein levels were observed by western blot. Cell type-specific localization of Nrf2 after TBI was detected at different time intervals by double immunofluorescence staining. NeuN, GFAP, IBA1 and NG2 were used as cell type-specific markers to neurons, astrocytes, microglia and NG2 glia, respectively. After TBI, Nrf2 protein levels peaked at 1 dpi. Robust transient Nrf2 accumulation was co-localized with neurons, which was predominant at 1 dpi. Continuous weak Nrf2 expression was detected in activated astrocytes, and the number of double positive cells peaked at 7 dpi. Inducible widespread immunostaining of Nrf2 was observed in the nucleus of the microglia, and the number of Nrf2+ microglia peaked at 7 dpi. In addition, we also explored colocalization of Nrf2 in NG2 glia, in which the percentage of Nrf2+ in NG2 glia reached a climax at 3 dpi. This study reveals that the accumulation of endogenous Nrf2 might mediate different pathophysical roles in neurons and glias after TBI, the cell-type specific and time-dependent expression provide insights to explain the roles of Nrf2 in different neural cells.	[Dong, Wenwen; Sun, Yingfu; Cheng, Hao; Wang, Linlin; Jiang, Zhenfei; Li, Bingxuan; Wen, Shuheng; Guo, Xiangshen; Guan, Dawei; Zhao, Rui] China Med Univ, Sch Forens Med, Dept Forens Pathol, Shenyang, Liaoning, Peoples R China; [Yang, Bei] China Med Univ, Coll Basic Med Sci, Dept Histol & Embryol, Shenyang, Liaoning, Peoples R China; [Guan, Dawei; Zhao, Rui] Collaborat Lab Intelligentized Forens Sci, Shenyang, Liaoning, Peoples R China		Guan, DW; Zhao, R (corresponding author), China Med Univ, Sch Forens Med, Dept Forens Pathol, Shenyang, Liaoning, Peoples R China.	dwguan@cmu.edu.cn; rzhao@cmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81602825, 81671862, 81772023]; Liaoning Provincial Department of Education Science Research Project for outstanding young investigator [LJQ2015119]; Liaoning Natural Science Foundation of China [201602882]; Science and Technology Research Program from the Education Department of Liaoning Province, China [LK201658]	National Natural Science Foundation of China, Grant/Award Number: 81602825, 81671862 and 81772023; the Liaoning Provincial Department of Education Science Research Project for outstanding young investigator, Grant/Award Number: LJQ2015119; the Liaoning Natural Science Foundation of China, Grant/Award Number: 201602882; the Science and Technology Research Program from the Education Department of Liaoning Province, China, Grant/Award Number: LK201658	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Bonfanti E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.256; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cuadrado A, 2018, PHARMACOL REV, V70, P348, DOI 10.1124/pr.117.014753; Dang J, 2012, J MOL NEUROSCI, V46, P578, DOI 10.1007/s12031-011-9645-9; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Gan L, 2012, J NEUROSCI, V32, P17775, DOI 10.1523/JNEUROSCI.3049-12.2012; Gupta K, 2013, BRIT J CLIN PHARMACO, V75, P907, DOI 10.1111/bcp.12022; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Habas A, 2013, P NATL ACAD SCI USA, V110, P18291, DOI 10.1073/pnas.1208764110; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jimenez-Blasco D, 2015, CELL DEATH DIFFER, V22, P1877, DOI 10.1038/cdd.2015.49; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Liddell JR, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030065; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Nakano Y, 2017, J NEUROSCI RES, V95, P2030, DOI 10.1002/jnr.24047; Pajares M, 2016, AUTOPHAGY, V12, P1902, DOI 10.1080/15548627.2016.1208889; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P1766, DOI 10.1089/ars.2013.5745; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Schafer MKE, 2018, MATRIX BIOL, V68-69, P571, DOI 10.1016/j.matbio.2017.10.002; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamazaki H, 2015, PATHOL INT, V65, P210, DOI 10.1111/pin.12261; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhang DF, 2016, PAK J PHARM SCI, V29, P1365; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang RR, 2017, MOL NEUROBIOL, V54, P6006, DOI 10.1007/s12035-016-0111-0; Zhao R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/412576	60	3	3	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2019	50	2					1981	1993		10.1111/ejn.14399			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IL1HO	WOS:000477050500010	30828870				2022-02-06	
J	Elias, DA; MacLaren, VV; Brien, EK; Metcalfe, AWS				Elias, David A.; MacLaren, Vance V.; Brien, Erin K.; Metcalfe, Arron W. S.			Exaggerated Functional Impairment due to Malingered Neurocognitive Dysfunction Following Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Postconcussion syndrome; Malingering; Chronic pain; Disability management	ASSESSMENT SCHEDULE 2.0; PERFORMANCE VALIDITY; MUSCULOSKELETAL PAIN; POOR EFFORT; TASK-FORCE; QUESTIONNAIRE; SYMPTOMS; RECOVERY; DSM-5; SCALE	Objective: Functional impairment associated with Neurocognitive Disorder is often claimed in medico-legal settings after mild Traumatic Brain Injury (mTBI). This case-control study examined self-reported functional impairment and the plausibility of chronic disability claims following uncomplicated mTBI. Method: Independent Medical Evaluations included a battery of performance and symptom validity tests, along with self-reports of physical or emotional complaints and functional impairment. Slick and colleagues' (Slick, D. J., Sherman, E. M., & Iverson, G. L. (1999). Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13, 545-561.) criteria ruled out probable malingering in 21 mTBI cases without psychiatric comorbidity and their self-reports were compared to those of seven non-malingering cases with a psychiatric comorbidity, 17 who were probable malingerers, and 31 orthopedic pain sufferers. Coherence Analysis of medical documentation corroborated assignment of mTBI cases to non-malingering versus probable malingering groups. Results: Probable malingerers reported more postconcussion symptoms than non-malingerers (d = 0.79) but they did not differ significantly on tests of neurocognitive performance. Probable malingerers and orthopedic pain patients gave significantly higher ratings of functional impairment (d = 1.28 and 1.26) than non-malingerers. Orthopedic pain patients reported more disability due to pain than non-malingerers (d = 1.03), but pain catastrophizing was rated more highly by the probable malingerers (d = 1.21) as well as by the orthopedic pain patients (d = 0.98). The non-malingerers reported lower emotional distress than the other three groups, but only the probable malingerers reported elevated depression symptoms compared to the non-malingerers (d = 1.01). Conclusions: The combined evaluation of performance validity, function, and coherence analysis would appear to enhance the difficult clinical evaluation of postconcussion symptoms in the medical-legal setting.	[Elias, David A.; MacLaren, Vance V.; Brien, Erin K.] Canadian Hlth Solut Inc, St John, NB E2M 5Z4, Canada; [Elias, David A.] Dalhousie Univ, Sch Med, St John, NB E2M 5Z4, Canada; [Metcalfe, Arron W. S.] Canadian Imaging Res Ctr, St John, NB E2M 5Z4, Canada		Elias, DA (corresponding author), Canadian Hlth Solut Inc, POB 3033, Grand Bay Westfield, NB E5K 4V3, Canada.	david.elias@canhs.ca			Scientific Research and Experimental Development (SR&ED) Tax Incentive Program from Government of Canada	This research was funded in part through the Scientific Research and Experimental Development (SR&ED) Tax Incentive Program from the Government of Canada. Special thanks to Amelia Barry, Mike Barry, Geoff Cook, James French, Rachel Hill-Elias, Darren Kerr, Neil Manson, Brendan Sheehan, and Andre Touchburn for their vital work in the clinical assessment of cases reported in this study.	APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Beck A. T., 1996, MANUAL BECK DEPRESSI, V1, P82; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bruns D, 2014, PSYCHOL INJ LAW, V7, P335, DOI 10.1007/s12207-014-9206-y; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Carone D. A., 2013, MILD TRAUMATIC BRAIN, P203; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; Gatchel RJ, 2006, J OCCUP REHABIL, V16, P75, DOI 10.1007/s10926-005-9005-0; Gervais R. O., 2017, NEUROPSYCHOLOGICAL E; Gold LH, 2014, J AM ACAD PSYCHIATRY, V42, P173; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Green P., 2004, MEMORY COMPLAINTS IN; Green P.J.E., 2008, MANUAL NONVERBAL MED; Greher MR, 2017, J PSYCHIATR PRACT, V23, P134, DOI 10.1097/PRA.0000000000000218; Houben RMA, 2005, J BEHAV MED, V28, P415, DOI 10.1007/s10865-005-9011-x; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Linton SJ, 1998, CLIN J PAIN, V14, P209, DOI 10.1097/00002508-199809000-00007; Linton SJ, 2003, CLIN J PAIN, V19, P80, DOI 10.1097/00002508-200303000-00002; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Lovell M. R., 2015, IMPACT TEST ADM INTE; Margison DA, 2007, J OCCUP ENVIRON MED, V49, P59, DOI 10.1097/JOM.0b013e31802db51e; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; POLLARD CA, 1984, PERCEPT MOTOR SKILL, V59, P974, DOI 10.2466/pms.1984.59.3.974; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Rondinelli R.D., 2008, AMA GUIDES EVALUATIO; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schultz IZ, 2013, PSYCHOL INJ LAW, V6, P299, DOI 10.1007/s12207-013-9174-7; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Stewart-Patterson C., 2010, IAIABC J, V47, P19; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Ustun T, 2010, MEASURING HLTH DISAB; Wodushek TR, 2017, J PSYCHIATR PRACT, V23, P214, DOI 10.1097/PRA.0000000000000233	50	3	3	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	2019	34	5					648	656		10.1093/arclin/acy086			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	IO3MG	WOS:000479283900006	30462149	Bronze			2022-02-06	
J	Galea, OA; Bristow, HD; Chisholm, SM; Mersch, ME; Nullmeyer, J; Reid, CR; Treleaven, JM				Galea, Olivia A.; Bristow, Hayden D.; Chisholm, Scott M.; Mersch, Michaela E.; Nullmeyer, Jocelyn; Reid, Chantelle R.; Treleaven, Julia M.			Single and dual tandem gait assessment post concussion: What performance time is clinically relevant across adult ages and what can influence results?	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Adults; Concussion; Dual task; Mild traumatic brain injury; Healthy individual data; Single tandem gait	TRAUMATIC BRAIN-INJURY; BALANCE CONTROL; TASK; STABILITY; INTERFERENCE; ADOLESCENTS; LOCOMOTOR; DEFICITS; WALKING; GENDER	Aim: The three-metre tandem gait test (TG) is used to assess postural control during locomotion following sports concussion. However, values used to determine a pass/fail result are currently based on young athletic populations. Times for test completion may be influenced by several intrinsic or extrinsic factors. The aim of this study was to collate healthy individual single, dual task as well as dual task cost - motor TG times for a non-elite athlete population, across several age groups, and to investigate several potential influencing factors. Methods: Healthy individuals aged 18-55+, who had never experienced a concussion completed single and dual task TG following the SCAT5 protocol. A separate group (n = 20, age, foot length and body mass index matched) performed the tests with alternate instructions. Results: Mean best TG time for all participants were: single task 21.03 (+/- 5.26s), dual task 29.59 (+/- 9.84s) and DTC-motor 8.57 (+/- 7.5s:41.7%). Age and foot length but not specificity of verbal instructions were related to TG times. Significantly slower single and dual task times were identified for the 55 + age group when compared to the three youngest groups (p < 0.01). No difference was seen for DTC-motor time or % between age groups (p > 0.05). Conclusion: Healthy individual data collected exceeded previously reported average times. Faster times were evident in younger participants and those with longer foot length. Results from this study can be used as a reliable guideline to inform clinical decisions around the pass/fail result of TGT across age ranges in non-elite athlete populations post-concussion.	[Galea, Olivia A.; Bristow, Hayden D.; Chisholm, Scott M.; Mersch, Michaela E.; Nullmeyer, Jocelyn; Reid, Chantelle R.; Treleaven, Julia M.] Univ Queensland, Sch Hlth & Rehabil Sci, Bldg 84a Therapies Annexe, St Lucia, Qld 4072, Australia		Galea, OA (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Bldg 84a Therapies Annexe, St Lucia, Qld 4072, Australia.	olivia.galea@uqconnect.edu.au	Treleaven, Julia/N-1379-2019	Treleaven, Julia/0000-0002-6258-3972; GALEA, Olivia/0000-0001-5013-7580	Research Training Program Scholarship	This study was supported by a Research Training Program Scholarship.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Cohen HS, 2018, LARYNGOSCOPE, V128, P1687, DOI 10.1002/lary.27022; Cohen HS, 2012, J VESTIBUL RES-EQUIL, V22, P95, DOI 10.3233/VES-2012-0443; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eemanipure S., 2011, IRAN REHAB J, V9, P11; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Gill J, 2001, J GERONTOL A-BIOL, V56, pM438, DOI 10.1093/gerona/56.7.M438; Guskiewicz K. M., 2013, BRIT J SPORT MED, V47, P1; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lynall R. C., 2017, BRIT J SPORT MED, V51, pA49; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moreau W. J., 2017, BRIT J SPORT MED, V51, pA74; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; Schneiders AG, 2010, J SCI MED SPORT, V13, P382, DOI 10.1016/j.jsams.2010.01.003; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Strobach T, 2017, ADV COGN PSYCHOL, V13, P28, DOI 10.5709/acp-0204-7; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; WHIPPLE R, 1993, J GERONTOL, V48, P71, DOI 10.1093/geronj/48.Special_Issue.71	37	3	3	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUL	2019	42						166	172		10.1016/j.msksp.2019.04.006			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	IC2BJ	WOS:000470764100023	31031162				2022-02-06	
J	Hannonen, J; Perhomaa, M; Salokorpi, N; Serlo, W; Sequeiros, RB; Sinikumpu, J				Hannonen, Juuli; Perhomaa, Marja; Salokorpi, Niina; Serlo, Willy; Sequeiros, Roberto Blanco; Sinikumpu, Jaakko			Interventional magnetic resonance imaging as a diagnostic and therapeutic method in treating acute pediatric atlantoaxial rotatory subluxation	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						atlantoaxial subluxation; atlantoaxial rotational fixation; C1-C2; close reduction; magnetic resonance imaging; interventional magnetic resonance imaging	GRISELS-SYNDROME; ROTARY SUBLUXATION; ACQUIRED TORTICOLLIS; FIXATION-SUBLUXATION; FOLLOW-UP; CHILDREN; TOMOGRAPHY; MANAGEMENT	Atlantoaxial rotatory subluxation or fixation (AARF) is a rare condition, usually occurring in pediatric patients. It mimics benign torticollis but may result in permanent disability or death. The condition requires prompt diagnosis by thorough examination to avoid any treatment delays. Spiral computed tomography (CT) with three-dimensional reconstruction CT is recommended for identifying incongruence between C1 and C2 vertebrae, and magnetic resonance imaging (MRI) may be performed to exclude ligamentous injuries. In addition to static imaging, dynamic CT involves the reduction between C1 and C2 being confirmed using CT with the head turned maximally to the left and right. The present report (level of evidence, III) provides a method for treating AARF that has similar advantages as dynamic CT but avoids ionizing radiation by replacing CT with interventional MRI. The new method comprised simultaneous axial traction and manual closed reduction, performed under general anesthesia, and the use of interventional MRI to ensure that reduction was achieved and held. The head is turned maximally to the right and left during the manual reduction. A rigid cervical collar was used following reduction. Dynamic CT was not required but prior diagnostic static CT was performed in preparation. No further CT was required. There appears to be no previous studies on interventional MRI in AARF care. Being superior in its diagnostic soft-tissue visualization performance and lacking ionizing radiation, interventional MRI is a potential option for investigating and treating acute AARF in non-syndromic patients with no trauma history.	[Hannonen, Juuli; Serlo, Willy; Sinikumpu, Jaakko] Oulu Univ Hosp, Dept Children & Adolescents, 52 Kajaanintie St, Oulu 90220, Finland; [Perhomaa, Marja] Oulu Univ Hosp, Dept Radiol, Pediat Imaging, Oulu 90220, Finland; [Salokorpi, Niina] Oulu Univ Hosp, Pediat Neurosurg, Dept Neurosurg, Oulu 90220, Finland; [Salokorpi, Niina; Serlo, Willy; Sinikumpu, Jaakko] Univ Oulu, PEDEGO Res Grp, Oulu 90014, Finland; [Salokorpi, Niina; Serlo, Willy; Sinikumpu, Jaakko] Univ Oulu, Med Res Ctr Oulu, Oulu 90014, Finland; [Salokorpi, Niina; Serlo, Willy; Sinikumpu, Jaakko] Univ Oulu, Oulu Craniofacial Ctr, SF-90220 Oulu, Finland; [Sequeiros, Roberto Blanco] Turku Univ Hosp, Dept Radiol, Turku 20521, Finland		Hannonen, J (corresponding author), Oulu Univ Hosp, Dept Children & Adolescents, 52 Kajaanintie St, Oulu 90220, Finland.	juuli.hannonen@gmail.com	Salokorpi, Niina/AAU-3466-2021; Salokorpi, Niina/ABC-1513-2020	Salokorpi, Niina/0000-0001-7929-626X; Hannonen, Juuli/0000-0001-7241-709X; Blanco Sequeiros, Roberto/0000-0002-0167-9639	Emil Aaltonen foundation; Foundation of Pediatric Research	The Emil Aaltonen foundation and Foundation of Pediatric Research supported the present study.	Alanay A, 2002, J PEDIATR ORTHOPED, V22, P763, DOI 10.1097/00004694-200211000-00014; Barcelos ACES, 2014, GLOB SPINE J, V4, P179, DOI 10.1055/s-0033-1363936; Been HD, 2007, SPINE, V32, pE163, DOI 10.1097/01.brs.0000257342.69537.5f; Beier AD, 2012, J NEUROSURG-PEDIATR, V9, P144, DOI 10.3171/2011.11.PEDS11147; Ciftdemir M, 2012, BALK MED J, V29, P277, DOI 10.5152/balkanmedj.2012.029; Cornejo VJF, 2003, CHILD NERV SYST, V19, P342, DOI 10.1007/s00381-003-0749-6; Dagtekin A, 2011, CLIN NEUROL NEUROSUR, V113, P399, DOI 10.1016/j.clineuro.2010.12.020; Deichmueller CMC, 2010, EUR ARCH OTO-RHINO-L, V267, P1467, DOI 10.1007/s00405-010-1241-z; FIELDING JW, 1977, J BONE JOINT SURG AM, V59, P37, DOI 10.2106/00004623-197759010-00005; Galer C, 2005, INT J PEDIATR OTORHI, V69, P1689, DOI 10.1016/j.ijporl.2005.03.046; Gourin CG, 2002, AM J OTOLARYNG, V23, P60, DOI 10.1053/ajot.2002.28781; Haque S, 2012, RADIOGRAPHICS, V32, P557, DOI 10.1148/rg.322105143; Hicazi A, 2002, SPINE, V27, P2771, DOI 10.1097/00007632-200212150-00006; Holcomb JD, 2001, ANN OTO RHINOL LARYN, V110, P1137, DOI 10.1177/000348940111001210; JOHNSON DP, 1986, J BONE JOINT SURG BR, V68, P698, DOI 10.1302/0301-620X.68B5.3782225; Lee SC, 2002, BRIT J NEUROSURG, V16, P154, DOI 10.1080/02688690220131778; Li Veetai, 1995, P531; Maheshwaran S, 1995, CHILD NERV SYST, V11, P667, DOI 10.1007/BF00262228; Maile S, 2007, EUR J EMERG MED, V14, P167, DOI 10.1097/MEJ.0b013e328014081c; Martinez-Lage JF, 2001, ACTA NEUROCHIR, V143, P1223, DOI 10.1007/s007010100018; McGuire KJ, 2002, J PEDIATR ORTHOPED, V22, P766; Meek MF, 2001, CLEFT PALATE-CRAN J, V38, P268, DOI 10.1597/1545-1569(2001)038<0268:LMDGSA>2.0.CO;2; Mezue WC, 2002, J LARYNGOL OTOL, V116, P280, DOI 10.1258/0022215021910753; Mihara H, 2001, J SPINAL DISORD, V14, P494, DOI 10.1097/00002517-200112000-00005; Missori P, 2005, J NEUROSURG, V103, P563, DOI 10.3171/ped.2005.103.6.0563; Muniz AE, 1999, PEDIATR EMERG CARE, V15, P25, DOI 10.1097/00006565-199902000-00008; Neal KM, 2015, J AM ACAD ORTHOP SUR, V23, P382, DOI 10.5435/JAAOS-D-14-00115; Nicholson P, 1999, INT ORTHOP, V23, P47, DOI 10.1007/s002640050302; Ortiz GL, 2013, J PEDIATR REHAB MED, V6, P175, DOI 10.3233/PRM-130253; Osiro S, 2012, CHILD NERV SYST, V28, P821, DOI 10.1007/s00381-012-1706-z; Pang D, 2010, NEUROSURGERY, V66, pA161, DOI 10.1227/01.NEU.0000365800.94865.D4; Pang DL, 2005, NEUROSURGERY, V57, P954, DOI 10.1227/01.NEU.0000180052.81699.81; Pang DL, 2005, NEUROSURGERY, V57, P941, DOI 10.1227/01.NEU.0000181309.13211.3A; Park SH, 2013, ANN REHABIL MED-ARM, V37, P713, DOI 10.5535/arm.2013.37.5.713; Pilge H, 2011, SPINE, V36, pE747, DOI 10.1097/BRS.0b013e3181fab0e4; Rahimi Scott Y, 2003, Neurosurg Focus, V15, pECP1; Schwarz N, 1998, ARCH ORTHOP TRAUM SU, V117, P288, DOI 10.1007/s004020050249; Sia KJ, 2012, J LARYNGOL OTOL, V126, P529, DOI 10.1017/S0022215112000175; Sobolewski BA, 2008, PEDIATR EMERG CARE, V24, P852, DOI 10.1097/PEC.0b013e31818ea0d3; Subach BR, 1998, SPINE, V23, P2174, DOI 10.1097/00007632-199810150-00006; Tauchi R, 2011, J BONE JOINT SURG BR, V93B, P1084, DOI 10.1302/0301-620X.93B8.26803; Tsai SW, 2005, J MANIP PHYSIOL THER, V28, P352, DOI 10.1016/j.jmpt.2005.04.006; Wurm G, 2004, NEUROPEDIATRICS, V35, P134, DOI 10.1055/s-2004-815836	43	3	3	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUL	2019	18	1					18	24		10.3892/etm.2019.7565			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IK5DN	WOS:000476606000002	31258633	Green Published, gold			2022-02-06	
J	Holzer, KJ; Carbone, JT; DeLisi, M; Vaughn, MG				Holzer, Katherine J.; Carbone, Jason T.; DeLisi, Matt; Vaughn, Michael G.			Traumatic brain injury and coextensive psychopathology: New evidence from the 2016 Nationwide Emergency Department Sample (NEDS)	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Traumatic brain injury; Mental health; Posttraumatic stress disorder; Emergency care	GENERAL-POPULATION; JUVENILE-OFFENDERS; HEAD-INJURIES; PREVALENCE; DELINQUENCY; TEMPERAMENT; VIOLENCE; COSTS	Traumatic brain injury (TBI) is a significant public health issue associated with increased medical comorbidity and economic burden. The majority of studies of TBI among clinical populations are geographically limited and rely on small samples. As such, the current study seeks to examine the prevalence and psychosocial correlates of TBI in a nationally representative emergency department (ED) sample. Using the 2016 Nationwide Emergency Department Sample, logistic regression was employed to examine the relationship between TBI history, socio-demographic factors and mental health disorders. An estimated 179,986 adults age 18 and older were admitted to United States EDs in 2016 with a personal history of TBI. The majority of patients were male (69.71%), ages 50 years or older (50.92%) with Medicare (44.30%) or Medicaid (28.65%) insurance. Diagnoses of posttraumatic stress disorder (AOR = 3.99), affective disorders (AOR = 2.97), anxiety disorders (AOR = 1.68), personality and behavior disorders (AOR = 2.77), and schizophrenia (AOR = 2.80) were significantly associated with history of TBI. These results provide insight into the developmental pathogenesis of TBI and its comorbid psychiatric consequences.	[Holzer, Katherine J.; Carbone, Jason T.; Vaughn, Michael G.] St Louis Univ, Sch Social Work, Coll Publ Hlth & Social Justice, 3550 Lindell Blvd, St Louis, MO 63103 USA; [DeLisi, Matt] Iowa State Univ, Dept Sociol, Ames, IA 50011 USA; [Vaughn, Michael G.] Yonsei Univ, Grad Sch Social Welf, Seoul, South Korea		Holzer, KJ (corresponding author), St Louis Univ, Sch Social Work, Coll Publ Hlth & Social Justice, 3550 Lindell Blvd, St Louis, MO 63103 USA.	katie.holzer@slu.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH014592] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH014592] Funding Source: NIH RePORTER		Agency for Healthcare Research and Quality, 2018, HCUP NAT EM DEP SAMP; Agency for Healthcare Research and Quality, 2016, HCUP NEDS DESCR DAT; Behnken M, 2016, AM J CRIM JUSTICE, V41, P185, DOI 10.1007/s12103-015-9301-y; Behnken MP, 2015, ROUT INT HANDB, P418; Cook PJ, 1999, JAMA-J AM MED ASSOC, V282, P447, DOI 10.1001/jama.282.5.447; Daigle LE, 2018, J CRIM JUST, V58, P78, DOI 10.1016/j.jcrimjus.2018.07.005; Deb S, 1999, AM J PSYCHIAT, V156, P374; DeLisi M, 2014, J CRIM JUST, V42, P10, DOI 10.1016/j.jcrimjus.2013.11.001; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finkelstein E., 2006, INCIDENCE EC BURDEN; Garofalo C, 2017, J CRIM JUST, V51, P9, DOI 10.1016/j.jcrimjus.2017.05.015; Gottfredson M. R., 1990, GEN THEORY CRIME; Jang SJ, 2003, J QUANT CRIMINOL, V19, P79, DOI 10.1023/A:1022570729068; Lai HMX, 2015, DRUG ALCOHOL DEPEN, V154, P1, DOI 10.1016/j.drugalcdep.2015.05.031; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Prehn K, 2013, SOC NEUROSCI-UK, V8, P136, DOI 10.1080/17470919.2012.686923; Schofield PW, 2019, BRAIN INJURY, V33, P412, DOI 10.1080/02699052.2018.1552020; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Veeh CA, 2018, PSYCHOL CRIME LAW, V24, P1016, DOI 10.1080/1068316X.2018.1497632; Velotti P, 2017, PSYCHIAT PSYCHOL LAW, V24, P128, DOI 10.1080/13218719.2016.1164639; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; World Health Organization, 1993, ICD 10 CLASS MENT BE	32	3	3	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JUL	2019	114						149	152		10.1016/j.jpsychires.2019.05.002			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	IE1DY	WOS:000472127300022	31078785				2022-02-06	
J	Jimenez, N; Virtue, A; Segar, K; Vander Stoep, A; Rivara, FP				Jimenez, Nathalia; Virtue, Alyssa; Segar, Karen; Vander Stoep, Ann; Rivara, Frederick P.			Effect of School Services on Academic Performance After Traumatic Brain Injury in Hispanic and Non-Hispanic Students	JOURNAL OF SCHOOL HEALTH			English	Article						disability; rehabilitation; Hispanic; school services; injury control and prevention	CHILDREN; RETURN; NEEDS; REINTEGRATION; FAMILIES; SUPPORT; TBI	BACKGROUND School reintegration after traumatic brain injuries (TBI) requires school support; however, implementation of services is complex. This study evaluates disparities in receipt of school services for Hispanic children and its effect on academic performance. METHODS Secondary analyses of school data on receipt of pre- and post-TBI school services. A logistic regression compared receipt of services between Hispanic and non-Hispanic white (NHW) children, and a linear regression evaluated services' effect on academic performance. RESULTS The study includes 419 children; 46 Hispanic, 373 NHW. For NHW children there were no differences in receipt of pre- and post-TBI services; Hispanic children had significant increase in receipt of services from 5% to 27% (p < .001). Compared to NHWs, Hispanics had lower grade point average (GPA) at baseline (2.3 [confidence interval, CI: 1.9-2.7] vs 2.9 [CI: 2.8-3.0]). No differences in GPA were found between groups after injury among students who received post-TBI services. CONCLUSIONS Students who receive post-TBI school services benefit academically. NHW students maintain their academic performance and Hispanics increase their performance to their NHW peers' level. This highlights the importance of providing post-TBI school services to ensure better outcomes for all children.	[Jimenez, Nathalia] Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol, Anesthesiol, 401 Broadway,4th Floor, Seattle, WA 98122 USA; [Jimenez, Nathalia] Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pain Med, 401 Broadway,4th Floor, Seattle, WA 98122 USA; [Virtue, Alyssa] Univ Washington, Harborview Injury Prevent & Res Ctr, 401 Broadway,4th Floor, Seattle, WA 98122 USA; [Segar, Karen] Harborview Injury Prevent & Res Ctr, 401 Broadway,4th Floor, Seattle, WA 98122 USA; [Vander Stoep, Ann] Univ Washington, Inst Child Hlth, Dept Psychiat, POB 3549, Seattle, WA 98195 USA; [Vander Stoep, Ann] Univ Washington, Inst Child Hlth, Dept Behav Sci, POB 3549, Seattle, WA 98195 USA; [Vander Stoep, Ann] Univ Washington, Inst Child Hlth, Dept Epidemiol, POB 3549, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Epidemiol & Pediat Dent, Pediat, 401 Broadway,4th Floor, Seattle, WA 98122 USA		Jimenez, N (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol, Anesthesiol, 401 Broadway,4th Floor, Seattle, WA 98122 USA.; Jimenez, N (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pain Med, 401 Broadway,4th Floor, Seattle, WA 98122 USA.	njimen@uw.edu; akvirtue@uw.edu; ksegar@uw.edu; annv@uw.edu; fpr@uw.edu		Jimenez, Nathalia/0000-0002-6785-8330	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453-04]; Harborview Injury Prevention & Research Center's INSIGHT Student Internship Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development (grant K23HD078453-04 to Dr. N. J.) and Harborview Injury Prevention & Research Center's INSIGHT Student Internship Training Program.	Andersson K, 2016, BRAIN INJURY, V30, P829, DOI 10.3109/02699052.2016.1146963; Botcheva L, 2004, J SCHOOL HEALTH, V74, P68, DOI 10.1111/j.1746-1561.2004.tb04203.x; Callahan, 2003, ED POLICY ANAL ARCH, V11, P36, DOI [https://doi.org/10.14507/epaa.v11n36.2003, DOI 10.14507/EPAA.V11N36.2003]; Carney J, 2009, DEV DISABIL RES REV, V15, P152, DOI 10.1002/ddrr.57; Flores A, PEW RES CTR FACTS LA; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Sabin JA, 2005, J SCHOOL HEALTH, V75, P141; Savage RC, 2001, NEUROREHABILITATION, V16, P49; United States Department of Education, IDEA SECT 618 DAT PR; US Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC	20	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	JUL	2019	89	7					519	526		10.1111/josh.12776			8	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	IC3ZM	WOS:000470902300001	31016747	Green Accepted			2022-02-06	
J	Kibayashi, K				Kibayashi, Kazuhiko			Prevention of head trauma and death in patients with head injuries: A forensic autopsy study	IATSS RESEARCH			English	Article						Head injury; Brain injury; Traffic accident; Fall; Autopsy	ACCIDENTS; SCORE	This forensic study investigated patients with head injury to find methods of preventing head trauma and death of patients with head injuries. Autopsy information of patients who died alter experiencing blunt force trauma in the head owing to different causes was reviewed In addition, the manners of the death of patients who had mild to moderate head injuries on admission were analyzed. The records of 68 adult patients (2008-2015) with skull fractures or traumatic intracranial lesions due to blunt force trauma were assessed in this study. These patients were divided into four groups according to the causes of trauma: traffic accidents (n = 20), simple fall (n = 18), fall from height (n = 23), and blow (n = 7). The demographic information (Glasgow coma scale [GCS] score on admission and current medication and fall histories), autopsy findings, and severity of the injury, as indicated by the Abbreviated Injury Scale and Injury Severity Score, were compared among the different groups. The causes of death of seven patients with mild (GCS score of 13-15) or moderate (GCS score of 9-12) head injuries on admission were analyzed. The numbers of patients with current medication, fall history, subdural hematoma. and head injury alone as the cause of death were significantly higher in the simple fall group. The incidence of skull fractures and the number of deaths from multiple head and trunk injuries were significantly higher in the traffic accident group. Of the seven patients with mild or moderate head injuries on admission, four and three died from the acute onset of a pre-existing condition and exacerbation of traumatic brain injury, respectively. These results indicate that preventions of simple falls in individuals with current medication or fall history may decrease the number of deaths due to simple falls, and patients with head injuries due to traffic accidents should be examined for coexisting trunk injuries: in addition, those with mild or moderate head injuries must be cautiously monitored for the onset of a pre-existing condition and exacerbation of traumatic brain injury. (C) 2019 International Association of Traffic and Safety Sciences. Production and hosting by Elsevier Ltd.	[Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan		Kibayashi, K (corresponding author), Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kibayashi.kazuhiko@twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26293164]; General Insurance Association of Japan	This study was performed as a part of the Strategic Research Base Development Program for Private Universities ("Diagnosis and research of traumatic brain injury for medico-legal investigation of death (2014-2018)", Project Chief: Kazuhiko Kibayashi) with the support of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. This study was supported by Grants-in-Aid for Scientific Research (B) to Kazuhiko Kibayashi (No. 26293164) fromthe Japan society for the Promotion of Science and a medical research grant on traffic accident from The General Insurance Association of Japan.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Calosevic S, 2015, INJURY, V46, pS27, DOI 10.1016/j.injury.2015.10.049; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Chang Huan J, 2010, JAMA, V303, P288, DOI 10.1001/jama.303.3.288; Ferraris VA, 2010, J TRAUMA, V69, P645, DOI 10.1097/TA.0b013e3181d8941d; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kibayashi K, 2000, Leg Med (Tokyo), V2, P175, DOI 10.1016/S1344-6223(00)80021-8; Kibayashi K., 2015, THE JAPAN TIMES, P89; Kibayashi K, 2007, AM J FOREN MED PATH, V28, P73, DOI 10.1097/01.paf.0000257428.80088.94; Kibayashi K, 2014, IATSS RES, V38, P71, DOI 10.1016/j.iatssr.2014.07.002; Kibayashi K, 2013, MED SCI LAW, V53, P172, DOI 10.1177/0025802412473596; Kibayashi K, 2012, AM J FOREN MED PATH, V33, P206, DOI 10.1097/PAF.0b013e3181fe33e8; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Matsuyama T, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000012350, 10.1097/md.0000000000012350]; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Oliver GJ, 2017, INJURY, V48, P978, DOI 10.1016/j.injury.2017.01.039; Pfeifer R, 2017, WORLD J SURG, V41, P3111, DOI 10.1007/s00268-017-4122-4; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13	21	3	3	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0386-1112	2210-4240		IATSS RES	IATSS Res.	JUL	2019	43	2					71	74		10.1016/j.iatssr.2019.06.004			4	Transportation	Emerging Sources Citation Index (ESCI)	Transportation	IK5WS	WOS:000476656700002		gold			2022-02-06	
J	Kohler, K; Nallapareddy, S; Ercole, A				Kohler, Katharina; Nallapareddy, Sri; Ercole, Ari			In Silico Model of Critical Cerebral Oxygenation after Traumatic Brain Injury: Implications for Rescuing Hypoxic Tissue	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; blood flow; head trauma; traumatic brain injury	NORMOBARIC HYPEROXIA; BLOOD-FLOW; DIFFUSION; CARE; METABOLISM; DELIVERY; CAPILLARIES; MANAGEMENT; TENSION; MUSCLES	Cerebral oxygen delivery is central to the modern intensive care of patients with severe traumatic brain injury. Low brain tissue oxygen tension (PbtO2) results from microvascular collapse and diffusion limitation and is associated with adverse outcome. A number of therapies to improve oxygen delivery are known to be effective in improving PbtO2. Their relative effectiveness and microscopic regions of hypoxia, however, may exist/persist even in the presence of normal PbtO2. Unfortunately, there are no methods currently for assessing this quantitatively. We used an in silico (computational) simulation approach to understand the effect of common interventions on the microscopic distribution of brain tissue oxygen tension. We constructed a non-linear mathematical model of cerebral oxygen supply, diffusion, and consumption for a simplified geometry. Model parameters were chosen to agree with clinical parameters. We found that it was possible to create a plausible diffusion-limited scenario with a significant hypoxic fraction by increasing the mean diffusion distance. We found that increasing cerebral blood flow/blood oxygen content or suppressing the cerebral metabolic rate were most effective at improving PbtO2 and reduced the hypoxic fraction. Within the limitations of our modeling assumptions, increasing the arterial oxygen partial pressure was less effective and only improved PbtO2 by creating a region of hyperoxic tissue with no improvement in hypoxic fraction. The in silico simulations can be useful in understanding the likely physiological effect of complex treatments for which measurement techniques do not exist.	[Kohler, Katharina; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93 Hills Rd, Cambridge CB2 0QQ, England; [Nallapareddy, Sri] Ipswich Hosp NHS Trust, Ipswich, Suffolk, England		Ercole, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93 Hills Rd, Cambridge CB2 0QQ, England.	ae105@cam.ac.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093			Chisholm KI, 2016, ADV EXP MED BIOL, V876, P233, DOI 10.1007/978-1-4939-3023-4_29; Chisholm KI, 2016, J CEREBR BLOOD F MET, V36, P1955, DOI 10.1177/0271678X15606457; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Clarke DD, 1999, BASIC NEUROCHEMISTRY, V6th; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Hadjistassou C, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0245; Hudetz AG, 1997, MICROCIRCULATION, V4, P233, DOI 10.3109/10739689709146787; IVANOV KP, 1981, MICROVASC RES, V22, P143, DOI 10.1016/0026-2862(81)90084-4; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409, DOI 10.1113/jphysiol.1919.sp001839; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stolmeijer R, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7841295; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123	24	3	3	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2109	2116		10.1089/neu.2018.6187			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600432	30688156				2022-02-06	
J	Lambrinakos-Raymond, K; Ali, S; Dubrovsky, AS; Burstein, B				Lambrinakos-Raymond, Kristen; Ali, Samina; Dubrovsky, Alexander Sasha; Burstein, Brett			Low Usage of Analgesics for Pediatric Concussion-Related Pain in US Emergency Departments Between 2007 and 2015	JOURNAL OF PEDIATRICS			English	Article; Proceedings Paper	Annual Meeting of the Pediatric-Academic-Societies	MAY 05-08, 2018	Toronto, CANADA	Pediat Acad Soc			TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MANAGEMENT; CHILDREN; HEADACHE; SYMPTOMS; OPIOIDS; VISITS	Objective To estimate the proportion of pediatric patients with a concussion who received analgesia when presenting with pain to US emergency departments, and to describe the analgesics used. Study design This was a repeated cross-sectional analysis study using the National Hospital Ambulatory Medical Care Survey database of nationally representative emergency department visits from 2007 to 2015. We included children under 18 years old with isolated concussions. Survey weighting procedures were applied to generate population-level estimates and to perform multivariable logistic regression to identify factors associated with analgesic administration. Results There were an estimated 1.54 million isolated concussion visits during the 9-year study period. Pain at presentation was reported frequently (78%), with the majority rated as moderate (36%) or severe (27%). Among all children reporting pain, 42% received no analgesics, including 40% with moderate-to-severe pain intensity. Multivariable analysis found younger age, male sex, and treatment in a nonacademic hospital were all negatively associated with analgesic administration. The medications most frequently administered were acetaminophen (54%), nonsteroidal anti-inflammatories (44%), and opioids (13%). Conclusions Analgesic medications seem to be underused in the treatment of pediatric concussion-related pain. Following acetaminophen and nonsteroidal anti-inflammatories, opioids, which are not recommended for this condition, were the most frequently prescribed analgesics. Further research should establish optimal, consistent, and responsible pain management strategies for pediatric concussions.	[Lambrinakos-Raymond, Kristen; Dubrovsky, Alexander Sasha; Burstein, Brett] McGill Univ, Hlth Ctr, Dept Pediat, Div Pediat Emergency Med,Montreal Childrens Hosp, Montreal, PQ, Canada; [Ali, Samina] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Ali, Samina] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada		Burstein, B (corresponding author), McGill Univ, Hlth Ctr, Div Pediat Emergency Med, Montreal Childrens Hosp, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	brett.burstein@mail.mcgill.ca		Ali, Samina/0000-0002-0595-364X			[Anonymous], NAMCS NHAMCS AMB HLT; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bresee N, 2018, AM J EMERG MED, V36, P2225, DOI 10.1016/j.ajem.2018.04.007; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Conidi FX, 2012, HEADACHE, V52, P15, DOI 10.1111/j.1526-4610.2012.02138.x; Fein JA, 2012, PEDIATRICS, V130, pE1391, DOI 10.1542/peds.2012-2536; Friedman BW, 2018, AM J EMERG MED, V36, P285, DOI 10.1016/j.ajem.2017.10.034; Goyal MK, 2015, JAMA PEDIATR, V169, P996, DOI 10.1001/jamapediatrics.2015.1915; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Groenewald Cornelius, 2016, Evid Based Nurs, V19, P83, DOI 10.1136/ebnurs-2016-102312; Hagan JF, 2001, PEDIATRICS, V108, P793; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Khera R, 2018, JAMA-J AM MED ASSOC, V320, P133, DOI 10.1001/jama.2018.6823; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Le May S, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0186; Le May S, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/4809394; Lumba-Brown A, REPORT PEDIATRIC MIL; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCaig LF, 2013, ANN EMERG MED, V62, P549, DOI 10.1016/j.annemergmed.2013.04.028; McCaig LF, 2012, ANN EMERG MED, V60, P716, DOI 10.1016/j.annemergmed.2012.07.010; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miech R, 2015, PEDIATRICS, V136, pE1169, DOI 10.1542/peds.2015-1364; Petrelli T, 2017, PAED CHILD HEALT-CAN, V22, P2, DOI 10.1093/pch/pxw011; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Ranapurwala SI, 2019, PHARMACOEPIDEM DR S, V28, P4, DOI 10.1002/pds.4564; Rich A., COMP PAIN SCALE; Schechter NL, 2016, JAMA PEDIATR, V170, P425, DOI 10.1001/jamapediatrics.2016.0504; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Whisner C. M., 2018, CJEM, P1; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	40	3	3	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUL	2019	210						20	25		10.1016/j.jpeds.2019.02.035			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics	IE6PH	WOS:000472497600006	30955787				2022-02-06	
J	Makri, A; Koulenti, A; Argyrou, K; Gordon, W; Constantinidou, F				Makri, Andrea; Koulenti, Aphroditi; Argyrou, Kyriaki; Gordon, Wayne; Constantinidou, Fofi			The Risk for Traumatic Brain Injury and Persisting Symptomatology in Elementary, Secondary, and University-Level Students An International Perspective With the Greek Version of the Brain Injury Screening Questionnaire	TOPICS IN LANGUAGE DISORDERS			English	Article						pediatric; prevalence; screening; symptoms; traumatic brain injury; young adults	BEHAVIOR PROBLEMS; CHILDREN; EPIDEMIOLOGY; DEPRESSION; DIAGNOSIS; SYMPTOMS; EPILEPSY; RECOVERY; AGE	Purpose: This study is part of the first systematic program in the Republic of Cyprus examining the prevalence of traumatic brain injury (TBI) in children, teenagers, and university students. The study incorporated the Greek Version of the Brain Injury Screening Questionnaire (BISQ-G) as the primary tool to identify students with TBI. Methods: The BISQ-G was sent out to 2,800 families of children (aged 6-18 years) attending rural and urban elementary and secondary schools from varied socioeconomic backgrounds. Nine hundred forty-four questionnaires (33.8%) were returned. In addition to school-aged children, 322 university students (aged 17-25 years) were recruited from 3 universities and completed the BISQ-G. Results: Analyses indicated that 5.8% elementary, 9.7% secondary, and 22.7% university students had symptoms consistent with TBI. Several participants reported more than 1 TBI. Etiology of TBI was similar in all 3 groups and included sports, biking, and falls. Factor analyses yielded a 7-factor structure for the BISQ-G. Discussion/Conclusions: The BISQ-G is a valid tool for the identification of individuals with a prior history of TBI. Causes and symptoms of TBI were similar to those reported in the international literature. The article concludes with suggestions for TBI management in the schools.	[Makri, Andrea; Koulenti, Aphroditi; Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Kallipoleos 75, CY-1678 Nicosia, Cyprus; [Argyrou, Kyriaki] Minist Educ & Culture, Educ Psychol Serv, Strovolos, Cyprus; [Gordon, Wayne] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus		Constantinidou, F (corresponding author), Univ Cyprus, Dept Psychol, Kallipoleos 75, CY-1678 Nicosia, Cyprus.	fofic@ucy.ac.cy					Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Cantor JB, 2006, J HEAD TRAUMA REHAB, V21, P424, DOI 10.1097/00001199-200609000-00039; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention (CDC) National Centre for Injury Prevention and Control, 2016, TRAUM BRAIN INJ US F; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Chesire D. J., 2015, SCH PSYCHOL FORUM, V9, P199; Constantinidou F., 2009, THESIS; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Dimitriadou M, 2020, NEUROPSYCHOL REHABIL, V30, P1024, DOI 10.1080/09602011.2018.1543127; Gordon W. A., 2004, ARCH PHYS MED REH S2, V85, P1, DOI DOI 10.1016/J.APMR.2003.08.118; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gorman S, 2017, DEV NEUROPSYCHOL, V42, P127, DOI 10.1080/87565641.2017.1315581; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Higgins KM, 2017, SOPHIA ST CROSS-CULT, V16, P1, DOI 10.1007/978-3-319-43893-1_1; Hux K, 2013, BRAIN INJURY, V27, P1348, DOI 10.3109/02699052.2013.823657; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Ichkova A, 2017, NEUROCHEM INT, V111, P93, DOI 10.1016/j.neuint.2017.03.022; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McFadden KL, 2011, J NEUROTRAUM, V28, P21, DOI 10.1089/neu.2010.1515; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; National Institute of Neurological Disorders and Stroke, 2018, TRAUM BRAIN INJ INF; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Robinson S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00451; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Thurman DJ, 2018, EPILEPSIA, V59, P905, DOI 10.1111/epi.14068; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; U. S. Department of Health and Human Services, 2006, HLTH US 2006 CHARTBO; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	50	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2019	39	3			SI		276	292		10.1097/TLD.0000000000000188			17	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	IM3IN	WOS:000477887000005					2022-02-06	
J	Miki, K; Natori, Y; Kai, Y; Mori, M; Yamada, T; Noguchi, N				Miki, Kenji; Natori, Yoshihiro; Kai, Yasutoshi; Mori, Megumu; Yamada, Tetsuhisa; Noguchi, Naoki			How to Remove a Penetrating Intracranial Large Nail	WORLD NEUROSURGERY			English	Article						Intracranial; Penetrating foreign body; Superior sagittal sinus	INJURY	BACKGROUND: The incidence of penetrating intracranial foreign bodies is and to date, not many relevant studies have been published worldwide. In particular, a nail penetrating intracranially, just near the superior sagittal sinus (SSS), is extremely rare. We treated the case of a large nail that penetrated the middle of the head and strategized its removal. CASE DESCRIPTION: A 70-year-old man had experienced headache lasting a day. Computed tomography of the brain revealed a nail penetrating the middle of his head; in particular, the tip of the nail had penetrated the right ventricle, causing a slight subarachnoid hemorrhage. Angiography showed that the nail was very close to the SSS and that the venous flow was normal. However, there was a risk of the nail penetrating through the SSS or injuring other arteries, and we removed the nail directly from the intracranial view to stop bleeding from the SSS or other vessels. Fortunately, there was no bleeding, and we washed the hole created by the nail penetration and concluded the surgery. CONCLUSIONS: Our technique is useful and safe for removing large nails penetrating the head.	[Miki, Kenji; Natori, Yoshihiro; Kai, Yasutoshi; Mori, Megumu; Yamada, Tetsuhisa; Noguchi, Naoki] Aso Iizuka Hosp, Dept Neurosurg, Iizuka, Fukuoka, Japan		Miki, K (corresponding author), Aso Iizuka Hosp, Dept Neurosurg, Iizuka, Fukuoka, Japan.	mickeydreamk@yahoo.co.jp					Birk DM, 2015, J NEUROSURG, V123, P81, DOI 10.3171/2014.10.JNS141349; Chan SK, 2014, HONG KONG MED J, V20, P67, DOI 10.12809/hkmj134028; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; HELLING TS, 1992, J TRAUMA, V32, P398, DOI 10.1097/00005373-199203000-00019; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kim PE, 2002, NEUROIMAG CLIN N AM, V12, P229, DOI 10.1016/S1052-5149(02)00007-2; Paiva WS, 2010, CLIN OPHTHALMOL, V4, P1103, DOI 10.2147/OPTH.S9638; Riley JP, 2017, WORLD NEUROSURG, V97, DOI 10.1016/j.wneu.2016.09.083; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Sani S, 2005, J NEUROSURG, V103, P567, DOI 10.3171/jns.2005.103.3.0567; Shin TH, 2012, J KOREAN NEUROSURG S, V52, P414, DOI 10.3340/jkns.2012.52.4.414; Skoch J, 2013, J NEUROL SURG REP, V74, P23, DOI 10.1055/s-0033-1346976; Su YM, 2016, J SURG CASE REP, V3, P1; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z	14	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2019	127						442	445		10.1016/j.wneu.2019.04.161			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IF5NH	WOS:000473128300242	31029823				2022-02-06	
J	Pavone, V; Testa, G; Riccioli, M; Di Stefano, A; Condorelli, G; Sessa, G				Pavone, Vito; Testa, Gianluca; Riccioli, Maria; Di Stefano, Antonio; Condorelli, Giuseppe; Sessa, Giuseppe			Surgical treatment with cannulated screws for pediatric femoral neck fractures: A case series	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Femoral neck fracture; Pediatric age; Reduction and fixation; Cannulated screws; Hip decompression; Avascular necrosis	TERM-FOLLOW-UP; HIP-FRACTURES; AVASCULAR NECROSIS; CHILDREN; FEMUR; HEAD	Introduction: Femoral neck fractures are uncommon injuries in children, but the high incidence of long-term complications makes it important clinical entity. Early surgical treatment to achieve optimal results and to avoid a high rate of complications is widely advised. The purpose of this study was to retrospectively analyze the outcome of 8 children who sustained a femoral neck fracture. Patients and methods: The patients (6 boys and 2 girls with an average age of 9.2 years) were treated within 24 h following admission to hospital by closed reduction and internal fixation. The type of fracture was distinguished according to Delbet's classification system. The outcome was analyzed using Ratliff's criteria, and a detailed record of complications was maintained. Results: According Delbet's classification system, there were 3 type I, 2 type II, 2 type III, and 1 type IV fractures. The average follow-up was 39.2 months (range 8-95). A satisfactory outcome was obtained in 6 (75%) children. Avascular necrosis was the most notable complication, which was reported in the 2 fair outcomes (25%). Conclusions: Early and aggressive surgical treatment aimed at anatomical reduction result in a satisfactory outcome in pediatric femur neck fractures. Development of avascular necrosis is the main complication. (C) 2019 Elsevier Ltd. All rights reserved.	[Pavone, Vito; Testa, Gianluca; Riccioli, Maria; Di Stefano, Antonio; Condorelli, Giuseppe; Sessa, Giuseppe] Univ Catania, Dept Orthopaed & Traumatol Surg, AOU Policlin Vittorio Emanuele, Catania, Italy; [Pavone, Vito; Testa, Gianluca; Riccioli, Maria; Di Stefano, Antonio; Condorelli, Giuseppe; Sessa, Giuseppe] AOU Policlin Vittorio Emanuele, Dept Orthoped & Traumatol Surg, Via Plebiscito 628, I-95127 Catania, Italy		Pavone, V (corresponding author), AOU Policlin Vittorio Emanuele, Dept Orthoped & Traumatol Surg, Via Plebiscito 628, I-95127 Catania, Italy.	vpavone@unict.it	Testa, Gianluca/J-4328-2017	Testa, Gianluca/0000-0001-5246-9714			Bagatur AE, 2002, J PEDIATR ORTHOP B, V11, P219; Bali K, 2011, CLIN ORTHOP SURG, V3, P302, DOI 10.4055/cios.2011.3.4.302; Boardman MJ, 2009, J AM ACAD ORTHOP SUR, V17, P162, DOI 10.5435/00124635-200903000-00005; Bombaci Hasan, 2006, Acta Orthop Traumatol Turc, V40, P6; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; CANALE ST, 1990, ORTHOP CLIN N AM, V21, P341; Colonna PC, 1929, AM J SURG, V6, P793, DOI [10.1016/S0002-9610(29)90726-1, DOI 10.1016/S0002-9610(29)90726-1, 10.1016/s0002-9610(29)90726-1]; DAVISON BL, 1992, J PEDIATR ORTHOPED, V12, P355, DOI 10.1097/01241398-199205000-00014; Dhar SA, 2009, J CHILD ORTHOP, V3, P473, DOI 10.1007/s11832-009-0209-2; Eberl R, 2010, ACTA ORTHOP, V81, P442, DOI 10.3109/17453674.2010.501744; Estrada LS, 2002, CLIN ORTHOP RELAT R, P110; Flynn JM, 2002, J BONE JOINT SURG BR, V84B, P108, DOI 10.1302/0301-620X.84B1.11972; FORLIN E, 1992, J PEDIATR ORTHOPED, V12, P503, DOI 10.1097/01241398-199207000-00017; HUGHES LO, 1994, J BONE JOINT SURG AM, V76A, P283, DOI 10.2106/00004623-199402000-00019; Inan U, 2009, J CHILD ORTHOP, V3, P259, DOI 10.1007/s11832-009-0180-y; Kuo FC, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0387-9; LEUNG PC, 1986, J BONE JOINT SURG BR, V68, P537, DOI 10.1302/0301-620X.68B4.3733826; LiN Z, 2012, CHINA J ORTHOP TRAUM, V25, P546; Maeda S, 2003, INJURY, V34, P283, DOI 10.1016/S0020-1383(02)00281-4; Mirdad T, 2002, INJURY, V33, P823, DOI 10.1016/S0020-1383(02)00013-X; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Neto PFT, 2008, J CHILD ORTHOP, V2, P97, DOI 10.1007/s11832-008-0078-0; Ng GPK, 1996, INJURY, V27, P419, DOI 10.1016/0020-1383(96)00025-3; Pape HC, 1999, J TRAUMA, V46, P58, DOI 10.1097/00005373-199901000-00010; RATLIFF AHC, 1974, ORTHOP CLIN N AM, V5, P903; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528, DOI 10.1302/0301-620X.44B3.528; Shrader MW, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000238794.82466.3d; SMITH LD, 1953, J BONE JOINT SURG AM, V35-A, P367, DOI 10.2106/00004623-195335020-00009; Song KS, 2010, J BONE JOINT SURG BR, V92B, P1148, DOI 10.1302/0301-620X.92B8.24482; SWIONTKOWSKI MF, 1986, J TRAUMA, V26, P384, DOI 10.1097/00005373-198604000-00013; Taylor Kenneth F, 2002, Am J Orthop (Belle Mead NJ), V31, P408; Tetsunaga T, 2014, J PEDIATR ORTHOP B, V23, P44, DOI 10.1097/01.bpb.0000434244.41569.6b; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; Varshney MK, 2009, J ORTHOP TRAUMATOL, V10, P211, DOI 10.1007/s10195-009-0072-4	34	3	4	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2019	50			2			S40	S44		10.1016/j.injury.2019.01.043			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	IE7BE	WOS:000472528600009	30770123				2022-02-06	
J	Reilly, C; Zhang, NH; Babcock, L; Wade, SL; Rhine, T				Reilly, Caroline; Zhang, Nanhua; Babcock, Lynn; Wade, Shari L.; Rhine, Tara			Emergency Department Care of Young Children at Risk for Traumatic Brain Injury What Are We Doing and Do Parents Understand?	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; computed tomography; parental communication	PATIENT-CENTERED CARE; COMMUNICATION; MANAGEMENT; EXPOSURE	Objectives The aims of the study were to describe emergency department (ED) management of young children with head injury and to assess parental comfort level and perceptions of ED care. Methods This was a prospective observational study of children younger than 5 years who presented to a pediatric ED after head injury. Children were eligible if clinical observation was an appropriate ED management option per the Pediatric Emergency Care Academic Research Network's neuroimaging clinical decision rule. Demographics, injury variables, and ED clinician surveys explaining the care provided were collected at time of study enrollment. Parents were subsequently contacted to assess understanding of ED management and comfort with care. Results One hundred four children were enrolled with a mean (standard deviation) age of 1.19 (1.34) years. Thirty (29%) had emergent neuroimaging and 59 (57%) were placed into a period of observation per clinician report. A total of 37 children received a head computed tomography, of which 21 (57%) were normal. Eighty-four parents (81%) completed the phone follow-up. Of these children, there was a significant difference between whether parents and clinicians reported that the child had been clinically observed in the ED (P < 0.0001). Parents of children who did not receive a head CT were more likely to be uncomfortable with the decision to obtain neuroimaging compared with those who did receive a head CT (P = 0.003). Conclusions Parents are not always comfortable with the medical care practices provided and are often unaware of clinical observation when it does occur. Better parent-clinician communication could improve parental understanding and reduce overall discomfort.	[Reilly, Caroline; Babcock, Lynn; Rhine, Tara] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat, Cincinnati, OH 45229 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA		Rhine, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org			Dr. Rhine's Emergency, Medical, Fire, & Transportation Research Grant from the Ohio Department of Public Safety; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	This work was funded by Dr. Rhine's Emergency, Medical, Fire, & Transportation Research Grant from the Ohio Department of Public Safety.	Aita V, 2005, PATIENT EDUC COUNS, V58, P296, DOI 10.1016/j.pec.2004.12.008; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Boutis K, 2013, PEDIATRICS, V132, P305, DOI 10.1542/peds.2013-0378; Cramm KJ, 2008, ANN EMERG MED, V51, P361, DOI 10.1016/j.annemergmed.2007.09.032; Dean M, 2014, ACAD MED, V89, P1617, DOI 10.1097/ACM.0000000000000396; Dudley N, 2015, PEDIATRICS, V135, pE255, DOI 10.1542/peds.2014-3424; Faul M, 2010, TRAUMATIC BRAIN INJU; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Karpas A, 2013, PEDIATR EMERG CARE, V29, P30, DOI 10.1097/PEC.0b013e31827b5090; Krug SE, 2006, PEDIATRICS, V118, P2242, DOI 10.1542/peds.2006-2588; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Musso MW, 2015, ANN EMERG MED, V65, P151, DOI 10.1016/j.annemergmed.2014.08.012; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Nishijima DK, 2015, JAMA PEDIATR, V169, P1141, DOI 10.1001/jamapediatrics.2015.2743; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Robey TE, 2014, ACAD EMERG MED, V21, P122, DOI 10.1111/acem.12311; Schonfeld D, 2015, POSTGRAD MED J, V91, P634, DOI 10.1136/postgradmedj-2013-305004rep; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Stewart M, 2000, J FAM PRACTICE, V49, P796; Zwank MD, 2014, EMERG MED J, V31, P824, DOI 10.1136/emermed-2012-202294	22	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUL	2019	35	7					468	473		10.1097/PEC.0000000000001042			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	II7ME	WOS:000475375300011	28121973				2022-02-06	
J	Shafi, R; Smith, PM; Colantonio, A				Shafi, Reema; Smith, Peter M.; Colantonio, Angela			Assault predicts time away from work after claims for work-related mild traumatic brain injury	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							PHYSICAL ASSAULT; VIOLENCE; EPIDEMIOLOGY; OUTCOMES; CARE	Introduction Workplace violence carries a substantial economic loss burden. Up to 10% of all traumatic brain injury (TBI) admissions result from physical assault. There remains a paucity of research on assault as a mechanism of injury, taking into account sex, and its association with work re-entry. Objectives The aim of this study was to characterise, by sex, the sample of workers who had sustained a work-related mild TBI (wr-mTBI) and to assess the independent influence of assault, as a mechanism of injury, on time away from work. Methods A population-based retrospective cohort of workers' compensation claimants in Australia (n=3129) who had sustained a wr-mTBI was used for this study. A multivariable logistic regression analysis assessed whether workers who had sustained wr-mTBI as a result of assault (wr-mTBI-assault) were more likely to claim time off work compared with workers who had sustained a wr-mTBI due to other mechanisms. Results Among claimants who sustained a wr-mTBI, 9% were as a result of assault. The distribution of demographic and vocational variables differed between the wr-mTBI-assault, and not due to assault, both in the full sample, and separately for men and women. After controlling for potential confounding factors, workers who sustained wr-mTBI-assault, compared with other mechanisms, were more likely to take days off work (OR 2.14, 95% CI 1.53 to 2.99) within a 3-month timeframe. Conclusion The results have policy-related implications. Sex-specific and workplace-specific prevention strategies need to be considered and provisions to support returnto- work and well-being within this vulnerable cohort should be examined.	[Shafi, Reema] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Smith, Peter M.] Inst Work & Hlth, Toronto, ON, Canada; [Smith, Peter M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Shafi, R (corresponding author), Univ Toronto, Toronto, ON M5G 1V7, Canada.	reema.shafi@yahoo.com	Smith, Peter/AAE-4293-2021	Smith, Peter/0000-0001-8286-4563; Shafi, Reema/0000-0002-1034-980X; Colantonio, Angela/0000-0003-2094-4765	Institute of Gender and Health [CGW-126580]	This study was funded by Institute of Gender and Health (grant no: CGW-126580).	Allison PD, 1999, SOCIOL METHOD RES, V28, P186, DOI 10.1177/0049124199028002003; Amram O, 2015, INT J ENV RES PUB HE, V12, P15594, DOI 10.3390/ijerph121215009; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; Austin PC, 2002, J VASC SURG, V36, P194, DOI 10.1067/mva.2002.125015; Australian Bureau of Statistics, 2005, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2006, AUSTR NZ STAND IND C; Australian Bureau of Statistics (ABS), 2011, CENS POP HOUS SOC IN; Australian Safety and Compensation Council, 2005, TYP OCC CLASS SYST; Bates A, 2016, J SOC WORK DISABIL R, V15, P305, DOI 10.1080/1536710X.2016.1220886; Benavides FG, 2000, J EPIDEMIOL COMMUN H, V54, P494, DOI 10.1136/jech.54.7.494; Census Bureau US, 2011, WORKPL VIOL 1993 200; Centers for Disease Control and Prevention, 2017, TBI GET FACTS; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; El-Gilany AH, 2010, J INTERPERS VIOLENCE, V25, P716, DOI 10.1177/0886260509334395; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gacki-Smith J, 2009, J NURS ADMIN, V39, P340, DOI 10.1097/NNA.0b013e3181ae97db; Gray SE, 2017, INJURY, V48, P2470, DOI 10.1016/j.injury.2017.09.019; Guerriero EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151462; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kim H, 2013, DISABIL REHABIL, V35, P2213, DOI 10.3109/09638288.2013.774063; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; Kowalenko T, 2005, ANN EMERG MED, V46, P142, DOI 10.1016/j.annemergmed.2004.10.010; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; Matthews KA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6605a1; McDonald JH., 2014, HDB BIOL STAT; Mollayeva T, 2016, WORK, V54, P415, DOI 10.3233/WOR-162339; Moylan LB, 2014, J PSYCHOSOC NURS MEN, V52, P36, DOI 10.3928/02793695-20140903-01; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ruseckaite R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002396; Simpson K, 2005, J EPIDEMIOL COMMUN H, V59, P1072, DOI 10.1136/jech.2005.036723; Statistics Canada, 2007, CRIM VICT WORKPL; Sullivan KA, 2017, J CLIN EXP NEUROPSYC, V39, P408, DOI 10.1080/13803395.2016.1230597; Terry DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198128; Tiesman HM, 2014, J OCCUP ENVIRON MED, V56, P621, DOI 10.1097/JOM.0000000000000147; Tiesman HM, 2013, AM J IND MED, V56, P693, DOI 10.1002/ajim.22182; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Virtanen M, 2006, OCCUP ENVIRON MED, V63, P212, DOI 10.1136/oem.2005.020297; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454; Workplace Safety and Insurance Board, 2015, NUMB 2014 WSIB STAT; Xing K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142954	53	3	3	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	JUL	2019	76	7					471	478		10.1136/oemed-2018-105621			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	ID7XN	WOS:000471896300007	31126965	Green Published, hybrid			2022-02-06	
J	Sullivan, RM; Cozza, SJ; Dougherty, JG				Sullivan, Rachel M.; Cozza, Stephen J.; Dougherty, Joseph G.			Children of Military Families	CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Military dependents; Parental illness and injury; Deployment cycle; Military culture; TRICARE; Military One Source; War; Isolation	TRAUMATIC BRAIN-INJURY; DEPLOYMENT; PARENTS; YOUTH; EXPERIENCE; BEHAVIOR; SERVICE; IMPACT	There are special considerations when treating depression in the children of military families, due to both unique stressors and unique access to treatment and support resources. This article provides a brief overview of the history of military family care, an understanding of ongoing efforts to provide excellent and timely care for these children, and an understanding of the unique stressors and challenges that the depressed military child faces. The Department of Defense is dedicated to providing for the unique needs of military children and providing robust services to care for these children and their families.	[Sullivan, Rachel M.] Tripler Army Med Ctr, Dept Behav Hlth, 1 Jarrett White Rd, Honolulu, HI 96859 USA; [Cozza, Stephen J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Dougherty, Joseph G.] Walter Reed Natl Mil Med Ctr, Child & Adolescent Psychiat, 4494 North Palmer Rd, Bethesda, MD 20889 USA		Sullivan, RM (corresponding author), Tripler Army Med Ctr, Dept Behav Hlth, 1 Jarrett White Rd, Honolulu, HI 96859 USA.	rmrsullivan@gmail.com					Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Cederbaum JA, 2014, J ADOLESCENT HEALTH, V54, P672, DOI 10.1016/j.jadohealth.2013.09.006; Chandra A, 2010, PEDIATRICS, V125, P16, DOI 10.1542/peds.2009-1180; Charles N, 2007, NEUROREHABILITATION, V22, P61; Chartrand MM, 2008, ARCH PEDIAT ADOL MED, V162, P1009, DOI 10.1001/archpedi.162.11.1009; Committee on the Assessment of the Readjustment Needs of Military Personnel Veterans and Their Families; board on the Health of Select Populations Institute of Medicine, 2013, RET HOM IQ AFGH ASS; Cozza SJ, 2013, MILITARY CHILDREN FA; Cozza SJ, 2017, MIL MED, V182, pE1684, DOI 10.7205/MILMED-D-16-00101; Cozza SJ, 2014, CHILD ADOL PSYCH CL, V23, pXIII, DOI 10.1016/j.chc.2014.01.005; Currier JM, 2007, J CLIN CHILD ADOLESC, V36, P253, DOI 10.1080/15374410701279669; Easterbrooks MA, 2013, FUTURE CHILD, V23, P99; Esposito-Smythers C, 2011, J FAM PSYCHOL, V25, P497, DOI 10.1037/a0024534; Fairbank JA, 2018, J DEV BEHAV PEDIATR, V39, P683, DOI 10.1097/DBP.0000000000000606; FINKELSTEIN H, 1988, J CLIN PSYCHOL, V44, P3, DOI 10.1002/1097-4679(198801)44:1<3::AID-JCLP2270440102>3.0.CO;2-1; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gewirtz AH, 2011, PROF PSYCHOL-RES PR, V42, P56, DOI 10.1037/a0022345; Hisle-Gorman E, 2015, J AM ACAD CHILD PSY, V54, P294, DOI 10.1016/j.jaac.2014.12.017; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Holmes AK, 2013, FUTURE CHILD, V23, P143, DOI 10.1353/foc.2013.0017; Jensen PS, 1996, J AM ACAD CHILD PSY, V35, P433, DOI 10.1097/00004583-199604000-00009; Johnson NH, 2018, MIL MED, V183, pE502, DOI 10.1093/milmed/usy003; LAGRONE DM, 1978, AM J PSYCHIAT, V135, P1040; Lemmon MAJKM, 2009, PEDIATR REV, V30, pE42, DOI 10.1542/pir.30-6-e42; Lester P, 2013, FUTURE CHILD, V23, P121, DOI 10.1353/foc.2013.0015; Mansfield AJ, 2011, ARCH PEDIAT ADOL MED, V165, P999, DOI 10.1001/archpediatrics.2011.123; Meadows Sarah O, 2017, Rand Health Q, V6, P7; Millegan J, 2013, GEN HOSP PSYCHIAT, V35, P556, DOI 10.1016/j.genhosppsych.2013.04.015; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Palmer C, 2008, MIL PSYCHOL, V20, P205, DOI 10.1080/08995600802118858; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; Pincus S. H., 2001, US ARMY MED DEP  APR, V8, P139; Reinherz Helen Z., 2000, Journal of the American Academy of Child and Adolescent Psychiatry, V39, P223, DOI 10.1097/00004583-200002000-00023; Riviere LA, 2012, MIL MED, V177, P1169, DOI 10.7205/MILMED-D-12-00164; ROSEN LN, 1993, MIL MED, V158, P465, DOI 10.1093/milmed/158.7.465; ROSENHECK R, 1985, HOSP COMMUNITY PSYCH, V36, P538; Sullivan K, 2015, JAMA PEDIATR, V169, P922, DOI 10.1001/jamapediatrics.2015.1413; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V720; Van Ost SL, 2014, CARE MILITARY SERVIC; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	39	3	3	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1056-4993	1558-0490		CHILD ADOL PSYCH CL	Child Adolesc. Psychiatr. N. Am.	JUL	2019	28	3					337	+		10.1016/j.chc.2019.02.004			13	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	IC6OD	WOS:000471090500006	31076112				2022-02-06	
J	Swietek, B; Skotak, M; Chandra, N; Pfister, BJ				Swietek, Bogumila; Skotak, Maciej; Chandra, Namas; Pfister, Bryan J.			Characterization of a controlled shock wave delivered by a pneumatic table-top gas driven shock tube	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							DESIGN	Blast simulators facilitate the creation of shock waves and measurement of pressure morphology in a controlled laboratory setting and are currently a vital model for replicating blast-induced neurotrauma. Due to the maintenance and operation cost of conventional blast simulators, we developed a pneumatic, table-top, gas-driven shock tube to test an alternative method of shock wave generation using a membrane-less driver section. Its unique operational mechanism based on air gun technology does not rely on a plastic membrane rupture for the generation of pressure pulses, allowing the simulator to be quickly reset and thus decreasing the experimental turnaround time. The focus of this study is to demonstrate that this proof-of-concept device can generate shock waves with diverse characteristics based on the selection of driver gas, driver pressurization, and driven section material. Pressure waves were generated using compressed nitrogen or helium at 15 psig and 80 psig and were analyzed based on their velocity and profile shape characteristics. At 15 psig, independent of the type of driver gas, driver pressurization, and driven section material, pressure pulses travelled at sonic velocities. At 80 psig, generation of shock waves was observed in all conditions. The choice of the driver gas affected the velocities of the resulting pressure waves and the shape of pressure waveforms, particularly the peak overpressure and rise time values. Our results demonstrate that depending on the selection of driver gas and magnitude of driver pressurization, the shock wave signatures can be controlled and altered using a piston-based driver section.	[Swietek, Bogumila; Skotak, Maciej; Chandra, Namas; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Fenster Hall, Newark, NJ 07103 USA; [Swietek, Bogumila] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA		Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Fenster Hall, Newark, NJ 07103 USA.	pfister@njit.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294	New Jersey Commission of Brain Injury Research [BIR11PJT003]	This study was supported by the New Jersey Commission of Brain Injury Research (Grant No. BIR11PJT003). This study would have not been possible if not due to Dr. William Spillers and Dr. Robert D. Stoll, Department of Civil Engineering and Engineering Mechanics, Columbia University, NY. The authors would like to express great appreciation to Dr. Patrick L. Walter at Department of Engineering, Texas Christian University, Fort Worth, Texas, for sharing his extensive knowledge on shock tube design and pressure sensor measurements, and to Eren Alan for his technical help. We acknowledge also the help received from Karlin Yeh, who contributed to LabView program development.	Baker W.E., 1973, EXPLOSIONS AIR; Birch RS, 2003, APPL ACOUST, V64, P269, DOI 10.1016/S0003-682X(02)00088-9; Boyer A., 1965, DTIC DOCUMENT; Bradley, 1962, SHOCK WAVES CHEM PHY; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Downey MS, 2011, SHOCK WAVES, V21, P315, DOI 10.1007/s00193-011-0310-6; DRYER M, 1967, J GEOPHYS RES, V72, P2955, DOI 10.1029/JZ072i011p02955; EMRICH RJ, 1953, J APPL PHYS, V24, P360, DOI 10.1063/1.1721279; Heufer K., 2012, P 28 INT S SHOCK WAV; HOOKER WJ, 1963, J CHEM PHYS, V38, P214, DOI 10.1063/1.1733464; Jiang Z, 1999, SHOCK WAVES, V9, P1, DOI 10.1007/s001930050133; KIEFER JH, 1985, J PHYS CHEM-US, V89, P2013, DOI 10.1021/j100256a043; Kinney G. F., 1985, EXPLOSIVE SHOCKS AIR, V282, P1; Kleinschmit N. N., 2011, THESIS, V22; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Mejia-Alvarez R, 2015, SHOCK WAVES, V25, P635, DOI 10.1007/s00193-015-0579-y; Ngo T., 2007, EJSE LOADING STRUCTU, P76; PARK C, 1973, COMBUST FLAME, V20, P369, DOI 10.1016/0010-2180(73)90029-1; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Selvan V, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024132; Skotak M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00052; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; TAKANO Y, 1984, J PHYS E SCI INSTRUM, V17, P644, DOI 10.1088/0022-3735/17/8/005; Tranter RS, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2976671; Tranter RS, 2001, REV SCI INSTRUM, V72, P3046, DOI 10.1063/1.1379963; Varas J. M., 2011, FRONTIERS NEUROLOGY	26	3	3	0	2	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	JUL	2019	90	7							075116	10.1063/1.5099633			8	Instruments & Instrumentation; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Instruments & Instrumentation; Physics	IN4QX	WOS:000478661400066	31370428				2022-02-06	
J	Zheng, WJ; Li, LM; Hu, ZH; Liao, W; Lin, QC; Zhu, YH; Lin, SH				Zheng, Wen-Jian; Li, Liang-Ming; Hu, Zi-Hui; Liao, Wei; Lin, Qi-Chang; Zhu, Yong-Hua; Lin, Shao-Hua			Complications in Staged Late Titanium Cranioplasty and Ventriculoperitoneal Shunting for Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Cerebral hemorrhage; Cranioplasty; Extradural collection; Sunken skin flap; Ventriculoperitoneal shunt	DECOMPRESSIVE CRANIECTOMY; HYDROCEPHALUS; PREDICTION; INFECTION; COLLAPSE; OUTCOMES; RISK	BACKGROUND: Hydrocephalus is a common complication following decompressive craniectomy. Ventriculoperitoneal shunt (VPS) is required for some patients before receiving a cranioplasty (CP). The presence of a VPS is regarded as a risk factor for overall CP complications. METHODS: A retrospective survey was conducted on 176 patients with traumatic brain injury who underwent late (>3 months) titanium CP (Ti-CP) in our hospital from April 2014 to July 2018. Thirteen patients (7.4%) had preoperative VPS. Propensity score matching was performed for these 13 patients with a ratio of 1:5. A total of 78 patients were selected. Preoperative clinical parameters and postoperative complications were analyzed. The period of postoperative follow-up ranged from 3 to 63 months (mean 21.3 +/- 17.0 months). RESULTS: The overall complication rate was greater in the VPS group (P = 0.010). These patients were more likely to develop a sunken skin flap (P < 0.001). The rate of postoperative cerebral hemorrhage was greater in the VPS group. Logistic analysis showed that preoperative VPS was an independent risk factor for postoperative extradural collection (odds ratio 17.714, P < 0.001). VPS was not related to postoperative infection and seizure. Post-operative drainage duration longer than 2.5 days significantly increased the risk of postoperative infection (odds ratio 7.715, P = 0.023). CONCLUSIONS: The presence of a VPS significantly increased the risk of extradural collection in patients with traumatic brain injury who underwent late Ti-CP. It also was related to postoperative hemorrhage. The sunken skin flap in patients with VPS increased surgical difficulty and the likelihood of extradural accumulation. Preoperative VPS was not related to postoperative infection and seizure in Ti-CP.	[Zheng, Wen-Jian; Li, Liang-Ming; Hu, Zi-Hui; Liao, Wei; Lin, Qi-Chang; Zhu, Yong-Hua; Lin, Shao-Hua] Zhongshan City Peoples Hosp, Dept Neurosurg, Zhongshan, Guangdong, Peoples R China		Zheng, WJ (corresponding author), Zhongshan City Peoples Hosp, Dept Neurosurg, Zhongshan, Guangdong, Peoples R China.	297229614@qq.com	zheng, wenjian/W-2471-2019; zheng, wenjian/C-9538-2018	zheng, wenjian/0000-0001-5490-3852; zheng, wenjian/0000-0001-5490-3852			Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Centers for Disease Control and Prevention, 2017, NAT HEALTHC SAF NETW; Gordon CR, 2014, OPER NEUROSURG, V10, P179, DOI 10.1227/NEU.0000000000000296; Hill CS, 2012, BRIT J NEUROSURG, V26, P832, DOI 10.3109/02688697.2012.692839; Honeybul S, 2018, ACTA NEUROCHIR, V160, P885, DOI 10.1007/s00701-018-3514-z; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Jeong Se Ho, 2016, Korean J Neurotrauma, V12, P6, DOI 10.13004/kjnt.2016.12.1.6; Jung Young Taek, 2015, Korean J Neurotrauma, V11, P93, DOI 10.13004/kjnt.2015.11.2.93; Kim SP, 2014, J KOREAN NEUROSURG S, V56, P410, DOI 10.3340/jkns.2014.56.5.410; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lai CH, 2016, J DIABETES COMPLICAT, V30, P426, DOI 10.1016/j.jdiacomp.2015.12.026; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Randolph J. J., 2014, PRACT ASSESS RES EVA, V19, P18; Roth J, 2011, NEUROSURGERY, V68, pE271, DOI 10.1227/NEU.0b013e3181fe6165; Shibahashi K, 2017, WORLD NEUROSURG, V101, P20, DOI 10.1016/j.wneu.2017.01.106; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Wang HF, 2017, J CRANIOFAC SURG, V28, pE560, DOI 10.1097/SCS.0000000000003863; Wiggins A, 2013, NEUROSURGERY, V72, P248, DOI 10.1227/NEU.0b013e31827b98f3; Yang NR, 2018, WORLD NEUROSURG, V110, pE160, DOI 10.1016/j.wneu.2017.10.117; Yoshioka N, 2018, WORLD NEUROSURG, V119, P311, DOI 10.1016/j.wneu.2018.08.076; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405; Zheng WJ, 2018, WORLD NEUROSURG, V120, pE811, DOI 10.1016/j.wneu.2018.08.172; Zhu HF, 2018, WORLD NEUROSURG, V113, P198, DOI 10.1016/j.wneu.2018.02.080	29	3	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2019	127						E1166	E1171		10.1016/j.wneu.2019.04.079			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IF5NH	WOS:000473128300145	30995562				2022-02-06	
J	Haran, FJ; Schumacher, P; Markwald, R; Handy, JD; Tsao, JW				Haran, F. J.; Schumacher, Patrick; Markwald, Rachel; Handy, Justin D.; Tsao, Jack W.			Relationships Between Sleepiness, Mood, and Neurocognitive Performance in Military Personnel	FRONTIERS IN NEUROLOGY			English	Article						assessment; depression; statistical methods; sleep disorders; military	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; BASE-LINE; COGNITIVE PERFORMANCE; DEPRESSIVE SYMPTOMS; SUBSEQUENT RECOVERY; DEPRIVATION; STRESS; RESTRICTION; CONSEQUENCES	Neurocognitive computerized assessment tools (NCATs) were developed to assist military clinicians with the tracking of recovery from injury and return to full duty decisions with a recent focus on the setting of post-concussion evaluations. However, there is limited data on the impact of deployment on neurocognitive functioning, sleepiness, and mood in healthy, non-concussed Service members. Automated Neuropsychological Assessment Metrics version 4 TBI Military (ANAM) data was obtained for a sample of active duty deployed personnel (n = 72) without recent history of mild traumatic brain injury (mTBI). A linear regression was conducted to examine the effects of sleepiness and mood state on neurocognitive performance. The overall multivariate regression was statistically significant. Negative mood states were the most salient predictors of neurocognitive performance with higher levels of endorsement associated with lower scores. The findings support measures of negative mood state, but not sleepiness, as relevant predictors of neurocognitive performance as measured by the ANAM. These results indicate that mood needs to be considered when reviewing neurocognitive data to ensure that appropriate clinical decisions are made; in particular for return-to-duty decisions in deployed settings after concussion recovery.	[Haran, F. J.] Naval Med Res Ctr, Silver Spring, MD 20910 USA; [Haran, F. J.; Tsao, Jack W.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Schumacher, Patrick; Tsao, Jack W.] Univ Tennessee, Knoxville, TN USA; [Schumacher, Patrick; Tsao, Jack W.] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN USA; [Markwald, Rachel] Naval Hlth Res Ctr, San Diego, CA USA; [Handy, Justin D.] Stress & Motivated Behav Inst, Syracuse, NY USA		Haran, FJ (corresponding author), Naval Med Res Ctr, Silver Spring, MD 20910 USA.; Haran, FJ (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	francis.j.haran.mil@mail.mil		Markwald, Rachel/0000-0002-0432-3937	US Navy Bureau of Medicine Wounded, Ill, and Injured Directorate [255]	This project was supported by the US Navy Bureau of Medicine and Surgery Wounded, Ill, and Injured Directorate (Project #255).	Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020; [Anonymous], 2013, 649013 DODI; Axelsson J, 2008, CHRONOBIOL INT, V25, P297, DOI 10.1080/07420520802107031; Babson KA, 2010, J BEHAV THER EXP PSY, V41, P297, DOI 10.1016/j.jbtep.2010.02.008; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Balkin TJ, 2008, CHEST, V134, P653, DOI 10.1378/chest.08-1064; Balkin TJ, 2004, J SLEEP RES, V13, P219, DOI 10.1111/j.1365-2869.2004.00407.x; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Bravo AJ, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12624; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Campbell DJ, 2009, MIL PSYCHOL, V21, pS47, DOI 10.1080/08995600903249149; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cohen J., 2013, STAT POWER ANAL BEHA; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corporation R, 2015, SLEEP MIL PROM HLTH; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Craney T. A., 2002, Quality Engineering, V14, P391, DOI 10.1081/QEN-120001878; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Dinges DF, 1997, SLEEP, V20, P267; Dorrian J, 2005, SLEEP DEPRIVATION IT; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eisen SV, 2014, AM J PREV MED, V47, P754, DOI 10.1016/j.amepre.2014.07.049; Franzen Peter L, 2008, Dialogues Clin Neurosci, V10, P473; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Graham R., 2014, SPORTS RELATED CONCU, P309; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hosek J., 2006, DEPLOYMENTS AFFECT S, DOI [10.1037/e660572007-001, DOI 10.1037/E660572007-001]; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P254, DOI 10.1080/09084280903297594; Johnson DR, 2008, ARCH CLIN NEUROPSYCH, V23, P73, DOI 10.1016/j.acn.2007.10.001; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Killgore WDS, 2012, NEUROREPORT, V23, P741, DOI 10.1097/WNR.0b013e3283565056; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Krueger GP, 1990, SUSTAINED MILITARY P; LeBlanc V, 2017, QUANT METH PSYCHOL, V13, P46, DOI 10.20982/tqmp.13.1.p046; Lieberman HR, 2016, PHYSIOL BEHAV, V165, P86, DOI 10.1016/j.physbeh.2016.06.037; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lowe CJ, 2017, NEUROSCI BIOBEHAV R, V80, P586, DOI 10.1016/j.neubiorev.2017.07.010; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; MHAT-V, 2008, MENT HLTH ADV TEAM M; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Ralph CS, 2017, INT J PSYCHOPHYSIOL, V117, P37, DOI 10.1016/j.ijpsycho.2017.04.002; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Taber KH, 2010, PTSD RES Q, V21, P1; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vartanian O, 2018, PHYSIOL BEHAV, V194, P137, DOI 10.1016/j.physbeh.2018.05.008; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289	70	3	3	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 27	2019	10								674	10.3389/fneur.2019.00674			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IF7CX	WOS:000473240200001	31316453	Green Published, gold			2022-02-06	
J	Oeur, RA; Gilchrist, MD; Hoshizaki, TB				Oeur, R. Anna; Gilchrist, Michael D.; Hoshizaki, T. Blaine			Parametric study of impact parameters on peak head acceleration and strain for collision impacts in sport	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Collision; concussion; head impact; Hybrid III; sport	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; PROFESSIONAL FOOTBALL; INTRACRANIAL-PRESSURE; CONCUSSION; RECONSTRUCTION; SOCCER; THRESHOLD; DYNAMICS; KICKS	Collisions are a common cause of concussions. The nature of a collision impact is governed by the velocity of the striking players and the body parts involved. The purpose of this study was to describe the effects of velocity, mass, surface stiffness and location on peak linear and angular acceleration and strain. A variable-mass pendulum fitted with simplified impact surfaces representing the stiffness of an unprotected head, a protected (helmet) and a well-padded (i.e. shoulder pad) condition were used to impact a Hybrid III headform at four locations and velocities. Headform accelerations were input into a finite-element model to approximate peak strain in the cerebrum. Stiffness was most influential on peak linear and angular acceleration, and strain was most influenced by velocity. Interaction effects demonstrated that the 9 kg mass had consistently higher peak linear and angular acceleration and strain than the 15 kg mass between 3.0 and 4.5 m/s. Mass and velocity interactions may have important implications for age and size related concussion risk.	[Oeur, R. Anna; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Oeur, RA (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	anna.oeur@emory.edu			Natural Sciences and Engineering Research Council of Canada (NSERC), Postgraduate Scholarship-Doctoral (PGS D)Natural Sciences and Engineering Research Council of Canada (NSERC)	We acknowledge the support of the Natural Sciences and Engineering Research Council of Canada (NSERC), Postgraduate Scholarship-Doctoral (PGS D).	ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gennarelli T, 1971, P 15 STAPP CAR CRASH; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gimbel GM, 2008, EUR J SPORT SCI, V8, P341, DOI 10.1080/17461390802438763; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Gurdjian E, 1963, P 7 STAPP CAR CRASH; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hodgson V, 1983, 27 STAPP CAR CRASH C; Hodgson V.R., 1972, SAE TECHNICAL PAPERS, V720956; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hutchison M, 2013, BRIT J SPORT MED, V47; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Kang J, 2005, HYBRID 3 DUMMY NECK; Karpman S, 2016, CLIN J SPORT MED, V26, P332, DOI 10.1097/JSM.0000000000000235; Karton C, 2014, MECH CONCUSSION SPOR, P18; Katis A, 2010, J SPORT SCI, V28, P1233, DOI 10.1080/02640414.2010.504781; Kendall M., 2016, HUMAN KINETICS; Khalil Zhou CTB, 1996, P 1996 INT IRCOBI C; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KRUSKAL W, 1989, AM STAT, V43, P2, DOI 10.2307/2685157; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mertz HJ, 1989, INT C EXP, V16; Nahum A, 1977, 21 STAPP CAR CRASH C; Oeur RA, 2019, INT J CRASHWORTHINES, V24, P326, DOI 10.1080/13588265.2018.1441617; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Oeur RA, 2016, INT RES COUNCIL BIOM; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rousseau P, 2014, HUMAN KINETICS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Seidi M, 2015, INT J CRASHWORTHINES, V20, P134, DOI 10.1080/13588265.2014.983261; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Trosseille X, 1992, 36 STAPP CAR CRASH C; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Walsh ES, 2012, ASTM INT F08 S MECH; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Zanetti K, 2013, INT RES COUNC BIOMEC, P525; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P 39 STAPP CAR CRASH	75	3	3	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness	JAN 2	2021	26	1					16	25		10.1080/13588265.2019.1634336		JUN 2019	10	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PT2UC	WOS:000473832000001					2022-02-06	
J	Wowro, SJ; Tong, G; Krech, J; Rolfs, N; Berger, F; Schmitt, KRL				Wowro, Sylvia J.; Tong, Giang; Krech, Jana; Rolfs, Nele; Berger, Felix; Schmitt, Katharina R. L.			Combined Cyclosporin A and Hypothermia Treatment Inhibits Activation of BV-2 Microglia but Induces an Inflammatory Response in an Ischemia/Reperfusion Hippocampal Slice Culture Model	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						cyclosporin A; hypothermia; oxygen-glucose deprivation/reperfusion; organotypic hippocampal slice culture; BV-2 microglia; primary neuron; inflammation; DAMPs	RNA-BINDING PROTEIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERMEABILITY TRANSITION PORE; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; GLUCOSE DEPRIVATION; CEREBRAL-ISCHEMIA; GLUTAMATE RELEASE; IL-6 RELEASE; NEURONS	Introduction: Hypothermia attenuates cerebral ischemia-induced neuronal cell death associated with neuroinflammation. The calcineurin inhibitor cyclosporin A (CsA) has been shown to be neuroprotective by minimizing activation of inflammatory pathways. Therefore, we investigated whether the combination of hypothermia and treatment with CsA has neuroprotective effects in an oxygen-glucose deprivation/reperfusion (OGD/R) injury model in neuronal and BV-2 microglia monocultures, as well as in an organotypic hippocampal slice culture (OHSC). Methods: Murine primary neurons, BV-2 microglia, and OHSC were pretreated with CsA and exposed to 1 h OGD (0.2% O-2) followed by reperfusion at normothermia (37 degrees C) or hypothermia (33.5 degrees C). Cytotoxicity was measured by lactate dehydrogenase and glutamate releases. Damage-associated molecular patterns (DAMPs) high mobility group box 1 (HMGB1), heat shock protein 70 (Hsp70), and cold-inducible RNA-binding protein (CIRBP) were detected in cultured supernatant by western blot analysis. Interleukin-6 (IL-6), Interleukin-1 alpha and -1 beta (IL-1 alpha/IL1-beta), tumor necrosis factor-alpha (TNF-alpha), monocyte chemotactic protein 1 (MCP1), inducible nitric oxide synthase (iNOS), glia activation factors ionized calcium-binding adapter molecule 1 (Iba1), and transforming growth factor beta 1 (TGF-beta 1) gene expressions were analyzed by RT-qPCR. Results: Exposure to OGD plus 10 mu M CsA was sufficient to induce necrotic cell death and subsequent release of DAMPs in neurons but not BV-2 microglia. Moreover, OGD/R-induced secondary injury was also observed only in the neurons, which was not attenuated by cooling and no increased toxicity by CsA was observed. BV-2 microglia were not sensitive to OGD/R-induced injury but were susceptible to CsA-induced toxicity in a dose dependent manner, which was minimized by hypothermia. CsA attenuated IL-1 beta and Iba1 expressions in BV-2 microglia exposed to OGD/R. Hypothermia reduced IL-1 beta and iNOS expressions but induced TNF-alpha and Iba1 expressions in the microglia. However, these observations did not translate to the ex vivo OHCS model, as general high expressions of most cytokines investigated were observed. Conclusion: Treatment with CsA has neurotoxic effects on primary neurons exposed to OGD but could inhibit BV-2 microglia activation. However, CsA and hypothermia treatment after ischemia/reperfusion injury results in cytotoxic neuroinflammation in the complex ex vivo OHSC.	[Wowro, Sylvia J.; Tong, Giang; Krech, Jana; Rolfs, Nele; Berger, Felix; Schmitt, Katharina R. L.] Charite, Dept Congenital Heart Dis Pediat Cardiol, Univ Herzzentrum Berlin, Med Heart Ctr, Berlin, Germany; [Wowro, Sylvia J.; Tong, Giang; Krech, Jana; Rolfs, Nele; Berger, Felix; Schmitt, Katharina R. L.] German Heart Inst Berlin, Berlin, Germany; [Wowro, Sylvia J.; Berger, Felix; Schmitt, Katharina R. L.] Charite Univ Med Berlin, Berlin, Germany; [Wowro, Sylvia J.; Berger, Felix; Schmitt, Katharina R. L.] Free Univ Berlin, Berlin, Germany; [Wowro, Sylvia J.; Berger, Felix; Schmitt, Katharina R. L.] Humboldt Univ, Berlin, Germany; [Wowro, Sylvia J.; Berger, Felix; Schmitt, Katharina R. L.] Berlin Inst Hlth, Berlin, Germany		Wowro, SJ (corresponding author), Charite, Dept Congenital Heart Dis Pediat Cardiol, Univ Herzzentrum Berlin, Med Heart Ctr, Berlin, Germany.; Wowro, SJ (corresponding author), German Heart Inst Berlin, Berlin, Germany.; Wowro, SJ (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Wowro, SJ (corresponding author), Free Univ Berlin, Berlin, Germany.; Wowro, SJ (corresponding author), Humboldt Univ, Berlin, Germany.; Wowro, SJ (corresponding author), Berlin Inst Hlth, Berlin, Germany.	Sylvia.wowro@charite.de	Tong, Giang/AAY-9865-2021	Tong, Giang/0000-0002-3470-9750; Lucht, Jana/0000-0001-8687-8313; Wowro, Sylvia/0000-0003-1728-9210	Stiftung KinderHerz, Essen, Germany [2511-3-14-015]; German Research Foundation (DFG)German Research Foundation (DFG); Open Access Publication Fund of Charite Universitatsmedizin Berlin	This study was financially supported by the Stiftung KinderHerz, Essen, Germany (Grant Number 2511-3-14-015). We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite Universitatsmedizin Berlin.	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Becerra-Calixto A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00088; Bhalala US, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00144; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Fakharnia F, 2017, J MOL NEUROSCI, V61, P52, DOI 10.1007/s12031-016-0843-3; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Furman JL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0158-7; Gabryel B, 2004, POL J PHARMACOL, V56, P129; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gulke E, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418774254; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hovens IB., 2014, NEUROIMMUNOL NEUROIN, V1, P82; Jin R, 2013, J CARDIOVASC TRANSL, V6, P834, DOI 10.1007/s12265-013-9508-6; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Kaminska B, 2001, BRIT J PHARMACOL, V133, P997, DOI 10.1038/sj.bjp.0704177; Kawabori M, 2015, CURR MED CHEM, V22, P1258, DOI 10.2174/0929867322666150209154036; Kawakami M, 2013, BRAIN SCI, V3, P1325, DOI 10.3390/brainsci3031325; Kim JY, 2018, EXPERT OPIN THER TAR, V22, P191, DOI 10.1080/14728222.2018.1439477; Kono H, 2014, CURR OPIN IMMUNOL, V26, P147, DOI 10.1016/j.coi.2013.12.004; Krech J, 2017, MITOCHONDRION, V35, P1, DOI 10.1016/j.mito.2017.04.001; Kurisu K, 2018, NEUROPHARMACOLOGY, V134, P302, DOI 10.1016/j.neuropharm.2017.08.025; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Li DD, 2007, EXP NEUROL, V206, P280, DOI 10.1016/j.expneurol.2007.05.017; Li Q, 2016, MOL NEUROBIOL, V53, P4226, DOI 10.1007/s12035-015-9362-4; Liao Y, 2017, INT J CANCER, V141, P2164, DOI 10.1002/ijc.30833; Lim JH, 2006, J NEUROCHEM, V97, P140, DOI 10.1111/j.1471-4159.2006.03715.x; Liu J, 2016, AM J EMERG MED, V34, P1080, DOI 10.1016/j.ajem.2016.02.066; Liu LQ, 2018, NEUROL RES, V40, P508, DOI 10.1080/01616412.2018.1454090; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862; Lyden P, 2016, STROKE, V47, P2888, DOI 10.1161/STROKEAHA.116.014200; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Meyers EA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022244; Mizuma A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00467; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Nagamoto-Combs K, 2010, J NEUROSCI, V30, P9641, DOI 10.1523/JNEUROSCI.0828-10.2010; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Partoazar A, 2017, FUND CLIN PHARMACOL, V31, P185, DOI 10.1111/fcp.12244; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Rojanathammanee L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0255-2; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Sakurai-Yamashita Y, 2006, CELL MOL NEUROBIOL, V26, P823, DOI 10.1007/s10571-006-9077-1; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KRL, 2006, NEUROSCI LETT, V404, P309, DOI 10.1016/j.neulet.2006.05.064; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Terpolilli NA, 2012, J CEREBR BLOOD F MET, V32, P1332, DOI 10.1038/jcbfm.2012.12; Trumbeckaite S, 2013, MITOCHONDRION, V13, P539, DOI 10.1016/j.mito.2012.07.110; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Zawadzka M, 2012, J MOL MED, V90, P1459, DOI 10.1007/s00109-012-0925-9; Zhang LN, 2019, J MOL MED, V97, P281, DOI 10.1007/s00109-019-01745-5; Zhao WY, 2017, BRAIN RES, V1669, P141, DOI 10.1016/j.brainres.2017.06.006; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027; Zou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087915	78	3	4	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUN 25	2019	13								273	10.3389/fncel.2019.00273			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IF6AB	WOS:000473162400001	31293389	gold, Green Published			2022-02-06	
J	Buchmann, I; Finkel, L; Dangel, M; Erz, D; Harscher, KM; Kaupp-Merkle, M; Lieper, J; Rockstroh, B; Randerath, J				Buchmann, Ilka; Finkel, Lisa; Dangel, Mareike; Erz, Dorothee; Harscher, Kathi Maren; Kaupp-Merkle, Moritz; Lieper, Joachim; Rockstroh, Brigitte; Randerath, Jennifer			A combined therapy for limb apraxia and related anosognosia	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Naturalistic Action Therapy; limb apraxia; Anosognosia for apraxia; rehabilitation; tool-use	HEMISPHERE STROKE PATIENTS; TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; IDEOMOTOR APRAXIA; AWARENESS; OUTCOMES	Left hemisphere stroke frequently leads to limb apraxia, a disorder that has been reported to impact independence in daily life and rehabilitation success. Nonetheless, there is a shortcoming in research and availability of applicable trainings. Further, to date, anosognosia for limb apraxia has largely been neglected. Therefore, we developed a Naturalistic Action Therapy that trains object selection and application with an errorless learning approach and which includes supported self-evaluation. The current study presents the results of two stroke patients participating in the training. The procedure entailed two baseline and one post-training sessions including standardized limb apraxia and anosognosia assessments as well as 18 naturalistic action tasks. The training consisted of 15 sessions during which 4-6 of the 18 naturalistic action tasks (e.g., pour water into a glass, make a phone call) were trained. Both patients showed improvement in trained and untrained tasks as well as in standardized apraxia and anosognosia assessments. Training effects appeared strongest for the trained items. The procedure is documented in detail and easy to administer and thus may have the potential to be applied by relatives. The results of this pilot-study are promising and suggest that the approach is suitable for further evaluation.	[Buchmann, Ilka; Finkel, Lisa; Dangel, Mareike; Erz, Dorothee; Harscher, Kathi Maren; Kaupp-Merkle, Moritz; Rockstroh, Brigitte; Randerath, Jennifer] Univ Konstanz, Dept Psychol, Pb 216,Univ Str 10, D-78457 Constance, Germany; [Buchmann, Ilka; Finkel, Lisa; Lieper, Joachim; Rockstroh, Brigitte; Randerath, Jennifer] Univ Konstanz, Lurija Inst Rehabil Sci & Hlth Res, Constance, Germany; [Erz, Dorothee] Johannes Gutenberg Univ Mainz, Dept Psychol, Mainz, Germany; [Lieper, Joachim] Kliniken Schmieder, Allensbach, Germany		Randerath, J (corresponding author), Univ Konstanz, Dept Psychol, Pb 216,Univ Str 10, D-78457 Constance, Germany.; Randerath, J (corresponding author), Univ Konstanz, Kliniken Schmieder, Lurija Inst, Pb 216,Univ Str 10, D-78457 Constance, Germany.	J_Randerath@hotmail.com	Randerath, Jennifer/AAC-1530-2019	Randerath, Jennifer/0000-0002-0794-5571	DFGGerman Research Foundation (DFG)European Commission [RA2492/3-1]; EU FP7 Marie Curie Zukunftskolleg Incoming Fellowship Programme at the University of Konstanz [291784]; Landesgraduiertenforderungsgesetz (LGFG) in Baden-Wurttemberg	This work was supported by grants of the DFG (grant number RA2492/3-1) and the EU FP7 Marie Curie Zukunftskolleg Incoming Fellowship Programme at the University of Konstanz (https://www.uni-konstanz.de/zukunftskolleg/news/current-news/single-news/Zukunftskolleg-Goes-Europe-Six-Successfull-Years-with-Marie-Curie/) (grant number 291784) awarded to Dr Jennifer Randerath and the Landesgraduiertenforderungsgesetz (LGFG) in Baden-Wurttemberg awarded to MSc Ilka Buchmann.	Barde LHF, 2007, J INT NEUROPSYCH SOC, V13, P997, DOI 10.1017/S1355617707070981; Berlucchi G, 2011, NEUROPSYCHOL REHABIL, V21, P560, DOI 10.1080/09602011.2011.573255; Besharati S, 2015, NEUROPSYCHOL REHABIL, V25, P319, DOI 10.1080/09602011.2014.923319; Bienkiewicz MMN, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00353; Bolognini N, 2015, BRAIN, V138, P428, DOI 10.1093/brain/awu343; Buchmann I, 2020, CLIN NEUROPSYCHOL, V34, P217, DOI 10.1080/13854046.2019.1585575; Buchmann I, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00119; Buchmann I, 2017, CORTEX, V94, P49, DOI 10.1016/j.cortex.2017.06.001; Buxbaum LJ, 2008, AM J PHYS MED REHAB, V87, P149, DOI 10.1097/PHM.0b013e31815e6727; Buxbaum Laurel J, 2018, Handb Clin Neurol, V151, P349, DOI 10.1016/B978-0-444-63622-5.00017-6; Cantagallo A, 2012, NEUROPSYCHOL REHABIL, V22, P473, DOI 10.1080/09602011.2012.658317; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; De Luca R, 2018, NEUROPSYCHOL REHABIL, V28, P879, DOI 10.1080/09602011.2016.1211937; Della Sala S, 2009, CLIN NEUROPSYCHOL, V23, P406, DOI 10.1080/13854040802251393; Donkervoort M, 2001, NEUROPSYCHOL REHABIL, V11, P549, DOI 10.1080/09602010143000093; Donkervoort M, 2006, CLIN REHABIL, V20, P1085, DOI 10.1177/0269215506071257; Dovern A, 2012, J NEUROL, V259, P1269, DOI 10.1007/s00415-011-6336-y; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Geusgens C, 2006, NEUROPSYCHOL REHABIL, V16, P213, DOI 10.1080/09602010500172350; Geusgens CAV, 2007, J CLIN EXP NEUROPSYC, V29, P831, DOI 10.1080/13803390601125971; Goldenberg G, 1998, NEUROPSYCHOL REHABIL, V8, P123; Goldenberg G, 1998, NEUROPSYCHOLOGIA, V36, P581, DOI 10.1016/S0028-3932(97)00165-6; Goldenberg G, 2001, NEUROPSYCHOL REHABIL, V11, P147, DOI 10.1080/09602010042000204; Goldenberg G., 2013, APRAXIA COGNITIVE SI, P219; Hanna-Pladdy B, 2003, NEUROLOGY, V60, P487, DOI 10.1212/WNL.60.3.487; HARRINGTON DL, 1992, BRAIN, V115, P857, DOI 10.1093/brain/115.3.857; Harvey Richard L, 2009, Curr Treat Options Cardiovasc Med, V11, P251; Hermsdorfer J., 2013, ENG PSYCHOL COGNITIV, P343; Huber W., 1983, AACHENER APHASIE TES; Kollen B, 2005, STROKE, V36, P2676, DOI 10.1161/01.STR.0000190839.29234.50; Kusch M, 2018, NEUROPSYCHOLOGY, V32, P509, DOI 10.1037/neu0000451; Mihailidis Alex, 2008, BMC Geriatr, V8, P28, DOI 10.1186/1471-2318-8-28; Morady K, 2009, NEUROCASE, V15, P1, DOI 10.1080/13554790802524214; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Pedersen PM, 1996, J NEUROL REHABIL, V10, P243; Peskine A, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P198, DOI 10.1017/CBO9780511544880.011; Plummer P, 2003, PHYS THER, V83, P732, DOI 10.1093/ptj/83.8.732; Randerath J., 2019, NATURALISTIC ACTION; Randerath J., 2017, DIAGNOSTIC INSTRUMEN; Randerath J, 2011, NEUROPSYCHOLOGIA, V49, P2410, DOI 10.1016/j.neuropsychologia.2011.04.017; Smania N, 2000, ARCH PHYS MED REHAB, V81, P379, DOI 10.1053/mr.2000.6921; Smania N, 2006, NEUROLOGY, V67, P2050, DOI 10.1212/01.wnl.0000247279.63483.1f; Unsal-Delialioglu S, 2008, INT J REHABIL RES, V31, P177, DOI 10.1097/MRR.0b013e3282fc0fb9; van Heugten CM, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P244; van Heugten CM, 1998, CLIN REHABIL, V12, P294, DOI 10.1191/026921598674468328; van Heugten CM, 2000, DISABIL REHABIL, V22, P547; Weiss PH, 2008, NEUROLOGY, V70, P834, DOI 10.1212/01.wnl.0000297513.78593.dc; Worthington A, 2016, NEUROREHABILITATION, V39, P163, DOI 10.3233/NRE-161348; Wu AJ, 2014, TOP STROKE REHABIL, V21, P211, DOI 10.1310/tsr2103-211	49	3	4	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 25	2020	30	10					2016	2034		10.1080/09602011.2019.1628075		JUN 2019	19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OK4VL	WOS:000475128200001	31210088	Green Published, hybrid			2022-02-06	
J	Kinder, HA; Baker, EW; Howerth, EW; Duberstein, KJ; West, FD				Kinder, Holly A.; Baker, Emily W.; Howerth, Elizabeth W.; Duberstein, Kylee J.; West, Franklin D.			Controlled Cortical Impact Leads to Cognitive and Motor Function Deficits that Correspond to Cellular Pathology in a Piglet Traumatic Brain Injury Model	JOURNAL OF NEUROTRAUMA			English	Article						behavior testing; controlled cortical impact; gait analysis; pig model; traumatic brain injury	CLOSED-HEAD INJURY; LONG-TERM MOTOR; WHITE-MATTER; HIPPOCAMPAL-FORMATION; BEHAVIORAL DEFICITS; SPATIAL MEMORY; ANIMAL-MODELS; DOMESTIC PIG; MOUSE MODEL; CHILDREN	Traumatic brain injury (TBI) is a leading cause of death and disability in the United States, with children who sustain a TBI having a greater risk of developing long-lasting cognitive, behavioral, and motor function deficits. This has led to increased interest in utilizing large animal models to study pathophysiologic and functional changes after injury in hopes of identifying novel therapeutic targets. In the present study, a controlled cortical impact (CCI) piglet TBI model was utilized to evaluate cognitive, motor, and histopathologic outcomes. CCI injury (4 m/sec velocity, 9 mm depression, 400 msec dwell time) was induced at the parietal cortex. Compared with normal pigs (n = 5), TBI pigs (n = 5) exhibited appreciable cognitive deficiencies, including significantly impaired spatial memory in spatial T-maze testing and a significant decrease in exploratory behaviors followed by marked hyperactivity in open field testing. Additionally, gait analysis revealed significant increases in cycle time and stance percent, significant decreases in hind reach, and a shift in the total pressure index from the front to the hind limb on the affected side, suggesting TBI impairs gait and balance. Pigs were sacrificed 28 days post-TBI and histological analysis revealed that TBI lead to a significant decrease in neurons and a significant increase in microglia activation and astrogliosis/astrocytosis at the perilesional area, a significant loss in neurons at the dorsal hippocampus, and significantly increased neuroblast proliferation at the subventricular zone. These data demonstrate a strong relationship between TBI-induced cellular changes and functional outcomes in our piglet TBI model that lay the framework for future studies that assess the ability of therapeutic interventions to contribute to functional improvements.	[Kinder, Holly A.; Baker, Emily W.; Howerth, Elizabeth W.; Duberstein, Kylee J.; West, Franklin D.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Kinder, Holly A.; Baker, Emily W.; Duberstein, Kylee J.; West, Franklin D.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Howerth, Elizabeth W.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA		West, FD (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Regenerat Biosci Ctr, Rhodes Ctr Anim & Dairy Sci, 425 River Rd, Athens, GA 30602 USA.	westf@uga.edu		Kinder, Holly/0000-0001-8310-7265	University of Georgia Research Foundation	We would like to thank Madelaine Wendzik, Shelley Tau, Kayla Hargrove, Jaime Certusi, Sarah Lewis, Olivia Fuller, Caroline Coleman, Kathryn Sellman, Alex Ross, Natalie Bishop, Julianne Gillis, and Andrea Kuehndorf for their significant and integral involvement in all pig work. We would also like to thank Rick Utley and Kelly Parham at the UGA Swine Unit for their pig expertise and for providing us with piglets. Lastly, we would like to thank Randy Nation for his help in designing and building our behavior testing arenas. This work was supported by The University of Georgia Research Foundation.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ahmad AS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00172; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2000, BRAIN INJURY, V14, P679; Antonson AM, 2017, BRAIN BEHAV IMMUN, V59, P300, DOI 10.1016/j.bbi.2016.09.019; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baker EW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206481; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Beretta E, 2009, BRAIN INJURY, V23, P751, DOI 10.1080/02699050903133988; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Chang Q, 2003, BEHAV BRAIN RES, V144, P19, DOI 10.1016/S0166-4328(03)00063-9; Conrad MS, 2015, ANNU REV ANIM BIOSCI, V3, P245, DOI 10.1146/annurev-animal-022114-111049; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Coppoletta JM, 1933, AM J PATHOL, V9, P55; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duberstein KJ, 2014, PHYSIOL BEHAV, V125, P8, DOI 10.1016/j.physbeh.2013.11.004; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Elmore MRP, 2012, ANIM COGN, V15, P667, DOI 10.1007/s10071-012-0495-9; Fang MR, 2005, NEUROSIGNALS, V14, P102, DOI 10.1159/000086292; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HOLM IE, 1994, HIPPOCAMPUS, V4, P115, DOI 10.1002/hipo.450040112; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Irvine K., 2017, J NEUROTRAUMA   1229; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kuhn S, 2014, HUM BRAIN MAPP, V35, P1129, DOI 10.1002/hbm.22239; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LANKE J, 1993, BRAIN RES, V605, P221, DOI 10.1016/0006-8993(93)91744-D; LAURBERG S, 1981, J COMP NEUROL, V200, P433, DOI 10.1002/cne.902000310; Lehnung M, 2003, BRAIN INJURY, V17, P855, DOI 10.1080/0269905031000089369; Lehnung M, 2001, CHILD NEUROPSYCHOL, V7, P59, DOI 10.1076/chin.7.2.59.3129; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Liu HN, 2014, J NUTR, V144, P1903, DOI 10.3945/jn.114.199828; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Matute C, 2010, CELL CALCIUM, V47, P150, DOI 10.1016/j.ceca.2009.12.004; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Qu WR, 2016, NEURAL REGEN RES, V11, P248, DOI 10.4103/1673-5374.177732; Radlowski EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091951; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUSSELL PA, 1973, ANIM BEHAV, V21, P109, DOI 10.1016/S0003-3472(73)80047-8; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Rytych JL, 2012, J NUTR, V142, P2050, DOI 10.3945/jn.112.165522; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schonfeld LM, 2017, J NEUROTRAUM, V34, P505, DOI 10.1089/neu.2016.4440; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stephens J, 2017, J MOTOR BEHAV, V49, P20, DOI 10.1080/00222895.2016.1204267; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	109	3	3	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2019	36	19					2810	2826		10.1089/neu.2019.6405		JUN 2019	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JB8IG	WOS:000472107800001	31084390				2022-02-06	
J	Khalifa, M; Gallego, B				Khalifa, Mohamed; Gallego, Blanca			Grading and assessment of clinical predictive tools for paediatric head injury: a new evidence-based approach	BMC EMERGENCY MEDICINE			English	Article						Paediatric head injury; Clinical prediction; Clinical decision support; Grading and assessment; Evidence-based; Emergency medicine	DECISION-SUPPORT-SYSTEMS; TRAUMATIC BRAIN-INJURY; DIAGNOSTIC MANAGEMENT STRATEGIES; COMPUTED-TOMOGRAPHY; EMERGENCY CARE; IDENTIFYING CHILDREN; INTRACRANIAL INJURY; EXTERNAL VALIDATION; RADIATION-EXPOSURE; NEXUS-II	BackgroundMany clinical predictive tools have been developed to diagnose traumatic brain injury among children and guide the use of computed tomography in the emergency department. It is not always feasible to compare tools due to the diversity of their development methodologies, clinical variables, target populations, and predictive performances. The objectives of this study are to grade and assess paediatric head injury predictive tools, using a new evidence-based approach, and to provide emergency clinicians with standardised objective information on predictive tools to support their search for and selection of effective tools.MethodsPaediatric head injury predictive tools were identified through a focused review of literature. Based on the critical appraisal of published evidence about predictive performance, usability, potential effect, and post-implementation impact, tools were evaluated using a new framework for grading and assessment of predictive tools (GRASP). A comprehensive analysis was conducted to explain why certain tools were more successful.ResultsFourteen tools were identified and evaluated. The highest-grade tool is PECARN; the only tool evaluated in post-implementation impact studies. PECARN and CHALICE were evaluated for their potential effect on healthcare, while the remaining 12 tools were only evaluated for predictive performance. Three tools; CATCH, NEXUS II, and Palchak, were externally validated. Three tools; Haydel, Atabaki, and Buchanich, were only internally validated. The remaining six tools; Da Dalt, Greenes, Klemetti, Quayle, Dietrich, and Guzel did not show sufficient internal validity for use in clinical practice.ConclusionsThe GRASP framework provides clinicians with a high-level, evidence-based, comprehensive, yet simple and feasible approach to grade, compare, and select effective predictive tools. Comparing the three main tools which were assigned the highest grades; PECARN, CHALICE and CATCH, to the remaining 11, we find that the quality of tools' development studies, the experience and credibility of their authors, and the support by well-funded research programs were correlated with the tools' evidence-based assigned grades, and were more influential, than the sole high predictive performance, on the wide acceptance and successful implementation of the tools. Tools' simplicity and feasibility, in terms of resources needed, technical requirements, and training, are also crucial factors for their success.	[Khalifa, Mohamed] Macquarie Univ, Australian Inst Hlth Innovat, Fac Med & Hlth Sci, 75 Talavera Rd, Sydney, NSW 2113, Australia; [Gallego, Blanca] Univ New South Wales, Ctr Big Data Res Hlth, Lowy Canc Res Ctr, Fac Med, Level 4,Cnr High & Bot St, Sydney, NSW 2052, Australia		Khalifa, M (corresponding author), Macquarie Univ, Australian Inst Hlth Innovat, Fac Med & Hlth Sci, 75 Talavera Rd, Sydney, NSW 2113, Australia.	mohamed.khalifa@mq.edu.au		Khalifa, Mohamed/0000-0002-5919-8352	Commonwealth Government Funded Research Training Program, Australia	This work was supported by the Commonwealth Government Funded Research Training Program, Australia. The funding body has no role in the design of the study or collection, analysis, or interpretation of data or writing the manuscript. These tasks were the sole responsibility of the study researchers.	Adams ST, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8312; Ahmadi S, 2017, INT J PEDIATR-MASSHA, V5, P6285, DOI 10.22038/ijp.2017.26693.2299; Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Ansari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049864; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Atabaki Shireen M, 2017, Pediatr Qual Saf, V2, pe019, DOI 10.1097/pq9.0000000000000019; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl Franz E, 2015, Evid Based Med, V20, P33, DOI 10.1136/ebmed-2014-110090; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Barrett J., 2016, USE CLIN DECISION RU; Beattie P, 2006, AUST J PHYSIOTHER, V52, P157, DOI 10.1016/S0004-9514(06)70024-1; Bennett P, 2017, J AM MED INFORM ASSN, V24, P655, DOI 10.1093/jamia/ocw151; Bozan O, 2019, EUR J TRAUMA EMERG S, V45, P849, DOI 10.1007/s00068-017-0865-8; Bregstein JS, 2014, CURR OPIN PEDIATR, V26, P272, DOI 10.1097/MOP.0000000000000096; Bressan S, 2015, ACTA PAEDIATR, V104, P47, DOI 10.1111/apa.12797; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Buchanich JM, 2007, CLIN DECISION MAKING; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dalziel K, 2019, ANN EMERG MED, V73, P429, DOI 10.1016/j.annemergmed.2018.09.030; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Ebell MH, 2001, EVIDENCE BASED DIAGN; Fuller G, 2012, EXTERNAL VALIDATION; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gerdung C, 2012, CAN J EMERG MED, V14, P243, DOI 10.2310/8000.2012.110387; Gokharman FD, 2017, TURK J MED SCI, V47, P1770, DOI 10.3906/sag-1703-206; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gupta M, 2018, ACAD EMERG MED, V25, P728, DOI 10.1111/acem.13431; Guzel A, 2009, PEDIATR NEUROSURG, V45, P262, DOI 10.1159/000228984; Harty E, 2010, EMERG MED J, V2009; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Holmes MW, 2013, ARCH DIS CHILD, V98, P939, DOI 10.1136/archdischild-2012-302820; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Kadom Nadja, 2018, PEDIAT ACCIDENTAL TR, P65; Kappen T, 2015, PREDICTION MODELS DE, P89; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Khalifa M, 2018, HLTH DAT AN 2018; Kish MA, 2001, CLIN INFECT DIS, V32, P851, DOI 10.1086/319366; Klemetti S, 2009, PEDIATR EMERG CARE, V25, P811, DOI 10.1097/PEC.0b013e3181c32e74; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lyttle M, 2017, G273 ACCURACY PHYS P; Lyttle MD, 2013, EMERG MED J, V30, P790, DOI 10.1136/emermed-2012-201887; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McGraw M, 2019, CAN J EMERG MED, V21, P120, DOI 10.1017/cem.2018.444; Mihindu E, 2014, AM SURGEON, V80, P841; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Mueller DL, 2011, J TRAUMA, V70, P724, DOI 10.1097/TA.0b013e3182092ff8; Musen MA, 2014, BIOMEDICAL INFORM, P643, DOI [10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-8_22]; Nakhjavan-Shahraki B, 2017, EUR J TRAUMA EMERG S, V43, P755, DOI 10.1007/s00068-017-0811-9; Nichol G, 1999, ANN EMERG MED, V34, P438, DOI 10.1016/S0196-0644(99)80044-4; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Oman KS, 2010, EVIDENCE BASED PRACT; Osheroff JA, 2012, EDITOR IMPROVING OUT; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Osmond M. H., 2006, ACAD EMERG MED, V13, pS11, DOI DOI 10.1197/j.aem.2006.03.008; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; OSMOND MH, 2002, CANADIAN ASSESSMENT; Palchak MJ, 2009, PEDIATR EMERG CARE, V25, P61, DOI 10.1097/PEC.0b013e318196e9c0; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Radiologists TRANZCo, 2015, APPR IM REF CLIN GUI; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Sempertegui Cardenas PX, 2016, VALIDACION ESCALA PR; Shekelle PG, 1999, WESTERN J MED, V170, P348; Shortliffe EH, 2013, BIOMEDICAL INFORM CO; Srivastava AK, 2018, NEUROMETHODS, V139, P1, DOI 10.1007/978-1-4939-8564-7_1; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Steyerberg EW, 2008, CLIN PREDICTION MODE; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Stiell IG, 1997, JAMA-J AM MED ASSOC, V278, P2075, DOI 10.1001/jama.1997.03550230051036; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; STIELL IG, 1995, ANN EMERG MED, V26, P405, DOI 10.1016/S0196-0644(95)70106-0; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; Taljaard M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006701; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335; Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375; Wilk S, 2013, METHOD INFORM MED, V52, P18, DOI 10.3414/ME11-01-0099	100	3	3	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	JUN 14	2019	19								35	10.1186/s12873-019-0249-y			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ID3YW	WOS:000471614000001	31200643	Green Published, gold			2022-02-06	
J	Taylor, K; Hoshizaki, TB; Gilchrist, M				Taylor, Karen; Hoshizaki, T. Blaine; Gilchrist, Michael			The influence of impact force redistribution and redirection on maximum principal strain for helmeted head impacts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Helmet technology; impact redirection; impact redistribution; dominant coordinate component; brain injury; maximum principal strain	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; PROFESSIONAL FOOTBALL; HIGH-SCHOOL; CONCUSSION; DIRECTION; LOCATION; MILD; ACCELERATIONS; PERFORMANCE	Sporting helmets with linear attenuating strategies are proficient at reducing the risk of traumatic brain injury. However, the continued high incidence of concussion in American football, has led researchers to investigate novel helmet liner strategies. These strategies typically supplement existing technologies by adding or integrating head-helmet decoupling mechanisms. Decoupling strategies aim to redirect or redistribute impact force around the head, reducing impact energy transferred to the brain. This results in decreased brain tissue strain, which is beneficial in injury risk reduction due to the link between tissue strain and concussive injury. The purpose of this study was to mathematically demonstrate the effect of ten cases, representing theoretical redirection and redistribution helmet liner strategies, on brain tissue strain resulting from impacts to the head. The kinematic response data from twenty head impacts collected in the laboratory was mathematically modified to represent the altered response of the ten different cases and used as input parameters to determine the effect on maximum principal strain (MPS) values, calculated using finite element modeling. The results showed that a reduced dominant coordinate component (contributes the greatest to resultant) of rotational acceleration decreased maximum principal strain in American football helmets. The study theoretically demonstrates that liner strategies, if applied correctly, can influence brain motion, reduce brain tissue strain, and could decrease injury risk in an American football helmet.	[Taylor, Karen; Hoshizaki, T. Blaine] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON, Canada; [Gilchrist, Michael] Univ Coll Dublin, UCD Engn & Mat Sci Ctr, Sch Mech & Mat Engn, Room 226, Belfield, Ireland		Taylor, K (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON, Canada.	ktayl078@uottawa.ca		Taylor, Karen/0000-0003-1578-2343			Aare M., 2003, INT RES COUNC BIOM I, P349; Ahmadisoleymani SS, 2015, PROCEDIA MANUF, V3, P3796, DOI 10.1016/j.promfg.2015.07.882; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Breedlove KM, 2017, J ATHL TRAINING, V52, P802, DOI 10.4085/1062-6050-52.6.01; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Fowler JN, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029982; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1987, 31 STAPP CAR CRASH C; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hodgson VR, 1983, P 27 STAPP CAR CRASH, P225; Horgan T, 2005, THESIS; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Kendall M., 2016, THESIS; Kendell M, 2013, INT RES COUNC BIOM I; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liao S, 2016, MED SCI SPORT EXER, V48, P1239, DOI 10.1249/MSS.0000000000000896; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Nahum AM, 1977, 21 ANN STAPP CAR CRA; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2013, COMPUT METHOD BIOMEC, V17, P1; Post A, 2012, INT RES COUNC BIOM I; Post A, 2018, INT J CRASHWORTHINES, V23, P278, DOI 10.1080/13588265.2017.1316048; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; REID SE, 1975, J TRAUMA, V15, P150, DOI 10.1097/00005373-197502000-00007; Rowson S., 2009, J BIOMECHANICAL ENG, V131, P7; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tarriere C, 1987, HEAD INJ S NEW ORL; Thibault L., 1971, P 15 STAPP CAR CRASH; Trosseille X, 1992, 36 STAPP CAR CRASH C; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Zhang L, 2001, THESIS	57	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	OCT 3	2019	22	13					1047	1060		10.1080/10255842.2019.1626840		JUN 2019	14	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	IY0HZ	WOS:000473556200001	31204489				2022-02-06	
J	Ansado, J; Blunt, A; Chen, JK; Koski, L; Ptito, A				Ansado, Jennyfer; Blunt, Aaron; Chen, Jen-Kai; Koski, Lisa; Ptito, Alain			Impact of non-invasive brain stimulation on transcallosal modulation in mild traumatic brain injury: a multimodal pilot investigation	BRAIN INJURY			English	Article						Concussion; working memory network; corpus callosum; transcallosal mediation; rTMS intervention; dMRI; fMRI	TRANSCRANIAL MAGNETIC STIMULATION; SPORTS-RELATED CONCUSSION; CORPUS-CALLOSUM; WORKING-MEMORY; PREFRONTAL CORTEX; INTERHEMISPHERIC-TRANSFER; WHITE-MATTER; EPIDEMIOLOGY; ORGANIZATION; PERFORMANCE	Background: We combined performance on working memory (WM) tasks with diffusion (dMRI) and functional (fMRI) magnetic resonance imaging in young adults who had suffered a concussion to better understand the inter-hemispheric effects of unilateral repetitive transcranial magnetic stimulation (rTMS). Methods: The article is presenting pilot data on 8 symptomatic patients with persistent post-concussion symptoms for over 6 months. They received 20 sessions of rTMS over the left dorsolateral prefrontal cortex. Fractional anisotropy and mean diffusivity of the corpus callosum (CC) and fMRI measurement of blood-oxygen-level dependent signal changes during WM tasks were carried out before and after rTMS stimulation. Results: After participants had completed the rTMS sessions, we observed three main results: (1) bilateralization of activation within the WM network; (2) shift from transcallosal inhibition to transcallosal activation of the right-sided WM network via the anterior callosal fibres; and (3) shift from transcallosal activation to transcallosal inhibition of the right-sided WM network via the posterior parts of the CC. More nuanced patterns of transcallosal mediation in the region of the right-sided WM network were observed via the medial part of the CC. Conclusion: Our preliminary results encourage trends of further research supporting the use of rTMS to restore inter-hemispheric balance within the bilateral WM network in young adults with a history of concussion.	[Ansado, Jennyfer; Blunt, Aaron; Chen, Jen-Kai; Koski, Lisa; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Ptito, Alain] McGill Univ, Dept Psychol, Hlth Ctr, Montreal, PQ, Canada; [Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Ptito, A (corresponding author), McGill Univ, Hlth Ctr, Neurol Neurosurg, Dept Psychol, 3801 Univ, Montreal, PQ H3A 264, Canada.; Ptito, A (corresponding author), Montreal Neurol Inst, 3801 Univ, Montreal, PQ H3A 264, Canada.	alain.ptito@mcgill.ca			CHU Sainte-Justine Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-86509]	This work was supported by the CHU Sainte-Justine Foundation to JA [N/A]; Canadian Institutes of Health Research to AP (CIHR) [MOP-86509].	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andoh J, 2013, NEUROIMAGE, V79, P162, DOI 10.1016/j.neuroimage.2013.04.078; Andoh J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00161; Ansado J, 2015, EUR J NEUROSCI, V42, P1675, DOI 10.1111/ejn.12869; Ansado J, 2013, NEUROPSYCHOLOGY, V27, P464, DOI 10.1037/a0032854; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; BARBAS H, 1984, EXP BRAIN RES, V55, P187; BERLUCCHI G, 1983, BEHAV BRAIN SCI, V6, P171, DOI 10.1017/S0140525X0001534X; Blackmon K, 2015, EPILEPSIA, V56, P527, DOI 10.1111/epi.12931; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Bottari C., 2008, BRAIN INJ S1, V22, P1; Bottari C, 2017, NEUROPSYCHOL REHABIL, V27, P871, DOI 10.1080/09602011.2015.1110528; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catani M., 2012, ATLAS HUMAN BRAIN CO; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; COOK ND, 1984, BRAIN LANG, V23, P116, DOI 10.1016/0093-934X(84)90010-5; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Expert Panel, 2006, MED SCI SPORTS EXERC, V38, P2031; Fernandez-Miranda JC, 2008, NEUROSURGERY, V62, P989, DOI [10.1227/01.NEU.0000297076.98175.67, 10.1227/01.neu.0000333767.05328.49]; Holler-Wallscheid MS, 2017, P NATL ACAD SCI USA, V114, pE830, DOI 10.1073/pnas.1601983114; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Homae F, 2014, NEUROIMAGE, V85, P354, DOI 10.1016/j.neuroimage.2013.06.023; Khedr EM, 2014, NEUROREHAB NEURAL RE, V28, P740, DOI 10.1177/1545968314521009; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kurth F, 2013, HUM BRAIN MAPP, V34, P2259, DOI 10.1002/hbm.22060; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lebel C., 2017, NMR BIOMED; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14769; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; Olesen PJ, 2003, COGNITIVE BRAIN RES, V18, P48, DOI 10.1016/j.cogbrainres.2003.09.003; Pandya D., 2009, FIBER PATHWAYS BRAIN; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Putnam MC, 2008, J NEUROSCI, V28, P2912, DOI 10.1523/JNEUROSCI.2295-07.2008; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Raybaud C, 2010, NEURORADIOLOGY, V52, P447, DOI 10.1007/s00234-010-0696-3; Rossi S, 2004, TRENDS COGN SCI, V8, P273, DOI 10.1016/j.tics.2004.04.012; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; SELTZER B, 1986, EXP BRAIN RES, V62, P459; Shin SS, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00015; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Thiel A, 2006, BRAIN LANG, V98, P57, DOI 10.1016/j.bandl.2006.01.007; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; Van Wagenen WP, 1940, ARCH NEURO PSYCHIATR, V44, P740, DOI 10.1001/archneurpsyc.1940.02280100042004; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Voineskos AN, 2010, BIOL PSYCHIAT, V68, P825, DOI 10.1016/j.biopsych.2010.06.021; Volz LJ, 2015, BRAIN STRUCT FUNCT, V220, P1093, DOI 10.1007/s00429-013-0702-8; Wang CC, 2014, RESTOR NEUROL NEUROS, V32, P825, DOI 10.3233/RNN-140410; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wong NML, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00108; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	68	3	3	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1021	1031		10.1080/02699052.2019.1605620		JUN 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000474134100001	31170014				2022-02-06	
J	Li, XM; Han, LM; Guo, YD; Chang, YF; Yan, J; Wang, Y; Li, N; Ding, YJ; Cai, JF				Li, Xingmei; Han, Leiming; Guo, Yadong; Chang, Yunfeng; Yan, Jie; Wang, Yong; Li, Na; Ding, Yanjun; Cai, Jifeng			Rapid detection and cellular fluorescence imaging of the TBI biomarker Let-7i using a DNA-AgNC nanoprobe	NEW JOURNAL OF CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; SILVER NANOCLUSTERS; MICRORNA; HIPPOCAMPUS	Traumatic brain injury (TBI), known as intracranial injury, has been a serious threat to human health. The nonspecific and variable symptoms of TBI have motivated extensive research on miRNAs that serve as significant biomarkers for the TBI diagnosis. However, the current detection methods of TBI miRNAs are conducted only at the in vitro level and involve complex operation systems. Herein, we proposed a novel fluorescence biosensing strategy for cell imaging and rapid detection of Let-7i (a kind of TBI-related miRNAs) based on DNA-functionalized silver nanoclusters (DNA-AgNCs). Moreover, a self-designed DNA-AgNC nanoprobe was fabricated using a hairpin-structured oligonucleotide template to improve the sensitivity and photostability of DNA-AgNCs; in the presence of Let-7i, the strong fluorescence of DNA-AgNCs was quickly switched off, and the entire quantitative analysis process could be completed within 1 h. Cell viability studies demonstrated satisfactorily low cytotoxicity of the DNA-based nanoprobe for HeLa cells. Moreover, confocal fluorescence imaging presented obvious color brightness differences in the HeLa cells before and after Let-7i transfection; this indicated that fluorescence imaging by the proposed nanoprobe might indirectly reflect the levels of cellular Let-7i. Based on the abovementioned investigations, it can be concluded that the Let-7i biosensing method based on the multifunctional DNA-AgNCs may provide a promising strategy for TBI biomarker detection and a bioimaging tool.	[Li, Xingmei; Han, Leiming; Guo, Yadong; Chang, Yunfeng; Yan, Jie; Wang, Yong; Ding, Yanjun; Cai, Jifeng] Cent S Univ, Sch Basic Med Sci, Dept Forens Sci, Changsha 410013, Hunan, Peoples R China; [Li, Na] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha 410013, Hunan, Peoples R China		Ding, YJ; Cai, JF (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Forens Sci, Changsha 410013, Hunan, Peoples R China.	dingyanjun@csu.edu.cn; cjf_jifeng@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772025, 81571855, 81772026]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [2017JJ3511]	This paper was financially supported by the National Natural Science Foundation of China (No. 81772025, 81571855 and 81772026) and Natural Science Foundation of Hunan Province (No. 2017JJ3511).	Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Brian L., 2013, NEUROIMAGE-CLIN, V2, P534; Ding YJ, 2017, ANAL BIOANAL CHEM, V409, P7027, DOI 10.1007/s00216-017-0650-x; Du CY, 2017, INT J NANOMED, V12, P8599, DOI 10.2147/IJN.S146968; Henry L, 2014, ARCH CLIN NEUROPSYCH, V29; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lee J, 2015, BIOSENS BIOELECTRON, V68, P642, DOI 10.1016/j.bios.2015.01.058; Li JJ, 2014, CHEM COMMUN, V50, P7107, DOI 10.1039/c4cc00160e; Obliosca JM, 2013, NANOSCALE, V5, P8443, DOI 10.1039/c3nr01601c; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Park S, 2007, INHAL TOXICOL, V19, P59, DOI 10.1080/08958370701493282; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Petty JT, 2004, J AM CHEM SOC, V126, P5207, DOI 10.1021/ja031931o; Pratik S., 2012, ACS NANO, V6, P8803; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Shah P, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1377; Shah P, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/4/045101; Shah P, 2012, ACS NANO, V6, P8803, DOI 10.1021/nn302633q; Shang L, 2012, NANO RES, V5, P531, DOI 10.1007/s12274-012-0238-x; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069284, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0062988, 10.1371/journal.pone.0078025]; Wang K. K. W., 2013, P SOC PHOTO-OPT INS, V8723, P381; Xia XD, 2014, BIOSENS BIOELECTRON, V51, P36, DOI 10.1016/j.bios.2013.07.036; Zhang J, 2015, ANAL CHEM, V87, P2959, DOI 10.1021/ac504515g	28	3	3	1	33	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	JUN 7	2019	43	21					7997	8004		10.1039/c9nj00489k			8	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	IC7EW	WOS:000471136900008					2022-02-06	
J	Nowicki, M; Pearlman, L; Campbell, C; Hicks, R; Fraser, DD; Hutchison, J				Nowicki, Magda; Pearlman, Lisa; Campbell, Craig; Hicks, Rhiannon; Fraser, Douglas D.; Hutchison, Jamie			Agitated behavior scale in pediatric traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; agitation; pediatric	RELIABILITY; PREVALENCE; MANAGEMENT; SEDATION; VALIDITY; OUTCOMES	Agitation following TBI commonly occurs during the acute recovery phase. The ABS is a valid measure of agitation in adults following TBI. The objective of the study was to determine if ABS scores accurately measure acute agitation in pediatric patients recovering from TBI. The ABS was completed twice daily for 4 days and mean ABS scores were calculated. Physicians assessed patients' agitation daily using a VAS. In addition, interventions for agitation were recorded. The association between ABS and VAS scores was assessed using Spearman's correlation. The relationship between the number of medication classes taken for agitation (0, 1-2, or >= 3) and ABS scores was assessed using one-way analysis of variance. Finally, the association between the use of hand restraints and ABS scores was examined using an unpaired two-sample t-test. Twenty-six pediatric patients with acute TBI were included. ABS scores significantly associated with VAS scores. Patients that required interventions for agitation (hand restraints or >= 3 medication classes) had higher ABS scores than patients that did not receive any intervention. The study supports the use of ABS scoring to measure agitation in pediatric patients with TBI. However, additional studies are warranted to further support the validity of this scale.	[Nowicki, Magda; Campbell, Craig] Western Univ, Schulich Sch Med Dent, London, ON, Canada; [Pearlman, Lisa] London Hlth Sci Ctr, Childrens Hosp, London, ON, Canada; [Campbell, Craig; Hicks, Rhiannon] London Hlth Sci Ctr, Childrens Hosp, Dept Pediat, Div Neurol & Neurosurg, London, ON, Canada; [Campbell, Craig] Western Univ, Fac Clin Neurol Sci & Epidemiol, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Dept Psychiat, London, ON, Canada; [Hutchison, Jamie] Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada		Campbell, C (corresponding author), Childrens Hosp LHSC, Div Neurol, 800 Commissioners Rd E, London, ON N6A4G5, Canada.	Craig.campbell@lhsc.on.ca					Allen D., 2011, ENCY CLIN NEUROPSYCH, P51; Amato S, 2012, REHABIL NURS, V37, P19, DOI 10.1002/RNJ.00001; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Campbell C, 2010, PEDIAT CHILD HLTH SA, V15, p51A; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Deshmukh Parikshit, 2010, Psychiatry (Edgmont), V7, P32; IBM Corp, 2016, IBM SPSS STAT WIND V; Janzen S, 2014, BRAIN INJURY, V28, P318, DOI 10.3109/02699052.2013.860478; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Kerson AG, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0189-5; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Malviya S, 2002, BRIT J ANAESTH, V88, P241, DOI 10.1093/bja/88.2.241; Marr A., 2004, CENTRAL NERVOUS SYST; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Minnick AF, 1998, J NURS ADMIN, V28, P19, DOI 10.1097/00005110-199811000-00007; Pearlman L, 2011, CDN J NEUROL SCI S1, V38, pS66; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Sonnier L, 2011, PEDIATR DRUGS, V13, P1, DOI 10.2165/11538550-000000000-00000; WILKINSON AA, 2017, BMC PEDIATR, V17, DOI DOI 10.1186/S12887-017-0969-7; Wilkinson AA, 2016, PEDIATR CRIT CARE ME, V17, P638, DOI 10.1097/PCC.0000000000000752; Wolffbrandt MM, 2013, REHABIL NURS, V38, P133, DOI 10.1002/rnj.82	24	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2019	33	7					916	921		10.1080/02699052.2019.1565893			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OM5BT	WOS:000586040800011	30696278				2022-02-06	
J	Zelinkova, V; Brazinova, A; Taylor, MS; Rusnak, M; Plancikova, D; Melichova, J; Majdan, M				Zelinkova, Veronika; Brazinova, Alexandra; Taylor, Mark S.; Rusnak, Martin; Plancikova, Dominika; Melichova, Juliana; Majdan, Marek			Location of traumatic brain injury-related deaths: epidemiological analysis of 11 European countries	BRAIN INJURY			English	Article						Traumatic brain injury; deaths; location of death; mechanism of injuries; death certification	STATISTICS; CERTIFICATION	Background: Understanding the factors related to traumatic brain injury (TBI)-related mortality is important in obtaining a complete picture of the predictors and burden of injury-related deaths. Objective: To analyze deaths due to TBI occurring inside versus outside hospitals. Methods: Data were obtained by requests to the representatives of national statistical offices and health administration institutions for one reported calendar year (2014 or the nearest available year). Results: A total of 4513 cases of TBI-related deaths were identified. Of these, 2045 (45%) occurred outside and 2468 (55%) in hospitals. The pooled out-of-hospital age-adjusted mortality rate was 5.5 (95% CI = 4.8-6.3), and in-hospital age-adjusted rate was 6.6 (95% CI = 5.2-7.9) per 100 000 people. Outside (25%) or inside (53%) hospitals, the most common cause of TBI-related deaths was falls. The age group of 15-24 years and traffic-related, suicide-related, and violence-related mechanisms were the most significant factors associated with deaths occurring outside hospitals. Conclusions: The results of this study may be of use in planning and allocation of public health resources, and identification of the situations most commonly associated with fatalities in different locations.	[Zelinkova, Veronika; Brazinova, Alexandra; Taylor, Mark S.; Rusnak, Martin; Plancikova, Dominika; Melichova, Juliana; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@truni.sk	Brazinova, Alexandra/C-4265-2016	Brazinova, Alexandra/0000-0003-0625-256X			Berlin A, 2009, LONDON J PRIM CARE, V2, P130, DOI 10.1080/17571472.2009.11493267; Brazinova A, 2016, EUR J PUBLIC HEALTH, V26; Brazinova A, 2014, REPORT TBI MORTALITY; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Burton KR, 2009, BURNS, V35, P572, DOI 10.1016/j.burns.2008.10.003; CENTER-TBI, CTR TBI 2018; Centers for Disease Control and Prevention, 2001, RAT TBI REL HOSP AG; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CRAN, R 3 3 0 WIND 32 64 B; Danilova I, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0078-0; Davis JS, 2014, J TRAUMA ACUTE CARE, V77, P213, DOI 10.1097/TA.0000000000000292; EUROSTAT, 2013, REV EUR STAND POP RE; EUROSTAT, POP 1 JAN AG GROUP S; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gedeborg R, 2012, J TRAUMA ACUTE CARE, V72, P765, DOI 10.1097/TA.0b013e3182288272; Hodgson NF, 2000, CAN J SURG, V43, P130; Jougla E, 1998, REV EPIDEMIOL SANTE, V46, P447; Lu TH, 2007, INJURY PREV, V13, P276, DOI 10.1136/ip.2006.012930; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; World Health Organization [Internet], CLASS	27	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2019	33	7					830	835		10.1080/02699052.2019.1605622			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OM5BT	WOS:000586040800002	31007078				2022-02-06	
J	Mrozek, S; Delamarre, L; Capilla, F; Al-Saati, T; Fourcade, O; Constantin, JM; Geeraerts, T				Mrozek, Segolene; Delamarre, Louis; Capilla, Florence; Al-Saati, Talal; Fourcade, Olivier; Constantin, Jean-Michel; Geeraerts, Thomas			Cerebral Expression of Glial Fibrillary Acidic Protein, Ubiquitin Carboxy-Terminal Hydrolase-L1, and Matrix Metalloproteinase 9 After Traumatic Brain Injury and Secondary Brain Insults in Rats	BIOMARKER INSIGHTS			English	Article						traumatic brain injury; hypoxia; hypotension; GFAP; UCH-L1; MMP-9	INTENSIVE-CARE-UNIT; MATRIX METALLOPROTEINASES; HYPOXIA-HYPOTENSION; CEREBROSPINAL-FLUID; MODEL; VULNERABILITY; BIOLOGY; UCH-L1; ROLES; L1	Glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1), and matrix metalloproteinase 9 (MMP-9) are potential biomarkers of traumatic brain injury (TBI) but also of secondary insults to the brain. The aim of this study was to describe the cerebral distribution of GFAP, UCH-L1, and MMP-9 in a rat model of diffuse TBI associated with standardized hypoxia-hypotension (HH). Adult male Sprague-Dawley rats were allocated to Sham (n = 10), TBI (n = 10), HH (n = 10), and TBI+HH (n = 10) groups. After 4 hours, brains were rapidly removed and immunostaining of GFAP, UCH-L1, and MMP-9 was performed. Areas of interest that have been described as particularly sensitive to hypoxic insults were analyzed. For GFAP, in the neocortex, immunostaining revealed a significant decrease in strong staining for HH and TBI+HH groups compared with TBI group (P < .0001). For UCH-L1, the total immunostaining (6 regions of interest) reported a significant increase in strong staining (P < .0001) and decrease in weak staining (P < .0001) for the HH and TBI+HH groups compared with the Sham and TBI groups. For MMP-9, for the HH and TBI+HH groups, a significant increase in moderate (P < .0001) and weak staining (P < .0001) and a decrease in negative staining (P < .0001) compared with the Sham and TBI groups were observed. UCH-L1 and MMP-9 immunostainings increased after HH alone or HH combined with TBI compared with TBI alone. GFAP immunostaining decreased particularly in the neocortex after HH alone or HH combined with TBI compared with TBI alone. These three biomarkers could therefore be considered as potential biomarkers of HH insults independently of TBI.	[Mrozek, Segolene; Delamarre, Louis; Fourcade, Olivier; Geeraerts, Thomas] Univ Hosp Toulouse, Dept Anesthesiol & Crit Care, Toulouse, France; [Capilla, Florence; Al-Saati, Talal] Univ Hosp Toulouse, INSERM US006 CREFRE, Expt Histopathol Dept, Toulouse, France; [Constantin, Jean-Michel] Univ Hosp Clermont Ferrand, Dept Anesthesiol & Crit Care, Clermont Ferrand, France; [Geeraerts, Thomas] Univ Toulouse 3 Paul Sabatier, Inserm UPS, ToNIC Toulouse NeuroImaging Ctr, Toulouse, France		Mrozek, S (corresponding author), Hop Pierre Paul Riquet, Pole Anesthesie Reanimat, F-31059 Toulouse 9, France.	mrozek.s@chu-toulouse.fr		Delamarre, Louis/0000-0002-4051-3834	la Fondation des "Gueules Cassees," Paris, France; Association REAMU, Toulouse, France	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from la Fondation des "Gueules Cassees," Paris, France, and Association REAMU, Toulouse, France.	Abernathy LM, 2015, J THORAC ONCOL, V10, P1703, DOI 10.1097/JTO.0000000000000677; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Blanie A, 2012, J NEUROTRAUM, V29, P2782, DOI 10.1089/neu.2012.2381; Caldeira MV, 2014, PROG NEUROBIOL, V112, P50, DOI 10.1016/j.pneurobio.2013.10.003; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Geng XG, 2018, MED SCI MONITOR, V24, DOI 10.12659/MSM.908568; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; HAYASHI T, 1992, NEUROREPORT, V3, P519, DOI 10.1097/00001756-199206000-00016; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kim M, 2015, EXP DERMATOL, V24, P680, DOI 10.1111/exd.12745; Kolar M, 2008, ACTA NEUROCHIR SUPPL, V102, P373, DOI 10.1007/978-3-211-85578-2_71; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Liu CL, 2014, TURK NEUROSURG, V24, P363, DOI 10.5137/1019-5149.JTN.8551-13.0; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mrozek S, 2016, BRAIN RES, V1646, P334, DOI 10.1016/j.brainres.2016.06.007; Mrozek S, 2014, CRIT CARE, V18, DOI 10.1186/cc13841; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Simon D, 2017, BRAIN INJURY, V31, P390, DOI 10.1080/02699052.2016.1259501; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	42	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1177-2719			BIOMARK INSIGHTS	Biomark. Insights	JUN 4	2019	14								1177271919851515	10.1177/1177271919851515			13	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	IF1EP	WOS:000472822000001	31210728	gold, Green Published			2022-02-06	
J	Bulut, EA; Karabay, N; Soysal, P; Isik, AT				Bulut, Esra Ates; Karabay, Nuri; Soysal, Pinar; Isik, Ahmet Turan			An elderly patient with Alzheimer's disease, normal pressure hydrocephalus and traumatic brain injury: presented with behavioral symptoms similar to behavioral variant frontotemporal dementia	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Traumatic brain injury; dementia; Alzheimer's disease; normal pressure hydrocephalus	DIAGNOSIS	Objective: Traumatic brain injury (TBI) is nondegenerative insult to brain from external mechanical forces. It may cause cognitive impairment, psychological problems in the long period. Besides traumatic brain injury also induces neuroinflammation and neurodegeneration process, and increases risk of dementia. It may cause various psychiatric complications such as depression, posttraumatic stress disorder, generalized anxiety disorder, and other cognitive and behavioral sequela according to site of involvement in the brain. Methods: We report a patient who has behavioral symptoms, amnesia and gait apraxy after TBI. Patient's symptoms were similar to behavioral variant Frontotemporal Dementia (bv FTD). Results: After detailed neurocognitive and radiologic evaluation he was diagnosed with Normal Pressure Hydrocephalus (NPH), and Alzheimer's Disease (AD) following TBI. Conclusion: Comprehensive geriatric assessment, including detailed radiological examinations, if it is necessary, is recommended for the optimum management of elderly patients with cognitive and psychosocial problems in order to avoid misdiagnosis and inappropriate treatment.	[Bulut, Esra Ates; Isik, Ahmet Turan] Dokuz Eylul Univ, Fac Med, Dept Geriatr Med, Izmir, Turkey; [Karabay, Nuri] Dokuz Eylul Univ, Fac Med, Dept Radiol, Izmir, Turkey; [Soysal, Pinar] Bezmialem Vakif Univ, Fac Med, Dept Geriatr Med, Istanbul, Turkey; [Isik, Ahmet Turan] Dokuz Eylul Univ, Unit Aging Brain & Dementia, Dept Geriatr Med, Fac Med, Izmir, Turkey		Isik, AT (corresponding author), Dokuz Eylul Univ, Tip Fak, Geriatr Bilim Dali, Yaslanan Beyin & Demans Unitesi, TR-35340 Izmir, Turkey.	atisik@yahoo.com	Bulut, Esra Ates/AAL-8673-2020; SOYSAL, Pinar/AAA-8894-2021	Bulut, Esra Ates/0000-0002-1124-9720; ISIK, Ahmet Turan/0000-0001-5867-6503; SOYSAL, Pinar/0000-0002-6042-1718			Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mesulam M., 2002, OXFORD PRINCIPLES FR, P8, DOI 10.1093/acprof:oso/9780195134971.003.0002; Nogueira ML, 2016, ALZHEIMERS DEMENT, V12, P324, DOI 10.1016/j.jalz.2015.10.005; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Relkin Norman, 2005, Neurosurgery, V57, pS4; Soysal P, 2014, INT UROL NEPHROL, V46, P1627, DOI 10.1007/s11255-014-0739-5; Spalletta G, 2004, J NEUROL, V251, P688, DOI 10.1007/s00415-004-0403-6; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003	15	3	3	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	JUN 3	2019	129	6					623	626		10.1080/00207454.2018.1552690			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HR0UZ	WOS:000462845700013	30475083				2022-02-06	
J	Amaegberi, NV; Semenkova, GN; Kvacheva, ZB; Lisovskaya, AG; Pinchuk, SV; Shadyro, OI				Amaegberi, Nadezda V.; Semenkova, Galina N.; Kvacheva, Zinaida B.; Lisovskaya, Alexandra G.; Pinchuk, Serge V.; Shadyro, Oleg I.			2-Hexadecenal inhibits growth of C6 glioma cells	CELL BIOCHEMISTRY AND FUNCTION			English	Article						2-Hexadecenal; apoptosis; C6 glioma cells; cytoskeleton; proliferation	TRAUMATIC BRAIN-INJURY; PATHWAY; MYELOPEROXIDASE; PRODUCT; REORGANIZATION; DECOMPOSITION; GLIOBLASTOMA; ACTIVATION; MECHANISM; MONOCYTES	2-Hexadecenal (2HD) formation in the organism occurs via irreversible enzymatic degradation of sphingosine-1-phosphate or nonenzymatic gamma-, UV-, or HOCl-induced destruction of a number of sphingolipids including S1P. The current research focuses on the study of 2HD effects on C6 glioma cells growth. The results obtained show that 2HD causes a dose-dependent decrease in proliferative and mitotic indices. The change in the mitotic index is due to the redistribution of cells in the different phases of mitosis. These processes are accompanied by cytoskeleton rearrangement and changes in cell morphology, which are expressed in F-actin redistribution, change in the number and type of filopodia and fibrils, leading to cell shape changes, decrease in intercellular contacts and monolayer rarefaction. Cells treatment with 2HD leads to apoptosis induction and signalling pathways modification, including activation of JNK, p38, and ERK1/2 MAPK but not PI3K. The effects observed are not related to the cytotoxicity of 2HD. Significance of the study: 2HD-an unsaturated aldehyde, which level can rise under conditions of oxidative stress as a result of nonenzymatic sphingolipids' destruction. The mechanisms of 2HD action on various cell types have not been sufficiently studied. Therefore, the study on functional role of this aldehyde in different cell types that may be its target is relevant. This study demonstrated that 2HD inhibits growth of C6 glioma cells due to modification of intracellular processes of signal transduction, cytoskeleton rearrangement, change in the mitotic regimen and apoptosis induction.	[Amaegberi, Nadezda V.; Semenkova, Galina N.; Lisovskaya, Alexandra G.; Shadyro, Oleg I.] Belarusian State Univ, Dept Radiat Chem & Chem Pharmaceut Technol, Fac Chem, 4 Nezavisimosti Ave, Minsk 220030, BELARUS; [Kvacheva, Zinaida B.; Pinchuk, Serge V.] NAS Belarus, Inst Biophys & Cell Engn, Minsk, BELARUS; [Lisovskaya, Alexandra G.] Univ Notre Dame, Notre Dame Radiat Lab, Notre Dame, IN 46556 USA		Amaegberi, NV (corresponding author), Belarusian State Univ, Dept Radiat Chem & Chem Pharmaceut Technol, Fac Chem, 4 Nezavisimosti Ave, Minsk 220030, BELARUS.	n.amaegberi@gmail.com	Semenkova, Galina/Q-7258-2019; Lisovskaya, Alexandra/AAH-3225-2020	Lisovskaya, Alexandra/0000-0001-7556-8977; Shadyro, Oleg/0000-0002-8589-4490; Semenkova, Galina/0000-0001-6048-4383; Amaegberi, Nadezda/0000-0001-8907-867X	Ministry of Education of Belarus [20170712]	Ministry of Education of Belarus, Grant/Award Number: 20170712	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bernhart E, 2018, REDOX BIOL, V15, P441, DOI 10.1016/j.redox.2018.01.003; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cui XD, 2014, MOL MED REP, V9, P1641, DOI 10.3892/mmr.2014.2036; Engberink RDO, 2010, MOL IMAGING, V9, P268, DOI 10.2310/7290.2010.00016; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gellhaar S, 2017, CELL TISSUE RES, V369, P445, DOI 10.1007/s00441-017-2626-8; Ghosh S, 1997, FASEB J, V11, P45, DOI 10.1096/fasebj.11.1.9034165; Granot Z, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/701067; Green PS, 2004, J NEUROCHEM, V90, P724, DOI 10.1111/j.1471-4159.2004.02527.x; Gudinaviciene Inga, 2004, Medicina (Kaunas), V40, P112; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hoffman L, 2017, MOL BIOL CELL, V28, P2661, DOI 10.1091/mbc.E17-02-0087; Holzer M, 2001, NEUROSCIENCE, V105, P1041, DOI 10.1016/S0306-4522(01)00246-9; Ishaque A., 2007, ANIMAL CELL BIOTECHN, V24, P285, DOI DOI 10.1007/978-1-59745-399-8_13; Kato F, 1999, TOXICOL IN VITRO, V13, P923, DOI 10.1016/S0887-2333(99)00078-8; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Kulahava TA, 2006, NEUROSCI LETT, V398, P286, DOI 10.1016/j.neulet.2006.01.013; Kumar A, 2011, CELL SIGNAL, V23, P1144, DOI 10.1016/j.cellsig.2011.02.009; Lewin B, 2007, CELLS, P1056; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lisovskaya AG, 2012, PHOTOCHEM PHOTOBIOL, V88, P899, DOI 10.1111/j.1751-1097.2012.01148.x; Lisovskaya AG, 2011, LIPIDS, V46, P271, DOI 10.1007/s11745-010-3506-0; Liu FF, 2018, ACTA PHARM SIN B, V8, P552, DOI 10.1016/j.apsb.2018.01.008; Liu Z, 2010, NEW J CHEM, V34, P470, DOI 10.1039/b9nj00710e; Massara M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01349; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Melin BS, 2017, NAT GENET, V49, P789, DOI 10.1038/ng.3823; Nagra RM, 1997, J NEUROIMMUNOL, V78, P97, DOI 10.1016/S0165-5728(97)00089-1; NAUSEEF WM, 1988, HEMATOL ONCOL CLIN N, V2, P135; Nusshold C, 2016, FREE RADICAL BIO MED, V90, P59, DOI 10.1016/j.freeradbiomed.2015.11.010; Pirko I, 2004, FASEB J, V18, P179, DOI 10.1096/fj.02-1124fje; Ray RS, 2016, NEUROSCI BIOBEHAV R, V68, P611, DOI 10.1016/j.neubiorev.2016.06.031; Schumacher F, 2017, J LIPID RES, V58, P1648, DOI 10.1194/jlr.M076562; Serres S, 2009, J NEUROSCI, V29, P4820, DOI 10.1523/JNEUROSCI.0406-09.2009; Shadyro Oleg, 2015, Lipid Insights, V8, P1, DOI 10.4137/LPI.S24081; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Upadhyaya P, 2012, BIOCHEM BIOPH RES CO, V424, P18, DOI 10.1016/j.bbrc.2012.06.012; Wang HX, 2015, NEOPLASIA, V17, P239, DOI 10.1016/j.neo.2015.02.002; Wang WY, 2014, ARTERIOSCL THROM VAS, V34, P526, DOI 10.1161/ATVBAHA.113.302544; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	47	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0263-6484	1099-0844		CELL BIOCHEM FUNCT	Cell Biochem. Funct.	JUN	2019	37	4					281	289		10.1002/cbf.3400			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ID7YH	WOS:000471898400009	31038222				2022-02-06	
J	Brearly, TW; Rowland, JA; Martindale, SL; Shura, RD; Curry, D; Taber, KH				Brearly, Timothy W.; Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.; Curry, David; Taber, Kathy H.			Comparability of iPad and Web-Based NIH Toolbox Cognitive Battery Administration in Veterans	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Cognition; Assessment; Toolbox; mHealth; Telehealth; Tablet	INDIVIDUALS; VALIDATION; VALIDITY	Objective: The purpose of this study was to evaluate the comparability of National Institutes of Health Toolbox Cognitive Battery test scores across iPad application and web-based personal computer administration platforms. Original test norms were developed using a personal computer-based administration and no previous studies assessing platform comparability have been published. Method: Participants (N = 62; final analyzed sample n = 49) were combat-exposed post-deployment veterans without neurologic disorder, severe mental illness, current substance use disorder, or a history of moderate or severe traumatic brain injury. All participants completed both iPad and web-based versions of tests on the same day in an experimental within-subjects crossover design. Standalone validity measures were incorporated to exclude invalid performance. Outcome measures included the Dimensional Change Card Sort Test, Flanker Inhibitory Control and Attention Test, List Sorting Working Memory Test, and Pattern Comparison Processing Speed Test. Results: Score differences between platforms were found on the Flanker Inhibitory Control and Attention Test. Scores were moderately correlated across tests, with the exception of low correlations for the Pattern Comparison Processing Speed Test. Most participants preferred iPad to web administration, regardless of administration order. Conclusions: Results suggest caution when interpreting iPad-acquired scores, particularly for the Flanker Inhibitory Control and Attention Test. iPad-based testing offers valuable improvements; however, the development of iPad-specific norms may be necessary to ensure valid interpretation of acquired data.	[Brearly, Timothy W.; Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.; Curry, David; Taber, Kathy H.] Salisbury VA Hlth Care Syst, Mid Atlantic Mental Illness Res Educ & Clin Ctr, Salisbury, NC USA; [Brearly, Timothy W.; Rowland, Jared A.; Martindale, Sarah L.; Curry, David; Taber, Kathy H.] Salisbury VA Hlth Care Syst, Res & Acad Affairs Serv Line, Salisbury, NC USA; [Brearly, Timothy W.] Walter Reed Natl Mil Med Ctr, Neuropsychol Assessment Serv, Directorate Behav Hlth Consultat & Educ, Bethesda, MD USA; [Brearly, Timothy W.; Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.] Wake Forest Sch Med, Dept Psychiat & Behav Sci, Winston Salem, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.] Salisbury VA Hlth Care Syst, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Shura, Robert D.; Taber, Kathy H.] Via Coll Osteopath Med, Blacksburg, VA USA; [Taber, Kathy H.] Baylor Coll Med, Houston, TX 77030 USA		Brearly, TW (corresponding author), Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA.	tbrearly@gmail.com	Rowland, Jared A./AAN-3030-2021; Martindale, Sarah L/O-8553-2018; Brearly, Timothy/T-1739-2019	Rowland, Jared A./0000-0002-3655-3411; Martindale, Sarah L/0000-0002-0059-3454; Brearly, Timothy/0000-0002-6320-0654	U.S. Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC)United States Department of Defense [W81XWH-13-2-0095]; U.S. Department of Veterans Affairs CENCUS Department of Veterans Affairs [I01RX002172-01]; Salisbury VA Health Care System; Mid-Atlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC); U.S. Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment; Veterans AffairsUS Department of Veterans Affairs [I01RX002172] Funding Source: NIH RePORTER	This work was supported by the U.S. Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) [Award No. W81XWH-13-2-0095]; U.S. Department of Veterans Affairs CENC [Award No. I01RX002172-01]; Salisbury VA Health Care System; Mid-Atlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC); and the U.S. Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment.	Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; Brearly TW, 2017, NEUROPSYCHOL REV, V27, P174, DOI 10.1007/s11065-017-9349-1; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Carlozzi NE, 2017, REHABIL PSYCHOL, V62, P443, DOI 10.1037/rep0000195; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Green P., 2005, MED SYMPTOM VALIDITY; Grosch MC, 2011, CLIN NEUROPSYCHOL, V25, P1119, DOI 10.1080/13854046.2011.609840; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Holdnack JA, 2017, REHABIL PSYCHOL, V62, P496, DOI 10.1037/rep0000198; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Luxton DD, 2014, PROF PSYCHOL-RES PR, V45, P27, DOI 10.1037/a0034547; Miller JB, 2017, ARCH CLIN NEUROPSYCH, V32, P541, DOI 10.1093/arclin/acx050; National Institutes of Health and Northwestern University, 2017, NIH TOOLB AN GUID CO; National Institutes of Health and Northwestern University, 2017, NIH TOOLB ADM MAN EL; Northwestern University, 2017, MAN NIH TOOLB ASS CT; Northwestern University, 2018, NIH TOOLB PROMIS IPA; RStudio Team, 2018, RSTUDIO INT DEV R; Tudor G, 1994, Stat Methods Med Res, V3, P345, DOI 10.1177/096228029400300404; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P435, DOI 10.1037/rep0000183; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded	27	3	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2019	34	4					524	530		10.1093/arclin/acy070			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	IS9UK	WOS:000482493200009	30260372	hybrid			2022-02-06	
J	Carmichael, JP; Staton, EW; Blatchford, PJ; Stevens-Lapsley, J				Carmichael, Joel P.; Staton, Elizabeth W.; Blatchford, Patrick J.; Stevens-Lapsley, Jennifer			EPIDEMIOLOGY OF NECK INJURIES ACCOMPANYING SPORT CONCUSSIONS IN YOUTH OVER A 13-YEAR PERIOD IN A COMMUNITY-BASED HEALTHCARE SYSTEM	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Cervical spine; concussion; epidemiology; movement system; neck injury; whiplash	HIGH-SCHOOL; STRENGTH; HEAD; SYMPTOMS; PERFORMANCE; RETURN; BRAIN; RISK; TIME; PLAY	Background: The same trauma that produces concussion may also produce neck injury. The signs of concussion and neck injury are similar, and symptoms after acceleration-deceleration trauma to the head-neck complex do not accurately discriminate between them. Research on the epidemiology of neck injury among sport-concussed youth is sparse. Purpose: The purpose of this study was to investigate the epidemiology of diagnosed neck injury in non-sport-related concussion (Non-SRC) versus sport-related concussion (SRC) in youth by age, sex, and sport. Study design: Cross-sectional epidemiologic study Methods: De-identified data from community-based electronic health records over 13 years were extracted to analyze rates and characteristics of neck injuries among non-SRCs and SRCs in youth aged five to 21. Neck injury diagnosis prevalence rates and odds ratios were calculated to estimate risk of neck injury among concussed youth, comparing non-SRCs to SRCs by age and sex. Results: Sixteen thousand, eight hundred eighty-five concussion records were extracted, of which 3,040 SRCs and 2,775 non-SRCs in youth aged five to 21 were identified by cross-filtering sport-related keywords (e.g., football, basketball, soccer, running, swimming, batting, horseback riding, skiing, etc.) with all ICD-9 and ICD-10 concussion codes. The prevalence of neck injuries diagnosed among SRCs (7.2%) was significantly different than the prevalence of neck injuries diagnosed among non-SRCs (12.1%, p < 0.000). Neck injury diagnoses were significantly more prevalent in females overall (p < 0.000) and among non-SRCs (p < 0.000). The prevalence of neck injury diagnoses was not significantly higher in concussed females versus concussed males with SRC (p = 0.164). Among youth aged five to 21 exposed to concussions, non-SRCs were more likely to be accompanied by a neck injury diagnosis than SRCs (OR 1.66; 95% CI 1.39 to 1.98; p < 0.000). Similarly, female-to-male neck injury proportion ratios were significantly higher in females in non-SRCs compared to SRCs (IPR 1.90, 95% CI 1.60 to 2.25, p < 0.000). Sports with highest prevalence of concussion differ from sports with highest prevalence of concussion-related neck injury in both sexes. Conclusions: The overall prevalence of diagnosed neck injuries in youth was higher in non-SRCs compared to SRCs (12.1 vs. 7.2%, p < 0.001), with the highest prevalence at age 14 in both sexes. The risk of neck injury diagnosis accompanying concussion was significantly higher in females compared to males (6.1% difference; p < 0.000).	[Carmichael, Joel P.; Stevens-Lapsley, Jennifer] Univ Colorado, Phys Therapy Program, Dept Phys Med & Rehabil, Aurora, CO USA; [Staton, Elizabeth W.] Univ Colorado, Dept Family Med, Aurora, CO USA; [Blatchford, Patrick J.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA; [Stevens-Lapsley, Jennifer] Eastern Colorado Geriatr Res Educ & Clin Ctr, Aurora, CO USA		Carmichael, JP (corresponding author), 13121 E 17th Ave,Mail Stop C244, Aurora, CO 80045 USA.	joel.carmichael@ucdenver.edu	Carmichael, Joel/ABG-8934-2021	Carmichael, Joel/0000-0001-5570-2075	NIH/NCATS Colorado CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001082]; Health Data Compass Data Warehouse project	Supported by NIH/NCATS Colorado CTSA Grant Number UL1 TR001082 and by the Health Data Compass Data Warehouse project (healthdatacompass.org).	Agel J, 2007, J ATHL TRAINING, V42, P270; Bahr R, 2014, BRIT J SPORT MED, V48, P1265, DOI 10.1136/bjsports-2014-093832; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Catenaccio E, 2017, PM&R, V9, P884, DOI 10.1016/j.pmrj.2017.01.005; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Delaney JS, 2005, BRIT J SPORT MED, V39, P189; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; Freitag P, 2001, NEUROREHAB NEURAL RE, V15, P31, DOI 10.1177/154596830101500105; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gimse R, 1997, J CLIN EXP NEUROPSYC, V19, P838, DOI 10.1080/01688639708403764; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; Hamilton DF, 2012, BONE JOINT RES, V1, P152, DOI 10.1302/2046-3758.17.2000079; Hootman J., 2010, SPORTS INJURY RES, P55; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kumar S, 2000, ACCIDENT ANAL PREV, V32, P233, DOI 10.1016/S0001-4575(99)00114-1; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Master CL, 2016, CURR SPORT MED REP, V15, P230, DOI 10.1249/JSR.0000000000000272; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Register-Mihalik JK, 2017, NEUROL CLIN, V35, P387, DOI 10.1016/j.ncl.2017.03.009; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; RUBIN AM, 1995, AM J OTOL, V16, P216; Saposnik G, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0377-1; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; WOODWARD AH, 1995, NEUROLOGY, V45, P2117; Yadla S, 2008, CURR REV MUSCULOSKE, V1, P65, DOI 10.1007/s12178-007-9008-x; Zuckerman SL, 2018, BRIT J SPORT MED, V52, P261, DOI 10.1136/bjsports-2016-096005	47	3	3	0	4	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	JUN	2019	14	3					334	344		10.26603/ijspt20190334			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	JS7LQ	WOS:000500485900002	31681492	Green Published			2022-02-06	
J	Christie, LJ; McCluskey, A; Lovarini, M				Christie, Lauren J.; McCluskey, Annie; Lovarini, Meryl			Constraint-induced movement therapy for upper limb recovery in adult neurorehabilitation: An international survey of current knowledge and experience	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						stroke; survey research; traumatic brain injury; upper limb function	SUBACUTE STROKE; ARM; OPINIONS	Introduction Constraint-induced movement therapy (CIMT) is an effective intervention for upper limb recovery following stroke and traumatic brain injury. Despite strong evidence, the use of CIMT in practice is limited. The aim of this study was to investigate clinician knowledge and experience of delivering CIMT protocols internationally in neurorehabilitation. Methods A cross-sectional survey was conducted online. The survey was distributed through occupational therapy and physiotherapy associations, neurological interest groups and list serves in 11 countries. Passive snowball sampling was used to recruit participants. Descriptive and inferential statistics were used for analysis. Results Complete surveys were returned by 169 respondents (64.5% occupational therapists; 34.3% physiotherapists; 1.2% other). Most respondents were from the United Kingdom (36.1%), Australia (28.4%) and Denmark (7.7%). Most participants delivered CIMT to individuals (79.3%) rather than in groups. A modified version of CIMT was used most often (74.6%), with one hour sessions per day (30.2%), provided to stroke survivors (96.4%) and people with traumatic brain injury (37.3%). Most respondents (88.8%) used intensive graded practice as a component of a CIMT program, but only 43.2% reported using a mitt restraint for most waking hours, and only 38.5% used a transfer package. Conclusion These findings suggest that CIMT is being used globally but not always with fidelity to the original trials. A range of strategies are needed for improving clinicians' knowledge and skills to increase the frequency of program delivery and enhance program delivery with fidelity.	[Christie, Lauren J.; McCluskey, Annie; Lovarini, Meryl] Univ Sydney, Discipline Occupat Therapy, Fac Hlth Sci, Sydney, NSW, Australia; [Christie, Lauren J.] South Western Sydney Local Hlth Dist SWSLHD, Liverpool Hosp Brain Injury Rehabil Unit, Liverpool, Merseyside, England; [Christie, Lauren J.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp BIRRG, Liverpool, NSW, Australia; [McCluskey, Annie] StrokeEd Collaborat, Sydney, NSW, Australia		Christie, LJ (corresponding author), Liverpool Hosp Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	lauren.christie1@health.nsw.gov.au	Christie, Lauren/AAO-6419-2020	Christie, Lauren/0000-0003-4900-5614; Lovarini, Meryl/0000-0003-4304-0793; McCluskey, Annie/0000-0002-9719-6657			Abdullahi A, 2014, INT J THER REHABIL, V21, P140, DOI 10.12968/ijtr.2014.21.3.140; Aday LA, 2006, DESIGNING CONDUCTING; Centre for Epidemiology and Evidence, 2018, HEALTHSTATS NSW; Christie L., 2018, WFOT C 2018 CAP TOWN; Corbetta D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004433.pub3; Daniel L, 2012, TOP STROKE REHABIL, V19, P268, DOI 10.1310/tsr1903-268; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; Eigbogba B, 2010, PHYS THERAPY REV, V15, P121; Fay P, 2018, CONSTRAINT INDUCED T; Fleet A, 2014, PHYSIOTHER CAN, V66, P60, DOI 10.3138/ptc.2012-61; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3; Harris ML, 2015, AM J EPIDEMIOL, V181, P737, DOI 10.1093/aje/kwv006; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison Training UK, 2018, HARR TRAIN TRAIN COU; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Kwah LK, 2013, J PHYSIOTHER, V59, P189, DOI 10.1016/S1836-9553(13)70183-8; Kwakkel G, 2016, NEUROREHAB NEURAL RE, V30, P804, DOI 10.1177/1545968315624784; Kwakkel G, 2015, LANCET NEUROL, V14, P224, DOI 10.1016/S1474-4422(14)70160-7; Lindsay M.P., 2010, CANADIAN BEST PRACTI; Meharg A., 2015, CONSTRAINT INDUCED M; Morris D M, 2006, Eura Medicophys, V42, P257; Myint JMWW, 2008, CLIN REHABIL, V22, P112, DOI 10.1177/0269215507080141; Nijland R, 2011, INT J STROKE, V6, P425, DOI 10.1111/j.1747-4949.2011.00646.x; Page SJ, 2002, CLIN REHABIL, V16, P55, DOI 10.1191/0269215502cr473oa; Page SJ, 2005, NEUROREHAB NEURAL RE, V19, P27, DOI 10.1177/1545968304272701; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P14, DOI 10.1016/S0003-9993(03)00481-7; Pedlow K, 2014, ARCH PHYS MED REHAB, V95, P276, DOI 10.1016/j.apmr.2013.08.240; Stevenson T, 2012, PHYSIOTHER CAN, V64, P397, DOI 10.3138/ptc.2011-24; Stirman SW, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-65; Stroke Foundation, 2017, CLIN GUID STROK MAN; Taub E, 2013, STROKE, V44, P1383, DOI 10.1161/STROKEAHA.111.000559; University of Alabama Birmingham, 2017, CI THER TRAIN COURS; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Walker J, 2009, AUST OCCUP THER J, V56, P436, DOI 10.1111/j.1440-1630.2009.00825.x; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	36	3	3	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	JUN	2019	66	3					401	412		10.1111/1440-1630.12567			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	IF6MW	WOS:000473195800015	30714621				2022-02-06	
J	Dash, GK; Rathore, C; Jeyaraj, MK; Wattamwar, P; Sarma, SP; Radhakrishnan, K				Dash, Gopal K.; Rathore, Chaturbhuj; Jeyaraj, Malcolm K.; Wattamwar, Pandurang; Sarma, Sankara P.; Radhakrishnan, Kurupath			Predictors of seizure outcome following resective surgery for drug-resistant epilepsy associated with focal gliosis	JOURNAL OF NEUROSURGERY			English	Article						focal gliosis; epilepsy surgery; seizure outcome	FRONTAL-LOBE EPILEPSY; CORTICAL DYSPLASIA; PROGNOSTIC-FACTORS; CORTEX; ULEGYRIA; ENCEPHALOMALACIAS; SELECTION	OBJECTIVE The authors studied the clinical characteristics and postoperative outcomes of drug-resistant epilepsy associated with focal gliosis. METHODS From their epilepsy surgery database, the authors selected the patients with drug-resistant epilepsy and MRI-defined focal gliosis who underwent focal resective surgery. All patients underwent standard presurgical evaluation. Intracranial electroencephalography (EEG) was performed in patients with discordant presurgical data, ill-defined lesions, and lesions close to eloquent regions. Completeness of resection was defined on the basis of extraoperative and intraoperative electrocorticography studies. Favorable postoperative outcome was defined as Engel class I outcome during the last 2 years of follow-up. RESULTS Sixty-six patients fulfilled inclusion criteria. An initial precipitating injury was present in 38 (57.6%) patients, mainly in the form of perinatal injury (n = 10), trauma (n = 10), and meningoencephalitis (n = 8). Gliosis involved a single lobe in 38 (57.6%) patients and 2 adjacent lobes in 14 (21.2%) patients; the remaining 14 (21.2%) patients had multilobar gliosis. In patients with unilobar or bilobar gliosis, the posterior region of the head was involved in 34 (65%) patients and the frontal lobes in 12 (23%) patients. During a median follow-up of 4 years (range 2-9 years), 41 (62.1%) patients had favorable outcome. On multivariate analysis, the presence of a well-defined aura (p = 0.019), electrocorticographically defined completeness of resection (p = 0.024), and normal postoperative EEG findings at 1 year (p = 0.003) were predictive of favorable postoperative seizure outcome. CONCLUSIONS Focal gliosis is a common etiology for drug-resistant extratemporal epilepsy in developing countries and is most often located in the posterior region of the head. The majority of these patients have perinatal injuries or neurological infections as initial precipitating injuries. Patients with focal gliosis have good postoperative seizure outcomes after well-planned resective surgery.	[Dash, Gopal K.; Rathore, Chaturbhuj; Jeyaraj, Malcolm K.; Wattamwar, Pandurang; Radhakrishnan, Kurupath] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, R Madhavan Nayar Ctr Comprehens Epilepsy Care, Trivandrum, Kerala, India; [Rathore, Chaturbhuj] Sumandeep Vidyapeeth, Smt BK Shah Med Inst & Res Ctr, Dept Neurol, Vadodara, Gujarat, India; [Dash, Gopal K.] Narayana Hrudayalaya Hosp, Dept Neurol, Bengaluru, Karnataka, India; [Jeyaraj, Malcolm K.] Stanley Med Coll, Dept Neurol, Chennai, Tamil Nadu, India; [Wattamwar, Pandurang] United CIIGMA Hosp, Dept Neurol, Aurangabad, Maharashtra, India; [Sarma, Sankara P.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Radhakrishnan, Kurupath] Amrita Inst Med Sci, Dept Neurol, Amrita Adv Epilepsy Ctr, Kochi, Kerala, India		Rathore, C (corresponding author), Smt BK Shah Med Inst & Res Ctr, Vadodara, Gujarat, India.	cbrathore@rediffmail.com	Rathore, Chaturbhuj/AAI-7336-2020				BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Caraballo RH, 2004, PEDIATR NEUROL, V31, P24, DOI 10.1016/j.pediatrneurol.2003.12.008; Chandra PS, 2012, INDIAN J NEUROSURG, V1, P33, DOI 10.4103/2277-9167.94368; Chaudhry N, 2010, EPILEPTIC DISORD, V12, P38, DOI 10.1684/epd.2010.0301; Chemmanam T, 2009, J CLIN NEUROPHYSIOL, V26, P123, DOI 10.1097/WNP.0b013e31819d8030; Cukiert A, 1996, CAN J NEUROL SCI, V23, P114, DOI 10.1017/S0317167100038828; Dalmagro CL, 2005, EPILEPSIA, V46, P1442, DOI 10.1111/j.1528-1167.2005.70904.x; Dash GK, 2012, SEIZURE-EUR J EPILEP, V21, P361, DOI 10.1016/j.seizure.2012.03.005; Elsharkawy AE, 2009, J NEUROL NEUROSUR PS, V80, P773, DOI 10.1136/jnnp.2008.164145; Elsharkawy AE, 2008, J NEUROSURG, V108, P676, DOI 10.3171/JNS/2008/108/4/0676; Engel J, 1993, SURG TREATMENT EPILE, P609, DOI DOI 10.1159/000325660; Foerster O, 1930, BRAIN, V53, P99, DOI 10.1093/brain/53.2.99; Jeha LE, 2007, BRAIN, V130, P574, DOI 10.1093/brain/awl364; Jehi LE, 2009, EPILEPSIA, V50, P2040, DOI 10.1111/j.1528-1167.2009.02070.x; Kannoth S, 2009, EPILEPSY BEHAV, V16, P58, DOI 10.1016/j.yebeh.2009.07.019; Kazemi NJ, 1997, EPILEPSIA, V38, P670, DOI 10.1111/j.1528-1157.1997.tb01236.x; Krsek P, 2010, EPILEPSIA, V51, P2440, DOI 10.1111/j.1528-1167.2010.02730.x; Kuchukhidze G, 2008, J NEUROL NEUROSUR PS, V79, P547, DOI 10.1136/jnnp.2007.118216; Lachhwani D.K., 2008, TXB EPILEPSY SURG, P134; Lee SK, 2005, ANN NEUROL, V58, P525, DOI 10.1002/ana.20569; Li L, 1991, Zhonghua Wai Ke Za Zhi, V29, P242; Marin-Padilla M., 2000, INT PEDIAT, V15, P221; Menon R, 2012, NEUROLOGY, V79, P770, DOI 10.1212/WNL.0b013e3182644f7d; Nikas I, 2008, J CHILD NEUROL, V23, P51, DOI 10.1177/0883073807308694; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; Oguni H, 2008, PEDIATR NEUROL, V38, P345, DOI 10.1016/j.pediatrneurol.2007.10.016; PALMINI A, 1995, ANN NEUROL, V37, P476, DOI 10.1002/ana.410370410; Rathore C, 2011, NEUROLOGY, V76, P1925, DOI 10.1212/WNL.0b013e31821d74b3; Rathore C, 2011, EPILEPSIA, V52, P627, DOI 10.1111/j.1528-1167.2010.02890.x; Rathore C, 2011, SEIZURE-EUR J EPILEP, V20, P107, DOI 10.1016/j.seizure.2010.10.033; Rathore C, 2010, J CLIN NEUROPHYSIOL, V27, P255, DOI 10.1097/WNP.0b013e3181eaa5fa; Saini J, 2010, ACTA RADIOL, V51, P218, DOI 10.3109/02841850903433805; SPERLING MR, 1990, ANN NEUROL, V28, P320, DOI 10.1002/ana.410280304; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Udani Vrajesh, 2005, Indian Journal of Pediatrics, V72, P309, DOI 10.1007/BF02724012; Usui N, 2008, EPILEPSIA, V49, P1998, DOI 10.1111/j.1528-1167.2008.01697.x	37	3	3	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2019	130	6					2071	2079		10.3171/2018.3.JNS172949			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA9MH	WOS:000469880800040	30141758	Bronze			2022-02-06	
J	Fonda, JR; Gregor, KL; Fortier, CB; Scioli-Salter, ER; McGlinchey, RE; Rasmusson, A				Fonda, Jennifer R.; Gregor, Kristin L.; Fortier, Catherine B.; Scioli-Salter, Erica R.; McGlinchey, Regina E.; Rasmusson, Ann			Tobacco dependence is associated with increased risk for multi-morbid clustering of posttraumatic stress disorder, depressive disorder, and pain among post-9/11 deployed veterans	PSYCHOPHARMACOLOGY			English	Article						PTSD comorbidity; Tobacco use; Pain; Depression	TRAUMATIC BRAIN-INJURY; CLINICAL-TRIALS; PSYCHOMETRIC PROPERTIES; NICOTINE DEPENDENCE; SMOKING-CESSATION; CIGARETTE-SMOKING; UNITED-STATES; HEALTH; COMORBIDITY; AFGHANISTAN	RationaleTobacco use is highly prevalent among individuals with posttraumatic stress disorder (PTSD), depressive disorders, and pain. Research has revealed pairwise relationships among these conditions but has not examined more complex relationships that may influence symptom severity, chronicity, and treatment outcome.ObjectiveTo examine the clustering of current PTSD, depressive disorders, and clinically significant pain according to current tobacco use and dependence among post-9/11 deployed veterans.MethodsLogistic regression was used to examine the clustering of these conditions in relationship to current tobacco use/dependence, while adjusting for age and total combat exposure, in 343 post-9/11 deployed veterans enrolled in the Translational Research Center for TBI and Stress Disorders (TRACTS) cohort (Mage=32.1+8.3years; 38% current tobacco use; 25% low and 12% moderate/high tobacco dependence).ResultsA three-way clustering of PTSD, depressive disorder, and pain was more likely than any single or pairwise combination of these conditions in moderate/high tobacco-dependent veterans compared to tobacco non-users (adjusted ORs=3.50 to 4.18). This multi-morbidity cluster also was associated with increased PTSD severity.ConclusionsModerate to high dependence on tobacco is associated with substantially increased clustering of PTSD, depression, and clinically significant pain in veterans. Research examining synergistic interactions among these conditions, biological vulnerabilities shared among them, and the direct impact of tobacco use on the pathophysiology of PTSD, depression, and pain is needed. The results of such work may spur development of more effective integrated treatments to reduce the negative impact of these multi-morbid conditions on veterans' wellbeing and long-term health.	[Fonda, Jennifer R.; Fortier, Catherine B.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA 02130 USA; [Fonda, Jennifer R.; Fortier, Catherine B.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders Tracts, Boston, MA 02130 USA; [Fonda, Jennifer R.; Fortier, Catherine B.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Gregor, Kristin L.; Scioli-Salter, Erica R.; Rasmusson, Ann] VA Boston Healthcare Syst, Boston, MA USA; [Gregor, Kristin L.; Scioli-Salter, Erica R.; Rasmusson, Ann] US Dept Vet Affairs, Womens Hlth Sci Div, Natl Ctr PTSD, Boston, MA USA; [Scioli-Salter, Erica R.; Rasmusson, Ann] Boston Univ, Sch Med, Dept Psychiat, Boston, MA USA		Fonda, JR (corresponding author), VA Boston Healthcare Syst, GRECC, Boston, MA 02130 USA.; Fonda, JR (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders Tracts, Boston, MA 02130 USA.; Fonda, JR (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.	Jennifer.Fonda@va.gov	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904; Rasmusson, Ann/0000-0002-3488-9042	VA National Center for PTSD, Women's Health Science Division, Department of Veteran AffairsUS Department of Veterans Affairs; Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B9254-C]; VA Clinical Science Research and Development Merit Review [CX001327]	This work was supported by the VA National Center for PTSD, Women's Health Science Division, Department of Veteran Affairs; the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (B9254-C); and a VA Clinical Science Research and Development Merit Review (CX001327).	Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P29; [Anonymous], 2012, AN VA HLTH CAR UT OP; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Beckham JC, 1997, ADDICT BEHAV, V22, P637, DOI 10.1016/S0306-4603(96)00071-8; Breslau N, 2000, BIOL PSYCHIAT, V48, P902, DOI 10.1016/S0006-3223(00)00933-1; Carpenter VL, 2015, J CLIN PSYCHIAT, V76, P959, DOI 10.4088/JCP.14m09053; Centers for Disease Control and Prevention, 2018, OFF SMOK HLTH INT DA; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Cypel YS, 2016, PUBLIC HEALTH REP, V131, P714, DOI 10.1177/0033354916664864; Ditre JW, 2011, PSYCHOL BULL, V137, P1065, DOI 10.1037/a0025544; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Familoni BO, 2016, PSYCHOPHYSIOLOGY, V53, P1417, DOI 10.1111/psyp.12681; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fu SS, 2007, NICOTINE TOB RES, V9, P1071, DOI 10.1080/14622200701488418; Galatzer-Levy IR, 2013, DEPRESS ANXIETY, V30, P489, DOI 10.1002/da.22048; Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81; Gibbon M., 1997, USERS GUIDE STRUCTUR; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; GRICHNIK KP, 1991, MT SINAI J MED, V58, P217; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooten WM, 2011, PAIN, V152, P223, DOI 10.1016/j.pain.2010.10.045; Hosseinzadeh A, 2016, J LEUKOCYTE BIOL, V100, P1105, DOI 10.1189/jlb.3AB0815-379RR; Izumi Y, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.133; Jamal A, 2018, MORB MORTAL WKLY REP, V67; Japuntich SJ, 2016, PSYCHOL TRAUMA-US, V8, P123, DOI 10.1037/tra0000093; Kaminska M, 2000, BRAIN RES BULL, V52, P229, DOI 10.1016/S0361-9230(00)00251-3; Karp JF, 2005, J CLIN PSYCHIAT, V66, P591, DOI 10.4088/JCP.v66n0508; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Koenen KC, 2005, ARCH GEN PSYCHIAT, V62, P1258, DOI 10.1001/archpsyc.62.11.1258; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McFall M, 2007, CLIN TRIALS, V4, P178, DOI 10.1177/1740774507076923; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Patterson AL, 2012, J PAIN, V13, P285, DOI 10.1016/j.jpain.2011.11.008; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Rasmusson AM, 2006, PSYCHOPHARMACOLOGY, V186, P473, DOI 10.1007/s00213-006-0367-6; Rasmusson AM, 2003, CNS SPECTRUMS, V8, P651, DOI 10.1017/S1092852900008841; Rasmusson AM, 2006, J PSYCHOPHARMACOL, V20, P693, DOI 10.1177/0269881106060193; Rasmusson AM, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0908-9; Riley JL, 2009, J PAIN, V10, P944, DOI 10.1016/j.jpain.2009.03.005; Room R, 2004, BIOMED PHARMACOTHER, V58, P111, DOI 10.1016/j.biopha.2003.12.003; Rosa C, 2012, SUBST ABUSE REHABIL, V3, P81, DOI 10.2147/SAR.S31836; Rothman K.J., 2008, Modern epidemiology, V3rd; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Sandi C, 2011, TRENDS NEUROSCI, V34, P165, DOI 10.1016/j.tins.2011.01.006; Scioli-Salter E, 2016, J REHABIL RES DEV, V53, P95, DOI 10.1682/JRRD.2014.10.0267; Scioli-Salter ER, 2015, CLIN J PAIN, V31, P363, DOI 10.1097/AJP.0000000000000115; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tibuakuu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184914; U. S. Department of Health & Human Services, 2015, SUBT AB MENT HLTH SE; U. S. National Institute on Drug Abuse, 1999, NAT I DRUG AB NIDA C; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; WEISS J M, 1970, American Journal of Physiology, V218, P864; Widome R, 2011, NICOTINE TOB RES, V13, P623, DOI 10.1093/ntr/ntr028	66	3	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2019	236	6					1729	1739		10.1007/s00213-018-5155-6			11	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	IH4AW	WOS:000474435000004	30617565				2022-02-06	
J	Hoopsick, RA; Benson, KR; Homish, DL; Homish, GG				Hoopsick, Rachel A.; Benson, Katelyn R.; Homish, D. Lynn; Homish, Gregory G.			Resiliency factors that protect against post-deployment drug use among male US Army Reserve and National Guard soldiers	DRUG AND ALCOHOL DEPENDENCE			English	Article						Resiliency; Drug use; Reserve soldiers; Social support; Deployment preparation; Marital satisfaction	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; ALCOHOL-USE DISORDERS; BASE-LINE PREVALENCE; SOCIAL SUPPORT; SUBSTANCE USE; PSYCHIATRIC-DISORDERS; COMBAT EXPOSURE; SERVICE MEMBERS; UNIT COHESION	Background: Service members who have been deployed are at risk for substance use, especially Reserve/Guard troops. However, it is unclear what modifiable factors protect against substance use in this at-risk population. Our objective was to examine the effects of pre-, peri-, and post-deployment resiliency factors on post-deployment drug use. Methods: Data were drawn from Operation: SAFETY (Soldiers and Families Excelling Through the Years), an ongoing study examining the health of US Army Reserve/National Guard (USAR/NG) soldiers. This sample consisted of male USAR/NG soldiers with at least one combat deployment (N = 228). At baseline, we assessed the following as potential protective factors: deployment preparation, unit support and support from family/friends during soldiers' most recent deployment, and marital satisfaction. We examined the relations between each of these resiliency factors with drug use at the first follow-up assessment using the NIDA modified ASSIST 2.0. Results: Greater unit support (AOR = 0.56, 95% CI: 0.34, 0.92; p < 0.05) and support from family/friends during deployment (AOR = 0.64, 95% CI: 0.43, 0.96; p < 0.05) were associated with lower odds of drug use, controlling for age, rank, years of military service, combat exposure, traumatic brain injury, time since last deployment, and baseline drug use. Deployment preparation and marital satisfaction were not associated with drug use (ps > 0.05). Conclusions: Social support provided to soldiers during deployment, either by his unit or his family/friends, showed evidence of protection against post-deployment drug use. In addition to existing post-deployment efforts, we recommend interventions that facilitate stronger interpersonal relationships during deployment.	[Hoopsick, Rachel A.; Benson, Katelyn R.; Homish, D. Lynn; Homish, Gregory G.] Univ Buffalo State Univ New York, Dept Community Hlth & Hlth Behav, 435 Main St,335 Kimball Tower, Buffalo, NY 14214 USA		Hoopsick, RA (corresponding author), Univ Buffalo State Univ New York, Dept Community Hlth & Hlth Behav, 435 Main St,335 Kimball Tower, Buffalo, NY 14214 USA.	rachelh@buffalo.edu	Hoopsick, Rachel A./ABH-7046-2020	Hoopsick, Rachel A./0000-0001-5992-9007	National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA034072]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; State University of New York; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA034072] Funding Source: NIH RePORTER	Research reported in this manuscript was supported by the National Institute on Drug Abuse award number R01DA034072 to Gregory G. Homish and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo, The State University of New York. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams RS, 2016, J TRAUMA STRESS, V29, P356, DOI 10.1002/jts.22121; Ali R, 2002, ADDICTION, V97, P1183; Servies Tammy, 2012, MSMR, V19, P11; Bennett AS, 2013, SUBST USE MISUSE, V48, P894, DOI 10.3109/10826084.2013.796991; Bloeser Katharine, 2014, US Army Med Dep J, P109; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Cederbaum JA, 2017, PUBLIC HEALTH REP, V132, P85, DOI 10.1177/0033354916679984; Center for Behavioral Health Statistics and Quality (CBHSQ), 2016, RES 2015 NAT SURV DR; Cerda M, 2014, AM J PREV MED, V47, P461, DOI 10.1016/j.amepre.2014.06.015; Defense Science Board Task Force, 2007, DEPL MEMB NAT GUARD; Eekhout I, 2016, LANCET PSYCHIAT, V3, P58, DOI 10.1016/S2215-0366(15)00368-5; Fink DS, 2016, J AFFECT DISORDERS, V202, P171, DOI 10.1016/j.jad.2016.05.025; Fink DS, 2016, PREV SCI, V17, P347, DOI 10.1007/s11121-015-0624-1; Fink DS, 2015, PSYCHIAT SERV, V66, P514, DOI 10.1176/appi.ps.201400128; Fuehrlein BS, 2018, AM J ADDICTION, V27, P383, DOI 10.1111/ajad.12731; Goldmann E, 2012, ANN EPIDEMIOL, V22, P71, DOI 10.1016/j.annepidem.2011.11.003; Green CA, 2001, AM J PREV MED, V21, P298, DOI 10.1016/S0749-3797(01)00365-8; Griffith J, 2017, COMMUNITY MENT HLT J, V53, P766, DOI 10.1007/s10597-017-0132-9; Hines LA, 2013, OCCUP MED-OXFORD, V63, P354, DOI 10.1093/occmed/kqt065; Hoopsick RA, 2018, QUAL LIFE RES, V27, P137, DOI 10.1007/s11136-017-1706-2; Hoopsick RA, 2017, J ADDICT DIS, V36, P243, DOI 10.1080/10550887.2017.1366735; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kelley ML, 2017, J NERV MENT DIS, V205, P99, DOI 10.1097/NMD.0000000000000555; Laffaye C, 2008, J TRAUMA STRESS, V21, P394, DOI 10.1002/jts.20348; Leonard KE, 2008, PSYCHOL ADDICT BEHAV, V22, P25, DOI 10.1037/0893-164X.22.1.25; LOCKE HJ, 1959, MARRIAGE FAM LIVING, V21, P251, DOI 10.2307/348022; Maguen S, 2012, PSYCHIAT SERV, V63, P1206, DOI 10.1176/appi.ps.201200051; Maoz H, 2016, J TRAUMA STRESS, V29, P556, DOI 10.1002/jts.22135; McAndrew LM, 2017, PSYCHOL TRAUMA-US, V9, P52, DOI 10.1037/tra0000152; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Norman SB, 2014, J STUD ALCOHOL DRUGS, V75, P557, DOI 10.15288/jsad.2014.75.557; Orra MG, 2014, DRUG ALCOHOL DEPEN, V142, P325, DOI 10.1016/j.drugalcdep.2014.07.005; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Platteborze PL, 2013, MIL MED, V178, P1078, DOI 10.7205/MILMED-D-13-00193; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Polusny MA, 2009, MIL MED, V174, P353, DOI 10.7205/MILMED-D-01-1608; Renshaw KD, 2011, J AFFECT DISORDERS, V128, P321, DOI 10.1016/j.jad.2010.07.022; Reserve Forces Policy Board, 2017, IMPR TOT FORC US NAT; Rice V, 2016, WORK, V54, P335, DOI 10.3233/WOR-162301; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Romero DH, 2015, J COUNS PSYCHOL, V62, P242, DOI 10.1037/cou0000061; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shea MT, 2013, PSYCHIAT RES, V210, P1042, DOI 10.1016/j.psychres.2013.08.039; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; Substance Abuse and Mental Health Services Administration [SAMHSA], 2017, NSDUH SER H; Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Behavioral Health Statistics and Quality, 2017, HHS PUBL, V17-5037; Tamburrino MB, 2015, PSYCHIAT RES, V226, P142, DOI 10.1016/j.psychres.2014.12.038; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P596, DOI 10.1001/jamapsychiatry.2018.0296; Ursano RJ, 2018, MIL MED, V183, pE51, DOI 10.1093/milmed/usx002; Van Voorhees EE, 2018, PSYCHOL SERV, V15, P181, DOI 10.1037/ser0000187; Vest BM, 2018, SOC PSYCH PSYCH EPID, V53, P413, DOI 10.1007/s00127-017-1477-7; Vest Bonnie M, 2017, Mil Behav Health, V5, P313, DOI 10.1080/21635781.2017.1343694; Vogt D., 2012, MANUAL DEPLOYMENT RI; Welsh JA, 2015, AM J COMMUN PSYCHOL, V56, P69, DOI 10.1007/s10464-015-9726-y; Wooten NR, 2013, J HUM BEHAV SOC ENVI, V23, P699, DOI 10.1080/10911359.2013.795049; Wright KM, 2012, J CLIN PSYCHOL, V68, P782, DOI 10.1002/jclp.21864; Yan GW, 2013, J GEN INTERN MED, V28, pS549, DOI 10.1007/s11606-012-2247-6	58	3	3	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	JUN 1	2019	199						42	49		10.1016/j.drugalcdep.2019.02.017			8	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	IC4OV	WOS:000470946100006	30981048	Green Accepted			2022-02-06	
J	Huang, GH; Chen, K; Sun, YY; Zhu, L; Sun, ZL; Feng, DF				Huang, Guo-Hui; Chen, Kui; Sun, Yi-Yu; Zhu, Liang; Sun, Zhao-Liang; Feng, Dong-Fu			4-Phenylbutyrate Ameliorates Anxiety Disorder by Inhibiting Endoplasmic Reticulum Stress after Diffuse Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						DAI; anxiety disorder; DAI; ER stress; DAI; UPR	TRAUMATIC BRAIN-INJURY; RAT MODEL; MOUSE MODEL; ER STRESS; PHENYLBUTYRATE; PROTECTS; SEQUELAE; ACID; DIAGNOSIS; DEATH	Diffuse axonal injury (DAI) is accompanied frequently by adverse sequelae and psychiatric disorders, such as anxiety, leading to a decreased quality of life, social isolation, and poor outcomes in patients. The mechanisms regulating psychiatric disorders post-DAI are not well elucidated, however. Previous studies showed that endoplasmic reticulum (ER) stress functions as a pivotal factor in neurodegeneration disease. In this study, we showed that DAI can trigger ER stress and unfolded protein response (UPR) activation in both the acute and chronic periods, leading to cell death and anxiety disorder. Treatment with 4-phenylbutyrate (4-PBA) is able to inhibit the UPR and cell apoptosis and relieve the anxiety disorder in our DAI model. Later (14 days post-DAI) 4-PBA treatment, however, can restore only the related gene expression of ER stress and UPR but not the psychiatric disorder. Therefore, the early (5 min after DAI) administration of 4-PBA might be a therapeutic approach for blocking the ER stress/UPR-induced cell death and anxiety disorder after DAI.	[Huang, Guo-Hui; Chen, Kui; Sun, Yi-Yu; Zhu, Liang; Sun, Zhao-Liang; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Neurosurg, Sch Med, 280 Mo He Rd, Shanghai 201999, Peoples R China; [Huang, Guo-Hui; Chen, Kui; Sun, Yi-Yu; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Inst Traumat Med, Sch Med, Shanghai, Peoples R China		Feng, DF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Neurosurg, Sch Med, 280 Mo He Rd, Shanghai 201999, Peoples R China.	drneuro@163.com		Huang, Guo-Hui/0000-0002-1904-5407	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372047]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [16411971800]	We gratefully acknowledge the following funding source: the National Natural Science Foundation of China (81372047) and Science and Technology Commission of Shanghai Municipality (16411971800).	Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Brusilow S W, 1996, Adv Pediatr, V43, P127; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; CREMER JE, 1977, J PHYSIOL-LONDON, V266, pP70; Cuadrado-Tejedor M, 2013, CURR PHARM DESIGN, V19, P5076, DOI 10.2174/1381612811319280006; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Huang GH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00085; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lee JY, 2014, J NEUROTRAUM, V31, P582, DOI 10.1089/neu.2013.3146; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Raghubir R, 2011, METHOD ENZYMOL, V489, P259, DOI 10.1016/B978-0-12-385116-1.00015-7; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; Wright J. M., 2004, PHYSIOL GENOMICS, V16, P204, DOI DOI 10.1152/PHYSIOLGENOMICS.00160.2003; Yokoi N, 2015, NAT MED, V21, P19, DOI 10.1038/nm.3759	46	3	3	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1856	1868		10.1089/neu.2018.6048			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600016	30582423				2022-02-06	
J	Ichkova, A; Fukuda, AM; Nishiyama, N; Paris, G; Obenaus, A; Badaut, J				Ichkova, Aleksandra; Fukuda, Andrew M.; Nishiyama, Nina; Paris, Germaine; Obenaus, Andre; Badaut, Jerome			Small Interference RNA Targeting Connexin-43 Improves Motor Function and Limits Astrogliosis After Juvenile Traumatic Brain Injury	ASN NEURO			English	Article						traumatic brain injury; astrocyte network; gliovascular unit; blood-brain barrier; drug targets	GAP-JUNCTIONS; REACTIVE ASTROCYTES; AQUAPORIN 4; EDEMA; GLIA; INHIBITION; EXPRESSION; DIFFUSION; RESPONSES; DAMAGE	Juvenile traumatic brain injury (jTBI) is the leading cause of death and disability for children and adolescents worldwide, but there are no pharmacological treatments available. Aquaporin 4 (AQP4), an astrocytic perivascular protein, is increased after jTBI, and inhibition of its expression with small interference RNA mitigates edema formation and reduces the number of reactive astrocytes after jTBI. Due to the physical proximity of AQP4 and gap junctions, coregulation of AQP4 and connexin 43 (Cx43) expressions, and the possibility of water diffusion via gap junctions, we decided to address the potential role of astrocytic gap junctions in jTBI pathophysiology. We evaluated the role of Cx43 in the spread of the secondary injuries via the astrocyte network, such as edema formation associated with blood-brain barrier dysfunctions, astrogliosis, and behavioral outcome. We observed that Cx43 was altered after jTBI with increased expression in the perilesional cortex and in the hippocampus at several days post injury. In a second set of experiments, cortical injection of small interference RNA against Cx43 decreased Cx43 protein expression, improved motor function recovery, and decreased astrogliosis but did not result in differences in edema formation as measured via T2-weighted imaging or diffusion-weighted imaging at 1 day or 3 days. Based on our findings, we can speculate that while decreasing Cx43 has beneficial roles, it likely does not contribute to the spread of edema early after jTBI.	[Ichkova, Aleksandra; Badaut, Jerome] Univ Bordeaux, CNRS, UMRS287, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Fukuda, Andrew M.; Badaut, Jerome] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA; [Fukuda, Andrew M.; Nishiyama, Nina; Paris, Germaine; Obenaus, Andre; Badaut, Jerome] Loma Linda Univ, Med Ctr, Dept Pediat, Loma Linda, CA 92350 USA; [Fukuda, Andrew M.] Brown Univ, Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Obenaus, Andre] Univ Calif Riverside, Ctr Glial Neuronal Interact, Div Biomed Sci, Riverside, CA 92521 USA; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA		Badaut, J (corresponding author), Univ Bordeaux, CNRS, UMRS287, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	Jerome.badaut@u-bordeaux.fr	Fukuda, Andrew/ABD-1038-2021	Fukuda, Andrew/0000-0002-7927-6602; , Andre/0000-0003-0081-6950	National Institute of Health NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01HD061946]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; TRAIL Laboratory of Excellence TRAIL [ANR-10-LABX-57]; EraNet Neuron (CNSAflame); EraNet Neuron (TRAINS); Fondation des Gueules cassees; ANR NanospaceFrench National Research Agency (ANR) [ANR-17-CE37-0011]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25 MH101076]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a grant from the National Institute of Health NINDS R01HD061946, The Swiss National Science Foundation (J. B.), TRAIL Laboratory of Excellence TRAIL (ANR-10-LABX-57 to JB), EraNet Neuron (CNSAflame and TRAINS), Fondation des Gueules cassees, and ANR Nanospace (ANR-17-CE37-0011). Dr. Fukuda's research time is currently supported by the R25 MH101076 from the National Institute of Mental Health.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Andersson HC, 2011, NEUROL RES, V33, P614, DOI 10.1179/1743132810Y.0000000020; Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Ayer R, 2010, BRAIN RES, V1315, P150, DOI 10.1016/j.brainres.2009.12.016; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Bennett MVL, 2012, BRAIN RES, V1487, P3, DOI 10.1016/j.brainres.2012.08.042; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Clement T, 2020, J NEUROSCI RES, V98, P9, DOI 10.1002/jnr.24354; Davidson JO, 2013, EXP NEUROL, V248, P301, DOI 10.1016/j.expneurol.2013.06.026; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Farahani R, 2005, GLIA, V50, P351, DOI 10.1002/glia.20213; Faul M, 2010, TRAUMATIC BRAIN INJU; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; GrangeMessent V, 1996, J SUBMICR CYTOL PATH, V28, P151; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Jullienne A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22268-y; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Manaenko A, 2009, NEUROL RES, V31, P173, DOI 10.1179/174313209X393591; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Velazquez JLP, 2006, EUR J NEUROSCI, V23, P1, DOI 10.1111/j.1460-9568.2005.04523.x; Velazquez JLP, 2003, NEUROSCIENTIST, V9, P5, DOI 10.1177/1073858402239586; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Wu ZL, 2013, NEUROL RES, V35, P255, DOI 10.1179/1743132813Y.0000000165; Zweckberger K, 2009, NEUROSCI LETT, V454, P115, DOI 10.1016/j.neulet.2009.02.014	49	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	JUN	2019	11								1759091419847090	10.1177/1759091419847090			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ID4ZF	WOS:000471684100001	31194577	Green Published, gold			2022-02-06	
J	Joshi, S; Musuka, TD				Joshi, Stuti; Musuka, Tapuwa D.			Guillain-Barre syndrome as a complication of hypertensive basal ganglia haemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Guillain-Barre syndrome; Hypertensive intracranial haemorrhage; Acute inflammatory demyelinating polyradiculoneuropathy; AIDP		We aimed to study the potential relationship of Guillain-Barre syndrome (GBS) and intracranial haemorrhage (ICH). We present a case of a 70-year-old hypertensive woman who developed global weakness, eventually becoming quadriplegic, during an inpatient stay for treatment of a basal ganglia haemorrhagic stroke. Guillain-Barre syndrome was confirmed and treatment initiated. She responded well to intravenous immunoglobulin treatment and then subsequently continued with rehabilitation. There have been a few case reports of GBS as a complication of spontaneous intracranial haemorrhage (ICH) or traumatic brain injury. It may not be a coincidence that our patient developed GBS shortly after presentation. There may be an immunological explanation with immune activation following neuronal injury after ICH with associated blood-brain barrier breakdown. GBS following ICH adds further complexity to treating patients who are already critically ill. If patients develop new weakness after ICH, there should be a high index of suspicion for GBS. It should be distinguished from critical illness neuropathy/myopathy and other causes of weakness in critical care patients because the treatment is very different. Immune activation and sensitization to myelin-associated proteins may be the underlying pathophysiological basis. (C) 2019 Elsevier Ltd. All rights reserved.	[Joshi, Stuti; Musuka, Tapuwa D.] Fiona Stanley Hosp, Dept Neurol, Murdoch, WA, Australia		Joshi, S (corresponding author), Fiona Stanley Hosp, Dept Neurol, Murdoch, WA, Australia.	soshi24@gmail.com					DUNCAN R, 1987, POSTGRAD MED J, V63, P479, DOI 10.1136/pgmj.63.740.479; Hahn AF, 1998, LANCET, V352, P635, DOI 10.1016/S0140-6736(97)12308-X; Hantson P., 2013, OA CASE REPORTS, V2, P86, DOI [10.13172/2052-0077-2-9-797, DOI 10.13172/2052-0077-2-9-797]; Jia H., 2017, NEUROIMMUNOL NEUROIN, V4, P61, DOI [10.20517/2347-8659.2016.51, DOI 10.20517/2347-8659.2016.51]; Mantero V, 2013, CLIN NEUROPHYSIOL, V124, P1037, DOI 10.1016/j.clinph.2012.09.020; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; Song W, 2012, NEUROL SCI, V33, P657, DOI 10.1007/s10072-011-0823-x; Vargas F, 2000, INTENS CARE MED, V26, P623, DOI 10.1007/s001340051213; Wu Q, 2016, EUR NEUROL, V76, P182, DOI 10.1159/000450603; Yang B, 2016, J NEUROIMMUNOL, V293, P17, DOI 10.1016/j.jneuroim.2016.02.003	10	3	3	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2019	64						54	56		10.1016/j.jocn.2019.02.018			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC6LJ	WOS:000471083300021	30852075				2022-02-06	
J	Kadar, R; Rochford, D; Omi, E; Thomas, Y; Patel, K; Kulstad, E				Kadar, Rachel; Rochford, Daniel; Omi, Ellen; Thomas, Yalaunda; Patel, Kunal; Kulstad, Erik			Trends in demographics and outcome of patients presenting with traumatic brain injury	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Brain injuries; traumatic; Patient outcome assessment; Demography; Emergency service hospital	EMERGENCY-DEPARTMENT INTUBATION; PROGESTERONE; DISPOSITION; MODERATE	Objective To analyze the trends in demographics and outcomes of patients presenting with traumatic brain injury by performing a retrospective database review of the Illinois Department of Public Health (IDPH) Trauma Registry. Methods We utilized the IDPH Trauma Registry to retrieve data on patients treated for traumatic brain injuries at our large, tertiary care hospital from 2004 to 2012, inclusive. From this data, logistic regression models were used to analyze and compare basic demographics such as age, sex, and clinical outcome. Results Three thousand and thirty-nine patients were analyzed with a mean age of 43 (standard deviation, 24) and a median age of 41 (interquartile range, 23 to 60). Over the study period, patients' age increased steadily from 32 to 49 years. The percentage of female patients increased, from 16.4% to 27.5% over the last 4 years. Overall mortality was greater for males than females (22.1% vs. 17.3%; odds ratio [OR], 1.36; 95% confidence interval [CI], 1.10 to 1.68). Mortality decreased over the period (OR, 0.88; 95% CI, 0.85 to 0.91), with a greater decrease in females (OR, 0.84; 95% CI, 0.78 to 0.90) than in males (OR, 0.90; 95% CI, 0.86 to 0.94). Conclusion Although the age of patients presenting with traumatic brain injury is increasing substantially, the data suggests that overall mortality appears to be decreasing, and this decrease appears to be greater in females than in males. These changes in trends found in the IDPH Trauma Registry supports the importance for further analysis of other reliable public datasets to identify areas of future study.	[Kadar, Rachel; Rochford, Daniel; Omi, Ellen; Thomas, Yalaunda] Advocate Christ Med Ctr, Dept Emergency Med, 4440 West 95th St, Oak Lawn, IL 60453 USA; [Patel, Kunal] MetroHlth Med Ctr, Cleveland, OH USA; [Kulstad, Erik] UT Southwestern Med Ctr, Dept Emergency Med, Dallas, TX USA		Rochford, D (corresponding author), Advocate Christ Med Ctr, Dept Emergency Med, 4440 West 95th St, Oak Lawn, IL 60453 USA.	Daniel.Rochford@advocatehealth.com		Rochford, Daniel/0000-0002-0122-0924; Kadar, Rachel/0000-0002-2583-3637			Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Green SM, 2013, ANN EMERG MED, V61, P423, DOI 10.1016/j.annemergmed.2012.09.010; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Kerem Y, 2015, ANN EMERG MED, V65, P232, DOI 10.1016/j.annemergmed.2014.09.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCaig LF, 2013, ANN EMERG MED, V62, P549, DOI 10.1016/j.annemergmed.2013.04.028; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; TEASDALE G, 1974, LANCET, V2, P81; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yang CC, 2013, BRAIN INJURY, V27, P1008, DOI 10.3109/02699052.2013.794975; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	17	3	3	1	1	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	JUN	2019	6	2					113	118		10.15441/ceem.18.010			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	IF7ZN	WOS:000473306500003	30947490	Green Published, Green Submitted, gold			2022-02-06	
J	Lah, S; Gott, C; Parry, L; Black, C; Epps, A; Gascoigne, M				Lah, Suncica; Gott, Chloe; Parry, Louise; Black, Carly; Epps, Adrienne; Gascoigne, Michael			Selective, age-related autobiographical memory deficits in children with severe traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article						acquired brain injury; development; retrograde memory	TEMPORAL-LOBE EPILEPSY; FUNCTIONAL NEUROANATOMY; ANTEROGRADE AMNESIA; HEAD-INJURY; RETROGRADE; CHILDHOOD; SELF; RECOVERY; OUTCOMES	Objectives Autobiographical memory (AM) is a complex function that involves re-experiencing of past personal events (episodic memory) scaffolded by personal facts (semantic memory). While AM is supported by a brain network and cognitive skills that are vulnerable to disruption by child traumatic brain injury (TBI), AM has not been examined in this patient population. Design Cross-sectional study. Methods Participants included children with severe closed TBI (n = 14) and healthy control (NC) children (n = 20) of comparable age, sex, and socioeconomic status. Participants completed (1) the Child Autobiographical Interview (Willoughby et al., 2012, Front. Psychol., 3, 53), which required recall of autobiographical events and distinguished episodic (internal) from non-episodic (external) details, and self-rating of event phenomenological qualities, and (2) a battery of neuropsychological tests. Results Children with TBI recalled significantly fewer internal details relative to NCs, but the between-group difference was eliminated when specific probes were provided. The groups did not differ in either recall of external details or in ratings of events' phenomenological qualities. The gap between the groups in recall of internal details increased with age, as the greater number of internal details was associated with older age in the NC group, but not in the TBI group. Poorer verbal memory and lower IQ were related to recall of fewer internal details in the TBI group. Conclusions This study unveils, to our knowledge for the first time, that severe child TBI is associated with a selective deficit in autobiographical memory that involves episodic, but spares semantic details, and identifies the risk factors for this impairment.	[Lah, Suncica; Gascoigne, Michael] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Lah, Suncica; Gott, Chloe; Black, Carly; Gascoigne, Michael] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Parry, Louise; Epps, Adrienne] Sydney Childrens Hosp, Rehab2Kids, Brain Injury Rehabil Program, Randwick, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au			ARC Centre of Excellence in Cognition and its DisordersAustralian Research Council [CE1101021]	This research was supported by the ARC Centre of Excellence in Cognition and its Disorders (CE1101021) www.ccd.edu.au.	Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Berzonsky M.D., 2003, BLACKWELL HDB ADOLES, P330, DOI DOI 10.1002/9780470756607.CH16; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bluck S, 2005, SOC COGNITION, V23, P91, DOI 10.1521/soco.23.1.91.59198; Buhrmester D., 1986, FRIENDSHIP SOCIAL IN, P41, DOI DOI 10.1007/978-1-4612-4880-4_3; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gascoigne MB, 2015, NEUROPSYCHOLOGIA, V66, P10, DOI 10.1016/j.neuropsychologia.2014.11.010; Gascoigne MB, 2013, J INT NEUROPSYCH SOC, V19, P1076, DOI 10.1017/S1355617713000970; Gott C, 2014, CHILD NEUROPSYCHOL, V20, P625, DOI 10.1080/09297049.2013.840362; Herfurth K, 2010, EPILEPSY BEHAV, V19, P365, DOI 10.1016/j.yebeh.2010.07.012; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Korkman M., 2007, NEPSY 2 CLIN INTERPR, V2nd ed ed; Lah S, 2006, EPILEPSIA, V47, P615, DOI 10.1111/j.1528-1167.2006.00476.x; Lah S, 2004, NEUROPSYCHOLOGIA, V42, P1666, DOI 10.1016/j.neuropsychologia.2004.04.008; Larson Reed, 1986, BEING ADOLESCENT CON; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Levine B, 2004, BRAIN COGNITION, V55, P54, DOI 10.1016/s0278-2626(03)00280-x; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Mayes AR, 1997, CORTEX, V33, P197, DOI 10.1016/S0010-9452(08)70001-7; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Picard L, 2009, CONSCIOUS COGN, V18, P864, DOI 10.1016/j.concog.2009.07.008; Pillemer D. B., 1992, AFFECT ACCURACY RECA, V4, P236, DOI DOI 10.1017/CBO9780511664069; Piolino P, 2007, CONSCIOUS COGN, V16, P84, DOI 10.1016/j.concog.2005.09.010; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Schmidtke K, 1997, NEUROPSYCHOLOGIA, V35, P505, DOI 10.1016/S0028-3932(96)00109-1; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; TEASDALE G, 1974, LANCET, V2, P81; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P11; Wang Q., 2013, WILEY HDB DEV CHILDR, P605, DOI DOI 10.1002/9781118597705; Wareham P, 2006, CLIN PSYCHOL REV, V26, P535, DOI 10.1016/j.cpr.2006.05.001; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2005, WECHSLER INTELLIGENC; Wiebe S, 2000, CAN J NEUROL SCI, V27, pS6, DOI 10.1017/S0317167100000561; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Willoughby KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00053; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	59	3	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	JUN	2019	13	2					253	271		10.1111/jnp.12141			19	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	ID5HK	WOS:000471707100006	29265704				2022-02-06	
J	McGuire, MJ; Gertz, SM; McCutcheon, JD; Richardson, CR; Poulsen, DJ				McGuire, Matthew J.; Gertz, Steven M.; McCutcheon, Jolie D.; Richardson, Chelsea R.; Poulsen, David J.			Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 148; post-traumatic epilepsy; epileptogenesis; lateral fluid-percussion injury; seizure; video-EEG monitoring; wireless telemetry	POSTTRAUMATIC SEIZURES; BIOMARKER DISCOVERY; HEAD-INJURY; EPILEPSY; MULTICENTER; MODEL; RAT; HARMONIZATION; RISK	The lateral fluid percussion injury (FPI) model is well established and has been used to study TBI and post-traumatic epilepsy (PTE). However, considerable variability has been reported for the specific parameters used in different studies that have employed this model, making it difficult to harmonize and interpret the results between laboratories. For example, variability has been reported regarding the size and location of the craniectomy, how the Luer lock hub is placed relative to the craniectomy, the atmospheric pressure applied to the dura and the duration of the pressure pulse. Each of these parameters can impact injury severity, which directly correlates with the incidence of PTE. This has been manifested as a wide range of mortality rates, righting reflex times and incidence of convulsive seizures reported. Here we provide a detailed protocol for the method we have used to help facilitate harmonization between studies. We used FPI in combination with a wireless EEG telemetry system to continuously monitor for electrographic changes and detect seizure activity. FPI is induced by creating a 5 mm craniectomy over the left hemisphere, between the Bregma and Lambda and adjacent to the lateral ridge. A Luer lock hub is secured onto the skull over the craniectomy. This hub is connected to the FPI device, and a 20-millisecond pressure pulse is delivered directly to the intact dura through pressure tubing connected to the hub via a twist lock connector. Following recovery, rats are re-anesthetized to remove the hub. Five 0.5 mm, stainless steel EEG electrode screws are placed in contact with the dura through the skull and serve as four recording electrodes and one reference electrode. The electrode wires are collected into a pedestal connector which is secured into place with bone cement. Continuous video/EEG recordings are collected for up to 4 weeks post TBI.	[McGuire, Matthew J.; Gertz, Steven M.; Poulsen, David J.] Jacobs Sch Med & Biomed Sci, Dept Neurosurg, Buffalo, NY 14203 USA; [McCutcheon, Jolie D.] Univ Buffalo, Comparat Med Lab Anim Facil, Buffalo, NY USA; [Richardson, Chelsea R.] Emka Technol, Falls Church, VA USA		Poulsen, DJ (corresponding author), Jacobs Sch Med & Biomed Sci, Dept Neurosurg, Buffalo, NY 14203 USA.	davidpou@buffalo.edu					Annegers JF, 1998, EPILEPSIA, V39, P206, DOI 10.1111/j.1528-1157.1998.tb01360.x; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Ciszek R, 2019, EPILEPSY RES, V150, P17, DOI 10.1016/j.eplepsyres.2018.12.010; Curia G., 2016, TRANSLATIONAL RES TR; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Eastman CL, 2015, EXP NEUROL, V264, P150, DOI 10.1016/j.expneurol.2014.12.010; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Immonen R, 2019, EPILEPSY RES, V150, P46, DOI 10.1016/j.eplepsyres.2019.01.001; Kamnaksh A, 2019, EPILEPSY RES, V149, P92, DOI 10.1016/j.eplepsyres.2018.11.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ndode-Ekane XE, 2019, EPILEPSY RES, V151, P7, DOI 10.1016/j.eplepsyres.2019.01.006; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Simonato M, 2013, CURR OPIN NEUROL, V26, P195, DOI 10.1097/WCO.0b013e32835efe29; Smith D, 2018, EPILEPSY RES, V147, P87, DOI 10.1016/j.eplepsyres.2018.09.005; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; Wohlgehagen E., 2015, MOD RES INFLAMM, V4, P9, DOI DOI 10.4236/MRI.2015.42002; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	28	3	3	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2019		148							e59637	10.3791/59637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IF7WE	WOS:000473295900078	31282886	Bronze			2022-02-06	
J	Morinaga, Y; Nii, K; Sakamoto, K; Inone, R; Mitsutake, T; Hanada, H				Morinaga, Yusuke; Nii, Kouhei; Sakamoto, Kimiya; Inone, Ritsurou; Mitsutake, Takafumi; Hanada, Hayatsura			Efficacy of trazodone for treating paroxysmal sympathetic hyperactivity presenting after thalamic hemorrhage: A case report	DRUG DISCOVERIES AND THERAPEUTICS			English	Article						Paroxysmal sympathetic hyperactivity; thalamic hemorrhage; trazodone	TRAUMATIC BRAIN-INJURY; DYSAUTONOMIA; MANAGEMENT; DIAGNOSIS	Paroxysmal sympathetic hyperactivity (PSH) is a clinical condition characterized by abnormal paroxysmal surges in sympathetic nervous system activity. PSH is known to occur after severe head injury and hypoxic encephalopathy. Cases of PSH that develop after stroke have been reported worldwide; however, PSH is not commonly reported in the field of stroke research in Japan. Some studies have suggested that gabapentin may improve the symptoms of PSH. To our knowledge, this is the first case report demonstrating the efficacy of trazodone for the treatment of PSH that developed after thalamic hemorrhage. A 45-year-old woman presented to our clinic with headache and paralysis of the left side of her body after experiencing right thalamic hemorrhage; a conservative treatment was initiated at our hospital. Immediately upon hospitalisation, she developed high fever, tachycardia, tachypnea, constipation, and overactive bladder and had breathing difficulties. Blood sampling revealed elevated levels of myocardial escape enzymes; however, coronary angiography did not show any significant stenosis or occlusion. The patient's symptoms improved after the administration of trazodone. She was diagnosed with catecholamine cardiomyopathy associated with PSH after intracranial hemorrhage and was subsequently transferred to a recovery and rehabilitation hospital unit where the oral administration of trazodone continued. Prolonged PSH contributes significantly to the impairment of daily activities in patients with stroke; therefore, early diagnosis and treatment are critical. Here, we report on the efficacy of trazodone as an effective treatment option for improving clinical outcomes and reducing the stay in the stroke care unit.	[Morinaga, Yusuke; Nii, Kouhei; Sakamoto, Kimiya; Inone, Ritsurou; Mitsutake, Takafumi; Hanada, Hayatsura] Fukuoka Univ, Chikushi Hosp, Dept Neurosurg, Chikushino City, Fukuoka, Japan		Morinaga, Y (corresponding author), Fukuoka Univ, Chikushi Hosp, Dept Neurosurg & Neurosci, 1-1-1 Zokumyoin, Chikushino, Fukuoka 8188502, Japan.	yu_the_morio@yahoo.co.jp					Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; DETEJADA IS, 1991, J UROLOGY, V145, P60, DOI 10.1016/S0022-5347(17)38247-2; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Inoue Daisuke, 2019, No Shinkei Geka, V47, P79, DOI 10.11477/mf.1436203899; Li YC, 2015, PAIN PHYSICIAN, V18, pE583; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Samuel S, 2016, J NEUROSCI NURS, V48, P82, DOI 10.1097/JNN.0000000000000207; Yamada H, 2018, J STROKE CEREBROVASC, V27, P2768, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.002	18	3	4	0	1	INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT	TOKYO	INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT, TOKYO, 00000, JAPAN	1881-7831	1881-784X		DRUG DISCOV THER	Drug Discov. Ther.	JUN	2019	13	3					168	171		10.5582/ddt.2019.01038			4	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	IJ2RP	WOS:000475752900008	31327791	gold			2022-02-06	
J	Olij, BF; Panneman, MJM; van Beeck, EF; Haagsma, JA; Hartholt, KA; Polinder, S				Olij, Branko F.; Panneman, Martien J. M.; van Beeck, Ed F.; Haagsma, Juanita A.; Hartholt, Klaas A.; Polinder, Suzanne			Fall-related healthcare use and mortality among older adults in the Netherlands, 1997-2016	EXPERIMENTAL GERONTOLOGY			English	Article						Accidental falls; Aged; Hospital departments	TRAUMATIC BRAIN-INJURY; HOSPITAL ADMISSIONS; TRENDS; DEATHS	Objectives: Fall-related injuries are a leading cause of morbidity among older adults, leading to a high healthcare consumption and mortality. We aim to describe and quantify time trends of fall-related healthcare use and mortality among adults aged >= 65 years in the Netherlands, 1997-2016. Design: Data were extracted from the Dutch Injury Surveillance System, Dutch Hospital Discharge Registry, and Cause-of-Death Statistics Netherlands, by age, sex, diagnosis, injury location, and year. Measurements: Absolute numbers and age-standardized rates of fall-related Emergency Department (ED) visits, hospital admissions, and fatalities, as well as average length of hospital stay (LOS) were calculated. Results: Between 1997 and 2016, absolute numbers of fall-related ED visits increased by 48%, hospital admissions increased by 59%, and mortality showed an almost threefold increase. These absolute numbers doubled among adults aged >= 85 years. A shift in fall-related injury diagnosis was observed over the years with a growing share of skull/brain injuries. In contrast to the increase in absolute numbers, standardized incidence rates of ED visits decreased by 30% (p = 0.00), whereas incidence rates of hospital admissions and mortality did not significantly change over time. Furthermore, the absolute number of hospital admission days almost halved, due to a reduced average LOS from 18.5 (95% confidence interval (CI): 18.2-18.8) days (1997) to 6.1 (95% CI, 6.1-6.2) days (2016). Conclusion: Even though the standardized incidence rates of ED visits decreased in the past twenty years, the absolute number of fall-related ED visits increased. The number of hospital admissions has also increased, but the total number of admission days has almost halved during the same period. If the observed trends would continue, this may have implications for healthcare resource allocation, as the burden of care in EDs increases, and the admission duration reduces.	[Olij, Branko F.; van Beeck, Ed F.; Haagsma, Juanita A.; Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Panneman, Martien J. M.] Consumer & Safety Inst, Amsterdam, Netherlands; [Hartholt, Klaas A.] Reinier de Graaf Grp Delft, Dept Surg Traumatol, Delft, Netherlands		Olij, BF (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	b.olij@erasmusmc.nl	Hartholt, Klaas A/Q-1782-2016	Hartholt, Klaas A/0000-0001-5019-9239			[Anonymous], 2017, POPULATION; Banning R, 2012, STAT METHODS STAT NE; Burns E, 2018, MMWR-MORBID MORTAL W, V67, P509, DOI 10.15585/mmwr.mm6718a1; Cassell E, 2013, OSTEOPOROSIS INT, V24, P99, DOI 10.1007/s00198-012-1937-6; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Gaakeer M I, 2016, Ned Tijdschr Geneeskd, V160, pD970; Gagne M, 2013, CHRON DIS INJ CAN, V33, P226; Gommer A. M, 2016, RIVM BRIEFRAPPORT 20; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Irsraels A, 2013, METHODS STANDARDISAT; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2018, AGING CLIN EXP RES, V30, P1111, DOI 10.1007/s40520-018-0898-9; Kannus P, 2018, ARCH GERONTOL GERIAT, V77, P64, DOI 10.1016/j.archger.2018.04.008; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Meerding WJ, 2010, INT J INJ CONTROL SA, V17, P13, DOI 10.1080/17457300903523237; Nilson F, 2016, INT J INJ CONTROL SA, V23, P277, DOI 10.1080/17457300.2015.1032980; Padron-Monedero A, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0670-6; Panneman M, 2016, VEILIGHEIDNL RAPPORT; Patterson BW, 2017, J AM GERIATR SOC, V65, pE135, DOI 10.1111/jgs.14982; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Shankar KN, 2017, WEST J EMERG MED, V18, P785, DOI 10.5811/westjem.2017.5.33615; WHO, INT CLASS DIS ICD	26	3	3	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	JUN	2019	120						95	100		10.1016/j.exger.2019.03.003			6	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	HP9TJ	WOS:000462035600012	30878641	Green Submitted			2022-02-06	
J	Santos-Veloso, MAO; de Melo, MISL; Cavalcanti, RAN; Bezerra, LS; Chaves-Markman, AV; de Lima, SG				Oliveira Santos-Veloso, Marcelo Antonio; Souza Lacerda de Melo, Maria Isa; Neves Cavalcanti, Roberta Azevedo; Bezerra, Lucas Soares; Chaves-Markman, Andrea Virginia; de Lima, Sandro Goncalves			Prevalence of depression and anxiety and their association with cardiovascular risk factors in Northeast Brasil primary care patients	REVISTA DA ASSOCIACAO MEDICA BRASILEIRA			English	Article						Anxiety; Depression; Risk Factors; Cardiovascular diseases; Primary Health Care	TYPE-2 DIABETES-MELLITUS; MENTAL-DISORDERS; HYPERTENSION; DYSLIPIDEMIA; SYMPTOMS; OBESITY; STRESS; IMPACT; RATES	BACKGROUND: Depression and anxiety disorders (DAD) are the most prevalent mental health conditions worldwide. Among the adult population served in basic care, it is estimated that depression affects about 14.3% of these individuals worldwide, and between 21.4% and 31% in Brasil. Anxiety affects up to 33.7% of the population during their lifetimes. OBJECTIVES: estimate the prevalence proportions of DAD among patients in a municipality in Northeast Brasil and study the association between DAD and cardiovascular risk factors. METHODS: a cross-sectional study with the medical records of patients from primary care centers in Jaboatao dos Guararapes, Pernambuco. Patients aged 18 years and regularly followed-up were included. Exclusion criteria: a history of traumatic brain injury, alcohol or drug abuse, previous stroke, medical conditions or medications that mimic DAD symptoms. Subjects were divided into two groups depending on the presence or absence of DAD, and cardiovascular risk factors were compared between groups. RESULTS: A total of 1030 subjects were initially included, of whom 215 (20%) were excluded. No-DAD subjects had more history of myocardial infarction and alcoholism. The prevalence of depression was 10.3%, anxiety disorder was 27.1%, and mixed DAD represented 4.5%. There was a significant association between DAD and hypertension (OR = 2.11; 95%CI: 1.16 -3.84; p=0.01), obesity (OR = 4.47; 95%CI:1.74 -11.46; p=0.002), and hyperlipidemia (OR = 3.88; 95%CI: 1.81-8.3; p<0.001). CONCLUSION: DAD were associated with an increased risk for arterial hypertension, obesity, and hyperlipidemia.	[Oliveira Santos-Veloso, Marcelo Antonio; Bezerra, Lucas Soares; Chaves-Markman, Andrea Virginia; de Lima, Sandro Goncalves] Univ Fed Pernambuco, Epidemiol & Cardiol Res Grp Epicardio, Recife, PE, Brazil; [Souza Lacerda de Melo, Maria Isa; Neves Cavalcanti, Roberta Azevedo; Bezerra, Lucas Soares; Chaves-Markman, Andrea Virginia; de Lima, Sandro Goncalves] Mauricio Nassau Univ, Recife, PE, Brazil		Santos-Veloso, MAO (corresponding author), Curso Med, Rua Jonathas de Vasconcelos 316, BR-51021140 Recife, PE, Brazil.	marcelosantos.med@gmail.com	Veloso, Marcelo Antonio Oliveira Santos/I-1021-2017; Bezerra, Lucas Soares/K-4575-2019	Veloso, Marcelo Antonio Oliveira Santos/0000-0001-6025-9821; Bezerra, Lucas Soares/0000-0001-6880-0205; Ferreira Chaves, Andrea Virginia/0000-0002-9008-402X			ABESO, 2016, DIR BRAS OB, P1; Molina MRAL, 2012, REV PSIQ CLIN-BRAZIL, V39, P194, DOI 10.1590/S0101-60832012000600003; Akincigil A, 2017, PSYCHIAT SERV, V68, P660, DOI 10.1176/appi.ps.201600096; Albert PR, 2015, J PSYCHIATR NEUROSCI, V40, P219, DOI 10.1503/jpn.150205; Balestrieri M, 2010, PSYCHIAT RES, V176, P197, DOI 10.1016/j.psychres.2008.11.011; Bandelow B, 2015, DIALOGUES CLIN NEURO, V17, P327; Bradley SM, 2015, TRENDS CARDIOVAS MED, V25, P614, DOI 10.1016/j.tcm.2015.02.002; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Butnoriene J, 2015, INT J CARDIOL, V190, P360, DOI 10.1016/j.ijcard.2015.04.122; Coelho CLS, 2013, REV BRAS PSIQUIATR, V35, P142, DOI 10.1590/1516-4446-2012-0875; Combs H, 2014, MED CLIN N AM, V98, P1007, DOI 10.1016/j.mcna.2014.06.003; Dortland AKBV, 2013, PSYCHONEUROENDOCRINO, V38, P209, DOI 10.1016/j.psyneuen.2012.05.017; Dortland AKBV, 2013, PSYCHOSOM MED, V75, P83, DOI 10.1097/PSY.0b013e318274d30f; dos Santos ER, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150046; Faludi AA, 2017, ARQ BRAS CARDIOL, V109, P1, DOI [10.5935/abc.20170188, 10.5935/abc.20170121]; Fergus TA, 2018, J BEHAV MED, V41, P43, DOI 10.1007/s10865-017-9873-8; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Goldberg DP, 2017, J AFFECT DISORDERS, V213, P199, DOI 10.1016/j.jad.2017.02.025; Goncalves DA, 2014, CAD SAUDE PUBLICA, V30, P623, DOI 10.1590/0102-311X00158412; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Hettema JM, 2015, PSYCHOL MED, V45, P3075, DOI 10.1017/S0033291715001038; Ho AK, 2015, J HYPERTENS, V33, P2215, DOI 10.1097/HJH.0000000000000693; Ivanovs R, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00276; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Mahdavian M, 2018, CAN RESPIR J, V2018, DOI 10.1155/2018/6460379; Mathers C, 2018, DIS BURDEN MORTALITY; Mattei G, 2018, J NERV MENT DIS, V206, P316, DOI 10.1097/NMD.0000000000000807; Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685; Nobre F, 2018, ARQ BRAS CARDIOL, V110, P1; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; O'Connor PJ, 2009, ANN FAM MED, V7, P328, DOI 10.1370/afm.964; Oliveira JEP, 2017, DIRETRIZES SOC BRASI; Organizacao Pan-americana de Saude; Organizacao Mundial de Saude, 2018, OPAS OMS BRAS FOLH I; Ringoir L, 2014, FAM MED, V46, P447; Santos CJ, 2018, NUTR NEUROSCI, V21, P33, DOI 10.1080/1028415X.2016.1213529; Santos MAO, 2018, REV BR NEURO PSIQ, V22, P153; Seldenrijk A, 2015, J PSYCHOSOM RES, V78, P123, DOI 10.1016/j.jpsychores.2014.10.007; Semenkovich K, 2015, DRUGS, V75, P577, DOI 10.1007/s40265-015-0347-4; SILVA Amos de Souza, 2012, MONOGRAFIA; Stewart JC, 2016, PSYCHOSOM MED, V78, P593, DOI 10.1097/PSY.0000000000000315; Tejada Paola Andrea, 2014, rev.fac.med., V62, P101, DOI 10.15446/revfacmed.v62n1.43759; Tu HP, 2017, PSYCHIAT QUART, V88, P75, DOI 10.1007/s11126-016-9436-0; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wu EL, 2012, J PSYCHOSOM RES, V73, P169, DOI 10.1016/j.jpsychores.2012.07.002	44	3	5	0	5	ASSOC MEDICA BRASILEIRA	SAO PAULO	RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL		1806-9282		REV ASSOC MED BRAS	Rev. Assoc. Med. Bras.	JUN	2019	65	6					801	809		10.1590/1806-9282.65.6.801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IK5VJ	WOS:000476653100015	31340308	Green Submitted, Green Published, gold			2022-02-06	
J	Riegler, KE; Guty, ET; Arnett, PA				Riegler, Kaitlin E.; Guty, Erin T.; Arnett, Peter A.			Validity of the ImPACT Post-Concussion Symptom Scale (PCSS) Affective Symptom Cluster as a Screener for Depression in Collegiate Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Brain concussion; Depression (emotion); Sports; Symptoms; Construct validity; Screening tests; Beck Depression Inventory	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; BASE-LINE; SEX-DIFFERENCES; NEUROCOGNITIVE PERFORMANCE; POSTCONCUSSION SYMPTOMS; FOOTBALL PLAYERS; PREDICTORS; RECOVERY	Objective: The relationship between depression and sports-related concussion is complex and has implications both pre- and post-injury. The current study established the construct validity, convergent and discriminant, of the affective symptom cluster of The Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) post-concussion symptom scale (PCSS) as a screening tool for depression. Method: Nine hundred and thirty (M = 695, F = 235) college athletes were assessed at baseline using the ImPACT PCSS and Beck-Depression Inventory-Fast Screen (BDI-FS). Previous factor analysis identified four symptom clusters on the PCSS: affective, physical, cognitive, and sleep. Clinically significant depression was operationalized as a BDI-FS score >= 4. Receiver Operating Characteristic curves (ROC) were used to determine the ideal cutoff, Chi-square tests of independence were calculated to establish convergent validity, and Fisher's r-to-z comparisons were used to establish discriminant validity of the affective symptom cluster. Results: The 90th percentile cutoff yielded the highest sensitivity and specificity on the affective symptom cluster for males (4) and females (6). The correlation between BDI-FS and the 90th percentile cutoff was statistically significantly higher in females (phi = .96) than males (phi = .83), Z = 9.49, p < .001. When correlating the BDI-FS with each PCSS symptom cluster, the correlation with the affective symptom cluster was stronger than its correlation with cognitive, sleep, and physical clusters across gender. Discussion: By utilizing a measure of depression within an existing and commonly used assessment, clinicians can easily screen for depression and identify athletes at risk for complicated recovery even in the absence of a supplemental depression assessment.	[Riegler, Kaitlin E.; Guty, Erin T.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Riegler, KE (corresponding author), Penn State Univ, 372 Moore Bldg, University Pk, PA 16802 USA.	ker45@psu.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Barth JT, 1989, MILD HEAD INJURY, P257; Basso M. R., 2013, SECONDARY INFLUENCES, P39; Beck AT, 1996, PSYCHOL CORPORATION; Beck ATSB., 2000, BDI FAST SCREEN MED; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenberg L., 2017, 37 ANN M NAT AC NEUR; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnston LH, 1998, J SPORT REHABIL, V7, P206, DOI 10.1123/jsr.7.3.206; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mainwaring L, 1999, CAN J REHABIL, V12, P145; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Putukian M., 2017, BR J SPORTS MED, V51, pA28; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Streiner DL, 2003, J PERS ASSESS, V81, P209, DOI 10.1207/S15327752JPA8103_03; Strober LB, 2015, J CLIN EXP NEUROPSYC, V37, P722, DOI 10.1080/13803395.2015.1063591; Sufrinko A, 2017, J ATHL TRAINING, V52, P676, DOI 10.4085/1062-6050-52.4.01; Valovich McLeod T. C., 2017, ATHLETIC TRAINING SP, V9, P271, DOI [10.3928/19425864-20171010-03, DOI 10.3928/19425864-20171010-03]; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	52	3	3	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2019	34	4					563	574		10.1093/arclin/acy081			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	IS9UK	WOS:000482493200013	30418516	Bronze			2022-02-06	
J	Rodriguez-Villar, S; Kennedy, RC; Dall'Antonia, M; Menichetti, CP				Rodriguez-Villar, Sancho; Kennedy, Robert Charles; Dall'Antonia, Martino; Menichetti, Carlos Pilasi			Management of industrial high-pressure fluid injection injuries (IHPFII): the Water Jetting Association (WJA) experience with water driven injuries	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Industrial high-pressure fluid injuries; High-pressure fluid injection; Water jetting; Hydrostatic injuries; Ultra-high pressure; High-pressure water jet injury; Water jet injury	FUNGAL-INFECTIONS; TISSUE	BackgroundIndustrial high-pressure fluid injection injuries (IHPFII) are largely occupational in nature, where these injuries are most often sustained by male manual workers. Such traumatic injuries are largely sustained with water, grease, paint, gasoline or paint thinner. IHPFII are extremely serious injuries with life and limb-threatening potential carrying the risk of life-long disability.MethodsWe reviewed the Water Jetting Association (c) adverse incident database of advisory alerts detailing cases from around the world that have been brought to the association's attention and the English-language literature on high-pressure hydrostatic injuries from 1937 to 2018.ResultsAccidents involving high-pressure water jets in the industry are uncommon. The clinical impact in all of the cases reviewed and the effects of water jet impacts range from instant fatalities at scene to loss of limb function and amputation. The majority of observed fatalities are due to major hemorrhage (exsanguination) secondary to the direct dissection of great vessels or high-energy blunt soft tissue injury and traumatic brain injury.ConclusionsAs with any other trauma, IHPWJI commonly result in amputation or death. Nonetheless, a lack of comprehension of the potential severity of injuries and range of infective complications appears to be largely due to the apparent benignity of the initial presentation of the wound. This in turn leads to delays (both avoidable and unavoidable) in the transfer to appropriate medical facilities and definitive care. There is an identifiable need for education (including for health care providers across multiple levels), training and the availability of personal trauma kits for the timely and effective management of IHPWJI from the initial jet impact on the scene, as well as a need for an established referral system.	[Rodriguez-Villar, Sancho; Menichetti, Carlos Pilasi] Kings Coll Hosp NHS Trust Fdn, Denmark Hill, London SE5 9RS, England; [Kennedy, Robert Charles] Water Jetting Assoc, Thames Innovat Ctr, 2 Veridion Way, Erith DA18 4AL, Kent, England; [Dall'Antonia, Martino] Lewisham & Greenwich NHS Trust Fdn, Stadium Rd, London SE18 4QH, England		Rodriguez-Villar, S (corresponding author), Kings Coll Hosp NHS Trust Fdn, Denmark Hill, London SE5 9RS, England.	sancho.villar@nhs.net; robert@waterjetting.org.uk; mdallantonia@nhs.net; cpilasi@nhs.net		RODRIGUEZ-VILLAR, SANCHO/0000-0002-8976-9101			Amsdell SL, 2013, PLAST RECONSTR SURG, V132, p586E, DOI 10.1097/PRS.0b013e31829f4bb4; Anaissie EJ, 2002, CLIN INFECT DIS, V34, P780, DOI 10.1086/338958; [Anonymous], 2013, COD PRACT SAF WORK U; [Anonymous], 2015, COD PRACT US HIGH PR; Bandino JP, 2015, AM J CLIN DERMATOL, V16, P399, DOI 10.1007/s40257-015-0138-4; Borenstein TR, 2013, RHODE ISLAND MED J, V98, P38; Chaudhry Sonia, 2013, Am J Orthop (Belle Mead NJ), V42, P379; Department for Environmental, 2011, FOOD RUR AFF REV FUN; Hogan CJ, 2006, J ORTHOP TRAUMA, V20, P503, DOI 10.1097/00005131-200608000-00010; Jeffery SLA, 2016, ADV WOUND CARE, V5, P464, DOI 10.1089/wound.2015.0653; Kronen R, 2017, INT J INFECT DIS, V62, P102, DOI 10.1016/j.ijid.2017.07.002; McDonald A, 2013, RR976 HLTH SAF LAB H; Murray CK, 2011, J TRAUMA, V71, pS62, DOI 10.1097/TA.0b013e3182218c99; Radojevic N, 2015, J FORENSIC SCI, V60, P1652, DOI 10.1111/1556-4029.12861; Rees CE, 1937, J AMER MED ASSOC, V109, P866, DOI 10.1001/jama.1937.92780370004012c; Resuscitation Council (UK), 2015, TRAUM CARD ARR TREAT; Rosenwasser MP, 2014, J AM ACAD ORTHOP SUR, V22, P38, DOI 10.5435/JAAOS-22-01-38; SCHOO MJ, 1980, J TRAUMA, V20, P229, DOI 10.1097/00005373-198003000-00007; Vitrat-Hincky V, 2009, SCAND J INFECT DIS, V41, P491, DOI 10.1080/00365540902856537; Willy C, 2016, UNFALLCHIRURG, V119, P388, DOI 10.1007/s00113-016-0178-0	20	3	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2019	45	3					507	515		10.1007/s00068-019-01106-4			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ID8IO	WOS:000471927600019	30895338	Green Published, hybrid			2022-02-06	
J	Rosen, A; Oscarsson, N; Kvarnstoom, A; Gennser, M; Sandstrom, G; Blennow, K; Seeman-Lodding, H; Zetterberg, H				Rosen, Anders; Oscarsson, Nicklas; Kvarnstrom, Andreas; Gennser, Mikael; Sandstrom, Goran; Blennow, Kaj; Seeman-Lodding, Helen; Zetterberg, Henrik			Serum tau concentration after diving - an observational pilot study	DIVING AND HYPERBARIC MEDICINE			English	Article						Tau protein; Decompression sickness; Venous gas emboli; Diving research; Biomarkers; Central nervous system; Stress	BRAIN-INJURY; BLOOD BIOMARKERS; ULTRASOUND; BETA	Introduction: Increased concentrations of tau protein are associated with medical conditions involving the central nervous system, such as Alzheimer's disease, traumatic brain injury and hypoxia. Diving, by way of an elevated ambient pressure, can affect the nervous system, however it is not known whether it causes a rise in tau protein levels in serum. A prospective observational pilot study was performed to investigate changes in tau protein concentrations in serum after diving and also determine their relationship, if any, to the amount of inert gas bubbling in the venous blood. Methods: Subjects were 10 navy divers performing one or two dives per day, increasing in depth, over four days. Maximum dive depths ranged from 52-90 metres' sea water (msw). Air or trimix (nitrogen/oxygen/helium) was used as the breathing gas and the oxygen partial pressure did not exceed 160 kPa. Blood samples taken before the first and after the last dives were analyzed. Divers were monitored for the presence of venous gas emboli (VGE) at 10 to 15 minute intervals for up to 120 minutes using precordial Doppler ultrasound. Results: Median tau protein before diving was 0.200 pg.mL(-1)(range 0.100 to 1.10 pg.mL(-1)) and after diving was 0.450 pg.mL(-1) (range 0.100 to 1.20 pg.mL(-1); P = 0.016). Glial fibrillary acidic protein and neurofilament light protein concentrations analyzed in the same assay did not change after diving. No correlation was found between serum tau protein concentration and the amount of VGE. Conclusion: Repeated diving to between 52-90 msw is associated with a statistically significant increase in serum tau protein concentration, which could indicate neuronal stress.	[Rosen, Anders; Kvarnstrom, Andreas; Seeman-Lodding, Helen] Sahlgrens Univ Hosp, Dept Anesthesia & Intens Care Med, Gothenburg, Sweden; [Oscarsson, Nicklas] Angered Hosp, Dept Surg, Gothenburg, Sweden; [Gennser, Mikael] Royal Inst Technol, KTH, Dept Environm Physiol, Sch Chem Biotechnol & Hlth, Stockholm, Sweden; [Sandstrom, Goran] Swedish Armed Forces, Ctr Def Med, Gothenburg, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Gothenburg, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Rosen, A (corresponding author), Sahlgrens Univ Hosp, Dept Anesthesia & Intens Care Med, Goteborgsvagen 31, S-43180 Molndal, Sweden.	anders.rosen@vgregion.se	Oscarsson, Nicklas/AAH-9594-2020; Sandstrom, Goran/A-6822-2013	Sandstrom, Goran/0000-0001-7352-4356; Rosen, Anders/0000-0001-6739-6730; Oscarsson, Nicklas/0000-0002-0460-1829	Swedish Society for Military Medical Officers; Herbert and Karin Jacobssons Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission; European Research CouncilEuropean Research Council (ERC)European Commission; Swedish State Support for Clinical Research (ALFGBG); UK Dementia Research Institute at UCL; Hjarnfonden; Frimurarestiftelsen	The Swedish Society for Military Medical Officers, and the Herbert and Karin Jacobssons Foundation provided financial contribution for this study. HZ is a Wallenberg Academy Fellow supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Research Council, the European Research Council, Swedish State Support for Clinical Research (ALFGBG), the UK Dementia Research Institute at UCL, Hjarnfonden and Frimurarestiftelsen.	Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Bennett M., 2016, DIVING SUBAQUATIC ME; Bennett P, 2003, BENNETT ELLIOTTS PHY; Blogg SL, 2014, DIVING HYPERB MED, V44, P35; Cicognola C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0130-3; Cicognola C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00143; Di Battista AP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01367; Evered L, 2018, JAMA NEUROL, V75, P542, DOI 10.1001/jamaneurol.2017.4913; Francis TJR, 2003, BENNETT ELLIOTTS PHY; Gren M, 2016, BRAIN INJURY, V30, P1226, DOI 10.1080/02699052.2016.1179792; Lucey BP, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0161-4; Mattsson N, 2017, ANN NEUROL, V82, P665, DOI 10.1002/ana.25067; Mitchell SJ., 2016, DIVING SUBAQUATIC ME; Moghekar A, 2012, ARCH NEUROL-CHICAGO, V69, P246, DOI 10.1001/archneurol.2011.732; Mollerlokken A, 2016, DIVING HYPERB MED, V46, P26; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Nishi R. Y., 2003, BENNETT ELLIOTTS PHY, V5th; Nishi RY, 2000, RTO MEETING PROCEEDI; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2015, DIVING HYPERB MED, V45, P240; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Slats D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.008; Thompson AGB, 2018, J NEUROL NEUROSUR PS, V89, P955, DOI 10.1136/jnnp-2017-317793; YOUNT DE, 1986, AVIAT SPACE ENVIR MD, V57, P149; Zetterberg H, 2017, NEUROPATH APPL NEURO, V43, P194, DOI 10.1111/nan.12378; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	28	3	3	2	3	SOUTH PACIFIC UNDERWATER MED SOC	MELBOURNE	C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE, VIC 3004, AUSTRALIA	1833-3516			DIVING HYPERB MED	Diving Hyperb. Med.	JUN	2019	49	2					88	95	PMID 31177514	10.28920/dhm49.2.88-95			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	JB7RI	WOS:000488761500004	31177514	Green Published, Green Submitted			2022-02-06	
J	Sarmiento, K; Daugherty, J; DePadilla, L				Sarmiento, Kelly; Daugherty, Jill; DePadilla, Lara			Youth and high school sports coaches' experience with and attitudes about concussion and access to athletic trainers by sport type and age of athlete coached	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Coach; Education; Sports; Training	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; EDUCATION; SYMPTOMS	Introduction: Concussions are a commonly reported injury in youth and high school sports and much of the responsibility related to concussion identification and response for young athletes is allocated to sports coaches. This paper presents findings on concussion-related education, access to resources, experiences, and attitudes among a large number of youth and high school sports coaches across a variety of sports nationwide. Methodology: Data were collected among coaches who completed the Centers for Disease Control and Prevention's (CDC) HEADS UP online concussion training pre-test between November 2016 and November 2017. Coaches' concussion -related education, access to resources, experiences, and attitudes were compared by age of athlete coached and level of contact of sport Medium and large effect sizes were considered of practical significance for interpretation. Results: During the study period, 187,801 youth sports or high school sports coaches completed the CDC HEADS UP online training and corresponding pre-test. Access to previous concussion training significantly varied among respondents by age of athlete coached. For example, 27.4% of coaches of athletes aged 5 and younger had taken previous training compared to 72.9% of coaches of athletes aged 14-18. About one-quarter (27.4%) of all coaches reported ever having had to pull an athlete out of a game because of a possible concussion and 19.5% reported access to an athletic trainer at all games and practices. These variables differed significantly among coaches by age of athletes coached; coaches of older athletes were more likely to report access to an athletic trainer and having had to pull an athlete out of a game compared to coaches of younger athletes. No statistical differences by level of contact were considered to be of practical significance based on effect size. Conclusion: Most coaches in this study report having access to education and hold attitudes consistent with best practices about concussion safety; however, overall access to concussion-related resources is limited. While differences in access to concussion -related education, experience, resources, and attitudes among coaches of varying levels of contact were small, medium to large variations were identified by age of athlete coached. Practical applications: Coaches bear an important part of the responsibility to prevent, identify, and manage concussions in young athletes. Tailored educational efforts may assist coaches of young athletes with recognition of concussion signs and symptoms and with feeling comfortable deciding whether an athlete needs to be evaluated for a possible concussion. Published by Elsevier Ltd.	[Sarmiento, Kelly; Daugherty, Jill; DePadilla, Lara] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	KSarmiento@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CDC (U.S. Department of Health and Human Services Centers for Disease Control and Prevention), 2013, RES SCH HLTH POL PRA; Centers for Disease Control and Prevention, 2017, WHAT IS CONC; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Enniss Toby M, 2018, Trauma Surg Acute Care Open, V3, pe000153, DOI 10.1136/tsaco-2017-000153; Fitzpatrick J, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116675272; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kroshus E, 2017, CHILD CARE HLTH DEV, V43, P758, DOI 10.1111/cch.12433; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mirabelli MH, 2015, AM FAM PHYSICIAN, V92, P371; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; MOSES S, 2018, SPORTS CONTACT LEVEL; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Waltzman D, 2019, WHAT RES SAYS UNPUB; Zaiontz C, 2013, EFFECT SIZE CHI SQUA; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	34	3	3	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	JUN	2019	69						217	225		10.1016/j.jsr.2019.01.005			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	IH4ZJ	WOS:000474500300022	31235231	Green Accepted			2022-02-06	
J	Taipale, J				Taipale, Jaakko			Judges' socio-technical review of contested expertise	SOCIAL STUDIES OF SCIENCE			English	Article						law and science; meta-expertise; socio-technical review; traumatic brain injury	SCIENCE; LEGAL; DNA; LAW; SOCIOLOGY; KNOWLEDGE; TRIAL	This article investigates how civil court judges practice meta-expertise in cases that feature contradictory and inconclusive medical expertise. The empirical case study consists of a sample of eleven Helsinki district court verdicts from 2014-2017, drawn from a larger number of similar traffic insurance compensation cases. The case-type features a medical controversy concerning traumatic brain injury (TBI) diagnostics. I contend that the difficulties judges face in evaluating the medical expertise result from epistemic asymmetries between legal and medical professionals. This study highlights the importance of explaining and understanding how judges overcome uncertainty and discriminate between expert positions. Drawing from earlier studies on meta-expertise and judges' practice of evaluating expertise in court, I introduce the concept 'socio-technical review' to describe judges' practice of facilitating highly technical and esoteric scientific expertise to needs of judicial decision making. I argue that socio-technical review is a special form of practicing meta-expertise, which effectively allows meta-experts to manage epistemic asymmetries. In examining how meta-expertise is practiced in the TBI case-type, the paper contributes to general sociological understanding of decision-making under uncertainty and suggests further studies in comparable settings.	[Taipale, Jaakko] Univ Helsinki, Fac Social Sci, POB 18 Unioninkatu 35, FI-00014 Helsinki, Finland		Taipale, J (corresponding author), Univ Helsinki, Fac Social Sci, POB 18 Unioninkatu 35, FI-00014 Helsinki, Finland.	jaakko.taipale@helsinki.fi		Taipale, Jaakko/0000-0003-1590-2499			Aronson JD, 2007, GENETIC WITNESS SCI; Burns S, 2001, HUM STUD, V24, P227, DOI 10.1023/A:1017563922116; Burns SL, 2008, HUM STUD, V31, P107, DOI 10.1007/s10746-008-9081-1; CAUDILL D, 2006, NO MAGIC WAND IDEALI; Collins H., 2007, RETHINKING EXPERTISE; Collins H, 2016, STUD HIST PHILOS SCI, V56, P103, DOI 10.1016/j.shpsa.2015.07.003; Collins H, 2011, ARGUMENTATION, V25, P401, DOI 10.1007/s10503-011-9217-8; Coopmans C, 2014, SOC STUD SCI, V44, P758, DOI 10.1177/0306312714531472; Derksen L, 2000, SOC STUD SCI, V30, P803, DOI 10.1177/030631200030006001; Edmond G, 2001, SCI TECHNOL HUM VAL, V26, P191, DOI 10.1177/016224390102600204; Edmond G, 2000, SOC STUD SCI, V30, P265, DOI 10.1177/030631200030002003; Edmond G, 1997, PUBLIC UNDERST SCI, V6, P329, DOI 10.1088/0963-6625/6/4/003; Edmond G., 2000, MOD LAW REV, V63, P251, DOI DOI 10.1111/MLR.2000.63.ISSUE-2; European Commission, 2017, SPEC EUR 461 DES EUR; Filippi C.G., 2014, AM J BIOETHICS AJOB, V5, P9; Golan T, 2004, SOC STUD SCI, V34, P469, DOI 10.1177/0306312704045705; Goldman AI, 2001, PHILOS PHENOMEN RES, V63, P85, DOI 10.1111/j.1933-1592.2001.tb00093.x; Horwitz P, 2008, NOTRE DAME LAW REV, V83, P1061; Jasanoff S, 2005, AM J PUBLIC HEALTH, V95, pS49, DOI 10.2105/AJPH.2004.045732; Jasanoff S, 1998, SOC STUD SCI, V28, P713, DOI 10.1177/030631298028005003; JASANOFF S, 1993, JUDICATURE, V77, P77; Jasanoff S., 1995, SCI BAR LAW SCI TECH; Jones OD, 2013, J NEUROSCI, V33, P17624, DOI 10.1523/JNEUROSCI.3254-13.2013; Kirkland A, 2012, SOC STUD SCI, V42, P237, DOI 10.1177/0306312711435832; Kutrovatz G, 2010, THEORY OF SCI, V32, P479; Lynch M, 2005, SOC STUD SCI, V35, P269, DOI 10.1177/0306312705048715; Lynch M., 2008, TRUTH MACHINE CONTEN; Lynch M, 2014, SCI PRACTICE TURN PH, P93; Lynch M, 2007, SPONTANEOUS GENER, V1, P17; Lynch Michael, 2004, STATES KNOWLEDGE COP; Ministry of Justice Finland, COD JUD PROC UN ENGL; Prainsack B, 2009, SOC STUD SCI, V39, P51, DOI 10.1177/0306312708097289; Redmayne M, 1999, U CALIFORNIA DAVIS L, V30, P1027; Shapin S, 1999, CONFIGURATIONS, V7, P1, DOI 10.1353/con.1999.0010; Shapin S., 1995, PERSPECT SCI, V3, P255; Soler Lena., 2014, SCI PRACTICE TURN PH, DOI [https://doi.org/10.4324/9781315857985, DOI 10.4324/9781315857985]; Tadei A, 2016, NORD PSYCHOL, V68, P204, DOI 10.1080/19012276.2015.1125303; Turner SP, 2014, POLITICS EXPERTISE	38	3	3	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0306-3127	1460-3659		SOC STUD SCI	Soc. Stud. Sci.	JUN	2019	49	3					310	332		10.1177/0306312719854538			23	History & Philosophy Of Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	History & Philosophy of Science	IC9TG	WOS:000471326400002	31185873	Green Accepted			2022-02-06	
J	Wei, HJ; Liu, L; Chen, FL; Wang, D; Wang, L; Wang, ZG; Jiang, RC; Dong, JF; Chen, JL; Zhang, JN				Wei, Hui-Jie; Liu, Li; Chen, Fang-Lian; Wang, Dong; Wang, Liang; Wang, Zeng-Guang; Jiang, Rong-Cai; Dong, Jing-Fei; Chen, Jie-Li; Zhang, Jian-Ning			Decreased numbers of circulating endothelial progenitor cells are associated with hyperglycemia in patients with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; endothelial progenitor cells; vascular repair; vascular remodeling; angiogenesis; neovascularization; blood glucose; hyperglycemia; traumatic brain injury; mobilization; suppression; senescence; alternative therapy; brain damage; neural regeneration	EPC; MANAGEMENT; LEVEL	Hyperglycemia reduces the number of circulating endothelial progenitor cells, accelerates their senescence and impairs their function. However, the relationship between blood glucose levels and endothelial progenitor cells in peripheral blood of patients with traumatic brain injury is unclear. In this study, 101 traumatic brain injury patients admitted to the Department of Neurosurgery, Tianjin Medical University General Hospital or the Department of Neurosurgery, Tianjin Huanhu Hospital, China, were enrolled from April 2005 to March 2007. The number of circulating endothelial progenitor cells and blood glucose levels were measured at 1, 4, 7, 14 and 21 days after traumatic brain injury by flow cytometry and automatic biochemical analysis, respectively. 'I he number of circulating endothelial progenitor cells and blood sugar levels in 37 healthy control subjects were also examined. Compared with controls, the number of circulating endothelial progenitor cells in traumatic brain injury patients was decreased at 1 day after injury, and then increased at 4 days after injury, and reached a peak at 7 days after injury. Compared with controls, blood glucose levels in traumatic brain injury patients peaked at 1 day and then decreased until 7 days and then remained stable. At 1, 4, and 7 days after injury, the number of circulating endothelial progenitor cells was negatively correlated with blood sugar levels (r = -0.147, P < 0.05). Our results verify that hyperglycemia in patients with traumatic brain injury is associated with decreased numbers of circulating endothelial progenitor cells. This study was approved by the Ethical Committee of Tianjin Medical University General Hospital, China (approval No. 200501) in January 2015.	[Wei, Hui-Jie; Liu, Li; Chen, Fang-Lian; Wang, Dong; Wang, Liang; Wang, Zeng-Guang; Jiang, Rong-Cai; Dong, Jing-Fei; Chen, Jie-Li; Zhang, Jian-Ning] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [Wei, Hui-Jie; Liu, Li; Chen, Fang-Lian; Wang, Dong; Wang, Liang; Wang, Zeng-Guang; Jiang, Rong-Cai; Dong, Jing-Fei; Chen, Jie-Li; Zhang, Jian-Ning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Wei, Hui-Jie; Liu, Li; Chen, Fang-Lian; Wang, Dong; Wang, Liang; Wang, Zeng-Guang; Jiang, Rong-Cai; Dong, Jing-Fei; Chen, Jie-Li; Zhang, Jian-Ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Wei, Hui-Jie; Liu, Li; Chen, Fang-Lian; Wang, Dong; Wang, Liang; Wang, Zeng-Guang; Jiang, Rong-Cai; Dong, Jing-Fei; Chen, Jie-Li; Zhang, Jian-Ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Wang, Liang] Peking Univ, Dept Neurosurg, Int Hosp, Beijing, Peoples R China; [Dong, Jing-Fei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX USA; [Chen, Jie-Li] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA		Chen, JL; Zhang, JN (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China.; Chen, JL; Zhang, JN (corresponding author), Tianjin Neurol Inst, Tianjin, Peoples R China.; Chen, JL; Zhang, JN (corresponding author), Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China.; Chen, JL; Zhang, JN (corresponding author), Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China.; Chen, JL (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772229, 81200907]; Natural Science Foundation of Tianjin of ChinaNatural Science Foundation of Tianjin [12JCQNJC06800]; Science and Technology Projects in Key Areas of Traditional Chinese Medicine of Tianjin of China [2018001]; Scientific Research Program Project of Tianjin Education Commission of China [2018ZD03]	This work was supported by the National Natural Science Foundation of China, No. 30772229 (to JNZ), No. 81200907 (to HJW); the Natural Science Foundation of Tianjin of China, No. 12JCQNJC06800 (to HJW); the Science and Technology Projects in Key Areas of Traditional Chinese Medicine of Tianjin of China, No. 2018001 (to ZGW); and the Scientific Research Program Project of Tianjin Education Commission of China, No. 2018ZD03 (to ZGW).; This work was supported by the National Natural Science Foundation of China, No. 30772229 (to JNZ), No. 81200907 (to HJW); the Natural Science Foundation of Tianjin of China, No. 12JCQNJC06800 (to HJW); the Science and Technology Projects in Key Areas of Traditional Chinese Medicine of Tianjin of China, No. 2018001 (to ZGW); and the Scientific Research Program Project of Tianjin Education Commission of China, No. 2018ZD03 (to ZGW). The funding bodies played no role in the study design, in the collection, analysis and interpretation of data, in the writing of the paper, and in the decision to submit the paper for publication.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Balistreri CR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32170-2; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Elia AC, 2018, J TOXICOL ENV HEAL A, V81, P333, DOI 10.1080/15287394.2018.1442758; Hou ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep07890; Issan Y, 2013, PROSTAG OTH LIPID M, V100, P15, DOI 10.1016/j.prostaglandins.2012.12.002; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Kim JH, 2015, BIOELECTROCHEMISTRY, V101, P114, DOI 10.1016/j.bioelechem.2014.08.017; Kim MS, 2018, ARCH VIROL, V163, P3395, DOI 10.1007/s00705-018-4018-0; Lee KTD, 2019, LASER MED SCI, V34, P913, DOI 10.1007/s10103-018-2675-6; Lemmey HAL, 2018, VASC PHARMACOL, V103, P29, DOI 10.1016/j.vph.2018.01.002; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Madonna R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172800; Ng ACT, 2018, LANCET DIABETES ENDO, V6, P757, DOI 10.1016/S2213-8587(18)30257-2; Oishi K, 2012, J SURG RES, V176, P164, DOI 10.1016/j.jss.2011.03.080; Pattuwage L, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000234; Poynter R, 2017, J CLIN EPIDEMIOL, V84, P33, DOI 10.1016/j.jclinepi.2016.11.019; Rodriguez-Carrio J, 2018, CURR MED CHEM, V25, P4497, DOI 10.2174/0929867324666170606101823; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Solymar M, 2018, DIABETES VASC DIS RE, V15, P277, DOI 10.1177/1479164118757922; Sriganesh K, 2012, J NEUROSURG ANESTH, V24, P427, DOI 10.1097/ANA.0b013e31825d589a; Stormann P, 2019, EUR J TRAUMA EMERG S, V45, P527, DOI 10.1007/s00068-018-0935-6; Su H, 2017, J BIOMAT SCI-POLYM E, V28, P2066, DOI 10.1080/09205063.2017.1373989; Vafaei R, 2017, J CELL BIOCHEM, V118, P4753, DOI 10.1002/jcb.26143; van Bommel EJM, 2018, BONE, V112, P173, DOI 10.1016/j.bone.2018.04.025; Wang FJ, 2018, ZHONGGUO ZUZHI GONGC, V22, P4706; Wang T, 2018, INT J CARDIOL, V268, P214, DOI 10.1016/j.ijcard.2018.03.129; Wang T, 2018, NEURAL REGEN RES, V13, P887, DOI 10.4103/1673-5374.232484; Yamashita Y, 2019, INT J FOOD SCI NUTR, V70, P294, DOI 10.1080/09637486.2018.1508425; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Zhao ZH, 2018, CHEM-BIOL INTERACT, V286, P45, DOI 10.1016/j.cbi.2018.03.002; Zheng LF, 2019, LIFE SCI, V216, P29, DOI 10.1016/j.lfs.2018.11.008; Zhong Y, 2019, INT J MOL MED, V43, P294, DOI 10.3892/ijmm.2018.3933	34	3	3	0	18	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2019	14	6					984	990		10.4103/1673-5374.250577			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HL2GM	WOS:000458522600015	30762009	Green Published, gold			2022-02-06	
J	Williams, ET; Buchanan, DT; Buysse, DJ; Thompson, HJ				Williams, Ellita T.; Buchanan, Diana Taibi; Buysse, Daniel J.; Thompson, Hilaire J.			Injury, Sleep, and Functional Outcome in Hospital Patients With Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						actigraphy; neuro step-down unit; outcome; TBI	ACUTE-PHASE; COGNITIVE FUNCTION; SEVERITY SCORE; UNITED-STATES; REHABILITATION; RECOVERY; MODERATE; CONSCIOUSNESS; TRAJECTORIES; INTERRATER	Problem: Uninterrupted nighttime sleep is associatedwith better cognition and functional outcomes in healthy adults, but the relationship between sleep and functional outcome in individuals hospitalized with severe traumatic brain injury (TBI) remains to be clarified. Objective: The aims of this study were to (1) describe nighttime rest-activity variablesVwake bouts (counts), total wake time (minutes), and sleep efficiency (SE) (percentage; time asleep/ time in bed) Vin people on a neuroscience step-down unit (NSDU) post-TBI and (2) describe the association between injury and nighttime rest-activity on post-TBI functional outcome (using Functional Independence Measure [ FIM] at discharge from inpatient care). Methods: This study is a cross-sectional, descriptive pilot study. We recruited participants from the NSDU (n = 17 [ age: mean (SD), 63.4 (17.9)]; 82% male, 94% white) who wore wrist actigraphy (source of nighttime rest-activity variables) for up to 5 nights. For injury variables, we used Glasgow Coma Scale (GCS) score and Injury Severity Score (ISS). We used Spearman > and regression to measure associations. Results: Glasgow Coma Scale mean (SD) score was 8.8 (4.9), ISS mean (SD) score was 23.6 (6.7), and FIM mean (SD) score was 48 (14.5). Averages of nighttime rest-activity variables (8 PMY7 AM) were as follows: SE, 73% (SD, 16); wake bouts, 41 counts (SD, 18); total wake time, 74 minutes (SD, 47). Correlations showed significance between FIM and GCS (P =.005) and between SE and GCS (P =.015). GCS was the only statistically significant variable associated with FIM (P =.013); we eliminated other variables from the model as nonsignificant (P 9.10). Sleep efficiency and FIM association was nonsignificant (P =.40). In a separate model (ISS, GCS, and SE [ dependent variable]), GCS was significant (P =.04), but ISS was not (P =.25). Conclusion: Patients with severe TBI on the NSDU have poor actigraphic sleep at night. GCS has a stronger association to functional outcome than nighttime rest-activity variables.	[Williams, Ellita T.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Buchanan, Diana Taibi; Thompson, Hilaire J.] Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Buysse, Daniel J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Sleep Med Psychiat & Clin & Translat Sci, Pittsburgh, PA USA		Williams, ET (corresponding author), Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA.	ellitaw@pitt.edu	Buysse, Daniel/AAJ-1608-2021	Buysse, Daniel/0000-0002-3288-1864; Buchanan, Diana/0000-0002-5997-0453	NIH/NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [5TL1TR000422]; NIH/NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR009759, F31NR015715]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R25NS094093-04]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000422, TL1TR002318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR015715, T32NR009759] Funding Source: NIH RePORTER	This work was funded, in part, by the following grants: NIH/NCATS 5TL1TR000422, NIH/NINR F31NR015715, NIH/NINR T32NR009759 and NIH 5R25NS094093-04.	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Anafi RC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-362; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Bubolz M. M., 1993, SOURCEBOOK FAMILY TH, P419, DOI DOI 10.1007/978-0-387-85764-0_17; Buchanan DT, 2017, J CLIN SLEEP MED, V13, P11, DOI 10.5664/jcsm.6376; Chen PY, 2015, J HEAD TRAUMA REHAB, V30, pE50, DOI 10.1097/HTR.0000000000000086; Chiu HY, 2014, INT J NURS STUD, V51, P892, DOI 10.1016/j.ijnurstu.2013.10.020; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hagen C., 1997, RANCHO AMIGOS COGNIT; Hagen C, 1972, RANCHO AMIGOS LEVELS; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hosseini Seyed Hossein, 2017, Anesth Pain Med, V7, pe33653, DOI 10.5812/aapm.33653; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Malkmus P., 1974, LEVELS COGNITIVE FUN; Mazwi Nicole L, 2015, Handb Clin Neurol, V128, P553, DOI 10.1016/B978-0-444-63521-1.00035-2; Nazem S, 2016, J HEAD TRAUMA REHAB, V31, P136, DOI 10.1097/HTR.0000000000000225; Nelson J, 2015, J NEUROSCI NURS, V47, pE9, DOI 10.1097/JNN.0000000000000136; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ohayon MM, 2005, SLEEP, V28, P981; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Ren DX, 2017, J HEAD TRAUMA REHAB, V32, pE29, DOI 10.1097/HTR.0000000000000294; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Ugras GA, 2015, J NEUROSCI NURS, V47, P104, DOI 10.1097/JNN.0000000000000122; Van der Maren S, 2017, SLEEP, V40, pA438, DOI 10.1093/sleepj/zsx050.1174; van Enkhuizen J, 2014, BEHAV BRAIN RES, V261, P40, DOI 10.1016/j.bbr.2013.12.003; Vermaelen J, 2015, CRIT CARE CLIN, V31, P551, DOI 10.1016/j.ccc.2015.03.012; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Williams ET, 2017, J NURSING DOCTORAL S, V7, P48; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697	42	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2019	51	3					134	141		10.1097/JNN.0000000000000441			8	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	HX7BT	WOS:000467559300008	30964844	Green Accepted			2022-02-06	
J	Xu, SY; Liu, M; Gao, Y; Cao, Y; Bao, JG; Lin, YY; Wang, Y; Luo, QZ; Jiang, JY; Zhong, CL				Xu, Si-Yi; Liu, Min; Gao, Yang; Cao, Yang; Bao, Jin-Gang; Lin, Ying-Ying; Wang, Yong; Luo, Qi-Zhong; Jiang, Ji-Yao; Zhong, Chun-Long			Acute histopathological responses and long-term behavioral outcomes in mice with graded controlled cortical impact injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; controlled cortical impact; histopathology; behavioral manifestations; neural regeneration	TRAUMATIC BRAIN-INJURY; NEURONAL DEGENERATION; FUNCTIONAL RECOVERY; ASTROCYTES; APOPTOSIS; PATHOLOGY; DAMAGE; MODEL; GFAP	While animal models of controlled cortical impact often display short-term motor dysfunction after injury, histological examinations do not show severe cortical damage. Thus, this model requires further improvement. Mice were subjected to injury at three severities using a Pin-Point (TM)-controlled cortical impact device to establish secondary brain injury mouse models. Twenty-four hours after injury, hematoxylin-eosin staining, Fluoro-Jade B histofluorescence, and immunohistochemistry were performed for brain slices. Compared to the uninjured side, we observed differences of histopathological findings, neuronal degeneration, and glial cell number in the CA2 and CA3 regions of the hippocampus on the injured side. The Morris water maze task and beam-walking test verified long-term (14-28 days) spatial learning/memory and motor balance. To conclude, the histopathological responses were positively correlated with the degree of damage, as were the long-term behavioral manifestations after controlled cortical impact. All animal procedures were approved by the Institutional Animal Care and Use Committee at Shanghai Jiao Tong University School of Medicine.	[Xu, Si-Yi; Gao, Yang; Cao, Yang; Bao, Jin-Gang; Lin, Ying-Ying; Wang, Yong; Luo, Qi-Zhong] Shanghai Jiao Tong Univ, Dept Neurosurg, Ren Ji Hosp, Sch Med, Shanghai, Peoples R China; [Xu, Si-Yi; Liu, Min; Jiang, Ji-Yao; Zhong, Chun-Long] Tongji Univ, Dept Neurosurg, Shanghai East Hosp, Sch Med, Shanghai, Peoples R China		Zhong, CL (corresponding author), Tongji Univ, Dept Neurosurg, Shanghai East Hosp, Sch Med, Shanghai, Peoples R China.	drchunlongzhong@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771332, 81571184, 81070990]; Shanghai Key Medical Discipline for Critical Care Medicine of China [2017zz02017]; Key Discipline Construction Project of Pudong Health Bureau of Shanghai of China [PWZxk2017-23, PWYgf2018-05]; Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai of China [PWR12018-07]	This study was supported by the National Natural Science Foundation of China, No. 81771332, 81571184, 81070990 (all to CLZ); the Shanghai Key Medical Discipline for Critical Care Medicine of China, No. 2017zz02017 (to CLZ); the Key Discipline Construction Project of Pudong Health Bureau of Shanghai of China, No. PWZxk2017-23, PWYgf2018-05 (both to CLZ) and the Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai of China, No. PWR12018-07 (to CLZ).; This study was supported by the National Natural Science Foundation of China, No. 81771332, 81571184, 81070990 (all to CLZ); the Shanghai Key Medical Discipline for Critical Care Medicine of China, No. 2017zz02017 (to CLZ); the Key Discipline Construction Project of Pudong Health Bureau of Shanghai of China, No. PWZxk2017-23, PWYgf2018-05 (both to CLZ) and the Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai of China, No. PWR12018-07 (to CLZ). The conception, design, execution, and analysis of experiments, as well as the preparation of and decision to publish this manuscript, were made independent of any funding organization.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen T, 2017, NEURAL REGEN RES, V12, P433, DOI 10.4103/1673-5374.202947; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Dvela-Levitt M, 2014, J NEUROTRAUM, V31, P1942, DOI 10.1089/neu.2014.3544; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Freyaldenhoven TE, 1997, BRAIN RES, V759, P9, DOI 10.1016/S0006-8993(97)00045-0; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jiang L, 2017, NEURAL REGEN RES, V12, P90, DOI 10.4103/1673-5374.198990; Kunkler PE, 1997, J CEREBR BLOOD F MET, V17, P26, DOI 10.1097/00004647-199701000-00005; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Xu HH, 2017, ZHONGGUO ZUZHI GONGC, V21, P5320; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	37	3	4	4	13	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2019	14	6					997	1003		10.4103/1673-5374.250579			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HL2GM	WOS:000458522600017	30762011	gold, Green Published			2022-02-06	
J	Xu, YQ; Qin, ML; Feng, SY; Huang, Y; Jia, Z				Xu, Y-Q; Qin, M-L; Feng, S-Y; Huang, Y.; Jia, Z.			Expressions and significance of calcitonin gene-related peptide and nerve growth factor in rabbit model of traumatic brain injury complicated with tibial fracture: preliminary results	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Calcitonin gene-related peptide; Nerve growth factor; Traumatic brain injury; Fracture; Rabbit model	CGRP; SERUM; NGF	OBJECTIVE: This paper aims to establish the rabbit model of traumatic brain injury (TBI) complicated with tibial fracture and to investigate the expressions and significance of calcitonin gene-related peptide (CGRP) and nerve growth factor (NGF) in cerebrospinal fluid (CSF) and serum. MATERIALS AND METHODS: 60 rabbits were randomly divided into control group, TBI group, fracture group (F group), and TBI complicated with fracture group (TBI+F group), with 15 white rabbits in each group. After modeling, the expression levels of CGRP and NGF in the CSF, and serum were detected. At the 7th week after the operation. X-ray was used to evaluate the healing of fracture rabbits. RESULTS: Serum NGF content was compared among groups at the same time point. TBI+F group had significantly higher serum NGF content than the other three groups at each time point after the operation (p<0.05). From the 3rd day after the operation, TBI group and F group had significantly higher serum NGF content than control group (p<0.05). On the 7th and 14th days after the operation. TBI group had significantly higher serum NGF content than the F group (p<0.05). The CSF NGF content in TBI group and TBI+F group showed an upward trend, and it was higher in TBI+F group and TBI group than that in F group and control group from the 7th day (p<0.05). On the 0th and 3rd days, TBI+F group had significantly higher serum NGF content than the other three groups (p<0.05). TBI+F group had a significantly higher healing number than F group on the 14th day (p<0.05). CONCLUSIONS: NGF and CGRP are mainly present in the CSF. When TBI complicated with F occurs, the serum NGF and CGRP increase. which may be involved in the fracture healing.	[Xu, Y-Q; Qin, M-L; Feng, S-Y; Huang, Y.; Jia, Z.] Hunan Prov Peoples Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China		Qin, ML (corresponding author), Hunan Prov Peoples Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China.	646969515@qq.com					Bauche S, 2013, NEUROMUSCULAR DISORD, V23, P998, DOI 10.1016/j.nmd.2013.07.005; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Cirera E, 2014, INJURY, V45, P2076, DOI 10.1016/j.injury.2014.09.016; Eftekhari S, 2015, BRAIN RES, V1600, P93, DOI 10.1016/j.brainres.2014.11.031; Grider JR, 2007, AM J PHYSIOL-GASTR L, V292, pG429, DOI 10.1152/ajpgi.00376.2006; Guo TZ, 2018, J PAIN, V19, P1147, DOI 10.1016/j.jpain.2018.04.006; Harvey L, 2016, ARCH GERONTOL GERIAT, V67, P61, DOI 10.1016/j.archger.2016.06.014; He HT, 2016, MOL MED REP, V13, P3977, DOI 10.3892/mmr.2016.5023; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Jin P, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.173; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Kang JY, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-015-0236-5; Lewis PC, 2017, MIL MED, V182, pE1742, DOI 10.7205/MILMED-D-16-00350; Liang W, 2016, J APPL BIOMATER FUNC, V14, pE431, DOI 10.5301/jabfm.5000295; Liu WO, 2019, EUR REV MED PHARMACO, V23, P3933, DOI 10.26355/eurrev_201905_17822; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; Maegele M, 2004, SHOCK, V21, P32, DOI 10.1097/00024382-200403001-00127; Pelham H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01009-7; Rapp AE, 2015, J ORTHOP RES, V33, P1235, DOI 10.1002/jor.22892; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Tonra JR, 1998, J COMP NEUROL, V392, P489; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Zhang DL, 2019, EUR REV MED PHARMACO, V23, P740, DOI 10.26355/eurrev_201901_16888; Zhang YF, 2016, NAT MED, V22, P1160, DOI 10.1038/nm.4162; Zhuang YF, 2013, ASIAN PAC J TROP MED, V6, P383, DOI 10.1016/S1995-7645(13)60043-7	30	3	3	0	5	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JUN	2019	23	12					5040	5050					11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IK6BB	WOS:000476669300002	31298358				2022-02-06	
J	Yang, JZ; Yeates, K; Sullivan, L; Singichetti, B; Newton, A; Xun, PC; Taylor, HG; MacDonald, J; Pommering, T; Tiso, M; Cohen, D; Huang, YG; Patterson, J; Lu, ZL				Yang, Jingzhen; Yeates, Keith; Sullivan, Lindsay; Singichetti, Bhavna; Newton, Alison; Xun, Pengcheng; Taylor, H. Gerry; MacDonald, James; Pommering, Thomas; Tiso, Michael; Cohen, Daniel; Huang, Yungui; Patterson, Jeremy; Lu, Zhong-lin			Rest Evaluation for Active Concussion Treatment (ReAct) Protocol: a prospective cohort study of levels of physical and cognitive rest after youth sports-related concussion	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; OF-LIFE INVENTORY; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; CHILDREN; RECOVERY; RELIABILITY; RECOMMENDATIONS; PERSPECTIVE	Introduction Although current guidelines for the early clinical management of sports-related concussion (SRC) call for a gradual return-to-activity, the optimal level of rest needed to promote recovery remains unknown. This paper describes the protocol of the Rest Evaluation for Active Concussion Treatment (ReAct) study which objectively measures physical and cognitive rest following SRC and its relation to recovery among youth athletes. Methods and analysis Youth athletes aged 11-17 years are recruited preinjury and enrolled within 72 hours following a physician-diagnosed concussion. Injury information and acute clinical presentation are assessed at the time of injury. Youth participants are prospectively followed to objectively monitor daily physical and cognitive rest using two electronic devices: ActiGraph (to measure physical rest and sleep) and Narrative Clip (to measure cognitive rest), along with self-reported postconcussive symptoms using daily surveys. Other concussion outcomes, including functional outcomes, are assessed by surveying youth and their parents at three time points: (1) within 72 hours of injury, (2) at day 7 postenrolment and (3) at symptom resolution (or a maximum of 45 days postconcussion). Ethics and dissemination This study has received ethical approval from the Institutional Review Board (IRB) at the participating institution (IRB at Nationwide Children's Hospital, IRB16-00613). The results of the study will be presented at national and international scientific conferences and published in peer-reviewed journals.	[Yang, Jingzhen; Sullivan, Lindsay; Singichetti, Bhavna; Newton, Alison] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Yang, Jingzhen; Taylor, H. Gerry; MacDonald, James; Pommering, Thomas; Cohen, Daniel] Ohio State Univ, Pediat, Columbus, OH 43210 USA; [Yeates, Keith] Univ Calgary, Psychol, Calgary, AB, Canada; [Xun, Pengcheng] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Taylor, H. Gerry] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [MacDonald, James; Pommering, Thomas] Nationwide Childrens Hosp, Sports Med, Columbus, OH USA; [Tiso, Michael] Ohio State Univ, Sport & Internal Med, Columbus, OH 43210 USA; [Cohen, Daniel] Nationwide Childrens Hosp, Emergency Med, Columbus, OH USA; [Huang, Yungui; Patterson, Jeremy] Nationwide Childrens Hosp, Res Informat Solut & Innovat, Res Inst, Columbus, OH USA; [Lu, Zhong-lin] Ohio State Univ, Psychol, Columbus, OH 43210 USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA.; Yang, JZ (corresponding author), Ohio State Univ, Pediat, Columbus, OH 43210 USA.	Ginger.Yang@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Xun, Pengcheng/0000-0002-6245-4505; MacDonald, James/0000-0002-0432-0808; Singichetti, Bhavna/0000-0002-2188-3979	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R21HD086451-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD086451] Funding Source: NIH RePORTER	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grant number [1R21HD086451-01A1].	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Andersen PK, 1997, BIOMETRICS, V53, P1475, DOI 10.2307/2533513; ANGRIST J, 2004, SEMIPARAMETRIC CAUSA; [Anonymous], 2014, NARRATIVE CLIP A NEW; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Berger Ivona, 2017, Glob Pediatr Health, V4, p2333794X17745973, DOI 10.1177/2333794X17745973; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Claar RL, 2006, PAIN, V121, P77, DOI 10.1016/j.pain.2005.12.002; CogState L., 1999, COGSPORT COMP SOFTWA; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Graham R., 2014, SPORT RELATED CONCUS; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kirkwood MW, 2012, CLIN J SPORT MED, V22, P383, DOI 10.1097/JSM.0b013e31826396fc; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Little R. J., 2019, STAT ANAL MISSING DA, V793; LUMBABROWN A, 2018, JAMA PEDIAT, V172; Maas, 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-1881.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M., 2000, STANDARDIZED ASSESSM; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2015, PEDIATRICS, V135, P362, DOI 10.1542/peds.2014-3665; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Proust-Lima C, 2011, AM J EPIDEMIOL, V174, P1077, DOI 10.1093/aje/kwr243; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; von Baeyer CL, 2009, PAIN, V143, P223, DOI 10.1016/j.pain.2009.03.002; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	62	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	4							e028386	10.1136/bmjopen-2018-028386			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7MA	WOS:000471157200272	31015276	Green Published, gold			2022-02-06	
J	Turkstra, LS; Duff, MC; Politis, AM; Mutlu, B				Turkstra, Lyn Siobhan; Duff, Melissa Collins; Politis, Adam Michael; Mutlu, Bilge			Detection of text-based social cues in adults with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Language; adults; brain injuries; emotions; humans; writing	EMOTION RECOGNITION; COMMUNICATION-SKILLS; IMMEDIACY BEHAVIORS; PREFRONTAL LESIONS; TEACHER IMMEDIACY; LANGUAGE USE; COGNITION; DEFICITS; MIND; ADOLESCENTS	Objectives: Written text contains verbal immediacy cues-word form or grammatical cues that indicate positive attitude or liking towards an object, action, or person. We asked if adults with moderate-severe traumatic brain injury (TBI) would respond to these cues, given evidence of TBI-related social communication impairments. Methods: Sixty-nine adults with TBI and 74 healthy comparison (HC) peers read pairs of sentences containing different types of immediacy cues (e.g., speaker A said "these Canadians" vs. B said "those Canadians.") and identified which speaker (A or B) had a more positive attitude towards the underlined entity (Task 1); and pairs of sentences comprised of a context sentence (e.g., Fred is asked, "Did you visit Joan and Sue?") and a statement sentence (Fred says, "I visited Sue and Joan.") and were asked to indicate how much Fred liked or disliked the underlined words (Task 2). Results: HC group scores were significantly higher on Task 1, indicating more sensitivity to cues. On Task 2, TBI and HC group ratings differed across cue types and immediacy types, and the TBI group appeared to have less sensitivity to these cues. Conclusions: Findings suggest that TBI-related impairments may reduce sensitivity to subtle social cues in text.	[Turkstra, Lyn Siobhan; Politis, Adam Michael] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Turkstra, Lyn Siobhan] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Turkstra, Lyn Siobhan] Univ Wisconsin, Dept Surg, Madison, WI 53706 USA; [Duff, Melissa Collins] Vanderbilt Univ, Dept Hearing & Speech Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Politis, Adam Michael] NIH, Dept Rehabil Med, Bethesda, MD 20892 USA; [Mutlu, Bilge] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA		Turkstra, LS (corresponding author), IAHS, Sch Rehabil Sci, Room 403G,1400 Main St West, Hamilton, ON L8S 1C7, Canada.	turkstrl@mcmaster.ca	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	National Center for Medical Rehabilitation Research (NCMRR) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD071089]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This work was supported by the National Center for Medical Rehabilitation Research (NCMRR) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under Grant R01 HD071089.	Allen M, 2006, COMMUN EDUC, V55, P21, DOI 10.1080/03634520500343368; Bazarova NN, 2013, J LANG SOC PSYCHOL, V32, P121, DOI 10.1177/0261927X12456384; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Biber D., 1991, VARIATION SPEECH WRI; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Borelli JL, 2011, PERS RELATIONSHIP, V18, P341, DOI 10.1111/j.1475-6811.2010.01294.x; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Byom L., 2016, INT J LANGUAGE COMMU; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dethier M, 2012, J CLIN EXP NEUROPSYC, V34, P936, DOI 10.1080/13803395.2012.702734; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Fullwood C, 2015, CYBERPSYCH BEH SOC N, V18, P147, DOI 10.1089/cyber.2014.0463; GORHAM J, 1988, COMMUN EDUC, V37, P40, DOI 10.1080/03634528809378702; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Ireland ME., 2014, OXFORD HDB LANGUAGES, P201, DOI DOI 10.1093/OXFORDHB/9780199838639.013.034; Jones CA, 2011, BRAIN INJURY, V25, P844, DOI 10.3109/02699052.2011.585507; Khan SA., 2007, THESIS; Lee D, 2011, CYBERPSYCH BEH SOC N, V14, P337, DOI 10.1089/cyber.2010.0069; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P619, DOI 10.1080/13803395.2011.553586; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; MEHRABIAN A, 1968, J PERS, V36, P21, DOI 10.1111/j.1467-6494.1968.tb01457.x; MEHRABIAN A, 1967, J CONSULT PSYCHOL, V31, P414, DOI 10.1037/h0024834; Mehrabian A., 2011, PERMISSION ADD STIMU; Mehrabian A., 1972, NONVERBAL COMMUNICAT, P31; Menchik DA, 2008, AM J SOCIOL, V114, P332, DOI 10.1086/590650; Meulenbroek P, 2016, J VOCAT REHABIL, V44, P15, DOI 10.3233/JVR-150777; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; O'Grady M., 2015, FORRESTER RES MOBILE; O'Sullivan PB, 2004, J LANG SOC PSYCHOL, V23, P464, DOI 10.1177/0261927X04269588; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 1999, J PERS SOC PSYCHOL, V77, P1296, DOI 10.1037/0022-3514.77.6.1296; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; RIGGIO RE, 1989, PERS INDIV DIFFER, V10, P93, DOI 10.1016/0191-8869(89)90184-0; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A., 2017, NEUROPSYCHOLOGY; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Simmons RA, 2005, PSYCHOL SCI, V16, P932, DOI 10.1111/j.1467-9280.2005.01639.x; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Turman PD, 2008, WESTERN J COMM, V72, P162, DOI 10.1080/10570310802038424; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wechsler D., 2008, WECHSLER ADULT INTEL; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6; [No title captured]	69	3	3	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 28	2019	29	5					789	803		10.1080/09602011.2017.1333012			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HP4NI	WOS:000461652400010	28594270	Green Accepted			2022-02-06	
J	Schneider, ALC; Selvin, E; Liang, ML; Latour, L; Turtzo, LC; Koton, S; Coresh, J; Mosley, T; Whitlow, CT; Zhou, Y; Wong, DF; Ling, G; Gottesman, RF				Schneider, Andrea L. C.; Selvin, Elizabeth; Liang, Menglu; Latour, Lawrence; Turtzo, L. Christine; Koton, Silvia; Coresh, Josef; Mosley, Thomas; Whitlow, Christopher T.; Zhou, Yun; Wong, Dean F.; Ling, Geoffrey; Gottesman, Rebecca F.			Association of Head Injury with Brain Amyloid Deposition: The ARIC-PET Study	JOURNAL OF NEUROTRAUMA			English	Article						cohort study; epidemiology; head injury; PET amyloid imaging	CHRONIC TRAUMATIC ENCEPHALOPATHY; ATHEROSCLEROSIS RISK; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; 1ST EXPOSURE; BETA; AGE; COMMUNITIES; DEMENTIA; ACCUMULATION	Our objective was to examine associations of head injury with total and regional brain amyloid deposition. We performed cross-sectional analyses of 329 non-demented participants (81 with prior head injury) in the Atherosclerosis Risk in Communities-Positron Emission Tomography (ARIC-PET) Study who underwent (18-)florbetapir PET imaging in 2012-2014. A history of head injury was defined by self-report or emergency department/hospitalization International Classification of Diseases, Ninth Revision codes. Generalized linear regression models adjusted for demographic, socioeconomic, and dementia/cardiovascular risk factors were used to estimate prevalence ratios (PRs; 95% confidence intervals [CIs]) for elevated (> 1.2) global and regional standard uptake value ratios (SUVRs). Mean age of participants was 76 years, 57% were women, and 43% were black. Head injury was associated with increased prevalence of elevated SUVR >1.2 globally (PR: 1.31; 95% CI: 1.19-1.57), as well as in the orbitofrontal cortex (PR: 1.23); (95% CI: 1.04-1.46), prefrontal cortex (PR: 1.18; 95% CI: 1.00-1.39), superior frontal cortex (PR: 1.24; 95% CI: 1.05-1.48), and posterior cingulate (PR: 1.26; 95% CI: 1.04-1.52). There also was evidence for a dose-response relationship, whereby a history of >= 1 head injury was associated with elevated SUVR >1.2 in the prefrontal cortex and superior frontal cortex compared with persons with a history of one head injury (all, p < 0.05). In conclusion, head injury was associated with increased amyloid deposition globally and in the frontal cortex and posterior cingulate, with suggestion of a dose-response association of head injuries with beta-amyloid deposition. Further work is needed to determine if increased amyloid deposition contributes to dementia in this population.	[Schneider, Andrea L. C.; Ling, Geoffrey; Gottesman, Rebecca F.] Johns Hopkins Univ, Dept Neurol, 1800 Orleans St,Suite 6005, Baltimore, MD 21287 USA; [Selvin, Elizabeth; Liang, Menglu; Koton, Silvia; Coresh, Josef; Gottesman, Rebecca F.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21287 USA; [Wong, Dean F.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21287 USA; [Latour, Lawrence; Turtzo, L. Christine] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Koton, Silvia] Tel Aviv Univ, Dept Nursing, Tel Aviv, Israel; [Mosley, Thomas] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Whitlow, Christopher T.; Zhou, Yun] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Ling, Geoffrey] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD USA		Schneider, ALC (corresponding author), Johns Hopkins Univ, Dept Neurol, 1800 Orleans St,Suite 6005, Baltimore, MD 21287 USA.	achris13@jhmi.edu	Latour, Larry/AAH-5663-2021; Gottesman, Rebecca/ABA-8468-2020	Latour, Larry/0000-0001-6160-5263; Gottesman, Rebecca/0000-0002-9504-1256; liang, menglu/0000-0002-0185-8557	National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN 268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN26 8201100012C]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 HL096812, HL096814, HL096899, HL096902, HL096917]; National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040282]; National Institutes of Health (NIH)/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065729]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG052573]; NIH/NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K24DK106414]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01-HL70825]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL096899, U01HL096812, U01HL096917, U01HL096902, U01HL096814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K24DK106414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065729, ZIANS003120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040282, P30AG049638, K24AG052573] Funding Source: NIH RePORTER	The ARIC Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201100005C, HHSN268201100006C, HHSN 268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN26 8201100012C. Neurocognitive data are collected with funding from grants U01 HL096812, HL096814, HL096899, HL096902, and HL096917 from the National Institute of Neurological Disorders and Stroke (NINDS), with previous brain MRI examinations funded by grant R01-HL70825 from the NHLBI. The ARIC-PET study is funded by the National Institute on Aging (NIA) grant R01AG040282. Dr. Schneider is supported by the National Institutes of Health (NIH)/NINDS through an administrative supplement to award R25NS065729. Dr. Gottesman is also supported by the NIH/NIA grant K24AG052573. Dr. Selvin is supported by NIH/NIDDK grant K24DK106414. Avid Radiopharmaceuticals provided the florbetapir isotope for the study.r Avid Radiopharmaceuticals had no role in the study design or interpretation of results. Neither Avid nor the primary sponsor (NIH/NIA) had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Aisen PS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0283-5; [Anonymous], 2015, C TRAUM BRAIN INJ US; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Catafau AM, 2016, J NUCL MED, V57, P1740, DOI 10.2967/jnumed.115.171652; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gottesman RF, 2017, JAMA-J AM MED ASSOC, V317, P1443, DOI 10.1001/jama.2017.3090; Gottesman RF, 2016, NEUROLOGY, V87, P473, DOI 10.1212/WNL.0000000000002914; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Joshi A, 2012, J NUCL MED, V53, DOI 10.2967/jnumed.111.090340; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Knopman David S, 2016, Alzheimers Dement (Amst), V2, P1; Knopman DS, 2015, STROKE, V46, P433, DOI 10.1161/STROKEAHA.114.007847; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Mosley TH, 2005, NEUROLOGY, V64, P2056, DOI 10.1212/01.WNL.0000165985.97397.88; Ponto L.L., 2015, J NEUROPSYCHIATRY CL, V28, P89, DOI DOI 10.1053/APMR.2002.28802; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilmoth K., 2017, CLIN NEUROPSYCHOL, P1; WONG D, 2018, J NUCL MED, V51, P913, DOI DOI 10.2967/JNUMED.109.069088; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032	42	3	3	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2549	2557		10.1089/neu.2018.6213		MAY 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000470630200001	30963804	Green Published			2022-02-06	
J	Stolwyk, RJ; Charlton, JL; Ross, PE; Bedard, M; Marshall, S; Gagnon, S; Gooden, JR; Ponsford, JL				Stolwyk, Renerus J.; Charlton, Judith L.; Ross, Pamela E.; Bedard, Michel; Marshall, Shawn; Gagnon, Sylvain; Gooden, James R.; Ponsford, Jennie L.			Characterizing on-road driving performance in individuals with traumatic brain injury who pass or fail an on-road driving assessment	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; on-road driving; assessment; rehabilitation	NEUROPSYCHOLOGICAL ASPECTS; COGNITIVE DEFICITS; PREDICTION; ABILITY; RETURN; TESTS; AWARENESS; SIMULATOR	Objective: To characterise on-road driving performance in individuals with traumatic brain injury who fail on-road driving assessment, compared with both those who pass assessment and healthy controls, and the injury and cognitive factors associated with driving performance. Study design: Cross-sectional. Methods: Forty eight participants with traumatic brain injury (Age M = 40.50 SD = 14.62, 77% male, post-traumatic amnesia days M = 28.74 SD =27.68) and 48 healthy matched controls completed a standardised on-road driving assessment in addition to cognitive measures. Results: Individuals with traumatic brain injury who passed on-road driving assessment performed no differently from controls while individuals with traumatic brain injury who failed the assessment demonstrated significantly worse driving performance relative to controls across a range of driving manoeuvres and error types including observation of on-road environment, speed control, gap selection, lane position, following distance and basic car control. Longer time post-injury and reduced visual perception were both significantly correlated with reduced driving skills. Conclusions: This exploratory study indicated that drivers with traumatic brain injury who failed on-road assessment demonstrated a heterogeneous pattern of impaired driving manoeuvres, characterised by skill deficits across both operational (e.g., basic car control and lane position) and tactical domains (e.g., following distance, gap selection, and observation) of driving. These preliminary findings can be used for implementation of future driving assessments and rehabilitation programs.	[Stolwyk, Renerus J.; Gooden, James R.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk,Clayton Campus, Clayton, Vic 3800, Australia; [Stolwyk, Renerus J.; Gooden, James R.; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Charlton, Judith L.] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Ross, Pamela E.] Epworth Rehabil, Richmond, Vic, Australia; [Bedard, Michel] Lakehead Univ, Ctr Res & Safe Driving, Thunder Bay, ON, Canada; [Marshall, Shawn] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Gagnon, Sylvain] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk,Clayton Campus, Clayton, Vic 3800, Australia.	rene.stolwyk@monash.edu	; Ponsford, Jennie/H-8341-2014	Gooden, James/0000-0001-6835-9528; Stolwyk, Renerus/0000-0002-4975-3332; Charlton, Judith/0000-0002-5990-2151; Ponsford, Jennie/0000-0003-0430-125X	Transport Accident Commission (Victoria, Australia); Ontario Neurotrauma Foundation (Ontario, Canada) [DCP013]	This research project was jointly supported by the Transport Accident Commission (Victoria, Australia) and the Ontario Neurotrauma Foundation (Ontario, Canada) [DCP013].	Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN, P59; Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Colarusso R.P., 2003, MOTOR FREE VISUAL PE; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Devos H, 2014, CEREBROVASC DIS, V38, P226, DOI 10.1159/000368219; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; Fisk GD, 1998, BRAIN INJURY, V12, P683; Gooden JR, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000212; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; McKay A, 2016, J HEAD TRAUMA REHAB, V31, pE44, DOI 10.1097/HTR.0000000000000209; MEYERS J, 1995, MEYERS SCORING SYSTE; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [DOI 10.1007/978-1-4613-2173-6_19, 10.1007/978-1-4613-2173-6_19]; Molnar LJ, 2013, TRANSPORT RES F-TRAF, V20, P29, DOI 10.1016/j.trf.2013.05.001; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Occupational Therapy Australia, 1998, COMP STAND OCC THER; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Reitan R, 1988, HALSTEAD REITAN NEUR; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1991, SYMBOL DIGIT MODALIT; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Vlahodimitrakou Z, 2013, ACCIDENT ANAL PREV, V61, P253, DOI 10.1016/j.aap.2013.03.027	42	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 22	2019	41	11					1313	1320		10.1080/09638288.2018.1424955			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HU3WT	WOS:000465206300007	29334804				2022-02-06	
J	Demock, M; Kornguth, S				Demock, Melissa; Kornguth, Steven			A Mechanism for the Development of Chronic Traumatic Encephalopathy From Persistent Traumatic Brain Injury	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; chronic traumatic encephalopathy; major histocompatibility complex; Human Leukocyte Antigen; tauopathy; tau protein; electrostatic binding; protein-protein interaction	CLASS-I; ENDOPLASMIC-RETICULUM; EXTRACELLULAR TAU; HLA-DR; MITOCHONDRIA; ENDOCYTOSIS; POLYLYSINE; SEQUENCE; COMPLEX; BINDING	A mechanism that describes the progression of traumatic brain injury (TBI) to end-stage chronic traumatic encephalopathy (CTE) is offered in this article. This mechanism is based upon the observed increase in the concentration of both tau protein and of human leukocyte antigen (HLA) class I proteins; the HLA increase is expressed on the cell membrane of neural cells. These events follow the inflammatory responses caused by the repetitive TBI. Associated inflammatory changes include macrophage entry into the brain parenchyma from increased permeability of the blood-brain barrier (BBB) and microglial activation at the base of the sulci. The release of interferon gamma from the microglia and macrophages induces the marked increased expression of HLA class I proteins by the neural cells and subsequent redistribution of the tau proteins to the glial and neuronal surface. In those individuals with highly expressed HLA class I C. the high level of HLA binds tau protein electrostatically. The ionic region of HLA class I C (amino acid positions 50-90) binds to the oppositely charged ionic region of tau (amino acid positions 93-133). These interactions thereby shift the cellular localization of the tau and orient the tau spatially so that the cross-linking sites of tau (275-280 and 306-311) are aligned. This alignment facilitates the cross-linking of tau to form the intracellular and extracellular microfibrils of tau. the primary physiological characteristic of tauopathy. Following endocytosis of the membrane HLA/tau complex. these microfibrils accumulate and produce a tau-storage-like disease. Therefore, tauopathy is the secondary collateral process of brain injury, resulting from the substantial increase in tau and HLA expression on neural cells. This proposed mechanism suggests several potential targets for mitigating the clinical progression of TBI to CTE.	[Demock, Melissa] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Kornguth, Steven] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA; [Kornguth, Steven] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Kornguth, Steven] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Kornguth, Steven] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA		Kornguth, S (corresponding author), Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA.; Kornguth, S (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.	steve_kornguth@utexas.edu		kornguth, steven/0000-0002-3709-0359			DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Giannetti AM, 2000, PROTEIN SCI, V9, P2427, DOI 10.1110/ps.9.12.2427; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Gonzalez-Marrero I, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/164653; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HUET C, 1980, CELL, V21, P429, DOI 10.1016/0092-8674(80)90479-1; ITO U, 1980, STROKE, V11, P606, DOI 10.1161/01.STR.11.6.606; Karagiannis SN, 2001, IMMUNOLOGY, V103, P319, DOI 10.1046/j.1365-2567.2001.01238.x; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kolarova M., 2012, INT J ALZHEIMERS DIS, V2012, DOI [10.1155/2012/731526, DOI 10.1155/2012/731526]; KORNGUTH S, 1990, AM J NEURORADIOL, V11, P313; KORNGUTH S, 1995, SCIENCE, V270, P720; KORNGUTH SE, 1961, CANCER RES, V21, P907; KORNGUTH SE, 1989, CANCER RES, V49, P6390; Kornguth S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918808216; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Kornguth S, 2013, NAV ENG J, V125, P85; LARHAMMAR D, 1982, P NATL ACAD SCI-BIOL, V79, P3687, DOI 10.1073/pnas.79.12.3687; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Perreault S, 2009, J NEUROPATH EXP NEUR, V68, P503, DOI 10.1097/NEN.0b013e3181a1fc49; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Tanielian TL, 2008, INVISIBLE WOUNDS WAR, pxliii; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P18, DOI 10.1097/00005072-196301000-00003; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Zhang Timothy G, 2013, P ASME 2013 INT MECH; Zhao H, 2016, SPR SER TRANSL STROK, P189, DOI 10.1007/978-3-319-32337-4_10	46	3	3	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	MAY 20	2019	13								1179069519849935	10.1177/1179069519849935			5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HZ0RZ	WOS:000468550800001	31205424	Green Published, gold			2022-02-06	
J	Sudhakar, SK; Choi, TJ; Ahmed, OJ				Sudhakar, Shyam Kumar; Choi, Thomas J.; Ahmed, Omar J.			Biophysical Modeling Suggests Optimal Drug Combinations for Improving the Efficacy of GABA Agonists after Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						chloride; depolarization block; GABA; neuroprotection; potassium	FAST-SPIKING INTERNEURONS; EXTRACELLULAR POTASSIUM CONCENTRATION; CORTICAL SPREADING DEPRESSION; GATED K+ CHANNELS; PYRAMIDAL NEURONS; POSTTRAUMATIC SEIZURES; NA-K-2CL COTRANSPORTER; SYNAPTIC INHIBITION; ION CONCENTRATIONS; LAYER 4	Traumatic brain injuries (TBI) lead to dramatic changes in the surviving brain tissue. Altered ion concentrations, coupled with changes in the expression of membrane-spanning proteins, create a post-TBI brain state that can lead to further neuronal loss caused by secondary excitotoxicity. Several GABA receptor agonists have been tested in the search for neuroprotection immediately after an injury, with paradoxical results. These drugs not only fail to offer neuroprotection, but can also slow down functional recovery after TBI. Here, using computational modeling, we provide a biophysical hypothesis to explain these observations. We show that the accumulation of intracellular chloride ions caused by a transient upregulation of Na+-K+-2Cl(-) (NKCC1) co-transporters as observed following TBI, causes GABA receptor agonists to lead to excitation and depolarization block, rather than the expected hyperpolarization. The likelihood of prolonged, excitotoxic depolarization block is further exacerbated by the extremely high levels of extracellular potassium seen after TBI. Our modeling results predict that the neuroprotective efficacy of GABA receptor agonists can be substantially enhanced when they are combined with NKCC1 co-transporter inhibitors. This suggests a rational, biophysically principled method for identifying drug combinations for neuroprotection after TBI.	[Sudhakar, Shyam Kumar; Choi, Thomas J.; Ahmed, Omar J.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Ahmed, Omar J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Ahmed, Omar J.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Ahmed, Omar J.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI USA; [Ahmed, Omar J.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA		Sudhakar, SK; Ahmed, OJ (corresponding author), LSA Psychol, 4040 East Hall,530 Church St, Ann Arbor, MI 48109 USA.	shyamk@umich.edu; ojahmed@umich.edu	Sudhakar, Shyam Kumar/K-9321-2019		NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03 MH111316] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH111316] Funding Source: NIH RePORTER		Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; AGMON A, 1989, NEUROSCI LETT, V99, P137, DOI 10.1016/0304-3940(89)90278-4; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; [Anonymous], 2017, NAT MED, V23, P1113, DOI 10.1038/nm.4426; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Ben-Ari Y, 2017, TRENDS NEUROSCI, V40, P536, DOI 10.1016/j.tins.2017.07.001; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Bianchi D, 2012, J COMPUT NEUROSCI, V33, P207, DOI 10.1007/s10827-012-0383-y; Bikson M, 2003, J NEUROPHYSIOL, V90, P2402, DOI 10.1152/jn.00467.2003; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; BRAILOWSKY S, 1986, BRAIN RES, V362, P322, DOI 10.1016/0006-8993(86)90457-9; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; CHOI DW, 1987, J NEUROSCI, V7, P369; Cleary RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057148; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Dargaei Z, 2018, P NATL ACAD SCI USA, V115, pE1618, DOI 10.1073/pnas.1716871115; Deeb TZ, 2012, EPILEPSIA, V53, P79, DOI 10.1111/epi.12037; Degenetais E, 2002, CEREB CORTEX, V12, P1, DOI 10.1093/cercor/12.1.1; Ding FF, 2016, SCIENCE, V352, P550, DOI 10.1126/science.aad4821; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dulla CG, 2016, NEUROSCIENTIST, V22, P295, DOI 10.1177/1073858415585108; Durand DM, 2010, PHILOS T R SOC B, V365, P2347, DOI 10.1098/rstb.2010.0050; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Engl E, 2015, J PHYSIOL-LONDON, V593, P3417, DOI 10.1113/jphysiol.2014.282517; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Farries MA, 2010, J NEUROSCI, V30, P13180, DOI 10.1523/JNEUROSCI.1909-10.2010; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V404, P83, DOI 10.1113/jphysiol.1988.sp017280; Frohlich F, 2008, NEUROSCIENTIST, V14, P422, DOI 10.1177/1073858408317955; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Golomb D, 2007, PLOS COMPUT BIOL, V3, P1498, DOI 10.1371/journal.pcbi.0030156; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Guan D, 2007, J NEUROPHYSIOL, V97, P1931, DOI 10.1152/jn.00933.2006; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hall ED, 1998, BRAIN RES, V798, P325, DOI 10.1016/S0006-8993(98)00478-8; HANSEN AJ, 1980, PFLUG ARCH EUR J PHY, V389, P1, DOI 10.1007/BF00587921; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; HANSEN AJ, 1977, ACTA PHYSIOL SCAND, V99, P412, DOI 10.1111/j.1748-1716.1977.tb10394.x; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; HARTINGS JA, 1923, J NEUROSCI, V11, P602; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; Hertle Daniel, 2012, Acta Neurochir Suppl, V114, P383, DOI 10.1007/978-3-7091-0956-4_74; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hille B, 2001, ION CHANNELS EXCITAB, V3rd; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Houston CM, 2009, J NEUROSCI, V29, P10416, DOI 10.1523/JNEUROSCI.1670-09.2009; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; Im HK, 1996, BRAIN RES, V714, P165, DOI 10.1016/0006-8993(95)01519-1; Jedlicka P, 2011, HIPPOCAMPUS, V21, P885, DOI 10.1002/hipo.20804; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; JING J, 1993, BRAIN RES, V604, P251, DOI 10.1016/0006-8993(93)90376-X; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kihira Y, 2010, J BIOL CHEM, V285, P15048, DOI 10.1074/jbc.M109.074260; Kirmse K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8750; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Koga K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-62; Krishnan GP, 2018, P NATL ACAD SCI USA, V115, P6858, DOI 10.1073/pnas.1715841115; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Levy RB, 2012, J NEUROSCI, V32, P5609, DOI 10.1523/JNEUROSCI.5158-11.2012; Liu PW, 2014, J NEUROSCI, V34, P4991, DOI 10.1523/JNEUROSCI.1925-13.2014; Liu YQ, 2012, PEDIATR RES, V71, P559, DOI 10.1038/pr.2012.7; Locke RE, 1997, J NEUROPHYSIOL, V78, P2321, DOI 10.1152/jn.1997.78.5.2321; Lodish H., 2000, MOL CELL BIOL; LOTHMAN E, 1975, BRAIN RES, V88, P15, DOI 10.1016/0006-8993(75)90943-9; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; MacDonald V, 2002, MOVEMENT DISORD, V17, P1166, DOI 10.1002/mds.10258; Madikians A, 2006, INDIAN J NEUROTRAUM, V3, P9; Marie B.L., 2009, BIOL NMDA RECEPTOR; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 1998, J NEUROSCI, V18, P8111; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Morozova EO, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005233; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Muralidhar S, 2014, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00052; Nakamura S., 2012, J SME, V1, P1; Nernst W., 1889, BER KGL PR AKAD WISS, P83; Nernst W., 1889, Z PHYS CHEM, V4U, P129, DOI [10.1515/zpch- 1889-0412., DOI 10.1515/ZPCH-1889-0112]; Nernst W., 1888, Z ELKTROCHEM ANGEW P, V2, P613, DOI 10.1515/zpch-1888-0174; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Perucca E, 1997, PHARMACOL RES, V35, P241, DOI 10.1006/phrs.1997.0124; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Ransom CB, 2010, J NEUROSCI, V30, P7672, DOI 10.1523/JNEUROSCI.0290-10.2010; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Ritter P, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00077; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sato SS, 2017, P NATL ACAD SCI USA, V114, pE8770, DOI 10.1073/pnas.1702861114; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Sivakumaran S, 2016, EPILEPSIA, V57, P222, DOI 10.1111/epi.13270; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; SOMJEN GG, 1979, ANNU REV PHYSIOL, V41, P159, DOI 10.1146/annurev.ph.41.030179.001111; Somjen GG, 2004, IONS BRAIN NORMAL FU; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sterratt D., 2011, PRINCIPLES COMPUTATI; Sudhakar SK, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005754; Sudhakar SK, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004641; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; SYPERT GW, 1974, EXP NEUROL, V45, P19, DOI 10.1016/0014-4886(74)90097-1; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Tecoult E, 2000, J NEUROSURG ANESTH, V12, P255, DOI 10.1097/00008506-200007000-00010; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Tseng KY, 2006, SYNAPSE, V59, P412, DOI 10.1002/syn.20255; Tucker KR, 2012, J NEUROSCI, V32, P14519, DOI 10.1523/JNEUROSCI.1251-12.2012; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Urban-Ciecko J, 2010, J NEUROPHYSIOL, V104, P746, DOI 10.1152/jn.00988.2009; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Vierling-Claassen D, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00198; Wallace AE, 1999, RESTOR NEUROL NEUROS, V14, P35; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Wang H., 2008, P NATL ACAD SCI USA, V105, P5; WATSON CW, 1945, J NEUROPHYSIOL, V8, P221; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	152	3	3	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1632	1645		10.1089/neu.2018.6065			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900014	30484362	Green Published			2022-02-06	
J	Macerollo, A; Edwards, MJ; Huang, HC; Lu, MK; Chen, HJ; Tsai, CH; Chen, JC				Macerollo, Antonella; Edwards, Mark J.; Huang, Hui-Chun; Lu, Ming-Kuei; Chen, Hsuan-Ju; Tsai, Chon-Haw; Chen, Jui Cheng			Peripheral trauma and risk of dystonia: What are the evidences and potential co-risk factors from a population insurance database?	PLOS ONE			English	Article							ONSET BLEPHAROSPASM; CERVICAL DYSTONIA; FOCAL DYSTONIA; SCOLIOSIS	Background Dystonia is a neurological syndrome typically resulting in abnormal postures. Objectives We tested the role of physical injury as potential risk factor for development of dystonia using The National Health Insurance Research Database of Taiwan. Methods We identified 65704 people who were coded in the database as having had peripheral traumatic injuries (ICD-9-CM 807-848 and 860-959) in the year 2000. Patients with traumatic brain or spine injuries were excluded from analysis. We matched them using purposive sampling with 65704 people in the database who had not suffered peripheral trauma. We looked then at the incidence of dystonia occurring at least 1 year from the date of the peripheral trauma until 2011. Psychiatric symptoms (depression and anxiety) and sleeps difficulties have been investigated as potential covariates. Results We found 189 patients with dystonia (0.28%) in the trauma group, and 52 patients with dystonia (0.08%) in the non-trauma group. Trauma was independently associated with dystonia (adjusted HR = 3.12, 95% CI = 2.30-4.24). The incidence density of dystonia in the trauma group was 2.27 per 10000 person-years, while it was 0.71 per 10000 person-years in the non-trauma group Beyond the peripheral trauma, other variables associated to the incidence of dystonia included female sex, aged 40 years and above, depression and sleep disorders. Conclusion These data from a large population dataset support traumatic injury as a risk factor for the development of dystonia.	[Macerollo, Antonella] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Macerollo, Antonella] Univ Liverpool, Fac Hlth & Life Sci, Sch Psychol, Liverpool, Merseyside, England; [Edwards, Mark J.] St Georges Univ London, Dept Mol & Clin Sci, London, England; [Huang, Hui-Chun; Lu, Ming-Kuei; Tsai, Chon-Haw; Chen, Jui Cheng] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Lu, Ming-Kuei; Chen, Hsuan-Ju; Tsai, Chon-Haw; Chen, Jui Cheng] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan		Chen, JC (corresponding author), China Med Univ Hosp, Dept Neurol, Taichung, Taiwan.; Chen, JC (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.	andrewtw717@gmail.com	Lu, Ming-Kuei/AAF-3338-2020; Edwards, Mark J/F-1052-2012	Lu, Ming-Kuei/0000-0002-2768-4399; Edwards, Mark J/0000-0002-8283-9015	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10601010036]; Taiwan Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo, Kiyo Aoshima Memorial Funds, Japan [MOST 105-2911-I-039 -501, 105-2911-I-039-505, DMR-105181, DMR-106-205, MOST 105-2632-B-039-003, MOST 105-2314-B-039-005-MY2, CMU104-N-12]	Funding for this study was provided by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10601010036), Taiwan Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo, Kiyo Aoshima Memorial Funds, Japan, MOST 105-2911-I-039 -501, 105-2911-I-039-505, DMR-105181, DMR-106-205, MOST 105-2632-B-039-003-, MOST 105-2314-B-039-005-MY2 and CMU104-N-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzino L, 2010, EUR J NEUROL, V17, P576, DOI 10.1111/j.1468-1331.2009.02884.x; Berman BD, 2017, J NEUROL NEUROSUR PS, V88, P595, DOI 10.1136/jnnp-2016-315461; BHATIA KP, 1993, BRAIN, V116, P843, DOI 10.1093/brain/116.4.843; Defazio G, 1998, J NEUROL NEUROSUR PS, V64, P25, DOI 10.1136/jnnp.64.1.25; Defazio G, 2007, J NEUROL NEUROSUR PS, V78, P877, DOI 10.1136/jnnp.2007.119891; Defazio G, 2011, NEUROLOGY, V77, P631, DOI 10.1212/WNL.0b013e3182299e13; Defazio G, 2003, NEUROLOGY, V60, P1012, DOI 10.1212/01.WNL.0000049932.22065.60; Defazio G, 2017, NEUROL SCI, V38, P819, DOI 10.1007/s10072-017-2839-3; Edwards MJ, 2013, CURR OPIN NEUROL, V26, P442, DOI 10.1097/WCO.0b013e3283633953; Frei K, 2017, J NEUROL SCI, V379, P183, DOI 10.1016/j.jns.2017.05.040; Frei KP, 2004, MOVEMENT DISORD, V19, P1492, DOI 10.1002/mds.20239; JANKOVIC J, 1991, NEUROLOGY, V41, P1088, DOI 10.1212/WNL.41.7.1088; LANG AE, 1995, CAN J NEUROL SCI, V22, P136, DOI 10.1017/S031716710004021X; Macerollo A, 2015, J NEUROL NEUROSUR PS, V86, P933, DOI 10.1136/jnnp-2014-309040; Macerollo A, 2015, DYSTONIA DYSTONIC SY; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Martino D, 2013, J NEUROL, V260, P1081, DOI 10.1007/s00415-012-6765-2; Martino D, 2007, MOVEMENT DISORD, V22, P576, DOI 10.1002/mds.21322; Martino D, 2007, J NEUROL NEUROSUR PS, V78, P260, DOI 10.1136/jnnp.2006.103713; Martino D, 2012, MOVEMENT DISORD, V27, P1447, DOI 10.1002/mds.25088; Miller KE, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0827-1; Molloy A, 2015, J NEUROL NEUROSUR PS, V86, P331, DOI 10.1136/jnnp-2014-307699; Newman JRB, 2014, J CLIN NEUROSCI, V21, P2145, DOI 10.1016/j.jocn.2014.03.032; Roze E, 2009, BRAIN, V132, P756, DOI 10.1093/brain/awn363; Schrag A, 2004, BRAIN, V127, P2360, DOI 10.1093/brain/awh262; Schweinfurth JM, 2002, LARYNGOSCOPE, V112, P220, DOI 10.1097/00005537-200202000-00004; SHALE H, 1987, MOVEMENT DISORD, V2, P321, DOI 10.1002/mds.870020411; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Zurowski M, 2013, MOVEMENT DISORD, V28, P914, DOI 10.1002/mds.25501; ANN NEUROL, V48, P113	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2019	14	5							e0216772	10.1371/journal.pone.0216772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HX7AR	WOS:000467556300049	31075156	Green Accepted, Green Published, Green Submitted, gold			2022-02-06	
J	Tabor, J; Collins, R; Debert, CT; Shultz, SR; Mychasiuk, R				Tabor, Jason; Collins, Reid; Debert, Chantel T.; Shultz, Sandy R.; Mychasiuk, Richelle			Neuroendocrine Whiplash: Slamming the Breaks on Anabolic-Androgenic Steroids Following Repetitive Mild Traumatic Brain Injury in Rats May Worsen Outcomes	FRONTIERS IN NEUROLOGY			English	Article						concussion; adolescent; prefrontal cortex; pituitary; amygdala; HPA axis	PITUITARY-ADRENAL AXIS; ESTROGEN-RECEPTOR-ALPHA; MESSENGER-RNA LEVELS; GENE-EXPRESSION; NANDROLONE DECANOATE; RISK-FACTORS; HIPPOCAMPAL NEUROGENESIS; PREFRONTAL CORTEX; OXIDATIVE STRESS; CONCUSSION	Sport-related concussion is an increasingly common injury among adolescents, with repetitive mild traumatic brain injuries (RmTBI) being a significant risk factor for long-term neurobiological and psychological consequences. It is not uncommon for younger professional athletes to consume anabolic-androgenic steroids (AAS) in an attempt to enhance their performance, subjecting their hormonally sensitive brains to potential impairment during neurodevelopment. Furthermore, RmTBI produces acute neuroendocrine dysfunction, specifically in the anterior pituitary, disrupting the hypothalamic-pituitary adrenal axis, lowering cortisol secretion that is needed to appropriately respond to injury. Some AAS users exhibit worse symptoms post-RmTBI if they quit their steroid regime. We sought to examine the pathophysiological outcomes associated with the abrupt cessation of the commonly abused AAS, Metandienone (Met) on RmTBI outcomes in rats. Prior to injury, adolescent male rats received either Met or placebo, and exercise. Rats were then administered RmTBIs or sham injuries, followed by steroid and exercise cessation (SEC) or continued treatment. A behavioral battery was conducted to measure outcomes consistent with clinical representations of post-concussion syndrome and chronic AAS exposure, followed by analysis of serum hormone levels, and qRT-PCR for mRNA expression and telomere length. RmTBI increased loss of consciousness and anxiety-like behavior, while also impairing balance and short-term working memory. SEC induced hyperactivity while Met treatment alone increased depressive-like behavior. There were cumulative effects whereby RmTBI and SEC exacerbated anxiety and short-term memory outcomes. mRNA expression in the prefrontal cortex, amygdala, hippocampus, and pituitary were modified in response to Met and SEC. Analysis of telomere length revealed the negative impact of SEC while Met and SEC produced changes in serum levels of testosterone and corticosterone. We identified robust changes in mRNA to serotonergic circuitry, neuroinflammation, and an enhanced stress response. Interestingly, Met treatment promoted glucocorticoid secretion after injury, suggesting that maintained AAS may be more beneficial than abstaining after mTBI.	[Tabor, Jason; Collins, Reid; Debert, Chantel T.; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Tabor, Jason; Collins, Reid; Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Debert, Chantel T.] Univ Calgary, Dept Clin Neurosci, Div Phys Med & Rehabil, Calgary, AB, Canada; [Debert, Chantel T.; Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Shultz, Sandy R.; Mychasiuk, Richelle] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Shultz, Sandy R.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia		Shultz, SR (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic, Australia.; Shultz, SR (corresponding author), Univ Melbourne, Dept Med, Melbourne, Vic, Australia.	sandy.shultz@monash.edu		Debert, Chantel/0000-0002-2704-0438	Alberta Children's Hospital Research Institute; Alberta Children's Hospital Foundation; Canadian Institute for Health ResearchCanadian Institutes of Health Research (CIHR); National Scientific and Engineering Research Council; Integrated Concussion Research Program	The authors would like to thank the Alberta Children's Hospital Research Institute, Alberta Children's Hospital Foundation, the Canadian Institute for Health Research, the National Scientific and Engineering Research Council, and the Integrated Concussion Research Program for their financial support.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Afonso VM, 2003, PHYSIOL BEHAV, V80, P19, DOI 10.1016/S0031-9384(03)00216-6; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Alsio J, 2009, BASIC CLIN PHARMACOL, V105, P307, DOI 10.1111/j.1742-7843.2009.00439.x; Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; Arzt E, 1999, FRONT NEUROENDOCRIN, V20, P71, DOI 10.1006/frne.1998.0176; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Avtanski D, 2014, MOL ENDOCRINOL, V28, P40, DOI 10.1210/me.2013-1245; Bahrke MS, 2000, SPORTS MED, V29, P397, DOI 10.2165/00007256-200029060-00003; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; CALOGERO AE, 1990, ENDOCRINOLOGY, V126, P1888, DOI 10.1210/endo-126-4-1888; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chester DS, 2015, BEHAV BRAIN RES, V283, P97, DOI 10.1016/j.bbr.2015.01.034; Clark AS, 2003, NEUROSCI BIOBEHAV R, V27, P413, DOI 10.1016/S0149-7634(03)00064-2; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Crowley SK, 2014, PSYCHOPHARMACOLOGY, V231, P3619, DOI 10.1007/s00213-014-3572-8; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; Davis SW, 2013, CURR TOP DEV BIOL, V106, P1, DOI 10.1016/B978-0-12-416021-7.00001-8; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Faul M, 2010, TRAUMATIC BRAIN INJU; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Germanakis I, 2013, FOOD CHEM TOXICOL, V61, P101, DOI 10.1016/j.fct.2013.03.018; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Godar SC, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv035; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Grimes JM, 2006, BEHAV NEUROSCI, V120, P1242, DOI 10.1037/0735-7044.120.6.1242; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Handelsman DJ, 1997, INT J ANDROL, V20, P159, DOI 10.1046/j.1365-2605.1997.d01-285.x; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jabbi M, 2007, MOL PSYCHIATR, V12, P483, DOI 10.1038/sj.mp.4001975; JAROW JP, 1990, AM J SPORT MED, V18, P429, DOI 10.1177/036354659001800417; Jensen JB, 1999, J NEUROENDOCRINOL, V11, P465; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Kanayama G, 2008, DRUG ALCOHOL DEPEN, V98, P1, DOI 10.1016/j.drugalcdep.2008.05.004; Kanayama G, 2010, DRUG ALCOHOL DEPEN, V109, P6, DOI 10.1016/j.drugalcdep.2010.01.011; KASHKIN KB, 1989, JAMA-J AM MED ASSOC, V262, P3166, DOI 10.1001/jama.262.22.3166; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Li DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111741; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Lorang M, 2011, J CHILD ADOLES SUBST, V20, P358, DOI 10.1080/1067828X.2011.598842; Lumia AR, 2010, PHYSIOL BEHAV, V100, P199, DOI 10.1016/j.physbeh.2010.01.007; Matrisciano F, 2010, NEUROPHARMACOLOGY, V58, P1078, DOI 10.1016/j.neuropharm.2010.01.015; McBride JA, 2016, ASIAN J ANDROL, V18, P373, DOI 10.4103/1008-682X.173938; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mills J, 2001, NEUROSURGERY, V70, P205, DOI [10.1227/neu.013e3182250918, DOI 10.1227/NEU.013E3182250918]; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Naoi M, 2018, J NEURAL TRANSM, V125, P53, DOI 10.1007/s00702-017-1709-8; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piacentino D, 2015, CURR NEUROPHARMACOL, V13, P101, DOI 10.2174/1570159X13666141210222725; Pomara C, 2015, CURR NEUROPHARMACOL, V13, P132, DOI 10.2174/1570159X13666141210221434; POPE HG, 1994, ARCH GEN PSYCHIAT, V51, P375, DOI 10.1001/archpsyc.1994.03950050035004; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rainer Q, 2014, NEUROPHARMACOLOGY, V83, P79, DOI 10.1016/j.neuropharm.2014.03.015; Ricci LA, 2006, PHARMACOL BIOCHEM BE, V85, P1, DOI 10.1016/j.pbb.2006.06.022; Ritchie EV, 2018, BRAIN INJURY, V32, P523, DOI 10.1080/02699052.2018.1429662; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Rosenberg D, 2002, ANN NY ACAD SCI, V968, P65, DOI 10.1111/j.1749-6632.2002.tb04327.x; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Salas-Ramirez KY, 2010, BEHAV BRAIN RES, V208, P328, DOI 10.1016/j.bbr.2009.11.026; Salberg S, 2018, J NEUROTRAUM, V35, P1895, DOI 10.1089/neu.2018.5744; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Schlussman SD, 2000, NEUROSCI LETT, V284, P190, DOI 10.1016/S0304-3940(00)01016-8; Scully KM, 1997, MOL ENDOCRINOL, V11, P674, DOI 10.1210/me.11.6.674; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shahidi NT, 2001, CLIN THER, V23, P1355, DOI 10.1016/S0149-2918(01)80114-4; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Thiblin I, 1999, BRIT J PHARMACOL, V126, P1301, DOI 10.1038/sj.bjp.0702412; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Wu FCW, 1997, CLIN CHEM, V43, P1289; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zilles K., 1985, CORTEX RAT STEREOTAX	115	3	3	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 8	2019	10								481	10.3389/fneur.2019.00481			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX4EF	WOS:000467346700001	31133974	Green Published, gold			2022-02-06	
J	Castano-Leon, AM; Cicuendez, M; Navarro, B; Paredes, I; Munarriz, PM; Cepeda, S; Hilario, A; Ramos, A; Gomez, PA; Lagares, A				Castano-Leon, Ana M.; Cicuendez, Marta; Navarro, Blanca; Paredes, Igor; Munarriz, Pablo M.; Cepeda, Santiago; Hilario, Amaya; Ramos, Ana; Gomez, Pedro A.; Lagares, Alfonso			Longitudinal Analysis of Corpus Callosum Diffusion Tensor Imaging Metrics and its Association with Neurological Outcome	JOURNAL OF NEUROTRAUMA			English	Article						axial diffusivity; diffusion tensor imaging; fractional anisotropy; longitudinal analysis; ordinal regression analysis; outcome measures; radial diffusivity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; WHITE-MATTER CHANGES; AXONAL INJURY; HEAD-INJURY; SERIAL CHANGES; MODERATE; MR; EPIDEMIOLOGY; MANAGEMENT; INTEGRITY	Traumatic axonal injury (TAI) is the main cause of cognitive and psychological disfunction after a traumatic brain injury (TBI). Diffusion tensor imaging (DTI) is considered a useful technique for indirect assessment of white matter (WM) integrity after a TBI. Scattered WM alterations and its relationship with patient severity have been discovered in normal appearing conventional magnetic resonance imaging (MRI) studies based on DTI sequences. However, there is a lack of large sample studies on the longitudinal changes of DTI metrics to be used to determine the temporal profile after head injury and its association with patient outcome. We performed a prospective observational study in 118 moderate-to-severe TBI patients. The study included clinical outcome assessment based on the Glasgow Outcome Scale Extended (GOSE) and serial DTI studies in the early subacute setting (< 60 days) and 6 and 12 months after injury. Fractional anisotropy (FA) and axial and radial diffusivities (AD and RD, respectively) were measured in the three portions of corpus callosum (genu, body, splenium) at each time-point and compared with normalized values from an age-matched control group. Longitudinal FA analysis and its correlation with patient improvement also was done by non-parametric testing and ordinal regression analysis. Our main results indicated that between all the time-points, dynamic changes in DTI metrics in all three portions of corpus callosum were detected, but TBI patients continued to show significantly lower FA and AD values and higher RD values compared with controls. We also have discovered differences in the change of DTI metrics among different time-points in patient subgroups according with their outcome improvement. In conclusion, even without normalization of DTI metrics in the long-term, knowledge of the temporal profile of change in DTI metrics can provide important information about patients' clinical recovery after TBI.	[Castano-Leon, Ana M.; Cicuendez, Marta; Navarro, Blanca; Paredes, Igor; Munarriz, Pablo M.; Cepeda, Santiago; Gomez, Pedro A.; Lagares, Alfonso] Univ Complutense Madrid, Hosp Univ 12 Octubre, Dept Neurosurg, Avda Cordoba SN, Madrid 28041, Spain; [Hilario, Amaya; Ramos, Ana] Univ Complutense Madrid, Hosp Univ 12 Octubre, Dept Radiol, Madrid, Spain		Castano-Leon, AM (corresponding author), Univ Complutense Madrid, Hosp Univ 12 Octubre, Dept Neurosurg, Avda Cordoba SN, Madrid 28041, Spain.	ana.maria.castano.leon@gmail.com	Castano-Leon, Ana M/ABF-6322-2020; Cepeda, Santiago/AAE-3200-2021; Munarriz, Pablo M/S-3398-2018; Paredes, Igor/AAW-6313-2021; Lagares, Alfonso/B-2969-2011; Gomez, Pedro/E-2411-2014	Castano-Leon, Ana M/0000-0002-7918-5049; Cepeda, Santiago/0000-0003-1667-8548; Munarriz, Pablo M/0000-0002-9888-7046; Paredes, Igor/0000-0002-3846-4164; Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238	ISCIII European institution; FEDER European institution; FIS project [PI14/0157]	This research was jointly funded by the ISCIII and FEDER European institutions, with FIS project number PI14/0157. The sponsor had no role in the design or conduct of this research.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Leon AMC, 2018, J NEUROTRAUM, V35, P2365, DOI 10.1089/neu.2018.5691; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JENNETT B, 1975, LANCET, V1, P480; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Ljungqvist J, 2017, BRAIN INJURY, V31, P344, DOI 10.1080/02699052.2016.1256500; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Verde AR, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00051; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429	52	3	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2019	36	19					2785	2802		10.1089/neu.2018.5978		MAY 2019	18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JB8IG	WOS:000469288600001	30963801				2022-02-06	
J	Booth, M; Powell, J; McKeon, PO; McKeon, JMM				Booth, Matthew; Powell, Jacob; McKeon, Patrick O.; McKeon, Jennifer M. Medina			Vestibular Rehabilitation Therapy for Management of Concussion: A Critically Appraised Topic	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						injury management; traumatic brain injury; postural control	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; ADHERENCE; CONSENSUS; DIZZINESS; SYMPTOMS	Focused Clinical Question: In patients who have sustained a concussion, does vestibular rehabilitation therapy improve clinical symptoms of dizziness and self-reported balance deficits and/or influence return-to-participation timelines beyond that of preintervention scores or standard care? Clinical Bottom Line: The evidence supported the use of VRT to attenuate clinical symptoms of dizziness and self-reported balance deficits.	[Booth, Matthew; McKeon, Patrick O.; McKeon, Jennifer M. Medina] Ithaca Coll, Exercise & Sport Sci, Ithaca, NY 14850 USA; [Booth, Matthew] Univ N Carolina, Chapel Hill, NC 27515 USA; [Powell, Jacob] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA		McKeon, JMM (corresponding author), Ithaca Coll, Exercise & Sport Sci, Ithaca, NY 14850 USA.	jmckeon@ithaca.edu		Powell, Jacob/0000-0002-3899-9433			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Brewer BW, 2003, J ATHL TRAINING, V38, P158; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fisher A. Craig, 1993, Journal of Athletic Training, V28, P312; Goldsmith ES, 2018, J GEN INTERN MED, V33, pS61, DOI 10.1007/s11606-018-4327-8; Gordon S., 1991, AUST J SCI MED SPORT, V23, P53, DOI [https://doi.org/10.1016/S0031-9406(10)61642-2, DOI 10.1016/S0031-9406(10)61642-2]; Henderson J., 2015, 2015 ATHLETIC TRAINE; Howard JS, 2018, INT J ATHL THER TRAI, V23, P53, DOI 10.1123/ijatt.2018-0020; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McDonnell MN, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub4; McKeon PO, 2016, INT J ATHL THER TRAI, V21, P1, DOI 10.1123/ijatt.2016-0062; Moore Brian M, 2016, J Allied Health, V45, pe59; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Niven A, 2007, J SPORT REHABIL, V16, P93, DOI 10.1123/jsr.16.2.93; Quatman-Yates C, 2016, PHYS THER, V96, P1753, DOI 10.2522/ptj.20150557; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Wilkerson GB, 2018, J ATHL TRAINING, V53, P320, DOI 10.4085/1062-6050-8-17; 2017, INT J ATHL THER TRAI, V22, P1, DOI DOI 10.1123/IJATT.2017-0088	27	3	3	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	MAY	2019	24	3					100	107		10.1123/ijatt.2018-0057			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HW1VQ	WOS:000466471600003		Bronze			2022-02-06	
J	Bouvier, D; Balayssac, D; Durif, J; Mourgues, C; Sarret, C; Pereira, B; Sapin, V				Bouvier, Damien; Balayssac, David; Durif, Julie; Mourgues, Charline; Sarret, Catherine; Pereira, Bruno; Sapin, Vincent			Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury-PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial	BMJ OPEN			English	Article							MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CHILDREN; PECARN; ELIMINATION; VALIDATION; GUIDELINES; DESIGN; FAMILY	Introduction S100B serum analysis in clinical routine could reduce the number of cranial CT (CCT) scans performed on children with mild traumatic brain injury (mTBI). Sampling should take place within 3 hours of trauma and cut-off levels should be based on paediatric reference ranges. The aim of this study is to evaluate the utility of measuring serum S100B in the management of paediatric mTBI by demonstrating a decrease in the number of CCT scans prescribed in an S100B biomonitoring group compared with a 'conventional management' control group, with the assumption of a 30% relative decrease of the number of CCT scans between the two groups. Methods and analysis The protocol is a randomised, multicentre, unblinded, prospective, interventional study (nine centres) using a stepped wedge cluster design, comparing two groups (S100B biomonitoring and control). Children in the control group will have CCT scans or be hospitalised according to the current recommendations of the French Society of Paediatrics (SFP). In the S100B biomonitoring group, blood sampling to determine serum S100B protein levels will take place within 3 hours after mTBI and subsequent management will depend on the assay. If S100B is in the normal range according to age, the children will be discharged from the emergency department after 6 hours' observation. If the result is abnormal, CCT scans or hospitalisation will be prescribed in accordance with current SFP recommendations. The primary outcome measure will be the proportion of CCT scans performed (absence/presence of CCT scan for each patient) in the 48 hours following mTBI. Ethics and dissemination The protocol presented (Version 5, 03 November 2017) has been approved by the ethics committee Comite de Protection des Personnes sud-est 6 (first approval 08 June 2016, IRB: 00008526). Participation in the study is voluntary and anonymous. The study findings will be disseminated in international peer-reviewed journals and presented at relevant conferences.	[Bouvier, Damien; Sapin, Vincent] Univ Clermont Auvergne, CHU Clermont Ferrand, Biochem & Mol Genet Dept, CNRS,INSERM,GReD, Clermont Ferrand, France; [Balayssac, David] Univ Clermont Auvergne, CHU Clermont Ferrand, DRCI, NEURO DOL,INSERM,U1107, Clermont Ferrand, France; [Durif, Julie] CHU Clermont Ferrand, Biochem & Mol Genet Dept, Clermont Ferrand, France; [Mourgues, Charline; Pereira, Bruno] CHU Clermont Ferrand, DRCI, Clermont Ferrand, France; [Sarret, Catherine] CHU Clermont Ferrand, Pediat Dept, Clermont Ferrand, France		Bouvier, D (corresponding author), Univ Clermont Auvergne, CHU Clermont Ferrand, Biochem & Mol Genet Dept, CNRS,INSERM,GReD, Clermont Ferrand, France.	dbouvier@chu-clermontferrand.fr	Balayssac, David/AAZ-3007-2020; Balayssac, David/K-2265-2015	Balayssac, David/0000-0002-6126-6588; Bouvier, Damien/0000-0002-2707-4320	French Ministry of Health [PHRC-15-188]	This study is funded by a grant from the French Ministry of Health (PHRC-15-188).	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Hemming K, 2014, STATA J, V14, P363, DOI 10.1177/1536867X1401400208; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lorton F, 2014, ARCH PEDIATRIE, V21, P790, DOI 10.1016/j.arcped.2014.04.015; Machin D, 2004, J INTERN MED, V255, P521, DOI 10.1111/j.1365-2796.2004.01319.x; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mdege ND, 2011, J CLIN EPIDEMIOL, V64, P936, DOI 10.1016/j.jclinepi.2010.12.003; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	44	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2019	9	5							e027365	10.1136/bmjopen-2018-027365			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7YG	WOS:000471192800269	31129587	Green Published, gold			2022-02-06	
J	Bussey, MD; McLean, M; Pinfold, J; Anderson, N; Kiely, R; Romanchuk, J; Salmon, D				Bussey, M. D.; McLean, M.; Pinfold, J.; Anderson, N.; Kiely, R.; Romanchuk, J.; Salmon, D.			History of concussion is associated with higher head acceleration and reduced cervical muscle activity during simulated rugby tackle: An exploratory study	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Head acceleration; Rugby union; EMG; Impact sensor; Rugby tackle	SEGMENT DYNAMIC STABILIZATION; INJURIES; SPORTS; EPIDEMIOLOGY; PLAYERS; RISK; ACTIVATION; STRENGTH; IMPACTS; LEAGUE	Objectives: The objective of this study is to explore the effect of concussion history on head control during front on rugby tackles in non-professional male and female Rugby Union players. Design: An observational cross-sectional design. Setting: A laboratory-based study of simulated front on rugby tackles with a dynamic relatively-weighted (similar to 50% body-mass) tackle bag. Participants: 27 club Rugby Union players were recruited; 10 (7female) with no-concussion history, 10 (3female) within 12-months of concussion and 7 (3female) with 24 + months since last concussion. Main outcome measures: Linear and rotational head acceleration measured with a skin mounted CSx (R) triaxial accelerometer. Normalized Surface EMG amplitude of the bilateral sternocleidomastoid (Scm), upper trapezius (Trap) and splenius capitis (Spl). All outcome measures were synchronised with moment of impact with the tackle bag. Results: A mixed-model analysis showed that players with 12-Month concussion history had the highest head acceleration (females = 48.6g, males = 68.3g, p < 0.05) with lower Trap (6.9-11.7%, p < 0.05) and Spl (3-12%, p < 0.05) amplitudes compared to athletes with No-concussion. Conclusions: These findings suggest probable disruption to neuromuscular control of the head in athletes with concussion history as a potential mechanism for recurrent concussion incidence. (C) 2019 Elsevier Ltd. All rights reserved.	[Bussey, M. D.; McLean, M.; Pinfold, J.; Anderson, N.; Romanchuk, J.] Univ Otago, Sch Phys Educ Sport & Exercise Sci, Dunedin 9013, New Zealand; [Kiely, R.] Australian Sports Inst, Bruce, Australia; [Salmon, D.] New Zealand Rugby, Wellington, New Zealand		Bussey, MD (corresponding author), Univ Otago, Sch Phys Educ Sport & Exercise Sci, Dunedin 9013, New Zealand.	melanie.bussey@otago.ac.nz		Bussey, Melanie/0000-0002-5746-3861; Romanchuk, Janelle/0000-0002-8442-9589	School of Physical Education Sport and Exercise Sciences; CSx Systems Ltd (Auckland, New Zealand)	This study was funded by the School of Physical Education Sport and Exercise Sciences, there was no additional external funding received for this study. CSx Systems Ltd (http://csx.co.nz/, Auckland, New Zealand) provided support for this study by offering the impact sensors without cost. The funder did not have any role on the designing of the study and has not role on deciding whether the report can be submitted for publication.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Cholewicki J, 2000, J BIOMECH, V33, P1377, DOI 10.1016/S0021-9290(00)00118-4; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Falla D, 2004, J ELECTROMYOGR KINES, V14, P463, DOI 10.1016/j.jelekin.2004.03.003; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gardner-Morse M. G, 2001, J BIOMECHANICS, V34; Gennarelli T. A, 1983, HEAD INJURY MAN EXPT, DOI [10.1007/978-3-7091-4147-2_1, DOI 10.1007/978-3-7091-4147-2_1]; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hamish O., 2017, BRIT J SPORT MED, V51, pA4, DOI DOI 10.1136/BJSPORTS-2016-097270.8; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hermens HJ., 1999, EUROPEAN RECOMMENDAT; Hides JA, 2017, MED SCI SPORT EXER, V49, P2385, DOI 10.1249/MSS.0000000000001372; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hides JA, 2016, MANUAL THER, V24, P46, DOI 10.1016/j.math.2016.05.001; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kemp SP, 2015, ENGLAND PROFESSIONAL; King D, 2017, SPORTS MED, V47, P197, DOI 10.1007/s40279-016-0576-z; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Kumar S, 2005, CLIN BIOMECH, V20, P343, DOI 10.1016/j.clinbiomech.2004.11.016; Lee SH, 2006, ACM T GRAPHIC, V25, P1188, DOI 10.1145/1141911.1142013; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Register-Mihalik JK, 2017, NEUROL CLIN, V35, P387, DOI 10.1016/j.ncl.2017.03.009; Salmon DM, 2018, J STRENGTH COND RES, V32, P2166, DOI 10.1519/JSC.0000000000001874; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P398, DOI 10.1016/j.jelekin.2010.01.002; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Smart DJ, 2013, J STRENGTH COND RES, V27, P3033, DOI 10.1519/JSC.0b013e31828c26d3; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	42	3	3	0	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAY	2019	37						105	112		10.1016/j.ptsp.2019.03.012			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HZ2ZD	WOS:000468716400018	30928840				2022-02-06	
J	Flatt, AA; Wilkerson, GB; Allen, JR; Keith, CM; Esco, MR				Flatt, Andrew A.; Wilkerson, Gary B.; Allen, Jeff R.; Keith, Clay M.; Esco, Michael R.			Daily Heart Rate Variability before and after Concussion in an American College Football Player	SPORTS			English	Article						autonomic; cardiac-parasympathetic; traumatic brain injury; sports medicine; sports science	SPORTS CONCUSSION; EXERCISE; CONNECTIVITY; RELIABILITY; ADAPTATION; RESPONSES; MARKERS; SYSTEM; TIME; TERM	This case report demonstrates the effects of sport-related concussion (SRC) on heart rate variability (HRV) in an American college football player. Daily measures of resting, ultra-short natural logarithm of the root mean square of successive differences (LnRMSSD), subjective wellbeing, and Player Load were obtained each training day throughout a 4-week spring camp and 4 weeks of preseason training. SRC occurred within the first 2 weeks of the preseason. During spring camp and preseason pre-SRC, the athlete demonstrated minimal day-to-day fluctuations in LnRMSSD, which increased post-SRC (LnRMSSD coefficient of variation pre-SRC 3.1%, post-SRC = 5.8%). Moderate decrements in daily-averaged LnRMSSD were observed post-SRC relative to pre-SRC (Effect Size +/- 90% Confidence Interval = -1.12 +/- 0.80), and the 7-day rolling average fell below the smallest worthwhile change for the remainder of the preseason. LnRMSSD responses to SRC appeared similar to trends associated with stress and training fatigue. Therefore, performance and sports medicine staff should maintain regular communication regarding player injury and fatigue status so that HRV can be interpreted in the appropriate context. Detection and monitoring of autonomic dysregulation post-SRC may require near-daily assessment, as LnRMSSD showed greater daily fluctuations rather than chronic suppression following the head injury.	[Flatt, Andrew A.] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Biodynam & Human Performance Ctr, 11935 Abercorn, St Savannah, GA 31419 USA; [Flatt, Andrew A.; Esco, Michael R.] Univ Alabama, Dept Kinesiol, Exercise Physiol Lab, Tuscaloosa, AL 35487 USA; [Wilkerson, Gary B.] Univ Tennessee, Grad Athlet Training Program, Chattanooga, TN 37403 USA; [Allen, Jeff R.; Keith, Clay M.] Univ Alabama, Dept Athlet Sports Med, Tuscaloosa, AL 35487 USA		Flatt, AA (corresponding author), Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Biodynam & Human Performance Ctr, 11935 Abercorn, St Savannah, GA 31419 USA.; Flatt, AA (corresponding author), Univ Alabama, Dept Kinesiol, Exercise Physiol Lab, Tuscaloosa, AL 35487 USA.	aflatt@georgiasouthern.edu; gary-wilkerson@utc.edu; jallen@ia.ua.edu; ckeith@ia.ua.edu; mresco@ua.edu	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329; Flatt, Andrew/0000-0003-2998-8537			Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Boyd LJ, 2011, INT J SPORT PHYSIOL, V6, P311, DOI 10.1123/ijspp.6.3.311; Cohen J, 1998, STAT POWER ANAL BEHA; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Flatt AA, 2020, J STRENGTH COND RES, V34, P1649, DOI 10.1519/JSC.0000000000002475; Flatt AA, 2019, J SCI MED SPORT, V22, P616, DOI 10.1016/j.jsams.2018.11.022; Flatt AA, 2018, J STRENGTH COND RES, V32, P3127, DOI 10.1519/JSC.0000000000002241; Flatt AA, 2018, SPORTS, V6, DOI 10.3390/sports6030093; Flatt AA, 2019, J SCI MED SPORT, V22, P222, DOI 10.1016/j.jsams.2018.07.014; Flatt AA, 2017, J SCI MED SPORT, V20, P606, DOI 10.1016/j.jsams.2016.10.017; Flatt AA, 2016, J STRENGTH COND RES, V30, P378, DOI 10.1519/JSC.0000000000001095; Fullagar HHK, 2017, INT J SPORT PHYSIOL, V12, P1264, DOI 10.1123/ijspp.2016-0550; Holzman JB, 2017, NEUROSCI BIOBEHAV R, V74, P233, DOI 10.1016/j.neubiorev.2016.12.032; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jennings JR, 2016, PSYCHOPHYSIOLOGY, V53, P444, DOI 10.1111/psyp.12586; La Fountaine MF, 2018, INT J PSYCHOPHYSIOL, V132, P155, DOI 10.1016/j.ijpsycho.2017.11.016; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; Laborde S, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e01002; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; Nakamura FY, 2017, J STRENGTH COND RES, V31, P548, DOI 10.1519/JSC.0000000000001514; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tulppo MP, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00341; Wellman AD, 2017, J STRENGTH COND RES, V31, P2704, DOI 10.1519/JSC.0000000000002106; Winkelmann T, 2017, BRAIN STRUCT FUNCT, V222, P1061, DOI 10.1007/s00429-016-1185-1	37	3	3	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4663		SPORTS	Sports	MAY	2019	7	5							97	10.3390/sports7050097			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	IC4TC	WOS:000470957300002	31035597	gold, Green Published, Green Submitted			2022-02-06	
J	Hardesty, W; Singichetti, B; Yi, HG; Leonard, JC; Yang, JZ				Hardesty, Walter; Singichetti, Bhavna; Yi, Honggang; Leonard, Julie C.; Yang, Jingzhen			CHARACTERISTICS AND COSTS OF PEDIATRIC EMERGENCY DEPARTMENT VISITS FOR SPORTS- AND RECREATION-RELATED CONCUSSIONS, 2006-2014	JOURNAL OF EMERGENCY MEDICINE			English	Article						concussion; ED utilization; healthcare cost; policy	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; HEALTH-CARE UTILIZATION; LYSTEDT LAW; CHILDREN; MANAGEMENT; LEGISLATION; TRENDS; RULES	Background: Although concussion-related emergency department (ED) visits increased after the passage of concussion laws, little is known about how the laws may disproportionately impact ED utilization and associated health care costs among children in different demographic groups. Objective: Our aim was to examine the patient and clinical characteristics of pediatric ED visits and associated health care costs for sports-and recreation-related concussions (SRRCs) before and after concussion law enactment. Methods: We retrospectively analyzed ED visits for SRRCs by children ages 5-18 years between 2006 and 2014 in the Pediatric Health Information System database (n = 123,220). ED visits were categorized as "prelaw,'' "immediate post-law,'' and "post-law'' according to the respective state concussion law's effective date. Multinomial logistic regression models were used to assess the impact of the law on ED utilization. Results: The majority of visits were by males (n = 83,208; 67.6%), children aged 10-14 years (n = 49,863; 40.9%), and privately insured patients (n = 62,376; 50.6%). Female sex, older age, and insured by Medicaid/Medicare were characteristics associated with increased ED visits during the immediate post-law and post-law periods compared to their counterparts. A significant decrease in proportion of imaging use was observed from pre-law to post-law (adjusted odds ratio 0.49; 95% confidence interval 0.47-0.50; p < 0.0001). While annual adjusted costs per ED visits decreased, annual total adjusted costs per hospital for SRRCs increased from pre-law to post-law (p < 0.0001). Conclusions: Concussion laws might have impacted pediatric concussion-related ED utilization, with increased annual total adjusted costs. These results may have important implications for policy interventions and their effects on health care systems. (C) 2019 Elsevier Inc. All rights reserved.	[Hardesty, Walter; Singichetti, Bhavna; Yi, Honggang; Leonard, Julie C.; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr RB3, Columbus, OH 43205 USA; [Hardesty, Walter; Leonard, Julie C.; Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Yi, Honggang] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing, Jiangsu, Peoples R China		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr RB3, Columbus, OH 43205 USA.			Leonard, Julie/0000-0003-3670-1944; Singichetti, Bhavna/0000-0002-2188-3979	College of Medicine, The Ohio State University, United States	This work was supported in part by Roessler Research Scholarship (WH) at College of Medicine, The Ohio State University, United States.	Aldana PR, ARE YOU READY SILENT; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Baker DR, 2018, AM J SPORT MED, V46, P396, DOI 10.1177/0363546517738742; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Bharadwaj S, 2016, CURR OPIN PEDIATR, V28, P121, DOI 10.1097/MOP.0000000000000297; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Getz KD, 2015, PEDIATR BLOOD CANCER, V62, P1775, DOI 10.1002/pbc.25569; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gouripeddi Ramkiran, 2012, AMIA Annu Symp Proc, V2012, P281; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Harvey HH, YOUTH SPORTS TRAUMAT; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Federation of State High School Associations, 2016, HIGH SCH SPORTS PART; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Sandoval E, 2010, J EMERG MED, V38, P115, DOI 10.1016/j.jemermed.2007.09.042; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Zamarripa A, 2017, J PEDIATR-US, V181, P229, DOI 10.1016/j.jpeds.2016.10.071	33	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAY	2019	56	5					571	579		10.1016/j.jemermed.2019.01.001			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	HV5JE	WOS:000466019400028	30857833				2022-02-06	
J	Ottomanelli, L; Bakken, S; Dillahunt-Aspillaga, C; Pastorek, N; Young, C				Ottomanelli, Lisa; Bakken, Shana; Dillahunt-Aspillaga, Christina; Pastorek, Nicholas; Young, Cynthia			Vocational Rehabilitation in the Veterans Health Administration Polytrauma System of Care: Current Practices, Unique Challenges, and Future Directions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						employment; polytrauma; traumatic brain injury; Veterans; Veterans Health Administration; vocational rehabilitation	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SUPPORTED EMPLOYMENT; COMMUNITY REINTEGRATION; SERVICE MEMBERS; UNITED-STATES; MODEL SYSTEM; VA; PREVALENCE; OUTCOMES	Objective/Purpose: Veterans and service members (V/SMs) with traumatic brain injury (TBI) and comorbid conditions are treated in the Veterans Health Administration (VHA) Polytrauma System of Care (PSC). These V/SMs comprise a unique population with distinct needs for restoring community reintegration, including participation in meaningful employment. Low employment rates after TBI vary and are influenced by many factors. Employment is a central aspect of the VHA priority of facilitating adjustment, and addressing vocational needs alongside healthcare is critical to community reintegration. The purpose of this article is to outline current practices of addressing vocational rehabilitation in the PSC, discuss the unique challenges in serving Veterans with polytrauma, and outline future directions to improve vocational services and outcomes. Methods: Briefly review literature on V/SM with TBI and employment, describe the PSC and VHA vocational programs for V/SM with polytrauma, and synthesize proceedings on vocational rehabilitation from the 2017 VHA "Community Reintegration in the Polytrauma System of Care" meeting. Conclusions: To advance and expand vocational services the following guidelines were recommended: (1) designing flexible services based on individualized needs, (2) increasing access to vocational services through communication and collaboration, (3) promoting cross-disciplinary education and engagement in vocational care, and (4) systematically tracking employment outcomes.	[Ottomanelli, Lisa; Dillahunt-Aspillaga, Christina] Univ S Florida, Coll Behav & Community Sci, Rehabil Outcomes Res Sect, James A Haley Vet Hosp,US Dept Vet Affairs, Tampa, FL USA; [Ottomanelli, Lisa; Dillahunt-Aspillaga, Christina] Univ S Florida, Coll Behav & Community Sci, Rehabil & Mental Hlth Counseling Program, Dept Child & Family Studies, Tampa, FL USA; [Bakken, Shana] Vet Hlth Adm, Off Mental Hlth & Suicide Prevent, Washington, DC USA; [Pastorek, Nicholas] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Pastorek, Nicholas] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Young, Cynthia] Hunter Holmes McGuire VA Med Ctr, Serv Member Transit Adv Rehabil STAR Program, Dept Phys Med & Rehabil, Richmond, VA USA		Ottomanelli, L (corresponding author), Rehabil Outcomes Res Sect, 151R,8900 Grand Oak Circle, Tampa, FL 33637 USA.	Lisa.Ottomanelli-Slone@va.gov		Pastorek, Nicholas/0000-0002-9290-380X	Veterans Health Administration, US Department of Veterans AffairsUS Department of Veterans Affairs	This work was supported by Veterans Health Administration, US Department of Veterans Affairs.	Abraham KM, 2017, PSYCHIAT SERV, V68, P938, DOI 10.1176/appi.ps.201600412; Beck L, 2010, OVERSIGHT HEARING ON; Benedek DM, 2011, CLINICAL MANUAL FOR; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Cifu D.X., 2015, TRAUMATIC BRAIN INJU, P6; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Department of Veterans Affairs, 2016, YVA; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dillahunt-Aspillaga C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115873; Drebing CE, 2012, J REHABIL RES DEV, V49, P101, DOI 10.1682/JRRD.2010.06.0105; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Epidemiology Program Postdeployment Health Group Office of Public Health, 2015, AN VA HLTH CAR UT OP, P13; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Golding H, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0081; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lew HL, 2013, J REHABIL RES DEV, V50, pXI, DOI 10.1682/JRRD.2013.09.0212; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Veterans Health Administration Office of Research and Development, 2013, VHA HDB 1172 01 POLY, V1172. 01, P81; Webster J, 2018, J VOCAT REHABIL, V48, P111, DOI 10.3233/JVR-170919; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	45	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		158	166		10.1097/HTR.0000000000000493			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100012	31058758				2022-02-06	
J	Regensburger, AP; Konrad, V; Trollmann, R; Eyupoglu, IY; Huebner, H; Zierk, J; Volkl, TMK; Fahlbusch, FB				Regensburger, A. P.; Konrad, V.; Trollmann, R.; Eyuepoglu, I. Y.; Huebner, H.; Zierk, J.; Voelkl, T. M. K.; Fahlbusch, F. B.			Treatment of severe traumatic brain injury in German pediatric intensive care units-a survey of current practice	CHILDS NERVOUS SYSTEM			English	Article						ICP; Neuromonitoring; Neuroimaging; Adjuvant therapy	DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; SEIZURE PROPHYLAXIS; CHILDREN; LEVETIRACETAM; EPIDEMIOLOGY; OXYGENATION; PHENYTOIN; OUTCOMES; STATES	Purpose German pediatric guidelines for severe traumatic brain injury (TBI) management expired in 2011. Thus, divergent evidence-based institutional protocols are predominantly being followed. We performed a survey of current Pediatric Intensive Care Unit (PICU) management of isolated severe TBI in Germany to reveal potential varying practices. Methods Seventy German PICUs were invited to join an anonymous online survey from February to May 2017. Twenty-nine participants (41.4%) successfully completed the survey (17 university hospitals and 12 district hospitals). The majority of items were polar (yes/no) or scaled (e.g., never - always). Main topics were imaging, neurosurgery, neuromonitoring, adjuvant therapy, and medication. Severity of TBI was defined via Glasgow Coma Scale. Results The majority of respondents (93.1%) had internal TBI standards, and patients were mainly administered to interdisciplinary trauma units. The use of advanced neuromonitoring techniques, intracranial hypertension management, and drug treatment differed between PICUs. Routine administration of hypertonic saline in TBI-associated cerebral edema was performed by 3.4%, while it was never an option for 31.0% of the participants. Prophylactic anticonvulsive therapy was restrictively performed. If indicated, the main anticonvulsive drugs used were phenobarbital and levetiracetam. Neuroendocrine follow-up was recommended/performed by 58.6% of the PICUs. Conclusions This survey provides an overview of the current PICU practices of isolated severe TBI management in Germany and demonstrates a wide instrumental and therapeutical range, revealing an unmet need for the revised national guideline and further (international) clinical trials for the treatment of severe TBI in pediatrics.	[Regensburger, A. P.; Konrad, V.; Trollmann, R.; Zierk, J.; Fahlbusch, F. B.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Pediat & Adolescent Med, Loschgestr 15, D-91054 Erlangen, Germany; [Eyuepoglu, I. Y.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Neurosurg, Erlangen, Germany; [Huebner, H.] Inst Womens Healthcare IFG, Erlangen, Germany; [Huebner, H.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Gynecol & Obstet, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany; [Voelkl, T. M. K.] Josefinum Augsburg, Dept Pediat & Adolescent Med, Augsburg, Germany		Regensburger, AP (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Pediat & Adolescent Med, Loschgestr 15, D-91054 Erlangen, Germany.	adrian.regensburger@uk-erlangen.de	Huebner, Hanna/U-1003-2019				Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; AWMF, 2011, REGISTER ID 024 018; Bakhru RN, 2016, ANN AM THORAC SOC, V13, P1527, DOI 10.1513/AnnalsATS.201601-078OC; Bansal S, 2014, J NEUROSURG-PEDIATR, V13, P209, DOI 10.3171/2013.10.PEDS13256; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Elsasser G, 2011, UNFALLE GEWALT SELBS; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; Kipfmueller F, 2013, KLIN PADIATR, V225, P34, DOI 10.1055/s-0032-1329945; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kurz JE, 2016, PEDIATR CRIT CARE ME, V17, P649, DOI 10.1097/PCC.0000000000000765; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Reinisch JF, 2016, ANN PLAS SURG, V76, P3, DOI 10.1097/SAP.0000000000000546; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Schrieff-Elson LE, 2015, CHILD NERV SYST, V31, P2257, DOI 10.1007/s00381-015-2892-2; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stowe CD, 2000, J CLIN PHARMACOL, V40, P1452; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEASDALE G, 1974, LANCET, V2, P81; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Weintraub D, 2012, NEUROREHABILITATION, V30, P219, DOI 10.3233/NRE-2012-0748; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	37	3	3	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAY	2019	35	5					815	822		10.1007/s00381-019-04098-z			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HT9IL	WOS:000464882300013	30826957				2022-02-06	
J	Thiessen, A; Brown, J; Freeland, T; Brewer, CH				Thiessen, Amber; Brown, Jessica; Freeland, Tonya; Brewer, Chung Hwa			Identification and Expression of Themes Depicted in Visual Scene and Grid Displays by Adults With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							ATTENTION PATTERNS; HUMAN ENGAGEMENT; CHRONIC APHASIA; PEOPLE; COMMUNICATION; PERFORMANCE; SURVIVORS	Purpose: The study purpose was to compare the speed and accuracy with which people with traumatic brain injury (TBI) identified themes depicted in visual scene and grid displays. Additionally, we compared the verbal responses associated with the 2 display types to determine whether adults with TBI tended to produce more action or naming messages. Method: Thirteen adults with and 13 without TBI viewed grid and visual scene displays matched for content and theme. They then provided verbal responses stating the theme or central idea of each image. Results: Although no significant differences were noted between groups for theme identification accuracy, adults with TBI required significantly more time than adults without TBI to process both display types. Both participant groups more rapidly and accurately identified visual scenes than grid displays. Additionally, participants with and without TBI produced more action messages in response to visual scenes and naming messages in response to grid displays. Conclusions: This investigation provides preliminary evidence that themes that depicted visual scenes maybe more rapidly and accurately identified than those depicted in grid displays. Additionally, visual scenes may more effectively represent action messages, and grids may more effectively represent naming messages for people with TBI.	[Thiessen, Amber] Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77004 USA; [Brown, Jessica] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA; [Freeland, Tonya] Harris Hlth Syst, Houston, TX USA; [Brewer, Chung Hwa] Eden Home Hlth, Bellingham, WA USA		Thiessen, A (corresponding author), Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77004 USA.	althiess@central.uh.edu					Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Beck A. R., 1998, AUGMENTATIVE ALTERNA, V14, P184; Beukelman DR, 2015, AUGMENT ALTERN COMM, V31, P234, DOI 10.3109/07434618.2015.1052152; Brock K, 2017, APHASIOLOGY, V31, P1282, DOI 10.1080/02687038.2016.1274874; Brown J, 2015, AUGMENT ALTERN COMM, V31, P15, DOI 10.3109/07434618.2014.995224; Brown JA, 2016, J HEAD TRAUMA REHAB, V31, pE32, DOI 10.1097/HTR.0000000000000148; Burke R, 2004, BRAIN INJURY, V18, P497, DOI 10.1080/02699050310001645784; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Dietz A., 2006, PERSPECTIVES AUGMENT, V15, P13, DOI 10.1044/aac15.1.13; Doyle M, 2000, AUG ALTER COMMUN SER, P271; Drager KDR, 2003, J SPEECH LANG HEAR R, V46, P298, DOI 10.1044/1092-4388(2003/024); Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Griffith J, 2014, AM J SPEECH-LANG PAT, V23, P213, DOI 10.1044/2014_AJSLP-13-0089; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hux K, 2010, APHASIOLOGY, V24, P643, DOI 10.1080/02687030902869299; Kertesz A., 2006, W APHASIA BATTERY RE; Koul R., 1998, AUGMENTATIVE ALTERNA, V14, DOI [10.1080/07434619812331278166, DOI 10.1080/07434619812331278166]; LIGHT J, 1991, AUGMENT ALTERN COMM, V7, P186, DOI DOI 10.1080/07434619112331275893; McKelvey ML, 2007, J MED SPEECH-LANG PA, V15, P305; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mohd Razali N., 2011, J STAT MODEL ANAL, V2, P21; Schlosser R. W., 2002, AUGMENT ALTERN COMM, V18, P102, DOI [DOI 10.1080/07434610212331281201, 10.1080/07434610212331281201]; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Simone R., 1995, ICONICITY LANGUAGE; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Thiessen A, 2017, J COMMUN DISORD, V69, P58, DOI 10.1016/j.jcomdis.2017.07.001; Thiessen A, 2017, AM J SPEECH-LANG PAT, V26, P428, DOI 10.1044/2016_AJSLP-16-0024; Thiessen A, 2016, J SPEECH LANG HEAR R, V59, P290, DOI 10.1044/2015_JSLHR-L-14-0115; Thiessen A, 2014, AUGMENT ALTERN COMM, V30, P120, DOI 10.3109/07434618.2014.905798; Thistle JJ, 2013, AUGMENT ALTERN COMM, V29, P235, DOI 10.3109/07434618.2013.815800; Underwood G, 2005, COGNITIVE PROCESS, P163; Vas AK, 2015, J CLIN EXP NEUROPSYC, V37, P152, DOI 10.1080/13803395.2014.994478; Wallace S.E, 2016, COGNITIVE COMMUNICAT, P253; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace SE, 2010, PERSPECT AUGMENT ALT, V19, P79	37	3	3	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2019	28	2					664	675		10.1044/2018_AJSLP-18-0086			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	IB2NS	WOS:000470106600022	31021655				2022-02-06	
J	Tripathi, BB; Espindola, D; Pinton, GF				Tripathi, Bharat B.; Espindola, David; Pinton, Gianmarco F.			Piecewise parabolic method for propagation of shear shock waves in relaxing soft solids: One-dimensional case	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						piecewise parabolic method; relaxation mechanisms; shear shock waves; traumatic brain injury	NUMERICAL-SIMULATION; ATTENUATION; TISSUE; MOTION; MODEL; FLOW	Shear shock waves can be generated spontaneously deep within the brain during a traumatic injury. This recently observed behavior could be a primary mechanism for the generation of traumatic brain injuries. However, shear shock wave physics and its numerical modeling are relatively unstudied. Existing numerical solvers used in biomechanics are not designed for the extremely large Mach numbers (greater than 1) observed in the brain. Furthermore, soft solids, such as the brain, have a complex nonclassical viscoleastic response, which must be accurately modeled to capture the nonlinear wave behavior. Here, we develop a 1D inviscid velocity-stress-like system to model the propagation of shear shock waves in a homogeneous medium. Then a generalized Maxwell body is used to model a relaxing medium that can describe experimentally determined attenuation laws. Finally, the resulting system is solved numerically with the piecewise parabolic method, a high-order finite volume method. The nonlinear and the relaxing components of this method are validated with theoretical predictions. Comparisons between numerical solutions obtained for the proposed model and the experiments of plane shear shock wave propagation based on high frame-rate ultrasound imaging and tracking are shown to be in excellent agreement.	[Tripathi, Bharat B.; Espindola, David; Pinton, Gianmarco F.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27515 USA; [Tripathi, Bharat B.; Espindola, David; Pinton, Gianmarco F.] North Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Pinton, Gianmarco F.] Taylor Hall,Room 348,109 Mason Farm Rd, Chapel Hill, NC 27599 USA		Pinton, GF (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27515 USA.; Pinton, GF (corresponding author), North Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.	gia@email.unc.edu		Espindola, David/0000-0001-6675-9560; Tripathi, Bharat/0000-0001-6757-0735	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS091195]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091195] Funding Source: NIH RePORTER	This work is done under the framework of NIH R01-NS091195.	Aki K., 2002, QUANTITATIVE SEISMOL, VSecond; Almgren AS, 2010, ASTROPHYS J, V715, P1221, DOI 10.1088/0004-637X/715/2/1221; BLACKSTOCK DT, 1964, J ACOUST SOC AM, V36, P534, DOI 10.1121/1.1918996; Carcione J.M., 2007, WAVE FIELDS REAL MED; Catheline S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164301; Catheline S, 2003, J ACOUST SOC AM, V114, P3087, DOI 10.1121/1.1610457; Chen W, 2004, J ACOUST SOC AM, V115, P1424, DOI 10.1121/1.1646399; Cobbold RS, 2006, FDN BIOMEDICAL ULTRA; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; Dagrau F, 2011, J ACOUST SOC AM, V130, P20, DOI 10.1121/1.3583549; DAI WL, 1994, J COMPUT PHYS, V115, P485, DOI 10.1006/jcph.1994.1212; Deffieux T, 2009, IEEE T MED IMAGING, V28, P313, DOI 10.1109/TMI.2008.925077; EMMERICH H, 1987, GEOPHYSICS, V52, P1252, DOI 10.1190/1.1442386; Espindola David, 2017, 2017 IEEE International Ultrasonics Symposium (IUS), DOI 10.1109/ULTSYM.2017.8091653; Espindola D, 2017, J ACOUST SOC AM, V141, P3549, DOI DOI 10.1121/1.4987514; Espindola D, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.044024; Giammarinaro B, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032643; Giammarinaro B, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.014011; Ginter S, 2000, ULTRASONICS, V37, P693, DOI 10.1016/S0041-624X(00)00012-3; Godunov, 1959, MAT SBORNIK, V47, P271; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Hamilton MF, 2004, J ACOUST SOC AM, V116, P41, DOI 10.1121/1.1736652; Kaser M, 2007, GEOPHYS J INT, V168, P224, DOI 10.1111/j.1365-246X.2006.03193.x; Leveque R. J., 2002, FINITE VOLUME METHOD; Lifshitz E, 1986, COURSE THEORETICAL P, V7, P3; LIU HP, 1976, GEOPHYS J ROY ASTR S, V47, P41, DOI 10.1111/j.1365-246X.1976.tb01261.x; Lombard B, 2011, J COMPUT PHYS, V230, P6099, DOI 10.1016/j.jcp.2011.04.015; Mangan R, 2016, EXTREME MECH LETT, V9, P204, DOI 10.1016/j.eml.2016.07.004; Mignone A, 2005, ASTROPHYS J SUPPL S, V160, P199, DOI 10.1086/430905; Miller GH, 2002, J COMPUT PHYS, V183, P26, DOI 10.1006/jcph.2002.7158; Miller GH, 2001, J COMPUT PHYS, V167, P131, DOI 10.1006/jcph.2000.6665; Moczo P, 1997, B SEISMOL SOC AM, V87, P1305; Moczo P., 2004, FINITE DIFFERENCE ME; Moczo P, 2014, FINITE-DIFFERENCE MODELLING OF EARTHQUAKE MOTIONS: WAVES AND RUPTURES, P1, DOI 10.1017/CBO9781139236911; OCONNELL RJ, 1978, GEOPHYS RES LETT, V5, P5, DOI 10.1029/GL005i001p00005; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Pinton G, 2010, J ACOUST SOC AM, V127, P683, DOI 10.1121/1.3277202; Renier M, 2008, AIP CONF PROC, V1022, P303, DOI 10.1063/1.2956214; Rouze NC, 2018, IEEE T ULTRASON FERR, V65, P780, DOI 10.1109/TUFFC.2018.2815505; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Smoller J, 2012, SHOCK WAVES REACTION; Sytine IV, 2000, J COMPUT PHYS, V158, P225, DOI 10.1006/jcph.1999.6416; Szabo TL, 2000, J ACOUST SOC AM, V107, P2437, DOI 10.1121/1.428630; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; TRANGENSTEIN JA, 2009, NUMERICAL SOLUTION H; Tripathi BB, 2017, SHOCK WAVES, V27, P879, DOI 10.1007/s00193-017-0734-8; Urban MW, 2009, PHYS MED BIOL, V54, P5919, DOI 10.1088/0031-9155/54/19/017; VAN LEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; Waters KR, 2000, J ACOUST SOC AM, V108, P556, DOI 10.1121/1.429586; Wochner MS, 2008, J ACOUST SOC AM, V123, P2488, DOI 10.1121/1.2890739; WOODWARD P, 1984, J COMPUT PHYS, V54, P115, DOI 10.1016/0021-9991(84)90142-6; YANG HQ, 1992, J COMPUT PHYS, V102, P139, DOI 10.1016/S0021-9991(05)80012-9; Ye W, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2901; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	56	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	MAY	2019	35	5							e3187	10.1002/cnm.3187			17	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	IC9TA	WOS:000471325800003	30861631				2022-02-06	
J	Umer, A; Mattila, J; Liedes, H; Koikkalainen, J; Lotjonen, J; Katila, A; Frantzen, J; Newcombe, V; Tenovuo, O; Menon, D; van Gils, M				Umer, Adil; Mattila, Jussi; Liedes, Hilkka; Koikkalainen, Juha; Lotjonen, Jyrki; Katila, Ari; Frantzen, Janek; Newcombe, Virginia; Tenovuo, Olli; Menon, David; van Gils, Mark			A Decision Support System for Diagnostics and Treatment Planning in Traumatic Brain Injury	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Clinical decision support; traumatic brain injury; web-based tool		Traumatic brain injury (TBI) occurs when an external force causes functional or structural alterations in the brain. Clinical characteristics of TBI vary greatly from patient to patient, and a large amount of data is gathered during various phases of clinical care in these patients. It is hard for clinicians to efficiently integrate and interpret all of these data and plan interventions in a timely manner. This paper describes the technical architecture and functionality of a web-based decision support system (DSS), which not only provides advanced support for visualizing complex TBI data but also predicts a possible outcome by using a state-of-the-art Disease State Index machine-learning algorithm. The DSS is developed by using a three-layered architecture and by employing modern programming principles, software design patterns, and using robust technologies (C#, ASP.NET MVC, HTML5, JavaScript, Entity Framework, etc.). The DSS is comprised of a patient overview module, a disease-state prediction module, and an imaging module. After deploying it on a web-server, the DSS was made available to two hospitals in U.K. and Finland. Afterwards, we conducted a validation study to evaluate its usability in clinical settings. Initial results of the study indicate that especially less experience clinicians may benefit from this type of decision support software tool.	[Umer, Adil; Liedes, Hilkka; van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Tampere 1000, Finland; [Mattila, Jussi; Koikkalainen, Juha; Lotjonen, Jyrki] Combinostics Oy, Tampere 33100, Finland; [Katila, Ari; Frantzen, Janek; Tenovuo, Olli] Turku Univ, Cent Hosp, Turku 20521, Finland; [Katila, Ari; Frantzen, Janek; Tenovuo, Olli] Univ Turku, SF-20500 Turku, Finland; [Newcombe, Virginia; Menon, David] Univ Cambridge, Cambridge CB2 1TN, England		Umer, A (corresponding author), VTT Tech Res Ctr Finland Ltd, Tampere 1000, Finland.	adil.umer@vtt.fi; jussi.mattila@combinostics.com; hilkka.liedes@vtt.fi; juha.koikkalainen@combinostics.com; jyrki.lotjonen@combinostics.com; ari.katila@tyks.fi; janek.frantzen@tyks.fi; vfjn2@cam.ac.uk; olli.tenovuo@tyks.fi; dkm13@cam.ac.uk; mark.vangils@vtt.fi		van Gils, Mark/0000-0002-0029-1771; Newcombe, Virginia/0000-0001-6044-9035; Lotjonen, Jyrki/0000-0002-8698-4340; Liedes, Hilkka/0000-0003-4655-7675	7th Framework Program by the European Commission - Project TBIcare [GA-270259]; National Institute for Health Research (NIHR), U.K. through the NIHR Cambridge Biomedical Centre	This work was supported in part by the 7th Framework Program by the European Commission in the cofunded Project TBIcare (GA-270259). The work of D. Menon was supported by the National Institute for Health Research (NIHR), U.K. through the NIHR Cambridge Biomedical Centre and a Senior Investigator Award.	[Anonymous], 2013, ASP MVC 4 OVERVIEW; Betts D., 2012, EXPLORING CQRS EVENT, P201; Betts D., 2013, DEPENDENCY INJECTION, P11; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Jadhav L. S., 2015, IJARCET, V4, P2601; Liedes H, 2016, STUD HEALTH TECHNOL, V224, P175, DOI 10.3233/978-1-61499-653-8-175; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Mattila J, 2012, IEEE T BIO-MED ENG, V59, P234, DOI 10.1109/TBME.2011.2170986; Mattila J, 2011, J ALZHEIMERS DIS, V27, P163, DOI 10.3233/JAD-2011-110365; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Microsoft Patterns & Practices Team, 2009, ARCH PATT STYL; Microsoft Patterns & Practices Team, 2009, REP PATT; Microsoft Redmond WA USA, 2013, US 3 TIER ARCH MOD; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Soininen H, 2012, NEURODEGENER DIS, V10, P149, DOI 10.1159/000332600; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; The Microsoft Dynamics AX Team, 2012, US UNITOFWORK CLASS; Vassiliadis P, 2009, INT J DATA WAREHOUS, V5, P1, DOI 10.4018/jdwm.2009070101; Yoon J, 2017, IEEE J BIOMED HEALTH, V21, P1133, DOI 10.1109/JBHI.2016.2574857	22	3	3	0	15	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194	2168-2208		IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	MAY	2019	23	3					1261	1268		10.1109/JBHI.2018.2842717			8	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	HX0DT	WOS:000467060400037	29993563	Green Submitted			2022-02-06	
J	Westerhof-Evers, HJ; Visser-Keizer, AC; Fasotti, L; Spikman, JM				Westerhof-Evers, Herma J.; Visser-Keizer, Annemarie C.; Fasotti, Luciano; Spikman, Jacoba M.			Social cognition and emotion regulation: a multifaceted treatment (T-ScEmo) for patients with traumatic brain injury	CLINICAL REHABILITATION			English	Article						Traumatic brain injury; treatment; social cognition; behavior; emotion regulation	RECOGNITION; BEHAVIOR; IMPAIRMENTS; VALIDATION; CHILDREN; DEFICITS; PEOPLE; ADULTS; FACES	Background: Many patients with moderate to severe traumatic brain injury have deficits in social cognition. Social cognition refers to the ability to perceive, interpret, and act upon social information. Few studies have investigated the effectiveness of treatment for impairments of social cognition in patients with traumatic brain injury. Moreover, these studies have targeted only a single aspect of the problem. They all reported improvements, but evidence for transfer of learned skills to daily life was scarce. We evaluated a multifaceted treatment protocol for poor social cognition and emotion regulation impairments (called T-ScEmo) in patients with traumatic brain injury and found evidence for transfer to participation and quality of life. Purpose: In the current paper, we describe the theoretical underpinning, the design, and the content of our treatment of social cognition and emotion regulation (T-ScEmo). Theory into practice: The multifaceted treatment that we describe is aimed at improving social cognition, regulation of social behavior and participation in everyday life. Some of the methods taught were already evidence-based and derived from existing studies. They were combined, modified, or extended with newly developed material. Protocol design: T-ScEmo consists of 20 one-hour individual sessions and incorporates three modules: (1) emotion perception, (2) perspective taking and theory of mind, and (3) regulation of social behavior. It includes goal-setting, psycho-education, function training, compensatory strategy training, self-monitoring, role-play with participation of a significant other, and homework assignments. Recommendations: It is strongly recommended to offer all three modules, as they build upon each other. However, therapists can vary the time spent per module, in line with the patients' individual needs and goals. In future, development of e-learning modules and virtual reality sessions might shorten the treatment.	[Westerhof-Evers, Herma J.; Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Westerhof-Evers, Herma J.; Visser-Keizer, Annemarie C.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Fasotti, Luciano] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Fasotti, Luciano] Klimmendaal Rehabil Ctr, Arnhem, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands		Westerhof-Evers, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, POB 30002, NL-9750 RA Haren, Netherlands.	h.j.evers@umcg.nl		Westerhof-Evers, Herma/0000-0001-7412-3378; Spikman, Jacoba/0000-0002-6477-0763	Dutch brain foundation [F2008 (1)-18]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dutch brain foundation: F2008 (1)-18.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Balconi M, 2011, NEUROSCI RES, V71, P251, DOI 10.1016/j.neures.2011.07.1833; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Bellack AS, 1997, SOCIAL SKILLS TRAINI; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bolte Sven, 2002, Int J Circumpolar Health, V61 Suppl 2, P61; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; D'Zurilla TJ., 1982, ADV COGNITIVE BEHAV, P201, DOI [10.1016/B978-0-12-010601-1.50010-3, DOI 10.1016/B978-0-12-010601-1.50010-3]; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; de Gelder B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00181; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; Ekman P., 1999, HDB COGNITION EMOTIO, P45, DOI 10.1002/0470013494.ch3; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Grinspan D, 2003, J GENET PSYCHOL, V164, P88, DOI 10.1080/00221320309597505; Guercio JM, 2004, BRAIN INJURY, V18, P593, DOI 10.1080/02699050310001646116; Heesterman W, 2004, VERS VAARDIGHEIDSTRA; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Judd T, 1999, NEUROPSYCHOTHERAPY C; Keijsers GPJ, 2004, PROTOCOLLAIRE BEHAND; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kunecke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084053; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LEWIS FD, 1988, BEHAV THER, V19, P203, DOI 10.1016/S0005-7894(88)80043-1; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; OBERMAN LM, 2003, NEUROSCIENCE, V2, P167, DOI DOI 10.1080/17470910701391943; Penn DL, 2007, PSYCHIAT SERV, V58, P449; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; Silver M, 2001, AUTISM, V5, P299, DOI 10.1177/1362361301005003007; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Van Dam-Baggen R, 2000, SOCIAALVAARDIGHEIDST; van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853; Westerhof-Evers HJ, 2019, BRAIN INJURY, V33, P78, DOI 10.1080/02699052.2018.1531303; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winegardner J, 2016, NEUROREHABILITATION, V39, P153, DOI 10.3233/NRE-161347; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	57	3	3	1	17	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAY	2019	33	5					820	833		10.1177/0269215519829803			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HU6YW	WOS:000465429200002	30798631	Green Published			2022-02-06	
J	Yang, JR; Kuo, CF; Chung, TT; Liao, HT				Yang, Jia-Ruei; Kuo, Chang-Fu; Chung, Ting-Ting; Liao, Han-Tsung			Increased Risk of Dementia in Patients with Craniofacial Trauma: A Nationwide Population-Based Cohort Study	WORLD NEUROSURGERY			English	Article						Facial bone fracture; Mild traumatic brain injury; Neurodegenerative disease; Postinjury comorbidities; Posttraumatic epilepsy; Traumatic brain injury	CLOSED-HEAD INJURIES; BRAIN-INJURY; ALZHEIMERS-DISEASE; FACIAL FRACTURES; MAXILLOFACIAL FRACTURES; EPILEPSY; EPIDEMIOLOGY; IMPACT; DIAGNOSIS; ACCURACY	OBJECTIVE: The role of maxillofacial trauma in dementia risk is not well established. The aim of this study was to evaluate the association between craniofacial trauma, including facial bone fracture and traumatic brain injury (TBI), and dementia. METHODS: Using Taiwan's National Health Insurance Research Database, we identified 501,889 adults who had had >= 1 medical record of craniofacial trauma between 2000 and 2010 and did not have a dementia diagnosis at baseline. Diagnoses of craniofacial trauma, including facial bone fracture and TBI, and dementia were made using International Classification of Diseases, Ninth Revision codes. The standardized incidence ratio was used to determine whether craniofacial trauma was associated with a greater risk of incident dementia compared with the general population. The Cox proportional hazards model was used to predict the risk of dementia among the trauma cohort by comparing the patients with and without comorbidities. RESULTS: A total of 501,889 patients with craniofacial trauma were included, of which 1.5% (n = 7804) developed dementia. Facial bone fracture (standardized incidence ratio, 1.58; 95% confidence interval, 1.25-2.00) was shown to be associated with an increased dementia risk compared with the general population. In addition, craniofacial trauma accompanied with postinjury comorbidities was associated with an increased risk of dementia during follow-up periods compared with the group without comorbidities. CONCLUSIONS: Craniofacial traumas, especially facial bone fracture, were associated with an increased risk of subsequent dementia. Maintaining a high index of suspicion for associated TBIs in all patients with facial trauma is crucial, even if no obvious initial signs and symptoms of brain injury are observed.	[Yang, Jia-Ruei] Chang Gung Mem Hosp, Dept Surg, Taoyuan, Taiwan; [Kuo, Chang-Fu] Chang Gung Mem Hosp, Div Rheumatol, Dept Allergy & Immunol, Taoyuan, Taiwan; [Chung, Ting-Ting] Chang Gung Mem Hosp, Off Big Data Res, Taoyuan, Taiwan; [Kuo, Chang-Fu] Univ Nottingham, Sch Med, Div Rheumatol, Dept Orthopaed & Dermatol, Nottingham, England; [Liao, Han-Tsung] Chang Gung Univ, Chang Gung Mem Hosp, Div Trauma Plast Surg,Coll Med, Dept Plast & Reconstruct Surg,Craniofacial Res Ct, Taoyuan, Taiwan; [Liao, Han-Tsung] Xiamen Chang Gung Mem Hosp, Dept Plast Surg, Xiamen, Peoples R China		Liao, HT (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Div Trauma Plast Surg,Coll Med, Dept Plast & Reconstruct Surg,Craniofacial Res Ct, Taoyuan, Taiwan.; Liao, HT (corresponding author), Xiamen Chang Gung Mem Hosp, Dept Plast Surg, Xiamen, Peoples R China.	lia01211@gmail.com		LIAO, HAN-TSUNG/0000-0001-9259-9839	Center for Big Data Analytics and Statistics [CLRPG3D0044]	The authors would like to thank Chang Gung Memorial Hospital for statistical assistance and support from the maintenance project of the Center for Big Data Analytics and Statistics (grant CLRPG3D0044). This manuscript was edited by Wallace Academic Editing.	Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bangen KJ, 2010, CLIN NEUROPSYCHOL, V24, P1193, DOI 10.1080/13854041003736778; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Breteler MMB, 1995, AM J EPIDEMIOL, V142, P1300, DOI 10.1093/oxfordjournals.aje.a117597; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Down KE, 1995, INT J ORAL MAX SURG, V24, P409, DOI 10.1016/S0901-5027(05)80469-2; Eggers C, 2017, J NEUROL, V264, P1715, DOI 10.1007/s00415-017-8503-2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Gottesman RF, 2010, LANCET NEUROL, V9, P895, DOI 10.1016/S1474-4422(10)70164-2; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Hohlrieder M, 2004, INT J ORAL MAX SURG, V33, P389, DOI 10.1016/j.ijom.2003.10.011; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institute of Medicine, 2009, GULF WAR HLTH, V7; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; Kamei Satoshi, 2016, Brain Nerve, V68, P317, DOI 10.11477/mf.1416200400; Kato Hiroko, 2016, Brain Nerve, V68, P309, DOI 10.11477/mf.1416200399; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Knopman DS, 2007, BRIT J RADIOL, V80, pS121, DOI 10.1259/bjr/75681080; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Levine DA, 2015, JAMA-J AM MED ASSOC, V314, P41, DOI 10.1001/jama.2015.6968; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Martin RCG, 2002, AM SURGEON, V68, P477; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; National Center for Injury Prevention, 2003, C MILD TRAUM BRAIN I, P18; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Pandey S, 2015, J MAXILLOFAC ORAL SU, V14, P32, DOI 10.1007/s12663-013-0578-4; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; RONTAL E, 1979, ANN OTO RHINOL LARYN, V88, P382, DOI 10.1177/000348947908800315; SAHAI H, 1993, BIOMETRICAL J, V35, P857, DOI 10.1002/bimj.4710350716; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Selassie AW, 2014, EPILEPSY RES, V108, P305, DOI 10.1016/j.eplepsyres.2013.12.002; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Takada LT, 2013, SEMIN NEUROL, V33, P348, DOI 10.1055/s-0033-1359314; Tung YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129043; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001; 1990, AM J EPIDEMIOL, V131, P491	70	3	3	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E563	E574		10.1016/j.wneu.2019.01.133			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700073	30716485				2022-02-06	
J	Zheng, TT; Peng, J; Pei, T; Shi, Y; Liu, L; Chen, KK; Xiao, HT; Chen, Y				Zheng, Tingting; Peng, Jiao; Pei, Tao; Shi, Yu; Liu, Li; Chen, Keke; Xiao, Haitao; Chen, Yun			Cornel iridoid glycoside exerts a neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-kappa B and STAT3	3 BIOTECH			English	Article						Neuroinflammation; Rats; Glycoside; mRNA; Protein	FOCAL CEREBRAL-ISCHEMIA	Traumatic brain injury leads to problems with movement and cognitive deficits and has a high mortality rate. Cornel iridoid glycoside, the active ingredient of Cornus officinalis, has been reported to ameliorate apoptosis and inflammation in rats. We investigated the therapeutic effect of cornel iridoid glycoside on neuroinflammation in rats with brain injury. Rats were treated with cornel iridoid glycoside, and then measurements of antioxidant, proinflammatory marker, and NF-kappa B and STAT3 mRNA and protein levels, as well as a histopathologic analysis, were conducted. Cornel iridoid glycoside significantly reduced lipid peroxidation and TNF-alpha and IL-6 levels but increased the levels of antioxidants. In addition, cornel iridoid glycoside significantly decreased the expression of NF-kappa B and STAT3. Histopathological analyses showed that cornel iridoid glycoside reduced the severity of neuroinflammation and apoptosis. Therefore, cornel iridoid glycoside significantly ameliorated neuroinflammation by reducing lipid peroxidation and proinflammatory marker levels and increasing antioxidant levels in rats with brain injury.	[Zheng, Tingting; Shi, Yu; Liu, Li; Chen, Keke; Chen, Yun] Peking Univ, Dept Ultrasound, Shenzhen Hosp, Shenzhen 518036, Guangdong, Peoples R China; [Zheng, Tingting; Shi, Yu; Liu, Li; Chen, Keke; Chen, Yun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen Key Lab Drug Addict & Medicat Safety, Shenzhen 518036, Guangdong, Peoples R China; [Peng, Jiao] Peking Univ, Dept Pharm, Shenzhen Hosp, Shenzhen 518036, Guangdong, Peoples R China; [Pei, Tao] Peking Univ, Dept Stomatol, Shenzhen Hosp, Shenzhen 518036, Guangdong, Peoples R China; [Xiao, Haitao] Shenzhen Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Shenzhen 518061, Guangdong, Peoples R China		Chen, Y (corresponding author), Peking Univ, Dept Ultrasound, Shenzhen Hosp, Shenzhen 518036, Guangdong, Peoples R China.; Chen, Y (corresponding author), Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen Key Lab Drug Addict & Medicat Safety, Shenzhen 518036, Guangdong, Peoples R China.; Xiao, HT (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Shenzhen 518061, Guangdong, Peoples R China.	ToddaParkergw@yahoo.com; cc76357566ranl@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871358, 81660479]; China Postdoctoral FoundationChina Postdoctoral Science Foundation [2018M640807]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2016YFC0104707]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2018A0303130228]; Shenzhen Science and Technology Innovation Committee Foundation [JCYJ20180223181216494, JCYJ20180507183224565]; Griffth University-Peking University Collaborative Travel Grants Scheme [036]	This study was supported by the National Natural Science Foundation of China (No. 81871358, No. 81660479), the China Postdoctoral Foundation (No. 2018M640807), Ministry of Science and Technology of China (No. 2016YFC0104707), Natural Science Foundation of Guangdong Province (No. 2018A0303130228), Shenzhen Science and Technology Innovation Committee Foundation (No. JCYJ20180223181216494, No. JCYJ20180507183224565) and Griffth University-Peking University Collaborative Travel Grants Scheme (No. 036 Research Internal).	Balic M, 2011, APPL IMMUNOHISTO M M, V19, P33, DOI 10.1097/PAI.0b013e3181ebf4e8; Collins C., 2002, OCCUPATIONAL THERAPY, P395; Ha H, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/781460, DOI 10.1155/2012/781460]; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Jiang ZQ, 2014, J INTERCULT ETHNOPHA, V3, P201, DOI 10.5455/jice.20140916011549; Kaddour T., 2016, J ACUTE DIS, V5, P470, DOI DOI 10.1016/j.joad.2016.08.028; Katano H, 1999, NEUROREPORT, V10, P2439, DOI 10.1097/00001756-199908200-00002; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li Chun-yang, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1667; Lin L, 2009, ALZHEIMERS DEMENT J, V5, P66, DOI [10.1016/j.jalz.2008.10.006, DOI 10.1016/J.JALZ.2008.10.006]; Ma DL, 2018, NEUROCHEM RES, V43, P959, DOI 10.1007/s11064-018-2501-3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murata M, 2001, CHEM-BIOL INTERACT, V130, P617, DOI 10.1016/S0009-2797(00)00289-1; Muthuviveganandavel V, 2008, PESTIC BIOCHEM PHYS, V91, P12, DOI 10.1016/j.pestbp.2007.11.010; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Suzuki S, 2001, EXP NEUROL, V170, P63, DOI 10.1006/exnr.2001.7701; Tag H. M., 2014, Journal of Basic and Applied Zoology, V67, P149, DOI 10.1016/j.jobaz.2014.01.003; Taiwe GS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1269-8; Wang Rui, 2007, Zhong Yao Cai, V30, P946; Wen S, 2009, CELL ADHES MIGR, V3, P107, DOI 10.4161/cam.3.1.7602; Wen-jing T, 2016, BIOMED RES INT, V2016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Ya BL, 2010, NEUROCHEM RES, V35, P773, DOI 10.1007/s11064-010-0134-2; Yao RQ, 2009, BRAIN RES BULL, V79, P69, DOI 10.1016/j.brainresbull.2008.12.010; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Yin LL, 2014, J NEUROIMMUNOL, V274, P28, DOI 10.1016/j.jneuroim.2014.06.022; Yu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055839; Zhao Q, 2019, J NEUROIMMUNOL, V330, P96, DOI [10.1016/j.jneuroim.2019.01.014, DOI 10.1016/J.JNEUROIM.2019.01.014]	29	3	4	3	16	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-572X	2190-5738		3 BIOTECH	3 Biotech	MAY	2019	9	5							195	10.1007/s13205-019-1697-5			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	HW7AR	WOS:000466842700001	31065495	Bronze, Green Published			2022-02-06	
J	Chiou, KS; Jiang, T; Chiaravalloti, N; Hoptman, MJ; DeLuca, J; Genova, H				Chiou, Kathy S.; Jiang, Tony; Chiaravalloti, Nancy; Hoptman, Matthew J.; DeLuca, John; Genova, Helen			Longitudinal examination of the relationship between changes in white matter organization and cognitive outcome in chronic TBI	BRAIN INJURY			English	Article						Longitudinal studies; diffusion tensor imaging; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TENSOR IMAGING METRICS; WORKING-MEMORY; CORPUS-CALLOSUM; SERIAL CHANGES; AXONAL INJURY; HEAD-INJURY; MODERATE; MILD; RECOVERY	Background and Objective: Changes in cerebral white matter organization have been documented in acute phases of recovery from traumatic brain injury (TBI). However, little is known about reorganization processes in more chronic stages of recovery. The current study identified changes in white matter organization in chronic cases of TBI, and determined the relationship between structural changes and cognitive functioning. Methods: 15 adults with moderate to severe TBI and eight healthy controls completed neuropsychological testing and diffusion tensor imaging (DTI) scanning. Participants returned 3 years from the initial session to complete identical neuropsychological tests and scans. Results: Adults with TBI were found to have significantly reduced fractional anisotropy (FA), a metric of white matter organization, compared to healthy participants at baseline and also at 3-year follow-up. Within the sample of adults with TBI, increases in FA were observed over time. Importantly, increases in FA in the TBI sample were also correlated with improvements in cognitive performance. Conclusions: This study provides evidence of a dynamic process of white matter change occurring beyond the initial phases of recovery after moderate to severe TBI. The observed relationship between structural reorganization and changes in cognitive performance has implications for rehabilitation potential in more chronic phases of recovery.	[Chiou, Kathy S.] Univ Nebraska Lincoln, Dept Psychol, Lincoln, NE USA; [Jiang, Tony; Chiaravalloti, Nancy; DeLuca, John; Genova, Helen] Kessler Fdn, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA; [Chiaravalloti, Nancy; DeLuca, John; Genova, Helen] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Hoptman, Matthew J.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Hoptman, Matthew J.] NYU, Sch Med, Dept Psychiat, New York, NY USA		Genova, H (corresponding author), Kessler Fdn, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA.	hgenova@kesslerfoundation.org	Hoptman, Matthew J./N-1035-2014	Hoptman, Matthew J./0000-0003-4485-6102; Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research [CBIR12IRG004]	This work was supported by the New Jersey Commission on Brain Injury Research [CBIR12IRG004].	Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Delis D, 2000, DELIS KAPLAN EXECUTI; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jang SH, 2009, NEUROREHABILITATION, V24, P273, DOI 10.3233/NRE-2009-0478; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	62	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2019	33	7					846	853		10.1080/02699052.2019.1606449		APR 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OM5BT	WOS:000470442800001	31017479				2022-02-06	
J	Kasch, H; Jensen, LL				Kasch, Helge; Jensen, Luana Leonora			Minor Head Injury Symptoms and Recovery From Whiplash Injury: A 1-Year Prospective Study	REHABILITATION PROCESS AND OUTCOME			English	Article						neck pain; whiplash; disability; recovery; Rivermead Head Injury Questionnaire; post-concussion syndrome	TRAUMATIC BRAIN-INJURY	AIM: To examine concussion-related disability in neck injuries, the Rivermead Head Injury Follow-Up Questionnaire (RHFUQ) was applied. Furthermore, we wanted to investigate symptoms found in post-concussion syndrome (PCS) and global pain. neck pain intensities obtained from acute whiplash patients within 1 week and at 6 months after injury in a prospective study on 1-year work disability. METHODS: A total of 143 consecutive acute whiplash-injured patients were admitted to the study from the Emergency Unit (Aarhus University Hospital). Patients with direct head trauma or reported retro- or anterograde amnesia were excluded from the study. Average neck pain and global pain intensity were measured on a Visual Analogue Scale (VAS 0-10). The RHFUQ (10 items, score from 0 to 4. total score from 0 to 40) was fulfilled after 1 week and 6 months. Patients underwent neurological examination within 1 week after injury. Recovery (return to work) was assessed 1 year post-injury. RESULTS: In total, 97% completed the study, and 9% (12/138) did not recover. Non-recovered patients reported more neck pain and global pain after 1 week (P< .003) and 6 months (P< .008) and higher PCS symptom score after 1 week (P< .001) and 6 months (P< .002). Using the RHFUQ total score as a predictive test. a receiver-operating characteristic curve (ROC) area of 0.77 (0.61-0.92) and a cut-off at 10 points revealed a sensitivity of 75% and a specificity of 67.2%. At 1 week, 8 of 10 items reached higher scores among non-recovered and 10 of 10 items after 6 months post-injury. CONCLUSIONS: RHFUQ is useful in acute whiplash patients for predicting 1-year work disability. PCS-related symptoms along with neck pain and global pain are more burdensome in the non-recovered group. This emphasizes that post-concussion symptoms are not a sign of brain injury alone, but are found in other types of mishaps like whiplash injuries.	[Kasch, Helge] Spinal Cord Injury Ctr Western Denmark, Dept Neurol, Postbox 130, DK-8800 Viborg, Denmark; [Kasch, Helge] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Jensen, Luana Leonora] Aarhus Univ Hosp, Dept Anesthesiol, Aarhus, Denmark		Kasch, H (corresponding author), Spinal Cord Injury Ctr Western Denmark, Dept Neurol, Postbox 130, DK-8800 Viborg, Denmark.	helge_kasch@clin.au.dk	Kasch, Helge/Q-3170-2019; Kasch, Helge/H-1325-2012	Kasch, Helge/0000-0002-9302-4946; Kasch, Helge/0000-0002-9302-4946			Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Kasch H, 2016, WHIPLASH INJURY PERS; Kasch H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002050; Myrtveit SM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007239; SPITZER WO, 1995, SPINE, V20, pS1; Sterling M, 2011, SPINE, V36, pS330, DOI 10.1097/BRS.0b013e3182388523; Walton David M, 2013, Open Orthop J, V7, P494, DOI 10.2174/1874325001307010494; 2007, J REHABIL MED, V39, P405, DOI DOI 10.2340/16501977-0057; 2014, PAIN, V155, P309, DOI DOI 10.1016/J.PAIN.2013.10.016; 2008, PAIN, V139, P248, DOI DOI 10.1016/J.PAIN.2008.04.008; 1996, J NEUROL NEUROSURG P, V60, P510; 2005, PAIN, V114, P141, DOI DOI 10.1016/J.PAIN.2004.12.005; 2013, CANCER EPIDEM BIOMAR, V22, P374, DOI DOI 10.1158/1055-9965.EPI-12-0987; 2001, NEUROLOGY, V56, P1637; 2008, EUR J NEUROL, V15, P1222, DOI DOI 10.1111/J.1468-1331.2008.02301.X; 2012, ARCH PHYS MED REHAB, V93, P287, DOI DOI 10.1016/J.APMR.2011.08.041; 2012, CLIN J PAIN, V28, P484, DOI DOI 10.1097/AJP.0B013E3182527D13; 1993, PAIN, V55, P5; 2006, PAIN, V125, P216, DOI DOI 10.1016/J.PAIN.2006.05.024; 1994, PAIN, V58, P283; 2011, PAIN, V152, P1272, DOI DOI 10.1016/J.PAIN.2011.01.056	23	3	3	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-5727			REHABIL PROCESS OUTC	Rehabil. Process Outcome	APR 26	2019	8								1179572719845634	10.1177/1179572719845634			6	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	HV4HC	WOS:000465946400001	34497461	gold, Green Published			2022-02-06	
J	Kennedy, JE; Reid, MW; Lu, LH; Cooper, DB				Kennedy, J. E.; Reid, M. W.; Lu, L. H.; Cooper, D. B.			Validity of the CES-D for depression screening in military service members with a history of mild traumatic brain injury	BRAIN INJURY			English	Article						mild TBI; military; depression	SCALE; SYMPTOMS; LIFE	Primary Objective: To advance knowledge about the value of the Center for Epidemiologic Studies - Depression scale (CES-D) for depression screening in military service members with a history of mild traumatic brain injury (mTBI). Research Design: Retrospective data from 336 military service members with a history of mTBI were extracted from a TBI Repository at a large military medical center. Participants included in this study screened positive for mTBI in a primary care clinic or soldier readiness processing center and were enrolled in the TBI repository from November 6, 2014 to May 31, 2017. At the time of enrollment, participants completed the CES-D and their electronic medical records (EMR) were searched for diagnoses of depressive disorders. Methods and Procedures: Receiver-operating characteristic (ROC) analysis of the CES-D was used to discriminate cases with and without depression diagnoses. Main Outcomes and Results: Area under the ROC curve (AUC) was .897. Sensitivity (.824) and specificity (.826) were maximized at a cut score of 18 or greater, slightly higher than the standard cut of 16 established for civilian samples. Conclusions: Results suggest that the CES-D is a valid screening instrument for depressive disorders in military samples with a history of mTBI.	[Kennedy, J. E.; Reid, M. W.; Lu, L. H.] Brooke Army Med Ctr, DVBIC, Dept Neurol, Ft Sam Houston, TX 78234 USA; [Cooper, D. B.] South Texas Vet Healthcare Syst, San Antonio VA Polytrauma Rehabil Ctr, DVBIC, San Antonio, TX USA; [Cooper, D. B.] UT Hlth San Antonio, Dept Psychiat, San Antonio, TX USA		Kennedy, JE (corresponding author), DVBIC, Dept Neurol, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	Jan.e.kennedy2.ctr@mail.mil					Amare T, 2018, AIDS RES TREAT, V2018, DOI 10.1155/2018/5462959; [Anonymous], DOD WORLDW NUMB TBI; Armstrong NM, 2019, AGING MENT HEALTH, V23, P507, DOI 10.1080/13607863.2017.1423037; Carter JV, 2016, SURGERY, V159, P1638, DOI 10.1016/j.surg.2015.12.029; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Clover K, 2018, QUAL LIFE RES, V27, P1357, DOI 10.1007/s11136-018-1803-x; Copanitsanou P, 2018, ORTHOP NURS, V37, P43, DOI 10.1097/NOR.0000000000000417; Cowie MR, 2017, CLIN RES CARDIOL, V106, P1, DOI 10.1007/s00392-016-1025-6; Elmasry H, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000229; Epidemiology McCrea M.P, 2016, FRONTIERS NEUROSCIEN; January J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019085; Kennedy JE, 2017, 25 ANN MIL HLTH SYST; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Li YR, 2018, PSYCHOL HEALTH MED, V23, P952, DOI 10.1080/13548506.2018.1434314; Looby SE, 2018, MENOPAUSE, V25, P648, DOI [10.1097/gme.0000000000001058, 10.1097/GME.0000000000001058]; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mills JC, 2018, CLIN INFECT DIS, V67, P1575, DOI 10.1093/cid/ciy264; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Parhami I, 2013, AIDS BEHAV, V17, P2792, DOI 10.1007/s10461-012-0386-8; Polansky M, 2018, J REPROD INFANT PSYC, V36, P222, DOI 10.1080/02646838.2018.1448373; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapp PE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00091; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Riaz M, 2017, PAK J MED SCI, V33, P1318, DOI 10.12669/pjms.336.13911; SHINAR D, 1986, STROKE, V17, P241, DOI 10.1161/01.STR.17.2.241; Silverman Joel J, 2015, Am J Psychiatry, V172, P798, DOI 10.1176/appi.ajp.2015.1720501; Swets J A, 2000, Psychol Sci Public Interest, V1, P1, DOI 10.1111/1529-1006.001; van Dijk SEM, 2018, QUAL LIFE RES, V27, P1415, DOI 10.1007/s11136-018-1782-y; Vanderploeg RD, 2018, REHABIL PSYCHOL, V63, P194, DOI 10.1037/rep0000215; Verdier-Taillefer MH, 2001, NEUROEPIDEMIOLOGY, V20, P262, DOI 10.1159/000054800; Youngstrom EA, 2014, J PEDIATR PSYCHOL, V39, P204, DOI 10.1093/jpepsy/jst062	35	3	3	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2019	33	7					932	940		10.1080/02699052.2019.1610191		APR 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OM5BT	WOS:000470444100001	31017474				2022-02-06	
J	Hon, S; Gaona, SD; Faul, M; Holmes, JF; Nishijima, DK				Hon, Simson; Gaona, Samuel D.; Faul, Mark; Holmes, James F.; Nishijima, Daniel K.		Sacramento County Prehosp Res C	How Well Do EMS Providers Predict Intracranial Hemorrhage in Head-Injured Older Adults?	PREHOSPITAL EMERGENCY CARE			English	Article						emergency medical services; head injuries; closed	NEW-ORLEANS CRITERIA; TRAUMA TRIAGE; PARAMEDIC JUDGMENT; RULE; ANTICOAGULANT; SEVERITY; INDEX	Objective: To evaluate the accuracy of emergency medical services (EMS) provider judgment for traumatic intracranial hemorrhage (tICH) in older patients following head trauma in the field. We also compared EMS provider judgment with other sets of field triage criteria. Methods: This was a prospective observational cohort study conducted with five EMS agencies and 11 hospitals in Northern California. Patients 55 years and older who experienced blunt head trauma were transported by EMS between August 1, 2015 and September 30, 2016, and received an initial cranial computed tomography (CT) imaging, were eligible. EMS providers were asked, "What is your suspicion for the patient having intracranial hemorrhage (bleeding in the brain)?" Responses were recorded as ordinal categories (<1%, 1-5%, >5-10%, >10-50%, or >50%) and the incidences of tICH were recorded for each category. The accuracy of EMS provider judgment was compared to other sets of triage criteria, including current field triage criteria, current field triage criteria plus multivariate logistical regression risk factors, and actual transport. Results: Among the 673 patients enrolled, 319 (47.0%) were male and the median age was 75 years (interquartile range 64-85). Seventy-six (11.3%) patients had tICH on initial cranial CT imaging. The increase in EMS provider judgment correlated with an increase in the incidence of tICH. EMS provider judgment had a sensitivity of 77.6% (95% CI 67.1-85.5%) and a specificity of 41.5% (37.7-45.5%) when using a threshold of 1% or higher suspicion for tICH. Current field triage criteria (Steps 1-3) was poorly sensitive (26.3%, 95% CI 17.7-37.2%) in identifying tICH and current field trial criteria plus multivariate logistical regression risk factors was sensitive (97.4%, 95% CI 90.9-99.3%) but poorly specific (12.9%, 95% CI 10.4-15.8%). Actual transport was comparable to EMS provider judgment (sensitivity 71.1%, 95% CI 60.0-80.0%; specificity 35.3%, 95% CI 31.6-38.3%). Conclusions: As EMS provider judgment for tICH increased, the incidence for tICH also increased. EMS provider judgment, using a threshold of 1% or higher suspicion for tICH, was more accurate than current field triage criteria, with and without additional risk factors included.	[Hon, Simson; Gaona, Samuel D.; Holmes, James F.; Nishijima, Daniel K.] UC Davis Sch Med, Dept Emergency Med, Sacramento, CA USA; [Faul, Mark] Ctr Dis Control & Prevent, Atlanta, GA USA		Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 5 St,PSSB 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu		Faul, Mark/0000-0002-7683-0348	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177]; National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was funded by the Centers for Disease Control and Prevention (CDC), grant number U01CE002177. D.K. Nishijima was supported through Mentored Clinical Research Training Program Award (Grant Number UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	Brown LH, 2009, PREHOSP EMERG CARE, V13, P516, DOI 10.1080/10903120903144809; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; EMERMAN CL, 1991, J TRAUMA, V31, P1369, DOI 10.1097/00005373-199110000-00009; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; FRIES GR, 1994, ANN EMERG MED, V24, P885, DOI 10.1016/S0196-0644(94)70207-1; Garwe T, 2017, PREHOSP EMERG CARE, V21, P734, DOI 10.1080/10903127.2017.1332123; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jones CMC, 2016, PREHOSP EMERG CARE, V20, P6, DOI 10.3109/10903127.2015.1025157; Lavoie A, 2010, CAN J EMERG MED, V12, P111; Lemeshow S, 2000, APPL LOGISTIC REGRES; Levine SD, 2006, J EMERG MED, V31, P1, DOI 10.1016/j.jemermed.2005.08.007; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mulholland SA, 2005, INJURY, V36, P1298, DOI 10.1016/j.injury.2005.07.010; Mulholland SA, 2008, J TRAUMA, V64, P754, DOI 10.1097/01.ta.0000244384.85267.c5; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Newgard CD, 2013, J TRAUMA ACUTE CARE, V74, P1298, DOI 10.1097/TA.0b013e31828b7848; Newgard CD, 2012, J TRAUMA ACUTE CARE, V72, P1239, DOI 10.1097/TA.0b013e3182468b51; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Nishijima DK, 2017, PREHOSP EMERG CARE, V21, P209, DOI 10.1080/10903127.2016.1218985; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; SIMMONS E, 1995, ANN EMERG MED, V26, P461, DOI 10.1016/S0196-0644(95)70115-X; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Togha M, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-9	33	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN 2	2020	24	1					8	14		10.1080/10903127.2019.1597954		APR 2019	7	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	JZ7JU	WOS:000470553500001	30895835	Green Accepted			2022-02-06	
J	Rogers, A; McKinlay, A				Rogers, Alana; McKinlay, Audrey			The long-term effects of childhood traumatic brain injury on adulthood relationship quality	BRAIN INJURY			English	Article						Traumatic brain injury; prefrontal cortex; neuroplasticity	SYSTEMS BEHAVIOR SCALE; IMPAIRED AWARENESS; EXECUTIVE FUNCTION; SOCIAL OUTCOMES; SELF-AWARENESS; CHILDREN; SCHOOL; PREDICTORS; RECOVERY; TBI	Primary Objective: To investigated the long-term effect of childhood Traumatic Brain Injury (TBI) on adulthood Relationship Quality (RQ), examining injury severity, age of injury, and markers of prefrontal cortex (PFC) functioning, apathy, disinhibition, and executive dysfunction. Research Design: Longitudinal, between-subjects, cross-sectional design using retrospective and current data. Methods and Procedures: Participants (N = 169; 61 mild TBI (mTBI); 65 moderate to severe TBI (MSTBI); 43 orthopaedic injury (OI); Injury age: 1-17 years; Testing age: 18-31 years) completed a structured interview regarding their injury, demographic characteristics and RQ, the National Adults Reading Test, and Frontal Systems Behaviour Scale. Data were analyzed using IBM SPSS 25. Main Outcomes and Results: Adults who had experienced childhood TBI had significantly poorer RQ than adults who had experienced childhood OI. Severity of TBI did not impact adulthood RQ. Earlier age of injury predicted reduced adulthood RQ in the MSTBI group. Greater PFC dysfunction predicted poorer RQ in adults with a history of childhood TBI. While elevated levels of apathy, disinhibition, and executive dysfunction were associated with poorer RQ, no individual marker had predictive value. Conclusion: Experiencing a childhood TBI can have a long-term negative influence on adulthood RQ. Such RQ deficits can underpin reduced life satisfaction and increased health issues.	[Rogers, Alana] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Rogers, Alana; McKinlay, Audrey] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [McKinlay, Audrey] Univ Canterbury, Dept Psychol, Melbourne, Vic, Australia		Rogers, A (corresponding author), Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia.	alanar@student.unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514; Rogers, Alana/0000-0002-4503-594X	Lottery Health Research Committee of New Zealand	This work was supported by the Lottery Health Research Committee of New Zealand.	Adolphs D, 2002, HDB NEUROPSYCHOLOGY, P89; Aharon Peretz J., 2007, HUMAN FRONTAL LOBES, P540; Albicini M, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI [10.1097/HTR.0000000000000202, DOI 10.1097/HTR.0000000000000202]; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; [Anonymous], 2017, RETURNING ED TBI INT; Arnould A, 2015, BRAIN INJURY, V29, P1597, DOI 10.3109/02699052.2015.1075156; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barbey AK, 2013, NEUROPSYCHOLOGIA, V51, P1361, DOI 10.1016/j.neuropsychologia.2012.05.017; Barrett RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076916; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; BIGLER ED, 1987, J LEARN DISABIL, V20, P458, DOI 10.1177/002221948702000804; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Charles N, 2007, NEUROREHABILITATION, V22, P61; Chow T. W., 2007, HUMAN FRONTAL LOBES, P25; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., P567; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; de Vugt ME, 2003, INT J GERIATR PSYCH, V18, P149, DOI 10.1002/gps.807; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DeVellis R.F., 2017, SCALE DEV THEORY APP; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Faul M, 2010, TRAUMATIC BRAIN INJU; Glang A, 2008, NEUROREHABILITATION, V23, P477; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2012, NEUROREHABILITATION, V30, P173, DOI 10.3233/NRE-2012-0742; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Helps Y., 2008, HOSP SEPARATIONS DUE; Heverly-Fitt S, 2016, J PEDIATR PSYCHOL, V41, P235, DOI 10.1093/jpepsy/jsv085; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Jantz P, 2014, WORKING TRAUMATIC BR, P76; Jantz P, 2014, WORKING TRAUMATIC BR, P34; Jonsson CA, 2013, BRAIN INJURY, V27, P831, DOI 10.3109/02699052.2013.775493; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin H, 2012, PEDIATRICS, V129, P494, DOI [10.1542/peds.2011-1796, DOI 10.1542/PEDS.2011-1796]; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loving T, 2013, OXFORD HDB CLOSE REL, P615; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Ogar J, 2007, HUMAN FRONTAL LOBES, P59; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Prigatano GP, 2005, ACT NEUR S, V93, P39; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Reynolds J, 2014, ONE PLUS ONE; Rinsky JR, 2011, CHILD NEUROPSYCHOL, V17, P368, DOI 10.1080/09297049.2010.544649; Rodset M, 2008, SCAND J DISABIL RES, V10, P90, DOI 10.1080/15017410801927807; Rogge R., 2010, J FAMILY THEORY REV, V2, P227, DOI [10.1111/j.1756-2589.2010.00059.x, DOI 10.1111/J.1756-2589.2010.00059.X]; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; SMITH D, 1998, COGNITIVE NEUROPSYCH, V3, P71, DOI DOI 10.1080/135468098396251; Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tonks J, 2010, NEUROPSYCHOL REHABIL, V20, P922, DOI 10.1080/09602011.2010.519209; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2012, DEV SOCIAL NEUROSCIE, P207; Yumul JN, 2016, DEV NEUROREHABIL, V7, P1	90	3	3	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					649	656		10.1080/02699052.2019.1567936			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200013	30664366				2022-02-06	
J	Bayen, E; Ruet, A; Jourdan, C; Ghout, I; Meaude, L; Pradat-Diehl, P; Nelson, G; Vallat-Azouvi, C; Charanton, J; Aegerter, P; Azouvi, P				Bayen, Eleonore; Ruet, Alexis; Jourdan, Claire; Ghout, Idir; Meaude, Layide; Pradat-Diehl, Pascale; Nelson, Gaelle; Vallat-Azouvi, Claire; Charanton, James; Aegerter, Philippe; Azouvi, Philippe			Lawsuit and Traumatic Brain Injury: The Relationship Between Long-Lasting Sequelae and Financial Compensation in Litigants. Results From the PariS-TBI Study	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; litigation; compensation; disability; Paris-TBI; follow-up; lawsuit	CARE	Purpose: People with traumatic brain injury are frequently involved in a litigation because another person was at fault for causing the accident. A compensation amount will often be settled to compensate the victim for the past, present, future damages and losses suffered. We report descriptive data about the full and final personal compensation amount and investigated its association with patient's outcomes. Methods: We used a longitudinal prospective study of severe TBI patients injured in 2005-2007 (PariS-TBI). Questions regarding involvement in a litigation were asked concurrently with 4 and 8-year outcomes. Results: Among 160 participants assessed 4 and/or 8 years post-injury, a total of 67 persons declared being involved in a litigation, among which 38 people reported a compensation amount of a mean (sic)292,653 (standard deviation = 436,334; interquartile 25-50-75 = 37,000-100,000-500,000; minimum = 1,500-maximum = 2,000,000). A higher compensation amount was associated with more severe disability and cognitive impairment in patients, and with more informal care time provided by caregivers. However, no significant association related to patient's gender, age, years of education, motor/balance impairment, return to work status, mood and related to caregiver's subjective burden was found. Conclusion: Financial compensation was related to victims' long-term severity of impairment, although some extreme cases with severe disability were granted very poor compensation.	[Bayen, Eleonore; Pradat-Diehl, Pascale] Hop La Pitie Salpetriere, AP HP, Phys Med & Rehabil Dept, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Sorbonne Univ GRC18, Phys & Rehabil Dept, Paris, France; [Bayen, Eleonore] Univ Calif San Francisco, Global Brain Hlth Inst, San Francisco, CA 94143 USA; [Ruet, Alexis] Caen Fac Hosp, INSERM U1077, Phys Med & Rehabil Dept, Caen, France; [Jourdan, Claire] Lapeyronie Fac Hosp, Phys Med & Rehabil Dept, Montpellier, France; [Ghout, Idir; Aegerter, Philippe] Ambroise Pare Hosp, AP HP, Dept Biostat, Boulogne, France; [Meaude, Layide] Ambroise Pare Hosp, AP HP, Unite Rech Clin Paris Ile de France Ouest, Paris, France; [Pradat-Diehl, Pascale] INSERM, U1146, Lab Imagerie Biomed, Paris, France; [Nelson, Gaelle; Charanton, James] Reg Reference Ctr Brain Injury Parisian Area, Paris, France; [Vallat-Azouvi, Claire; Azouvi, Philippe] Univ Versailles St Quentin, EA4047, HANDIReSP, Lab Rech Clin & Sante Publ Handicaps Psych Cognit, Montigny Le Bretonneux, France; [Vallat-Azouvi, Claire; Azouvi, Philippe] Raymond Poincare Fac Hosp, AP HP, Phys Med & Rehabil Dept, Garches, France		Bayen, E (corresponding author), Hop La Pitie Salpetriere, AP HP, Phys Med & Rehabil Dept, Paris, France.; Bayen, E (corresponding author), Sorbonne Univ GRC18, Phys & Rehabil Dept, Paris, France.; Bayen, E (corresponding author), Univ Calif San Francisco, Global Brain Hlth Inst, San Francisco, CA 94143 USA.	eleonore.bayen@gbhi.org	AEGERTER, Philippe/AAY-6003-2021; RUET, Alexis/L-8726-2015	AEGERTER, Philippe/0000-0002-9156-5028; RUET, Alexis/0000-0002-5080-5734	French Ministry of Health (Programme hospitalier de recherche clinique) [AOM04084]; AP-HP (Departement de la recherche clinique et du developpement); Institut de recherche en sante publique (IRESP)	The authors thank all members of the CRFTC Steering Committee (Center ressource francilien des traumatises craniens) for their valuable help. The first part of this study and the 8 years evaluation was funded by a grant from the French Ministry of Health (Programme hospitalier de recherche clinique 2004 and 2012, AOM04084) and sponsored by AP-HP (Departement de la recherche clinique et du developpement). The second part of this study was funded by a grant from the Institut de recherche en sante publique (IRESP). The authors thank the International Society of Physical and Rehabilitation Medicine (ISPRM) and the French Physical and Rehabilitation Medicine Society (SOFMER) for accepting a communication on the present work in their annual congress in Paris in July 2018.	Aghababian V, 2010, ENCEPHALE, V36, P139, DOI 10.1016/j.encep.2009.06.002; [Anonymous], 2018, MAK BRAIN INJ CLAIM; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bayen E, 2018, DISABIL REHABIL, V40, P2040, DOI 10.1080/09638288.2017.1325522; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Gates TM, 2017, BRAIN INJURY, V31, P1044, DOI 10.1080/02699052.2017.1298002; Jou RC, 2015, ACCIDENT ANAL PREV, V85, P1, DOI 10.1016/j.aap.2015.08.021; Jou RC, 2014, ACCIDENT ANAL PREV, V67, P21, DOI 10.1016/j.aap.2014.02.003; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Jury Verdict Alert, 2015, 17 4 MILL 27 YEAR OL; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MAHONEY F I, 1965, Md State Med J, V14, P61; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Schaafsma FG, 2013, J REHABIL MED, V45, P446, DOI 10.2340/16501977-1135; Tikriti A., 2018, SETTLEMENT VALUE HEA; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wimo, 1998, HLTH EC DEMENTIA, DOI DOI 10.1186/S12913-017-2422-X; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	26	3	3	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 12	2019	10								320	10.3389/fneur.2019.00320			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HT2ZK	WOS:000464432800001	31031685	Green Published, gold			2022-02-06	
J	Khallaf, M; Thabet, AM; Ali, M; Sharkawy, E; Abdel-rehim, S				Khallaf, Mohammed; Thabet, Ahmed Mostafa; Ali, Mahmoud; Sharkawy, Essam; Abdel-rehim, Sherif			The effect of dexmedetomidine versus propofol in traumatic brain injury: evaluation of some hemodynamic and intracranial pressure changes	EGYPTIAN JOURNAL OF NEUROSURGERY			English	Article						Traumatic brain injuries; Sedation; Dexmedetomidine; Propofol	CRITICALLY-ILL PATIENTS; SEVERE HEAD-INJURY; INTENSIVE-CARE; SEDATION; MIDAZOLAM	Background Cerebral edema and increased intracranial pressure are of the major consequences of traumatic brain injury that affects the outcome. The aim of this study is to assess the efficacy of dexmedetomidine as an adjunct to conventional sedative therapy (propofol) compared to conventional sedative therapy alone in patients with traumatic brain injury, as regards its effects on hemodynamics and intracranial pressure. Methods This prospective randomized controlled clinical trial with 60 agitated and restless traumatic brain-injured patients was performed between May 2013 and May 2017. Patients who required mechanical ventilation, Glasgow coma scale (GCS) < 8, or hemodynamically instable were excluded. Patients were randomized into three equal groups: dexmedetomidine was infused in a dose of 0.5 mu g/kg/h for 48 h in the first group, propofol 1% was infused in a dose of 4 mg/kg/h for 48 h in the second group, and dexmedetomidine was infused in a dose of 0.2 mu g/kg/h and propofol was infused in a dose of 2 mg/kg/h for 48 h in the third group. ICP and CPP excursions and complications were assessed in the first 48 h. Results The number of ICP and CPP excursions per day was not significantly different between the three groups. Tachycardia, bradycardia, and hypertension in the three groups were statistically insignificant. As regards hypotension, there was a statistically significant difference between the three studied groups. Conclusion Dexmedetomidine or its combination with propofol is as effective as propofol alone in TBI; all alternatives are equal as regards the degree of sedation, effect on intracranial pressure, and cerebral perfusion pressure. The incidence of complications does not vary greatly between all groups.	[Khallaf, Mohammed] Assiut Univ Hosp, Dept Neurosurg, Assiut, Egypt; [Thabet, Ahmed Mostafa; Ali, Mahmoud; Sharkawy, Essam; Abdel-rehim, Sherif] Assiut Univ Hosp, Dept Anesthesia & Intens Care, Assiut, Egypt		Khallaf, M (corresponding author), Assiut Univ Hosp, Dept Neurosurg, Assiut, Egypt.	khallaf_1973@yahoo.com					Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chrysostomou C, 2008, EXPERT OPIN DRUG MET, V4, P619, DOI [10.1517/17425255.4.5.619, 10.1517/17425255.4.5.619 ]; Djaiani G, 2016, ANESTHESIOLOGY, V124, P362, DOI 10.1097/ALN.0000000000000951; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; FARLING PA, 1989, ANAESTHESIA, V44, P222, DOI 10.1111/j.1365-2044.1989.tb11228.x; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; McKeage K, 2003, CNS DRUGS, V17, P235, DOI 10.2165/00023210-200317040-00003; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Pajoumand M, 2016, J TRAUMA ACUTE CARE; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; RONAN KP, 1995, CRIT CARE MED, V23, P286, DOI 10.1097/00003246-199502000-00014; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Singh A., 2013, J DENT MED SCI, V3, P75; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Tanguy M, 2012, J NEUROTRAUM, V29, P1105, DOI 10.1089/neu.2011.1817; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130	22	3	3	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2520-8225		EGYPT J NEUROSURG	Egypt. J. Neurosurg.	APR 4	2019	34	1							17	10.1186/s41984-019-0041-z			10	Clinical Neurology; Surgery	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Surgery	WD0UD	WOS:000704661900001		gold			2022-02-06	
J	Richards, TM; Sharma, P; Kuang, A; Whitty, D; Ahmed, Z; Shah, PK				Richards, Tiffany M.; Sharma, Pawan; Kuang, Aaron; Whitty, Douglas; Ahmed, Zaghloul; Shah, Prithvi K.			Novel Speed-Controlled Automated Ladder Walking Device Reveals Walking Speed as a Critical Determinant of Skilled Locomotion after a Spinal Cord Injury in Adult Rats	JOURNAL OF NEUROTRAUMA			English	Article						cervical spinal cord; horizontal ladder; skilled locomotion; spinal cord injury	DORSAL FUNICULAR LESIONS; GAIT ANALYSIS; SENSORIMOTOR BEHAVIOR; FUNCTIONAL RECOVERY; RATING-SCALE; FORELIMB; TASK; VARIABILITY; STIMULATION; IMPAIRMENTS	The horizontal ladder task is an established method to assess skilled locomotor recovery after neurological dysfunction. Walking speed is often used as a standardized measure in locomotor assessment of overground walking in human and pre-clinical studies, but the assessment of walking speed is typically ignored during skilled locomotor tasks. Ample empirical evidence indicates that walking speeds on the horizontal ladder are largely non-uniform after central nervous system trauma, suggesting that it could pose a potential source of variability in assessing motor deficits. Here, we investigate whether walking speed influences the assessment of motor recovery during skilled walking after a spinal cord injury (SCI). We hypothesized that if rats walk at imposed walking speeds, motor deficits and recovery after an SCI will be more reliably assessed than when not controlling walking speeds. To address this, we developed a novel speed-controlled Automated Device for the Assessment and Training of Skilled locomotion (ADATS) as a surrogate device to the horizontal ladder. The ADATS allows testing at user-defined speeds, thereby forcing the rats to step consistently. Our results demonstrate that: 1) the ability to walk (or not) at one or multiple speeds on the ADATS serves as a gross measure of motor dysfunction/recovery after a spinal cord injury and 2) skilled motor deficits are more readily detected at lower than higher walking speeds. We conclude that walking speed is an important factor in the analyses of skilled locomotion and testing at multiple speeds is useful in accurately measuring recovery after neurotrauma in rats.	[Richards, Tiffany M.; Shah, Prithvi K.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Sharma, Pawan; Kuang, Aaron; Whitty, Douglas; Shah, Prithvi K.] SUNY Stony Brook, Dept Phys Therapy, Life Sci Bldg,Room 172, Stony Brook, NY 11794 USA; [Ahmed, Zaghloul] CUNY Coll Staten Isl, Ctr Dev Neurosci, Dept Phys Therapy, Staten Isl, NY USA; [Ahmed, Zaghloul] CUNY, Grad Ctr, New York, NY USA		Shah, PK (corresponding author), SUNY Stony Brook, Dept Phys Therapy, Life Sci Bldg,Room 172, Stony Brook, NY 11794 USA.	Prithvi.Shah@stonybrook.edu	Ahmed, zaghloul/AAV-8812-2021		Craig Neilsen Foundation Neilsen Pilot Research Grant 14 [338237]; Virgin Islands Board of Education Territorial Grant; Congressional Black Caucus Spouses Education Scholarship award; NYSDOH [C32248GG]	This research was funded, in part, by the Craig Neilsen Foundation Neilsen Pilot Research Grant 14 awarded to P. Shah (#338237) and the Virgin Islands Board of Education Territorial Grant and Congressional Black Caucus Spouses Education Scholarship awarded to T. Richards. This research was partially funded by an award from NYSDOH #C32248GG to ZA.	Antonow-Schlorke I, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/418627; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Batka RJ, 2014, ANAT REC, V297, P1839, DOI 10.1002/ar.22955; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Bieler L, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00540; Bolton DAE, 2006, BEHAV BRAIN RES, V168, P272, DOI 10.1016/j.bbr.2005.11.017; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brockett EG, 2013, NEUROSCIENCE, V240, P83, DOI 10.1016/j.neuroscience.2013.02.039; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dambreville C, 2015, J NEUROPHYSIOL, V114, P1119, DOI 10.1152/jn.00419.2015; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Ditunno JE, 2007, NEUROREHAB NEURAL RE, V21, P539, DOI 10.1177/1545968307301880; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Erschbamer MK, 2006, EXP NEUROL, V201, P154, DOI 10.1016/j.expneurol.2006.04.003; Espy DD, 2010, GAIT POSTURE, V32, P378, DOI 10.1016/j.gaitpost.2010.06.013; Fagoe ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150141; Fouad K, 2000, BEHAV BRAIN RES, V115, P107, DOI 10.1016/S0166-4328(00)00244-8; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; HRUSKA RE, 1979, LIFE SCI, V25, P171, DOI 10.1016/0024-3205(79)90389-8; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kanagal SG, 2008, BEHAV BRAIN RES, V187, P379, DOI 10.1016/j.bbr.2007.09.035; Kanagal SG, 2007, EXP NEUROL, V205, P513, DOI 10.1016/j.expneurol.2007.03.014; Kanagal SG, 2009, EXP NEUROL, V216, P193, DOI 10.1016/j.expneurol.2008.11.028; Kanagal SG, 2008, EXP NEUROL, V214, P229, DOI 10.1016/j.expneurol.2008.08.004; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Krizsan-Agbas D, 2014, J NEUROTRAUM, V31, P846, DOI 10.1089/neu.2013.3115; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Liu YP, 2016, EXP NEUROL, V283, P73, DOI 10.1016/j.expneurol.2016.05.021; Madinier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093121; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; McKenzie NC, 2004, GAIT POSTURE, V19, P226, DOI 10.1016/S0966-6362(03)00060-2; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Muir GD, 2000, EUR J NEUROSCI, V12, P3079, DOI 10.1046/j.1460-9568.2000.00205.x; Muir GD, 2007, EUR J NEUROSCI, V25, P1501, DOI 10.1111/j.1460-9568.2007.05411.x; Musselman KE, 2009, PHYS THER, V89, P601, DOI 10.2522/ptj.20080257; Nascimbeni A, 2015, GAIT POSTURE, V41, P304, DOI 10.1016/j.gaitpost.2014.09.008; Neckel ND, 2013, J NEUROSCI METH, V214, P27, DOI 10.1016/j.jneumeth.2013.01.008; Niederschuh SJ, 2015, ZOOLOGY, V118, P51, DOI 10.1016/j.zool.2014.09.003; Norrie BA, 2005, J NEUROPHYSIOL, V94, P255, DOI 10.1152/jn.00975.2004; Onifer SM, 2005, EXP NEUROL, V192, P25, DOI 10.1016/j.expneurol.2004.10.016; Onifer SM, 2011, RESTOR NEUROL NEUROS, V29, P275, DOI [10.3233/RNN-2011-598, 10.3233/RNN-2011-0598]; Parkkinen S, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/410972; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Pearson KG, 2000, PROG BRAIN RES, V128, P61; Postans NJ, 2004, ARCH PHYS MED REHAB, V85, P604, DOI 10.1016/j.apmr.2003.08.083; Quach L, 2011, J AM GERIATR SOC, V59, P1069, DOI 10.1111/j.1532-5415.2011.03408.x; Raffalt PC, 2018, J BIOMECH, V73, P168, DOI 10.1016/j.jbiomech.2018.03.045; Riek-Burchardt M, 2004, J NEUROSCI METH, V137, P227, DOI 10.1016/j.jneumeth.2004.02.012; Sandrow-Feinberg HR, 2009, J NEUROTRAUM, V26, P721, DOI 10.1089/neu.2008.0750; Schniepp R, 2012, MOVEMENT DISORD, V27, P125, DOI 10.1002/mds.23978; Shah PK, 2013, BRAIN, V136, P3362, DOI 10.1093/brain/awt265; Shah PK, 2012, EUR J NEUROSCI, V36, P2054, DOI 10.1111/j.1460-9568.2012.08106.x; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Singh A, 2014, J NEUROSCI METH, V226, P124, DOI 10.1016/j.jneumeth.2014.01.001; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Soblosky JS, 2001, BEHAV BRAIN RES, V119, P1, DOI 10.1016/S0166-4328(00)00328-4; Thibaudier Y, 2012, J NEUROPHYSIOL, V108, P709, DOI 10.1152/jn.00302.2012; Thota A, 2001, Biomed Sci Instrum, V37, P63; van Hedel HJA, 2009, NEUROREHAB NEURAL RE, V23, P343, DOI 10.1177/1545968308324224; Vidal P.M., 2017, J CELL BIOL CELL MET, V1, P1; VISINTIN M, 1994, PARAPLEGIA, V32, P540, DOI 10.1038/sc.1994.86; Wieseler J, 2010, J NEUROTRAUM, V27, P1697, DOI 10.1089/neu.2010.1311; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wuehr M, 2014, GAIT POSTURE, V39, P852, DOI 10.1016/j.gaitpost.2013.11.013; Zhang SX, 2016, SPINAL CORD, V54, P942, DOI 10.1038/sc.2016.30; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	70	3	4	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2019	36	18					2698	2721		10.1089/neu.2018.6152		APR 2019	24	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IV8QU	WOS:000463597500001	30688140				2022-02-06	
J	Alvarez, G; Suskauer, SJ; Slomine, B				Alvarez, Gabrielle; Suskauer, Stacy J.; Slomine, Beth			Clinical Features of Disorders of Consciousness in Young Children	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Consciousness disorders; Neuropsychology; Rehabilitation	TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; STATE; RECOVERY; PROFILE; ADULTS; COMA	Objectives: To investigate behavioral and demographic features of levels of consciousness in young children with brain injury, including the classifications of consciousness: conscious state (CS), minimally conscious state (MCS), and vegetative state (VS), and to investigate the course of recovery in children with disorders of consciousness (DOC). Design: Retrospective chart review and post hoc analysis. Setting: Pediatric inpatient rehabilitation unit. Participants: Children aged 6 months to 5 years (N=54) admitted for inpatient rehabilitation directly from an acute care hospital following new neurologic injury from 2011 to 2016. Interventions: Not applicable. Main Outcome Measures: Clinically abstracted behavioral features of DOC and levels of consciousness at admission and discharge, based on established guidelines from the Aspen Neurobehavioral Conference Workgroup. Results: Children in MCS were younger than children in CS. Commonly observed behaviors in children in VS were mouth movements or vocalizations, flexion withdrawal or motor posturing, visual or auditory startle, and localization to sound. Common features of MCS were contingent affect, visual fixation or pursuit, automatic motor behavior, and contingent communicative intent. No children in MCS showed command following or intelligible verbalizations. All children in CS showed functional object use, while functional communication was observed in a subset. By discharge, more than half of children in VS emerged to MCS, and a third emerged from MCS to CS. No child emerged from VS to CS. Conclusions: Visual and motor skills may be most applicable, and language-based skills may be least applicable for the assessment of DOC in very young children. Accurate classifications of consciousness may have important prognostic implications, and additional research is needed to develop clear guidelines for assessment of DOC in this population. (C) 2019 by the American Congress of Rehabilitation Medicine	[Alvarez, Gabrielle] Childrens Healthcare Atlanta, Dept Neuropsychol, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA; [Suskauer, Stacy J.] Kennedy Krieger Inst, Div Pediat Rehabil Med, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Slomine, Beth] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; [Slomine, Beth] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Alvarez, G (corresponding author), Childrens Healthcare Atlanta, Dept Neuropsychol, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA.	gabrielle.alvarez@choa.org					ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Atkinson J, 2012, DEV MED CHILD NEUROL, V54, P589, DOI 10.1111/j.1469-8749.2012.04294.x; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P788, DOI 10.1136/jnnp.2003.034876; Berthier NE, 2010, INFANT BEHAV DEV, V33, P555, DOI 10.1016/j.infbeh.2010.07.007; Bourgeois KS, 2005, INFANCY, V8, P233, DOI 10.1207/s15327078in0803_3; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Messinger DS, 2002, CURR DIR PSYCHOL SCI, V11, P1, DOI 10.1111/1467-8721.00156; Monti MM, 2013, HUM BRAIN MAPP, V34, P1245, DOI 10.1002/hbm.21507; Oller JW, 2012, MILESTONES NORMAL SP; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Pilon M, 1996, BRAIN INJURY, V10, P421, DOI 10.1080/026990596124287; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Reilly S, 2006, J PAEDIATR CHILD H, V42, P764, DOI 10.1111/j.1440-1754.2006.00974.x; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Wannez S, 2018, NEUROPSYCHOL REHABIL, V28, P1350, DOI 10.1080/09602011.2017.1310656; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3	22	3	4	2	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4					687	694		10.1016/j.apmr.2018.12.022			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FU	WOS:000462951800012	30639270				2022-02-06	
J	Asehnoune, K; Vourc'h, M; Roquilly, A				Asehnoune, Karim; Vourc'h, Mickael; Roquilly, Antoine			Hormone Therapy in Trauma Patients	CRITICAL CARE CLINICS			English	Article						Corticosteroids; Low-dose hydrocortisone; Trauma patients; Critical illness; Traumatic brain injury; Erythropoietin; Progesterone	CORTICOSTEROID INSUFFICIENCY CIRCI; COMMUNITY-ACQUIRED PNEUMONIA; LOW-DOSE HYDROCORTISONE; CARE MEDICINE SCCM; CRITICAL-ILLNESS; BRAIN-INJURY; SEPTIC SHOCK; DOUBLE-BLIND; ADRENAL INSUFFICIENCY; CORTISOL RESPONSE	Low-dose hydrocortisone reduces the dose of vasopressors and hospital length of stay; it may also decrease the rate of hospital-acquired pneumonia and time on ventilator. No major side effect was reported, but glycemia and natremia should be monitored. Progesterone did not enhance outcome of trauma patients. A meta-analysis suggested that oxandrolone was associated with shorter length of stay and reduced weight loss. Erythropoietin did not enhance neurologic outcome of traumatic brain-injured patients; such treatment, however, could reduce the mortality in subgroups of patients. This review focuses mainly on glucocorticoids, which are the most extensively investigated treatments in hormone therapy.	[Asehnoune, Karim; Vourc'h, Mickael; Roquilly, Antoine] Med Univ Nantes, Inst Rech Sante Nantes Biotech 2, Therapeut Antiinfect EA3826, 21 Blvd Benoni Goullin, F-44000 Nantes, France; [Asehnoune, Karim; Vourc'h, Mickael; Roquilly, Antoine] CHU Nantes, Hotel Dieu, Surg Intens Care Unit, 1 Pl Alexis Ricordeau, F-44093 Nantes, France		Asehnoune, K (corresponding author), Univ Hosp Nantes, Dept Anesthesia Crit Care & Pain Med, Pl Alexis Ricordeau, F-44000 Nantes, France.	karim.asehnoune@chu-nantes.fr		VOURC'H, Mickael/0000-0002-1576-7728			Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Angele Martin K., 2006, Clinics, V61, P479, DOI 10.1590/S1807-59322006000500017; Annane D, 2018, NEW ENGL J MED, V378, P809, DOI 10.1056/NEJMoa1705716; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2017, CRIT CARE MED, V45, P2089, DOI 10.1097/CCM.0000000000002724; Annane D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002243.pub3; Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Asehnoune K, 2012, INTENS CARE MED, V38, P1673, DOI 10.1007/s00134-012-2619-8; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chaudry IH, 2009, BRIT J SURG, V96, P1097, DOI 10.1002/bjs.6697; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Coleman T, 2004, CRIT CARE, V8, P337, DOI 10.1186/cc2897; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Gannon CJ, 2004, SHOCK, V21, P410, DOI 10.1097/00024382-200405000-00003; Gibbison B, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1659-4; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Halonen J, 2007, JAMA-J AM MED ASSOC, V297, P1562, DOI 10.1001/jama.297.14.1562; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hoen S, 2005, CRIT CARE MED, V33, P2737, DOI 10.1097/01.CCM.0000189743.55352.0E; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Lepelletier Y, 2010, BLOOD, V116, P3389, DOI 10.1182/blood-2010-05-282913; Li H, 2016, BURNS, V42, P717, DOI 10.1016/j.burns.2015.08.023; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu T, 2015, AM J SURG, V210, P911, DOI 10.1016/j.amjsurg.2015.03.021; Lykissas MG, 2007, CLIN NEUROL NEUROSUR, V109, P639, DOI 10.1016/j.clineuro.2007.05.013; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; McFarlane AC, 1997, ANN NY ACAD SCI, V821, P437, DOI 10.1111/j.1749-6632.1997.tb48299.x; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Orr R, 2004, DRUGS, V64, P725, DOI 10.2165/00003495-200464070-00004; Pastores SM, 2018, INTENS CARE MED, V44, P474, DOI 10.1007/s00134-017-4951-5; Reeves PT, 2016, SHOCK, V45, P367, DOI 10.1097/SHK.0000000000000517; Roquilly A, 2015, MOL IMMUNOL, V68, P120, DOI 10.1016/j.molimm.2015.06.030; Roquilly A, 2014, CRIT CARE MED, V42, pE752, DOI 10.1097/CCM.0000000000000658; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Roth-Isigkeit A, 2001, J ENDOCRINOL INVEST, V24, P777, DOI 10.1007/BF03343927; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Van den Berghe G, 2016, AM J RESP CRIT CARE, V194, P1337, DOI 10.1164/rccm.201607-1516CI; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Venet F, 2018, NAT REV NEPHROL, V14, P121, DOI 10.1038/nrneph.2017.165; Venet F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0740-0; Venkatesh B, 2018, NEW ENGL J MED, V378, P797, DOI 10.1056/NEJMoa1705835; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; Weis F, 2009, CRIT CARE MED, V37, P1685, DOI 10.1097/CCM.0b013e31819fca77; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051; Wolf SE, 2006, J BURN CARE RES, V27, P131, DOI 10.1097/01.BCR.0000202620.55751.4F; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao Guo-min, 2007, Zhonghua Wai Ke Za Zhi, V45, P106; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	68	3	3	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	APR	2019	35	2					201	+		10.1016/j.ccc.2018.11.009			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR4NC	WOS:000463122200003	30784604				2022-02-06	
J	Bai, W; Li, P; Ning, YL; Jiang, YL; Yang, N; Chen, X; Zhou, YG				Bai, Wei; Li, Ping; Ning, Ya-Lei; Jiang, Yu-Lin; Yang, Nan; Chen, Xing; Zhou, Yuan-Guo			REDUCTION IN BLOOD GLUTAMATE LEVELS COMBINED WITH THE GENETIC INACTIVATION OF A(2A)R SIGNIFICANTLY ALLEVIATE TRAUMATIC BRAIN INJURY-INDUCED ACUTE LUNG INJURY	SHOCK			English	Article						Acute lung injury; adenosine A(2A) receptor; glutamate; inflammatory response; traumatic brain injury	SCAVENGERS OXALOACETATE; ADENOSINE RECEPTORS; PERITONEAL-DIALYSIS; PLASMA GLUTAMATE; IMPACT; INFLAMMATION; PYRUVATE	Traumatic brain injury-induced acute lung injury (TBI-ALI) is a serious complication of traumatic brain injury (TBI). Our previous clinical study found that high levels of blood glutamate after TBI were closely related to the occurrence and severity of TBI-ALI, while it remains unknown whether a high concentration of blood glutamate directly causes or aggravates TBI-ALI. We found that inhibition of the adenosine A(2A) receptor (A(2A)R) after brain injury alleviated the TBI-ALI; however, it is unknown whether lowering blood glutamate levels in combination with inhibiting the A(2A)R would lead to better effects. Using mouse models of moderate and severe TBI, we found that intravenous administration of L-glutamate greatly increased the lung water content, lung-body index, level of inflammatory markers in bronchoalveolar lavage fluid and acute lung injury score and significantly decreased the PaO2/FiO(2) ratio. Moreover, the incidence of TBI-ALI and the mortality rate were significantly increased, and the combined administration of A(2A)R activator and exogenous glutamate further exacerbated the above damaging effects. Conversely, lowering the blood glutamate level through peritoneal dialysis or intravenous administration of oxaloacetate notably improved the above parameters, and a further improvement was seen with concurrent A(2A)R genetic inactivation. These data suggest that A(2A)R activation aggravates the damaging effect of high blood glutamate concentrations on the lung and that combined treatment targeting both A(2A)R and blood glutamate may be an effective way to prevent and treat TBI-ALI.	Third Mil Med Univ, Mol Biol Ctr, State Key Lab Trauma Burn & Combined Injury, Res Inst Surg, Chongqing, Peoples R China; [Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China		Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China.; Zhou, YG (corresponding author), Third Mil Med Univ, Mol Biol Ctr, Res Inst Surg, Chongqing 400042, Peoples R China.	ygzhou@tmmu.edu.cn	Li, ping/J-6507-2019	Li, Ping/0000-0002-4926-3835	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171022, 81571888]; Foundational and Cutting-Edge Research Plan of Chongqing [cstc2014jcyjA10072]	This work was supported by grants from the National Natural Science Foundation of China (No. 31171022, No. 81571888) and the Foundational and Cutting-Edge Research Plan of Chongqing (No. cstc2014jcyjA10072).	Aggarwal NR, 2013, AM J RESP CELL MOL, V48, P635, DOI 10.1165/rcmb.2012-0351OC; Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Bai W, 2017, FRONT MOL NEUROSCI, V10, DOI [10.3389/fnmol.2017.00443, 10.3389/fnmol.2017.00400]; Bai W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05574-9; BEGLEY DJ, 1994, J CHROMATOGR B, V657, P185, DOI 10.1016/0378-4347(94)80085-5; Boyko M, 2012, NEUROTHERAPEUTICS, V9, P649, DOI 10.1007/s13311-012-0129-6; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; CHEN HI, 1981, AM J PHYSIOL, V240, pH109, DOI 10.1152/ajpheart.1981.240.1.H109; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Dickman KG, 2004, AM J RESP CELL MOL, V30, P139, DOI 10.1165/rcmb.2003-0177OC; Gupta R, 2013, AMINO ACIDS, V44, P757, DOI 10.1007/s00726-012-1400-1; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Jin WS, 2017, ACTA NEUROPATHOL, V134, P207, DOI 10.1007/s00401-017-1721-y; Kaur Baninder, 2017, Pathophysiology, V24, P71, DOI 10.1016/j.pathophys.2017.02.001; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Maillet I, 2016, CLIN SCI, V130, P1939, DOI 10.1042/CS20160530; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mortier S, 2005, PERITON DIALYSIS INT, V25, P16; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rogachev B, 2013, J NEUROSURG ANESTH, V25, P262, DOI 10.1097/ANA.0b013e318283f86a; Rogachev B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.002; Said SI, 2001, TRENDS PHARMACOL SCI, V22, P344, DOI 10.1016/S0165-6147(00)01744-2; Sedy J, 2015, J NEUROTRAUM, V32, P1135, DOI 10.1089/neu.2014.3609; Sedy J, 2012, J APPL PHYSIOL, V112, P1, DOI 10.1152/japplphysiol.00574.2011; Sharma AK, 2016, AM J RESP CRIT CARE, V193, P988, DOI 10.1164/rccm.201506-1253OC; Yang SJ, 2017, NEUROTOX RES, V32, P107, DOI 10.1007/s12640-017-9717-x; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	35	3	3	3	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	APR	2019	51	4					502	510		10.1097/SHK.0000000000001170			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	HR6SS	WOS:000463284100014	29688987				2022-02-06	
J	Chen, XR; Chen, YZ; Xu, Y; Gao, QL; Shen, ZW; Zheng, WB				Chen, Xiran; Chen, Yanzi; Xu, Yuan; Gao, Qilu; Shen, Zhiwei; Zheng, Wenbin			Microstructural and Neurochemical Changes in the Rat Brain After Diffuse Axonal Injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						diffuse axonal injury; magnetic resonance imaging; diffusion kurtosis imaging; chemical exchange saturation transfer; glutamate	SATURATION-TRANSFER; PROTON MRS; KURTOSIS; TRAUMA; MODERATE; MARKER; TISSUE; MODEL; MILD	Background Diffuse axonal injury (DAI) is one of the devastating types of traumatic brain injury, but is difficult to detect on conventional imaging in its early stages. Purpose To test the technical feasibility and diagnostic value of diffusion kurtosis imaging (DKI) and glutamate chemical exchange saturation transfer (GluCEST) imaging in the brain after DAI. Study Type Prospective. Animal Model Sixty Sprague-Dawley rats. The DAI model was induced by using the impact acceleration model of Marmarou et al with modified settings. Field Strength/Sequence A 7.0T animal MR scanner with a fast spin-echo sequence (T-2-weighted imaging), fast spin-echo multislice sequence (DKI), echo planar imaging in the signal of the chemical exchange saturation transfer sequence (CEST), and point-resolved spectroscopy sequence (hydrogenproton magnetic resonance spectroscopy, H-1-MRS). Assessment Brain MRI scanned before and 2 hours after injury. DKI images were processed with MatLab and MRIcro software, GluCEST images were processed using software routines written in MatLab, and spectroscopic data were postprocessed with LCModel. Statistical Tests The parameters of these techniques were assessed using the independent sample t-test and Pearson correlation. Results Mean kurtosis and mean diffusivity values were significantly higher than controls in the parietal lobe, hippocampus, and thalamus (P < 0.01). However, fractional anisotropy was lower only in the parietal lobe, with no detectable changes in the hippocampus and thalamus. GluCEST values of the parietal lobe, hippocampus, and thalamus were significantly higher than controls in DAI rats (P < 0.01). This change was further validated through H-1-MRS. A positive correlation was observed between glutamate (Glu) and glutamate compound (Glx) concentrations and GluCEST values (Glu: R-2 = 0.589, Glx: R-2 = 0.878). Data Conclusion DKI and GluCEST might be acceptably sensitive for tracking microstructural and neurochemical changes in the brain following DAI.	[Chen, Xiran] Southern Med Univ, Affiliated Hosp 3, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Chen, Yanzi; Xu, Yuan; Gao, Qilu; Shen, Zhiwei; Zheng, Wenbin] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Shantou, Guangdong, Peoples R China		Zheng, WB (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Shantou, Guangdong, Peoples R China.	hwenb@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571627]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [2014A030313481]; Shantou University Innovation project, Shantou, China; Medical Scientific Research Foundation of Guangdong Province, China [B2014284]	Contract grant sponsor: National Natural Science Foundation of China; Contract grant number: 81571627; Contract grant sponsor: Natural Science Foundation of Guangdong Province, China; Contract grant number: 2014A030313481; Contract grant sponsor: Shantou University Innovation project, Shantou, China; Contract grant sponsor: Medical Scientific Research Foundation of Guangdong Province, China; Contract grant number: B2014284.	Aime S, 2004, CURR PHARM BIOTECHNO, V5, P509, DOI 10.2174/1389201043376580; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen XR, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4757025; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Dagher AP, 2000, J MAGN RESON IMAGING, V12, P745, DOI 10.1002/1522-2586(200011)12:5<745::AID-JMRI12>3.0.CO;2-H; Davis KA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7095; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hori M, 2012, MAGN RESON MED SCI, V11, P221, DOI 10.2463/mrms.11.221; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; Sherry AD, 2008, ANNU REV BIOMED ENG, V10, P391, DOI 10.1146/annurev.bioeng.9.060906.151929; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zheng WB, 2015, BIO-MED MATER ENG, V26, pS1169, DOI 10.3233/BME-151413; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	38	3	3	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	APR	2019	49	4					1069	1077		10.1002/jmri.26258			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	HO8UF	WOS:000461233600016	30079492				2022-02-06	
J	Feigenbaum, LA; Kim, KJ; Gaunaurd, IA; Kaplan, LD; Scavo, VA; Bennett, C; Gailey, RS				Feigenbaum, Luis A.; Kim, Kyoung J.; Gaunaurd, Ignacio A.; Kaplan, Lee D.; Scavo, Vincent A.; Bennett, Christopher; Gailey, Robert S.			POST-CONCUSSIVE CHANGES IN BALANCE AND POSTURAL STABILITY MEASURED WITH CANESENSE (TM) AND THE BALANCE ERROR SCORING SYSTEM (BESS) IN DIVISION I COLLEGIATE FOOTBALL PLAYERS: A CASE SERIES	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Balance Error Scoring System; CaneSense (TM); Concussion; Performance-based measure; Postural Stability	SPORTS-RELATED CONCUSSION; LOWER-EXTREMITY INJURY; TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; INTERNATIONAL-CONFERENCE; MUSCULOSKELETAL INJURY; CEREBRAL CONCUSSION; CONSENSUS STATEMENT; HIGH-SCHOOL; RECOVERY	Introduction: Impairments in postural stability have been identified following sports-related concussion. CaneSense (TM) is a recently developed mobile lower limb motion capture system and mobile application for movement assessment which provides an objective measure of postural stability. One of the components within CaneSense (TM) is the Post-Concussive Excursion Index (PCEI), a measure of postural stability expressed as a percentage of symmetry between lower limbs. Purpose: The purpose of this case series is to examine pre-and post-concussion differences using two separate measures, CaneSense (TM), and a known test, the Balance Error Scoring System (BESS), in Division I collegiate football players. Methods: A convenience sample of eight football players diagnosed with a concussion, were the subjects in this case series. All subjects underwent baseline testing prior to the start of pre-season camp consisting of the single limb stance (SLS) test with CaneSense (TM) and the BESS test. Twenty-four to 72 hours following their concussion, SLS with CaneSense (TM) test and the BESS test, were administered. Segmental excursions for the thigh and shank segments for each lower limb were combined into the Post-Concussion Excursion Profile (PCEP), which represents each segment's maximum excursion in the medial-lateral and anterior-posterior direction. The PCEI is a single metric generated to quantify differences within subjects by comparing the PCEP value between lower limbs during SLS where 100% suggests absolute symmetry. Results: The PCEI value decreased significantly post-concussion (41.43 +/- 15.53% vs. 87.41 +/- 6.05%, p < 0.001) demonstrating a 52.6% decrease in inter-limb symmetry when compared to baseline values. There was an unanticipated 36.36% improvement in composite BESS performance post-concussion (10.5 +/- 4.87 errors vs. 16.5 +/- 8.49 errors, p = 0.10). Conclusions: Differences in inter-limb postural stability were found in subjects post-concussion. By assessing postural stability in both lower limbs individually, using the PCEI, impairments were detected that otherwise would have likely gone undiagnosed using the BESS test alone.	[Feigenbaum, Luis A.; Kim, Kyoung J.; Gaunaurd, Ignacio A.; Gailey, Robert S.] Univ Miami, Miller Sch Med, Dept Phys Therapy, 5915 Ponce de Leon Blvd,Fifth Floor, Coral Gables, FL 33146 USA; [Bennett, Christopher] Univ Miami, Mus Engn Technol Program, Frost Sch Mus, Coral Gables, FL 33146 USA; [Kim, Kyoung J.; Gaunaurd, Ignacio A.; Bennett, Christopher; Gailey, Robert S.] Univ Miami, Neil Spielholz Funct Outcomes Res & Evaluat Ctr, Coral Gables, FL 33146 USA; [Feigenbaum, Luis A.; Kaplan, Lee D.; Scavo, Vincent A.] Univ Miami, Miller Sch Med, UHlth Sports Med Inst, Miami, FL 33136 USA		Feigenbaum, LA (corresponding author), Univ Miami, Miller Sch Med, Dept Phys Therapy, 5915 Ponce de Leon Blvd,Fifth Floor, Coral Gables, FL 33146 USA.	lfeigenbaum@miami.edu			Commercialization Grant through the Wallace H. Coulter Center for Translational Research at the University of Miami	This work was supported in part by a Commercialization Grant through the Wallace H. Coulter Center for Translational Research at the University of Miami.	Agostini V, 2011, GAIT POSTURE, V34, P248, DOI 10.1016/j.gaitpost.2011.05.008; Agrawal V, 2009, PROSTHET ORTHOT INT, V33, P148, DOI 10.1080/03093640902777254; Allseits E, 2017, J BIOMECH, V55, P27, DOI 10.1016/j.jbiomech.2017.02.016; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; BURMAN E, 2016, BMJ OPEN SPORT EXERC, V24, P1, DOI DOI 10.1080/14681366.2015.1057215; Butler RJ, 2013, SPORTS HEALTH, V5, P417, DOI 10.1177/1941738113498703; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chaudhry H, 2004, J REHABIL RES DEV, V41, P713, DOI 10.1682/JRRD.2003.09.0140; Chmielewski TL, 2006, J ORTHOP SPORT PHYS, V36, P308, DOI 10.2519/jospt.2006.2013; Clendaniel RA, 2000, OTOLARYNG CLIN N AM, V33, P519, DOI 10.1016/S0030-6665(05)70225-5; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fino PC, 2017, CLIN J SPORT MED, V1, P1; FRIDEN T, 1989, AM J SPORT MED, V17, P118, DOI 10.1177/036354658901700120; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gailey RS, 2013, J REHABIL RES DEV, V50, P905, DOI 10.1682/JRRD.2012.05.0099; Gaunaurd IA, 2017, J ORTHOP SPORT PHYS, V47, pA181; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2002, AM J SPORT MED, V30, P630; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kim KJ, 2018, J BIOMECH, V71, P151, DOI 10.1016/j.jbiomech.2018.01.042; Kim KJ, 2016, IEEE T NEUR SYS REH, V24, P1191, DOI 10.1109/TNSRE.2016.2532121; Kim KJ, 2016, IEEE ENG MED BIO, P4987, DOI 10.1109/EMBC.2016.7591847; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mathiasen R, 2018, J NEUROTRAUM, V35, P691, DOI 10.1089/neu.2017.5072; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Plisky PJ, 2006, J ORTHOP SPORT PHYS, V36, P911, DOI 10.2519/jospt.2006.2244; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; PRIETO TE, 1993, CLIN PHARMACOL THER, V54, P228, DOI 10.1038/clpt.1993.134; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Westmoreland BF, 1994, MED NEUROSCIENCE APP; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	86	3	3	0	3	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	APR	2019	14	2					296	307		10.26603/ijspt20190296			12	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	IB1KH	WOS:000470023600014	30997281				2022-02-06	
J	Hao, HH; Liu, Q; Wu, D; Xing, H; Geng, YH				Hao, Haihu; Liu, Qiang; Wu, Dou; Xing, Hao; Geng, Yahui			Tetrahydropalmatine reduces cell death and improves functional recovery after traumatic spinal cord injury in rats	TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Tetrahydropalmatine; Spinal cord injury; Cytokines; Edema; Neuroprotection	FACTOR-KAPPA-B; BRAIN-INJURY; INFLAMMATION; REGENERATION; INSIGHTS	Purpose: To investigate the effectiveness of tetrahydropalmatine (THP) in the treatment of spinal cord injury (SCI) in rats. Methods: Adult Sprague Dawley rats were divided into 3 groups: normal control group, SCI group, and SCI group treated with THP (100 mg kg-1). The effect of THP on spinal cord water content, levels of inflammatory mediators, oxidative stress and apoptosis were determined. Locomotor activity in rats was measured using Basso, Beattie and Bresnahan (BBB) scores. Various oxidative stress markers as well as cytokine levels (NF-kappa B, IL-6, IL-1 beta and TNF-alpha were determined. Apoptotic index was measured using TUNEL assay. Results: After 72 h of treatment with THP, BBB scores in SCI group of rats significantly increased from 4.19 +/- 0.41 to 8.89 +/- 0.47 (p < 0.05). Tunel assay revealed a higher apoptotic index (42.50 +/- 3.19) in the tissues of SCI rats than in SCI rats treated with THP (31.48 +/- 1.19, p < 0.01). Expressions of inflammatory cytokines were significantly upregulated in SCI rats. However, THP administration resulted in significant downregulation of the expressions (p < 0.01). Conclusion: These results indicate that THP attenuates traumatic SCI in rats via modulation of the levels of anti-inflammatory mediators. Thus, THP has a promising potential for the management of SCI.	[Hao, Haihu] Shanxi Acad Med Sci, Dept Orthoped, Taiyuan 030032, Shanxi, Peoples R China; Shanxi Da Yi Hosp, Taiyuan 030032, Shanxi, Peoples R China		Hao, HH (corresponding author), Shanxi Acad Med Sci, Dept Orthoped, Taiyuan 030032, Shanxi, Peoples R China.	HeimsRacquyende@yahoo.com			administration of Shanxi Academy of Medical Sciences; Shanxi Da Yi Hospital, Taiyuan, China	The authors acknowledge the administration of Shanxi Academy of Medical Sciences and Shanxi Da Yi Hospital, Taiyuan, China for providing facilities and funds required for the research.	[Anonymous], 2006, RESOURCE BOOK DESIGN, P23; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Chen F, 1999, CLIN CHEM, V45, P7; Chen X, 2011, BRAIN RES, V1372, P160, DOI 10.1016/j.brainres.2010.11.089; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Huang LX, 2018, MICROB PATHOGENESIS, V114, P197, DOI 10.1016/j.micpath.2017.11.047; Jin W, 2011, ANN CLIN LAB SCI, V41, P25; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Leung WC, 2003, PROG NEURO-PSYCHOPH, V27, P775, DOI 10.1016/S0278-5846(03)00108-8; Liang WB, 2010, BIOMATERIALS, V31, P8634, DOI 10.1016/j.biomaterials.2010.07.084; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Loannou S, 2010, MEDIAT INFLAMM, V2010; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Ormond DR, 2012, J NEUROSURG-SPINE, V16, P497, DOI 10.3171/2012.1.SPINE11769; Rafati DS, 2008, J NEUROSCI RES, V86, P566, DOI 10.1002/jnr.21508; Yun KJ, 2009, INT IMMUNOPHARMACOL, V9, P1323, DOI 10.1016/j.intimp.2009.08.001; Zhu SP, 2016, MOL NEUROBIOL, V53, P4375, DOI 10.1007/s12035-015-9372-2; 2014, INFLAMM RES, V63, P381, DOI DOI 10.1007/S00011-014-0710-Z	26	3	3	1	11	PHARMACOTHERAPY GROUP	BENIN CITY	UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA	1596-5996			TROP J PHARM RES	Trop. J. Pharm. Res.	APR	2019	18	4					703	711		10.4314/tjpr.v18i4.4			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HW5FP	WOS:000466715100004		gold			2022-02-06	
J	Kong, TH; Lee, JW; Park, YA; Seo, YJ				Kong, Tae Hoon; Lee, Jae Woo; Park, Yoon Ah; Seo, Young Joon			Clinical Features of Fracture versus Concussion of the Temporal Bone after Head Trauma	JOURNAL OF AUDIOLOGY AND OTOLOGY			English	Article						Temporal bone; Craniocerebral trauma; Hearing loss; Facial paralysis	LABYRINTHINE CONCUSSION; MANAGEMENT; CLASSIFICATION	Background and Objectives: Temporal bone fracture (TBF) is a common occurrence in cases of head trauma. Although the incidence of temporal bone concussion (TBC) has increased in cases of head trauma, it has not been extensively studied. We assessed the characteristics of TBF and TBC in patients with head trauma. Subjects and Methods: We conducted a retrospective review of 432 patients with head injury who visited our hospital between January 2011 and April 2016. Of these patients, 211 who met the inclusion criteria were included in the study. Their clinical characteristics, causes of injury, and hearing function were analyzed. Results: Among the 211 patients, 157 had TBFs and 54 had TBCs. Ear symptoms were more common among patients with TBF than among those with TBC. Car accidents were the most common cause of both TBF and TBC, but assault and sports injuries were more common among patients with TBC than among those with TBF. The occurrence of facial palsy in both cases of TBF and TBC. Hearing loss was observed among 35 patients with TBF and 11 patients with TBC. However, patients with TBF showed conductive hearing loss with an air-bone gap. Hearing function of these patients with TBF recovered with a reduced air-bone gap, but the patients with TBC showed little recovery. Conclusions: Emergency physicians should focus more on temporal bone injury in patients with head trauma. Therefore, an early complete diagnostic battery, which includes high-resolution computed tomography, audio-metric tests, neurologic examination, and vestibular tests, be performed in patients with head trauma.	[Kong, Tae Hoon; Lee, Jae Woo; Park, Yoon Ah; Seo, Young Joon] Yonsei Univ, Wonju Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 20 Ilsan Ro, Wonju 26426, South Korea		Seo, YJ (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 20 Ilsan Ro, Wonju 26426, South Korea.	okas2000@hanmail.net	KONG, TAEHOON/AAG-5079-2020; Seo, Young Joon/AAS-6148-2021		Gangwon Institute for Regional Program Evaluation - Korea government (Ministry of Trade, Industry and Energy) [R0005797]; Ministry of Trade, Industry & Energy (MOTIE, Korea) [20001819]	This work was supported by the Gangwon Institute for Regional Program Evaluation grant funded by the Korea government (Ministry of Trade, Industry and Energy) (No. R0005797) and by the Technology Innovation Program (or Industrial Strategic Technology Development Program) (20001819) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea).	Amin Z, 2008, Med J Malaysia, V63, P373; Brodie HA, 1997, AM J OTOL, V18, P188; Chiaramonte R, 2013, NEURORADIOL J, V26, P52, DOI 10.1177/197140091302600109; Choi HG, 2015, OTOL NEUROTOL, V36, P1048, DOI 10.1097/MAO.0000000000000662; Choi Mi Suk, 2013, Korean J Audiol, V17, P13, DOI 10.7874/kja.2013.17.1.13; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Grant JR, 2008, OTOL NEUROTOL, V29, P344, DOI 10.1097/MAO.0b013e3181690792; HASSO AN, 1988, OTOLARYNG CLIN N AM, V21, P295; HITCHIN AD, 1973, BRIT J ORAL SURG, V11, P114, DOI 10.1016/0007-117X(73)90027-9; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Kang HM, 2012, EUR ARCH OTO-RHINO-L, V269, P1893, DOI 10.1007/s00405-011-1849-7; Kim SY, 2016, CLIN EXP OTORHINOLAR, V9, P206, DOI 10.21053/ceo.2015.01116; NICOL JW, 1994, J ACCID EMERG MED, V11, P218; Odebode TO, 2006, J TRAUMA, V61, P388, DOI 10.1097/01.ta.0000224140.26660.5c; Sanus GZ, 2009, SURG NEUROL, V71, P304, DOI 10.1016/j.surneu.2008.02.007; Ulug T, 2006, J OTOLARYNGOL, V35, P380, DOI 10.2310/7070.2006.0069; Valvassori GE, 2003, BALLENGERS OTORHINOL, P195; Villarreal IM, 2016, CASE REP OTOLARYNGOL, V2016, DOI 10.1155/2016/2123182	19	3	3	0	3	KOREAN AUDIOLOGICAL SOC	SEOUL	DEPT OTORHINOLARY-HEAD&NECK SURG, SEOUL ST MARYS HOSP, CATHOLIC UNIV KOREA COLL MED, #505BANGPO-DONG, SEOUL, 06591, SOUTH KOREA	2384-1621	2384-1710		J AUDIOL OTOL	J. Audiol. Otol.	APR	2019	23	2					96	102		10.7874/jao.2018.00339			7	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	HT0DF	WOS:000464235100006	30857384	Green Published, gold, Green Submitted			2022-02-06	
J	Linder, SM; Cruickshank, J; Zimmerman, NM; Figler, R; Alberts, JL				Linder, Susan M.; Cruickshank, Jason; Zimmerman, Nicole M.; Figler, Richard; Alberts, Jay L.			A technology-enabled electronic incident report to document and facilitate management of sport concussion A cohort study of youth and young adults	MEDICINE			English	Article						documentation; emergency medicine; epidemiology; sports medicine; traumatic brain injury	COMPUTED-TOMOGRAPHY; PATIENT-CARE; EDUCATION; STRATEGY; CHILDREN; INJURY; HEAD	Despite the widespread awareness of concussion across all levels of sport, the management of concussion from youth to college is inconsistent and fragmented. A fundamental gap contributing to inconsistent care is the lack of a scalable, systematic approach to document initial injury characteristics following concussion. The purpose of this study was to determine differences in injury profiles and management of youth, high school, and college athletes using a mobile application for incident report documentation. A cohort study was conducted in which concussion electronic incident report data from 46 high schools and colleges, and Cleveland Clinic ambulatory concussion clinics were gathered and analyzed. In sum, 1421 ( N=88 youth, N=1171 high school and N=162 college) athletes with sport-related concussions were included. Despite the relative absence of red flags, youth athletes had a greater probability of being sent to the emergency department than high school and collegiate athletes. Over 60% of athletes were removed from play immediately post-injury. Injury recognition was delayed in 25% of athletes due to delayed symptom reporting ( 20% of males, 16% of females) or delayed symptom onset ( 5% of males, 9% of females). A significantly greater incidence of red flags was evident in males, and in high school and collegiate athletes compared to youth athletes. The high frequency of youth athletes sent to the emergency department, despite the absence of red flags, may be a reflection of inadequate medical coverage at youth events, ultimately resulting in unnecessary utilization of emergency medicine services. The relatively high incidence of delayed injury reporting implies that additional educational efforts targeting student-athletes and the utilization of resources to improve injury detection are warranted. The systematic collection of injury-related demographics through the electronic mobile application facilitated interdisciplinary communication and improved the efficiency of managing athletes with concussion.	[Linder, Susan M.; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Cruickshank, Jason; Figler, Richard; Alberts, Jay L.] Cleveland Clin, Concuss Ctr, Cleveland, OH 44106 USA; [Zimmerman, Nicole M.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Zimmerman, Nicole M.; Alberts, Jay L.] Cleveland Clin, Off Clin Transformat, Cleveland, OH 44106 USA; [Alberts, Jay L.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA		Linder, SM (corresponding author), Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Alberts, JL (corresponding author), Dept Biomed Engn, 9500 Euclid Ave,ND-20, Cleveland, OH 44195 USA.	linders@ccf.org; albertj@ccf.org			Edward F. and Barbara A. Bell Family Endowed Chair	This project was supported the Edward F. and Barbara A. Bell Family Endowed Chair to JLA.	Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2016, BRIDGE LINKING ENG S, V46, P23; Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bacon CEW, 2017, J ATHL TRAINING, V52, P667, DOI 10.4085/1062-6050-52.3.15; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; LaBella C, 2014, JAMA-J AM MED ASSOC, V312, P739, DOI 10.1001/jama.2014.6668; Mascha EJ, 2010, STAT MED, V29, P2890, DOI 10.1002/sim.4066; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McLeod TCV, 2019, CLIN J SPORT MED, V29, P298, DOI 10.1097/JSM.0000000000000530; Mihindu E, 2014, AM SURGEON, V80, P841; Nottingham SL, 2017, J ATHL TRAINING, V52, P656, DOI 10.4085/1062-6050-52.3.14; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Parma C, 2014, AM SURGEON, V80, P664; Porter ME, 2013, HARVARD BUS REV, V91, P24; Porter ME, 2013, HARVARD BUS REV, V91, P50; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Sefton J. M., 2004, J ATHL TRAINING, V39, pS52; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Zirkel P, 2016, PHYS DISABIL, V35, P1; 2015, J ATHL TRAINING, V50, P156, DOI DOI 10.4085/1062-6050-50.2.03	35	3	3	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	APR	2019	98	14							e14948	10.1097/MD.0000000000014948			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HX3WF	WOS:000467323600010	30946318	gold, Green Published			2022-02-06	
J	Suleiman, A; Lithgow, B; Mansouri, B; Moussavi, Z				Suleiman, Abdelbaset; Lithgow, Brian; Mansouri, Behzad; Moussavi, Zahra			Using EVestG Assessments for Detection of Symptomology Consequent to a Lateral-Impact Concussion	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Vestibular; Lateral-impact; Concussion; Coup; contrecoup impact; Electrovestibulography (EVestG)	FOOTBALL; INJURY; HEAD	This study was conducted to investigate plausible differences in vestibular response due to lateral-impact concussion using electrovestibulography (EVestG). EVestG signals are recorded non-invasively from the external ear in response to vestibular stimuli; the EVestG signal consists of peripheral vestibulo-acoustic signals and the brainstem's response. In this study we investigated the relationship between characteristic features of the extracted field potentials (FPs) of EVestG signals in participants with lateral-impact concussion in comparison with those of healthy controls. Twelve lateral-impact concussed participants (5 right and 6 left lateral-impact) and 12 age-and-gender-matched healthy controls were tested by EVestG. Characteristic features were extracted from the FPs during side tilt, and a leave-one-out linear discriminant analysis (LDA) classification was applied to the extracted features. The results show a clear asymmetry on the impacted side between the left and right FPs after lateral-impact compared to those from healthy controls. The LDA classification resulted in a sensitivity of 67%, specificity of 92 and 79% overall accuracy for separating lateral-impact concussed participants from controls. EVestG appears to have diagnostic potential in diagnosing lateral-impact concussion.	[Suleiman, Abdelbaset; Lithgow, Brian; Mansouri, Behzad; Moussavi, Zahra] Univ Manitoba, Biomed Engn Program, Winnipeg, MB R3T 5V6, Canada; [Lithgow, Brian; Moussavi, Zahra] Riverview Hlth Ctr, Winnipeg, MB R3L 2P4, Canada; [Mansouri, Behzad] Univ Manitoba, Dept Internal Med Neurol, Winnipeg, MB R3E 0W2, Canada; [Lithgow, Brian; Moussavi, Zahra] Univ Manitoba, Dept Elect & Comp Engn, Winnipeg, MB R3T 5V6, Canada; [Lithgow, Brian] Alfred Hosp, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3004, Australia; [Lithgow, Brian] Monash Univ, Melbourne, Vic 3004, Australia; [Mansouri, Behzad] Univ Manitoba, Dept Ophthalmol, Winnipeg, MB R3E 0W2, Canada		Suleiman, A (corresponding author), Univ Manitoba, Biomed Engn Program, Winnipeg, MB R3T 5V6, Canada.	Suleimaa@myumanitoba.ca; Zahra.Moussavi@umanitoba.ca			MITACS; Neural Diagnostics Canada Ltd.; Riverview Health Centre Foundation	This study was supported by MITACS, Neural Diagnostics Canada Ltd. and Riverview Health Centre Foundation.	BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Daroff R.B., 2015, BRADLEYS NEUROLOGY C; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Lithgow B, 2012, ANN BIOMED ENG, V40, P1835, DOI 10.1007/s10439-012-0526-3; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	9	3	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	APR	2019	39	2			SI		218	223		10.1007/s40846-018-0405-y			6	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HQ3VD	WOS:000462337700007					2022-02-06	
J	Dennis, J; Yengo-Kahn, AM; Kirby, P; Solomon, GS; Cox, NJ; Zuckerman, SL				Dennis, Jessica; Yengo-Kahn, Aaron M.; Kirby, Paul; Solomon, Gary S.; Cox, Nancy J.; Zuckerman, Scott L.			Diagnostic Algorithms to Study Post-Concussion Syndrome using Electronic Health Records: Validating a Method to Capture an Important Patient Population	JOURNAL OF NEUROTRAUMA			English	Article						diagnostic algorithm; electronic health records; post-concussion syndrome	TRAUMATIC BRAIN-INJURY; PHENOME-WIDE ASSOCIATION; OUTCOME PREDICTION; MILD; RISK; CATALOG; DISEASE; TIME; AGE	Post-concussion syndrome (PCS) is characterized by persistent cognitive, somatic, and emotional symptoms after a mild traumatic brain injury (mTBI). Genetic and other biological variables may contribute to PCS etiology, and the emergence of biobanks linked to electronic health records (EHRs) offers new opportunities for research on PCS. We sought to validate the EHR data of PCS patients by comparing two diagnostic algorithms deployed in the Vanderbilt University Medical Center de-identified database of 2.8 million patient EHRs. The algorithms identified individuals with PCS by: 1) natural language processing (NLP) of narrative text in the EHR combined with structured demographic, diagnostic, and encounter data; or 2) coded billing and procedure data. The predictive value of each algorithm was assessed, and cases and controls identified by each approach were compared on demographic and medical characteristics. The NLP algorithm identified 507 cases and 10,857 controls. The negative predictive value in controls was 78% and the positive predictive value (PPV) in cases was 82%. Conversely, the coded algorithm identified 1142 patients with two or more PCS billing codes and had a PPV of 76%. Comparisons of PCS controls to both case groups recovered known epidemiology of PCS: cases were more likely than controls to be female and to have pre-morbid diagnoses of anxiety, migraine, and post-traumatic stress disorder. In contrast, controls and cases were equally likely to have attention deficit hyperactive disorder and learning disabilities, in accordance with the findings of recent systematic reviews of PCS risk factors. We conclude that EHRs are a valuable research tool for PCS. Ascertainment based on coded data alone had a predictive value comparable to an NLP algorithm, recovered known PCS risk factors, and maximized the number of included patients.	[Dennis, Jessica; Cox, Nancy J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Dennis, Jessica; Cox, Nancy J.] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA; [Yengo-Kahn, Aaron M.; Kirby, Paul; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA		Dennis, J (corresponding author), Vanderbilt Univ, Med Ctr, Div Med Genet, 511J Light Hall, Nashville, TN 37232 USA.	Jessica.dennis@vumc.org	Yengo-Kahn, Aaron/AAV-7647-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Dennis, Jessica/0000-0002-8507-9699	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MFE-142936]; Vanderbilt Institute for Clinical and Translational Research [VR20299]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10RR025141]; Clinical and Translational Science AwardsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR002243, UL1TR000445, UL1RR024975]; NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445];  [R01 MH113362];  [U54MD010722];  [U01HG009086]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002243, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG009086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH113362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD010722] Funding Source: NIH RePORTER	Jessica Dennis is supported by the Canadian Institutes of Health Research (award MFE-142936). Support for Nancy J. Cox was provided by R01 MH113362, U54MD010722, and U01HG009086. This project was supported by a Vanderbilt Institute for Clinical and Translational Research micro-grant (VR20299) and was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN. The datasets used for this project were obtained from Vanderbilt University Medical Center's Synthetic Derivative, which is supported by numerous sources: institutional funding, private agencies, and federal grants. These include the National Institutes of Health (NIH)-funded Shared Instrumentation Grant S10RR025141; and Clinical and Translational Science Awards grants UL1TR002243, UL1TR000445, and UL1RR024975. The REDCap tool used in this study was supported by grants UL1 TR000445 from NCATS/NIH.	Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castro VM, 2015, AM J PSYCHIAT, V172, P363, DOI 10.1176/appi.ajp.2014.14030423; Chen CY, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0133-7; Cnossen MC, 2017, J NEUROTRAUMA; Denny JC, 2016, ANNU REV GENOM HUM G, V17, P353, DOI 10.1146/annurev-genom-090314-024956; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Faul M, 2010, TRAUMATIC BRAIN INJU; Ford E, 2016, J AM MED INFORM ASSN, V23, P1007, DOI 10.1093/jamia/ocv180; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kirby JC, 2016, J AM MED INFORM ASSN, V23, P1046, DOI 10.1093/jamia/ocv202; Lingren T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159621; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; R Core Team, 2017, R LANG ENV STAT COMP; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smoller JW, 2017, AM J MED GENET B, V174, P117, DOI [10.1002/ajmg.b.32526, 10.1002/ajmg.b.32548]; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Walsh CG, 2017, CLIN PSYCHOL SCI, V5, P457, DOI 10.1177/2167702617691560; Wei WQ, 2016, J AM MED INFORM ASSN, V23, pE20, DOI 10.1093/jamia/ocv130; Wei WQ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0166-y; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	49	3	3	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2167	2177		10.1089/neu.2018.5916		MAR 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000462600100001	30773988	Green Submitted, Green Published			2022-02-06	
J	Murphy, MA; Mun, S; Horstemeyer, MF; Baskes, MI; Bakhtiary, A; LaPlaca, MC; Gwaltney, SR; Williams, LN; Prabhu, RK				Murphy, M. A.; Mun, Sungkwang; Horstemeyer, M. F.; Baskes, M. I.; Bakhtiary, A.; LaPlaca, Michelle C.; Gwaltney, Steven R.; Williams, Lakiesha N.; Prabhu, R. K.			Molecular dynamics simulations showing 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) membrane mechanoporation damage under different strain paths	JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS			English	Article						traumatic brain injury; molecular dynamics; mechanoporation; strain state analysis; phospholipid bilayer deformation	TRAUMATIC BRAIN-INJURY; PORE FORMATION; MECHANICAL CHARACTERIZATION; CONSTITUTIVE MODEL; ELEMENT-ANALYSIS; LIPID-BILAYERS; SIMPLE SHEAR; CALCIUM; RUPTURE; TISSUE	Continuum finite element material models used for traumatic brain injury lack local injury parameters necessitating nanoscale mechanical injury mechanisms be incorporated. One such mechanism is membrane mechanoporation, which can occur during physical insults and can be devastating to cells, depending on the level of disruption. The current study investigates the strain state dependence of phospholipid bilayer mechanoporation and failure. Using molecular dynamics, a simplified membrane, consisting of 72 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) phospholipids, was subjected to equibiaxial, 2:1 non-equibiaxial, 4:1 non-equibiaxial, strip biaxial, and uniaxial tensile deformations at a von Mises strain rate of 5.45 x 10(8) s(-1), resulting in velocities in the range of 1 to 4.6 m center dot s(-1). A water bridge forming through both phospholipid bilayer leaflets was used to determine structural failure. The stress magnitude, failure strain, headgroup clustering, and damage responses were found to be strain state-dependent. The strain state order of detrimentality in descending order was equibiaxial, 2:1 non-equibiaxial, 4:1 non-equibiaxial, strip biaxial, and uniaxial. The phospholipid bilayer failed at von Mises strains of .46, .47, .53, .77, and 1.67 during these respective strain path simulations. Additionally, a Membrane Failure Limit Diagram (MFLD) was created using the pore nucleation, growth, and failure strains to demonstrate safe and unsafe membrane deformation regions. This MFLD allowed representative equations to be derived to predict membrane failure from in-plane strains. These results provide the basis to implement a more accurate mechano-physiological internal state variable continuum model that captures lower length scale damage and will aid in developing higher fidelity injury models.	[Murphy, M. A.; Mun, Sungkwang; Horstemeyer, M. F.; Bakhtiary, A.; Williams, Lakiesha N.; Prabhu, R. K.] Mississippi State Univ, CAVS, Mississippi State, MS 39762 USA; [Murphy, M. A.; Bakhtiary, A.; Williams, Lakiesha N.; Prabhu, R. K.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Horstemeyer, M. F.] Mississippi State Univ, Dept Mech Engn, Mississippi State, MS 39762 USA; [Baskes, M. I.] Mississippi State Univ, Dept Aerosp Engn, Mississippi State, MS 39762 USA; [Baskes, M. I.] Los Alamos Natl Lab, Los Alamos, NM USA; [LaPlaca, Michelle C.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Gwaltney, Steven R.] Mississippi State Univ, Dept Chem, Mississippi State, MS 39762 USA; [Gwaltney, Steven R.] Mississippi State Univ, Ctr Computat Sci, Mississippi State, MS 39762 USA		Prabhu, RK (corresponding author), Mississippi State Univ, CAVS, Mississippi State, MS 39762 USA.; Prabhu, RK (corresponding author), Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA.	rprabhu@abe.msstate.edu	Gwaltney, Steven/W-2783-2019; baskes, mike/P-9956-2019; Prabhu, Raj/M-7188-2017	Gwaltney, Steven/0000-0003-3833-5087; baskes, mike/0000-0001-5584-767X; Bakhtiarydavijani, Amirhamed/0000-0002-1483-5346; Murphy, Michael/0000-0001-9158-1709; Prabhu, Raj/0000-0002-6073-4802; Mun, Sungkwang/0000-0002-3347-2587	Engineer Research and Development Center [W912HZ-13-C-0037]	This work was supported by the Engineer Research and Development Center [grant number W912HZ-13-C-0037].	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Awasthi N, 2016, J CHEM THEORY COMPUT, V12, P3261, DOI 10.1021/acs.jctc.6b00369; Begonia MT, 2014, J BIOMECH, V47, P3704, DOI 10.1016/j.jbiomech.2014.09.026; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Bouvard JL, 2010, ACTA MECH, V213, P71, DOI 10.1007/s00707-010-0349-y; Cheng XP, 2015, SEMIN CELL DEV BIOL, V45, P24, DOI 10.1016/j.semcdb.2015.10.031; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; El Sayed T, 2008, J BIOMECH, V41, P1458, DOI 10.1016/j.jbiomech.2008.02.023; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; GURSON AL, 1977, J ENG MATER-T ASME, V99, P2, DOI 10.1115/1.3443401; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hille B., 2001, IONIC CHANNELS EXCIT, VThird; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Horstemeyer MF, 2010, INT J PLASTICITY, V26, P1310, DOI 10.1016/j.ijplas.2010.06.005; Horstemeyer MF, 2003, MODEL SIMUL MATER SC, V11, P265, DOI 10.1088/0965-0393/11/3/301; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Horstemeyer MF, 2000, INT J DAMAGE MECH, V9, P255, DOI 10.1177/105678950000900304; Horstemeyer MF, 1999, INT J SOLIDS STRUCT, V36, P5029, DOI 10.1016/S0020-7683(98)00239-X; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Keeler S.P., 1963, T ASM, V56, P25; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koshiyama K, 2011, J BIOMECH, V44, P2053, DOI 10.1016/j.jbiomech.2011.05.014; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7; Lindahl E, 2000, BIOPHYS J, V79, P426, DOI 10.1016/S0006-3495(00)76304-1; Marrink SJ, 2009, BBA-BIOMEMBRANES, V1788, P149, DOI 10.1016/j.bbamem.2008.10.006; MATLAB, 2013, MATLAB IM PROC TOOLB; Melcrova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38035; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; Nahum AM, 1977, SAE TECHNICAL PAPER; NARTEN AH, 1971, J CHEM PHYS, V55, P2263, DOI 10.1063/1.1676403; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; NOCSAE, 2013, ND00213M13 NOCSAE DO; Ovalle-Garcia E, 2011, J PHYS CHEM B, V115, P4826, DOI 10.1021/jp111985z; Pedersen UR, 2006, BBA-BIOMEMBRANES, V1758, P573, DOI 10.1016/j.bbamem.2006.03.035; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Rawicz W, 2008, BIOPHYS J, V94, P4725, DOI 10.1529/biophysj.107.121731; Safari M, 2011, MAT SCI APPL, V2, P496, DOI [10.4236/msa.2011.25067, DOI 10.4236/MSA.2011.25067]; Schwenk CF, 2004, PURE APPL CHEM, V76, P37, DOI 10.1351/pac200476010037; Shigematsu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15369; Shigematsu T, 2014, CHEM PHYS LIPIDS, V183, P43, DOI 10.1016/j.chemphyslip.2014.05.005; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Tolpekina TV, 2004, J CHEM PHYS, V121, P8014, DOI 10.1063/1.1796254; Tomasini MD, 2010, EXP BIOL MED, V235, P181, DOI 10.1258/ebm.2009.009187	65	3	3	1	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-1102	1538-0254		J BIOMOL STRUCT DYN	J. Biomol. Struct. Dyn.	MAR 24	2019	37	5					1346	1359		10.1080/07391102.2018.1453376			14	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	HN7XN	WOS:000460406700018	29629830				2022-02-06	
J	Svingos, AM; Asken, BM; Bauer, RM; DeKosky, ST; Hromas, GA; Jaffee, MS; Hayes, RL; Clugston, JR				Svingos, Adrian M.; Asken, Breton M.; Bauer, Russell M.; DeKosky, Steven T.; Hromas, Gabrielle A.; Jaffee, Michael S.; Hayes, Ronald L.; Clugston, James R.			Exploratory study of sport-related concussion effects on peripheral micro-RNA expression	BRAIN INJURY			English	Article						Concussion; biomarker; micro-RNA; miR-153; miR-223; miR-let-7a	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CIRCULATING MICRORNAS; BIOMARKERS; PROGNOSIS; DIAGNOSIS; MIR-223; MILD	Objective: Explore changes in micro-RNA (miRNA) expression in blood after sport-related concussion (SRC) in collegiate athletes. Methods: Twenty-seven collegiate athletes (similar to 41% male, similar to 75% white, age 18.8 +/- 0.8 years) provided both baseline and post-SRC blood samples. Serum was analyzed for expression of miR-153-3p (n = 27), miR-223-3p (n = 23), miR-26a-5p (n = 26), miR-423-3p (n = 23), and miR-let-7a-5p (n = 23) at both time points via quantitative polymerase chain reaction (qPCR). Nonparametric analyses were used to compare miRNA expression changes between baseline and SRC and to evaluate associations with clinical outcomes (symptom severity, cognition, balance, and oculomotor function, and clinical recovery time). Results: Participants manifested a significant increase in miRNA expression following SRC for miR153-3p (Z = -2.180, p = .029, 59% of the participants increased post-SRC), miR223-3p (Z = -1.998, p = .046, 70% increased), and miR-let-7a-5p (Z = -2.190, p = .029, 65% increased). There were no statistically significant associations between changes in miRNA expression and clinical test scores, acute symptom severity, or clinical recovery time. Conclusion: MiR-153-3p, miR-223-3p, and miR-let-7a-5p were significantly upregulated acutely following SRC in male and female collegiate athletes compared to baseline levels, though several athletes demonstrated no change or a decrease in expression. The biological mechanisms and functional implications of the increased expression of these circulating miRNA are unclear and require more research, as does their relevance to clinical outcomes.	[Svingos, Adrian M.; Asken, Breton M.; Bauer, Russell M.; Hromas, Gabrielle A.] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [DeKosky, Steven T.; Jaffee, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Banyan Labs, Alachua, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA		Svingos, AM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	adrianmchambers@phhp.ufl.edu		DeKosky, Steven/0000-0003-3743-2758; Bauer, Russell/0000-0001-6807-2535; Clugston, James/0000-0002-2103-1039; Svingos, Adrian/0000-0001-7271-2136; Asken, Breton/0000-0001-8419-142X	University of FloridaUniversity of Florida	We thank Dr. Laura Ranum, PhD (Director, Centre for NeuroGenetics, University of Florida College of Medicine) and Dr. Lien Nguyen, PhD (Postdoctoral Associate, Centre for NeuroGenetics, University of Florida College of Medicine) for providing an independent technical review of the methodology for this study. We also thank Dr. Shelley Heaton, PhD (Clinical Associate Professor, Department of Clinical and Health Psychology, University of Florida), for her determination that the manuscript is free of biased presentation based on her independent review, in accordance with requirements pertaining to the University of Florida's financial stake in Banyan Biomarkers, Inc.	Bilen J, 2006, CELL CYCLE, V5, P2835, DOI 10.4161/cc.5.24.3579; Chen YJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00057; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grissom R.J., 2012, EFFECT SIZES RES UNI, V2; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Jia LH, 2016, CELL BIOCHEM FUNCT, V34, P233, DOI 10.1002/cbf.3184; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; LI M, 2014, SCI REP-UK, V4, P1, DOI DOI 10.1038/srep06581; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Long JM, 2012, J BIOL CHEM, V287, P31298, DOI 10.1074/jbc.M112.366336; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018	38	3	3	2	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					1	7		10.1080/02699052.2019.1573379			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100001	30704304	Green Accepted			2022-02-06	
J	Rodrigues, AC; Lima, MDM; de Souza, LC; Furtado, C; Marques, CE; Goncalves, L; Lima, MV; Lasmar, RP; Caramelli, P				Rodrigues, Ana Carolina; Martins Lima, Mariana Drummond; de Souza, Leonardo Cruz; Furtado, Celso; Marques, Cimar Eustaquio; Goncalves, Lucas; Lima, Marcus Vinicius; Lasmar, Rodrigo Pace; Caramelli, Paulo			No Evidence of Association Between Soccer Heading and Cognitive Performance in Professional Soccer Players: Cross-Sectional Results	FRONTIERS IN NEUROLOGY			English	Article						soccer; heading; injury; brain; cognitive functioning	NEURON-SPECIFIC ENOLASE; BRAIN-TISSUE DAMAGE; NEUROPSYCHOLOGICAL IMPAIRMENT; SERUM-LEVELS; BIOCHEMICAL MARKERS; FOOTBALL; S-100B; FEMALE; INJURY; CONSEQUENCE	Although the scientific community has focused on the effects of concussions in contact sports, the role of subconcussive impacts, as it can occur during soccer heading, has recently gained attention, considering that it may represent an additional mechanism of cumulative brain injury. The aim of this study is to investigate the effects of soccer heading on cognitive functioning in active professional soccer players. Male soccer players (n = 44), from two soccer teams that play in the Brazilian A Series Championship, and non-athletes (n = 47), comparable in age and education, were submitted to cognitive assessment, consisting of computerized and conventional neuropsychological testing (Neupsilin battery). In the computerized cognitive assessment, soccer players performed better than controls on reaction time measures in general motor coordination, executive functioning and memory tests, and on accuracy measures in executive functioning tests. There were no significant differences between groups on the Neupsilin battery. A comparison between two sub-groups of soccer players, based on the self-reported number of headings, did not show significant differences on tests performance. No significant correlations were found between an estimate of exposure to heading during professional soccer career and cognitive performance. Our data demonstrate no evidence of cognitive impairment in soccer players, compared to non-athletes, and no association between heading exposure and performance on neuropsychological tests. Longitudinal investigations, including neuroimaging assessment, will help to clarify whether soccer heading may be associated with brain injury and cognitive dysfunction.	[Rodrigues, Ana Carolina] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Rodrigues, Ana Carolina; Martins Lima, Mariana Drummond; de Souza, Leonardo Cruz; Caramelli, Paulo] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Grp Pesquisa Neurol Cognit & Comportamento, Belo Horizonte, MG, Brazil; [Furtado, Celso; Marques, Cimar Eustaquio] Amer Futebol Clube, Dept Med, Belo Horizonte, MG, Brazil; [Goncalves, Lucas] Clube Atlet Mineiro, Dept Anal Desempenho, Belo Horizonte, MG, Brazil; [Lima, Marcus Vinicius; Lasmar, Rodrigo Pace] Clube Atlet Mineiro, Dept Med, Belo Horizonte, MG, Brazil; [Lasmar, Rodrigo Pace] Fac Ciencias Med Minas Gerais, Belo Horizonte, MG, Brazil		Caramelli, P (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Grp Pesquisa Neurol Cognit & Comportamento, Belo Horizonte, MG, Brazil.	caramelli@ufmg.br	de Souza, Leonardo C/C-1833-2016; CARAMELLI, PAULO/H-9735-2012	de Souza, Leonardo C/0000-0001-5027-9722; CARAMELLI, PAULO/0000-0002-4786-6990	CNPq, Brazil (bolsa de produtividade em pesquisa)	We greatly thank the soccer players and the technical commissions from America Futebol Clube and Clube Atletico Mineiro, Brazil, and all non-athletes who composed the control group for their essential contribution to this study. PC is supported by CNPq, Brazil (bolsa de produtividade em pesquisa).	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baldivia Beatriz, 2008, Dement. neuropsychol., V2, P173, DOI 10.1590/S1980-57642009DN20300003; Bamac B, 2011, BIOL SPORT, V28, P177, DOI 10.5604/959284; Chaddock L, 2011, MED SCI SPORT EXER, V43, P1920, DOI 10.1249/MSS.0b013e318218ca74; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Fonseca Rochele Paz, 2008, Psychol. Neurosci., V1, P55, DOI 10.1590/S1983-32882008000100009; Fonseca RP, 2009, INSTRUMENTO AVALIACA; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Huang Z, 2010, NEUROSCIENCE, V168, P179, DOI 10.1016/j.neuroscience.2010.03.027; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kemp S, 2016, BRAIN INJURY, V30, P1068, DOI 10.3109/02699052.2016.1148776; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Loprinzi PD, 2015, MAYO CLIN PROC, V90, P450, DOI 10.1016/j.mayocp.2014.12.023; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Mussack T, 2003, EUR J MED RES, V8, P457; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Schneider W., 2002, E PRIME REFERENCE GU; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shen XY, 2018, BIOL PSYCHIAT-COGN N, V3, P878, DOI 10.1016/j.bpsc.2018.06.007; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2008, BIOMARK INSIGHTS, V3, P87; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Tysvaer A, 1981, Br J Sports Med, V15, P163; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zheng DM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-138	54	3	3	5	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 12	2019	10								209	10.3389/fneur.2019.00209			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO7CO	WOS:000461092300001	30915024	gold, Green Published			2022-02-06	
J	Zhang, YC; Wu, F; Iqbal, K; Gong, CX; Hu, W; Liu, F				Zhang, Yanchong; Wu, Feng; Iqbal, Khalid; Gong, Cheng-Xin; Hu, Wen; Liu, Fei			Subacute to chronic Alzheimer-like alterations after controlled cortical impact in human tau transgenic mice	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; ELEVATED PLUS-MAZE; PROTEIN-TAU; HEAD-INJURY; NEUROFIBRILLARY TANGLES; MESSENGER-RNA; COGNITIVE IMPAIRMENT; EXPRESSION PATTERNS; ANIMAL-MODELS; OPEN-FIELD	Repetitive traumatic brain injury (TBI) has been linked to late life development of chronic traumatic encephalopathy (CTE), a neurodegenerative disorder histopathologically characterized by perivascular tangles of hyperphosphorylated tau at the depth of sulci to later widespread neurofibrillary pathology. Although tau hyperphosphorylation and neurofibrillary-like pathology have been observed in the brain of transgenic mice overexpressing human tau with aggregation-prone mutation after TBI, they have not been consistently recapitulated in rodents expressing wild-type tau only. Here, we characterized Alzheimer-like alterations behaviorally, biochemically and immunohistochemically 6 weeks and 7 months after unilateral mild-to-moderate controlled cortical impact (CCI) in 5-7-month-old Tg/htau mice, which express all six isoforms of non-mutated human tau in a mouse tau null background. We detected hyperphosphorylation of tau at multiple sites in ipsilateral hippocampus 6 weeks but not 7 months after CCI. However, neuronal accumulation of AT8 positive phospho-tau was sustained in the chronic phase, in parallel to prolonged astrogliosis, and decreased neural and synaptic markers. The mice with CCI also exhibited cognitive and locomotor impairment. These results indicate subacute to chronic Alzheimer-like alterations after CCI in Tg/htau mice. This is the first known study providing insight into the role of CCI in Alzheimer-like brain alterations in young adult mice expressing only non-mutated human tau.	[Zhang, Yanchong; Wu, Feng; Iqbal, Khalid; Gong, Cheng-Xin; Hu, Wen; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA; [Zhang, Yanchong; Wu, Feng] Nantong Univ, Minist Educ, Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Zhang, Yanchong; Wu, Feng] Nantong Univ, Coinnovat Ctr Neuroregenerat Jiangsu Prov, Nantong, Jiangsu, Peoples R China		Hu, W; Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	hoo208@hotmail.com; feiliu63@hotmail.com		Liu, Fei/0000-0001-8601-4419	New York State Office for People with Developmental Disabilities (OPWDD); Alzheimer's Association, USAAlzheimer's Association [DSAD-15-363172, 2016-NIRG-397030]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31671046, 81773713]	We are grateful to Dr. Peter Davies from The Feinstein Institute for Medical Research, Manhasset, NY, USA for generously providing antibody PHF-1 and late Dr. Dale Schenk from Elan Pharmaceuticals, Allegan, MI, USA, for 12E8 antibody. This work was funded in part by the New York State Office for People with Developmental Disabilities (OPWDD) and by grants from the Alzheimer's Association, USA (DSAD-15-363172 and 2016-NIRG-397030) and from National Natural Science Foundation of China (31671046 and 81773713).	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bird TD, 2008, GENET MED, V10, P231, DOI 10.1097/GIM.0b013e31816b64dc; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BROWNING MD, 1993, BIOL PSYCHIAT, V34, P529, DOI 10.1016/0006-3223(93)90195-J; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chohan MO, 2015, NEUROSURGERY, V76, P201, DOI 10.1227/NEU.0000000000000577; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gong CX, 2018, J ALZHEIMERS DIS, V64, pS107, DOI 10.3233/JAD-179921; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gu JL, 2017, J BIOL CHEM, V292, P10600, DOI 10.1074/jbc.M117.783498; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hiraiwa M, 2003, J NEUROTRAUM, V20, P755, DOI 10.1089/089771503767869980; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu W, 2018, J ALZHEIMERS DIS, V64, P709, DOI 10.3233/JAD-180177; Hu W, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00311; Hu W, 2016, ALZHEIMERS DEMENT, V12, P1066, DOI 10.1016/j.jalz.2016.01.014; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Iqbal K, 2010, BIOCHEM SOC T, V38, P962, DOI 10.1042/BST0380962; Jin NN, 2015, J BIOL CHEM, V290, P15219, DOI 10.1074/jbc.M115.645507; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08187; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Katsinelos T, 2018, CELL REP, V23, P2039, DOI 10.1016/j.celrep.2018.04.056; Khan MM, 2012, STROKE, V43, P1376, DOI 10.1161/STROKEAHA.111.635516; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leroy O, 2006, BBA-MOL BASIS DIS, V1762, P460, DOI 10.1016/j.bbadis.2005.12.003; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Masumura M, 2000, J NEUROTRAUM, V17, P123, DOI 10.1089/neu.2000.17.123; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon B, 2018, BRAIN INJURY, V32, P1285, DOI 10.1080/02699052.2018.1486457; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Niblock M, 2012, BIOCHEM SOC T, V40, P677, DOI 10.1042/BST20120091; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qian W, 2014, NEUROSCI BULL, V30, P367, DOI 10.1007/s12264-013-1411-2; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15709; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiao QL, 2012, J NEUROSCI, V32, P13587, DOI 10.1523/JNEUROSCI.2617-12.2012; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	92	3	3	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 7	2019	9								3789	10.1038/s41598-019-40678-4			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN9GT	WOS:000460508600019	30846870	Green Published, gold			2022-02-06	
J	Kayhanian, S; Young, AMH; Ewen, RL; Piper, RJ; Guilfoyle, MR; Donnelly, J; Fernandes, HM; Garnett, M; Smielewski, P; Czosnyka, M; Agrawal, S; Hutchinson, PJ				Kayhanian, Saeed; Young, Adam M. H.; Ewen, Ross L.; Piper, Rory J.; Guilfoyle, Mathew R.; Donnelly, Joseph; Fernandes, Helen M.; Garnett, Matthew; Smielewski, Peter; Czosnyka, Marek; Agrawal, Shruti; Hutchinson, Peter J.			Thresholds for identifying pathological intracranial pressure in paediatric traumatic brain injury	SCIENTIFIC REPORTS			English	Article							TOMOGRAPHY SCAN; CT; SEGMENTATION; CHILDREN	Intracranial pressure (ICP) monitoring forms an integral part of the management of severe traumatic brain injury (TBI) in children. The prediction of elevated ICP from imaging is important when deciding on whether to implement invasive ICP monitoring for a patient. However, the radiological markers of pathologically elevated ICP have not been specifically validated in paediatric studies. Here in, we describe an objective, non-invasive, quantitative method of stratifying which patients are likely to require invasive monitoring. A retrospective review of patients admitted to Cambridge University Hospital's Paediatric Intensive Care Unit between January 2009 and December 2016 with a TBI requiring invasive neurosurgical monitoring was performed. Radiological biomarkers of TBI (basal cistern volume, ventricular volume, volume of extra-axial haematomas) from CT scans were measured and correlated with epochs of continuous high frequency variables of pressure monitoring around the time of imaging. 38 patients were identified. Basal cistern volume was found to correlate significantly with opening ICP (r = -0.53, p < 0.001). The optimal threshold of basal cistern volume for predicting high ICP(>= 20 mmHg) was a relative volume of 0.0055 (sensitivity 79%, specificity 80%). Ventricular volume and extra-axial haematoma volume did not correlate significantly with opening ICP. Our results show that the features of pathologically elevated ICP in children may differ considerably from those validated in adults. The development of quantitative parameters can help to predict which patients would most benefit from invasive neurosurgical monitoring and we present a novel radiological threshold for this.	[Kayhanian, Saeed; Ewen, Ross L.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Young, Adam M. H.; Piper, Rory J.; Guilfoyle, Mathew R.; Donnelly, Joseph; Fernandes, Helen M.; Garnett, Matthew; Smielewski, Peter; Czosnyka, Marek; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Acad Neurosurg, Cambridge, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Paediat Intens Care, Cambridge, England		Young, AMH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Acad Neurosurg, Cambridge, England.	ay276@cam.ac.uk	Donnelly, Joseph/N-6803-2019; Piper, Rory/AAN-6122-2021	Donnelly, Joseph/0000-0002-6502-8069; Piper, Rory/0000-0002-6422-5853	Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; Woolf Fisher Scholarship. MC-NIHR BRC; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G1002277] Funding Source: UKRI	We gratefully acknowledge financial support as follows. Research support: the Medical Research Council (MRC, Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: Peter J Hutchinson - NIHR Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship, NIHR Global Health Research Group on Neurotrauma, and NIHR Cambridge BRC. Joseph Donnelly is supported by a Woolf Fisher Scholarship. MC-NIHR BRC.	Adelson PD, 1998, ACT NEUR S, V71, P104; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson R. E., 2004, COMPLICATIONS INTRAC; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; El Khamlichi Abdeslam, 2005, Clin Neurosurg, V52, P214; Figaji A. A., TARGETED TREATMENT S, DOI [10.1007/S00381-017-3562-3, DOI 10.1007/S00381-017-3562-3]; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Nguyen HS, 2017, NEURORADIOL J, V30, P10, DOI 10.1177/1971400916678227; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kouvarellis AJ, 2011, CHILD NERV SYST, V27, P1139, DOI 10.1007/s00381-011-1464-3; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mandell JG, 2015, J NEUROSURG-PEDIATR, V15, P113, DOI 10.3171/2014.9.PEDS12426; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; Muschelli J, 2015, NEUROIMAGE, V114, P379, DOI 10.1016/j.neuroimage.2015.03.074; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817	25	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 5	2019	9								3537	10.1038/s41598-019-39848-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7OV	WOS:000460381600110	30837528	Green Published, gold			2022-02-06	
J	Leitner, D; Miller, H; Libben, M				Leitner, Damian; Miller, Harry; Libben, Maya			Comparison of the Buschke Selective Reminding Test and the California Verbal Learning Test - Second Edition in a heterogeneous sample of people with traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Assessment; California Verbal Learning Test; Second Edition; memory; neuropsychology; Selective Reminding Test; tests; traumatic brain injury	NEUROPSYCHOLOGICAL OUTCOMES; CVLT-II; CLINICAL NEUROPSYCHOLOGISTS; PERSISTENT SYMPTOMS; COGNITIVE SEQUELAE; MEMORY ASSESSMENT; UNITED-STATES; TASK-FORCE; DEFICITS; PERFORMANCE	This study examined score and classification differences between the Buschke Selective Reminding Test (SRT) and the California Verbal Learning Test - Second Edition (CVLT-II) in a TBI sample. Seventy-nine participants with traumatic brain injury (TBI) were included and were comprised of 49 mild TBI, 11 moderate TBI, and 14 severe TBI. The majority of participants with mild TBI were involved in litigation. Scores were compared between the CVLT-II and SRT on the total sample and after segregating TBI severity. Correlations between the SRT and CVLT-II were variable (r = .23 to .72). Total List score was lower on the SRT across all levels of TBI severity (p < .006). Learning score was lower on the SRT in mild and severe TBI groups (p < .006). Long delay free recall score was lower on the SRT in mild TBI group only (p < .006). Across TBI severity, lower scores were found on the CVLT-II between severe and mild TBI (p = .04). Scores on the SRT did not differ between TBI severities. The two tests appear to provide different clinical interpretations in a TBI sample. Results may be due to features of the normative data, test procedures, and/or word lists. Clinical implications and limitations are discussed.	[Leitner, Damian; Miller, Harry] Kelowna Gen Hosp, Dept Psychol, 2268 Pandosy St, Kelowna, BC V1Y 1T2, Canada; [Libben, Maya] Univ British Columbia Okanagan, Dept Psychol, Kelowna, BC, Canada		Leitner, D (corresponding author), Kelowna Gen Hosp, Dept Psychol, 2268 Pandosy St, Kelowna, BC V1Y 1T2, Canada.	Canadian_02@hotmail.com					Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Argimon IL, 2014, UNIV PSYCHOL, V13, P253; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Barr W.B., 2014, HDB NEUROPSYCHOLOGY, DOI [10.1007/978-1-4939-0784-7_18, DOI 10.1007/978-1-4939-0784-7_18]; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict, 2001, HOPKINS VERBAL LEARN; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; BUSCHKE H, 1984, J CLIN NEUROPSYCHOL, V6, P433, DOI 10.1080/01688638408401233; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; Faul M, 2010, TRAUMATIC BRAIN INJU; Fidell L.S., 1983, USING MULTIVARIATE S; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Griffen J., 2014, HDB NEUROPSYCHOLOGY, P25; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Grober E, 2010, ALZ DIS ASSOC DIS, V24, P284, DOI 10.1097/WAD.0b013e3181cfc78b; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heaton RK, 1991, COMPREHENSIVE NORMS; Heilbronner RL, 2004, CLIN NEUROPSYCHOL, V18, P312, DOI 10.1080/13854040490501574; Holster J., 2012, ARCH ASSESSMENT PSYC, V2, P44; Hort J, 2010, EUR J NEUROL, V17, P1236, DOI 10.1111/j.1468-1331.2010.03040.x; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lacritz L H, 2001, Appl Neuropsychol, V8, P180, DOI 10.1207/S15324826AN0803_8; Larrabee GJ, 1988, NEUROPSYCHOLOGY, V2, P173, DOI 10.1037//0894-4105.2.3-4.173; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lemos R, 2014, ARCH CLIN NEUROPSYCH, V29, P670, DOI 10.1093/arclin/acu031; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; LORING DW, 1987, J CLIN EXP NEUROPSYC, V9, P340, DOI 10.1080/01688638708405055; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malek-Ahmadi M, 2011, AGING NEUROPSYCHOL C, V18, P280, DOI 10.1080/13825585.2010.540642; McCartney-Filgate M., 1988, ARCH CLIN NEUROPSYCH, V3, P121, DOI [10.1016/0887-6177(88)90057-1, DOI 10.1016/0887-6177(88)90057-1]; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McDowell BD, 2004, ARCH CLIN NEUROPSYCH, V19, P319, DOI 10.1016/S0887-6177(03)00023-4; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Muramatsu T., 2012, SEISHIN SHINKEIGAKU, V115, P1051; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; PAIVIO A, 1971, J EXP PSYCHOL, V89, P40, DOI 10.1037/h0031193; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radomski AD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0318-0; Rey A, 1958, LEXAMEN CLINIQUE PSY; Ross SR, 2006, J CLIN EXP NEUROPSYC, V28, P111, DOI 10.1080/13803390590929270; RUFF RM, 1989, J CLIN EXP NEUROPSYC, V11, P539, DOI 10.1080/01688638908400912; SASS KJ, 1990, NEUROLOGY, V40, P1694, DOI 10.1212/WNL.40.11.1694; Shelton C., 2004, J COGNITIVE REHABILI, V22, P5; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stepanov II, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/312503; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Strober L, 2009, MULT SCLER J, V15, P1077, DOI 10.1177/1352458509106615; Uttl B, 2005, PSYCHOL SCI, V16, P460; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vilkki J, 1998, NEUROPSYCHOLOGY, V12, P268, DOI 10.1037/0894-4105.12.2.268; Wechsler D., 2009, WECHSLER MEMORY SCAL	85	3	3	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2019	26	2					124	138		10.1080/23279095.2017.1362561			15	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HR3RD	WOS:000463056200003	28925733				2022-02-06	
J	Sweeney, JE; Johnson, AM				Sweeney, James Ernest; Johnson, Andrew M.			An index of decline or recovery following nonimpact and impact mTBI	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Diagnosis; etiology; tests; treatment	PREMORBID INTELLIGENCE; HALSTEAD-REITAN; PERFORMANCE; IMPAIRMENT; VALIDITY; SCORES; LEVEL	This study investigated the degree to which litigants/insurance claimants sustaining Nonimpact mild traumatic brain injury (mTBI) in motor vehicle accidents differed from compensation-seeking motor vehicle accident victims that suffered Impact mTBI in terms of neuropsychological decline/recovery, using as a control litigants/insurance claimants that did not experience mTBI in motor vehicle accidents. A clinical index (C-Voc) was employed as the dependent measure for decline/recovery, consisting of T-score algebraic differences between a highly sensitive neurocognitive measure (Category Test) and a relatively insensitive "hold" measure (Wechsler Adult Intelligence Scale Vocabulary subtest). Nonimpact mTBI subjects showed significantly greater neurocognitive decline than Impact mTBI participants and, interestingly, Impact mTBI individuals did not differ significantly from individuals with no diagnosis of mTBI. These findings suggest that Nonimpact subjects may experience significantly greater persistent neurocognitive residua of mTBI than Impact participants.	[Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada		Sweeney, JE (corresponding author), 401-242 Rideau St, Ottawa, ON K1N 0B7, Canada.	jsweeney@neuroinjury.com	Johnson, Andrew M/B-2048-2012	Johnson, Andrew M./0000-0002-7269-3016			ADAMS RL, 1981, J CONSULT CLIN PSYCH, V49, P298, DOI 10.1037/0022-006X.49.2.298; Boone K.B., 2013, CLIN PRACTICE FORENS; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Heaton RK, 1991, COMPREHENSIVE NORMS; Heaton RK, 2009, NEUROPSYCHOLOGICAL A, P127; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Johnstone B, 1997, ARCH CLIN NEUROPSYCH, V12, P591, DOI 10.1016/S0887-6177(97)00002-4; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; MCFIE J, 1975, ASSESSMENT ORGANIC I; Sweeney JE, 2019, APPL NEUROPSYCH-ADUL, V26, P65, DOI 10.1080/23279095.2017.1359783; Sweeney JE, 2017, APPL NEUROPSYCH-ADUL, V24, P446, DOI 10.1080/23279095.2016.1198909; Sweeney JE, 2017, APPL NEUROPSYCH-ADUL, V24, P169, DOI 10.1080/23279095.2015.1119694; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tremont G, 1998, CLIN NEUROPSYCHOL, V12, P560, DOI 10.1076/clin.12.4.560.7238; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wolfson, 1993, HALSTEAD REITAN NEUR; YATES AJ, 1954, PSYCHOL BULL, V51, P359, DOI 10.1037/h0059891	23	3	3	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2019	26	2					181	185		10.1080/23279095.2017.1392304			5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HR3RD	WOS:000463056200008	29161151				2022-02-06	
J	Bartek, J; Laugesen, C; Mirza, S; Forsse, A; Petersen, MA; Corell, A; Dyhrfort, PW; Redebrandt, HN; Reen, L; Zolfaghari, S; Tobieson, L; Carlsvard, B; Bergholt, B; Bashir, A; Soerensen, P; Bilgin, A; Johansson, C; Lindvall, P; Forander, P; Bellander, BM; Springborg, JB; Jakola, AS				Bartek, Jiri, Jr.; Laugesen, Christian; Mirza, Sadia; Forsse, Axel; Petersen, Michael Anders; Corell, Alba; Dyhrfort, Philip Wilhelm; Redebrandt, Henrietta Nittby; Reen, Linus; Zolfaghari, Shaian; Tobieson, Lovisa; Carlsvard, Bjoern; Bergholt, Bo; Bashir, Asma; Soerensen, Preben; Bilgin, Arzu; Johansson, Conny; Lindvall, Peter; Forander, Petter; Bellander, Bo-Michael; Springborg, Jacob B.; Jakola, Asgeir S.			Scandinavian Multicenter Acute Subdural Hematoma (SMASH) Study: Study Protocol for a Multinational Population-Based Consecutive Cohort	NEUROSURGERY			English	Article						Acute subdural hematoma; Outcome; Elderly; Predictors	BRAIN-INJURY; RISK-FACTORS; MORTALITY; AGE; CLASSIFICATION; MORBIDITY; ADULT	BACKGROUND Traumatic acute subdural hematomas (ASDHs) are associated with high rate of morbidity and mortality, especially in elderly individuals. However, recent reports indicate that the morbidity and mortality rates might have improved. OBJECTIVE To evaluate postoperative (30-d) mortality in younger vs elderly (70 yr) patients with ASDH. Comparing younger and elderly patients, the secondary objectives are morbidity patterns of care and 6 mo outcome according to Glasgow outcome scale (GOS). Finally, in patients with traumatic ASDH, we aim to provide prognostic variables. METHODS This is a large-scale population-based Scandinavian study including all neurosurgical departments in Denmark and Sweden. All adult (18 yr) patients surgically treated between 2010 and 2014 for a traumatic ASDH in Denmark and Sweden will be included. Identification at clinicaltrials.gov is NCT03284190. EXPECTED OUTCOMES We expect to provide data on potential differences between younger vs elderly patients in terms of mortality and morbidity. We hypothesize that elderly patients selected for surgery have a similar pattern of care as compared with younger patients. We will provide functional outcome in terms of GOS at 6 mo in younger vs elderly patients undergoing ASDH evacuation. Finally, clinical useful prognostic factors for favorable (GOS 4-5) vs unfavorable (GOS 1-3) will be identified. DISCUSSION An improved understanding of the clinical outcome, treatment and resource allocation, clinical course, and the prognostic factors of traumatic ASDH will allow neurosurgeons to make better treatment decisions.	[Bartek, Jiri, Jr.; Laugesen, Christian; Springborg, Jacob B.] Copenhagen Univ Hosp, Dept Neurosurg, Rigshosp, Copenhagen, Denmark; [Bartek, Jiri, Jr.; Mirza, Sadia; Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Karolinskavagen, Stockholm, Sweden; [Forsse, Axel; Petersen, Michael Anders] Odense Univ Hosp, Dept Neurosurg, Odense, Denmark; [Corell, Alba; Jakola, Asgeir S.] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden; [Dyhrfort, Philip Wilhelm; Forander, Petter] Uppsala Univ Hosp, Dept Neurosurg, Uppsala, Sweden; [Redebrandt, Henrietta Nittby; Reen, Linus; Zolfaghari, Shaian] Lund Univ Hosp, Dept Neurosurg, Lund, Sweden; [Tobieson, Lovisa; Carlsvard, Bjoern] Linkoping Univ Hosp, Dept Neurosurg, Linkoping, Sweden; [Soerensen, Preben; Bilgin, Arzu] Alborg Univ Hosp, Dept Neurosurg, Aalborg, Denmark; [Bergholt, Bo; Bashir, Asma] Arhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark; [Johansson, Conny; Lindvall, Peter] Umea Univ Hosp, Dept Neurosurg, Umea, Sweden; [Jakola, Asgeir S.] Sahlgrens Acad, Inst Neurosci & Physiol, Gothenburg, Sweden		Bartek, J (corresponding author), Karolinska Univ Hosp, Dept Neurosurg, Karolinskavagen, Stockholm, Sweden.	jiri.bartek@sll.se	Laugesen, Christian/AAF-6826-2020; Lindvall, Peter/AAK-1225-2020; Jakola, Asgeir/J-1738-2018	Lindvall, Peter/0000-0002-9552-2957; Zolfaghari, Shaian/0000-0002-4904-7665; Laugesen, Christian/0000-0001-9253-9457; Jakola, Asgeir/0000-0002-2860-9331; Forsse, Axel/0000-0002-0325-0262			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Fuller GF, 2000, AM FAM PHYSICIAN, V61, P2159; Hanif S, 2009, Ir Med J, V102, P255; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P191, DOI 10.1007/BF01808958; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Ibanez FAL, 2011, WORLD NEUROSURG, V75, P709, DOI 10.1016/j.wneu.2010.11.010; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; McGinity MJ, 2017, BRIT J NEUROSURG, P1; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Vyas NA, 2007, SURG NEUROL, V67, P314, DOI 10.1016/j.surneu.2006.03.039; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	24	3	3	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2019	84	3					799	803		10.1093/neuros/nyy173			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HO1AC	WOS:000460636600076	29762769				2022-02-06	
J	Glang, AE; McCart, M; Slocumb, J; Gau, JM; Davies, SC; Gomez, D; Beck, L				Glang, Ann E.; McCart, Melissa; Slocumb, Jody; Gau, Jeff M.; Davies, Susan C.; Gomez, Doug; Beck, Laura			Preliminary Efficacy of Online Traumatic Brain Injury Professional Development for Educators: An Exploratory Randomized Clinical Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; education; randomized controlled trial; schools; staff development; training program; Web-based	BUILDING STATEWIDE INFRASTRUCTURE; EARLY-CHILDHOOD; ATTENTION PROBLEMS; STUDENTS; KNOWLEDGE; CHILDREN; TBI; DISABILITY; SERVICES; BEHAVIOR	Objective: To examine the efficacy of an online traumatic brain injury (TBI) professional development intervention, In the Classroom After Concussion: Best Practices for Student Success. Design: A randomized controlled trial with a sample of 100 general educators, who were randomly assigned to the In the Classroom Web site (treatment group) or the LEARNet Web site (control group). Participants completed the pretest, accessed the In the Classroom or LEARNet site and the posttest and completed follow-up assessments 60 days after posttest. Measures: (1) Knowledge of effective strategies for working with students with TBI; (2) knowledge application; (3) self-efficacy in handling situations presented in text and video scenarios, and (4) a standardized self-efficacy measure. Results: On the posttest assessment, In the Classroom educators showed significantly greater gains in knowledge (P < .0001, d = 1.36 [large effect]), TBI knowledge application (P = .0261, d = 0.46), and general self-efficacy (P = .0106, d = 0.39) than the LEARNet controls. In the Classroom educators maintained significant gains in knowledge (P = .001, d = 0.82) and general self-efficacy (P = .018, d = 0.38) but not in TBI knowledge application (P = .921, d = 0.02). Conclusion: Given the prevalence of TBI, it is important to develop evidence-based, cost-effective approaches to knowledge transfer and exchange in TBI professional development. In the Classroom is one such approach.	[Glang, Ann E.; McCart, Melissa; Slocumb, Jody; Gau, Jeff M.; Davies, Susan C.; Gomez, Doug; Beck, Laura] Univ Oregon, Ctr Brain Injury Res & Training, 1244 Walnut St,Suite 220, Eugene, OR 97403 USA		Glang, AE (corresponding author), Univ Oregon, Ctr Brain Injury Res & Training, 1244 Walnut St,Suite 220, Eugene, OR 97403 USA.	aglang@uoregon.edu	McCart, Melissa/AAN-1506-2020		National Institute on Disability, Independent Living, and Rehabilitation Research grant [90IF0067]	This project was completed with funding from the National Institute on Disability, Independent Living, and Rehabilitation Research grant #90IF0067.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cook DA, 2010, ACAD MED, V85, P909, DOI 10.1097/ACM.0b013e3181d6c319; Davies S., 2013, PHYS DISABILITIES ED, V32, P55; Davies SC., 2014, CONT SCH PSYCHOL, V18, P81, DOI [10.1007/s40688-013-0003-5, DOI 10.1007/S40688-013-0003-5]; De La Paz S., 2004, Journal of Technology and Teacher Education, V12, P561; Dede C, 2009, J TEACH EDUC, V60, P8, DOI 10.1177/0022487108327554; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Dreer LE, 2007, REHABIL PSYCHOL, V52, P351, DOI 10.1037/0090-5550.52.3.351; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ernst WJ, 2016, EXCEPTIONALITY, V24, P123, DOI 10.1080/09362835.2015.1107832; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Faul M, 2010, TRAUMATIC BRAIN INJU; Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699; Fisher JB, 2010, J TEACH EDUC, V61, P302, DOI 10.1177/0022487110369556; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Graff DM, 2016, J CHILD NEUROL, V31, P1569, DOI 10.1177/0883073816666205; Haarbauer-Krupa J., 2012, ASHA LEADER, V17, P10; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Masters J, 2010, J EDUC COMPUT RES, V43, P355, DOI 10.2190/EC.43.3.e; Meyen E. L., 2005, Journal of Special Education Technology, V20, P41; Mitchem K., 2009, TEACH EDUC SPEC EDUC, V32, P297, DOI DOI 10.1177/0888406409343520; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Moon J, 2014, J TEACH EDUC, V65, P172, DOI 10.1177/0022487113511497; Reeves T.D., 2013, J ED RES POLICY STUD, V1, P50; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2018, NEUROREHABILITATION, V42, P269, DOI 10.3233/NRE-172383; Tschannen-Moran M, 2001, TEACH TEACH EDUC, V17, P783, DOI 10.1016/S0742-051X(01)00036-1; U.S. Department of Education Institute of Educational Sciences National Center for Education Statistics, 2016, 2016014 NCES US DEP; U.S. Department of Education Office of Planning Evaluation and Policy Development, 2010, EVALUATION EVIDENCE; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Yoon KS., 2007, REV EVIDENCE TEACHER	51	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		77	86		10.1097/HTR.0000000000000447			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400010	30499929				2022-02-06	
J	Hang, B				Hang, Brian (Tho)			Updates in Concussion Care: New Data, New Guidelines	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						concussion; mild traumatic brain injury; return to learn; return to play protocol; chronic traumatic encephalopathy; second impact syndrome	STATEMENT	There has been increased public awareness, research, and legislation regarding to concussion or mild traumatic brain injury (mTBI) in young athletes. Along with this, there has been an increase in the number of annual emergency department (ED) visits for the evaluation of sports-and non-sportsrelated head injuries. Several medical organizations have published recommendations regarding the management of concussion and subsequent return to activities. The purpose of this article is to: (1) summarize these guidelines and provide up-to-date recommendations regarding concussion treatment, and (2) provide this author's approach to the concussion management in both the ED and sports medicine clinic settings.	[Hang, Brian (Tho)] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Emergency Med, 225 E Chicago Ave,Box 62, Chicago, IL 60611 USA; [Hang, Brian (Tho)] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Sports Med, 225 E Chicago Ave,Box 62, Chicago, IL 60611 USA		Hang, B (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Emergency Med, 225 E Chicago Ave,Box 62, Chicago, IL 60611 USA.; Hang, B (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Sports Med, 225 E Chicago Ave,Box 62, Chicago, IL 60611 USA.	bhang@luriechildrens.org					[Anonymous], BIC HELM LAWS CHILDR; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; National Collegiate Athletic Association, EST PROB COMP PROF A; National Highway Traffic Safety Administration, 2015, 812202 DOT HS NAT HI	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	MAR	2019	20	1					71	80					10	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	IE8AH	WOS:000472595700010					2022-02-06	
J	Herrold, AA; Smith, B; Aaronson, AL; Coleman, J; Pape, TLB				Herrold, Amy A.; Smith, Bridget; Aaronson, Alexandra L.; Coleman, John; Pape, Theresa L-B			Relationships and Evidence-Based Theoretical Perspectives on Persisting Symptoms and Functional Impairment Among Mild Traumatic Brain Injury and Behavioral Health Conditions	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			mild traumatic brain injury; PTSD; post-traumatic stress disorder; Veteran	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; ENDURING FREEDOM; VETERANS; ASSOCIATION; SOLDIERS; POLYMORPHISM; SEVERITY; EXPOSURE; VARIANT	The purpose of this study is to characterize and describe the relationships between symptoms and functional impairment following mild traumatic brain injury (mTBI) and behavioral health conditions (BHCs) in order to inform evidence-based theories on why symptoms and functional impairments persist in some individuals but not others. This is a retrospective, multi-site, cross-sectional study utilizing data collected from a total of 289 Operation Iraqi Freedom/Operation Enduring Freedom Veterans who were classified into diagnostic groups using the symptom attribution and classification algorithm and the VA clinical reminder and comprehensive traumatic brain injury evaluation. The Neurobehavioral Symptom Inventory was used to assess mTBI symptom number and severity. The World Health Organization Disability Assessment Schedule 2.0 was used to assess functional impairment. Symptom profiles differed between diagnostic groups irrespective of symptom attribution method used. Veterans with both mTBI and BHCs and those with BHCs alone had consistently greater number of symptoms and more severe symptoms relative to no symptom and symptoms resolved groups. Symptom number and severity were significantly associated with functional impairment. Both symptom number and functional impairment were significantly associated with the number of mTBI exposures. Together, these results informed evidence-based theories on understanding why symptoms and functional impairment persist among some OEF/OIF Veterans.	[Herrold, Amy A.; Smith, Bridget; Pape, Theresa L-B] Edward Hines Jr VA Hosp, Res Serv, 5000 S 5th Ave,MC 151 H, Hines, IL 60141 USA; [Herrold, Amy A.; Smith, Bridget; Pape, Theresa L-B] Edward Hines Jr VA Hosp, Ctr Innovat & Complex Chron Healthcare, 5000 S 5th Ave,MC 151 H, Hines, IL 60141 USA; [Herrold, Amy A.; Aaronson, Alexandra L.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, 710 N Lakeshore Dr, Chicago, IL 60611 USA; [Smith, Bridget] Northwestern Univ, Feinberg Sch Med, Dept Pediat, 310 E Super St,Morton 4-685, Chicago, IL 60611 USA; [Aaronson, Alexandra L.] Edward Hines Jr VA Hosp, Mental Hlth Serv Line, 5000 S 5th Ave,MC116A, Hines, IL 60141 USA; [Coleman, John] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Pape, Theresa L-B] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 710 N Lakeshore Dr, Chicago, IL 60611 USA		Herrold, AA (corresponding author), Edward Hines Jr VA Hosp, Res Serv, 5000 S 5th Ave,MC 151 H, Hines, IL 60141 USA.; Herrold, AA (corresponding author), Edward Hines Jr VA Hosp, Ctr Innovat & Complex Chron Healthcare, 5000 S 5th Ave,MC 151 H, Hines, IL 60141 USA.; Herrold, AA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, 710 N Lakeshore Dr, Chicago, IL 60611 USA.				U.S. Department of Veterans Affairs (VA), Health Services Research and Development (HSR& D) Service Directed Research (SDR) [SDR-08-377]; Office of the Secretary of Defense for Health Affairs	U.S. Department of Veterans Affairs (VA), Health Services Research and Development (HSR& D) Service Directed Research (SDR) grant SDR-08-377. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Abdallah CG, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.12; Almli LM, 2015, AM J MED GENET B, V168, P327, DOI 10.1002/ajmg.b.32315; Astafiev SV, 2016, NEUROIMAGE-CLIN, V11, P10, DOI 10.1016/j.nicl.2016.01.004; Baldassarre ME, 2013, CLIN NEUROPSYCHOL, V27, P541; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark R, 2013, J PSYCHIATR RES, V47, P1849, DOI 10.1016/j.jpsychires.2013.08.013; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Epidemiology Program P-DHG, 2017, AN VA HLTH CAR UT OP; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Group TMoC-mTBIW, 2016, VA DOD CLIN PRACT GU; Herrold AA, 2015, GRAY MATTER DENSITY; Herrold AA, 2014, NEURAL REGEN RES, V9, P1712, DOI 10.4103/1673-5374.143408; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Linacre J, USERS GUIDE WINSTEPS; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; McGlinchey R. E., 2017, INT J METH PSYCH RES, V26, P1; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Ustun T, 2010, MEASURING HLTH DISAB; Waltzman D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170564; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1	43	3	3	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			138	147		10.1093/milmed/usy306			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100024	30901443	hybrid			2022-02-06	
J	Maynard, C; Nelson, K; Fihn, SD				Maynard, Charles; Nelson, Karin; Fihn, Stephan D.			Characteristics of younger women Veterans with service connected disabilities	HELIYON			English	Article						Public health	GENDER-DIFFERENCES; MENTAL-HEALTH; AFGHANISTAN; DEPRESSION; DIAGNOSES; IRAQ; VA	Objectives: There has been an increase in the number of women Veterans with service connected disabilities, which are illnesses or injuries incurred or aggravated during military service. We compared military service and disability characteristics in women and men <= 50 years of age. Methods: This study included 4,029,672 living Veterans who had at least 1 service connected condition and an active award status as of October 1, 2016. The date of last award as well as demographic, military service, and disability characteristics were obtained from the Veterans Benefits Administration (VBA) VETSNET file. Results: Among 388,947 women Veterans with service connected conditions, almost 60% (n = 231,364) were <= 50 years of age. Roughly 55% of both women and men <= 50 years had a >= 50% combined rating, although there were differences with respect to individual service connected conditions. Women less often had service connected post traumatic stress disorder (23% vs 32%), but more often had major depression (15% vs 7%). While traumatic brain disease was more common in men, migraine headache was much more common in women (32% vs 18%). Less than half had a VA outpatient visit in the previous year. Conclusions: The findings of significant numbers of younger women with service connected PTSD, depression, or migraine headache should be considered within the context of post deployment health. These findings raise questions regarding outreach to women Veterans who have these conditions, but do not use VA health care.	[Maynard, Charles; Nelson, Karin] Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Maynard, Charles; Nelson, Karin; Fihn, Stephan D.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Nelson, Karin; Fihn, Stephan D.] Univ Washington, Dept Med, Seattle, WA USA		Maynard, C (corresponding author), Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA.; Maynard, C (corresponding author), Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.	cmaynard@uw.edu	Fihn, Stephan/ABA-1040-2020; Maynard, Charles/N-3906-2015	Maynard, Charles/0000-0002-1644-7814	Department of Veterans Affairs, Clinical System Development and EvaluationUS Department of Veterans Affairs	This work was supported by the Department of Veterans Affairs, Clinical System Development and Evaluation.	Altalib HH, 2017, CEPHALALGIA, V37, P3, DOI 10.1177/0333102416631959; Carlson KF, 2013, HEADACHE, V53, P1573, DOI 10.1111/head.12216; Curry JF, 2014, J AFFECT DISORDERS, V152, P434, DOI 10.1016/j.jad.2013.10.012; Elbogen EB, 2013, PSYCHIAT SERV, V64, P134, DOI 10.1176/appi.ps.004792011; Frayne S. M., 2018, SOURCEBOOK WOMEN VET, V4, P1; Higgins DM, 2017, WOMEN HEALTH ISS, V27, P463, DOI 10.1016/j.whi.2017.01.008; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; MacLean A, 2010, ARMED FORCES SOC, V36, P765, DOI 10.1177/0095327X09356166; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Maynard C., 2018, PUBL HLTH REP, V133, P141; Maynard C., 1977, J SOCIOL SOCIAL WELF, V4, P494; Maynard C, 2018, MIL MED, V183, pE371, DOI 10.1093/milmed/usy040; Maynard C, 2017, MED CARE, V55, P965, DOI 10.1097/MLR.0000000000000806; Meshberg-Cohen S, 2017, PSYCHIAT SERV, V68, P396, DOI 10.1176/appi.ps.201500533; Murdoch M, 2003, MED CARE, V41, P950, DOI 10.1097/00005650-200308000-00008; National Center for Veterans Analysis and Statistics, PRES FUT WOM VET; Sairsingh H, 2018, MIL MED, V183, pE133, DOI 10.1093/milmed/usx065; Sayer NA, 2014, PSYCHIAT SERV, V65, P663, DOI 10.1176/appi.ps.201300017; Sripada RK, 2018, HEALTH SERV RES, V53, P4565, DOI 10.1111/1475-6773.12859; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; Veterans Benefits Administration, 38 CFR BOOK C SCHED; Veterans Benefits Administration, COMB RAT; Ziobrowski H, 2017, J PSYCHOSOM RES, V101, P110, DOI 10.1016/j.jpsychores.2017.08.011	24	3	3	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	MAR	2019	5	3							e01284	10.1016/j.heliyon.2019.e01284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR3UZ	WOS:000463067400127	30886930	gold, Green Published			2022-02-06	
J	Noh, D; Choi, S; Choi, H; Lee, Y; Lee, K				Noh, Daji; Choi, Sooyoung; Choi, Hojung; Lee, Youngwon; Lee, Kija			Evaluating traumatic brain injury using conventional magnetic resonance imaging and susceptibility-weighted imaging in dogs	JOURNAL OF VETERINARY SCIENCE			English	Article						Dogs; magnetic resonance imaging; susceptibility-weighted imaging; brain injuries; traumatic brain injury	SEVERE HEAD-INJURY; CLINICAL-APPLICATIONS; CEREBRAL MICROBLEEDS; PROGNOSTIC VALUE; MRI	Susceptibility-weighted imaging (SWI) is a magnetic resonance imaging (MRI) sequence used for evaluating traumatic brain injury (TBI). Although SWI is being increasingly used in veterinary medicine, there are no systematic studies regarding its use. We aimed to evaluate TBI lesions by using conventional MRI and SWI in 11 dogs and determine the correlation between clinical status and conventional MRI or SWI findings. The modified Glasgow coma scale (MGCS) at presentation and a previously used MRI grading system (MRGr; grades 1-6) were used to evaluate the brain lesions, and correlations between MGCS score and each MRGr were assessed. Conventional MRI revealed 23 lesions in 11 dogs with variable MGCS scores (range: 11-17). SWI showed comparable findings for all of the lesions except for subdural hemorrhage, and it revealed additional lesions in four dogs. The median MRGr was 2 on both conventional MRI and SWI. The MRGr of the conventional MRI assessments and the MGCS scores showed a significant negative correlation (r = -0.685). In conclusion, SWI had better TBI lesion-detection ability, but conventional MRI had a better correlation with early clinical status and subdural hemorrhage. Thus, a combination of conventional MRI and SWI examinations can improve TBI diagnosis in dogs.	[Noh, Daji; Lee, Kija] Kyungpook Natl Univ, Coll Vet Med, 80 Daehak Ro, Daegu 41566, South Korea; [Choi, Sooyoung] Kangwon Natl Univ, Coll Vet Med, Chunchon 24341, South Korea; [Choi, Hojung; Lee, Youngwon] Chungnam Natl Univ, Coll Vet Med, Daejeon 24341, South Korea		Lee, K (corresponding author), Kyungpook Natl Univ, Coll Vet Med, 80 Daehak Ro, Daegu 41566, South Korea.	leekj@knu.ac.kr		NOH, DAJI/0000-0002-1447-2194; Choi, Sooyoung/0000-0002-7973-4714; Choi, Hojung/0000-0001-7167-0755			Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hoelper BM, 2000, ACTA NEUROCHIR SUPPL, V76, P21; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Pace MC, 2006, MINERVA ANESTESIOL, V72, P235; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Platt S, 2016, IN PRACTICE, V38, P3, DOI 10.1136/inp.i76; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Shams S, 2015, AM J NEURORADIOL, V36, P1089, DOI 10.3174/ajnr.A4248; Shores A., 1983, CURRENT VET THERAPY, P847; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Tamura S, 2006, VET RADIOL ULTRASOUN, V47, P142, DOI 10.1111/j.1740-8261.2006.00120.x; Tao JJ, 2015, NEURAL REGEN RES, V10, P1879, DOI 10.4103/1673-5374.170322; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Verma RK, 2013, EUR J RADIOL, V82, P1539, DOI 10.1016/j.ejrad.2013.03.021	23	3	3	0	0	KOREAN SOC VETERINARY SCIENCE	SEOUL	SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 08826, SOUTH KOREA	1229-845X	1976-555X		J VET SCI	J. Vet. Sci.	MAR	2019	20	2							e10	10.4142/jvs.2019.20.e10			7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	IA0LZ	WOS:000469249400010	30944533	Green Published, gold			2022-02-06	
J	Przekwas, A; Garimella, HT; Tan, XG; Chen, ZJ; Miao, YY; Harrand, V; Kraft, RH; Gupta, RK				Przekwas, Andrzej; Garimella, Harsha T.; Tan, X. Gary; Chen, Z. J.; Miao, Yuyang; Harrand, Vincent; Kraft, Reuben H.; Gupta, Raj K.			Biomechanics of Blast TBI With Time-Resolved Consecutive Primary, Secondary, and Tertiary Loads	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			Blast injury; traumatic brain injury; mathematical model; multiscale modeling; injury biomechanics	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; MECHANISMS; EXPOSURE	Blast-induced traumatic brain injury (bTBI) has become a signature casualty of recent military operations. In spite of significant clinical and preclinical TBI research, current understanding of injury mechanisms and short- and long-term outcomes is limited. Mathematical models of bTBI biomechanics may help in better understanding of injury mechanisms and in the development of improved neuroprotective strategies. Until present, bTBI has been analyzed as a single event of a blast pressure wave propagating through the brain. In many bTBI events, the loads on the body and the head are spatially and temporarily distributed, involving the primary intracranial pressure wave, followed by the head rotation and then by head impact on the ground. In such cases, the brain microstructures may experience time/space distributed (consecutive) damage and recovery events. The paper presents a novel multiscale simulation framework that couples the body/brain scale biomechanics with micro-scale mechanobiology to study the effects of micro-damage to neuro-axonal structures. Our results show that the micro-mechanical responses of neuro-axonal structures occur sequentially in time with damage and relaxation periods in different parts of the brain. A new integrated computational framework is described coupling the brain-scale biomechanics with micro-mechanical damage to axonal and synaptic structures.	[Przekwas, Andrzej; Garimella, Harsha T.; Chen, Z. J.; Miao, Yuyang; Harrand, Vincent] CFD Res Corp, 701 McMillan Way NW, Huntsville, AL 35806 USA; [Tan, X. Gary] US Naval Res Lab, 4555 Overlook Ave, Washington, DC 20375 USA; [Kraft, Reuben H.] Penn State Univ, 320 Leonhard Bldg, University Pk, PA 16801 USA; [Gupta, Raj K.] US Army MRMC, DoD Blast Program, Coordinating Off, 504 Scott St, Ft Detrick, MD 21702 USA		Przekwas, A (corresponding author), CFD Res Corp, 701 McMillan Way NW, Huntsville, AL 35806 USA.				DoD Blast Injury Research Program Coordinating Office, US Army Medical Research and Material Command [W81XWH-14-C 0045]; Office of the Secretary of Defense for Health Affairs	This work has resulted from the project titled "Physics and Physiology Based Human Body Model of Blast Injury and Protection" (Contract #W81XWH-14-C 0045) managed by the DoD Blast Injury Research Program Coordinating Office, US Army Medical Research and Material Command. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Brix KA, 2017, J NEUROTRAUM, V34, pS18, DOI 10.1089/neu.2017.5222; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Carson A, 2017, J NEUROL NEUROSUR PS, V88, P462, DOI 10.1136/jnnp-2016-315510; Dal Cengio Leonardi A., 2011, THESIS; Effgen GB, 2017, J NEUROTRAUM, V34, P914, DOI 10.1089/neu.2016.4477; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190881; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Gupta RK, 2017, DEF LIFE SCI J, V2, P3, DOI DOI 10.14429/dlsj.2.10369; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Iacono D, 2017, PHYS MED REH CLIN N, V28, P301, DOI 10.1016/j.pmr.2016.12.007; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Przekwas AJ, MIL HLTH SYST RES S; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Somayaji MR, 2018, CURR NEUROPHARMACOL, V16, P484, DOI 10.2174/1570159X15666170828165711; Tan X., 2013, ASME 2013 INT MECH E; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Tan XG, 2012, ENHANCED ARTICULATED, P821, DOI [10.1115/IMECE2012-89067, DOI 10.1115/IMECE2012-89067]; Van der Horst MJ, 2002, THESIS; Yap YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176997; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	32	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			195	205		10.1093/milmed/usy344			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100031	30901406	Bronze			2022-02-06	
J	Pushchina, EV; Varaksin, AA; Obukhov, DK				Pushchina, E. V.; Varaksin, A. A.; Obukhov, D. K.			Cystathionine -Synthase in the Brain of the Trout Oncorhynchus mykiss after Unilateral Eye Damage and in Conditions of in vitro Cultivation	RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY			English	Article						hydrogen sulfide; cystathionine -synthase; optic nerve; reparative neurogenesis; radial glia; neurosphere-like complex; primary cell culture	HYDROGEN-SULFIDE; OPTIC-NERVE; REPARATIVE NEUROGENESIS; CELL-PROLIFERATION	Expression of cystathionine -synthase (CBS) in the brain of adult trout under normal conditions and 1 week after an eye injury was assessed using Western blot analysis. The study of CBS distribution in the brain of intact trout and after a mechanical eye injury in the telencephalon, tectum, cerebellum, and brainstem was carried out by the method of immunoperoxidase labeling on free-floating sections. The results of the study showed an increase in CBS expression in different brain divisions after an eye injury. In the visual projection center of the brain (tectum), radial glia cells expressing CBS were revealed after the injury. The emergence of CBS+ heterogeneous radial glia in the trout tectum after eye injury indicates the ability of the reactive neural stem cells (NSC) to synthesize hydrogen sulfide. CBS+ fibers and cells were found in the proliferative zones of cerebellum (valvula) and telencephalon (ventral region). In the intact trout tegmentum, CBS expression was observed in large neurons of the dorsal region and in the proliferative zones. After the eye injury, reactive neurogenic niches appeared in the brainstem, and no CBS-immunopositivity was detected in the periventricular zone. The increased expression of H2S-producing CBS enzyme after a traumatic impact can probably be explained by the neuroprotective functions of hydrogen sulfide, which are implemented in the matrix zones of the brain associated with reparative neurogenesis. A cultivation of trout brain cells showed the formation of neurosphere-like complexes, a part of which exhibited CBS-immunopositivity in the monolayer.	[Pushchina, E. V.; Varaksin, A. A.] Russian Acad Sci, Far East Branch, Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia; [Pushchina, E. V.] Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine; [Obukhov, D. K.] St Petersburg Univ, St Petersburg 199034, Russia		Pushchina, EV (corresponding author), Russian Acad Sci, Far East Branch, Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia.; Pushchina, EV (corresponding author), Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine.	puschina@mail.ru	Pushchina, Evgeniya Vladislavovna/P-9789-2015; Varaksin, Anatoliy/AAN-1585-2021	Pushchina, Evgeniya Vladislavovna/0000-0003-0388-3147; 	Russian FederationRussian Federation [MD-4318.2015.4]; Far East Program for Basic Research for 2015-2017, Far East Branch, Russian Academy of Sciences [15-I-6-116]	The work was financially supported by the president of the Russian Federation (grant no. MD-4318.2015.4) and the Far East Program for Basic Research for 2015-2017, Far East Branch, Russian Academy of Sciences (project no. 15-I-6-116, section III).	BRAUN K, 1985, CELL TISSUE RES, V240, P101, DOI 10.1007/BF00217563; DOE C, 2002, J NEUROBIOL, V36, P111, DOI DOI 10.1002/(SICI)1097-4695(199808)36:2; Hinsch K, 2007, NEUROSCIENCE, V146, P679, DOI 10.1016/j.neuroscience.2007.01.071; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Nagpure BV, 2015, HANDB EXP PHARMACOL, V230, P193, DOI 10.1007/978-3-319-18144-8_10; Ogino T, 2016, J COMP NEUROL, V524, P2982, DOI 10.1002/cne.24001; Palencia G, 2015, J NEUROL SCI, V351, P78, DOI 10.1016/j.jns.2015.02.043; Puschina EV, 2012, NEUROPHYSIOLOGY+, V43, P437, DOI 10.1007/s11062-012-9258-0; Pushchina EV, 2018, RUSS J DEV BIOL+, V49, P264, DOI [10.1134/S047514501805004X, 10.1134/S1062360418050041]; Pushchina EV, 2017, RUSS J DEV BIOL+, V48, P307, DOI 10.1134/S106236041705006X; Pushchina EV, 2016, RUSS J DEV BIOL+, V47, P11, DOI 10.1134/S1062360416010057; Pushchina EV, 2015, RUSS J MAR BIOL+, V41, P499, DOI 10.1134/S1063074015060115; Pushchina E V, 2012, Zh Evol Biokhim Fiziol, V48, P85; Pushchina EV, 2011, NEUROCHEM J+, V5, P24, DOI 10.1134/S1819712411010090; Pushchina E.V., 2015, ADV BIOSCI BIOTECHNO, V6, P539, DOI [10.4236/abb.2015.68057, DOI 10.4236/ABB.2015.68057]; Pushchina E. V., 2017, NEUROCHEMICAL ORG AD; Pushchina E.V., 2015, AM J BIOSCI ADULT RE, V3, P12; Pushchina EV., 2011, NEUROPHYSIOLOGY, V43, P109; Pushchina EV, 2019, NEURAL REGEN RES, V14, P156, DOI 10.4103/1673-5374.243721; Pushchina EV, 2016, NEURAL REGEN RES, V11, P578, DOI 10.4103/1673-5374.180742; Pushchina YV, 2012, RUSS J DEV BIOL+, V43, P35, DOI 10.1134/S1062360412010055; Sodha NR, 2015, METHOD ENZYMOL, V555, P127, DOI 10.1016/bs.mie.2014.11.041; Ugrumov MV, 2010, NEUROCHEM RES, V35, P837, DOI 10.1007/s11064-010-0127-1; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wu DD, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/186908; Zhang XZ, 2014, ACS CHEM NEUROSCI, V5, P876, DOI 10.1021/cn500185g	29	3	3	0	2	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1062-3604	1608-3326		RUSS J DEV BIOL+	Russ. J. Dev. Biol.	MAR	2019	50	2					39	58		10.1134/S1062360419020048			20	Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology	IC6DW	WOS:000471061300002					2022-02-06	
J	Pushchina, EV; Kapustyanov, IA; Varaksin, AA				Pushchina, E. V.; Kapustyanov, I. A.; Varaksin, A. A.			Proliferation and Neuro- and Gliogenesis in Normal and Mechanically Damaged Mesencephalic Tegmentum in Juvenile Chum Salmon, Oncorhynchus keta	RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY			English	Article						mesencephalic tegmentum; chum salmon; traumatic injury; PCNA; HuCD; GFAP; reparative neurogenesis; radial glia; constitutive and reactive neurogenic niche	FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; ADULT NEUROGENESIS; OPTIC TECTUM; RADIAL GLIA; REPARATIVE NEUROGENESIS; ASTROGLIAL ARCHITECTURE; SELF-RENEWAL; BRAIN	Processes of proliferation and constitutive neuro- and gliogenesis in the mesencephalic tegmentum of intact juvenile chum salmon, Oncorhynchus keta, and at 3 days after a traumatic injury were studied by immunohistochemistry (IHC) labeling of PCNA, HuCD, and GFAP. In the chum tegmentum, the proliferative activity was revealed both in separate cells and in small cell clusters of the periventricular zone (PVZ). The presence of constitutive neurogenic zones provides the processes of persistent brain growth. After damage to the tegmentum, proliferation in PVZ is activated, the constitutive neurogenic zones reactivate, reactive neurogenic niches form in the parenchyma, and the proliferative activity is also initiated in the centers of secondary proliferation (basal tegmentum). It was first found that traumatic damage to the tegmentum leads to accelerated differentiation of neurons in the subventricular zone (SVZ) and dorsomedial tegmentum as well as to the appearance of HuCD+ cells with the ependymo- and radioglial phenotype in SVZ, which are absent in intact animals. It was first shown that the local foci of posttraumatic neurogenesis, located in the reticular formation parenchyma, and the zones of posttraumatic gliosis, which contribute to a more efficient process of cell migration to the injury area, are formed as a result of tegmentum damage. The data obtained provide new information on the constitutive biology of neural stem cells and their involvement in brain regeneration.	[Pushchina, E. V.; Varaksin, A. A.] Russian Acad Sci, Far East Branch, Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia; [Pushchina, E. V.] Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine; [Kapustyanov, I. A.] Far Eastern Fed Univ, Vladivostok 690091, Russia		Pushchina, EV (corresponding author), Russian Acad Sci, Far East Branch, Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia.; Pushchina, EV (corresponding author), Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine.	puschina@mail.ru	Varaksin, Anatoliy/AAN-1585-2021; Pushchina, Evgeniya Vladislavovna/P-9789-2015	Pushchina, Evgeniya Vladislavovna/0000-0003-0388-3147	Russian FederationRussian Federation [MD-4318.2015.4]; Far East Program for Basic Research for 2015-2017, Far East Branch, Russian Academy of Sciences [15-I-6-116]	The work was financially supported by the president of the Russian Federation (grant no. MD-4318.2015.4) and the Far East Program for Basic Research for 2015-2017, Far East Branch, Russian Academy of Sciences (project no. 15-I-6-116, section III).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Ahmed S, 2009, CELL ADHES MIGR, V3, P412, DOI 10.4161/cam.3.4.8803; Alunni A, 2005, EUR J HISTOCHEM, V49, P157; Alunni A, 2010, DEV NEUROBIOL, V70, P693, DOI 10.1002/dneu.20799; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Beckervordersandforth R, 2014, STEM CELL REP, V2, P153, DOI 10.1016/j.stemcr.2014.01.004; BODEGA G, 1993, ANAT EMBRYOL, V187, P385; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Butler A.B., 2005, COMP VERTEBRATE NEUR; Candal E, 2005, DEV BRAIN RES, V154, P101, DOI 10.1016/j.devbrainres.2004.10.008; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Dirian L, 2014, DEV CELL, V30, P123, DOI 10.1016/j.devcel.2014.05.012; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Than-Trong E, 2015, GLIA, V63, P1406, DOI 10.1002/glia.22856; Ferretti P, 2011, EUR J NEUROSCI, V34, P951, DOI 10.1111/j.1460-9568.2011.07833.x; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Frojdo EM, 2002, COMP BIOCHEM PHYS A, V133, P17, DOI 10.1016/S1095-6433(02)00110-1; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Kalman M, 1998, ANAT EMBRYOL, V198, P409, DOI 10.1007/s004290050193; Kalman M, 2001, ANAT EMBRYOL, V204, P59, DOI 10.1007/s004290100180; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kawai H, 2001, GLIA, V36, P406, DOI 10.1002/glia.1126; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Margotta Vito, 2002, Italian Journal of Anatomy and Embryology, V107, P185; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Merkulov G. A., 1969, KURS PATOLOGOGISTOLO; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Mueller T, 2002, MECH DEVELOP, V117, P123, DOI 10.1016/S0925-4773(02)00194-6; Nakamura H., 2013, PATTERNING CELL TYPE; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olivera-Pasilio V, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00088; Onteniente B., 1983, J COMP NEUROL, V141, P283; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pushchina EV, 2017, RUSS J DEV BIOL+, V48, P307, DOI 10.1134/S106236041705006X; Pushchina EV, 2016, RUSS J DEV BIOL+, V47, P11, DOI 10.1134/S1062360416010057; Pushchina E. V., 2007, Russian Journal of Developmental Biology, V38, P286, DOI 10.1134/S1062360407050037; Pushchina E. V., 2017, NEUROCHEMICAL ORG AD; Rapacioli M, 2012, DEV DYNAM, V241, P1043, DOI 10.1002/dvdy.23785; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; RUBIO M, 1992, NEUROSCI LETT, V134, P203, DOI 10.1016/0304-3940(92)90517-B; Stukaneva ME, 2017, RUSS J DEV BIOL+, V48, P321, DOI 10.1134/S1062360417050071; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Teles MC, 2012, J COMP PHYSIOL A, V198, P427, DOI 10.1007/s00359-012-0721-6; Wasowicz M, 1999, J NEUROCYTOL, V28, P639, DOI 10.1023/A:1007004714712; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Wullimann MF, 2004, J COMP NEUROL, V475, P143, DOI 10.1002/cne.20183; Xu L, 2015, MOL NEUROBIOL, V51, P131, DOI 10.1007/s12035-014-8692-y; Zupanc GKH, 1999, J EXP BIOL, V202, P1435; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	66	3	3	0	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1062-3604	1608-3326		RUSS J DEV BIOL+	Russ. J. Dev. Biol.	MAR	2019	50	2					59	76		10.1134/S106236041902005X			18	Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology	IC6DW	WOS:000471061300003					2022-02-06	
J	Saunders, RN; Dull, MB; Witte, AB; Regan, JM; Davis, AT; Koehler, TJ; Gibson, CJ; Iskander, GA; Rodriguez, CH; Cohle, SD; Chapman, AJ				Saunders, Rachel N.; Dull, Matthew B.; Witte, Amanda B.; Regan, James M.; Davis, Alan T.; Koehler, Tracy J.; Gibson, Charles J.; Iskander, Gaby A.; Rodriguez, Carlos H.; Cohle, Stephen D.; Chapman, Alistair J.			The danger zone: Injuries and conditions associated with immediately fatal motorcycle crashes in the state of Michigan	AMERICAN JOURNAL OF SURGERY			English	Article						Motorcycle; On-scene fatalities; Injuries; Cause of death; Crash conditions	HELMET LAW; REPEAL; IMPACT	Background: Immediately fatal motorcycle crashes have not been well characterized. This study catalogues injuries sustained in fatal motorcycle crashes and assesses the impact of crash conditions on injury patterns. Methods: Autopsy records from the office of the medical examiner of Kent County, MI and publicly available traffic reports were queried for information pertaining to motorcyclists declared dead on-scene between January 1, 2007, and December 31, 2016. Results: A total of 71 autopsies of on-scene motorcycle crash fatalities were identified. The two most prevalent injuries were traumatic brain injury (TBI) (85%) and rib fractures (79%). The majority of fatalities occurred in daylight hours (54.3%) and in a 55 mph speed limit zone (63.8%). Conclusions: This study provides a catalogue of the injuries sustained in immediately fatal motorcycle crashes and the associated conditions. Advocacy efforts that highlight the risks associated with motorcycle riding and that promote safe riding practices are warranted. (C) 2018 Elsevier Inc. All rights reserved.	[Saunders, Rachel N.] Michigan State Univ, Spectrum Hlth, Gen Surg Residency, 221 Michigan NE,Suite 402, Grand Rapids, MI USA; [Dull, Matthew B.] Michigan State Univ, Spectrum Hlth, Surg Crit Care Fellowship, Grand Rapids, MI USA; [Witte, Amanda B.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Regan, James M.; Davis, Alan T.] Michigan State Univ, Dept Surg, Spectrum Hlth, OME Scholarly Act Support, Grand Rapids, MI USA; [Koehler, Tracy J.] OME Scholarly Act Support, Spectrum Hlth, Grand Rapids, MI USA; [Gibson, Charles J.; Iskander, Gaby A.] Michigan State Univ, Spectrum Hlth Hosp, Acute Care Surg, Grand Rapids, MI USA; [Rodriguez, Carlos H.] Michigan State Univ, Dept Surg, Spectrum Hlth Hosp, Coll Human Med, Grand Rapids, MI USA; [Cohle, Stephen D.] Off Med Examiner Kent Cty, Grand Rapids, MI USA; [Chapman, Alistair J.] Michigan State Univ, Coll Human Med, Spectrum Hlth Hosp, Acute Care Surg, 221 Michigan NE,Suite 402, Grand Rapids, MI 49503 USA		Chapman, AJ (corresponding author), Michigan State Univ, Coll Human Med, Spectrum Hlth Hosp, Acute Care Surg, 221 Michigan NE,Suite 402, Grand Rapids, MI 49503 USA.	Rachel.Saunders@spectrumhealth.org; Alistair.Chapman@spectrumhealth.org		Saunders, Rachel/0000-0001-7560-8895			Ashie A, 2018, TRAFFIC INJ PREV, P1; Bardes JM, 2018, J TRAUMA ACUTE CARE, V84, P893, DOI 10.1097/TA.0000000000001882; Burgess-Wise D, 1973, HIST MOTOR CYCLES; Carter PM, 2017, AM J PUBLIC HEALTH, V107, P166, DOI 10.2105/AJPH.2016.303525; Hothem Z, 2017, AM J SURG, V214, P407, DOI 10.1016/j.amjsurg.2016.09.052; National Center for Statistics and Analysis, 2018, 812492 DOT HS NAT CT; Saunders RN, 2018, AM J SURG, V215, P424, DOI 10.1016/j.amjsurg.2017.09.033; Talving P, 2010, J TRAUMA, V68, P441, DOI [10.1097/TA.0b013e3181cbf303, 10.1097/TA.0b013e3181bb80bf]; Yu WY, 2011, INT J EPIDEMIOL, V40, P794, DOI 10.1093/ije/dyr040; Zhao H, 2012, CHIN J TRAUMATOL, V15, P170, DOI 10.3760/cma.j.issn.1008-1275.2012.03.009	10	3	3	1	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	MAR	2019	217	3					552	555		10.1016/j.amjsurg.2018.10.007			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HL5VL	WOS:000458798900046	30352664				2022-02-06	
J	Schwartzenburg, J; Juncker, M; Reed, R; Desai, S				Schwartzenburg, Joshua; Juncker, Meredith; Reed, Ryan; Desai, Shyamal			Increased ISGylation in Cases of TBI-Exposed ALS Veterans	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Amyotrophic lateral sclerosis; Biomarker; ISG15; ISG15 conjugates; ISGylation; Traumatic brain injury; Veterans	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; STIMULATED GENE 15; HEAD-INJURY; UBIQUITIN; UPDATE	Veterans who have served in the military are at a nearly 60% greater risk of being diagnosed with amyotrophic lateral sclerosis (ALS). Literature reports suggest that a history of traumatic brain injury (TBI) may be a risk factor for ALS in veterans. However, no diagnostic biomarkers are available for identifying ALS risk/development in TBI-exposed veterans. Here, using a Wes assay, we show that ISGylation, a conjugated form of interferon-stimulated gene 15 protein, is significantly elevated in the lumbar spinal cords (SC-Ls) of TBI-ALS compared with ALS veterans without a previous history of TBI (nonTBI-ALS). Although not as striking as in TBI-ALS veterans, ISGylation is also increased in nonTBI-ALS compared with normal veterans. Notably, no changes in ISGylation were seen in occipital lobe samples obtained from the same patients, suggesting that elevated ISGylation is distinct to ALS disease-specific SC-Ls. Moreover, we detected increased ISGylation in cerebral spinal fluid samples of TBI-ALS veterans. Other results using cultured lymphocyte cell lines show a similar trend of increased ISGylation in ALS patients from the general population. Together, these data suggest that ISGylation could serve as a diagnostic biomarker for TBI-ALS veterans, nonTBI-ALS veterans, and nonveterans affected by ALS.	[Schwartzenburg, Joshua; Juncker, Meredith; Reed, Ryan; Desai, Shyamal] LSUHSC Sch Med, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA		Desai, S (corresponding author), LSUHSC Sch Med, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	sdesai@lsuhsc.edu	Sander-Effron, Samuel/AAX-2231-2020; Effron, Sam Sander/AAF-9758-2021	Juncker, Meredith/0000-0001-6136-0366	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS060960] Funding Source: Medline		Burks J, 2014, ONCOGENE, V33, P794, DOI 10.1038/onc.2012.633; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1052935; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Kim CD, 2017, J NEUROPATH EXP NEUR, V76, P578, DOI 10.1093/jnen/nlx038; Koval ED, 2013, HUM MOL GENET, V22, P4127, DOI 10.1093/hmg/ddt261; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; Oskarsson B, 2018, MAYO CLIN PROC, V93, P1617, DOI 10.1016/j.mayocp.2018.04.007; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Rossi JL, 2015, J NEUROTRAUM, V32, P1101, DOI 10.1089/neu.2014.3611; SiddooAtwal C, 1996, CANCER RES, V56, P443; SLOMKA MJ, 1995, J VIROL METHODS, V55, P27, DOI 10.1016/0166-0934(95)00042-S; Walt GS, 2018, J NEUROPATH EXP NEUR, V77, P1091, DOI 10.1093/jnen/nly092; Wang Ren-Gang, 2012, Shengli Xuebao, V64, P577; Wang RG, 2011, GLIA, V59, P946, DOI 10.1002/glia.21167; Watanabe Y, 2017, EUR J EPIDEMIOL, V32, P867, DOI 10.1007/s10654-017-0327-y; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Wood LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016422	22	3	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAR	2019	78	3					209	218		10.1093/jnen/nly129			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	HO0XE	WOS:000460628300002	30657969	Green Published, Bronze			2022-02-06	
J	Smith, A; Gruskin, K; Monuteaux, MC; Stack, AM; Sundberg, M; Yim, R; Seneski, A; Becker, T				Smith, Alla; Gruskin, Karen; Monuteaux, Michael C.; Stack, Anne M.; Sundberg, Melissa; Yim, Ramy; Seneski, Annie; Becker, Theresa			Reducing the Cranial CT Rate for Pediatric Minor Head Trauma at Three Community Hospitals	PEDIATRIC QUALITY & SAFETY			English	Article							CHILDREN; INJURY; RULES; CARE	Objective: Efforts to reduce the rate of computerized cranial tomography (CT) in pediatric patients with minor head trauma (MHT) have focused on academic medical centers. However, community hospitals deliver the majority of pediatric emergency care. We aimed to reduce cranial CT utilization in patients presenting with MHT at 3 community hospital emergency departments (EDs). Methods: Multidisciplinary stakeholder teams at each site oversaw the quality improvement effort, which included education about an evidence-based guideline for MHT and individual provider feedback on CT rates. Given the variation in hospital structure, we tailored the specifics of the intervention to each site. We used statistical process control methodology to measure CT rates over time. The primary balancing measure was returned to the ED within 72 hours with clinically important traumatic brain injury. Results: We included 3,215 pediatric ED visits for MHT: 1,253 in the baseline period and 1,962 in the intervention period. The CT rate dropped from 18% in the baseline period to 13% in the intervention period, a 28% relative reduction. Pediatric providers saw 72% of the intervention period encounters and drove this reduction. There was no increase in the number of children who returned to their local ED within 72 hours with clinically important traumatic brain injury. Conclusions: We safely reduced the proportion of children with MHT who received a cranial CT through a multicenter community ED quality improvement initiative. We did not see an increase in missed clinically important traumatic brain injury.	[Smith, Alla] Boston Childrens Hosp, Dept Med Crit Care, 333 Longwood Ave, Boston, MA 02115 USA; [Gruskin, Karen; Monuteaux, Michael C.; Stack, Anne M.; Sundberg, Melissa; Yim, Ramy; Seneski, Annie; Becker, Theresa] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA		Smith, A (corresponding author), Boston Childrens Hosp, Dept Med Crit Care, 333 Longwood Ave, Boston, MA 02115 USA.	alla.smith@childrens.harvard.edu					Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Athey J, 2001, PEDIATR EMERG CARE, V17, P170, DOI 10.1097/00006565-200106000-00005; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Graves JM, 2014, J AM COLL RADIOL, V11, P717, DOI 10.1016/j.jacr.2013.12.002; Hamilton BE., NATL VITAL STAT REPO; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kaplan HC, 2012, BMJ QUAL SAF, V21, P13, DOI 10.1136/bmjqs-2011-000010; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; National Institute of Nursing Research, 2016, NCI BEST PRACTICES B, P1; National Toxicology Program, 2008, NEMA STAND PUBL, P1; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Puffenbarger MS, 2019, ACAD EMERG MED, V26, P784, DOI 10.1111/acem.13666; Stockman JA., 2011, YB PEDIAT, P392	19	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA		2472-0054		PEDIATR QUAL SAF	Pediatr. Qual. Saf.	MAR-APR	2019	4	2							e147	10.1097/pq9.0000000000000147			7	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	WR0BR	WOS:000714175400008	31321364	Green Published, gold			2022-02-06	
J	Smith, EE; Allen, JJB				Smith, Ezra E.; Allen, John J. B.			Theta-Band Functional Connectivity and Single-Trial Cognitive Control in Sports-Related Concussion: Demonstration of Proof-of-Concept for a Potential Biomarker of Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						EEG; Cognitive function; Head injuries; Biomarkers; Humans; Athletes	TRAUMATIC BRAIN-INJURY; BEHAVIORAL ADAPTATION; ERROR-DETECTION; FRONTAL THETA; DYNAMICS; ANXIETY; LESIONS; MECHANISM; ANTERIOR; HISTORY	Objectives: This report examined theta-band neurodynamics for potential biomarkers of brain health in athletes with concussion. Methods: Participants included college-age contact/collision athletes with (N=24) and without a history of concussion (N=16) in Study 1. Study 2 (N=10) examined changes over time in contact/collision athletes. There were two primary dependent variables: (1) theta-band phase-synchronization (e.g., functional connectivity) between medial and right-lateral electrodes; and (2) the within-subject correlation between synchronization strength on error trials and post-error reaction time (i.e., operationalization of cognitive control). Results: Head injury history was inversely related with medial-lateral connectivity. Head injury was also related to declines in a neurobehavioral measure of cognitive control (i.e., the single-trial relationship between connectivity and post-error slowing). Conclusions: Results align with a theory of connectivity-mediated cognitive control. Mild injuries undetectable by behavioral measures may still be apparent on direct measures of neural functioning. This report demonstrates that connectivity and cognitive control measures may be useful for tracking recovery from concussion. Theoretically relevant neuroscientific findings in healthy adults may have applications in patient populations, especially with regard to monitoring brain health. (JINS 2019, 25, 314-323)	[Smith, Ezra E.; Allen, John J. B.] Univ Arizona, Dept Psychol, 1503 E Univ Blvd, Tucson, AZ 85721 USA		Smith, EE (corresponding author), Univ Arizona, Dept Psychol, 1503 E Univ Blvd, Tucson, AZ 85721 USA.	ezrasmith@email.arizona.edu	Smith, Ezra/W-8776-2019	Smith, Ezra/0000-0001-5163-7827	National Collegiate Athletics Association (NCAA); Graduate and Professional Student Council of the University of Arizona	Many thanks to the athletes who participated in the study; the project would not have been possible without them. Also, special thanks to the Dianne Goodridge, ATC, for her support of the project and her support of student-athletes. Finally, several research assistants were crucial to the completion of this project, especially Margaret Tobias, Jamie Velo, and Kenia Carrera. This work was funded by the National Collegiate Athletics Association (NCAA) and the Graduate and Professional Student Council of the University of Arizona. None of the authors have potential conflicts of interest to be disclosed.	Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Bailey NW, 2017, BRAIN INJURY, V31, P379, DOI 10.1080/02699052.2016.1239273; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Buzsaki Gyorgy, 2006, RHYTHMS BRAIN; Buzzell G.A., 2018, ADOLESCENT COGNITIVE, DOI [10.1101/366831, DOI 10.1101/366831]; Cavanagh JF, 2017, BIOL PSYCHIAT-COGN N, V2, P413, DOI 10.1016/j.bpsc.2017.01.004; Cavanagh JF, 2015, J PHYSIOL-PARIS, V109, P3, DOI 10.1016/j.jphysparis.2014.04.003; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen J., 1983, APPL MULTIPLE REGRES; Cohen MX, 2013, CEREB CORTEX, V23, P1061, DOI 10.1093/cercor/bhs069; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Cohen MX, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00002; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; COOK EW, 1992, PSYCHOPHYSIOLOGY, V29, P350, DOI 10.1111/j.1469-8986.1992.tb01709.x; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hill KE, 2016, PSYCHOPHYSIOLOGY, V53, P1143, DOI 10.1111/psyp.12671; Hogan AM, 2006, BRAIN, V129, P2177, DOI 10.1093/brain/awl160; Iverson G.L., 2016, J ATTEN DISORD, V1, P1; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Olvet DM, 2010, PSYCHIAT RES, V179, P30, DOI 10.1016/j.psychres.2010.06.008; Olvet DM, 2009, BRAIN RES, V1284, P89, DOI 10.1016/j.brainres.2009.05.079; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; PERRIN F, 1990, ELECTROEN CLIN NEURO, V76, P565; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Reches A, 2017, BRAIN INJURY, V31, P237, DOI 10.1080/02699052.2016.1231343; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smith EE, 2017, INT J PSYCHOPHYSIOL, V111, P98, DOI 10.1016/j.ijpsycho.2016.11.005; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; van de Vijver I, 2011, J COGNITIVE NEUROSCI, V23, P4106, DOI 10.1162/jocn_a_00110; Wessel JR, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13041; Wessel JR, 2016, NEUROBIOL AGING, V38, P205, DOI 10.1016/j.neurobiolaging.2015.10.014; Wessel JR, 2014, CORTEX, V50, P45, DOI 10.1016/j.cortex.2013.09.002; Zambrano-Vazquez L, 2014, NEUROPSYCHOLOGIA, V61, P197, DOI 10.1016/j.neuropsychologia.2014.06.023; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472	68	3	3	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2019	25	3					314	323		10.1017/S135561771800108X			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	HO8ML	WOS:000461206600008	30681045	Green Accepted			2022-02-06	
J	Versek, C; Rissmiller, A; Tran, A; Taya, M; Chowdhury, K; Bex, P; Sridhar, S				Versek, Craig; Rissmiller, Armen; Tran, Anthony; Taya, Munish; Chowdhury, Kaushik; Bex, Peter; Sridhar, Srinivas			Portable System for Neuro-Optical Diagnostics Using Virtual Reality Display	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			neurology; ophthalmology; EEG; vision diagnostics; portable system; TBI; glaucoma; amblyopia; VEP	TRAUMATIC BRAIN-INJURY; VISUAL DYSFUNCTION; VISION	A new product prototype system for diagnosing vision and neurological disorders, called NeuroDotVR, is described herein: this system utilizes a novel wireless NeuroDot brain sensor [Versek C et al. J Neural Eng. 2018 Aug; 15(4):046027] that quantitatively measures visual evoked potentials and fields resulting from custom visual stimuli displayed on a smartphone housed in a virtual reality headset. The NeuroDot brain sensor is unique in that it can be operated both in regular electroencephalography mode, as well as a new electric field encephalography mode, which yields improvements in signal sensitivity and provides new diagnostic information. Steady state and transient visual evoked potentials and fields using reversing checkerboard stimuli are presented with case studies in amblyopia, glaucoma, and dark adaptation. These preliminary data sets highlight potential clinical applications that may be pursued in further product development and scientific studies.	[Versek, Craig; Sridhar, Srinivas] NeuroFieldz Inc, 41 Esty Farm Rd, Newton, MA 02459 USA; [Rissmiller, Armen; Tran, Anthony; Taya, Munish; Chowdhury, Kaushik; Bex, Peter; Sridhar, Srinivas] Northeastern Univ, Dept Phys, 110 Forsyth St,111 Dana Res Ctr, Boston, MA 02115 USA		Versek, C (corresponding author), NeuroFieldz Inc, 41 Esty Farm Rd, Newton, MA 02459 USA.			Chowdhury, Kaushik/0000-0002-3570-2622	United States National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R41AG057250-01]; Office of the Secretary of Defense for Health Affairs; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R41AG057250] Funding Source: NIH RePORTER	This work was supported in part by the United States National Institutes of Health grant 1R41AG057250-01. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Bevington P.R., 2003, DATA REDUCTION ERROR; Bossi M, 2017, INVEST OPHTH VIS SCI, V58, P3031, DOI 10.1167/iovs.16-20913; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Google VR, DISCOVER PLATFORMS D; Husing B, 2006, IMPACT ASSESSMENT NE; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Petrov Y, 2014, NEUROIMAGE, V90, P140, DOI 10.1016/j.neuroimage.2013.12.041; Petrov Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067692; Robinson AK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16377-3; Sridhar S, 2017, PCT/US2017/059803, Patent No. 2017059803; Sridhar S, 2012, PCT/US2016/0081577, Patent No. 20160081577; Sridhar S, 2014, PCT/US2016/0120432, Patent No. 20160120432; To L, 2011, IEEE T NEUR SYS REH, V19, P280, DOI 10.1109/TNSRE.2011.2115255; Tobimatsu S, 2006, CLIN NEUROPHYSIOL, V117, P1414, DOI 10.1016/j.clinph.2006.01.004; Versek C, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aac3f9; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005	18	3	5	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			584	592		10.1093/milmed/usy286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100084	30901414	Green Published			2022-02-06	
J	Wong, AWK; Chen, C; Baum, MC; Heaton, RK; Goodman, B; Heinemann, AW				Wong, Alex W. K.; Chen, Cynthia; Baum, M. Carolyn; Heaton, Robert K.; Goodman, Berrit; Heinemann, Allen W.			Cognitive, Emotional, and Physical Functioning as Predictors of Paid Employment in People With Stroke, Traumatic Brain Injury, and Spinal Cord Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							FUNCTION PERFORMANCE-TEST; CLINICAL UTILITY; EXECUTIVE FUNCTION; MENTAL-ILLNESS; NIH TOOLBOX; WORK; OUTCOMES; RETURN; INDIVIDUALS; VALIDITY	OBJECTIVE. Our objective was to examine demographic. cognitive. emotional. and physical factors that predict return to paid employment for people after neurological injury. METHOD. Four hundred eighty adults with stroke (n = 149), traumatic brain injury (n = 155), and spinal cord injury (n = 176) completed an occupational outcome questionnaire and physical. emotional. and cognitive assessments at three rehabilitation facilities. RESULTS. Odds of employment were predicted by being married or partnered, having more education, requiring fewer prompts for task sequencing, and having higher inhibitory control (but were not predicted by specific type of injury). Participants who returned to work within 3 mo were more likely to work with the same employer and to take a full-time position than those who returned later. CONCLUSION. Executive functioning, in particular sequencing and inhibitory control, strongly predicts employment and highlights the importance of cognitive strategy training during occupational therapy with people who have sustained neurological injuries.	[Wong, Alex W. K.; Baum, M. Carolyn] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO 63130 USA; [Wong, Alex W. K.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Chen, Cynthia] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Goodman, Berrit] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA		Wong, AWK (corresponding author), Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO 63130 USA.; Wong, AWK (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wongal@wustl.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685	National Institute on Disability, Independent Living, and Rehabilitation Research Grant [H133B090024]; Eunice Kennedy Shriver National of Child Health and Human Development National Center for Medical Rehabilitation Research Grant [K12HD055931]; Craig H. Neilsen Foundation [290474, 542448]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931] Funding Source: NIH RePORTER	This study was supported by National Institute on Disability, Independent Living, and Rehabilitation Research Grant H133B090024 to the Shirley Ryan AbilityLab (Chicago). Alex W. K. Wong was supported in part by the Eunice Kennedy Shriver National of Child Health and Human Development National Center for Medical Rehabilitation Research Grant K12HD055931 and by Craig H. Neilsen Foundation Grants 290474 and 542448. The contents of this article do not necessarily represent the policy of the funding agencies. We acknowledge Megen Devine at Washington University School of Medicine for editorial assistance.	BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Baum CM, 2017, NEUROPSYCHOL REHABIL, V27, P603, DOI 10.1080/09602011.2016.1176934; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Busch MA, 2009, J NEUROL NEUROSUR PS, V80, P888, DOI 10.1136/jnnp.2008.163295; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Desiron HAM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-615; Enderby P, 1996, DISABIL REHABIL, V18, P238, DOI 10.3109/09638289609166307; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fraser L, 2009, WORK, V33, P261, DOI 10.3233/WOR-2009-0874; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Hackett ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041795; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Johansson BB, 2011, ACTA NEUROL SCAND, V123, P147, DOI 10.1111/j.1600-0404.2010.01417.x; Khazaeipour Z, 2014, J SPINAL CORD MED, V37, P338, DOI 10.1179/2045772313Y.0000000174; Kirsh B, 2009, WORK, V32, P391, DOI 10.3233/WOR-2009-0851; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koenig J, 2011, ASSESSING 21 CENTURY; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kutner M.H., 2004, APPL LINEAR REGRESSI, V4th; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Magasi S, 2018, ARCH PHYS MED REHAB, V99, P1, DOI 10.1016/j.apmr.2017.06.030; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; National Spinal Cord Injury Statistical Center, 2016, SPIN CORD INJ SCI FA; O'Brien AN, 2010, WORK, V36, P441, DOI 10.3233/WOR-2010-1047; O'Neill K, 2010, WORK, V36, P423, DOI 10.3233/WOR-2010-1046; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; TEASDALE G, 1974, LANCET, V2, P81; Teodorescu M., 2017, EUROPEAN J PUBLIC HL, V27, DOI 10.1093/eurpub/ckx186.214; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P409, DOI 10.1037/rep0000201; U. S. Equal Employment Opportunity Commission, 2005, ADA YOUR EMPL RIGHTS; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang YC, 2014, WORK, V47, P553, DOI 10.3233/WOR-131627; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wolf TJ, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.017293	47	3	3	0	6	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	MAR-APR	2019	73	2							7302205010	10.5014/ajot.2019.031203			15	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HW1UV	WOS:000466469000002	30915962	Green Published			2022-02-06	
